Psyllid ID: psy12709
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 253 | 2.2.26 [Sep-21-2011] | |||||||
| Q9GM70 | 397 | Serine/threonine-protein | yes | N/A | 0.924 | 0.589 | 0.556 | 7e-73 | |
| Q9UEE5 | 414 | Serine/threonine-protein | yes | N/A | 0.924 | 0.565 | 0.539 | 1e-70 | |
| Q0KHT7 | 784 | Probable serine/threonine | no | N/A | 0.924 | 0.298 | 0.540 | 2e-70 | |
| Q91XS8 | 371 | Serine/threonine-protein | yes | N/A | 0.920 | 0.628 | 0.512 | 2e-66 | |
| O94768 | 372 | Serine/threonine-protein | no | N/A | 0.920 | 0.626 | 0.508 | 4e-66 | |
| Q8BG48 | 372 | Serine/threonine-protein | yes | N/A | 0.924 | 0.629 | 0.502 | 5e-65 | |
| O43293 | 454 | Death-associated protein | no | N/A | 0.913 | 0.508 | 0.454 | 2e-54 | |
| O54784 | 448 | Death-associated protein | no | N/A | 0.913 | 0.515 | 0.445 | 6e-54 | |
| O88764 | 448 | Death-associated protein | no | N/A | 0.913 | 0.515 | 0.445 | 6e-54 | |
| Q9UIK4 | 370 | Death-associated protein | no | N/A | 0.905 | 0.618 | 0.441 | 6e-54 |
| >sp|Q9GM70|ST17A_RABIT Serine/threonine-protein kinase 17A OS=Oryctolagus cuniculus GN=STK17A PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 273 bits (699), Expect = 7e-73, Method: Compositional matrix adjust.
Identities = 133/239 (55%), Positives = 174/239 (72%), Gaps = 5/239 (2%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
RGKFA VRKC K + E+AAKF+RKRR+ D +I+HE AVL LAQ + ++ LHE+
Sbjct: 51 GRGKFAVVRKCIQKDSGKEFAAKFMRKRRKGQDCRMEIIHEIAVLELAQDNPWVINLHEV 110
Query: 80 YETPHEMVLVLEMVPDGEL--QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
YET EM+LVLE GE+ Q + D + E+D + M+QILE + FLH H++ HLDL
Sbjct: 111 YETSSEMILVLEYAAGGEISDQCVADRDEAFNEKDVQRLMRQILEGVHFLHTHDVVHLDL 170
Query: 138 KPQNILLTKDN---NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMW 194
KPQNILLT ++ +IK+ DFG+SR+V + E++EI+GTP+YVAPE+LSY+PIS+ATDMW
Sbjct: 171 KPQNILLTSESPLGDIKIVDFGLSRIVKNSEELREIMGTPEYVAPEILSYDPISMATDMW 230
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
S+GVL YV+L+ SPF GDNKQETFLNISQ N S+ E+ F +S A DFI+ LV P
Sbjct: 231 SIGVLTYVMLTGISPFLGDNKQETFLNISQMNLSYSEEEFDTVSESAVDFIKKLLVKKP 289
|
Acts as a positive regulator of apoptosis. May also act as a regulator of cellular reactive oxygen species. Oryctolagus cuniculus (taxid: 9986) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9UEE5|ST17A_HUMAN Serine/threonine-protein kinase 17A OS=Homo sapiens GN=STK17A PE=1 SV=2 | Back alignment and function description |
|---|
Score = 266 bits (680), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 129/239 (53%), Positives = 175/239 (73%), Gaps = 5/239 (2%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
RGKFA VRKC K + E+AAKF+RKRR+ D +I+HE AVL LAQ + ++ LHE+
Sbjct: 68 GRGKFAVVRKCIKKDSGKEFAAKFMRKRRKGQDCRMEIIHEIAVLELAQDNPWVINLHEV 127
Query: 80 YETPHEMVLVLEMVPDGEL--QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
YET EM+LVLE GE+ Q + D ++ E+D + M+QILE + FLH ++ HLDL
Sbjct: 128 YETASEMILVLEYAAGGEIFDQCVADREEAFKEKDVQRLMRQILEGVHFLHTRDVVHLDL 187
Query: 138 KPQNILLTKDN---NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMW 194
KPQNILLT ++ +IK+ DFG+SR++ + E++EI+GTP+YVAPE+LSY+PIS+ATDMW
Sbjct: 188 KPQNILLTSESPLGDIKIVDFGLSRILKNSEELREIMGTPEYVAPEILSYDPISMATDMW 247
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
S+GVL YV+L+ SPF G++KQETFLNISQ N S+ E+ F +S A DFI++ LV P
Sbjct: 248 SIGVLTYVMLTGISPFLGNDKQETFLNISQMNLSYSEEEFDVLSESAVDFIRTLLVKKP 306
|
Acts as a positive regulator of apoptosis. Also acts as a regulator of cellular reactive oxygen species. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0KHT7|Y2666_DROME Probable serine/threonine-protein kinase CG32666 OS=Drosophila melanogaster GN=CG32666 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 265 bits (678), Expect = 2e-70, Method: Compositional matrix adjust.
Identities = 128/237 (54%), Positives = 170/237 (71%), Gaps = 3/237 (1%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+RGKFA+VR+ HK T +AAKF+++RRR+ ++I HE AVL L + + IV L+ +
Sbjct: 44 ARGKFAAVRRAIHKNTGSHFAAKFLKRRRRAQSSDKEIKHEIAVLMLCEGEDNIVNLNAV 103
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
+ET + L+LE+ GELQ ++D ++ + E R M+++L+AL FLHD +I HLDLKP
Sbjct: 104 HETRSDTALLLELATGGELQTILDNEECLTEAQARHCMREVLKALKFLHDRSIAHLDLKP 163
Query: 140 QNILLTKD---NNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSV 196
QNILL + + +KLCDFGISRVV + + V+E+ GTPDYVAPEVL YEP+SL TD+WSV
Sbjct: 164 QNILLAGERIEDGLKLCDFGISRVVCEGINVREMAGTPDYVAPEVLQYEPLSLLTDIWSV 223
Query: 197 GVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
GVL YVLLS SPF GD KQETFLNISQC +F ++LFG +S A DFI+ L P
Sbjct: 224 GVLTYVLLSGFSPFGGDTKQETFLNISQCALTFPDNLFGGVSPVAIDFIRRALRIKP 280
|
Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q91XS8|ST17B_RAT Serine/threonine-protein kinase 17B OS=Rattus norvegicus GN=Stk17b PE=1 SV=1 | Back alignment and function description |
|---|
Score = 252 bits (643), Expect = 2e-66, Method: Compositional matrix adjust.
Identities = 122/238 (51%), Positives = 170/238 (71%), Gaps = 5/238 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RGKFA VR+C K T EYAAKF++KRRR D +ILHE AVL LA+ ++ LHE+Y
Sbjct: 41 RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELARSCPHVINLHEVY 100
Query: 81 ETPHEMVLVLEMVPDGELQRLV--DIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
ET E++LVLE GE+ L ++ + + E D +KQILE + +LH +NI HLDLK
Sbjct: 101 ETATEIILVLEYAAGGEIFNLCLPELAEMVSENDVIRLIKQILEGVHYLHQNNIVHLDLK 160
Query: 139 PQNILLTKD---NNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
PQNILL+ +IK+ DFG+SR + + E++EI+GTP+Y+APE+L+Y+PI+ ATDMW+
Sbjct: 161 PQNILLSSIYPLGDIKIVDFGMSRKIGNASELREIMGTPEYLAPEILNYDPITTATDMWN 220
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+G++AY+LL+ SPF G++ QET+LNISQ N + E++F +S A DFIQS LV +P
Sbjct: 221 IGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEEMFSSVSQLATDFIQSLLVKNP 278
|
Acts as a positive regulator of apoptosis. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O94768|ST17B_HUMAN Serine/threonine-protein kinase 17B OS=Homo sapiens GN=STK17B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (641), Expect = 4e-66, Method: Compositional matrix adjust.
Identities = 121/238 (50%), Positives = 168/238 (70%), Gaps = 5/238 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RGKFA VR+C K T EYAAKF++KRRR D +ILHE AVL LA+ R++ LHE+Y
Sbjct: 41 RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 100
Query: 81 ETPHEMVLVLEMVPDGELQRLV--DIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
E E++L+LE GE+ L ++ + + E D +KQILE + +LH +NI HLDLK
Sbjct: 101 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLK 160
Query: 139 PQNILLTKD---NNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
PQNILL+ +IK+ DFG+SR + E++EI+GTP+Y+APE+L+Y+PI+ ATDMW+
Sbjct: 161 PQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWN 220
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+G++AY+LL+ SPF G++ QET+LNISQ N + E+ F +S A DFIQS LV +P
Sbjct: 221 IGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNP 278
|
Acts as a positive regulator of apoptosis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8BG48|ST17B_MOUSE Serine/threonine-protein kinase 17B OS=Mus musculus GN=Stk17b PE=2 SV=1 | Back alignment and function description |
|---|
Score = 247 bits (631), Expect = 5e-65, Method: Compositional matrix adjust.
Identities = 120/239 (50%), Positives = 168/239 (70%), Gaps = 5/239 (2%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
RGKFA VR+C K T EYAAK ++KRRR D +ILHE AVL LA+ ++ LHE+
Sbjct: 40 GRGKFAVVRQCISKSTGQEYAAKSLKKRRRGQDCRAEILHEIAVLELARSCPHVINLHEV 99
Query: 80 YETPHEMVLVLEMVPDGELQRLV--DIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
YE E++LVLE GE+ L ++ + + E D +KQILE + +LH +NI HLDL
Sbjct: 100 YENATEIILVLEYAAGGEIFNLCLPELAEMVSENDVIRLIKQILEGVHYLHQNNIVHLDL 159
Query: 138 KPQNILLTKD---NNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMW 194
KPQNILL+ +IK+ DFG+SR + + E++EI+GTP+Y+APE+L+Y+PI+ ATDMW
Sbjct: 160 KPQNILLSSIYPLGDIKIVDFGMSRKIGNASELREIMGTPEYLAPEILNYDPITTATDMW 219
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
++G++AY+LL+ SPF G++ QET+LNISQ N + E++F +S A DFIQS LV +P
Sbjct: 220 NIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEEMFSSVSQLATDFIQSLLVKNP 278
|
Acts as a positive regulator of apoptosis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O43293|DAPK3_HUMAN Death-associated protein kinase 3 OS=Homo sapiens GN=DAPK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 212 bits (540), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 109/240 (45%), Positives = 151/240 (62%), Gaps = 9/240 (3%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQM----QDILHEAAVLYLAQKSERIVGLH 77
G+FA VRKC K T EYAAKFI+KRR S + ++I E +L + I+ LH
Sbjct: 22 GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN-IITLH 80
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+I+E ++VL+LE+V GEL + ++ + E + ++KQIL+ + +LH I H DL
Sbjct: 81 DIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDL 140
Query: 138 KPQNILLTKDN----NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDM 193
KP+NI+L N IKL DFGI+ + E K I GTP++VAPE+++YEP+ L DM
Sbjct: 141 KPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADM 200
Query: 194 WSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
WS+GV+ Y+LLS SPF G+ KQET NIS N+ F E+ F + S AKDFI+ LV DP
Sbjct: 201 WSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDP 260
|
Isoform 2 can phosphorylate myosin, PPP1R12A and MYL12B. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O54784|DAPK3_MOUSE Death-associated protein kinase 3 OS=Mus musculus GN=Dapk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (536), Expect = 6e-54, Method: Compositional matrix adjust.
Identities = 107/240 (44%), Positives = 151/240 (62%), Gaps = 9/240 (3%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRR----RSMDQMQDILHEAAVLYLAQKSERIVGLH 77
G+FA VRKC K T +EYAAKFI+KRR R ++I E ++L + I+ LH
Sbjct: 22 GQFAIVRKCQQKGTGMEYAAKFIKKRRLPSSRRGVSREEIEREVSILREIRHPN-IITLH 80
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+++E ++VL+LE+V GEL + ++ + E + ++KQIL+ + +LH I H DL
Sbjct: 81 DVFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDL 140
Query: 138 KPQNILLTKDN----NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDM 193
KP+NI+L + IKL DFGI+ + E K I GTP++VAPE+++YEP+ L DM
Sbjct: 141 KPENIMLLDKHAASPRIKLIDFGIAHRIEAGSEFKNIFGTPEFVAPEIVNYEPLGLEADM 200
Query: 194 WSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
WS+GV+ Y+LLS SPF G+ KQET NIS N+ F E+ F S AKDFI+ LV DP
Sbjct: 201 WSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSSTSELAKDFIRRLLVKDP 260
|
Serine/threonine kinase which is involved in the regulation of apoptosis, autophagy, transcription, actin cytoskeleton reorganization, cell motility, smooth muscle contraction, and mitosis, particularly cytokinesis. Regulates both type I apoptotic and type II autophagic cell deaths signal, depending on the cellular setting. The former is caspase-dependent, while the latter is caspase-independent and is characterized by the accumulation of autophagic vesicles. Regulates myosin phosphorylation in both smooth muscle and non-muscle cells. In smooth muscle, regulates myosin either directly by phosphorylating MYL12B and MYL9 or through inhibition of smooth muscle myosin phosphatase (SMPP1M) via phosphorylation of PPP1R12A, and the inhibition of SMPP1M functions to enhance muscle responsiveness to Ca(2+) and promote a contractile state. Enhances transcription from AR-responsive promoters in a hormone- and kinase-dependent manner. Phosphorylates STAT3 and enhances its transcriptional activity. Positively regulates the canonical Wnt/beta-catenin signaling through interaction with NLK and TCF7L2. Can disrupt the NLK-TCF7L2 complex thereby influencing the phosphorylation of TCF7L2 by NLK. Phosphorylates histone H3 on 'Thr-11' at centromeres during mitosis. Involved in the formation of promyelocytic leukemia protein nuclear body (PML-NB), one of many subnuclear domains in the eukaryotic cell nucleus, and which is involved in oncogenesis and viral infection. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O88764|DAPK3_RAT Death-associated protein kinase 3 OS=Rattus norvegicus GN=Dapk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (536), Expect = 6e-54, Method: Compositional matrix adjust.
Identities = 107/240 (44%), Positives = 151/240 (62%), Gaps = 9/240 (3%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRR----RSMDQMQDILHEAAVLYLAQKSERIVGLH 77
G+FA VRKC K T +EYAAKFI+KRR R ++I E ++L + I+ LH
Sbjct: 22 GQFAIVRKCQQKGTGMEYAAKFIKKRRLPSSRRGVSREEIEREVSILREIRHPN-IITLH 80
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+++E ++VL+LE+V GEL + ++ + E + ++KQIL+ + +LH I H DL
Sbjct: 81 DVFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDL 140
Query: 138 KPQNILLTKDN----NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDM 193
KP+NI+L + IKL DFGI+ + E K I GTP++VAPE+++YEP+ L DM
Sbjct: 141 KPENIMLLDKHAASPRIKLIDFGIAHRIEAGSEFKNIFGTPEFVAPEIVNYEPLGLEADM 200
Query: 194 WSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
WS+GV+ Y+LLS SPF G+ KQET NIS N+ F E+ F S AKDFI+ LV DP
Sbjct: 201 WSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSSTSELAKDFIRRLLVKDP 260
|
Serine/threonine kinase which is involved in the regulation of apoptosis, autophagy, transcription, actin cytoskeleton reorganization, cell motility, smooth muscle contraction, and mitosis, particularly cytokinesis. Regulates both type I apoptotic and type II autophagic cell deaths signal, depending on the cellular setting. The former is caspase-dependent, while the latter is caspase-independent and is characterized by the accumulation of autophagic vesicles. Regulates myosin phosphorylation in both smooth muscle and non-muscle cells. In smooth muscle, regulates myosin either directly by phosphorylating MYL12B and MYL9 or through inhibition of smooth muscle myosin phosphatase (SMPP1M) via phosphorylation of PPP1R12A, and the inhibition of SMPP1M functions to enhance muscle responsiveness to Ca(2+) and promote a contractile state. Enhances transcription from AR-responsive promoters in a hormone- and kinase-dependent manner. Phosphorylates STAT3 and enhances its transcriptional activity. Positively regulates the canonical Wnt/beta-catenin signaling through interaction with NLK and TCF7L2. Can disrupt the NLK-TCF7L2 complex thereby influencing the phosphorylation of TCF7L2 by NLK. Phosphorylates histone H3 on 'Thr-11' at centromeres during mitosis. Involved in the formation of promyelocytic leukemia protein nuclear body (PML-NB), one of many subnuclear domains in the eukaryotic cell nucleus, and which is involved in oncogenesis and viral infection. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9UIK4|DAPK2_HUMAN Death-associated protein kinase 2 OS=Homo sapiens GN=DAPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (536), Expect = 6e-54, Method: Compositional matrix adjust.
Identities = 106/240 (44%), Positives = 156/240 (65%), Gaps = 11/240 (4%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKR-----RRSMDQMQDILHEAAVLYLAQKSERIVGL 76
G+FA V+KC K T +EYAAKFI+KR RR + + ++I E ++L ++ L
Sbjct: 32 GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSR-EEIEREVSILRQVL-HHNVITL 89
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
H++YE ++VL+LE+V GEL + ++ + E++ S++KQIL+ + +LH I H D
Sbjct: 90 HDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFD 149
Query: 137 LKPQNILLTKDN----NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATD 192
LKP+NI+L N +IKL DFG++ + D VE K I GTP++VAPE+++YEP+ L D
Sbjct: 150 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEAD 209
Query: 193 MWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTD 252
MWS+GV+ Y+LLS SPF GD KQET NI+ ++ F E+ F S AKDFI+ LV +
Sbjct: 210 MWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKE 269
|
Isoform 2 can phosphorylate MYL9. It can induce membrane blebbing and autophagic cell death. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 253 | ||||||
| 427780801 | 565 | Putative serine/threonine-protein kinase | 0.920 | 0.412 | 0.567 | 4e-77 | |
| 270013236 | 339 | hypothetical protein TcasGA2_TC011812 [T | 0.924 | 0.690 | 0.590 | 2e-76 | |
| 91090882 | 374 | PREDICTED: similar to CG32666 CG32666-PB | 0.924 | 0.625 | 0.590 | 3e-76 | |
| 403278583 | 406 | PREDICTED: serine/threonine-protein kina | 0.952 | 0.593 | 0.544 | 9e-73 | |
| 147899107 | 417 | serine/threonine kinase 17a [Xenopus lae | 0.924 | 0.561 | 0.560 | 3e-72 | |
| 395850019 | 412 | PREDICTED: serine/threonine-protein kina | 0.924 | 0.567 | 0.560 | 5e-72 | |
| 149704784 | 366 | PREDICTED: serine/threonine-protein kina | 0.916 | 0.633 | 0.556 | 5e-72 | |
| 348568444 | 386 | PREDICTED: serine/threonine-protein kina | 0.924 | 0.606 | 0.560 | 7e-72 | |
| 296209141 | 414 | PREDICTED: serine/threonine-protein kina | 0.924 | 0.565 | 0.556 | 8e-72 | |
| 344270945 | 410 | PREDICTED: serine/threonine-protein kina | 0.924 | 0.570 | 0.556 | 1e-71 |
| >gi|427780801|gb|JAA55852.1| Putative serine/threonine-protein kinase 17a [Rhipicephalus pulchellus] | Back alignment and taxonomy information |
|---|
Score = 293 bits (751), Expect = 4e-77, Method: Compositional matrix adjust.
Identities = 134/236 (56%), Positives = 179/236 (75%), Gaps = 3/236 (1%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+RGKFA+VR+C H+ + ++AAK+IRKRRR+ D +I+HEA VL +A+ R+V + E+
Sbjct: 40 ARGKFATVRRCVHRESGRDFAAKYIRKRRRASDVRHEIVHEALVLKMAEPCSRVVDVREV 99
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
+ETP E++L+LE+ GELQ ++D ++ +PE+D M+QILEA+ FLH+ NI HLD+KP
Sbjct: 100 FETPSELILILELAAGGELQHVLDSEECLPEKDVVRLMRQILEAVQFLHERNIAHLDIKP 159
Query: 140 QNILLTKD---NNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSV 196
QN+LLT +I LCDFGISRV+ E++EI+GTPDYVAPE+L YEPISLATD+WS+
Sbjct: 160 QNLLLTSSFPQGDILLCDFGISRVIGKGTEIREIVGTPDYVAPEILQYEPISLATDIWSL 219
Query: 197 GVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTD 252
GVL YVLLS HSPF GD KQETF NI+ + F EDLFG +S+ AKDFI +V D
Sbjct: 220 GVLTYVLLSGHSPFGGDTKQETFCNITNGSLDFPEDLFGDVSNSAKDFIGRLIVRD 275
|
Source: Rhipicephalus pulchellus Species: Rhipicephalus pulchellus Genus: Rhipicephalus Family: Ixodidae Order: Ixodida Class: Arachnida Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270013236|gb|EFA09684.1| hypothetical protein TcasGA2_TC011812 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 291 bits (744), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 140/237 (59%), Positives = 183/237 (77%), Gaps = 3/237 (1%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+RGK+A+V + HK T VEYAAKF++KRRR+ DQM++I+HE AVL + R++ LHE+
Sbjct: 5 NRGKYATVCRAVHKETGVEYAAKFVKKRRRNQDQMKEIIHEIAVLMQCSSTNRVIRLHEV 64
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
YE+ EMVLVLE+ GELQ ++D + E + R MKQIL+ ++FLH+ NI HLDLKP
Sbjct: 65 YESATEMVLVLELAAGGELQHILDGGQCLGEAEARKAMKQILDGVSFLHERNIVHLDLKP 124
Query: 140 QNILLTKDNN---IKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSV 196
QN+LL+ ++N IKLCDFGIS+V+ V+V+EIIGT DYVAPEVLSY+PI L+TD+WS+
Sbjct: 125 QNLLLSIEDNCDDIKLCDFGISKVLEPGVKVREIIGTVDYVAPEVLSYDPICLSTDIWSI 184
Query: 197 GVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
GVLAYVLLS ++PF D+KQ+TFLNIS+C SF D F +SS A DFI+S LVTDP
Sbjct: 185 GVLAYVLLSGYTPFGADDKQQTFLNISKCALSFEPDHFEDVSSPAIDFIKSALVTDP 241
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|91090882|ref|XP_973170.1| PREDICTED: similar to CG32666 CG32666-PB [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 290 bits (743), Expect = 3e-76, Method: Compositional matrix adjust.
Identities = 140/237 (59%), Positives = 182/237 (76%), Gaps = 3/237 (1%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
RGK+A+V + HK T VEYAAKF++KRRR+ DQM++I+HE AVL + R++ LHE+
Sbjct: 40 GRGKYATVCRAVHKETGVEYAAKFVKKRRRNQDQMKEIIHEIAVLMQCSSTNRVIRLHEV 99
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
YE+ EMVLVLE+ GELQ ++D + E + R MKQIL+ ++FLH+ NI HLDLKP
Sbjct: 100 YESATEMVLVLELAAGGELQHILDGGQCLGEAEARKAMKQILDGVSFLHERNIVHLDLKP 159
Query: 140 QNILLTKDNN---IKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSV 196
QN+LL+ ++N IKLCDFGIS+V+ V+V+EIIGT DYVAPEVLSY+PI L+TD+WS+
Sbjct: 160 QNLLLSIEDNCDDIKLCDFGISKVLEPGVKVREIIGTVDYVAPEVLSYDPICLSTDIWSI 219
Query: 197 GVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
GVLAYVLLS ++PF D+KQ+TFLNIS+C SF D F +SS A DFI+S LVTDP
Sbjct: 220 GVLAYVLLSGYTPFGADDKQQTFLNISKCALSFEPDHFEDVSSPAIDFIKSALVTDP 276
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|403278583|ref|XP_003930877.1| PREDICTED: serine/threonine-protein kinase 17A [Saimiri boliviensis boliviensis] | Back alignment and taxonomy information |
|---|
Score = 279 bits (713), Expect = 9e-73, Method: Compositional matrix adjust.
Identities = 134/246 (54%), Positives = 181/246 (73%), Gaps = 5/246 (2%)
Query: 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER 72
+L+ +P GKFA VRKC K + E+AAKF+RKRR+ D +I+HE AVL LAQ S
Sbjct: 53 SLLLKLPDMGKFAVVRKCIKKDSGKEFAAKFMRKRRKGQDCRMEIIHEIAVLELAQDSPW 112
Query: 73 IVGLHEIYETPHEMVLVLEMVPDGEL--QRLVDIQDGIPEQDTRSYMKQILEALAFLHDH 130
++ LHE+YETP EM+LVLE GE+ Q + D ++ E+D + M+QILE + FLH H
Sbjct: 113 VINLHEVYETPSEMILVLEYAAGGEIFDQCVADREEAFKEKDVQRLMRQILEGVHFLHTH 172
Query: 131 NITHLDLKPQNILLTKDN---NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPI 187
++ HLDLKPQNILLT ++ +IK+ DFG+SR++ + E++EI+GTP+YVAPE+LSY+PI
Sbjct: 173 DVVHLDLKPQNILLTSESPLGDIKIVDFGLSRILKNSEELREIMGTPEYVAPEILSYDPI 232
Query: 188 SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247
S+ATDMWS+GVL YV+L+ SPF G+NKQETFLNISQ N S+ E+ F +S A DFI++
Sbjct: 233 SMATDMWSIGVLTYVMLTGISPFLGNNKQETFLNISQMNLSYSEEEFDILSESAVDFIRT 292
Query: 248 CLVTDP 253
LV P
Sbjct: 293 LLVKKP 298
|
Source: Saimiri boliviensis boliviensis Species: Saimiri boliviensis Genus: Saimiri Family: Cebidae Order: Primates Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
| >gi|147899107|ref|NP_001091414.1| serine/threonine kinase 17a [Xenopus laevis] gi|126631406|gb|AAI33766.1| LOC100049105 protein [Xenopus laevis] | Back alignment and taxonomy information |
|---|
Score = 277 bits (709), Expect = 3e-72, Method: Compositional matrix adjust.
Identities = 134/239 (56%), Positives = 177/239 (74%), Gaps = 5/239 (2%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
RGKFA VRKC K T E+AAKF+RKRR+ D +I+HE AVL LA+ S ++ LHE+
Sbjct: 62 GRGKFAVVRKCVEKETGKEFAAKFMRKRRKGQDCRMEIIHEIAVLELARGSPWVIKLHEV 121
Query: 80 YETPHEMVLVLEMVPDGEL--QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
YET EM+LVLE GE+ Q + + ++ E+D R M+QILE +AFLH HNI HLDL
Sbjct: 122 YETATEMILVLEYAAGGEIFNQCVAEREEAFKEKDVRRLMRQILEGVAFLHRHNIVHLDL 181
Query: 138 KPQNILLTKD---NNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMW 194
KPQN+LLT D +IK+ DFG+SR++N+ E++EI+GTP+YVAPE+LSYEPIS ATDMW
Sbjct: 182 KPQNVLLTSDCPLGDIKIVDFGLSRILNNNEELREIMGTPEYVAPEILSYEPISTATDMW 241
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
S+GVLAY++L+ SPF GD+KQ+TFLNISQ N +++ + F IS A DFI++ L+ P
Sbjct: 242 SIGVLAYIMLTGTSPFLGDDKQQTFLNISQLNVTYNSEDFEDISDSAIDFIKALLIRKP 300
|
Source: Xenopus laevis Species: Xenopus laevis Genus: Xenopus Family: Pipidae Order: Anura Class: Amphibia Phylum: Chordata Superkingdom: Eukaryota |
| >gi|395850019|ref|XP_003797599.1| PREDICTED: serine/threonine-protein kinase 17A [Otolemur garnettii] | Back alignment and taxonomy information |
|---|
Score = 276 bits (707), Expect = 5e-72, Method: Compositional matrix adjust.
Identities = 134/239 (56%), Positives = 177/239 (74%), Gaps = 5/239 (2%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
RGKFA VRKC K + E+AAKF+RKRR+ D +I+HE AVL LAQ + ++ LHE+
Sbjct: 67 GRGKFAVVRKCIKKDSGKEFAAKFMRKRRKGQDCRMEIIHEIAVLELAQDNPWVINLHEV 126
Query: 80 YETPHEMVLVLEMVPDGEL--QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
YETP EM+LVLE GE+ Q + D ++ E+D + M+QILE + FLH HN+ HLDL
Sbjct: 127 YETPSEMILVLEYAAGGEIFDQCVADREEAFKEKDVQRLMRQILEGVHFLHIHNVVHLDL 186
Query: 138 KPQNILLTKDN---NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMW 194
KPQNILLT D+ +IK+ DFG+SR++ + E++EI+GTP+YVAPE+LSY+PIS+ATDMW
Sbjct: 187 KPQNILLTSDSPLGDIKIVDFGLSRIMKNSEELREIMGTPEYVAPEILSYDPISMATDMW 246
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
S+GVL YV+L+ SPF G+NKQETFLNISQ N S+ E+ F +S A DFI++ LV P
Sbjct: 247 SIGVLTYVMLTGISPFLGNNKQETFLNISQMNLSYSEEEFDVVSESAIDFIKTLLVKKP 305
|
Source: Otolemur garnettii Species: Otolemur garnettii Genus: Otolemur Family: Galagidae Order: Primates Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
| >gi|149704784|ref|XP_001495494.1| PREDICTED: serine/threonine-protein kinase 17A-like [Equus caballus] | Back alignment and taxonomy information |
|---|
Score = 276 bits (707), Expect = 5e-72, Method: Compositional matrix adjust.
Identities = 132/237 (55%), Positives = 177/237 (74%), Gaps = 5/237 (2%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
GKFA VRKC K + E+AAKF+RKRR+ D +I+HE AVL LAQ + ++ LHE+YE
Sbjct: 22 GKFAVVRKCIEKDSGKEFAAKFMRKRRKGQDCRMEIIHEIAVLELAQDNPWVINLHEVYE 81
Query: 82 TPHEMVLVLEMVPDGEL--QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
TP EM+LVLE GE+ Q + D ++ E+D + M+QILE ++FLH H++ HLDLKP
Sbjct: 82 TPSEMILVLEYAAGGEIFDQCVADREEAFKEKDVQRLMRQILEGVSFLHAHDVVHLDLKP 141
Query: 140 QNILLTKDN---NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSV 196
QNILLT ++ +IK+ DFG+SR++ + E++EI+GTP+YVAPE+LSY+PIS+ATDMWS+
Sbjct: 142 QNILLTSESPLGDIKIVDFGLSRIMKNSEELREIMGTPEYVAPEILSYDPISMATDMWSI 201
Query: 197 GVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
GVL YV+L+ SPF GDNKQETFLNISQ N S+ E+ F +S A DFI++ LV P
Sbjct: 202 GVLTYVMLTGISPFLGDNKQETFLNISQMNLSYSEEEFDAVSESAVDFIKTLLVKKP 258
|
Source: Equus caballus Species: Equus caballus Genus: Equus Family: Equidae Order: Perissodactyla Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
| >gi|348568444|ref|XP_003470008.1| PREDICTED: serine/threonine-protein kinase 17A-like [Cavia porcellus] | Back alignment and taxonomy information |
|---|
Score = 276 bits (705), Expect = 7e-72, Method: Compositional matrix adjust.
Identities = 134/239 (56%), Positives = 177/239 (74%), Gaps = 5/239 (2%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
SRGKFA VRKC K + E+AAKF+RKRR+ D +I+HE AVL LAQ + ++ LHE+
Sbjct: 41 SRGKFAVVRKCIKKDSGKEFAAKFMRKRRKGQDCRMEIIHEIAVLELAQDNPWVINLHEV 100
Query: 80 YETPHEMVLVLEMVPDGEL--QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
YETP EM+LVLE GE+ Q + D ++ E+D + M+QILE + FLH H++ HLDL
Sbjct: 101 YETPSEMILVLEYAAGGEIFDQCVADREEAFKEKDVQRLMRQILEGVHFLHTHDVVHLDL 160
Query: 138 KPQNILLTKDN---NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMW 194
KPQNILLT ++ +IK+ DFG+SR++ D E++EI+GTP+YVAPE+LSY+PISLATDMW
Sbjct: 161 KPQNILLTSESPLGDIKIVDFGLSRIMKDSEELREIMGTPEYVAPEILSYDPISLATDMW 220
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
S+GVL YV+L+ SPF GD+KQETFLNISQ N S+ E+ F +S A DFI+ L+ P
Sbjct: 221 SIGVLTYVMLTGVSPFLGDSKQETFLNISQMNVSYSEEEFDGVSESAVDFIKGLLLKKP 279
|
Source: Cavia porcellus Species: Cavia porcellus Genus: Cavia Family: Caviidae Order: Rodentia Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
| >gi|296209141|ref|XP_002751407.1| PREDICTED: serine/threonine-protein kinase 17A [Callithrix jacchus] | Back alignment and taxonomy information |
|---|
Score = 276 bits (705), Expect = 8e-72, Method: Compositional matrix adjust.
Identities = 133/239 (55%), Positives = 177/239 (74%), Gaps = 5/239 (2%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
RGKFA VRKC K + E+AAKF+RKRR+ D +I+HE AVL LAQ + ++ LHE+
Sbjct: 68 GRGKFAVVRKCIKKDSGKEFAAKFMRKRRKGQDCRMEIIHEIAVLELAQDNPWVINLHEV 127
Query: 80 YETPHEMVLVLEMVPDGEL--QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
YETP EM+LVLE GE+ Q + D ++ E+D + M+QILE + FLH H++ HLDL
Sbjct: 128 YETPSEMILVLEYAAGGEIFDQCVADREEAFKEKDVQRLMRQILEGVHFLHTHDVVHLDL 187
Query: 138 KPQNILLTKDN---NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMW 194
KPQNILLT D+ +IK+ DFG+SR++ + E++EI+GTP+YVAPE+LSY+PIS+ATDMW
Sbjct: 188 KPQNILLTSDSPLGDIKIVDFGLSRILKNSEELREIMGTPEYVAPEILSYDPISMATDMW 247
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
S+GVL YV+L+ SPF G+NKQETFLNISQ N S+ E+ F +S A DFI++ LV P
Sbjct: 248 SIGVLTYVMLTGISPFLGNNKQETFLNISQMNLSYSEEEFDILSESALDFIRALLVKKP 306
|
Source: Callithrix jacchus Species: Callithrix jacchus Genus: Callithrix Family: Cebidae Order: Primates Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
| >gi|344270945|ref|XP_003407302.1| PREDICTED: serine/threonine-protein kinase 17A [Loxodonta africana] | Back alignment and taxonomy information |
|---|
Score = 275 bits (704), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 133/239 (55%), Positives = 176/239 (73%), Gaps = 5/239 (2%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
RGKFA VRKC K + E+AAKF+RKRR+ D +I+HE AVL LAQ + ++ LHE+
Sbjct: 64 GRGKFAVVRKCVKKDSGKEFAAKFMRKRRKGQDCRMEIIHEIAVLELAQDNPWVINLHEV 123
Query: 80 YETPHEMVLVLEMVPDGEL--QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
YETP EM+LVLE GE+ Q + D + E+D + M+QILE + FLH H++ HLDL
Sbjct: 124 YETPSEMILVLEYAAGGEIFDQCVADRDEAFKEKDVQRLMRQILEGVHFLHTHDVVHLDL 183
Query: 138 KPQNILLTKDN---NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMW 194
KPQNILLT ++ +IK+ DFG+SR++ + E++EI+GTP+YVAPE+LSY+PIS+ATDMW
Sbjct: 184 KPQNILLTSESPLGDIKIVDFGLSRIMKNSEELREIMGTPEYVAPEILSYDPISMATDMW 243
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
S+GVL YV+L+ SPF GDNKQETFLNISQ N S+ E+ F +S A DFI++ LV P
Sbjct: 244 SIGVLTYVMLTGISPFLGDNKQETFLNISQMNLSYSEEEFDVVSESAIDFIKALLVKKP 302
|
Source: Loxodonta africana Species: Loxodonta africana Genus: Loxodonta Family: Elephantidae Order: Proboscidea Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 253 | ||||||
| UNIPROTKB|F1PCL9 | 367 | STK17A "Uncharacterized protei | 0.920 | 0.634 | 0.554 | 5.1e-67 | |
| UNIPROTKB|Q9GM70 | 397 | STK17A "Serine/threonine-prote | 0.920 | 0.586 | 0.558 | 6.5e-67 | |
| ZFIN|ZDB-GENE-030131-5556 | 367 | stk17a "serine/threonine kinas | 0.920 | 0.634 | 0.554 | 1.2e-65 | |
| UNIPROTKB|Q9UEE5 | 414 | STK17A "Serine/threonine-prote | 0.920 | 0.562 | 0.542 | 8.5e-65 | |
| UNIPROTKB|F1NAF6 | 406 | STK17A "Uncharacterized protei | 0.920 | 0.573 | 0.546 | 2.9e-64 | |
| FB|FBgn0052666 | 784 | Drak "Death-associated protein | 0.924 | 0.298 | 0.540 | 7.6e-64 | |
| ZFIN|ZDB-GENE-061103-427 | 358 | zgc:153952 "zgc:153952" [Danio | 0.920 | 0.650 | 0.546 | 6.9e-63 | |
| RGD|620457 | 371 | Stk17b "serine/threonine kinas | 0.920 | 0.628 | 0.512 | 6.2e-62 | |
| UNIPROTKB|Q91XS8 | 371 | Stk17b "Serine/threonine-prote | 0.920 | 0.628 | 0.512 | 6.2e-62 | |
| UNIPROTKB|Q5ZM34 | 372 | STK17B "Uncharacterized protei | 0.920 | 0.626 | 0.516 | 1.6e-61 |
| UNIPROTKB|F1PCL9 STK17A "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 681 (244.8 bits), Expect = 5.1e-67, P = 5.1e-67
Identities = 132/238 (55%), Positives = 177/238 (74%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RGKFA VRKC K + E+AAKF+RKRR+ D +I+HE AVL LAQ + ++ LHE+Y
Sbjct: 22 RGKFAVVRKCIKKDSGKEFAAKFMRKRRKGQDCRMEIIHEIAVLELAQDNPWVINLHEVY 81
Query: 81 ETPHEMVLVLEMVPDGEL--QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
ETP EM+LVLE GE+ Q + D ++ E+D + M+QILE + FLH H++ HLDLK
Sbjct: 82 ETPSEMILVLEYAAGGEIFDQCVADREEAFKEKDVQRLMRQILEGVRFLHAHDVVHLDLK 141
Query: 139 PQNILLTKDN---NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
PQNILLT ++ +IK+ DFG+SR++ + E++EI+GTP+YVAPE+LSY+PIS+ATDMWS
Sbjct: 142 PQNILLTSESPLGDIKIVDFGLSRIMKNSEELREIMGTPEYVAPEILSYDPISMATDMWS 201
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+GVL YV+L+ SPF GDNKQETFLNISQ + S+ E+ F +S A DFI++ LV P
Sbjct: 202 IGVLTYVMLTGISPFLGDNKQETFLNISQMSLSYSEEEFDVVSESAIDFIKTLLVKKP 259
|
|
| UNIPROTKB|Q9GM70 STK17A "Serine/threonine-protein kinase 17A" [Oryctolagus cuniculus (taxid:9986)] | Back alignment and assigned GO terms |
|---|
Score = 680 (244.4 bits), Expect = 6.5e-67, P = 6.5e-67
Identities = 133/238 (55%), Positives = 174/238 (73%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RGKFA VRKC K + E+AAKF+RKRR+ D +I+HE AVL LAQ + ++ LHE+Y
Sbjct: 52 RGKFAVVRKCIQKDSGKEFAAKFMRKRRKGQDCRMEIIHEIAVLELAQDNPWVINLHEVY 111
Query: 81 ETPHEMVLVLEMVPDGEL--QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
ET EM+LVLE GE+ Q + D + E+D + M+QILE + FLH H++ HLDLK
Sbjct: 112 ETSSEMILVLEYAAGGEISDQCVADRDEAFNEKDVQRLMRQILEGVHFLHTHDVVHLDLK 171
Query: 139 PQNILLTKDN---NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
PQNILLT ++ +IK+ DFG+SR+V + E++EI+GTP+YVAPE+LSY+PIS+ATDMWS
Sbjct: 172 PQNILLTSESPLGDIKIVDFGLSRIVKNSEELREIMGTPEYVAPEILSYDPISMATDMWS 231
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+GVL YV+L+ SPF GDNKQETFLNISQ N S+ E+ F +S A DFI+ LV P
Sbjct: 232 IGVLTYVMLTGISPFLGDNKQETFLNISQMNLSYSEEEFDTVSESAVDFIKKLLVKKP 289
|
|
| ZFIN|ZDB-GENE-030131-5556 stk17a "serine/threonine kinase 17a" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 668 (240.2 bits), Expect = 1.2e-65, P = 1.2e-65
Identities = 132/238 (55%), Positives = 174/238 (73%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RGKFA VRKC K + E+AAK++RKRR+ D +I+HE AVL LA R+V LHE+Y
Sbjct: 53 RGKFAVVRKCVEKSSGKEFAAKYMRKRRKGQDCRTEIIHEIAVLELAAACPRVVNLHEVY 112
Query: 81 ETPHEMVLVLEMVPDGEL--QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
E P EMVLVLE GE+ Q + D + EQ+ + MKQILE ++FLH++N+ HLDLK
Sbjct: 113 EMPSEMVLVLEYAAGGEIFNQCVADRDEAFTEQEVKRLMKQILEGVSFLHNNNVVHLDLK 172
Query: 139 PQNILLTKDN---NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
PQNILLT ++ +IK+ DFG+SR++++ EV+EI+GTP+YVAPEVL+YEPIS ATDMWS
Sbjct: 173 PQNILLTSESPLGDIKIVDFGLSRLLSNSHEVREIMGTPEYVAPEVLNYEPISTATDMWS 232
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+GVL YV+L+ SPF GD+KQETFLNISQ N S+ E+ + A FI+S L+ +P
Sbjct: 233 IGVLVYVMLTGISPFLGDDKQETFLNISQINISYSEEELEQLDGSAIRFIKSLLIKEP 290
|
|
| UNIPROTKB|Q9UEE5 STK17A "Serine/threonine-protein kinase 17A" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 660 (237.4 bits), Expect = 8.5e-65, P = 8.5e-65
Identities = 129/238 (54%), Positives = 175/238 (73%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RGKFA VRKC K + E+AAKF+RKRR+ D +I+HE AVL LAQ + ++ LHE+Y
Sbjct: 69 RGKFAVVRKCIKKDSGKEFAAKFMRKRRKGQDCRMEIIHEIAVLELAQDNPWVINLHEVY 128
Query: 81 ETPHEMVLVLEMVPDGEL--QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
ET EM+LVLE GE+ Q + D ++ E+D + M+QILE + FLH ++ HLDLK
Sbjct: 129 ETASEMILVLEYAAGGEIFDQCVADREEAFKEKDVQRLMRQILEGVHFLHTRDVVHLDLK 188
Query: 139 PQNILLTKDN---NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
PQNILLT ++ +IK+ DFG+SR++ + E++EI+GTP+YVAPE+LSY+PIS+ATDMWS
Sbjct: 189 PQNILLTSESPLGDIKIVDFGLSRILKNSEELREIMGTPEYVAPEILSYDPISMATDMWS 248
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+GVL YV+L+ SPF G++KQETFLNISQ N S+ E+ F +S A DFI++ LV P
Sbjct: 249 IGVLTYVMLTGISPFLGNDKQETFLNISQMNLSYSEEEFDVLSESAVDFIRTLLVKKP 306
|
|
| UNIPROTKB|F1NAF6 STK17A "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 655 (235.6 bits), Expect = 2.9e-64, P = 2.9e-64
Identities = 130/238 (54%), Positives = 174/238 (73%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RGKFA V+KC K T+ E+AAKF+RKRR+ D +I+HE AVL LAQ + ++ LHE+Y
Sbjct: 58 RGKFAVVKKCIQKDTEREFAAKFMRKRRKGQDCRMEIIHEIAVLELAQCNLWVINLHEVY 117
Query: 81 ETPHEMVLVLEMVPDGEL--QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
ET EM+LVLE GE+ Q + + ++ E+D + MKQILE ++FLH +N+ HLDLK
Sbjct: 118 ETATEMILVLEYAAGGEIFDQCVAEREEAFKEKDVKRLMKQILEGVSFLHRNNVVHLDLK 177
Query: 139 PQNILLTKDN---NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
PQNILLT + +IK+ DFG+SR+V E++EI+GTP+YVAPE+LSY+PIS ATDMWS
Sbjct: 178 PQNILLTSKSPLGDIKIVDFGLSRIVKSSEELREIMGTPEYVAPEILSYDPISTATDMWS 237
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+GVLAY++L+ SPF GD+KQETFLNISQ N + + F IS A DF+++ LV P
Sbjct: 238 IGVLAYIMLTGISPFLGDDKQETFLNISQMNVCYTGEDFDLISESAVDFMKTLLVKKP 295
|
|
| FB|FBgn0052666 Drak "Death-associated protein kinase related" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 651 (234.2 bits), Expect = 7.6e-64, P = 7.6e-64
Identities = 128/237 (54%), Positives = 170/237 (71%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+RGKFA+VR+ HK T +AAKF+++RRR+ ++I HE AVL L + + IV L+ +
Sbjct: 44 ARGKFAAVRRAIHKNTGSHFAAKFLKRRRRAQSSDKEIKHEIAVLMLCEGEDNIVNLNAV 103
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
+ET + L+LE+ GELQ ++D ++ + E R M+++L+AL FLHD +I HLDLKP
Sbjct: 104 HETRSDTALLLELATGGELQTILDNEECLTEAQARHCMREVLKALKFLHDRSIAHLDLKP 163
Query: 140 QNILLTKD---NNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSV 196
QNILL + + +KLCDFGISRVV + + V+E+ GTPDYVAPEVL YEP+SL TD+WSV
Sbjct: 164 QNILLAGERIEDGLKLCDFGISRVVCEGINVREMAGTPDYVAPEVLQYEPLSLLTDIWSV 223
Query: 197 GVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
GVL YVLLS SPF GD KQETFLNISQC +F ++LFG +S A DFI+ L P
Sbjct: 224 GVLTYVLLSGFSPFGGDTKQETFLNISQCALTFPDNLFGGVSPVAIDFIRRALRIKP 280
|
|
| ZFIN|ZDB-GENE-061103-427 zgc:153952 "zgc:153952" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 642 (231.1 bits), Expect = 6.9e-63, P = 6.9e-63
Identities = 130/238 (54%), Positives = 168/238 (70%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RGKFA V+KC K T E+AAKF+RKRR+ D DIL+E AVL A+ + +VGLHE+Y
Sbjct: 33 RGKFAVVKKCVEKTTGKEHAAKFLRKRRKGQDCRGDILNEIAVLESAEANPYVVGLHEVY 92
Query: 81 ETPHEMVLVLEMVPDGEL--QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
ET E++LVLE GE+ Q + D + E+D +QIL ++ LH +NI HLDLK
Sbjct: 93 ETTSEIILVLECAAGGEIFNQCVADNDEAFTEKDVIRLARQILMGVSCLHQNNIVHLDLK 152
Query: 139 PQNILLTKDN---NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
PQNILLT +I++ DFG+SR V+ V EV+EI+GTP+YVAPE+L YEPIS ATDMWS
Sbjct: 153 PQNILLTSAQPLGDIRIVDFGLSRRVDSVSEVREILGTPEYVAPEILDYEPISTATDMWS 212
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+GVL YV+L+ SPF G+ KQETFLNISQ N + +D+F IS A +FIQS L+ +P
Sbjct: 213 IGVLTYVMLTGESPFLGEEKQETFLNISQVNVDYSQDVFQGISDLAVNFIQSLLIKNP 270
|
|
| RGD|620457 Stk17b "serine/threonine kinase 17b" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 633 (227.9 bits), Expect = 6.2e-62, P = 6.2e-62
Identities = 122/238 (51%), Positives = 170/238 (71%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RGKFA VR+C K T EYAAKF++KRRR D +ILHE AVL LA+ ++ LHE+Y
Sbjct: 41 RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELARSCPHVINLHEVY 100
Query: 81 ETPHEMVLVLEMVPDGELQRLV--DIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
ET E++LVLE GE+ L ++ + + E D +KQILE + +LH +NI HLDLK
Sbjct: 101 ETATEIILVLEYAAGGEIFNLCLPELAEMVSENDVIRLIKQILEGVHYLHQNNIVHLDLK 160
Query: 139 PQNILLTKD---NNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
PQNILL+ +IK+ DFG+SR + + E++EI+GTP+Y+APE+L+Y+PI+ ATDMW+
Sbjct: 161 PQNILLSSIYPLGDIKIVDFGMSRKIGNASELREIMGTPEYLAPEILNYDPITTATDMWN 220
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+G++AY+LL+ SPF G++ QET+LNISQ N + E++F +S A DFIQS LV +P
Sbjct: 221 IGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEEMFSSVSQLATDFIQSLLVKNP 278
|
|
| UNIPROTKB|Q91XS8 Stk17b "Serine/threonine-protein kinase 17B" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 633 (227.9 bits), Expect = 6.2e-62, P = 6.2e-62
Identities = 122/238 (51%), Positives = 170/238 (71%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RGKFA VR+C K T EYAAKF++KRRR D +ILHE AVL LA+ ++ LHE+Y
Sbjct: 41 RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELARSCPHVINLHEVY 100
Query: 81 ETPHEMVLVLEMVPDGELQRLV--DIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
ET E++LVLE GE+ L ++ + + E D +KQILE + +LH +NI HLDLK
Sbjct: 101 ETATEIILVLEYAAGGEIFNLCLPELAEMVSENDVIRLIKQILEGVHYLHQNNIVHLDLK 160
Query: 139 PQNILLTKD---NNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
PQNILL+ +IK+ DFG+SR + + E++EI+GTP+Y+APE+L+Y+PI+ ATDMW+
Sbjct: 161 PQNILLSSIYPLGDIKIVDFGMSRKIGNASELREIMGTPEYLAPEILNYDPITTATDMWN 220
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+G++AY+LL+ SPF G++ QET+LNISQ N + E++F +S A DFIQS LV +P
Sbjct: 221 IGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEEMFSSVSQLATDFIQSLLVKNP 278
|
|
| UNIPROTKB|Q5ZM34 STK17B "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 629 (226.5 bits), Expect = 1.6e-61, P = 1.6e-61
Identities = 123/238 (51%), Positives = 167/238 (70%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RG+ VRKC K T EYAAKF++KRRR D +ILHE AVL L + + RIV LHE+Y
Sbjct: 41 RGRCGVVRKCIAKSTGQEYAAKFLKKRRRGQDCKAEILHEIAVLELTKSNPRIVNLHEVY 100
Query: 81 ETPHEMVLVLEMVPDGELQRLV--DIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
ET +E++LVLE GE+ L D+ D I E D ++QILE L LH+ NI HLDLK
Sbjct: 101 ETANEIILVLEYAAGGEIFNLCVPDLDDRISESDIIRLIRQILEGLCCLHEKNIVHLDLK 160
Query: 139 PQNILLTKDN---NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
PQNILL+ N ++K+ DFG+SR + + E+++I+GT +Y+APE+L+Y+PI+ ATDMW+
Sbjct: 161 PQNILLSSINPLGDVKIVDFGMSRKIENSTELRQIMGTTEYLAPEILNYDPITTATDMWN 220
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+GV++Y+LL+ SPF G + QETFLNISQ N + E+ F +S AKDFIQ L+ +P
Sbjct: 221 IGVISYMLLTQESPFVGADNQETFLNISQVNVDYSEETFSSVSQPAKDFIQKLLIKNP 278
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9GM70 | ST17A_RABIT | 2, ., 7, ., 1, 1, ., 1 | 0.5564 | 0.9249 | 0.5894 | yes | N/A |
| Q91XS8 | ST17B_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.5126 | 0.9209 | 0.6280 | yes | N/A |
| Q8BG48 | ST17B_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.5020 | 0.9249 | 0.6290 | yes | N/A |
| Q9UEE5 | ST17A_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.5397 | 0.9249 | 0.5652 | yes | N/A |
| P25323 | MYLKA_DICDI | 2, ., 7, ., 1, 1, ., 1, 8 | 0.3771 | 0.9169 | 0.7864 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 253 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-80 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-68 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-55 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-55 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-50 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-48 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-47 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-43 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-43 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-40 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-40 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-39 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-38 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-35 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-35 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-35 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-34 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-34 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-33 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-33 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-33 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-33 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-33 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-32 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-32 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-32 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-32 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-32 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-31 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-31 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-31 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-31 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-31 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-30 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-30 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-30 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-30 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-30 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-30 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-30 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-29 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-29 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-29 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-28 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-28 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-28 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-28 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-28 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-28 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-28 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-27 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-27 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-27 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-27 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-27 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-27 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-27 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-27 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-27 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-27 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-26 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-26 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-26 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-26 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-26 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-26 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-26 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-26 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-25 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-25 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-25 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-25 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-25 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-25 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-25 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-25 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-25 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-24 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-24 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-24 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-24 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-24 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-24 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-24 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-24 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-24 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-23 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-23 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-23 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-23 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-23 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-23 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-22 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-22 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-22 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-22 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-22 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-22 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-22 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-21 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-21 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-21 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-21 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-20 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-20 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-20 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-20 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-19 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-19 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-19 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-19 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-19 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-19 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-18 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-18 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-18 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-17 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-16 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-12 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-11 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-08 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-07 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 5e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-06 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 2e-06 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 3e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-06 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 9e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-04 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 2e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-04 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 7e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.002 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 0.002 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 0.002 | |
| PRK01723 | 239 | PRK01723, PRK01723, 3-deoxy-D-manno-octulosonic-ac | 0.003 | |
| COG0510 | 269 | COG0510, ycfN, Thiamine kinase and related kinases | 0.003 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 2e-80
Identities = 87/234 (37%), Positives = 130/234 (55%), Gaps = 4/234 (1%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G F V K T A K I+K++ + IL E +L K IV L++++
Sbjct: 9 EGSFGKVYLARDKKTGKLVAIKVIKKKKIK-KDRERILREIKIL-KKLKHPNIVRLYDVF 66
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
E ++ LV+E G+L L+ + + E + R Y++QIL AL +LH I H DLKP+
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPE 126
Query: 141 NILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLA 200
NILL +D ++KL DFG++R ++ ++ +GTP+Y+APEVL + A D+WS+GV+
Sbjct: 127 NILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVIL 186
Query: 201 YVLLSSHSPFAGDNK-QETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
Y LL+ PF GD++ E F I + F IS +AKD I+ LV DP
Sbjct: 187 YELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP-EWDISPEAKDLIRKLLVKDP 239
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 7e-68
Identities = 77/239 (32%), Positives = 117/239 (48%), Gaps = 8/239 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL-YLAQKSERIVGLHEI 79
G F +V K HK T A K ++KR + Q E +L L IV L +
Sbjct: 9 SGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL--SHPNIVRLIDA 66
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
+E + LV+E G+L + + E + + QIL L +LH + I H DLKP
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKP 126
Query: 140 QNILLTKDNNIKLCDFGISRVVNDV-VEVKEIIGTPDYVAPEVL-SYEPISLATDMWSVG 197
+NILL ++ +K+ DFG+++ + + +GTP Y+APEVL D+WS+G
Sbjct: 127 ENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLG 186
Query: 198 VLAYVLLSSHSPFAGD---NKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
V+ Y LL+ PF+G+ ++ + I F E + S +AKD I+ CL DP
Sbjct: 187 VILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDP 245
|
Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 2e-55
Identities = 87/244 (35%), Positives = 127/244 (52%), Gaps = 13/244 (5%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQD-ILHEAAVLYLAQKSERIVGLHE 78
S+G + V K T YA K I+K D +L E +L AQ S +V L+
Sbjct: 2 SKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYY 60
Query: 79 IYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
++ + LV+E +P G+L L++ + E R Y+ +I+ AL +LH + I H DLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 139 PQNILLTKDNNIKLCDFGISRV---------VNDVVEVKEIIGTPDYVAPEVLSYEPISL 189
P NIL+ + ++KL DFG+S+V +D E K I+GTPDY+APEV+ + S
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSK 180
Query: 190 ATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249
D WS+G + Y L PF G+ +E F NI + ED+ +S +A D I L
Sbjct: 181 TVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDV--EVSDEAIDLISKLL 238
Query: 250 VTDP 253
V DP
Sbjct: 239 VPDP 242
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 4e-55
Identities = 80/235 (34%), Positives = 123/235 (52%), Gaps = 7/235 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V K T YA K ++K++ +++ L E +L IV LH
Sbjct: 3 KGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYA 61
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++T ++ LVLE P GEL + + E+ R Y +I+ AL +LH I + DLKP
Sbjct: 62 FQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKP 121
Query: 140 QNILLTKDNNIKLCDFGISR-VVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
+NILL D +IKL DFG+++ + ++ GTP+Y+APEVL + A D WS+GV
Sbjct: 122 ENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGV 181
Query: 199 LAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
L Y +L+ PF ++++E + I + F E +S +A+D I L DP
Sbjct: 182 LLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLISGLLQKDP 232
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 1e-52
Identities = 82/262 (31%), Positives = 129/262 (49%), Gaps = 27/262 (10%)
Query: 15 IFCMP-SRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSER 72
F G F++V K T EYA K + KR+ +++ + E VL
Sbjct: 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPG 63
Query: 73 IVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNI 132
I+ L+ ++ + VLE P+GEL + + + E+ TR Y +IL AL +LH I
Sbjct: 64 IIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGI 123
Query: 133 THLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI---------------------I 171
H DLKP+NILL KD +IK+ DFG ++V++ + +
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183
Query: 172 GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE 231
GT +YV+PE+L+ +P ++D+W++G + Y +L+ PF G N+ TF I + +SF
Sbjct: 184 GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPP 243
Query: 232 DLFGHISSQAKDFIQSCLVTDP 253
+ AKD I+ LV DP
Sbjct: 244 N----FPPDAKDLIEKLLVLDP 261
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 2e-50
Identities = 68/187 (36%), Positives = 103/187 (55%), Gaps = 6/187 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G F +V K T + A K I+K S ++++L E +L IV L+ ++
Sbjct: 3 EGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL-LEELLREIEILKK-LNHPNIVKLYGVF 60
Query: 81 ETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
E + + LV+E G L L + + + E + + QILE L +LH + I H DLKP
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 140 QNILLTKDN-NIKLCDFGISRVVNDVV-EVKEIIGTPDYVAPEVLSYEP-ISLATDMWSV 196
+NILL DN +KL DFG+S+++ +K I+GTP Y+APEVL + S +D+WS+
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSL 180
Query: 197 GVLAYVL 203
GV+ Y L
Sbjct: 181 GVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 5e-48
Identities = 76/242 (31%), Positives = 114/242 (47%), Gaps = 15/242 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL-YLAQKSERIVGL--H 77
RG F SV K T A K + S ++++ + E +L L + IV
Sbjct: 10 RGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL--QHPNIVRYYGS 67
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
E E + + + LE V G L L+ +PE R Y +QILE LA+LH + I H D+
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDI 127
Query: 138 KPQNILLTKDNNIKLCDFGISRVVNDVVEVKE---IIGTPDYVAPEVLSYEPISLATDMW 194
K NIL+ D +KL DFG ++ + D+ + + GTP ++APEV+ E A D+W
Sbjct: 128 KGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIW 187
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLN---ISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251
S+G + + P++ L S E H+S +AKDF++ CL
Sbjct: 188 SLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPE----HLSEEAKDFLRKCLRR 243
Query: 252 DP 253
DP
Sbjct: 244 DP 245
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 1e-47
Identities = 72/238 (30%), Positives = 119/238 (50%), Gaps = 9/238 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
+G F V K Y K I S + +D L+E +L I+ +E +
Sbjct: 10 KGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKIL-KKLNHPNIIKYYESF 68
Query: 81 ETPHEMVLVLEMVPDGELQRLVD----IQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
E ++ +V+E G+L + + PE+ + Q+ AL +LH I H D
Sbjct: 69 EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRD 128
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEV-KEIIGTPDYVAPEVLSYEPISLATDMWS 195
+KPQNI LT + +KL DFGIS+V++ V++ K ++GTP Y++PE+ +P + +D+WS
Sbjct: 129 IKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWS 188
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+G + Y L + PF G+N E L I + + + SS+ ++ + S L DP
Sbjct: 189 LGCVLYELCTLKHPFEGENLLELALKILKGQY---PPIPSQYSSELRNLVSSLLQKDP 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-43
Identities = 68/243 (27%), Positives = 107/243 (44%), Gaps = 19/243 (7%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFI-----RKRRRSMDQMQDILHEAAVLYLAQKSERIVG 75
+G V K HK T YA K I + R+ + + L +S +V
Sbjct: 11 QGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-------ESPYVVK 63
Query: 76 LHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLH-DHNITH 134
+ + E+ +VLE + G L L+ IPE +QIL+ L +LH +I H
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIH 123
Query: 135 LDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK-EIIGTPDYVAPEVLSYEPISLATDM 193
D+KP N+L+ +K+ DFGIS+V+ + ++ +GT Y++PE + E S A D+
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADI 183
Query: 194 WSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLF---GHISSQAKDFIQSCLV 250
WS+G+ PF Q +F + S + +DFI +CL
Sbjct: 184 WSLGLTLLECALGKFPFL-PPGQPSFFEL-MQAICDGPPPSLPAEEFSPEFRDFISACLQ 241
Query: 251 TDP 253
DP
Sbjct: 242 KDP 244
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-43
Identities = 67/235 (28%), Positives = 122/235 (51%), Gaps = 4/235 (1%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHE 78
S+G F SV + T +A K ++K + +Q+ ++ E A++ + +S + L+
Sbjct: 5 SKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYY 64
Query: 79 IYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
+++ + LV+E + G+ L+ G+PE + Y+ +++ + LH I H D+K
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIK 124
Query: 139 PQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
P+N+L+ + ++KL DFG+SR +E K+ +GTPDY+APE + +D WS+G
Sbjct: 125 PENLLIDQTGHLKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGC 181
Query: 199 LAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ + L + PF + F NI ++ E++ S +A D I L DP
Sbjct: 182 VIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 3e-42
Identities = 86/266 (32%), Positives = 119/266 (44%), Gaps = 37/266 (13%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILH---EAAVLYLAQKSERIVGLH 77
RG F V K T YA K +RK M + I H E +L A S IV L+
Sbjct: 11 RGAFGEVWLVRDKDTGQVYAMKVLRKS--DMIKRNQIAHVRAERDILADA-DSPWIVKLY 67
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
++ + LV+E +P G+L L+ +D PE+ R Y+ +++ AL +H H D+
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDI 127
Query: 138 KPQNILLTKDNNIKLCDFGISRVVNDV------------------------------VEV 167
KP NIL+ D +IKL DFG+ + +N V
Sbjct: 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRA 187
Query: 168 KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNF 227
+GTPDY+APEVL P L D WS+GV+ Y +L PF D QET+ I
Sbjct: 188 NSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKE 247
Query: 228 SFHEDLFGHISSQAKDFIQSCLVTDP 253
S +S +A D I L+ DP
Sbjct: 248 SLRFPPDPPVSPEAIDLICR-LLCDP 272
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-40
Identities = 77/235 (32%), Positives = 118/235 (50%), Gaps = 7/235 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL-YLAQKSERIVGLHEI 79
RG F V K + T A K I + + ++ I+ E +L L K IV
Sbjct: 10 RGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL--KHPNIVKYIGS 67
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
ET + ++LE +G L++++ PE Y+ Q+L+ LA+LH+ + H D+K
Sbjct: 68 IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKA 127
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVE-VKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
NIL TKD +KL DFG++ +NDV + ++GTP ++APEV+ S A+D+WS+G
Sbjct: 128 ANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGC 187
Query: 199 LAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
LL+ + P+ N I Q + H L IS + KDF+ C DP
Sbjct: 188 TVIELLTGNPPYYDLNPMAALFRIVQDD---HPPLPEGISPELKDFLMQCFQKDP 239
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 3e-40
Identities = 79/235 (33%), Positives = 120/235 (51%), Gaps = 6/235 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSM-DQMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V K T YA K ++K D ++ + E VL LA K + LH
Sbjct: 5 KGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSC 64
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++T + V+E V G+L + E R Y +I+ L FLH+ I + DLK
Sbjct: 65 FQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKL 124
Query: 140 QNILLTKDNNIKLCDFGISRV-VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
N+LL + +IK+ DFG+ + + V GTPDY+APE+LSY+P A D W++GV
Sbjct: 125 DNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGV 184
Query: 199 LAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
L Y +L+ SPF GD++ E F +I + + +S +AK ++S L +P
Sbjct: 185 LLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSKEAKSILKSFLTKNP 235
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-39
Identities = 74/233 (31%), Positives = 119/233 (51%), Gaps = 8/233 (3%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G F V HK + YA K + K + + Q++ +L+E +L + + +V L+ +
Sbjct: 12 GSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRIL-QSIRHPFLVNLYGSF 70
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
+ + LV+E VP GEL + PE R Y Q++ AL +LH +I + DLKP+
Sbjct: 71 QDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPE 130
Query: 141 NILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLA 200
N+LL D IK+ DFG ++ V + GTP+Y+APE++ + A D W++G+L
Sbjct: 131 NLLLDSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILI 188
Query: 201 YVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
Y +L+ + PF DN + + I + F S AKD I++ L D
Sbjct: 189 YEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDLIRNLLQVDL 237
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 4e-39
Identities = 71/235 (30%), Positives = 114/235 (48%), Gaps = 7/235 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
+G F V K HK T E A K I+ S ++ + I++E +L K IV + Y
Sbjct: 10 KGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKC-KHPNIVKYYGSY 66
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
E+ +V+E G L+ L+ + + E K++L+ L +LH + I H D+K
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKA 126
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVL 199
NILLT D +KL DFG+S ++D ++GTP ++APEV++ +P D+WS+G+
Sbjct: 127 ANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGIT 186
Query: 200 AYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ-AKDFIQSCLVTDP 253
A L P++ + I+ S KDF++ CL +P
Sbjct: 187 AIELAEGKPPYSELPPMKALFKIAT--NGPPGLRNPEKWSDEFKDFLKKCLQKNP 239
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 2e-38
Identities = 73/257 (28%), Positives = 113/257 (43%), Gaps = 27/257 (10%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRS-MDQMQDILHEAAVLYLAQKSERIVGLHEI 79
G F V + A K + K+ S +++ L E +L IV L++
Sbjct: 10 EGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDF 66
Query: 80 YETPHEMVLVLEMVPDGELQRLVD---IQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
++ + LV+E V G L+ L+ + + E + + QIL AL +LH I H D
Sbjct: 67 FQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRD 126
Query: 137 LKPQNILLTKDNN-IKLCDFGISRVVND-------VVEVKEIIGTPDYVAPEVL---SYE 185
+KP+NILL +D +KL DFG+++++ D +GTP Y+APEVL S
Sbjct: 127 IKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLA 186
Query: 186 PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETF---------LNISQCNFSFHEDLFGH 236
S ++D+WS+G+ Y LL+ PF G+ L
Sbjct: 187 YASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPEL 246
Query: 237 ISSQAKDFIQSCLVTDP 253
IS A D ++ L DP
Sbjct: 247 ISKAASDLLKKLLAKDP 263
|
Length = 384 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 5e-35
Identities = 79/268 (29%), Positives = 123/268 (45%), Gaps = 40/268 (14%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ---MQDILHEAAVLYLAQKSERIVGLH 77
+G V K T +A K + K+ M + ++ +L E +L + L+
Sbjct: 11 KGDVGRVFLVRLKGTGKLFALKVLDKK--EMIKRNKVKRVLTEQEILATL-DHPFLPTLY 67
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHL 135
++T + LV++ P GEL RL+ Q G + E+ R Y ++L AL +LH I +
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYR 127
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEII------------------------ 171
DLKP+NILL + +I L DF +S+ +
Sbjct: 128 DLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSF 187
Query: 172 ------GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQC 225
GT +Y+APEV+S + A D W++G+L Y +L +PF G N+ ETF NI +
Sbjct: 188 RSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKK 247
Query: 226 NFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+F +SS A+D I+ LV DP
Sbjct: 248 EVTFPGS--PPVSSSARDLIRKLLVKDP 273
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 6e-35
Identities = 77/263 (29%), Positives = 112/263 (42%), Gaps = 35/263 (13%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
G + V K K+T A K I+ R S + L E +L I+ L +++
Sbjct: 10 GTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLL-KELNHPNIIKLLDVFR 68
Query: 82 TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQN 141
++ LV E + + + D Q G+PE +SY+ Q+L+ LAF H H I H DLKP+N
Sbjct: 69 HKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPEN 128
Query: 142 ILLTKDNNIKLCDFGISRVVN-DVVEVKEIIGTPDYVAPEVL----SYEPISLATDMWSV 196
+L+ + +KL DFG++R V + T Y APE+L Y D+WSV
Sbjct: 129 LLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST---PVDIWSV 185
Query: 197 GVLAYVLLSSHSPFAGDN---------------KQETFLNISQC----NFSFH------- 230
G + LLS F G + E + + FSF
Sbjct: 186 GCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPL 245
Query: 231 EDLFGHISSQAKDFIQSCLVTDP 253
LF + S QA D + L DP
Sbjct: 246 PKLFPNASPQALDLLSQMLHYDP 268
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 6e-35
Identities = 72/237 (30%), Positives = 117/237 (49%), Gaps = 9/237 (3%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G + V K T A K ++K +++++ +L E +L KSE +V L +
Sbjct: 12 GGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDIL-TTTKSEWLVKLLYAF 70
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
+ + L +E VP G+ + L++ + E R YM ++ EA+ LH+ H DLKP+
Sbjct: 71 QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPE 130
Query: 141 NILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLA 200
N L+ +IKL DFG+S+ V ++G+PDY+APEVL + D WS+G +
Sbjct: 131 NFLIDASGHIKLTDFGLSK--GIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCML 188
Query: 201 YVLLSSHSPFAGDNKQETFLNISQCNFSFH----EDLFGHISSQAKDFIQSCLVTDP 253
Y L PF+G ET+ N+ + +D ++S +A D I + DP
Sbjct: 189 YEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLI-NDP 244
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-34
Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 10/230 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
G F V K +A K ++KR Q + I E +L IV L+
Sbjct: 3 VGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRT 61
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++ + +++E GEL ++ + E R Y+ ++ A +LH+ I + DLKP
Sbjct: 62 FKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKP 121
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVL 199
+N+LL + +KL DFG ++ + + GTP+YVAPE++ + + D WS+G+L
Sbjct: 122 ENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGIL 181
Query: 200 AYVLLSSHSPFAGDNK--QETFLNISQCNFSFHEDLF--GHISSQAKDFI 245
Y LL+ PF D++ E + +I + N L +I AKD I
Sbjct: 182 LYELLTGRPPFGEDDEDPMEIYNDILKGN----GKLEFPNYIDKAAKDLI 227
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 7e-34
Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
G V K + T A K + RR L E L Q +V L +++
Sbjct: 11 GAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ-HPYVVKLLDVFP 69
Query: 82 TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQN 141
VLV+E +P + L D + +PE +SYM+ +L+ +A++H + I H DLKP N
Sbjct: 70 HGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPAN 129
Query: 142 ILLTKDNNIKLCDFGISRVVNDVVEVK--EIIGTPDYVAPEVL----SYEPISLATDMWS 195
+L++ D +K+ DFG++R+ ++ + T Y APE+L Y+P D+W+
Sbjct: 130 LLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP---GVDLWA 186
Query: 196 VGVLAYVLLSSHSPFAGDN 214
VG + LL+ F G+N
Sbjct: 187 VGCIFAELLNGSPLFPGEN 205
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-33
Identities = 72/278 (25%), Positives = 117/278 (42%), Gaps = 64/278 (23%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQD-----------ILHEAAVLYLAQK 69
G + V K K T A K IR +D ++ +L E K
Sbjct: 9 EGTYGVVYKARDKKTGEIVALKKIR-----LDNEEEGIPSTALREISLLKEL-------K 56
Query: 70 SERIVGLHEIYETPHEMVLVLEMVPDGELQRLVD-IQDGIPEQDTRSYMKQILEALAFLH 128
IV L ++ T ++ LV E D +L++ +D + +S M Q+L LA+ H
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 129 DHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK----EIIGTPDYVAPEVL-- 182
H I H DLKPQNIL+ +D +KL DFG++R + ++ E++ T Y APE+L
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFG--IPLRTYTHEVV-TLWYRAPEILLG 172
Query: 183 --SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ---------------ETFLNISQC 225
Y S A D+WSVG + +++ F GD++ E++ +++
Sbjct: 173 SKHY---STAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229
Query: 226 -----NFSFH-----EDLFGHISSQAKDFIQSCLVTDP 253
F E + + + D + L +P
Sbjct: 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNP 267
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 69/233 (29%), Positives = 112/233 (48%), Gaps = 8/233 (3%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G F VR HK T YA K ++KR M Q+Q + E ++L + IV + +
Sbjct: 29 GSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSIL-MELSHPFIVNMMCSF 87
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
+ + + +LE V GEL + P + Y +++ A +LH +I + DLKP+
Sbjct: 88 QDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPE 147
Query: 141 NILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLA 200
N+LL ++K+ DFG ++ V D + GTP+Y+APEV+ + A D W++GVL
Sbjct: 148 NLLLDNKGHVKVTDFGFAKKVPD--RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLL 205
Query: 201 YVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
Y ++ + PF D + I F +A+D ++ L TD
Sbjct: 206 YEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRARDLVKGLLQTDH 254
|
Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-33
Identities = 74/234 (31%), Positives = 112/234 (47%), Gaps = 12/234 (5%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G F V +I++ YA K + + Q Q + +E VL I+ L
Sbjct: 12 GTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVL-KEVSHPFIIRLFWTE 70
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
+ +++E VP GEL + Y +I+ AL +LH I + DLKP+
Sbjct: 71 HDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPE 130
Query: 141 NILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLA 200
NILL K+ +IKL DFG ++ + D + GTP+Y+APEV+ + + A D W++G+L
Sbjct: 131 NILLDKEGHIKLTDFGFAKKLRD--RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILI 188
Query: 201 YVLLSSHSPFAGDNKQETFLNI--SQCNFSFHEDLFGHISSQAKDFIQSCLVTD 252
Y +L + PF DN + I + F H DL+ AKD I+ LV D
Sbjct: 189 YEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLY------AKDLIKKLLVVD 236
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-33
Identities = 76/248 (30%), Positives = 121/248 (48%), Gaps = 22/248 (8%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
RG F V+ K T YA K ++K + + + E +L ++ S I L
Sbjct: 11 RGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYA 69
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQD-TRSYMKQILEALAFLHDHNITHLDLK 138
++ + LV+E P G+L L++ + ++D + Y+ +++ A+ +H H D+K
Sbjct: 70 FQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIK 129
Query: 139 PQNILLTKDNNIKLCDFGISR--VVNDVVEVKEIIGTPDYVAPEVL---------SYEPI 187
P+N+L+ + +IKL DFG + N +V K +GTPDY+APEVL +Y
Sbjct: 130 PENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGV- 188
Query: 188 SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNI--SQCNFSFHEDLFGHISSQAKDFI 245
D WS+GV+AY ++ SPF +T+ NI Q F ED +SS D I
Sbjct: 189 --ECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP--KVSSDFLDLI 244
Query: 246 QSCLVTDP 253
QS L+
Sbjct: 245 QS-LLCGQ 251
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 9e-33
Identities = 83/277 (29%), Positives = 124/277 (44%), Gaps = 40/277 (14%)
Query: 11 YQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKS 70
Y+ L + G + V KC +K T A K ++ D + L E VL +
Sbjct: 3 YEVL--GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RH 59
Query: 71 ERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDH 130
E IV L E + + LV E V L+ L G+P RSY+ Q+L+A+A+ H H
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 131 NITHLDLKPQNILLTKDNNIKLCDFGISRVV--NDVVEVKEIIGTPDYVAPEVL----SY 184
NI H D+KP+NIL+++ +KLCDFG +R + + + + T Y APE+L +Y
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179
Query: 185 EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQC--------------NFSFH 230
D+W++G + LL F GD+ + I +C N F
Sbjct: 180 GK---PVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236
Query: 231 EDLF--------------GHISSQAKDFIQSCLVTDP 253
F G +SS A DF+++CL DP
Sbjct: 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDP 273
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-32
Identities = 69/236 (29%), Positives = 107/236 (45%), Gaps = 7/236 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RG F V C K + K I + + D+ +E VL L I+ +E +
Sbjct: 10 RGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN-IIEYYENF 68
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
+++V+E P G L + + + E + QIL AL +H I H DLK
Sbjct: 69 LEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLK 128
Query: 139 PQNILLTKDNNI-KLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
QNILL K + K+ DFGIS++++ + ++GTP Y++PE+ +P + +D+W++G
Sbjct: 129 TQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALG 188
Query: 198 VLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ Y L S F N L I F+ D S + I S L DP
Sbjct: 189 CVLYELASLKRAFEAANLPALVLKIMSGTFAPISD---RYSPDLRQLILSMLNLDP 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-32
Identities = 69/236 (29%), Positives = 114/236 (48%), Gaps = 25/236 (10%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
GKF V HK T+ + K I+ + + E V L + + + L+
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVT 79
Query: 82 TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQN 141
T VL+++ + DG+L L+ + + E + + ++Q++EAL LH HNI H D+K +N
Sbjct: 80 TLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLEN 139
Query: 142 ILLT-KDNNIKLCDFGISRVVN-----DVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
+L + I LCD+G+ +++ D GT DY +PE + ++ D W+
Sbjct: 140 VLYDRAKDRIYLCDYGLCKIIGTPSCYD--------GTLDYFSPEKIKGHNYDVSFDWWA 191
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDL--FGHISSQAKDFIQSCL 249
VGVL Y LL+ PF D +E L++ + L ++S A DF+QS L
Sbjct: 192 VGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQQKKLPFIKNVSKNANDFVQSML 245
|
Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 6e-32
Identities = 83/239 (34%), Positives = 123/239 (51%), Gaps = 11/239 (4%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
G F V K HK T + AAK I+ S ++++D + E +L K IVGL+E Y
Sbjct: 16 GAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILS-ECKHPNIVGLYEAYF 72
Query: 82 TPHEMVLVLEMVPDGELQRLVD-IQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
+++ +++E G L ++ ++ G+ E R +Q+LEAL FLH H + H DLK
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAG 132
Query: 141 NILLTKDNNIKLCDFGISRVVNDVVEVKE-IIGTPDYVAPEVLSYE-----PISLATDMW 194
NILLT D ++KL DFG+S ++ ++ IGTP ++APEV++ E P D+W
Sbjct: 133 NILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIW 192
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
S+G+ L P N L I + D SS DF++SCLV DP
Sbjct: 193 SLGITLIELAQMEPPHHELNPMRVLLKILKSE-PPTLDQPSKWSSSFNDFLKSCLVKDP 250
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-32
Identities = 66/192 (34%), Positives = 101/192 (52%), Gaps = 2/192 (1%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQD-ILHEAAVLYLAQKSERIVGLHEI 79
RG +A V K T+ YA K I+K + D+ D + E V A +VGLH
Sbjct: 5 RGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSC 64
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++T + V+E V G+L + Q +PE+ R Y +I AL FLH+ I + DLK
Sbjct: 65 FQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKL 124
Query: 140 QNILLTKDNNIKLCDFGISRV-VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
N+LL + +IKL D+G+ + + GTP+Y+APE+L E + D W++GV
Sbjct: 125 DNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 184
Query: 199 LAYVLLSSHSPF 210
L + +++ SPF
Sbjct: 185 LMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-32
Identities = 71/235 (30%), Positives = 113/235 (48%), Gaps = 6/235 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ-MQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V K T YA K ++K D ++ + E VL L K + LH
Sbjct: 10 KGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 69
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++T + V+E V G+L + E Y +I L FLH I + DLK
Sbjct: 70 FQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKL 129
Query: 140 QNILLTKDNNIKLCDFGISRV-VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
N++L + +IK+ DFG+ + + + GTPDY+APE+++Y+P + D W+ GV
Sbjct: 130 DNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 189
Query: 199 LAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
L Y +L+ PF G+++ E F +I + N S+ + L S +A + L P
Sbjct: 190 LLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSL----SKEAVSICKGLLTKHP 240
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-31
Identities = 70/237 (29%), Positives = 119/237 (50%), Gaps = 9/237 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGLHEI 79
+G F V K K K YA K I + + + ++ + EA VL A+ S I+ +E
Sbjct: 10 KGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVL--AKLDSSYIIRYYES 67
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+ ++ +V+E +G+L +L+ +Q G +PE + QIL LA LH I H D+
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDI 127
Query: 138 KPQNILLTKDNNIKLCDFGISRVVND-VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSV 196
K N+ L +N+K+ D G++++++D I+GTP Y++PE+ +P + +D+W++
Sbjct: 128 KSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWAL 187
Query: 197 GVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
GV+ Y + PF +N+ L I + F + S Q I CL D
Sbjct: 188 GVVLYECCTGKHPFDANNQGALILKIIRGVF---PPVSQMYSQQLAQLIDQCLTKDY 241
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 72/240 (30%), Positives = 123/240 (51%), Gaps = 12/240 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILH---EAAVLYLAQKSER--IVG 75
+G F V + K T+ YA K + K+ + +++ H E +L E IVG
Sbjct: 3 KGTFGQVYQVRKKDTRRIYAMKVLSKK--EIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 76 LHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
L ++T ++ LV + + GEL + + E + Y+ +++ AL LH ++I +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 136 DLKPQNILLTKDNNIKLCDFGISRV-VNDVVEVKEIIGTPDYVAPEVLSYEP-ISLATDM 193
DLKP+NILL +I LCDFG+S+ + D GT +Y+APEVL E + D
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180
Query: 194 WSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
WS+GVL + + SPF ++ Q+ + NI+ F +++ +S + + F++ L +P
Sbjct: 181 WSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNV---LSDEGRQFVKGLLNRNP 237
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-31
Identities = 69/236 (29%), Positives = 115/236 (48%), Gaps = 4/236 (1%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ-MQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V C K T YA K + K+R + Q L+E +L S IV L
Sbjct: 3 KGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYA 61
Query: 80 YETPHEMVLVLEMVPDGELQ-RLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+ET ++ LV+ ++ G+L+ + ++ + G PE Y QI+ L LH I + DL
Sbjct: 62 FETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDL 121
Query: 138 KPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
KP+N+LL N+++ D G++ + ++K GTP Y+APEVL E + D +++G
Sbjct: 122 KPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALG 181
Query: 198 VLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
Y +++ SPF ++ + + + S +AKD ++ L DP
Sbjct: 182 CTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDP 237
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 7e-31
Identities = 71/238 (29%), Positives = 115/238 (48%), Gaps = 11/238 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
+G + SV K YA K + S + +D ++E +L + I+ E +
Sbjct: 10 KGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRIL-ASVNHPNIISYKEAF 68
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDG----IPEQDTRSYMKQILEALAFLHDHNITHLD 136
+++ +V+E P G+L + + + IPEQ+ Q+L L LH+ I H D
Sbjct: 69 LDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRD 128
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSV 196
LK NILL ++ +K+ D GIS+V+ + K IGTP Y+APEV P S +D+WS+
Sbjct: 129 LKSANILLVANDLVKIGDLGISKVLKKNM-AKTQIGTPHYMAPEVWKGRPYSYKSDIWSL 187
Query: 197 GVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ-AKDFIQSCLVTDP 253
G L Y + + PF + Q+ + + + I SQ ++FI+S L P
Sbjct: 188 GCLLYEMATFAPPFEARSMQDLRYKVQRGKY----PPIPPIYSQDLQNFIRSMLQVKP 241
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 8e-31
Identities = 67/237 (28%), Positives = 116/237 (48%), Gaps = 9/237 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSER--IVGLH 77
+G F V + TK +A K++ K++ ++++L+E +L Q+ +V L
Sbjct: 10 KGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRIL---QELNHPFLVNLW 66
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
++ M LV++++ G+L+ + + E+ + ++ +I+ AL +LH I H D+
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDI 126
Query: 138 KPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
KP NILL + ++ + DF I+ V GTP Y+APEVL + S+A D WS+G
Sbjct: 127 KPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLG 186
Query: 198 VLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLF-GHISSQAKDFIQSCLVTDP 253
V AY L P+ T + + + L+ S++A D I L DP
Sbjct: 187 VTAYECLRGKRPY--RGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDP 241
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 84/248 (33%), Positives = 124/248 (50%), Gaps = 25/248 (10%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRK---RRRSMD----QMQDILHEAAVLYLAQKSERI 73
RG F V+ HK +K YA K + K +RS + +DI+ A SE I
Sbjct: 53 RGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-------NSEWI 105
Query: 74 VGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
V LH ++ + +V+E +P G+L L+ D IPE+ R Y +++ AL +H
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYTAEVVLALDAIHSMGFI 164
Query: 134 HLDLKPQNILLTKDNNIKLCDFG--ISRVVNDVVEVKEIIGTPDYVAPEVLSYEPIS--- 188
H D+KP N+LL K ++KL DFG + N +V +GTPDY++PEVL +
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYY 224
Query: 189 -LATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNI--SQCNFSFHEDLFGHISSQAKDFI 245
D WSVGV Y +L +PF D+ T+ I + + +F +D+ IS QAKD I
Sbjct: 225 GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI--EISKQAKDLI 282
Query: 246 QSCLVTDP 253
+ L
Sbjct: 283 CAFLTDRE 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-30
Identities = 75/239 (31%), Positives = 115/239 (48%), Gaps = 16/239 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V HK YA K ++K+ + + I+ E VL K +VGLH
Sbjct: 5 KGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYS 64
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++T ++ VL+ V GEL + + PE R Y +I AL +LH NI + DLKP
Sbjct: 65 FQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKP 124
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKE----IIGTPDYVAPEVLSYEPISLATDMWS 195
+NILL ++ L DFG+ + + +E + GTP+Y+APEVL +P D W
Sbjct: 125 ENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWC 181
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE--DLFGHISSQAKDFIQSCLVTD 252
+G + Y +L PF + E + NI ++ L +IS A+ ++ L D
Sbjct: 182 LGAVLYEMLYGLPPFYSRDTAEMYDNI------LNKPLRLKPNISVSARHLLEGLLQKD 234
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-30
Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 2/211 (0%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ-MQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V K T YA K ++K D ++ + E VL L+ K + LH
Sbjct: 10 KGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSC 69
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++T + V+E V G+L + E Y +I L FLH I + DLK
Sbjct: 70 FQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKL 129
Query: 140 QNILLTKDNNIKLCDFGISRV-VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
N++L + +IK+ DFG+ + + D V K GTPDY+APE+++Y+P + D W+ GV
Sbjct: 130 DNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 189
Query: 199 LAYVLLSSHSPFAGDNKQETFLNISQCNFSF 229
L Y +L+ +PF G+++ E F +I + N ++
Sbjct: 190 LLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 220
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-30
Identities = 78/283 (27%), Positives = 126/283 (44%), Gaps = 62/283 (21%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSM---DQM------QDILHEAAVLYLAQKSE 71
RG F VR K T YA K +RK M +Q+ +DIL EA +
Sbjct: 11 RGAFGEVRLVQKKDTGHIYAMKKLRKS--EMLEKEQVAHVRAERDILAEA-------DNP 61
Query: 72 RIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHN 131
+V L+ ++ + + L++E +P G++ L+ +D E++TR Y+ + + A+ +H
Sbjct: 62 WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121
Query: 132 ITHLDLKPQNILLTKDNNIKLCDFGI------------------SRVVNDVVEVKE---- 169
H D+KP N+LL +IKL DFG+ + N + + +
Sbjct: 122 YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181
Query: 170 -----------------IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAG 212
+GTPDY+APEV + D WS+GV+ Y +L + PF
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 213 DNKQETFLNISQCN--FSFHEDLFGHISSQAKDFIQSCLVTDP 253
DN QET+ I F +++ +S +AKD I+ L +
Sbjct: 242 DNPQETYRKIINWKETLQFPDEV--PLSPEAKDLIKR-LCCEA 281
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 6e-30
Identities = 74/238 (31%), Positives = 117/238 (49%), Gaps = 6/238 (2%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRR--RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
GK VRK YA K ++K + + E VL ++ +V LH
Sbjct: 14 GKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA 73
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++T ++ L+L+ V GEL + ++ E + R Y+ +I+ AL LH I + D+K
Sbjct: 74 FQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKL 133
Query: 140 QNILLTKDNNIKLCDFGISR--VVNDVVEVKEIIGTPDYVAPEVLSYEPI--SLATDMWS 195
+NILL + ++ L DFG+S+ + + GT +Y+APEV+ A D WS
Sbjct: 134 ENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWS 193
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+GVL + LL+ SPF D +Q + IS+ +S++A+DFIQ L DP
Sbjct: 194 LGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDP 251
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-30
Identities = 70/218 (32%), Positives = 108/218 (49%), Gaps = 14/218 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDI---LHEAAVLYLAQKSERIVGLH 77
+G F V K T YA K ++K + Q D+ + E +L LA K + LH
Sbjct: 5 KGSFGKVMLAELKGTDEVYAIKVLKKD--VILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
++T + V+E V G+L + E +R Y ++ AL FLH H + + DL
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122
Query: 138 KPQNILLTKDNNIKLCDFGISR--VVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
K NILL + + KL DFG+ + ++N V GTPDY+APE+L + D W+
Sbjct: 123 KLDNILLDAEGHCKLADFGMCKEGILNGVT-TTTFCGTPDYIAPEILQELEYGPSVDWWA 181
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDL 233
+GVL Y +++ PF DN+ + F +I H+D+
Sbjct: 182 LGVLMYEMMAGQPPFEADNEDDLFESI------LHDDV 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-30
Identities = 69/215 (32%), Positives = 109/215 (50%), Gaps = 2/215 (0%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ-MQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V K T YA K ++K D ++ + E VL L K + LH
Sbjct: 10 KGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSC 69
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++T + V+E V G+L + E Y +I L FLH I + DLK
Sbjct: 70 FQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKL 129
Query: 140 QNILLTKDNNIKLCDFGISRV-VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
N++L + +IK+ DFG+ + + D V + GTPDY+APE+++Y+P + D W+ GV
Sbjct: 130 DNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGV 189
Query: 199 LAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDL 233
L Y +L+ PF G+++ E F +I + N S+ + L
Sbjct: 190 LLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSL 224
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 8e-30
Identities = 57/165 (34%), Positives = 83/165 (50%), Gaps = 3/165 (1%)
Query: 90 LEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN 149
LE+VP G L +L+ PE R Y +QIL L +LHD N H D+K NIL+ +
Sbjct: 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV 140
Query: 150 IKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVL-SYEPISLATDMWSVGVLAYVLLSSHS 208
+KL DFG+++ V + K G+P ++APEV+ LA D+WS+G + +
Sbjct: 141 VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKP 200
Query: 209 PFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
P++ I + H+S +AKDFI CL DP
Sbjct: 201 PWSQLEGVAAVFKIG--RSKELPPIPDHLSDEAKDFILKCLQRDP 243
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-29
Identities = 79/236 (33%), Positives = 116/236 (49%), Gaps = 9/236 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQ-KSERIVGLHE 78
+G F V + + T+ YA K IRK S ++ L E VL AQ IV L
Sbjct: 3 KGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVL--AQVNCPFIVPLKF 60
Query: 79 IYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
+++P ++ LVL + GEL + + R Y ++L AL LH N+ + DLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 139 PQNILLTKDNNIKLCDFGISRV-VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
P+NILL +I LCDFG+ ++ + D + GTP+Y+APE+L + A D W++G
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLG 180
Query: 198 VLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
VL Y +L+ PF +N E + I Q F + AKD + L DP
Sbjct: 181 VLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG----FDRDAKDLLIGLLSRDP 232
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-29
Identities = 72/247 (29%), Positives = 113/247 (45%), Gaps = 20/247 (8%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGL--HE 78
+G F +VRK K K I + + Q ++ E +L K IV
Sbjct: 10 KGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILR-ELKHPNIVRYYDRI 68
Query: 79 IYETPHEMVLVLEMVPDGELQRLVDIQ------DGIPEQDTRSYMKQILEALAFLH---- 128
I + + +V+E G+L +L IQ I E+ + Q+L AL H
Sbjct: 69 IDRSNQTLYIVMEYCEGGDLAQL--IQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 129 -DHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVVEVKEIIGTPDYVAPEVLSYEP 186
+ + H DLKP NI L +NN+KL DFG+++++ D K +GTP Y++PE L++
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMS 186
Query: 187 ISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246
+D+WS+G L Y L + PF N+ + I + F + SS+ + I+
Sbjct: 187 YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR---RIPYRYSSELNEVIK 243
Query: 247 SCLVTDP 253
S L DP
Sbjct: 244 SMLNVDP 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 6e-29
Identities = 69/235 (29%), Positives = 112/235 (47%), Gaps = 6/235 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V K + YA K ++K D ++ + E +L LA+ + L+
Sbjct: 5 KGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCC 64
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++TP + V+E V G+L + E R Y +I AL FLHD I + DLK
Sbjct: 65 FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKL 124
Query: 140 QNILLTKDNNIKLCDFGISRV-VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
N+LL + + KL DFG+ + + + GTPDY+APE+L + D W++GV
Sbjct: 125 DNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGV 184
Query: 199 LAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
L Y +L H+PF +N+ + F I + +S A D +++ + +P
Sbjct: 185 LLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLSQDAVDILKAFMTKNP 235
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-28
Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 4/204 (1%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
G F K +Y K I + S + ++ E AVL K IV E +E
Sbjct: 11 GSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLS-NMKHPNIVQYQESFE 69
Query: 82 TPHEMVLVLEMVPDGELQRLVDIQDGI--PEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
+ +V++ G+L + ++ Q G+ PE + QI AL +HD I H D+K
Sbjct: 70 ENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKS 129
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEV-KEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
QNI LTKD IKL DFGI+RV+N VE+ + IGTP Y++PE+ P + +D+W++G
Sbjct: 130 QNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGC 189
Query: 199 LAYVLLSSHSPFAGDNKQETFLNI 222
+ Y + + F N + L I
Sbjct: 190 VLYEMCTLKHAFEAGNMKNLVLKI 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 77/237 (32%), Positives = 115/237 (48%), Gaps = 10/237 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ-MQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V K T +A K ++K D ++ + E VL LA + + L
Sbjct: 5 KGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCT 64
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDL 137
++T + V+E + G+L + IQ E R Y +I+ L FLH I + DL
Sbjct: 65 FQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDL 122
Query: 138 KPQNILLTKDNNIKLCDFGISRV-VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSV 196
K N+LL KD +IK+ DFG+ + +N + GTPDY+APE+L + + + D WS
Sbjct: 123 KLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSF 182
Query: 197 GVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
GVL Y +L SPF G+++ E F +I F IS +AKD + DP
Sbjct: 183 GVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR----WISKEAKDCLSKLFERDP 235
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 78/249 (31%), Positives = 126/249 (50%), Gaps = 20/249 (8%)
Query: 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAV--LYL 66
GGY GK VRK T T +A K ++K +Q +D H A +
Sbjct: 7 GGY----------GKVFQVRKVTGADTGKIFAMKVLKKATIVRNQ-KDTAHTKAERNILE 55
Query: 67 AQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRS-YMKQILEALA 125
A K IV L ++T ++ L+LE + GEL ++ ++GI +DT Y+ +I AL
Sbjct: 56 AVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLE-REGIFMEDTACFYLSEISLALE 114
Query: 126 FLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR-VVNDVVEVKEIIGTPDYVAPEVLSY 184
LH I + DLKP+NILL ++KL DFG+ + +++ GT +Y+APE+L
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR 174
Query: 185 EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244
A D WS+G L Y +L+ PF +N+++T I + + L +++ +A+D
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN----LPPYLTPEARDL 230
Query: 245 IQSCLVTDP 253
++ L +P
Sbjct: 231 LKKLLKRNP 239
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-28
Identities = 70/249 (28%), Positives = 119/249 (47%), Gaps = 33/249 (13%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSER---IVGL 76
RG F V +K T YA K ++K + D+++ ++ E + + SER +V L
Sbjct: 9 RGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRI-FETANSERHPFLVNL 67
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVDIQDGI-PEQDTRSYMKQILEALAFLHDHNITHL 135
++T + V+E G+L ++ I + E Y ++ L +LH++ I +
Sbjct: 68 FACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEII----------GTPDYVAPEVLSYE 185
DLK N+LL + +K+ DFG+ KE + GTP+++APEVL+
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGL---------CKEGMGFGDRTSTFCGTPEFLAPEVLTET 176
Query: 186 PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLF-GHISSQAKDF 244
+ A D W +GVL Y +L SPF GD+++E F +I E + +S +A
Sbjct: 177 SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-----DEVRYPRFLSREAISI 231
Query: 245 IQSCLVTDP 253
++ L +P
Sbjct: 232 MRRLLRRNP 240
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-28
Identities = 68/252 (26%), Positives = 115/252 (45%), Gaps = 33/252 (13%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIR-------KRR----RSMDQMQDILHEAAVLYLAQK 69
+G+F+ V K + A K ++ K R + +D ++ + H + YLA
Sbjct: 12 KGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASF 71
Query: 70 SERIVGLHEIYETPHEMVLVLEMVPDGELQRLVD--IQDG--IPEQDTRSYMKQILEALA 125
I +E+ +VLE+ G+L R++ + IPE+ Y Q+ AL
Sbjct: 72 ---------IEN--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 126 FLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVEVKEIIGTPDYVAPEVLSY 184
+H I H D+KP N+ +T +KL D G+ R + ++GTP Y++PE +
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 185 EPISLATDMWSVGVLAYVLLSSHSPFAGD--NKQETFLNISQCNFS-FHEDLFGHISSQA 241
+ +D+WS+G L Y + + SPF GD N I +C++ D H S +
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPAD---HYSEEL 237
Query: 242 KDFIQSCLVTDP 253
+D + C+ DP
Sbjct: 238 RDLVSRCINPDP 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-28
Identities = 66/192 (34%), Positives = 100/192 (52%), Gaps = 2/192 (1%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQD-ILHEAAVLYLAQKSERIVGLHEI 79
RG +A V K YA K ++K D+ D + E V A + +VGLH
Sbjct: 5 RGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSC 64
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++T + LV+E V G+L + Q +PE+ R Y +I AL FLH+ I + DLK
Sbjct: 65 FQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKL 124
Query: 140 QNILLTKDNNIKLCDFGISRV-VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
N+LL D +IKL D+G+ + + GTP+Y+APE+L E + D W++GV
Sbjct: 125 DNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGV 184
Query: 199 LAYVLLSSHSPF 210
L + +++ SPF
Sbjct: 185 LMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-28
Identities = 71/242 (29%), Positives = 116/242 (47%), Gaps = 13/242 (5%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
G F V + T A K IR + +++I E VL L K +V + +
Sbjct: 11 GTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEV 69
Query: 82 TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQN 141
++ + +E G L+ L++ + E R Y Q+LE LA+LH H I H D+KP N
Sbjct: 70 HREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPAN 129
Query: 142 ILLTKDNNIKLCDFGISRVVND-----VVEVKEIIGTPDYVAPEVLSYEPIS---LATDM 193
I L + IKL DFG + + + EV+ + GTP Y+APEV++ A D+
Sbjct: 130 IFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADI 189
Query: 194 WSVGVLAYVLLSSHSPFAG-DNKQETFLNISQCNF-SFHEDLFGHISSQAKDFIQSCLVT 251
WS+G + + + P++ DN+ + ++ + + L +S + KDF+ CL +
Sbjct: 190 WSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSL--QLSPEGKDFLDRCLES 247
Query: 252 DP 253
DP
Sbjct: 248 DP 249
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-28
Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 18/219 (8%)
Query: 18 MPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM-DQMQDILHEAAVLYLAQKSERIVGL 76
+ S G + +V HK T+ +A K I K+ + +Q+Q + E +L A+ + +V +
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSM 66
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
+ET + +V+E V G+ L+ +P R Y + + AL +LH++ I H D
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRD 126
Query: 137 LKPQNILLTKDNNIKLCDFGISRV--------------VNDVVEV--KEIIGTPDYVAPE 180
LKP N+L+T +IKL DFG+S++ D E K++ GTP+Y+APE
Sbjct: 127 LKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186
Query: 181 VLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETF 219
V+ + D W++G++ Y L PF GD +E F
Sbjct: 187 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF 225
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 7e-28
Identities = 68/204 (33%), Positives = 100/204 (49%), Gaps = 2/204 (0%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V HK + YA K ++K+ + + I+ E VL K +VGLH
Sbjct: 5 KGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS 64
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++T ++ VL+ + GEL + + E R Y +I AL +LH NI + DLKP
Sbjct: 65 FQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKP 124
Query: 140 QNILLTKDNNIKLCDFGISRV-VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
+NILL +I L DFG+ + + GTP+Y+APEVL +P D W +G
Sbjct: 125 ENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA 184
Query: 199 LAYVLLSSHSPFAGDNKQETFLNI 222
+ Y +L PF N E + NI
Sbjct: 185 VLYEMLYGLPPFYSRNTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 1e-27
Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 3/205 (1%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
G + V KC HK TK A K + + + + L E +L K E IV L E +
Sbjct: 12 GAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLR-TLKQENIVELKEAFR 70
Query: 82 TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQN 141
++ LV E V L+ L ++ +G+P + RSY+ Q+++A+ + H ++I H D+KP+N
Sbjct: 71 RRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPEN 130
Query: 142 ILLTKDNNIKLCDFGISRVVNDVVEVK--EIIGTPDYVAPEVLSYEPISLATDMWSVGVL 199
+L++ ++ +KLCDFG +R +++ E + T Y +PE+L P A DMWSVG +
Sbjct: 131 LLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCI 190
Query: 200 AYVLLSSHSPFAGDNKQETFLNISQ 224
L F G+++ + I +
Sbjct: 191 LGELSDGQPLFPGESEIDQLFTIQK 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-27
Identities = 63/235 (26%), Positives = 108/235 (45%), Gaps = 8/235 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGLHEI 79
+G F V K K T A K I + D+++DI E L +Q +S I +
Sbjct: 11 KGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFL--SQCRSPYITKYYGS 67
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
+ ++ +++E G L+ + E ++++L L +LH+ H D+K
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKA 126
Query: 140 QNILLTKDNNIKLCDFGIS-RVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
NILL+++ ++KL DFG+S ++ + + + +GTP ++APEV+ D+WS+G+
Sbjct: 127 ANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGI 186
Query: 199 LAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
A L P + + I + N E S KDF+ CL DP
Sbjct: 187 TAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG--NKFSKPFKDFVSLCLNKDP 239
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-27
Identities = 74/238 (31%), Positives = 116/238 (48%), Gaps = 13/238 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSER---IVGL 76
+G F V K + YA K ++K + D++ L E+ VL K+ R + L
Sbjct: 5 KGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVL----KNTRHPFLTSL 60
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
++T + V+E V GEL + + E TR Y +I+ AL +LH I + D
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 137 LKPQNILLTKDNNIKLCDFGISRV-VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
LK +N++L KD +IK+ DFG+ + + D +K GTP+Y+APEVL A D W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 180
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+GV+ Y ++ PF + ++ F I + F L S+ AK + L+ DP
Sbjct: 181 LGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTL----SADAKSLLSGLLIKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-27
Identities = 70/210 (33%), Positives = 112/210 (53%), Gaps = 14/210 (6%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRK-----RRRSMDQMQ-DILHEAAVLYLAQKSERI 73
S GK VRK T YA K ++K R R +M+ DIL E + I
Sbjct: 8 SFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPF-------I 60
Query: 74 VGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
V LH ++T ++ L+L+ + G+L + + E+D + Y+ ++ AL LH I
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISR-VVNDVVEVKEIIGTPDYVAPEVLSYEPISLATD 192
+ DLKP+NILL ++ +IKL DFG+S+ ++ + GT +Y+APEV++ + + D
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSAD 180
Query: 193 MWSVGVLAYVLLSSHSPFAGDNKQETFLNI 222
WS GVL + +L+ PF G +++ET I
Sbjct: 181 WWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 74/265 (27%), Positives = 117/265 (44%), Gaps = 39/265 (14%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ-MQDILHEAAVLYLAQKSERIVGLHEIY 80
G F SV +K T A K ++K+ S ++ M L E L + IV L E++
Sbjct: 10 GTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNEHPNIVKLKEVF 67
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
E+ V E + +G L +L+ + G E RS + QIL+ LA +H H H DLK
Sbjct: 68 RENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLK 126
Query: 139 PQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVL----SYEPISLATDMW 194
P+N+L++ +K+ DFG++R + + + T Y APE+L SY S D+W
Sbjct: 127 PENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSY---SSPVDIW 183
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNI-------------------SQCNFSFHE---- 231
++G + L + F G ++ + I S+ F F +
Sbjct: 184 ALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPT 243
Query: 232 ---DLFGHISSQAKDFIQSCLVTDP 253
L + S +A D I+ L DP
Sbjct: 244 SLHQLIPNASPEAIDLIKDMLRWDP 268
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-27
Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 8/236 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDI--LHEAAVLYLAQKSERIVGLHE 78
+G F V C T E A K + S + +++ L L + ERIV +
Sbjct: 12 QGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYG 71
Query: 79 IYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
+ + +E +P G ++ + + E TR Y +QILE + +LH + I H D+K
Sbjct: 72 CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIK 131
Query: 139 PQNILLTKDNNIKLCDFGISRVVNDV----VEVKEIIGTPDYVAPEVLSYEPISLATDMW 194
NIL N+KL DFG S+ + + +K + GTP +++PEV+S E D+W
Sbjct: 132 GANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVW 191
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLV 250
SVG +L+ P+A I+ + L H+S A++F++ V
Sbjct: 192 SVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQ--LPSHVSPDARNFLRRTFV 245
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-27
Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 7/215 (3%)
Query: 42 KFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRL 101
K + R S + +D L+E +L L Q I+ + + + +++ +E G L
Sbjct: 31 KEVNLTRLSEKERRDALNEIVILSLLQH-PNIIAYYNHFMDDNTLLIEMEYANGGTLYDK 89
Query: 102 VDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159
+ Q G E+ Y+ QI+ A++++H I H D+K NI LTK IKL DFGIS+
Sbjct: 90 IVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISK 149
Query: 160 VVNDVVEVKE-IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQET 218
++ + E ++GTP Y++PE+ + +D+W++G + Y LL+ F N
Sbjct: 150 ILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL 209
Query: 219 FLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ I Q N + + SS+ + S L DP
Sbjct: 210 VVKIVQGN---YTPVVSVYSSELISLVHSLLQQDP 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-27
Identities = 78/263 (29%), Positives = 116/263 (44%), Gaps = 34/263 (12%)
Query: 22 GKFASVRKCTHKIT-KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGLHEI 79
G + V KC HK T ++ KF+ D+M + + L Q + E +V L E+
Sbjct: 12 GSYGMVMKCKHKETGQIVAIKKFLE---SEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
+ + LV E V L L +G+ E R Y+ QIL + F H HNI H D+KP
Sbjct: 69 FRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKP 128
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEV-KEIIGTPDYVAPEVLSYEP-ISLATDMWSVG 197
+NIL+++ +KLCDFG +R + EV + + T Y APE+L + A D+W+VG
Sbjct: 129 ENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVG 188
Query: 198 VLAYVLLSSHSPFAGDNKQETFLNISQC--NFSFH------------------------- 230
L +L+ F GD+ + +I +C N
Sbjct: 189 CLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPL 248
Query: 231 EDLFGHISSQAKDFIQSCLVTDP 253
E F +S D + CL DP
Sbjct: 249 EKRFPKLSGLVLDLAKQCLRIDP 271
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 8/207 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQD-ILHEAAVLYLAQKSERIVGLHEI 79
+G F V K YA K ++K+ + Q+ I+ E VL K +VGLH
Sbjct: 5 KGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYS 64
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++T ++ VL+ V GEL + + E R Y ++ A+ +LH NI + DLKP
Sbjct: 65 FQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKP 124
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKE----IIGTPDYVAPEVLSYEPISLATDMWS 195
+NILL ++ L DFG+ + + VE +E GTP+Y+APEVL EP D W
Sbjct: 125 ENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWC 181
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNI 222
+G + Y +L PF + + + NI
Sbjct: 182 LGAVLYEMLYGLPPFYSRDVSQMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-27
Identities = 65/239 (27%), Positives = 114/239 (47%), Gaps = 16/239 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMD-QMQDILHEAAVLYLAQKSERIVGLHEI 79
G + SV K HK T A K + ++ +Q+I+ E ++L S IV +
Sbjct: 13 EGSYGSVYKAIHKETGQVVAIKVV-----PVEEDLQEIIKEISILKQC-DSPYIVKYYGS 66
Query: 80 YETPHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
Y ++ +V+E G + ++ I + E++ + + Q L+ L +LH + H D+K
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIK 126
Query: 139 PQNILLTKDNNIKLCDFGIS-RVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
NILL ++ KL DFG+S ++ + + + +IGTP ++APEV+ + D+WS+G
Sbjct: 127 AGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLG 186
Query: 198 VLAYVLLSSHSPFAGDNKQETFLNISQC---NFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ A + P++ + I S E S + DF++ CLV DP
Sbjct: 187 ITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKW----SPEFNDFVKKCLVKDP 241
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-27
Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 8/207 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKR----RRSMDQMQDILHEAAVLYLAQKSERIVGL 76
+G F V K+ YA K ++K+ R+ + + I+ E VL K +VGL
Sbjct: 5 KGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRK---EQKHIMAERNVLLKNVKHPFLVGL 61
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
H ++T ++ VL+ V GEL + + PE R Y +I AL +LH NI + D
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRD 121
Query: 137 LKPQNILLTKDNNIKLCDFGISRV-VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
LKP+NILL ++ L DFG+ + + GTP+Y+APEV+ +P D W
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWC 181
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNI 222
+G + Y +L PF + E + NI
Sbjct: 182 LGAVLYEMLYGLPPFYCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-27
Identities = 64/192 (33%), Positives = 101/192 (52%), Gaps = 2/192 (1%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQD-ILHEAAVLYLAQKSERIVGLHEI 79
RG +A V K T+ YA K ++K + D+ D + E V A +VGLH
Sbjct: 5 RGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 64
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++T + V+E V G+L + Q +PE+ R Y +I AL +LH+ I + DLK
Sbjct: 65 FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKL 124
Query: 140 QNILLTKDNNIKLCDFGISRV-VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
N+LL + +IKL D+G+ + + GTP+Y+APE+L E + D W++GV
Sbjct: 125 DNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 184
Query: 199 LAYVLLSSHSPF 210
L + +++ SPF
Sbjct: 185 LMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 3e-26
Identities = 73/233 (31%), Positives = 112/233 (48%), Gaps = 11/233 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RG F V+ HK T+ YA K + K E + S +V L +
Sbjct: 53 RGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 112
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
+ + +V+E +P G+L L+ D +PE+ R Y +++ AL +H H D+KP
Sbjct: 113 QDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPD 171
Query: 141 NILLTKDNNIKLCDFGISRVVND--VVEVKEIIGTPDYVAPEVLSYEP----ISLATDMW 194
N+LL K ++KL DFG +N +V +GTPDY++PEVL + D W
Sbjct: 172 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNI--SQCNFSFHEDLFGHISSQAKDFI 245
SVGV Y +L +PF D+ T+ I + + +F +D IS +AK+ I
Sbjct: 232 SVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISKEAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-26
Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 35/217 (16%)
Query: 69 KSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLH 128
K +V L E++ ++ LV E L L G+PE + + Q L+A+ F H
Sbjct: 58 KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 129 DHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEVKEIIGTPDYVAPEVL----S 183
HN H D+KP+NIL+TK IKLCDFG +R++ + + + T Y APE+L
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ 177
Query: 184 YEPISLATDMWSVGVLAYVLLSSHSPFAGDNK-------QETF-------LNISQCNFSF 229
Y P D+W++G + LL+ + G + ++T I N F
Sbjct: 178 YGP---PVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234
Query: 230 H-------------EDLFGHISSQAKDFIQSCLVTDP 253
E F +ISS A F++ CL DP
Sbjct: 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDP 271
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-26
Identities = 71/237 (29%), Positives = 113/237 (47%), Gaps = 11/237 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSER--IVGLH 77
+G F V K T YA K ++K + D++ L E+ VL Q + + L
Sbjct: 5 KGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVL---QNTRHPFLTALK 61
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
++T + V+E GEL + + E R Y +I+ AL +LH ++ + DL
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121
Query: 138 KPQNILLTKDNNIKLCDFGISRV-VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSV 196
K +N++L KD +IK+ DFG+ + ++D +K GTP+Y+APEVL A D W +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181
Query: 197 GVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
GV+ Y ++ PF + ++ F I F L S +AK + L DP
Sbjct: 182 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL----SPEAKSLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 5e-26
Identities = 73/238 (30%), Positives = 117/238 (49%), Gaps = 12/238 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ-MQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V K +A K ++K +D ++ + E VL LA ++ + L+
Sbjct: 5 KGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCT 64
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRS--YMKQILEALAFLHDHNITHLDL 137
++T + V+E + G+L + IQD R+ Y +I+ L FLH I + DL
Sbjct: 65 FQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122
Query: 138 KPQNILLTKDNNIKLCDFGISR--VVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
K N++L +D +IK+ DFG+ + V D GTPDY+APE+L + + D WS
Sbjct: 123 KLDNVMLDRDGHIKIADFGMCKENVFGDN-RASTFCGTPDYIAPEILQGLKYTFSVDWWS 181
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
GVL Y +L SPF GD++ E F +I + I+ ++KD ++ DP
Sbjct: 182 FGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR----WITKESKDILEKLFERDP 235
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-26
Identities = 67/238 (28%), Positives = 109/238 (45%), Gaps = 8/238 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR---RSMDQMQDILHEAAVLYLAQKSERIVGLH 77
+G F V C + T YA K + K+R R + M L+E +L S +V L
Sbjct: 10 KGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVN-SRFVVSLA 66
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVD--IQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
YET + LVL ++ G+L+ + G E+ Y +I L LH I +
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYR 126
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
DLKP+NILL +I++ D G++ + + ++ +GT Y+APEV+ E + + D W
Sbjct: 127 DLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWG 186
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+G L Y ++ SPF ++ + + E+ S A+ + L DP
Sbjct: 187 LGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-26
Identities = 73/238 (30%), Positives = 120/238 (50%), Gaps = 6/238 (2%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRR--RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
GK VRK + + YA K ++K + + E VL ++S +V LH
Sbjct: 14 GKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 73
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++T ++ L+L+ + GEL + ++ EQ+ + Y +I+ AL LH I + D+K
Sbjct: 74 FQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKL 133
Query: 140 QNILLTKDNNIKLCDFGISR--VVNDVVEVKEIIGTPDYVAPEVLSYEPI--SLATDMWS 195
+NILL + ++ L DFG+S+ ++V GT +Y+AP+++ A D WS
Sbjct: 134 ENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWS 193
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+GVL Y LL+ SPF D ++ + IS+ +S+ AKD IQ L+ DP
Sbjct: 194 MGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDP 251
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 7e-26
Identities = 77/266 (28%), Positives = 122/266 (45%), Gaps = 42/266 (15%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI-Y 80
G F+ V K + T YA K ++K +S++Q+ + L E L I+ L E+ +
Sbjct: 10 GTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPNILRLIEVLF 68
Query: 81 ETPH-EMVLVLEMVPDGELQRLVDIQDG---IPEQDTRSYMKQILEALAFLHDHNITHLD 136
+ + LV E++ D L L I+ +PE+ +SYM Q+L++L +H + I H D
Sbjct: 69 DRKTGRLALVFELM-DMNLYEL--IKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRD 125
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVL----SYEPISLATD 192
+KP+NIL+ KD+ +KL DFG R + E I T Y APE L Y P D
Sbjct: 126 IKPENILI-KDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGP---KMD 181
Query: 193 MWSVGVLAYVLLSSHSPFAGDNK------------------QETFLNISQCNFSFH---- 230
+W+VG + + +LS F G N+ + F N++F
Sbjct: 182 IWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKG 241
Query: 231 ---EDLFGHISSQAKDFIQSCLVTDP 253
L + S++ D ++ L DP
Sbjct: 242 TGLRKLLPNASAEGLDLLKKLLAYDP 267
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-26
Identities = 60/171 (35%), Positives = 94/171 (54%), Gaps = 5/171 (2%)
Query: 63 VLYLAQ-KSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGI--PEQDTRSYMKQ 119
V+ LA+ K IV ++ + +V+E G+L + ++ Q G+ E S+ Q
Sbjct: 50 VILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ 109
Query: 120 ILEALAFLHDHNITHLDLKPQNILLTKDNNI-KLCDFGISRVVNDVVEVKEI-IGTPDYV 177
I L +HD I H D+K QNI L+K+ + KL DFGI+R +ND +E+ +GTP Y+
Sbjct: 110 ISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYL 169
Query: 178 APEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFS 228
+PE+ P + TD+WS+G + Y L + PF G+N + L I Q F+
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-25
Identities = 61/220 (27%), Positives = 105/220 (47%), Gaps = 5/220 (2%)
Query: 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSE 71
Q + + G F H + +YA K IR + S ++D EA VL K
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSA-VEDSRKEA-VLLAKMKHP 58
Query: 72 RIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHD 129
IV E +E + +V+E G+L + + +Q G PE + Q+ + +H+
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 130 HNITHLDLKPQNILLTKDNNIKLCDFGISRVV-NDVVEVKEIIGTPDYVAPEVLSYEPIS 188
+ H D+K +NI LT++ +KL DFG +R++ + +GTP YV PE+ P +
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178
Query: 189 LATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFS 228
+D+WS+G + Y L + PF ++ + L + Q ++
Sbjct: 179 NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 73/242 (30%), Positives = 121/242 (50%), Gaps = 15/242 (6%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRK-----RRRSMDQMQDILHEAAVLYLAQKSERIVGL 76
GK VRK T T YA K ++K + ++++ + E VL ++S +V L
Sbjct: 14 GKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRT---ERNVLEHVRQSPFLVTL 70
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
H ++T ++ L+L+ V GE+ + +D E + R Y +I+ AL LH I + D
Sbjct: 71 HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRD 130
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE----IIGTPDYVAPEVL-SYEPISLAT 191
+K +NILL + ++ L DFG+S+ + E KE GT +Y+APE++ A
Sbjct: 131 IKLENILLDSEGHVVLTDFGLSKEF--LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAV 188
Query: 192 DMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251
D WS+G+L + LL+ SPF + ++ T +S+ I +A+D + L
Sbjct: 189 DWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRK 248
Query: 252 DP 253
DP
Sbjct: 249 DP 250
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 3e-25
Identities = 62/249 (24%), Positives = 107/249 (42%), Gaps = 23/249 (9%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFI--RKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHE 78
G A V + A K I K + S+D ++ E + +V +
Sbjct: 11 VGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD---ELRKEVQAMSQCN-HPNVVKYYT 66
Query: 79 IYETPHEMVLVLEMVPDGELQRLVDI------QDGIPEQDTRSYMKQILEALAFLHDHNI 132
+ E+ LV+ + G L +DI + G+ E + +K++L+ L +LH +
Sbjct: 67 SFVVGDELWLVMPYLSGGSL---LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ 123
Query: 133 THLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV-----KEIIGTPDYVAPEVLSYEP- 186
H D+K NILL +D ++K+ DFG+S + D + K +GTP ++APEV+
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 187 ISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNF-SFHEDL-FGHISSQAKDF 244
D+WS G+ A L + +P++ + + Q + S + S +
Sbjct: 184 YDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKM 243
Query: 245 IQSCLVTDP 253
I CL DP
Sbjct: 244 ISLCLQKDP 252
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-25
Identities = 77/241 (31%), Positives = 120/241 (49%), Gaps = 12/241 (4%)
Query: 18 MPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ-MQDILHEAAVLYLAQKSERIVGL 76
M +G F V K T +A K ++K MD ++ + E VL LA + + L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRS--YMKQILEALAFLHDHNITH 134
+ ++T + V+E + G+L + IQ R+ Y +I+ L FLH I +
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVY 119
Query: 135 LDLKPQNILLTKDNNIKLCDFGISR--VVNDVVEVKEIIGTPDYVAPEVLSYEPISLATD 192
DLK NILL D +IK+ DFG+ + ++ D + GTPDY+APE+L + + + D
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCTFCGTPDYIAPEILLGQKYNTSVD 178
Query: 193 MWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTD 252
WS GVL Y +L SPF G +++E F +I N + L + +AKD + V +
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWL----TREAKDILVKLFVRE 234
Query: 253 P 253
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-25
Identities = 62/240 (25%), Positives = 113/240 (47%), Gaps = 14/240 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL--YLAQKSERIVGLHE 78
RG + +V + H T A K I D + DI E A+L + I +
Sbjct: 11 RGAYGAVYRGKHVPTGRVVALKIINLDTPD-DDVSDIQREVALLSQLRQSQPPNITKYYG 69
Query: 79 IYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
Y + +++E G ++ L+ I E+ ++++L AL ++H + H D+K
Sbjct: 70 SYLKGPRLWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIREVLVALKYIHKVGVIHRDIK 128
Query: 139 PQNILLTKDNNIKLCDFGISRVVNDVVEVKE-IIGTPDYVAPEVL----SYEPISLATDM 193
NIL+T N+KLCDFG++ ++N + +GTP ++APEV+ Y+ D+
Sbjct: 129 AANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYD---TKADI 185
Query: 194 WSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
WS+G+ Y + + + P++ + + I + ED S ++F+ +CL +P
Sbjct: 186 WSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLED--NGYSKLLREFVAACLDEEP 243
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-25
Identities = 69/235 (29%), Positives = 112/235 (47%), Gaps = 7/235 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V K T YA K +RK + D++ + E+ VL + + L
Sbjct: 5 KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-NTRHPFLTALKYA 63
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++T + V+E GEL + + E+ R Y +I+ AL +LH ++ + D+K
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 123
Query: 140 QNILLTKDNNIKLCDFGISRV-VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
+N++L KD +IK+ DFG+ + ++D +K GTP+Y+APEVL A D W +GV
Sbjct: 124 ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 183
Query: 199 LAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ Y ++ PF + + F I F L S +AK + L DP
Sbjct: 184 VMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL----SPEAKSLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 5e-25
Identities = 74/241 (30%), Positives = 113/241 (46%), Gaps = 14/241 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G V K H+ T A K IR Q Q IL E +L+ S IVG + +
Sbjct: 11 AGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQ-ILRELDILHKCN-SPYIVGFYGAF 68
Query: 81 ETPHEMVLVLEMVPDGELQRLVD-IQDGIPEQDTRSYMKQILEALAFLH-DHNITHLDLK 138
++ + +E + G L +++ +Q IPE+ +L+ L +LH H I H D+K
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVK 128
Query: 139 PQNILLTKDNNIKLCDFGISRV-VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
P NIL+ IKLCDFG+S VN + K +GT Y+APE + S+ +D+WS+G
Sbjct: 129 PSNILVNSRGQIKLCDFGVSGQLVNSL--AKTFVGTSSYMAPERIQGNDYSVKSDIWSLG 186
Query: 198 VLAYVLLSSHSPFAGDNKQ-ETFLNISQCNFSFHED---LFGHI-SSQAKDFIQSCLVTD 252
+ L + P+ +N + + Q +E L S +DF+ CL+ D
Sbjct: 187 LSLIELATGRFPYPPENDPPDGIFELLQY--IVNEPPPRLPSGKFSPDFQDFVNLCLIKD 244
Query: 253 P 253
P
Sbjct: 245 P 245
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 6e-25
Identities = 71/238 (29%), Positives = 117/238 (49%), Gaps = 8/238 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR---RSMDQMQDILHEAAVLYLAQKSERIVGLH 77
+G F V C + T YA K + K+R R + M L+E +L S+ +V L
Sbjct: 10 KGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVN-SQFVVNLA 66
Query: 78 EIYETPHEMVLVLEMVPDGELQ-RLVDIQD-GIPEQDTRSYMKQILEALAFLHDHNITHL 135
YET + LVL ++ G+L+ + ++ + G E+ Y +IL L LH N +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYR 126
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
DLKP+NILL +I++ D G++ + + ++ +GT Y+APEVL+ + +L+ D W
Sbjct: 127 DLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWG 186
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+G L Y ++ SPF G ++ + + E S +AK + L DP
Sbjct: 187 LGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 7e-25
Identities = 71/287 (24%), Positives = 110/287 (38%), Gaps = 82/287 (28%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ-------------MQDILHEAAVLYLAQ 68
G +A V K K T A K I+ R + +Q++ H
Sbjct: 11 GTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP-------- 62
Query: 69 KSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIP---EQDTRSYMKQILEALA 125
I+GL +++ + LV E + + +L+++ I+D D +SYM L L
Sbjct: 63 ---NIIGLLDVFGHKSNINLVFEFM-ETDLEKV--IKDKSIVLTPADIKSYMLMTLRGLE 116
Query: 126 FLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPD---------- 175
+LH + I H DLKP N+L+ D +KL DFG++R G+P+
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR----------SFGSPNRKMTHQVVTR 166
Query: 176 -YVAPEVL----SYEPISLATDMWSVGVLAYVLLSSHSPFAGDN---------------K 215
Y APE+L Y DMWSVG + LL GD+
Sbjct: 167 WYRAPELLFGARHYGV---GVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPT 223
Query: 216 QETFLNISQ----CNFSFH-----EDLFGHISSQAKDFIQSCLVTDP 253
+E + ++ F + +F S A D +Q L +P
Sbjct: 224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNP 270
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 7e-25
Identities = 75/266 (28%), Positives = 116/266 (43%), Gaps = 35/266 (13%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQM-QDILHEAAVLYLAQKSER--IVGLH 77
G + +V K T A K +R S + + L E A+L + E IV L
Sbjct: 9 EGAYGTVYKARDLNTGRFVALKKVRVPL-SEEGIPLSTLREIALLKQLESFEHPNIVRLL 67
Query: 78 EI---YETPHEMV--LVLEMVPDGELQRLVD--IQDGIPEQDTRSYMKQILEALAFLHDH 130
++ T E+ LV E V D +L + + G+P + + M+Q+L + FLH H
Sbjct: 68 DVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH 126
Query: 131 NITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLA 190
I H DLKPQNIL+T D +K+ DFG++R+ + + + ++ T Y APEVL +
Sbjct: 127 RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATP 186
Query: 191 TDMWSVGVLAYVLLSSHSPFAGDNK----QETF------------LNISQCNFSFH---- 230
DMWSVG + L F G ++ + F N+S SF
Sbjct: 187 VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTP 246
Query: 231 ---EDLFGHISSQAKDFIQSCLVTDP 253
+ I + D ++ L +P
Sbjct: 247 RSFKSFVPEICEEGLDLLKKMLTFNP 272
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 8e-25
Identities = 63/236 (26%), Positives = 113/236 (47%), Gaps = 11/236 (4%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
G V K T + T E A K +R R+ + I++E ++ K IV ++ Y
Sbjct: 30 GASGEVYKATDRATGKEVAIKKMRLRK---QNKELIINEILIMK-DCKHPNIVDYYDSYL 85
Query: 82 TPHEMVLVLEMVPDGELQRLVDIQDGI-PEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
E+ +V+E + G L ++ E +++L+ L +LH N+ H D+K
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSD 145
Query: 141 NILLTKDNNIKLCDFGIS-RVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVL 199
NILL+KD ++KL DFG + ++ + + ++GTP ++APEV+ + D+WS+G++
Sbjct: 146 NILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIM 205
Query: 200 AYVLLSSHSPFAGDNKQETFLNISQ--CNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ P+ + I+ + + + S + KDF+ CLV DP
Sbjct: 206 CIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW---SPEFKDFLNKCLVKDP 258
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 8e-25
Identities = 70/238 (29%), Positives = 111/238 (46%), Gaps = 8/238 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR---RSMDQMQDILHEAAVLYLAQKSERIVGLH 77
+G F V C + T YA K + K+R R + M L+E +L S +V L
Sbjct: 10 KGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVN-SRFVVSLA 66
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDI--QDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
YET + LVL ++ G+L+ + + G E Y +I L LH I +
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYR 126
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
DLKP+NILL +I++ D G++ V + +K +GT Y+APEV+ E + + D W+
Sbjct: 127 DLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWA 186
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+G L Y +++ SPF K+ + + E+ S A+ + L DP
Sbjct: 187 LGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-25
Identities = 70/233 (30%), Positives = 114/233 (48%), Gaps = 11/233 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RG F V+ HK ++ YA K + K E + S +V L +
Sbjct: 53 RGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF 112
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
+ + +V+E +P G+L L+ D +PE+ + Y +++ AL +H + H D+KP
Sbjct: 113 QDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPD 171
Query: 141 NILLTKDNNIKLCDFGISRVVND--VVEVKEIIGTPDYVAPEVLSYEP----ISLATDMW 194
N+LL K ++KL DFG +++ +V +GTPDY++PEVL + D W
Sbjct: 172 NMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNI--SQCNFSFHEDLFGHISSQAKDFI 245
SVGV + +L +PF D+ T+ I + + +F ED+ IS AK+ I
Sbjct: 232 SVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV--EISKHAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-24
Identities = 59/211 (27%), Positives = 107/211 (50%), Gaps = 8/211 (3%)
Query: 44 IRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVD 103
+RK++R +++L V+ + IV ++ Y E+ +V+E + G L +V
Sbjct: 54 LRKQQR-----RELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV- 107
Query: 104 IQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI-SRVVN 162
+ E+ + +L+AL+FLH + H D+K +ILLT D +KL DFG ++V
Sbjct: 108 THTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167
Query: 163 DVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNI 222
+V K ++GTP ++APEV+S P D+WS+G++ ++ P+ + + I
Sbjct: 168 EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI 227
Query: 223 SQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
++L +S + + F+ LV DP
Sbjct: 228 RDNLPPKLKNLH-KVSPRLRSFLDRMLVRDP 257
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-24
Identities = 55/169 (32%), Positives = 92/169 (54%), Gaps = 26/169 (15%)
Query: 69 KSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDI---QDGIPEQDTRSYMKQILEALA 125
K E IV LH++ T ++++LV E + D +L++ +D + + +S+ Q+L+ +A
Sbjct: 56 KHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 126 FLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV--------NDVVEVKEIIGTPDYV 177
F H++ + H DLKPQN+L+ K +KL DFG++R N+VV T Y
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-------TLWYR 167
Query: 178 APEVL----SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNI 222
AP+VL +Y S + D+WSVG + +++ F G N ++ L I
Sbjct: 168 APDVLLGSRTY---STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-24
Identities = 71/243 (29%), Positives = 113/243 (46%), Gaps = 25/243 (10%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RG F V K T+ YA K + K E + + + I LH +
Sbjct: 11 RGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF 70
Query: 81 ETPHEMVLVLEMVPDGELQRLVD-IQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
+ + + LV++ G+L L+ +D +PE R Y+ +++ A+ +H + H D+KP
Sbjct: 71 QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKP 130
Query: 140 QNILLTKDNNIKLCDFGISRVVND--VVEVKEIIGTPDYVAPEVLS--------YEPISL 189
N+LL + +I+L DFG +N V+ +GTPDY++PE+L Y P
Sbjct: 131 DNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGP--- 187
Query: 190 ATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLF------GHISSQAKD 243
D WS+GV Y +L +PF ++ ET+ I HE+ F +S +AKD
Sbjct: 188 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN-----HEERFQFPSHITDVSEEAKD 242
Query: 244 FIQ 246
IQ
Sbjct: 243 LIQ 245
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-24
Identities = 65/251 (25%), Positives = 117/251 (46%), Gaps = 19/251 (7%)
Query: 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ 68
G Y T+ + ++G+ +V++ + V A K K + +D ++ + H V YL
Sbjct: 11 GAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70
Query: 69 KSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLH 128
+ + + +E VP G + +++ +PE Y KQIL+ +A+LH
Sbjct: 71 CLDDNT-----------ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 129 DHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE-------VKEIIGTPDYVAPEV 181
++ + H D+K N++L + IKL DFG +R + V +K + GTP ++APEV
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 182 LSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQA 241
++ +D+WS+G + + + P A ++ I + L S+ A
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA-HRGLMPRLPDSFSAAA 238
Query: 242 KDFIQSCLVTD 252
DF+ SCL D
Sbjct: 239 IDFVTSCLTRD 249
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-24
Identities = 74/284 (26%), Positives = 119/284 (41%), Gaps = 55/284 (19%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F VR K T YA K + K DQ+ + E VL S +V L+
Sbjct: 11 KGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVL-AESDSPWVVSLYYS 69
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++ + L++E +P G+L ++ D E TR YM + + A+ +H H D+KP
Sbjct: 70 FQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKP 129
Query: 140 QNILLTKDNNIKLCDFGI------------------------------SRVVNDV----- 164
NIL+ + +IKL DFG+ S V+ +
Sbjct: 130 DNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMS 189
Query: 165 -------------VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFA 211
+ +GTPDY+APE+ + D WS+G + + L PF
Sbjct: 190 SKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFC 249
Query: 212 GDNKQETFLNIS--QCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+N ET+ I + F +D+ H+S +A+D I+ L+T+
Sbjct: 250 SENSHETYRKIINWRETLYFPDDI--HLSVEAEDLIRR-LITNA 290
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-24
Identities = 48/153 (31%), Positives = 83/153 (54%), Gaps = 13/153 (8%)
Query: 69 KSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDI--QDGIPEQDTRSYMKQILEALAF 126
IV L ++ + +++ LV E + D +L++ +D G+ +SY+ Q+L+ +A+
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 127 LHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV--KEIIGTPDYVAPEVL-- 182
H H + H DLKPQN+L+ ++ +KL DFG++R V E++ T Y APE+L
Sbjct: 115 CHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLG 173
Query: 183 --SYEPISLATDMWSVGVLAYVLLSSHSPFAGD 213
Y S D+WS+G + +++ F GD
Sbjct: 174 SRQY---STPVDIWSIGCIFAEMVNRRPLFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 3e-24
Identities = 69/247 (27%), Positives = 120/247 (48%), Gaps = 23/247 (9%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL---YLAQKSER-IVGL 76
+G F V C + T YA K + K+R + +E A++ LA+ R IV L
Sbjct: 3 KGGFGEVSACQMRATGKLYACKKLNKKRLKKRKG----YEGAMVEKRILAKVHSRFIVSL 58
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVDIQD----GIPEQDTRSYMKQILEALAFLHDHNI 132
++T ++ LV+ ++ G+L+ + D G PE Y QI+ L LH I
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI 118
Query: 133 THLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE-VKEIIGTPDYVAPEVLSYEPISLAT 191
+ DLKP+N+LL D N+++ D G++ + D K GTP ++APE+L E +
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSV 178
Query: 192 DMWSVGVLAYVLLSSHSPFAG-----DNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246
D +++GV Y ++++ PF +NK+ ++ + ++ + S +K F +
Sbjct: 179 DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-SVTYPDKF----SPASKSFCE 233
Query: 247 SCLVTDP 253
+ L DP
Sbjct: 234 ALLAKDP 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 3e-24
Identities = 71/236 (30%), Positives = 111/236 (47%), Gaps = 8/236 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V K T YA K ++K + D++ L E VL + + L
Sbjct: 5 KGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ-NSRHPFLTALKYS 63
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLH-DHNITHLDLK 138
++T + V+E GEL + + E R Y +I+ AL +LH + N+ + DLK
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLK 123
Query: 139 PQNILLTKDNNIKLCDFGISRV-VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
+N++L KD +IK+ DFG+ + + D +K GTP+Y+APEVL A D W +G
Sbjct: 124 LENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 183
Query: 198 VLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
V+ Y ++ PF + ++ F I F L S +AK + L DP
Sbjct: 184 VVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL----SPEAKSLLSGLLKKDP 235
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-24
Identities = 68/238 (28%), Positives = 110/238 (46%), Gaps = 10/238 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQK--SERIVGLHE 78
+G F V C T E A K ++ S + +++ + L + ERIV +
Sbjct: 12 QGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYG 71
Query: 79 IYETPHEMVL--VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
P E L +E +P G ++ + + E TR Y +QILE +++LH + I H D
Sbjct: 72 CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRD 131
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDV----VEVKEIIGTPDYVAPEVLSYEPISLATD 192
+K NIL N+KL DFG S+ + + +K + GTP +++PEV+S E D
Sbjct: 132 IKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKAD 191
Query: 193 MWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLV 250
+WSVG +L+ P+A I+ + L H+S +DF++ V
Sbjct: 192 IWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA--TQPTNPVLPPHVSDHCRDFLKRIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 7e-24
Identities = 67/238 (28%), Positives = 112/238 (47%), Gaps = 10/238 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ--KSERIVGLHE 78
+G F V C T E AAK ++ S + +++ + L + + ERIV +
Sbjct: 12 QGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYG 71
Query: 79 IYETPHE--MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
E + + +E +P G ++ + + E TR Y +QILE +++LH + I H D
Sbjct: 72 CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRD 131
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDV----VEVKEIIGTPDYVAPEVLSYEPISLATD 192
+K NIL N+KL DFG S+ + + ++ + GTP +++PEV+S E D
Sbjct: 132 IKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKAD 191
Query: 193 MWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLV 250
+WS+G +L+ P+A I+ + L HIS A+DF+ V
Sbjct: 192 VWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA--TQPTNPQLPSHISEHARDFLGCIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 7e-24
Identities = 72/235 (30%), Positives = 116/235 (49%), Gaps = 11/235 (4%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
G F V K +K T V AAK I + S ++++D + E +L + IV L + +
Sbjct: 16 GAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDIL-ASCDHPNIVKLLDAFY 72
Query: 82 TPHEMVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
+ + +++E G + +++++ + E R KQ LEAL +LH++ I H DLK
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAG 132
Query: 141 NILLTKDNNIKLCDFGISRVVNDVVEVKE-IIGTPDYVAPEVLSYE-----PISLATDMW 194
NIL T D +IKL DFG+S ++ ++ IGTP ++APEV+ E P D+W
Sbjct: 133 NILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW 192
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249
S+G+ + P N L I++ SS+ KDF++ CL
Sbjct: 193 SLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWSSEFKDFLKKCL 246
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-23
Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 10/210 (4%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
G F V K +K T AAK I + S ++++D + E +L IV L +
Sbjct: 23 GAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNH-PYIVKLLGAFY 79
Query: 82 TPHEMVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
++ +++E P G + ++++ G+ E + +Q+LEAL +LH I H DLK
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAG 139
Query: 141 NILLTKDNNIKLCDFGIS-RVVNDVVEVKEIIGTPDYVAPEVLSYE-----PISLATDMW 194
N+LLT D +IKL DFG+S + V + IGTP ++APEV+ E P D+W
Sbjct: 140 NVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIW 199
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQ 224
S+G+ + P N L I++
Sbjct: 200 SLGITLIEMAQIEPPHHELNPMRVLLKIAK 229
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 1e-23
Identities = 53/192 (27%), Positives = 89/192 (46%), Gaps = 9/192 (4%)
Query: 21 RGKFASVRKCTHKI----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGL 76
G F V K K KVE A K + K S Q+++ L EA ++ +V L
Sbjct: 9 EGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH-PNVVKL 66
Query: 77 HEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
+ + +V+E + G+L L + + D S+ QI + +L N H
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHR 126
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGT-P-DYVAPEVLSYEPISLATDM 193
DL +N L+ ++ +K+ DFG+SR + D ++ G P ++APE L + +D+
Sbjct: 127 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDV 186
Query: 194 WSVGVLAYVLLS 205
WS GVL + + +
Sbjct: 187 WSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-23
Identities = 77/284 (27%), Positives = 115/284 (40%), Gaps = 64/284 (22%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQM-------QDILHEAAVLYLAQKSERIV 74
G+ VRK T YA K +RK M +DIL EA +E +V
Sbjct: 15 GEVCLVRKVD---TNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-------DNEWVV 64
Query: 75 GLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGI-PEQDTRSYMKQILEALAFLHDHNIT 133
L+ ++ + V++ +P G++ L+ I+ GI E R Y+ ++ A+ +H
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLL-IRLGIFEEDLARFYIAELTCAIESVHKMGFI 123
Query: 134 HLDLKPQNILLTKDNNIKLCDFG---------------------------------ISRV 160
H D+KP NIL+ +D +IKL DFG I R
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 161 VNDVVEVK-----------EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSP 209
+E + ++GTP+Y+APEVL + D WSVGV+ Y +L P
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 243
Query: 210 FAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
F D ET L + + H +S +A D I L
Sbjct: 244 FLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGA 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-23
Identities = 74/245 (30%), Positives = 115/245 (46%), Gaps = 23/245 (9%)
Query: 26 SVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85
SV KC K T + +A K I Q Q IL E + + KS IV + +
Sbjct: 16 SVTKCRLKNTGMIFALKTITTDPNPDLQKQ-ILRELEINK-SCKSPYIVKYYGAFLDESS 73
Query: 86 --MVLVLEMVPDGELQRL---VDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
+ + +E G L + V + G I E+ + +L+ L++LH I H D+KP
Sbjct: 74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKP 133
Query: 140 QNILLTKDNNIKLCDFGIS-RVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
NILLT+ +KLCDFG+S +VN + GT Y+APE + +P S+ +D+WS+G+
Sbjct: 134 SNILLTRKGQVKLCDFGVSGELVNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGL 191
Query: 199 LAYVLLSSHSPFAGDNKQ--------ETFLNISQCNFSFHEDLFGHI--SSQAKDFIQSC 248
+ + PF + + +N+ N ++ I S + KDFI+ C
Sbjct: 192 TLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP--NPELKDEPGNGIKWSEEFKDFIKQC 249
Query: 249 LVTDP 253
L DP
Sbjct: 250 LEKDP 254
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 2e-23
Identities = 64/259 (24%), Positives = 111/259 (42%), Gaps = 46/259 (17%)
Query: 22 GKFASVRKCTHKITKVEYAAKFI---------RKRRRSM--------DQMQDILHEAAVL 64
G F SV + + A K + + R+RSM ++++ HE V
Sbjct: 11 GSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQ 70
Query: 65 YLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEAL 124
YL + + + LE VP G + L++ E R++++QIL+ L
Sbjct: 71 YLGSSLDA-----------DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGL 119
Query: 125 AFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPD--------- 175
+LH+ I H D+K NIL+ IK+ DFGIS+ +E + +
Sbjct: 120 NYLHNRGIIHRDIKGANILVDNKGGIKISDFGISK----KLEANSLSTKTNGARPSLQGS 175
Query: 176 --YVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDL 233
++APEV+ + D+WS+G L +L+ PF + + I + + ++
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE---NASPEI 232
Query: 234 FGHISSQAKDFIQSCLVTD 252
+ISS+A DF++ D
Sbjct: 233 PSNISSEAIDFLEKTFEID 251
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 3e-23
Identities = 67/238 (28%), Positives = 112/238 (47%), Gaps = 8/238 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR---RSMDQMQDILHEAAVLYLAQKSERIVGLH 77
+G F V C + T YA K + K+R R + M L+E +L S +V L
Sbjct: 10 KGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVN-SRFVVSLA 66
Query: 78 EIYETPHEMVLVLEMVPDGELQ-RLVDIQD-GIPEQDTRSYMKQILEALAFLHDHNITHL 135
YET + LVL ++ G+L+ + ++ + G EQ Y ++ L L I +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR 126
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
DLKP+NILL +I++ D G++ + + V+ +GT Y+APEV++ E + + D W
Sbjct: 127 DLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWG 186
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+G L Y ++ SPF ++ + + E+ S AK + L +P
Sbjct: 187 LGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 4e-23
Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 11/211 (5%)
Query: 21 RGKFASVRKCTHKI----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGL 76
G F V K T K T+ + A K + K S ++ ++ L EA+++ IV L
Sbjct: 9 EGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLS-HPNIVRL 66
Query: 77 HEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
+ + +V E +P G+L L + + +D QI + + +L N H
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHR 126
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVV--NDVVEVKEIIGTP-DYVAPEVLSYEPISLATD 192
DL +N L+T++ +K+ DFG+SR + +D + P ++APE L + +D
Sbjct: 127 DLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSD 186
Query: 193 MWSVGVLAYVLLS-SHSPFAGDNKQETFLNI 222
+WS GVL + + + P+ G + +E +
Sbjct: 187 VWSFGVLLWEIFTLGEQPYPGMSNEEVLELL 217
|
Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 4e-23
Identities = 67/216 (31%), Positives = 95/216 (43%), Gaps = 36/216 (16%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQD-----ILHEAAVLYLAQK--SERIV 74
G + V K +K T A K IR M+ ++ + E +L QK IV
Sbjct: 10 GTYGQVYKARNKKTGELVALKKIR-----MENEKEGFPITAIREIKLL---QKLRHPNIV 61
Query: 75 GLHEIYETPH--EMVLVLE-MVPDGELQRLVD---IQDGIPEQDTRSYMKQILEALAFLH 128
L EI + + +V E M D +L L+D ++ + + YMKQ+LE L +LH
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYM--DHDLTGLLDSPEVKFTESQ--IKCYMKQLLEGLQYLH 117
Query: 129 DHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK---EIIGTPDYVAPEVL--- 182
+ I H D+K NIL+ D +KL DFG++R +I T Y PE+L
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGA 176
Query: 183 -SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQE 217
Y P DMWSVG + L F G + E
Sbjct: 177 TRYGP---EVDMWSVGCILAELFLGKPIFQGSTELE 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 6e-23
Identities = 57/217 (26%), Positives = 113/217 (52%), Gaps = 6/217 (2%)
Query: 38 EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGE 97
+ A K + R++ Q +++L V+ + + +V +++ Y E+ +++E + G
Sbjct: 48 QVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 98 LQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI 157
L +V Q + E+ + + +L+AL +LH + H D+K +ILLT D +KL DFG
Sbjct: 105 LTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGF 163
Query: 158 -SRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ 216
+++ DV + K ++GTP ++APEV+S P D+WS+G++ ++ P+ D+
Sbjct: 164 CAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV 223
Query: 217 ETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ + ++ IS +DF++ L +P
Sbjct: 224 QAMKRLRDSPPPKLKN-AHKISPVLRDFLERMLTREP 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 1e-22
Identities = 61/254 (24%), Positives = 104/254 (40%), Gaps = 31/254 (12%)
Query: 21 RGKFASVRKCTHKI---TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLH 77
G F V K K E A K + K S ++ +D L EA V+ +V L
Sbjct: 5 EGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKL-GHPNVVRLL 62
Query: 78 EIYETPHEMVLVLEMVPDGELQ---------RLVDIQDGIPEQDTRSYMKQILEALAFLH 128
+ + LVLE + G+L + + +D S+ QI + + +L
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 129 DHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV---APEVLSYE 185
H DL +N L+ +D +K+ DFG+SR V D ++ G + APE L
Sbjct: 123 SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG 182
Query: 186 PISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNF-----SFHEDLFGHISS 239
+ +D+WS GVL + + + +P+ G + +E + + ++L+
Sbjct: 183 IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY----- 237
Query: 240 QAKDFIQSCLVTDP 253
+ + SC DP
Sbjct: 238 ---ELMLSCWQLDP 248
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-22
Identities = 66/246 (26%), Positives = 113/246 (45%), Gaps = 21/246 (8%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQM-----QDILHEAAVLYLAQKSERIVG 75
RG+F+ V + T + V A K ++ D M D + E +L ++
Sbjct: 12 RGQFSEVYRATCLLDGVPVALKKVQ----IFDLMDAKARADCIKEIDLLKQLNHPN-VIK 66
Query: 76 LHEIYETPHEMVLVLEMVPDGELQRLV----DIQDGIPEQDTRSYMKQILEALAFLHDHN 131
+ + +E+ +VLE+ G+L R++ + IPE+ Y Q+ AL +H
Sbjct: 67 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126
Query: 132 ITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVEVKEIIGTPDYVAPEVLSYEPISLA 190
+ H D+KP N+ +T +KL D G+ R + ++GTP Y++PE + +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186
Query: 191 TDMWSVGVLAYVLLSSHSPFAGD--NKQETFLNISQCNF-SFHEDLFGHISSQAKDFIQS 247
+D+WS+G L Y + + SPF GD N I QC++ D H S + + +
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD---HYSEELRQLVNM 243
Query: 248 CLVTDP 253
C+ DP
Sbjct: 244 CINPDP 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 2e-22
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G + V K HK T A K + D+ ++I E +L I + +
Sbjct: 16 EGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 81 ETP------HEMVLVLEMVPDGELQRLV---DIQDGIPEQDTRSY-MKQILEALAFLHDH 130
++ LV+E+ G + LV + +++ +Y +++ L LA+LH++
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN 132
Query: 131 NITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE-IIGTPDYVAPEVLSYEPISL 189
+ H D+K QNILLTK+ +KL DFG+S ++ + + IGTP ++APEV++ +
Sbjct: 133 KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPD 192
Query: 190 AT-----DMWSVGVLAYVLLSSHSPFA 211
A+ D+WS+G+ A L P
Sbjct: 193 ASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-22
Identities = 58/185 (31%), Positives = 96/185 (51%), Gaps = 5/185 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
+G + V H+ +Y K + R S + + EA +L K IV E +
Sbjct: 10 KGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLS-QLKHPNIVAYRESW 68
Query: 81 ETPHEMV-LVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDL 137
E ++ +V+ G+L + Q G +PE + QI AL +LH+ +I H DL
Sbjct: 69 EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDL 128
Query: 138 KPQNILLTKDNNIKLCDFGISRVVNDVVEVKE-IIGTPDYVAPEVLSYEPISLATDMWSV 196
K QN+ LT+ N IK+ D GI+RV+ + ++ +IGTP Y++PE+ S +P + +D+W++
Sbjct: 129 KTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWAL 188
Query: 197 GVLAY 201
G Y
Sbjct: 189 GCCVY 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 2e-22
Identities = 56/193 (29%), Positives = 91/193 (47%), Gaps = 10/193 (5%)
Query: 21 RGKFASVRKCTHKI----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGL 76
G F V K T K +VE A K + K S Q+++ L EA ++ IV L
Sbjct: 9 EGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLD-HPNIVKL 66
Query: 77 HEIYETPHEMVLVLEMVPDGEL-QRLVDIQD-GIPEQDTRSYMKQILEALAFLHDHNITH 134
+ +++V+E +P G+L L + + D S+ QI + +L N H
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIH 126
Query: 135 LDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGT-P-DYVAPEVLSYEPISLATD 192
DL +N L+ ++ +K+ DFG+SR + D K G P ++APE L + +D
Sbjct: 127 RDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSD 186
Query: 193 MWSVGVLAYVLLS 205
+WS GVL + + +
Sbjct: 187 VWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 3e-22
Identities = 61/194 (31%), Positives = 83/194 (42%), Gaps = 53/194 (27%)
Query: 104 IQDGIPEQDTRSY-MKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN 162
I+ I E + Y M Q+L+AL ++H N+ H DLKP NILL D +KL DFG++R ++
Sbjct: 99 IRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158
Query: 163 DVVEVKEIIGTPDYVA------PEVL----SYEPISLATDMWSVG-VLAYVLL------- 204
++ E E DYVA PE+L Y + DMWSVG +L +LL
Sbjct: 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRY---TKGVDMWSVGCILGEMLLGKPLFPG 215
Query: 205 -----------------------SSHSPFAGDNKQETFLNISQCN--FSFHEDLFGHISS 239
S SPFA T L+ E L S
Sbjct: 216 TSTLNQLEKIIEVIGPPSAEDIESIKSPFA-----ATMLDSLPSRPRKPLDE-LLPKASD 269
Query: 240 QAKDFIQSCLVTDP 253
A D ++ LV +P
Sbjct: 270 DALDLLKKLLVFNP 283
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-22
Identities = 59/190 (31%), Positives = 101/190 (53%), Gaps = 17/190 (8%)
Query: 73 IVGLHEIYETPHEMVLVLEMVPDGELQRLVD-IQDGIPEQDTRSYMKQILEALAFLHDHN 131
I LH ++ + + LV++ G+L L+ +D +PE R Y+ +++ A+ +H
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 132 ITHLDLKPQNILLTKDNNIKLCDFG--ISRVVNDVVEVKEIIGTPDYVAPEVL------- 182
H D+KP N+LL K+ +I+L DFG + + + V+ +GTPDY++PE+L
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 183 -SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNI--SQCNFSFHEDLFGHISS 239
Y P D WS+GV Y +L +PF ++ ET+ I + +F F D+ +S
Sbjct: 183 GRYGP---ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD-VSE 238
Query: 240 QAKDFIQSCL 249
+AKD I+ +
Sbjct: 239 EAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 4e-22
Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 8/199 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDI--LHEAAVLYLAQKSERIVGLHE 78
RG F V C T E A K + S + +++ L L + +RIV +
Sbjct: 12 RGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYG 71
Query: 79 IYETPHE--MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
P E + + +E +P G ++ + + E TR Y +QIL+ +++LH + I H D
Sbjct: 72 CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRD 131
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDV----VEVKEIIGTPDYVAPEVLSYEPISLATD 192
+K NIL N+KL DFG S+ + + +K + GTP +++PEV+S E D
Sbjct: 132 IKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKAD 191
Query: 193 MWSVGVLAYVLLSSHSPFA 211
+WSV +L+ P+A
Sbjct: 192 VWSVACTVVEMLTEKPPWA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 6e-22
Identities = 63/224 (28%), Positives = 112/224 (50%), Gaps = 6/224 (2%)
Query: 31 THKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVL 90
T K T + A K + R++ Q +++L V+ E +V ++ Y E+ +V+
Sbjct: 42 TEKHTGKQVAVKKMDLRKQ---QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98
Query: 91 EMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNI 150
E + G L +V + E+ + +L AL++LH+ + H D+K +ILLT D I
Sbjct: 99 EFLEGGALTDIV-THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRI 157
Query: 151 KLCDFGI-SRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSP 209
KL DFG ++V +V + K ++GTP ++APEV+S P D+WS+G++ ++ P
Sbjct: 158 KLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
Query: 210 FAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ + + I +D +SS + F+ LV +P
Sbjct: 218 YFNEPPLQAMRRIRDNLPPRVKDSH-KVSSVLRGFLDLMLVREP 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 6e-22
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 48 RRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDG 107
R ++ ++D+ H V YL + T + + LE VP G + +
Sbjct: 56 RSEIETLKDLDHLNIVQYLGFE-----------TTEEYLSIFLEYVPGGSIGSCLRTYGR 104
Query: 108 IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV--- 164
EQ R + +Q+LE LA+LH I H DLK N+L+ D K+ DFGIS+ +D+
Sbjct: 105 FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN 164
Query: 165 VEVKEIIGTPDYVAPEV--LSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNK-QETF-L 220
+ + G+ ++APEV + S D+WS+G + + + P++ + F L
Sbjct: 165 DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL 224
Query: 221 NISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ D+ ++S A DF+ +C +P
Sbjct: 225 GNKRSAPPIPPDVSMNLSPVALDFLNACFTINP 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 6e-22
Identities = 71/262 (27%), Positives = 115/262 (43%), Gaps = 38/262 (14%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
RG F VR K T YA K +RK +Q+ I E +L A S +V +
Sbjct: 11 RGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYS 69
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++ + L++E +P G++ L+ +D + E++T+ Y+ + + A+ +H H D+KP
Sbjct: 70 FQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKP 129
Query: 140 QNILLTKDNNIKLCDFGIS------------RVVNDVVEVK------------------- 168
N+LL ++KL DFG+ R +N +
Sbjct: 130 DNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNR 189
Query: 169 -----EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNIS 223
+GTPDY+APEV + D WS+GV+ Y +L + PF + QET+ +
Sbjct: 190 RQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVM 249
Query: 224 QCNFSFHEDLFGHISSQAKDFI 245
+ IS +AKD I
Sbjct: 250 NWKETLIFPPEVPISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 7e-22
Identities = 67/243 (27%), Positives = 114/243 (46%), Gaps = 15/243 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQM--QDILHEAAVLYLAQKSERIVGLHE 78
RG+F+ V + T + + A K ++ MD QD + E +L I L
Sbjct: 12 RGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDS 70
Query: 79 IYETPHEMVLVLEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHNITH 134
E +E+ +VLE+ G+L +++ + IPE+ Y Q+ A+ +H + H
Sbjct: 71 FIED-NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMH 129
Query: 135 LDLKPQNILLTKDNNIKLCDFGISRVV-NDVVEVKEIIGTPDYVAPEVLSYEPISLATDM 193
D+KP N+ +T +KL D G+ R + ++GTP Y++PE + + +D+
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDI 189
Query: 194 WSVGVLAYVLLSSHSPFAGDNKQETFL--NISQCNFSFHEDLFG-HISSQAKDFIQSCLV 250
WS+G L Y + + SPF GD L I QC++ L H S + ++ + C+
Sbjct: 190 WSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP---PLPTEHYSEKLRELVSMCIY 246
Query: 251 TDP 253
DP
Sbjct: 247 PDP 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-21
Identities = 68/262 (25%), Positives = 112/262 (42%), Gaps = 38/262 (14%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
RG F VR K T YA K +RK +Q+ I E +L A + +V +
Sbjct: 11 RGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA-WVVKMFYS 69
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++ + L++E +P G++ L+ +D + E+ T+ Y+ + + A+ +H H D+KP
Sbjct: 70 FQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKP 129
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVK------------------------------- 168
N+LL ++KL DFG+ + +
Sbjct: 130 DNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNR 189
Query: 169 -----EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNIS 223
+GTPDY+APEV + D WS+GV+ Y +L + PF + QET+ +
Sbjct: 190 RQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVM 249
Query: 224 QCNFSFHEDLFGHISSQAKDFI 245
+ IS +AKD I
Sbjct: 250 NWKETLVFPPEVPISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-21
Identities = 54/177 (30%), Positives = 90/177 (50%), Gaps = 13/177 (7%)
Query: 73 IVGLHEIYETPHEMVL-VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHN 131
IV L + E P ++ V E VP L+ ++ +P +T M Q+L+ALA H+
Sbjct: 40 IVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQG 99
Query: 132 ITHLDLKPQNILLTKDN---NIKLCDFGISRVVNDVVEV--------KEIIGTPDYVAPE 180
I H DLKPQNI++++ + K+ DFGI ++ V + E++GTP Y APE
Sbjct: 100 IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
Query: 181 VLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQET-FLNISQCNFSFHEDLFGH 236
L EP++ +D+++ G++ L+ G + E + +S + S + GH
Sbjct: 160 QLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGH 216
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-21
Identities = 49/135 (36%), Positives = 80/135 (59%), Gaps = 10/135 (7%)
Query: 69 KSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDT-RSYMKQILEALAFL 127
K + IV L+++ + ++ LV E D +L++ D +G + + +S+M Q+L+ LAF
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115
Query: 128 HDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK----EIIGTPDYVAPEVL- 182
H HN+ H DLKPQN+L+ K+ +KL DFG++R + V+ E++ T Y P+VL
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLARAFG--IPVRCYSAEVV-TLWYRPPDVLF 172
Query: 183 SYEPISLATDMWSVG 197
+ S + DMWS G
Sbjct: 173 GAKLYSTSIDMWSAG 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 2e-21
Identities = 75/253 (29%), Positives = 115/253 (45%), Gaps = 33/253 (13%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIR-----KRRRSMDQMQDILHEAAVLYLAQKSERIVG 75
+G + SV K H+ T V A K IR + + DILH+A Y IV
Sbjct: 11 KGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY-------IVD 63
Query: 76 LHEIYETPHEMVLVLEMVPDGELQRLVD---IQDGIPEQDTRSYMKQILEALAFL-HDHN 131
+ + + + +E + G L +L +GIPE R +++ L FL +HN
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 132 ITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV-KEIIGTPDYVAPEVLSYE----- 185
I H D+KP N+L+ + +KLCDFG+S N V + K IG Y+APE +
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNIGCQSYMAPERIKSGGPNQN 181
Query: 186 -PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNI-SQCNFSFHED---LFGHISSQ 240
++ +D+WS+G+ + P+ ET+ NI +Q + D L S
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYP----PETYANIFAQLSAIVDGDPPTLPSGYSDD 237
Query: 241 AKDFIQSCLVTDP 253
A+DF+ CL P
Sbjct: 238 AQDFVAKCLNKIP 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 5e-21
Identities = 64/252 (25%), Positives = 107/252 (42%), Gaps = 33/252 (13%)
Query: 22 GKFASVRKCTHKITKVEYAAKFI-----RKRRRSMDQMQDILHEAAVLYLAQKSERIVGL 76
G SV K H T A K + R+ + + I+HE +S IV
Sbjct: 16 GNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-------RSPYIVSF 68
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHL 135
+ + + + + +E + G L R+ IP + ++E L +L++ H I H
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHR 128
Query: 136 DLKPQNILLTKDNNIKLCDFGIS-RVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMW 194
D+KP NIL+ IKLCDFG+S ++N + + +GT Y++PE + ++ +D+W
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELINSIADT--FVGTSTYMSPERIQGGKYTVKSDVW 186
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHI-------------SSQA 241
S+G+ L PFA + + DL I
Sbjct: 187 SLGISIIELALGKFPFA-FSNIDDDGQDDPMGIL---DLLQQIVQEPPPRLPSSDFPEDL 242
Query: 242 KDFIQSCLVTDP 253
+DF+ +CL+ DP
Sbjct: 243 RDFVDACLLKDP 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 9e-21
Identities = 66/241 (27%), Positives = 116/241 (48%), Gaps = 16/241 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDI-LHEAAVLYLAQKSE--RIVGLH 77
RG F V C T YA K + K+R M Q + + L+E +L L + IV +
Sbjct: 4 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 63
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+ TP ++ +L+++ G+L + E + R Y +I+ L +H+ + + DL
Sbjct: 64 YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDL 123
Query: 138 KPQNILLTKDNNIKLCDFGISRVVNDVVEVK--EIIGTPDYVAPEVL----SYEPISLAT 191
KP NILL + ++++ D G++ D + K +GT Y+APEVL +Y+ +
Sbjct: 124 KPANILLDEHGHVRISDLGLA---CDFSKKKPHASVGTHGYMAPEVLQKGVAYDS---SA 177
Query: 192 DMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251
D +S+G + + LL HSPF +K + I + + +L S + + ++ L
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236
Query: 252 D 252
D
Sbjct: 237 D 237
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-20
Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 8/206 (3%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
G + V K +K+T A K IR + + E ++L IV L ++
Sbjct: 11 GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK-ELNHPNIVKLLDVIH 69
Query: 82 TPHEMVLVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
T +++ LV E + +L++ +D GIP +SY+ Q+L+ LAF H H + H DLKP
Sbjct: 70 TENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 128
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVE--VKEIIGTPDYVAPEV-LSYEPISLATDMWSV 196
QN+L+ + IKL DFG++R V E++ T Y APE+ L + S A D+WS+
Sbjct: 129 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSL 187
Query: 197 GVLAYVLLSSHSPFAGDNKQETFLNI 222
G + +++ + F GD++ + I
Sbjct: 188 GCIFAEMVTRRALFPGDSEIDQLFRI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-20
Identities = 64/236 (27%), Positives = 112/236 (47%), Gaps = 11/236 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
+G F V K TK A K I + D+++DI E VL S I + Y
Sbjct: 14 KGSFGEVYKGIDNRTKEVVAIKII-DLEEAEDEIEDIQQEITVLSQCD-SPYITRYYGSY 71
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDT--RSYMKQILEALAFLHDHNITHLDLK 138
++ +++E + G +D+ P ++T + +++IL+ L +LH H D+K
Sbjct: 72 LKGTKLWIIMEYLGGGSA---LDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 139 PQNILLTKDNNIKLCDFGISRVVNDV-VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
N+LL++ ++KL DFG++ + D ++ +GTP ++APEV+ D+WS+G
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLG 188
Query: 198 VLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ A L P + + I + + L G S K+F+++CL DP
Sbjct: 189 ITAIELAKGEPPNSDLHPMRVLFLIPK---NSPPTLEGQYSKPFKEFVEACLNKDP 241
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-20
Identities = 66/244 (27%), Positives = 114/244 (46%), Gaps = 17/244 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RG F V K +A K + K E + + ++ I LH +
Sbjct: 11 RGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF 70
Query: 81 ETPHEMVLVLEMVPDGELQRLVD-IQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
+ + + LV++ G+L L+ +D +PE R Y+ +++ A+ +H + H D+KP
Sbjct: 71 QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKP 130
Query: 140 QNILLTKDNNIKLCDFG--ISRVVNDVVEVKEIIGTPDYVAPEVLS--------YEPISL 189
NIL+ + +I+L DFG + + + V+ +GTPDY++PE+L Y P
Sbjct: 131 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGP--- 187
Query: 190 ATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNI--SQCNFSFHEDLFGHISSQAKDFIQS 247
D WS+GV Y +L +PF ++ ET+ I + F F + +S AKD I+
Sbjct: 188 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV-TDVSEDAKDLIRR 246
Query: 248 CLVT 251
+ +
Sbjct: 247 LICS 250
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-20
Identities = 59/223 (26%), Positives = 108/223 (48%), Gaps = 5/223 (2%)
Query: 34 ITKVEYAAKFIRKRRRSM--DQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91
I V+ + K + ++ + Q +++L V+ + E +V ++ Y E+ +V+E
Sbjct: 38 IATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 97
Query: 92 MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIK 151
+ G L +V + E+ + +L+AL+ LH + H D+K +ILLT D +K
Sbjct: 98 FLEGGALTDIV-THTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVK 156
Query: 152 LCDFGI-SRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPF 210
L DFG ++V +V K ++GTP ++APE++S P D+WS+G++ ++ P+
Sbjct: 157 LSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216
Query: 211 AGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ + I N +S K F+ LV DP
Sbjct: 217 FNEPPLKAMKMIRD-NLPPKLKNLHKVSPSLKGFLDRLLVRDP 258
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 5e-20
Identities = 66/252 (26%), Positives = 112/252 (44%), Gaps = 31/252 (12%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RG F +V K HK + A K IR +Q + +L + V+ + IV +
Sbjct: 14 RGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKR-LLMDLDVVMRSSDCPYIVKFYGA- 71
Query: 81 ETPHE---------MVLVLEMVPDGELQRLV-DIQDG-IPEQDTRSYMKQILEALAFL-H 128
E M + L+ + + V ++ IPE+ ++AL +L
Sbjct: 72 -LFREGDCWICMELMDISLD-----KFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE 125
Query: 129 DHNITHLDLKPQNILLTKDNNIKLCDFGIS-RVVNDVVEVKEIIGTPDYVAPEVL---SY 184
+ I H D+KP NILL ++ NIKLCDFGIS ++V+ + + ++ G Y+APE + +
Sbjct: 126 ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPSAR 184
Query: 185 EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFS----FHEDLFGHISSQ 240
+ + +D+WS+G+ Y + + P+ N F ++Q S
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPILSNSEEREFSPS 242
Query: 241 AKDFIQSCLVTD 252
+FI CL+ D
Sbjct: 243 FVNFINLCLIKD 254
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 5e-20
Identities = 54/210 (25%), Positives = 105/210 (50%), Gaps = 3/210 (1%)
Query: 44 IRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVD 103
IR+ ++++ ++ K+ IV + Y E+ +V+E + G L +V
Sbjct: 50 IRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV- 108
Query: 104 IQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI-SRVVN 162
+ + E + ++ L+AL FLH + + H D+K NILL D ++KL DFG +++
Sbjct: 109 TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168
Query: 163 DVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNI 222
+ + ++GTP ++APEV++ + D+WS+G++A ++ P+ +N I
Sbjct: 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228
Query: 223 SQCNFSFHEDLFGHISSQAKDFIQSCLVTD 252
+ N + +S+ +DF+ CL D
Sbjct: 229 AT-NGTPELQNPEKLSAIFRDFLNRCLDMD 257
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 7e-20
Identities = 48/132 (36%), Positives = 72/132 (54%), Gaps = 3/132 (2%)
Query: 85 EMVLVLEMVPDGELQRLVDI--QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNI 142
++ LV E V D +L +D + G+P + + M Q+L L FLH H + H DLKPQNI
Sbjct: 83 KLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 141
Query: 143 LLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYV 202
L+T IKL DFG++R+ + + + ++ T Y APEVL + D+WSVG +
Sbjct: 142 LVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE 201
Query: 203 LLSSHSPFAGDN 214
+ F G +
Sbjct: 202 MFRRKPLFRGSS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 8e-20
Identities = 67/241 (27%), Positives = 118/241 (48%), Gaps = 16/241 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDI-LHEAAVLYLAQKSE--RIVGLH 77
RG F V C T YA K + K+R M Q + + L+E +L L + IV +
Sbjct: 4 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMT 63
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+ TP ++ +L+++ G+L + E++ R Y +I+ L +H+ + + DL
Sbjct: 64 YAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDL 123
Query: 138 KPQNILLTKDNNIKLCDFGISRVVNDVVEVK--EIIGTPDYVAPEVL----SYEPISLAT 191
KP NILL + ++++ D G++ D + K +GT Y+APEVL +Y+ +
Sbjct: 124 KPANILLDEHGHVRISDLGLA---CDFSKKKPHASVGTHGYMAPEVLQKGTAYDS---SA 177
Query: 192 DMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251
D +S+G + + LL HSPF +K + I + + + +L S + K ++ L
Sbjct: 178 DWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236
Query: 252 D 252
D
Sbjct: 237 D 237
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 9e-20
Identities = 65/236 (27%), Positives = 109/236 (46%), Gaps = 11/236 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
+G F V K T+ A K I + D+++DI E VL S + + Y
Sbjct: 14 KGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSY 71
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIP--EQDTRSYMKQILEALAFLHDHNITHLDLK 138
++ +++E + G +D+ P E + +K+IL+ L +LH H D+K
Sbjct: 72 LKGTKLWIIMEYLGGGSA---LDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 139 PQNILLTKDNNIKLCDFGISRVVNDV-VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
N+LL++ ++KL DFG++ + D ++ +GTP ++APEV+ D+WS+G
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLG 188
Query: 198 VLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ A L P + + I + N L G S K+FI +CL DP
Sbjct: 189 ITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLTGEFSKPFKEFIDACLNKDP 241
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-19
Identities = 75/250 (30%), Positives = 110/250 (44%), Gaps = 31/250 (12%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKR--RRSMDQMQDIL------HEAAVLYLAQKSER 72
+G + V T+V A K I +R R ++I H V YL SE
Sbjct: 18 KGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN 77
Query: 73 IVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRS----YMKQILEALAFLH 128
G +I+ +E VP G L L+ + G P +D Y KQILE L +LH
Sbjct: 78 --GFFKIF---------MEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLH 125
Query: 129 DHNITHLDLKPQNILL-TKDNNIKLCDFGISRVVNDVVEVKEII-GTPDYVAPEVLSYEP 186
D+ I H D+K N+L+ T +K+ DFG S+ + + E GT Y+APEV+ P
Sbjct: 126 DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGP 185
Query: 187 --ISLATDMWSVGVLAYVLLSSHSPFAG-DNKQETFLNISQCNFSFHEDLFGHISSQAKD 243
D+WS+G + + PF Q + F H ++ +S++AK+
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM--FKIHPEIPESLSAEAKN 243
Query: 244 FIQSCLVTDP 253
FI C DP
Sbjct: 244 FILRCFEPDP 253
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-19
Identities = 61/198 (30%), Positives = 97/198 (48%), Gaps = 23/198 (11%)
Query: 44 IRKRRRSMDQM---QDILHEAAVLYLAQKSERIVGL----HEIYETPHEMV-LVLEMVPD 95
++K R MD+ L E ++L + +S IV L H + + LV E + D
Sbjct: 31 LKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-D 89
Query: 96 GELQRLVDIQ-----DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN- 149
+L++ +D +P + +S+M Q+L+ +A H H + H DLKPQN+L+ K
Sbjct: 90 SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL 149
Query: 150 IKLCDFGISRVVNDVVEVK----EIIGTPDYVAPEV-LSYEPISLATDMWSVGVLAYVLL 204
+K+ D G+ R + VK EI+ T Y APEV L S D+WSVG + +
Sbjct: 150 LKIADLGLGR--AFSIPVKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
Query: 205 SSHSPFAGDNKQETFLNI 222
F GD++ + L+I
Sbjct: 207 RKQPLFPGDSELQQLLHI 224
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-19
Identities = 61/234 (26%), Positives = 111/234 (47%), Gaps = 7/234 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
+G F V K T+ A K I + D+++DI E VL S + + Y
Sbjct: 14 KGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSY 71
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
++ +++E + G L++ + E + +++IL+ L +LH H D+K
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 130
Query: 141 NILLTKDNNIKLCDFGISRVVNDV-VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVL 199
N+LL++ +KL DFG++ + D ++ +GTP ++APEV+ D+WS+G+
Sbjct: 131 NVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 190
Query: 200 AYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
A L P + + + I + N L G+ S K+F+++CL +P
Sbjct: 191 AIELAKGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVEACLNKEP 241
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 2e-19
Identities = 49/144 (34%), Positives = 81/144 (56%), Gaps = 21/144 (14%)
Query: 69 KSERIVGLHEI-----YETPHEMVLVLE-MVPDGELQRLVDIQDGIP--EQDTRSYMKQI 120
+ E I+GL +I E +++ +V E M + +L ++ I+ P + + ++ QI
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELM--ETDLHKV--IKSPQPLTDDHIQYFLYQI 112
Query: 121 LEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV--- 177
L L +LH N+ H DLKP NIL+ + ++K+CDFG++R V+ + K + T +YV
Sbjct: 113 LRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL-T-EYVVTR 170
Query: 178 ---APEV-LSYEPISLATDMWSVG 197
APE+ LS + A D+WSVG
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVG 194
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-19
Identities = 57/190 (30%), Positives = 105/190 (55%), Gaps = 13/190 (6%)
Query: 69 KSERIVGLHEI-----YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEA 123
K E I+G+ +I +E+ +++ +V E++ +L +L+ Q + + ++ QIL
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH-LSNDHIQYFLYQILRG 118
Query: 124 LAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE----VKEIIGTPDYVAP 179
L ++H N+ H DLKP N+LL + ++K+CDFG++R+ + + + E + T Y AP
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178
Query: 180 EV-LSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH-EDLFGHI 237
E+ L+ + + A D+WSVG + +LS+ F G + I + EDL I
Sbjct: 179 EIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238
Query: 238 SSQAKDFIQS 247
S +A+++I+S
Sbjct: 239 SLRARNYIKS 248
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-19
Identities = 51/153 (33%), Positives = 81/153 (52%), Gaps = 9/153 (5%)
Query: 104 IQDGIPEQDT--RSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV 161
I+ G P D +S++ QIL L ++H N+ H DLKP N+L+ D +K+CDFG++R
Sbjct: 96 IRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF 155
Query: 162 NDVVEV-----KEIIGTPDYVAPEV-LSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNK 215
++ E + T Y APE+ LS++ + A D+WSVG + LL F G +
Sbjct: 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY 215
Query: 216 QETFLNISQCNFSFHEDLFGHISSQ-AKDFIQS 247
+ I Q + E+ I S A+++I+S
Sbjct: 216 VDQLNQILQVLGTPDEETLSRIGSPKAQNYIRS 248
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 4e-19
Identities = 55/197 (27%), Positives = 102/197 (51%), Gaps = 4/197 (2%)
Query: 57 ILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSY 116
I++E V+ K+ IV + Y E+ +V+E + G L +V + + E +
Sbjct: 63 IINEILVMR-ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAV 120
Query: 117 MKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI-SRVVNDVVEVKEIIGTPD 175
++ L+AL FLH + + H D+K NILL D ++KL DFG +++ + + ++GTP
Sbjct: 121 CRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
Query: 176 YVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFG 235
++APEV++ + D+WS+G++A ++ P+ +N I+ N +
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPE 239
Query: 236 HISSQAKDFIQSCLVTD 252
+S+ +DF+ CL D
Sbjct: 240 RLSAVFRDFLNRCLEMD 256
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-19
Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 10/216 (4%)
Query: 45 RKRRRSMDQ-MQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMV---PDGEL-Q 99
K +R D+ + DI+ E ++ + IV ++ + + +V++++ P GE
Sbjct: 42 GKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFN 101
Query: 100 RLVDIQDGIPEQDTRSYMKQILEALAFLH-DHNITHLDLKPQNILLTKDNNIKLCDFGIS 158
L + + E+ + Q++ AL +LH + I H DL P NI+L +D+ + + DFG++
Sbjct: 102 SLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161
Query: 159 RVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQET 218
+ ++ ++GT Y PE++ EP D+W+ G + Y + + PF N
Sbjct: 162 KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL 221
Query: 219 FLNISQCNFS-FHEDLFGHISSQAKDFIQSCLVTDP 253
I + + E ++ S D I SCL D
Sbjct: 222 ATKIVEAVYEPLPEGMY---SEDVTDVITSCLTPDA 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-19
Identities = 48/140 (34%), Positives = 76/140 (54%), Gaps = 3/140 (2%)
Query: 85 EMVLVLEMVPDGELQRLVDI--QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNI 142
++ LV E V D +L+ +D G+P + + M+Q L L FLH + I H DLKP+NI
Sbjct: 81 KVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENI 139
Query: 143 LLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYV 202
L+T +KL DFG++R+ + + + ++ T Y APEVL + DMWSVG +
Sbjct: 140 LVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE 199
Query: 203 LLSSHSPFAGDNKQETFLNI 222
+ F G+++ + I
Sbjct: 200 MFRRKPLFCGNSEADQLGKI 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-19
Identities = 69/273 (25%), Positives = 114/273 (41%), Gaps = 50/273 (18%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G F V T YA K +RK+ + +Q+ + E +L A +E +V L+ +
Sbjct: 12 GAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSF 70
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
+ + V++ +P G++ L+ + PE R Y+ ++ A+ +H H D+KP
Sbjct: 71 QDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPD 130
Query: 141 NILLTKDNNIKLCDFGI----------------SRVVNDVVEVKE--------------- 169
NIL+ D +IKL DFG+ S + D +E +
Sbjct: 131 NILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLK 190
Query: 170 -----------------IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAG 212
++GTP+Y+APEVL + + D WSVGV+ + +L PF
Sbjct: 191 TLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLA 250
Query: 213 DNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245
ET L + + H +S +A D I
Sbjct: 251 PTPTETQLKVINWENTLHIPPQVKLSPEAVDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-19
Identities = 48/137 (35%), Positives = 70/137 (51%), Gaps = 2/137 (1%)
Query: 74 VGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
V L+ ++ + LVLE V GE + P Y QI+ +L NI
Sbjct: 94 VNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIV 153
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDM 193
+ DLKP+N+LL KD IK+ DFG ++VV+ + GTP+Y+APE+L A D
Sbjct: 154 YRDLKPENLLLDKDGFIKMTDFGFAKVVD--TRTYTLCGTPEYIAPEILLNVGHGKAADW 211
Query: 194 WSVGVLAYVLLSSHSPF 210
W++G+ Y +L PF
Sbjct: 212 WTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-18
Identities = 49/151 (32%), Positives = 78/151 (51%), Gaps = 8/151 (5%)
Query: 69 KSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVD-IQDG--IPEQDTRSYMKQILEALA 125
+ IV L ++ + L+ E + +L++ +D + G + + +SY+ QIL+ +
Sbjct: 57 QHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115
Query: 126 FLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV--KEIIGTPDYVAPEVLS 183
F H + H DLKPQN+L+ IKL DFG++R V V E++ T Y APEVL
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLL 174
Query: 184 YEP-ISLATDMWSVGVLAYVLLSSHSPFAGD 213
P S D+WS+G + + + F GD
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-18
Identities = 65/237 (27%), Positives = 105/237 (44%), Gaps = 16/237 (6%)
Query: 27 VRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86
V K K T A K +R R + ++ + IL + V+ + IV + + T ++
Sbjct: 31 VYKMRFKKTGHVMAVKQMR-RTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89
Query: 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQNILLT 145
+ +E++ + L IQ IPE I++AL +L + H + H D+KP NILL
Sbjct: 90 FICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD 149
Query: 146 KDNNIKLCDFGIS-RVVNDVVEVKEIIGTPDYVAPEVLSYEPIS----LATDMWSVGVLA 200
N+KLCDFGIS R+V+ + + G Y+APE + + + D+WS+G+
Sbjct: 150 ASGNVKLCDFGISGRLVDSKAKTRS-AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISL 208
Query: 201 YVLLSSHSPFAGDNKQ-ETFLNISQCN---FSFHEDLFGHISSQAKDFIQSCLVTDP 253
L + P+ + E I Q +E S F+ CL D
Sbjct: 209 VELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGF----SPDFCSFVDLCLTKDH 261
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-18
Identities = 57/178 (32%), Positives = 90/178 (50%), Gaps = 4/178 (2%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
G V K HK + + A K I + + Q I+ E VL+ S IVG + +
Sbjct: 16 GNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQ-IIRELQVLHECN-SPYIVGFYGAFY 73
Query: 82 TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQ 140
+ E+ + +E + G L +++ IPE+ +L LA+L + H I H D+KP
Sbjct: 74 SDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPS 133
Query: 141 NILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
NIL+ IKLCDFG+S + D + +GT Y++PE L S+ +D+WS+G+
Sbjct: 134 NILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 190
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 57/188 (30%), Positives = 96/188 (51%), Gaps = 10/188 (5%)
Query: 73 IVGLHEIYETPHEMVLVLEMVPDGELQRLVD--IQDGIP--EQDTRSYMKQILEALAFLH 128
IV + +++ +++L++E G+L + + +++ +P E + QI+ AL +H
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186
Query: 129 DHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV---KEIIGTPDYVAPEVLSYE 185
+ H DLK NI L IKL DFG S+ +D V + GTP Y+APE+ +
Sbjct: 187 SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK 246
Query: 186 PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245
S DMWS+GV+ Y LL+ H PF G +++E + Q + ++ +SS K +
Sbjct: 247 RYSKKADMWSLGVILYELLTLHRPFKGPSQREI---MQQVLYGKYDPFPCPVSSGMKALL 303
Query: 246 QSCLVTDP 253
L +P
Sbjct: 304 DPLLSKNP 311
|
Length = 478 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-18
Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 24/199 (12%)
Query: 73 IVGLHE--IYETPH--EMVLVLEMVPD----GELQRLVDIQD------GIPEQDTRSYMK 118
IV HE + P E VL++ +V D G+L++ +I+ E +
Sbjct: 93 IVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQ--EIKSRAKTNRTFREHEAGLLFI 150
Query: 119 QILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV----VNDVVEVKEIIGTP 174
Q+L A+ +H ++ H D+K NILL + +KL DFG S++ V+D V + GTP
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVG-RTFCGTP 209
Query: 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLF 234
YVAPE+ +P S DM+S+GVL Y LL+ PF G+N +E + + L
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY---DPLP 266
Query: 235 GHISSQAKDFIQSCLVTDP 253
IS + ++ + + L +DP
Sbjct: 267 PSISPEMQEIVTALLSSDP 285
|
Length = 496 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 3e-18
Identities = 69/240 (28%), Positives = 106/240 (44%), Gaps = 18/240 (7%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
G +V K H +T+ A K I Q Q I+ E +LY S I+G + +
Sbjct: 12 GNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQ-IMSELEILYKCD-SPYIIGFYGAFF 69
Query: 82 TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQN 141
+ + + E + G L D+ IPE +++ L +L I H D+KP N
Sbjct: 70 VENRISICTEFMDGGSL----DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSN 125
Query: 142 ILLTKDNNIKLCDFGISR-VVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLA 200
+L+ +KLCDFG+S +VN + K +GT Y+APE +S E + +D+WS+G+
Sbjct: 126 MLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISF 183
Query: 201 YVLLSSHSPFAGDNKQETFL---NISQCNFSFHEDL----FGHISSQAKDFIQSCLVTDP 253
L P+ K + L + QC ED G S + FI C+ P
Sbjct: 184 MELALGRFPYPQIQKNQGSLMPLQLLQC--IVDEDPPVLPVGQFSEKFVHFITQCMRKQP 241
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 4e-18
Identities = 50/185 (27%), Positives = 95/185 (51%), Gaps = 3/185 (1%)
Query: 69 KSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLH 128
K+ IV + + E+ +V+E + G L +V + + E + ++ L+AL FLH
Sbjct: 74 KNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV-TETCMDEAQIAAVCRECLQALEFLH 132
Query: 129 DHNITHLDLKPQNILLTKDNNIKLCDFGI-SRVVNDVVEVKEIIGTPDYVAPEVLSYEPI 187
+ + H D+K N+LL D ++KL DFG +++ + + ++GTP ++APEV++ +
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 188 SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247
D+WS+G++A ++ P+ +N I+ N + +S +DF+
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSPIFRDFLNR 251
Query: 248 CLVTD 252
CL D
Sbjct: 252 CLEMD 256
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-18
Identities = 54/166 (32%), Positives = 88/166 (53%), Gaps = 11/166 (6%)
Query: 20 SRGKFASV----RKCTHKITKVEYAAKFIRKRRRSMDQM-QDILHEAAVLYLAQKSERIV 74
SRG F V +K K+ YA K ++K M + E L L+ KS IV
Sbjct: 13 SRGAFGKVYLGRKKNNSKL----YAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIV 67
Query: 75 GLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITH 134
L+ ++ + + LV+E + G+++ L+ I E+ Y+ ++ AL +LH H I H
Sbjct: 68 HLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIH 127
Query: 135 LDLKPQNILLTKDNNIKLCDFGISRV-VNDVVEVKEIIGTPDYVAP 179
DLKP N+L++ + +IKL DFG+S+V +N + + +I+ TP P
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 5e-18
Identities = 53/188 (28%), Positives = 94/188 (50%), Gaps = 9/188 (4%)
Query: 69 KSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLH 128
K IV + Y E+ +V+E + G L +V + + E + ++ L+AL FLH
Sbjct: 74 KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLH 132
Query: 129 DHNITHLDLKPQNILLTKDNNIKLCDFGI-SRVVNDVVEVKEIIGTPDYVAPEVLSYEPI 187
+ + H D+K NILL D ++KL DFG +++ + + ++GTP ++APEV++ +
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 188 SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNIS---QCNFSFHEDLFGHISSQAKDF 244
D+WS+G++A ++ P+ +N I+ E L S+ +DF
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL----SAIFRDF 248
Query: 245 IQSCLVTD 252
+ CL D
Sbjct: 249 LNRCLEMD 256
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 5e-18
Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 4/178 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G V K H+ + + A K I + + Q I+ E VL+ S IVG + +
Sbjct: 11 AGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQ-IIRELKVLHEC-NSPYIVGFYGAF 68
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKP 139
+ E+ + +E + G L +++ IPE +L L +L + H I H D+KP
Sbjct: 69 YSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKP 128
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
NIL+ IKLCDFG+S + D + +GT Y++PE L ++ +D+WS+G
Sbjct: 129 SNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYTVQSDIWSLG 185
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 6e-18
Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 28/204 (13%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQD-----ILHEAAVLYLAQKSERIVGL 76
G + V + + A K +R MD +D L E +L L + IV L
Sbjct: 18 GTYGIVYRARDTTSGEIVALKKVR-----MDNERDGIPISSLREITLL-LNLRHPNIVEL 71
Query: 77 HEIYETPH--EMVLVLEMVPDGELQRLVD-IQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
E+ H + LV+E + +L L+D + E + M Q+L L +LH++ I
Sbjct: 72 KEVVVGKHLDSIFLVMEYC-EQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFII 130
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPD-----YVAPEVL-SYEPI 187
H DLK N+LLT +K+ DFG++R + TP Y APE+L
Sbjct: 131 HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM----TPKVVTLWYRAPELLLGCTTY 186
Query: 188 SLATDMWSVG-VLAYVLLSSHSPF 210
+ A DMW+VG +LA +L H P
Sbjct: 187 TTAIDMWAVGCILAELLA--HKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-18
Identities = 56/178 (31%), Positives = 91/178 (51%), Gaps = 4/178 (2%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
G V K +HK + + A K I + + Q I+ E VL+ S IVG + +
Sbjct: 16 GNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ-IIRELQVLHECN-SPYIVGFYGAFY 73
Query: 82 TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQ 140
+ E+ + +E + G L +++ IPEQ +++ L +L + H I H D+KP
Sbjct: 74 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 133
Query: 141 NILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
NIL+ IKLCDFG+S + D + +GT Y++PE L S+ +D+WS+G+
Sbjct: 134 NILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 1e-17
Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 58 LHEAAVLYLAQKSERIVGLHEIY--ETPHEMVLVLEMVPDGELQRLVDIQDG---IPEQD 112
L E +L L + IV + E+ ++ +V+E V + +L+ L++ E
Sbjct: 52 LREINIL-LKLQHPNIVTVKEVVVGSNLDKIYMVMEYV-EHDLKSLMETMKQPFLQSEVK 109
Query: 113 TRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV-KEII 171
M Q+L +A LHD+ I H DLK N+LL +K+CDFG++R ++ +++
Sbjct: 110 C--LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLV 167
Query: 172 GTPDYVAPEVLSYEPI-SLATDMWSVGVLAYVLLSSHSPFAGDN 214
T Y APE+L S A DMWSVG + LL+ F G +
Sbjct: 168 VTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-17
Identities = 67/230 (29%), Positives = 92/230 (40%), Gaps = 41/230 (17%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
G F V K HK TK A K + L E +L L K E +V L EI
Sbjct: 23 GTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICR 81
Query: 82 TPHEM--------VLVLEMVPDGELQRL---VDIQDGIPEQDTRSYMKQILEALAFLHDH 130
T LV E + +L L +++ + E + MK +L L ++H +
Sbjct: 82 TKATPYNRYKGSFYLVFEFC-EHDLAGLLSNKNVKFTLSE--IKKVMKMLLNGLYYIHRN 138
Query: 131 NITHLDLKPQNILLTKDNNIKLCDFGISRV------------VNDVVEVKEIIGTPDYVA 178
I H D+K NIL+TKD +KL DFG++R N VV T Y
Sbjct: 139 KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-------TLWYRP 191
Query: 179 PEVL----SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQ 224
PE+L Y P DMW G + + + G+ +Q ISQ
Sbjct: 192 PELLLGERDYGP---PIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQ 238
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-17
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 9/209 (4%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
G + V K ++T A K IR + + E ++L Q IV L ++
Sbjct: 13 GTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN-IVRLQDVVH 71
Query: 82 TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDT--RSYMKQILEALAFLHDHNITHLDLKP 139
+ + LV E + D +L++ +D + ++Y+ QIL +A+ H H + H DLKP
Sbjct: 72 SEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKP 130
Query: 140 QNILLTKDNN-IKLCDFGISRVVNDVVE--VKEIIGTPDYVAPEV-LSYEPISLATDMWS 195
QN+L+ + N +KL DFG++R V E++ T Y APE+ L S D+WS
Sbjct: 131 QNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRHYSTPVDIWS 189
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQ 224
VG + +++ F GD++ + I +
Sbjct: 190 VGCIFAEMVNQKPLFPGDSEIDELFKIFR 218
|
Length = 294 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-17
Identities = 65/242 (26%), Positives = 113/242 (46%), Gaps = 15/242 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR---RSMDQMQDILHEAAVLYLAQKSERIVGLH 77
+G F V K T YA K + K+R +S ++M L E +L S IV L
Sbjct: 3 KGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMA--LLEKEILEKVN-SPFIVNLA 59
Query: 78 EIYETPHEMVLVLEMVPDGELQ-RLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
+E+ + LV+ ++ G+L+ + ++ + G+ + Y QI + LH +I +
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR 119
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
D+KP+N+LL N +L D G++ + D + + GT Y+APE+L EP S D ++
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFA 179
Query: 196 VGVLAYVLLSSHSPFAGD----NKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251
+G Y +++ +PF K+E + F F + ++KD + L
Sbjct: 180 MGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNF---TEESKDICRLFLAK 236
Query: 252 DP 253
P
Sbjct: 237 KP 238
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-17
Identities = 67/244 (27%), Positives = 109/244 (44%), Gaps = 22/244 (9%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G +V K H+ T YA K I + Q I E +L +V H+++
Sbjct: 84 SGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQ-ICREIEILRDVNHPN-VVKCHDMF 141
Query: 81 ETPHEMVLVLEMVPDGELQ--RLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
+ E+ ++LE + G L+ + D EQ +QIL +A+LH +I H D+K
Sbjct: 142 DHNGEIQVLLEFMDGGSLEGTHIAD------EQFLADVARQILSGIAYLHRRHIVHRDIK 195
Query: 139 PQNILLTKDNNIKLCDFGISRVVNDVVE-VKEIIGTPDYVAPEVLS-------YEPISLA 190
P N+L+ N+K+ DFG+SR++ ++ +GT Y++PE ++ Y+ A
Sbjct: 196 PSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD--GYA 253
Query: 191 TDMWSVGVLAYVLLSSHSPFA-GDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249
D+WS+GV PF G L + C S + S + + FI CL
Sbjct: 254 GDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQPPEAPATASREFRHFISCCL 312
Query: 250 VTDP 253
+P
Sbjct: 313 QREP 316
|
Length = 353 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-17
Identities = 55/220 (25%), Positives = 102/220 (46%), Gaps = 41/220 (18%)
Query: 71 ERIVGLHEIYETPH-----EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALA 125
E ++ + +I PH ++ +V E++ D +L +++ + + + ++ Q+L L
Sbjct: 64 ENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLK 122
Query: 126 FLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE-VKEIIGTPDYVAPEV-LS 183
++H N+ H DLKP N+LL + ++K+CDFG++R ++ + + E + T Y APE+ L+
Sbjct: 123 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 184 YEPISLATDMWSVGVLAYVLLSSHSPFAG-----------------DNKQETFL------ 220
+ A D+WSVG + LL F G + F+
Sbjct: 183 CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242
Query: 221 -------NISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ +F+ LF H + A D ++ LV DP
Sbjct: 243 RYIRSLPYTPRQSFA---RLFPHANPLAIDLLEKMLVFDP 279
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-17
Identities = 63/200 (31%), Positives = 94/200 (47%), Gaps = 8/200 (4%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
G +A+V K K+T+ A K IR I + + L K IV LH+I
Sbjct: 16 GTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL--KHANIVTLHDIIH 73
Query: 82 TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQN 141
T + LV E + Q L + + + + + +M Q+L L++ H I H DLKPQN
Sbjct: 74 TERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQN 133
Query: 142 ILLTKDNNIKLCDFGISRV--VNDVVEVKEIIGTPDYVAPEVL--SYEPISLATDMWSVG 197
+L+ + +KL DFG++R V E++ T Y P+VL S E S DMW VG
Sbjct: 134 LLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTE-YSTPIDMWGVG 191
Query: 198 VLAYVLLSSHSPFAGDNKQE 217
+ Y + + F G +E
Sbjct: 192 CILYEMATGRPMFPGSTVKE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-17
Identities = 72/274 (26%), Positives = 113/274 (41%), Gaps = 52/274 (18%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSM-DQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G F V TK YA K +RK+ + +Q+ + E +L A +E +V L+ +
Sbjct: 12 GAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSF 70
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGI-PEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
+ + V++ +P G++ L+ I+ GI PE R Y+ ++ A+ +H H D+KP
Sbjct: 71 QDKDNLYFVMDYIPGGDMMSLL-IRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKP 129
Query: 140 QNILLTKDNNIKLCDFGI----------------SRVVNDVVEVKEIIGTP--------- 174
NIL+ +D +IKL DFG+ V D ++ G P
Sbjct: 130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRL 189
Query: 175 -----------------------DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFA 211
+Y+APEVL + D WSVGV+ Y +L PF
Sbjct: 190 KPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL 249
Query: 212 GDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245
ET + + S H +S +A D I
Sbjct: 250 AQTPLETQMKVINWQTSLHIPPQAKLSPEASDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 7e-17
Identities = 59/207 (28%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 21 RGKFASVRKCTHKITK---VEYAAKFIRKRRRSM--DQMQDILHEAAVLYLAQKSERIVG 75
G F V C + E A ++ S D E +L E IV
Sbjct: 14 EGHFGKVELCRYDPLGDNTGEQVA--VKSLNHSGEEQHRSDFEREIEILRTLD-HENIVK 70
Query: 76 LHEIYETPHE--MVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHDHNI 132
+ E P + L++E +P G L+ L +D I + + QI + + +L
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRY 130
Query: 133 THLDLKPQNILLTKDNNIKLCDFGISRVVN---DVVEVKEIIGTP-DYVAPEVLSYEPIS 188
H DL +NIL+ ++ +K+ DFG+++V+ D VKE +P + APE L S
Sbjct: 131 IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFS 190
Query: 189 LATDMWSVGVLAYVLLS----SHSPFA 211
A+D+WS GV Y L + S SP A
Sbjct: 191 SASDVWSFGVTLYELFTYGDPSQSPPA 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-17
Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 36/214 (16%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRR---------RSMDQMQDILHEAAVLYLAQKSER 72
G +A+V K K+T A K IR R + ++D+ H
Sbjct: 17 GTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA-----------N 65
Query: 73 IVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNI 132
IV LH+I T + LV E + Q L D + I + + ++ Q+L L + H +
Sbjct: 66 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKV 125
Query: 133 THLDLKPQNILLTKDNNIKLCDFGISRV--------VNDVVEVKEIIGTPDYVAPEV-LS 183
H DLKPQN+L+ + +KL DFG++R N+VV T Y P++ L
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-------TLWYRPPDILLG 178
Query: 184 YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQE 217
S DMW VG + Y + + F G +E
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-16
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRR---------RSMDQMQDILHEAAVLYLAQKSER 72
G +A+V K K+T+ A K IR R + ++D+ H
Sbjct: 17 GTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA-----------N 65
Query: 73 IVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNI 132
IV LH+I T + LV E + Q + D + + + + ++ QIL LA+ H +
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKV 125
Query: 133 THLDLKPQNILLTKDNNIKLCDFGISRV--VNDVVEVKEIIGTPDYVAPEV-LSYEPISL 189
H DLKPQN+L+ + +KL DFG++R V E++ T Y P+V L S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 190 ATDMWSVGVLAYVLLSSHSPFAGDNKQE 217
DMW VG + + + S F G ++
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-16
Identities = 50/181 (27%), Positives = 97/181 (53%), Gaps = 5/181 (2%)
Query: 69 KSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLH 128
+ E I+ L +I+ +P E + + + +L RL+ + + +Q + ++ QIL L ++H
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQILRGLKYVH 125
Query: 129 DHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEV-LSYEPI 187
+ H DLKP NIL+ ++ ++K+CDFG++R+ + ++ + T Y APE+ L+++
Sbjct: 126 SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKY 183
Query: 188 SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAK-DFIQ 246
+ D+WS G + +L F G + F I+ + +D+ I S+ F+Q
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243
Query: 247 S 247
S
Sbjct: 244 S 244
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-16
Identities = 44/133 (33%), Positives = 74/133 (55%), Gaps = 5/133 (3%)
Query: 73 IVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYM-KQILEALAFLHDHN 131
IV Y ++ +V+E G LQ + + G + +Y+ ++ L+ LA+LH+
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121
Query: 132 ITHLDLKPQNILLTKDNNIKLCDFGIS-RVVNDVVEVKEIIGTPDYVAPEVLSYEPIS-- 188
H D+K NILLT+D ++KL DFG+S ++ + + K IGTP ++APEV + E
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGY 181
Query: 189 -LATDMWSVGVLA 200
D+W++G+ A
Sbjct: 182 DGKCDIWALGITA 194
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-16
Identities = 60/194 (30%), Positives = 92/194 (47%), Gaps = 6/194 (3%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
G +A+V K K+ A K IR + I EA++L K IV LH+I
Sbjct: 16 GSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLK-GLKHANIVLLHDIIH 73
Query: 82 TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQN 141
T + LV E V Q + G+ ++ + ++ Q+L L+++H I H DLKPQN
Sbjct: 74 TKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQN 133
Query: 142 ILLTKDNNIKLCDFGISRV--VNDVVEVKEIIGTPDYVAPEV-LSYEPISLATDMWSVGV 198
+L++ +KL DFG++R V E++ T Y P+V L S DMW VG
Sbjct: 134 LLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYSTCLDMWGVGC 192
Query: 199 LAYVLLSSHSPFAG 212
+ ++ + F G
Sbjct: 193 IFVEMIQGVAAFPG 206
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-16
Identities = 66/201 (32%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
G +A+V K K+T A K IR I EA++L K IV LH+I
Sbjct: 16 GSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-REASLLK-DLKHANIVTLHDIIH 73
Query: 82 TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQN 141
T + LV E + Q + D G+ + R ++ Q+L LA+ H + H DLKPQN
Sbjct: 74 TKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQN 133
Query: 142 ILLTKDNNIKLCDFGISRV--------VNDVVEVKEIIGTPDYVAPEVL--SYEPISLAT 191
+L+++ +KL DFG++R N+VV T Y P+VL S E S +
Sbjct: 134 LLISERGELKLADFGLARAKSVPSKTYSNEVV-------TLWYRPPDVLLGSTE-YSTSL 185
Query: 192 DMWSVGVLAYVLLSSHSPFAG 212
DMW VG + Y + + F G
Sbjct: 186 DMWGVGCIFYEMATGRPLFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-16
Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 14/193 (7%)
Query: 22 GKFASVRKCTHKITK---VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER-IVGLH 77
G F SV K + + VE A K + K+ ++ L EA+V+ AQ IV L
Sbjct: 6 GNFGSVVKGVYLMKSGKEVEVAVKTL-KQEHIAAGKKEFLREASVM--AQLDHPCIVRLI 62
Query: 78 EIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
+ + ++LV+E+ P G L + L ++ IP D + Q+ +A+L + H D
Sbjct: 63 GVCKGE-PLMLVMELAPLGPLLKYLKKRRE-IPVSDLKELAHQVAMGMAYLESKHFVHRD 120
Query: 137 LKPQNILLTKDNNIKLCDFGISRVV---NDVVEVKEIIGTP-DYVAPEVLSYEPISLATD 192
L +N+LL + K+ DFG+SR + +D P + APE ++Y S +D
Sbjct: 121 LAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSD 180
Query: 193 MWSVGVLAYVLLS 205
+WS GV + S
Sbjct: 181 VWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-16
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 13/212 (6%)
Query: 21 RGKFASVRKCTHKI---TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLH 77
G F VR+ + A K ++ + S D M D L EAA++ + E ++ L+
Sbjct: 5 DGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIM-HSLDHENLIRLY 62
Query: 78 EIYETPHEMVLVLEMVPDGEL-QRLVDIQDGI-PEQDTRSYMKQILEALAFLHDHNITHL 135
+ T H +++V E+ P G L RL G Y QI + +L H
Sbjct: 63 GVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHR 121
Query: 136 DLKPQNILLTKDNNIKLCDFGISR---VVNDVVEVKEIIGTP-DYVAPEVLSYEPISLAT 191
DL +NILL D+ +K+ DFG+ R D ++E + P + APE L S A+
Sbjct: 122 DLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHAS 181
Query: 192 DMWSVGVLAYVLLS-SHSPFAGDNKQETFLNI 222
D+W GV + + + P+AG + + I
Sbjct: 182 DVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-16
Identities = 47/134 (35%), Positives = 76/134 (56%), Gaps = 8/134 (5%)
Query: 85 EMVLVLEMVPDGELQRLVDIQDG-IPEQDTRSYM-KQILEALAFLHDHNITHLDLKPQNI 142
++ LV+E G + LV G ++D +Y+ ++IL LA LH H + H D+K QN+
Sbjct: 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNV 152
Query: 143 LLTKDNNIKLCDFGISRVVNDVVEVKE-IIGTPDYVAPEVLSYEPISLAT-----DMWSV 196
LLT++ +KL DFG+S ++ V + IGTP ++APEV++ + AT D+WS+
Sbjct: 153 LLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSL 212
Query: 197 GVLAYVLLSSHSPF 210
G+ A + P
Sbjct: 213 GITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-16
Identities = 52/176 (29%), Positives = 88/176 (50%), Gaps = 10/176 (5%)
Query: 85 EMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNI 142
++ LV+E G + L+ G + E+ ++IL L+ LH H + H D+K QN+
Sbjct: 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNV 142
Query: 143 LLTKDNNIKLCDFGISRVVNDVVEVKE-IIGTPDYVAPEVLSYEPISLAT-----DMWSV 196
LLT++ +KL DFG+S ++ V + IGTP ++APEV++ + AT D+WS+
Sbjct: 143 LLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSL 202
Query: 197 GVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTD 252
G+ A + P + I + + S + + FI+SCLV +
Sbjct: 203 GITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS--KKWSKKFQSFIESCLVKN 256
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-16
Identities = 60/198 (30%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDI----LHEAAVLYLAQKSERIVGLH 77
G +A+V K +I A K I SM + + + EA++L K IV LH
Sbjct: 16 GSYATVYKGISRINGQLVALKVI-----SMKTEEGVPFTAIREASLLK-GLKHANIVLLH 69
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+I T + V E + Q ++ G+ + R +M Q+L LA++H +I H DL
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129
Query: 138 KPQNILLTKDNNIKLCDFGISRV--VNDVVEVKEIIGTPDYVAPEVL-SYEPISLATDMW 194
KPQN+L++ +KL DFG++R + E++ T Y P+VL S A D+W
Sbjct: 130 KPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSALDIW 188
Query: 195 SVGVLAYVLLSSHSPFAG 212
G + +L F G
Sbjct: 189 GAGCIFIEMLQGQPAFPG 206
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 9e-16
Identities = 42/139 (30%), Positives = 77/139 (55%), Gaps = 11/139 (7%)
Query: 69 KSERIVGLHEIYETPHE----MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEAL 124
K + I+ + +I P + +V++++ + +L ++ + E+ R ++ Q+L L
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGL 120
Query: 125 AFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR-VVNDVVEVK----EIIGTPDYVAP 179
++H N+ H DLKP N+L+ +D +++ DFG++R + + E K E + T Y AP
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 180 EVL-SYEPISLATDMWSVG 197
E+L S + A DMWSVG
Sbjct: 181 ELLLSLPEYTTAIDMWSVG 199
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-15
Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 6/157 (3%)
Query: 71 ERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMK---QILEALAFL 127
+ ++ L + + ++ E++ G L + +G S + Q+ E +A+L
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYL 120
Query: 128 HDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTP-DYVAPEVLSYEP 186
+ N H DL +NIL+ +D K+ DFG++R++ + V + P + APE S+
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 187 ISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNI 222
S +D+WS G+L Y + + P+ G N E + I
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-15
Identities = 47/163 (28%), Positives = 79/163 (48%), Gaps = 4/163 (2%)
Query: 69 KSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLH 128
K IV Y + ++ + +E G LQ + + + E ++ L+ LA+LH
Sbjct: 64 KHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 129 DHNITHLDLKPQNILLTKDNNIKLCDFGI-SRVVNDVVEVKEIIGTPDYVAPEVLSYEP- 186
H D+K NILLT + ++KL DFG+ +++ + + K IGTP ++APEV + E
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 187 --ISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNF 227
+ D+W+VG+ A L P + +S+ NF
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-15
Identities = 66/259 (25%), Positives = 111/259 (42%), Gaps = 30/259 (11%)
Query: 15 IFCMPSRGK-FASVRKCTHKITKVEYAAKFIRKR------------RRSMDQMQDILHEA 61
+F K F+ +R+ H Y A+ +R ++S ++ QDI+ E
Sbjct: 7 LFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV 66
Query: 62 AVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQI 120
L + + Y H LV+E G L+++ + + E + +
Sbjct: 67 RFLQ-KLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGA 124
Query: 121 LEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPE 180
L+ LA+LH HN+ H D+K NILL++ +KL DFG + ++ +GTP ++APE
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---PANXFVGTPYWMAPE 181
Query: 181 VL------SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLF 234
V+ Y+ D+WS+G+ L P N +I+Q +
Sbjct: 182 VILAMDEGQYDG---KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS-- 236
Query: 235 GHISSQAKDFIQSCLVTDP 253
GH S ++F+ SCL P
Sbjct: 237 GHWSEYFRNFVDSCLQKIP 255
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-15
Identities = 54/185 (29%), Positives = 96/185 (51%), Gaps = 16/185 (8%)
Query: 44 IRKRRRSMDQMQD---ILHEAAVLYLAQKSERIVGLHEIYETP-----HEMVLVLEMVPD 95
I+K + + D IL E +L L + + IV + I P ++ +V E++ +
Sbjct: 30 IKKINDVFEHVSDATRILREIKLLRLLRHPD-IVEIKHIMLPPSRREFKDIYVVFELM-E 87
Query: 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDF 155
+L +++ D + + + ++ Q+L AL ++H N+ H DLKP+NIL D +K+CDF
Sbjct: 88 SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDF 147
Query: 156 GISRV-VND---VVEVKEIIGTPDYVAPEVLS--YEPISLATDMWSVGVLAYVLLSSHSP 209
G++RV ND + + + T Y APE+ + + A D+WS+G + +L+
Sbjct: 148 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 207
Query: 210 FAGDN 214
F G N
Sbjct: 208 FPGKN 212
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-15
Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 4/176 (2%)
Query: 56 DILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRS 115
++ + ++ K IV Y ++ + +E G LQ + + + E
Sbjct: 51 AVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY 110
Query: 116 YMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGIS-RVVNDVVEVKEIIGTP 174
++ L+ L +LH H D+K NILLT + ++KL DFG+S ++ + + K IGTP
Sbjct: 111 VSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTP 170
Query: 175 DYVAPEVLSYEP---ISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNF 227
++APEV + E + D+W+VG+ A L P + +++ NF
Sbjct: 171 YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-15
Identities = 70/306 (22%), Positives = 116/306 (37%), Gaps = 71/306 (23%)
Query: 2 CNKFFVNGGYQTLIFCMPSR-GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ------- 53
G Y + + GK +++K KI ++ + + K R+ +
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKV--KIIEI---SNDVTKDRQLVGMCGIHFTT 67
Query: 54 ------MQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDG 107
M +I HE I+GL ++Y + LV++++ +L+++VD +
Sbjct: 68 LRELKIMNEIKHE-----------NIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIR 115
Query: 108 IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR-VVNDVV- 165
+ E + + QIL L LH H DL P NI + K+ DFG++R
Sbjct: 116 LTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175
Query: 166 -------------EVKEIIGTPDYVAPEVL-SYEPISLATDMWSVGVLAYVLLSSHSPFA 211
E+ + T Y APE+L E A DMWSVG + LL+ F
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235
Query: 212 GDNKQETFLNI-------------------SQCNFSFH-----EDLFGHISSQAKDFIQS 247
G+N+ + I F+ + +F + S A D +QS
Sbjct: 236 GENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQS 295
Query: 248 CLVTDP 253
L +P
Sbjct: 296 LLKLNP 301
|
Length = 335 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-15
Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 23/227 (10%)
Query: 34 ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMV 93
I K+ Y+ K +S ++ QDI+ E L + I Y H LV+E
Sbjct: 55 IKKMSYSGK------QSNEKWQDIIKEVKFLQRIKHPNSI-EYKGCYLREHTAWLVMEYC 107
Query: 94 PDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKL 152
G L+++ + + E + + L+ LA+LH HN+ H D+K NILLT+ +KL
Sbjct: 108 L-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKL 166
Query: 153 CDFGISRVVNDVVEVKEIIGTPDYVAPEVL------SYEPISLATDMWSVGVLAYVLLSS 206
DFG + + + +GTP ++APEV+ Y+ D+WS+G+ L
Sbjct: 167 ADFGSASIAS---PANSFVGTPYWMAPEVILAMDEGQYDG---KVDVWSLGITCIELAER 220
Query: 207 HSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
P N +I+Q + S ++F+ SCL P
Sbjct: 221 KPPLFNMNAMSALYHIAQNESPTLQS--NEWSDYFRNFVDSCLQKIP 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-15
Identities = 60/234 (25%), Positives = 116/234 (49%), Gaps = 13/234 (5%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY- 80
G + SV + + A K + + +S+ + E +L K E ++GL +++
Sbjct: 26 GAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK-HMKHENVIGLLDVFT 84
Query: 81 -----ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
E +E+ LV ++ +L +V Q + ++ + + Q+L L ++H I H
Sbjct: 85 PATSIENFNEVYLVTNLM-GADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHSAGIIHR 142
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEV-LSYEPISLATDMW 194
DLKP N+ + +D +++ DFG++R +D E+ + T Y APE+ L++ + D+W
Sbjct: 143 DLKPSNVAVNEDCELRILDFGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIW 200
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ-AKDFIQS 247
SVG + LL + F G++ + I + + ++ ISS+ A+ +IQS
Sbjct: 201 SVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQS 254
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 7e-15
Identities = 46/131 (35%), Positives = 73/131 (55%), Gaps = 4/131 (3%)
Query: 119 QILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVA 178
QIL L ++H I H DLKP NI + +D +K+ DFG++R +D E+ + T Y A
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRA 183
Query: 179 PEV-LSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHI 237
PE+ L++ + D+WSVG + LL+ + F G + + I + E+L I
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243
Query: 238 SSQ-AKDFIQS 247
SS+ A+++IQS
Sbjct: 244 SSESARNYIQS 254
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 9e-15
Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 15/121 (12%)
Query: 108 IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN----IKLCDFGISRVVND 163
IP +S + QIL + +LH + + H DLKP NIL+ + +K+ D G++R+ N
Sbjct: 105 IPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164
Query: 164 ----VVEVKEIIGTPDYVAPEVL----SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNK 215
+ ++ ++ T Y APE+L Y A D+W++G + LL+ F G
Sbjct: 165 PLKPLADLDPVVVTIWYRAPELLLGARHYTK---AIDIWAIGCIFAELLTLEPIFKGREA 221
Query: 216 Q 216
+
Sbjct: 222 K 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-14
Identities = 43/175 (24%), Positives = 80/175 (45%), Gaps = 11/175 (6%)
Query: 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILL-TK 146
L +E + G + L+ E +Y +Q+L L++LH++ I H D+K N+L+ +
Sbjct: 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDST 139
Query: 147 DNNIKLCDFGIS-RVVNDVVEVKE----IIGTPDYVAPEVLSYEPISLATDMWSVGVLAY 201
+++ DFG + R+ E ++GT ++APEVL E + D+WSVG +
Sbjct: 140 GQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVII 199
Query: 202 VLLSSHSPFAGDNKQETF---LNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ ++ P+ + I+ + + H+S +D CL P
Sbjct: 200 EMATAKPPWNAEKHSNHLALIFKIASATTA--PSIPEHLSPGLRDVTLRCLELQP 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-14
Identities = 54/187 (28%), Positives = 100/187 (53%), Gaps = 12/187 (6%)
Query: 69 KSERIVGLHEIY------ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILE 122
K E ++GL +++ E +++ LV ++ +L +V Q + + + + QIL
Sbjct: 74 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILR 131
Query: 123 ALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEV- 181
L ++H +I H DLKP N+ + +D +K+ DFG++R +D E+ + T Y APE+
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIM 189
Query: 182 LSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ- 240
L++ + D+WSVG + LL+ + F G + + I + + +L ISS+
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249
Query: 241 AKDFIQS 247
A+++IQS
Sbjct: 250 ARNYIQS 256
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-14
Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 31/231 (13%)
Query: 34 ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGLHEIYETPHEMVLVLEM 92
I K+ Y+ K +S ++ QDI+ E V +L Q + + Y H LV+E
Sbjct: 45 IKKMSYSGK------QSNEKWQDIIKE--VRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96
Query: 93 VPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIK 151
G ++++ + + E + + L+ LA+LH H H D+K NILLT+ +K
Sbjct: 97 CL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVK 155
Query: 152 LCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLA---------TDMWSVGVLAYV 202
L DFG + +V+ +GTP ++APEV+ LA D+WS+G+
Sbjct: 156 LADFGSASLVS---PANSFVGTPYWMAPEVI------LAMDEGQYDGKVDVWSLGITCIE 206
Query: 203 LLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
L P N +I+Q + S ++F+ SCL P
Sbjct: 207 LAERKPPLFNMNAMSALYHIAQNDSPTLSS--NDWSDYFRNFVDSCLQKIP 255
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-14
Identities = 50/196 (25%), Positives = 92/196 (46%), Gaps = 20/196 (10%)
Query: 22 GKFASVRKCTHKITK--VEYAAKFIRKR-----RRSMDQMQDILHEAAVLYLAQKSERIV 74
G F V+K +K+ K ++ A K ++ R M + +I+H+ Y+ R++
Sbjct: 6 GNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV----RMI 61
Query: 75 GLHEIYETPHEMVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
G+ E ++LV+EM G L + L +D I + M Q+ + +L N
Sbjct: 62 GVCE----AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISRVV---NDVVEVKEIIGTP-DYVAPEVLSYEPISL 189
H DL +N+LL + K+ DFG+S+ + + + + P + APE +++ S
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 190 ATDMWSVGVLAYVLLS 205
+D+WS G+ + S
Sbjct: 178 RSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (177), Expect = 2e-14
Identities = 64/235 (27%), Positives = 108/235 (45%), Gaps = 53/235 (22%)
Query: 22 GKFASVRKCTHKITKVEYAAKFI-----RKRRRS-----MDQMQDILHEAAVLYLAQKSE 71
G+F V HK T+ + K I ++R +S ++ M+++ H+ V Y+ +
Sbjct: 24 GRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYI----D 79
Query: 72 RIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQD------GIPEQDTRSYMKQILEALA 125
R + + ++ +++E G+L R +IQ I E +Q+L ALA
Sbjct: 80 RFLN-----KANQKLYILMEFCDAGDLSR--NIQKCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 126 FLHD-------HNITHLDLKPQNILLT-----------KDNNI------KLCDFGISRVV 161
+ H+ + H DLKPQNI L+ + NN+ K+ DFG+S+ +
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 162 NDVVEVKEIIGTPDYVAPEVLSYEPISL--ATDMWSVGVLAYVLLSSHSPFAGDN 214
+GTP Y +PE+L +E S +DMW++G + Y L S +PF N
Sbjct: 193 GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247
|
Length = 1021 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-14
Identities = 53/194 (27%), Positives = 88/194 (45%), Gaps = 10/194 (5%)
Query: 36 KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95
+ + A K I++ S D + + EA V+ + E++V L+ + + +V E + +
Sbjct: 28 QYDVAIKMIKEGSMSED---EFIEEAKVM-MKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83
Query: 96 G-ELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCD 154
G L L + K + E +A+L H DL +N L+ +K+ D
Sbjct: 84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSD 143
Query: 155 FGISRVVNDVVEVKEIIGTP---DYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPF 210
FG+SR V D E +G+ + PEVL Y S +D+W+ GVL + + S P+
Sbjct: 144 FGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPY 202
Query: 211 AGDNKQETFLNISQ 224
N ET +SQ
Sbjct: 203 ERFNNSETVEKVSQ 216
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-14
Identities = 41/144 (28%), Positives = 75/144 (52%), Gaps = 7/144 (4%)
Query: 69 KSERIVGLHEIYETPH----EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEAL 124
K + ++ +I + PH E + V+ + +L +++ + + ++ QIL L
Sbjct: 57 KHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGL 116
Query: 125 AFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV--VNDVVEVKEIIGTPDYVAPEVL 182
+LH I H D+KP N+L+ + +K+CDFG++RV ++ + + + T Y APE+L
Sbjct: 117 KYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176
Query: 183 SYEP-ISLATDMWSVGVLAYVLLS 205
+ A D+WSVG + LL
Sbjct: 177 MGSRHYTSAVDIWSVGCIFAELLG 200
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-14
Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 5/160 (3%)
Query: 95 DGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCD 154
D +L+ L + E + Q+L + ++H I H DLK +NI L K+N +K+ D
Sbjct: 90 DCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGD 148
Query: 155 FGISRVVNDVVEV-KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGD 213
FG+SR++ ++ GTP Y++PE L ++ +D+WS+G + Y + F G
Sbjct: 149 FGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208
Query: 214 NKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
N L I + + + S Q +QS L DP
Sbjct: 209 NFLSVVLRIVEGPTPSLPETY---SRQLNSIMQSMLNKDP 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-14
Identities = 43/136 (31%), Positives = 76/136 (55%), Gaps = 8/136 (5%)
Query: 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILL-TK 146
+V E + + +L +++ Q + E+ R +M Q+L L ++H N+ H DLKP N+ + T+
Sbjct: 93 IVQEYM-ETDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTE 150
Query: 147 DNNIKLCDFGISRVVNDVVEVK----EIIGTPDYVAPE-VLSYEPISLATDMWSVGVLAY 201
D +K+ DFG++R+V+ K E + T Y +P +LS + A DMW+ G +
Sbjct: 151 DLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFA 210
Query: 202 VLLSSHSPFAGDNKQE 217
+L+ FAG ++ E
Sbjct: 211 EMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 3e-14
Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 12/210 (5%)
Query: 21 RGKFASVRKCT-HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
G+F V T + TKV A K ++ +M + L EA ++ + +++V L+ +
Sbjct: 16 AGQFGEVWMGTWNGTTKV--AVKTLKPG--TMS-PEAFLQEAQIMKKLRH-DKLVQLYAV 69
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+ +V E + G L + +G + QI E +A+L N H DL
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDL 129
Query: 138 KPQNILLTKDNNIKLCDFGISRVV-NDVVEVKEIIGTP-DYVAPEVLSYEPISLATDMWS 195
+NIL+ ++ K+ DFG++R++ +D +E P + APE +Y ++ +D+WS
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWS 189
Query: 196 VGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
G+L +++ P+ G +E + +
Sbjct: 190 FGILLTEIVTYGRVPYPGMTNREVLEQVER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-14
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSM-DQMQDILHEAAVLYLAQ-KSERIVGLHEI 79
G F +V T+ T A K + + ++ QDI+ E V +L Q K +
Sbjct: 32 GSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKE--VKFLQQLKHPNTIEYKGC 89
Query: 80 YETPHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
Y H LV+E G L+++ + + E + + L+ LA+LH HN+ H D+K
Sbjct: 90 YLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148
Query: 139 PQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVL------SYEPISLATD 192
NILLT+ +KL DFG + + +GTP ++APEV+ Y+ D
Sbjct: 149 AGNILLTEPGQVKLADFGSASKSS---PANSFVGTPYWMAPEVILAMDEGQYDG---KVD 202
Query: 193 MWSVGVLAYVLLSSHSPFAGDNKQETFLNISQ 224
+WS+G+ L P N +I+Q
Sbjct: 203 VWSLGITCIELAERKPPLFNMNAMSALYHIAQ 234
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-13
Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 9/198 (4%)
Query: 22 GKFASVRKCTHKITKVE--YAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
G F +V+K +K+ K E A K ++ ++L EA V+ + IV + I
Sbjct: 6 GNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD-NPYIVRMIGI 64
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
E M LV+E+ G L + + + E++ + Q+ + +L + N H DL
Sbjct: 65 CEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAA 123
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTP----DYVAPEVLSYEPISLATDMWS 195
+N+LL + K+ DFG+S+ + + + APE ++Y S +D+WS
Sbjct: 124 RNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWS 183
Query: 196 VGVLAYVLLS-SHSPFAG 212
GVL + S P+ G
Sbjct: 184 FGVLMWEAFSYGQKPYKG 201
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-13
Identities = 41/176 (23%), Positives = 87/176 (49%), Gaps = 6/176 (3%)
Query: 54 MQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDT 113
+Q L EA ++ Q +++V L+ + + ++ E + G L + +G
Sbjct: 45 VQAFLEEANLMKTLQH-DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP 103
Query: 114 RS--YMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVEVKEI 170
+ + QI E +A++ N H DL+ N+L+++ K+ DFG++RV+ D +E
Sbjct: 104 KLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 163
Query: 171 IGTP-DYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
P + APE +++ ++ +D+WS G+L Y +++ P+ G + + + +
Sbjct: 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-13
Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 22 GKFASVRKCTH-KITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G+F V T+ K TKV A K ++ S++ A + + +++V LH +
Sbjct: 17 GQFGEVWMATYNKHTKV--AVKTMKPGSMSVEAFLA----EANVMKTLQHDKLVKLHAVV 70
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
T + ++ E + G L + +G P + QI E +AF+ N H DL+
Sbjct: 71 -TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 129
Query: 139 PQNILLTKDNNIKLCDFGISRVVNDVVEV-KEIIGTP-DYVAPEVLSYEPISLATDMWSV 196
NIL++ K+ DFG++RV+ D +E P + APE +++ ++ +D+WS
Sbjct: 130 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 189
Query: 197 GVLAYVLLS-SHSPFAGDNKQE 217
G+L +++ P+ G + E
Sbjct: 190 GILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-13
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
+G F V K K E A K R D + L EA +L IV L +
Sbjct: 5 KGNFGDVYKGVLK-GNTEVAVKTCRSTLPP-DLKRKFLQEAEIL-KQYDHPNIVKLIGVC 61
Query: 81 ETPHEMVLVLEMVPDGE-LQRLVDIQDGIPEQDTRSYMKQILEALA---FLHDHNITHLD 136
+ +V+E+VP G L L ++ + + ++ L+A A +L N H D
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLT---VKKLLQMSLDAAAGMEYLESKNCIHRD 118
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVV-----EVKEIIGTP-DYVAPEVLSYEPISLA 190
L +N L+ ++N +K+ DFG+SR + +K+I P + APE L+Y +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI---PIKWTAPEALNYGRYTSE 175
Query: 191 TDMWSVGVLAYVLLS-SHSPFAGDNKQET 218
+D+WS G+L + S +P+ G + Q+T
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGMSNQQT 204
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-13
Identities = 55/188 (29%), Positives = 92/188 (48%), Gaps = 10/188 (5%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
G+F V + + K + A K IR+ S +D + EA V+ + ++V L+ +
Sbjct: 15 GQFGLVWL-GYWLEKRKVAIKTIREGAMSE---EDFIEEAQVM-MKLSHPKLVQLYGVCT 69
Query: 82 TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYM-KQILEALAFLHDHNITHLDLKPQ 140
+ LV E + G L + Q G Q+T M + E +A+L N+ H DL +
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAAR 129
Query: 141 NILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTP---DYVAPEVLSYEPISLATDMWSVG 197
N L+ ++ +K+ DFG++R V D + GT + +PEV S+ S +D+WS G
Sbjct: 130 NCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFG 188
Query: 198 VLAYVLLS 205
VL + + S
Sbjct: 189 VLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-13
Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 19/216 (8%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIR--KRRRSMDQMQDILHEAAVLYLAQKSER-IVGLHE 78
G+F V + K+ + A I+ K + Q QD L EA+++ Q S I+ L
Sbjct: 16 GEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM--GQFSHHNIIRLEG 73
Query: 79 IYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSY-----MKQILEALAFLHDHNIT 133
+ +++ E + +G L + + DG + SY ++ I + +L D N
Sbjct: 74 VVTKFKPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPD----YVAPEVLSYEPISL 189
H DL +NIL+ + K+ DFG+SRV+ D E + APE ++Y +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189
Query: 190 ATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
A+D+WS G++ + ++S P+ + E I+
Sbjct: 190 ASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND 225
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-13
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 22 GKFASVRKCT---HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSE-----RI 73
G+F V + + K+ A K K S + L EA Y+ ++ + ++
Sbjct: 17 GQFGDVYQGVYMSPENEKIAVAVK-TCKNCTSPSVREKFLQEA---YIMRQFDHPHIVKL 72
Query: 74 VGLHEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNI 132
+G+ I E P + +V+E+ P GEL L + + Y Q+ ALA+L
Sbjct: 73 IGV--ITENP--VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRF 128
Query: 133 THLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGT-P-DYVAPEVLSYEPISLA 190
H D+ +N+L++ + +KL DFG+SR + D K G P ++APE +++ + A
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSA 188
Query: 191 TDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
+D+W GV + +L PF G + I
Sbjct: 189 SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN 223
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-12
Identities = 67/253 (26%), Positives = 113/253 (44%), Gaps = 31/253 (12%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKS----ERIVGL 76
+G + V K +K + A K +D + DI E Y K+ +V
Sbjct: 28 KGTYGKVFKVLNKKNGSKAAVKI-------LDPIHDIDEEIEAEYNILKALSDHPNVVKF 80
Query: 77 HEIY-----ETPHEMVLVLEMVPDGELQRLVD----IQDGIPEQDTRSYMKQILEALAFL 127
+ +Y + ++ LVLE+ G + LV + + E + + L L L
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140
Query: 128 HDHNITHLDLKPQNILLTKDNNIKLCDFGIS-RVVNDVVEVKEIIGTPDYVAPEVLSYEP 186
H + H D+K NILLT + +KL DFG+S ++ + + +GTP ++APEV++ E
Sbjct: 141 HVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 200
Query: 187 ISLAT-----DMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQC-NFSFHE-DLFGHISS 239
+T D+WS+G+ A L P A + I + + H+ +L+ S+
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELW---SN 257
Query: 240 QAKDFIQSCLVTD 252
+ DFI+ CL D
Sbjct: 258 EFNDFIRKCLTKD 270
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-12
Identities = 34/114 (29%), Positives = 60/114 (52%), Gaps = 3/114 (2%)
Query: 102 VDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV 161
VD +P + + +++LEALA+LH I H D+K +NI L + N L DFG + +
Sbjct: 176 VDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235
Query: 162 NDVVEVKEI---IGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAG 212
+ + + GT + +PE+L+ +P TD+WS G++ + + + G
Sbjct: 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-12
Identities = 40/124 (32%), Positives = 60/124 (48%), Gaps = 22/124 (17%)
Query: 111 QDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI 170
+D SY Q+ + FL H DL +NILL+++N +K+CDFG++R +I
Sbjct: 173 EDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR---------DI 223
Query: 171 IGTPDYV------------APEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQE 217
PDYV APE + + + +D+WS GVL + + S SP+ G E
Sbjct: 224 YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE 283
Query: 218 TFLN 221
F
Sbjct: 284 EFCR 287
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-12
Identities = 41/121 (33%), Positives = 58/121 (47%), Gaps = 9/121 (7%)
Query: 110 EQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN--DVVEV 167
E +S+MKQ+LE L + H N H D+K NILL IKL DFG++R+ N +
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 168 KEIIGTPDYVAPEVL----SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNIS 223
+ T Y PE+L Y P A D+WS G + L + F + + IS
Sbjct: 175 TNKVITLWYRPPELLLGEERYGP---AIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231
Query: 224 Q 224
+
Sbjct: 232 R 232
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-12
Identities = 43/132 (32%), Positives = 69/132 (52%), Gaps = 9/132 (6%)
Query: 86 MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLT 145
+ L++E VP G L+ + + + + +QI E +A+LH + H DL +N+LL
Sbjct: 83 LQLIMEYVPLGSLRDYLP-KHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD 141
Query: 146 KDNNIKLCDFGISRVV---NDVVEVKEIIGTPDY-VAPEVLSYEPISLATDMWSVGVLAY 201
D +K+ DFG+++ V ++ V+E +P + A E L S A+D+WS GV Y
Sbjct: 142 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLY 201
Query: 202 VLL----SSHSP 209
LL S SP
Sbjct: 202 ELLTHCDSKQSP 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-12
Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 21 RGKFASVRKCTHKI----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGL 76
+G F SV C + T A K + + + + ++D E +L Q + IV
Sbjct: 14 KGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQ-HDNIVKY 70
Query: 77 HEIYETP--HEMVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
+ + + LV+E +P G L+ L ++ + + Y QI + + +L
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYV 130
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISRVV---NDVVEVKEIIGTPDY-VAPEVLSYEPISL 189
H DL +NIL+ +N +K+ DFG+++V+ + +V+E +P + APE L+ S+
Sbjct: 131 HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSV 190
Query: 190 ATDMWSVGVLAYVLLS----SHSPFA------GDNKQ 216
A+D+WS GV+ Y L + S SP A G++KQ
Sbjct: 191 ASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQ 227
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 8/166 (4%)
Query: 94 PDGELQRLV--DIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIK 151
D E++ L+ D +G+ D S+ Q+ + FL N H DL +N+LL + +K
Sbjct: 218 NDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVK 277
Query: 152 LCDFGISRVV---NDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SH 207
+CDFG++R + ++ V ++APE + + +D+WS G+L + + S
Sbjct: 278 ICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGG 337
Query: 208 SPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+P+ G TF N + + + H + + D + C ++P
Sbjct: 338 TPYPGMIVDSTFYNKIKSGYRMAKP--DHATQEVYDIMVKCWNSEP 381
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-12
Identities = 42/144 (29%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 120 ILEALAFLHDH-NITHLDLKPQNILLTKDNNIKLCDFGIS-RVVNDVVEVKEIIGTPDYV 177
I++AL +LH ++ H D+KP N+L+ ++ +KLCDFGIS +V+ V + + G Y+
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID-AGCKPYM 170
Query: 178 APE----VLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQC----NFSF 229
APE L+ + + +D+WS+G+ L + P+ D+ + F + Q +
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPY--DSWKTPFQQLKQVVEEPSPQL 228
Query: 230 HEDLFGHISSQAKDFIQSCLVTDP 253
+ F S + +DF+ CL +
Sbjct: 229 PAEKF---SPEFQDFVNKCLKKNY 249
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-12
Identities = 49/188 (26%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 33 KITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92
K K E I ++ ++ ++++ HE V Y +E + + + L++E
Sbjct: 39 KSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---------DGGNGIKLIMEF 89
Query: 93 VPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIK 151
+P G L+ L ++ I + Y QI + + +L H DL +N+L+ ++ +K
Sbjct: 90 LPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVK 149
Query: 152 LCDFGISRVVNDVVE---VKEIIGTPDY-VAPEVLSYEPISLATDMWSVGVLAYVLL--- 204
+ DFG+++ + E VK+ + +P + APE L +A+D+WS GV Y LL
Sbjct: 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYC 209
Query: 205 -SSHSPFA 211
S SP
Sbjct: 210 DSESSPMT 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-12
Identities = 51/176 (28%), Positives = 88/176 (50%), Gaps = 23/176 (13%)
Query: 50 SMDQMQDILHEAAVLYLAQKSERIVGLHEIY-----ETPHEMVLVLEMVPDGELQRLVDI 104
+MD +D L EA ++ K R L ++Y E P + +V E++ G L +
Sbjct: 42 TMDP-KDFLAEAQIM----KKLRHPKLIQLYAVCTLEEP--IYIVTELMKYGSLLEYLQG 94
Query: 105 QDG----IPEQ-DTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159
G +P+ D + Q+ +A+L N H DL +N+L+ ++N K+ DFG++R
Sbjct: 95 GAGRALKLPQLIDMAA---QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR 151
Query: 160 VV-NDVVEVKEIIGTP-DYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAG 212
V+ D+ E +E P + APE Y S+ +D+WS G+L +++ P+ G
Sbjct: 152 VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-12
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 13/210 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G+F V + K++ A K IR+ S D D + EA V+ +V L+ +
Sbjct: 14 SGQFGVVHLGKWR-GKIDVAIKMIREGAMSED---DFIEEAKVMMKLSH-PNLVQLYGVC 68
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYM-KQILEALAFLHDHNITHLDLKP 139
+ +V E + +G L + + G + M + EA+ +L + H DL
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAA 128
Query: 140 QNILLTKDNNIKLCDFGISR-VVNDVVEVKEIIGTP---DYVAPEVLSYEPISLATDMWS 195
+N L+ +DN +K+ DFG++R V++D + GT + PEV Y S +D+WS
Sbjct: 129 RNCLVGEDNVVKVSDFGLARYVLDD--QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWS 186
Query: 196 VGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
GVL + + S P+ + E ++S
Sbjct: 187 FGVLMWEVFSEGKMPYERFSNSEVVESVSA 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-12
Identities = 39/122 (31%), Positives = 60/122 (49%), Gaps = 22/122 (18%)
Query: 111 QDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI 170
+D Y Q+ + + FL H DL +NILL+++N +K+CDFG++R +I
Sbjct: 179 EDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR---------DI 229
Query: 171 IGTPDYV------------APEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQE 217
PDYV APE + ++ +D+WS GVL + + S SP+ G E
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 289
Query: 218 TF 219
F
Sbjct: 290 EF 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 39/122 (31%), Positives = 59/122 (48%), Gaps = 22/122 (18%)
Query: 111 QDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI 170
+D Y Q+ + FL H DL +NILL+++N +K+CDFG++R +I
Sbjct: 174 EDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR---------DI 224
Query: 171 IGTPDYV------------APEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQE 217
PDYV APE + + + +D+WS GVL + + S SP+ G E
Sbjct: 225 YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE 284
Query: 218 TF 219
F
Sbjct: 285 EF 286
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-11
Identities = 51/185 (27%), Positives = 81/185 (43%), Gaps = 18/185 (9%)
Query: 73 IVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNI 132
+V LH+ + + LVL+ G+L + IPE+ + + +++ AL LH I
Sbjct: 47 MVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGI 106
Query: 133 THLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATD 192
DL P NILL +I+L F V D + + + Y APEV + A D
Sbjct: 107 VCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM--YCAPEVGGISEETEACD 164
Query: 193 MWSVGVLAYVLLS----SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248
WS+G + + LL+ +G N T LNI + +S +A+ +Q
Sbjct: 165 WWSLGAILFELLTGKTLVECHPSGINTH-TTLNIPEW-----------VSEEARSLLQQL 212
Query: 249 LVTDP 253
L +P
Sbjct: 213 LQFNP 217
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-11
Identities = 34/115 (29%), Positives = 51/115 (44%), Gaps = 34/115 (29%)
Query: 110 EQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND------ 163
E + YM Q+LE + +LH+++I H D+K NIL+ +K+ DFG++R +
Sbjct: 114 ESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173
Query: 164 -------------VVEVKEIIGTPDYVAPEVL----SYEPISLATDMWSVG-VLA 200
VV T Y PE+L Y A D+W +G V A
Sbjct: 174 GGGGGGTRKYTNLVV-------TRWYRPPELLLGERRYTT---AVDIWGIGCVFA 218
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-11
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 24/220 (10%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
+G + V K T+K A K + D ++I E +L +V + ++
Sbjct: 32 KGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 81 ETPHEMV-----LVLEMVPDGELQRLVDIQDGIPEQDTR------SY-MKQILEALAFLH 128
++V LVLE+ G + LV G+ R SY + L L LH
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVK---GLLICGQRLDEAMISYILYGALLGLQHLH 145
Query: 129 DHNITHLDLKPQNILLTKDNNIKLCDFGIS-RVVNDVVEVKEIIGTPDYVAPEVLSYE-- 185
++ I H D+K NILLT + +KL DFG+S ++ + + +GTP ++APEV++ E
Sbjct: 146 NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQ 205
Query: 186 ---PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNI 222
D+WS+G+ A L P + +T I
Sbjct: 206 YDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-11
Identities = 52/177 (29%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 58 LHEAAVLYLAQKSE-RIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSY 116
L EA +L Q S IV L + + +V+E+V G+ ++ P +
Sbjct: 41 LQEARIL--KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTF--LRTEGPRLKVKEL 96
Query: 117 MKQILEALA---FLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE-----VK 168
++ + A A +L + H DL +N L+T+ N +K+ DFG+SR D V +K
Sbjct: 97 IQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156
Query: 169 EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
+I + APE L+Y S +D+WS G+L + S P+A + Q+T I Q
Sbjct: 157 QI--PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ 211
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-11
Identities = 44/172 (25%), Positives = 84/172 (48%), Gaps = 7/172 (4%)
Query: 58 LHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRS 115
L EA ++ Q R+V L+ + T + ++ E + +G L + +G +
Sbjct: 49 LAEANLMKQLQH-PRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLID 106
Query: 116 YMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV-NDVVEVKEIIGTP 174
QI E +AF+ N H DL+ NIL+++ K+ DFG++R++ ++ +E P
Sbjct: 107 MAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFP 166
Query: 175 -DYVAPEVLSYEPISLATDMWSVGV-LAYVLLSSHSPFAGDNKQETFLNISQ 224
+ APE ++Y ++ +D+WS G+ L ++ P+ G E N+ +
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER 218
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-11
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 23/209 (11%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDI----LHEAAVLYLAQKSERIVGL 76
+G F V K T K K A K ++ D Q++ L EA +L IV L
Sbjct: 5 KGNFGEVFKGTLK-DKTPVAVKTCKE-----DLPQELKIKFLSEARILK-QYDHPNIVKL 57
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEA---LAFLHDHNIT 133
+ + +V+E+VP G+ L ++ E T+ +K L+A +A+L N
Sbjct: 58 IGVCTQRQPIYIVMELVPGGDF--LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI 115
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE----VKEIIGTPDYVAPEVLSYEPISL 189
H DL +N L+ ++N +K+ DFG+SR +D + +K+I + APE L+Y S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSS 173
Query: 190 ATDMWSVGVLAYVLLS-SHSPFAGDNKQE 217
+D+WS G+L + S P+ G Q+
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQ 202
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-11
Identities = 49/188 (26%), Positives = 97/188 (51%), Gaps = 14/188 (7%)
Query: 69 KSERIVGLHEIYETP-------HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQIL 121
K E ++GL +++ TP H+ LV+ + +L +L+ + + E + + Q+L
Sbjct: 72 KHENVIGLLDVF-TPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK-LSEDRIQFLVYQML 128
Query: 122 EALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEV 181
+ L ++H I H DLKP N+ + +D +K+ DFG++R + E+ + T Y APEV
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS--EMTGYVVTRWYRAPEV 186
Query: 182 -LSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHI-SS 239
L++ + D+WSVG + +L+ F G + + + I + + ++ + S
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246
Query: 240 QAKDFIQS 247
AK++++
Sbjct: 247 DAKNYVKK 254
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-11
Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 2/95 (2%)
Query: 113 TRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI-- 170
TR+ MKQ+L A+ ++HD + H D+K +NI L D I L DFG + E +
Sbjct: 269 TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGW 328
Query: 171 IGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS 205
+GT +PE+L+ + TD+WS G++ +LS
Sbjct: 329 VGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-11
Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 32 HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91
+++TKV A K ++ D + D++ E ++ + K + I+ L + +++E
Sbjct: 48 NRVTKV--AVKMLKSDATEKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 104
Query: 92 MVPDGELQRLVDIQ-----------DGIPEQ-----DTRSYMKQILEALAFLHDHNITHL 135
G L+ + + +PE+ D S Q+ + +L H
Sbjct: 105 YASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR 164
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIG---TPDYVAPEVLSYEPISLATD 192
DL +N+L+T+DN +K+ DFG++R ++ + K+ ++APE L + +D
Sbjct: 165 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 224
Query: 193 MWSVGVLAYVLLS-SHSPFAGDNKQETF 219
+WS GVL + + + SP+ G +E F
Sbjct: 225 VWSFGVLLWEIFTLGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 9e-11
Identities = 42/159 (26%), Positives = 77/159 (48%), Gaps = 9/159 (5%)
Query: 53 QMQDILHEAAVLYLAQKSE-RIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDG--IP 109
Q D L EA+++ Q I+ L + ++++ E + +G L + + DG
Sbjct: 48 QRLDFLTEASIM--GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTV 105
Query: 110 EQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE 169
Q ++ I + +L + N H DL +NIL+ + K+ DFG+SR + D
Sbjct: 106 GQLVG-MLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT 164
Query: 170 IIG--TP-DYVAPEVLSYEPISLATDMWSVGVLAYVLLS 205
G P + APE ++Y + A+D+WS G++ + ++S
Sbjct: 165 TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 2/99 (2%)
Query: 108 IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV-VNDVVE 166
+P KQILE L +LH I H D+K +NI + + + + D G ++ V
Sbjct: 154 LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF 213
Query: 167 VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS 205
+ + GT + APEVL+ + + D+WS G++ + +L+
Sbjct: 214 LG-LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-10
Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 16/190 (8%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
+G+F V ++ KV A K I+ + Q L EA+V+ + S + L I
Sbjct: 16 KGEFGDVMLGDYRGNKV--AVKCIKNDATA----QAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 81 ETPHEMVLVLEMVPDGEL-----QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
E + +V E + G L R + G + + EA+ +L +N H
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG---DCLLKFSLDVCEAMEYLEANNFVHR 126
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
DL +N+L+++DN K+ DFG+++ + + ++ + APE L + S +D+WS
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKKFSTKSDVWS 184
Query: 196 VGVLAYVLLS 205
G+L + + S
Sbjct: 185 FGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-10
Identities = 54/227 (23%), Positives = 100/227 (44%), Gaps = 27/227 (11%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRR----SMDQMQDILHEAAVL--YLAQKSERIVG 75
G+F SV + ++ + + K K + + +M+D L EA + + R++G
Sbjct: 10 GEFGSVME--GQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIG 67
Query: 76 L------HEIYETPHEMVLVLEMVPDGELQ------RLVDIQDGIPEQDTRSYMKQILEA 123
+ E Y +P V++L + G+L RL D +P Q +M I
Sbjct: 68 VCLQTVESEGYPSP---VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 124 LAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV--NDVVEVKEIIGTP-DYVAPE 180
+ +L + H DL +N +L ++ N+ + DFG+S+ + D I P ++A E
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184
Query: 181 VLSYEPISLATDMWSVGVLAY-VLLSSHSPFAGDNKQETFLNISQCN 226
L+ + +D+WS GV + + +P+ G E + + Q N
Sbjct: 185 SLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-10
Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 20/154 (12%)
Query: 111 QDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR-VVND---VVE 166
+D S+ Q+ + +AFL N H DL +N+LLT +K+CDFG++R ++ND VV+
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVK 200
Query: 167 ------VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETF 219
VK ++APE + + +D+WS G+L + + S +P+ G F
Sbjct: 201 GNARLPVK-------WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF 253
Query: 220 LNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ + + + H ++ D +++C DP
Sbjct: 254 YKLIKEGYRMAQPE--HAPAEIYDIMKTCWDADP 285
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-10
Identities = 64/244 (26%), Positives = 107/244 (43%), Gaps = 32/244 (13%)
Query: 17 CMPSRGKFASVRKCTHKITK--VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIV 74
C RG + V K K K EYA K I SM ++I L K ++
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREI-----ALLRELKHPNVI 61
Query: 75 GLHEIYETPHE-MVLVLEMVPDGELQRLVDIQDG---------IPEQDTRSYMKQILEAL 124
L +++ + + V +L + +L ++ +P +S + QIL+ +
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 125 AFLHDHNITHLDLKPQNILLTKD----NNIKLCDFGISRVVND----VVEVKEIIGTPDY 176
+LH + + H DLKP NIL+ + +K+ D G +R+ N + ++ ++ T Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 177 VAPE-VLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFG 235
APE +L + A D+W++G + LL+S F +QE +I N FH D
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQE---DIKTSN-PFHHDQLD 235
Query: 236 HISS 239
I S
Sbjct: 236 RIFS 239
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-10
Identities = 46/169 (27%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN 148
E++ + EL +D +D + S+ Q+ + ++FL N H DL +NILLT
Sbjct: 200 TSEILEEDELA--LDTEDLL------SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR 251
Query: 149 NIKLCDFGISRVVNDVVE--VKEIIGTP-DYVAPEVLSYEPISLATDMWSVGVLAYVLLS 205
K+CDFG++R + + VK P ++APE + + +D+WS G+L + + S
Sbjct: 252 ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
Query: 206 -SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
SP+ G F + + + S+ D ++SC DP
Sbjct: 312 LGSSPYPGMPVDSKFYKMIKEGYRMLSPECA--PSEMYDIMKSCWDADP 358
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 33/111 (29%), Positives = 58/111 (52%), Gaps = 19/111 (17%)
Query: 119 QILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN----DVVEVK------ 168
+I + ++H + H DLKP NILL + + D+G + D++++
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 169 ---------EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPF 210
+I+GTPDY+APE L P S +TD++++GV+ Y +L+ P+
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-10
Identities = 48/187 (25%), Positives = 96/187 (51%), Gaps = 8/187 (4%)
Query: 36 KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95
K+ A K +R+ S ++IL EA V+ + +V L I + ++ L+ +++P
Sbjct: 36 KIPVAIKVLREET-SPKANKEILDEAYVM-ASVDHPHVVRLLGICLSS-QVQLITQLMPL 92
Query: 96 GELQRLV-DIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCD 154
G L V + +D I Q ++ QI + +++L + + H DL +N+L+ ++K+ D
Sbjct: 93 GCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITD 152
Query: 155 FGISRVVN-DVVEVKEIIG-TP-DYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPF 210
FG++++++ D E G P ++A E + + + +D+WS GV + L++ P+
Sbjct: 153 FGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212
Query: 211 AGDNKQE 217
G E
Sbjct: 213 EGIPAVE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-10
Identities = 39/123 (31%), Positives = 59/123 (47%), Gaps = 13/123 (10%)
Query: 80 YETPHEMVLVLEMVPDGEL----QRLVDIQDGIPEQDTRSYM-KQILEALAFLHDHNITH 134
E ++ LV+E++ D L Q +D + SY+ Q+L + LH I H
Sbjct: 90 LEEFQDVYLVMELM-DANLCQVIQMDLD-------HERMSYLLYQMLCGIKHLHSAGIIH 141
Query: 135 LDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMW 194
DLKP NI++ D +K+ DFG++R + + T Y APEV+ D+W
Sbjct: 142 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 201
Query: 195 SVG 197
SVG
Sbjct: 202 SVG 204
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-10
Identities = 31/102 (30%), Positives = 54/102 (52%), Gaps = 2/102 (1%)
Query: 108 IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV 167
I D + + +L A+ +LH++ I H D+K +NI + ++ L DFG + D+
Sbjct: 179 IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238
Query: 168 KEI--IGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSH 207
K GT APE+L+ +P A D+WS G++ + + + H
Sbjct: 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 50/203 (24%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 37 VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDG 96
V A K ++ D + D++ E ++ + K + I+ L + +++E G
Sbjct: 48 VTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 106
Query: 97 ELQRLV------------DIQDGIPEQ----DTRSYMKQILEALAFLHDHNITHLDLKPQ 140
L+ + DI EQ D S Q+ + +L H DL +
Sbjct: 107 NLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166
Query: 141 NILLTKDNNIKLCDFGISRVVNDVVEVKEIIG---TPDYVAPEVLSYEPISLATDMWSVG 197
N+L+T++N +K+ DFG++R VN++ K+ ++APE L + +D+WS G
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226
Query: 198 VLAYVLLS-SHSPFAGDNKQETF 219
VL + + + SP+ G +E F
Sbjct: 227 VLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-09
Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 3/95 (3%)
Query: 119 QILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVA 178
Q+L L ++H I H DLKP N+ + +D +K+ DFG++R + E+ + T Y A
Sbjct: 125 QMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD--AEMTGYVVTRWYRA 182
Query: 179 PEV-LSYEPISLATDMWSVGVLAYVLLSSHSPFAG 212
PEV L++ + D+WSVG + +L+ + F G
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-09
Identities = 41/144 (28%), Positives = 72/144 (50%), Gaps = 11/144 (7%)
Query: 63 VLYLAQKSERIVGLHEIY------ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSY 116
VL + I+GL ++ E ++ +V+E++ D L +++ ++ + + SY
Sbjct: 75 VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSY 130
Query: 117 M-KQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPD 175
+ Q+L + LH I H DLKP NI++ D +K+ DFG++R + + T
Sbjct: 131 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 176 YVAPEVLSYEPISLATDMWSVGVL 199
Y APEV+ D+WSVG +
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCI 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-09
Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 14/162 (8%)
Query: 53 QMQDILHEAAVLYLAQ-KSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQ 111
Q +D L EA+++ Q I+ L + +++V E + +G L + DG Q
Sbjct: 48 QRRDFLSEASIM--GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG---Q 102
Query: 112 DT----RSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV 167
T ++ I + +L D H DL +NIL+ + K+ DFG+SRV+ D E
Sbjct: 103 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162
Query: 168 KEIIGTPD----YVAPEVLSYEPISLATDMWSVGVLAYVLLS 205
+ APE ++Y + A+D+WS G++ + ++S
Sbjct: 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 3/87 (3%)
Query: 118 KQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK---EIIGTP 174
+Q+L A+ ++H I H D+K +N+L+ +I L DFG + I GT
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 175 DYVAPEVLSYEPISLATDMWSVGVLAY 201
D APEVL+ +P + + D+WS G++ +
Sbjct: 327 DTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 5/135 (3%)
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYM-KQILEALAFLHDHNITHLDLKP 139
E ++ LV+E++ D L +++ ++ + + SY+ Q+L + LH I H DLKP
Sbjct: 96 EEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 151
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVL 199
NI++ D +K+ DFG++R + + T Y APEV+ D+WSVG +
Sbjct: 152 SNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 211
Query: 200 AYVLLSSHSPFAGDN 214
L+ F G +
Sbjct: 212 MGELVKGSVIFQGTD 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 37/120 (30%), Positives = 63/120 (52%), Gaps = 5/120 (4%)
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYM-KQILEALAFLHDHNITHLDLKP 139
E ++ LV+E++ D L +++ ++ + + SY+ Q+L + LH I H DLKP
Sbjct: 92 EEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 147
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVL 199
NI++ D +K+ DFG++R + + T Y APEV+ D+WSVG +
Sbjct: 148 SNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 207
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 34/113 (30%), Positives = 60/113 (53%), Gaps = 4/113 (3%)
Query: 111 QDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI 170
+D S Q+ + +L H DL +N+L+T+DN +K+ DFG++R V+++ K+
Sbjct: 134 KDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 171 IG---TPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETF 219
++APE L + +D+WS GVL + + + SP+ G +E F
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-09
Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 21/203 (10%)
Query: 37 VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDG 96
V A K ++ D + D++ E ++ L K + I+ L + + +++E G
Sbjct: 45 VTVAVKMLKDNATDKD-LADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKG 103
Query: 97 ELQRLV------------DIQDGIPEQ----DTRSYMKQILEALAFLHDHNITHLDLKPQ 140
L+ + DI EQ D S Q+ + +L H DL +
Sbjct: 104 NLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR 163
Query: 141 NILLTKDNNIKLCDFGISRVVNDVVEVKEIIG---TPDYVAPEVLSYEPISLATDMWSVG 197
N+L+T+DN +K+ DFG++R V+D+ K+ ++APE L + +D+WS G
Sbjct: 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 198 VLAYVLLS-SHSPFAGDNKQETF 219
+L + + + SP+ G +E F
Sbjct: 224 ILMWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-09
Identities = 44/191 (23%), Positives = 86/191 (45%), Gaps = 18/191 (9%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
+G+F V ++ KV ++ + Q L EA+V+ + +V L +
Sbjct: 16 KGEFGDVMLGDYRGQKVA-----VKCLKDDSTAAQAFLAEASVMTTLRH-PNLVQLLGVV 69
Query: 81 ETPHEMVLVLEMVPDGELQRLVDI-----QDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
+ + +V E + G L VD + I + + E + +L + N H
Sbjct: 70 LQGNPLYIVTEYMAKGSL---VDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHR 126
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTP-DYVAPEVLSYEPISLATDMW 194
DL +N+L+++D K+ DFG+++ + + ++ P + APE L + S +D+W
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL---PVKWTAPEALREKKFSTKSDVW 183
Query: 195 SVGVLAYVLLS 205
S G+L + + S
Sbjct: 184 SFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-09
Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 17/212 (8%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G+F V + +++ A K I + S + D + EA V+ + ++V L+ +
Sbjct: 14 SGQFGVVHLGKWR-AQIKVAIKAINEGAMSEE---DFIEEAKVM-MKLSHPKLVQLYGVC 68
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQ-ILEALAFLHDHNITHLDLKP 139
+ +V E + +G L + + G +D M Q + E + +L ++ H DL
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAA 128
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTP------DYVAPEVLSYEPISLATDM 193
+N L++ +K+ DFG++R V D E + + PEV ++ S +D+
Sbjct: 129 RNCLVSSTGVVKVSDFGMTRYVLD----DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 194 WSVGVLAY-VLLSSHSPFAGDNKQETFLNISQ 224
WS GVL + V PF + E IS+
Sbjct: 185 WSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-09
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 17 CMPSRGKFASVRKCTHKITK--VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIV 74
C RG + V K K K +YA K I SM ++I L K ++
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREI-----ALLRELKHPNVI 61
Query: 75 GLHEIYET-PHEMVLVLEMVPDGELQRLVDIQDG---------IPEQDTRSYMKQILEAL 124
L +++ + V +L + +L ++ +P +S + QIL+ +
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 125 AFLHDHNITHLDLKPQNILLTKD----NNIKLCDFGISRVVND----VVEVKEIIGTPDY 176
+LH + + H DLKP NIL+ + +K+ D G +R+ N + ++ ++ T Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 177 VAPE-VLSYEPISLATDMWSVGVLAYVLLSSHSPF 210
APE +L + A D+W++G + LL+S F
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 5e-09
Identities = 38/135 (28%), Positives = 71/135 (52%), Gaps = 5/135 (3%)
Query: 88 LVLEMVPDGELQRLV-DIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK 146
LV +++P G L V + +D I Q ++ QI + + +L + + H DL +N+L+
Sbjct: 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKS 144
Query: 147 DNNIKLCDFGISRVVN-DVVEVKEIIGTP--DYVAPEVLSYEPISLATDMWSVGVLAYVL 203
N++K+ DFG++R++ D E G ++A E + Y + +D+WS GV + L
Sbjct: 145 PNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWEL 204
Query: 204 LS-SHSPFAGDNKQE 217
++ P+ G +E
Sbjct: 205 MTFGGKPYDGIPTRE 219
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-09
Identities = 35/111 (31%), Positives = 58/111 (52%), Gaps = 2/111 (1%)
Query: 116 YMKQILEALAFLHDHNITHLDLKPQNILLT-KDNNIKLCDFGISRVVNDVVEVKEIIGTP 174
Y Q+ ALA++H I H DLKPQN+L+ + +KLCDFG ++ + I +
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234
Query: 175 DYVAPEV-LSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQ 224
Y APE+ L + D+WS+G + ++ + F+G + + + I Q
Sbjct: 235 FYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285
|
Length = 440 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-09
Identities = 40/156 (25%), Positives = 67/156 (42%), Gaps = 14/156 (8%)
Query: 76 LHE--IYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
LHE + +PH V G ++ + D QI + +L H+
Sbjct: 95 LHEFLVRNSPHSDV--------GAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFV 146
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISRVV--NDVVEVKEIIGTP-DYVAPEVLSYEPISLA 190
H DL +N L+ + +K+ DFG+SR + D V+ P ++ PE + Y +
Sbjct: 147 HRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE 206
Query: 191 TDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQC 225
+D+WS GV+ + + S P+ G + QE I
Sbjct: 207 SDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-09
Identities = 35/112 (31%), Positives = 59/112 (52%), Gaps = 18/112 (16%)
Query: 112 DTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR-VVND---VVE- 166
D + Q+ + + FL N H D+ +N+LLT K+CDFG++R ++ND VV+
Sbjct: 213 DLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272
Query: 167 -----VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAG 212
VK ++APE + ++ +D+WS G+L + + S SP+ G
Sbjct: 273 NARLPVK-------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 7e-09
Identities = 34/101 (33%), Positives = 56/101 (55%), Gaps = 4/101 (3%)
Query: 116 YM-KQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV-NDVVEVKEIIGT 173
YM QI A+ +L N H DL +N L+ +++ +K+ DFG+SR++ D
Sbjct: 108 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 167
Query: 174 P-DYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAG 212
P + APE L+Y S+ +D+W+ GVL + + + SP+ G
Sbjct: 168 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-09
Identities = 49/195 (25%), Positives = 84/195 (43%), Gaps = 32/195 (16%)
Query: 54 MQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGE-----LQRLVDIQDGI 108
M+ + H+ V A SE + + Y + + L+ + DGE L LVD+
Sbjct: 55 MKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGSL---LDFLKDGEGRALKLPNLVDMA--- 108
Query: 109 PEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVEV 167
Q+ +A++ N H DL+ NIL+ K+ DFG++R++ D
Sbjct: 109 ---------AQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159
Query: 168 KEIIGTP-DYVAPEVLSYEPISLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQ- 224
++ P + APE Y ++ +D+WS G+L L++ P+ G N +E + +
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG 219
Query: 225 --------CNFSFHE 231
C S HE
Sbjct: 220 YRMPCPQDCPISLHE 234
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-09
Identities = 48/191 (25%), Positives = 88/191 (46%), Gaps = 22/191 (11%)
Query: 58 LHEAAVLYLAQKSERIVGLHEIY-ETPHEMVLVLEMVPDGELQRLVDIQDG----IPEQD 112
L EA ++ + +++V L+ + E P + +V E + G L + DG +P+
Sbjct: 49 LQEAQIMK-KLRHDKLVPLYAVVSEEP--IYIVTEFMGKGSLLDFLKEGDGKYLKLPQ-- 103
Query: 113 TRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVEVKEII 171
QI + +A++ N H DL+ NIL+ + K+ DFG++R++ D ++
Sbjct: 104 LVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA 163
Query: 172 GTP-DYVAPEVLSYEPISLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQ----- 224
P + APE Y ++ +D+WS G+L L++ P+ G +E + +
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP 223
Query: 225 ----CNFSFHE 231
C S HE
Sbjct: 224 CPQGCPESLHE 234
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 9e-09
Identities = 37/141 (26%), Positives = 72/141 (51%), Gaps = 13/141 (9%)
Query: 94 PDGELQRLVD---IQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNI 150
P GE D ++ + ++D S+ Q+ + FL H DL +N+L+T+D+ +
Sbjct: 112 PPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVM 171
Query: 151 KLCDFGISRVVNDVVEVKEIIGTPD------YVAPEVLSYEPISLATDMWSVGVLAYVLL 204
K+ DFG++R ++ + ++ T + ++APE L + +D+WS GVL + +
Sbjct: 172 KIADFGLARDIHHIDYYRK---TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
Query: 205 S-SHSPFAGDNKQETFLNISQ 224
+ SP+ G +E F + +
Sbjct: 229 TLGGSPYPGIPVEELFKLLKE 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-08
Identities = 48/191 (25%), Positives = 87/191 (45%), Gaps = 22/191 (11%)
Query: 58 LHEAAVLYLAQKSERIVGLHEIY-ETPHEMVLVLEMVPDGELQRLVDIQDG----IPEQD 112
L EA V+ + E++V L+ + E P + +V E + G L + + G +P+
Sbjct: 49 LQEAQVMK-KLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQ-- 103
Query: 113 TRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVEVKEII 171
QI +A++ N H DL+ NIL+ ++ K+ DFG++R++ D ++
Sbjct: 104 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 163
Query: 172 GTP-DYVAPEVLSYEPISLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNI------- 222
P + APE Y ++ +D+WS G+L L + P+ G +E +
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 223
Query: 223 --SQCNFSFHE 231
+C S H+
Sbjct: 224 CPPECPESLHD 234
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-08
Identities = 42/178 (23%), Positives = 82/178 (46%), Gaps = 16/178 (8%)
Query: 44 IRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVD 103
++ + + D + H A L + E IV + + +++V E + G+L + +
Sbjct: 40 VKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLR 99
Query: 104 IQ--DGI-------PEQDTRSYM----KQILEALAFLHDHNITHLDLKPQNILLTKDNNI 150
D + P + T+S M +QI + +L + H DL +N L+ ++ +
Sbjct: 100 AHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159
Query: 151 KLCDFGISRVV--NDVVEVKEIIGTP-DYVAPEVLSYEPISLATDMWSVGVLAYVLLS 205
K+ DFG+SR V D V P ++ PE + Y + +D+WS+GV+ + + +
Sbjct: 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 36/122 (29%), Positives = 70/122 (57%), Gaps = 4/122 (3%)
Query: 88 LVLEMVPDGELQRLV-DIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK 146
LV +++P G L V + +D I QD ++ QI + +++L + + H DL +N+L+
Sbjct: 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKS 144
Query: 147 DNNIKLCDFGISRVVN-DVVEVKEIIG-TP-DYVAPEVLSYEPISLATDMWSVGVLAYVL 203
N++K+ DFG++R+++ D E G P ++A E + + + +D+WS GV + L
Sbjct: 145 PNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWEL 204
Query: 204 LS 205
++
Sbjct: 205 MT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-08
Identities = 28/86 (32%), Positives = 50/86 (58%), Gaps = 2/86 (2%)
Query: 120 ILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAP 179
+ E + +L + H DL +NIL+++D K+ DFG++RV + V+ ++ + AP
Sbjct: 109 VAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL--PVKWTAP 166
Query: 180 EVLSYEPISLATDMWSVGVLAYVLLS 205
E L ++ S +D+WS GVL + + S
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-08
Identities = 33/112 (29%), Positives = 58/112 (51%), Gaps = 4/112 (3%)
Query: 112 DTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR-VVNDVVEVKEI 170
D S+ QI + +L + + H DL +N+L+ + +K+ DFG+SR V + VK
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187
Query: 171 IG-TP-DYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETF 219
G P ++A E L + +D+WS GVL + +++ +P+ G + F
Sbjct: 188 KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 29/72 (40%), Positives = 41/72 (56%), Gaps = 7/72 (9%)
Query: 114 RSYMKQILEALAFLHDHNITHLDLKPQNILLT-KDNNIKLCDFGIS---RV-VNDVVEVK 168
++ M+QIL AL LH I H D+KPQNI+ + + K+ D G + RV +N + K
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYI--PK 315
Query: 169 EIIGTPDYVAPE 180
E + P Y APE
Sbjct: 316 EFLLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-08
Identities = 60/252 (23%), Positives = 100/252 (39%), Gaps = 25/252 (9%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIR-KRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G F V K K + A R K S D +D E VL I+ L
Sbjct: 18 GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 77
Query: 81 ETPHEMVLVLEMVPDGEL------QRLVDIQDG----------IPEQDTRSYMKQILEAL 124
E + L +E P G L R+++ + Q + + +
Sbjct: 78 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 137
Query: 125 AFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIG--TPDYVAPEVL 182
+L H DL +NIL+ ++ K+ DFG+SR V VK+ +G ++A E L
Sbjct: 138 DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMAIESL 195
Query: 183 SYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQA 241
+Y + +D+WS GVL + ++S +P+ G E + + Q + + L + +
Sbjct: 196 NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPL--NCDDEV 252
Query: 242 KDFIQSCLVTDP 253
D ++ C P
Sbjct: 253 YDLMRQCWREKP 264
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-08
Identities = 30/104 (28%), Positives = 56/104 (53%), Gaps = 6/104 (5%)
Query: 119 QILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTP---- 174
QI + FL H++ H DL +N+L+ N+K+ D G+ R V + +++G
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY-AADYYKLMGNSLLPI 190
Query: 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQE 217
+++PE + Y S+ +D+WS GV+ + + S P+ G + Q+
Sbjct: 191 RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 234
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 5e-08
Identities = 30/125 (24%), Positives = 58/125 (46%), Gaps = 20/125 (16%)
Query: 100 RLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI 157
RL + + + Q QI +++LH + H D+ +N ++ ++ +K+ D +
Sbjct: 104 RLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163
Query: 158 SRVV----------NDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-S 206
SR + N+ VK ++A E L + S A+D+WS GVL + L++
Sbjct: 164 SRDLFPMDYHCLGDNENRPVK-------WMALESLVNKEYSSASDVWSFGVLLWELMTLG 216
Query: 207 HSPFA 211
+P+
Sbjct: 217 QTPYV 221
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-08
Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 53 QMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDG-IPEQ 111
Q +D L EA+++ I+ L + ++++ E + +G L + DG
Sbjct: 48 QRRDFLSEASIMGQFDHPN-IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI 106
Query: 112 DTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV----NDVVEV 167
++ I + +L + N H DL +NIL+ + K+ DFG+SR + +D
Sbjct: 107 QLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 166
Query: 168 KEIIGT-P-DYVAPEVLSYEPISLATDMWSVGVLAYVLLS 205
+ G P + APE ++Y + A+D+WS G++ + ++S
Sbjct: 167 SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-08
Identities = 36/135 (26%), Positives = 70/135 (51%), Gaps = 5/135 (3%)
Query: 88 LVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK 146
LV ++ P G L + +D + Q ++ QI + + +L +H + H +L +NILL
Sbjct: 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS 144
Query: 147 DNNIKLCDFGISRVV--NDVVEVKEIIGTP-DYVAPEVLSYEPISLATDMWSVGVLAYVL 203
D+ +++ DFG++ ++ +D TP ++A E + + + +D+WS GV + +
Sbjct: 145 DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEM 204
Query: 204 LS-SHSPFAGDNKQE 217
+S P+AG E
Sbjct: 205 MSYGAEPYAGMRPHE 219
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 8e-08
Identities = 25/58 (43%), Positives = 36/58 (62%)
Query: 165 VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNI 222
VE + I+GTPDY+APE+L +P A D W++GV + L+ PF + Q+ F NI
Sbjct: 535 VEGERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNI 592
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 40/175 (22%), Positives = 73/175 (41%), Gaps = 34/175 (19%)
Query: 50 SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQ---------- 99
SM + + L+EA+V+ +V L + T ++V+E++ G+L+
Sbjct: 49 SMRERIEFLNEASVMK-EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEA 107
Query: 100 RLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159
Q +I + +A+L H DL +N ++ +D +K+ DFG++R
Sbjct: 108 ENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
Query: 160 VVNDVVEVKEIIGTPDY-------------VAPEVLSYEPISLATDMWSVGVLAY 201
D+ E DY +APE L + +D+WS GV+ +
Sbjct: 168 ---DIYET-------DYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-07
Identities = 31/87 (35%), Positives = 44/87 (50%), Gaps = 9/87 (10%)
Query: 104 IQDGIPEQDTR------SYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI 157
I D +P QD R M+Q+L L LH I H D+KP+N+L+T D +K+ DFG
Sbjct: 297 IPDNMP-QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGA 355
Query: 158 SRVVNDVVEVKEIIGT--PDYVAPEVL 182
+ + + + G P Y PE L
Sbjct: 356 AVDMCTGINFNPLYGMLDPRYSPPEEL 382
|
Length = 507 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 24/224 (10%)
Query: 22 GKFASVRKCTHKI--TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
G F V + K K+ A K +++ D +D E VL I+ L
Sbjct: 13 GNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH-RDFAGELEVLCKLGHHPNIINLLGA 71
Query: 80 YETPHEMVLVLEMVPDGEL------QRLVDIQDGIP-EQDTRSYM--KQILE-------A 123
E + + +E P G L R+++ E T S + +Q+L+
Sbjct: 72 CENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATG 131
Query: 124 LAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIG--TPDYVAPEV 181
+ +L + H DL +N+L+ ++ K+ DFG+SR + V VK+ +G ++A E
Sbjct: 132 MQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGRLPVRWMAIES 189
Query: 182 LSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
L+Y + +D+WS GVL + ++S +P+ G E + + Q
Sbjct: 190 LNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-07
Identities = 34/132 (25%), Positives = 64/132 (48%), Gaps = 15/132 (11%)
Query: 87 VLVLEMVPDGELQRLV----DIQDGIPEQDTRSYMK-QILEALAFLHDHNITHLDLKPQN 141
+LVLE P G+L+ + + + ++D M ++ L +LH + H DL +N
Sbjct: 71 LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRN 130
Query: 142 ILLTKDNNIKLCDFGI--SRVVNDVVEVKEIIGTP-DYVAPEV-------LSYEPISLAT 191
LT D ++K+ D+G+ + D K+ P ++APE+ L + + +
Sbjct: 131 CQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKS 190
Query: 192 DMWSVGVLAYVL 203
++WS+GV + L
Sbjct: 191 NIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-07
Identities = 30/126 (23%), Positives = 50/126 (39%), Gaps = 15/126 (11%)
Query: 35 TKVEYAAKFIRKRRRSMDQMQDILHEAAVL-YLAQKSERIVGLHEIYETPHEMVLVLEMV 93
+Y K R + D E A+L LA+K + + E+ L++E +
Sbjct: 20 KDEDYVLKINPSREKG----ADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75
Query: 94 PDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNI---THLDLKPQNILLTKDNNI 150
L D + E++ +Q+ E LA LH + H DL P NIL+ +
Sbjct: 76 EGETL-------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKIL 128
Query: 151 KLCDFG 156
+ D+
Sbjct: 129 GIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-07
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 27/209 (12%)
Query: 60 EAAVLYLAQKSER-IVGLHEIYETPHEMVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYM 117
EAA + ++Q S + +V + + E ++V E V G L L ++ I
Sbjct: 48 EAASM-MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVA 106
Query: 118 KQILEALAFLHDHNITHLDLKPQNILLTKDNN--------IKLCDFGISRVVNDVVEVKE 169
KQ+ AL FL D +TH ++ +N+LL ++ + IKL D GIS V + E
Sbjct: 107 KQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE 166
Query: 170 IIGTPDYVAPEVLSYEP--ISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNF 227
I +V PE + P +SLA D WS G + + F+G +K + L+ SQ
Sbjct: 167 RI---PWVPPECIE-NPQNLSLAADKWSFGTTLWEI------FSGGDKPLSALD-SQKKL 215
Query: 228 SFHED---LFGHISSQAKDFIQSCLVTDP 253
F+ED L ++ + I C+ +P
Sbjct: 216 QFYEDRHQLPAPKWTELANLINQCMDYEP 244
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-07
Identities = 48/217 (22%), Positives = 99/217 (45%), Gaps = 20/217 (9%)
Query: 22 GKFASVRKCTHK---ITKVEYAAKFIRKRRRSMDQMQDILHEAAVL--YLAQKSERIVG- 75
G+F SV + ++++ A K ++ + ++++ L EAA + + +++G
Sbjct: 10 GEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGV 69
Query: 76 ---LHEIYETPHEMVLVLEMVPDGELQ------RLVDIQDGIPEQDTRSYMKQILEALAF 126
+ + P MV +L + G+L RL + + +P Q +M I + +
Sbjct: 70 CFEASSLQKIPKPMV-ILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEY 128
Query: 127 LHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV--NDVVEVKEIIGTP-DYVAPEVLS 183
L + N H DL +N +L +D + + DFG+S+ + D I P ++A E L+
Sbjct: 129 LSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA 188
Query: 184 YEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETF 219
+ +D+W+ GV + + + +P+ G E +
Sbjct: 189 DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY 225
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-07
Identities = 50/221 (22%), Positives = 98/221 (44%), Gaps = 20/221 (9%)
Query: 18 MPSRGKFASVRKCTHKI---TKVEYAAKFIRKRRRSMDQMQDILHEAAVL--YLAQKSER 72
M +G+F SVR+ K + + A K ++ S +++ L EAA + + +
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 73 IVGLHEIYET----PHEMVLVLEMVPDGELQ------RLVDIQDGIPEQDTRSYMKQILE 122
++G+ P MV +L + G+L R+ + +P Q +M I
Sbjct: 66 LIGVSLRSRAKGRLPIPMV-ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 123 ALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV--NDVVEVKEIIGTP-DYVAP 179
+ +L N H DL +N +L ++ + + DFG+S+ + D P ++A
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLAL 184
Query: 180 EVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETF 219
E L+ + +D+W+ GV + +++ +P+AG E +
Sbjct: 185 ESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY 225
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 4/103 (3%)
Query: 119 QILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV--NDVVEVKEIIGTP-D 175
QI + +L H H DL +NIL+ + ++K+ D G+SR + D V+ P
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191
Query: 176 YVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQE 217
++ PE + Y S +D+WS GV+ + + S P+ G + QE
Sbjct: 192 WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE 234
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-07
Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 22/208 (10%)
Query: 36 KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95
+++ A K +++ D +D E VL I+ L E + L +E P
Sbjct: 22 RMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80
Query: 96 GEL------QRLVDIQDGIP-EQDTRSYM--KQILE-------ALAFLHDHNITHLDLKP 139
G L R+++ T S + +Q+L + +L H DL
Sbjct: 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA 140
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEIIG--TPDYVAPEVLSYEPISLATDMWSVG 197
+NIL+ ++ K+ DFG+SR V VK+ +G ++A E L+Y + +D+WS G
Sbjct: 141 RNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 198
Query: 198 VLAYVLLS-SHSPFAGDNKQETFLNISQ 224
VL + ++S +P+ G E + + Q
Sbjct: 199 VLLWEIVSLGGTPYCGMTCAELYEKLPQ 226
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 43/182 (23%), Positives = 79/182 (43%), Gaps = 25/182 (13%)
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMK------QILEALAFLHDHNIT 133
YE+P++ L P+ + + I E SYM Q+ + FL N
Sbjct: 209 YESPYDQYLPSA--PERTRRDTL-----INESPALSYMDLVGFSYQVANGMEFLASKNCV 261
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPD------YVAPEVLSYEPI 187
H DL +N+L+ + +K+CDFG++R D++ I ++APE +
Sbjct: 262 HRDLAARNVLICEGKLVKICDFGLAR---DIMRDSNYISKGSTFLPLKWMAPESIFNNLY 318
Query: 188 SLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246
+ +D+WS G+L + + + +P+ E F N + + + H S + + +Q
Sbjct: 319 TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP--AHASDEIYEIMQ 376
Query: 247 SC 248
C
Sbjct: 377 KC 378
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-07
Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 19/169 (11%)
Query: 55 QDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQR-----------LVD 103
QD EA +L + Q + IV + + +++V E + G+L R L
Sbjct: 52 QDFQREAELLTVLQH-QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAG 110
Query: 104 IQDGIPEQDTRSYM----KQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159
+D P Q T M QI + +L + H DL +N L+ + +K+ DFG+SR
Sbjct: 111 GEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
Query: 160 VV--NDVVEVKEIIGTP-DYVAPEVLSYEPISLATDMWSVGVLAYVLLS 205
+ D V P ++ PE + Y + +D+WS GV+ + + +
Sbjct: 171 DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 5e-07
Identities = 27/108 (25%), Positives = 53/108 (49%), Gaps = 15/108 (13%)
Query: 60 EAAVLYLAQKSERIVGLH--EIYE-TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSY 116
EA +L A+K+ G++ +Y+ P +V+E + ++D I E+
Sbjct: 47 EARLLSRARKA----GVNTPVVYDVDPDNKTIVMEYIEG------KPLKDVI-EEGNDEL 95
Query: 117 MKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164
+++I + LH I H DL NI++ D+ + L DFG+ + +++
Sbjct: 96 LREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSDEI 142
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-07
Identities = 54/191 (28%), Positives = 85/191 (44%), Gaps = 27/191 (14%)
Query: 34 ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE-TPHEMVLVLEM 92
T + K +R +QM+ L EA Q S + L + E TP+ +LV+E
Sbjct: 20 YTPAQVVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQCLGQCTEVTPY--LLVMEF 76
Query: 93 VPDGELQRLVDIQDG----IPEQDTRSYMK-QILEALAFLHDHNITHLDLKPQNILLTKD 147
P G+L+ + P+ T M +I L LH +N H DL +N LLT D
Sbjct: 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD 136
Query: 148 NNIKLCDFGISRVVNDVVEVKEIIGTPD-------YVAPEVLSYEPISL-------ATDM 193
+K+ D+G+S N E + TPD ++APE++ +L +++
Sbjct: 137 LTVKIGDYGLSH--NKYKEDYYV--TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNV 192
Query: 194 WSVGVLAYVLL 204
WS+GV + L
Sbjct: 193 WSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-07
Identities = 34/132 (25%), Positives = 69/132 (52%), Gaps = 9/132 (6%)
Query: 88 LVLEMVPDGELQRLV-DIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK 146
L+ +++P G L V + +D I Q ++ QI + + +L + + H DL +N+L+
Sbjct: 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKT 144
Query: 147 DNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPI-----SLATDMWSVGVLAY 201
++K+ DFG+++++ + KE V + ++ E I + +D+WS GV +
Sbjct: 145 PQHVKITDFGLAKLLG--ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 202
Query: 202 VLLSSHS-PFAG 212
L++ S P+ G
Sbjct: 203 ELMTFGSKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 25/98 (25%), Positives = 50/98 (51%), Gaps = 17/98 (17%)
Query: 118 KQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV----------NDVVEV 167
KQ+ +A+L + H DL +N L+ ++ +K+ DFG+SR + ND + +
Sbjct: 137 KQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPI 196
Query: 168 KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS 205
+ ++ PE + Y + +D+W+ GV+ + + S
Sbjct: 197 R-------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 44/170 (25%), Positives = 75/170 (44%), Gaps = 20/170 (11%)
Query: 55 QDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVD--------IQD 106
+D EA +L Q E IV + + +++V E + G+L + + + D
Sbjct: 52 KDFQREAELLTNLQH-EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 110
Query: 107 GIPEQDT----RSYM----KQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGIS 158
G P Q S M QI + +L + H DL +N L+ + +K+ DFG+S
Sbjct: 111 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 170
Query: 159 RVV--NDVVEVKEIIGTP-DYVAPEVLSYEPISLATDMWSVGVLAYVLLS 205
R V D V P ++ PE + Y + +D+WS GV+ + + +
Sbjct: 171 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-06
Identities = 30/124 (24%), Positives = 55/124 (44%), Gaps = 23/124 (18%)
Query: 44 IRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLH--EIYET-PHEMVLVLEMVPDGELQR 100
+R+ R EA +L A R G+ +Y+ P ++V+E + GEL +
Sbjct: 41 LRRER--------TRREARILAKA----REAGVPVPIVYDVDPDNGLIVMEYIE-GELLK 87
Query: 101 LVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160
+++ P+ ++++ + LH I H DL NI+L+ I DFG+
Sbjct: 88 -DALEEARPD-----LLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140
Query: 161 VNDV 164
++V
Sbjct: 141 SDEV 144
|
Length = 204 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 3e-06
Identities = 31/124 (25%), Positives = 56/124 (45%), Gaps = 16/124 (12%)
Query: 44 IRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET-PHEMVLVLEMVPDGELQRLV 102
IR+ R EA ++ A+K+ V + +Y P ++V+E + +GE L
Sbjct: 41 IRRERTRR--------EARIMSRARKAG--VNVPAVYFVDPENFIIVMEYI-EGE--PLK 87
Query: 103 DIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN 162
D+ + + ++I + LH I H DL N++L+ I L DFG++
Sbjct: 88 DLINSNGME-ELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145
Query: 163 DVVE 166
D+ +
Sbjct: 146 DLED 149
|
Length = 211 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-06
Identities = 44/186 (23%), Positives = 92/186 (49%), Gaps = 24/186 (12%)
Query: 50 SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLV-----DI 104
S+ + + L+EA+V+ +V L + ++V+E++ G+L+ + +
Sbjct: 49 SLRERIEFLNEASVMK-GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEA 107
Query: 105 QD--GIPEQDTRSYMK---QILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159
++ G P + ++ +I + +A+L+ H DL +N ++ D +K+ DFG++R
Sbjct: 108 ENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
Query: 160 VVNDVVEV-------KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFA 211
D+ E K ++ ++APE L + ++DMWS GV+ + + S + P+
Sbjct: 168 ---DIYETDYYRKGGKGLLPV-RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ 223
Query: 212 G-DNKQ 216
G N+Q
Sbjct: 224 GLSNEQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-06
Identities = 42/188 (22%), Positives = 90/188 (47%), Gaps = 23/188 (12%)
Query: 50 SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQR----LVDIQ 105
SM + + L+EA+V+ +V L + ++++E++ G+L+ L
Sbjct: 49 SMRERIEFLNEASVMK-EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEM 107
Query: 106 DGIPEQDTRSYMK------QILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159
+ P Q S K +I + +A+L+ + H DL +N ++ +D +K+ DFG++R
Sbjct: 108 ENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
Query: 160 VVNDVVEV-------KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFA 211
D+ E K ++ +++PE L + +D+WS GV+ + + + + P+
Sbjct: 168 ---DIYETDYYRKGGKGLLPV-RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 223
Query: 212 GDNKQETF 219
G + ++
Sbjct: 224 GMSNEQVL 231
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-06
Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 10/96 (10%)
Query: 119 QILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI--SRVVNDVVEVKEIIGTP-D 175
+I + +H HN H DL +N LT D +K+ D+GI SR D +E ++ P
Sbjct: 107 EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166
Query: 176 YVAPEVLSYEPISLAT-------DMWSVGVLAYVLL 204
++APE++ L T ++W++GV + L
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 9e-06
Identities = 24/89 (26%), Positives = 47/89 (52%), Gaps = 11/89 (12%)
Query: 79 IYE-TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
IY+ P E +V+E + D++D + + ++++ E +A LH I H DL
Sbjct: 403 IYDVDPEEKTIVMEYIGG------KDLKDVL--EGNPELVRKVGEIVAKLHKAGIVHGDL 454
Query: 138 KPQNILLTKDNNIKLCDFGISRVVNDVVE 166
N ++ +D+ + L DFG+ + +D++E
Sbjct: 455 TTSNFIV-RDDRLYLIDFGLGK-YSDLIE 481
|
Length = 535 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 42/161 (26%), Positives = 68/161 (42%), Gaps = 18/161 (11%)
Query: 55 QDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLV----------DI 104
+D EA +L Q E IV + + ++V E + G+L + +
Sbjct: 53 KDFEREAELLTNFQH-ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKS 111
Query: 105 QDGIPEQDTRSYM----KQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160
D + T S + QI + +L + H DL +N L+ D +K+ DFG+SR
Sbjct: 112 PDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD 171
Query: 161 V--NDVVEVKEIIGTP-DYVAPEVLSYEPISLATDMWSVGV 198
V D V P ++ PE + Y + +D+WS GV
Sbjct: 172 VYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 212
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 17/49 (34%), Positives = 33/49 (67%)
Query: 109 PEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI 157
++ ++ MK +L L ++H+H I+H D+KP+NI++ +N + D+GI
Sbjct: 124 NKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGI 172
|
Length = 294 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 9e-05
Identities = 54/230 (23%), Positives = 95/230 (41%), Gaps = 38/230 (16%)
Query: 21 RGKFASVRKCTHKITKVE-----YAAKFIRKR---------RRSMDQMQDILHEAAVLYL 66
RG+F V K + E K ++K RR +D + + H+ V
Sbjct: 15 RGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV--- 71
Query: 67 AQKSERIVGLHEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTR--------SYM 117
R++GL E PH M+L E G+L Q L + + +
Sbjct: 72 -----RLLGLCREAE-PHYMIL--EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 118 KQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV--NDVVEVKEIIGTPD 175
QI + L + H DL +N L++ +K+ +S+ V ++ +++ +
Sbjct: 124 TQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR 183
Query: 176 YVAPEVLSYEPISLATDMWSVGVLAYVLLSSHS-PFAGDNKQETFLNISQ 224
++APE + + S +D+WS GVL + + + PF G + +E LN Q
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-VLNRLQ 232
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 37/122 (30%), Positives = 58/122 (47%), Gaps = 12/122 (9%)
Query: 85 EMVLVLEMVPDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNIL 143
E ++V E V G L + + G +P + +Q+ AL++L D N+ H ++ +NIL
Sbjct: 90 ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNIL 149
Query: 144 LTK----DNN---IKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVL-SYEPISLATDMWS 195
L + + IKL D G+S E E I ++APE + +S A D WS
Sbjct: 150 LARLGLAEGTSPFIKLSDPGVSFTALSREERVERI---PWIAPECVPGGNSLSTAADKWS 206
Query: 196 VG 197
G
Sbjct: 207 FG 208
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 1e-04
Identities = 39/169 (23%), Positives = 66/169 (39%), Gaps = 17/169 (10%)
Query: 42 KFIRKRRRSMDQMQDI---LHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGEL 98
+ + + + E A L + +V L+ + E ++V E V G L
Sbjct: 29 QEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRD-ENIMVEEYVKFGPL 87
Query: 99 QRLVDIQDGIPEQDTRSY-MKQILEALAFLHDHNITHLDLKPQNILLTKDNN-------I 150
+ + + KQ+ AL +L D + H ++ +NIL+ + I
Sbjct: 88 DVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFI 147
Query: 151 KLCDFGISRVVNDVVEVKEIIGTPDYVAPEVL--SYEPISLATDMWSVG 197
KL D GI V E E I ++APE + +++A D WS G
Sbjct: 148 KLSDPGIPITVLSREERVERI---PWIAPECIRNGQASLTIAADKWSFG 193
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 32/119 (26%), Positives = 52/119 (43%), Gaps = 16/119 (13%)
Query: 106 DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR-VVNDV 164
+G+PE +K +L AL ++H H +K +ILL+ D + L S ++
Sbjct: 96 EGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG 155
Query: 165 VEVKEIIGTPDY-------VAPEVL-----SYEPISLATDMWSVGVLAYVLLSSHSPFA 211
+ + P ++PEVL Y S D++SVG+ A L + H PF
Sbjct: 156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKS---DIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 29/101 (28%), Positives = 51/101 (50%), Gaps = 9/101 (8%)
Query: 126 FLHDHNITHLDLKPQNILLT-----KDNNIKLCDFGISRVV--NDVVEVK-EIIGTPDYV 177
+L + H DL +N L++ D +K+ DFG++R + +D + E + ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180
Query: 178 APEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQE 217
APE L + +D+WS GVL + +L+ P+ N QE
Sbjct: 181 APESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 26/90 (28%), Positives = 45/90 (50%), Gaps = 3/90 (3%)
Query: 119 QILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR--VVNDVVEVKEIIGTP-D 175
QI + +L N H DL +N L+ ++ IK+ DFG+SR D ++ P
Sbjct: 146 QIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR 205
Query: 176 YVAPEVLSYEPISLATDMWSVGVLAYVLLS 205
++A E + + A+D+W+ GV + +L
Sbjct: 206 WMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 40/147 (27%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 60 EAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTR-SYMK 118
E A + + IV L+ + E ++V E V G L + + + + K
Sbjct: 53 ETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAK 112
Query: 119 QILEALAFLHDHNITHLDLKPQNILLTKDN-------NIKLCDFGISRVVNDVVEVKEII 171
Q+ AL++L D ++ H ++ +NILL ++ IKL D GI V+ +E +
Sbjct: 113 QLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPIT---VLSRQECV 169
Query: 172 GTPDYVAPE-VLSYEPISLATDMWSVG 197
++APE V + +S+A D WS G
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFG 196
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 27/116 (23%), Positives = 52/116 (44%), Gaps = 7/116 (6%)
Query: 97 ELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDH---NITHLDLKPQNILLTKDNNIKLC 153
E + L ++ + + R I +AL FLH + +L P+ I++ + L
Sbjct: 766 EGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR 825
Query: 154 DFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSP 209
+ ++ + K I + YVAPE + I+ +D++ G++ LL+ SP
Sbjct: 826 -LSLPGLL--CTDTKCFISSA-YVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 2e-04
Identities = 22/69 (31%), Positives = 35/69 (50%), Gaps = 6/69 (8%)
Query: 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK 146
+V+E + EL R+ ++D PE + +ILE + + H I H DL NIL+
Sbjct: 107 AVVMEYIDGVELYRVRVLED--PE----EVLDEILEEIVKAYKHGIIHGDLSEFNILVDD 160
Query: 147 DNNIKLCDF 155
D I + D+
Sbjct: 161 DEKIYIIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 2e-04
Identities = 26/96 (27%), Positives = 48/96 (50%), Gaps = 5/96 (5%)
Query: 119 QILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND----VVEVKEIIGTP 174
Q+ + + +L H DL +N +L + +K+ DFG++R + D V P
Sbjct: 106 QVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165
Query: 175 -DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSP 209
++A E L + + +D+WS GVL + L++ +P
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 31/102 (30%), Positives = 47/102 (46%), Gaps = 19/102 (18%)
Query: 119 QILEALAFLHDH-NITHLDLKPQNILL-TKDN---------------NIKLCDFGISRVV 161
Q AL + H ++ H DLKP+NIL+ T D +++CD G
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG--GCC 296
Query: 162 NDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVL 203
++ I+ T Y +PEV+ +TDMWS+G + Y L
Sbjct: 297 DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL 338
|
Length = 467 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 31/107 (28%), Positives = 48/107 (44%), Gaps = 23/107 (21%)
Query: 112 DTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEII 171
QI + +L N H DL +N L+ K+ IK+ DFG+SR +
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY--------- 181
Query: 172 GTPDY-------VAP-EVLSYEPISL-----ATDMWSVGVLAYVLLS 205
+ DY V P +S+E I L A+D+W+ GV + +L+
Sbjct: 182 -SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 25/93 (26%), Positives = 38/93 (40%), Gaps = 22/93 (23%)
Query: 78 EIY-ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQD----------TRSYMKQILEALAF 126
++Y E VL +E + DG ++ DI + R++++Q+L
Sbjct: 232 KVYWEYTTRRVLTMEWI-DG--IKISDI-AALKSAGIDRKELAELLVRAFLRQLLR---- 283
Query: 127 LHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159
H D P NIL+ D I L DFGI
Sbjct: 284 ---DGFFHADPHPGNILVRSDGRIVLLDFGIVG 313
|
Length = 517 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 19/45 (42%), Positives = 26/45 (57%), Gaps = 1/45 (2%)
Query: 116 YM-KQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159
YM QI + +L N H DL +N L+ K+ IK+ DFG+SR
Sbjct: 134 YMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 42/164 (25%), Positives = 69/164 (42%), Gaps = 14/164 (8%)
Query: 50 SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIP 109
S Q + L EA L S IV L + + M++V E + +G L + +G
Sbjct: 46 SDKQRRGFLAEALTLGQFDHSN-IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG-- 102
Query: 110 EQDTRSYMKQILEALA----FLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV 165
Q + +L LA +L + H L +L+ D K+ F R+ D
Sbjct: 103 -QLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKS 159
Query: 166 E-VKEIIGTPDYV---APEVLSYEPISLATDMWSVGVLAYVLLS 205
E + + V APE + Y S A+D+WS G++ + ++S
Sbjct: 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 4/94 (4%)
Query: 116 YMK-QILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV--NDVVEVKEIIG 172
YM QI + +L N H DL +N L+ IK+ DFG+SR + D ++
Sbjct: 133 YMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAV 192
Query: 173 TP-DYVAPEVLSYEPISLATDMWSVGVLAYVLLS 205
P ++A E + + A+D+W+ GV + + +
Sbjct: 193 LPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|234975 PRK01723, PRK01723, 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.003
Identities = 19/70 (27%), Positives = 32/70 (45%), Gaps = 8/70 (11%)
Query: 88 LVLEMVPDGELQRLVDI--QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLT 145
+++E + + LV + + + E+ + I + +A HD + H DL NILL
Sbjct: 123 ILIERIEGA--RDLVALLQEAPLSEEQWQ----AIGQLIARFHDAGVYHADLNAHNILLD 176
Query: 146 KDNNIKLCDF 155
D L DF
Sbjct: 177 PDGKFWLIDF 186
|
Length = 239 |
| >gnl|CDD|223584 COG0510, ycfN, Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.003
Identities = 16/63 (25%), Positives = 25/63 (39%), Gaps = 5/63 (7%)
Query: 98 LQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNI-----THLDLKPQNILLTKDNNIKL 152
L+ Q+ +D K++ E L + H DL P N+LLT + L
Sbjct: 116 YLELLWQQNSRAYRDNHLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFL 175
Query: 153 CDF 155
D+
Sbjct: 176 IDW 178
|
Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.004
Identities = 48/208 (23%), Positives = 87/208 (41%), Gaps = 38/208 (18%)
Query: 35 TKVEYAAKFIRKRRRSMDQMQDILHEAAVL--YLAQKSERIVGLHEIYETPHEMVLVLEM 92
+++ A K + + D+ D L EA ++ + Q R++G+ P ++LE+
Sbjct: 35 VELQVAVKTLPESCSEQDES-DFLMEALIMSKFNHQNIVRLIGV-SFERLPR--FILLEL 90
Query: 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILE-------ALAFLHDHNITHLDLKPQNILLT 145
+ G+L+ + PE+ + MK +L +L +++ H D+ +N LLT
Sbjct: 91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLT 150
Query: 146 ---KDNNIKLCDFGISRVVNDVVEVKEIIGTPDY------------VAPEVLSYEPISLA 190
K+ DFG++R +I Y + PE +
Sbjct: 151 CKGPGRVAKIADFGMAR---------DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK 201
Query: 191 TDMWSVGVLAYVLLS-SHSPFAGDNKQE 217
TD+WS GVL + + S + P+ G QE
Sbjct: 202 TDVWSFGVLLWEIFSLGYMPYPGRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 253 | |||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| KOG4250|consensus | 732 | 100.0 | ||
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0196|consensus | 996 | 100.0 | ||
| KOG0614|consensus | 732 | 100.0 | ||
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG1006|consensus | 361 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG0587|consensus | 953 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| KOG0666|consensus | 438 | 100.0 | ||
| KOG1035|consensus | 1351 | 100.0 | ||
| KOG1151|consensus | 775 | 100.0 | ||
| KOG0671|consensus | 415 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0984|consensus | 282 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| KOG0669|consensus | 376 | 100.0 | ||
| KOG0200|consensus | 609 | 100.0 | ||
| KOG0668|consensus | 338 | 100.0 | ||
| KOG0664|consensus | 449 | 100.0 | ||
| KOG1152|consensus | 772 | 100.0 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG2052|consensus | 513 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG3653|consensus | 534 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0670|consensus | 752 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1025|consensus | 1177 | 99.98 | ||
| KOG1345|consensus | 378 | 99.98 | ||
| KOG0665|consensus | 369 | 99.97 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1163|consensus | 341 | 99.97 | ||
| KOG0576|consensus | 829 | 99.97 | ||
| KOG1027|consensus | 903 | 99.97 | ||
| KOG1165|consensus | 449 | 99.97 | ||
| KOG1290|consensus | 590 | 99.97 | ||
| KOG1164|consensus | 322 | 99.95 | ||
| KOG1024|consensus | 563 | 99.95 | ||
| KOG1167|consensus | 418 | 99.95 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| KOG1240|consensus | 1431 | 99.92 | ||
| KOG0590|consensus | 601 | 99.91 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG0603|consensus | 612 | 99.91 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG1166|consensus | 974 | 99.89 | ||
| KOG0195|consensus | 448 | 99.88 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0606|consensus | 1205 | 99.86 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| KOG4158|consensus | 598 | 99.79 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.75 | |
| KOG1023|consensus | 484 | 99.73 | ||
| KOG0590|consensus | 601 | 99.72 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| KOG1033|consensus | 516 | 99.68 | ||
| KOG0601|consensus | 524 | 99.61 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.59 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.56 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.55 | |
| KOG1243|consensus | 690 | 99.55 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.53 | |
| KOG0601|consensus | 524 | 99.44 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.43 | |
| KOG1266|consensus | 458 | 99.42 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.41 | |
| KOG0606|consensus | 1205 | 99.41 | ||
| KOG3087|consensus | 229 | 99.39 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.31 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.27 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.26 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.21 | |
| KOG3741|consensus | 655 | 99.17 | ||
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.08 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 99.06 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 99.0 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.98 | |
| KOG2137|consensus | 700 | 98.94 | ||
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.85 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.82 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.7 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.57 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.54 | |
| KOG1235|consensus | 538 | 98.41 | ||
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.26 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.22 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.19 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.17 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.16 | |
| KOG2270|consensus | 520 | 98.12 | ||
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.11 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.03 | |
| KOG2268|consensus | 465 | 98.0 | ||
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.98 | |
| KOG0576|consensus | 829 | 97.98 | ||
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.96 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.76 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.71 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.68 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.65 | |
| KOG1035|consensus | 1351 | 97.61 | ||
| PLN02236 | 344 | choline kinase | 97.52 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.48 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.41 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.39 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.2 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.13 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.1 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.06 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.74 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.72 | |
| KOG1236|consensus | 565 | 96.7 | ||
| PTZ00384 | 383 | choline kinase; Provisional | 96.54 | |
| KOG1826|consensus | 2724 | 96.4 | ||
| PTZ00296 | 442 | choline kinase; Provisional | 96.37 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.33 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.27 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.91 | |
| KOG2269|consensus | 531 | 95.37 | ||
| KOG1093|consensus | 725 | 94.82 | ||
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.78 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.17 |
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=343.56 Aligned_cols=238 Identities=30% Similarity=0.503 Sum_probs=222.8
Q ss_pred eeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 11 YQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
-+|...+.||+|+|+.||.+.+..+|..||+|++++.. ....+.+++.+|+.+.+ .++|||||+++.+|++.+.+|+|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr-~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHR-SLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHH-hcCCCcEEeeeeEeecCCceEEE
Confidence 44559999999999999999999999999999998754 44456779999999988 99999999999999999999999
Q ss_pred EeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-cccc
Q psy12709 90 LEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEVK 168 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~ 168 (253)
.|.|..++|.+++..+.++++.+++.+++|++.|+.|||+.+|+|||+|..|++++++.+|||+|||++...... ....
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~ 176 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKK 176 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccc
Confidence 999999999999998899999999999999999999999999999999999999999999999999999877633 5667
Q ss_pred ccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 169 EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
..+|||.|.|||++.....+.++||||+||++|-|+.|++||...+-++.+..|.......|. .+|.++++||.++
T Consensus 177 TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI~~l 252 (592)
T KOG0575|consen 177 TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLIRKL 252 (592)
T ss_pred eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHHHHH
Confidence 789999999999999999999999999999999999999999999999999999999998888 8899999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|++||
T Consensus 253 L~~~P 257 (592)
T KOG0575|consen 253 LRPNP 257 (592)
T ss_pred hcCCc
Confidence 99998
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=325.70 Aligned_cols=241 Identities=30% Similarity=0.507 Sum_probs=221.3
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
-...++ +++.||+|+||+||+++.+++++.||+|++.+.. ....+.+....|..++. ..+||.|+.++..|++++.
T Consensus 23 ~~~dF~--~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~-~v~hPFiv~l~ysFQt~~k 99 (357)
T KOG0598|consen 23 GPDDFE--ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILS-KIKHPFIVKLIYSFQTEEK 99 (357)
T ss_pred Chhhee--eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHH-hCCCCcEeeeEEecccCCe
Confidence 345555 9999999999999999999999999999998876 33356789999999999 5999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc-cccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV-VNDV 164 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~-~~~~ 164 (253)
+|+|+||+.||.|...+++.+.|++..++-++.+|+.|+.|||+.||+|||+||+||+++..|+++|+|||+++. ....
T Consensus 100 LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 999999999999999999889999999999999999999999999999999999999999999999999999984 4555
Q ss_pred ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
..+...+||+.|+|||++.+..++.++|.||||+++|+|++|.+||.+.+...++++|..++...+.. -+|.+.+++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~---~ls~~ardl 256 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG---YLSEEARDL 256 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc---cCCHHHHHH
Confidence 66677899999999999999999999999999999999999999999999999999999988444441 589999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|+++|+.||
T Consensus 257 l~~LL~rdp 265 (357)
T KOG0598|consen 257 LKKLLKRDP 265 (357)
T ss_pred HHHHhccCH
Confidence 999999997
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-52 Score=328.41 Aligned_cols=243 Identities=33% Similarity=0.522 Sum_probs=218.4
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
..++|. +.+.||+|+||+||+|.++.++.+||||.+.+........+-+..|+.+++ .++|+|||.++++...++.+
T Consensus 8 ~~~~y~--~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLk-el~H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 8 VVGDYE--LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILK-ELKHPNIVRLLDCIEDDDFI 84 (429)
T ss_pred ccccce--ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHH-hcCCcceeeEEEEEecCCeE
Confidence 445566 999999999999999999999999999999998777777888999999998 78899999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC------CceEEEeeccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD------NNIKLCDFGISRV 160 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~------~~~~l~df~~~~~ 160 (253)
|+|||||+||+|.++++.++.+++..++.++.|++.|+++||+++|+||||||+||+++.. -.+||.|||+++.
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999999999899999999999999999999999999999999999999875 3589999999999
Q ss_pred ccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHH
Q psy12709 161 VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
..+.......+|+|-|||||++..+.|+.|+|+||+|+++|+|++|++||+..+..+.+..+..+....+. .....++.
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~-~~~~~s~~ 243 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV-LPAELSNP 243 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc-hhhhccCc
Confidence 88877778889999999999999999999999999999999999999999999999998877666544432 22356666
Q ss_pred HHHHHHHhcccCC
Q psy12709 241 AKDFIQSCLVTDP 253 (253)
Q Consensus 241 l~~li~~~l~~dP 253 (253)
+.+++...|+.||
T Consensus 244 ~~~Ll~~ll~~~~ 256 (429)
T KOG0595|consen 244 LRELLISLLQRNP 256 (429)
T ss_pred hhhhhhHHHhcCc
Confidence 7777777777654
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=321.28 Aligned_cols=234 Identities=28% Similarity=0.467 Sum_probs=208.8
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC-eEEEEEecc
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH-EMVLVLEMV 93 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~ 93 (253)
.++.||+|+.|+||++.++.+++.+|+|++.. ..+....+++.+|+.+++ .+.||+||.+++.|..+. .+.++||||
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~-~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILR-SCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHh-hCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 77899999999999999999999999999944 455666789999999999 669999999999999999 499999999
Q ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCceEEEeeccccccccccccccccc
Q psy12709 94 PDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIG 172 (253)
Q Consensus 94 ~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 172 (253)
+||+|++++..-+.+++..+..++.+++++|.|||+ ++|+||||||.|+++...|.|||||||.+....+. ......|
T Consensus 161 DgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~tfvG 239 (364)
T KOG0581|consen 161 DGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IANTFVG 239 (364)
T ss_pred CCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hcccccc
Confidence 999999999887889999999999999999999995 99999999999999999999999999999876555 4466789
Q ss_pred CccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHhhcccccccCCccCCCCHHHHHHHHH
Q psy12709 173 TPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGD-----NKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247 (253)
Q Consensus 173 ~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~ 247 (253)
|..|||||.+.+..|+.++||||||++++|+.+|+.||... +..+.+..|.....+.... ..+|+++++||..
T Consensus 240 T~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~--~~fS~ef~~FV~~ 317 (364)
T KOG0581|consen 240 TSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE--GEFSPEFRSFVSC 317 (364)
T ss_pred cccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc--ccCCHHHHHHHHH
Confidence 99999999999999999999999999999999999999774 5556666666644433332 1599999999999
Q ss_pred hcccCC
Q psy12709 248 CLVTDP 253 (253)
Q Consensus 248 ~l~~dP 253 (253)
||++||
T Consensus 318 CL~Kdp 323 (364)
T KOG0581|consen 318 CLRKDP 323 (364)
T ss_pred HhcCCc
Confidence 999998
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=330.35 Aligned_cols=240 Identities=33% Similarity=0.518 Sum_probs=218.5
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc-----hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS-----MDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
|.+.+.||+|+||.|-+|..+.+++.||+|++.+.... .+....+.+|++++. .+.||+||+++++|+..+..|
T Consensus 174 yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILk-kL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 174 YIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILK-KLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHH-hcCCCCEEEEeeeeecCCceE
Confidence 34999999999999999999999999999999876532 234456789999998 889999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC---CceEEEeeccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD---NNIKLCDFGISRVVNDV 164 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~---~~~~l~df~~~~~~~~~ 164 (253)
+|+||++||.|.+.+-.+..+.+...+.+.+||+.|+.|||++||+||||||+||++..+ -.+||+|||+++...+.
T Consensus 253 mVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~ 332 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG 332 (475)
T ss_pred EEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccc
Confidence 999999999999998888889999999999999999999999999999999999999877 67999999999999888
Q ss_pred ccccccccCccccCccccCCCCC---CccccHHHHHHHHHHHHhCCCCCCCCChHH-HHHHhhcccccccCCccCCCCHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPI---SLATDMWSVGVLAYVLLSSHSPFAGDNKQE-TFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~---~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
......+|+|.|.|||++.+... ..+.|+||+||++|-+++|.+||....... ..++|.++...+.+.....+|++
T Consensus 333 sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Isee 412 (475)
T KOG0615|consen 333 SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEE 412 (475)
T ss_pred eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHH
Confidence 88889999999999999977653 347899999999999999999998866655 88899999998888888899999
Q ss_pred HHHHHHHhcccCC
Q psy12709 241 AKDFIQSCLVTDP 253 (253)
Q Consensus 241 l~~li~~~l~~dP 253 (253)
.++||.+||..||
T Consensus 413 a~dlI~~mL~VdP 425 (475)
T KOG0615|consen 413 ALDLINWMLVVDP 425 (475)
T ss_pred HHHHHHHhhEeCc
Confidence 9999999999998
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=306.98 Aligned_cols=237 Identities=30% Similarity=0.498 Sum_probs=222.7
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
.-..|+ +++.||.|+||.|-+++++.++..||+|++.+.. ....+.++..+|..+++ ...||.++++++.+.+.+.
T Consensus 42 ~l~dfe--~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~-~v~~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 42 SLQDFE--RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLK-AVSHPFLVKLYGTFKDNSN 118 (355)
T ss_pred chhhhh--heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHh-hccCceeEEEEEeeccCCe
Confidence 334555 9999999999999999999999999999998876 55677889999999998 7789999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~ 165 (253)
+++||||.+||.|..++++.+.|++..++.++.|++.|++|||++++++||++|+||++|.+|.+||+|||+++.....
T Consensus 119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 9999999999999999999899999999999999999999999999999999999999999999999999999987664
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
+...+|+|.|+|||++.++++..++|-|+||+++|||+.|.+||.+.+....+++|..++..+|. -+++++++||
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdLl 272 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDLL 272 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHHH
Confidence 56778999999999999999999999999999999999999999999999999999999998887 7899999999
Q ss_pred HHhcccC
Q psy12709 246 QSCLVTD 252 (253)
Q Consensus 246 ~~~l~~d 252 (253)
+.+|+.|
T Consensus 273 ~~LL~vD 279 (355)
T KOG0616|consen 273 KKLLQVD 279 (355)
T ss_pred HHHHhhh
Confidence 9999886
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=328.26 Aligned_cols=242 Identities=29% Similarity=0.475 Sum_probs=217.9
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
.+.|+ +++.||+|+||.||+|+-+.+|..||+|++++.. ...++.+.+..|-.++. ..+++.||+++..|.+.+.+
T Consensus 140 ~~DFe--~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~-~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 140 LDDFE--LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILA-EVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cccch--hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhh-hcCCCcEEEEEEEecCCCee
Confidence 34556 9999999999999999999999999999999876 55577888888999998 58999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc---
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND--- 163 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~--- 163 (253)
||||||++||++..++...+.+++..++.++.+++.|++.+|+.|++||||||+|++||..|++||+|||++.....
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999999999999899999999999999999999999999999999999999999999999999999964310
Q ss_pred ----------------------c-----cc------------------ccccccCccccCccccCCCCCCccccHHHHHH
Q psy12709 164 ----------------------V-----VE------------------VKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198 (253)
Q Consensus 164 ----------------------~-----~~------------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~ 198 (253)
. .. .....|+|.|+|||++.+..|+..+|.|||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 0 00 01236889999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 199 LAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 199 ~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
++|||+.|.+||.+.+..+.+.+|..+..+...+....+++++.|||.+||. ||
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~ 430 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DP 430 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CH
Confidence 9999999999999999999999999998666655556889999999999998 65
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-50 Score=324.42 Aligned_cols=240 Identities=31% Similarity=0.559 Sum_probs=218.3
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
..+|. +.+.||.|+|++|++|.++.++++||||++.+... ......-+..|-..+.++..||+|++++..|.++..+
T Consensus 72 ~~DF~--Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 72 PNDFK--FGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred hhhcc--hhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 45566 89999999999999999999999999999987652 2333456667778888777999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE 166 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 166 (253)
|.|+||+++|+|.+++.+-+.|++...+.++.+|+.|++|||++||+||||||+||+++.+|+++|.|||.++.++....
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999997753211
Q ss_pred ------------c--cccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCC
Q psy12709 167 ------------V--KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHED 232 (253)
Q Consensus 167 ------------~--~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 232 (253)
. ...+|+..|.+||++.+...++.+|+|+|||++|+|+.|++||.+.++-..+++|......+++
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~- 308 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE- 308 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC-
Confidence 1 3468899999999999999999999999999999999999999999999999999999998887
Q ss_pred ccCCCCHHHHHHHHHhcccCC
Q psy12709 233 LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 ~~~~~~~~l~~li~~~l~~dP 253 (253)
.+++.+++||++.|..||
T Consensus 309 ---~fp~~a~dLv~KLLv~dp 326 (604)
T KOG0592|consen 309 ---GFPEDARDLIKKLLVRDP 326 (604)
T ss_pred ---CCCHHHHHHHHHHHccCc
Confidence 789999999999999998
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-51 Score=308.91 Aligned_cols=238 Identities=29% Similarity=0.484 Sum_probs=213.4
Q ss_pred eeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeee-EEEeCC-eEEE
Q psy12709 11 YQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHE-IYETPH-EMVL 88 (253)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~-~~~~~~-~~~l 88 (253)
|+ ++++||+|+||+||++.+..+|..+|.|.+.-..-+....++...|+..++ +++||||+++++ .|..+. .+++
T Consensus 21 y~--Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLk-QL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 21 YQ--ILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLK-QLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HH--HHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHH-hcCCchHHHHHHHhhhccchhhHH
Confidence 55 999999999999999999999999999999977777788899999999998 999999999998 444444 5999
Q ss_pred EEeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 89 VLEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHD--HN--ITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~--~~--~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
+||+|.+|+|...+.. +.-+++..++.+..|++.|+..+|. .. ++||||||.||+++.+|.+||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999888754 4559999999999999999999998 44 99999999999999999999999999998
Q ss_pred cccc-ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCH
Q psy12709 161 VNDV-VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 161 ~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
++.. .......|+|.||+||.+.+.+|++++||||+||++|||+.-+.||.+++--+...+|..+..++... .-+|.
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~--~~YS~ 255 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD--EHYST 255 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH--HHhhh
Confidence 7654 44566789999999999999999999999999999999999999999998888888999987764432 27899
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
++.++|..|+.+||
T Consensus 256 ~l~~li~~ci~vd~ 269 (375)
T KOG0591|consen 256 DLRELINMCIAVDP 269 (375)
T ss_pred HHHHHHHHHccCCc
Confidence 99999999999987
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=306.28 Aligned_cols=240 Identities=28% Similarity=0.436 Sum_probs=212.5
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|+.+.++|.|+||+||+|.++.+|..||||++.....+....+-.++|++++. +++|+|+|.++++|.....+++|+||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLK-qLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLK-QLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHH-hcccchHHHHHHHHHhcceeEEEeee
Confidence 44899999999999999999999999999999887777777888999999998 99999999999999999999999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc-cccccccc
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVEVKEII 171 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~-~~~~~~~~ 171 (253)
|+..-|+++-+...+++.+.++.++.|++.|+.|+|+++++||||+|+||+++.+|.+||||||+++.... ........
T Consensus 83 ~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYV 162 (396)
T KOG0593|consen 83 CDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYV 162 (396)
T ss_pred cchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhh
Confidence 99988888776677899999999999999999999999999999999999999999999999999997763 33444456
Q ss_pred cCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc--------------------
Q psy12709 172 GTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH-------------------- 230 (253)
Q Consensus 172 ~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-------------------- 230 (253)
.+.+|.|||.+.+ ..|....|||++||++.||++|++.|++.++-+.+..|...-....
T Consensus 163 ATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~ 242 (396)
T KOG0593|consen 163 ATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPE 242 (396)
T ss_pred hhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCC
Confidence 7889999999877 5799999999999999999999999999998888776655322111
Q ss_pred -------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 -------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 -------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+..++.++.-+.||+++||+.||
T Consensus 243 ~~~~epLe~k~p~~s~~~ld~~k~cL~~dP 272 (396)
T KOG0593|consen 243 PEHPEPLERKYPKISNVLLDLLKKCLKMDP 272 (396)
T ss_pred CCCccchhhhcccchHHHHHHHHHHhcCCc
Confidence 22446788889999999999998
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=319.16 Aligned_cols=242 Identities=33% Similarity=0.571 Sum_probs=218.4
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc---hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS---MDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
...++|. +.+.||.|+||+|+.|.+..++..||+|++.+.... ......+.+|+..++....||||+++++++..
T Consensus 14 ~~~g~y~--~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 14 LSIGKYE--LGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred cccCcee--eeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 3456777 999999999999999999999999999977764211 23455777899999866559999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-CceEEEeecccccc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD-NNIKLCDFGISRVV 161 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~-~~~~l~df~~~~~~ 161 (253)
...+++||||+.||.|.+.+...+.+.+.+++.+.+|++.|++|||++|++||||||+|++++.+ +++||+|||++...
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999999999888889999999999999999999999999999999999999999 99999999999977
Q ss_pred -cccccccccccCccccCccccCCCC-CC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCC-
Q psy12709 162 -NDVVEVKEIIGTPDYVAPEVLSYEP-IS-LATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHI- 237 (253)
Q Consensus 162 -~~~~~~~~~~~~~~~~~PE~~~~~~-~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~- 237 (253)
.........+|++.|+|||++.+.. |+ .++||||+|+++|.|++|..||...+....+..|..+....|. .+
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~----~~~ 247 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS----YLL 247 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC----CcC
Confidence 4556677789999999999999987 75 7899999999999999999999999999999999999888887 44
Q ss_pred CHHHHHHHHHhcccCC
Q psy12709 238 SSQAKDFIQSCLVTDP 253 (253)
Q Consensus 238 ~~~l~~li~~~l~~dP 253 (253)
|++++.||.+||..||
T Consensus 248 S~~~~~Li~~mL~~~P 263 (370)
T KOG0583|consen 248 SPEARSLIEKMLVPDP 263 (370)
T ss_pred CHHHHHHHHHHcCCCc
Confidence 9999999999999998
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=323.36 Aligned_cols=238 Identities=33% Similarity=0.548 Sum_probs=225.6
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccc-ccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKR-RRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
|-|+ +.+.||.|+.|.|.+|++..+|..+|||++.+. .........+++|+.+++ ++.||||+++|++|+....+|
T Consensus 12 Gpwk--LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMk-Li~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 12 GPWK--LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMK-LIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred ccee--ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHH-HhcCCCeeeeeeeeccCceEE
Confidence 4567 999999999999999999999999999999887 455666789999999998 999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV 167 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 167 (253)
+|.||++||.|.+++..++++++.+++.+.+|++.|+.|||..+++|+|++|+|++++.++++||.|||.+....+..-.
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL 168 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999988777888
Q ss_pred cccccCccccCccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLSYEPI-SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~ 246 (253)
...+|.|.|.+||++.+.+| ..++||||+|++||.|++|++||++++.+..+.++..+.+..|. .+|+++++||.
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs----~Is~eaQdLLr 244 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS----NISSEAQDLLR 244 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC----cCCHHHHHHHH
Confidence 88899999999999999988 57899999999999999999999999999999999999998876 89999999999
Q ss_pred HhcccCC
Q psy12709 247 SCLVTDP 253 (253)
Q Consensus 247 ~~l~~dP 253 (253)
+||..||
T Consensus 245 ~ml~VDp 251 (786)
T KOG0588|consen 245 RMLDVDP 251 (786)
T ss_pred HHhccCc
Confidence 9999998
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=317.26 Aligned_cols=238 Identities=29% Similarity=0.539 Sum_probs=220.7
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
..++ +++.||+|+||+|+++..+.+++.||||++++.. ...+..+..+.|..++....+||.++.++..|..+++++
T Consensus 368 ~~F~--~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 368 DDFR--LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cceE--EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3455 9999999999999999999999999999999876 556778899999999998888999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc-cccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV-VNDVVE 166 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~-~~~~~~ 166 (253)
.||||+.||++...+. ...|++..++.++.+++.||.|||++||+|||+|.+||++|.+|.+||.|||+++. +.....
T Consensus 446 fvmey~~Ggdm~~~~~-~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~ 524 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH-TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDR 524 (694)
T ss_pred EEEEecCCCcEEEEEe-cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCc
Confidence 9999999999554443 46699999999999999999999999999999999999999999999999999985 445567
Q ss_pred ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHH
Q psy12709 167 VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~ 246 (253)
+...+|||.|+|||++.+..|+.+.|-|+||+++|+|+.|+.||+++++++.+.+|......+|. .+|.+...+++
T Consensus 525 TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~~il~ 600 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAIAIMR 600 (694)
T ss_pred cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHHHHHH
Confidence 78899999999999999999999999999999999999999999999999999999999888887 88999999999
Q ss_pred HhcccCC
Q psy12709 247 SCLVTDP 253 (253)
Q Consensus 247 ~~l~~dP 253 (253)
++|.+||
T Consensus 601 ~ll~k~p 607 (694)
T KOG0694|consen 601 RLLRKNP 607 (694)
T ss_pred HHhccCc
Confidence 9999998
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=304.85 Aligned_cols=236 Identities=29% Similarity=0.519 Sum_probs=221.3
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVL 90 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 90 (253)
+|++.+.||+|.||+|-+|.....|+.||||.+++.. .+.....++.+|+.++. .++||||+.++++|+..+.+.+||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMS-sLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMS-SLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHh-hcCCCceeehhhhhcCCceEEEEE
Confidence 3449999999999999999999999999999999876 45566889999999999 999999999999999999999999
Q ss_pred eccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccccccc
Q psy12709 91 EMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI 170 (253)
Q Consensus 91 e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (253)
||..+|.|.+++...+.+++.+.+.+.+|+.+|+.|||+++++|+|++.+||++|.|+++||.|||++..+.........
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTF 212 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTF 212 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999988888888899
Q ss_pred ccCccccCccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 171 IGTPDYVAPEVLSYEPI-SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
+|+|-|.+||++++.+| .++.|.||||+++|-+..|..||++.+......+|..+...-|. -+.+...||.+||
T Consensus 213 CGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-----~PSdA~gLIRwmL 287 (668)
T KOG0611|consen 213 CGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-----TPSDASGLIRWML 287 (668)
T ss_pred cCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-----CCchHHHHHHHHH
Confidence 99999999999999988 68999999999999999999999999999999999988765544 4788999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
-.||
T Consensus 288 mVNP 291 (668)
T KOG0611|consen 288 MVNP 291 (668)
T ss_pred hcCc
Confidence 9998
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=315.68 Aligned_cols=235 Identities=31% Similarity=0.529 Sum_probs=220.4
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|.+.+.||+|+||.||+|..+.+...||+|.+.+..+...+.+.+.+|+++++ .++||||+..++.|+...++|+|+||
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r-~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILR-SLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHH-hcCCcchhhHHHhhcccceEEEEehh
Confidence 44889999999999999999999999999999999998989999999999998 89999999999999999999999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc-ccccc
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE-VKEII 171 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~~~ 171 (253)
+.| +|..++...+.++++.+..++.++++|+.|||+++|.|+|++|.||++..+|.+|+||||+++.++.... .....
T Consensus 83 a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsik 161 (808)
T KOG0597|consen 83 AVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIK 161 (808)
T ss_pred hhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeecc
Confidence 977 9999999999999999999999999999999999999999999999999999999999999998876443 34567
Q ss_pred cCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhccc
Q psy12709 172 GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251 (253)
Q Consensus 172 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (253)
|+|.|||||...+++++..+|+|||||++||++.|++||-..+..+....|......+|. ..|..+..|++..|.+
T Consensus 162 GtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f~nfl~gLL~k 237 (808)
T KOG0597|consen 162 GTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSFVNFLQGLLIK 237 (808)
T ss_pred CcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHHHHHHHHHhhc
Confidence 999999999999999999999999999999999999999998888888888887776666 7899999999999999
Q ss_pred CC
Q psy12709 252 DP 253 (253)
Q Consensus 252 dP 253 (253)
||
T Consensus 238 dP 239 (808)
T KOG0597|consen 238 DP 239 (808)
T ss_pred Ch
Confidence 98
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=301.41 Aligned_cols=235 Identities=31% Similarity=0.472 Sum_probs=208.4
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
+|+ +.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+..+. ..+|+||+++++++..++.+++
T Consensus 2 ~y~--~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~l 78 (291)
T cd05612 2 DLE--RIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLK-EVSHPFIIRLFWTEHDQRFLYM 78 (291)
T ss_pred Cce--eeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHH-hCCCCcHhhhHhhhccCCeEEE
Confidence 455 99999999999999999999999999999876432 2234567788888887 7799999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccccc
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK 168 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 168 (253)
+|||+++++|.+++.....+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~ 156 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TW 156 (291)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998765432 22
Q ss_pred ccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 169 EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
...+++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.+..+.+..+.......+. .+++.++++|++|
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~ 232 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIKKL 232 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHHHHHHHH
Confidence 346789999999999888999999999999999999999999998888888888777665544 6699999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|+.||
T Consensus 233 l~~dp 237 (291)
T cd05612 233 LVVDR 237 (291)
T ss_pred cCCCH
Confidence 99998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=304.01 Aligned_cols=239 Identities=29% Similarity=0.493 Sum_probs=211.0
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
+..++|+ +.+.||+|+||+||+|.+..++..||+|++.+.. ........+.+|+..+. ..+|+||+++++.+..++
T Consensus 15 ~~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~ 91 (329)
T PTZ00263 15 WKLSDFE--MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILM-ELSHPFIVNMMCSFQDEN 91 (329)
T ss_pred CCchheE--EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHH-hCCCCCCCcEEEEEEcCC
Confidence 3456676 9999999999999999999999999999997653 22334567888998888 679999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
.++++|||+.|++|.+.+.....+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998765432
Q ss_pred ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
. ....+++.|+|||++.+..++.++|+||+|+++|+|++|+.||.+.+..+.+..+..+....+. .++.++++|
T Consensus 172 ~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~l 245 (329)
T PTZ00263 172 T--FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRARDL 245 (329)
T ss_pred c--ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC----CCCHHHHHH
Confidence 2 2346789999999999988999999999999999999999999998888888888776655443 579999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||+.||
T Consensus 246 i~~~L~~dP 254 (329)
T PTZ00263 246 VKGLLQTDH 254 (329)
T ss_pred HHHHhhcCH
Confidence 999999998
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=279.50 Aligned_cols=240 Identities=27% Similarity=0.373 Sum_probs=209.3
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
+|..++.+|+|.||.||+|.+.++|+.||||+++.............+|++.++ .++|+||+.++++|.+.+.+.+|+|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lq-el~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQ-ELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHH-HccCcchhhhhhhccCCCceEEEEE
Confidence 444899999999999999999999999999999988776666778999999999 7789999999999999999999999
Q ss_pred ccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccc-
Q psy12709 92 MVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE- 169 (253)
Q Consensus 92 ~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~- 169 (253)
|+ ..+|+.+++.. -.++..+++.++.+++++++|||++.|+|||+||.|++++++|.+|+.|||+++.+........
T Consensus 82 fm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH 160 (318)
T ss_pred ec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence 99 45899998764 4589999999999999999999999999999999999999999999999999998765443322
Q ss_pred cccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC-----------------
Q psy12709 170 IIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE----------------- 231 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~----------------- 231 (253)
...+..|.|||.+-| ..|+...|+||+||+++||+.|.+.|++.++-+.+..|-....++..
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~ 240 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ 240 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhc
Confidence 367889999998654 57899999999999999999999999998888777666544333332
Q ss_pred -------CccCCCCHHHHHHHHHhcccCC
Q psy12709 232 -------DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 232 -------~~~~~~~~~l~~li~~~l~~dP 253 (253)
.+.+..++++.||+.+||..||
T Consensus 241 ~P~~~~~~lf~aas~d~ldLl~~m~~ynP 269 (318)
T KOG0659|consen 241 FPKPPLNNLFPAASSDALDLLSKMLTYNP 269 (318)
T ss_pred CCCCccccccccccHHHHHHHHhhhccCc
Confidence 2446678999999999999998
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=303.34 Aligned_cols=238 Identities=26% Similarity=0.344 Sum_probs=208.4
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--CeEEEEEe
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP--HEMVLVLE 91 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e 91 (253)
+.+++||+|+||+||+|.+..+|+.||+|++...........-..+||.+++ .++||||+++.++.... ..+|+|+|
T Consensus 120 eki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr-~l~HpNIikL~eivt~~~~~siYlVFe 198 (560)
T KOG0600|consen 120 EKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILR-RLDHPNIIKLEEIVTSKLSGSIYLVFE 198 (560)
T ss_pred HHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHH-hcCCCcccceeeEEEecCCceEEEEEe
Confidence 3889999999999999999999999999999998887888889999999998 89999999999999877 68999999
Q ss_pred ccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc--ccc
Q psy12709 92 MVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV--EVK 168 (253)
Q Consensus 92 ~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~ 168 (253)
||+. +|.-++... -.|++.+++.++.||+.+++|||++|++|||||..||+++++|.+||.|||++.+..... ...
T Consensus 199 YMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T 277 (560)
T KOG0600|consen 199 YMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYT 277 (560)
T ss_pred cccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccc
Confidence 9977 676676643 469999999999999999999999999999999999999999999999999999665432 345
Q ss_pred ccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCC---------------
Q psy12709 169 EIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHED--------------- 232 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~--------------- 232 (253)
..+-+.+|.|||.+.|. .|+.+.|+||+|||+.||++|++.|++.++.+.+..|.+.-.++.+.
T Consensus 278 ~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp 357 (560)
T KOG0600|consen 278 SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKP 357 (560)
T ss_pred cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCC
Confidence 56778999999998765 69999999999999999999999999999998888775533333221
Q ss_pred ----------ccCCCCHHHHHHHHHhcccCC
Q psy12709 233 ----------LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 ----------~~~~~~~~l~~li~~~l~~dP 253 (253)
.+..+|+...+|+.++|..||
T Consensus 358 ~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP 388 (560)
T KOG0600|consen 358 QQPYKRRLRETFKDFPASALDLLEKLLSLDP 388 (560)
T ss_pred CCcccchHHHHhccCCHHHHHHHHHHhccCc
Confidence 123578899999999999998
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=301.90 Aligned_cols=232 Identities=30% Similarity=0.482 Sum_probs=203.6
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
+.||+|+||+||+|.++.+++.||+|++.+... .........+|+..+. ..+|+||+++++.+..++.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQ-NTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHH-hCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 468999999999999999999999999986532 2344566778888887 77999999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-ccccccccccCc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVVEVKEIIGTP 174 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~ 174 (253)
++|.+.+.....+++..+..++.|++.|++|||++|++|+||+|+||+++.++.++|+|||++.... .........+++
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 159 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence 9999999888889999999999999999999999999999999999999999999999999987532 222333456899
Q ss_pred cccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 175 ~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.|+|||++.+..++.++|+||+||++|+|++|+.||.+.+.......+.......+. .+++++.++|.+||+.||
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~dP 234 (323)
T cd05571 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 234 (323)
T ss_pred cccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHccCCH
Confidence 999999999899999999999999999999999999988887777777666554443 789999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=298.85 Aligned_cols=234 Identities=24% Similarity=0.383 Sum_probs=205.3
Q ss_pred EEeecCCCCceEEEEEEeccCCce-EEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC-eEEEEEec
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVE-YAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH-EMVLVLEM 92 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~-v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~ 92 (253)
+.+.+|+|+||+||+|..+ |.. ||+|++..........+.+.+|+..+. ..+||||+++++++..+. ..++||||
T Consensus 45 ~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~-~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLS-RLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred hhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHH-hCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 6677999999999999987 444 999999987766655889999999998 699999999999999988 79999999
Q ss_pred cCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCCEEEcCCC-ceEEEeeccccccccc-ccc
Q psy12709 93 VPDGELQRLVDI--QDGIPEQDTRSYMKQILEALAFLHDHN-ITHLDLKPQNILLTKDN-NIKLCDFGISRVVNDV-VEV 167 (253)
Q Consensus 93 ~~g~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~-~~h~di~~~ni~~~~~~-~~~l~df~~~~~~~~~-~~~ 167 (253)
+++|+|.+++.. ...++...+..++.++++|++|||+++ |+|+|+|++|++++.++ ++||+|||+++..... ...
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~ 201 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSM 201 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccc
Confidence 999999999977 577999999999999999999999999 99999999999999998 9999999999876543 333
Q ss_pred cccccCccccCccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLS--YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
....|++.|||||++. ...++.++||||+|+++|||+||+.||.+.........+......++.+ ..+++.+..++
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--~~~~~~l~~l~ 279 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--KECPPHLSSLM 279 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccCCHHHHHHH
Confidence 3468899999999999 5689999999999999999999999999988876666665544444332 24899999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
..||+.||
T Consensus 280 ~~CW~~dp 287 (362)
T KOG0192|consen 280 ERCWLVDP 287 (362)
T ss_pred HHhCCCCC
Confidence 99999998
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=298.66 Aligned_cols=237 Identities=30% Similarity=0.499 Sum_probs=206.7
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
|++++.||+|+||.||+|.+..+++.||+|++.+... .......+..|...+.....+++|+.+++.+..++.+++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 4499999999999999999999999999999986532 233456677788888756566779999999999999999999
Q ss_pred ccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-cccccccc
Q psy12709 92 MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVVEVKEI 170 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~~~~~~~ 170 (253)
|++|++|.+++.....+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.... ........
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 161 (324)
T cd05587 82 YVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF 161 (324)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeee
Confidence 99999999999877889999999999999999999999999999999999999999999999999886432 22233345
Q ss_pred ccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcc
Q psy12709 171 IGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLV 250 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (253)
.+++.|+|||++.+..++.++|+||+|+++|+|++|+.||.+.+..+.+..+.......+. .+++++.++|.+||+
T Consensus 162 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~ 237 (324)
T cd05587 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLLT 237 (324)
T ss_pred cCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhh
Confidence 6889999999999999999999999999999999999999998888888888776655544 689999999999999
Q ss_pred cCC
Q psy12709 251 TDP 253 (253)
Q Consensus 251 ~dP 253 (253)
+||
T Consensus 238 ~~P 240 (324)
T cd05587 238 KHP 240 (324)
T ss_pred cCH
Confidence 998
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=298.78 Aligned_cols=237 Identities=30% Similarity=0.513 Sum_probs=207.6
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
|++.+.||+|+||+||+|.+..++..||+|++.+... ..........|...+.....|++|+.+++.+...+.+++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 4499999999999999999999999999999986542 223345566777777767789999999999999999999999
Q ss_pred ccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-cccccccc
Q psy12709 92 MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVVEVKEI 170 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~~~~~~~ 170 (253)
|+++++|...+.....+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.... ........
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~ 161 (323)
T cd05616 82 YVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTF 161 (323)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccC
Confidence 99999999998877889999999999999999999999999999999999999999999999999987532 22223345
Q ss_pred ccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcc
Q psy12709 171 IGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLV 250 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (253)
.+++.|+|||++.+..++.++|+||+|+++|+|++|+.||.+.+....+..+......++. .+++++.+++.+||+
T Consensus 162 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~l~ 237 (323)
T cd05616 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMT 237 (323)
T ss_pred CCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----cCCHHHHHHHHHHcc
Confidence 6789999999999999999999999999999999999999998888888888877665554 689999999999999
Q ss_pred cCC
Q psy12709 251 TDP 253 (253)
Q Consensus 251 ~dP 253 (253)
.||
T Consensus 238 ~~p 240 (323)
T cd05616 238 KHP 240 (323)
T ss_pred cCH
Confidence 997
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=291.76 Aligned_cols=246 Identities=27% Similarity=0.414 Sum_probs=211.6
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
|..+.-.|++.+.||.|..++||+|.....+..||||++..+..+.+ ...+.+|+..+. +++||||++++..|..++.
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~ms-l~~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMS-LIDHPNIVTYHCSFVVDSE 98 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhh-hcCCCCcceEEEEEEecce
Confidence 44455556699999999999999999999999999999998776544 789999999998 9999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDI--QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
+|+||+||.+|++.+++.. ..++++..+..+++++++||.|||++|.+|||||+.||+++.+|.|+|.|||.+..+..
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999999999986 45699999999999999999999999999999999999999999999999998875432
Q ss_pred c-----ccccccccCccccCcccc--CCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc------c
Q psy12709 164 V-----VEVKEIIGTPDYVAPEVL--SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF------H 230 (253)
Q Consensus 164 ~-----~~~~~~~~~~~~~~PE~~--~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~------~ 230 (253)
. .......++++|+|||++ ....|+.++||||+|++..|+.+|..||..-.+..++..-.++.++. +
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence 1 111445789999999995 33479999999999999999999999999887777766555555432 2
Q ss_pred CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 ~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.+....+++.++++|..||++||
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP 281 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDP 281 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCc
Confidence 23334678889999999999998
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=294.39 Aligned_cols=236 Identities=30% Similarity=0.476 Sum_probs=199.7
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC--eEEEEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH--EMVLVL 90 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~ 90 (253)
+...+.||+|+||+||++.+..+|...|+|.+...... ..+.+++|+..+.++ +|||||++++...... .+.++|
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeEeee
Confidence 44889999999999999999999999999998876322 267899999999955 5999999999854444 699999
Q ss_pred eccCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-CCceEEEeecccccccc----c
Q psy12709 91 EMVPDGELQRLVDIQD-GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK-DNNIKLCDFGISRVVND----V 164 (253)
Q Consensus 91 e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~-~~~~~l~df~~~~~~~~----~ 164 (253)
||+++|+|.+++...+ .+++..++.+++|++.+++|||++|++|+||||.||+++. ++.+||.|||.+..... .
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 9999999999998866 6999999999999999999999999999999999999999 79999999999886653 2
Q ss_pred ccccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhcccccccCCccCCCCHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAG-DNKQETFLNISQCNFSFHEDLFGHISSQAK 242 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~ 242 (253)
.......+++.|+|||++... ...+++||||+||++.||+||+.||.. ....+....+......+ .....+|++++
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P--~ip~~ls~~a~ 253 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP--EIPDSLSDEAK 253 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC--CCCcccCHHHH
Confidence 334456789999999999853 344599999999999999999999987 44545455555544333 44568999999
Q ss_pred HHHHHhcccCC
Q psy12709 243 DFIQSCLVTDP 253 (253)
Q Consensus 243 ~li~~~l~~dP 253 (253)
+|+.+||+.||
T Consensus 254 ~Fl~~C~~~~p 264 (313)
T KOG0198|consen 254 DFLRKCFKRDP 264 (313)
T ss_pred HHHHHHhhcCc
Confidence 99999999998
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=298.52 Aligned_cols=232 Identities=29% Similarity=0.482 Sum_probs=202.9
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
+.||+|+||.||++.+..++..||+|++..... .......+.+|+..+. ..+|+||+++++.+..++.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-NTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHH-hCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 468999999999999999999999999986532 2344566777888887 77999999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-ccccccccccCc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVVEVKEIIGTP 174 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~ 174 (253)
++|...+.....+++..++.++.|++.|+.|||++|++|+||+|+||++++++.++|+|||++.... .........+++
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 159 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence 9999988877789999999999999999999999999999999999999999999999999887532 222223456889
Q ss_pred cccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 175 ~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.|+|||++.+..++.++|+||+|+++|+|++|+.||...+.......+.......+. .++++++++|.+||++||
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~dP 234 (323)
T cd05595 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 234 (323)
T ss_pred CcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHccCCH
Confidence 999999999889999999999999999999999999988888877777666555444 789999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=298.91 Aligned_cols=233 Identities=30% Similarity=0.490 Sum_probs=204.8
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
+.||+|+||+||+|.++.+++.||+|++.+.. ...........|...+....+|+||+++++.+..++.+++||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999987653 22344566778888887677899999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-ccccccccccCc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVVEVKEIIGTP 174 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~ 174 (253)
++|.+.+.....+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.... .........+++
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP 160 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence 9999998888889999999999999999999999999999999999999999999999999987532 222333456889
Q ss_pred cccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 175 ~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.|+|||++.+..++.++|+||+|+++|+|++|+.||...+..+.+..+.......+. .+++++.++|++||+.||
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~L~~dP 235 (320)
T cd05590 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLSQDAVDILKAFMTKNP 235 (320)
T ss_pred cccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHcccCH
Confidence 999999999888999999999999999999999999999888888888776655443 679999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=299.89 Aligned_cols=239 Identities=29% Similarity=0.501 Sum_probs=205.9
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
.|+ +.+.||+|+||.||+|.+..++..||+|++.+... .......+.+|+..+. ..+|+||+++++.+..++..++
T Consensus 2 ~y~--~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~iv~~~~~~~~~~~~~l 78 (333)
T cd05600 2 DFQ--ILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILT-TTKSEWLVKLLYAFQDDEYLYL 78 (333)
T ss_pred CcE--EEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHH-hCCCCCCccEEEEEEcCCEEEE
Confidence 455 99999999999999999999999999999986542 2344567788888887 6679999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccccc
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK 168 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 168 (253)
+|||++|++|.+++.....+++..++.++.|++.++.|||++|++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~ 156 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YAN 156 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccC
Confidence 999999999999998878899999999999999999999999999999999999999999999999999875543 223
Q ss_pred ccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCc----cCCCCHHHHHH
Q psy12709 169 EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDL----FGHISSQAKDF 244 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~----~~~~~~~l~~l 244 (253)
...+++.|+|||++.+..++.++||||+|+++|+|++|..||...+..+.+..+........... ...+++++.++
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~l 236 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDL 236 (333)
T ss_pred CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHH
Confidence 45688999999999988999999999999999999999999999888877777665432222211 13679999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||+.+|
T Consensus 237 i~~~l~~~~ 245 (333)
T cd05600 237 ITKLINDPS 245 (333)
T ss_pred HHHHhhChh
Confidence 999998765
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=292.26 Aligned_cols=240 Identities=27% Similarity=0.414 Sum_probs=199.2
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc-hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS-MDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
|+..+.||+|+||+||+|.+..++..||+|.+.+.... ......+.+|+..+. ..+|++|+++++.+..++.+++++|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILE-KVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHH-hcCCCcEEEEEEEEccCCeEEEEEE
Confidence 44899999999999999999999999999998764422 222345678888888 7799999999999999999999999
Q ss_pred ccCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccc
Q psy12709 92 MVPDGELQRLVDI--QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE 169 (253)
Q Consensus 92 ~~~g~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (253)
|+++++|...+.. ...+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 9999999887754 34589999999999999999999999999999999999999999999999999876544333344
Q ss_pred cccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 170 IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
..+++.|+|||++.+..++.++||||+|+++|+|++|+.||...........+..............+|+++.+||.+||
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 240 (285)
T cd05631 161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240 (285)
T ss_pred CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHh
Confidence 56889999999999999999999999999999999999999876543332222221122222333478999999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
+.||
T Consensus 241 ~~~P 244 (285)
T cd05631 241 TKNP 244 (285)
T ss_pred hcCH
Confidence 9998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=297.06 Aligned_cols=239 Identities=30% Similarity=0.506 Sum_probs=206.5
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch------------HHHHHHHHHHHHHHHhcCCCCceeeeeE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM------------DQMQDILHEAAVLYLAQKSERIVGLHEI 79 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~------------~~~~~~~~e~~~~~~~~~~~~i~~~~~~ 79 (253)
+|++.+.||+|.||.|.+|.+..+++.||+|++++..... ...++..+|+.++. .+.|+|||+++++
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailK-kl~H~nVV~LiEv 176 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILK-KLHHPNVVKLIEV 176 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHH-hcCCcCeeEEEEe
Confidence 3459999999999999999999999999999998754211 12368899999998 8899999999999
Q ss_pred EEeC--CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecc
Q psy12709 80 YETP--HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI 157 (253)
Q Consensus 80 ~~~~--~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~ 157 (253)
..+. +.+|+|+|||..|.+.+.-.....+++.+++.++++++.+|+|||.+|++||||||.|++++.+|.+||.|||.
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGV 256 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGV 256 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccce
Confidence 9876 48999999999887765433222389999999999999999999999999999999999999999999999999
Q ss_pred cccc------cccccccccccCccccCccccCCCC----CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccc
Q psy12709 158 SRVV------NDVVEVKEIIGTPDYVAPEVLSYEP----ISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNF 227 (253)
Q Consensus 158 ~~~~------~~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~ 227 (253)
+..+ +.........|+|.|+|||...+.. .+.+.||||+|+++|.|+.|+.||-+....+.+.+|.....
T Consensus 257 s~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL 336 (576)
T KOG0585|consen 257 SNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPL 336 (576)
T ss_pred eeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcc
Confidence 9866 2233344578999999999986632 36789999999999999999999999999999999999888
Q ss_pred cccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 228 SFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 228 ~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.+|.. +++.++++|||.+||.+||
T Consensus 337 ~fP~~--pe~~e~~kDli~~lL~KdP 360 (576)
T KOG0585|consen 337 EFPEN--PEINEDLKDLIKRLLEKDP 360 (576)
T ss_pred cCCCc--ccccHHHHHHHHHHhhcCh
Confidence 77764 4789999999999999998
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=297.12 Aligned_cols=233 Identities=32% Similarity=0.474 Sum_probs=201.8
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
+.||+|+||+||+|.+..+++.||+|+++.... ..........|...+....+|+||+++++++..++.+++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 468999999999999999999999999986542 2233445566777777677999999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc-cccccccccCc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVEVKEIIGTP 174 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~ 174 (253)
++|..++.....+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++..... ........+++
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~ 160 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence 99999988777899999999999999999999999999999999999999999999999999875422 22333456889
Q ss_pred cccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 175 ~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.|+|||++.+..++.++|+||+|+++|+|++|+.||.+.+..+.+..+.......+. .+++++.++|.+||+.||
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~ll~~~l~~~P 235 (316)
T cd05592 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR----WISKEAKDCLSKLFERDP 235 (316)
T ss_pred cccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHccCCH
Confidence 999999999888999999999999999999999999998888888777665444433 689999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=303.99 Aligned_cols=236 Identities=28% Similarity=0.458 Sum_probs=209.1
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|...++||+|+.|.||.|....++..||+|.+...... ..+-+.+|+..++ ..+|+|||.+++.|..++.+|+||||
T Consensus 275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~-~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMR-DLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHH-hccchHHHHHHHHhcccceeEEEEee
Confidence 34889999999999999999999999999999875543 3457889999998 89999999999999999999999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-cccccc
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVKEII 171 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~ 171 (253)
++||+|.+++.... +++.++..++++++.||+|||.+||+|+||+.+||+++.+|.+||+|||+|....... ......
T Consensus 352 m~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmV 430 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMV 430 (550)
T ss_pred cCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccccc
Confidence 99999999987544 9999999999999999999999999999999999999999999999999998765433 445568
Q ss_pred cCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhccc
Q psy12709 172 GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251 (253)
Q Consensus 172 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (253)
|+|+|||||+.....|+++.||||||++++||+.|++||-+.+.-.....|...+. +..+....+|+.+++|+.+||+.
T Consensus 431 GTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~-P~lk~~~klS~~~kdFL~~cL~~ 509 (550)
T KOG0578|consen 431 GTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PKLKNPEKLSPELKDFLDRCLVV 509 (550)
T ss_pred CCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC-CCcCCccccCHHHHHHHHHHhhc
Confidence 99999999999999999999999999999999999999987666666656655443 44444568999999999999999
Q ss_pred CC
Q psy12709 252 DP 253 (253)
Q Consensus 252 dP 253 (253)
||
T Consensus 510 dv 511 (550)
T KOG0578|consen 510 DV 511 (550)
T ss_pred ch
Confidence 86
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=300.12 Aligned_cols=237 Identities=27% Similarity=0.418 Sum_probs=207.4
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCC-ceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITK-VEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
.++|+ +.+.||+|+||.||+|.+...+ ..||+|.+.+.. ........+.+|+..+. ..+||||+++++++..++.
T Consensus 29 ~~~y~--~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 29 YEDFN--FIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILN-YINHPFCVNLYGSFKDESY 105 (340)
T ss_pred hhhcE--EEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHH-hCCCCCCcceEEEEEeCCE
Confidence 34566 9999999999999999877554 689999987643 22334567788888887 7799999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~ 165 (253)
++++|||++|++|.+++..+..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 9999999999999999988888999999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
.....+++.|+|||++.+..++.++|+||+|+++|+|++|..||.+.+....+..+.......+. .++++++++|
T Consensus 185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li 259 (340)
T PTZ00426 185 -TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKHLM 259 (340)
T ss_pred -cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHH
Confidence 23456889999999998888999999999999999999999999998888888888776655544 6799999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
++||+.||
T Consensus 260 ~~~l~~dp 267 (340)
T PTZ00426 260 KKLLSHDL 267 (340)
T ss_pred HHHcccCH
Confidence 99999987
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=296.05 Aligned_cols=230 Identities=33% Similarity=0.514 Sum_probs=202.2
Q ss_pred cCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCCc
Q psy12709 19 PSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGE 97 (253)
Q Consensus 19 lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 97 (253)
||+|+||+||+|.+..+++.||+|++.+.. ........+.+|+..+. ..+|+||+++++.+..++..++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLA-QVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999999999999999987543 23344567778888887 6799999999999999999999999999999
Q ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc-cccccccccCccc
Q psy12709 98 LQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVEVKEIIGTPDY 176 (253)
Q Consensus 98 L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~ 176 (253)
|.+.+.....+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++..... ........+++.|
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y 159 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence 999998777899999999999999999999999999999999999999999999999999875322 2223345688999
Q ss_pred cCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 177 VAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 177 ~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+|||++.+..++.++|+||+|+++|+|++|+.||...+..+.+..+.......+. .++++++++|.+||+.||
T Consensus 160 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred CCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCC----cCCHHHHHHHHHHcCCCH
Confidence 9999999989999999999999999999999999988888888877766554443 789999999999999998
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=302.75 Aligned_cols=236 Identities=26% Similarity=0.440 Sum_probs=213.0
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|..++.||+|+||.||+|.+..+++.||+|++..... .++..++.+|+..+. .++++||.++|+.+..+..++++|||
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls-~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLS-QCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHH-hcCcchHHhhhhheeecccHHHHHHH
Confidence 3388999999999999999999999999999987654 455789999999999 88999999999999999999999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-ccccccc
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEVKEII 171 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~ 171 (253)
+.||++.++++....+++.++..++++++.|+.|||..+.+|+||++.||++..+|.+++.|||.+...... .......
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfv 172 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFV 172 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccccc
Confidence 999999999987777799999999999999999999999999999999999999999999999999866543 3336778
Q ss_pred cCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhccc
Q psy12709 172 GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251 (253)
Q Consensus 172 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (253)
|+|.|||||++.+..|+.++||||||++++||++|.+|+....++.+...|.+..++..+ ..+|+.+++||..||++
T Consensus 173 GTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~---~~~S~~~kEFV~~CL~k 249 (467)
T KOG0201|consen 173 GTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLD---GDFSPPFKEFVEACLDK 249 (467)
T ss_pred ccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccc---cccCHHHHHHHHHHhhc
Confidence 999999999999889999999999999999999999999998887777777665544333 38899999999999999
Q ss_pred CC
Q psy12709 252 DP 253 (253)
Q Consensus 252 dP 253 (253)
||
T Consensus 250 ~P 251 (467)
T KOG0201|consen 250 NP 251 (467)
T ss_pred Cc
Confidence 98
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=288.73 Aligned_cols=240 Identities=31% Similarity=0.467 Sum_probs=213.3
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc-hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS-MDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
+.++ +++.||+|.-|+||+|..+.++..+|+|++.+.... .....++..|..+|. .++||.++.+|..|+.+...+
T Consensus 77 ~~f~--llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~-~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 77 RHFR--LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILS-LLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred HHHH--HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHH-hcCCCccchhhheeeccceeE
Confidence 3445 888999999999999999999999999999987643 455678888888888 899999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc--
Q psy12709 88 LVLEMVPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-- 163 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~-- 163 (253)
++||||+||+|..+.++++ .|++..++.++.+++.||+|||..||++||+||+||+|.++|++.|+||.++.....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 9999999999999987754 499999999999999999999999999999999999999999999999998764310
Q ss_pred -------------------------------c-c-----------------------cccccccCccccCccccCCCCCC
Q psy12709 164 -------------------------------V-V-----------------------EVKEIIGTPDYVAPEVLSYEPIS 188 (253)
Q Consensus 164 -------------------------------~-~-----------------------~~~~~~~~~~~~~PE~~~~~~~~ 188 (253)
. . ......|+-.|.|||++.+..-+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 01123456699999999999999
Q ss_pred ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 189 LATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 189 ~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.+.|.|++|+.+|||+.|..||++.+.++.+.+|......++... .+|..++|||+++|.+||
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccCh
Confidence 999999999999999999999999999999999999888888764 889999999999999998
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=300.01 Aligned_cols=236 Identities=29% Similarity=0.457 Sum_probs=201.4
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
++++.||+|+||+||+|.+..+++.||+|++.+... .......+.+|+..+. ..+|++|+++++.+..++.+++||||
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~-~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILV-EADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHH-hCCCCCcceEEEEEecCCeEEEEEcC
Confidence 399999999999999999999999999999976432 2334556777888887 77999999999999999999999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-------
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV------- 165 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~------- 165 (253)
++|++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 162 (363)
T cd05628 83 LPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRN 162 (363)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccccc
Confidence 9999999999888889999999999999999999999999999999999999999999999999986432110
Q ss_pred -----------------------------cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH
Q psy12709 166 -----------------------------EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ 216 (253)
Q Consensus 166 -----------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 216 (253)
......+++.|+|||++.+..++.++|+||+||++|+|++|+.||.+.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~ 242 (363)
T cd05628 163 LNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242 (363)
T ss_pred ccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHH
Confidence 012346889999999999889999999999999999999999999998888
Q ss_pred HHHHHhhcccccccCCccCCCCHHHHHHHHHhcc
Q psy12709 217 ETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLV 250 (253)
Q Consensus 217 ~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (253)
+.+.++.........+....++++++++|.+++.
T Consensus 243 ~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~ 276 (363)
T cd05628 243 ETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC 276 (363)
T ss_pred HHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC
Confidence 8888877644332222223579999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=296.83 Aligned_cols=233 Identities=30% Similarity=0.483 Sum_probs=204.0
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
+.||+|+||+||+|.+..++..||+|++.+... ..........|...+....+|++|+++++.+..++.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 468999999999999999999999999986532 2344556777888887677999999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-ccccccccccCc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVVEVKEIIGTP 174 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~ 174 (253)
++|...+.....+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+.... .........+++
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence 9999998877889999999999999999999999999999999999999999999999999887532 222233446789
Q ss_pred cccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 175 ~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.|+|||++.+..++.++|+||+|+++|+|++|+.||...+..+.+..+.......+. .+++++.++|.+||+.||
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ll~~~L~~dp 235 (321)
T cd05591 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV----WLSKEAVSILKAFMTKNP 235 (321)
T ss_pred cccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhccCH
Confidence 999999999889999999999999999999999999999988888888776654443 579999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=296.90 Aligned_cols=232 Identities=30% Similarity=0.494 Sum_probs=202.5
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
+.||+|+||+||++.+..++..||+|++.+.. ........+.+|+..+. ..+|+||+++++.+..++.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLK-NTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999999999999999997653 22344567778888887 78999999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc-cccccccccCc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVEVKEIIGTP 174 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~ 174 (253)
++|...+.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++..... ........+++
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 159 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP 159 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence 99999888777899999999999999999999999999999999999999999999999999875322 22233456889
Q ss_pred cccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 175 ~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.|+|||++.+..++.++|+||+|+++|+|++|+.||.+.+..+....+.......+. .+++++.++|.+||++||
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~dP 234 (328)
T cd05593 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLIKDP 234 (328)
T ss_pred CccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCC----CCCHHHHHHHHHHcCCCH
Confidence 999999999888999999999999999999999999988887777776665554443 789999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=295.54 Aligned_cols=237 Identities=30% Similarity=0.503 Sum_probs=206.9
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
|++.+.||+|+||+||+|.+..+++.||+|++.+... ..........|...+....+|++|+++++.+...+.+++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 4488999999999999999999999999999986532 233445677788888766678889999999999999999999
Q ss_pred ccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc-ccccccc
Q psy12709 92 MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVEVKEI 170 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~-~~~~~~~ 170 (253)
|++|++|.+++.....+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++..... .......
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~ 161 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTF 161 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCc
Confidence 999999999998778899999999999999999999999999999999999999999999999999875322 2223344
Q ss_pred ccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcc
Q psy12709 171 IGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLV 250 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (253)
.+++.|+|||++.+..++.++|+||+|+++|+|++|+.||.+.+.......+.......+. .+++++.+++.+||+
T Consensus 162 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~l~ 237 (323)
T cd05615 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLMT 237 (323)
T ss_pred cCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHHHcc
Confidence 5789999999999888999999999999999999999999998888888888776665554 679999999999999
Q ss_pred cCC
Q psy12709 251 TDP 253 (253)
Q Consensus 251 ~dP 253 (253)
+||
T Consensus 238 ~~p 240 (323)
T cd05615 238 KHP 240 (323)
T ss_pred cCH
Confidence 997
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=301.29 Aligned_cols=240 Identities=30% Similarity=0.475 Sum_probs=204.5
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
+|+ +++.||+|+||+||+|.+..+++.||+|++.+.. ........+.+|+..+. ..+|+||+++++.+..++.+++
T Consensus 2 ~y~--~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~-~l~h~~iv~~~~~~~~~~~~~l 78 (364)
T cd05599 2 DFE--SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILA-EADNPWVVKLYYSFQDENYLYL 78 (364)
T ss_pred Cce--EEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCCCcceEEEEEcCCeEEE
Confidence 455 9999999999999999999999999999998653 22334556778888887 7789999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc--
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE-- 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~-- 166 (253)
||||++|++|.+++.....+++..++.++.|++.|++|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999999998878899999999999999999999999999999999999999999999999998865421100
Q ss_pred -------------------------------------ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCC
Q psy12709 167 -------------------------------------VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSP 209 (253)
Q Consensus 167 -------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 209 (253)
.....+++.|+|||++.+..++.++|+||+||++|+|++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 0123578999999999888899999999999999999999999
Q ss_pred CCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 210 FAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 210 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
|.+.+..+....+.........+....+|++++++|.+||. ||
T Consensus 239 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p 281 (364)
T cd05599 239 FCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EA 281 (364)
T ss_pred CCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CH
Confidence 99988887777776654433332233679999999999996 54
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=282.22 Aligned_cols=247 Identities=32% Similarity=0.559 Sum_probs=227.3
Q ss_pred cceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 4 KFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
.+.+.+.|+ +.+.||+|.|+.|+++.+..+|..+++|++..........+++.+|+.+-+ .++||||+++.+.....
T Consensus 6 ~~~f~d~y~--l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~-~LqHP~IvrL~~ti~~~ 82 (355)
T KOG0033|consen 6 STKFSDNYD--VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR-KLQHPNIVRLHDSIQEE 82 (355)
T ss_pred ccccchhhh--HHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHH-hcCCCcEeehhhhhccc
Confidence 455667777 999999999999999999999999999998877666667889999999998 88999999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC---CceEEEeeccccc
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD---NNIKLCDFGISRV 160 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~---~~~~l~df~~~~~ 160 (253)
...++|+|++.|+.|-.-+-.+.-+++..+..+++|++.++.|+|.+||+|||++|.|+++.+. .-+||+|||++..
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999999999996666556668999999999999999999999999999999999999764 4599999999998
Q ss_pred ccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHH
Q psy12709 161 VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
.++...-....|+|.|+|||++...+++..+|||+.|+++|-++.|.+||.+.+..+.+++|..+....+.+..+.++++
T Consensus 163 l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~ 242 (355)
T KOG0033|consen 163 VNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPE 242 (355)
T ss_pred eCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHH
Confidence 88766667788999999999999999999999999999999999999999999999999999999999999899999999
Q ss_pred HHHHHHHhcccCC
Q psy12709 241 AKDFIQSCLVTDP 253 (253)
Q Consensus 241 l~~li~~~l~~dP 253 (253)
.++||.+||..||
T Consensus 243 Ak~LvrrML~~dP 255 (355)
T KOG0033|consen 243 AKSLIRRMLTVNP 255 (355)
T ss_pred HHHHHHHHhccCh
Confidence 9999999999998
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=299.49 Aligned_cols=246 Identities=31% Similarity=0.411 Sum_probs=217.0
Q ss_pred cceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 4 KFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
+.++-++|+ ++++||.|+||.||+|+.+++++.||||.+++....+++ ..-.+|+..++++..||||+++.+++.+.
T Consensus 5 ~~~~m~RY~--~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 5 QVIFMDRYT--VIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred ehhHHHHHH--HHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 455667888 999999999999999999999999999999987766554 45567999999787799999999999998
Q ss_pred C-eEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 84 H-EMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 84 ~-~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
+ .+++||||| ..+|..++..+ ..|++..++.++.|++++|+++|++|+.|||+||+||++..+..+||.|||+++..
T Consensus 82 ~~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 82 DRILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred CceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc
Confidence 8 999999999 55899988765 56999999999999999999999999999999999999999999999999999988
Q ss_pred cccccccccccCccccCcccc-CCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC---------
Q psy12709 162 NDVVEVKEIIGTPDYVAPEVL-SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE--------- 231 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~PE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--------- 231 (253)
...........+.+|.|||++ ++.-|+.+.|+|++||+++|+.+-++.|++.++.+...+|...-.++.+
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 877777777889999999996 6667899999999999999999999999999998888777554333332
Q ss_pred -----------------CccCCCCHHHHHHHHHhcccCC
Q psy12709 232 -----------------DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 232 -----------------~~~~~~~~~l~~li~~~l~~dP 253 (253)
.+.+..++++.++|.+|+++||
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP 279 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDP 279 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCC
Confidence 3445689999999999999998
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=301.98 Aligned_cols=238 Identities=29% Similarity=0.459 Sum_probs=201.1
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
+|+ +++.||.|+||+||+|.+..+++.||+|++.+.. ........+.+|+..+. ..+|+||+++++.+..++.+++
T Consensus 2 ~y~--~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~-~l~hp~iv~~~~~~~~~~~~~l 78 (377)
T cd05629 2 DFH--TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLA-ESDSPWVVSLYYSFQDAQYLYL 78 (377)
T ss_pred Cce--EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHH-hCCCCCcceEEEEEEcCCeeEE
Confidence 455 9999999999999999999999999999987643 22344567788888887 7899999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc--
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE-- 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~-- 166 (253)
||||++|++|.+++.....+++..++.++.|++.|++|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999999999998778899999999999999999999999999999999999999999999999998853211000
Q ss_pred ----------------------------------------------ccccccCccccCccccCCCCCCccccHHHHHHHH
Q psy12709 167 ----------------------------------------------VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLA 200 (253)
Q Consensus 167 ----------------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l 200 (253)
.....+++.|+|||++.+..++.++|+||+||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 0013578899999999988999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcc
Q psy12709 201 YVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLV 250 (253)
Q Consensus 201 ~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (253)
|+|++|..||.+.+..+.+..+.........+....++.+++++|.+||.
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~ 288 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT 288 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc
Confidence 99999999999888877777766533222222223579999999999997
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=295.97 Aligned_cols=233 Identities=31% Similarity=0.502 Sum_probs=201.3
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
+.||+|+||+||+|.+..++..||+|++.+... .......+..|...+.+..+|+||+++++.+..++.+++||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 468999999999999999999999999976532 2233455666666666688999999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-ccccccccccCc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVVEVKEIIGTP 174 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~ 174 (253)
++|...+.....+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.... .........+++
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence 9999998877889999999999999999999999999999999999999999999999999986432 222233456789
Q ss_pred cccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 175 ~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..+.+..+.......+ +.+++++.++|.+||+.||
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~~p 235 (323)
T cd05575 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQKDR 235 (323)
T ss_pred hhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhhcCH
Confidence 99999999998999999999999999999999999999888888877766544333 4679999999999999997
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=294.09 Aligned_cols=236 Identities=27% Similarity=0.465 Sum_probs=202.8
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHH--HhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLY--LAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~--~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
|++++.||+|+||.||+|.+..++..||+|++.+.. ........+.+|+..+. ...+|+||+++++++..++.+++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 348999999999999999999999999999998654 22233456666766554 245799999999999999999999
Q ss_pred EeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc-ccccc
Q psy12709 90 LEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVEVK 168 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~-~~~~~ 168 (253)
|||++|++|...+. ...+++..+..++.|++.|+.|||++|++|+||+|+||++++++.++|+|||++..... .....
T Consensus 81 ~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05589 81 MEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159 (324)
T ss_pred EcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence 99999999988876 45689999999999999999999999999999999999999999999999998864322 22233
Q ss_pred ccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 169 EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
...+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||.+.+..+....+.......+. .+++++.++|.+|
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~ 235 (324)
T cd05589 160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISIMRRL 235 (324)
T ss_pred ccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHH
Confidence 456889999999999889999999999999999999999999998888888887776655444 6799999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|+.||
T Consensus 236 L~~dP 240 (324)
T cd05589 236 LRRNP 240 (324)
T ss_pred hhcCH
Confidence 99998
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=293.49 Aligned_cols=233 Identities=29% Similarity=0.446 Sum_probs=201.9
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
+.||+|+||.||+|.++.++..||+|.+.+... ..........|...+....+|++|+++++.+..++.+++||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999986532 1233456677777777677999999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-ccccccccccCc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVVEVKEIIGTP 174 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~ 174 (253)
++|...+.....+++..+..++.|++.|++|||++|++|+||+|+||+++.++.++|+|||++.... .........+++
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence 9999998877789999999999999999999999999999999999999999999999999886432 122233456789
Q ss_pred cccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 175 ~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.|+|||++.+..++.++|+||+|+++|+|++|+.||.+.+..+....+.......+. .++.+++++|.+||+.||
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dP 235 (316)
T cd05620 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR----WITKESKDILEKLFERDP 235 (316)
T ss_pred CccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHccCCH
Confidence 999999999999999999999999999999999999988888888777665544433 679999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=300.30 Aligned_cols=240 Identities=34% Similarity=0.537 Sum_probs=206.5
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch-HHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM-DQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
+|+ +.+.||+|+||+||+|.+..+++.||+|++.+..... .....+.+|+..+. ...|+||+++++.+..++.+++
T Consensus 2 ~y~--~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~l 78 (350)
T cd05573 2 DFE--VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILA-DADSPWIVKLYYSFQDEEHLYL 78 (350)
T ss_pred Cce--EEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHH-hcCCCCccchhhheecCCeEEE
Confidence 455 9999999999999999999999999999998654222 44566777888887 7789999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc---
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV--- 165 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~--- 165 (253)
||||+++++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 99999999999999877789999999999999999999999999999999999999999999999999987654322
Q ss_pred ---------------------------cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy12709 166 ---------------------------EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQET 218 (253)
Q Consensus 166 ---------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 218 (253)
......+++.|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 22334678999999999999999999999999999999999999999888877
Q ss_pred HHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 219 FLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 219 ~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+..+.........+....+++++.++|.+||+ ||
T Consensus 239 ~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp 272 (350)
T cd05573 239 YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DP 272 (350)
T ss_pred HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-Ch
Confidence 77777633322222234589999999999997 76
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=274.00 Aligned_cols=242 Identities=29% Similarity=0.452 Sum_probs=218.4
Q ss_pred cceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 4 KFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
+.|..+++. +.+.||+|.||.||+|..++++..||+|++.+... ......++.+|+.+.. .++||||+++|++|.+
T Consensus 17 ~~~~l~dfe--igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs-~L~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 17 KTWTLDDFE--IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQS-HLRHPNILRLYGYFHD 93 (281)
T ss_pred cccchhhcc--ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeec-ccCCccHHhhhhheec
Confidence 345556666 99999999999999999999999999999987652 2233567778888887 8999999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVD--IQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
...+|+++||..+|++...+. ....+++.....++.|++.|+.|+|.++++||||+|+|++++..|.+++.|||.+..
T Consensus 94 ~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 94 SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 999999999999999988887 445699999999999999999999999999999999999999999999999999986
Q ss_pred ccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHH
Q psy12709 161 VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
.. ...-...+++..|.|||+..+...+...|+|++|++.|+++.|.+||.+.+..+.++.|.+.....|. .+|.+
T Consensus 174 ~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~----~is~~ 248 (281)
T KOG0580|consen 174 AP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS----TISGG 248 (281)
T ss_pred cC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc----ccChh
Confidence 55 33445678999999999999999999999999999999999999999999999999999999888885 88999
Q ss_pred HHHHHHHhcccCC
Q psy12709 241 AKDFIQSCLVTDP 253 (253)
Q Consensus 241 l~~li~~~l~~dP 253 (253)
++|+|.+||.+||
T Consensus 249 a~dlI~~ll~~~p 261 (281)
T KOG0580|consen 249 AADLISRLLVKNP 261 (281)
T ss_pred HHHHHHHHhccCc
Confidence 9999999999998
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=292.47 Aligned_cols=233 Identities=30% Similarity=0.452 Sum_probs=201.2
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
+.||+|+||+||+|.+..+++.||+|.++.... ..........|...+....+||||+++++++..++.+++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 468999999999999999999999999986532 1233455666777777677999999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-ccccccccccCc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVVEVKEIIGTP 174 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~ 174 (253)
++|..++.....+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.... .........+++
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence 9999999877779999999999999999999999999999999999999999999999999986432 122233456789
Q ss_pred cccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 175 ~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.|+|||++.+..++.++|+||+|+++|+|++|+.||.+.+..+.+..+.......+. .++.+++++|.+||+.||
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~~P 235 (316)
T cd05619 161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR----WLTREAKDILVKLFVREP 235 (316)
T ss_pred cccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHHHhccCH
Confidence 999999999889999999999999999999999999998888888777665544333 579999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=294.49 Aligned_cols=233 Identities=31% Similarity=0.489 Sum_probs=200.0
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
+.||+|+||+||+|.+..++..||+|++.+... .......+..|...+.+..+|+||+++++.+..++.++++|||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999976432 1222345556666555578999999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc-cccccccccCc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVEVKEIIGTP 174 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~ 174 (253)
++|.+.+.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++..... ........+++
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 160 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP 160 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence 99999998777889999999999999999999999999999999999999999999999999875322 22233456889
Q ss_pred cccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 175 ~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.|+|||++.+..++.++||||+|+++|+|++|+.||.+.+..+.+..+....... .+.+++++.++|.+||++||
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~~~p 235 (325)
T cd05602 161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL----KPNITNSARHLLEGLLQKDR 235 (325)
T ss_pred cccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCC----CCCCCHHHHHHHHHHcccCH
Confidence 9999999999999999999999999999999999999988888887776654433 34789999999999999987
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=292.64 Aligned_cols=233 Identities=34% Similarity=0.554 Sum_probs=203.1
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
+.||+|+||+||+|.+..++..||+|++.+.. ..........+|+..+....+|+||+++++++...+.+++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999998654 22334556677888887666899999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-ccccccccccCc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVVEVKEIIGTP 174 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~ 174 (253)
++|...+.....+++..+..++.|++.++.|||++|++|+||+|+||+++.++.++|+|||++.... .........+++
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~ 160 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence 9999998877789999999999999999999999999999999999999999999999999886422 222223346788
Q ss_pred cccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 175 ~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.|+|||++.+..++.++|+||+|+++|+|++|+.||.+.+.......+.......+. .+++++.++|++||+.||
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~dP 235 (318)
T cd05570 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSKEAKSILKSFLTKNP 235 (318)
T ss_pred cccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----cCCHHHHHHHHHHccCCH
Confidence 999999999999999999999999999999999999998888888877766555443 679999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=292.07 Aligned_cols=240 Identities=38% Similarity=0.621 Sum_probs=222.4
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc-hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS-MDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
|++.+.||+|.||.||.|..+.+|..+|+|++.+.... ......+.+|+.+++....||||+.+.+.|+..+.+++|||
T Consensus 37 Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmE 116 (382)
T KOG0032|consen 37 YELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVME 116 (382)
T ss_pred EEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEE
Confidence 44999999999999999999999999999999876642 23467899999999977679999999999999999999999
Q ss_pred ccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC----CceEEEeecccccccccccc
Q psy12709 92 MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD----NNIKLCDFGISRVVNDVVEV 167 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~----~~~~l~df~~~~~~~~~~~~ 167 (253)
++.||.|.+.+... .+++..+..+++|++.+++|||+.|++|+|++|+|+++... +.++++|||++.........
T Consensus 117 L~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~ 195 (382)
T KOG0032|consen 117 LCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERL 195 (382)
T ss_pred ecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceE
Confidence 99999999988766 49999999999999999999999999999999999999754 47999999999987776677
Q ss_pred cccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~ 247 (253)
...+|++.|+|||++....++...||||+|+++|.|++|..||.+.+.......|..+.+.+.......+|+.++++|..
T Consensus 196 ~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ 275 (382)
T KOG0032|consen 196 HTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRK 275 (382)
T ss_pred eeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHH
Confidence 78899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcccCC
Q psy12709 248 CLVTDP 253 (253)
Q Consensus 248 ~l~~dP 253 (253)
||..||
T Consensus 276 ll~~dp 281 (382)
T KOG0032|consen 276 LLEFDP 281 (382)
T ss_pred hcccCc
Confidence 999998
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=295.42 Aligned_cols=232 Identities=30% Similarity=0.485 Sum_probs=201.5
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
+.||+|+||+||+|.+..++..||+|++.+... .........+|+..+. ..+|+||+++++.+..++.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~-~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ-NSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 468999999999999999999999999986542 2234456677877776 78999999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCceEEEeeccccccc-ccccccccccC
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVVEVKEIIGT 173 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~ 173 (253)
++|...+.....+++..+..++.|++.|+.|||+ .|++|+||+|+||+++.++.++|+|||++.... .........++
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 159 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence 9999988877789999999999999999999997 799999999999999999999999999986432 22223344688
Q ss_pred ccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 174 PDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 174 ~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+.|+|||++.+..++.++|+||+|+++|+|++|+.||.+.+.......+.......+. .+++++.++|.+||+.||
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~~dP 235 (325)
T cd05594 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGLLKKDP 235 (325)
T ss_pred cccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHhhcCH
Confidence 9999999999889999999999999999999999999988887777777666555544 689999999999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=298.01 Aligned_cols=237 Identities=27% Similarity=0.425 Sum_probs=199.5
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
|++++.||+|+||+||+|.+..++..||+|++.+.. ........+.+|+..+. ..+|+||+++++.+..++.+++|||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~-~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILA-EADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHH-hcCCCCeeeeEEEEecCCEEEEEEe
Confidence 449999999999999999999999999999998654 23344567888888887 7799999999999999999999999
Q ss_pred ccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc------
Q psy12709 92 MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV------ 165 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~------ 165 (253)
|++|++|.+++.....+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 99999999999877889999999999999999999999999999999999999999999999999875321000
Q ss_pred ------------------------------------------cccccccCccccCccccCCCCCCccccHHHHHHHHHHH
Q psy12709 166 ------------------------------------------EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVL 203 (253)
Q Consensus 166 ------------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l 203 (253)
......+++.|+|||++.+..++.++||||+||++|+|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el 241 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence 01123578999999999888899999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcc
Q psy12709 204 LSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLV 250 (253)
Q Consensus 204 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (253)
++|+.||...+..+....+.........+....+++++.+||.+|+.
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~ 288 (381)
T cd05626 242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCC 288 (381)
T ss_pred HhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHcc
Confidence 99999998887776666665433322222223689999999999553
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=296.92 Aligned_cols=235 Identities=24% Similarity=0.394 Sum_probs=207.8
Q ss_pred eeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEE
Q psy12709 11 YQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVL 90 (253)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 90 (253)
....+++.||+|.||.||.|..+ ....|++|.+....-. ..++.+|+.++. .+.|++||++++++..++.+++||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~---~~~f~~Ea~iMk-~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMS---PEAFLREAQIMK-KLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccC---hhHHHHHHHHHH-hCcccCeEEEEEEEecCCceEEEE
Confidence 33447789999999999999987 3346899988764333 246779999998 889999999999999998999999
Q ss_pred eccCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc--cc
Q psy12709 91 EMVPDGELQRLVDI--QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV--VE 166 (253)
Q Consensus 91 e~~~g~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~--~~ 166 (253)
||++.|+|.++++. ...++..+++.++.|++.+++||++++++|||+.++||+|++++.+||+|||+++...+. ..
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 99999999999987 455899999999999999999999999999999999999999999999999999965433 22
Q ss_pred ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 167 VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
.........|+|||.+....++.++||||+|++|||++| |+.||.+.+..++...+.++...+... .+|+++.+++
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~---~CP~~vY~lM 437 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPE---GCPDEVYELM 437 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCC---CCCHHHHHHH
Confidence 333455679999999999999999999999999999999 999999999999999999998877664 8999999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
..||+.+|
T Consensus 438 ~~CW~~~P 445 (468)
T KOG0197|consen 438 KSCWHEDP 445 (468)
T ss_pred HHHhhCCc
Confidence 99999988
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=293.09 Aligned_cols=233 Identities=30% Similarity=0.478 Sum_probs=197.0
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
+.||+|+||+||+|.+..+++.||+|++++... .......+.+|...+....+|+||+++++.+..++.+++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 368999999999999999999999999987542 2334556778888888777899999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccc-cccccccccccCc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV-NDVVEVKEIIGTP 174 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~-~~~~~~~~~~~~~ 174 (253)
++|...+.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++... ..........+++
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence 999998887788999999999999999999999999999999999999999999999999998642 2222333456889
Q ss_pred cccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDN---------KQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 175 ~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
.|+|||++.+..++.++|+||+|+++|+|++|+.||.... .......+.......+ ..++.++.++|
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li 236 (329)
T cd05588 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKASSVL 236 (329)
T ss_pred cccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence 9999999999899999999999999999999999996321 1223344444444333 36899999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
.+||+.||
T Consensus 237 ~~~L~~dP 244 (329)
T cd05588 237 KGFLNKDP 244 (329)
T ss_pred HHHhccCH
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=298.21 Aligned_cols=239 Identities=28% Similarity=0.443 Sum_probs=202.1
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
|++++.||+|+||+||+|.+..+++.||+|++.+... .......+.+|+..+. ..+|++|+++++.+..++.+++|||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~-~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILA-EADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHH-hCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 4499999999999999999999999999999976432 2344567888888887 7799999999999999999999999
Q ss_pred ccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-------
Q psy12709 92 MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV------- 164 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~------- 164 (253)
|++|++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.+|.++|+|||++......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 9999999999887777999999999999999999999999999999999999999999999999987432100
Q ss_pred -----------------------------------------ccccccccCccccCccccCCCCCCccccHHHHHHHHHHH
Q psy12709 165 -----------------------------------------VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVL 203 (253)
Q Consensus 165 -----------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l 203 (253)
.......+++.|+|||++.+..++.++|+||+||++|+|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence 001123578899999999988999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 204 LSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 204 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
++|+.||.+.+..+....+.........+....+++++.++|.+|+. ||
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p 290 (382)
T cd05625 242 LVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GP 290 (382)
T ss_pred HhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHcc-CH
Confidence 99999999888777776666544443333335789999999998764 55
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=292.47 Aligned_cols=233 Identities=30% Similarity=0.459 Sum_probs=199.6
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
+.||+|+||+||+|.+..++..|++|++.+... .......+..|...+.+..+|+||+++++.+...+..++||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 468999999999999999999999999976432 2233445666666555588999999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-ccccccccccCc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVVEVKEIIGTP 174 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~ 174 (253)
++|...+.....+++..+..++.|++.++.|||++|++|+||+|+||+++.++.++|+|||++.... .........+++
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP 160 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence 9999888777779999999999999999999999999999999999999999999999999887532 222233446789
Q ss_pred cccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 175 ~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.|+|||++.+..++.++|+||+|+++|+|++|+.||...+....+..+.......+ ...+.++.++|.+||+.||
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~~p 235 (321)
T cd05603 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLHKDQ 235 (321)
T ss_pred ccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccCCH
Confidence 99999999888899999999999999999999999998888777777766544333 3679999999999999987
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=299.28 Aligned_cols=240 Identities=28% Similarity=0.420 Sum_probs=202.3
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
+|+ +++.||+|+||+||+|.+..+++.||+|++.+... .......+.+|+..+. ..+|+||+++++.+..++.+++
T Consensus 2 ~y~--~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~h~~iv~~~~~~~~~~~~~l 78 (376)
T cd05598 2 MFV--KIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILA-EADNEWVVKLYYSFQDKDNLYF 78 (376)
T ss_pred Cce--EEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHH-hCCCCCcceEEEEEEcCCEEEE
Confidence 455 99999999999999999999999999999876432 2233566778888887 7799999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc----
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV---- 164 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~---- 164 (253)
||||++|++|.+++.....+++..++.++.|++.|++|||++|++|+||+|+||+++.++.++|+|||++..+...
T Consensus 79 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 9999999999999988788999999999999999999999999999999999999999999999999987432100
Q ss_pred ----------------------------------------ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHH
Q psy12709 165 ----------------------------------------VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLL 204 (253)
Q Consensus 165 ----------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~ 204 (253)
.......+++.|+|||++.+..++.++||||+||++|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 0011235788999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 205 SSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 205 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+|+.||...+..+....+.........+....+++++.++|.+|+. ||
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~-~p 286 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCC-GA 286 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhc-CH
Confidence 9999999888777766665544433333334789999999999764 55
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=296.95 Aligned_cols=237 Identities=29% Similarity=0.473 Sum_probs=219.5
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe-EEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE-MVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-~~lv~e 91 (253)
|+.++.+|+|+||.++++.++.+++.|++|.+...............|+..+. .+.||||+.+.+.|..++. .+++|+
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis-~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLS-KLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHH-hccCCCeeeeccchhcCCceEEEEEe
Confidence 33899999999999999999999999999999988877777778899999998 5999999999999999998 999999
Q ss_pred ccCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-ccc
Q psy12709 92 MVPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVK 168 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~ 168 (253)
|++||++.+.+.... .++++.+..++.|++.|+.|||++.|+|||+++.|||++.++.|+|+|||+++..+... ...
T Consensus 85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~ 164 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLAS 164 (426)
T ss_pred ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhh
Confidence 999999999887654 48999999999999999999999999999999999999999999999999999888765 566
Q ss_pred ccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 169 EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
...|++.|++||.+.+.+|..++|||||||++|||++-+++|.+.+......+|......+.. ..+|.+++.+|+.|
T Consensus 165 tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~el~~lv~~~ 241 (426)
T KOG0589|consen 165 TVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSSELRSLVKSM 241 (426)
T ss_pred eecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccHHHHHHHHHH
Confidence 778999999999999999999999999999999999999999999999999998888755444 48999999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|+.+|
T Consensus 242 l~~~P 246 (426)
T KOG0589|consen 242 LRKNP 246 (426)
T ss_pred hhcCC
Confidence 99998
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=291.20 Aligned_cols=233 Identities=28% Similarity=0.427 Sum_probs=200.8
Q ss_pred EeecCCCCceEEEEEEec---cCCceEEEEEeccccc--chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEE
Q psy12709 16 FCMPSRGKFASVRKCTHK---ITKVEYAAKFIRKRRR--SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVL 90 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 90 (253)
++.||+|+||.||++.+. .+++.||+|++..... .......+.+|+..+. ..+|+||+++++.+..++.++++|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~-~l~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILE-AVKHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHH-hCCCCchhceeeEEecCCeEEEEE
Confidence 368999999999999864 4688999999876432 2233456678888887 789999999999999999999999
Q ss_pred eccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc-cccccc
Q psy12709 91 EMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVEVKE 169 (253)
Q Consensus 91 e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~-~~~~~~ 169 (253)
||++|++|.+.+.....+++..+..++.|++.++.|||++|++|+||+|+||+++.++.++|+|||++..... ......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT 159 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccc
Confidence 9999999999998888889999999999999999999999999999999999999999999999999864322 222334
Q ss_pred cccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 170 IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
..+++.|+|||++.+..++.++||||+|+++|+|++|+.||...+.......+.......+ +.+++++.++|.+||
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l 235 (323)
T cd05584 160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLLKKLL 235 (323)
T ss_pred cCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHc
Confidence 4688999999999888889999999999999999999999999888887777777655443 377999999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
++||
T Consensus 236 ~~~p 239 (323)
T cd05584 236 KRNP 239 (323)
T ss_pred ccCH
Confidence 9997
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=286.03 Aligned_cols=241 Identities=29% Similarity=0.520 Sum_probs=200.1
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
+|+ +.+.||+|+||+||+|.++.++..|++|++............+.+|+..+. ..+|+||+++++++..++.+++|
T Consensus 2 ~y~--~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 2 KFE--VLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLR-TLKQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred Cce--EEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHH-hCCCccccchhhhEecCCEEEEE
Confidence 455 999999999999999999999999999999876544444567788998887 77999999999999999999999
Q ss_pred EeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc--cc
Q psy12709 90 LEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV--EV 167 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~ 167 (253)
|||++++.+..+......+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 9999988777666556679999999999999999999999999999999999999999999999999987653321 22
Q ss_pred cccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc-----------------
Q psy12709 168 KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH----------------- 230 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----------------- 230 (253)
....+++.|+|||++.+..++.++|+||+|+++|+|++|+.||.+.+..+....+.....+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 234578899999999888899999999999999999999999988766555444332211110
Q ss_pred -----------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 -----------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 -----------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
......+|.++.+||++||++||
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P 272 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNP 272 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCc
Confidence 00112378899999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=294.66 Aligned_cols=233 Identities=28% Similarity=0.457 Sum_probs=203.5
Q ss_pred EeecCCCCceEEEEEEec---cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 16 FCMPSRGKFASVRKCTHK---ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
++.||+|+||.||++.+. .++..||+|++.+............+|+..+. ..+|+||+++++.+..++.+++||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILA-EVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHH-hCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 367999999999999864 57899999999876544444556778888877 77899999999999999999999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-ccccccc
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEVKEII 171 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~ 171 (253)
+++++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+...... .......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 159 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC 159 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceeccc
Confidence 999999999987778999999999999999999999999999999999999999999999999998754332 2333456
Q ss_pred cCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhccc
Q psy12709 172 GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251 (253)
Q Consensus 172 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (253)
+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+..+....+.......+. .+++++.++|++||++
T Consensus 160 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~l~~ 235 (318)
T cd05582 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRALFKR 235 (318)
T ss_pred CChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhc
Confidence 789999999998888899999999999999999999999998888888777776655443 6899999999999999
Q ss_pred CC
Q psy12709 252 DP 253 (253)
Q Consensus 252 dP 253 (253)
||
T Consensus 236 ~P 237 (318)
T cd05582 236 NP 237 (318)
T ss_pred CH
Confidence 98
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=295.65 Aligned_cols=241 Identities=32% Similarity=0.474 Sum_probs=202.6
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
++|+ +.+.||+|+||+||+|.+..++..||+|++.+... .......+.+|+..+. ..+|+||+++++.+..++.++
T Consensus 43 ~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~-~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 43 EDFD--VIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA-HANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred HHcE--EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHH-hCCCCCcceEEEEEecCCEEE
Confidence 4555 99999999999999999999999999999976432 2223345667788777 789999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc--
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-- 165 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-- 165 (253)
+||||++|++|.+++.. ..+++..+..++.|++.|++|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 99999999999998864 458899999999999999999999999999999999999999999999999987654321
Q ss_pred cccccccCccccCccccCCC----CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYE----PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQA 241 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 241 (253)
......+++.|+|||++.+. .++.++|+||+||++|+|++|+.||.+.+....+..+.........+....+|.++
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 22345688999999998654 37889999999999999999999999988888888877654333333334689999
Q ss_pred HHHHHHhcccCC
Q psy12709 242 KDFIQSCLVTDP 253 (253)
Q Consensus 242 ~~li~~~l~~dP 253 (253)
+++|++||+.+|
T Consensus 279 ~~li~~~L~~~p 290 (370)
T cd05596 279 KDLICAFLTDRE 290 (370)
T ss_pred HHHHHHHccChh
Confidence 999999998776
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=281.20 Aligned_cols=243 Identities=28% Similarity=0.459 Sum_probs=209.9
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe----
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET---- 82 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~---- 82 (253)
+..+|. .++.||+|++|.|..|.++.+|..||+|++.......-..++..+|+..++ ..+|+||+.+.+++..
T Consensus 20 i~~~y~--~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr-~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 20 IPRYYV--LIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLR-HLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred ccceec--ccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHH-HhcCCCcceEEeeccccccc
Confidence 344444 689999999999999999999999999999988877788899999999998 7779999999999876
Q ss_pred -CCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 83 -PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 83 -~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
-..+|+|+|+| +.+|...++.+..++..++..++.|++.|++|+|+.+++|||+||.|++++.+..+||+|||+++..
T Consensus 97 ~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 34799999999 7799999998888999999999999999999999999999999999999999999999999999977
Q ss_pred cc---cccccccccCccccCcccc-CCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc-------
Q psy12709 162 ND---VVEVKEIIGTPDYVAPEVL-SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH------- 230 (253)
Q Consensus 162 ~~---~~~~~~~~~~~~~~~PE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~------- 230 (253)
.. .........|.+|.|||++ +...|+.+.||||+||+++||++|++.|++.+.-+.+..|...-.++.
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 53 2222345668899999996 556899999999999999999999999999877766655544333332
Q ss_pred --------------------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 --------------------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 --------------------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+..+++..+|+.+||..||
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP 298 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDP 298 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCc
Confidence 23457889999999999999998
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=290.85 Aligned_cols=233 Identities=30% Similarity=0.465 Sum_probs=196.8
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
+.||+|+||+||+|.+..++..||+|++.+... .......+.+|+..+....+|+||+++++++..++.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 468999999999999999999999999987542 3344556778888888777999999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-ccccccccccCc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVVEVKEIIGTP 174 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~ 174 (253)
++|...+.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.... .........+++
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence 9999988877889999999999999999999999999999999999999999999999999987532 222233456789
Q ss_pred cccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGD---------NKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 175 ~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---------~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
.|+|||++.+..++.++|+||+|+++|+|++|+.||... ........+.......+ ..++.++.++|
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll 236 (329)
T cd05618 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAASVL 236 (329)
T ss_pred cccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCHHHHHHH
Confidence 999999999999999999999999999999999999521 11223334444444333 37899999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
++||+.||
T Consensus 237 ~~~L~~dP 244 (329)
T cd05618 237 KSFLNKDP 244 (329)
T ss_pred HHHhcCCH
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=295.87 Aligned_cols=238 Identities=29% Similarity=0.463 Sum_probs=201.8
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
++++.||+|+||+||+|.+..+++.||+|++.... ........+.+|+..+. ..+|++|+++++.+..++.+++||||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILV-EADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHH-hCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 39999999999999999999999999999997643 22344567777888877 77999999999999999999999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-------
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV------- 165 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~------- 165 (253)
++|++|.+++.....+++..++.++.|++.++.|||++|++|+||+|+||+++.+|.++|+|||++.......
T Consensus 83 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~ 162 (360)
T cd05627 83 LPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRN 162 (360)
T ss_pred CCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccc
Confidence 9999999999888889999999999999999999999999999999999999999999999999886432110
Q ss_pred -----------------------------cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH
Q psy12709 166 -----------------------------EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ 216 (253)
Q Consensus 166 -----------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 216 (253)
......+++.|+|||++.+..++.++|+||+||++|+|++|+.||.+.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~ 242 (360)
T cd05627 163 LTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242 (360)
T ss_pred cccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHH
Confidence 011235789999999999999999999999999999999999999998888
Q ss_pred HHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 217 ETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 217 ~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+..+.........+....++++++++|.+|+. ||
T Consensus 243 ~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p 278 (360)
T cd05627 243 ETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DS 278 (360)
T ss_pred HHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-Ch
Confidence 8887776543322222223579999999999764 55
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=291.71 Aligned_cols=233 Identities=30% Similarity=0.463 Sum_probs=200.8
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
+.||+|+||+||+|.+..++..||+|++.+... .......+..|...+.+..+|+||+++++.+..++.+++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 468999999999999999999999999976532 2233455666666666688999999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-ccccccccccCc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVVEVKEIIGTP 174 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~ 174 (253)
++|...+.....+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.... .........+++
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP 160 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence 9999988878889999999999999999999999999999999999999999999999999987432 222233456889
Q ss_pred cccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 175 ~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.|+|||++.+..++.++|+||+|+++|+|++|+.||...+..+.+..+....... .+..+..+.++|.+||+.||
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ll~~ll~~~p 235 (325)
T cd05604 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVL----RPGASLTAWSILEELLEKDR 235 (325)
T ss_pred hhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccC----CCCCCHHHHHHHHHHhccCH
Confidence 9999999999899999999999999999999999999988888877776654333 24689999999999999987
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=289.55 Aligned_cols=233 Identities=30% Similarity=0.468 Sum_probs=197.5
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
+.||+|+||+||+|.+..++..||+|++.+... .......+.+|+..+.+..+|++|+.+++.+...+.+++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999987542 2344567788888888778899999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-ccccccccccCc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVVEVKEIIGTP 174 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~ 174 (253)
++|...+.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.... .........+++
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence 9999988877789999999999999999999999999999999999999999999999999887432 222333456889
Q ss_pred cccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHhhcccccccCCccCCCCHHHHHHHHH
Q psy12709 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGD-------NKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247 (253)
Q Consensus 175 ~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-------~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~ 247 (253)
.|+|||++.+..++.++|+||+|+++|+|++|+.||... .....+..+.......+ ..+|..+.++|.+
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~ 236 (327)
T cd05617 161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVKASHVLKG 236 (327)
T ss_pred ccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHHHHHHHHH
Confidence 999999999999999999999999999999999999532 22233344444333332 3689999999999
Q ss_pred hcccCC
Q psy12709 248 CLVTDP 253 (253)
Q Consensus 248 ~l~~dP 253 (253)
||+.||
T Consensus 237 ~L~~dP 242 (327)
T cd05617 237 FLNKDP 242 (327)
T ss_pred HhccCH
Confidence 999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=282.80 Aligned_cols=240 Identities=27% Similarity=0.416 Sum_probs=198.8
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch-HHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM-DQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
|++.+.||+|+||+||++.+..++..||+|++....... .....+.+|+..+. ..+|++|+++++.+..++.++++||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE-KVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHH-hcCCCCEeeeeeeecCCCeEEEEEe
Confidence 449999999999999999999999999999987644222 22345677888887 6799999999999999999999999
Q ss_pred ccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccc
Q psy12709 92 MVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE 169 (253)
Q Consensus 92 ~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (253)
|+.+++|.+.+... ..+++..+..++.|++.++.|||+.|++|+||+|+||++++++.++|+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 99999998877543 4589999999999999999999999999999999999999999999999999876544333334
Q ss_pred cccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 170 IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
..+++.|+|||++.+..++.++|+||+|+++|++++|+.||.+.........+.......+......+++.+.++|.+||
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 240 (285)
T cd05605 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL 240 (285)
T ss_pred ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHc
Confidence 46788999999998888999999999999999999999999886654433333222111222233468999999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
+.||
T Consensus 241 ~~~P 244 (285)
T cd05605 241 TKDP 244 (285)
T ss_pred cCCH
Confidence 9998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=293.29 Aligned_cols=240 Identities=30% Similarity=0.471 Sum_probs=201.6
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
.++|+ +.+.||+|+||.||+|.++.+++.||+|++.+... .......+.+|+..+. ..+|+||+++++.+..++.+
T Consensus 42 ~~~y~--i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~-~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 42 AEDYE--VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred hhhcE--EEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHH-hCCCCCCCeEEEEEEcCCEE
Confidence 35666 99999999999999999999999999999875432 2223345566777666 88999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV- 165 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~- 165 (253)
++||||++|++|.+++... .+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 9999999999999998754 58999999999999999999999999999999999999999999999999987654321
Q ss_pred -cccccccCccccCccccCCCC----CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHH
Q psy12709 166 -EVKEIIGTPDYVAPEVLSYEP----ISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 166 -~~~~~~~~~~~~~PE~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
......+++.|+|||++.+.. ++.++|+||+|+++|+|++|..||.+.+....+..+.........+....++++
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 277 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence 223456899999999986543 778999999999999999999999998888888887765433333333578999
Q ss_pred HHHHHHHhccc
Q psy12709 241 AKDFIQSCLVT 251 (253)
Q Consensus 241 l~~li~~~l~~ 251 (253)
++++|.+||+.
T Consensus 278 ~~~li~~~L~~ 288 (371)
T cd05622 278 AKNLICAFLTD 288 (371)
T ss_pred HHHHHHHHcCC
Confidence 99999999973
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=274.20 Aligned_cols=239 Identities=32% Similarity=0.544 Sum_probs=221.0
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccc------cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR------RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
-.+.+|.|..++|.++.++.++..+++|++.... ....-.+...+|+.++++...||+|+++.++++.+.-+++
T Consensus 21 pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~Fl 100 (411)
T KOG0599|consen 21 PKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFL 100 (411)
T ss_pred hHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhh
Confidence 6689999999999999999999999999986433 1222346677889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccccc
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK 168 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 168 (253)
|+|.|+.|.|.+++.....+++.+.+.+++|++.+++|||.++|+|+|++|+||+++++.+++|+|||+++.........
T Consensus 101 VFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLr 180 (411)
T KOG0599|consen 101 VFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLR 180 (411)
T ss_pred hhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCchhHH
Confidence 99999999999999988889999999999999999999999999999999999999999999999999999888888888
Q ss_pred ccccCccccCccccCC------CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHH
Q psy12709 169 EIIGTPDYVAPEVLSY------EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAK 242 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~ 242 (253)
..+|+|.|+|||.+.. ..|+.+.|+|++|+++|.++.|-+||-.....-++..|..++.++..+..-++|.+.+
T Consensus 181 elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~K 260 (411)
T KOG0599|consen 181 ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVK 260 (411)
T ss_pred HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHH
Confidence 8999999999999844 3578899999999999999999999999999999999999999999988899999999
Q ss_pred HHHHHhcccCC
Q psy12709 243 DFIQSCLVTDP 253 (253)
Q Consensus 243 ~li~~~l~~dP 253 (253)
+||++||+.||
T Consensus 261 dLIsrlLqVdp 271 (411)
T KOG0599|consen 261 DLISRLLQVDP 271 (411)
T ss_pred HHHHHHHeeCc
Confidence 99999999998
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=292.96 Aligned_cols=241 Identities=28% Similarity=0.462 Sum_probs=201.7
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
.++|+ +.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+..+. ..+|+||+++++.+..++.+
T Consensus 42 ~~~y~--~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~-~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 42 AEDYD--VVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred HHHCe--EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHH-hCCCCCEeeEEEEEEcCCEE
Confidence 35566 99999999999999999999999999999876432 2223345667777776 88999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV- 165 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~- 165 (253)
++||||++|++|.+++... .+++..+..++.|++.|++|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 9999999999999998754 58999999999999999999999999999999999999999999999999997654322
Q ss_pred -cccccccCccccCccccCCCC----CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHH
Q psy12709 166 -EVKEIIGTPDYVAPEVLSYEP----ISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 166 -~~~~~~~~~~~~~PE~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
......+++.|+|||++.+.. ++.++|+||+|+++|+|++|+.||.+.+....+..+.........+....++..
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 277 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence 123456899999999986543 678999999999999999999999998888888877765433332222467999
Q ss_pred HHHHHHHhcccC
Q psy12709 241 AKDFIQSCLVTD 252 (253)
Q Consensus 241 l~~li~~~l~~d 252 (253)
++++|..||+.+
T Consensus 278 ~~~li~~~L~~~ 289 (370)
T cd05621 278 AKNLICAFLTDR 289 (370)
T ss_pred HHHHHHHHccCc
Confidence 999999999744
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=290.12 Aligned_cols=237 Identities=29% Similarity=0.436 Sum_probs=195.9
Q ss_pred eEEEeecCCCCceEEEEEEec---cCCceEEEEEeccccc--chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHK---ITKVEYAAKFIRKRRR--SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
|++.+.||+|+||+||++.+. .++..||+|++.+... ..........|+..+....+|++|+++++.+..++.++
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 449999999999999999874 4688999999876432 22334567788888886668999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc--c
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV--V 165 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~--~ 165 (253)
++|||+++++|.+.+..+..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 82 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~ 161 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE 161 (332)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC
Confidence 99999999999999887788999999999999999999999999999999999999999999999999998754321 2
Q ss_pred cccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHhhcccccccCCccCCCCHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDN----KQETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
......+++.|+|||++.+. .++.++||||+|+++|+|++|+.||.... .......+....... ...+++.
T Consensus 162 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 237 (332)
T cd05614 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF----PSFIGPE 237 (332)
T ss_pred ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC----CCCCCHH
Confidence 22334688999999998765 47889999999999999999999996532 223333343333322 2378999
Q ss_pred HHHHHHHhcccCC
Q psy12709 241 AKDFIQSCLVTDP 253 (253)
Q Consensus 241 l~~li~~~l~~dP 253 (253)
++++|.+||+.||
T Consensus 238 ~~~li~~~l~~dp 250 (332)
T cd05614 238 AQDLLHKLLRKDP 250 (332)
T ss_pred HHHHHHHHcCCCH
Confidence 9999999999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=290.91 Aligned_cols=240 Identities=29% Similarity=0.454 Sum_probs=202.3
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
+|+ +.+.||+|+||+||+|.+..+++.||+|++.+... .......+.+|+..+. ..+|++|+++++.+..++.+++
T Consensus 2 ~y~--~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~-~~~~~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 2 DFD--VKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS-ISNSPWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred Cce--EEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCCCcceeeEEecCCeEEE
Confidence 455 99999999999999999999999999999986543 2334456667777776 7899999999999999999999
Q ss_pred EEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc-
Q psy12709 89 VLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE- 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~- 166 (253)
||||+++++|.+++... ..+++..+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999999999875 6799999999999999999999999999999999999999999999999999976543221
Q ss_pred -ccccccCccccCccccC------CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCH
Q psy12709 167 -VKEIIGTPDYVAPEVLS------YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 167 -~~~~~~~~~~~~PE~~~------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
.....+++.|+|||++. ...++.++||||+|+++|+|++|+.||...+....+..+.........+....+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 22346788999999986 45677899999999999999999999998888777777765433222222346899
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
++.+||.+||+ ||
T Consensus 239 ~~~~li~~ll~-~p 251 (330)
T cd05601 239 DFLDLIQSLLC-GQ 251 (330)
T ss_pred HHHHHHHHHcc-Ch
Confidence 99999999997 76
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=290.97 Aligned_cols=232 Identities=30% Similarity=0.510 Sum_probs=197.9
Q ss_pred cCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhc--CCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 19 PSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQ--KSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 19 lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~--~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
||+|+||+||+|.+..++..||+|++.+... ..........|...+.... +|++|+.+++.+..++.+++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999999875432 2233444555666666455 899999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc-cccccccccCc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVEVKEIIGTP 174 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~ 174 (253)
++|.+.+.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++..... ........+++
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence 99999988888899999999999999999999999999999999999999999999999999875322 22233456889
Q ss_pred cccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 175 DYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 175 ~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.|+|||++.+. .++.++||||+|+++|+|++|+.||.+.+..+.+..+.......+. ..+++++.++|++||++||
T Consensus 161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~~L~~~P 237 (330)
T cd05586 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLLNRNP 237 (330)
T ss_pred cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCCCH
Confidence 99999998654 4789999999999999999999999998888888877766655544 2579999999999999998
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=289.42 Aligned_cols=239 Identities=31% Similarity=0.529 Sum_probs=224.4
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.|=|. +.+.||+|.|+.|-+|.+.-+|..||||++.++........+++.|+..+. +..|||||++|++......+|
T Consensus 17 AGLYD--LekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMK-LVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 17 AGLYD--LEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMK-LVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred eeeeh--hhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHH-HhcCcCeeeeeehhcccceEE
Confidence 44566 889999999999999999999999999999999988888899999999998 999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-CCceEEEeecccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK-DNNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~-~~~~~l~df~~~~~~~~~~ 165 (253)
+|.|.-++|+|.+++-++ .++++...+.+..||+.|+.|+|+..++|+|++|+||++.+ -|.|||.|||++..+....
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999999988765 57999999999999999999999999999999999998776 5899999999998888888
Q ss_pred cccccccCccccCccccCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPIS-LATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
.....+|...|-|||++.+..|+ ++.||||||+++|.+.+|++||+..++.+.+-.|..|+.+.|. .+|.+.++|
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hvS~eCrdL 249 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HVSKECRDL 249 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hhhHHHHHH
Confidence 88888999999999999999885 6899999999999999999999999999999999999999988 789999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|..||..||
T Consensus 250 I~sMLvRdP 258 (864)
T KOG4717|consen 250 IQSMLVRDP 258 (864)
T ss_pred HHHHHhcCc
Confidence 999999998
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=277.79 Aligned_cols=235 Identities=31% Similarity=0.529 Sum_probs=206.1
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
+|+ +.+.||+|++|.||++.+..+++.+++|.+..... .......+.+|+..+. ..+|+||+++++++..++.+++
T Consensus 2 ~y~--~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~ 78 (290)
T cd05580 2 DFE--FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQ-SIRHPFLVNLYGSFQDDSNLYL 78 (290)
T ss_pred ceE--EEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCCccceeeEEEcCCeEEE
Confidence 455 99999999999999999999999999999876432 2344567888888887 6679999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccccc
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK 168 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 168 (253)
+|||+++++|.+++.....+++..+..++.|++.++.+||++|++|+||+|.||+++.++.++|+|||.+...... ..
T Consensus 79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~ 156 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TY 156 (290)
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CC
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998765443 23
Q ss_pred ccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 169 EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
...+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+.......+..+....+. .+++.++++|++|
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~ 232 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDLIRNL 232 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc----cCCHHHHHHHHHH
Confidence 345788999999998888899999999999999999999999888877777777665554443 6699999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|+.||
T Consensus 233 l~~~p 237 (290)
T cd05580 233 LQVDL 237 (290)
T ss_pred ccCCH
Confidence 99997
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=273.12 Aligned_cols=239 Identities=27% Similarity=0.384 Sum_probs=206.0
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--CeEEEEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP--HEMVLVL 90 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~ 90 (253)
|+.+..|+.|+||.||+|+|+.+++.||+|.++.............+|+.++. ..+|+||+.+-++.... +.+|+||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl-~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILL-KARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHH-hcCCCCeeeeEEEEeccccceeeeeH
Confidence 44899999999999999999999999999999988766666678889999998 77799999999998865 4799999
Q ss_pred eccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-ccc
Q psy12709 91 EMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVK 168 (253)
Q Consensus 91 e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~ 168 (253)
|||+. +|..++.. ..+|...+++-++.|+++|++|||.+.|+|||+|++|+++.+.|.+|++|||+++..+++. ...
T Consensus 157 e~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T 235 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYT 235 (419)
T ss_pred HHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccCc
Confidence 99966 88888876 4589999999999999999999999999999999999999999999999999999887653 344
Q ss_pred ccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCcc-------------
Q psy12709 169 EIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLF------------- 234 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~------------- 234 (253)
...-+.+|.|||.+.+. .|+.+.|+||+||++.+++++++.|++.+.-+...+|-..-.++.+...
T Consensus 236 ~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~ 315 (419)
T KOG0663|consen 236 PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMT 315 (419)
T ss_pred ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccc
Confidence 55678999999998665 5899999999999999999999999999998888877554333332211
Q ss_pred -------------C--CCCHHHHHHHHHhcccCC
Q psy12709 235 -------------G--HISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 235 -------------~--~~~~~l~~li~~~l~~dP 253 (253)
. .+++...+|+..+|..||
T Consensus 316 f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP 349 (419)
T KOG0663|consen 316 FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDP 349 (419)
T ss_pred cCCCCchhhhhhccccccchhHHHHHHHHhccCc
Confidence 1 145888999999999988
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=278.18 Aligned_cols=234 Identities=28% Similarity=0.471 Sum_probs=191.2
Q ss_pred cCCCCceEEEEEEeccCCceEEEEEecccccc-hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCCc
Q psy12709 19 PSRGKFASVRKCTHKITKVEYAAKFIRKRRRS-MDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGE 97 (253)
Q Consensus 19 lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 97 (253)
||+|+||+||+|.+..+++.|++|.+...... ......+..|+..+. ..+|++|+++.+++..++.++++|||++|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILA-KVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHH-hCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 79999999999999999999999998765422 223456677888887 7799999999999999999999999999999
Q ss_pred HHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-cccccccc
Q psy12709 98 LQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEVKEIIG 172 (253)
Q Consensus 98 L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 172 (253)
|...+.. +..+++..++.++.|++.++.|||++|++|+||+|+||+++.++.++|+|||.+...... .......+
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g 159 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG 159 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence 9877632 345899999999999999999999999999999999999999999999999998755432 22233467
Q ss_pred CccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccC
Q psy12709 173 TPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTD 252 (253)
Q Consensus 173 ~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 252 (253)
++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...........+.......+......+|+++.+++.+||+.|
T Consensus 160 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (280)
T cd05608 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKD 239 (280)
T ss_pred CcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCC
Confidence 88999999999999999999999999999999999999765433222222211111222233468999999999999999
Q ss_pred C
Q psy12709 253 P 253 (253)
Q Consensus 253 P 253 (253)
|
T Consensus 240 P 240 (280)
T cd05608 240 P 240 (280)
T ss_pred H
Confidence 8
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=273.75 Aligned_cols=237 Identities=29% Similarity=0.441 Sum_probs=203.1
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCC-ceeeeeEEEeCC------eEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER-IVGLHEIYETPH------EMV 87 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~-i~~~~~~~~~~~------~~~ 87 (253)
.+++||.|+||+||+|.++.+|+.||+|++......+.......+|+..+. ..+|+| |+.+++++...+ .++
T Consensus 15 ~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk-~L~~~~~iv~L~dv~~~~~~~~~~~~l~ 93 (323)
T KOG0594|consen 15 KVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLK-RLSHANHIVRLHDVIHTSNNHRGIGKLY 93 (323)
T ss_pred HHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHH-HhCCCcceEEEEeeeeecccccccceEE
Confidence 778899999999999999999999999999887665445567889999998 777777 999999999887 899
Q ss_pred EEEeccCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQD----GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
+|+||+ ..+|..++...+ +++...++.+++|++.|++|||+++|+|||+||+|++++++|.+||.|||+++...-
T Consensus 94 lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i 172 (323)
T KOG0594|consen 94 LVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSI 172 (323)
T ss_pred EEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcC
Confidence 999999 558999887654 588899999999999999999999999999999999999999999999999997663
Q ss_pred c-ccccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCC---------
Q psy12709 164 V-VEVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHED--------- 232 (253)
Q Consensus 164 ~-~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~--------- 232 (253)
+ ........+..|.|||++.+. .|+...||||+||+++||++++..|++.++.+....|-+.-.++.++
T Consensus 173 p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~ 252 (323)
T KOG0594|consen 173 PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLP 252 (323)
T ss_pred CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccc
Confidence 3 345566788999999998776 78999999999999999999999999999988877765543333221
Q ss_pred -----------------ccCCCCHHHHHHHHHhcccCC
Q psy12709 233 -----------------LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 -----------------~~~~~~~~l~~li~~~l~~dP 253 (253)
..+..+++..+++.+||+.||
T Consensus 253 ~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p 290 (323)
T KOG0594|consen 253 DYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDP 290 (323)
T ss_pred cccccCcCCCCccchHHhccccCccHHHHHHHHhccCc
Confidence 113344689999999999987
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=280.87 Aligned_cols=206 Identities=28% Similarity=0.439 Sum_probs=181.3
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +.+.||+|+||.||++.+..++..+++|.+.... .......+.+|+..+. ..+|+||+++++++..++.++
T Consensus 4 ~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 4 DDDFE--RISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLH-ECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred cccce--EEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHH-HCCCCCCCeEEEEEEECCEEE
Confidence 35666 9999999999999999999999999999987643 2344567889999988 779999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCceEEEeeccccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDH-NITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE 166 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 166 (253)
++|||+++++|.+++.....+++..+..++.+++.++.|||++ +++|+||+|+||+++.++.++|+|||++...... .
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 158 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M 158 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-c
Confidence 9999999999999998877899999999999999999999986 5999999999999999999999999998755332 2
Q ss_pred ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy12709 167 VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQET 218 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 218 (253)
.....+++.|+|||++.+..++.++|+||+|+++|+|++|+.||...+..+.
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~ 210 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 2334678999999999988899999999999999999999999977655443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=285.14 Aligned_cols=239 Identities=26% Similarity=0.410 Sum_probs=193.8
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC-----CeEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP-----HEMV 87 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~ 87 (253)
|++.+.||+|+||.||+|.+..++..||+|.+............+.+|+..+. .++|+||+++++++... ..++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLR-LLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHH-hCCCCCEeeecceEeccCCCCCceEE
Confidence 45999999999999999999999999999998765444444567888999988 77999999999988543 2589
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc-
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE- 166 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~- 166 (253)
++|||+. ++|.+++.....+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 9999995 68988888777899999999999999999999999999999999999999999999999999875432111
Q ss_pred ---ccccccCccccCccccCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc-----------------
Q psy12709 167 ---VKEIIGTPDYVAPEVLSY--EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQ----------------- 224 (253)
Q Consensus 167 ---~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~----------------- 224 (253)
.....+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 123457889999999865 5788999999999999999999999987665433322211
Q ss_pred ----------ccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 225 ----------CNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 225 ----------~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..........+.+++++.++|.+||+.||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 278 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDP 278 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCc
Confidence 11111122234678899999999999998
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=284.33 Aligned_cols=239 Identities=21% Similarity=0.368 Sum_probs=191.1
Q ss_pred cceeeEEEeecCCCCceEEEEEEec-----cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHK-----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
++|+ +.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+..+....+|+||+++++++...
T Consensus 7 ~~~~--~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 7 DRLR--LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hHce--eeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 4555 9999999999999999753 345679999987543 2344567889999998676999999999988764
Q ss_pred -CeEEEEEeccCCCcHHHHHhhc---------------------------------------------------------
Q psy12709 84 -HEMVLVLEMVPDGELQRLVDIQ--------------------------------------------------------- 105 (253)
Q Consensus 84 -~~~~lv~e~~~g~~L~~~~~~~--------------------------------------------------------- 105 (253)
+.++++|||+++++|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999888642
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc---ccccccCcccc
Q psy12709 106 -----DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE---VKEIIGTPDYV 177 (253)
Q Consensus 106 -----~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~ 177 (253)
.+++...+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++........ .....+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 2377788899999999999999999999999999999999999999999999875432211 11223457899
Q ss_pred CccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHH-HHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 178 APEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETF-LNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 178 ~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
|||++.+..++.++||||+|+++|+|++ |..||.+....+.+ ..+..+.... ....+++++.++|.+||+.||
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR---APENATPEIYRIMLACWQGDP 318 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHccCCh
Confidence 9999988889999999999999999997 99999875544333 3333322211 224778999999999999998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=277.95 Aligned_cols=240 Identities=28% Similarity=0.404 Sum_probs=193.9
Q ss_pred eEEEeecCCCCceEEEEEEecc-CCceEEEEEecccccchHHHHHHHHHHHHHHHh--cCCCCceeeeeEEE-----eCC
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKI-TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLA--QKSERIVGLHEIYE-----TPH 84 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~--~~~~~i~~~~~~~~-----~~~ 84 (253)
|++++.||+|+||+||+|.+.. ++..||+|.+..............+|+..+... .+|+||+++++++. .+.
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 4499999999999999999864 467899999876544333334555677666543 47999999999885 245
Q ss_pred eEEEEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN 162 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~ 162 (253)
.+++++|+++ ++|.+++... ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEecc
Confidence 6999999996 5888887653 458999999999999999999999999999999999999999999999999987655
Q ss_pred ccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc------------
Q psy12709 163 DVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH------------ 230 (253)
Q Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~------------ 230 (253)
.........+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||.+.+..+....+......+.
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (290)
T cd07862 162 FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 241 (290)
T ss_pred CCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccc
Confidence 44444455678999999999888899999999999999999999999998887776666543221111
Q ss_pred -----------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 -----------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 -----------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+.+++.++++|.+||+.||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 275 (290)
T cd07862 242 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNP 275 (290)
T ss_pred hhccCCCCCCHHHHccCCCHHHHHHHHHHhccCc
Confidence 11234678899999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=283.97 Aligned_cols=240 Identities=29% Similarity=0.470 Sum_probs=199.4
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
+|+ +.+.||+|+||+||++.+..+++.||+|++.+.. ........+.+|...+. ..+|++|+.+++.+..++..++
T Consensus 2 ~y~--i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~l~~~~~~~~~~~l 78 (331)
T cd05624 2 DFE--IIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLV-NGDCQWITTLHYAFQDENYLYL 78 (331)
T ss_pred Cce--EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEcCCEEEE
Confidence 455 9999999999999999999999999999987643 22233445666666665 7899999999999999999999
Q ss_pred EEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc-
Q psy12709 89 VLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE- 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~- 166 (253)
||||++|++|.+++.. ...+++..+..++.|++.+++|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999999999976 45789999999999999999999999999999999999999999999999999876543222
Q ss_pred -ccccccCccccCccccCC-----CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc-CCccCCCCH
Q psy12709 167 -VKEIIGTPDYVAPEVLSY-----EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH-EDLFGHISS 239 (253)
Q Consensus 167 -~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~ 239 (253)
.....+++.|+|||++.+ ..++.++|+||+|+++|+|++|+.||...+..+.+..+.......+ ......+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 123468899999999865 4578899999999999999999999998888777777765432221 122346799
Q ss_pred HHHHHHHHhcccC
Q psy12709 240 QAKDFIQSCLVTD 252 (253)
Q Consensus 240 ~l~~li~~~l~~d 252 (253)
+++++|.+||..+
T Consensus 239 ~~~~li~~ll~~~ 251 (331)
T cd05624 239 EAKDLIQRLICSR 251 (331)
T ss_pred HHHHHHHHHccCc
Confidence 9999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=278.18 Aligned_cols=240 Identities=27% Similarity=0.386 Sum_probs=195.8
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +.+.||.|+||+||+|.+..++..||+|.+...... .....+.+|+..+. ..+|+||+++++++..++..++
T Consensus 5 ~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 5 ETYV--KLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLK-NLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccce--EeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHH-hCCCCCEeeEEEEEcCCCeEEE
Confidence 4455 999999999999999999999999999998754322 22345678888887 7799999999999999999999
Q ss_pred EEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-cc
Q psy12709 89 VLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VE 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~ 166 (253)
+|||+++ +|.+++... ..++...+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 9999976 888877654 45789999999999999999999999999999999999999999999999998754322 22
Q ss_pred ccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC--------------
Q psy12709 167 VKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE-------------- 231 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-------------- 231 (253)
.....+++.|+|||++.+ ..++.++|+||+|+++|+|++|+.||.+.+..+....+......++.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 233456889999999865 56889999999999999999999999887776665544332111110
Q ss_pred ------------CccCCCCHHHHHHHHHhcccCC
Q psy12709 232 ------------DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 232 ------------~~~~~~~~~l~~li~~~l~~dP 253 (253)
...+.+++++++||++||+.||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp 273 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYET 273 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCc
Confidence 1123578899999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=294.19 Aligned_cols=239 Identities=28% Similarity=0.396 Sum_probs=204.6
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC----
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH---- 84 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~---- 84 (253)
++|+ +.+.||+|+||+||+|.+..+++.||+|.+............+.+|+..+. ..+|++++++.+.+...+
T Consensus 32 ~rY~--i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~-~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 32 KKYW--ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLL-NCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred CCEE--EEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHh-cCCCCcEEEeecceecccccCc
Confidence 4555 999999999999999999999999999999876666666777888888887 789999999988775432
Q ss_pred ----eEEEEEeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeec
Q psy12709 85 ----EMVLVLEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFG 156 (253)
Q Consensus 85 ----~~~lv~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~ 156 (253)
.+++||||+++++|.+.+.. ...+++..+..++.|++.++.|||+++++|+||+|+||+++.++.++|+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 37899999999999998864 2458999999999999999999999999999999999999999999999999
Q ss_pred cccccccc---ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCc
Q psy12709 157 ISRVVNDV---VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDL 233 (253)
Q Consensus 157 ~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 233 (253)
++...... .......+++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.+..+.+..+..+...+ .
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~---~ 265 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP---L 265 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC---C
Confidence 98754322 12234568899999999999899999999999999999999999999988887777766654432 2
Q ss_pred cCCCCHHHHHHHHHhcccCC
Q psy12709 234 FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP 253 (253)
.+.+++++.+++.+||+.||
T Consensus 266 ~~~~~~~l~~li~~~L~~dP 285 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSDP 285 (496)
T ss_pred CCCCCHHHHHHHHHHcccCh
Confidence 34789999999999999998
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=292.09 Aligned_cols=236 Identities=28% Similarity=0.384 Sum_probs=201.9
Q ss_pred eeEEEeecCCCCceEEEEEEeccC-CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKIT-KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVL 90 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 90 (253)
.|.+.+.||+|++|.||.|.+..+ +..|++|...... ......+.+|+..+. .++|+||+++++++..++.+++||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~-~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLA-ACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHH-hCCCCCEeEEEEEEEECCEEEEEE
Confidence 355999999999999999998877 7788888765432 333456677888887 789999999999999999999999
Q ss_pred eccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-
Q psy12709 91 EMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV- 165 (253)
Q Consensus 91 e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~- 165 (253)
||++|++|.+.+.. ..++++..+..++.|++.++.|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999999887643 4468999999999999999999999999999999999999999999999999998654322
Q ss_pred --cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 166 --EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 166 --~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
......+++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.+..+....+..+...+. ...+++++++
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~~ 301 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---PCPVSSGMKA 301 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---CccCCHHHHH
Confidence 12334688999999999988999999999999999999999999998888887777766554322 2368999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 302 li~~~L~~dP 311 (478)
T PTZ00267 302 LLDPLLSKNP 311 (478)
T ss_pred HHHHHhccCh
Confidence 9999999998
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=286.37 Aligned_cols=209 Identities=22% Similarity=0.346 Sum_probs=177.7
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC-
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH- 84 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~- 84 (253)
.+.++|+ +.+.||+|+||+||+|.+..++..||+|.+............+.+|+..+. ..+|+||+++++++...+
T Consensus 18 ~~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~ 94 (359)
T cd07876 18 TVLKRYQ--QLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLK-CVNHKNIISLLNVFTPQKS 94 (359)
T ss_pred hhhhceE--EEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHH-hCCCCCEeeeeeeeccCCC
Confidence 4456777 999999999999999999999999999999876555555677888888887 779999999999986543
Q ss_pred -----eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 85 -----EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 85 -----~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
.++++|||+++ ++...+. ..++...+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 95 LEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 57999999966 5555543 347899999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy12709 160 VVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFL 220 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 220 (253)
............+++.|+|||++.+..++.++|+||+|+++|+|++|+.||.+.+..+.+.
T Consensus 172 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~ 232 (359)
T cd07876 172 TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232 (359)
T ss_pred ccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 6544333344567889999999999899999999999999999999999998876654443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=275.25 Aligned_cols=235 Identities=31% Similarity=0.497 Sum_probs=218.1
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
.+++.||+|.||+|.+|.-+.+++.||+|++++.- ...++..+...|-..++ ..+||.+..+...|...++++.||||
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~-~~~HPFLt~LKYsFQt~drlCFVMey 249 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQ-NCRHPFLTSLKYSFQTQDRLCFVMEY 249 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHH-hccCcHHHHhhhhhccCceEEEEEEE
Confidence 37899999999999999999999999999999875 44566788888999998 89999999999999999999999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc-ccccccccccc
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV-VNDVVEVKEII 171 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~-~~~~~~~~~~~ 171 (253)
.+||.|.-.++....+++...+.+..+|+.|+.|||+++|+++|++.+|.+++.+|++||.|||+++. ..........+
T Consensus 250 anGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFC 329 (516)
T KOG0690|consen 250 ANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFC 329 (516)
T ss_pred ccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceecccc
Confidence 99999987777677799999999999999999999999999999999999999999999999999984 45556677889
Q ss_pred cCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhccc
Q psy12709 172 GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251 (253)
Q Consensus 172 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (253)
|+|.|+|||++....|..+.|.|.+|+++|+|++|+.||.+.+....+..|......+|. .+|++.+.|+..+|.+
T Consensus 330 GTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~eAktLLsGLL~k 405 (516)
T KOG0690|consen 330 GTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSPEAKTLLSGLLKK 405 (516)
T ss_pred CChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCHHHHHHHHHHhhc
Confidence 999999999999999999999999999999999999999999999999999988888777 7899999999999999
Q ss_pred CC
Q psy12709 252 DP 253 (253)
Q Consensus 252 dP 253 (253)
||
T Consensus 406 dP 407 (516)
T KOG0690|consen 406 DP 407 (516)
T ss_pred Ch
Confidence 98
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=273.78 Aligned_cols=240 Identities=29% Similarity=0.449 Sum_probs=199.8
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch-HHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM-DQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
|+..+.||.|+||+||+|.+..+++.||+|.+....... .....+.+|+..+. ..+|++|+.+.+.+..++..++++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~-~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILE-KVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHH-HcCCcCceeEEEEEecCCEEEEEEE
Confidence 448899999999999999999999999999987654222 22345677888887 6799999999999999999999999
Q ss_pred ccCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccc
Q psy12709 92 MVPDGELQRLVDI--QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE 169 (253)
Q Consensus 92 ~~~g~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (253)
|+++++|.+.+.. ...+++..+..++.|++.++.|||++|++|+||+|+||++++++.++|+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence 9999999887754 34699999999999999999999999999999999999999999999999998876543333334
Q ss_pred cccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 170 IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
..++..|+|||.+.+..++.++|+||+|+++|++++|..||...........+..............+++++.+++..||
T Consensus 161 ~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 240 (285)
T cd05632 161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL 240 (285)
T ss_pred CCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHc
Confidence 56789999999998888999999999999999999999999887665444333332222222333578999999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
+.||
T Consensus 241 ~~~P 244 (285)
T cd05632 241 TKDP 244 (285)
T ss_pred cCCH
Confidence 9998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=269.88 Aligned_cols=240 Identities=28% Similarity=0.432 Sum_probs=203.2
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch---HHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM---DQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
++|+ +.+.||.|++|.||.|.+..++.+|++|.++...... .....+.+|+..+. ..+|+||+++++++..++.
T Consensus 2 ~~~~--~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~ 78 (263)
T cd06625 2 TNWR--RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLK-NLQHERIVQYYGCLRDDET 78 (263)
T ss_pred Cccc--ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHH-hCCCCCeeeeEEEEccCCe
Confidence 3566 9999999999999999999999999999987654322 23457788888887 7799999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~ 165 (253)
+++++|++++++|.+.+.....+++..+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 99999999999999999887889999999999999999999999999999999999999999999999999987543321
Q ss_pred cc----cccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHH
Q psy12709 166 EV----KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQA 241 (253)
Q Consensus 166 ~~----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 241 (253)
.. ....++..|+|||.+.+..++.++|+||+|+++|++++|+.||.+.+......++....... .....++.++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 236 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP--QLPSHVSPDA 236 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC--CCCccCCHHH
Confidence 11 22346679999999998889999999999999999999999998876666555544433322 2334789999
Q ss_pred HHHHHHhcccCC
Q psy12709 242 KDFIQSCLVTDP 253 (253)
Q Consensus 242 ~~li~~~l~~dP 253 (253)
.++|.+||+.||
T Consensus 237 ~~li~~~l~~~p 248 (263)
T cd06625 237 RNFLRRTFVENA 248 (263)
T ss_pred HHHHHHHhhcCc
Confidence 999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=274.71 Aligned_cols=240 Identities=30% Similarity=0.497 Sum_probs=201.9
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++++.||+|+||+||++.+..++..||+|.+..............+|+..+... +|+||+++++++..+...+++||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-cccccccccccccccccccccccc
Confidence 4599999999999999999999999999999998776665555556688888844 999999999999999999999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccc-cccccccccc
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV-NDVVEVKEII 171 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~-~~~~~~~~~~ 171 (253)
+++++|.+++.....++...+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+... ..........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 159 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV 159 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999987788999999999999999999999999999999999999999999999999998753 2233344556
Q ss_pred cCccccCccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---HHHHHhhcccccccCCccCCCCHHHHHHHHH
Q psy12709 172 GTPDYVAPEVLS-YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ---ETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247 (253)
Q Consensus 172 ~~~~~~~PE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~ 247 (253)
+++.|+|||+.. +..++.++|+||+|+++++|++|..||...... .....................++.+.++|.+
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 239 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK 239 (260)
T ss_dssp SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence 788999999998 788899999999999999999999999887333 3333333322222222222335899999999
Q ss_pred hcccCC
Q psy12709 248 CLVTDP 253 (253)
Q Consensus 248 ~l~~dP 253 (253)
||+.||
T Consensus 240 ~l~~~p 245 (260)
T PF00069_consen 240 MLSKDP 245 (260)
T ss_dssp HSSSSG
T ss_pred HccCCh
Confidence 999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=274.63 Aligned_cols=240 Identities=28% Similarity=0.435 Sum_probs=196.0
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch-HHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM-DQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
|++.+.||+|+||+||+|.+..+++.|++|.+....... .....+.+|+..+. ..+|++++.+++.+..++.++++||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILE-KVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHH-hCCCCCeeeeeEEEecCCEEEEEEE
Confidence 448899999999999999999999999999987654322 22345667888887 7799999999999999999999999
Q ss_pred ccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccc
Q psy12709 92 MVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE 169 (253)
Q Consensus 92 ~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (253)
|++|++|.+.+... ..+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 99999999887543 3589999999999999999999999999999999999999999999999999876544333334
Q ss_pred cccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 170 IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
..++..|+|||.+.+..++.++|+||+|+++|+|++|+.||..........................+++++++||.+||
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 240 (285)
T cd05630 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL 240 (285)
T ss_pred CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHh
Confidence 56789999999999888999999999999999999999999875432211111111111112233478999999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
+.||
T Consensus 241 ~~~p 244 (285)
T cd05630 241 CKDP 244 (285)
T ss_pred hcCH
Confidence 9997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=280.23 Aligned_cols=239 Identities=28% Similarity=0.463 Sum_probs=197.5
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
+|+ +++.||+|+||+||++.+..+++.||+|++.+.. ........+.+|...+. ..+|++|+.+++.+..++.+++
T Consensus 2 ~y~--~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~l 78 (331)
T cd05597 2 DFE--ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLV-NGDRRWITNLHYAFQDENNLYL 78 (331)
T ss_pred Cce--EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHH-hCCCCCCCceEEEEecCCeEEE
Confidence 455 9999999999999999999999999999997643 22233455667777776 7799999999999999999999
Q ss_pred EEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc-
Q psy12709 89 VLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE- 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~- 166 (253)
||||++|++|.+++.. ...+++..++.++.|++.++.|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999999876 45689999999999999999999999999999999999999999999999999875543221
Q ss_pred -ccccccCccccCccccCC-----CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc-CCccCCCCH
Q psy12709 167 -VKEIIGTPDYVAPEVLSY-----EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH-EDLFGHISS 239 (253)
Q Consensus 167 -~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~ 239 (253)
.....+++.|+|||++.. ..++.++|+||+|+++|+|++|+.||.+.+..+.+..+........ ......+|+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 122457899999999863 3567899999999999999999999998887777776654332211 112245899
Q ss_pred HHHHHHHHhccc
Q psy12709 240 QAKDFIQSCLVT 251 (253)
Q Consensus 240 ~l~~li~~~l~~ 251 (253)
+++++|++||..
T Consensus 239 ~~~~li~~ll~~ 250 (331)
T cd05597 239 EAKDLIRRLICS 250 (331)
T ss_pred HHHHHHHHHccC
Confidence 999999998864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=272.26 Aligned_cols=231 Identities=26% Similarity=0.414 Sum_probs=190.2
Q ss_pred cCCCCceEEEEEEeccCCceEEEEEecccccch-HHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCCc
Q psy12709 19 PSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM-DQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGE 97 (253)
Q Consensus 19 lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 97 (253)
||+|+||+||++.++.+++.|++|.+....... ........|+..+. ..+|+||+++++.+..+..++++|||++|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~-~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILE-KVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHH-hcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999999999999999987543222 22334556788887 6699999999999999999999999999999
Q ss_pred HHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccccccCcc
Q psy12709 98 LQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPD 175 (253)
Q Consensus 98 L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (253)
|.+++... .+++...+..++.|++.|+.+||++|++|+||+|+||++++++.++|+|||++.............++..
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCC
Confidence 98877543 3588999999999999999999999999999999999999999999999999876654433344567889
Q ss_pred ccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHhhcccccccCCccCCCCHHHHHHHHHhccc
Q psy12709 176 YVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNK----QETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251 (253)
Q Consensus 176 ~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (253)
|+|||++.+..++.++|+||+|+++|+|++|+.||..... .+.............. ..++++++++|.+||+.
T Consensus 160 y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEH---QNFTEESKDICRLFLAK 236 (277)
T ss_pred ccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccccc---ccCCHHHHHHHHHHhcc
Confidence 9999999888899999999999999999999999976433 2222322222222221 36899999999999999
Q ss_pred CC
Q psy12709 252 DP 253 (253)
Q Consensus 252 dP 253 (253)
||
T Consensus 237 ~P 238 (277)
T cd05607 237 KP 238 (277)
T ss_pred CH
Confidence 98
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=275.54 Aligned_cols=240 Identities=26% Similarity=0.382 Sum_probs=192.2
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHh--cCCCCceeeeeEEEe-----CCe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLA--QKSERIVGLHEIYET-----PHE 85 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~--~~~~~i~~~~~~~~~-----~~~ 85 (253)
|++.+.||+|+||+||+|.+..++..|++|.+..............+|+..+... .+|+||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 4599999999999999999999999999999876443322233455566655533 479999999998864 346
Q ss_pred EEEEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
+++++|++.+ +|.+++... ..+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 8999999975 788777653 3489999999999999999999999999999999999999999999999999876654
Q ss_pred cccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccc----------------
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNF---------------- 227 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~---------------- 227 (253)
........++..|+|||++.+..++.++|+||+|+++|+|++|+.||......+....+.....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07863 161 QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRG 240 (288)
T ss_pred cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccccc
Confidence 3333345678899999999888899999999999999999999999988766655544432110
Q ss_pred -------cccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 228 -------SFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 228 -------~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.......+.++++++++|.+||++||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 273 (288)
T cd07863 241 AFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNP 273 (288)
T ss_pred ccCCCCCCchHHhCcCcCHHHHHHHHHHhccCc
Confidence 00112234678899999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=279.57 Aligned_cols=239 Identities=27% Similarity=0.447 Sum_probs=197.9
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
|++.+.||+|+||+||++.++.+++.|++|++.+... .......+.+|+..+. ..+|++|+++++.+..++.+++|||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV-NGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHh-hCCCCCEeeEEEEEecCCEEEEEEe
Confidence 3399999999999999999999999999999875432 2223344666666666 7899999999999999999999999
Q ss_pred ccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc--ccc
Q psy12709 92 MVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV--EVK 168 (253)
Q Consensus 92 ~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~ 168 (253)
|+++++|.+++.. ...+++..++.++.|++.++.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~ 161 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 161 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceec
Confidence 9999999999976 4568999999999999999999999999999999999999999999999999986543221 222
Q ss_pred ccccCccccCccccC-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc-CCccCCCCHHHH
Q psy12709 169 EIIGTPDYVAPEVLS-----YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH-EDLFGHISSQAK 242 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~l~ 242 (253)
...+++.|+|||++. ...++.++|+||+|+++|+|++|+.||...+..+.+..+.......+ ......+|++++
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~ 241 (332)
T cd05623 162 VAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAK 241 (332)
T ss_pred ccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHH
Confidence 346889999999985 34578899999999999999999999999888888887765443221 112246899999
Q ss_pred HHHHHhcccC
Q psy12709 243 DFIQSCLVTD 252 (253)
Q Consensus 243 ~li~~~l~~d 252 (253)
++|++||..+
T Consensus 242 ~li~~ll~~~ 251 (332)
T cd05623 242 DLIRRLICSR 251 (332)
T ss_pred HHHHHHccCh
Confidence 9999998654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=275.70 Aligned_cols=240 Identities=27% Similarity=0.378 Sum_probs=188.5
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +.+.||.|+||+||+|.+..+++.||+|++....... ......+|+..+. ..+|+||+++++++..++..++
T Consensus 5 ~~y~--~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 5 DSYE--KLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLK-GLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred ccce--EeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHh-hCCCCCcCeEEEEEecCCeEEE
Confidence 4555 9999999999999999999999999999987654322 2345667888887 7799999999999999999999
Q ss_pred EEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-cc
Q psy12709 89 VLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VE 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~ 166 (253)
||||+.+ +|.+.+.. ...+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 81 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 81 VFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred EEECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 9999965 66666554 456899999999999999999999999999999999999999999999999998754322 22
Q ss_pred ccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhccccccc--------------
Q psy12709 167 VKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ-ETFLNISQCNFSFH-------------- 230 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~i~~~~~~~~-------------- 230 (253)
.....+++.|+|||++.+ ..++.++|+||+|+++|+|++|..||.+.... +....+......+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 233457889999999765 45788999999999999999999999874332 22222211100000
Q ss_pred -C--------C-----ccCCCCHHHHHHHHHhcccCC
Q psy12709 231 -E--------D-----LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 -~--------~-----~~~~~~~~l~~li~~~l~~dP 253 (253)
. . ....+++++++||.+||+.||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp 276 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFP 276 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCc
Confidence 0 0 001346789999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=271.43 Aligned_cols=234 Identities=26% Similarity=0.426 Sum_probs=197.3
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC-----eE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH-----EM 86 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~ 86 (253)
+|.-.+.+|+|+||.||+|...+++++||||+.-.+..-. -+|+.+++ ..+||||+++..+|.... ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~-~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMR-KLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHH-hcCCcCeeeEEEEEEecCCCchhHH
Confidence 4558899999999999999999999999999987655422 25788887 889999999998886432 45
Q ss_pred EEEEeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-CceEEEeecccccc
Q psy12709 87 VLVLEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD-NNIKLCDFGISRVV 161 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~-~~~~l~df~~~~~~ 161 (253)
.+||||++. +|..+++. +..++...++-+..||++|++|||+.||+||||||.|+++|.+ |.+||||||.++..
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 689999955 88888774 5678999999999999999999999999999999999999986 99999999999977
Q ss_pred cccccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC---------
Q psy12709 162 NDVVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE--------- 231 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--------- 231 (253)
...........+..|.|||.+.+ ..|+.+.||||.|||+.||+.|++.|++.+..+.+..|.+...++..
T Consensus 177 ~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 177 VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 65544455667889999999755 57999999999999999999999999999998888777654433331
Q ss_pred ---------------C-ccCCCCHHHHHHHHHhcccCC
Q psy12709 232 ---------------D-LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 232 ---------------~-~~~~~~~~l~~li~~~l~~dP 253 (253)
. .....++++.+|+.++|+.+|
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P 294 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSP 294 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccCh
Confidence 1 335679999999999999987
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=265.29 Aligned_cols=237 Identities=29% Similarity=0.481 Sum_probs=205.6
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++.+.||+|++|.||+|.++.++..|++|.+............+.+|+..+. ..+|+||+++++.+..++.+++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLA-KLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHH-hcCCCCeehheeeeccCCEEEEEEEe
Confidence 34899999999999999999999999999998876555566778888998887 67999999999999999999999999
Q ss_pred cCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-cccc
Q psy12709 93 VPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVKE 169 (253)
Q Consensus 93 ~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~ 169 (253)
++|++|.+++... ..++...++.++.+++.++.+||++|++|+||+|+||++++++.++|+|||.+....... ....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 9999999998764 468999999999999999999999999999999999999999999999999887654322 2223
Q ss_pred cccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 170 IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
..+++.|+|||+..+..++.++|+||+|+++++|++|+.||...+.......+......... ..++.++.++|.+||
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~~l 237 (256)
T cd08529 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYSQQLAQLIDQCL 237 (256)
T ss_pred cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHHHHHHc
Confidence 45678999999998888999999999999999999999999988877777766654433322 278899999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
+.||
T Consensus 238 ~~~p 241 (256)
T cd08529 238 TKDY 241 (256)
T ss_pred cCCc
Confidence 9988
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=275.76 Aligned_cols=204 Identities=27% Similarity=0.434 Sum_probs=179.0
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +.+.||.|+||+||+|.+..++..+++|.+.... .......+.+|+..+. ..+|+||+++++++..++.++
T Consensus 4 ~~~y~--~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 4 DDDFE--KISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLH-ECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred hhhhh--eeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHH-HCCCCcccceeEEEEECCEEE
Confidence 45677 9999999999999999999999999999887643 2344567889999998 678999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCceEEEeeccccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDH-NITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE 166 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 166 (253)
++|||+++++|.+++.....+++..+..++.+++.++.|||++ +++|+||+|+||+++.++.++|+|||++...... .
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~ 158 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M 158 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-c
Confidence 9999999999999998777899999999999999999999985 7999999999999999999999999998754332 2
Q ss_pred ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH
Q psy12709 167 VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ 216 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 216 (253)
.....++..|+|||++.+..++.++|+||+|+++|++++|+.||......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 208 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 22345788999999999888999999999999999999999999765543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=282.29 Aligned_cols=212 Identities=22% Similarity=0.359 Sum_probs=181.1
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP-- 83 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-- 83 (253)
.+.++|+ +.+.||+|+||.||+|.+..+++.||+|++............+.+|+..+. ..+|+||+++++++...
T Consensus 21 ~~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~ii~~~~~~~~~~~ 97 (364)
T cd07875 21 TVLKRYQ--NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKS 97 (364)
T ss_pred chhccee--EEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHH-hcCCCCccccceeeccccc
Confidence 4556777 999999999999999999999999999999876555555667788888887 77999999999987543
Q ss_pred ----CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 84 ----HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 84 ----~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
..+++||||+++ +|...+.. .++...+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 98 ~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 98 LEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred ccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 357999999965 66666542 47889999999999999999999999999999999999999999999999998
Q ss_pred cccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q psy12709 160 VVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNIS 223 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~ 223 (253)
............+++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.+..+.+..+.
T Consensus 175 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 238 (364)
T cd07875 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238 (364)
T ss_pred ccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 6654434444567899999999999999999999999999999999999999887766665543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=266.36 Aligned_cols=234 Identities=28% Similarity=0.483 Sum_probs=201.5
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
+.||.|++|.||+|.+..++..|++|.+.+... ..........|...+....+|+|++++++.+..++.+++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 679999999999999999999999999876542 2223344555655666577999999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccccccCcc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPD 175 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (253)
++|.+++.....+++..+..++.|++.|+.+||+.+++|+||+|.||+++.++.++|+|||.+..... .....++..
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~ 158 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTPD 158 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCcC
Confidence 99999998777899999999999999999999999999999999999999999999999998875433 123356788
Q ss_pred ccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 176 YVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 176 ~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
|+|||.+.+..++.++|+||+|+++|++++|..||...+....+..+.......+......+++++.++|.+||+.||
T Consensus 159 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 236 (260)
T cd05611 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236 (260)
T ss_pred ccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCH
Confidence 999999988888999999999999999999999999888888777776666555555555789999999999999987
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=267.40 Aligned_cols=239 Identities=17% Similarity=0.248 Sum_probs=198.5
Q ss_pred ecceeeEEEeecCCCCceEEEEEEec---cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHK---ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
+++|+ +.+.||+|+||.||+|..+ ..+..|++|.++.... ......+.+|+..+. ..+|+||+++++++..++
T Consensus 4 ~~~~~--~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 4 NKSIK--IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLG-QFDHSNIVRLEGVITRGN 79 (266)
T ss_pred hHHeE--EeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHh-cCCCCCcCeEEEEEecCC
Confidence 34555 9999999999999999865 3456899999886533 333567888998887 579999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
..++||||+++++|.+++... ..+++..++.++.|++.|+++||++|++|+||+|+||+++.++.++++|||.+.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999988764 4689999999999999999999999999999999999999999999999997754322
Q ss_pred cccc--cccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHH
Q psy12709 164 VVEV--KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 164 ~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
.... ....++..|+|||.+.+..++.++||||+|+++|++++ |+.||.+.+..+....+......+ ....++..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 236 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP---APRNCPNL 236 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCCHH
Confidence 1111 11223468999999988899999999999999999775 999999888877777766543322 23478999
Q ss_pred HHHHHHHhcccCC
Q psy12709 241 AKDFIQSCLVTDP 253 (253)
Q Consensus 241 l~~li~~~l~~dP 253 (253)
+.+++.+||++||
T Consensus 237 ~~~li~~c~~~~p 249 (266)
T cd05064 237 LHQLMLDCWQKER 249 (266)
T ss_pred HHHHHHHHcCCCc
Confidence 9999999999998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=282.03 Aligned_cols=239 Identities=24% Similarity=0.369 Sum_probs=197.2
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC-----eEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH-----EMV 87 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~ 87 (253)
|++.+.||+|+||+||+|.+..+++.||+|.+............+.+|+..+. ..+|+||+++++++..++ ..+
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLC-FFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHH-hCCCCCcCCHhheecCCCccccceEE
Confidence 44899999999999999999999999999998765544555677889999888 779999999999998876 799
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc--c
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV--V 165 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~--~ 165 (253)
+++||+. ++|...+.....++...++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 9999996 578887777777999999999999999999999999999999999999999999999999998754322 1
Q ss_pred cccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccc------------------
Q psy12709 166 EVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCN------------------ 226 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~------------------ 226 (253)
......+++.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.+..+....+....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 22233567899999998764 47889999999999999999999998877666555443211
Q ss_pred -----ccccC-----CccCCCCHHHHHHHHHhcccCC
Q psy12709 227 -----FSFHE-----DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 227 -----~~~~~-----~~~~~~~~~l~~li~~~l~~dP 253 (253)
..++. ......++++.+||.+||+.||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP 276 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDP 276 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCCh
Confidence 11110 1224568899999999999998
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=270.85 Aligned_cols=230 Identities=16% Similarity=0.209 Sum_probs=196.2
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEecccccchH-HHHHHHHHHHHHHHhcCCCCceeeeeEEEe----CCeEEEEEe
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMD-QMQDILHEAAVLYLAQKSERIVGLHEIYET----PHEMVLVLE 91 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e 91 (253)
..|+.|+++.||+|.. +|+.||+|.+........ ....+.+|+..+. ..+|+||+++++++.+ ...++++||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLR-RIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHH-hcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 5789999999999987 588999999987654332 2467779999998 7799999999999876 347899999
Q ss_pred ccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCceEEEeeccccccccccccccc
Q psy12709 92 MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDH-NITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI 170 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (253)
|+++++|.+++.....++......++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~~ 180 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FKN 180 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--ccc
Confidence 999999999998877899999999999999999999985 89999999999999999999999999987554322 234
Q ss_pred ccCccccCccccCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 171 IGTPDYVAPEVLSY--EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 171 ~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
.++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.+..+.+..+......++.+ ..++++++++|.+|
T Consensus 181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li~~c 258 (283)
T PHA02988 181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIVEAC 258 (283)
T ss_pred cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHHHHH
Confidence 56789999999876 678999999999999999999999999888887777765544443322 36899999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|+.||
T Consensus 259 l~~dp 263 (283)
T PHA02988 259 TSHDS 263 (283)
T ss_pred hcCCc
Confidence 99998
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=279.38 Aligned_cols=209 Identities=22% Similarity=0.335 Sum_probs=178.8
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP-- 83 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-- 83 (253)
.+.++|+ +.+.||+|+||.||+|.+..+++.|++|.+..............+|+..+. ..+|+||+++++++...
T Consensus 14 ~~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~ 90 (355)
T cd07874 14 TVLKRYQ--NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKS 90 (355)
T ss_pred hhhhcee--EEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHH-HhCCCchhceeeeeecccc
Confidence 4556777 999999999999999999999999999999876655566677888888887 77999999999998643
Q ss_pred ----CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 84 ----HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 84 ----~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
...+++|||+++ ++...+. ..++...+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 91 ~~~~~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 91 LEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred ccccceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 357999999966 5655554 247899999999999999999999999999999999999999999999999998
Q ss_pred cccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy12709 160 VVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFL 220 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 220 (253)
............+++.|+|||++.+..++.++|+||+|+++|+|++|+.||.+.+..+.+.
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 228 (355)
T cd07874 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228 (355)
T ss_pred cCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 6654444445567899999999998889999999999999999999999998876554443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=280.88 Aligned_cols=234 Identities=26% Similarity=0.394 Sum_probs=187.9
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEecc
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMV 93 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 93 (253)
+.++.||.|+||+||+|.+..+++.|++|++.... .......+.+|+..+. ..+|+||+++++++..++.+++++||+
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILR-DVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHH-hCCCCCcceeeeEeccCCeEEEEEecC
Confidence 38899999999999999999999999999986543 2344567888999988 778999999999999999999999999
Q ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-cccccccc
Q psy12709 94 PDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEVKEIIG 172 (253)
Q Consensus 94 ~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 172 (253)
++++|... ...++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...... .......+
T Consensus 155 ~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 230 (353)
T PLN00034 155 DGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVG 230 (353)
T ss_pred CCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccccccccc
Confidence 99998653 23567788899999999999999999999999999999999999999999998765432 12233467
Q ss_pred CccccCccccCC-----CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHH
Q psy12709 173 TPDYVAPEVLSY-----EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247 (253)
Q Consensus 173 ~~~~~~PE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~ 247 (253)
+..|+|||.+.. ...+.++||||||+++|+|++|+.||......+....+..............+++++++||.+
T Consensus 231 t~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 310 (353)
T PLN00034 231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISC 310 (353)
T ss_pred CccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHH
Confidence 899999998743 234568999999999999999999997543332222221111112222334789999999999
Q ss_pred hcccCC
Q psy12709 248 CLVTDP 253 (253)
Q Consensus 248 ~l~~dP 253 (253)
||+.||
T Consensus 311 ~l~~~P 316 (353)
T PLN00034 311 CLQREP 316 (353)
T ss_pred HccCCh
Confidence 999997
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=263.35 Aligned_cols=237 Identities=25% Similarity=0.383 Sum_probs=208.0
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|+.++.||.|++|.||.+.+..++..+++|.+...........++.+|+..++ ..+|+||+++++++..++.+++++||
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILS-LLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHH-hCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 44999999999999999999999999999999876656666778889999888 67999999999999999999999999
Q ss_pred cCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-cccc
Q psy12709 93 VPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVKE 169 (253)
Q Consensus 93 ~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~ 169 (253)
+++++|.+++... ..++...+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 9999999988764 458999999999999999999999999999999999999999999999999987654332 2233
Q ss_pred cccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 170 IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
..+++.|.|||...+..++.++|+||+|+++++|++|..||......+....+..+...+.. ..++.++.++|.+||
T Consensus 161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~~l 237 (256)
T cd08221 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSELISLVHSLL 237 (256)
T ss_pred cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHHHHHHc
Confidence 45788999999998888899999999999999999999999988887777777665554332 578999999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
++||
T Consensus 238 ~~~p 241 (256)
T cd08221 238 QQDP 241 (256)
T ss_pred ccCc
Confidence 9987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=291.42 Aligned_cols=243 Identities=28% Similarity=0.430 Sum_probs=207.6
Q ss_pred CcceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeE-EE
Q psy12709 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI-YE 81 (253)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~-~~ 81 (253)
|+++..++.+.++.+.|.+|||+.||+|.+...+..||+|.+... +....+.+.+|+.+++++..|+|||.+++. ..
T Consensus 29 G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 29 GQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred ceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 677888999999999999999999999999988899999988765 566788999999999989999999999993 22
Q ss_pred eC------CeEEEEEeccCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEcCCCceE
Q psy12709 82 TP------HEMVLVLEMVPDGELQRLVDI--QDGIPEQDTRSYMKQILEALAFLHDHN--ITHLDLKPQNILLTKDNNIK 151 (253)
Q Consensus 82 ~~------~~~~lv~e~~~g~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~di~~~ni~~~~~~~~~ 151 (253)
.. -.++|.||||.|+.|-+++++ +..|++.++++++.+++.|+.+||... ++|||||-+|||+..+|.+|
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence 11 257899999999999999985 355999999999999999999999998 99999999999999999999
Q ss_pred EEeeccccccc-cccccc---------ccccCccccCcccc---CCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy12709 152 LCDFGISRVVN-DVVEVK---------EIIGTPDYVAPEVL---SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQET 218 (253)
Q Consensus 152 l~df~~~~~~~-~~~~~~---------~~~~~~~~~~PE~~---~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 218 (253)
|||||.+.... ...... ....|+.|.|||++ .+.+++.|+|||+|||+||.|+...+||.....
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--- 263 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--- 263 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---
Confidence 99999887332 111111 12468999999997 667889999999999999999999999976433
Q ss_pred HHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 219 FLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 219 ~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..|..+++.+|.. +.+|..+++||+.||++||
T Consensus 264 -laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP 295 (738)
T KOG1989|consen 264 -LAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNP 295 (738)
T ss_pred -eeEEeccccCCCC--ccHHHHHHHHHHHHhccCc
Confidence 2566777777663 6899999999999999998
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=262.25 Aligned_cols=237 Identities=26% Similarity=0.438 Sum_probs=200.7
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC-CeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP-HEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e 91 (253)
|++++.||.|++|.||.+.+..+++.|++|.+............+.+|+..+. ..+|+|++++.+.+... ..+++++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLS-QLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHH-hCCCCCeeeeeeeecCCCCEEEEEec
Confidence 34999999999999999999999999999999766555555667888888877 77899999999988654 46899999
Q ss_pred ccCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-cccc
Q psy12709 92 MVPDGELQRLVDI--QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEVK 168 (253)
Q Consensus 92 ~~~g~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~ 168 (253)
++++++|.+.+.. ...+++.+++.++.+++.++.+||++|++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 9999999998875 345899999999999999999999999999999999999999999999999998765332 2223
Q ss_pred ccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 169 EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
...+++.|+|||...+..++.++|+||+|++++++++|+.||...+.......+..+.... ....+++++.++|.+|
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~ 237 (257)
T cd08223 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPELGELIATM 237 (257)
T ss_pred cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHHHHHHHH
Confidence 3456789999999998889999999999999999999999998877766666655544322 2247899999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|+.||
T Consensus 238 l~~~p 242 (257)
T cd08223 238 LSKRP 242 (257)
T ss_pred hccCc
Confidence 99998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=267.33 Aligned_cols=236 Identities=28% Similarity=0.462 Sum_probs=202.1
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc-hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS-MDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
|++.+.||.|+||.||+|.+..++..|++|.+.+.... ......+.+|+..+. ..+|+||+++++.+..++..++++|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQ-ELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHH-hCCCCChHHHHHhhcCCCeEEEEEe
Confidence 44999999999999999999999999999999865432 245678888998887 7799999999999999999999999
Q ss_pred ccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccccc
Q psy12709 92 MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEII 171 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (253)
|+.|++|.+.+....++++..+..++.+++.++.+||+.|++|+||+|+||++++++.++|+|||.+.............
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 160 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS 160 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccC
Confidence 99999999999877789999999999999999999999999999999999999999999999999987655443334456
Q ss_pred cCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 172 GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNK---QETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 172 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
++..|+|||.+.+..++.++|+||+|+++|++++|..||...+. ............. .....+.++.++|.+|
T Consensus 161 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVL----YPATWSTEAIDAINKL 236 (258)
T ss_pred CChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcccccc----CcccCcHHHHHHHHHH
Confidence 77899999999888899999999999999999999999987664 3333332222222 2346789999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|+.||
T Consensus 237 l~~~p 241 (258)
T cd05578 237 LERDP 241 (258)
T ss_pred ccCCh
Confidence 99998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=266.53 Aligned_cols=239 Identities=31% Similarity=0.506 Sum_probs=212.6
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe----
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET---- 82 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~---- 82 (253)
+...|+..- +.||-|-.|+|-.|.++.++.++|+|++... .+..+|+...+....|+|||.++++++.
T Consensus 59 itedY~is~-qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 59 ITEDYSISW-QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred chhhheehh-hhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 455676433 6999999999999999999999999998642 2556788888889999999999999874
Q ss_pred CCeEEEEEeccCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC---CCceEEEeecc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK---DNNIKLCDFGI 157 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~---~~~~~l~df~~ 157 (253)
...+.+|||.++||.|...++.++. |++.++..+++||..|+.|||+.+|+|||+||+|++... |..+||+|||+
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 2478899999999999999988654 999999999999999999999999999999999999975 45699999999
Q ss_pred cccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHhhcccccccCCc
Q psy12709 158 SRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNK----QETFLNISQCNFSFHEDL 233 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~i~~~~~~~~~~~ 233 (253)
++...........+.+|.|.|||++...+|+...|+||+|+++|-|++|.+||.+... ..+...|..+...+|++.
T Consensus 211 AK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE 290 (400)
T KOG0604|consen 211 AKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE 290 (400)
T ss_pred ccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence 9988777777888999999999999999999999999999999999999999976433 356678999999999999
Q ss_pred cCCCCHHHHHHHHHhcccCC
Q psy12709 234 FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP 253 (253)
...+|+..+|+|+.+|+.||
T Consensus 291 Ws~VSe~aKdlIR~LLkt~P 310 (400)
T KOG0604|consen 291 WSCVSEAAKDLIRKLLKTEP 310 (400)
T ss_pred HhHHHHHHHHHHHHHhcCCc
Confidence 99999999999999999998
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=284.22 Aligned_cols=233 Identities=23% Similarity=0.327 Sum_probs=185.9
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--------C
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP--------H 84 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--------~ 84 (253)
|++.+.||+|+||+||+|.+..++..||+|.+..... ...+|+..+. ..+|+||+++++++... .
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~-~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ------YKNRELLIMK-NLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHH-hcCCCCCcceeeeEeecccccCCCce
Confidence 4499999999999999999999999999998864322 2346888887 77999999998887432 2
Q ss_pred eEEEEEeccCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-ceEEEeecccc
Q psy12709 85 EMVLVLEMVPDGELQRLVD----IQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN-NIKLCDFGISR 159 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~-~~~l~df~~~~ 159 (253)
.++++|||+++ ++.+++. ....+++..++.++.|++.|+.|||++|++||||+|+||+++.++ .++|+|||++.
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 47799999975 6655553 345689999999999999999999999999999999999999765 69999999998
Q ss_pred cccccccccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc--------
Q psy12709 160 VVNDVVEVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH-------- 230 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-------- 230 (253)
............+++.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+....+.....++.
T Consensus 220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 299 (440)
T PTZ00036 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299 (440)
T ss_pred hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc
Confidence 66544444445678899999997654 689999999999999999999999998877666555443211111
Q ss_pred ---------C--------CccCCCCHHHHHHHHHhcccCC
Q psy12709 231 ---------E--------DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 ---------~--------~~~~~~~~~l~~li~~~l~~dP 253 (253)
. ......|+++++||.+||++||
T Consensus 300 ~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP 339 (440)
T PTZ00036 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEP 339 (440)
T ss_pred hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCCh
Confidence 0 0112468899999999999998
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=279.59 Aligned_cols=238 Identities=20% Similarity=0.330 Sum_probs=193.1
Q ss_pred eEEEeecCCCCceEEEEEEecc-----CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKI-----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
|++.+.||+|+||.||+|.+.. ++..||+|.+..... .+....+.+|+..+.....|+||+++++.+..++..+
T Consensus 40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~ 118 (374)
T cd05106 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL 118 (374)
T ss_pred ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence 4499999999999999998643 335799999976543 3345678889999986669999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhc--------------------------------------------------------------
Q psy12709 88 LVLEMVPDGELQRLVDIQ-------------------------------------------------------------- 105 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~-------------------------------------------------------------- 105 (253)
++|||+++++|.+++...
T Consensus 119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (374)
T cd05106 119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK 198 (374)
T ss_pred EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence 999999999999887532
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc---ccccccCc
Q psy12709 106 --------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE---VKEIIGTP 174 (253)
Q Consensus 106 --------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~ 174 (253)
.+++...+++++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++........ .....++.
T Consensus 199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~ 278 (374)
T cd05106 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278 (374)
T ss_pred chhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCcc
Confidence 1367888999999999999999999999999999999999999999999999875433211 11122346
Q ss_pred cccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 175 ~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.|+|||++.+..++.++|+||+|+++|+|++ |+.||........+..+......... ...+++++.++|.+||+.||
T Consensus 279 ~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dp 356 (374)
T cd05106 279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR--PDFAPPEIYSIMKMCWNLEP 356 (374)
T ss_pred ceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC--CCCCCHHHHHHHHHHcCCCh
Confidence 7999999988889999999999999999997 99999876655444444443332222 23568999999999999998
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=268.36 Aligned_cols=240 Identities=30% Similarity=0.508 Sum_probs=203.2
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
+|+ +++.||+|+||.||++.+..+++.|++|.+..... .......+.+|+..+. ..+|+||+++++.+..++.+++
T Consensus 2 ~y~--~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 2 DFE--TIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILT-FAENPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred Cce--EeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHH-hCCCCCeeeeEEEEecCCEEEE
Confidence 455 99999999999999999999999999999876542 2233557778888887 7799999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc----
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV---- 164 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~---- 164 (253)
+|||++|++|.+++.....+++..+..++.+++.++.|||+++++|+||+|.||+++.++.++++|||.+......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999999999987778999999999999999999999999999999999999999999999999987631100
Q ss_pred ------------ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCC
Q psy12709 165 ------------VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHED 232 (253)
Q Consensus 165 ------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 232 (253)
.......++..|+|||.+.+..++.++|+||+|+++|++++|..||.+.+..+....+.......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEG 238 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCc
Confidence 00112345678999999988889999999999999999999999999888877777766655444432
Q ss_pred ccCCCCHHHHHHHHHhcccCC
Q psy12709 233 LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 ~~~~~~~~l~~li~~~l~~dP 253 (253)
. ..++.+++++|.+||++||
T Consensus 239 ~-~~~~~~~~~li~~~l~~~P 258 (305)
T cd05609 239 D-EALPADAQDLISRLLRQNP 258 (305)
T ss_pred c-ccCCHHHHHHHHHHhccCh
Confidence 2 3689999999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=296.29 Aligned_cols=239 Identities=26% Similarity=0.389 Sum_probs=197.5
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe--CCeE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET--PHEM 86 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~ 86 (253)
++|+ +++.||.|+||+||+|.+..++..+++|++............+..|+..+. .+.|+||++++++|.. ...+
T Consensus 13 ~~Ye--Il~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~-~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 13 NEYE--VIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMR-ELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred CCEE--EEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHH-HcCCCCcCeEEEEEEecCCCEE
Confidence 4566 999999999999999999999999999999876655566678889999988 7899999999998854 3579
Q ss_pred EEEEeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC-------CceecCCCCCCEEEcCC--------
Q psy12709 87 VLVLEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDH-------NITHLDLKPQNILLTKD-------- 147 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~-------~~~h~di~~~ni~~~~~-------- 147 (253)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+|+||+|+||+++.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 999999999999998864 25699999999999999999999985 49999999999999642
Q ss_pred ---------CceEEEeecccccccccccccccccCccccCccccCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChH
Q psy12709 148 ---------NNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSY--EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ 216 (253)
Q Consensus 148 ---------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 216 (253)
+.++|+|||++.............+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 3489999999986654434445578999999999854 45788999999999999999999999876554
Q ss_pred HHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 217 ETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 217 ~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.............+ ....+.++.+||.+||+.||
T Consensus 250 ~qli~~lk~~p~lp---i~~~S~eL~dLI~~~L~~dP 283 (1021)
T PTZ00266 250 SQLISELKRGPDLP---IKGKSKELNILIKNLLNLSA 283 (1021)
T ss_pred HHHHHHHhcCCCCC---cCCCCHHHHHHHHHHhcCCh
Confidence 44433333332222 23679999999999999998
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=262.37 Aligned_cols=236 Identities=25% Similarity=0.455 Sum_probs=201.9
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++.+.||.|++|.||++.+..++..|++|.+..... ........+|+..++ ..+|+||+++++.+..++.+++++||
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLA-KMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHH-hCCCCCcceEEEEEEECCEEEEEEee
Confidence 4499999999999999999999999999999875433 334567778888877 77999999999999999999999999
Q ss_pred cCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-cccc
Q psy12709 93 VPDGELQRLVDI--QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVKE 169 (253)
Q Consensus 93 ~~g~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~ 169 (253)
+++++|.+++.. ...+++..++.++.+++.++.+||++|++|+||+|+||+++.++.++++|||.+....... ....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 999999888764 2458999999999999999999999999999999999999999999999999987554322 1223
Q ss_pred cccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 170 IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
..+++.|+|||++.+..++.++|+||+|+++|+|++|+.||...+.......+..+...+.. ..++..++++|.+||
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l 236 (255)
T cd08219 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP---SHYSYELRSLIKQMF 236 (255)
T ss_pred ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC---cccCHHHHHHHHHHH
Confidence 45778899999998888999999999999999999999999988777777666655443322 367899999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
+.||
T Consensus 237 ~~~P 240 (255)
T cd08219 237 KRNP 240 (255)
T ss_pred hCCc
Confidence 9998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=294.17 Aligned_cols=241 Identities=22% Similarity=0.293 Sum_probs=195.7
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc-hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS-MDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
++|+ +.+.||+|+||.||+|.+..+++.||+|++...... .....++.+|+..+. ..+||||+++++++..++..+
T Consensus 2 grYe--Ii~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs-~L~HPNIVkl~~v~~d~~~ly 78 (932)
T PRK13184 2 QRYD--IIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAA-DLIHPGIVPVYSICSDGDPVY 78 (932)
T ss_pred CCeE--EEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHH-hCCCcCcCeEEEEEeeCCEEE
Confidence 4666 999999999999999999999999999999765432 333567888988887 778999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeec
Q psy12709 88 LVLEMVPDGELQRLVDIQ-----------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFG 156 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~ 156 (253)
++|||++|++|.+++... ...+...+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999999988531 224566788899999999999999999999999999999999999999999
Q ss_pred cccccccc-------------------ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH
Q psy12709 157 ISRVVNDV-------------------VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQE 217 (253)
Q Consensus 157 ~~~~~~~~-------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 217 (253)
++...... .......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99755210 00112357899999999999999999999999999999999999998755544
Q ss_pred HHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 218 TFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 218 ~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
........ .+........+|+.+.+++.+||+.||
T Consensus 239 i~~~~~i~-~P~~~~p~~~iP~~L~~LI~rcL~~DP 273 (932)
T PRK13184 239 ISYRDVIL-SPIEVAPYREIPPFLSQIAMKALAVDP 273 (932)
T ss_pred hhhhhhcc-ChhhccccccCCHHHHHHHHHHccCCh
Confidence 33221111 111111224789999999999999998
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=267.04 Aligned_cols=234 Identities=29% Similarity=0.465 Sum_probs=193.5
Q ss_pred cCCCCceEEEEEEeccCCceEEEEEecccccc-hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCCc
Q psy12709 19 PSRGKFASVRKCTHKITKVEYAAKFIRKRRRS-MDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGE 97 (253)
Q Consensus 19 lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 97 (253)
||+|+||+||+|.++.+++.|++|.+...... ......+.+|+..++ ..+|++|+++++.+...+.+++++||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILE-KVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHH-hCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 68999999999999999999999998764322 223445667888887 6689999999999999999999999999999
Q ss_pred HHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccccccCcc
Q psy12709 98 LQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPD 175 (253)
Q Consensus 98 L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (253)
|.+++.... .+++..+..++.|++.++.+||+.|++|+||+|+||++++++.++|+|||.+.............++..
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCC
Confidence 999887655 689999999999999999999999999999999999999999999999998876544333334456789
Q ss_pred ccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 176 YVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 176 ~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
|+|||.+.+..++.++|+||+|+++++|++|+.||...........+.......+......+++++.++|.+||+.||
T Consensus 160 y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (277)
T cd05577 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDP 237 (277)
T ss_pred cCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCCh
Confidence 999999988889999999999999999999999997765432222222222222333334679999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=269.72 Aligned_cols=239 Identities=32% Similarity=0.508 Sum_probs=203.5
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch-HHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM-DQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
+|+ +.+.||+|++|+||+|.+..+++.|++|.+....... .....+.+|+..+. ..+|++|+++++.+..+...++
T Consensus 2 ~y~--~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~l 78 (316)
T cd05574 2 HFK--KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILA-TLDHPFLPTLYASFQTETYLCL 78 (316)
T ss_pred ceE--EeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHH-hCCCCCchhheeeeecCCEEEE
Confidence 455 9999999999999999999999999999998765332 35567888888887 7789999999999999999999
Q ss_pred EEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc
Q psy12709 89 VLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 166 (253)
++||+.|++|.+++... ..+++..+..++.|++.++.|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999999988754 4689999999999999999999999999999999999999999999999998875432110
Q ss_pred ------------------------------ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH
Q psy12709 167 ------------------------------VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ 216 (253)
Q Consensus 167 ------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 216 (253)
.....++..|+|||...+..++.++|+||+|+++|++++|+.||.+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 11224567899999998888999999999999999999999999988887
Q ss_pred HHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 217 ETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 217 ~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+..+.......+.. ..++.+++++|.+||+.||
T Consensus 239 ~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p 273 (316)
T cd05574 239 ETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDP 273 (316)
T ss_pred HHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCH
Confidence 7777766555444432 2479999999999999987
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=281.12 Aligned_cols=214 Identities=30% Similarity=0.433 Sum_probs=187.6
Q ss_pred eeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcC-----CCCceeeeeEEEeCCe
Q psy12709 11 YQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQK-----SERIVGLHEIYETPHE 85 (253)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~-----~~~i~~~~~~~~~~~~ 85 (253)
|+|++++.||+|+||+|-+|.+..+++.||||+++... ....+...|+.++..+.+ .-|+|+++++|...++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 57789999999999999999999999999999998643 345577788888886663 3459999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC--CceEEEeecccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD--NNIKLCDFGISRVV 161 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~--~~~~l~df~~~~~~ 161 (253)
.++|+|.+ +.+|.+++..+ .+++...++.++.||+.+|..||+.||+|+||||+||++..- ..||++|||.++..
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999988 77999999875 468999999999999999999999999999999999999864 46999999999876
Q ss_pred cccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc
Q psy12709 162 NDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH 230 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~ 230 (253)
.... .....+..|.|||++.+.+|+.+.||||||||++||++|.+.|++.+..+.+..|......++
T Consensus 342 ~q~v--ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 342 SQRV--YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred CCcc--eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 5432 255678899999999999999999999999999999999999999999999988877655554
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=267.71 Aligned_cols=239 Identities=21% Similarity=0.326 Sum_probs=195.7
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCc--eEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKV--EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~--~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
++|+ +.+.||.|+||.||+|.++.++. .+++|.++.. ......+.+.+|+..+.+..+|+||+++++.+...+.+
T Consensus 2 ~~~~--~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 2 EDIK--FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred ccce--eeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 3455 99999999999999999887664 4688877642 22334567888999988677899999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCce
Q psy12709 87 VLVLEMVPDGELQRLVDIQD----------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNI 150 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~ 150 (253)
++++||+++++|.+++.... .++...++.++.|++.|+++||++|++|+||+|+||+++.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 99999999999999886532 47888999999999999999999999999999999999999999
Q ss_pred EEEeecccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccc
Q psy12709 151 KLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSF 229 (253)
Q Consensus 151 ~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~ 229 (253)
+|+|||++..............+..|+|||.+.+..++.++||||+|+++|+|++ |..||......+....+......
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~- 237 (297)
T cd05089 159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM- 237 (297)
T ss_pred EECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC-
Confidence 9999998864322111112223457999999988889999999999999999997 99999888877777666543221
Q ss_pred cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.....++++++++|.+||+.||
T Consensus 238 --~~~~~~~~~~~~li~~~l~~~p 259 (297)
T cd05089 238 --EKPRNCDDEVYELMRQCWRDRP 259 (297)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCh
Confidence 1223689999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=270.87 Aligned_cols=240 Identities=25% Similarity=0.364 Sum_probs=193.5
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
.+|+ +.+.||+|+||+||+|.++.++..|++|.+...... .......+|+..+. ..+|+||+++++++..++..++
T Consensus 6 ~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 6 ETYI--KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLK-DLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CceE--EEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHH-hCCCCCcceEEEEEeeCCeEEE
Confidence 4565 999999999999999999999999999998765432 22335667888887 7799999999999999999999
Q ss_pred EEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-cc
Q psy12709 89 VLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VE 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~ 166 (253)
+|||+++ +|...+... ..++...++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 9999976 777766543 45899999999999999999999999999999999999999999999999998754322 22
Q ss_pred ccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc----------------
Q psy12709 167 VKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF---------------- 229 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~---------------- 229 (253)
.....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+.+..+....+......+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 223456789999998755 467889999999999999999999998877665544433211110
Q ss_pred ---c-------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 ---H-------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 ---~-------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+ ....+.++++++++|.+||+.||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 274 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYES 274 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCCh
Confidence 0 11224678999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=260.74 Aligned_cols=237 Identities=28% Similarity=0.431 Sum_probs=204.7
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++.+.||.|++|.||+|.+..++..+++|.+............+.+|+..++ ..+|+|++++++.+..++..++++|+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLK-LLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHh-hCCCCchhheeeeEecCCEEEEEEec
Confidence 45999999999999999999999999999999876655566778889999888 67899999999999999999999999
Q ss_pred cCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-ceEEEeecccccccccccccc
Q psy12709 93 VPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN-NIKLCDFGISRVVNDVVEVKE 169 (253)
Q Consensus 93 ~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~-~~~l~df~~~~~~~~~~~~~~ 169 (253)
+++++|.+++... ..+++..+..++.+++.++++||++|++|+||+|+||+++.++ .++++|||.+...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence 9999999998763 3489999999999999999999999999999999999998654 589999999986654443344
Q ss_pred cccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 170 IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
..++..|+|||.+.+..++.++|+||+|+++|++++|+.||...+.......+....... ....++.++.++|.+||
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l 237 (256)
T cd08220 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP---ISDRYSPDLRQLILSML 237 (256)
T ss_pred cccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC---CCCCcCHHHHHHHHHHc
Confidence 567789999999988888999999999999999999999998877777666665543332 22368999999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
++||
T Consensus 238 ~~~p 241 (256)
T cd08220 238 NLDP 241 (256)
T ss_pred cCCh
Confidence 9997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=266.58 Aligned_cols=241 Identities=30% Similarity=0.463 Sum_probs=197.5
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
+|+ +.+.||+|++|.||+|.+..+++.|++|.+............+.+|+..+. ..+|+|++++++.+..++..+++
T Consensus 2 ~y~--~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 2 KYE--KLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLK-QLKHPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred cee--eeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHH-hCCCCCEeeeeeEEeeCCEEEEE
Confidence 455 999999999999999999999999999998765433333446678888887 67899999999999999999999
Q ss_pred EeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-ccc
Q psy12709 90 LEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVK 168 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~ 168 (253)
+||+++++|..++.....+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccccc
Confidence 9999999998887766679999999999999999999999999999999999999999999999999998654432 222
Q ss_pred ccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccc-------------------c
Q psy12709 169 EIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNF-------------------S 228 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~-------------------~ 228 (253)
...++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+.+..+....+..... .
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 3346778999999865 4578899999999999999999999988766554433322100 0
Q ss_pred ccC--------CccCCCCHHHHHHHHHhcccCC
Q psy12709 229 FHE--------DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 229 ~~~--------~~~~~~~~~l~~li~~~l~~dP 253 (253)
.+. ...+.++..+.+||.+||++||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 271 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDP 271 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCc
Confidence 000 1124678999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=262.32 Aligned_cols=231 Identities=23% Similarity=0.368 Sum_probs=193.9
Q ss_pred ecCCCCceEEEEEEe--ccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 18 MPSRGKFASVRKCTH--KITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 18 ~lg~g~~~~v~~~~~--~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
.||+|+||.||+|.. ..++..+++|++............+.+|+..+. ..+|+||+++++++. ++..++++|++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQ-QLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHH-hCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999999999965 356788999998766555556677888888887 679999999999875 4577899999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc----ccccc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE----VKEII 171 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~ 171 (253)
++|.+++.....+++..+..++.|++.++.+||++|++|+||+|.||+++.++.++|+|||.+........ .....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 99999998777899999999999999999999999999999999999999999999999999876543221 11122
Q ss_pred cCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcc
Q psy12709 172 GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLV 250 (253)
Q Consensus 172 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (253)
++..|+|||.+....++.++|+||+|+++|++++ |+.||......+....+....... ....+++++.++|.+||+
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERME---CPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC---CCCCCCHHHHHHHHHHhc
Confidence 3468999999988888999999999999999998 999998877777776666543321 224789999999999999
Q ss_pred cCC
Q psy12709 251 TDP 253 (253)
Q Consensus 251 ~dP 253 (253)
+||
T Consensus 237 ~~p 239 (257)
T cd05116 237 YGV 239 (257)
T ss_pred cCc
Confidence 998
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=269.12 Aligned_cols=239 Identities=23% Similarity=0.331 Sum_probs=195.0
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCce--EEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVE--YAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~--v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
++|+ +.+.||+|+||+||+|.++.++.. +++|.+... ........+.+|+..+.+..+|+||+++++++..++.+
T Consensus 7 ~~~~--~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 7 NDIK--FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred hhce--eeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 4566 899999999999999999877754 566665532 23344567888999998777999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCce
Q psy12709 87 VLVLEMVPDGELQRLVDIQ----------------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNI 150 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~ 150 (253)
++++||+++++|.+++... ..++...++.++.|++.|+++||++|++|+||+|+||+++.++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence 9999999999999988643 247899999999999999999999999999999999999999999
Q ss_pred EEEeecccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccc
Q psy12709 151 KLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSF 229 (253)
Q Consensus 151 ~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~ 229 (253)
+|+|||++..............+..|+|||.+.+..++.++|+||+|+++|++++ |..||...+..+....+.....
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-- 241 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-- 241 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCc--
Confidence 9999999864322111122223567999999988888999999999999999998 9999988777776665543311
Q ss_pred cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
......+++++.++|.+||+.||
T Consensus 242 -~~~~~~~~~~~~~li~~~l~~~p 264 (303)
T cd05088 242 -LEKPLNCDDEVYDLMRQCWREKP 264 (303)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCh
Confidence 11223578999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=261.35 Aligned_cols=240 Identities=28% Similarity=0.439 Sum_probs=201.8
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +.+.||.|++|.||+|.+..++..+++|++...... ....+.+|+..+. ..+|+||+++++.+..++.+++
T Consensus 3 ~~~~--~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~l 77 (262)
T cd06613 3 EDYE--LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLK-ECRHPNIVAYFGSYLRRDKLWI 77 (262)
T ss_pred cceE--EEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHH-hCCCCChhceEEEEEeCCEEEE
Confidence 3555 999999999999999999989999999999865433 4567888888887 7799999999999999999999
Q ss_pred EEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-c
Q psy12709 89 VLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-E 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~ 166 (253)
+||++++++|.+++... ..+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 99999999999988775 679999999999999999999999999999999999999999999999999987654322 2
Q ss_pred ccccccCccccCccccCCC---CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC-CccCCCCHHHH
Q psy12709 167 VKEIIGTPDYVAPEVLSYE---PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE-DLFGHISSQAK 242 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~l~ 242 (253)
.....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+.......+......++. .....++.+++
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence 2334567789999998776 7888999999999999999999999887766555544444222221 12235688899
Q ss_pred HHHHHhcccCC
Q psy12709 243 DFIQSCLVTDP 253 (253)
Q Consensus 243 ~li~~~l~~dP 253 (253)
+++.+||+.||
T Consensus 238 ~li~~~l~~~p 248 (262)
T cd06613 238 DFIKKCLTKDP 248 (262)
T ss_pred HHHHHHcCCCh
Confidence 99999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=266.55 Aligned_cols=238 Identities=20% Similarity=0.316 Sum_probs=200.0
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCC-----ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITK-----VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
+.|+ +++.||.|++|.||+|.+...+ ..|++|.+.... .......+.+|+..+. ..+|+||+++++++...
T Consensus 5 ~~~~--~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~-~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 5 SAVR--FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMS-DLQHPNIVCLLGVCTKE 80 (283)
T ss_pred HHcc--hhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHH-hcCCcccceEEEEEcCC
Confidence 3455 9999999999999999977554 679999887543 3344567788988887 77999999999999998
Q ss_pred CeEEEEEeccCCCcHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQ----------------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD 147 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~ 147 (253)
+..++++||+++++|.+++... ..++...++.++.|++.|+.+||++|++|+||+|+||+++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 9999999999999999988654 347888999999999999999999999999999999999999
Q ss_pred CceEEEeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q psy12709 148 NNIKLCDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNIS 223 (253)
Q Consensus 148 ~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~ 223 (253)
+.++|+|||++....... ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+....+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999987543221 1223345678999999988889999999999999999998 999999888888777776
Q ss_pred cccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 224 QCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 224 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
...... ....+|+++.+++.+||+.||
T Consensus 241 ~~~~~~---~~~~~~~~~~~l~~~c~~~~p 267 (283)
T cd05048 241 SRQLLP---CPEDCPARVYALMIECWNEIP 267 (283)
T ss_pred cCCcCC---CcccCCHHHHHHHHHHccCCh
Confidence 554332 234789999999999999998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=264.96 Aligned_cols=242 Identities=25% Similarity=0.366 Sum_probs=197.9
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
....|++.+.||+|+||.||+|.+..++..|++|++...... ....+.+|+..+. ..+|+||+++++.+..++.+++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~-~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVK-ECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHH-hcCCCCeeeeeEEEEeCCEEEE
Confidence 333455999999999999999999999999999998754332 2346778888887 7899999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-cc
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EV 167 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~ 167 (253)
++||+++++|.+++..+.++++..+..++.|++.++.|||+.|++|+|++|.||+++.++.++|+|||.+....... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR 163 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence 99999999999998877789999999999999999999999999999999999999999999999999987653321 22
Q ss_pred cccccCccccCccccC---CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC-CccCCCCHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLS---YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE-DLFGHISSQAKD 243 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~l~~ 243 (253)
....+++.|+|||.+. ...++.++|+||+|+++|+|++|+.||......+....+......++. .....++..+.+
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN 243 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence 3345678999999874 345778999999999999999999999765544433333333322221 122357899999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 244 li~~~l~~~P 253 (267)
T cd06646 244 FVKISLTKNP 253 (267)
T ss_pred HHHHHhhCCh
Confidence 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=265.57 Aligned_cols=247 Identities=28% Similarity=0.425 Sum_probs=204.0
Q ss_pred CCCcceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy12709 1 MCNKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80 (253)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 80 (253)
|+..+..+++|+ +++.||.|++|.||+|.+..++..+++|.+... .......+.+|+..+. ..+|+||+++++.+
T Consensus 4 ~~~~~~~~~~y~--i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~ 78 (292)
T cd06644 4 VRRDLDPNEVWE--IIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILA-TCNHPYIVKLLGAF 78 (292)
T ss_pred hhcccCcchhhh--hhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHH-hCCCCcEeeeEEEE
Confidence 345566778888 999999999999999999999999999998754 3344667788888887 77899999999999
Q ss_pred EeCCeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 81 ETPHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 81 ~~~~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
..++.++++|||+++++|..++.. ...+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred EeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccce
Confidence 999999999999999999887754 4568999999999999999999999999999999999999999999999999876
Q ss_pred ccccc-ccccccccCccccCccccC-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCc
Q psy12709 160 VVNDV-VEVKEIIGTPDYVAPEVLS-----YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDL 233 (253)
Q Consensus 160 ~~~~~-~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 233 (253)
..... .......+++.|+|||.+. ...++.++|+||+|+++|+|++|..||...+......++.....+ ....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~ 237 (292)
T cd06644 159 KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLSQ 237 (292)
T ss_pred eccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc-cCCC
Confidence 53221 2223345678999999984 344678999999999999999999999877666555555443221 2222
Q ss_pred cCCCCHHHHHHHHHhcccCC
Q psy12709 234 FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP 253 (253)
...++.++.++|.+||+.||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p 257 (292)
T cd06644 238 PSKWSMEFRDFLKTALDKHP 257 (292)
T ss_pred CcccCHHHHHHHHHHhcCCc
Confidence 34678999999999999988
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=280.46 Aligned_cols=239 Identities=31% Similarity=0.503 Sum_probs=222.9
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.+.|. +.+.||+|.|++|.+|.+..++..||+|.++++..+....+++.+|+.++. .++||||++++.+.+.+..+|
T Consensus 55 vg~y~--i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk-~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 55 VGLYV--IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMK-SLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccee--eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHH-hcCCcceeeeeeeeeecceeE
Confidence 34566 999999999999999999999999999999999988888888999999998 999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV 167 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 167 (253)
+||||+.++.+.+++..++...+..+..+..|+.+|++|||+++++|+|++++|++++.+.+++|+|||++..+......
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l 211 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML 211 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccc
Confidence 99999999999999999888888999999999999999999999999999999999999999999999999998887888
Q ss_pred cccccCccccCccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLSYEPI-SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~ 246 (253)
..+++.+.|.|||++.+..+ .++.|+||+|+++|.++.|.+||.+.+-.+....+..++...+. .++-+..++|.
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dce~lLr 287 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDCEDLLR 287 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeechhHHHHH
Confidence 88999999999999998876 57999999999999999999999998888887777777776666 77899999999
Q ss_pred HhcccCC
Q psy12709 247 SCLVTDP 253 (253)
Q Consensus 247 ~~l~~dP 253 (253)
++|..||
T Consensus 288 k~lvl~P 294 (596)
T KOG0586|consen 288 KFLVLNP 294 (596)
T ss_pred HhhccCc
Confidence 9998887
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=260.95 Aligned_cols=239 Identities=27% Similarity=0.416 Sum_probs=200.4
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++.+.||+|++|.||+|.+..++..|++|.++...........+.+|+..+. ..+|+||++++++....+.+++++||
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~-~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLE-LLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHH-hCCCCChhheeeeEecCCEEEEEEec
Confidence 44999999999999999999989999999999877665567788999999888 77999999999999999999999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccc-----
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV----- 167 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~----- 167 (253)
+++++|.+++.....+++..+..++.+++.++.+||+.|++|+||+|+||++++++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 160 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence 999999999987777899999999999999999999999999999999999999999999999998765432221
Q ss_pred cccccCccccCccccCCCC---CCccccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLSYEP---ISLATDMWSVGVLAYVLLSSHSPFAGDNKQ-ETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
....+++.|+|||.+.+.. .+.++|+||+|++++++++|+.||...... .....+.. ...+..+....++..+.+
T Consensus 161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccCHHHHH
Confidence 1235678999999987766 788999999999999999999999765332 22222222 222222222356899999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 240 li~~~l~~~p 249 (264)
T cd06626 240 FLDRCLESDP 249 (264)
T ss_pred HHHHHccCCc
Confidence 9999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=276.74 Aligned_cols=238 Identities=23% Similarity=0.368 Sum_probs=191.1
Q ss_pred eEEEeecCCCCceEEEEEEe-----ccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTH-----KITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
|++.+.||+|+||+||+|.+ ..++..||+|++..... ......+.+|+..+....+||||+++++.+..++..+
T Consensus 37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~ 115 (375)
T cd05104 37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL 115 (375)
T ss_pred eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence 44999999999999999974 34567899999875432 2334678889999986669999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcC-------------------------------------------------------------
Q psy12709 88 LVLEMVPDGELQRLVDIQD------------------------------------------------------------- 106 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~------------------------------------------------------------- 106 (253)
+||||+++++|.+++....
T Consensus 116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (375)
T cd05104 116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI 195 (375)
T ss_pred eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence 9999999999988875421
Q ss_pred --------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccc---cc
Q psy12709 107 --------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV---KE 169 (253)
Q Consensus 107 --------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~---~~ 169 (253)
.+++..+..++.|++.++.|||++|++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 275 (375)
T cd05104 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275 (375)
T ss_pred ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCC
Confidence 3678889999999999999999999999999999999999999999999998755432211 11
Q ss_pred cccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 170 IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
...+..|+|||.+.+..++.++|+||+|+++|+|++ |..||..........+.......... ....+.+++++|.+|
T Consensus 276 ~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~c 353 (375)
T cd05104 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLS--PECAPSEMYDIMKSC 353 (375)
T ss_pred CCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCC--CCCCCHHHHHHHHHH
Confidence 223457999999998899999999999999999998 89999876544433333332222211 135688999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|+.||
T Consensus 354 l~~dP 358 (375)
T cd05104 354 WDADP 358 (375)
T ss_pred ccCCh
Confidence 99998
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=262.52 Aligned_cols=240 Identities=26% Similarity=0.495 Sum_probs=198.0
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
++|+ +.+.||.|+||.||+|.+..++..|++|.+.... ........+.+|+..+. ..+|+||+++++++...+..+
T Consensus 2 ~~~~--i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~ 78 (267)
T cd08228 2 ANFQ--IEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLK-QLNHPNVIKYLDSFIEDNELN 78 (267)
T ss_pred ccee--eeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHH-hCCCcceeeeeeeEEECCeEE
Confidence 3555 9999999999999999999999999999886533 33444567788998887 779999999999999999999
Q ss_pred EEEeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 88 LVLEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
+++||+++++|.+++.. ...+++..+..++.+++.|+.|||+++++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999999988753 34478999999999999999999999999999999999999999999999998876543
Q ss_pred ccc-ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHhhcccccccCCccCCCCHH
Q psy12709 164 VVE-VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDN--KQETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 164 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
... .....+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||.... .......+.....+ ......++..
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 236 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP--PLPTEHYSEK 236 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCC--CCChhhcCHH
Confidence 221 123356789999999988888999999999999999999999996543 23444444443322 2222367889
Q ss_pred HHHHHHHhcccCC
Q psy12709 241 AKDFIQSCLVTDP 253 (253)
Q Consensus 241 l~~li~~~l~~dP 253 (253)
+.++|.+||+.||
T Consensus 237 ~~~li~~cl~~~p 249 (267)
T cd08228 237 LRELVSMCIYPDP 249 (267)
T ss_pred HHHHHHHHCCCCc
Confidence 9999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=275.66 Aligned_cols=240 Identities=24% Similarity=0.422 Sum_probs=195.4
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC---
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP--- 83 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--- 83 (253)
+.++|+ +++.||+|+||+||+|.+..++..||+|.+............+.+|+..+. ..+|+||+++++++...
T Consensus 13 ~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 13 VPERYQ--NLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK-HMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhh--hheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHH-hcCCCchhhhhhhhcccccc
Confidence 456777 999999999999999999999999999999876544445567778999888 77999999999987543
Q ss_pred ---CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 84 ---HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 84 ---~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
...+++++++ +++|.+++. ...+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 3578999988 778988875 45699999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc---------
Q psy12709 161 VNDVVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH--------- 230 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--------- 230 (253)
.... .....+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+.+..+....+......++
T Consensus 168 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 168 ADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred cCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 5432 233467889999999866 5678899999999999999999999987665554444332111111
Q ss_pred ------------------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 ------------------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 ------------------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.......++.+.+||.+||+.||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp 286 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDS 286 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCCh
Confidence 01123467789999999999998
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=262.40 Aligned_cols=237 Identities=26% Similarity=0.399 Sum_probs=198.9
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch-------HHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM-------DQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
|.+...||.|++|.||+|.+..++..|++|.+....... .....+.+|+..+. ..+|+||+++++++..++.
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK-ELQHENIVQYLGSSLDADH 80 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHH-hcCCCCeeeEEEEEEeCCc
Confidence 348899999999999999999899999999887654321 23356778888887 7799999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~ 165 (253)
.++++||+++++|.+++.....++...+..++.+++.++.+||+.|++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999887889999999999999999999999999999999999999999999999999987654211
Q ss_pred c-------ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCC
Q psy12709 166 E-------VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHIS 238 (253)
Q Consensus 166 ~-------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 238 (253)
. .....++..|+|||.+.+..++.++|+||+|+++|++++|+.||...+.......+..... ......++
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 237 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS---PEIPSNIS 237 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC---CcCCcccC
Confidence 1 1112466789999999888889999999999999999999999988766555554444222 12234689
Q ss_pred HHHHHHHHHhcccCC
Q psy12709 239 SQAKDFIQSCLVTDP 253 (253)
Q Consensus 239 ~~l~~li~~~l~~dP 253 (253)
.+++++|++||++||
T Consensus 238 ~~~~~li~~~l~~~p 252 (267)
T cd06628 238 SEAIDFLEKTFEIDH 252 (267)
T ss_pred HHHHHHHHHHccCCc
Confidence 999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=267.05 Aligned_cols=242 Identities=19% Similarity=0.282 Sum_probs=193.3
Q ss_pred ecceeeEEEeecCCCCceEEEEEEecc----------------CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCC
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKI----------------TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSE 71 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~----------------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~ 71 (253)
.++|+ +.+.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+..+. .++|+
T Consensus 4 ~~~~~--~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~-~l~h~ 79 (304)
T cd05096 4 RGHLL--FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILS-RLKDP 79 (304)
T ss_pred hhhCe--eeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHh-hcCCC
Confidence 35666 99999999999999998542 33479999987543 2344567888999888 67999
Q ss_pred CceeeeeEEEeCCeEEEEEeccCCCcHHHHHhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy12709 72 RIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQD-------------------GIPEQDTRSYMKQILEALAFLHDHNI 132 (253)
Q Consensus 72 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~-------------------~~~~~~~~~~~~~l~~~l~~lh~~~~ 132 (253)
||+++++++...+..+++|||+.+++|.+++.... .++...+..++.|++.|+.|||+.|+
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 99999999999999999999999999999886431 35677889999999999999999999
Q ss_pred eecCCCCCCEEEcCCCceEEEeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh--CC
Q psy12709 133 THLDLKPQNILLTKDNNIKLCDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS--SH 207 (253)
Q Consensus 133 ~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~--g~ 207 (253)
+|+||+|+||+++.++.++|+|||++....... ......++..|+|||++.+..++.++|+||+|+++|+|++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 999999999999999999999999987553321 1122334678999999988889999999999999999987 67
Q ss_pred CCCCCCChHHHHHHhhcc----cccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 208 SPFAGDNKQETFLNISQC----NFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 208 ~p~~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.||...+..+....+... .........+.++..+.++|.+||+.||
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 289 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDC 289 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCc
Confidence 889877766655443221 1111111224678999999999999998
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=275.64 Aligned_cols=191 Identities=24% Similarity=0.358 Sum_probs=167.9
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +++.||+|+||.||+|.+..+++.||+|.... ..+.+|+..+. .++|+||+++++++..+...++
T Consensus 92 ~~y~--~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 92 AGFS--ILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILR-AINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred CCcE--EEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHH-hCCCCCCCCEeEEEEECCeeEE
Confidence 4566 99999999999999999999999999997532 24567888887 7799999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc--cc
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV--VE 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~--~~ 166 (253)
++|++. ++|..++.....++...++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 999985 578888777777999999999999999999999999999999999999999999999999998643221 22
Q ss_pred ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCC
Q psy12709 167 VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFA 211 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 211 (253)
.....+++.|+|||++.+..++.++|+||+|+++|+|++|+.||-
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 334578999999999998899999999999999999999998764
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=261.33 Aligned_cols=236 Identities=20% Similarity=0.334 Sum_probs=199.2
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +.+.||.|++|.||+|.++.++..|++|.+..... ....+.+|+..++ ..+|++|+++++++..++.+++
T Consensus 6 ~~~~--~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 6 TDIT--MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMK-EIKHPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred HHeE--EeeecCCcccceEEEEEEecCCceEEEEEecCCch---HHHHHHHHHHHHH-hCCCCChhheEEEEcCCCCcEE
Confidence 3455 99999999999999999999999999999875432 2456778999888 6799999999999999999999
Q ss_pred EEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc
Q psy12709 89 VLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 166 (253)
+|||+++++|.+++... ..++...++.++.|++.++.+||++|++|+||+|+||++++++.++|+|||.+........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999999999988653 3588999999999999999999999999999999999999999999999999876543322
Q ss_pred cc--ccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 167 VK--EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 167 ~~--~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
.. ....+..|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+.+..+..... ......+|+++.+
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 236 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---MERPEGCPPKVYE 236 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCCHHHHH
Confidence 11 1223457999999988899999999999999999998 9999998877777766655322 1223478999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 237 li~~cl~~~p 246 (263)
T cd05052 237 LMRACWQWNP 246 (263)
T ss_pred HHHHHccCCc
Confidence 9999999998
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=262.05 Aligned_cols=237 Identities=32% Similarity=0.562 Sum_probs=206.8
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
..+.||.|+++.|-.|....++.+||||++.+... -...++++|++++.....|+||++++++|+++..+|+|||.+.
T Consensus 82 t~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g--HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 82 TSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG--HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc--hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 34689999999999999999999999999988643 3356899999999999999999999999999999999999999
Q ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc---eEEEeecccccccc--------
Q psy12709 95 DGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN---IKLCDFGISRVVND-------- 163 (253)
Q Consensus 95 g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~---~~l~df~~~~~~~~-------- 163 (253)
||+|...|.++..|++.++.+++++++.||.+||.+||+|+|++|+||+-...+. ||||||.+......
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 9999999998999999999999999999999999999999999999999977544 89999998864321
Q ss_pred cccccccccCccccCccccC---C--CCCCccccHHHHHHHHHHHHhCCCCCCCC---------------ChHHHHHHhh
Q psy12709 164 VVEVKEIIGTPDYVAPEVLS---Y--EPISLATDMWSVGVLAYVLLSSHSPFAGD---------------NKQETFLNIS 223 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~---~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~---------------~~~~~~~~i~ 223 (253)
......++|+..|||||+.. + ..|+.+.|.||||+++|-|++|.+||.+. =....+.+|.
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 12223456777999999862 2 35789999999999999999999999663 1346678899
Q ss_pred cccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 224 QCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 224 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.+...+|......+|.+.+++|+.+|..||
T Consensus 320 EGkYeFPdkdWahIS~eakdlisnLlvrda 349 (463)
T KOG0607|consen 320 EGKYEFPDKDWAHISSEAKDLISNLLVRDA 349 (463)
T ss_pred ccCCcCChhhhHHhhHHHHHHHHHHHhccH
Confidence 999999999889999999999999998775
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=263.47 Aligned_cols=237 Identities=26% Similarity=0.420 Sum_probs=200.9
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
+|+ +.+.||.|++|.||+|.+..++..|++|.+.... .......+.+|+..++ ..+|+||+++.+.+..+..++++
T Consensus 2 ~y~--~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 2 LFT--LLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLS-QCRSPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred hhh--hhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHH-HcCCCCeeeeeEEEEECCeEEEE
Confidence 455 8999999999999999999999999999987653 2334566788888887 66799999999999999999999
Q ss_pred EeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-cccc
Q psy12709 90 LEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEVK 168 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~ 168 (253)
+|++++++|.+++... ++++..++.++.|++.++.+||+.+++|+||+|+||++++++.++|+|||.+...... ....
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence 9999999999998755 7899999999999999999999999999999999999999999999999998766543 2223
Q ss_pred ccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 169 EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
...+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+.......+.....+.... ..+++++.+++.+|
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~ 234 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG--NKFSKPFKDFVSLC 234 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcc--cccCHHHHHHHHHH
Confidence 3456778999999988889999999999999999999999998776665555544432222111 23899999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|..||
T Consensus 235 l~~~p 239 (274)
T cd06609 235 LNKDP 239 (274)
T ss_pred hhCCh
Confidence 99988
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=263.82 Aligned_cols=235 Identities=28% Similarity=0.426 Sum_probs=195.8
Q ss_pred EEEeecCCCCceEEEEEEec----cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 14 LIFCMPSRGKFASVRKCTHK----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
.+.+.||.|+||.||+|... ..+..|++|.+.. .........+.+|+..+.+. +|+||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccc-ccccccccccccccccccccc
Confidence 47889999999999999988 3457799999954 33444577889999999844 999999999999988889999
Q ss_pred EeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc---
Q psy12709 90 LEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV--- 164 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~--- 164 (253)
+||+++++|.+++... ..++...+..++.|++.|+.|||+++++|++|+++||+++.++.+||+|||.+......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999876 67999999999999999999999999999999999999999999999999999866321
Q ss_pred ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
...........|+|||.+.+..++.++||||+|+++|++++ |+.||...+..+....+......... ..++..+.+
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 236 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIP---DNCPKDIYS 236 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSB---TTSBHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceec---cchhHHHHH
Confidence 11223345679999999988889999999999999999999 78999998888888777665543322 368999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 237 li~~C~~~~p 246 (259)
T PF07714_consen 237 LIQQCWSHDP 246 (259)
T ss_dssp HHHHHT-SSG
T ss_pred HHHHHcCCCh
Confidence 9999999998
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=274.81 Aligned_cols=246 Identities=21% Similarity=0.346 Sum_probs=196.9
Q ss_pred cceeecceeeEEEeecCCCCceEEEEEEeccC-----CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeee
Q psy12709 4 KFFVNGGYQTLIFCMPSRGKFASVRKCTHKIT-----KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHE 78 (253)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~ 78 (253)
+.|...+.+|++.+.||+|+||.||+|.+... +..||+|++..... ....+.+.+|+..+..+..||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 34555667777999999999999999987532 34699999875433 3345678899999985656999999999
Q ss_pred EEEeCCeEEEEEeccCCCcHHHHHhhc-----------------------------------------------------
Q psy12709 79 IYETPHEMVLVLEMVPDGELQRLVDIQ----------------------------------------------------- 105 (253)
Q Consensus 79 ~~~~~~~~~lv~e~~~g~~L~~~~~~~----------------------------------------------------- 105 (253)
++...+.+++||||+++++|.+++..+
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 999999999999999999998877532
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q psy12709 106 -------------------------------------------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNI 142 (253)
Q Consensus 106 -------------------------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni 142 (253)
..++...+..++.|++.|+.|||+++++|+||+|.||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 2367788899999999999999999999999999999
Q ss_pred EEcCCCceEEEeeccccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHH
Q psy12709 143 LLTKDNNIKLCDFGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQET 218 (253)
Q Consensus 143 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~ 218 (253)
+++.++.++|+|||++........ .....+++.|+|||.+.+..++.++||||+|+++|+|++ |..||........
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 999999999999999875432211 122234578999999988889999999999999999997 9999987554433
Q ss_pred H-HHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 219 F-LNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 219 ~-~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
. ..+... ..++ ....++.++.+++.+||+.||
T Consensus 349 ~~~~~~~~-~~~~--~~~~~~~~l~~li~~cl~~dP 381 (400)
T cd05105 349 FYNKIKSG-YRMA--KPDHATQEVYDIMVKCWNSEP 381 (400)
T ss_pred HHHHHhcC-CCCC--CCccCCHHHHHHHHHHCccCH
Confidence 3 333332 2222 224789999999999999998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=258.88 Aligned_cols=237 Identities=30% Similarity=0.466 Sum_probs=204.2
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++.+.||+|+||++|++.+..+++.|++|.+............+.+|+..++ ..+|+||+++.+.+...+..++++||
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLS-NMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHH-hCCCCCeeeeEeeecCCCeEEEEEec
Confidence 44999999999999999999999999999998766555555678888999887 77899999999999999999999999
Q ss_pred cCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc-ccc
Q psy12709 93 VPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE-VKE 169 (253)
Q Consensus 93 ~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~ 169 (253)
+.+++|.+.+... ..+++..+..++.|++.++.+||+++++|+||+|+||+++.++.++++|||.+........ ...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 9999999988653 2578999999999999999999999999999999999999999999999999876543222 122
Q ss_pred cccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 170 IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
..+++.|+|||...+..++.++|+||+|++++++++|+.||......+....+..+..... ...++.++.++|.+||
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l 237 (256)
T cd08218 161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---SSHYSYDLRNLVSQLF 237 (256)
T ss_pred ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---cccCCHHHHHHHHHHh
Confidence 3467789999999888899999999999999999999999988887777776655544322 2478999999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
+.+|
T Consensus 238 ~~~p 241 (256)
T cd08218 238 KRNP 241 (256)
T ss_pred hCCh
Confidence 9987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=264.23 Aligned_cols=238 Identities=25% Similarity=0.418 Sum_probs=198.5
Q ss_pred eeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEE
Q psy12709 11 YQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVL 90 (253)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 90 (253)
.+|++.+.||+|++|.||+|.+..++..|++|.+...... ....+.+|+..+. ..+|+||+++++.+..+...++|+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~-~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMR-ENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHH-hCCCCCEeeEEEEEEeCCEEEEee
Confidence 3455999999999999999999999999999998765433 2456778888887 789999999999999999999999
Q ss_pred eccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-cccc
Q psy12709 91 EMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVKE 169 (253)
Q Consensus 91 e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~ 169 (253)
||+++++|.+++.. ..++..++..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence 99999999998864 458999999999999999999999999999999999999999999999999887543322 1223
Q ss_pred cccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 170 IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
..+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...........+.... .++......++..+.++|.+||
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l 254 (296)
T cd06654 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCL 254 (296)
T ss_pred ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-CCCCCCccccCHHHHHHHHHHC
Confidence 457789999999988888999999999999999999999998776644443333222 2222233468899999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
.+||
T Consensus 255 ~~~p 258 (296)
T cd06654 255 DMDV 258 (296)
T ss_pred cCCc
Confidence 9987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=259.93 Aligned_cols=240 Identities=24% Similarity=0.392 Sum_probs=201.8
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
+|+ +.+.||.|++|+||+|....++..+++|++....... ....+.+|+..+. ..+|+|++++++.+..++.++++
T Consensus 2 ~y~--~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 2 DYE--LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMS-QCNHPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred cce--eeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHH-hcCCCCEEEEEEEEeeCCEEEEE
Confidence 455 9999999999999999998899999999987655433 5678888998887 77999999999999999999999
Q ss_pred EeccCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc
Q psy12709 90 LEMVPDGELQRLVDIQ---DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE 166 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 166 (253)
+|++++++|.+++... ..+++..+..++.|++.++.+||+.|++|+|++|+||++++++.++|+|||++........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999998764 3589999999999999999999999999999999999999999999999999876543222
Q ss_pred c-----cccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCc--cCCCC
Q psy12709 167 V-----KEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDL--FGHIS 238 (253)
Q Consensus 167 ~-----~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~--~~~~~ 238 (253)
. ....++..|+|||.+... .++.++|+||+|+++++|++|+.||...+....+..+........... ...++
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS 237 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccccc
Confidence 1 223467899999998766 788899999999999999999999988777666655544433222221 23678
Q ss_pred HHHHHHHHHhcccCC
Q psy12709 239 SQAKDFIQSCLVTDP 253 (253)
Q Consensus 239 ~~l~~li~~~l~~dP 253 (253)
+++.+++.+||+.||
T Consensus 238 ~~~~~li~~~l~~~p 252 (267)
T cd06610 238 KSFRKMISLCLQKDP 252 (267)
T ss_pred HHHHHHHHHHcCCCh
Confidence 999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=262.88 Aligned_cols=240 Identities=24% Similarity=0.374 Sum_probs=197.8
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +.+.||+|+||.||+|.+..+++.|++|.++.... .....+.+|+..+. ..+|+||+++++.+..++.+++
T Consensus 9 ~~~~--~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~-~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 9 EDFE--LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMK-DCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred HHHH--HHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHH-hCCCCCeeeEEEEEEeCCEEEE
Confidence 4666 88999999999999999999999999999875432 23445677887777 7799999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-ccc
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEV 167 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~ 167 (253)
++||+++++|.+++.....+++..++.++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998754332 122
Q ss_pred cccccCccccCccccC---CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc-CCccCCCCHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLS---YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH-EDLFGHISSQAKD 243 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~l~~ 243 (253)
....++..|+|||.+. ...++.++|+||+|+++|+|++|+.||..................++ ......+++.+.+
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH 243 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence 3346788999999874 44578899999999999999999999876554443333333333222 1122357899999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 244 li~~~l~~~P 253 (267)
T cd06645 244 FVKMALTKNP 253 (267)
T ss_pred HHHHHccCCc
Confidence 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=260.30 Aligned_cols=230 Identities=29% Similarity=0.495 Sum_probs=197.1
Q ss_pred cCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCCc
Q psy12709 19 PSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGE 97 (253)
Q Consensus 19 lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 97 (253)
||.|++|.||+|.+..++..|++|.+.+... .......+.+|+..+. ..+|+||+++++.+..++.+++++||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILE-ECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHH-hCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 6999999999999999999999999976543 2334567888888887 6699999999999999999999999999999
Q ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccccccCcccc
Q psy12709 98 LQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV 177 (253)
Q Consensus 98 L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 177 (253)
|.+++.....++...+..++.+++.++++||+++++|+||+|+||+++.++.++|+|||.+.............+++.|+
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYV 159 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCcc
Confidence 99999877779999999999999999999999999999999999999999999999999998665443333446788999
Q ss_pred CccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHhhc--ccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 178 APEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDN--KQETFLNISQ--CNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 178 ~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~i~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
|||.+.+..++.++|+||+|+++|++++|..||.... ..+.+..+.. .....+ ...++++.++|.+||+.||
T Consensus 160 ~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~~~p 235 (262)
T cd05572 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP----NYIDKAAKDLIKQLLRRNP 235 (262)
T ss_pred ChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC----cccCHHHHHHHHHHccCCh
Confidence 9999988888999999999999999999999998766 5555655553 222222 2458999999999999987
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=263.21 Aligned_cols=237 Identities=25% Similarity=0.416 Sum_probs=199.7
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
+|++.+.||.|++|.||+|.+..++..|++|.+..... .....+.+|+..+. ..+|+|++++++.+..++.+++++|
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMK-ELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHH-hcCCCceeeeeeeEecCceEEEEEE
Confidence 34499999999999999999999999999999875433 23456778888887 7799999999999999999999999
Q ss_pred ccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc-cccc
Q psy12709 92 MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE-VKEI 170 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~~ 170 (253)
|+++++|..++.. ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 97 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 175 (296)
T cd06655 97 YLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (296)
T ss_pred ecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCc
Confidence 9999999998864 4589999999999999999999999999999999999999999999999998875443221 2234
Q ss_pred ccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcc
Q psy12709 171 IGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLV 250 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (253)
.++..|+|||.+.+..++.++|+||+|+++|++++|+.||...+.......+.... .+.......+++.+.++|.+||.
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~ 254 (296)
T cd06655 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSPIFRDFLNRCLE 254 (296)
T ss_pred CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CcccCCcccCCHHHHHHHHHHhh
Confidence 56789999999988889999999999999999999999998877765554444332 22222335789999999999999
Q ss_pred cCC
Q psy12709 251 TDP 253 (253)
Q Consensus 251 ~dP 253 (253)
.||
T Consensus 255 ~dp 257 (296)
T cd06655 255 MDV 257 (296)
T ss_pred cCh
Confidence 987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=259.19 Aligned_cols=232 Identities=25% Similarity=0.344 Sum_probs=200.4
Q ss_pred eecCCCCceEEEEEEeccC---CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEecc
Q psy12709 17 CMPSRGKFASVRKCTHKIT---KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMV 93 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 93 (253)
+.||+|+||.||+|.+... +..|++|.+....... ....+.+|+..+. ..+|++++++++++..+..+++++||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMK-KLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHh-hcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999876 8899999998765443 5678889999888 556999999999999999999999999
Q ss_pred CCCcHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 94 PDGELQRLVDIQ---------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 94 ~g~~L~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
++++|.+++... ..+++..++.++.|++.|+++||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 67999999999999999999999999999999999999999999999999999866543
Q ss_pred c---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHH
Q psy12709 165 V---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 165 ~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
. ......++..|+|||.+....++.++|+||+|+++|+|++ |..||...+..+....+...... .....+|++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 235 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL---PKPEYCPDE 235 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCccCChH
Confidence 2 2233446778999999988889999999999999999999 69999998887777777653322 223467999
Q ss_pred HHHHHHHhcccCC
Q psy12709 241 AKDFIQSCLVTDP 253 (253)
Q Consensus 241 l~~li~~~l~~dP 253 (253)
+.+++.+||+.||
T Consensus 236 ~~~li~~~l~~~p 248 (262)
T cd00192 236 LYELMLSCWQLDP 248 (262)
T ss_pred HHHHHHHHccCCc
Confidence 9999999999997
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=264.52 Aligned_cols=238 Identities=28% Similarity=0.443 Sum_probs=196.5
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++++.||+|++|+||+|.+..++..|++|.+.... .......+.+|+..+. ..+|+||+++++.+..++.+++++||
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILH-KAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHH-hcCCCcHHhhhhheecCCeEEEEEee
Confidence 349999999999999999999999999999887542 3334567888999888 67999999999999999999999999
Q ss_pred cCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCceEEEeeccccccccccccc
Q psy12709 93 VPDGELQRLVDIQ---DGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK 168 (253)
Q Consensus 93 ~~g~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 168 (253)
+++++|..++... ..+++..+..++.+++.++.|||+ .+++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~ 159 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LAK 159 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-ccc
Confidence 9999999888753 368999999999999999999997 59999999999999999999999999988754332 222
Q ss_pred ccccCccccCccccCCCC------CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHH
Q psy12709 169 EIIGTPDYVAPEVLSYEP------ISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAK 242 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~~------~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~ 242 (253)
...+++.|+|||.+.+.. ++.++|+||+|+++|++++|+.||...........+.......+....+.+++++.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQ 239 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHH
Confidence 335677899999985543 47899999999999999999999987665555444333222233334456899999
Q ss_pred HHHHHhcccCC
Q psy12709 243 DFIQSCLVTDP 253 (253)
Q Consensus 243 ~li~~~l~~dP 253 (253)
++|.+||+.||
T Consensus 240 ~li~~~l~~~p 250 (286)
T cd06622 240 DFVAKCLNKIP 250 (286)
T ss_pred HHHHHHcccCc
Confidence 99999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=257.82 Aligned_cols=232 Identities=24% Similarity=0.338 Sum_probs=192.7
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDG 96 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 96 (253)
+.||+|+||.||+|.+..++..|++|.+.... ..+....+.+|+..+. ..+|+||+++++++..++..++++||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILK-QYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHH-hCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46999999999999999999999999876543 2344567888988887 679999999999999999999999999999
Q ss_pred cHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccccc---cccc
Q psy12709 97 ELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK---EIIG 172 (253)
Q Consensus 97 ~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~---~~~~ 172 (253)
+|.+++... ..+++..++.++.|++.++.|||++|++|+||+|.||+++.++.++|+|||.+.......... ....
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 999998754 458999999999999999999999999999999999999999999999999987543221111 1122
Q ss_pred CccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhccc
Q psy12709 173 TPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251 (253)
Q Consensus 173 ~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (253)
+..|+|||.+.+..++.++|+||+|+++|++++ |..||...........+...... .....++..+.+++.+||++
T Consensus 159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~ 235 (252)
T cd05084 159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL---PCPELCPDAVYRLMERCWEY 235 (252)
T ss_pred ceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---CCcccCCHHHHHHHHHHcCC
Confidence 356999999988889999999999999999998 99999877776655555443222 12246789999999999999
Q ss_pred CC
Q psy12709 252 DP 253 (253)
Q Consensus 252 dP 253 (253)
||
T Consensus 236 ~p 237 (252)
T cd05084 236 DP 237 (252)
T ss_pred Ch
Confidence 98
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=258.65 Aligned_cols=235 Identities=23% Similarity=0.347 Sum_probs=196.4
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +.+.||+|++|+||.|... .+..+++|.+....... ..+.+|+..+. ..+|+||+++++++...+.+++
T Consensus 4 ~~~~--~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~---~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 4 KDLT--FLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMM-KLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred HHeE--EeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccH---HHHHHHHHHHh-cCCCCCeeeEEEEEccCCCcEE
Confidence 4566 9999999999999999775 34569999887544332 35778888887 6789999999999999899999
Q ss_pred EEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccc
Q psy12709 89 VLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV 167 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 167 (253)
+|||+.+++|.+++... ..+++..++.++.|++.++.+||+.|++|+||+|.||+++.++.++|+|||.+.........
T Consensus 77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999999999998764 46899999999999999999999999999999999999999999999999988754332211
Q ss_pred --cccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 168 --KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 168 --~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||......+....+......+.. ...++.++++
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l 233 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASEKVYAI 233 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCHHHHHH
Confidence 12234467999999988889999999999999999998 99999888777777777665443322 3568999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
+.+||+.||
T Consensus 234 i~~cl~~~p 242 (256)
T cd05113 234 MYSCWHEKA 242 (256)
T ss_pred HHHHcCCCc
Confidence 999999998
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=259.14 Aligned_cols=234 Identities=19% Similarity=0.366 Sum_probs=195.9
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
.|+++++||.|++|.||+|.+. ++..|++|.+..... ....+.+|+..+. ..+|+||+++++.+..++..++++|
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM---SVQAFLEEANLMK-TLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred HeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch---hHHHHHHHHHHHH-hCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 3449999999999999999865 566799998765332 2457788888887 7789999999999999999999999
Q ss_pred ccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc--c
Q psy12709 92 MVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE--V 167 (253)
Q Consensus 92 ~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~--~ 167 (253)
++++++|.+++... ..++...+..++.+++.+++|||+.+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 99999999988653 4578889999999999999999999999999999999999999999999999976543221 1
Q ss_pred cccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~ 246 (253)
....++..|+|||...+..++.++|+||+|+++|+|++ |..||...........+...... +....++.++.+++.
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~ 238 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM---PRMENCPDELYDIMK 238 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHH
Confidence 12234567999999988889999999999999999998 99999988877777766554322 222468999999999
Q ss_pred HhcccCC
Q psy12709 247 SCLVTDP 253 (253)
Q Consensus 247 ~~l~~dP 253 (253)
+||++||
T Consensus 239 ~~l~~~p 245 (261)
T cd05072 239 TCWKEKA 245 (261)
T ss_pred HHccCCc
Confidence 9999988
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=263.21 Aligned_cols=238 Identities=22% Similarity=0.324 Sum_probs=199.9
Q ss_pred cceeeEEEeecCCCCceEEEEEEecc-----CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKI-----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
+.|+ +.+.||+|++|.||+|.+.. ++..|++|.+..... ......+.+|+..+. ...|+||+++++++..+
T Consensus 5 ~~~~--~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 5 DTIV--LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLT-NFQHENIVKFYGVCTEG 80 (280)
T ss_pred HHhh--HHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHH-hcCCCCchheeeEEecC
Confidence 3455 89999999999999998753 357899999876543 334568888999888 67899999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQD--------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN 149 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~~--------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~ 149 (253)
+..+++|||+++++|.+++...+ .+++..+..++.+++.++.+||++|++|+||+|+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999987542 3788899999999999999999999999999999999999999
Q ss_pred eEEEeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcc
Q psy12709 150 IKLCDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQC 225 (253)
Q Consensus 150 ~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~ 225 (253)
++|+|||.+....... .......++.|+|||.+.+..++.++|+||+|+++|+|++ |+.||...+..+....+..+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999987543211 1122234578999999998999999999999999999998 99999888888777777665
Q ss_pred cccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 226 NFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 226 ~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+. ..++..+++++.+||+.||
T Consensus 241 ~~~~~~---~~~~~~~~~li~~~l~~~p 265 (280)
T cd05049 241 RLLQRP---RTCPSEVYDIMLGCWKRDP 265 (280)
T ss_pred CcCCCC---CCCCHHHHHHHHHHcCCCc
Confidence 544333 3789999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=276.39 Aligned_cols=245 Identities=22% Similarity=0.352 Sum_probs=210.1
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCc---e-EEEEEecc-cccchHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKV---E-YAAKFIRK-RRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~---~-v~iK~~~~-~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 80 (253)
|...-.+..+.++||+|+||.||+|..+..+. . ||+|.... .....++...+.+|++.++ ..+|+||++++++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr-~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMR-QLNHPNVVRFYGVA 230 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHH-hCCCCCEEEEEEEE
Confidence 33444445577899999999999999885432 3 89998886 3366788899999999999 69999999999999
Q ss_pred EeCCeEEEEEeccCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 81 ETPHEMVLVLEMVPDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 81 ~~~~~~~lv~e~~~g~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
.....+++|||+|+||+|.+++.+++. ++..+...++.+.+.|++|||+++++||||-++|++++.++.+||+|||+++
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999999999999998764 9999999999999999999999999999999999999999999999999987
Q ss_pred ccccccccc-ccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCC
Q psy12709 160 VVNDVVEVK-EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHI 237 (253)
Q Consensus 160 ~~~~~~~~~-~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 237 (253)
.-....... ......+|+|||.+....++.++||||+|+++||+++ |..||.+....+....|.......+.+ ...
T Consensus 311 ~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~~ 388 (474)
T KOG0194|consen 311 AGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SKT 388 (474)
T ss_pred CCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CCC
Confidence 654222222 2235679999999999999999999999999999999 899999999999999985544433332 377
Q ss_pred CHHHHHHHHHhcccCC
Q psy12709 238 SSQAKDFIQSCLVTDP 253 (253)
Q Consensus 238 ~~~l~~li~~~l~~dP 253 (253)
++++..++.+|+..||
T Consensus 389 p~~~~~~~~~c~~~~p 404 (474)
T KOG0194|consen 389 PKELAKVMKQCWKKDP 404 (474)
T ss_pred HHHHHHHHHHhccCCh
Confidence 9999999999999998
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=257.56 Aligned_cols=235 Identities=21% Similarity=0.347 Sum_probs=196.5
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +.+.||+|++|.||+|.+. ++..|++|.++..... .+.+.+|+..+. ..+|+||+++++++..++..++
T Consensus 6 ~~~~--~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~---~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 6 TSIQ--LLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD---PKDFLAEAQIMK-KLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred hhee--eEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc---HHHHHHHHHHHH-HCCCCCccceeEEEecCCCeee
Confidence 4455 9999999999999999976 4567999998764432 346778888887 6689999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc
Q psy12709 89 VLEMVPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 166 (253)
++|++++++|.+++.... .++...+..++.+++.++.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999999987644 589999999999999999999999999999999999999999999999999876543211
Q ss_pred c--cccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 167 V--KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 167 ~--~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
. ........|+|||.+.+..++.++|+||+|+++++|++ |+.||.+.........+......+ ....+++.+.+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 235 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP---CPPGCPKELYD 235 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCcCCHHHHH
Confidence 1 11122357999999988889999999999999999999 999999888777777665543221 22467999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
++.+||+.||
T Consensus 236 li~~~l~~~P 245 (261)
T cd05068 236 IMLDCWKEDP 245 (261)
T ss_pred HHHHHhhcCc
Confidence 9999999998
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=256.87 Aligned_cols=233 Identities=22% Similarity=0.346 Sum_probs=195.0
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++.+.||+|+||.||++..+ ++..+++|.+...... ...+.+|+..++ ..+|+||+++++++..++..+++|||
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~---~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS---EEDFIEEAKVMM-KLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred cEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc---HHHHHHHHHHHH-HCCCCCceeEEEEEccCCCEEEEEEc
Confidence 338999999999999999876 4567999987754333 246778888887 77899999999999999999999999
Q ss_pred cCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccc--cc
Q psy12709 93 VPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV--KE 169 (253)
Q Consensus 93 ~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~ 169 (253)
+++++|.+++... ..++...++.++.+++.+++|||++|++|+||+|+||+++.++.++++|||.+......... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 9999999988653 45899999999999999999999999999999999999999999999999988754322111 12
Q ss_pred cccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 170 IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
...+..|+|||.+.+..++.++|+||+|+++|++++ |+.||...+..+....+......... ...+.++.+++.+|
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~c 237 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMTVYEVMYSC 237 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHHHHHHHHH
Confidence 234468999999988889999999999999999999 99999988887777777665433222 25688999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|+.||
T Consensus 238 ~~~~p 242 (256)
T cd05114 238 WHEKP 242 (256)
T ss_pred ccCCc
Confidence 99998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=263.41 Aligned_cols=241 Identities=32% Similarity=0.552 Sum_probs=198.9
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
+|+ +.+.||+|++|.||+|.+..++..|++|.+............+.+|+..+. ...|+||+++++++..++..+++
T Consensus 2 ~y~--~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 2 KYE--VLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLR-QLRHENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred cee--EEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHH-hcCCCCeeehhheEEECCEEEEE
Confidence 455 999999999999999999999999999998866554555568888999888 66799999999999999999999
Q ss_pred EeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc--cc
Q psy12709 90 LEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV--EV 167 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~ 167 (253)
+||++++.+..+......++...+..++.+++.++.+||+.+++|+|++|+||+++.++.++|+|||.+....... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 9999988777777666779999999999999999999999999999999999999999999999999987654432 22
Q ss_pred cccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc----------------
Q psy12709 168 KEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH---------------- 230 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---------------- 230 (253)
....++..|+|||.+.+. .++.++|+||+|+++|++++|+.||......+....+.......+
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 334567889999999877 788999999999999999999999987665544433222110000
Q ss_pred ------------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 ------------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 ------------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
......+++++.++|++||+.||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 273 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDP 273 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCc
Confidence 01112358999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=260.61 Aligned_cols=237 Identities=18% Similarity=0.318 Sum_probs=194.0
Q ss_pred eeEEEeecCCCCceEEEEEEecc-----CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKI-----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
+|++.+.||+|++|+||+|.+.. ++..|++|.+.... ......++.+|+..+. ..+|+||+++++++..+...
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~-~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMK-EFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHH-hCCCCCeeeEEEEEcCCCCe
Confidence 34499999999999999998652 35679999886432 2234456788888887 67999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeec
Q psy12709 87 VLVLEMVPDGELQRLVDIQD----------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFG 156 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~----------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~ 156 (253)
+++|||+++++|.+++.... .++...+..++.+++.++.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg 164 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCC
Confidence 99999999999999886522 24677889999999999999999999999999999999999999999999
Q ss_pred cccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCC
Q psy12709 157 ISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHED 232 (253)
Q Consensus 157 ~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~ 232 (253)
++........ .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+.........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~- 243 (277)
T cd05062 165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKP- 243 (277)
T ss_pred CccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC-
Confidence 9875432211 111234568999999988889999999999999999999 78999988887777666555433222
Q ss_pred ccCCCCHHHHHHHHHhcccCC
Q psy12709 233 LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 ~~~~~~~~l~~li~~~l~~dP 253 (253)
...++.+.++|.+||+.||
T Consensus 244 --~~~~~~~~~li~~~l~~~p 262 (277)
T cd05062 244 --DNCPDMLFELMRMCWQYNP 262 (277)
T ss_pred --CCCCHHHHHHHHHHcCCCh
Confidence 3678999999999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=264.75 Aligned_cols=238 Identities=25% Similarity=0.372 Sum_probs=192.3
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++++.||.|++|.||+|.+..++..|++|.+...... .......+|+..+. ..+|+||+++++++..++..++++||
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~-~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLK-DLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHH-hcCCCCcceEEEEEecCCeEEEEEec
Confidence 44999999999999999999999999999998754322 22345667888887 77999999999999999999999999
Q ss_pred cCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-ccccc
Q psy12709 93 VPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVKEI 170 (253)
Q Consensus 93 ~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~ 170 (253)
+++ +|...+.. ...++...+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 86 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (301)
T cd07873 86 LDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNE 164 (301)
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccccc
Confidence 975 78777654 4568999999999999999999999999999999999999999999999999987543221 22233
Q ss_pred ccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc-------------------c
Q psy12709 171 IGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF-------------------H 230 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-------------------~ 230 (253)
.+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+..+....+......+ +
T Consensus 165 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (301)
T cd07873 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYP 244 (301)
T ss_pred ceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccC
Confidence 567899999997653 57889999999999999999999998877665544332211110 0
Q ss_pred -------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 -------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 -------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+.++++++++|.+||+.||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~li~~ml~~dp 274 (301)
T cd07873 245 KYRADCLHNHAPRLDSDGAELLSKLLQFEG 274 (301)
T ss_pred ccccccHHhhcCCCCHHHHHHHHHHhcCCc
Confidence 11224678999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=260.98 Aligned_cols=235 Identities=20% Similarity=0.339 Sum_probs=196.5
Q ss_pred eEEEeecCCCCceEEEEEEec-----cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHK-----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
|.+.+.||.|+||+||++.+. .++..+++|.+.... ......+.+|+..+. ...|++|+++++++..++.++
T Consensus 7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLT-NLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHH-hCCCCCcceEEEEEecCCccE
Confidence 339999999999999999853 345678999886532 334567888998888 668999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEe
Q psy12709 88 LVLEMVPDGELQRLVDIQD-------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCD 154 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~-------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~d 154 (253)
+++||+++++|.+++.... .+++..++.++.|++.++++||++|++|+||+|+||+++.++.++|+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEecc
Confidence 9999999999999986543 389999999999999999999999999999999999999999999999
Q ss_pred eccccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhccccccc
Q psy12709 155 FGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFH 230 (253)
Q Consensus 155 f~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~ 230 (253)
||.+........ .....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||......+....+..+.....
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 243 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR 243 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 999875432211 112233568999999998889999999999999999998 9999988887777777766554322
Q ss_pred CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 ~~~~~~~~~~l~~li~~~l~~dP 253 (253)
...++.++.+++.+||+.||
T Consensus 244 ---~~~~~~~l~~li~~~l~~~p 263 (288)
T cd05093 244 ---PRTCPKEVYDLMLGCWQREP 263 (288)
T ss_pred ---CCCCCHHHHHHHHHHccCCh
Confidence 23678999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=261.18 Aligned_cols=240 Identities=26% Similarity=0.492 Sum_probs=197.6
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
++|+ +.+.||+|++|.||+|.+..++..+++|.+.... ........+.+|+..+. ...|+||+++++.+..++..+
T Consensus 2 ~~y~--~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~ 78 (267)
T cd08229 2 ANFR--IEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLK-QLNHPNVIKYYASFIEDNELN 78 (267)
T ss_pred chhh--hhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHH-HccCCchhhhhheeEeCCeEE
Confidence 3455 8899999999999999999999999999887643 33344567888998888 679999999999999999999
Q ss_pred EEEeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 88 LVLEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
+++|++++++|.+++.. ...+++..++.++.+++.++.+||++|++|+||+|+||+++.++.++++|||.+.....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999998763 34589999999999999999999999999999999999999999999999998875543
Q ss_pred cc-cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHhhcccccccCCccCCCCHH
Q psy12709 164 VV-EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNK--QETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 164 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
.. ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+... ......+...... ......+++.
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 236 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP--PLPSDHYSEE 236 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCC--CCCcccccHH
Confidence 22 12234577899999999888899999999999999999999999975433 2333333332222 1122367899
Q ss_pred HHHHHHHhcccCC
Q psy12709 241 AKDFIQSCLVTDP 253 (253)
Q Consensus 241 l~~li~~~l~~dP 253 (253)
++++|.+||+.||
T Consensus 237 ~~~li~~~l~~~p 249 (267)
T cd08229 237 LRQLVNMCINPDP 249 (267)
T ss_pred HHHHHHHhcCCCc
Confidence 9999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=260.87 Aligned_cols=235 Identities=30% Similarity=0.450 Sum_probs=196.1
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
+.+.||.|++|.||+|.+..++..+++|.+.... ......+.+|+..+. ..+|+||+++++.+..++..++++||++
T Consensus 9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~-~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILA-SCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHH-HCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 8899999999999999999999999999986543 344567778888887 6799999999999999999999999999
Q ss_pred CCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-cccccccc
Q psy12709 95 DGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEVKEIIG 172 (253)
Q Consensus 95 g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 172 (253)
+++|..++.. ..++++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||++...... .......+
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 165 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 165 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccccc
Confidence 9999887754 456899999999999999999999999999999999999999999999999998654322 12233457
Q ss_pred CccccCccccC-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHH
Q psy12709 173 TPDYVAPEVLS-----YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247 (253)
Q Consensus 173 ~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~ 247 (253)
++.|+|||.+. +..++.++|+||+|+++|+|++|+.||...+..+....+....... ......++.++.++|.+
T Consensus 166 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ 244 (282)
T cd06643 166 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWSSEFKDFLKK 244 (282)
T ss_pred cccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-CCCccccCHHHHHHHHH
Confidence 78999999973 3457789999999999999999999998877766665554433221 11223678999999999
Q ss_pred hcccCC
Q psy12709 248 CLVTDP 253 (253)
Q Consensus 248 ~l~~dP 253 (253)
||+.||
T Consensus 245 ~l~~~p 250 (282)
T cd06643 245 CLEKNV 250 (282)
T ss_pred HccCCh
Confidence 999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=258.23 Aligned_cols=235 Identities=22% Similarity=0.324 Sum_probs=193.7
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +.+.||.|++|+||+|.+..+ ..|++|.+....... ..+.+|+..+. ..+|+||+++++.+.. +..+
T Consensus 5 ~~~~~--~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~---~~~~~E~~~l~-~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 5 RESLR--LEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMK-KLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred hHHee--EeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCH---HHHHHHHHHHH-hCCCCCcceEEEEECC-CCcE
Confidence 45566 999999999999999988755 459999988644322 36778888888 6789999999998754 5689
Q ss_pred EEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~ 165 (253)
++|||+++++|.+++... ..++...+..++.+++.++.+||+++++|+||+|.||++++++.++|+|||.+.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999999998753 347899999999999999999999999999999999999999999999999987554322
Q ss_pred c--ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHH
Q psy12709 166 E--VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAK 242 (253)
Q Consensus 166 ~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~ 242 (253)
. .....++..|+|||...+..++.++|+||+|+++|++++ |..||.+....+....+...... .....+++.+.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~ 233 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPECPESLH 233 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC---CCccccCHHHH
Confidence 1 112334567999999988889999999999999999999 89999888777777666543322 12347899999
Q ss_pred HHHHHhcccCC
Q psy12709 243 DFIQSCLVTDP 253 (253)
Q Consensus 243 ~li~~~l~~dP 253 (253)
++|.+||++||
T Consensus 234 ~li~~~l~~~p 244 (262)
T cd05071 234 DLMCQCWRKEP 244 (262)
T ss_pred HHHHHHccCCc
Confidence 99999999998
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=257.49 Aligned_cols=237 Identities=29% Similarity=0.453 Sum_probs=200.4
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccc---cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEE
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR---RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVL 90 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 90 (253)
+..+.||+|++|+||+|.+..++..|++|.+.... ........+.+|+..+. ..+|+||+++++++..++.+++++
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLS-KLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHH-hcCCCCchheeeeEecCCeEEEEE
Confidence 38899999999999999999899999999987644 22344567888998887 679999999999999999999999
Q ss_pred eccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccccccc
Q psy12709 91 EMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI 170 (253)
Q Consensus 91 e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (253)
||+++++|.+++.....++...+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+............
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 161 (258)
T cd06632 82 ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF 161 (258)
T ss_pred EecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccccc
Confidence 99999999999987777999999999999999999999999999999999999999999999999988765443333445
Q ss_pred ccCccccCccccCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 171 IGTPDYVAPEVLSYEP-ISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
.++..|+|||.+.... ++.++|+||+|+++|++++|+.||...........+...... ......+++++.+++.+||
T Consensus 162 ~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l 239 (258)
T cd06632 162 KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL--PPIPDHLSDEAKDFILKCL 239 (258)
T ss_pred CCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC--CCcCCCcCHHHHHHHHHHh
Confidence 5778899999987766 889999999999999999999999876655555444432221 2233468999999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
+.||
T Consensus 240 ~~~p 243 (258)
T cd06632 240 QRDP 243 (258)
T ss_pred hcCc
Confidence 9987
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=261.52 Aligned_cols=239 Identities=26% Similarity=0.364 Sum_probs=192.1
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++.+.||.|++|.||+|.+..++..|++|.+............+.+|+..+. ..+|+||+++++++..++.+++|+||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLK-ELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHH-hcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 44999999999999999999999999999998765444334456778888887 77899999999999999999999999
Q ss_pred cCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-ccc
Q psy12709 93 VPDGELQRLVDIQ---DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVK 168 (253)
Q Consensus 93 ~~g~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~ 168 (253)
++ ++|.+++... ..+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 97 4787776542 458999999999999999999999999999999999999999999999999987543321 122
Q ss_pred ccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccc-------------------
Q psy12709 169 EIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFS------------------- 228 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~------------------- 228 (253)
...+++.|+|||.+.+. .++.++|+||+|+++++|++|+.||.+.........+......
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence 33457889999987654 5688999999999999999999999876654433322111000
Q ss_pred ------ccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 229 ------FHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 229 ------~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
........+++++.++|.+||+.||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 270 (285)
T cd07861 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDP 270 (285)
T ss_pred cccCcchhHHhcCCCCHHHHHHHHHHhcCCh
Confidence 0011224579999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=262.01 Aligned_cols=239 Identities=26% Similarity=0.408 Sum_probs=196.3
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
+|+ +.+.||+|+||.||++.+..++..+++|.+.... ......++.+|+..+. ..+|+||+++++.+..++.++++
T Consensus 2 ~~~--~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 2 DFE--KLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLH-ECNSPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred Cce--EEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEeeCCEEEEE
Confidence 455 9999999999999999999999999999987543 2344567888999988 66999999999999999999999
Q ss_pred EeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCceEEEeeccccccccccccc
Q psy12709 90 LEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK 168 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 168 (253)
+||+++++|.+++.....+++..+..++.|++.++.|||+ .+++|+||+|+||++++++.++|+|||.+...... ...
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~ 156 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MAN 156 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-ccc
Confidence 9999999999999877889999999999999999999997 58999999999999999999999999988654332 123
Q ss_pred ccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccc--------------------
Q psy12709 169 EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFS-------------------- 228 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~-------------------- 228 (253)
...+++.|+|||.+.+..++.++|+||+|+++|++++|+.||...+.......+......
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccch
Confidence 345788999999998888899999999999999999999999765544333222111000
Q ss_pred --------------ccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 229 --------------FHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 229 --------------~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.+......++.+++++|.+||+.||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 275 (308)
T cd06615 237 MAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNP 275 (308)
T ss_pred hhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCCh
Confidence 0010112378899999999999998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=270.36 Aligned_cols=211 Identities=23% Similarity=0.374 Sum_probs=180.0
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP-- 83 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-- 83 (253)
.+.++|+ +.+.||+|++|.||+|.+..+++.|++|.+.+..........+.+|+..+. ..+|+||+++++++...
T Consensus 13 ~~~~~y~--~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~ 89 (353)
T cd07850 13 TVLKRYQ--NLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMK-LVNHKNIIGLLNVFTPQKS 89 (353)
T ss_pred hhhcceE--EEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHH-hcCCCCCcceeeeeccCCC
Confidence 4567788 999999999999999999999999999999766555555667778998887 77999999999988643
Q ss_pred ----CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 84 ----HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 84 ----~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
...++|+||+.+ +|.+.+... ++...+..++.|++.|+++||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 90 ~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 90 LEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred ccccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 357999999965 777776543 8899999999999999999999999999999999999999999999999998
Q ss_pred cccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q psy12709 160 VVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNI 222 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i 222 (253)
............++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+....+..+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 229 (353)
T cd07850 167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI 229 (353)
T ss_pred eCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 665443333445678999999999889999999999999999999999999887765555444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=257.24 Aligned_cols=240 Identities=27% Similarity=0.495 Sum_probs=198.3
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
++|+ +.+.||.|++|.||+|.+..++..|++|.++... ........+.+|+..+. ..+|++++++++.+..++..+
T Consensus 2 ~~y~--~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~-~~~~~~i~~~~~~~~~~~~~~ 78 (267)
T cd08224 2 GNFK--IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLK-QLDHPNVIKYLASFIENNELN 78 (267)
T ss_pred Ccee--eeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHH-hCCCCCeeeeeeeeecCCeEE
Confidence 4566 9999999999999999999999999999987543 33334667888999888 679999999999999999999
Q ss_pred EEEeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 88 LVLEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
++|||+++++|..++.. ...++...++.++.+++.++.+||+.|++|+||+|+||+++.++.++++|||.+.....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999988854 24488999999999999999999999999999999999999999999999998875433
Q ss_pred cc-cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHhhcccccccCCccCCCCHH
Q psy12709 164 VV-EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDN--KQETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 164 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
.. ......+++.|.|||.+.+..++.++|+||+|+++|++++|+.||.... ..+....+..+...+.. ...++.+
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 236 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP--ADHYSEE 236 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCC--hhhcCHH
Confidence 21 2223456788999999988889999999999999999999999996543 22344444443322211 2367889
Q ss_pred HHHHHHHhcccCC
Q psy12709 241 AKDFIQSCLVTDP 253 (253)
Q Consensus 241 l~~li~~~l~~dP 253 (253)
+.++|.+||..||
T Consensus 237 ~~~~i~~cl~~~p 249 (267)
T cd08224 237 LRDLVSRCINPDP 249 (267)
T ss_pred HHHHHHHHcCCCc
Confidence 9999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=258.88 Aligned_cols=241 Identities=24% Similarity=0.384 Sum_probs=197.9
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc--------hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS--------MDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~--------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
+|.+.+.||.|++|.||+|.+..++..+++|.+...... ....+.+.+|+..+. ..+|+|++++++++..+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLK-DLDHLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHH-hcCCCCcceEEEEeccC
Confidence 455999999999999999999989999999988643211 122356778888887 77899999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
+.+++|+||+++++|.+++.....++...+..++.+++.++.+||+.+++|+||+|+||+++.++.++++|||.+.....
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 99999999999999999998877899999999999999999999999999999999999999999999999999875432
Q ss_pred cc---cccccccCccccCccccCCCC--CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcc--cccccCCccCC
Q psy12709 164 VV---EVKEIIGTPDYVAPEVLSYEP--ISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQC--NFSFHEDLFGH 236 (253)
Q Consensus 164 ~~---~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~~~~~~~ 236 (253)
.. ......++..|+|||.+.+.. ++.++|+||+|++++++++|..||...........+... ....+......
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMN 240 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccccc
Confidence 11 122234678899999987654 788999999999999999999999765554444333222 22333344457
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
++.++.++|.+||++||
T Consensus 241 ~~~~~~~li~~~l~~~p 257 (272)
T cd06629 241 LSPVALDFLNACFTINP 257 (272)
T ss_pred CCHHHHHHHHHHhcCCh
Confidence 89999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=259.22 Aligned_cols=232 Identities=29% Similarity=0.459 Sum_probs=188.2
Q ss_pred cceeeEEEeec--CCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 9 GGYQTLIFCMP--SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 9 ~~~~~~~~~~l--g~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
++|+ +.+.+ |.|+||+||++.++.++..+++|.+........ |........+|+||+++++.+..++.+
T Consensus 14 ~~~~--~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 14 KNCE--IVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred Hhhc--cccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3455 55555 999999999999999999999999876433221 222222244799999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-ceEEEeecccccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN-NIKLCDFGISRVVNDVV 165 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~-~~~l~df~~~~~~~~~~ 165 (253)
++||||+++++|.+++..+..+++..+..++.|+++++.+||+.|++|+||+|+||+++.++ .++++|||.+......
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence 99999999999999998777899999999999999999999999999999999999999998 9999999988755432
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH-HHhhcccccccCCccCCCCHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETF-LNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
....++..|+|||++.+..++.++|+||+|+++|+|++|+.||......... ....... +........+|+.++++
T Consensus 164 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 240 (267)
T PHA03390 164 --SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNANDF 240 (267)
T ss_pred --ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHHH
Confidence 2235678999999998888999999999999999999999999765443221 1111111 22223334789999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||+.||
T Consensus 241 i~~~l~~~p 249 (267)
T PHA03390 241 VQSMLKYNI 249 (267)
T ss_pred HHHHhccCh
Confidence 999999998
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=264.99 Aligned_cols=240 Identities=20% Similarity=0.297 Sum_probs=193.9
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCc----eEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKV----EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 81 (253)
+...+|+ +.+.||+|+||+||+|.+..++. .|++|.+.... .......+.+|+..+. ..+|+||+++++++.
T Consensus 4 ~~~~~f~--~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~-~l~h~niv~~~g~~~ 79 (316)
T cd05108 4 LKETEFK--KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMA-SVDNPHVCRLLGICL 79 (316)
T ss_pred cchhhce--eeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEc
Confidence 4455666 99999999999999999765554 48999986432 2334567778888877 779999999999987
Q ss_pred eCCeEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 82 TPHEMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 82 ~~~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
.+ ..+++++++++++|.+++..+ ..++...+..++.|++.|++|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 80 TS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred CC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 64 577999999999999988764 4588999999999999999999999999999999999999999999999999986
Q ss_pred ccccccc---cccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCC
Q psy12709 161 VNDVVEV---KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGH 236 (253)
Q Consensus 161 ~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 236 (253)
....... .....+..|+|||.+.+..++.++|+||+|+++|++++ |+.||.+....+....+.... ..+. .+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~ 235 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQ--PPI 235 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC-CCCC--CCC
Confidence 5432221 11223567999999988899999999999999999998 999998877665544433332 2222 246
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
++.++.+++.+||+.||
T Consensus 236 ~~~~~~~li~~cl~~~p 252 (316)
T cd05108 236 CTIDVYMIMVKCWMIDA 252 (316)
T ss_pred CCHHHHHHHHHHccCCh
Confidence 78999999999999988
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=260.78 Aligned_cols=238 Identities=30% Similarity=0.439 Sum_probs=191.3
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--CeEEEEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP--HEMVLVL 90 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~ 90 (253)
|++.+.||.|++|.||+|.+..++..|++|.++........ ....+|+..+.+..+|+|++++++++..+ +.+++|+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 34899999999999999999999999999998765433332 24457888888677899999999999987 8999999
Q ss_pred eccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccc
Q psy12709 91 EMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE 169 (253)
Q Consensus 91 e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (253)
||+++ ++.+.+.. ...+++..++.++.|++.++.+||++|++|+||+|+||+++. +.++|+|||.+...........
T Consensus 80 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~ 157 (282)
T cd07831 80 ELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTE 157 (282)
T ss_pred ecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCC
Confidence 99975 66666654 456899999999999999999999999999999999999999 9999999999976544333333
Q ss_pred cccCccccCccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccc------------------cc
Q psy12709 170 IIGTPDYVAPEVLS-YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFS------------------FH 230 (253)
Q Consensus 170 ~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~------------------~~ 230 (253)
..++..|+|||.+. +..++.++|+||+|+++|+|++|+.||++.+..+....+...... .+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07831 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237 (282)
T ss_pred CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence 45678999999764 455788999999999999999999999887665544433221111 00
Q ss_pred -------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 -------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 -------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+.+|.++.++|.+||++||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 267 (282)
T cd07831 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDP 267 (282)
T ss_pred ccccccHHHHcccccHHHHHHHHHHhccCc
Confidence 01123678999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=248.62 Aligned_cols=240 Identities=25% Similarity=0.298 Sum_probs=195.3
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC----
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH---- 84 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~---- 84 (253)
++-+|+|.+.||.|||+-||+++...+++.||+|++.... .+..+...+|+...+ ..+|||+++++++...+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~r-kf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHR-KFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHH-hhCCcchHHHHHHHHHhhccCc
Confidence 3344559999999999999999999999999999998755 455678899999988 888999999988865433
Q ss_pred -eEEEEEeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEcCCCceEEEeecc
Q psy12709 85 -EMVLVLEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHN--ITHLDLKPQNILLTKDNNIKLCDFGI 157 (253)
Q Consensus 85 -~~~lv~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~di~~~ni~~~~~~~~~l~df~~ 157 (253)
..|++++|...|+|.+.++. ...+++.++.+++.++++|+++||... ++|+||||.||++..++.+++.|||.
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence 59999999999999888764 335999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccc----------cccccCccccCccccCCC---CCCccccHHHHHHHHHHHHhCCCCCCCCChH--HHHHHh
Q psy12709 158 SRVVNDVVEV----------KEIIGTPDYVAPEVLSYE---PISLATDMWSVGVLAYVLLSSHSPFAGDNKQ--ETFLNI 222 (253)
Q Consensus 158 ~~~~~~~~~~----------~~~~~~~~~~~PE~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~i 222 (253)
+....-.-.. .....+..|.|||.+..+ ..+.++|||||||++|.|+.|..||...-.. .....+
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv 255 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV 255 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee
Confidence 8755321111 112457799999998655 4688999999999999999999999642221 122233
Q ss_pred hcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 223 SQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
...+...|.+ +.+|+.+.++|+.||++||
T Consensus 256 ~n~q~s~P~~--~~yse~l~~lik~mlqvdP 284 (302)
T KOG2345|consen 256 QNAQISIPNS--SRYSEALHQLIKSMLQVDP 284 (302)
T ss_pred eccccccCCC--CCccHHHHHHHHHHhcCCc
Confidence 4445555554 4699999999999999998
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=260.45 Aligned_cols=239 Identities=28% Similarity=0.423 Sum_probs=198.7
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++.+.||.|++|.||+|.+..++..|++|.+............+.+|+..++ ..+|+||+++++++..++..++|+||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQ-ACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHH-hCCCCCCcceeeEEecCCeeEEEecc
Confidence 45999999999999999999999999999999876654555668888999888 66799999999999999999999999
Q ss_pred cCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc--cccc
Q psy12709 93 VPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV--EVKE 169 (253)
Q Consensus 93 ~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~ 169 (253)
+ +++|.+++.. ...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 9 9999998864 4568999999999999999999999999999999999999999999999999987654332 2334
Q ss_pred cccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc-------------------
Q psy12709 170 IIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF------------------- 229 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~------------------- 229 (253)
..++..|+|||.+.+. .++.++|+||+|+++++|++|.+||.+......+..+......+
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence 4678899999998654 46889999999999999999999998777665554433211100
Q ss_pred -------cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 -------HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 -------~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.....+..+..+.++|.+||++||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 270 (286)
T cd07832 240 PESKPIPLEEIFPDASPEALDLLKGLLVYDP 270 (286)
T ss_pred CCCCcchHHHhCCCccHHHHHHHHHHhccCh
Confidence 011224678999999999999998
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=256.58 Aligned_cols=237 Identities=29% Similarity=0.424 Sum_probs=203.3
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe--CCeEEEEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET--PHEMVLVL 90 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~ 90 (253)
|++++.||.|++|.||+|.+..++..+++|.+............+.+|+..+. ..+|+||+++++.+.. +...++++
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILR-ELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHH-hcCCCccceeeeeeecCCCCEEEEEe
Confidence 44999999999999999999999999999999876666666677888888887 7899999999997754 45789999
Q ss_pred eccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 91 EMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLH-----DHNITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 91 e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh-----~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
||+++++|.+++.. ...+++..++.++.+++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999988865 356899999999999999999999 899999999999999999999999999998866
Q ss_pred ccccc-ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHH
Q psy12709 162 NDVVE-VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 162 ~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
..... .....+++.|+|||.+.+..++.++|+||+|+++++|++|+.||...+.......+...... .....++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 237 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR---RIPYRYSSE 237 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC---CCccccCHH
Confidence 54332 23346788999999998888899999999999999999999999988777766666655432 223478899
Q ss_pred HHHHHHHhcccCC
Q psy12709 241 AKDFIQSCLVTDP 253 (253)
Q Consensus 241 l~~li~~~l~~dP 253 (253)
+.+++.+||+.||
T Consensus 238 ~~~l~~~~l~~~p 250 (265)
T cd08217 238 LNEVIKSMLNVDP 250 (265)
T ss_pred HHHHHHHHccCCc
Confidence 9999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=263.60 Aligned_cols=237 Identities=26% Similarity=0.421 Sum_probs=197.0
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
+|++++.||.|++|.||+|.+..++..|++|.+...... ....+.+|+..+. ..+|+||+++++.+..++..++|+|
T Consensus 20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMR-ENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHH-hCCCCCEeeEEEEEecCCEEEEeec
Confidence 344999999999999999999999999999998754432 3456778888777 7899999999999999999999999
Q ss_pred ccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc-cccc
Q psy12709 92 MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE-VKEI 170 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~~ 170 (253)
|+++++|.+++.. ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 175 (297)
T cd06656 97 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (297)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcc
Confidence 9999999998864 4588999999999999999999999999999999999999999999999998875543221 2234
Q ss_pred ccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcc
Q psy12709 171 IGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLV 250 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (253)
.+++.|+|||.+.+..++.++|+||+|+++|++++|..||.+.+.......+.... .++......++..++++|.+||+
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~ 254 (297)
T cd06656 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSAVFRDFLNRCLE 254 (297)
T ss_pred cCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCccccCHHHHHHHHHHcc
Confidence 56789999999988889999999999999999999999997765544333332222 22222334678999999999999
Q ss_pred cCC
Q psy12709 251 TDP 253 (253)
Q Consensus 251 ~dP 253 (253)
.||
T Consensus 255 ~~p 257 (297)
T cd06656 255 MDV 257 (297)
T ss_pred CCh
Confidence 987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=260.10 Aligned_cols=238 Identities=20% Similarity=0.307 Sum_probs=196.5
Q ss_pred ceeeEEEeecCCCCceEEEEEEec-----cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHK-----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
.+++++++.||+|+||.||++... .++..+++|.+.... ......+.+|+..+. ...|+||+++++++..++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLT-VLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHh-cCCCCCCceEEEEEecCC
Confidence 345569999999999999999743 356678999876532 344567888888887 679999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQD---------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN 149 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~---------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~ 149 (253)
..++++||+++++|.+++.... .+++..++.++.|++.|+.|||++|++|+||+|+||++++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 9999999999999999887543 3788999999999999999999999999999999999999999
Q ss_pred eEEEeeccccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcc
Q psy12709 150 IKLCDFGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQC 225 (253)
Q Consensus 150 ~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~ 225 (253)
++|+|||.+........ .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+..+
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG 240 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC
Confidence 99999999875432211 112233578999999998899999999999999999998 99999887777777666554
Q ss_pred cccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 226 NFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 226 ~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.... ....+++.+.++|.+||+.||
T Consensus 241 ~~~~---~~~~~~~~~~~li~~cl~~~P 265 (280)
T cd05092 241 RELE---RPRTCPPEVYAIMQGCWQREP 265 (280)
T ss_pred ccCC---CCCCCCHHHHHHHHHHccCCh
Confidence 3321 224789999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=260.56 Aligned_cols=234 Identities=26% Similarity=0.454 Sum_probs=185.1
Q ss_pred ecCCCCceEEEEEEeccCCceEEEEEecccccchHH-HHHHHHHHHHHH--HhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 18 MPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ-MQDILHEAAVLY--LAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 18 ~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~-~~~~~~e~~~~~--~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
.||+|+||.||++.+..++..+++|.+.+....... .....++...+. ...+|++|+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998765432221 122233333322 24579999999999999999999999999
Q ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccccccCc
Q psy12709 95 DGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTP 174 (253)
Q Consensus 95 g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 174 (253)
+++|.+++..+..+++..+..++.|++.|+.+||+++++|+||+|+||++++++.++++|||.+........ ....+++
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 159 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-HASVGTH 159 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-cCcCCCc
Confidence 999999988888899999999999999999999999999999999999999999999999999865443222 2345788
Q ss_pred cccCccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 175 DYVAPEVLS-YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 175 ~~~~PE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.|+|||... +..++.++|+||+|+++|+|++|..||......... .+.......+......++++++++|++||+.||
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 238 (279)
T cd05633 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV 238 (279)
T ss_pred CccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcCCcCCccccCHHHHHHHHHHhcCCH
Confidence 999999986 456789999999999999999999999754322111 111111122223334789999999999999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=258.55 Aligned_cols=236 Identities=19% Similarity=0.323 Sum_probs=196.0
Q ss_pred EEEeecCCCCceEEEEEEeccC---CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe-----
Q psy12709 14 LIFCMPSRGKFASVRKCTHKIT---KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE----- 85 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~----- 85 (253)
++.+.||+|+||.||.|....+ +..|++|.+............+.+|+..+. ..+|+||+++++++...+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMK-DFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHH-hCCCCCeeeEEeeeccCCccccCc
Confidence 4889999999999999997754 478999999876555566678888988887 6789999999998866544
Q ss_pred -EEEEEeccCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccc
Q psy12709 86 -MVLVLEMVPDGELQRLVDIQ------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGIS 158 (253)
Q Consensus 86 -~~lv~e~~~g~~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~ 158 (253)
.++++||+++++|..++... ..++...+..++.|++.|+.|||+++++|+||+|+||++++++.++|+|||.+
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 89999999999998887432 35899999999999999999999999999999999999999999999999998
Q ss_pred cccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCcc
Q psy12709 159 RVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLF 234 (253)
Q Consensus 159 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 234 (253)
........ ......+..|+|||.+.+..++.++|+||+|+++|+|++ |..||.+....+....+..+.... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 237 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK---QP 237 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CC
Confidence 76533211 111223568999999988889999999999999999999 999998888777776665543322 23
Q ss_pred CCCCHHHHHHHHHhcccCC
Q psy12709 235 GHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP 253 (253)
..+++++.+++.+||+.||
T Consensus 238 ~~~~~~~~~li~~~l~~~p 256 (273)
T cd05035 238 EDCLDELYDLMYSCWRADP 256 (273)
T ss_pred cCCCHHHHHHHHHHcCCCh
Confidence 4789999999999999998
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=277.35 Aligned_cols=243 Identities=22% Similarity=0.364 Sum_probs=205.0
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
|..---+..+.+.||+|+||+||+|.+- ..||||++.......+..+.+.+|+..++ .-+|.||+-+.+++-.+..
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lk-kTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLK-KTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHh-hcchhhheeeehhhcCCce
Confidence 3333444558899999999999999986 45899999999988999999999999998 7799999999999988766
Q ss_pred EEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccc---
Q psy12709 86 MVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV--- 161 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~--- 161 (253)
.+|+.||+|.+|...+... ..|+....+.+++|++.|+.|||.++|+|+|++..|||+.+++.|+|+|||++..-
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 9999999999999988653 45899999999999999999999999999999999999999999999999998743
Q ss_pred cccccccccccCccccCccccCC---CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc-CCccCCC
Q psy12709 162 NDVVEVKEIIGTPDYVAPEVLSY---EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH-EDLFGHI 237 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-~~~~~~~ 237 (253)
..........+...|+|||++.- .++++.+||||+|+|+|||++|.+||........+..+-++-..+. .......
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~ 621 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNC 621 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccC
Confidence 33344455667889999999854 4689999999999999999999999996555555555555533333 2344577
Q ss_pred CHHHHHHHHHhcccCC
Q psy12709 238 SSQAKDFIQSCLVTDP 253 (253)
Q Consensus 238 ~~~l~~li~~~l~~dP 253 (253)
+.++++|+..||..+|
T Consensus 622 pk~mk~Ll~~C~~~~~ 637 (678)
T KOG0193|consen 622 PKAMKRLLSDCWKFDR 637 (678)
T ss_pred HHHHHHHHHHHHhcCc
Confidence 8899999999999875
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=255.74 Aligned_cols=231 Identities=24% Similarity=0.368 Sum_probs=192.7
Q ss_pred eecCCCCceEEEEEEeccCC---ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEecc
Q psy12709 17 CMPSRGKFASVRKCTHKITK---VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMV 93 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 93 (253)
+.||+|+||.||+|.....+ ..+++|.+...... .....+.+|+..+. ..+|+||+++++++. .+.+++++||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMA-QLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHH-hcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876544 78999998866543 44567888888887 678999999999876 45689999999
Q ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccccc----c
Q psy12709 94 PDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK----E 169 (253)
Q Consensus 94 ~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~----~ 169 (253)
++++|.+++.....+++..+..++.|++.++.+||+++++|+||+|+||+++.++.++|+|||.+.......... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 999999999877789999999999999999999999999999999999999999999999999987553322111 1
Q ss_pred cccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 170 IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
..++..|+|||.+.+..++.++|+||+|+++|++++ |..||...+..+....+...... .....+++.++++|.+|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~c 234 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL---PRPEECPQEIYSIMLSC 234 (257)
T ss_pred ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC---CCCCCCCHHHHHHHHHH
Confidence 112357999999988889999999999999999998 99999888777776666554332 22347889999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|++||
T Consensus 235 l~~~p 239 (257)
T cd05060 235 WKYRP 239 (257)
T ss_pred hcCCh
Confidence 99998
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=256.36 Aligned_cols=238 Identities=21% Similarity=0.330 Sum_probs=198.5
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccC---CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKIT---KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
++|+ +.+.||+|+||+||+|....+ ...|++|.++.... ......+.+|+..+. ..+|+||+++++.+..++.
T Consensus 4 ~~~~--~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 4 SYVT--IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLDFLTEASIMG-QFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred HHce--eeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-hHHHHHHHHHHHHHH-hCCCCCcceEeEEEecCCc
Confidence 4566 999999999999999998744 45799998875432 333456778888887 7789999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
.++++|++++++|.+++... +.++...+..++.+++.++.+||+++++|+||+|.||+++.++.++|+|||.+......
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999998764 46899999999999999999999999999999999999999999999999999866421
Q ss_pred c---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHH
Q psy12709 165 V---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 165 ~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
. .......+..|+|||.+.+..++.++|+||+|+++|++++ |..||......+....+......+. ...+++.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 236 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP---PMDCPSA 236 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHH
Confidence 1 1112233568999999988889999999999999999998 9999988777777766665433222 2377999
Q ss_pred HHHHHHHhcccCC
Q psy12709 241 AKDFIQSCLVTDP 253 (253)
Q Consensus 241 l~~li~~~l~~dP 253 (253)
+.+++.+||+.||
T Consensus 237 l~~li~~cl~~~p 249 (266)
T cd05033 237 LYQLMLDCWQKDR 249 (266)
T ss_pred HHHHHHHHcCCCc
Confidence 9999999999988
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=264.00 Aligned_cols=239 Identities=28% Similarity=0.399 Sum_probs=190.5
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++.+.||+|++|.||+|.+..+|..|++|.++...........+.+|+..+. ..+|+||+++++++...+.+++++||
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK-ELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHH-hcCCCCeeeHHHHhccCCceEEEEec
Confidence 44999999999999999999999999999998765443333456777888887 67999999999999999999999999
Q ss_pred cCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-cccccc
Q psy12709 93 VPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEVKEI 170 (253)
Q Consensus 93 ~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~ 170 (253)
+++ +|.+.+.. ...+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+...... ......
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence 975 67666544 566899999999999999999999999999999999999999999999999998755332 112233
Q ss_pred ccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCC-CCCChHHHHHHhhccccccc------------------
Q psy12709 171 IGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPF-AGDNKQETFLNISQCNFSFH------------------ 230 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~-~~~~~~~~~~~i~~~~~~~~------------------ 230 (253)
.+++.|+|||.+.+. .++.++|+||+|+++|+|++|..|+ .+.+..+.+..+......+.
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM 239 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCC
Confidence 467899999998664 4688999999999999999988875 44444444433322110000
Q ss_pred -------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 -------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 -------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.+..+.++++++++|.+||+.||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 269 (284)
T cd07839 240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNP 269 (284)
T ss_pred CCCcchhhhhcccCCHHHHHHHHHHhcCCh
Confidence 11224578999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=265.85 Aligned_cols=203 Identities=20% Similarity=0.280 Sum_probs=170.5
Q ss_pred EEeecCCC--CceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 15 IFCMPSRG--KFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 15 ~~~~lg~g--~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
+++.||+| ++++||++.++.+++.||+|.+............+.+|+..++ ..+|+||+++++++..++..++|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~-~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSK-LFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHH-hcCCCCeeeEEEEEEECCEEEEEEec
Confidence 67899999 7899999999999999999999876555555667777888777 77999999999999999999999999
Q ss_pred cCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-c----
Q psy12709 93 VPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-V---- 165 (253)
Q Consensus 93 ~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~---- 165 (253)
+++++|.+++..+ ..+++..++.++.|++.|+.|||+++++|+||+|+||+++.++.+++.||+........ .
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999999998653 45899999999999999999999999999999999999999999999999765432111 0
Q ss_pred ---cccccccCccccCccccCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy12709 166 ---EVKEIIGTPDYVAPEVLSY--EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQET 218 (253)
Q Consensus 166 ---~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 218 (253)
......++..|+|||++.+ ..++.++|+||+|+++|+|++|+.||........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 218 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 218 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence 0111234567999999865 4588999999999999999999999986554433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=258.73 Aligned_cols=237 Identities=19% Similarity=0.310 Sum_probs=195.5
Q ss_pred ceeeEEEeecCCCCceEEEEEEec----cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHK----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
+++ +.+.||+|+||+||+|... .++..+++|.+..... ......+.+|+..+. ..+|+||+++++++..++.
T Consensus 6 ~~~--~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 6 AVR--FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMA-ELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hce--eeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHh-hCCCCCeeeEEEEEecCCc
Confidence 455 8999999999999999853 4567899999875433 334567788988887 6789999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC
Q psy12709 86 MVLVLEMVPDGELQRLVDIQ-----------------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN 148 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~-----------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~ 148 (253)
.+++|||+++++|.+++..+ ..+++..+..++.+++.++.|||++|++|+||+|+||+++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 99999999999999988532 2367888999999999999999999999999999999999999
Q ss_pred ceEEEeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q psy12709 149 NIKLCDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224 (253)
Q Consensus 149 ~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~ 224 (253)
.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||.+....+....+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999987543221 1122234567999999988889999999999999999998 9999988777666666655
Q ss_pred ccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 225 CNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 225 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..... ....+++.+.+++.+||++||
T Consensus 242 ~~~~~---~~~~~~~~~~~li~~cl~~~p 267 (283)
T cd05090 242 RQLLP---CSEDCPPRMYSLMTECWQEGP 267 (283)
T ss_pred CCcCC---CCCCCCHHHHHHHHHHcccCc
Confidence 44332 224789999999999999998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=260.26 Aligned_cols=239 Identities=35% Similarity=0.520 Sum_probs=199.6
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +++.||.|++|+||+|.+..++..+++|.+... .......+.+|+..+. ..+|+||+++++.+..++..++
T Consensus 5 ~~~~--i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~l 79 (280)
T cd06611 5 DIWE--IIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILS-ECKHPNIVGLYEAYFYENKLWI 79 (280)
T ss_pred hHHH--HHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHH-hCCCCceeEEEEEEecCCeEEE
Confidence 4555 999999999999999999989999999998754 3344567788888887 6679999999999999999999
Q ss_pred EEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-cc
Q psy12709 89 VLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VE 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~ 166 (253)
+|||+++++|.+++... ..+++..++.++.|++.++.|||++|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 99999999999998764 56899999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccccccCccccCccccC-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHH
Q psy12709 167 VKEIIGTPDYVAPEVLS-----YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQA 241 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 241 (253)
.....+++.|+|||.+. ...++.++|+||+|+++|+|++|+.||...+.......+.....+. ......++.++
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 238 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT-LDQPSKWSSSF 238 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCC-cCCcccCCHHH
Confidence 23345778899999874 3456789999999999999999999998877766666665543321 11224678999
Q ss_pred HHHHHHhcccCC
Q psy12709 242 KDFIQSCLVTDP 253 (253)
Q Consensus 242 ~~li~~~l~~dP 253 (253)
.++|.+||+.||
T Consensus 239 ~~li~~~l~~~p 250 (280)
T cd06611 239 NDFLKSCLVKDP 250 (280)
T ss_pred HHHHHHHhccCh
Confidence 999999999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=256.76 Aligned_cols=236 Identities=30% Similarity=0.437 Sum_probs=200.9
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++.+.||.|++|.||+|.+..+++.|++|.+...... .....+.+|+..+. ..+|+|++++++.+..++..++++||
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLR-SCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHH-hcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 34999999999999999999999999999998775443 44678888999888 66799999999999999999999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCceEEEeecccccccccccc-ccc
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV-KEI 170 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~~~ 170 (253)
+++++|.+++.....+++..+..++.+++.++.+||+ .+++|+||+|+||+++.++.++|+|||.+......... ...
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 160 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF 160 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccce
Confidence 9999999999877889999999999999999999999 99999999999999999999999999998765433222 234
Q ss_pred ccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHhhcccccccCCccCC-CCHHHHHHHH
Q psy12709 171 IGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDN---KQETFLNISQCNFSFHEDLFGH-ISSQAKDFIQ 246 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~i~~~~~~~~~~~~~~-~~~~l~~li~ 246 (253)
.++..|+|||.+.+..++.++|+||||+++|++++|+.||.... ..+....+..... ...... ++..+.++|.
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~ 237 (264)
T cd06623 161 VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP---PSLPAEEFSPEFRDFIS 237 (264)
T ss_pred eecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC---CCCCcccCCHHHHHHHH
Confidence 56789999999988888999999999999999999999997764 3344444443222 122234 8999999999
Q ss_pred HhcccCC
Q psy12709 247 SCLVTDP 253 (253)
Q Consensus 247 ~~l~~dP 253 (253)
+||+++|
T Consensus 238 ~~l~~~p 244 (264)
T cd06623 238 ACLQKDP 244 (264)
T ss_pred HHccCCh
Confidence 9999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=256.59 Aligned_cols=238 Identities=25% Similarity=0.386 Sum_probs=197.2
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc----chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR----SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
|++.+.||+|+||+||+|.+. ++..+++|.+..... .......+.+|+..+. ..+|+||+++.+++..++.+++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLK-SLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred ccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHH-hcCCCCEeeEeeEeecCCeEEE
Confidence 348899999999999999864 788899998875432 2233467888888887 6689999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc-----
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND----- 163 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~----- 163 (253)
++||+++++|.+++.....+++..+..++.|++.++++||+.+++|+||+|+||++++++.++|+|||.+.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 999999999999998777889999999999999999999999999999999999999999999999998875421
Q ss_pred --cccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHH
Q psy12709 164 --VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQA 241 (253)
Q Consensus 164 --~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 241 (253)
........++..|+|||.+.+..++.++|+||+|++++++++|..||...+.......+...... .......+++++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-MPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-CCCCCCCCCHHH
Confidence 11122345678999999998888899999999999999999999999876655544444332111 122334789999
Q ss_pred HHHHHHhcccCC
Q psy12709 242 KDFIQSCLVTDP 253 (253)
Q Consensus 242 ~~li~~~l~~dP 253 (253)
.++|.+||++||
T Consensus 239 ~~~i~~~l~~~p 250 (265)
T cd06631 239 IDFVTSCLTRDQ 250 (265)
T ss_pred HHHHHHHhcCCc
Confidence 999999999987
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=259.05 Aligned_cols=238 Identities=25% Similarity=0.402 Sum_probs=194.9
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC-----
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP----- 83 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~----- 83 (253)
+.|+ +.+.||.|+||.||+|.+..++..|++|.+...... ...+..|+..+.+..+|+||+++++.+...
T Consensus 6 ~~y~--~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 6 GIFE--LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhh--HHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 4566 889999999999999999999999999998765433 246778888888677899999999998753
Q ss_pred -CeEEEEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 84 -HEMVLVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 84 -~~~~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
..+++++||+.+++|.+++... ..+++..+..++.|++.++.|||+++++|+|++|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 4689999999999999988763 3589999999999999999999999999999999999999999999999999875
Q ss_pred cccc-ccccccccCccccCccccC-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCcc
Q psy12709 161 VNDV-VEVKEIIGTPDYVAPEVLS-----YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLF 234 (253)
Q Consensus 161 ~~~~-~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 234 (253)
.... .......+++.|+|||++. ...++.++|+||+|+++|+|++|+.||...........+....... ...
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~ 238 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR--LKS 238 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCC--CCC
Confidence 4322 2223345788999999985 2357889999999999999999999997766555554443322222 122
Q ss_pred CCCCHHHHHHHHHhcccCC
Q psy12709 235 GHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP 253 (253)
..++.++++++.+||..||
T Consensus 239 ~~~~~~~~~li~~~l~~~p 257 (272)
T cd06637 239 KKWSKKFQSFIESCLVKNH 257 (272)
T ss_pred CCcCHHHHHHHHHHcCCCh
Confidence 3678999999999999987
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=261.97 Aligned_cols=239 Identities=20% Similarity=0.328 Sum_probs=196.1
Q ss_pred cceeeEEEeecCCCCceEEEEEEecc-------CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKI-------TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 81 (253)
++|. +.+.||+|+||.||.|.+.. +...+++|.+..... ......+.+|+..+....+|+||+++++++.
T Consensus 18 ~~~~--i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 18 DRLV--LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred HHeE--EeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 4455 99999999999999998653 234699999876432 3345678889998887778999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc
Q psy12709 82 TPHEMVLVLEMVPDGELQRLVDIQD----------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLT 145 (253)
Q Consensus 82 ~~~~~~lv~e~~~g~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~ 145 (253)
.++..++++||+++++|.+++..+. .++...++.++.|++.++.|||++|++|+||+|+||+++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 9999999999999999999987532 378889999999999999999999999999999999999
Q ss_pred CCCceEEEeeccccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy12709 146 KDNNIKLCDFGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLN 221 (253)
Q Consensus 146 ~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~ 221 (253)
.++.++|+|||.+........ ......++.|+|||.+.+..++.++|+||+|+++|+|++ |..||......+....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 999999999999875432111 111223468999999988889999999999999999998 8999988777666666
Q ss_pred hhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 222 ISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 222 i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+...... ......+.++.++|.+||+.+|
T Consensus 255 ~~~~~~~---~~~~~~~~~~~~li~~~l~~~p 283 (307)
T cd05098 255 LKEGHRM---DKPSNCTNELYMMMRDCWHAVP 283 (307)
T ss_pred HHcCCCC---CCCCcCCHHHHHHHHHHcccCh
Confidence 5543321 2224679999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=257.72 Aligned_cols=240 Identities=22% Similarity=0.286 Sum_probs=195.3
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCc----eEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKV----EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 81 (253)
+...+|+ +.+.||.|+||+||+|.+..++. +|++|.+..... ......+.+|+..+. ...|+||+++++++.
T Consensus 4 l~~~~~~--~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~ 79 (279)
T cd05109 4 LKETELK--KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMA-GVGSPYVCRLLGICL 79 (279)
T ss_pred cchhhee--eeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHHHHHHHHHHHHHH-hcCCCCCceEEEEEc
Confidence 3444555 99999999999999999876665 489998875432 333456778888777 778999999999887
Q ss_pred eCCeEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 82 TPHEMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 82 ~~~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
. ...+++++++++++|.+++..+ ..+++..+..++.|++.|+.|||+++++|+||+|+||++++++.++|+|||++..
T Consensus 80 ~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 80 T-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred C-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 5 4577899999999999988764 4589999999999999999999999999999999999999999999999999876
Q ss_pred ccccccc---cccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCC
Q psy12709 161 VNDVVEV---KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGH 236 (253)
Q Consensus 161 ~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 236 (253)
....... .....++.|+|||...+..++.++|+||+|+++|++++ |..||...........+........ ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 235 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ---PPI 235 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---Ccc
Confidence 5432221 11234568999999988889999999999999999998 9999988777666655555433322 246
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
+++++.++|.+||+.||
T Consensus 236 ~~~~~~~li~~~l~~dp 252 (279)
T cd05109 236 CTIDVYMIMVKCWMIDS 252 (279)
T ss_pred CCHHHHHHHHHHcCCCh
Confidence 89999999999999998
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=258.00 Aligned_cols=238 Identities=20% Similarity=0.337 Sum_probs=196.9
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccC-----CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKIT-----KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
++|+ +.+.||+|+||.||+|.+... +..|++|.+.... .......+.+|+..+. ..+|+||+++++++..+
T Consensus 6 ~~~~--~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 6 EKIT--LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMK-EFNCHHVVRLLGVVSTG 81 (277)
T ss_pred HHee--EEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHH-hCCCCceeEEEEEEcCC
Confidence 4555 999999999999999998743 3789999986543 2334556778888887 67899999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEE
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQD----------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLC 153 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~~----------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~ 153 (253)
+..++++||+++++|.+++.... .+++..+..++.|++.++.|||+++++|+||+|+||+++.++.++|+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999999886422 36778899999999999999999999999999999999999999999
Q ss_pred eecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccc
Q psy12709 154 DFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSF 229 (253)
Q Consensus 154 df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~ 229 (253)
|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|++++ |+.||...+..+....+.......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence 999987543321 1122334678999999988889999999999999999998 999999888877777666443222
Q ss_pred cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.....+.++.++|.+||+.||
T Consensus 242 ---~~~~~~~~~~~li~~~l~~~p 262 (277)
T cd05032 242 ---LPENCPDKLLELMRMCWQYNP 262 (277)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCh
Confidence 223679999999999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=258.42 Aligned_cols=240 Identities=21% Similarity=0.345 Sum_probs=196.2
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc----hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS----MDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
|+..+.||+|++|.||.+.+..++..|++|++...... ......+.+|+..+. ..+|+||+++++++..++.+++
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMA-RLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHH-HcCCCceehhhceeccCCeEEE
Confidence 34889999999999999999999999999998754421 224567888999888 6799999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-ceEEEeeccccccccccc-
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN-NIKLCDFGISRVVNDVVE- 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~-~~~l~df~~~~~~~~~~~- 166 (253)
++||++|++|.+++....++++..+..++.|++.|+.+||++|++|+||+|.||+++.++ .++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998778899999999999999999999999999999999999998776 599999999876543211
Q ss_pred ----ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcc-cccccCCccCCCCHHH
Q psy12709 167 ----VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQC-NFSFHEDLFGHISSQA 241 (253)
Q Consensus 167 ----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~l 241 (253)
.....++..|+|||.+.+..++.++|+||+|++++++++|+.||...........+... ...........+++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240 (268)
T ss_pred CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHH
Confidence 11234677899999998888899999999999999999999999764433222222111 1111222334678999
Q ss_pred HHHHHHhcccCC
Q psy12709 242 KDFIQSCLVTDP 253 (253)
Q Consensus 242 ~~li~~~l~~dP 253 (253)
.+++.+||+.||
T Consensus 241 ~~~i~~~l~~~p 252 (268)
T cd06630 241 RDVTLRCLELQP 252 (268)
T ss_pred HHHHHHHcCCCc
Confidence 999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=257.34 Aligned_cols=233 Identities=23% Similarity=0.343 Sum_probs=190.9
Q ss_pred eecCCCCceEEEEEEeccCCc--eEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 17 CMPSRGKFASVRKCTHKITKV--EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~--~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
+.||+|+||.||+|.+++++. .+++|.+... ........+.+|+..+.+..+|+||+++++++...+.++++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999999987775 4678877643 2234456788899999877799999999999999999999999999
Q ss_pred CCcHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccc
Q psy12709 95 DGELQRLVDIQD----------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGIS 158 (253)
Q Consensus 95 g~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~ 158 (253)
+++|.+++.... .++...++.++.+++.|++|||++|++|+||+|+||+++.++.++++|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999886432 3788999999999999999999999999999999999999999999999988
Q ss_pred ccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCC
Q psy12709 159 RVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHI 237 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 237 (253)
..............+..|+|||.+.+..++.++|+||+|+++++|++ |..||.+.+..+....+...... .....+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~ 236 (270)
T cd05047 160 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL---EKPLNC 236 (270)
T ss_pred cccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCC---CCCCcC
Confidence 53322111112223457999999988889999999999999999997 99999887777766666443211 122367
Q ss_pred CHHHHHHHHHhcccCC
Q psy12709 238 SSQAKDFIQSCLVTDP 253 (253)
Q Consensus 238 ~~~l~~li~~~l~~dP 253 (253)
+.++.+++.+||+.||
T Consensus 237 ~~~~~~li~~~l~~~p 252 (270)
T cd05047 237 DDEVYDLMRQCWREKP 252 (270)
T ss_pred CHHHHHHHHHHcccCh
Confidence 8999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=278.92 Aligned_cols=206 Identities=21% Similarity=0.339 Sum_probs=166.8
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHh-----cCCCCceeeeeEEEeC
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLA-----QKSERIVGLHEIYETP 83 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~-----~~~~~i~~~~~~~~~~ 83 (253)
++|+ +++.||+|+||+||+|.+..++..||+|++..... .......|+..+... .++.+++.+++++..+
T Consensus 129 ~~y~--i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 129 QRFK--ILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CcEE--EEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 4455 99999999999999999999999999999864321 122334455444422 2345688999988765
Q ss_pred -CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCC-------------
Q psy12709 84 -HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQNILLTKDN------------- 148 (253)
Q Consensus 84 -~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~di~~~ni~~~~~~------------- 148 (253)
..++++|+++ |++|.+++.....+++..++.++.|++.|+.|||+ .|++|+||||+||+++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 4789999988 77888888777789999999999999999999998 5999999999999998765
Q ss_pred ---ceEEEeecccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q psy12709 149 ---NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNI 222 (253)
Q Consensus 149 ---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i 222 (253)
.+||+|||.+..... ......+++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+....+
T Consensus 283 ~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred CCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 499999998754322 223456889999999999999999999999999999999999999887766555444
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=259.03 Aligned_cols=231 Identities=26% Similarity=0.413 Sum_probs=190.0
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEecc
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMV 93 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 93 (253)
++.+.||+|++|.||+|.+..++..|++|.+..... ......+.+|+..+. .++|+||+++++.+..++..++++||+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILY-KCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHH-hCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 489999999999999999999999999999876432 334567888988887 779999999999999999999999999
Q ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccccccC
Q psy12709 94 PDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGT 173 (253)
Q Consensus 94 ~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 173 (253)
++++|.... .+++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||.+...... ......++
T Consensus 82 ~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~~~ 156 (279)
T cd06619 82 DGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGT 156 (279)
T ss_pred CCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCCCC
Confidence 999986542 3788899999999999999999999999999999999999999999999998765432 22334678
Q ss_pred ccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHhhcccccccCCccCCCCHHHHHHHH
Q psy12709 174 PDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ-------ETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246 (253)
Q Consensus 174 ~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~~~l~~li~ 246 (253)
..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... .....+.... .+......++++++++|.
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~ 234 (279)
T cd06619 157 NAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVLPVGQFSEKFVHFIT 234 (279)
T ss_pred hhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCCCCCcCCHHHHHHHH
Confidence 8999999999888999999999999999999999999653221 1122222111 111122357899999999
Q ss_pred HhcccCC
Q psy12709 247 SCLVTDP 253 (253)
Q Consensus 247 ~~l~~dP 253 (253)
+||+.||
T Consensus 235 ~~l~~~P 241 (279)
T cd06619 235 QCMRKQP 241 (279)
T ss_pred HHhhCCh
Confidence 9999998
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=255.64 Aligned_cols=232 Identities=23% Similarity=0.359 Sum_probs=192.9
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEecc
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMV 93 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 93 (253)
++.+.||+|++|.||+|.++ ++..+++|.+....... ..+.+|+..+. ..+|+||+++++++...+..++++|++
T Consensus 7 ~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~---~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 7 TFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSE---DDFIEEAKVMM-KLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred chhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCH---HHHHHHHHHHH-hCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 39999999999999999876 56679999987544332 35667888887 678999999999999999999999999
Q ss_pred CCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccc--ccc
Q psy12709 94 PDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV--KEI 170 (253)
Q Consensus 94 ~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~ 170 (253)
+|++|.+++..+ ..+++..+..++.|++.++.+||++|++|+||+|+||++++++.++|+|||.+....+.... ...
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (256)
T cd05059 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161 (256)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence 999999988753 46899999999999999999999999999999999999999999999999988754332111 111
Q ss_pred ccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 171 IGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
..+..|+|||.+.+..++.++|+||+|+++|++++ |+.||...+..+....+....... ....+|+++.+++.+||
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl 238 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLY---RPKLAPTEVYTIMYSCW 238 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHh
Confidence 22357999999988889999999999999999999 899998887777776665543222 22368999999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
+.+|
T Consensus 239 ~~~p 242 (256)
T cd05059 239 HEKP 242 (256)
T ss_pred cCCh
Confidence 9987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=258.01 Aligned_cols=236 Identities=19% Similarity=0.301 Sum_probs=194.4
Q ss_pred eEEEeecCCCCceEEEEEEecc-----CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKI-----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
|++.+.||+|++|.||+|.+.. ++..|++|.+..... ......+.+|+..+. ..+|+||+++++++...+..+
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-EQDESDFLMEALIMS-KFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHH-hCCCCCEeeEEEEEccCCCcE
Confidence 3499999999999999999986 678899998865433 233456778888887 679999999999999989999
Q ss_pred EEEeccCCCcHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC---ceEEEeecc
Q psy12709 88 LVLEMVPDGELQRLVDIQD-------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN---NIKLCDFGI 157 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~---~~~l~df~~ 157 (253)
+++||++|++|.+++.... .+++..++.++.|++.++.|||+++++|+||+|+||+++.++ .++|+|||.
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence 9999999999999987543 488999999999999999999999999999999999998765 599999999
Q ss_pred ccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCc
Q psy12709 158 SRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDL 233 (253)
Q Consensus 158 ~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 233 (253)
+........ ......+..|+|||++.+..++.++||||+|+++|+|++ |..||.+.+..+....+...... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~ 242 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL---DP 242 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC---CC
Confidence 876532211 112223467999999988889999999999999999997 99999988877776665543322 12
Q ss_pred cCCCCHHHHHHHHHhcccCC
Q psy12709 234 FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP 253 (253)
...++.++.+++.+||+.||
T Consensus 243 ~~~~~~~~~~~i~~cl~~~p 262 (277)
T cd05036 243 PKGCPGPVYRIMTDCWQHTP 262 (277)
T ss_pred CCCCCHHHHHHHHHHcCCCc
Confidence 34789999999999999998
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=257.29 Aligned_cols=236 Identities=20% Similarity=0.310 Sum_probs=194.9
Q ss_pred EEEeecCCCCceEEEEEEeccCCc--eEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC------Ce
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKV--EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP------HE 85 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~--~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~------~~ 85 (253)
.+.+.||+|+||.||+|.+..++. .+++|.++...........+.+|+..+. ..+|+||+++++++... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMK-EFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHH-hCCCCCcceEEEEEccCCcccCCCC
Confidence 367899999999999999887664 6899998876555566778888998887 67999999999876432 25
Q ss_pred EEEEEeccCCCcHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 86 MVLVLEMVPDGELQRLVDI------QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
.++++||+.+++|.+++.. ...+++..+..++.|++.|+.|||+++++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 7899999999999887632 2347899999999999999999999999999999999999999999999999987
Q ss_pred ccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccC
Q psy12709 160 VVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFG 235 (253)
Q Consensus 160 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 235 (253)
....... ......++.|++||...+..++.++|+||+|+++|++++ |+.||.+....+.+..+..+..... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 237 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ---PP 237 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC---CC
Confidence 6543221 112234568999999998889999999999999999999 8999998888777777666543222 24
Q ss_pred CCCHHHHHHHHHhcccCC
Q psy12709 236 HISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 236 ~~~~~l~~li~~~l~~dP 253 (253)
.++..+.++|.+||++||
T Consensus 238 ~~~~~~~~li~~~l~~~p 255 (272)
T cd05075 238 DCLDGLYSLMSSCWLLNP 255 (272)
T ss_pred CCCHHHHHHHHHHcCCCc
Confidence 788999999999999998
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=255.74 Aligned_cols=237 Identities=27% Similarity=0.441 Sum_probs=199.9
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +.+.||.|++|.||+|....++..+++|.+..... ...+.+|+..++ ..+|+||+++++.+..+..+++
T Consensus 3 ~~y~--~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~-~l~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 3 EVFD--ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILK-QCDSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred ccch--hhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHH-hCCCCcEeeeeeeeecCCcEEE
Confidence 4566 99999999999999999998899999999875422 568888999888 5699999999999999999999
Q ss_pred EEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-c
Q psy12709 89 VLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-E 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~ 166 (253)
++|++++++|.+++.. ...+++..++.++.+++.++.+||+.+++|+|++|+||++++++.++|+|||.+....... .
T Consensus 76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 9999999999999875 4568999999999999999999999999999999999999999999999999987654432 2
Q ss_pred ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHH
Q psy12709 167 VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~ 246 (253)
.....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...........+..... ........++.++.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPP-PTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCC-CCCCchhhcCHHHHHHHH
Confidence 2234467899999999888899999999999999999999999987766555544433222 111222357889999999
Q ss_pred HhcccCC
Q psy12709 247 SCLVTDP 253 (253)
Q Consensus 247 ~~l~~dP 253 (253)
+||+.||
T Consensus 235 ~~l~~~P 241 (256)
T cd06612 235 KCLVKDP 241 (256)
T ss_pred HHHhcCh
Confidence 9999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=295.52 Aligned_cols=235 Identities=34% Similarity=0.518 Sum_probs=204.8
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
|++++.||+|+||.|.++.++.+++.||+|++.+-. ........+.+|-.++. ..+++=|+.++..|.++.++|+|||
T Consensus 77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv-~~ns~Wiv~LhyAFQD~~~LYlVMd 155 (1317)
T KOG0612|consen 77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMV-FGNSEWIVQLHYAFQDERYLYLVMD 155 (1317)
T ss_pred hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHH-cCCcHHHHHHHHHhcCccceEEEEe
Confidence 349999999999999999999999999999998733 11223345555666666 7778889999999999999999999
Q ss_pred ccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc--ccccc
Q psy12709 92 MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV--VEVKE 169 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~~ 169 (253)
|++||+|-.++.+...+++..++.++.+++.|+..+|+.|++||||+|+||+++..|+++|.|||.|-.++.. -....
T Consensus 156 Y~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~ 235 (1317)
T KOG0612|consen 156 YMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSV 235 (1317)
T ss_pred cccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEecc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999877632 23455
Q ss_pred cccCccccCccccCC-----CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcc--cccccCCccCCCCHHHH
Q psy12709 170 IIGTPDYVAPEVLSY-----EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQC--NFSFHEDLFGHISSQAK 242 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~l~ 242 (253)
..|||.|.|||++.. +.|++.+|.||+|+++|+|+.|..||...+-.+.|-+|... .+.+|. -..+|++++
T Consensus 236 aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~--~~~VSeeak 313 (1317)
T KOG0612|consen 236 AVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD--ETDVSEEAK 313 (1317)
T ss_pred ccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc--ccccCHHHH
Confidence 789999999999843 46889999999999999999999999999999999999887 455553 347999999
Q ss_pred HHHHHhcc
Q psy12709 243 DFIQSCLV 250 (253)
Q Consensus 243 ~li~~~l~ 250 (253)
+||.+.+.
T Consensus 314 dLI~~ll~ 321 (1317)
T KOG0612|consen 314 DLIEALLC 321 (1317)
T ss_pred HHHHHHhc
Confidence 99998875
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=259.97 Aligned_cols=237 Identities=34% Similarity=0.569 Sum_probs=204.5
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
|++.+.||+|++|.||+|.+..++..|++|++.+.. ........+.+|...+.+..+|+||+++++++..++..+++||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 349999999999999999999999999999997643 2334456777888888755459999999999999999999999
Q ss_pred ccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc-----
Q psy12709 92 MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE----- 166 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~----- 166 (253)
++++++|.+++.....++...++.++.|++.++.+||+.|++|+|++|+||+++.++.++++|||.+........
T Consensus 83 ~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~ 162 (280)
T cd05581 83 YAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162 (280)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCC
Confidence 999999999998887899999999999999999999999999999999999999999999999999876543221
Q ss_pred ----------------ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc
Q psy12709 167 ----------------VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH 230 (253)
Q Consensus 167 ----------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~ 230 (253)
.....++..|+|||...+..++.++|+||+|++++++++|+.||...+....+..+.......+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05581 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFP 242 (280)
T ss_pred CCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCC
Confidence 1223456789999999888889999999999999999999999998887777777765555544
Q ss_pred CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 ~~~~~~~~~~l~~li~~~l~~dP 253 (253)
. .+++.+.++|.+||+.||
T Consensus 243 ~----~~~~~~~~li~~~l~~~p 261 (280)
T cd05581 243 P----NFPPDAKDLIEKLLVLDP 261 (280)
T ss_pred C----ccCHHHHHHHHHHhcCCH
Confidence 4 679999999999999987
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=260.96 Aligned_cols=241 Identities=31% Similarity=0.510 Sum_probs=196.5
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
+|+ +.+.||+|++|.||+|.+..+++.|++|.+............+.+|+..+. ..+|+||+++++++..++..+++
T Consensus 2 ~y~--~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 2 KYE--NLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLK-QLRHENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred cee--EeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHH-hcCCcchhhHHHhcccCCeEEEE
Confidence 455 999999999999999999988999999998765544344556778888887 67999999999999999999999
Q ss_pred EeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-ccc
Q psy12709 90 LEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVK 168 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~ 168 (253)
+||++++++..+......++...++.++.|++.++.|||+.|++|+|++|+||++++++.++|+|||++....... ...
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence 9999999998887766679999999999999999999999999999999999999999999999999987543322 222
Q ss_pred ccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc------------------
Q psy12709 169 EIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF------------------ 229 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~------------------ 229 (253)
...++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+..+....+.......
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence 3346788999999765 346789999999999999999999998766544433332211100
Q ss_pred -c--------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 -H--------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 -~--------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+ ....+.++..+.+++.+||+.||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 271 (286)
T cd07846 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDP 271 (286)
T ss_pred cccccCcchHHHhCCCcCHHHHHHHHHHhcCCc
Confidence 0 01124678999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=260.25 Aligned_cols=241 Identities=19% Similarity=0.287 Sum_probs=197.9
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCC----------------ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCC
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITK----------------VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER 72 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~----------------~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~ 72 (253)
++|+ +++.||+|+||.||+|.+...+ ..|++|.+..... ......+.+|+..+. ..+|+|
T Consensus 5 ~~~~--~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~-~l~~~~ 80 (296)
T cd05051 5 QPLN--FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILS-RLSDPN 80 (296)
T ss_pred hhCc--ccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHH-hcCCCC
Confidence 4556 9999999999999999876543 4589998876533 244567888999988 678999
Q ss_pred ceeeeeEEEeCCeEEEEEeccCCCcHHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy12709 73 IVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQD-----------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQN 141 (253)
Q Consensus 73 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~-----------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~n 141 (253)
|+++++++..++..++++|++++++|..++.... .+++..++.++.|++.|+.|||+.|++|+||+|+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999987654 68999999999999999999999999999999999
Q ss_pred EEEcCCCceEEEeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh--CCCCCCCCChH
Q psy12709 142 ILLTKDNNIKLCDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS--SHSPFAGDNKQ 216 (253)
Q Consensus 142 i~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~--g~~p~~~~~~~ 216 (253)
|+++.++.++|+|||.+....... ......+++.|+|||.+.+..++.++||||+|+++|++++ |..||...+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999987543221 1122344668999999988889999999999999999998 78899887777
Q ss_pred HHHHHhhcc----cccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 217 ETFLNISQC----NFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 217 ~~~~~i~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+..+... .........+.+|+++.++|.+||+.||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 281 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDE 281 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccCh
Confidence 766655443 1122122234678999999999999998
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=254.70 Aligned_cols=236 Identities=29% Similarity=0.466 Sum_probs=205.1
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++.+.||.|++|.||++.+..++..+++|.+............+.+|+..++ ..+|+||+++.+++..+...++++|+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILA-SVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHH-hCCCCCchhhhhhhccCCEEEEEehh
Confidence 44999999999999999999999999999999876655566677788888887 66799999999999999999999999
Q ss_pred cCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccccc
Q psy12709 93 VPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK 168 (253)
Q Consensus 93 ~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 168 (253)
+++++|.+++.. ...+++..+..++.+++.|+.+||+.|++|+||+|.||+++.++.++|+|||.+...... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~ 159 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAK 159 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Ccc
Confidence 999999998865 355899999999999999999999999999999999999999999999999998765443 223
Q ss_pred ccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 169 EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
...+++.|+|||...+..++.++|+||+|++++++++|+.||...+..+....+......... ..++.++++++.+|
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~ 236 (256)
T cd08530 160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP---PIYSQDLQNFIRSM 236 (256)
T ss_pred cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc---hhhCHHHHHHHHHH
Confidence 345778999999998888999999999999999999999999988877766666655443322 37889999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|+.||
T Consensus 237 l~~~p 241 (256)
T cd08530 237 LQVKP 241 (256)
T ss_pred cCCCc
Confidence 99987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=260.10 Aligned_cols=239 Identities=21% Similarity=0.348 Sum_probs=198.0
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccC-----CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKIT-----KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
++|+ +.+.||+|++|.||++..... ...+++|.+..... ......+.+|+..+.+..+|+||+++++++..+
T Consensus 12 ~~~~--~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 12 DRLT--LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred hHeE--EeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 4455 999999999999999997643 36799999876533 234567888999888666899999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQ----------------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD 147 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~ 147 (253)
+.++++|||+++++|.+++... ..+++..++.++.|++.++.|||+++++|+||+|.||+++.+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence 9999999999999999988542 347899999999999999999999999999999999999999
Q ss_pred CceEEEeeccccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q psy12709 148 NNIKLCDFGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNIS 223 (253)
Q Consensus 148 ~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~ 223 (253)
+.++|+|||.+........ ......+..|+|||.+.+..++.++|+||+|+++|++++ |..||.+....+.+..+.
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 248 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 248 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999876543211 111223467999999988889999999999999999998 999999888777777665
Q ss_pred cccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 224 QCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 224 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
...... .....+.++.+++.+||+.||
T Consensus 249 ~~~~~~---~~~~~~~~~~~li~~~l~~~p 275 (293)
T cd05053 249 EGYRME---KPQNCTQELYHLMRDCWHEVP 275 (293)
T ss_pred cCCcCC---CCCCCCHHHHHHHHHHcccCc
Confidence 543221 223678999999999999998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=258.41 Aligned_cols=237 Identities=20% Similarity=0.312 Sum_probs=196.4
Q ss_pred cceeeEEEeecCCCCceEEEEEEecc-----CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKI-----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
++|. +.+.||+|++|.||+|.+.. ++..+++|.+.... ......+.+|+..+. ..+|+||+++++++..+
T Consensus 5 ~~~~--~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 5 RDIV--LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLT-NLQHEHIVKFYGVCGDG 79 (291)
T ss_pred HHeE--EeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHh-cCCCCCcceEEEEEccC
Confidence 3455 89999999999999998642 44568888876433 233456778888887 67899999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQD----------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD 147 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~ 147 (253)
+..+++|||+++++|.+++..+. .+++..++.++.+++.++.+||++|++|+||+|.||+++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999987542 27889999999999999999999999999999999999999
Q ss_pred CceEEEeeccccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q psy12709 148 NNIKLCDFGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNIS 223 (253)
Q Consensus 148 ~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~ 223 (253)
+.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..+....+.
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 9999999999875433211 122334678999999988889999999999999999999 999998888877777665
Q ss_pred cccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 224 QCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 224 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....... ....|.++.+++.+||++||
T Consensus 240 ~~~~~~~---~~~~~~~~~~li~~~l~~~P 266 (291)
T cd05094 240 QGRVLER---PRVCPKEVYDIMLGCWQREP 266 (291)
T ss_pred CCCCCCC---CccCCHHHHHHHHHHcccCh
Confidence 5444322 23678999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=254.70 Aligned_cols=234 Identities=21% Similarity=0.348 Sum_probs=193.8
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +++.||+|+||.||+|... ++..|++|.+....... .++.+|+..+. ..+|+||+++++++. .+..++
T Consensus 6 ~~~~--~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~---~~~~~E~~~l~-~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 6 ETLK--LVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSP---EAFLAEANLMK-QLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred HHce--eeeeeccCccceEEeeecC-CCceEEEEEecCCCCcH---HHHHHHHHHHH-hcCCcCeeeEEEEEc-cCCcEE
Confidence 4455 9999999999999999865 67789999987655433 46778888887 678999999999875 457899
Q ss_pred EEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-
Q psy12709 89 VLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV- 165 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~- 165 (253)
++|++.+++|.+++... ..++...+..++.+++.++++||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999999988653 358899999999999999999999999999999999999999999999999987654211
Q ss_pred -cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 166 -EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 166 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
......++..|+|||.+.+..++.++|+||+|+++|++++ |+.||.+.+..+....+....... .....+.++.+
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 234 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP---RPDNCPEELYE 234 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC---CCCCCCHHHHH
Confidence 1112234568999999988889999999999999999999 999999888777776665543322 22467899999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 235 li~~~l~~~p 244 (260)
T cd05067 235 LMRLCWKEKP 244 (260)
T ss_pred HHHHHccCCh
Confidence 9999999998
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=257.62 Aligned_cols=231 Identities=27% Similarity=0.425 Sum_probs=184.6
Q ss_pred ecCCCCceEEEEEEeccCCceEEEEEecccccchHH-HHHHHHHHHH--HHHhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 18 MPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ-MQDILHEAAV--LYLAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 18 ~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~-~~~~~~e~~~--~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
.||+|+||+||+|.+..+++.|++|.+.+....... ......|... +.....|++|+.+.+.+..++.+++|+||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999998765432211 1122223222 2224679999999999999999999999999
Q ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccccccCc
Q psy12709 95 DGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTP 174 (253)
Q Consensus 95 g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 174 (253)
|++|..++.....+++..++.++.|++.++.|||+.+++|+||+|+||+++.++.++|+|||.+....... .....++.
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~ 159 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH 159 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCCc
Confidence 99999998877789999999999999999999999999999999999999999999999999987543322 22346788
Q ss_pred cccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcc
Q psy12709 175 DYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDN---KQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLV 250 (253)
Q Consensus 175 ~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (253)
.|+|||.+.+. .++.++|+||+|+++|+|++|+.||.... .............. ....+|.++.+++.+||.
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~li~~~l~ 235 (278)
T cd05606 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE----LPDSFSPELRSLLEGLLQ 235 (278)
T ss_pred CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC----CCCcCCHHHHHHHHHHhh
Confidence 99999998654 68899999999999999999999997752 22322222222222 223679999999999999
Q ss_pred cCC
Q psy12709 251 TDP 253 (253)
Q Consensus 251 ~dP 253 (253)
.||
T Consensus 236 ~~p 238 (278)
T cd05606 236 RDV 238 (278)
T ss_pred cCH
Confidence 987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=260.74 Aligned_cols=238 Identities=21% Similarity=0.367 Sum_probs=195.8
Q ss_pred eeEEEeecCCCCceEEEEEEec-------cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHK-------ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
+|.+.+.||+|++|.||+|.+. .....+++|.+..... ......+.+|+..+....+|+||+++++++..++
T Consensus 13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 3449999999999999999863 2345689998875433 3445678889988886668999999999999989
Q ss_pred eEEEEEeccCCCcHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQ----------------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN 148 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~ 148 (253)
.+++++||+++++|.+++... ..++...+..++.|++.|+.|||++|++|+||+|+||+++.++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 171 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN 171 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence 999999999999999998653 2378889999999999999999999999999999999999999
Q ss_pred ceEEEeeccccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q psy12709 149 NIKLCDFGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224 (253)
Q Consensus 149 ~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~ 224 (253)
.++|+|||.+........ ......+..|+|||.+.+..++.++|+||+|+++|++++ |..||.+....+.+..+..
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 251 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLRE 251 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999999975543211 111223457999999988889999999999999999999 8999988887777776655
Q ss_pred ccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 225 CNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 225 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+... .....++.++.++|.+||+.||
T Consensus 252 ~~~~---~~~~~~~~~l~~li~~cl~~~p 277 (314)
T cd05099 252 GHRM---DKPSNCTHELYMLMRECWHAVP 277 (314)
T ss_pred CCCC---CCCCCCCHHHHHHHHHHcCCCc
Confidence 4322 2234778999999999999988
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=265.49 Aligned_cols=240 Identities=21% Similarity=0.359 Sum_probs=190.3
Q ss_pred cceeeEEEeecCCCCceEEEEEEec-----cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHK-----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
++|+ +.+.||.|+||.||+|.+. .+++.|++|++..... ......+..|+..+....+|+||+++++.+...
T Consensus 7 ~~~~--i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 7 DRLK--LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHhh--hhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 3555 9999999999999999754 3457899999875433 344567788999988666899999999987654
Q ss_pred -CeEEEEEeccCCCcHHHHHhhc---------------------------------------------------------
Q psy12709 84 -HEMVLVLEMVPDGELQRLVDIQ--------------------------------------------------------- 105 (253)
Q Consensus 84 -~~~~lv~e~~~g~~L~~~~~~~--------------------------------------------------------- 105 (253)
..+++++||+++++|.+++...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 5788999999999999887532
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc---ccccccCccccC
Q psy12709 106 ----DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE---VKEIIGTPDYVA 178 (253)
Q Consensus 106 ----~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~ 178 (253)
.+++...+..++.|++.++.|||++|++|+||+|.||+++.++.++|+|||++........ .....++..|+|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 2578889999999999999999999999999999999999999999999999976532211 112234568999
Q ss_pred ccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 179 PEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 179 PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
||++.+..++.++||||+||++|+|++ |..||.+....+.+........... .....++++.+++.+||+.+|
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~cl~~~p 317 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR--APEYATPEIYSIMLDCWHNNP 317 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC--CCccCCHHHHHHHHHHccCCh
Confidence 999999999999999999999999998 9999977544333322222222111 123678999999999999988
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=255.64 Aligned_cols=238 Identities=21% Similarity=0.326 Sum_probs=197.5
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCc---eEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKV---EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
+.|+ +.+.||+|+||.||+|.+..+++ .|++|.+.... .......+..|+..+. ..+|+||+++++++..++.
T Consensus 4 ~~~~--~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~-~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 4 SCVK--IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMG-QFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred HHeE--EEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHH-hCCCcCcceEEEEECCCCc
Confidence 4566 99999999999999999887665 59999987543 3445677888998887 7799999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
.++++||+++++|.+++... +.++...++.++.|++.++.+||++|++|+||+|+||+++.++.++++|||.+......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999999988753 45899999999999999999999999999999999999999999999999988754332
Q ss_pred cccc---ccc---cCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCC
Q psy12709 165 VEVK---EII---GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHI 237 (253)
Q Consensus 165 ~~~~---~~~---~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 237 (253)
.... ... .+..|+|||.+.+..++.++|+||+|+++|++++ |..||...+..+....+......+ ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~ 236 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLP---PPMDC 236 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCC---CcccC
Confidence 1111 111 1347999999988889999999999999999886 999998887777777665432222 12477
Q ss_pred CHHHHHHHHHhcccCC
Q psy12709 238 SSQAKDFIQSCLVTDP 253 (253)
Q Consensus 238 ~~~l~~li~~~l~~dP 253 (253)
+..+.+++.+||+.||
T Consensus 237 ~~~~~~li~~~l~~~p 252 (269)
T cd05065 237 PTALHQLMLDCWQKDR 252 (269)
T ss_pred CHHHHHHHHHHcCCCh
Confidence 9999999999999987
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=250.35 Aligned_cols=237 Identities=25% Similarity=0.377 Sum_probs=204.8
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEecc
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMV 93 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 93 (253)
++++.||+|+.|+|+++..+.+|...|||.+.++.. .++.+++...+....+..++|+||+.+++|-.+..+++.||.|
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 367789999999999999999999999999987654 4456788888998888889999999999999999999999988
Q ss_pred CCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCceEEEeecccccccccccccccc
Q psy12709 94 PDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDH-NITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEII 171 (253)
Q Consensus 94 ~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (253)
+.-++.++.. ..++++..+-.+...+++||.||-++ |++|||++|.||++|..|++|+||||++-++-++.......
T Consensus 174 -s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsA 252 (391)
T KOG0983|consen 174 -STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSA 252 (391)
T ss_pred -HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccccccc
Confidence 5556666543 56799999999999999999999875 79999999999999999999999999999888888888888
Q ss_pred cCccccCccccCC---CCCCccccHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhcccccccCCccCCCCHHHHHHHHH
Q psy12709 172 GTPDYVAPEVLSY---EPISLATDMWSVGVLAYVLLSSHSPFAG-DNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247 (253)
Q Consensus 172 ~~~~~~~PE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~ 247 (253)
|-+.|||||.+.- ..|+.++||||||++++|+.||+.||.+ ..+.+++-.+....+ +..+....+|+++++|+..
T Consensus 253 GC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~L~~~~gFSp~F~~fv~~ 331 (391)
T KOG0983|consen 253 GCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PLLPGHMGFSPDFQSFVKD 331 (391)
T ss_pred CCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CCCCcccCcCHHHHHHHHH
Confidence 9999999999844 3688999999999999999999999988 556677777766433 3333334589999999999
Q ss_pred hcccCC
Q psy12709 248 CLVTDP 253 (253)
Q Consensus 248 ~l~~dP 253 (253)
||++|+
T Consensus 332 CL~kd~ 337 (391)
T KOG0983|consen 332 CLTKDH 337 (391)
T ss_pred HhhcCc
Confidence 999986
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=253.41 Aligned_cols=233 Identities=19% Similarity=0.325 Sum_probs=198.1
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.+.|+ +.+.||.|++|.||+|... ++.|++|.+..... ...++.+|+..+. ..+|+||+++++++..++..+
T Consensus 5 ~~~~~--~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 5 SKELK--LGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMT-TLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred hhhcc--ceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHH-hcCCcceeeeEEEEcCCCCeE
Confidence 34555 9999999999999999875 78899999976543 4567888998888 668999999999999989999
Q ss_pred EEEeccCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~ 165 (253)
+++||+++++|.+++.... .+++..+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999999987655 68999999999999999999999999999999999999999999999999987664322
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
. .......|+|||.+....++.++|+||+|++++++++ |..||......+....+...... .....+|+++.++
T Consensus 157 ~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l 231 (256)
T cd05039 157 D--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM---EAPEGCPPEVYKV 231 (256)
T ss_pred c--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC---CCccCCCHHHHHH
Confidence 2 2234567999999988888999999999999999997 99999888777766665543221 2224679999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||+.||
T Consensus 232 i~~~l~~~p 240 (256)
T cd05039 232 MKDCWELDP 240 (256)
T ss_pred HHHHhccCh
Confidence 999999998
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=254.10 Aligned_cols=236 Identities=21% Similarity=0.354 Sum_probs=197.5
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +.+.||+|++|+||+|.++ ++..+++|.+...... ...+.+|+..++ ..+|+||+++++++..+...+
T Consensus 5 ~~~~~--i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 5 RESLK--LERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMK-KLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred hhhee--eeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHh-hCCCCCEeeeeeeeecCCceE
Confidence 34455 9999999999999999976 5577999998865443 346778888887 678999999999999989999
Q ss_pred EEEeccCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~ 165 (253)
+++|++++++|.+++.... .++...+..++.+++.++.+||++|++|+||+|+||++++++.++++|||.+.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999999987643 58999999999999999999999999999999999999999999999999987654321
Q ss_pred c--ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHH
Q psy12709 166 E--VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAK 242 (253)
Q Consensus 166 ~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~ 242 (253)
. ......+..|+|||.+.+..++.++|+||+|++++++++ |+.||.+.+.......+......+. ....+.++.
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 234 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR---PPNCPEELY 234 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHH
Confidence 1 112223468999999988889999999999999999998 9999998888777777665432221 235689999
Q ss_pred HHHHHhcccCC
Q psy12709 243 DFIQSCLVTDP 253 (253)
Q Consensus 243 ~li~~~l~~dP 253 (253)
+++.+||+.||
T Consensus 235 ~~i~~~l~~~p 245 (261)
T cd05034 235 DLMLQCWDKDP 245 (261)
T ss_pred HHHHHHcccCc
Confidence 99999999988
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=258.68 Aligned_cols=239 Identities=26% Similarity=0.400 Sum_probs=194.0
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEE------
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE------ 81 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~------ 81 (253)
.+.|+ +.+.||.|+||+||+|.+..++..+++|.+.... .....+..|+..+.+..+|+||+++++++.
T Consensus 15 ~~~~~--~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 15 AGIFE--LVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhh--hheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 35566 8999999999999999999999999999986543 234567788888887778999999999985
Q ss_pred eCCeEEEEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 82 TPHEMVLVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 82 ~~~~~~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
.++.++++|||+++++|.+++... ..+++..+..++.|++.++.|||++|++|+|++|+||+++.++.++|+|||.+.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 245799999999999999988753 347888899999999999999999999999999999999999999999999987
Q ss_pred ccccc-ccccccccCccccCccccC-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCc
Q psy12709 160 VVNDV-VEVKEIIGTPDYVAPEVLS-----YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDL 233 (253)
Q Consensus 160 ~~~~~-~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 233 (253)
..... .......+++.|+|||.+. ...++.++|+||+|+++|+|++|..||...........+.... .+...
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~ 247 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--PPKLK 247 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC--CCCCc
Confidence 54322 1223345788999999875 3457889999999999999999999997765544443333221 11222
Q ss_pred cCCCCHHHHHHHHHhcccCC
Q psy12709 234 FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP 253 (253)
...++.++.++|.+||+.||
T Consensus 248 ~~~~~~~~~~li~~cl~~~p 267 (282)
T cd06636 248 SKKWSKKFIDFIEGCLVKNY 267 (282)
T ss_pred ccccCHHHHHHHHHHhCCCh
Confidence 24689999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=283.66 Aligned_cols=239 Identities=21% Similarity=0.333 Sum_probs=208.1
Q ss_pred ceeeEEEeecCCCCceEEEEEEecc-----CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKI-----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
+...++.+.||+|+||+||+|.... ....||||.++.... ....+++.+|+..+. .++|||||++++++..++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-~~~~~dF~REaeLla-~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-NQARQDFRREAELLA-ELQHPNIVRLLGVCREGD 562 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-HHHHHHHHHHHHHHH-hccCCCeEEEEEEEccCC
Confidence 3344578999999999999998653 234599999886543 345789999999998 899999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCce
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQD--------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNI 150 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~--------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~ 150 (253)
..++|+|||..|+|.++++.+. +++..+.+.++.||+.++.||.++.++|||+-++|.+|.++..|
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence 9999999999999999996422 27889999999999999999999999999999999999999999
Q ss_pred EEEeeccccccccccccc---ccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhccc
Q psy12709 151 KLCDFGISRVVNDVVEVK---EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCN 226 (253)
Q Consensus 151 ~l~df~~~~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~ 226 (253)
||.|||+++......-.. .....++|||||.+..++++.++||||+|+++||+++ |+.||.+.+++++.+-|..+.
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~ 722 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ 722 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence 999999998765432222 3345689999999999999999999999999999999 999999999999999999888
Q ss_pred ccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 227 FSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 227 ~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.-... ..+|.++..|+..||+.+|
T Consensus 723 lL~~P---e~CP~~vY~LM~~CW~~~P 746 (774)
T KOG1026|consen 723 LLSCP---ENCPTEVYSLMLECWNENP 746 (774)
T ss_pred cccCC---CCCCHHHHHHHHHHhhcCc
Confidence 73322 4899999999999999988
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=257.59 Aligned_cols=236 Identities=27% Similarity=0.442 Sum_probs=198.9
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
.|+ .++.||.|++|.||.|.+..++..|++|.+..... ......+.+|+..+. ...|++|+++++.+..+...+++
T Consensus 5 ~y~--~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 5 LFT--KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLS-QCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred hhh--hhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEECCEEEEE
Confidence 445 88999999999999999998999999999875433 334567888888887 67999999999999999999999
Q ss_pred EeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-ccc
Q psy12709 90 LEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVK 168 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~ 168 (253)
|||++|++|.+++.. .++++..+..++.+++.++.+||+++++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence 999999999998874 568999999999999999999999999999999999999999999999999987554322 122
Q ss_pred ccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 169 EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
...++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...........+.... +......++.++.++|.+|
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~ 236 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLTGEFSKPFKEFIDAC 236 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC---CCCCchhhhHHHHHHHHHH
Confidence 3346778999999988889999999999999999999999998776655554443322 2233346789999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|+.||
T Consensus 237 l~~~p 241 (277)
T cd06640 237 LNKDP 241 (277)
T ss_pred cccCc
Confidence 99998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=250.60 Aligned_cols=237 Identities=30% Similarity=0.483 Sum_probs=200.7
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++.+.||+|++|.||++.+..++..+++|.+..... .....+.+|+..+. ...|++++++.+.+..++..++++|+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILK-KCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHH-hCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4488999999999999999998999999999987544 34568888998887 66799999999999999999999999
Q ss_pred cCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccccc
Q psy12709 93 VPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEII 171 (253)
Q Consensus 93 ~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (253)
+++++|.+++... ..+++..+..++.+++.++.+||++|++|+||+|+||++++++.++|+|||.+.............
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence 9999999998775 578999999999999999999999999999999999999999999999999987665443234456
Q ss_pred cCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhccc
Q psy12709 172 GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251 (253)
Q Consensus 172 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (253)
++..|+|||.+.+..++.++|+||+|++++++++|+.||...+.......+..... ........++..+.++|.+||+.
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~ 237 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP-PGLRNPEKWSDEFKDFLKKCLQK 237 (253)
T ss_pred cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCC-CCcCcccccCHHHHHHHHHHccC
Confidence 78899999999888889999999999999999999999988755554444433211 11111223489999999999999
Q ss_pred CC
Q psy12709 252 DP 253 (253)
Q Consensus 252 dP 253 (253)
||
T Consensus 238 ~p 239 (253)
T cd05122 238 NP 239 (253)
T ss_pred Ch
Confidence 98
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=253.59 Aligned_cols=239 Identities=28% Similarity=0.453 Sum_probs=195.4
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc---cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR---RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP-- 83 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-- 83 (253)
.+|+ +.+.||+|+||.||.|.+..++..|++|.+.... ........+.+|+..+. ..+|+||+++++.+..+
T Consensus 2 ~~~~--~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~ 78 (265)
T cd06652 2 TNWR--LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLK-NLLHERIVQYYGCLRDPME 78 (265)
T ss_pred Ccce--EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHH-hcCCCCeeeEEeEeccCCC
Confidence 3556 8999999999999999999999999999886433 22344568888999887 77999999999998764
Q ss_pred CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
..+++++||+++++|.+++.....+++..+..++.+++.++.+||+.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 47889999999999999988777789999999999999999999999999999999999999999999999998875432
Q ss_pred c----ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCH
Q psy12709 164 V----VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 164 ~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
. .......++..|+|||.+.+..++.++|+||+|+++|++++|+.||...........+...... ......++.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PVLPPHVSD 236 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCC--CCCchhhCH
Confidence 1 1122234677999999998888899999999999999999999999876555544443332221 122346788
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
.+.++|.+|+. +|
T Consensus 237 ~~~~~i~~~l~-~p 249 (265)
T cd06652 237 HCRDFLKRIFV-EA 249 (265)
T ss_pred HHHHHHHHHhc-Ch
Confidence 89999999984 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=256.00 Aligned_cols=238 Identities=24% Similarity=0.419 Sum_probs=201.2
Q ss_pred EEEeecCCCCceEEEEEEecc-CCceEEEEEecccc--------cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 14 LIFCMPSRGKFASVRKCTHKI-TKVEYAAKFIRKRR--------RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~-~~~~v~iK~~~~~~--------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
++.+.||+|++|.||+|.+.. .+..+++|.+.... .......++.+|+..+.+..+|+||+++++++..++
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 389999999999999999987 67889999876432 223445667788888887789999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
..++++||++|++|.+++.. ...+++..++.++.+++.++.+||+ .+++|+||+|.||+++.++.++|+|||.+.
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 162 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEeccccee
Confidence 99999999999999887743 3458999999999999999999996 789999999999999999999999999998
Q ss_pred cccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCH
Q psy12709 160 VVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
............++..|+|||.+.+..++.++|+||+|+++|++++|+.||...........+......+... ..+++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 240 (269)
T cd08528 163 QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE--GMYSE 240 (269)
T ss_pred ecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCc--ccCCH
Confidence 6554433344567889999999988889999999999999999999999998877776666665554443222 25789
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
++.++|.+||+.||
T Consensus 241 ~l~~li~~cl~~~p 254 (269)
T cd08528 241 DVTDVITSCLTPDA 254 (269)
T ss_pred HHHHHHHHHCCCCC
Confidence 99999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=259.28 Aligned_cols=241 Identities=28% Similarity=0.380 Sum_probs=193.2
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe----
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE---- 85 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~---- 85 (253)
+|+ +.+.||.|+||+||+|.+..+++.|++|..............+.+|+..+.....|+||+++++++...+.
T Consensus 2 ~y~--~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 2 AYE--KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred Cce--EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 455 99999999999999999999999999999876554444456778899999867678999999999987665
Q ss_pred -EEEEEeccCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-CCceEEEeeccc
Q psy12709 86 -MVLVLEMVPDGELQRLVDIQ-----DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK-DNNIKLCDFGIS 158 (253)
Q Consensus 86 -~~lv~e~~~g~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~-~~~~~l~df~~~ 158 (253)
.++++||+++ +|.+++... ..+++..++.++.|++.++.|||++|++|+||+|+||+++. ++.++|+|||.+
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 787776542 34799999999999999999999999999999999999999 889999999988
Q ss_pred cccccc-ccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc-------
Q psy12709 159 RVVNDV-VEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF------- 229 (253)
Q Consensus 159 ~~~~~~-~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~------- 229 (253)
...... .......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T cd07837 159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238 (295)
T ss_pred eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 754322 12222345778999998755 457889999999999999999999998876655554432211100
Q ss_pred -----------------cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 -----------------HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 -----------------~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.....+.++.++.++|.+||++||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P 279 (295)
T cd07837 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDP 279 (295)
T ss_pred hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCCh
Confidence 111224689999999999999998
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=266.17 Aligned_cols=239 Identities=31% Similarity=0.527 Sum_probs=218.2
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
..+. ++..||+|+||+|-+|..+.+.+.||||++++.- ...+..+..+.|.+.+....+.|.++++...|..-+++|
T Consensus 349 tDFn--Fl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 349 TDFN--FLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred cccc--eEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 3444 8999999999999999999999999999999875 333446677778888886778888999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc-cccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV-VNDVVE 166 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~-~~~~~~ 166 (253)
.||||++||+|--.+++-+.+.+..+..++.+++.+|-+||++||++||++.+||+++.+|++||.|||.++. ..+...
T Consensus 427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~T 506 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVT 506 (683)
T ss_pred eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcc
Confidence 9999999999988888778899999999999999999999999999999999999999999999999999984 344556
Q ss_pred ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHH
Q psy12709 167 VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~ 246 (253)
+...+++|.|+|||++..++|+.+.|.||+|+++|||+.|++||.+.+..+.+++|...+..+|. .+|.+..++++
T Consensus 507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkEAv~ick 582 (683)
T KOG0696|consen 507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKEAVAICK 582 (683)
T ss_pred eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHHHHHHHH
Confidence 67789999999999999999999999999999999999999999999999999999999999998 77999999999
Q ss_pred HhcccCC
Q psy12709 247 SCLVTDP 253 (253)
Q Consensus 247 ~~l~~dP 253 (253)
..|.+.|
T Consensus 583 g~ltK~P 589 (683)
T KOG0696|consen 583 GLLTKHP 589 (683)
T ss_pred HHhhcCC
Confidence 9999887
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=251.91 Aligned_cols=237 Identities=31% Similarity=0.508 Sum_probs=206.3
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++.+.||.|++|.||++.+..++..|++|.+............+.+|+..+. ..+|+|++++.+.+..++..++++|+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILK-KLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHH-hcCCCChhheEEEEecCCEEEEEEEe
Confidence 44999999999999999999999999999999877665566778888998887 66799999999999999999999999
Q ss_pred cCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-cc
Q psy12709 93 VPDGELQRLVDIQ----DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EV 167 (253)
Q Consensus 93 ~~g~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~ 167 (253)
+++++|.+.+... ..++...+..++.+++.++.+||+.|++|+|++|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 9999999988763 668999999999999999999999999999999999999999999999999987654432 22
Q ss_pred cccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~ 247 (253)
....+++.|+|||...+..++.++|+||+|+++++|++|+.||...+..+....+....... ....++.++.+++.+
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~ 237 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP---IPSQYSSELRNLVSS 237 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHH
Confidence 33457789999999988889999999999999999999999998887777776665544332 224789999999999
Q ss_pred hcccCC
Q psy12709 248 CLVTDP 253 (253)
Q Consensus 248 ~l~~dP 253 (253)
||..||
T Consensus 238 ~l~~~p 243 (258)
T cd08215 238 LLQKDP 243 (258)
T ss_pred HcCCCh
Confidence 999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=266.83 Aligned_cols=239 Identities=29% Similarity=0.465 Sum_probs=209.4
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHH-HHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ-MQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
..-+.||+|+||.|+-|+-+.+|+-||.|.+.+.+..... .....+|..++. ...++.||.+-..|+..+.+++|+..
T Consensus 188 ~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~-kV~s~FiVslaYAfeTkd~LClVLtl 266 (591)
T KOG0986|consen 188 RVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILE-KVSSPFIVSLAYAFETKDALCLVLTL 266 (591)
T ss_pred eeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHH-HhccCcEEEEeeeecCCCceEEEEEe
Confidence 3788999999999999999999999999998765532222 345566667776 77888999999999999999999999
Q ss_pred cCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccccccc
Q psy12709 93 VPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI 170 (253)
Q Consensus 93 ~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (253)
|+||+|.--+.+. ++|+++.+..++.+|+-++++||+++|++||++|+||++|+.|+++|+|+|++..+.........
T Consensus 267 MNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~r 346 (591)
T KOG0986|consen 267 MNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGR 346 (591)
T ss_pred ecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCccccc
Confidence 9999997766553 47999999999999999999999999999999999999999999999999999999888777778
Q ss_pred ccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcc
Q psy12709 171 IGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLV 250 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (253)
.||..|||||++.+..|+...|.|||||++|+|+.|+.||...........+.+.-...+......+|++++++.+..|+
T Consensus 347 vGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~ 426 (591)
T KOG0986|consen 347 VGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLT 426 (591)
T ss_pred cCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHc
Confidence 99999999999999999999999999999999999999998876665555555555555555556899999999999999
Q ss_pred cCC
Q psy12709 251 TDP 253 (253)
Q Consensus 251 ~dP 253 (253)
+||
T Consensus 427 Kdp 429 (591)
T KOG0986|consen 427 KDP 429 (591)
T ss_pred cCH
Confidence 998
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=254.14 Aligned_cols=238 Identities=28% Similarity=0.475 Sum_probs=195.2
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc---chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe--CC
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR---SMDQMQDILHEAAVLYLAQKSERIVGLHEIYET--PH 84 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~ 84 (253)
+|+ ..+.||+|++|.||+|.+..++..|++|.+..... .......+.+|+..+. ..+|+||+++++++.. +.
T Consensus 3 ~~~--~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~ 79 (266)
T cd06651 3 NWR--RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLK-NLQHERIVQYYGCLRDRAEK 79 (266)
T ss_pred Ccc--ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHH-HcCCCCeeeEEEEEEcCCCC
Confidence 455 89999999999999999999999999999875432 2334567888998887 6689999999999875 35
Q ss_pred eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
.+++++|++++++|.+++.....++....+.++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 78999999999999999987777899999999999999999999999999999999999999999999999998754321
Q ss_pred ----ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHH
Q psy12709 165 ----VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 165 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
.......++..|+|||.+.+..++.++|+||+|+++|++++|+.||...........+...... ......+++.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 237 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN--PQLPSHISEH 237 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC--CCCchhcCHH
Confidence 1112234678899999998888999999999999999999999999876655544443332221 2223467889
Q ss_pred HHHHHHHhcccCC
Q psy12709 241 AKDFIQSCLVTDP 253 (253)
Q Consensus 241 l~~li~~~l~~dP 253 (253)
++++| +||..||
T Consensus 238 ~~~li-~~~~~~p 249 (266)
T cd06651 238 ARDFL-GCIFVEA 249 (266)
T ss_pred HHHHH-HHhcCCh
Confidence 99999 5777787
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=260.61 Aligned_cols=239 Identities=28% Similarity=0.383 Sum_probs=194.9
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc---hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS---MDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
|++.+.||.|++|.||+|.+..++..|++|.+...... ......+.+|+..+. ..+|+||+++++++..++..++|
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQ-ELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHh-hcCCCCChhhhheeecCCEEEEE
Confidence 44899999999999999999999999999999865533 233455677888887 77899999999999999999999
Q ss_pred EeccCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-ccc
Q psy12709 90 LEMVPDGELQRLVDIQD-GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEV 167 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~ 167 (253)
|||+ +++|.+++.... .+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 889999997665 7999999999999999999999999999999999999999999999999998765432 222
Q ss_pred cccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc-----------------
Q psy12709 168 KEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF----------------- 229 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----------------- 229 (253)
.....++.|+|||.+.+ ..++.++|+||+|+++++|++|..||.+.+..+....+......+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence 23345678999998854 457889999999999999999988888766655544433211100
Q ss_pred -------cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 -------HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 -------~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
........+.++.++|.+||++||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 270 (298)
T cd07841 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNP 270 (298)
T ss_pred cccCCcchhhhcccccHHHHHHHHHHhcCCc
Confidence 011224568899999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=256.46 Aligned_cols=238 Identities=23% Similarity=0.361 Sum_probs=189.3
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
+|+ +++.||+|+||.||+|.++.+++.||+|.+........ ......|+....+..+|+||+++++.+..++.++++
T Consensus 2 ~~~--~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 2 DLE--VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred Cce--EEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 455 99999999999999999999999999999876543333 335556666666688999999999999999999999
Q ss_pred EeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 90 LEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDH-NITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
+||++ ++|.+++.. ...+++..++.++.|++.++.|||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99996 577766643 34589999999999999999999997 9999999999999999999999999998765433
Q ss_pred ccccccccCccccCccccCC----CCCCccccHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHhhcccccccCCccCCCCH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSY----EPISLATDMWSVGVLAYVLLSSHSPFAGD-NKQETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
.......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||... ...+....+..... +.-....+|.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 235 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS--PQLPAEKFSP 235 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC--CCCCccccCH
Confidence 22233456788999998865 34688999999999999999999999653 22233333332211 1111235799
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
++.++|.+||+.||
T Consensus 236 ~l~~li~~~l~~~p 249 (283)
T cd06617 236 EFQDFVNKCLKKNY 249 (283)
T ss_pred HHHHHHHHHccCCh
Confidence 99999999999998
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=258.52 Aligned_cols=233 Identities=29% Similarity=0.469 Sum_probs=194.9
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
+.+.||.|++|.||+|.++.++..+++|.+...... .....+.+|+..+. ...|+||+++++.+..++.+++++|+++
T Consensus 5 ~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILH-KCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred HHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHH-HCCCCchhhhheeeecCCEEEEEEEecC
Confidence 889999999999999999999999999998775432 44567788988887 5669999999999999999999999999
Q ss_pred CCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCceEEEeeccccccccccccccccc
Q psy12709 95 DGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIG 172 (253)
Q Consensus 95 g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 172 (253)
+++|.+++... ..+++..+..++.+++.++++||+ .|++|+||+|+||++++++.++|+|||.+......... ...+
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~~~ 161 (265)
T cd06605 83 GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-TFVG 161 (265)
T ss_pred CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-cccC
Confidence 99999999865 678999999999999999999999 99999999999999999999999999988755432221 2567
Q ss_pred CccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHhhcccccccCCccC-CCCHHHHHHHH
Q psy12709 173 TPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDN-----KQETFLNISQCNFSFHEDLFG-HISSQAKDFIQ 246 (253)
Q Consensus 173 ~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~i~~~~~~~~~~~~~-~~~~~l~~li~ 246 (253)
+..|+|||.+.+..++.++|+||+|++++++++|+.||.... ..+....+..... ..... .++++++++|.
T Consensus 162 ~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~ 238 (265)
T cd06605 162 TSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP---PRLPSGKFSPDFQDFVN 238 (265)
T ss_pred ChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC---CCCChhhcCHHHHHHHH
Confidence 789999999988899999999999999999999999996542 2222333322211 11112 28999999999
Q ss_pred HhcccCC
Q psy12709 247 SCLVTDP 253 (253)
Q Consensus 247 ~~l~~dP 253 (253)
+||..||
T Consensus 239 ~~l~~~p 245 (265)
T cd06605 239 LCLIKDP 245 (265)
T ss_pred HHcCCCc
Confidence 9999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=255.57 Aligned_cols=241 Identities=20% Similarity=0.283 Sum_probs=199.1
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCCc----eEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITKV----EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 80 (253)
++..+.|+ +.+.||+|+||+||+|.++.+++ .+++|....... ......+.+|+..+. ..+|+||+++++++
T Consensus 3 ~~~~~~~~--~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~ 78 (279)
T cd05057 3 ILKETELE--KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMA-SVDHPHVVRLLGIC 78 (279)
T ss_pred ccCHHHcE--EcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHH-hCCCCCcceEEEEE
Confidence 44556666 99999999999999999876654 588898775543 344567888888888 67999999999998
Q ss_pred EeCCeEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 81 ETPHEMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 81 ~~~~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
.. ...++++||+++++|.+.+... ..+++..+..++.|++.|++|||+++++|+||+|+||+++.++.++|+|||.+.
T Consensus 79 ~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 79 LS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred ec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 87 7899999999999999988764 468999999999999999999999999999999999999999999999999987
Q ss_pred cccccccc---cccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccC
Q psy12709 160 VVNDVVEV---KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFG 235 (253)
Q Consensus 160 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 235 (253)
........ .....+..|+|||.+....++.++|+||+|+++|++++ |+.||......+....+......+.. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~ 234 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQP---P 234 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCC---C
Confidence 65432211 11123457999999988888999999999999999998 99999988877777766654332222 3
Q ss_pred CCCHHHHHHHHHhcccCC
Q psy12709 236 HISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 236 ~~~~~l~~li~~~l~~dP 253 (253)
..+.++.+++.+||..||
T Consensus 235 ~~~~~~~~~~~~~l~~~p 252 (279)
T cd05057 235 ICTIDVYMVLVKCWMIDA 252 (279)
T ss_pred CCCHHHHHHHHHHcCCCh
Confidence 578899999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=259.94 Aligned_cols=241 Identities=20% Similarity=0.326 Sum_probs=198.1
Q ss_pred cceeeEEEeecCCCCceEEEEEEec-------cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHK-------ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 81 (253)
..-+|++.+.||+|+||.||.|... .++..|++|.+.... .......+.+|+..+....+|+||+++++++.
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3444559999999999999999753 234579999887543 23446788899999886668999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc
Q psy12709 82 TPHEMVLVLEMVPDGELQRLVDIQ----------------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLT 145 (253)
Q Consensus 82 ~~~~~~lv~e~~~g~~L~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~ 145 (253)
..+..+++|||+++++|.+++... ..++...+..++.|++.|+.|||++|++|+||+|+||+++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 999999999999999999998753 2367788999999999999999999999999999999999
Q ss_pred CCCceEEEeeccccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy12709 146 KDNNIKLCDFGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLN 221 (253)
Q Consensus 146 ~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~ 221 (253)
.++.++|+|||.+........ .....+++.|+|||++.+..++.++||||+|+++|++++ |..||.+.+..+....
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 251 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 999999999999876543221 112234567999999988889999999999999999998 8899988888887777
Q ss_pred hhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 222 ISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 222 i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+....... ....++.+++++|.+||+.+|
T Consensus 252 ~~~~~~~~---~~~~~~~~~~~li~~cl~~~p 280 (304)
T cd05101 252 LKEGHRMD---KPANCTNELYMMMRDCWHAIP 280 (304)
T ss_pred HHcCCcCC---CCCCCCHHHHHHHHHHcccCh
Confidence 65543322 224689999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=259.30 Aligned_cols=239 Identities=21% Similarity=0.363 Sum_probs=194.8
Q ss_pred eeEEEeecCCCCceEEEEEEec-----cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHK-----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
.|++.+.||+|+||.||+|.+. .++..+++|.+..... ......+.+|+..+.+..+|+||+++++.+...+..
T Consensus 36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 3449999999999999999753 3456899998876533 333567888999998666899999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
++++||+.+++|.+++.... .++...+..++.+++.++.|||+++++|+||+|+||+++.++.++++|||.+......
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 194 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND 194 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCC
Confidence 99999999999999987543 3899999999999999999999999999999999999999999999999998754332
Q ss_pred cc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHH
Q psy12709 165 VE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 165 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
.. .....++..|+|||.+.+..++.++|+||+|+++|++++ |..||......+.+........... .....+++
T Consensus 195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 272 (302)
T cd05055 195 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA--QPEHAPAE 272 (302)
T ss_pred CceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC--CCCCCCHH
Confidence 11 112234568999999988889999999999999999998 9999987665554444333332222 22357899
Q ss_pred HHHHHHHhcccCC
Q psy12709 241 AKDFIQSCLVTDP 253 (253)
Q Consensus 241 l~~li~~~l~~dP 253 (253)
+.+++.+||++||
T Consensus 273 ~~~li~~cl~~~p 285 (302)
T cd05055 273 IYDIMKTCWDADP 285 (302)
T ss_pred HHHHHHHHcCCCc
Confidence 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=256.65 Aligned_cols=240 Identities=19% Similarity=0.341 Sum_probs=193.4
Q ss_pred cceeeEEEeecCCCCceEEEEEEecc-----CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKI-----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
+..+|++.+.||+|+||.||+|..+. .+..|++|.+..... ......+.+|+..+. ..+|+||+++++++..+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMK-GFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHH-hCCCCCeeeEEEEEcCC
Confidence 34455599999999999999997652 345799998865432 233445677888777 77899999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEE
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQ----------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLC 153 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~ 153 (253)
+..+++|||+++++|.+++... ...+...+..++.|++.++.|||+++++|+||+|+||+++.++.++|+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 9999999999999999998642 224667889999999999999999999999999999999999999999
Q ss_pred eeccccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccc
Q psy12709 154 DFGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSF 229 (253)
Q Consensus 154 df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~ 229 (253)
|||++........ .....++..|+|||.+.+..++.++|+||+|+++|++++ |..||.+...++....+.......
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 241 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9998875432111 111233567999999988889999999999999999998 889998888777766655443322
Q ss_pred cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
. ....++.+++++.+||+.||
T Consensus 242 ~---~~~~~~~~~~li~~~l~~~p 262 (288)
T cd05061 242 Q---PDNCPERVTDLMRMCWQFNP 262 (288)
T ss_pred C---CCCCCHHHHHHHHHHcCCCh
Confidence 1 23668999999999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=274.24 Aligned_cols=224 Identities=23% Similarity=0.370 Sum_probs=196.2
Q ss_pred EeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 16 FCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
++=||+|+.|-||+|+.. ++.||||++..-+ +.+|+-++ .++|+||+.+.+++.+...+++|||||..
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~elk---------ETdIKHLR-kLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRELK---------ETDIKHLR-KLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhhhh---------hhhHHHHH-hccCcceeeEeeeecCCceeEEeeecccc
Confidence 456899999999999876 8899999886422 23566676 78999999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccccccCcc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPD 175 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (253)
|-|..+++....++...+..+..+|+.++.|||.+.|+|||+|.-||+|..+..|||+|||-++..++-......+|+..
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVa 276 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVA 276 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHh
Confidence 99999999999999999999999999999999999999999999999999999999999999998877656667899999
Q ss_pred ccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 176 YVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 176 ~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
|||||++...+++.+.||||+|+|||||+||+.||.+.+.....--+-.+... ......+++.++-||++||+-.|
T Consensus 277 WMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~--LpvPstcP~GfklL~Kqcw~sKp 352 (904)
T KOG4721|consen 277 WMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLH--LPVPSTCPDGFKLLLKQCWNSKP 352 (904)
T ss_pred hhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCccc--ccCcccCchHHHHHHHHHHhcCC
Confidence 99999999999999999999999999999999999887665544333333332 33445889999999999998765
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=254.05 Aligned_cols=235 Identities=21% Similarity=0.351 Sum_probs=194.0
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +++.||+|++|+||+|.+. ++..+++|.+....... ..+.+|+..+. ..+|++++++++++.. +..+
T Consensus 5 ~~~~~--~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~E~~~l~-~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05070 5 RESLQ--LIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSP---ESFLEEAQIMK-KLRHDKLVQLYAVVSE-EPIY 76 (260)
T ss_pred hHHhh--hhheeccccCceEEEEEec-CCceeEEEEecCCCCCH---HHHHHHHHHHH-hcCCCceEEEEeEECC-CCcE
Confidence 44566 9999999999999999876 56679999987654433 36778888888 6789999999998854 5688
Q ss_pred EEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~ 165 (253)
++|||+++++|.+++... ..++...++.++.+++.++.|||+++++|+||+|.||++++++.++|+|||.+.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999988653 348999999999999999999999999999999999999999999999999987653321
Q ss_pred c--ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHH
Q psy12709 166 E--VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAK 242 (253)
Q Consensus 166 ~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~ 242 (253)
. .....++..|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+..+....+...... +.....+..++
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 233 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM---PCPQDCPISLH 233 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCCHHHH
Confidence 1 112233457999999988889999999999999999999 99999888877777766553222 12247899999
Q ss_pred HHHHHhcccCC
Q psy12709 243 DFIQSCLVTDP 253 (253)
Q Consensus 243 ~li~~~l~~dP 253 (253)
+++.+||++||
T Consensus 234 ~li~~~l~~~p 244 (260)
T cd05070 234 ELMLQCWKKDP 244 (260)
T ss_pred HHHHHHcccCc
Confidence 99999999998
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=249.99 Aligned_cols=237 Identities=32% Similarity=0.488 Sum_probs=204.2
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++.+.||+|++|.||++.+..++..|++|.+............+.+|+..+. ..+|++++++.+++..++..++++|+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLK-NLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHH-hCCCCCccEEEEEEEeCCEEEEEEec
Confidence 44999999999999999999989999999999887665566778899999988 66899999999999999999999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc-ccccc
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE-VKEII 171 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~~~ 171 (253)
+++++|.+++.....+++..+..++.+++.++.+||++|++|+||+|.||+++.++.++|+|||.+........ .....
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 160 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV 160 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccc
Confidence 99999999998777899999999999999999999999999999999999999999999999999886544322 22345
Q ss_pred cCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhccc
Q psy12709 172 GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251 (253)
Q Consensus 172 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (253)
++..|+|||...+..++.++|+|++|++++++++|..||...+......+....... .....+++.+.++|.+||+.
T Consensus 161 ~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~ 237 (254)
T cd06627 161 GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP---PLPEGISPELKDFLMQCFQK 237 (254)
T ss_pred cchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCC---CCCCCCCHHHHHHHHHHHhC
Confidence 678999999988888889999999999999999999999876665555444432222 22347799999999999999
Q ss_pred CC
Q psy12709 252 DP 253 (253)
Q Consensus 252 dP 253 (253)
||
T Consensus 238 ~p 239 (254)
T cd06627 238 DP 239 (254)
T ss_pred Ch
Confidence 87
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=254.00 Aligned_cols=238 Identities=21% Similarity=0.343 Sum_probs=197.3
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCC---ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITK---VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
.+|+ +.+.||+|+||.||+|.+..++ ..+++|.+..... ......+.+|+..+. ..+|+||+++++++..++.
T Consensus 4 ~~~~--~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 4 SCIK--IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMG-QFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred HHeE--eeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHH-hCCCCCcceEEEEEecCCc
Confidence 4566 9999999999999999986544 3699998875433 334567888888887 6799999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
.+++|||+++++|.+++... ..++...+..++.|++.++.+||+++++|+||+|+||+++.++.++++|||.+......
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999998764 45899999999999999999999999999999999999999999999999998765432
Q ss_pred ccc----cccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCH
Q psy12709 165 VEV----KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 165 ~~~----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
... .....+..|+|||.+.+..++.++|+||+|+++|++++ |..||...+..+....+..... .+ ....+++
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~ 236 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-LP--APMDCPA 236 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-CC--CCCCCCH
Confidence 111 11122457999999988889999999999999999887 9999988777777666665432 22 2246799
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
.+.+++.+||+++|
T Consensus 237 ~~~~li~~~l~~~p 250 (267)
T cd05066 237 ALHQLMLDCWQKDR 250 (267)
T ss_pred HHHHHHHHHcccCc
Confidence 99999999999987
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=255.86 Aligned_cols=234 Identities=22% Similarity=0.364 Sum_probs=198.3
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++++.||.|++|.||+|.+.. +..+++|.+..... .....+.+|+..++ ..+|+||+++++++..++.++++|||
T Consensus 8 y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~--~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 8 FTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL--LKQQDFQKEVQALK-RLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch--hhHHHHHHHHHHHh-cCCCcchhheeeeEecCCCeEEEEee
Confidence 3489999999999999999987 88899999876543 23456788888887 77899999999999999999999999
Q ss_pred cCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc-ccc
Q psy12709 93 VPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE-VKE 169 (253)
Q Consensus 93 ~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~ 169 (253)
+++++|.+++... ..++...+..++.+++.|+.+||++|++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~ 163 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSD 163 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccC
Confidence 9999999998753 3589999999999999999999999999999999999999999999999999876543211 122
Q ss_pred cccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 170 IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
...+..|+|||......++.++|+||+|+++++|++ |+.||...+..+.+..+...... .....+++.+.++|.+|
T Consensus 164 ~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~ 240 (261)
T cd05148 164 KKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM---PCPAKCPQEIYKIMLEC 240 (261)
T ss_pred CCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC---CCCCCCCHHHHHHHHHH
Confidence 234568999999988889999999999999999998 89999888877777776644322 22357899999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|+.||
T Consensus 241 l~~~p 245 (261)
T cd05148 241 WAAEP 245 (261)
T ss_pred cCCCc
Confidence 99998
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=250.85 Aligned_cols=238 Identities=30% Similarity=0.455 Sum_probs=202.9
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--CeEEEEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP--HEMVLVL 90 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~ 90 (253)
|++.+.||+|++|.||+|.+..++..+++|++............+.+|+..+. ..+|+||+++++.+... +.+++++
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILS-SLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHH-HcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 34889999999999999999999999999999877655566778889999888 67799999999999988 8999999
Q ss_pred eccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc---c
Q psy12709 91 EMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE---V 167 (253)
Q Consensus 91 e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~ 167 (253)
|++++++|.+++.....+++..+..++.+++.++.+||+.|++|+|++|+||+++.++.++|+|||.+........ .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 9999999999998777899999999999999999999999999999999999999999999999999887655432 3
Q ss_pred cccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHhhcccccccCCccCCCCHHHHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDN-KQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~ 246 (253)
....++..|.|||.+.+...+.++|+||+|++++++++|..||.... .......+.... .........+..++++|.
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSG--EPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred cCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccC--CCcCCCcccCHHHHHHHH
Confidence 34567889999999988889999999999999999999999998765 222222332211 112233466999999999
Q ss_pred HhcccCC
Q psy12709 247 SCLVTDP 253 (253)
Q Consensus 247 ~~l~~dP 253 (253)
+||+.||
T Consensus 239 ~~l~~~p 245 (260)
T cd06606 239 KCLRRDP 245 (260)
T ss_pred HhCcCCh
Confidence 9999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=261.51 Aligned_cols=243 Identities=20% Similarity=0.304 Sum_probs=197.6
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccC-------CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKIT-------KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-------~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~ 79 (253)
.-.+.+|++.+.||+|+||.||.|.+... +..|++|.+... ........+.+|+..+.+..+|+||+++++.
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 33444455999999999999999986432 236899987753 3334467888999999866699999999999
Q ss_pred EEeCCeEEEEEeccCCCcHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEE
Q psy12709 80 YETPHEMVLVLEMVPDGELQRLVDIQD----------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNIL 143 (253)
Q Consensus 80 ~~~~~~~~lv~e~~~g~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~ 143 (253)
+..++.+++++||+++++|.+++.... .++...+..++.|++.|+.|||++|++|+||+|+||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 166 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 999999999999999999999886532 3677888999999999999999999999999999999
Q ss_pred EcCCCceEEEeeccccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy12709 144 LTKDNNIKLCDFGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETF 219 (253)
Q Consensus 144 ~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~ 219 (253)
++.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 246 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999875543221 111223457999999988889999999999999999998 89999988877777
Q ss_pred HHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 220 LNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 220 ~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+....... ....++.++.++|.+||+.+|
T Consensus 247 ~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p 277 (334)
T cd05100 247 KLLKEGHRMD---KPANCTHELYMIMRECWHAVP 277 (334)
T ss_pred HHHHcCCCCC---CCCCCCHHHHHHHHHHcccCh
Confidence 7665543222 224678999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=258.58 Aligned_cols=235 Identities=19% Similarity=0.305 Sum_probs=195.4
Q ss_pred EEEeecCCCCceEEEEEEecc-----CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 14 LIFCMPSRGKFASVRKCTHKI-----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++.+.||.|+||.||+|.+.. .+..|++|.+..... ......+.+|+..+. ..+|+||+++++++...+..++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~-~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRS-RLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHh-cCCCCCcCeEEEEEcCCCceEE
Confidence 388999999999999998753 357899999875432 233456777777776 7789999999999999999999
Q ss_pred EEeccCCCcHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEE
Q psy12709 89 VLEMVPDGELQRLVDIQ----------------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKL 152 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l 152 (253)
++||+.+++|.+++... ..++...+..++.|++.|+.|+|++|++|+||+|.||+++.++.++|
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl 165 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKI 165 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEe
Confidence 99999999999987521 24788889999999999999999999999999999999999999999
Q ss_pred Eeeccccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhccccc
Q psy12709 153 CDFGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFS 228 (253)
Q Consensus 153 ~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~ 228 (253)
+|||++........ ......++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+....+....+......
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~ 245 (283)
T cd05091 166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL 245 (283)
T ss_pred cccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999875433221 122334678999999988889999999999999999998 88999988888888777766543
Q ss_pred ccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 229 FHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+. ...++.++.+++.+||+.||
T Consensus 246 ~~---~~~~~~~~~~li~~cl~~~p 267 (283)
T cd05091 246 PC---PDDCPAWVYTLMLECWNEFP 267 (283)
T ss_pred CC---CCCCCHHHHHHHHHHhCCCc
Confidence 32 24789999999999999998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=251.69 Aligned_cols=230 Identities=21% Similarity=0.364 Sum_probs=189.0
Q ss_pred ecCCCCceEEEEEEec--cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 18 MPSRGKFASVRKCTHK--ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 18 ~lg~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
.||.|+||.||+|... ..+..|++|++..... ......+.+|+..++ ..+|+||+++++++.. +..+++|||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~-~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMH-QLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC-hHHHHHHHHHHHHHH-hcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999875 3456799998875432 344567888999888 6799999999998764 578999999999
Q ss_pred CcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccc----ccc
Q psy12709 96 GELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV----KEI 170 (253)
Q Consensus 96 ~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~----~~~ 170 (253)
++|.+++.. ...+++..++.++.+++.++.+||++|++|+||+|+||+++.++.++|+|||.+......... ...
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999998874 456899999999999999999999999999999999999999999999999998754332111 111
Q ss_pred ccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 171 IGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
..+..|+|||.+....++.++|+||+|+++|++++ |+.||......+....+..+.... .....++++.++|.+||
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~c~ 235 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD---CPAECPPEMYALMKDCW 235 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCCHHHHHHHHHHc
Confidence 22468999999988889999999999999999996 999999888777776665544322 22467999999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
+.||
T Consensus 236 ~~~~ 239 (257)
T cd05115 236 IYKW 239 (257)
T ss_pred CCCh
Confidence 9987
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=255.28 Aligned_cols=240 Identities=26% Similarity=0.426 Sum_probs=195.3
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC---
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH--- 84 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--- 84 (253)
.++|+ +.+.||.|++|+||+|.+..++..+++|++..... ....+.+|+..+.+...|+||+++++.+....
T Consensus 5 ~~~y~--~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 5 TGIFE--LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred hhhee--heeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 35666 99999999999999999998899999999876543 23577889999987778999999999997544
Q ss_pred ---eEEEEEeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecc
Q psy12709 85 ---EMVLVLEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI 157 (253)
Q Consensus 85 ---~~~lv~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~ 157 (253)
.+++++||+++++|.+++.. +..+++..+..++.|++.|+.+||+++++|+||+|+||+++.++.++|+|||.
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 58999999999999998764 34689999999999999999999999999999999999999999999999998
Q ss_pred ccccccc-ccccccccCccccCccccCC-----CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC
Q psy12709 158 SRVVNDV-VEVKEIIGTPDYVAPEVLSY-----EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE 231 (253)
Q Consensus 158 ~~~~~~~-~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 231 (253)
+...... .......++..|+|||.+.. ..++.++|+||+|++++++++|+.||...........+...... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~ 238 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP-TL 238 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC-CC
Confidence 8754322 22233456788999998754 24677899999999999999999999876655555555443221 11
Q ss_pred CccCCCCHHHHHHHHHhcccCC
Q psy12709 232 DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 232 ~~~~~~~~~l~~li~~~l~~dP 253 (253)
.....++.+++++|.+||+.||
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp 260 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNY 260 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcCh
Confidence 1112478899999999999998
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=252.07 Aligned_cols=235 Identities=24% Similarity=0.360 Sum_probs=200.4
Q ss_pred EEEeecCCCCceEEEEEEeccCC----ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITK----VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
++.+.||.|+||.||+|.+...+ ..+++|.+..... ......+.+|+..+. ..+|+||+++++++...+..+++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMR-KLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHH-hcCCCchheEEEEEcCCCeeEEE
Confidence 47899999999999999998766 8899999865433 224568888999888 55999999999999999999999
Q ss_pred EeccCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccc
Q psy12709 90 LEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV 167 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 167 (253)
||++++++|.+++..... +++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999999999999876544 899999999999999999999999999999999999999999999999999765443221
Q ss_pred c--ccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 168 K--EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 168 ~--~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
. ...+++.|+|||.+.+..++.++|+||+|+++++|++ |..||...+.......+......... ..++.++.++
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 236 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKP---ENCPPEIYKL 236 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---CcCCHHHHHH
Confidence 1 1235678999999988889999999999999999998 89999888887777777665543322 3589999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
+.+||+.||
T Consensus 237 i~~~l~~~p 245 (258)
T smart00219 237 MLQCWAEDP 245 (258)
T ss_pred HHHHCcCCh
Confidence 999999998
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=260.38 Aligned_cols=243 Identities=26% Similarity=0.341 Sum_probs=195.5
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--C
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP--H 84 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~ 84 (253)
..++|+ +.+.||.|++|.||+|.+..++..|++|.+..............+|+..+. ..+|+||+++++++... +
T Consensus 5 ~~~~y~--~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~ 81 (309)
T cd07845 5 SVTEFE--KLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLL-NLRHPNIVELKEVVVGKHLD 81 (309)
T ss_pred ccccee--EeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHH-hCCCCCCcceEEEEecCCCC
Confidence 345666 999999999999999999999999999998765433333345567888887 77999999999998765 5
Q ss_pred eEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
.+++|+||+.+ +|.+++.. ...+++..++.++.|++.++.+||+.|++|+||+|+||++++++.++|+|||.+.....
T Consensus 82 ~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 82 SIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred eEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 78999999965 78777765 45689999999999999999999999999999999999999999999999999876543
Q ss_pred cc-cccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCC---------
Q psy12709 164 VV-EVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHED--------- 232 (253)
Q Consensus 164 ~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~--------- 232 (253)
.. .......++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+.+..+.+..+......+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 21 2222334678999999865 457889999999999999999999999888877766554422111100
Q ss_pred -----------------ccCCCCHHHHHHHHHhcccCC
Q psy12709 233 -----------------LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 -----------------~~~~~~~~l~~li~~~l~~dP 253 (253)
.....++++.++|.+||+.||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp 278 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDP 278 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCCh
Confidence 012368899999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=254.72 Aligned_cols=240 Identities=25% Similarity=0.361 Sum_probs=193.9
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC----
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP---- 83 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~---- 83 (253)
.++|+ +.+.||+|++|.||+|.+..+++.+++|.+...... ...+.+|+..+.+..+|+|++++++++...
T Consensus 21 ~~~y~--~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 21 TDTWE--IIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV---DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCeE--EEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH---HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 45566 999999999999999999999999999998754322 345667888888676899999999998753
Q ss_pred -CeEEEEEeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccc
Q psy12709 84 -HEMVLVLEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGIS 158 (253)
Q Consensus 84 -~~~~lv~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~ 158 (253)
+.+++++||+++++|.+++.. ...+++..++.++.|++.++++||+.+++|+||+|+||+++.++.++|+|||.+
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 368999999999999988753 346899999999999999999999999999999999999999999999999998
Q ss_pred ccccccc-cccccccCccccCccccCCC-----CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCC
Q psy12709 159 RVVNDVV-EVKEIIGTPDYVAPEVLSYE-----PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHED 232 (253)
Q Consensus 159 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 232 (253)
....... ......++..|+|||.+... .++.++|+||+|+++|+|++|+.||...........+...... ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~ 254 (291)
T cd06639 176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP-TLL 254 (291)
T ss_pred hhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC-CCC
Confidence 7544322 12234567889999997543 2578999999999999999999999887665555554433221 111
Q ss_pred ccCCCCHHHHHHHHHhcccCC
Q psy12709 233 LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 ~~~~~~~~l~~li~~~l~~dP 253 (253)
....++.++.++|.+||+.||
T Consensus 255 ~~~~~~~~l~~li~~~l~~~p 275 (291)
T cd06639 255 HPEKWCRSFNHFISQCLIKDF 275 (291)
T ss_pred cccccCHHHHHHHHHHhhcCh
Confidence 223577889999999999988
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=256.93 Aligned_cols=237 Identities=29% Similarity=0.424 Sum_probs=193.7
Q ss_pred eEEEeecCCCCceEEEEEEec---cCCceEEEEEeccccc--chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHK---ITKVEYAAKFIRKRRR--SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
|++.+.||.|+||.||.|.+. .++..|++|.+..... .......+.+|+..+.+..+|++|+++++.+..+..++
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 349999999999999999875 4788999999875432 22234567788888886768999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc--
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-- 165 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-- 165 (253)
+++||+++++|.+.+....++++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (290)
T cd05613 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161 (290)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccccc
Confidence 999999999999999888889999999999999999999999999999999999999999999999999987653321
Q ss_pred cccccccCccccCccccCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHhhcccccccCCccCCCCH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYE--PISLATDMWSVGVLAYVLLSSHSPFAGDNK----QETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
......++..|+|||.+.+. .++.++|+||+|+++|++++|..||..... .+....+.....+.+ ..+++
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 237 (290)
T cd05613 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----QEMSA 237 (290)
T ss_pred ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC----ccCCH
Confidence 12234567899999998653 467889999999999999999999975332 233333333333222 36899
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
.+.+++.+||+.||
T Consensus 238 ~~~~ll~~~l~~~p 251 (290)
T cd05613 238 LAKDIIQRLLMKDP 251 (290)
T ss_pred HHHHHHHHHhcCCH
Confidence 99999999999987
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=255.73 Aligned_cols=239 Identities=26% Similarity=0.378 Sum_probs=191.3
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEE-----eC
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE-----TP 83 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~ 83 (253)
++|+ +.+.||+|++|.||+|.+..++..+++|++...... ...+.+|+..+..+.+|+||+++++.+. .+
T Consensus 18 ~~~~--~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 18 DTWE--IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI---DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred ccee--eeeeeccCCCcEEEEEEECCCCceeEEEeeccccch---HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 4555 999999999999999999999999999987653322 2456778888886668999999999873 34
Q ss_pred CeEEEEEeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 84 HEMVLVLEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
+.++++|||++|++|.+++.. ...+++..+..++.+++.++.+||+.+++|+|++|+||+++.++.++|+|||.+.
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 579999999999999987652 3458899999999999999999999999999999999999999999999999987
Q ss_pred ccccc-ccccccccCccccCccccCC-----CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCc
Q psy12709 160 VVNDV-VEVKEIIGTPDYVAPEVLSY-----EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDL 233 (253)
Q Consensus 160 ~~~~~-~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 233 (253)
..... .......+++.|+|||.+.. ..++.++|+||+|+++|+|++|+.||...........+...... ....
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~ 251 (286)
T cd06638 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP-TLHQ 251 (286)
T ss_pred ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC-cccC
Confidence 54322 12223457889999998753 34788999999999999999999999876655444443332211 1112
Q ss_pred cCCCCHHHHHHHHHhcccCC
Q psy12709 234 FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP 253 (253)
...++.++.++|.+||+.||
T Consensus 252 ~~~~~~~~~~li~~~l~~~p 271 (286)
T cd06638 252 PELWSNEFNDFIRKCLTKDY 271 (286)
T ss_pred CCCcCHHHHHHHHHHccCCc
Confidence 23468899999999999998
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=257.14 Aligned_cols=239 Identities=28% Similarity=0.427 Sum_probs=194.4
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++++.||.|++|.||+|.+..++..|++|.+............+.+|+..+. ..+|+||+++++++..++..+++|||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK-ELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHH-hcCCCCCcchhhhcccCCcEEEEeec
Confidence 44999999999999999999999999999998765544444567888999888 77999999999999999999999999
Q ss_pred cCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-cccc
Q psy12709 93 VPDGELQRLVDI--QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVKE 169 (253)
Q Consensus 93 ~~g~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~ 169 (253)
+. ++|..++.. ...+++..++.++.+++.|++|||+.+++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 96 578887754 3458999999999999999999999999999999999999999999999999887543321 2222
Q ss_pred cccCccccCccccCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc------------------
Q psy12709 170 IIGTPDYVAPEVLSYEP-ISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH------------------ 230 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~------------------ 230 (253)
..+++.|+|||.+.+.. ++.++|+||+|+++|++++|+.||...+......++......+.
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence 34577899999886644 58889999999999999999999988766554444332211111
Q ss_pred -------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 -------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 -------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+.++++++++|.+||+.||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 269 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDP 269 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCc
Confidence 11224578999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=251.74 Aligned_cols=234 Identities=21% Similarity=0.331 Sum_probs=191.4
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +.+.||.|++|+||+|.+..+ ..+++|.+...... ...+.+|+..+. ..+|++++++++++.. +..++
T Consensus 6 ~~~~--~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~---~~~~~~E~~~l~-~l~h~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05069 6 ESLR--LDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMM---PEAFLQEAQIMK-KLRHDKLVPLYAVVSE-EPIYI 77 (260)
T ss_pred HHee--eeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCcc---HHHHHHHHHHHH-hCCCCCeeeEEEEEcC-CCcEE
Confidence 4455 999999999999999987654 45899987654332 246677888887 6789999999998854 56889
Q ss_pred EEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-
Q psy12709 89 VLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV- 165 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~- 165 (253)
+|||+.+++|.+++... ..++...+..++.+++.|+.|||++|++|+||+|+||++++++.++|+|||.+.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999999999988653 347899999999999999999999999999999999999999999999999987553321
Q ss_pred -cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 166 -EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 166 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
......++..|+|||...+..++.++|+||+|+++|++++ |+.||.+....+....+...... ......+..+++
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 234 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM---PCPQGCPESLHE 234 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccCHHHHH
Confidence 1112234567999999988889999999999999999999 99999988777777666554222 122468999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
++++||++||
T Consensus 235 li~~~l~~~p 244 (260)
T cd05069 235 LMKLCWKKDP 244 (260)
T ss_pred HHHHHccCCc
Confidence 9999999998
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=254.04 Aligned_cols=234 Identities=26% Similarity=0.442 Sum_probs=197.5
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEecc
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMV 93 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 93 (253)
+.++.||.|+||.||+|.+..++..|++|.+..... ......+.+|+..+. ..+|+||+++++.+..++..++++||+
T Consensus 7 ~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 7 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLS-QCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHH-hcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 388999999999999999998999999998865432 234567778888887 779999999999999999999999999
Q ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-ccccccc
Q psy12709 94 PDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVKEIIG 172 (253)
Q Consensus 94 ~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~ 172 (253)
++++|.+++.. ..++...+..++.+++.++.+||++|++|+||+|.||+++.++.++++|||.+....... ......+
T Consensus 85 ~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 163 (277)
T cd06641 85 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVG 163 (277)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccC
Confidence 99999998864 458999999999999999999999999999999999999999999999999887544321 1122356
Q ss_pred CccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccC
Q psy12709 173 TPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTD 252 (253)
Q Consensus 173 ~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 252 (253)
+..|+|||.+.+..++.++|+||+|+++|++++|..||...........+..... ......++.++.++|.+||+.|
T Consensus 164 ~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~ 240 (277)
T cd06641 164 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP---PTLEGNYSKPLKEFVEACLNKE 240 (277)
T ss_pred CccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC---CCCCcccCHHHHHHHHHHccCC
Confidence 7789999999888889999999999999999999999987776665555544322 2233478999999999999998
Q ss_pred C
Q psy12709 253 P 253 (253)
Q Consensus 253 P 253 (253)
|
T Consensus 241 p 241 (277)
T cd06641 241 P 241 (277)
T ss_pred h
Confidence 7
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=257.95 Aligned_cols=238 Identities=26% Similarity=0.414 Sum_probs=196.6
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +++.||+|++|+||++.+..++..|++|++..... ......+.+|+..+. ..+|+||+++++.+...+.+++
T Consensus 5 ~~~~--~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 5 EDLE--TISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMH-ECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred HHHH--HHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHH-HcCCCCcceEeeeEecCCEEEE
Confidence 4555 99999999999999999999999999998875433 333567888998887 6789999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCceEEEeecccccccccccc
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV 167 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 167 (253)
++||+++++|.+++...+.++...+..++.+++.++.|||+ .+++|+||+|+||++++++.++|+|||++...... ..
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~~ 159 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-IA 159 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-cc
Confidence 99999999999999877789999999999999999999997 58999999999999999999999999988654322 12
Q ss_pred cccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHhhcccccccCCccCC
Q psy12709 168 KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ-----------ETFLNISQCNFSFHEDLFGH 236 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----------~~~~~i~~~~~~~~~~~~~~ 236 (253)
....++..|+|||++.+..++.++|+||+|+++|++++|..||...... +....+....... .....
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 237 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR--LPSSD 237 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCC--CCchh
Confidence 2346788999999998888899999999999999999999999765432 2222222211111 11124
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
++.++.+||.+||++||
T Consensus 238 ~~~~~~~li~~~l~~dp 254 (284)
T cd06620 238 FPEDLRDFVDACLLKDP 254 (284)
T ss_pred cCHHHHHHHHHHhcCCc
Confidence 78899999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=255.51 Aligned_cols=238 Identities=27% Similarity=0.451 Sum_probs=200.6
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
+.|+ ..+.||.|++|.||+|.+..++..+++|++..... ....+.+|+..+. ..+|+|++++++.+..++..++
T Consensus 19 ~~~~--~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 19 ELYK--NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMK-DCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccch--HhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHH-HCCCCCeeEEEEEEEECCEEEE
Confidence 3455 88999999999999999998999999999976544 3457778888877 7789999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-c
Q psy12709 89 VLEMVPDGELQRLVDIQD-GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-E 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~ 166 (253)
++||+++++|.+++.... .++...+..++.+++.++.+||+.|++|+|++|+||+++.++.++|+|||.+....... .
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 999999999999998776 79999999999999999999999999999999999999999999999999886543321 1
Q ss_pred ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHH
Q psy12709 167 VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~ 246 (253)
.....++..|+|||.+.+..++.++|+||+|+++|++++|+.||...+.......+....... ......++.+++++|.
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~ 251 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP-LKNPEKWSPEFKDFLN 251 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CcchhhCCHHHHHHHH
Confidence 223346778999999988888999999999999999999999998877665555544433222 2222348899999999
Q ss_pred HhcccCC
Q psy12709 247 SCLVTDP 253 (253)
Q Consensus 247 ~~l~~dP 253 (253)
+||+.||
T Consensus 252 ~~l~~~p 258 (286)
T cd06614 252 KCLVKDP 258 (286)
T ss_pred HHhccCh
Confidence 9999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=266.24 Aligned_cols=245 Identities=27% Similarity=0.401 Sum_probs=198.5
Q ss_pred CcceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
+.++..++.+|++++.||+||.+.||++... +...|++|.+.....+.....-+.+|+..|.++..|.+|++++++-..
T Consensus 353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT 431 (677)
T ss_pred CeeEEECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence 4678888999999999999999999999866 455677777766667777788999999999999999999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
++.+|+|||+- ..+|...+++... .+.-.++.++.||+.+++++|+.||+|.|++|.|+++- .|.+||+|||++...
T Consensus 432 d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 432 DGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred CceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 99999999964 6699999987654 34458999999999999999999999999999999987 589999999999877
Q ss_pred cccc---cccccccCccccCccccCCC-----------CCCccccHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHhhccc
Q psy12709 162 NDVV---EVKEIIGTPDYVAPEVLSYE-----------PISLATDMWSVGVLAYVLLSSHSPFAGDN-KQETFLNISQCN 226 (253)
Q Consensus 162 ~~~~---~~~~~~~~~~~~~PE~~~~~-----------~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~i~~~~ 226 (253)
.... .....+|++.|||||.+... ..++++|||||||++|+|+.|++||..-. ....+..|....
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~ 589 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPN 589 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCC
Confidence 5432 22446899999999998433 25678999999999999999999997643 223333444432
Q ss_pred c--cccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 227 F--SFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 227 ~--~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
. .++.- .-..++.++++.||+.||
T Consensus 590 ~~Iefp~~---~~~~~li~~mK~CL~rdP 615 (677)
T KOG0596|consen 590 HEIEFPDI---PENDELIDVMKCCLARDP 615 (677)
T ss_pred ccccccCC---CCchHHHHHHHHHHhcCc
Confidence 2 22221 112239999999999998
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=251.99 Aligned_cols=232 Identities=24% Similarity=0.395 Sum_probs=195.4
Q ss_pred eecCCCCceEEEEEEecc-CC--ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEecc
Q psy12709 17 CMPSRGKFASVRKCTHKI-TK--VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMV 93 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~-~~--~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 93 (253)
+.||+|++|.||+|.+.. .+ ..|++|.+...... .....+.+|+..+. ..+|+||+++++++.. ...++++|++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMH-SLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHh-hcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 33 36899999876554 55678889999888 7799999999999988 8999999999
Q ss_pred CCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc----c
Q psy12709 94 PDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE----V 167 (253)
Q Consensus 94 ~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~ 167 (253)
++++|.+.+..+. .+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999999987654 589999999999999999999999999999999999999999999999999876543211 1
Q ss_pred cccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~ 246 (253)
....++..|+|||.+.+..++.++|+||+|+++++|++ |+.||...+..+....+.......+ ....+|.++.+++.
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~ 235 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE--RPEACPQDIYNVML 235 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--CCccCCHHHHHHHH
Confidence 12335678999999988899999999999999999998 9999988888777776654333322 22467899999999
Q ss_pred HhcccCC
Q psy12709 247 SCLVTDP 253 (253)
Q Consensus 247 ~~l~~dP 253 (253)
+||+.+|
T Consensus 236 ~~l~~~p 242 (257)
T cd05040 236 QCWAHNP 242 (257)
T ss_pred HHCCCCc
Confidence 9999998
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=253.52 Aligned_cols=232 Identities=36% Similarity=0.585 Sum_probs=199.8
Q ss_pred cCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCCc
Q psy12709 19 PSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGE 97 (253)
Q Consensus 19 lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 97 (253)
||.|++|.||++.+..+++.+++|.+..... .......+.+|+..+. ..+|+||+++++.+..++..++++|++++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILS-QAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHH-hCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 6899999999999998999999999876543 2344567788888887 6679999999999999999999999999999
Q ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc---------ccc
Q psy12709 98 LQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV---------EVK 168 (253)
Q Consensus 98 L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~---------~~~ 168 (253)
|.+++.....+++..+..++.|++.++.+||+++++|+||+|+||++++++.++|+|||++....... ...
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 159 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence 99999877789999999999999999999999999999999999999999999999999887543221 122
Q ss_pred ccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 169 EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
...++..|+|||.......+.++|+||+|++++++++|+.||......+....+......++... .++..+.++|.+|
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~ 237 (265)
T cd05579 160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDV--EVSDEAIDLISKL 237 (265)
T ss_pred CcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccc--cCCHHHHHHHHHH
Confidence 33567789999999888889999999999999999999999998888888877776555554432 3599999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|+.||
T Consensus 238 l~~~p 242 (265)
T cd05579 238 LVPDP 242 (265)
T ss_pred hcCCH
Confidence 99987
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=258.39 Aligned_cols=236 Identities=27% Similarity=0.437 Sum_probs=198.0
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
.|+ ..+.||+|++|.||+|.+..++..|++|.+..... ......+.+|+..+. ..+|+||+++++.+..++.+++|
T Consensus 5 ~y~--~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 5 LFT--KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLS-QCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHH--HHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHH-cCCCCccHhhhcccccCCceEEE
Confidence 455 78899999999999999998999999999875433 234567888998887 67899999999999999999999
Q ss_pred EeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-ccc
Q psy12709 90 LEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVK 168 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~ 168 (253)
+||+++++|.+++.. ..+++..+..++.+++.++.|||++|++|+||+|+||++++++.++++|||.+....... ...
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence 999999999998864 568999999999999999999999999999999999999999999999999987654322 112
Q ss_pred ccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 169 EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
...++..|+|||.+.+..++.++|+||+|++++++++|+.|+...........+..... ......++.++.++|.+|
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~ 236 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP---PTLEGQYSKPFKEFVEAC 236 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCC---CCCCcccCHHHHHHHHHH
Confidence 23567889999999988899999999999999999999999987666555544433322 222346789999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|+.+|
T Consensus 237 l~~~p 241 (277)
T cd06642 237 LNKDP 241 (277)
T ss_pred ccCCc
Confidence 99988
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=256.13 Aligned_cols=236 Identities=20% Similarity=0.313 Sum_probs=194.3
Q ss_pred eEEEeecCCCCceEEEEEEecc-----CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKI-----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
|++.+.||+|+||+||+|.+.. ....+++|.+..... ......+.+|+..+. ...|+||+++++.+..++..+
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLK-QVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHh-hCCCCCEeeEEEEEecCCCcE
Confidence 3489999999999999998753 235688888875443 233567888998887 779999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEE
Q psy12709 88 LVLEMVPDGELQRLVDIQ------------------------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNIL 143 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~ 143 (253)
+++||+.+++|.+++... ..++...+..++.+++.++.+||+.+++|+||+|+||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 999999999999987642 23778899999999999999999999999999999999
Q ss_pred EcCCCceEEEeeccccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy12709 144 LTKDNNIKLCDFGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETF 219 (253)
Q Consensus 144 ~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~ 219 (253)
+++++.++|+|||.+........ ......+..|+|||...+..++.++|+||+|+++++|++ |..||.+....+.+
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999875432211 122234568999999988889999999999999999998 99999988887777
Q ss_pred HHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 220 LNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 220 ~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+....... ....++.++.+++.+||++||
T Consensus 240 ~~~~~~~~~~---~~~~~~~~~~~~i~~cl~~~P 270 (290)
T cd05045 240 NLLKTGYRME---RPENCSEEMYNLMLTCWKQEP 270 (290)
T ss_pred HHHhCCCCCC---CCCCCCHHHHHHHHHHccCCc
Confidence 6655432221 123689999999999999998
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=251.78 Aligned_cols=238 Identities=22% Similarity=0.322 Sum_probs=196.7
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCc---eEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKV---EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
+.|+ ..+.||+|++|.||+|.+..++. .+++|.+..... ......+..|+..+. ..+|+|++++.+++...+.
T Consensus 5 ~~~~--~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 5 SHIT--KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMG-QFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred HHce--EeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHh-cCCCCCeeEEEEEEccCCC
Confidence 4455 89999999999999999876554 689998865432 334567788888877 7799999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
.+++||++++++|.+++... ..++...+..++.+++.|+.+||+.|++|+|++|+||+++.++.++++|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999988753 56899999999999999999999999999999999999999999999999998755322
Q ss_pred cc-c---cccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCH
Q psy12709 165 VE-V---KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 165 ~~-~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
.. . .....+..|+|||.+.+..++.++|+||+|+++|++++ |+.||...+..+....+......+ . ...++.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~-~--~~~~~~ 237 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP-A--PMDCPS 237 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC-C--CCCCCH
Confidence 11 1 11122357999999988888999999999999999997 999998877777777776543222 1 236789
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
++.+++.+||+.||
T Consensus 238 ~~~~li~~c~~~~p 251 (268)
T cd05063 238 AVYQLMLQCWQQDR 251 (268)
T ss_pred HHHHHHHHHcCCCc
Confidence 99999999999987
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=250.34 Aligned_cols=237 Identities=27% Similarity=0.451 Sum_probs=196.8
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc---cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--C
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR---RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP--H 84 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~ 84 (253)
+|+ +.+.||+|++|.||+|.+..+++.|++|.+.... ........+.+|+..+. ..+|+||+++++.+... .
T Consensus 3 ~~~--~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~-~l~h~~i~~~~~~~~~~~~~ 79 (264)
T cd06653 3 NWR--LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLK-NLRHDRIVQYYGCLRDPEEK 79 (264)
T ss_pred cee--eeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHH-HcCCCCcceEEEEEEcCCCC
Confidence 455 9999999999999999999999999999876432 23345668888999888 67899999999998764 4
Q ss_pred eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
.+++++|++++++|.+.+.....+++..+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 68899999999999999887777899999999999999999999999999999999999999999999999998754321
Q ss_pred ----ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHH
Q psy12709 165 ----VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 165 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
.......++..|+|||.+.+..++.++|+||+|++++++++|+.||..........++.... ........+++.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~p~~~~~~ 237 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP--TKPMLPDGVSDA 237 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCC--CCCCCCcccCHH
Confidence 11223456788999999988888999999999999999999999998776655554443322 222334578999
Q ss_pred HHHHHHHhccc
Q psy12709 241 AKDFIQSCLVT 251 (253)
Q Consensus 241 l~~li~~~l~~ 251 (253)
++++|.+||+.
T Consensus 238 ~~~~i~~~l~~ 248 (264)
T cd06653 238 CRDFLKQIFVE 248 (264)
T ss_pred HHHHHHHHhcC
Confidence 99999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=253.76 Aligned_cols=241 Identities=21% Similarity=0.296 Sum_probs=191.9
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCCc----eEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITKV----EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 80 (253)
++..+.|+ +.+.||.|+||+||+|.+..++. ++++|.+.... ......++..|+..+. ..+|+||+++++++
T Consensus 3 ~~~~~~~~--~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~-~l~h~~iv~~~~~~ 78 (279)
T cd05111 3 ILKETELR--KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMG-SLDHAYIVRLLGIC 78 (279)
T ss_pred cCCHhhce--eccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHh-cCCCCCcceEEEEE
Confidence 34456666 99999999999999999877665 46777765322 2233456666666666 77899999999987
Q ss_pred EeCCeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 81 ETPHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 81 ~~~~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
.. ...++++|++++++|.+++.. ...+++..+..++.|++.++.|||+++++|+||+|+||+++.++.++|+|||.+.
T Consensus 79 ~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 79 PG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred CC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 54 467889999999999999875 3568999999999999999999999999999999999999999999999999987
Q ss_pred cccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccC
Q psy12709 160 VVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFG 235 (253)
Q Consensus 160 ~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 235 (253)
...... ......++..|+|||.+.+..++.++|+||+|+++|++++ |..||.+.........+..+...... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~ 234 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQP---Q 234 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC---C
Confidence 543221 1122345568999999988889999999999999999998 99999887666555545443332222 2
Q ss_pred CCCHHHHHHHHHhcccCC
Q psy12709 236 HISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 236 ~~~~~l~~li~~~l~~dP 253 (253)
..+.++.+++.+||..||
T Consensus 235 ~~~~~~~~li~~c~~~~p 252 (279)
T cd05111 235 ICTIDVYMVMVKCWMIDE 252 (279)
T ss_pred CCCHHHHHHHHHHcCCCc
Confidence 567889999999999998
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=283.87 Aligned_cols=239 Identities=21% Similarity=0.348 Sum_probs=205.9
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCc-----eEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKV-----EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
+-..++...||+|+||.||.|....... .|++|.+.+. .+..+..++.+|...+. ..+||||++++++.-+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~-~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMS-KFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHh-cCCCcceeeEEEeecCCC
Confidence 4455688999999999999999875433 3888888764 34566889999999998 899999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQ-------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI 157 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~ 157 (253)
..++++|||.||+|..++++. ..++..+++.++.+++++++||++++++||||.++|++++....|||.|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999999875 3489999999999999999999999999999999999999999999999999
Q ss_pred ccccccccc--cc-ccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCc
Q psy12709 158 SRVVNDVVE--VK-EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDL 233 (253)
Q Consensus 158 ~~~~~~~~~--~~-~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 233 (253)
++....... .. .......|||||.+....++.++||||+|+++||+++ |..||.+.++.++..-+..+....+.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P-- 926 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP-- 926 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC--
Confidence 995533211 11 1245579999999999999999999999999999999 99999999999999866665533222
Q ss_pred cCCCCHHHHHHHHHhcccCC
Q psy12709 234 FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP 253 (253)
+.+++.+.+++.+||+.+|
T Consensus 927 -~~CP~~ly~lM~~CW~~~p 945 (1025)
T KOG1095|consen 927 -SYCPEKLYQLMLQCWKHDP 945 (1025)
T ss_pred -CCCChHHHHHHHHHccCCh
Confidence 4889999999999999998
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=256.16 Aligned_cols=239 Identities=26% Similarity=0.407 Sum_probs=194.8
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++.+.||.|++|+||+|.+..++..|++|++............+.+|+..+. ..+|++++++++++..++..++++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~-~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLK-ELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHH-hcCCCCccCHhheeccCCeEEEEEec
Confidence 34889999999999999999999999999999865544444456778898887 77899999999999999999999999
Q ss_pred cCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-cccc
Q psy12709 93 VPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVKE 169 (253)
Q Consensus 93 ~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~ 169 (253)
++ ++|.+++.... .+++..+..++.|++.++.+||+++++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 95 58988887655 68999999999999999999999999999999999999999999999999987543221 1122
Q ss_pred cccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccc----------------------
Q psy12709 170 IIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCN---------------------- 226 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~---------------------- 226 (253)
..++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+.......+....
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 3457789999987654 46889999999999999999999998776654433332211
Q ss_pred ---ccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 227 ---FSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 227 ---~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
........+.++..+.++|.+||++||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 268 (283)
T cd07835 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDP 268 (283)
T ss_pred cccccchhhhcCCCCHHHHHHHHHHhcCCh
Confidence 111122345788999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=253.30 Aligned_cols=236 Identities=26% Similarity=0.431 Sum_probs=197.9
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
+.-.+.||.|++|.||++.+..++..+++|.+..... .....+.+|+..+. ..+|+||+++++++..++..++++||
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~-~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMR-DYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHH-HcCCCChheEEEEEEcCCeEEEEEec
Confidence 3367899999999999999998999999998864332 33456788888777 77999999999999999999999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-ccccccc
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEVKEII 171 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~ 171 (253)
+.|++|.+++.. ..++...+..++.+++.++++||++|++|+||+|+||+++.++.++|+|||.+...... .......
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 176 (285)
T cd06648 98 LEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV 176 (285)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence 999999999876 56899999999999999999999999999999999999999999999999987654332 1222345
Q ss_pred cCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhccc
Q psy12709 172 GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251 (253)
Q Consensus 172 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (253)
+++.|+|||...+..++.++|+||+|+++|++++|+.||...+.......+..... +.......++..+.++|.+||+.
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~ 255 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP-PKLKNLHKVSPRLRSFLDRMLVR 255 (285)
T ss_pred CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCC-CCCcccccCCHHHHHHHHHHccc
Confidence 77899999999888899999999999999999999999988777666665554422 22222234889999999999999
Q ss_pred CC
Q psy12709 252 DP 253 (253)
Q Consensus 252 dP 253 (253)
||
T Consensus 256 ~p 257 (285)
T cd06648 256 DP 257 (285)
T ss_pred Ch
Confidence 87
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=257.01 Aligned_cols=241 Identities=27% Similarity=0.381 Sum_probs=194.8
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--CeE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP--HEM 86 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~ 86 (253)
++|+ +.+.||.|++|.||+|.+..+++.+++|.+............+.+|+..+. ..+|+||+++++++..+ +..
T Consensus 5 ~~y~--~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 5 DEYE--KLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILL-KLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred hhhh--hhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHH-hcCCCCEEEEEEEEEecCCCcE
Confidence 4566 899999999999999999999999999999765544333445677888887 66799999999998877 899
Q ss_pred EEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-
Q psy12709 87 VLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV- 164 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~- 164 (253)
++++||+++ +|.+++... ..+++..++.++.|++.|+.|||+.|++|+||+|+||++++++.++|+|||.+......
T Consensus 82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999999975 898888654 35899999999999999999999999999999999999999999999999988865443
Q ss_pred ccccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc--------------
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF-------------- 229 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-------------- 229 (253)
.......+++.|+|||.+.+. .++.++|+||+|+++++|++|..||...+..+....+......+
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 222334567889999998654 46889999999999999999999998877665554432211100
Q ss_pred ------------cCCccCC--CCHHHHHHHHHhcccCC
Q psy12709 230 ------------HEDLFGH--ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 ------------~~~~~~~--~~~~l~~li~~~l~~dP 253 (253)
.....+. +++.+.++|++||+.||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 278 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDP 278 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCc
Confidence 0011122 58899999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=251.31 Aligned_cols=238 Identities=22% Similarity=0.339 Sum_probs=195.5
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccC---CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKIT---KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
+.+|++.+.||.|++|.||+|.+... ...|++|....... ....+.+.+|+..+. ..+|+||+++++++.. +..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMR-QFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHH-hCCCCchhceeEEEcC-CCc
Confidence 44455999999999999999987644 34689998865432 344567888998887 6689999999998875 457
Q ss_pred EEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~ 165 (253)
+++|||+++++|.+++... ..++...+..++.+++.++++||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 8999999999999998764 358999999999999999999999999999999999999999999999999987654332
Q ss_pred ccc--ccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHH
Q psy12709 166 EVK--EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAK 242 (253)
Q Consensus 166 ~~~--~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~ 242 (253)
... .......|+|||.+....++.++|+||||++++++++ |..||...+..+....+....... ..+.+|.++.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 238 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP---MPPNCPPTLY 238 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCC---CCCCCCHHHH
Confidence 211 1223457999999988889999999999999999886 999998888777776666544332 2247899999
Q ss_pred HHHHHhcccCC
Q psy12709 243 DFIQSCLVTDP 253 (253)
Q Consensus 243 ~li~~~l~~dP 253 (253)
++|.+||..||
T Consensus 239 ~li~~~l~~~P 249 (270)
T cd05056 239 SLMTKCWAYDP 249 (270)
T ss_pred HHHHHHcCCCh
Confidence 99999999998
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=251.01 Aligned_cols=237 Identities=28% Similarity=0.443 Sum_probs=200.7
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++.+.||.|++|.||+|.++.++..+++|.+............+.+|+..++ ..+|+||+++++.+..++..++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~-~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLA-KMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHH-hCCCCChhhhhheeccCCeEEEEEec
Confidence 44999999999999999999999999999998776544445567778988887 77899999999999999999999999
Q ss_pred cCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc-eEEEeeccccccccccc-cc
Q psy12709 93 VPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN-IKLCDFGISRVVNDVVE-VK 168 (253)
Q Consensus 93 ~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~-~~l~df~~~~~~~~~~~-~~ 168 (253)
+++++|.+++.... .+++..+..++.+++.++.+||+++++|+|++|+||+++.++. ++++|||.+........ ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 99999999886543 4789999999999999999999999999999999999998864 69999998876543221 22
Q ss_pred ccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 169 EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
...+++.|+|||...+..++.++|+||+|++++++++|+.||...+..+....+....... ..+.++.+++++|.+|
T Consensus 161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~~ 237 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP---ISPNFSRDLRSLISQL 237 (257)
T ss_pred ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC---CCCCCCHHHHHHHHHH
Confidence 2356788999999988889999999999999999999999998877766666555544332 2347889999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|+.||
T Consensus 238 l~~~p 242 (257)
T cd08225 238 FKVSP 242 (257)
T ss_pred hccCh
Confidence 99987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=250.40 Aligned_cols=236 Identities=21% Similarity=0.375 Sum_probs=194.5
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
..++|+ +.+.||+|+||.||++.+. .+..+++|.+..... ....+.+|+..++ ..+|+||+++.+.+.. ...
T Consensus 4 ~~~~~~--~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 4 PRESLK--LEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMK-TLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred ccccee--EEeEecCccceEEEEEEec-CCccEEEEecCCChh---HHHHHHHHHHHHH-hcCCCCcceEEEEEcC-CCe
Confidence 345666 9999999999999999865 556699998875322 3457788888887 6789999999999887 788
Q ss_pred EEEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
++++||+++++|.+++... ..++...+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999999999998753 34788899999999999999999999999999999999999999999999988754322
Q ss_pred c--cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHH
Q psy12709 165 V--EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQA 241 (253)
Q Consensus 165 ~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 241 (253)
. ......++..|+|||.+.+..++.++|+||+|+++|++++ |+.||.+.+.......+......+ .....+.++
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 232 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP---RPENCPEEL 232 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC---CcccCCHHH
Confidence 1 1112234467999999988889999999999999999999 999999887777776665543222 224789999
Q ss_pred HHHHHHhcccCC
Q psy12709 242 KDFIQSCLVTDP 253 (253)
Q Consensus 242 ~~li~~~l~~dP 253 (253)
.+++.+||++||
T Consensus 233 ~~~i~~~l~~~p 244 (260)
T cd05073 233 YNIMMRCWKNRP 244 (260)
T ss_pred HHHHHHHcccCc
Confidence 999999999998
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=255.04 Aligned_cols=239 Identities=25% Similarity=0.358 Sum_probs=195.3
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
-...+|+ +.+.||+|++|+||+|.+..++..|++|.+.... ........+.+|+..+. ..+|+||+++.+++..++
T Consensus 12 ~~~~~y~--~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~-~l~h~niv~~~~~~~~~~ 88 (307)
T cd06607 12 DPEKLFT--DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ-QLRHPNTIEYKGCYLREH 88 (307)
T ss_pred Ccchhhh--hheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHH-hCCCCCEEEEEEEEEeCC
Confidence 3455677 9999999999999999999899999999986543 33344567888998887 678999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVD-IQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
..++|+||+.| ++.+++. ....+++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 89 ~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 89 TAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred eEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99999999975 6656554 345689999999999999999999999999999999999999999999999998865432
Q ss_pred cccccccccCccccCccccC---CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHH
Q psy12709 164 VVEVKEIIGTPDYVAPEVLS---YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
. ....+++.|+|||++. ...++.++|+||+|+++|++++|+.||.+.+.......+....... ......+.+
T Consensus 168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 242 (307)
T cd06607 168 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT--LSSNDWSDY 242 (307)
T ss_pred C---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC--CCchhhCHH
Confidence 2 2335677899999874 3567889999999999999999999998776665554444332211 112357889
Q ss_pred HHHHHHHhcccCC
Q psy12709 241 AKDFIQSCLVTDP 253 (253)
Q Consensus 241 l~~li~~~l~~dP 253 (253)
++++|.+||+.||
T Consensus 243 ~~~li~~~l~~~p 255 (307)
T cd06607 243 FRNFVDSCLQKIP 255 (307)
T ss_pred HHHHHHHHhcCCh
Confidence 9999999999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=253.82 Aligned_cols=235 Identities=26% Similarity=0.463 Sum_probs=194.1
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhc--CCCCceeeeeEEEeCCeEEEEEe
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ--KSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~--~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
++.+.||.|++|.||+|.+..++..|++|.+..... ......+.+|+..++... .|+|++++++++..+..+++++|
T Consensus 4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 388999999999999999999999999999875432 233456778888877554 59999999999999999999999
Q ss_pred ccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-ccccc
Q psy12709 92 MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVKEI 170 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~ 170 (253)
|+++++|.+++.. ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 83 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06917 83 YAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF 161 (277)
T ss_pred cCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccc
Confidence 9999999999865 468999999999999999999999999999999999999999999999999987654322 22334
Q ss_pred ccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccC-CCCHHHHHHHHHh
Q psy12709 171 IGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFG-HISSQAKDFIQSC 248 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~-~~~~~l~~li~~~ 248 (253)
.++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.........+.... +..... .+++++.+++.+|
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~ 238 (277)
T cd06917 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK---PPRLEDNGYSKLLREFVAAC 238 (277)
T ss_pred cCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCC---CCCCCcccCCHHHHHHHHHH
Confidence 577889999988654 56889999999999999999999998766655444333321 112222 3889999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|+.||
T Consensus 239 l~~~p 243 (277)
T cd06917 239 LDEEP 243 (277)
T ss_pred cCCCc
Confidence 99998
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=262.30 Aligned_cols=243 Identities=27% Similarity=0.445 Sum_probs=195.1
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC--
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH-- 84 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-- 84 (253)
+.++|+ +.+.||.|++|+||+|.+..++..|++|.+............+.+|+..+. ..+|+||+++++++....
T Consensus 3 ~~~~y~--~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~ni~~~~~~~~~~~~~ 79 (337)
T cd07858 3 VDTKYV--PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLR-HLDHENVIAIKDIMPPPHRE 79 (337)
T ss_pred ccccee--EEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHH-hcCCCCccchHHheeccccc
Confidence 456677 999999999999999999999999999998765433444556778888887 678999999999886542
Q ss_pred ---eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 85 ---EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 85 ---~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
..++++||+. ++|.+++.....+++..+..++.|++.|+.+||+++++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 80 AFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred ccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 5899999995 688888887778999999999999999999999999999999999999999999999999998765
Q ss_pred ccc-ccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccc-------------
Q psy12709 162 NDV-VEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCN------------- 226 (253)
Q Consensus 162 ~~~-~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~------------- 226 (253)
... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+.+.......+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 432 12223356778999998754 468889999999999999999999998765433332222110
Q ss_pred --------------ccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 227 --------------FSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 227 --------------~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
........+.+++++.++|.+||+.||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 279 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDP 279 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCCh
Confidence 011112235789999999999999998
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=276.61 Aligned_cols=237 Identities=31% Similarity=0.450 Sum_probs=205.6
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|+|+..||-|+||+||+|..++++...|.|++... +..+.+++.-|+.++. .++||+|+++++.|..++.+|++.||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa-~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILA-ECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhh-cCCChHHHHHHHHHhccCceEEEEee
Confidence 34899999999999999999988888888887653 4456789999999999 88999999999999999999999999
Q ss_pred cCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-cccccccc
Q psy12709 93 VPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVVEVKEI 170 (253)
Q Consensus 93 ~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~~~~~~~ 170 (253)
|.||-.+..+-. ..++++.++..++++++.||.|||+++|+|+|+++.||+++.+|.++|.|||.+.... ........
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsF 190 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSF 190 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccc
Confidence 999988876654 5679999999999999999999999999999999999999999999999999886432 22334567
Q ss_pred ccCccccCcccc-----CCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 171 IGTPDYVAPEVL-----SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 171 ~~~~~~~~PE~~-----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
.|+|+|||||+. ...+|+.++||||||+++.+|..+.+|-...+...++.+|.+..++... ..+.-+..+.|++
T Consensus 191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLl-qPS~Ws~~F~DfL 269 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLL-QPSHWSRSFSDFL 269 (1187)
T ss_pred cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCccc-CcchhhhHHHHHH
Confidence 899999999986 4457999999999999999999999999999999999888775443322 2245688899999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
++||.+||
T Consensus 270 k~cL~Knp 277 (1187)
T KOG0579|consen 270 KRCLVKNP 277 (1187)
T ss_pred HHHHhcCC
Confidence 99999998
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=248.41 Aligned_cols=231 Identities=24% Similarity=0.344 Sum_probs=192.8
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDG 96 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 96 (253)
+.||.|++|.||+|.+.. ++.|++|.+...... .....+.+|+..+. ..+|++|+++++++......++++|+++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILK-QYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHH-hCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 479999999999999887 999999998765443 44567888888887 779999999999999999999999999999
Q ss_pred cHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccc---ccccc
Q psy12709 97 ELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV---KEIIG 172 (253)
Q Consensus 97 ~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~ 172 (253)
+|.+++.. ...++...+..++.+++.++.+||+++++|+||+|+||+++.++.++|+|||.+......... .....
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99998865 345889999999999999999999999999999999999999999999999998754321111 11122
Q ss_pred CccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhccc
Q psy12709 173 TPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251 (253)
Q Consensus 173 ~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (253)
+..|+|||.+.+..++.++|+||+|+++|++++ |..||...........+....... ....++.++.+++.+||+.
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~ 234 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP---APQLCPEEIYRLMLQCWAY 234 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC---CCccCCHHHHHHHHHHhcc
Confidence 456999999988889999999999999999999 899998887776666665432211 1236789999999999999
Q ss_pred CC
Q psy12709 252 DP 253 (253)
Q Consensus 252 dP 253 (253)
||
T Consensus 235 ~p 236 (251)
T cd05041 235 DP 236 (251)
T ss_pred Ch
Confidence 88
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=254.04 Aligned_cols=240 Identities=25% Similarity=0.402 Sum_probs=191.2
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
+|+ +.+.||.|++|+||+|.++.+++.|++|.+............+.+|+..+. ..+|+||+++++++..++.+++|
T Consensus 3 ~y~--~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 3 QYE--KVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLK-EMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred ceE--EEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHH-hccCCCEeeEEEEEecCCeEEEE
Confidence 455 999999999999999999999999999998765444344456778888888 67999999999999999999999
Q ss_pred EeccCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-CCceEEEeeccccccccc-c
Q psy12709 90 LEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK-DNNIKLCDFGISRVVNDV-V 165 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~-~~~~~l~df~~~~~~~~~-~ 165 (253)
+||+++ ++.+.+..... +++..+..++.|++.|+.+||+++++|+||+|+||+++. ++.++++|||.+...... .
T Consensus 80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 999965 77766654433 578889999999999999999999999999999999986 457999999998754322 1
Q ss_pred cccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc--------------
Q psy12709 166 EVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH-------------- 230 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-------------- 230 (253)
......+++.|+|||.+.+. .++.++|+||+|+++|++++|..||...+..+...++......+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 22233457899999988654 578899999999999999999999987766555444322111110
Q ss_pred -----------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 -----------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 -----------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+.+++++.++|.+||+.||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P 272 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDP 272 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCCh
Confidence 01224678999999999999998
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=263.27 Aligned_cols=243 Identities=25% Similarity=0.403 Sum_probs=195.0
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe----
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET---- 82 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~---- 82 (253)
+.++|+ +.+.||.|++|.||+|.+..++..|++|.+............+.+|+..+. ..+|+||+++++++..
T Consensus 3 ~~~~y~--~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~ 79 (334)
T cd07855 3 VGSRYK--PIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILR-HFKHDNIIAIRDILRPPGAD 79 (334)
T ss_pred hhhcee--eeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHH-hcCCCCccCHHHhccccCCC
Confidence 345566 999999999999999999999999999999875544445567778998887 6789999999988763
Q ss_pred CCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN 162 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~ 162 (253)
...+++|+||+. ++|..++.....+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 80 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 80 FKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred CceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 347899999995 5898888777779999999999999999999999999999999999999999999999999987543
Q ss_pred cccc-----ccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc-------
Q psy12709 163 DVVE-----VKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF------- 229 (253)
Q Consensus 163 ~~~~-----~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~------- 229 (253)
.... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+.+.......+......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 2211 123356789999999755 457889999999999999999999998765543332222111100
Q ss_pred --------------------cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 --------------------HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 --------------------~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.....+..++++.++|++||+.||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 282 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDP 282 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCCh
Confidence 011234679999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=249.66 Aligned_cols=230 Identities=21% Similarity=0.326 Sum_probs=190.3
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEE-eCCeEEEEE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE-TPHEMVLVL 90 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~ 90 (253)
.|++.+.||+|++|.||++... +..+++|...... ....+.+|+..+. ..+|++++++++++. .++..++++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMT-QLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHH-hCCCCCeeeEEEEEEcCCCceEEEE
Confidence 3449999999999999999764 7789999886432 2346778888887 679999999998754 556799999
Q ss_pred eccCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccccc
Q psy12709 91 EMVPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK 168 (253)
Q Consensus 91 e~~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 168 (253)
||+++++|.+++..+. .+++..+..++.+++.++.+||++|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~ 157 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--D 157 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--C
Confidence 9999999999887643 37899999999999999999999999999999999999999999999999987543322 1
Q ss_pred ccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHH
Q psy12709 169 EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~ 247 (253)
....+..|+|||.+.+..++.++|+||+|+++|+|++ |+.||......+....+..... ......+++.+.++|.+
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~ 234 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPVVYDVMKQ 234 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCCHHHHHHHHH
Confidence 2234567999999988889999999999999999997 9999988777766666654322 22334789999999999
Q ss_pred hcccCC
Q psy12709 248 CLVTDP 253 (253)
Q Consensus 248 ~l~~dP 253 (253)
||+.||
T Consensus 235 ~l~~~p 240 (256)
T cd05082 235 CWHLDA 240 (256)
T ss_pred HhcCCh
Confidence 999988
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=253.07 Aligned_cols=240 Identities=28% Similarity=0.405 Sum_probs=194.6
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHh--cCCCCceeeeeEEEeCCe-----
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLA--QKSERIVGLHEIYETPHE----- 85 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~--~~~~~i~~~~~~~~~~~~----- 85 (253)
|++.+.||.|++|.||+|.++.++..|++|.+............+.+|+..+.+. .+|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 3489999999999999999998899999999986544333344566677666544 369999999999988776
Q ss_pred EEEEEeccCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
+++++|++++ +|.+++.... .+++..++.++.+++.|+.+||+.+++|+|++|+||+++.++.++|+|||.+.....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 9999999975 7888776532 489999999999999999999999999999999999999999999999999876644
Q ss_pred cccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccc---------------
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFS--------------- 228 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~--------------- 228 (253)
........++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....+......
T Consensus 160 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07838 160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS 239 (287)
T ss_pred CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchh
Confidence 33333345678899999998888999999999999999999999999887776666554331100
Q ss_pred --------ccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 229 --------FHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 229 --------~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
......+.+++.+.++|.+||+.||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 272 (287)
T cd07838 240 SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNP 272 (287)
T ss_pred hcccccccchhhhhhhhhHHHHHHHHHHhccCC
Confidence 0011123567889999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=265.29 Aligned_cols=193 Identities=24% Similarity=0.375 Sum_probs=166.5
Q ss_pred eEEEeecCCCCceEEEEEEec--cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHK--ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVL 90 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 90 (253)
|++++.||.|+||.||+|... ..+..|++|.+.... ...+|+..+. .++|+||+++++.+...+..+++|
T Consensus 94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~-~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILK-TISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred eEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHH-hcCCCCccceeeeEeeCCEEEEEe
Confidence 449999999999999999764 356789999876432 3356888887 779999999999999999999999
Q ss_pred eccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc---cc
Q psy12709 91 EMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV---EV 167 (253)
Q Consensus 91 e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~---~~ 167 (253)
|++. ++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 166 e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~ 244 (392)
T PHA03207 166 PKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244 (392)
T ss_pred hhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccc
Confidence 9985 5788887767789999999999999999999999999999999999999999999999999987554321 12
Q ss_pred cccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Q psy12709 168 KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDN 214 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 214 (253)
....+++.|+|||++.+..++.++||||+|+++|+|++|+.||.+..
T Consensus 245 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 24568899999999998899999999999999999999999996643
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=261.26 Aligned_cols=239 Identities=29% Similarity=0.449 Sum_probs=201.3
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC-----eEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH-----EMV 87 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~ 87 (253)
|++.+.||.|++|.||+|.+..++..|++|.+............+.+|+..+. ..+|+||+++.+++...+ .++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLR-HLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHH-hcCCcchhhhhhhhcccCcccccceE
Confidence 44999999999999999999988999999999876544555678888999888 668999999999998775 799
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc--
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-- 165 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-- 165 (253)
++++|++ ++|.+++.....+++..++.++.+++.++++||++|++|+||+|.||+++.++.++|+|||.+.......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 9999996 4888888777789999999999999999999999999999999999999999999999999998654432
Q ss_pred --cccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC-----------
Q psy12709 166 --EVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE----------- 231 (253)
Q Consensus 166 --~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~----------- 231 (253)
......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||.+.+..+.+..+......++.
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 12334567889999999877 7899999999999999999999999988877666655443222111
Q ss_pred ----------------CccCCCCHHHHHHHHHhcccCC
Q psy12709 232 ----------------DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 232 ----------------~~~~~~~~~l~~li~~~l~~dP 253 (253)
...+.++.++.++|.+||++||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 277 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDP 277 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCCh
Confidence 1234578999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=247.90 Aligned_cols=230 Identities=35% Similarity=0.566 Sum_probs=199.6
Q ss_pred cCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCCc
Q psy12709 19 PSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGE 97 (253)
Q Consensus 19 lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 97 (253)
||.|++|.||.+.+..++..+++|.+..... .......+.+|+..++ ..+|+||+++++.+..++.++++||++++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILS-RINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHH-HcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 6999999999999998899999999876543 2335667788888777 7789999999999999999999999999999
Q ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-ccccccccCccc
Q psy12709 98 LQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEVKEIIGTPDY 176 (253)
Q Consensus 98 L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~ 176 (253)
|.+++.....+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+...... .......++..|
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence 9999987777999999999999999999999999999999999999999999999999998765433 223344567899
Q ss_pred cCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 177 VAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 177 ~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+|||...+..++.++|+||+|+++|++++|+.||...+.......+.......+. ..+..+.++|++||..||
T Consensus 160 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLISGLLQKDP 232 (250)
T ss_pred cChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHhcCCH
Confidence 9999998888899999999999999999999999888877777777664444433 669999999999999987
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=263.02 Aligned_cols=245 Identities=20% Similarity=0.330 Sum_probs=195.2
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEec-----cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHK-----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 80 (253)
|.....++.+.+.||+|+||.||+|.+. ..++.||+|++...... .....+.+|+..+.++..|+||+++++.+
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 4444556668899999999999999864 34568999999865432 33457888999998665699999999999
Q ss_pred EeCCeEEEEEeccCCCcHHHHHhhcC------------------------------------------------------
Q psy12709 81 ETPHEMVLVLEMVPDGELQRLVDIQD------------------------------------------------------ 106 (253)
Q Consensus 81 ~~~~~~~lv~e~~~g~~L~~~~~~~~------------------------------------------------------ 106 (253)
..++..++|+||+++++|.+++....
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 99999999999999999999885421
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q psy12709 107 --------------------------------------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNI 142 (253)
Q Consensus 107 --------------------------------------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni 142 (253)
.++...+..++.|++.|+.|||+.+++|+||+|.||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 256667888999999999999999999999999999
Q ss_pred EEcCCCceEEEeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHH
Q psy12709 143 LLTKDNNIKLCDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQET 218 (253)
Q Consensus 143 ~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~ 218 (253)
+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||......+.
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 99999999999999987542211 1112345678999999988889999999999999999998 8999987665554
Q ss_pred HHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 219 FLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 219 ~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..........++ ....++.++.+++.+||..||
T Consensus 351 ~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P 383 (401)
T cd05107 351 FYNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKF 383 (401)
T ss_pred HHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCCh
Confidence 444333222221 223678999999999999987
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=255.56 Aligned_cols=237 Identities=26% Similarity=0.407 Sum_probs=189.1
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
..+.||+|+||.||++.+..++..|++|.+...... .....+.+|+..+.+..+|+||+++++++..++..++++|++.
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~ 86 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence 778999999999999999999999999998865443 4456778899888877779999999999999999999999985
Q ss_pred CCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCceEEEeeccccccccccccc
Q psy12709 95 DGELQRLVD-----IQDGIPEQDTRSYMKQILEALAFLHDH-NITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK 168 (253)
Q Consensus 95 g~~L~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 168 (253)
+ ++.++.. ....+++..+..++.+++.+++|||+. +++|+||+|+||+++.++.++|+|||++..........
T Consensus 87 ~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 165 (288)
T cd06616 87 I-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT 165 (288)
T ss_pred C-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccc
Confidence 4 5544332 235689999999999999999999975 99999999999999999999999999987554433333
Q ss_pred ccccCccccCccccCCC---CCCccccHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhhcccc-cccCCccCCCCHHHHH
Q psy12709 169 EIIGTPDYVAPEVLSYE---PISLATDMWSVGVLAYVLLSSHSPFAGDNK-QETFLNISQCNF-SFHEDLFGHISSQAKD 243 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~i~~~~~-~~~~~~~~~~~~~l~~ 243 (253)
...+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||..... .+....+..... ..+......++.++.+
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 245 (288)
T cd06616 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVN 245 (288)
T ss_pred cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHH
Confidence 34567889999998766 688899999999999999999999976542 122222222111 1122222358999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
||.+||++||
T Consensus 246 li~~~l~~~p 255 (288)
T cd06616 246 FINLCLIKDE 255 (288)
T ss_pred HHHHHccCCh
Confidence 9999999998
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=262.39 Aligned_cols=191 Identities=23% Similarity=0.325 Sum_probs=162.6
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
.+|+ +++.||+|+||+||+|.+..++..|++|+..... ...|+..+. ..+|+||+++++++..++..++
T Consensus 66 ~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 66 LGYT--VIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQ-NVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred cCcE--EEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHH-hCCCCCCcChhheEEeCCeeEE
Confidence 3455 9999999999999999999999999999854322 234677776 7799999999999999999999
Q ss_pred EEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccc
Q psy12709 89 VLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV 167 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 167 (253)
++|++.+ +|.+++.. ...+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 135 v~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 213 (357)
T PHA03209 135 VLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF 213 (357)
T ss_pred EEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence 9999965 67666644 466899999999999999999999999999999999999999999999999998754333333
Q ss_pred cccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCC-CCCC
Q psy12709 168 KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSH-SPFA 211 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~-~p~~ 211 (253)
....+++.|+|||++.+..++.++|+||+|+++|+|+++. .+|.
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 4456889999999999889999999999999999999854 4444
|
|
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=260.68 Aligned_cols=234 Identities=27% Similarity=0.440 Sum_probs=202.3
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEecc
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMV 93 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 93 (253)
.++++||.|+||.||+|.++++|..+|+|.++... ..+.+-.|+.+++ ++++++++++|+.+-....+|+|||||
T Consensus 36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----DLQEIIKEISIMQ-QC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----DLQEIIKEISIMQ-QCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----hHHHHHHHHHHHH-HcCCchhhhhhhhhccCCceEeehhhc
Confidence 37789999999999999999999999999998643 3567888999998 999999999999999999999999999
Q ss_pred CCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc-ccccc
Q psy12709 94 PDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE-VKEII 171 (253)
Q Consensus 94 ~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~~~ 171 (253)
..|+..+.++- +.++++.++..+++..++++.|||...-+||||++.||++.-+|..||.|||.+..+.+... .....
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVI 190 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVI 190 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccc
Confidence 99999998876 46799999999999999999999999999999999999999999999999999976654332 24467
Q ss_pred cCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhccc
Q psy12709 172 GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251 (253)
Q Consensus 172 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (253)
|+|-|+|||++..-.|+..+||||||++..+|..|++||....+.....-|-... ++.......-|.++.|+|++||.+
T Consensus 191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~P-PPTF~KPE~WS~~F~DFi~~CLiK 269 (502)
T KOG0574|consen 191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKP-PPTFKKPEEWSSEFNDFIRSCLIK 269 (502)
T ss_pred cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCC-CCCCCChHhhhhHHHHHHHHHhcC
Confidence 9999999999988889999999999999999999999998877765554443322 222222335688999999999998
Q ss_pred CC
Q psy12709 252 DP 253 (253)
Q Consensus 252 dP 253 (253)
+|
T Consensus 270 ~P 271 (502)
T KOG0574|consen 270 KP 271 (502)
T ss_pred CH
Confidence 87
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=251.36 Aligned_cols=239 Identities=18% Similarity=0.314 Sum_probs=198.7
Q ss_pred cceeeEEEeecCCCCceEEEEEEecc-----CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKI-----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
.+|+ +++.||.|+||+||+|..+. +...+++|.+..... ......+.+|+..+. ..+|+||+++++++...
T Consensus 5 ~~~~--~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNLQ--EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFR-KLSHKNVVRLLGLCREA 80 (275)
T ss_pred Hhce--eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHH-hcCCcceeeeEEEECCC
Confidence 4555 99999999999999999753 346789998865332 234567888999988 66999999999999998
Q ss_pred CeEEEEEeccCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEe
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQD---------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCD 154 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~d 154 (253)
+..+++|||+++++|.+++.... .++...+..++.|++.++.|||+++++|+||+|+||+++.++.++++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999999987655 689999999999999999999999999999999999999999999999
Q ss_pred ecccccccccc--cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccC
Q psy12709 155 FGISRVVNDVV--EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHE 231 (253)
Q Consensus 155 f~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~ 231 (253)
|+++....... ......++..|+|||.+.+..++.++|+||+|+++|++++ |..||...........+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence 99886432211 1222344567999999888888999999999999999999 88999887777777766655443332
Q ss_pred CccCCCCHHHHHHHHHhcccCC
Q psy12709 232 DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 232 ~~~~~~~~~l~~li~~~l~~dP 253 (253)
...++..+.+++.+||+.||
T Consensus 241 --~~~~~~~l~~~i~~~l~~~p 260 (275)
T cd05046 241 --PEGCPSRLYKLMTRCWAVNP 260 (275)
T ss_pred --CCCCCHHHHHHHHHHcCCCc
Confidence 24789999999999999998
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=254.19 Aligned_cols=241 Identities=19% Similarity=0.289 Sum_probs=192.2
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccC--------------CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCce
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKIT--------------KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIV 74 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~--------------~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~ 74 (253)
++|+ +.+.||+|+||.||+|.+... ...|++|.+.... .......+.+|+..+. ..+|+|++
T Consensus 5 ~~~~--~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~-~l~h~~i~ 80 (295)
T cd05097 5 QQLR--LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMS-RLKNPNII 80 (295)
T ss_pred HhCe--ehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHH-hCCCCCcC
Confidence 4555 999999999999999987543 2358999987543 3344567888999888 77999999
Q ss_pred eeeeEEEeCCeEEEEEeccCCCcHHHHHhhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q psy12709 75 GLHEIYETPHEMVLVLEMVPDGELQRLVDIQD------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNI 142 (253)
Q Consensus 75 ~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni 142 (253)
++++++...+..+++|||+.+++|.+++.... .++...+..++.+++.++.|||++|++|+||+|+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999885432 367888999999999999999999999999999999
Q ss_pred EEcCCCceEEEeeccccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh--CCCCCCCCChHH
Q psy12709 143 LLTKDNNIKLCDFGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS--SHSPFAGDNKQE 217 (253)
Q Consensus 143 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~--g~~p~~~~~~~~ 217 (253)
+++.++.++|+|||.+........ .....++..|+|||...+..++.++|+||||+++++|++ |..||...+..+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999875432211 112233568999999988889999999999999999988 678998777666
Q ss_pred HHHHhhc----ccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 218 TFLNISQ----CNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 218 ~~~~i~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+.. ..........+.+++.+.++|.+||+.||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 280 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDI 280 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCc
Confidence 5544322 11111112234678999999999999998
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=268.28 Aligned_cols=241 Identities=34% Similarity=0.543 Sum_probs=216.4
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.+-||..-.+.||+|-||+||-|.++.+|+.||||++.+.+....+...+.+|+.+++ ...||+|+.+.-.++..+.++
T Consensus 561 stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq-~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 561 STVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQ-NLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHH-hcCCCCeeEEEEeecCCceEE
Confidence 4456644457999999999999999999999999999998877777788999999998 889999999999999999999
Q ss_pred EEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC---CceEEEeecccccccc
Q psy12709 88 LVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD---NNIKLCDFGISRVVND 163 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~---~~~~l~df~~~~~~~~ 163 (253)
+|||.+.|.-|+-.+.. .+.+++..-+.++.||+-|++|||-++|+|+|+||+||++.+. -.+||||||+++...+
T Consensus 640 VVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE 719 (888)
T KOG4236|consen 640 VVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE 719 (888)
T ss_pred EEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence 99999988777776654 4669999999999999999999999999999999999999875 3599999999999888
Q ss_pred cccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
........|+|.|+|||++..+.|.+..|+||+|+++|--++|..||.. +++.-.+|....+++|.....++|++..|
T Consensus 720 ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~Aid 797 (888)
T KOG4236|consen 720 KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPEAID 797 (888)
T ss_pred hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHHHHH
Confidence 7777778999999999999999999999999999999999999999964 45566778888899999888999999999
Q ss_pred HHHHhccc
Q psy12709 244 FIQSCLVT 251 (253)
Q Consensus 244 li~~~l~~ 251 (253)
||..+|+.
T Consensus 798 lIn~LLqV 805 (888)
T KOG4236|consen 798 LINNLLQV 805 (888)
T ss_pred HHHHHHHH
Confidence 99999875
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=253.33 Aligned_cols=236 Identities=20% Similarity=0.326 Sum_probs=195.0
Q ss_pred eEEEeecCCCCceEEEEEEec-----cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHK-----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
|++.+.||+|+||.||+|.+. .++..|++|.+..... ......+.+|+..+. ..+|+||+++++++..++..+
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~ei~~l~-~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMA-EFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHHHHHHHHHHHHH-hcCCCchheEEEEEcCCCccE
Confidence 449999999999999999875 3578899999875432 233456778888887 678999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc
Q psy12709 88 LVLEMVPDGELQRLVDIQD----------------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLT 145 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~----------------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~ 145 (253)
+++||+++++|.+++.... .++...++.++.+++.++.+||+++++|+||+|.||+++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~ 164 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG 164 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec
Confidence 9999999999999886432 367888899999999999999999999999999999999
Q ss_pred CCCceEEEeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy12709 146 KDNNIKLCDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLN 221 (253)
Q Consensus 146 ~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~ 221 (253)
.++.++|+|||.+....... .......+..|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.+..+....
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~ 244 (288)
T cd05050 165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYY 244 (288)
T ss_pred CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999887543221 1112233567999999988889999999999999999998 8899988777777766
Q ss_pred hhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 222 ISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 222 i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+..+..... ...++.++.++|.+||+.||
T Consensus 245 ~~~~~~~~~---~~~~~~~l~~li~~~l~~~p 273 (288)
T cd05050 245 VRDGNVLSC---PDNCPLELYNLMRLCWSKLP 273 (288)
T ss_pred HhcCCCCCC---CCCCCHHHHHHHHHHcccCc
Confidence 665544322 23678999999999999998
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=246.25 Aligned_cols=231 Identities=24% Similarity=0.368 Sum_probs=190.9
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDG 96 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 96 (253)
+.||+|++|.||+|... ++..+++|.+..... ......+.+|+..+. ..+|+||+++++++...+..+++|||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP-QELKIKFLSEARILK-QYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCC-HHHHHHHHHHHHHHH-hCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 46899999999999865 688899999876443 333456788888887 679999999999999999999999999999
Q ss_pred cHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccc--cccccC
Q psy12709 97 ELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV--KEIIGT 173 (253)
Q Consensus 97 ~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~ 173 (253)
+|.+++... ..+++..+..++.+++.++.++|++|++|+||+|+||+++.++.++|+|||.+......... ......
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 999988653 45789999999999999999999999999999999999999999999999988643322111 111234
Q ss_pred ccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccC
Q psy12709 174 PDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTD 252 (253)
Q Consensus 174 ~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 252 (253)
..|+|||.+.+..++.++|+||+|+++|++++ |..||...........+...... .....++..+.+++.+||+.|
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~ 234 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM---SCPQKCPDDVYKVMQRCWDYK 234 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcccC
Confidence 57999999988889999999999999999998 99999887777666655543221 223468999999999999999
Q ss_pred C
Q psy12709 253 P 253 (253)
Q Consensus 253 P 253 (253)
|
T Consensus 235 p 235 (250)
T cd05085 235 P 235 (250)
T ss_pred c
Confidence 8
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=254.49 Aligned_cols=238 Identities=26% Similarity=0.429 Sum_probs=195.2
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +.+.||+|+||.||++.+..++..|++|.+..... .....+.+|+..+. ..+|+||+++++.+..++..++
T Consensus 19 ~~~~--~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~-~l~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 19 KKYT--RFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMR-ENKHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred hhce--eeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHh-hcCCCCeeehhheeeeCCcEEE
Confidence 4555 99999999999999999988999999999865432 23456788888777 6789999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-cc
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EV 167 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~ 167 (253)
|+||+++++|.+++... .++...+..++.+++.++.+||++|++|+|++|+||+++.++.++|+|||.+....... ..
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred EEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence 99999999999998743 47899999999999999999999999999999999999999999999999876543321 22
Q ss_pred cccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~ 247 (253)
....+++.|+|||.+....++.++|+||+|+++|++++|+.||...+.......+.... .+.......++..++++|.+
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-CCCCCCccccCHHHHHHHHH
Confidence 23356778999999988888999999999999999999999998765544333322221 12222233578899999999
Q ss_pred hcccCC
Q psy12709 248 CLVTDP 253 (253)
Q Consensus 248 ~l~~dP 253 (253)
||+.||
T Consensus 252 ~l~~~p 257 (293)
T cd06647 252 CLEMDV 257 (293)
T ss_pred HccCCh
Confidence 999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=250.72 Aligned_cols=239 Identities=29% Similarity=0.423 Sum_probs=192.1
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--CeEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP--HEMV 87 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~ 87 (253)
+|. ..+.||.|++|.||+|.+..++..+++|.+...... .....+.+|+..+. ..+|+||+++++++... +.++
T Consensus 2 ~~~--~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 2 KIV--ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINK-SCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred ceE--EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHH-hCCCCCeeeeeeEEEccCCCeEE
Confidence 455 999999999999999999999999999998765432 44567888999887 67899999999988653 4799
Q ss_pred EEEeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 88 LVLEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
++|||+++++|.+++.. ...++...+..++.+++.++.|||+.|++|+|++|+||+++.++.++|+|||++.....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999999887643 34588999999999999999999999999999999999999999999999999865433
Q ss_pred cccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHhhcccccccC-Cc--cC
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDN-----KQETFLNISQCNFSFHE-DL--FG 235 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~i~~~~~~~~~-~~--~~ 235 (253)
... ....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.... ..+....+......... .. ..
T Consensus 158 ~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd06621 158 SLA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236 (287)
T ss_pred ccc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence 221 23346778999999988889999999999999999999999997652 22333333332211111 11 12
Q ss_pred CCCHHHHHHHHHhcccCC
Q psy12709 236 HISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 236 ~~~~~l~~li~~~l~~dP 253 (253)
..++.+.++|.+||+.||
T Consensus 237 ~~~~~~~~li~~~l~~~p 254 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDP 254 (287)
T ss_pred chHHHHHHHHHHHcCCCc
Confidence 356789999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=251.84 Aligned_cols=234 Identities=22% Similarity=0.314 Sum_probs=184.2
Q ss_pred EEeecCCCCceEEEEEE----eccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--CeEEE
Q psy12709 15 IFCMPSRGKFASVRKCT----HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP--HEMVL 88 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~l 88 (253)
+++.||+|+||+||++. ...++..|++|.+..... ......+.+|+..+. ..+|+||+++++++... ..+++
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILK-TLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred eceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHH-hCCCCCEeeEEEEEecCCCceEEE
Confidence 99999999999998865 335678899999876532 233456778998887 67999999999987653 46899
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc--
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE-- 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~-- 166 (253)
+|||+++++|.+++... .+++..++.++.+++.++.+||++|++|+||+|+||++++++.++|+|||.+........
T Consensus 86 v~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 164 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 164 (283)
T ss_pred EecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhh
Confidence 99999999999998754 589999999999999999999999999999999999999999999999999876543221
Q ss_pred --ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--H------------HHHhhccccccc
Q psy12709 167 --VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQE--T------------FLNISQCNFSFH 230 (253)
Q Consensus 167 --~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~------------~~~i~~~~~~~~ 230 (253)
.....++..|+|||...+..++.++|+||+|+++|+|++|..||....... . ...........
T Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 243 (283)
T cd05080 165 RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL- 243 (283)
T ss_pred ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCC-
Confidence 111234557999999988889999999999999999999999986533210 0 00111111111
Q ss_pred CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 ~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+....++.++.+++.+||++||
T Consensus 244 -~~~~~~~~~~~~li~~cl~~~p 265 (283)
T cd05080 244 -PCPKNCPQEVYILMKNCWETEA 265 (283)
T ss_pred -CCCCCCCHHHHHHHHHHhccCh
Confidence 1224678999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=295.37 Aligned_cols=238 Identities=29% Similarity=0.442 Sum_probs=206.4
Q ss_pred eeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEE
Q psy12709 11 YQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVL 90 (253)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 90 (253)
.+++....||.|.||.||.|.+..+|.-.|+|-+............+.+|...+. ..+|||+++++++-.+.+..++.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE-~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLE-GLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHH-hccCccccccCceeecHHHHHHHH
Confidence 3444788999999999999999999999999988776655666778889999998 999999999999999999999999
Q ss_pred eccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-----c
Q psy12709 91 EMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-----V 165 (253)
Q Consensus 91 e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-----~ 165 (253)
|||+||+|.++++.....++.....+..|++.++.|||+.||+||||||.||+++.+|.+|++|||.+....+. .
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 99999999999987777888888999999999999999999999999999999999999999999999866543 2
Q ss_pred cccccccCccccCccccCCCC---CCccccHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhccc-ccccCCccCCCCHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEP---ISLATDMWSVGVLAYVLLSSHSPFAG-DNKQETFLNISQCN-FSFHEDLFGHISSQ 240 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~i~~~~-~~~~~~~~~~~~~~ 240 (253)
......|++.|||||++.+.. -..++||||||||+.||+||+.||.. ++.......+..+- ++.|+ .+|.+
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~----~ls~~ 1469 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPE----RLSSE 1469 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCch----hhhHh
Confidence 344568999999999996643 46789999999999999999999977 44445555555543 33333 58999
Q ss_pred HHHHHHHhcccCC
Q psy12709 241 AKDFIQSCLVTDP 253 (253)
Q Consensus 241 l~~li~~~l~~dP 253 (253)
.++||.+||+.||
T Consensus 1470 g~dFle~Cl~~dP 1482 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDP 1482 (1509)
T ss_pred HHHHHHHHHhcCc
Confidence 9999999999998
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=246.72 Aligned_cols=235 Identities=24% Similarity=0.365 Sum_probs=195.6
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
..|+ +.+.||.|++|.||+|.+. .+..+++|.+....... ..+.+|+..++ ..+|++++++++++......++
T Consensus 4 ~~~~--~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 4 SELT--LVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSE---EDFIEEAQVMM-KLSHPKLVQLYGVCTERSPICL 76 (256)
T ss_pred hHeE--EEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCH---HHHHHHHHHHH-hCCCCCeeeEEEEEccCCceEE
Confidence 3455 8999999999999999876 46789999887654433 35777888887 6799999999999999999999
Q ss_pred EEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc-
Q psy12709 89 VLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE- 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~- 166 (253)
++||+++++|.+++... ..+++..++.++.+++.++.+||+++++|+||+|.||+++.++.++|+|||.+........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999999988754 4589999999999999999999999999999999999999999999999998875432211
Q ss_pred -ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 167 -VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 167 -~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
......+..|+|||.+.+..++.++|+||+|+++|++++ |..||...........+..+...... ...+..+.++
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l 233 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQSVYEL 233 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCHHHHHH
Confidence 112233568999999988889999999999999999998 99999888877777776654332222 2468999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
+.+||+.||
T Consensus 234 ~~~~l~~~p 242 (256)
T cd05112 234 MQHCWKERP 242 (256)
T ss_pred HHHHcccCh
Confidence 999999998
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=255.47 Aligned_cols=234 Identities=26% Similarity=0.438 Sum_probs=195.7
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
....||.|+||.||++.+..++..|++|.+.... ......+.+|+..+. ..+|+||+++++.+..++..++++||++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~-~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMR-DYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHH-hCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 5678999999999999999899999999986533 234556888988887 6799999999999999999999999999
Q ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-ccccccccC
Q psy12709 95 DGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEVKEIIGT 173 (253)
Q Consensus 95 g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~ 173 (253)
+++|.+++. ...+++..+..++.+++.++.+||++|++|+||+|+||++++++.++|+|||++...... .......++
T Consensus 103 ~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~ 181 (292)
T cd06658 103 GGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGT 181 (292)
T ss_pred CCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecC
Confidence 999999875 445899999999999999999999999999999999999999999999999988654322 122234567
Q ss_pred ccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 174 PDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 174 ~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..|+|||.+.+..++.++|+||+|+++|++++|+.||...+.......+..... ........++..+.+++.+||+.||
T Consensus 182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P 260 (292)
T cd06658 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP-PRVKDSHKVSSVLRGFLDLMLVREP 260 (292)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CccccccccCHHHHHHHHHHccCCh
Confidence 899999999888899999999999999999999999988776665554443221 1212223678999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=255.85 Aligned_cols=234 Identities=24% Similarity=0.459 Sum_probs=196.1
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
....||.|+||.||+|.+..++..|++|.+..... .....+.+|+..+. ..+|+|++++++.+..++..++++||++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~-~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMR-DYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHH-hCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 55689999999999999999999999999865433 22456778888877 6789999999999999999999999999
Q ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-cccccccC
Q psy12709 95 DGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVKEIIGT 173 (253)
Q Consensus 95 g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~ 173 (253)
+++|..++.. ..+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+....... ......++
T Consensus 102 ~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~ 180 (297)
T cd06659 102 GGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT 180 (297)
T ss_pred CCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecC
Confidence 9999988754 458999999999999999999999999999999999999999999999999886543221 22234577
Q ss_pred ccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 174 PDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 174 ~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..|+|||.+.+..++.++|+||+|+++++|++|+.||...+.......+.... .........++..+.++|.+||+.||
T Consensus 181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~i~~~l~~~P 259 (297)
T cd06659 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNAHKISPVLRDFLERMLTREP 259 (297)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CCCccccCCCCHHHHHHHHHHhcCCc
Confidence 89999999988889999999999999999999999998777666555544332 22223335678999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=255.48 Aligned_cols=241 Identities=29% Similarity=0.368 Sum_probs=188.0
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC----
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH---- 84 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~---- 84 (253)
++|+ +.+.||+|++|.||+|.+..++..|++|.+..............+|+..++ ..+|+||+++++++...+
T Consensus 12 ~~y~--~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 12 SKYE--KLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQ-LLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hheE--EEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHH-hCCCCCccceEEEEeccccccc
Confidence 4566 999999999999999999999999999998765443333345667888877 779999999999886543
Q ss_pred ----eEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 85 ----EMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 85 ----~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
..++++||+.+ +|...+... ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 46999999965 777766544 368999999999999999999999999999999999999999999999999987
Q ss_pred ccccccc-----ccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCc
Q psy12709 160 VVNDVVE-----VKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDL 233 (253)
Q Consensus 160 ~~~~~~~-----~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 233 (253)
....... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.+.......+.......+...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 6543221 1223456789999987654 468899999999999999999999988766544433333211111100
Q ss_pred ----------------------------cCCCCHHHHHHHHHhcccCC
Q psy12709 234 ----------------------------FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 ----------------------------~~~~~~~l~~li~~~l~~dP 253 (253)
....++.+.++|.+||+.||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P 295 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDP 295 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCCh
Confidence 01235678899999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=273.81 Aligned_cols=231 Identities=27% Similarity=0.452 Sum_probs=195.5
Q ss_pred ecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCCc
Q psy12709 18 MPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGE 97 (253)
Q Consensus 18 ~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 97 (253)
.||+|.||+||.|.|..+...+|||-++.... ...+-+++|+.... .++|.|||++++.+.+++.+-+.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~-~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHS-TLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHH-HHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 79999999999999999999999999875433 33567777777666 8999999999999999999999999999999
Q ss_pred HHHHHhhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-CCceEEEeeccccccc-cccccccccc
Q psy12709 98 LQRLVDIQ-DGI--PEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK-DNNIKLCDFGISRVVN-DVVEVKEIIG 172 (253)
Q Consensus 98 L~~~~~~~-~~~--~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~-~~~~~l~df~~~~~~~-~~~~~~~~~~ 172 (253)
|.++++.. +++ ++..+-.+.+||+.+++|||.+.|+|||||-+||++.- +|.+||+|||-++... -...+....|
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG 738 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG 738 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence 99999875 566 89999999999999999999999999999999999975 7999999999998653 3455677789
Q ss_pred CccccCccccCCC--CCCccccHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 173 TPDYVAPEVLSYE--PISLATDMWSVGVLAYVLLSSHSPFAGD-NKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 173 ~~~~~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
+..|||||++..+ .|..++||||+||++.||.||++||-.. ++.....++.. .....++..++|.+.+.+|.+|+
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGm--yKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGM--YKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcc--eecCCCCcHHHHHHHHHHHHHHc
Confidence 9999999999665 4788999999999999999999999653 33333333333 33333444588999999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
.+||
T Consensus 817 epd~ 820 (1226)
T KOG4279|consen 817 EPDP 820 (1226)
T ss_pred CCCc
Confidence 9997
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=252.97 Aligned_cols=241 Identities=20% Similarity=0.305 Sum_probs=190.4
Q ss_pred cceeeEEEeecCCCCceEEEEEEec----------------cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCC
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHK----------------ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER 72 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~----------------~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~ 72 (253)
++|+ +.+.||.|+||+||++.+. .++..+++|.+.... .......+.+|+..+. ..+|+|
T Consensus 5 ~~~~--~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~-~l~~~~ 80 (296)
T cd05095 5 KRLT--FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMS-RLKDPN 80 (296)
T ss_pred hhce--eeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHH-hCCCCC
Confidence 4566 9999999999999998643 234568999987542 2344567888999888 679999
Q ss_pred ceeeeeEEEeCCeEEEEEeccCCCcHHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy12709 73 IVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQD-----------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQN 141 (253)
Q Consensus 73 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~-----------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~n 141 (253)
|+++++++..++..++++||+++++|.+++.... .++...+..++.+++.|+.+||++|++|+||+|+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999887532 25677899999999999999999999999999999
Q ss_pred EEEcCCCceEEEeeccccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh--CCCCCCCCChH
Q psy12709 142 ILLTKDNNIKLCDFGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS--SHSPFAGDNKQ 216 (253)
Q Consensus 142 i~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~--g~~p~~~~~~~ 216 (253)
|+++.++.++|+|||.+........ ......++.|++||...+..++.++|+||+|+++|+|++ |..||...+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999875432211 111233568999999888889999999999999999998 78999876665
Q ss_pred HHHHHhhcc----cccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 217 ETFLNISQC----NFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 217 ~~~~~i~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+........ ......+....+++.+.+++.+||+.||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 281 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNA 281 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCc
Confidence 554433210 0001111224678999999999999998
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=258.58 Aligned_cols=240 Identities=23% Similarity=0.396 Sum_probs=196.1
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC--
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH-- 84 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-- 84 (253)
+.++|+ +++.||+|++|.||+|.+..++..||+|.+............+.+|+..+. ..+|+||+++++++..+.
T Consensus 13 ~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 13 VPDRYR--DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK-HMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred cccceE--EEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHH-hcCCCCccceeeeecCCccc
Confidence 567777 999999999999999999999999999998765444444567788999887 779999999999987653
Q ss_pred ----eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 85 ----EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 85 ----~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
.++++++++ |++|..++. ...+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+..
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 468999998 779988876 45689999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc---------
Q psy12709 161 VNDVVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH--------- 230 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--------- 230 (253)
.... .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||...+....+..+.......+
T Consensus 168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 168 TDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred cccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 5332 123356788999999865 4578899999999999999999999987766555444333221111
Q ss_pred ------------------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 ------------------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 ------------------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+.+++++.++|.+||+.||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 286 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDA 286 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCCh
Confidence 11224678899999999999998
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=251.76 Aligned_cols=239 Identities=29% Similarity=0.398 Sum_probs=194.6
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--CeEEEEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP--HEMVLVL 90 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~ 90 (253)
|++.+.||.|++|.||+|.+..++..+++|.+............+.+|+..+. ..+|+|++++++++... +..++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQ-KLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHH-hccCCCeeeheeeEecCCCCcEEEEe
Confidence 45899999999999999999999999999999876544444567788888887 66799999999999988 7999999
Q ss_pred eccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc--cc
Q psy12709 91 EMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV--EV 167 (253)
Q Consensus 91 e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~ 167 (253)
||+++ +|.+++... ..+++..++.++.+++.|+++||+.|++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence 99975 888877654 568999999999999999999999999999999999999999999999999987654432 12
Q ss_pred cccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC---------------
Q psy12709 168 KEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE--------------- 231 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--------------- 231 (253)
....++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||...+.......+......+..
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence 23345778999998754 45788999999999999999999999887765555444332111110
Q ss_pred -----------CccCC-CCHHHHHHHHHhcccCC
Q psy12709 232 -----------DLFGH-ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 232 -----------~~~~~-~~~~l~~li~~~l~~dP 253 (253)
..... +++.+.++|.+||+.||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P 272 (287)
T cd07840 239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDP 272 (287)
T ss_pred cccccchhHHHHHhcccCCHHHHHHHHHHcCCCh
Confidence 01112 38899999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=247.92 Aligned_cols=228 Identities=23% Similarity=0.326 Sum_probs=190.3
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++.+.||+|+||.||++.. +++.|++|.+.... ....+.+|+..+. ..+|+|++++++.+..+ ..++++||
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~----~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV----TAQAFLEETAVMT-KLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred ceeeeeeccCCCCceEeccc--CCCceEEEeecCcc----hHHHHHHHHHHHH-hCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 44999999999999999864 67889999986532 2346778888887 77999999999998764 57899999
Q ss_pred cCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccccccc
Q psy12709 93 VPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI 170 (253)
Q Consensus 93 ~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (253)
+.+++|.+++.... .++...+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~~~ 157 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNS 157 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--CCCC
Confidence 99999999987643 4789999999999999999999999999999999999999999999999988654321 1122
Q ss_pred ccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 171 IGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
.....|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..+....+....... ....+++++.+++.+||
T Consensus 158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l 234 (254)
T cd05083 158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME---PPEGCPADVYVLMTSCW 234 (254)
T ss_pred CCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC---CCCcCCHHHHHHHHHHc
Confidence 33568999999988889999999999999999998 999999888877777665543222 22478999999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
+.+|
T Consensus 235 ~~~p 238 (254)
T cd05083 235 ETEP 238 (254)
T ss_pred CCCh
Confidence 9987
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=258.37 Aligned_cols=239 Identities=21% Similarity=0.368 Sum_probs=189.0
Q ss_pred cceeeEEEeecCCCCceEEEEEEec-----cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHK-----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
++|+ +.+.||+|+||+||+|.+. .+++.||+|.++.... ......+.+|+..+..+.+|+||+++++.+...
T Consensus 7 ~~~~--~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 7 DRLK--LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hHhc--ccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 4566 9999999999999999853 4578899999875432 344567888999998777899999999987654
Q ss_pred -CeEEEEEeccCCCcHHHHHhhc---------------------------------------------------------
Q psy12709 84 -HEMVLVLEMVPDGELQRLVDIQ--------------------------------------------------------- 105 (253)
Q Consensus 84 -~~~~lv~e~~~g~~L~~~~~~~--------------------------------------------------------- 105 (253)
..++++|||+++++|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4688999999999999988642
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc---cccccc
Q psy12709 106 ----------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE---VKEIIG 172 (253)
Q Consensus 106 ----------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~ 172 (253)
..++...+..++.|++.|+.|||++|++|+||+|.||+++.++.++|+|||++........ .....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1357778889999999999999999999999999999999999999999999875432111 112234
Q ss_pred CccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHH-hhcccccccCCccCCCCHHHHHHHHHhcc
Q psy12709 173 TPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLN-ISQCNFSFHEDLFGHISSQAKDFIQSCLV 250 (253)
Q Consensus 173 ~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (253)
+..|+|||.+.+..++.++|+||+|+++|++++ |..||........... +..... .+. ....++++.+++.+||+
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~cl~ 320 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRA--PDYTTPEMYQTMLDCWH 320 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC-CCC--CCCCCHHHHHHHHHHcc
Confidence 567999999988889999999999999999997 9999977544333322 322222 111 12568899999999999
Q ss_pred cCC
Q psy12709 251 TDP 253 (253)
Q Consensus 251 ~dP 253 (253)
.||
T Consensus 321 ~~p 323 (343)
T cd05103 321 GEP 323 (343)
T ss_pred CCh
Confidence 998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=252.35 Aligned_cols=242 Identities=26% Similarity=0.363 Sum_probs=192.6
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
+.-.|++.+.||+|++|.||+|.+..++..|++|.+...... .....+.+|+..+.+..+|+||+++++++..+...++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 334455999999999999999999988999999999765432 2345566677777767789999999999999999999
Q ss_pred EEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCceEEEeeccccccccccc
Q psy12709 89 VLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 166 (253)
+||++. +++.+++.. ...+++..+..++.+++.++.|||+ .|++|+||+|+||++++++.++|+|||.+........
T Consensus 92 v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred EeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 999985 477776654 4568999999999999999999997 5999999999999999999999999999876544333
Q ss_pred ccccccCccccCccccCCCC----CCccccHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhhcccccccCCccCCCCHHH
Q psy12709 167 VKEIIGTPDYVAPEVLSYEP----ISLATDMWSVGVLAYVLLSSHSPFAGDNK-QETFLNISQCNFSFHEDLFGHISSQA 241 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~l 241 (253)
.....++..|+|||.+.+.. ++.++|+||+|+++|+|++|+.||..... .+.+..+........ .....+++++
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 249 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PPNEGFSPDF 249 (296)
T ss_pred ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC-CCCCCCCHHH
Confidence 33345677899999986554 78899999999999999999999976333 344444433322111 1112578999
Q ss_pred HHHHHHhcccCC
Q psy12709 242 KDFIQSCLVTDP 253 (253)
Q Consensus 242 ~~li~~~l~~dP 253 (253)
.++|.+||+.||
T Consensus 250 ~~li~~~l~~~p 261 (296)
T cd06618 250 CSFVDLCLTKDH 261 (296)
T ss_pred HHHHHHHccCCh
Confidence 999999999988
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=252.94 Aligned_cols=234 Identities=26% Similarity=0.385 Sum_probs=194.2
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
|...+.||+|+||.||++.+..++..+++|.+.... ........+.+|+..+. ..+|+|++++++++..++..++++|
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ-RIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHH-hCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 338889999999999999999899999999987653 33344567888998887 6689999999999999999999999
Q ss_pred ccCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccccccc
Q psy12709 92 MVPDGELQRLVD-IQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI 170 (253)
Q Consensus 92 ~~~g~~L~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (253)
|+.| ++.+.+. ...++++..+..++.+++.++.+||+++++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~ 181 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---NSF 181 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---ccc
Confidence 9976 6666554 3566899999999999999999999999999999999999999999999999988654322 234
Q ss_pred ccCccccCccccC---CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHH
Q psy12709 171 IGTPDYVAPEVLS---YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247 (253)
Q Consensus 171 ~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~ 247 (253)
.+++.|+|||.+. ...++.++|+||+|+++|+|++|+.||...........+......... ...+++.++++|.+
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~ 259 (317)
T cd06635 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--SNEWSDYFRNFVDS 259 (317)
T ss_pred cCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCC--CccccHHHHHHHHH
Confidence 5678899999973 456788999999999999999999999877666666665554433222 23678999999999
Q ss_pred hcccCC
Q psy12709 248 CLVTDP 253 (253)
Q Consensus 248 ~l~~dP 253 (253)
||+.+|
T Consensus 260 ~l~~~p 265 (317)
T cd06635 260 CLQKIP 265 (317)
T ss_pred HccCCc
Confidence 999987
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=255.11 Aligned_cols=242 Identities=26% Similarity=0.442 Sum_probs=194.5
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe-C
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET-P 83 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~ 83 (253)
+.+.++|+ +.+.||.|+||.||+|.+..+++.|++|.+.+..........+.+|+..+. ..+||||+++.+++.. +
T Consensus 6 ~~~~~~y~--~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 6 FEITNRYV--DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLK-HLRHENIISLSDIFISPL 82 (328)
T ss_pred eccccceE--EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHH-hcCCCCeeeEeeeEecCC
Confidence 34566777 999999999999999999999999999998765444444567788999887 7799999999999876 4
Q ss_pred CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
...++++|++ +++|..++. ..+++...+..++.|++.++.+||+++++|+||+|.||+++.++.++|+|||.+.....
T Consensus 83 ~~~~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 83 EDIYFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred CcEEEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 5789999998 568888876 44588889999999999999999999999999999999999999999999999875433
Q ss_pred cccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcc-----------------
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQC----------------- 225 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~----------------- 225 (253)
. .....++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||........+..+.+.
T Consensus 161 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 161 Q--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred C--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 2 123345778999998765 56889999999999999999999999876653333222111
Q ss_pred ----------cccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 226 ----------NFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 226 ----------~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
...+.....+.++++++++|++||+.||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 276 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDP 276 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCCh
Confidence 1111122334678999999999999988
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=249.43 Aligned_cols=239 Identities=18% Similarity=0.244 Sum_probs=195.3
Q ss_pred ecceeeEEEeecCCCCceEEEEEEecc----CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe-
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKI----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET- 82 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~- 82 (253)
.++|+ +.+.||+|+||.||+|.+.. .+..|++|.+... ........+.+|+..+. ..+|+||++++++...
T Consensus 5 ~~~~~--~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~-~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 5 RDRVT--LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLY-GLSHQNILPILHVCIED 80 (280)
T ss_pred hhheE--EeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEecC
Confidence 45566 99999999999999999886 2577899887643 34455677888888887 6699999999998765
Q ss_pred CCeEEEEEeccCCCcHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEe
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQ--------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCD 154 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~d 154 (253)
+...+++++++++++|.+++... ..++...+..++.+++.|+.|||+++++|+||+|+||+++.++.++++|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 56889999999999999988653 3488999999999999999999999999999999999999999999999
Q ss_pred eccccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhccccccc
Q psy12709 155 FGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFH 230 (253)
Q Consensus 155 f~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~ 230 (253)
||+++....... .....++..|+|||.+.+..++.++||||+|+++|++++ |+.||...+..+....+..... ++
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~ 239 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR-LA 239 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC-CC
Confidence 999875432211 111234567999999988889999999999999999999 9999988777666655554322 22
Q ss_pred CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 ~~~~~~~~~~l~~li~~~l~~dP 253 (253)
. ...+++++.+++.+||+.||
T Consensus 240 ~--~~~~~~~~~~li~~~l~~~p 260 (280)
T cd05043 240 Q--PINCPDELFAVMACCWALDP 260 (280)
T ss_pred C--CCcCCHHHHHHHHHHcCCCh
Confidence 2 23678999999999999987
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=253.08 Aligned_cols=238 Identities=32% Similarity=0.459 Sum_probs=196.6
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEecc
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMV 93 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 93 (253)
++.+.||.|++|.||+|.+..++..+++|.+............+.+|+..++ ..+|++|+++++++..++.+++++||+
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLK-ELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHH-HhcCCCcchHHHhhccCCCEEEEEecc
Confidence 4889999999999999999999999999998876555445567888888888 667999999999999999999999999
Q ss_pred CCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-cccccc
Q psy12709 94 PDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVKEII 171 (253)
Q Consensus 94 ~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~ 171 (253)
++ ++.+.+.. ...+++..+..++.+++.++.+||+.+++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~ 159 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV 159 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence 76 77776665 4578999999999999999999999999999999999999999999999999987665433 222345
Q ss_pred cCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc---------------------
Q psy12709 172 GTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF--------------------- 229 (253)
Q Consensus 172 ~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--------------------- 229 (253)
++..|+|||.+.+. .++.++|+||+|+++|++++|+.||...+..+....+......+
T Consensus 160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05118 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239 (283)
T ss_pred CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence 67789999998776 78899999999999999999999998877665544432211110
Q ss_pred -----cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 -----HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 -----~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.....+.++.++.++|.+||++||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P 268 (283)
T cd05118 240 KAGMPLPKLFPNASPQALDLLSQMLHYDP 268 (283)
T ss_pred ccccCHHHhhhhhCHHHHHHHHHHhccCc
Confidence 011224578899999999999998
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=264.47 Aligned_cols=193 Identities=23% Similarity=0.318 Sum_probs=165.3
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
....+|+ +.+.||+|+||.||+|.+..++..|++|.... ....+|+..+. .++|+||+++++++..++.
T Consensus 166 ~~~~gy~--i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~-~L~HpnIv~l~~~~~~~~~ 234 (461)
T PHA03211 166 VAGLGFA--IHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLR-RLSHPAVLALLDVRVVGGL 234 (461)
T ss_pred cccCCeE--EEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHH-HCCCCCCCcEEEEEEECCE
Confidence 3455666 99999999999999999999999999996432 23457888887 7799999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
.+++++++. ++|..++... ..+++..++.++.|++.+|.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 235 ~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 235 TCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 999999995 5777766543 46999999999999999999999999999999999999999999999999998765332
Q ss_pred cc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCC
Q psy12709 165 VE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPF 210 (253)
Q Consensus 165 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 210 (253)
.. .....+++.|+|||++.+..++.++||||||+++|+|++|..|+
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 11 22346889999999999989999999999999999999987654
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=250.55 Aligned_cols=238 Identities=28% Similarity=0.445 Sum_probs=192.1
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++.+.||.|++|+||+|.+..++..|++|.+...... .....+.+|+..+. .++|+||+++++.+...+..++++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMK-ELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHH-hhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 44999999999999999999999999999998765432 22345667888887 66899999999999999999999999
Q ss_pred cCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-ccc
Q psy12709 93 VPDGELQRLVDIQ---DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVK 168 (253)
Q Consensus 93 ~~g~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~ 168 (253)
+++ +|.+++... ..+++..+..++.|++.++.+||+.|++|+||+|+||++++++.++++|||.+....... ...
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 976 787777643 358999999999999999999999999999999999999999999999999987543321 112
Q ss_pred ccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc-----------------
Q psy12709 169 EIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH----------------- 230 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----------------- 230 (253)
...++..|+|||.+.+. .++.++|+||+|+++|++++|+.||.+.+..+....+......+.
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence 23457789999987554 568899999999999999999999988776665554432211110
Q ss_pred --------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 --------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 --------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+.++.++.++|.+||+.||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 269 (284)
T cd07836 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNP 269 (284)
T ss_pred cCCChHHHHHHhhhcCcHHHHHHHHHhcCCc
Confidence 11123568889999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=251.91 Aligned_cols=237 Identities=30% Similarity=0.431 Sum_probs=192.8
Q ss_pred eEEEeecCCCCceEEEEEEec---cCCceEEEEEeccccc--chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHK---ITKVEYAAKFIRKRRR--SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
|++.+.||.|++|.||++.+. .++..|++|.+.+... .......+.+|+..+.+..+|++|+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 349999999999999999864 4678899999875432 22334567788998987778999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc--
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-- 165 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-- 165 (253)
+||||+++++|.+.+.....+++..++.++.|++.++.+||+.+++|+||+|.||+++.++.++++|||++.......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 161 (288)
T cd05583 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161 (288)
T ss_pred EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccccc
Confidence 999999999999988777779999999999999999999999999999999999999999999999999887543321
Q ss_pred cccccccCccccCccccCCCC--CCccccHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHhhcccccccCCccCCCCH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEP--ISLATDMWSVGVLAYVLLSSHSPFAGDNK----QETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
......++..|++||...+.. .+.++|+||+|+++|+|++|..||..... .+....+....... ...++.
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 237 (288)
T cd05583 162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF----PKTMSA 237 (288)
T ss_pred ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC----CcccCH
Confidence 122235678999999987654 67899999999999999999999964332 22223333332222 236789
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
+++++|.+||+.||
T Consensus 238 ~l~~li~~~l~~~p 251 (288)
T cd05583 238 EARDFIQKLLEKDP 251 (288)
T ss_pred HHHHHHHHHhcCCH
Confidence 99999999999987
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=250.58 Aligned_cols=202 Identities=29% Similarity=0.415 Sum_probs=167.0
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +++.||+|++|.||+|.+..++..|++|.+...... .......+|+..+. ..+|+||+++.+++..++..++
T Consensus 5 ~~y~--~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~-~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 5 TSYL--NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLK-GLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred ceeE--EEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHH-hcCCCCEeEEEEEEecCCeEEE
Confidence 4566 999999999999999999999999999998754322 22235567888887 6789999999999999999999
Q ss_pred EEeccCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-cc
Q psy12709 89 VLEMVPDGELQRLVD-IQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VE 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~ 166 (253)
++||+.+ ++...+. ....++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 81 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 81 VFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred EEecccC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 9999964 5655443 3456788899999999999999999999999999999999999999999999988754322 11
Q ss_pred ccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q psy12709 167 VKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNK 215 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 215 (253)
.....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 2233467899999998654 578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=249.82 Aligned_cols=233 Identities=26% Similarity=0.423 Sum_probs=194.8
Q ss_pred EeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 16 FCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
...||.|++|.||++..+.++..|++|.+.... ......+.+|+..+. ..+|+||+++++.+..++..+++|||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMR-DYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHH-hcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 457999999999999999999999999886432 233557888888887 77899999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-ccccccccCc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEVKEIIGTP 174 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~ 174 (253)
++|.+++. ...+++..+..++.|++.++++||+.|++|+||+|.||+++.++.++|+|||.+...... .......+++
T Consensus 102 ~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 180 (292)
T cd06657 102 GALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 180 (292)
T ss_pred CcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCc
Confidence 99999875 445899999999999999999999999999999999999999999999999988654332 1222345678
Q ss_pred cccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 175 ~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.|+|||.+.+..++.++|+||+|+++|++++|..||.+....+....+..... ........++..+.+++.+||+.||
T Consensus 181 ~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~P 258 (292)
T cd06657 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PKLKNLHKVSPSLKGFLDRLLVRDP 258 (292)
T ss_pred cccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-cccCCcccCCHHHHHHHHHHHhCCc
Confidence 89999999888889999999999999999999999988776655554443322 2222234679999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=257.42 Aligned_cols=243 Identities=28% Similarity=0.419 Sum_probs=195.2
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--C
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP--H 84 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~ 84 (253)
+.++|+ +.+.||+|++|.||+|.+..++..+++|.+............+.+|+..+.+..+|+||+++++++... .
T Consensus 5 ~~~~y~--~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 5 ILRKYE--ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhHHH--HhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 456777 999999999999999999989999999998765444445567778998888555999999999998654 3
Q ss_pred eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
.+++|+|++++ +|..++... .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 83 DIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred eEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 68999999964 888888755 6889999999999999999999999999999999999999999999999988754322
Q ss_pred c------cccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcc------------
Q psy12709 165 V------EVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQC------------ 225 (253)
Q Consensus 165 ~------~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~------------ 225 (253)
. ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+....+....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 1 1222346778999998754 45788999999999999999999999876655444332221
Q ss_pred ---------------cccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 226 ---------------NFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 226 ---------------~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.........+.++.++.++|.+||+.||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 283 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNP 283 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCc
Confidence 1111223334579999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=250.22 Aligned_cols=240 Identities=27% Similarity=0.393 Sum_probs=187.5
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +.+.||.|++|+||+|.+..+++.|++|.+....... ......+|+..+. ..+|+||+++++++..++..++
T Consensus 5 ~~y~--~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 5 ETYK--KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLK-DLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred ccee--EEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHh-hCCCcceeeEEEEEecCCeEEE
Confidence 4566 9999999999999999999899999999987643221 1234567888887 7799999999999999999999
Q ss_pred EEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-c
Q psy12709 89 VLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-E 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~ 166 (253)
|+||+.+ +|.+++... ..+++..++.++.|++.|+.|||+++++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 9999975 888877653 468999999999999999999999999999999999999999999999999886543211 1
Q ss_pred ccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHhhcccc-----------------
Q psy12709 167 VKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDN-KQETFLNISQCNF----------------- 227 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~i~~~~~----------------- 227 (253)
.....++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.... ..+....+.....
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 112235678999999865 457889999999999999999999997655 2222222211000
Q ss_pred ---------cccCCccCCCC--HHHHHHHHHhcccCC
Q psy12709 228 ---------SFHEDLFGHIS--SQAKDFIQSCLVTDP 253 (253)
Q Consensus 228 ---------~~~~~~~~~~~--~~l~~li~~~l~~dP 253 (253)
.........++ .++.++|.+||+.||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p 276 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEP 276 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCc
Confidence 00001112344 889999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=254.81 Aligned_cols=192 Identities=27% Similarity=0.459 Sum_probs=157.4
Q ss_pred EeecCCCCceEEEEEEec--cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe--CCeEEEEEe
Q psy12709 16 FCMPSRGKFASVRKCTHK--ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET--PHEMVLVLE 91 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e 91 (253)
.+.||+|+||+||+|.++ .++..|++|.+...... ....+|+..+. ..+|+||+++++.+.. +..+++++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLR-ELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHH-hcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 458999999999999966 46788999998754332 34667888887 7799999999999864 457899999
Q ss_pred ccCCCcHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc----CCCceEEEeeccc
Q psy12709 92 MVPDGELQRLVDIQ---------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLT----KDNNIKLCDFGIS 158 (253)
Q Consensus 92 ~~~g~~L~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~----~~~~~~l~df~~~ 158 (253)
++. ++|.+++... ..+++..++.++.|++.|+.|||++|++|+||+|+||++. .++.++|+|||++
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 985 4777766421 2488999999999999999999999999999999999994 5578999999999
Q ss_pred ccccccc----cccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCC
Q psy12709 159 RVVNDVV----EVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGD 213 (253)
Q Consensus 159 ~~~~~~~----~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 213 (253)
....... ......+++.|+|||++.+. .++.++|+||+||++|+|++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 7654321 22334678899999998764 5788999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=249.40 Aligned_cols=236 Identities=21% Similarity=0.337 Sum_probs=186.9
Q ss_pred eEEEeecCCCCceEEEEEEe----ccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--CeE
Q psy12709 13 TLIFCMPSRGKFASVRKCTH----KITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP--HEM 86 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~----~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~ 86 (253)
|++++.||+|+||.||.|.. ..++..|++|.+.... .......+.+|+..+. ...|+|++++.+++... ..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILR-NLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHH-hCCCCCeeeeeeEEecCCCCce
Confidence 44999999999999999974 4567889999987543 2344567888999888 77999999999998775 578
Q ss_pred EEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~ 165 (253)
+++|||++|++|.+++... ..++...+..++.+++.++++||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999999999998654 358999999999999999999999999999999999999999999999999987654321
Q ss_pred c----ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---------------HHHHHHhhccc
Q psy12709 166 E----VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNK---------------QETFLNISQCN 226 (253)
Q Consensus 166 ~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------------~~~~~~i~~~~ 226 (253)
. .....++..|+|||.+.+..++.++|+||+|+++|+++++..|...... ......+....
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK 243 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCc
Confidence 1 1223455679999999888899999999999999999997765422110 11111112221
Q ss_pred ccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 227 FSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 227 ~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
. .+....++.++.++|.+||+.||
T Consensus 244 ~---~~~~~~~~~~~~~li~~~l~~~p 267 (284)
T cd05079 244 R---LPRPPNCPEEVYQLMRKCWEFQP 267 (284)
T ss_pred c---CCCCCCCCHHHHHHHHHHccCCc
Confidence 1 12234689999999999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=252.85 Aligned_cols=241 Identities=29% Similarity=0.376 Sum_probs=192.3
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC----
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH---- 84 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~---- 84 (253)
++|+ +.+.||.|++|+||+|.++.++..|++|.+............+.+|+..+. ..+|+||+++++++....
T Consensus 7 ~~~~--~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~-~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 7 DKFD--IIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILR-QLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhh--eeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHH-hCCCCCeeeeeheecCcchhhh
Confidence 4566 999999999999999999999999999999765544444456778888887 668999999999987654
Q ss_pred ------eEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecc
Q psy12709 85 ------EMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI 157 (253)
Q Consensus 85 ------~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~ 157 (253)
.+++++||+++ ++...+.. ...+++..+..++.|++.|+.|||+.|++|+||+|+||++++++.++|+|||.
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 79999999976 66565554 34689999999999999999999999999999999999999999999999999
Q ss_pred cccccccc--cccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC---
Q psy12709 158 SRVVNDVV--EVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE--- 231 (253)
Q Consensus 158 ~~~~~~~~--~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--- 231 (253)
+....... .......+..|+|||.+.+. .++.++|+||+|+++++|++|+.||...+..+....+......+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 87654322 11223456789999987653 5688999999999999999999999877666555444332111110
Q ss_pred -----------------------CccCCCCHHHHHHHHHhcccCC
Q psy12709 232 -----------------------DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 232 -----------------------~~~~~~~~~l~~li~~~l~~dP 253 (253)
.....+|..+.++|.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 287 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDP 287 (302)
T ss_pred ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCCh
Confidence 1123578999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=254.16 Aligned_cols=240 Identities=25% Similarity=0.370 Sum_probs=191.7
Q ss_pred eEEEeecCCCCceEEEEEEeccC--CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC----CeE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKIT--KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP----HEM 86 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~--~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~----~~~ 86 (253)
|++.+.||+|+||.||++.+..+ +..||+|.+............+.+|+..+....+|+||+++++..... ..+
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 44999999999999999999887 889999998764444444567788999888677899999999875432 468
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV- 165 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~- 165 (253)
+++++++. ++|.+.+.....+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 160 (332)
T cd07857 82 YLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG 160 (332)
T ss_pred EEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccc
Confidence 89999985 6898888777789999999999999999999999999999999999999999999999999987543221
Q ss_pred ----cccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc-----------
Q psy12709 166 ----EVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF----------- 229 (253)
Q Consensus 166 ----~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----------- 229 (253)
......+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||...+.......+......+
T Consensus 161 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (332)
T cd07857 161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSP 240 (332)
T ss_pred cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhh
Confidence 1123356789999998755 467899999999999999999999998766544443322211111
Q ss_pred ----------------cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 ----------------HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 ----------------~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.....+..+.++.+++.+||+.||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 280 (332)
T cd07857 241 KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDP 280 (332)
T ss_pred hHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCc
Confidence 112234568899999999999998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=255.98 Aligned_cols=240 Identities=25% Similarity=0.416 Sum_probs=192.3
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC---
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP--- 83 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--- 83 (253)
+.++|+ +.+.||+|+||.||+|.+..++..||+|.+............+.+|+..+. ..+|+||+++++++...
T Consensus 15 ~~~~y~--~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~-~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 15 VPERYQ--NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK-HMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred ccCceE--EEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHH-HcCCCcccceeeeeeecccc
Confidence 456677 999999999999999999999999999999875544444567778888887 77999999999988643
Q ss_pred ---CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 84 ---HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 84 ---~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
...+++++++ |++|.+++.. ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 3478888887 7799888764 4589999999999999999999999999999999999999999999999999875
Q ss_pred ccccccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc---------
Q psy12709 161 VNDVVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH--------- 230 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--------- 230 (253)
.... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+.......+.......+
T Consensus 170 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 170 TDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred cccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 4332 223456788999998765 4678899999999999999999999987665554443322211110
Q ss_pred ------------------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 ------------------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 ------------------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.......++++.++|.+||+.||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 288 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 288 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCCh
Confidence 01112468889999999999997
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=250.93 Aligned_cols=241 Identities=20% Similarity=0.303 Sum_probs=193.0
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCCc----eEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITKV----EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 80 (253)
++..+.|+ +.+.||+|+||.||+|.+..++. .+++|.+..... ......+.+|+..+. ..+|+||+++++++
T Consensus 3 ~~~~~~~~--~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~-~l~h~niv~~~~~~ 78 (303)
T cd05110 3 ILKETELK--RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMA-SMDHPHLVRLLGVC 78 (303)
T ss_pred ccchhhce--eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHH-hCCCCCcccEEEEE
Confidence 45566677 99999999999999999877665 468888765432 233346777888777 67999999999998
Q ss_pred EeCCeEEEEEeccCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 81 ETPHEMVLVLEMVPDGELQRLVDIQD-GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 81 ~~~~~~~lv~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
..+ ..+++++++++++|.+++.... .++...+..++.|++.++.|||+++++|+||+|+||+++.++.++|+|||.+.
T Consensus 79 ~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 79 LSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred cCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccc
Confidence 754 4678999999999999887643 58899999999999999999999999999999999999999999999999997
Q ss_pred ccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccC
Q psy12709 160 VVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFG 235 (253)
Q Consensus 160 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 235 (253)
....... ......+..|+|||.+.+..++.++|+||+|+++|++++ |+.||.+.........+......+. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 234 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ---PP 234 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC---CC
Confidence 6543211 112234568999999988889999999999999999997 9999987766555544443332222 23
Q ss_pred CCCHHHHHHHHHhcccCC
Q psy12709 236 HISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 236 ~~~~~l~~li~~~l~~dP 253 (253)
..+.++.+++.+||..||
T Consensus 235 ~~~~~~~~li~~c~~~~p 252 (303)
T cd05110 235 ICTIDVYMVMVKCWMIDA 252 (303)
T ss_pred CCCHHHHHHHHHHcCCCh
Confidence 578899999999999987
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=249.39 Aligned_cols=232 Identities=26% Similarity=0.393 Sum_probs=191.7
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEecc
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMV 93 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 93 (253)
..+.||.|++|+||+|.+..++..|++|.+..... .......+.+|+..++ ..+|+|++++++++..++..++++||+
T Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~ 103 (313)
T cd06633 25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ-QLKHPNTIEYKGCYLKEHTAWLVMEYC 103 (313)
T ss_pred cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHH-hCCCCCCccEEEEEEeCCEEEEEEecC
Confidence 67889999999999999999999999999875432 3344567888888887 668999999999999999999999999
Q ss_pred CCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccccccccc
Q psy12709 94 PDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIG 172 (253)
Q Consensus 94 ~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 172 (253)
.+ ++.+++.. ..++++..+..++.|++.++.|||++|++|+||+|+||+++.++.++|+|||.+..... .....+
T Consensus 104 ~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~~~~ 179 (313)
T cd06633 104 LG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFVG 179 (313)
T ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CCCccc
Confidence 65 66665544 45689999999999999999999999999999999999999999999999998864322 223456
Q ss_pred CccccCccccC---CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 173 TPDYVAPEVLS---YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 173 ~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
+..|+|||.+. ...++.++|+||+|+++|+|++|..||...+.......+..... +......++..+++++.+||
T Consensus 180 ~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l 257 (313)
T cd06633 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEWTDSFRGFVDYCL 257 (313)
T ss_pred cccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCccccCHHHHHHHHHHc
Confidence 78999999974 35678899999999999999999999988766555555444332 22223467889999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
+++|
T Consensus 258 ~~~P 261 (313)
T cd06633 258 QKIP 261 (313)
T ss_pred cCCh
Confidence 9997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=257.86 Aligned_cols=240 Identities=25% Similarity=0.420 Sum_probs=196.3
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe-
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE- 85 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~- 85 (253)
+.++|+ +.+.||+|++|.||+|.+..++..|++|.+............+.+|+..++ ..+|+|++++.+++...+.
T Consensus 13 ~~~~y~--~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 13 VPDRYQ--NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLK-HMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred ccCceE--EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHH-hccCCCHHHHHHHhhccccc
Confidence 566776 999999999999999999999999999998765444444567778998887 6799999999988876554
Q ss_pred -----EEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 86 -----MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 86 -----~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
.++++|++ +++|.+++.. ..+++..+..++.|++.++.+||++|++|+||+|+||++++++.++|+|||.+..
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999998 6699988874 4689999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc---------
Q psy12709 161 VNDVVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH--------- 230 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--------- 230 (253)
.... .....++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||.+......+..+......++
T Consensus 168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 168 TDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred cccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 5432 223356778999998755 3678899999999999999999999988776665555433221111
Q ss_pred ------------------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 ------------------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 ------------------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
......+++.+.++|.+||++||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P 286 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDP 286 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCCh
Confidence 01123568999999999999998
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=250.50 Aligned_cols=239 Identities=29% Similarity=0.391 Sum_probs=197.2
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|+..+.||+|++|.||+|....++..|++|.+............+.+|+..++ ..+|++++++++++...+.+++++|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLK-ELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHH-hcCCCCHHHHHhhhhcCCceEEEecC
Confidence 34889999999999999999999999999999876544444567778888887 66899999999999999999999999
Q ss_pred cCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-ccccc
Q psy12709 93 VPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVKEI 170 (253)
Q Consensus 93 ~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~ 170 (253)
++ ++|.+++... ..+++..+..++.+++.++.+||++|++|+||+|+||++++++.++|+|||.+....... .....
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence 97 4899988765 579999999999999999999999999999999999999999999999999987654332 22233
Q ss_pred ccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc--------------------
Q psy12709 171 IGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF-------------------- 229 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-------------------- 229 (253)
..+..|+|||.+.+. .++.++|+||+|++++++++|..||......+....+......+
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK 238 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence 456789999998766 78899999999999999999999998877665554443211100
Q ss_pred -----cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 -----HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 -----~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.....+.++..+.++|.+||+.||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P 267 (282)
T cd07829 239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNP 267 (282)
T ss_pred cCccchHHhcccccHHHHHHHHHhhccCc
Confidence 011223568899999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=264.40 Aligned_cols=226 Identities=32% Similarity=0.497 Sum_probs=196.7
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++...+|.|+|+.|..+.+..++..+++|++.+... +..+|+..+....+|+||+++.+++.++...|+|||.
T Consensus 324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred hccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 3388889999999999999999999999999987622 3345777777799999999999999999999999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE-cCCCceEEEeecccccccccccccccc
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILL-TKDNNIKLCDFGISRVVNDVVEVKEII 171 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~-~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (253)
+.|+.+.+.+.....+. .++..++.+|+.|+.|||.+|++|||++|+||++ +..|+++|+|||.++..+.. ....+
T Consensus 398 l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~ 474 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPA 474 (612)
T ss_pred ccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccc
Confidence 99998888877665555 7888899999999999999999999999999999 58899999999999876554 44557
Q ss_pred cCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhcccccccCCccCCCCHHHHHHHHHhcc
Q psy12709 172 GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ-ETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLV 250 (253)
Q Consensus 172 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (253)
.+..|.|||+.....++.++|+||||++||+|++|+.||.+.... +....+..+... ..+|.++++||.+||+
T Consensus 475 ~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~AKdLl~~LL~ 548 (612)
T KOG0603|consen 475 LTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDEAKDLLQQLLQ 548 (612)
T ss_pred hhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHHHHHHHHHhcc
Confidence 788999999999999999999999999999999999999886665 555555444433 4899999999999999
Q ss_pred cCC
Q psy12709 251 TDP 253 (253)
Q Consensus 251 ~dP 253 (253)
.||
T Consensus 549 ~dP 551 (612)
T KOG0603|consen 549 VDP 551 (612)
T ss_pred CCh
Confidence 998
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=247.84 Aligned_cols=231 Identities=20% Similarity=0.326 Sum_probs=189.4
Q ss_pred ecCCCCceEEEEEEeccCC------ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 18 MPSRGKFASVRKCTHKITK------VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 18 ~lg~g~~~~v~~~~~~~~~------~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
.||+|++|.||+|.+.... ..+++|.+..... ......+.+|+..+. ..+|+||+++++++...+..++++|
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMS-NFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHH-hcCCCCeeeEeeeecCCCCeEEEEe
Confidence 6899999999999986443 6799998865432 233567778888887 7799999999999999999999999
Q ss_pred ccCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-----ceEEEeecccc
Q psy12709 92 MVPDGELQRLVDIQ-------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN-----NIKLCDFGISR 159 (253)
Q Consensus 92 ~~~g~~L~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~-----~~~l~df~~~~ 159 (253)
++++++|.+++... ..++...+..++.+++.++.|||+.+++|+||+|+||++++++ .++++|||.+.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99999999988642 3378899999999999999999999999999999999999887 89999999987
Q ss_pred ccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccC
Q psy12709 160 VVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFG 235 (253)
Q Consensus 160 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 235 (253)
....... ......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+...... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 236 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL---QKPE 236 (269)
T ss_pred ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc---CCcc
Confidence 5432211 112234578999999988889999999999999999998 99999887777766655443322 1224
Q ss_pred CCCHHHHHHHHHhcccCC
Q psy12709 236 HISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 236 ~~~~~l~~li~~~l~~dP 253 (253)
.+|+.+.++|.+||+++|
T Consensus 237 ~~~~~~~~li~~~l~~~p 254 (269)
T cd05044 237 NCPDKIYQLMTNCWAQDP 254 (269)
T ss_pred cchHHHHHHHHHHcCCCc
Confidence 678999999999999998
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=248.30 Aligned_cols=239 Identities=28% Similarity=0.399 Sum_probs=192.0
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++.+.||.|++|+||+|....+++.|++|.+........ .....+|+..+.+...|+|++++++++..++..+++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 4589999999999999999998899999999876543322 234456788887554499999999999999999999999
Q ss_pred cCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccccccc
Q psy12709 93 VPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI 170 (253)
Q Consensus 93 ~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (253)
+ +++|.+.+.... .++...+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+............
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence 9 778888776654 6899999999999999999999999999999999999999999999999999866544333344
Q ss_pred ccCccccCccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc-------------------
Q psy12709 171 IGTPDYVAPEVLS-YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH------------------- 230 (253)
Q Consensus 171 ~~~~~~~~PE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~------------------- 230 (253)
.++..|+|||.+. +..++.++|+||+|++++++++|+.||+..+..+....+......+.
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence 5678899999874 34578899999999999999999999987766555443322111110
Q ss_pred -------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 -------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 -------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+..+.++.++|.+||+.||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 268 (283)
T cd07830 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDP 268 (283)
T ss_pred ccccccHHHHcccCCHHHHHHHHHhcccCc
Confidence 11122347889999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=264.78 Aligned_cols=232 Identities=22% Similarity=0.412 Sum_probs=204.6
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccc--cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC--eEEEEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR--RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH--EMVLVL 90 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~ 90 (253)
+...||+|+|-+||+|.|..+|..||...++... ......+++.+|+..+. .++|+||++++++|.+.. .+.+|+
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLK-sL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLK-SLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHc-cCCCCceeeeeeheecCCCceeeeee
Confidence 5579999999999999999999999987776554 44555689999999998 899999999999998866 599999
Q ss_pred eccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEcC-CCceEEEeecccccccccccc
Q psy12709 91 EMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHN--ITHLDLKPQNILLTK-DNNIKLCDFGISRVVNDVVEV 167 (253)
Q Consensus 91 e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~di~~~ni~~~~-~~~~~l~df~~~~~~~~~~~~ 167 (253)
|.+.+|+|+.++.+...++...++.|++||+++|.|||++. |+||||+-+||||+- -|.|||+|+|++...+.....
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ak 202 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAK 202 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccc
Confidence 99999999999999999999999999999999999999996 999999999999986 499999999999987766554
Q ss_pred cccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhcccccccCCccCCCCHHHHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAG-DNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~ 246 (253)
. ..|||.|||||+.. ..|....||||+|+++.||.|+.-||.. .+....|.++..+..+-... .--.++++++|.
T Consensus 203 s-vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~--kV~dPevr~fIe 278 (632)
T KOG0584|consen 203 S-VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS--KVKDPEVREFIE 278 (632)
T ss_pred e-eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh--ccCCHHHHHHHH
Confidence 4 78999999999986 7789999999999999999999999965 67778888888877654443 344899999999
Q ss_pred Hhccc
Q psy12709 247 SCLVT 251 (253)
Q Consensus 247 ~~l~~ 251 (253)
+||..
T Consensus 279 kCl~~ 283 (632)
T KOG0584|consen 279 KCLAT 283 (632)
T ss_pred HHhcC
Confidence 99975
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=253.79 Aligned_cols=204 Identities=17% Similarity=0.266 Sum_probs=168.3
Q ss_pred EeecCCC--CceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEecc
Q psy12709 16 FCMPSRG--KFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMV 93 (253)
Q Consensus 16 ~~~lg~g--~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 93 (253)
...||+| ++++||.|.+..+++.|++|++..........+.+.+|+..+. ..+|+||+++++++..++..++++|++
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~-~l~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSH-FFRHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHH-hCCCCCcceEeeeEecCCceEEEEecc
Confidence 3567777 8999999999999999999999876655555677788887766 789999999999999999999999999
Q ss_pred CCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc-----
Q psy12709 94 PDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE----- 166 (253)
Q Consensus 94 ~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~----- 166 (253)
.++++.+++... ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.+++.||+.+........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 999999988763 3589999999999999999999999999999999999999999999999975432211100
Q ss_pred ---ccccccCccccCccccCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy12709 167 ---VKEIIGTPDYVAPEVLSYE--PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFL 220 (253)
Q Consensus 167 ---~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 220 (253)
.....+...|+|||++.+. .++.++|+||+|+++|++++|+.||..........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~ 220 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL 220 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH
Confidence 0011234579999998764 46889999999999999999999998766544443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=254.90 Aligned_cols=241 Identities=29% Similarity=0.482 Sum_probs=188.4
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC---
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP--- 83 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--- 83 (253)
+.++|+ +.+.||+|++|.||+|.+..++..|++|.+..... ........+|+..+. ..+|+||+++++++...
T Consensus 3 ~~~~y~--i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~ 78 (336)
T cd07849 3 VGPRYQ--NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILR-RFKHENIIGILDIIRPPSFE 78 (336)
T ss_pred cccceE--EEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHH-hCCCCCcCchhheeeccccc
Confidence 456666 99999999999999999999999999999864322 233456778888887 66799999999887644
Q ss_pred --CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 84 --HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 84 --~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
...++++|++.+ ++...+. ...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~~~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 79 SFNDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred ccceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 358999999965 7777765 456899999999999999999999999999999999999999999999999998754
Q ss_pred ccccc----ccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccc---------
Q psy12709 162 NDVVE----VKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNF--------- 227 (253)
Q Consensus 162 ~~~~~----~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~--------- 227 (253)
..... .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+.+.......+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 33211 122356788999998654 5678899999999999999999999977554433322211000
Q ss_pred ---------------ccc---CCccCCCCHHHHHHHHHhcccCC
Q psy12709 228 ---------------SFH---EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 228 ---------------~~~---~~~~~~~~~~l~~li~~~l~~dP 253 (253)
... ....+.+++++.++|.+||+.||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 280 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNP 280 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCCh
Confidence 000 11234678899999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=253.81 Aligned_cols=243 Identities=28% Similarity=0.386 Sum_probs=193.4
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHH------------HHHHHHHHHHHHHhcCCCCcee
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ------------MQDILHEAAVLYLAQKSERIVG 75 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~------------~~~~~~e~~~~~~~~~~~~i~~ 75 (253)
.++|. .+.+.||.|++|+||+|.+..++..|++|.+......... ...+.+|+..+. ..+|+||++
T Consensus 7 ~~ry~-~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~ 84 (335)
T PTZ00024 7 SERYI-QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN-EIKHENIMG 84 (335)
T ss_pred ccchh-hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHH-hCCCcceee
Confidence 44554 1456799999999999999999999999998764322210 124677888887 779999999
Q ss_pred eeeEEEeCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEee
Q psy12709 76 LHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDF 155 (253)
Q Consensus 76 ~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df 155 (253)
+++++..++..+++||++. ++|.+++.....+++..+..++.|++.++.+||+.|++|+||+|.||+++.++.++|+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999999996 589888877777999999999999999999999999999999999999999999999999
Q ss_pred cccccccc---------------cccccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy12709 156 GISRVVND---------------VVEVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETF 219 (253)
Q Consensus 156 ~~~~~~~~---------------~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 219 (253)
|.+..... ........+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||.+.+..+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 98875541 0111122356789999998664 4688999999999999999999999888776655
Q ss_pred HHhhccccccc------------------------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 220 LNISQCNFSFH------------------------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 220 ~~i~~~~~~~~------------------------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+......+. ....+..+.++.++|.+||+.||
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 301 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNP 301 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCc
Confidence 54433111111 01123568889999999999998
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=245.66 Aligned_cols=237 Identities=20% Similarity=0.318 Sum_probs=192.0
Q ss_pred eEEEeecCCCCceEEEEEEecc---CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC-----
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKI---TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH----- 84 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----- 84 (253)
|.+.+.||+|++|+||+|.... ++..|++|.+...........++.+|+..+. ..+|+||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMK-EFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHh-cCCCCCcceEEEEEccCCCCCcc
Confidence 3488999999999999998653 4688999999876655556677888998887 778999999999886532
Q ss_pred -eEEEEEeccCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecc
Q psy12709 85 -EMVLVLEMVPDGELQRLVDIQ------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI 157 (253)
Q Consensus 85 -~~~lv~e~~~g~~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~ 157 (253)
..+++++|+.+++|..++... ..++...+..++.|++.+++|||++|++|+||+|+||+++.++.++++|||.
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 347889999999998776421 2478899999999999999999999999999999999999999999999999
Q ss_pred ccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCc
Q psy12709 158 SRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDL 233 (253)
Q Consensus 158 ~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 233 (253)
+........ .......+.|++||...+..++.++|+||+|+++|++++ |+.||...+..+.+..+....... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~ 236 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK---Q 236 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC---C
Confidence 875532211 112234568999999988888999999999999999999 899998877776666555443221 1
Q ss_pred cCCCCHHHHHHHHHhcccCC
Q psy12709 234 FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP 253 (253)
....++.+.+++.+||+.+|
T Consensus 237 ~~~~~~~~~~l~~~~l~~~p 256 (273)
T cd05074 237 PPDCLEDVYELMCQCWSPEP 256 (273)
T ss_pred CCCCCHHHHHHHHHHcCCCh
Confidence 23678999999999999988
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=243.02 Aligned_cols=234 Identities=29% Similarity=0.460 Sum_probs=187.9
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
....||+|+||.||+|.+..++..|++|.+.... ....+.+.+|+..+. ..+|+||+++++++..++.+++++||++
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHS-YLKHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHH-hcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence 4468999999999999999899999999887543 234567888988887 7799999999999999999999999999
Q ss_pred CCcHHHHHhhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-CCceEEEeeccccccccc-ccccc
Q psy12709 95 DGELQRLVDIQ-DGI--PEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK-DNNIKLCDFGISRVVNDV-VEVKE 169 (253)
Q Consensus 95 g~~L~~~~~~~-~~~--~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~-~~~~~l~df~~~~~~~~~-~~~~~ 169 (253)
+++|.+++... ..+ +...+..++.|++.++.+||++|++|+||+|.||+++. ++.++|+|||.+...... .....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 168 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET 168 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcccc
Confidence 99999988754 445 88889999999999999999999999999999999986 679999999988754322 22223
Q ss_pred cccCccccCccccCCCC--CCccccHHHHHHHHHHHHhCCCCCCCCChHHH-HHHhhcccccccCCccCCCCHHHHHHHH
Q psy12709 170 IIGTPDYVAPEVLSYEP--ISLATDMWSVGVLAYVLLSSHSPFAGDNKQET-FLNISQCNFSFHEDLFGHISSQAKDFIQ 246 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~l~~li~ 246 (253)
..+++.|+|||.+.... ++.++|+||+|+++|++++|+.||........ ...... ..........+++++++++.
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~ 246 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM--FKIHPEIPESLSAEAKNFIL 246 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh--hccCCCCCcccCHHHHHHHH
Confidence 45678999999986543 78899999999999999999999976433211 111111 11111223468899999999
Q ss_pred HhcccCC
Q psy12709 247 SCLVTDP 253 (253)
Q Consensus 247 ~~l~~dP 253 (253)
+||+.+|
T Consensus 247 ~~l~~~p 253 (268)
T cd06624 247 RCFEPDP 253 (268)
T ss_pred HHcCCCc
Confidence 9999987
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=243.15 Aligned_cols=232 Identities=19% Similarity=0.335 Sum_probs=184.1
Q ss_pred eecCCCCceEEEEEEecc---CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEE-eCCeEEEEEec
Q psy12709 17 CMPSRGKFASVRKCTHKI---TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE-TPHEMVLVLEM 92 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~e~ 92 (253)
+.||+|+||+||+|.+.. .+..+++|.+.... .......+.+|+..+. ..+|+||+++++++. .++..++++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMK-DFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHc-cCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998653 34679999876432 2334567778888777 679999999999765 45578899999
Q ss_pred cCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-----c
Q psy12709 93 VPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-----E 166 (253)
Q Consensus 93 ~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-----~ 166 (253)
+.+++|.+++... ...+...+..++.+++.|+.|||+.+++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9999999998754 346778888999999999999999999999999999999999999999999987543211 1
Q ss_pred ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 167 VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
.....++..|+|||...+..++.++||||+|+++|+|++ |.+||...+..+....+......... ..+++.+.+++
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li 235 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQP---EYCPDPLYEVM 235 (262)
T ss_pred cccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC---CcCCHHHHHHH
Confidence 112234568999999988889999999999999999999 56778776666655555443322211 35689999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
.+||+.+|
T Consensus 236 ~~cl~~~p 243 (262)
T cd05058 236 LSCWHPKP 243 (262)
T ss_pred HHHcCCCh
Confidence 99999988
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=244.80 Aligned_cols=237 Identities=22% Similarity=0.378 Sum_probs=185.3
Q ss_pred ceeeEEEeecCCCCceEEEEEE----eccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe--C
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCT----HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET--P 83 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~ 83 (253)
.|+ +++.||+|+||+||.|. +..++..|++|.+.... ......+.+|+..+. ..+|+||+++.+++.. .
T Consensus 5 ~~~--~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 5 HLK--FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILK-SLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cce--eeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHH-hCCCCCeeEEEEEEccCCC
Confidence 455 99999999999999997 34578899999987543 344567888999888 6799999999998654 3
Q ss_pred CeEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN 162 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~ 162 (253)
..+++++||+++++|.+++... ..++...+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 4689999999999999998654 458999999999999999999999999999999999999999999999999988654
Q ss_pred ccccc----cccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---------------HHHHhh
Q psy12709 163 DVVEV----KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQE---------------TFLNIS 223 (253)
Q Consensus 163 ~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------------~~~~i~ 223 (253)
..... ........|+|||...+..++.++|+||+|+++++|++|..|+....... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 32211 11122346999999988889999999999999999999877654322110 001111
Q ss_pred cccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 224 QCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 224 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.....+ .....++.++.++|.+||++||
T Consensus 240 ~~~~~~--~~~~~~~~~~~~li~~cl~~~p 267 (284)
T cd05081 240 KNNGRL--PAPPGCPAEIYAIMKECWNNDP 267 (284)
T ss_pred hcCCcC--CCCCCCCHHHHHHHHHHccCCh
Confidence 111111 1224678999999999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=247.46 Aligned_cols=236 Identities=16% Similarity=0.140 Sum_probs=175.2
Q ss_pred eeeEEEeecCCCCceEEEEEEeccC---CceEEEEEecccccchHHHH---------HHHHHHHHHHHhcCCCCceeeee
Q psy12709 11 YQTLIFCMPSRGKFASVRKCTHKIT---KVEYAAKFIRKRRRSMDQMQ---------DILHEAAVLYLAQKSERIVGLHE 78 (253)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~---------~~~~e~~~~~~~~~~~~i~~~~~ 78 (253)
.+|++.+.||+|+||+||+|.+..+ +..+++|+............ ....+...+. ...|++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~-~~~h~~i~~~~~ 90 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH-NIDHLGIPKYYG 90 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhc-cCCCCCCCcEEE
Confidence 3444999999999999999998877 66777776543332211100 1111122222 567999999998
Q ss_pred EEEeCC----eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEe
Q psy12709 79 IYETPH----EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCD 154 (253)
Q Consensus 79 ~~~~~~----~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~d 154 (253)
...... ..+++++.+ ..++.+.+......++..++.++.|++.++.|||+++++||||+|+||+++.++.++|+|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 765543 346778876 446777766555578889999999999999999999999999999999999999999999
Q ss_pred ecccccccccc--------cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--------
Q psy12709 155 FGISRVVNDVV--------EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQET-------- 218 (253)
Q Consensus 155 f~~~~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------- 218 (253)
||++....... ......+++.|+|||+..+..++.++||||+|+++++|++|+.||.+......
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~ 249 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCD 249 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHH
Confidence 99987553211 11223588999999999999999999999999999999999999987633221
Q ss_pred -HHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 219 -FLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 219 -~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
...+..... ..+..++++.++++.|++.+|
T Consensus 250 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 280 (294)
T PHA02882 250 FIKRLHEGKI-----KIKNANKFIYDFIECVTKLSY 280 (294)
T ss_pred HHHHhhhhhh-----ccCCCCHHHHHHHHHHHhCCC
Confidence 122222211 224668999999999999887
|
|
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=264.54 Aligned_cols=232 Identities=26% Similarity=0.397 Sum_probs=205.6
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEeccc-ccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEecc
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKR-RRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMV 93 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 93 (253)
-++.||.|+||-||.|.+..+...||||++... ..+.+.++++..|+..++ ...|||++.+.+.|..+.+.|+|||||
T Consensus 30 dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~-~l~HPntieYkgCyLre~TaWLVMEYC 108 (948)
T KOG0577|consen 30 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLR-QLRHPNTIEYKGCYLREHTAWLVMEYC 108 (948)
T ss_pred HHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHH-hccCCCcccccceeeccchHHHHHHHH
Confidence 677899999999999999999999999998754 355677899999999998 889999999999999999999999999
Q ss_pred CCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccccccccc
Q psy12709 94 PDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIG 172 (253)
Q Consensus 94 ~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 172 (253)
-| +-.+++.- ..++.+.++..+..+.+.++.|||+.+.+|+||++.||++++.|.|||.|||.+...... ....|
T Consensus 109 lG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---nsFvG 184 (948)
T KOG0577|consen 109 LG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---NSFVG 184 (948)
T ss_pred hc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch---hcccC
Confidence 55 77777765 467999999999999999999999999999999999999999999999999998765433 45689
Q ss_pred CccccCccccC---CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 173 TPDYVAPEVLS---YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 173 ~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
+|.|||||++. .+.|+-+.||||||++..++...++|+-+.+....+..|..+..+..+. +.-|+.++.|+..||
T Consensus 185 TPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs--~eWS~~F~~Fvd~CL 262 (948)
T KOG0577|consen 185 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS--NEWSDYFRNFVDSCL 262 (948)
T ss_pred CccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC--chhHHHHHHHHHHHH
Confidence 99999999974 4568999999999999999999999998888888888888876655553 467899999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
++=|
T Consensus 263 qKip 266 (948)
T KOG0577|consen 263 QKIP 266 (948)
T ss_pred hhCc
Confidence 9765
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=265.83 Aligned_cols=207 Identities=29% Similarity=0.425 Sum_probs=183.3
Q ss_pred cceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 4 KFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
.+..+.+|.+..-+.||+|+||.||++.++++|+.||+|.+.... .........+|+.+++ .++|+|||+++++-+..
T Consensus 6 ~l~~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~Eieilk-KLnh~NIVk~f~iee~~ 83 (732)
T KOG4250|consen 6 VLTSGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILK-KLNHPNIVKLFDIEETK 83 (732)
T ss_pred ccccCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHH-HcCchhhhhhcccCCcc
Confidence 344566788889999999999999999999999999999998765 3344568889999999 45599999999998765
Q ss_pred C------eEEEEEeccCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC--C--ce
Q psy12709 84 H------EMVLVLEMVPDGELQRLVDIQ---DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD--N--NI 150 (253)
Q Consensus 84 ~------~~~lv~e~~~g~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~--~--~~ 150 (253)
. ...++||||.||+|+..++.. .++++.+++.++.++..|+.+||++||+||||||.||++... | ..
T Consensus 84 ~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~Iy 163 (732)
T KOG4250|consen 84 FLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIY 163 (732)
T ss_pred ccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEE
Confidence 4 578999999999999999864 369999999999999999999999999999999999998754 3 48
Q ss_pred EEEeecccccccccccccccccCccccCccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCC
Q psy12709 151 KLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLS-YEPISLATDMWSVGVLAYVLLSSHSPFAG 212 (253)
Q Consensus 151 ~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 212 (253)
||+|||+++...+........||+.|.+||... .+.++...|.||+|+++|++.||..||..
T Consensus 164 KLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 164 KLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred eeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 999999999998888888889999999999987 47889999999999999999999999954
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=243.46 Aligned_cols=224 Identities=21% Similarity=0.313 Sum_probs=180.6
Q ss_pred eecCCCCceEEEEEEeccCC----------ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 17 CMPSRGKFASVRKCTHKITK----------VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~----------~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+..+. ..+|+||+++++++.. +..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~-~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMS-QLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHH-cCCCcchhheeeEEec-CCc
Confidence 46899999999999998766 34777776544322 467778888887 6789999999999888 778
Q ss_pred EEEEeccCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-------ceEEEeeccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQD-GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN-------NIKLCDFGIS 158 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~-------~~~l~df~~~ 158 (253)
++++||+++++|.+++.... .++...+..++.|++.++.|||++|++|+||+|+||+++.++ .++++|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999987655 689999999999999999999999999999999999999887 7999999998
Q ss_pred ccccccccccccccCccccCccccCCC--CCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccC
Q psy12709 159 RVVNDVVEVKEIIGTPDYVAPEVLSYE--PISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFG 235 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 235 (253)
..... .....+...|+|||.+.+. .++.++|+||+|+++|++++ |..||...+............ ..+.
T Consensus 156 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~-~~~~---- 227 (259)
T cd05037 156 ITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH-RLPM---- 227 (259)
T ss_pred ccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC-CCCC----
Confidence 76433 1223456789999998776 78899999999999999999 688887765444333332211 1111
Q ss_pred CCCHHHHHHHHHhcccCC
Q psy12709 236 HISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 236 ~~~~~l~~li~~~l~~dP 253 (253)
..+..+.++|.+||..||
T Consensus 228 ~~~~~~~~li~~~l~~~p 245 (259)
T cd05037 228 PDCAELANLINQCWTYDP 245 (259)
T ss_pred CCchHHHHHHHHHhccCh
Confidence 224889999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=250.95 Aligned_cols=242 Identities=24% Similarity=0.356 Sum_probs=188.2
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC----
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP---- 83 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~---- 83 (253)
.++|+ +.+.||.|++|.||+|.++.++..+++|.+..............+|+..+. ..+|+||+++++++...
T Consensus 7 ~~~y~--~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDYE--ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILK-KLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccEE--EEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHH-hcCCCCccchhhheecccccc
Confidence 36777 999999999999999999999999999998765433333345667888877 77999999999987543
Q ss_pred ----CeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccc
Q psy12709 84 ----HEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGIS 158 (253)
Q Consensus 84 ----~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~ 158 (253)
..++++++|+.+ ++...+.. ...+++..++.++.|++.++.+||++|++|+|++|+||++++++.++|+|||++
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 357999999965 56555543 456999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccc------------cccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcc
Q psy12709 159 RVVNDVVEV------------KEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQC 225 (253)
Q Consensus 159 ~~~~~~~~~------------~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~ 225 (253)
......... ....+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||.+.+.......+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 754322111 112346789999987554 5788999999999999999999999887766554443221
Q ss_pred ccccc--------------------------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 226 NFSFH--------------------------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 226 ~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
...+. ......+++++.++|.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 296 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDP 296 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCc
Confidence 11100 01123456789999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=245.79 Aligned_cols=226 Identities=23% Similarity=0.316 Sum_probs=180.1
Q ss_pred eecCCCCceEEEEEEeccCCc-------eEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 17 CMPSRGKFASVRKCTHKITKV-------EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~-------~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
+.||.|+||+||+|.+...+. ++++|.+.... ......+.+|...+. ..+|+||+++++++..++..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~-~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMS-QLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHH-hCCCCChhheeeEEEeCCCcEEE
Confidence 469999999999999865443 48888875433 233446667777776 77899999999999999999999
Q ss_pred EeccCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc--------eEEEeeccccc
Q psy12709 90 LEMVPDGELQRLVDIQD-GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN--------IKLCDFGISRV 160 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~--------~~l~df~~~~~ 160 (253)
|||+++++|..++..+. .+++..++.++.|++.+++|||++|++|+||+|+||+++.++. ++++|||.+..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999987643 5899999999999999999999999999999999999988765 69999998865
Q ss_pred ccccccccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhhcccccccCCccCCCC
Q psy12709 161 VNDVVEVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQCNFSFHEDLFGHIS 238 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 238 (253)
.... ....++..|+|||.+.+. .++.++|+||+|+++|++++| ..|+...+...... +.......+ ...+
T Consensus 158 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~ 229 (258)
T cd05078 158 VLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLP----APKW 229 (258)
T ss_pred cCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCC----CCCc
Confidence 4322 223467789999998764 578899999999999999998 57776655554433 222222222 2567
Q ss_pred HHHHHHHHHhcccCC
Q psy12709 239 SQAKDFIQSCLVTDP 253 (253)
Q Consensus 239 ~~l~~li~~~l~~dP 253 (253)
.++.++|.+||+.||
T Consensus 230 ~~~~~li~~~l~~~p 244 (258)
T cd05078 230 TELANLINQCMDYEP 244 (258)
T ss_pred HHHHHHHHHHhccCh
Confidence 889999999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=246.71 Aligned_cols=235 Identities=22% Similarity=0.343 Sum_probs=188.9
Q ss_pred EEEeecCCCCceEEEEEEec----cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe--CCeEE
Q psy12709 14 LIFCMPSRGKFASVRKCTHK----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET--PHEMV 87 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~ 87 (253)
++.+.||+|+||.||+|... .++..+++|.+...... .....+.+|+..+. ...|+||+++++++.. +...+
T Consensus 7 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~-~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILR-TLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHH-hCCCCChheEEeeeecCCCCceE
Confidence 38899999999999999865 34788999999865543 45668888998887 6699999999999887 55899
Q ss_pred EEEeccCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQD-GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE 166 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 166 (253)
+++||+++++|.+++.... .++...+..++.+++.++.+||++|++|+||+|.||+++.++.++|+|||.+........
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD 164 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCc
Confidence 9999999999999987644 589999999999999999999999999999999999999999999999999986542211
Q ss_pred c----cccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---------------HHHHhhcccc
Q psy12709 167 V----KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQE---------------TFLNISQCNF 227 (253)
Q Consensus 167 ~----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------------~~~~i~~~~~ 227 (253)
. ........|+|||...+..++.++|+||+|+++++|++|..|+....... ....+.. ..
T Consensus 165 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 243 (284)
T cd05038 165 YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE-GE 243 (284)
T ss_pred ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc-CC
Confidence 1 11233457999999988889999999999999999999999986532221 1111221 11
Q ss_pred cccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 228 SFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 228 ~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+ ....++.++.+++.+||+.||
T Consensus 244 ~~~--~~~~~~~~~~~li~~cl~~~p 267 (284)
T cd05038 244 RLP--RPPSCPDEVYDLMKLCWEAEP 267 (284)
T ss_pred cCC--CCccCCHHHHHHHHHHhccCh
Confidence 111 123678899999999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=249.13 Aligned_cols=235 Identities=26% Similarity=0.387 Sum_probs=192.5
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
.|+ ..+.||.|++|+||+|.+..++..+++|.+.... .......++.+|+..++ ..+|+|++++.+++..++..++
T Consensus 16 ~~~--~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 16 LFS--DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ-KLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred HHH--HHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHH-hCCCCCcccEEEEEEcCCeeEE
Confidence 445 7889999999999999999999999999987542 23344567788998888 6789999999999999999999
Q ss_pred EEeccCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccc
Q psy12709 89 VLEMVPDGELQRLVD-IQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV 167 (253)
Q Consensus 89 v~e~~~g~~L~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 167 (253)
++||+.| ++.+.+. ...+++...+..++.+++.++.+||+++++|+||+|.||+++.++.++++|||.+......
T Consensus 93 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 93 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 9999965 6766554 3456899999999999999999999999999999999999999999999999988754332
Q ss_pred cccccCccccCccccC---CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLS---YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
....+++.|+|||.+. ...++.++|+||+|+++|+|++|..||...........+.....+.. ....++..++++
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 246 (308)
T cd06634 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYFRNF 246 (308)
T ss_pred ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCc--CcccccHHHHHH
Confidence 2335678999999974 34578899999999999999999999977665555544444333222 223688999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||+++|
T Consensus 247 i~~cl~~~P 255 (308)
T cd06634 247 VDSCLQKIP 255 (308)
T ss_pred HHHHhhCCc
Confidence 999999988
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=252.78 Aligned_cols=238 Identities=25% Similarity=0.387 Sum_probs=189.8
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC---
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH--- 84 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--- 84 (253)
.++|+ +.+.||+|++|.||+|.+..++..|++|.+.+..........+.+|+..+. ..+|+||+++++++....
T Consensus 14 ~~~y~--~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 14 PERYT--SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLK-HMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ccceE--EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHH-hcCCCCccchhheecccccCC
Confidence 45566 999999999999999999989999999998765444444456788898887 679999999999987543
Q ss_pred ---eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 85 ---EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 85 ---~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
.+++++|++.. +|.... ...++...+..++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred CCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 46999999854 676654 345899999999999999999999999999999999999999999999999998754
Q ss_pred cccccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc-----------
Q psy12709 162 NDVVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF----------- 229 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----------- 229 (253)
... .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+.+....+..+......+
T Consensus 168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 168 DAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred CCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence 322 223356778999999865 457889999999999999999999998876554444333211100
Q ss_pred -------------c---CCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 -------------H---EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 -------------~---~~~~~~~~~~l~~li~~~l~~dP 253 (253)
. ....+..++++.++|.+||+.||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 285 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDV 285 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCCh
Confidence 0 01123578889999999999998
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=241.28 Aligned_cols=234 Identities=19% Similarity=0.271 Sum_probs=181.6
Q ss_pred eecCCCCceEEEEEEecc--CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 17 CMPSRGKFASVRKCTHKI--TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
+.||+|+||+||+|.... ....+++|.+..... ......+.+|+..+. ..+|+||+++++.+...+..+++|||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~-~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT-PDEQLLFLQEVQPYR-ELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCC-hHHHHHHHHHHHHHH-hCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999996542 345688887764432 333456777888777 6799999999999999999999999999
Q ss_pred CCcHHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc---c
Q psy12709 95 DGELQRLVDIQDG-----IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV---E 166 (253)
Q Consensus 95 g~~L~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~---~ 166 (253)
+++|.+++..... .++..+..++.|++.++.|||++|++|+||+|.||+++.++.++|+|||.+....... .
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999999876432 4577888999999999999999999999999999999999999999999886432211 1
Q ss_pred ccccccCccccCccccCC-------CCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhccc-cccc-CCccCC
Q psy12709 167 VKEIIGTPDYVAPEVLSY-------EPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCN-FSFH-EDLFGH 236 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~-~~~~-~~~~~~ 236 (253)
.....++..|+|||+... ..++.++|+||+|+++|+|++ |..||......+....+.... ...+ ......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 122334567999998643 356789999999999999999 889998877666555543332 2222 223347
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
+++.+.+++..|+ .||
T Consensus 239 ~~~~~~~~~~~~~-~dp 254 (269)
T cd05042 239 YSDRWYEVMQFCW-LDP 254 (269)
T ss_pred CCHHHHHHHHHHh-cCc
Confidence 8899999999998 476
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=251.65 Aligned_cols=239 Identities=25% Similarity=0.380 Sum_probs=188.7
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC----
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP---- 83 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~---- 83 (253)
.++|+ +.+.||.|++|.||+|.+..++..|++|.+..... .....+.+|+..+. ..+|+||+++++.+...
T Consensus 4 ~~~y~--~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~-~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 4 GSRYM--DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIR-RLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CcceE--EEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHH-hcCCCcchhhHhhhccccccc
Confidence 46666 99999999999999999999999999999876543 33467888999887 67999999999876543
Q ss_pred ----------CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-CCceEE
Q psy12709 84 ----------HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK-DNNIKL 152 (253)
Q Consensus 84 ----------~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~-~~~~~l 152 (253)
...++++||++ ++|.+++. ...+++..++.++.|++.|+.+||+.|++|+||+|+||+++. ++.+++
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEE
Confidence 35789999996 48888776 345899999999999999999999999999999999999985 557899
Q ss_pred Eeeccccccccccc----ccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccc
Q psy12709 153 CDFGISRVVNDVVE----VKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNF 227 (253)
Q Consensus 153 ~df~~~~~~~~~~~----~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~ 227 (253)
+|||.+........ .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+..+....+.....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999876532211 112345778999998644 5678899999999999999999999987665554443322110
Q ss_pred c--------------------------ccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 228 S--------------------------FHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 228 ~--------------------------~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
. +.....+.++.++.++|.+||+.||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 288 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNP 288 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCc
Confidence 0 0011224678999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=240.05 Aligned_cols=226 Identities=23% Similarity=0.318 Sum_probs=178.1
Q ss_pred eecCCCCceEEEEEEecc------------CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 17 CMPSRGKFASVRKCTHKI------------TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~------------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
+.||+|+||+||+|.... ....+++|.+..... +....+.+|+..+. ..+||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~l~-~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR--DISLAFFETASMMR-QVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh--hHHHHHHHHHHHHH-hCCCCCEeeEEEEEecCC
Confidence 468999999999998542 223588888765432 33446667777666 789999999999999988
Q ss_pred eEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc-------eEEEeec
Q psy12709 85 EMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN-------IKLCDFG 156 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~-------~~l~df~ 156 (253)
..++++||+++++|..++.. ...+++..++.++.|++.|+.|||+++++|+||+|+||+++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999888865 356899999999999999999999999999999999999987764 8999999
Q ss_pred ccccccccccccccccCccccCccccC-CCCCCccccHHHHHHHHHHHH-hCCCCCCCCChHHHHHHhhcccccccCCcc
Q psy12709 157 ISRVVNDVVEVKEIIGTPDYVAPEVLS-YEPISLATDMWSVGVLAYVLL-SSHSPFAGDNKQETFLNISQCNFSFHEDLF 234 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 234 (253)
.+...... ....++..|+|||.+. +..++.++||||+|+++|+|+ .|..||......+... +...... ..
T Consensus 158 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~----~~ 229 (262)
T cd05077 158 IPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCM----LV 229 (262)
T ss_pred CCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCcc----CC
Confidence 88654322 2234667899999886 466888999999999999997 5889987765443322 2222211 12
Q ss_pred CCCCHHHHHHHHHhcccCC
Q psy12709 235 GHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP 253 (253)
...++++.++|.+||+.||
T Consensus 230 ~~~~~~~~~li~~cl~~dp 248 (262)
T cd05077 230 TPSCKELADLMTHCMNYDP 248 (262)
T ss_pred CCChHHHHHHHHHHcCCCh
Confidence 3457889999999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=242.75 Aligned_cols=225 Identities=20% Similarity=0.298 Sum_probs=177.0
Q ss_pred ecCCCCceEEEEEEeccC------------------------CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCc
Q psy12709 18 MPSRGKFASVRKCTHKIT------------------------KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERI 73 (253)
Q Consensus 18 ~lg~g~~~~v~~~~~~~~------------------------~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i 73 (253)
.||+|+||.||+|....+ ...|++|.+..... .....+.+|+..+. ..+|+||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~~~-~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--DIALAFFETASLMS-QVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--HHHHHHHHHHHHHh-cCCCCCe
Confidence 699999999999985321 24588888865432 23345666776665 7899999
Q ss_pred eeeeeEEEeCCeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC----
Q psy12709 74 VGLHEIYETPHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN---- 148 (253)
Q Consensus 74 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~---- 148 (253)
+++++++..++..++||||+++++|..++.. .+.+++..+..++.|++.|+.|||+++++|+||+|+||+++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999998865 45689999999999999999999999999999999999998654
Q ss_pred ---ceEEEeecccccccccccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHH-hCCCCCCCCChHHHHHHhh
Q psy12709 149 ---NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLL-SSHSPFAGDNKQETFLNIS 223 (253)
Q Consensus 149 ---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~i~ 223 (253)
.++++|||.+...... ....++..|+|||.+.+ ..++.++|+||+|+++|+++ +|+.||......+....+.
T Consensus 159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 235 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE 235 (274)
T ss_pred ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHH
Confidence 3799999987543221 12345678999998865 56789999999999999985 6999998766554433222
Q ss_pred cccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 224 QCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 224 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.....+ ...++++.++|.+||+.||
T Consensus 236 -~~~~~~----~~~~~~~~~li~~cl~~~p 260 (274)
T cd05076 236 -KKHRLP----EPSCKELATLISQCLTYEP 260 (274)
T ss_pred -hccCCC----CCCChHHHHHHHHHcccCh
Confidence 222222 2456789999999999988
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=239.83 Aligned_cols=234 Identities=20% Similarity=0.258 Sum_probs=181.1
Q ss_pred eecCCCCceEEEEEEec--cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 17 CMPSRGKFASVRKCTHK--ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
+.||+|+||.||+|... .++..+++|.+...... .....+.+|+..+. ..+|+||+++++.+......+++|||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYR-SLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHH-hCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999865 34567999988765432 23346777888887 7799999999999999889999999999
Q ss_pred CCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc---
Q psy12709 95 DGELQRLVDIQD-----GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE--- 166 (253)
Q Consensus 95 g~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~--- 166 (253)
+++|.+++.... ..+...+..++.|++.++.|||+++++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999999886422 356678888999999999999999999999999999999999999999998864322211
Q ss_pred ccccccCccccCccccCCC-------CCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh-ccccccc-CCccCC
Q psy12709 167 VKEIIGTPDYVAPEVLSYE-------PISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNIS-QCNFSFH-EDLFGH 236 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~-------~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~-~~~~~~~-~~~~~~ 236 (253)
.....++..|+|||++.+. .++.++|+||+|+++|+|++ |+.||......+...... ......+ ......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 1123456789999998542 35789999999999999996 999998766655443322 2222222 122235
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
.++.+.+++++|+ .||
T Consensus 239 ~~~~~~~l~~~c~-~~P 254 (269)
T cd05087 239 LSDRWYEVMQFCW-LQP 254 (269)
T ss_pred CChHHHHHHHHHh-cCc
Confidence 7888999999998 566
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=267.59 Aligned_cols=233 Identities=23% Similarity=0.352 Sum_probs=209.0
Q ss_pred EEeecCCCCceEEEEEEeccCC---ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 15 IFCMPSRGKFASVRKCTHKITK---VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
|.+.||.|.||.|+.|..+..+ ..||||.++.... +.+..++..|+.++. +.+||||+++.++......+.+|+|
T Consensus 633 Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt-ekqrrdFL~EAsIMG-QFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 633 IEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT-EKQRRDFLSEASIMG-QFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred EEEEEecccccceecccccCCCCcceeEEEeeeccCcc-HHHHhhhhhhhhhcc-cCCCCcEEEEEEEEecCceeEEEhh
Confidence 8899999999999999998666 4599999987654 466789999999998 9999999999999999999999999
Q ss_pred ccCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc----
Q psy12709 92 MVPDGELQRLVDIQD-GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE---- 166 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~---- 166 (253)
||+.|+|+.+++.+. .|+..++..+++.|+++++||.++|++|||+.++||+|+.+-.+|+.|||+++...+...
T Consensus 711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~yt 790 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 790 (996)
T ss_pred hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcccc
Confidence 999999999998864 499999999999999999999999999999999999999999999999999997654331
Q ss_pred ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 167 VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
+..-.-..+|+|||.+...+++.++||||+|+++||.++ |+-||=..+++++...|.++-..++.. ++|.-|.+|+
T Consensus 791 t~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm---DCP~aL~qLM 867 (996)
T KOG0196|consen 791 TLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM---DCPAALYQLM 867 (996)
T ss_pred ccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC---CCcHHHHHHH
Confidence 111223579999999999999999999999999999887 999999999999999999987766663 8999999999
Q ss_pred HHhcccC
Q psy12709 246 QSCLVTD 252 (253)
Q Consensus 246 ~~~l~~d 252 (253)
..||++|
T Consensus 868 ldCWqkd 874 (996)
T KOG0196|consen 868 LDCWQKD 874 (996)
T ss_pred HHHHHHH
Confidence 9999986
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=259.66 Aligned_cols=236 Identities=27% Similarity=0.449 Sum_probs=215.7
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEecc
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMV 93 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 93 (253)
.+..||.|+||.|=++..+.....+|+|++++.. ....+.+++..|-+++. .++++.|+++|..|.+...+|++||-|
T Consensus 424 ~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~-~~~s~fIvrLYrTfrd~kyvYmLmEaC 502 (732)
T KOG0614|consen 424 RIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMM-ECRSDFIVRLYRTFRDSKYVYMLMEAC 502 (732)
T ss_pred hhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHH-hcCchHHHHHHHHhccchhhhhhHHhh
Confidence 6778999999999999988777779999998765 55566789999999998 677999999999999999999999999
Q ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccccccC
Q psy12709 94 PDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGT 173 (253)
Q Consensus 94 ~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 173 (253)
-||.+...++.++.|+....+.++..++.|++|||++||++||++|+|.+++.+|.+||.|||+++.......+-..+|+
T Consensus 503 lGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGT 582 (732)
T KOG0614|consen 503 LGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGT 582 (732)
T ss_pred cCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999888888889999
Q ss_pred ccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 174 PDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 174 ~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
|.|.|||++.++..+.+.|.|+||+++||+++|.+||++.++...++.|.++--...- ...+++...+||+++-+.+|
T Consensus 583 pEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~--Pr~I~k~a~~Lik~LCr~~P 660 (732)
T KOG0614|consen 583 PEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEF--PRRITKTATDLIKKLCRDNP 660 (732)
T ss_pred cccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhc--ccccchhHHHHHHHHHhcCc
Confidence 9999999999999999999999999999999999999999999999999886433322 24789999999999877776
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=248.10 Aligned_cols=201 Identities=28% Similarity=0.424 Sum_probs=166.3
Q ss_pred eEEEeecCCCCceEEEEEEecc--CCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--CeEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKI--TKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP--HEMV 87 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~--~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~ 87 (253)
|++.+.||+|++|.||+|.+.. ++..||+|.+.... ..........+|+..+. ..+|+||+++++++... +.++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLR-ELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHH-hcCCCCccceEEEEeCCCCceEE
Confidence 4499999999999999999998 88999999998743 12222356677888887 67999999999999988 7899
Q ss_pred EEEeccCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC----CCceEEEeeccc
Q psy12709 88 LVLEMVPDGELQRLVDIQ-----DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK----DNNIKLCDFGIS 158 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~----~~~~~l~df~~~ 158 (253)
+|+|++++ ++.+++... ..+++..++.++.|++.++.|||+++++|+||+|+||+++. ++.++|+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999965 565555321 25889999999999999999999999999999999999999 899999999998
Q ss_pred cccccccc----ccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q psy12709 159 RVVNDVVE----VKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNK 215 (253)
Q Consensus 159 ~~~~~~~~----~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 215 (253)
........ .....+++.|+|||.+.+. .++.++|+||+|+++++|++|+.||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 76543221 1233567789999987654 578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=246.39 Aligned_cols=191 Identities=28% Similarity=0.474 Sum_probs=155.7
Q ss_pred eecCCCCceEEEEEEecc--CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe--CCeEEEEEec
Q psy12709 17 CMPSRGKFASVRKCTHKI--TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET--PHEMVLVLEM 92 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 92 (253)
..||+|+||+||+|.+.. ++..|++|.+...... ..+.+|+..+. ..+|+||+++++++.. +..+++++||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLR-ELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHH-hCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 589999999999999664 5678999988754322 35667888887 7899999999998854 4578999999
Q ss_pred cCCCcHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE----cCCCceEEEeecccc
Q psy12709 93 VPDGELQRLVDI---------QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILL----TKDNNIKLCDFGISR 159 (253)
Q Consensus 93 ~~g~~L~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~----~~~~~~~l~df~~~~ 159 (253)
+.+ +|.+++.. ...+++..++.++.|++.|+.|||+.|++|+||+|+||++ +.++.++|+|||++.
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 865 67666542 1247889999999999999999999999999999999999 456789999999997
Q ss_pred cccccc----cccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCC
Q psy12709 160 VVNDVV----EVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGD 213 (253)
Q Consensus 160 ~~~~~~----~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 213 (253)
...... ......+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 654322 12234567899999998664 5788999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=221.92 Aligned_cols=237 Identities=28% Similarity=0.430 Sum_probs=202.5
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
-.++||.|.+|+||+|...++.+.||+|.++.....+.......+|+-.+. .++|.||++++++...+..+.+|+|||+
T Consensus 6 kmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllk-elkhknivrl~dvlhsdkkltlvfe~cd 84 (292)
T KOG0662|consen 6 KMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLK-ELKHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_pred HHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHH-HhhhcceeehhhhhccCceeEEeHHHhh
Confidence 568999999999999999999999999999988877777788899999988 8899999999999999999999999995
Q ss_pred CCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-ccccccc
Q psy12709 95 DGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVKEIIG 172 (253)
Q Consensus 95 g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~ 172 (253)
. .|..+... ++.++.+.++.++.|+++++.++|+.++.|+|++|.|.++..+|.+|+.|||+++.++-+- -.+....
T Consensus 85 q-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevv 163 (292)
T KOG0662|consen 85 Q-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV 163 (292)
T ss_pred H-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceee
Confidence 4 78887765 6779999999999999999999999999999999999999999999999999999876543 3445567
Q ss_pred CccccCccccCCCC-CCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCC------------------
Q psy12709 173 TPDYVAPEVLSYEP-ISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHED------------------ 232 (253)
Q Consensus 173 ~~~~~~PE~~~~~~-~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~------------------ 232 (253)
+..|.||.++.+.. |+...|+||.||++.|+.. |.+.|++.+..+.+..|-.--.++.++
T Consensus 164 tlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~yp 243 (292)
T KOG0662|consen 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYP 243 (292)
T ss_pred eeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCcc
Confidence 88999999987764 7889999999999999998 888899988887777665433333221
Q ss_pred -------ccCCCCHHHHHHHHHhcccCC
Q psy12709 233 -------LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 -------~~~~~~~~l~~li~~~l~~dP 253 (253)
+.+.++..-+|++++.|.-||
T Consensus 244 attswsqivp~lns~grdllqkll~cnp 271 (292)
T KOG0662|consen 244 ATTSWSQIVPKLNSTGRDLLQKLLKCNP 271 (292)
T ss_pred ccchHHHHhhhhcchhHHHHHHHhccCc
Confidence 234456667888888887776
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=236.95 Aligned_cols=214 Identities=24% Similarity=0.311 Sum_probs=175.3
Q ss_pred CCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCCcHHHH
Q psy12709 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRL 101 (253)
Q Consensus 22 g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~ 101 (253)
|.+++||++.+..+++.|++|.+...... .+|...+. ...|+||+++++++..++..+++|||++|++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~-------~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEY-------SRERLTII-PHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhh-------hhHHHHHH-hcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 89999999999999999999999764321 12333333 45689999999999999999999999999999999
Q ss_pred HhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccccccCccccCccc
Q psy12709 102 VDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEV 181 (253)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~ 181 (253)
+.....+++..+..++.|++.++.|||++|++|+||+|+||+++.++.++++|||.+....... .....+..|+|||.
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~y~aPE~ 153 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--DGEAVENMYCAPEV 153 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc--ccCCcCccccCCcc
Confidence 8877779999999999999999999999999999999999999999999999999876544321 22344667999999
Q ss_pred cCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 182 LSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 182 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+..++.++|+||+|+++|++++|+.|+....... .. .........+++.++++|.+||+.||
T Consensus 154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----~~---~~~~~~~~~~~~~~~~li~~~l~~dp 217 (237)
T cd05576 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----NT---HTTLNIPEWVSEEARSLLQQLLQFNP 217 (237)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----cc---ccccCCcccCCHHHHHHHHHHccCCH
Confidence 988888999999999999999999998875432210 00 00111223679999999999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=249.19 Aligned_cols=194 Identities=25% Similarity=0.344 Sum_probs=168.9
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC-eEEEEEecc
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH-EMVLVLEMV 93 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~ 93 (253)
-...||+|+||.||+|... ++..||||.+....... ..++.+|+..+. ..+|+|++++++++.+.+ ..++|+||+
T Consensus 79 ~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls-~l~H~Nlv~LlGyC~e~~~~~~LVYEym 154 (361)
T KOG1187|consen 79 ESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG--EREFLNEVEILS-RLRHPNLVKLLGYCLEGGEHRLLVYEYM 154 (361)
T ss_pred hhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc--hhHHHHHHHHHh-cCCCcCcccEEEEEecCCceEEEEEEcc
Confidence 4468999999999999977 44889999777655432 345999999999 666999999999999998 599999999
Q ss_pred CCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCCEEEcCCCceEEEeecccccccc-cccc
Q psy12709 94 PDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHN---ITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVEV 167 (253)
Q Consensus 94 ~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~-~~~~ 167 (253)
+.|+|.+.+.... ++++....+++.++++|++|||+.. ++|+|||+.||++|.+...||+|||++..... ....
T Consensus 155 ~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~ 234 (361)
T KOG1187|consen 155 PNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSV 234 (361)
T ss_pred CCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccce
Confidence 9999999887654 7899999999999999999999864 99999999999999999999999999976544 3333
Q ss_pred ccc-ccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Q psy12709 168 KEI-IGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAG 212 (253)
Q Consensus 168 ~~~-~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 212 (253)
... .++..|++||....+..+.++||||+|+++.|+++|+.|.+.
T Consensus 235 ~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 235 STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQ 280 (361)
T ss_pred eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCC
Confidence 333 789999999999888899999999999999999999988764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=262.92 Aligned_cols=148 Identities=31% Similarity=0.465 Sum_probs=133.5
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
++|+ +++.||.|+||+||+|.+..+++.||+|++.... ........+..|+..+. ..+|++|+++++.+...+.++
T Consensus 4 ~~y~--i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~-~l~hp~Iv~~~~~~~~~~~~~ 80 (669)
T cd05610 4 EEFV--IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-LSKSPFIVHLYYSLQSANNVY 80 (669)
T ss_pred CCEE--EEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHH-hcCCCCcCeEEEEEEECCEEE
Confidence 4566 9999999999999999999999999999997644 23334466777888776 789999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
+||||+.|++|.+++.....+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999999877778999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=239.16 Aligned_cols=236 Identities=25% Similarity=0.373 Sum_probs=191.9
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccc---cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR---RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
|.+.+.||+|++|+||++.+...+..+++|+.+... ........+.+|+..+. ..+|+||+++++.+..++..+++
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLS-KLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHH-hCCCCcHHHHHHHHhcCCceEEE
Confidence 449999999999999999998777767777665432 22333445667777776 67999999999999999999999
Q ss_pred EeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-
Q psy12709 90 LEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV- 164 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~- 164 (253)
+||+++++|.+++.. ...+++..++.++.|++.++.+||+.|++|+|++|+||+++. +.++++|||.+......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988753 345899999999999999999999999999999999999975 67999999988755332
Q ss_pred ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
.......+++.|+|||...+..++.++|+||+|++++++++|..||...........+.....+. ....++.++.++
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 236 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS---LPETYSRQLNSI 236 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC---CcchhcHHHHHH
Confidence 22223456788999999988888899999999999999999999998776666555554433222 224788999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||+.||
T Consensus 237 i~~~l~~~p 245 (260)
T cd08222 237 MQSMLNKDP 245 (260)
T ss_pred HHHHhcCCh
Confidence 999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=254.86 Aligned_cols=236 Identities=28% Similarity=0.444 Sum_probs=207.5
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVL 90 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 90 (253)
-|.-++.||-|+||.|-++...++...||+|.+.+.. ....+..+...|-.+|. ..+++-||++|..|.+++.+|.||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILA-EADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILA-EADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHh-hcCCcceEEEEEEeccCCceEEEE
Confidence 3558899999999999999999999999999998765 44455677777888887 778889999999999999999999
Q ss_pred eccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc------
Q psy12709 91 EMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV------ 164 (253)
Q Consensus 91 e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~------ 164 (253)
+|++||++-.++-+-+-|++..++.++.++.-|+++.|+.|++||||+|+||+||.+|++||+|||+|..+...
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 99999999988877788999999999999999999999999999999999999999999999999999865200
Q ss_pred -------------------------------------ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCC
Q psy12709 165 -------------------------------------VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSH 207 (253)
Q Consensus 165 -------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~ 207 (253)
.......|++.|+|||++....++.-+|.||.|++||+|+.|+
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence 0011236788999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 208 SPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 208 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
+||-..+..+...++..+.....-....++|++..++|.++
T Consensus 869 ~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kL 909 (1034)
T KOG0608|consen 869 PPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKL 909 (1034)
T ss_pred CCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHH
Confidence 99999999888888888877777777779999999999875
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=234.99 Aligned_cols=234 Identities=18% Similarity=0.244 Sum_probs=180.6
Q ss_pred eecCCCCceEEEEEEeccC--CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 17 CMPSRGKFASVRKCTHKIT--KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~--~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
+.||+|+||+||++....+ ...+++|.+..... ......+.+|+..+. ..+|+||+++++.+......+++|||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYR-ILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHh-ccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999975433 34566777655332 233567778887777 6799999999999999999999999999
Q ss_pred CCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc---ccc
Q psy12709 95 DGELQRLVDIQ----DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV---VEV 167 (253)
Q Consensus 95 g~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~---~~~ 167 (253)
+++|.+++... ...+...++.++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999988753 23567778899999999999999999999999999999999999999999987532211 111
Q ss_pred cccccCccccCccccCC-------CCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhccc-cc-ccCCccCCC
Q psy12709 168 KEIIGTPDYVAPEVLSY-------EPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCN-FS-FHEDLFGHI 237 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~-------~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~-~~-~~~~~~~~~ 237 (253)
....++..|+|||+... ..++.++|+||+|+++|+|++ |..||...+..+.+..+.... .. +.......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 23456788999998743 245778999999999999997 678998777766665543332 11 222334568
Q ss_pred CHHHHHHHHHhcccCC
Q psy12709 238 SSQAKDFIQSCLVTDP 253 (253)
Q Consensus 238 ~~~l~~li~~~l~~dP 253 (253)
++.+.+++..|| .||
T Consensus 239 ~~~~~~l~~~c~-~~P 253 (268)
T cd05086 239 SERWYEVLQFCW-LSP 253 (268)
T ss_pred cHHHHHHHHHHh-hCc
Confidence 999999999999 556
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=258.41 Aligned_cols=198 Identities=24% Similarity=0.322 Sum_probs=155.0
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCc-eEEEE--------------Eecc-cccchHHHHHHHHHHHHHHHhcCCC
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKV-EYAAK--------------FIRK-RRRSMDQMQDILHEAAVLYLAQKSE 71 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~-~v~iK--------------~~~~-~~~~~~~~~~~~~e~~~~~~~~~~~ 71 (253)
.++|+ +++.||+|+||+||+|..+.... ..+.| .+.+ ..........+.+|+..+. .++|+
T Consensus 147 ~~~Y~--ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~-~l~Hp 223 (501)
T PHA03210 147 LAHFR--VIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALG-RLNHE 223 (501)
T ss_pred hhccE--EEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHH-hCCCC
Confidence 35666 99999999999999987653321 12222 1111 1122233456788999888 77999
Q ss_pred CceeeeeEEEeCCeEEEEEeccCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC
Q psy12709 72 RIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQ-----DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK 146 (253)
Q Consensus 72 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~ 146 (253)
||+++++++..++..+++++++.+ ++.+++... .......++.++.|++.||.|||++|++|+||+|+||+++.
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 999999999999999999999854 565554321 12345678889999999999999999999999999999999
Q ss_pred CCceEEEeecccccccccc--cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCC
Q psy12709 147 DNNIKLCDFGISRVVNDVV--EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSP 209 (253)
Q Consensus 147 ~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 209 (253)
++.++|+|||++....... ......++..|+|||++.+..++.++||||+||++|+|++|..+
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999997654322 22235689999999999999999999999999999999998754
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=242.07 Aligned_cols=230 Identities=22% Similarity=0.335 Sum_probs=181.4
Q ss_pred CceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCCcHHHHH
Q psy12709 23 KFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLV 102 (253)
Q Consensus 23 ~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~ 102 (253)
+++.||.+.+..+++.||+|.+............+.+|+..+. ..+|+||+++++++..++..++++||+++++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~-~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSR-QLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHH-hcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 4466677777778999999999876555566778999999888 678999999999999999999999999999999998
Q ss_pred hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc--------cccccc
Q psy12709 103 DIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE--------VKEIIG 172 (253)
Q Consensus 103 ~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~ 172 (253)
... ..+++..+..++.|++.|+.|||+++++|+||+|+||+++.++.+++.||+.+........ .....+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 753 4588999999999999999999999999999999999999999999999998864432111 112235
Q ss_pred CccccCccccCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccc----------------------
Q psy12709 173 TPDYVAPEVLSYE--PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFS---------------------- 228 (253)
Q Consensus 173 ~~~~~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~---------------------- 228 (253)
+..|+|||.+.+. .++.++|+||+|+++|+|++|+.||..............+...
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN 250 (314)
T ss_pred cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence 5689999998653 5788999999999999999999999876554433221111100
Q ss_pred --------ccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 229 --------FHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 229 --------~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.+......++.++.+++.+||+.||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 283 (314)
T cd08216 251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDP 283 (314)
T ss_pred cccchhhhhhcchhhHHHHHHHHHHHHHhhcCC
Confidence 0011112345789999999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=236.80 Aligned_cols=237 Identities=30% Similarity=0.479 Sum_probs=205.6
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch-HHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM-DQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
|.++..||+|++++|-++..+.+...||+|++++.-.+. +.......|...+....++|.++-+...|..+++++.|.|
T Consensus 252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie 331 (593)
T KOG0695|consen 252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE 331 (593)
T ss_pred ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence 349999999999999999999999999999999876333 3355667788888889999999999999999999999999
Q ss_pred ccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc-cccccccccc
Q psy12709 92 MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV-VNDVVEVKEI 170 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~-~~~~~~~~~~ 170 (253)
|++||+|---++.+..++++.++.+..+++.|+.|||++||+++|++.+|++++.+|++||+|+|.++. ......++..
T Consensus 332 yv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstf 411 (593)
T KOG0695|consen 332 YVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTF 411 (593)
T ss_pred EecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcccccc
Confidence 999999977777777899999999999999999999999999999999999999999999999999984 4556677788
Q ss_pred ccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC--------CChHHHHHHhhcccccccCCccCCCCHHHH
Q psy12709 171 IGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAG--------DNKQETFLNISQCNFSFHEDLFGHISSQAK 242 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~--------~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~ 242 (253)
+++|.|.|||++++..|....|.|+||+++++|+.|+.||.- .+..-.++-|...+...|. .+|-...
T Consensus 412 cgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr----slsvkas 487 (593)
T KOG0695|consen 412 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR----SLSVKAS 487 (593)
T ss_pred cCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc----eeehhhH
Confidence 999999999999999999999999999999999999999932 2223344556666666665 5566677
Q ss_pred HHHHHhcccCC
Q psy12709 243 DFIQSCLVTDP 253 (253)
Q Consensus 243 ~li~~~l~~dP 253 (253)
.+++..|++||
T Consensus 488 ~vlkgflnkdp 498 (593)
T KOG0695|consen 488 HVLKGFLNKDP 498 (593)
T ss_pred HHHHHhhcCCc
Confidence 78888888887
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=256.32 Aligned_cols=233 Identities=23% Similarity=0.390 Sum_probs=203.6
Q ss_pred EEeecCCCCceEEEEEEeccCC---ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 15 IFCMPSRGKFASVRKCTHKITK---VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
+.++||+|+||.|++|.+...+ ..||||.+....... ...++.+|+..+. .+.|+|++++|++..+ ....+|||
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~-~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHML-KLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHH-hccCcceeEEeeeecc-chhhHHhh
Confidence 7789999999999999988533 349999998766543 6789999999998 8899999999999987 67889999
Q ss_pred ccCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccc
Q psy12709 92 MVPDGELQRLVDI--QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE 169 (253)
Q Consensus 92 ~~~g~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (253)
.+++|+|.+.+++ +..|-...+..++.||+.|+.||..++.+|||+-++|+++.....|||+|||+++.+........
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 9999999998876 45588899999999999999999999999999999999999999999999999998765433222
Q ss_pred ----cccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 170 ----IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 170 ----~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
......|+|||.++...++.++|+|++|+++|||++ |+.||.+...-.++.+|..+...+.. ..+|+++.++
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRP---k~csedIY~i 347 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRP---KYCSEDIYQI 347 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCC---CCChHHHHHH
Confidence 123469999999999999999999999999999999 99999999999999999865544333 3789999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
+++||..+|
T Consensus 348 mk~cWah~p 356 (1039)
T KOG0199|consen 348 MKNCWAHNP 356 (1039)
T ss_pred HHHhccCCc
Confidence 999999987
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=236.75 Aligned_cols=236 Identities=26% Similarity=0.393 Sum_probs=196.4
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
-++.||.|+||+|++-.++.+|+..|||.+..... ..+..++..|.....+..++|+|+++|+..-.++..|+.||.|
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM- 145 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM- 145 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence 56789999999999999999999999999987665 3456778888888888999999999999999999999999999
Q ss_pred CCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCceEEEeeccccccccccccc
Q psy12709 95 DGELQRLVD-----IQDGIPEQDTRSYMKQILEALAFLHDH-NITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK 168 (253)
Q Consensus 95 g~~L~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 168 (253)
..+++.+-. ++..+++..+-.+.-..+.||.||-+. .++|||++|+||+++..|.+||||||.+-.+.++-...
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT 225 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKT 225 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhh
Confidence 557766543 245688998888888899999999865 79999999999999999999999999998766655555
Q ss_pred ccccCccccCccccCCC--CCCccccHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhcccccccCC--ccCCCCHHHHH
Q psy12709 169 EIIGTPDYVAPEVLSYE--PISLATDMWSVGVLAYVLLSSHSPFAG-DNKQETFLNISQCNFSFHED--LFGHISSQAKD 243 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~--~~~~~~~~l~~ 243 (253)
...|-..|+|||.+... .++.++|+||||++++|+.||+.||+. .+..+...++..+.++.... ..-.+|..+..
T Consensus 226 ~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~ 305 (361)
T KOG1006|consen 226 VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVR 305 (361)
T ss_pred hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHH
Confidence 56788899999998443 488999999999999999999999987 44555555555554443322 22358999999
Q ss_pred HHHHhcccC
Q psy12709 244 FIQSCLVTD 252 (253)
Q Consensus 244 li~~~l~~d 252 (253)
+|..||.+|
T Consensus 306 fintCl~Kd 314 (361)
T KOG1006|consen 306 FINTCLIKD 314 (361)
T ss_pred HHHHHhhcc
Confidence 999999876
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=249.85 Aligned_cols=238 Identities=21% Similarity=0.321 Sum_probs=211.4
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
.+-...+..+||.|-||.||.|.++.....||||.++.+ .-..+++..|+..+. .++|+|++++++++..+..+|+
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMK-eikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMK-EIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHH-hhcCccHHHHhhhhccCCCeEE
Confidence 344456888999999999999999999999999998743 344678899999998 8999999999999999999999
Q ss_pred EEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc
Q psy12709 89 VLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 166 (253)
|+|||.-|+|.++++.. ..++.-.++.++.||.+|++||..++++|||+.++|.+|.++..||+.|||+++.+....-
T Consensus 341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 99999999999999863 4478888999999999999999999999999999999999999999999999998876433
Q ss_pred --ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 167 --VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 167 --~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
.......+-|.|||.+....++.++|||++|+++||+.| |-.||++.+-..++..+.++..+--. ..+++.+.+
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~P---eGCPpkVYe 497 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGP---EGCPPKVYE 497 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCC---CCCCHHHHH
Confidence 334456789999999999999999999999999999999 99999999999999888776655433 389999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
|+.+||+.+|
T Consensus 498 LMraCW~WsP 507 (1157)
T KOG4278|consen 498 LMRACWNWSP 507 (1157)
T ss_pred HHHHHhcCCc
Confidence 9999999988
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=254.22 Aligned_cols=236 Identities=26% Similarity=0.402 Sum_probs=201.4
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe-----CCeEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET-----PHEMV 87 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~ 87 (253)
++|.+.||.|.+|.||++..+.++...|+|+........+ .++.|.+++....+|+|++.++++|.. ++.+|
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de---EiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE---EIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH---HHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 4599999999999999999999999999999987655443 677888999999999999999999864 46899
Q ss_pred EEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc-c
Q psy12709 88 LVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-V 164 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~-~ 164 (253)
+|||||.||+..+++... ..+.++.+..+++.++.++.+||++.++|+||+-.||+++.++.|||+|||.+..... .
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~ 177 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV 177 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeeccc
Confidence 999999999999999763 4589999999999999999999999999999999999999999999999999875543 3
Q ss_pred ccccccccCccccCccccCCC-----CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYE-----PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
.......|+|.|||||++... .|+.++|+||||++..||.-|.+|+-...+...+..|..+.++. ......-+.
T Consensus 178 grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk-Lkrp~kWs~ 256 (953)
T KOG0587|consen 178 GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK-LKRPKKWSK 256 (953)
T ss_pred ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc-ccchhhHHH
Confidence 344567899999999998654 46789999999999999999999998888877777665543322 222345588
Q ss_pred HHHHHHHHhcccC
Q psy12709 240 QAKDFIQSCLVTD 252 (253)
Q Consensus 240 ~l~~li~~~l~~d 252 (253)
++-++|.+||.+|
T Consensus 257 ~FndFIs~cL~Kd 269 (953)
T KOG0587|consen 257 KFNDFISTCLVKD 269 (953)
T ss_pred HHHHHHHHHHhhc
Confidence 8999999999876
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=247.00 Aligned_cols=234 Identities=25% Similarity=0.400 Sum_probs=203.5
Q ss_pred EEEeecCCCCceEEEEEEeccC--C--ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 14 LIFCMPSRGKFASVRKCTHKIT--K--VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~--~--~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
++.++||.|-||.||+|..... | --||||.-+.+... +..+.+..|..+++ ..+||||+++++++.+. ..|+|
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMr-nfdHphIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMR-NFDHPHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHH-hCCCcchhheeeeeecc-ceeEE
Confidence 3556899999999999997632 3 24888887765554 44789999999998 99999999999999874 78999
Q ss_pred EeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccccc
Q psy12709 90 LEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK 168 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 168 (253)
||.++-|.|++++..+ ..++...+.-++.|++.|+.|||+...+||||.++||++.+..-|||.|||+++...+..-..
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence 9999999999999875 458899999999999999999999999999999999999999999999999999876544332
Q ss_pred --ccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 169 --EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 169 --~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
.....+-|+|||.++...++.++|||-+|+++||+++ |..||.+..+.++.-.+.++...+.. +.+|+.|.-|+
T Consensus 549 aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P---~nCPp~LYslm 625 (974)
T KOG4257|consen 549 ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCP---PNCPPALYSLM 625 (974)
T ss_pred ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCC---CCCChHHHHHH
Confidence 2345679999999999999999999999999999988 99999999999988888887766554 48999999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
.+||..||
T Consensus 626 skcWayeP 633 (974)
T KOG4257|consen 626 SKCWAYEP 633 (974)
T ss_pred HHHhccCc
Confidence 99999998
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=231.76 Aligned_cols=205 Identities=26% Similarity=0.435 Sum_probs=170.3
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCC----ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITK----VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
+..-++|+.++.||+|++|.||+|....++ +.||+|+++.+..........-+|+..++ .++|+|++.+..+|..
T Consensus 20 ve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~R-El~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 20 VEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLR-ELKHPNVISLVKVFLS 98 (438)
T ss_pred HHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHH-HhcCCcchhHHHHHhc
Confidence 344456779999999999999999776544 37999999877544444456667887777 8899999999999987
Q ss_pred -CCeEEEEEeccCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC----CceEE
Q psy12709 83 -PHEMVLVLEMVPDGELQRLVDIQ-----DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD----NNIKL 152 (253)
Q Consensus 83 -~~~~~lv~e~~~g~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~----~~~~l 152 (253)
+..+++++||.+. +|.+.+..+ ..++...++.++.|++.++.|||++-++|||++|.||++.-+ |.|||
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence 6799999999976 676666532 348999999999999999999999999999999999999877 89999
Q ss_pred Eeecccccccccc----cccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCC
Q psy12709 153 CDFGISRVVNDVV----EVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGD 213 (253)
Q Consensus 153 ~df~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 213 (253)
.|+|+++.+.++- +.....-+..|.|||.+.+. .|+++.|+|++||++.||++.++.|.+.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9999999776542 22344568899999998765 6899999999999999999999988663
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=263.33 Aligned_cols=235 Identities=27% Similarity=0.437 Sum_probs=192.3
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEE-------------
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY------------- 80 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~------------- 80 (253)
+.++.||+||||.||+++.+-+|+.||||+++... +.....++.+|+..+. .++|||||+++..|
T Consensus 482 EEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LA-rLnHpNVVRYysAWVEs~~~~~~~ei~ 559 (1351)
T KOG1035|consen 482 EELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLA-RLNHPNVVRYYSAWVESTAELTVLEIV 559 (1351)
T ss_pred HHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHh-hcCCcceeeeehhhhccCCcccccccc
Confidence 36679999999999999999999999999999877 6777899999999999 88999999999988
Q ss_pred --------------------------------------------------------------------------------
Q psy12709 81 -------------------------------------------------------------------------------- 80 (253)
Q Consensus 81 -------------------------------------------------------------------------------- 80 (253)
T Consensus 560 ~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~ 639 (1351)
T KOG1035|consen 560 ASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGS 639 (1351)
T ss_pred ccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCc
Confidence
Q ss_pred -------------------E-------eCCeEEEEEeccCCCcHHHHHhhcCCC-CHHHHHHHHHHHHHHHHHHHHCCce
Q psy12709 81 -------------------E-------TPHEMVLVLEMVPDGELQRLVDIQDGI-PEQDTRSYMKQILEALAFLHDHNIT 133 (253)
Q Consensus 81 -------------------~-------~~~~~~lv~e~~~g~~L~~~~~~~~~~-~~~~~~~~~~~l~~~l~~lh~~~~~ 133 (253)
. ....+|+-||||+..+++++++.+... .....+++.++|+.|+.|+|++|++
T Consensus 640 ~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giI 719 (1351)
T KOG1035|consen 640 VILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGII 719 (1351)
T ss_pred cccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCcee
Confidence 0 013578899999998999998866544 5889999999999999999999999
Q ss_pred ecCCCCCCEEEcCCCceEEEeeccccccc-------------------ccccccccccCccccCccccCCCC---CCccc
Q psy12709 134 HLDLKPQNILLTKDNNIKLCDFGISRVVN-------------------DVVEVKEIIGTPDYVAPEVLSYEP---ISLAT 191 (253)
Q Consensus 134 h~di~~~ni~~~~~~~~~l~df~~~~~~~-------------------~~~~~~~~~~~~~~~~PE~~~~~~---~~~~~ 191 (253)
||||||.|||+++++.|||+|||++.... +........||.-|+|||++.+.. |+.+.
T Consensus 720 HRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~Ki 799 (1351)
T KOG1035|consen 720 HRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKI 799 (1351)
T ss_pred eccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchh
Confidence 99999999999999999999999998721 011223457889999999986654 99999
Q ss_pred cHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 192 DMWSVGVLAYVLLSSHSPFAGDNKQ-ETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 192 Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
|+||||++++||+. ||....++ ..+.+++++..+.+..+...--+.-..+|.+||++||
T Consensus 800 DmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 800 DMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDP 859 (1351)
T ss_pred hhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCC
Confidence 99999999999987 47665554 3445566555555533333344456779999999998
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=241.77 Aligned_cols=239 Identities=29% Similarity=0.459 Sum_probs=193.6
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-----chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-----SMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
+++|= ++.+||+|+|+.||+|.|...++.||+|+-..... .....+...+|..+.. .++|+.||++|++|.-
T Consensus 462 n~RYL--lLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHK-eLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 462 NDRYL--LLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHK-ELDHPRIVKLYDYFSL 538 (775)
T ss_pred HHHHH--HHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhh-ccCcceeeeeeeeeee
Confidence 44555 89999999999999999999999999998665432 1222456667777665 8999999999999975
Q ss_pred C-CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEcCC---CceEEEeec
Q psy12709 83 P-HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHN--ITHLDLKPQNILLTKD---NNIKLCDFG 156 (253)
Q Consensus 83 ~-~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~di~~~ni~~~~~---~~~~l~df~ 156 (253)
+ +.++.|.|||+|.+|+-++..+.-+++.+++.++.|++.||.||.+.. |+|-|++|.||++-+. |.+||+|||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 5 589999999999999999998888999999999999999999999875 9999999999999764 779999999
Q ss_pred ccccccccc--------cccccccCccccCccccCCC----CCCccccHHHHHHHHHHHHhCCCCCCCCChH-HHHHH--
Q psy12709 157 ISRVVNDVV--------EVKEIIGTPDYVAPEVLSYE----PISLATDMWSVGVLAYVLLSSHSPFAGDNKQ-ETFLN-- 221 (253)
Q Consensus 157 ~~~~~~~~~--------~~~~~~~~~~~~~PE~~~~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~-- 221 (253)
+++.+.+.. -++...|+-+|+|||++.-+ ..+.+.||||+|+++|.++.|+.||...-.. +.++.
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 999775422 12345688899999997443 3577999999999999999999999765433 33321
Q ss_pred -hhcccccccCCccCCCCHHHHHHHHHhccc
Q psy12709 222 -ISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251 (253)
Q Consensus 222 -i~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (253)
+.....++|.. +.+|++.++||.+||++
T Consensus 699 IlkAtEVqFP~K--PvVsseAkaFIRRCLaY 727 (775)
T KOG1151|consen 699 ILKATEVQFPPK--PVVSSEAKAFIRRCLAY 727 (775)
T ss_pred hhcceeccCCCC--CccCHHHHHHHHHHHHh
Confidence 12233444443 58899999999999975
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=237.13 Aligned_cols=204 Identities=28% Similarity=0.442 Sum_probs=174.4
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCC-C----ceeeeeEEEe
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSE-R----IVGLHEIYET 82 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~-~----i~~~~~~~~~ 82 (253)
.++|+ +++.+|.|+||+|-.+.|.+.+..||+|+++.-. ...+...-|+..+++...+. + ++.+.++|+.
T Consensus 88 ~~Ry~--i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 88 TNRYE--IVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred cccee--hhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 56666 9999999999999999999999999999987532 22346667888888774443 2 7888888999
Q ss_pred CCeEEEEEeccCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-------------
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD------------- 147 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~------------- 147 (253)
.++.++|+|.+ |-++.+++..+. +++...++.++.|++.++++||+.+++|.|++|+||++.++
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999999988 879999998753 58999999999999999999999999999999999998533
Q ss_pred -------CceEEEeecccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy12709 148 -------NNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETF 219 (253)
Q Consensus 148 -------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 219 (253)
-.++++|||.+....... .....|..|.|||++.+-.|+..+||||+||++.|+.+|...|+..++.+.+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 248999999998755433 4557789999999999999999999999999999999999999998877644
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=223.25 Aligned_cols=228 Identities=38% Similarity=0.591 Sum_probs=193.1
Q ss_pred CceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCCcHHHHH
Q psy12709 23 KFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLV 102 (253)
Q Consensus 23 ~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~ 102 (253)
+||.||+|.+..++..+++|++........ ...+.+|+..++ ..+|++++++.+.+......++++|++++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~-~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILK-KLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHH-hCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999998899999999986554322 568888888887 559999999999999999999999999999999998
Q ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccccccCccccCcccc
Q psy12709 103 DIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVL 182 (253)
Q Consensus 103 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~ 182 (253)
.....++...+..++.+++.++.+||+.+++|+||+|.||+++.++.++++|||.+.............+...|+|||..
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 87666899999999999999999999999999999999999999999999999999876654444455678899999999
Q ss_pred CCCCCCccccHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 183 SYEPISLATDMWSVGVLAYVLLSSHSPFAG-DNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 183 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.+..++.++|+|++|++++++++|..||.. .........+......... ....++.++.+++.+||..||
T Consensus 159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p 229 (244)
T smart00220 159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-PEWKISPEAKDLIRKLLVKDP 229 (244)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-ccccCCHHHHHHHHHHccCCc
Confidence 888889999999999999999999999987 5555555544443333222 111288999999999999887
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=212.21 Aligned_cols=210 Identities=24% Similarity=0.382 Sum_probs=181.4
Q ss_pred EeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 16 FCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
++.||+|++|.|=+..+..+|...|+|.+..+-.+ ...+++..|+++..+..++|.++++|+....+..+++.||-| .
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~ 128 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-D 128 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcCh-HHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-h
Confidence 46899999999999999999999999999876553 446678889998888999999999999999999999999999 5
Q ss_pred CcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCceEEEeeccccccccccccccc
Q psy12709 96 GELQRLVD----IQDGIPEQDTRSYMKQILEALAFLHDH-NITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI 170 (253)
Q Consensus 96 ~~L~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (253)
.+|+.+-+ +...+++..+-+++..++.|+.+||++ .++|||++|.||+++..|.||+||||.+-.+.++-.....
T Consensus 129 tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~d 208 (282)
T KOG0984|consen 129 TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMD 208 (282)
T ss_pred hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHh
Confidence 57866543 456699999999999999999999987 7999999999999999999999999999877666555556
Q ss_pred ccCccccCccccCC----CCCCccccHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhcccc
Q psy12709 171 IGTPDYVAPEVLSY----EPISLATDMWSVGVLAYVLLSSHSPFAG-DNKQETFLNISQCNF 227 (253)
Q Consensus 171 ~~~~~~~~PE~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~i~~~~~ 227 (253)
.|-..|+|||.+.. ..|+.++||||||+++.||.+++.||.+ .++.+.+.++.+...
T Consensus 209 aGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 209 AGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred cCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCC
Confidence 78889999999744 3688999999999999999999999977 677777777666443
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=238.33 Aligned_cols=237 Identities=19% Similarity=0.288 Sum_probs=199.6
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
..++++||+|-||.|.+|.-. .+..||+|.++.... ....+++.+|++.+. +++||||+++++++..++.+++|+||
T Consensus 540 L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLs-qLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDAT-KNARNDFLKEIKILS-RLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred eehhhhhcCcccceeEEEEec-CceEEEEeecCcccc-hhHHHHHHHHHHHHh-ccCCCCeeEEEeeeecCCchHHHHHH
Confidence 348899999999999999876 468899999986544 333679999999999 66999999999999999999999999
Q ss_pred cCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccc---
Q psy12709 93 VPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV--- 167 (253)
Q Consensus 93 ~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--- 167 (253)
++.|+|..++..+. .+..+...+++.||+++++||.+.+++|||+.++|++++.++++||+|||.++........
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq 696 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ 696 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence 99999999998763 3456777889999999999999999999999999999999999999999999855433222
Q ss_pred cccccCccccCccccCCCCCCccccHHHHHHHHHHHHh--CCCCCCCCChHHHHHHhhccccccc----CCccCCCCHHH
Q psy12709 168 KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS--SHSPFAGDNKQETFLNISQCNFSFH----EDLFGHISSQA 241 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~--g~~p~~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~~l 241 (253)
......++|+|+|.+.-++++.++|+|++|+++||+++ .+.||...++++...+......... ....+-++.++
T Consensus 697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~l 776 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGL 776 (807)
T ss_pred cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHH
Confidence 22355789999999999999999999999999999877 8899999888888776544322222 22345678899
Q ss_pred HHHHHHhcccC
Q psy12709 242 KDFIQSCLVTD 252 (253)
Q Consensus 242 ~~li~~~l~~d 252 (253)
.+++-.||+.|
T Consensus 777 yelml~Cw~~e 787 (807)
T KOG1094|consen 777 YELMLRCWRRE 787 (807)
T ss_pred HHHHHHHhchh
Confidence 99999999876
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=226.01 Aligned_cols=240 Identities=25% Similarity=0.339 Sum_probs=194.2
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe--------C
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET--------P 83 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--------~ 83 (253)
.|+-+.+||+|.||.||+|..+.+++.|++|+.-..+..........+|+.+++ +++|+|++.+++++.. .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~-~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQ-LLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHH-HhcchhHHHHHHHHhhccCCccccc
Confidence 344778999999999999999999999999988776666666678889999998 9999999988887743 2
Q ss_pred CeEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN 162 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~ 162 (253)
..+++||++|+. +|.-++... ..++..++..++.+++.++.|+|++.++|||+++.|++++.+|.++|.|||+++.++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 359999999966 676666654 569999999999999999999999999999999999999999999999999998765
Q ss_pred ccccc-----cccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC-----
Q psy12709 163 DVVEV-----KEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE----- 231 (253)
Q Consensus 163 ~~~~~-----~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~----- 231 (253)
.+... .....+..|.+||.+.+. .+++..|+|..||++.+|+++.+.+++.+....+..|..--.....
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 43222 223457899999998664 6899999999999999999999999998888777655432111111
Q ss_pred -----------------CccC---------CCCHHHHHHHHHhcccCC
Q psy12709 232 -----------------DLFG---------HISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 232 -----------------~~~~---------~~~~~l~~li~~~l~~dP 253 (253)
.... .-+++..+|+.++|..||
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP 303 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDP 303 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCc
Confidence 0000 124578899999999998
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=243.03 Aligned_cols=236 Identities=25% Similarity=0.370 Sum_probs=201.9
Q ss_pred EEEeecCCCCceEEEEEEecc-------CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 14 LIFCMPSRGKFASVRKCTHKI-------TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
.+.+.||.|.||+|++|.... ....||+|.++..... .+...+..|+..+....+|+||+.+.+.....+.+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 466799999999999998551 1356999999877666 77899999999999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCce
Q psy12709 87 VLVLEMVPDGELQRLVDIQD----------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNI 150 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~ 150 (253)
++|.||+..|+|.++++... .++...+..++.|++.+++||++...+|||+-++||++..+..+
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~ 457 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVI 457 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEE
Confidence 99999999999999998655 38899999999999999999999999999999999999999999
Q ss_pred EEEeecccccccccccc--cccc--cCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCC-hHHHHHHhhc
Q psy12709 151 KLCDFGISRVVNDVVEV--KEII--GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDN-KQETFLNISQ 224 (253)
Q Consensus 151 ~l~df~~~~~~~~~~~~--~~~~--~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~-~~~~~~~i~~ 224 (253)
|++|||+++........ .... ....|+|||.+....++.++||||+|+++||+++ |..||++.. ..+.+..+..
T Consensus 458 kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~ 537 (609)
T KOG0200|consen 458 KIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKE 537 (609)
T ss_pred EEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhc
Confidence 99999999854332221 1111 3557999999999999999999999999999999 999999855 6666666666
Q ss_pred ccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 225 CNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 225 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+....... .+++++.++++.||+.+|
T Consensus 538 G~r~~~P~---~c~~eiY~iM~~CW~~~p 563 (609)
T KOG0200|consen 538 GNRMEQPE---HCSDEIYDLMKSCWNADP 563 (609)
T ss_pred CCCCCCCC---CCCHHHHHHHHHHhCCCc
Confidence 66544432 669999999999998887
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=209.67 Aligned_cols=206 Identities=23% Similarity=0.458 Sum_probs=177.0
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC--eE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH--EM 86 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~ 86 (253)
++|+ +.+++|+|.++.||.|....+++++++|+++. -..+++.+|+.+++.+..++||++++++..++. .+
T Consensus 38 ddYe--ivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 38 DDYE--IVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred chHH--HHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 4566 99999999999999999998999999999874 335689999999999999999999999998764 78
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-CceEEEeecccccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD-NNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~-~~~~l~df~~~~~~~~~~ 165 (253)
.+|+|+++..+...+.. .++.-.++.++.++++|+.|||++||+|+|++|.|++++.. ..++|+|+|++.+.-...
T Consensus 111 aLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 99999999887776643 47788999999999999999999999999999999999975 569999999998877666
Q ss_pred cccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCC-CCCChHHHHHHhhc
Q psy12709 166 EVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPF-AGDNKQETFLNISQ 224 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~-~~~~~~~~~~~i~~ 224 (253)
.......+..|-.||.+.. +.++...|+||+||+++.|...+-|| .+.++.+.+.+|.+
T Consensus 188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak 248 (338)
T KOG0668|consen 188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK 248 (338)
T ss_pred eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH
Confidence 6666677888999999744 56899999999999999999977665 66777666655543
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=224.50 Aligned_cols=207 Identities=24% Similarity=0.409 Sum_probs=180.6
Q ss_pred EeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC-----eEEEEE
Q psy12709 16 FCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH-----EMVLVL 90 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~ 90 (253)
-+.||.|+||.||.+.|-.+|+.|++|+++....+....+.+++|++++- ..+|+|++..+++..-.. .+|+++
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLc-fFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLS-SFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHH-hhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 35899999999999999999999999999988887888899999999998 999999999988876543 578999
Q ss_pred eccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc--cccc
Q psy12709 91 EMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV--VEVK 168 (253)
Q Consensus 91 e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~~ 168 (253)
|.+ ..+|...+-...+++...++-++.|++++++|||+.+|.||||+|.|.++++|..+||||||+++..... ....
T Consensus 137 ELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMT 215 (449)
T KOG0664|consen 137 ELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMT 215 (449)
T ss_pred HHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhH
Confidence 988 5589998888888999999999999999999999999999999999999999999999999999865432 3333
Q ss_pred ccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q psy12709 169 EIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQ 224 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~ 224 (253)
...-+.+|.|||++-+. .|+.+.||||+||++.|++..+..|...++-+.++.|.+
T Consensus 216 qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd 272 (449)
T KOG0664|consen 216 HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID 272 (449)
T ss_pred HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH
Confidence 44567899999998554 689999999999999999999999988777666655544
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=235.28 Aligned_cols=199 Identities=26% Similarity=0.437 Sum_probs=172.9
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHH------HHHHHHHHHHHHHhc--CCCCceeeeeEEEeCC
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ------MQDILHEAAVLYLAQ--KSERIVGLHEIYETPH 84 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~------~~~~~~e~~~~~~~~--~~~~i~~~~~~~~~~~ 84 (253)
|..++++|.|+||+|++|.+++....|++|.+.+.+--.+. .-.+-.|+.++.++. .|+||++++++|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 44999999999999999999999999999999887622222 234556888888443 3899999999999999
Q ss_pred eEEEEEec-cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 85 EMVLVLEM-VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 85 ~~~lv~e~-~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
.+|++||- -+|-+|.++++.++.+++.+++.+.+|++.+++.||+.||+|||||-+|+.++.+|-+||+|||.+....+
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ks 722 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKS 722 (772)
T ss_pred eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhcC
Confidence 99999994 45668999999999999999999999999999999999999999999999999999999999998876544
Q ss_pred cccccccccCccccCccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCC
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSYEPI-SLATDMWSVGVLAYVLLSSHSPFAG 212 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~ 212 (253)
. ......|+..|.|||++.+.+| ...-|||+||+++|.+...+.||.+
T Consensus 723 g-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 723 G-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred C-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 3 3345679999999999999887 5679999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=209.89 Aligned_cols=212 Identities=35% Similarity=0.517 Sum_probs=182.4
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEecc
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMV 93 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 93 (253)
.+.+.||.|++|+||++.+..++..+++|.+...... .....+.+|+..+. ..+|++++++++.+......++++|++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~-~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILK-KLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHH-hCCCCChhhheeeeecCCceEEEEecc
Confidence 4889999999999999999988999999999875543 24568888888887 558999999999999999999999999
Q ss_pred CCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc--ccccc
Q psy12709 94 PDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV--EVKEI 170 (253)
Q Consensus 94 ~g~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~ 170 (253)
++++|.+++..... ++...+..++.+++.++.+||+.+++|+|+++.||+++.++.++|+|||.+....... .....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 99999999987666 8999999999999999999999999999999999999999999999999988665432 22344
Q ss_pred ccCccccCcccc-CCCCCCccccHHHHHHHHHHHHhCCCCCCC--CChHHHHHHhhcccc
Q psy12709 171 IGTPDYVAPEVL-SYEPISLATDMWSVGVLAYVLLSSHSPFAG--DNKQETFLNISQCNF 227 (253)
Q Consensus 171 ~~~~~~~~PE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~--~~~~~~~~~i~~~~~ 227 (253)
.+...|++||.. ....++.++|+|++|++++++++|+.||.+ .......+.+..+..
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 567789999998 666778899999999999999999999987 444466666666553
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=219.56 Aligned_cols=234 Identities=19% Similarity=0.307 Sum_probs=179.1
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHH-hcCCCCceeeeeEEEeCC----eE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYL-AQKSERIVGLHEIYETPH----EM 86 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~-~~~~~~i~~~~~~~~~~~----~~ 86 (253)
|.++.+.||+|.||.||+|..+ |+.||||+|...... .-++|.++++. .++|+||+.+++.--.+. .+
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~-----SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDER-----SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred eeEEEEEecCccccceeecccc--CCceEEEEecccchh-----hhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 4569999999999999999997 888999999865432 22344444433 679999999998865443 69
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCCEEEcCCCceEEEeeccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDH--------NITHLDLKPQNILLTKDNNIKLCDFGIS 158 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--------~~~h~di~~~ni~~~~~~~~~l~df~~~ 158 (253)
|||++|-+.|||.|++.. ..++.....+++..++.+|++||.. .|+|||||..||+|.++|.+.|.|+|++
T Consensus 285 wLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 999999999999999985 5699999999999999999999953 4999999999999999999999999999
Q ss_pred ccccccc-----cccccccCccccCccccCCCC----C--CccccHHHHHHHHHHHHh----C------CCCCCC-----
Q psy12709 159 RVVNDVV-----EVKEIIGTPDYVAPEVLSYEP----I--SLATDMWSVGVLAYVLLS----S------HSPFAG----- 212 (253)
Q Consensus 159 ~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~----~--~~~~Di~slG~~l~~l~~----g------~~p~~~----- 212 (253)
....... ......|+.+|||||++...- + -..+||||+|.++||++. | ++||..
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 8665432 223457899999999986542 2 236999999999999865 2 468744
Q ss_pred CChHHHHHHhhcccccccCCccCCCCHH---HHHHHHHhcccCC
Q psy12709 213 DNKQETFLNISQCNFSFHEDLFGHISSQ---AKDFIQSCLVTDP 253 (253)
Q Consensus 213 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~---l~~li~~~l~~dP 253 (253)
.+.+++..-+-..+..|..+..+.-.+. +.++++.||..||
T Consensus 444 Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np 487 (513)
T KOG2052|consen 444 PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANP 487 (513)
T ss_pred CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCc
Confidence 3444454444333333333333333333 6678999999998
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=254.18 Aligned_cols=184 Identities=21% Similarity=0.263 Sum_probs=155.1
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
..+.||+|+||.||+|.+..++..||+|.+....... ..|+..+. ..+||||+++++++..++..++||||++
T Consensus 694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~~l~-~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP------SSEIADMG-KLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred cccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc------HHHHHHHh-hCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 5578999999999999999899999999987543221 23456666 6699999999999999999999999999
Q ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCCCCEEEcCCCceEEEeecccccccccccccccc
Q psy12709 95 DGELQRLVDIQDGIPEQDTRSYMKQILEALAFLH---DHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEII 171 (253)
Q Consensus 95 g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (253)
+++|.+++.. +++.....++.+++.|++||| +.+++|+|++|+||+++.++..++. ++....... .....
T Consensus 767 ~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~~~~ 839 (968)
T PLN00113 767 GKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DTKCF 839 (968)
T ss_pred CCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CCCcc
Confidence 9999999853 788999999999999999999 6699999999999999998887765 554432211 11225
Q ss_pred cCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Q psy12709 172 GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAG 212 (253)
Q Consensus 172 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 212 (253)
+++.|+|||++.+..++.++||||+|+++|||++|+.||..
T Consensus 840 ~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 840 ISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred ccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 67899999999999999999999999999999999999854
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=222.91 Aligned_cols=231 Identities=23% Similarity=0.302 Sum_probs=177.8
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHH-hcCCCCceeeeeEEEeCC----eEEEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYL-AQKSERIVGLHEIYETPH----EMVLV 89 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~-~~~~~~i~~~~~~~~~~~----~~~lv 89 (253)
+++.+|+|.||.||+|+.. ++.||||+++... .+....|-+++.. ...|+||++++..-+.+. .+++|
T Consensus 214 l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~-----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQE-----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hHHHhhcCccceeehhhcc--CceeEEEecCHHH-----HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 7889999999999999875 6999999998533 2333344433331 668999999999988766 89999
Q ss_pred EeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 90 LEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDH---------NITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---------~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
++|-+.|+|.+++..+- +++....+++..++++++|||+. .|+||||+..||+|.++++..|+|||++-.
T Consensus 287 t~fh~kGsL~dyL~~nt-isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKANT-ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eeeccCCcHHHHHHhcc-ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 99999999999998554 89999999999999999999963 599999999999999999999999999986
Q ss_pred cccc---ccccccccCccccCccccCCCC-C-----CccccHHHHHHHHHHHHhC------------CCCCC-----CCC
Q psy12709 161 VNDV---VEVKEIIGTPDYVAPEVLSYEP-I-----SLATDMWSVGVLAYVLLSS------------HSPFA-----GDN 214 (253)
Q Consensus 161 ~~~~---~~~~~~~~~~~~~~PE~~~~~~-~-----~~~~Di~slG~~l~~l~~g------------~~p~~-----~~~ 214 (253)
+... .......|+.+|||||++.+.- . -.+.||||+|.|+||+++. +.||. ..+
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 6532 2334478999999999986642 1 2479999999999999873 23443 234
Q ss_pred hHHHHHHhhcccccccC--Cc-cCCCCHHHHHHHHHhcccCC
Q psy12709 215 KQETFLNISQCNFSFHE--DL-FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 215 ~~~~~~~i~~~~~~~~~--~~-~~~~~~~l~~li~~~l~~dP 253 (253)
-+++...+...+..+.. .. ...-...+++.+.-||+.||
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDa 487 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDA 487 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCch
Confidence 44555554443332221 11 12345669999999999986
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=233.72 Aligned_cols=195 Identities=21% Similarity=0.222 Sum_probs=138.8
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccC----CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeE----
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKIT----KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI---- 79 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~----~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~---- 79 (253)
.++|+ +.+.||+|+||+||+|.+..+ +..||+|.+........ ...+ .+. ...+.++..+...
T Consensus 131 ~~~y~--l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~----~~~e--~l~-~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 131 KDDFV--LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI----WMNE--RVR-RACPNSCADFVYGFLEP 201 (566)
T ss_pred cCCeE--EeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH----HHHH--HHH-hhchhhHHHHHHhhhcc
Confidence 44565 999999999999999999988 89999998764322111 1111 111 1111111111111
Q ss_pred --EEeCCeEEEEEeccCCCcHHHHHhhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy12709 80 --YETPHEMVLVLEMVPDGELQRLVDIQDG--------------------IPEQDTRSYMKQILEALAFLHDHNITHLDL 137 (253)
Q Consensus 80 --~~~~~~~~lv~e~~~g~~L~~~~~~~~~--------------------~~~~~~~~~~~~l~~~l~~lh~~~~~h~di 137 (253)
...+..+++++||+.+++|.+++..... .....+..++.|++.++.|||+++++|+||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2345689999999999999998864321 123346678999999999999999999999
Q ss_pred CCCCEEEcC-CCceEEEeeccccccccc--ccccccccCccccCccccCCC----------------------CCCcccc
Q psy12709 138 KPQNILLTK-DNNIKLCDFGISRVVNDV--VEVKEIIGTPDYVAPEVLSYE----------------------PISLATD 192 (253)
Q Consensus 138 ~~~ni~~~~-~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~----------------------~~~~~~D 192 (253)
||+||+++. ++.++|+|||++...... .......+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 589999999999754322 222345678899999965322 1234569
Q ss_pred HHHHHHHHHHHHhCCCCCC
Q psy12709 193 MWSVGVLAYVLLSSHSPFA 211 (253)
Q Consensus 193 i~slG~~l~~l~~g~~p~~ 211 (253)
|||+||++|+|+++..|+.
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999999776653
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=226.38 Aligned_cols=212 Identities=25% Similarity=0.392 Sum_probs=179.8
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcC-----CCCceeeeeEEEeCCeEEEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQK-----SERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~-----~~~i~~~~~~~~~~~~~~lv 89 (253)
+....|+|-|++|-.|.++.-|..||||++.....-. +.=..|+.+|.++.. .-++++++..|...+++|+|
T Consensus 436 V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~---KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClV 512 (752)
T KOG0670|consen 436 VQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH---KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLV 512 (752)
T ss_pred EEeccccceeeeeeeccccCCCCeeEEEEeecchHHh---hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEE
Confidence 6667799999999999999988999999998754332 344567777776543 34689999999999999999
Q ss_pred EeccCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-CceEEEeecccccccccc
Q psy12709 90 LEMVPDGELQRLVDIQ---DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD-NNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~-~~~~l~df~~~~~~~~~~ 165 (253)
+|.+ ..+|.+++.+- -++....+..++.||+.||..|-+.|++|.||+|+||+|.++ ..+||||||.+...++..
T Consensus 513 FE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene 591 (752)
T KOG0670|consen 513 FEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENE 591 (752)
T ss_pred ehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccccc
Confidence 9988 77999999863 468889999999999999999999999999999999999986 568999999998766543
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE 231 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 231 (253)
. .....+.-|.|||++.|.+|+...|+||+||+|||+.||+..|++.++-.++......+..+|.
T Consensus 592 i-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 592 I-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred c-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 2 3334456899999999999999999999999999999999999999999988877777666663
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-31 Score=222.74 Aligned_cols=244 Identities=19% Similarity=0.222 Sum_probs=167.7
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEec----------------cCCceEEEEEecccccchH------------HHHHH
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHK----------------ITKVEYAAKFIRKRRRSMD------------QMQDI 57 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~----------------~~~~~v~iK~~~~~~~~~~------------~~~~~ 57 (253)
|..++|+ +.++||+|+||+||+|... ..++.|++|.+........ ..+..
T Consensus 142 ~~~d~F~--i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 142 WSSDDFQ--LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred ccccCce--EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 4566677 9999999999999999752 3456799999865332110 01122
Q ss_pred HHHHHHHHHhcCCC----CceeeeeEEEe--------CCeEEEEEeccCCCcHHHHHhhcC-------------------
Q psy12709 58 LHEAAVLYLAQKSE----RIVGLHEIYET--------PHEMVLVLEMVPDGELQRLVDIQD------------------- 106 (253)
Q Consensus 58 ~~e~~~~~~~~~~~----~i~~~~~~~~~--------~~~~~lv~e~~~g~~L~~~~~~~~------------------- 106 (253)
..|+..+.+..+++ +++++++++.. .+..++|+||+++++|.+++....
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 23555555333322 23556666542 346899999999999998875321
Q ss_pred -----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccc--cccCccccCc
Q psy12709 107 -----GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE--IIGTPDYVAP 179 (253)
Q Consensus 107 -----~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~~~P 179 (253)
.++...++.++.+++.++.|||+.+++|+||+|.||+++.++.++|+|||++........... ...++.|+||
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 134567888999999999999999999999999999999999999999999875433222121 2347899999
Q ss_pred cccCCCCC----------------------CccccHHHHHHHHHHHHhCCC-CCCCCChH-----------HHHHHhhcc
Q psy12709 180 EVLSYEPI----------------------SLATDMWSVGVLAYVLLSSHS-PFAGDNKQ-----------ETFLNISQC 225 (253)
Q Consensus 180 E~~~~~~~----------------------~~~~Di~slG~~l~~l~~g~~-p~~~~~~~-----------~~~~~i~~~ 225 (253)
|.+..... ....|+||+|+++++|++|.. |+...... ..+..+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 98753321 124699999999999999886 66532111 111122222
Q ss_pred cccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 226 NFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 226 ~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
...+ ......++...+|+.+||..+|
T Consensus 460 ~~~~--~~~d~~s~~~~dLi~~LL~~~~ 485 (507)
T PLN03224 460 KYDF--SLLDRNKEAGWDLACKLITKRD 485 (507)
T ss_pred CCCc--ccccccChHHHHHHHHHhccCC
Confidence 2222 2345679999999999999765
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=231.78 Aligned_cols=233 Identities=21% Similarity=0.290 Sum_probs=199.8
Q ss_pred EEeecCCCCceEEEEEEeccCC----ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITK----VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVL 90 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 90 (253)
..+.||+|+||+||+|..--.+ -+|++|++... ........+.+|+..+. ..+|+|+++++++..... +.+|+
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~ma-sldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMA-SLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHh-cCCCchHHHHhhhcccch-HHHHH
Confidence 5678999999999999977444 45888887654 33445678889999998 899999999999998765 88999
Q ss_pred eccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-cc--
Q psy12709 91 EMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VE-- 166 (253)
Q Consensus 91 e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~-- 166 (253)
+|+++|+|.++++. ++.+-....+.+..||++++.|||.+.++||||-++||+|..-..+|+.|||+++..... .+
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 99999999998876 467999999999999999999999999999999999999999999999999999866432 22
Q ss_pred ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 167 VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
.......+-|+|-|.+....++.++||||+|+++||++| |..|+.+...+++-..+..+.. . +..+..+-++..++
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-L--sqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-L--SQPPICTIDVYMVM 933 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-C--CCCCCccHHHHHHH
Confidence 222344678999999999999999999999999999999 9999999999999888887766 2 22358899999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
.+||..|+
T Consensus 934 vkCwmid~ 941 (1177)
T KOG1025|consen 934 VKCWMIDA 941 (1177)
T ss_pred HHHhccCc
Confidence 99998875
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=206.84 Aligned_cols=239 Identities=25% Similarity=0.435 Sum_probs=189.7
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeE-EEeCCe
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI-YETPHE 85 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~-~~~~~~ 85 (253)
..+-|. +.+.+|.|.||.+-+|.++.++..+++|.++++.... +++.+|...-..+..|.||+.-|++ |+..+.
T Consensus 22 l~d~y~--I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~---~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 22 LEDVYT--INKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQ---ADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhhh--HHHHhcccceeeEEeeeccCCceEEEeeccCcchhhH---HHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 344555 9999999999999999999999999999999876554 5888888765558899999998887 555678
Q ss_pred EEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC--CceEEEeecccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD--NNIKLCDFGISRVVND 163 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~--~~~~l~df~~~~~~~~ 163 (253)
++.++||++-|+|.+-+.. .++-+...+.+..|+++|+.|+|+++++||||+.+||++... ..+||||||.....+.
T Consensus 97 YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred EEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 8899999999999887764 558899999999999999999999999999999999999753 4799999999876543
Q ss_pred cccccccccCccccCccccCCC-----CCCccccHHHHHHHHHHHHhCCCCCCCCChH----HHHHHhhcccccccCCcc
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSYE-----PISLATDMWSVGVLAYVLLSSHSPFAGDNKQ----ETFLNISQCNFSFHEDLF 234 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~i~~~~~~~~~~~~ 234 (253)
. .........|.+||..... ...+.+|+|.+|++++++++|..||+..... -.+.+-..++-+-....+
T Consensus 176 t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F 253 (378)
T KOG1345|consen 176 T--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF 253 (378)
T ss_pred e--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence 2 2223345678888875322 2467899999999999999999999753222 223333344444445566
Q ss_pred CCCCHHHHHHHHHhcccCC
Q psy12709 235 GHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP 253 (253)
..+|+.+..+.++-|.++|
T Consensus 254 ~~fs~~a~r~Fkk~lt~~~ 272 (378)
T KOG1345|consen 254 NPFSEKALRLFKKSLTPRF 272 (378)
T ss_pred cccCHHHHHHHHHhcCCcc
Confidence 7889999999999888765
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=209.51 Aligned_cols=216 Identities=22% Similarity=0.332 Sum_probs=187.8
Q ss_pred CcceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
..|.+..+|. -++++|.|+- .|-.|.|.-.+++|++|+...+.......++..+|...++ ...|+||++++.+|.-
T Consensus 11 s~ftv~~Ry~--nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~-~v~~~nii~l~n~ftP 86 (369)
T KOG0665|consen 11 STFTVPKRYV--NLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMK-CVNHKNIISLLNVFTP 86 (369)
T ss_pred cceeeeeeee--eecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhh-hhcccceeeeeeccCc
Confidence 4577888888 9999999999 8888999999999999999888766666788999999998 9999999999999964
Q ss_pred C------CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeec
Q psy12709 83 P------HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFG 156 (253)
Q Consensus 83 ~------~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~ 156 (253)
. ...|+|||++. .+|...+. -.++-..+..+..|++.|+++||+.||+|||++|+||++..++.+|++|||
T Consensus 87 ~~~l~~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 87 QKTLEEFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred cccHHHHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccch
Confidence 3 26899999995 47877765 347888999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcc
Q psy12709 157 ISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQC 225 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~ 225 (253)
++..............+..|.|||++.+..+....||||+||++.+|++|+..|++.+.-+.+.++.+-
T Consensus 164 ~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~ 232 (369)
T KOG0665|consen 164 LARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQ 232 (369)
T ss_pred hhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHH
Confidence 998655543444556788999999999999999999999999999999999999988777777665543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=193.03 Aligned_cols=183 Identities=36% Similarity=0.588 Sum_probs=160.2
Q ss_pred cCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCCcH
Q psy12709 19 PSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGEL 98 (253)
Q Consensus 19 lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L 98 (253)
||.|++|.||++.+..++.++++|++....... ....+.+|+..++ ...+++|+++++++......++++|+++|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~-~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILK-KLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHH-hcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999999889999999998755432 3457888888888 66889999999999999999999999998999
Q ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-CCceEEEeecccccccccc-cccccccCcc
Q psy12709 99 QRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK-DNNIKLCDFGISRVVNDVV-EVKEIIGTPD 175 (253)
Q Consensus 99 ~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~-~~~~~l~df~~~~~~~~~~-~~~~~~~~~~ 175 (253)
.+++... ..++...+..++.+++.++.+||+.|++|+|++|.||+++. ++.++|+||+.+....... ..........
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence 9998765 46899999999999999999999999999999999999999 8999999999997654432 1233456789
Q ss_pred ccCccccCCC-CCCccccHHHHHHHHHHH
Q psy12709 176 YVAPEVLSYE-PISLATDMWSVGVLAYVL 203 (253)
Q Consensus 176 ~~~PE~~~~~-~~~~~~Di~slG~~l~~l 203 (253)
|++||..... ..+.++|+|++|++++++
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 9999998777 778899999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=192.36 Aligned_cols=240 Identities=22% Similarity=0.323 Sum_probs=200.4
Q ss_pred CcceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
.++++.++|+ ++++||+|+||.+|.|..-.+|.+||||+-...-.- -.+.-|......+..-.+|+.+.-++.+
T Consensus 9 ~~~iv~gky~--lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e 82 (341)
T KOG1163|consen 9 EELIVGGKYK--LVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTE 82 (341)
T ss_pred hhheeccceE--EEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccc
Confidence 4688999999 999999999999999999999999999987654332 2566778888877788889999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC---CceEEEeeccc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD---NNIKLCDFGIS 158 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~---~~~~l~df~~~ 158 (253)
...-.+||+.+ |.+|+++.+- ...++...++-++-|++.-++|+|.++.+|+||+|+|+++.-+ ..+.++|||++
T Consensus 83 ~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 83 KDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred cccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccch
Confidence 99999999987 8899999875 4569999999999999999999999999999999999999865 46899999999
Q ss_pred cccccc--------ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHhhcccc
Q psy12709 159 RVVNDV--------VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDN---KQETFLNISQCNF 227 (253)
Q Consensus 159 ~~~~~~--------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~i~~~~~ 227 (253)
+...+. .......|+.+|.+--...+...+++.|+-|+|.++.++--|..||++.. ....++.|.+.+.
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM 241 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence 866432 23344678889998888777788999999999999999999999998854 4455666665544
Q ss_pred c-ccCCccCCCCHHHHHHHHHhc
Q psy12709 228 S-FHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 228 ~-~~~~~~~~~~~~l~~li~~~l 249 (253)
+ +++.++..+|.++.-.+.-|-
T Consensus 242 s~~ie~LC~G~P~EF~myl~Y~R 264 (341)
T KOG1163|consen 242 STPIEVLCKGFPAEFAMYLNYCR 264 (341)
T ss_pred CCCHHHHhCCCcHHHHHHHHHHh
Confidence 4 446677788988888777663
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=224.45 Aligned_cols=238 Identities=23% Similarity=0.370 Sum_probs=205.7
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++++.+|+|++|.||++.++.+++..++|+++..... ...-+..|+-++. -++|+||+.+++.+...+..|+.|||
T Consensus 17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~-dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLR-DCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred hhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeee-cCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 34999999999999999999999999999999876543 3556777888887 99999999999999999999999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-ccccccc
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEVKEII 171 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~ 171 (253)
|.||+|++.-.-.+++++.++..+.++.+.+++|||+.|-+||||+-.||++++.|.+++.|||.+...... .......
T Consensus 94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krksfi 173 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFI 173 (829)
T ss_pred cCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhccc
Confidence 999999998877889999999999999999999999999999999999999999999999999998765432 2334578
Q ss_pred cCccccCcccc---CCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC-CccCCCCHHHHHHHHH
Q psy12709 172 GTPDYVAPEVL---SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE-DLFGHISSQAKDFIQS 247 (253)
Q Consensus 172 ~~~~~~~PE~~---~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~l~~li~~ 247 (253)
|++.|+|||+- ....|...+|+|++|++..++..-+.|.-...+........+..++++. +....-++.+.+|++.
T Consensus 174 GtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~ 253 (829)
T KOG0576|consen 174 GTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKG 253 (829)
T ss_pred CCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHH
Confidence 99999999985 4446788999999999999999999998777777777666666665553 2334568889999999
Q ss_pred hcccCC
Q psy12709 248 CLVTDP 253 (253)
Q Consensus 248 ~l~~dP 253 (253)
||.+||
T Consensus 254 altknp 259 (829)
T KOG0576|consen 254 ALTKNP 259 (829)
T ss_pred HhcCCC
Confidence 999998
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=224.21 Aligned_cols=230 Identities=26% Similarity=0.315 Sum_probs=183.5
Q ss_pred eEEEeecCCCCce-EEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFA-SVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~-~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
+.-.+.+|.|+.| .||+|... ++.||||.+-.. ....+.+|+..++....|+||++++..-.+....|+..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 3345678999886 68999875 889999977543 334677999999999999999999999999999999999
Q ss_pred ccCCCcHHHHHhhc-CC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC---C--CceEEEeeccccccc
Q psy12709 92 MVPDGELQRLVDIQ-DG---IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK---D--NNIKLCDFGISRVVN 162 (253)
Q Consensus 92 ~~~g~~L~~~~~~~-~~---~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~---~--~~~~l~df~~~~~~~ 162 (253)
.| ..+|++++... .. -.....+.++.|+++|+++||+.+|+|||++|.||+|.. + ..++|.|||+++.+.
T Consensus 584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 99 56999999864 11 112456788999999999999999999999999999987 2 458999999999775
Q ss_pred ccc----cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCC
Q psy12709 163 DVV----EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHI 237 (253)
Q Consensus 163 ~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 237 (253)
..+ ......|+..|+|||++.....+.+.||||+||++|+.++ |.+||...-.++ .+|..+.....+- .+.-
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L-~~~~ 739 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHL-EPLP 739 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeee-ccCc
Confidence 432 2344578899999999999888889999999999999999 589997654433 3555555544321 1122
Q ss_pred CHHHHHHHHHhcccCC
Q psy12709 238 SSQAKDFIQSCLVTDP 253 (253)
Q Consensus 238 ~~~l~~li~~~l~~dP 253 (253)
..+..|||.+|+++||
T Consensus 740 d~eA~dLI~~ml~~dP 755 (903)
T KOG1027|consen 740 DCEAKDLISRMLNPDP 755 (903)
T ss_pred hHHHHHHHHHhcCCCc
Confidence 2289999999999998
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=194.90 Aligned_cols=238 Identities=19% Similarity=0.290 Sum_probs=204.3
Q ss_pred CCcceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy12709 2 CNKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81 (253)
Q Consensus 2 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 81 (253)
.+.++++-.|+ +.++||.|+||..|.|...-++.+||||.-+.....+ ++..|......+...++|...+.+..
T Consensus 21 s~~~~VG~hyr--VGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP----QLrdEYr~YKlL~g~~GIP~vYYFGq 94 (449)
T KOG1165|consen 21 SGVLMVGPHYR--VGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP----QLRDEYRTYKLLGGTEGIPQVYYFGQ 94 (449)
T ss_pred CCceEecccce--eccccccCcceeeecccccccCceEEEEeccccCCcc----hHHHHHHHHHHHcCCCCCCceeeecc
Confidence 36778999999 9999999999999999999999999999987655443 67788888888889999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-----ceEEEee
Q psy12709 82 TPHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN-----NIKLCDF 155 (253)
Q Consensus 82 ~~~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~-----~~~l~df 155 (253)
++-+-.+|+|.+ |-+|+++..- ...|+...+.-++.|++.-++++|++.+++|||+|+|++|..-+ .+.++||
T Consensus 95 eG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 95 EGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred ccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEec
Confidence 999999999988 8899999875 45699999999999999999999999999999999999998643 4899999
Q ss_pred ccccccccc--------ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC---CChHHHHHHhhc
Q psy12709 156 GISRVVNDV--------VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAG---DNKQETFLNISQ 224 (253)
Q Consensus 156 ~~~~~~~~~--------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~---~~~~~~~~~i~~ 224 (253)
|+++...++ ++.....|+.+||+--...+...+++.|+-|||-++.+++-|.+||.+ .+..+.+++|..
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 999976543 233456788999999999999999999999999999999999999977 567788888866
Q ss_pred ccc-cccCCccCCCCHHHHHHHH
Q psy12709 225 CNF-SFHEDLFGHISSQAKDFIQ 246 (253)
Q Consensus 225 ~~~-~~~~~~~~~~~~~l~~li~ 246 (253)
.+. ++...++..+|+++...+.
T Consensus 254 ~Kr~T~i~~Lc~g~P~efa~Yl~ 276 (449)
T KOG1165|consen 254 TKRSTPIEVLCEGFPEEFATYLR 276 (449)
T ss_pred ccccCCHHHHHhcCHHHHHHHHH
Confidence 544 4445666777877766554
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-29 Score=199.74 Aligned_cols=137 Identities=25% Similarity=0.434 Sum_probs=115.9
Q ss_pred CcceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCC-------CCcee
Q psy12709 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKS-------ERIVG 75 (253)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~-------~~i~~ 75 (253)
|..|..++|- ++++||=|.|++||+|.|.+..+.||+|+.+... -..+....||..+++...+ ..||+
T Consensus 72 GD~F~~gRY~--v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 72 GDVFNGGRYH--VQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred cccccCceEE--EEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 4455557777 9999999999999999999999999999987532 2345777899888865543 35999
Q ss_pred eeeEEEe----CCeEEEEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEc
Q psy12709 76 LHEIYET----PHEMVLVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDH-NITHLDLKPQNILLT 145 (253)
Q Consensus 76 ~~~~~~~----~~~~~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~di~~~ni~~~ 145 (253)
+++.|.. +.++++|+|++ |.+|..+|... .+++...++.+++|++.+|.|||+. ||+|.||||+||++.
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 9999975 34899999998 88888888763 5799999999999999999999975 999999999999993
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-27 Score=189.75 Aligned_cols=202 Identities=22% Similarity=0.199 Sum_probs=164.0
Q ss_pred eeEEEeecCCCCceEEEEEEeccCC-ceEEEEEecccccchHHHHHHHHHHHHHHHhc---CCCCceeeeeEE-EeCCeE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITK-VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ---KSERIVGLHEIY-ETPHEM 86 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~---~~~~i~~~~~~~-~~~~~~ 86 (253)
+|.+.+.||+|+||.||.|.+..++ ..+|+|+.......... .+..|...+..+. ...++..+++.+ ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 4449999999999999999998765 67888887765432221 4445565555444 456899999999 577789
Q ss_pred EEEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-----CceEEEeecccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD-----NNIKLCDFGISR 159 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~-----~~~~l~df~~~~ 159 (253)
++||+.+ |.+|.++.... ..++...+..++.|++.+|+++|+.|++||||+|.|+.+... ..+.++|||+++
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999977 89999988554 469999999999999999999999999999999999999875 459999999998
Q ss_pred --cccccc--------c-ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH
Q psy12709 160 --VVNDVV--------E-VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ 216 (253)
Q Consensus 160 --~~~~~~--------~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 216 (253)
...... . .....|+.+|+|+.+..+...+++.|+||++.++.+++.|..||.+....
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~ 243 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT 243 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence 321111 1 12345889999999999999999999999999999999999999776543
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=189.16 Aligned_cols=237 Identities=18% Similarity=0.262 Sum_probs=192.0
Q ss_pred eeEEEeecCCCCceEEEEEEeccC-----CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe-CCe
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKIT-----KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET-PHE 85 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~ 85 (253)
++++...+-.|.||.||.|...+. .+.|.+|.++.. .+.-+...+..|.-.+. -..|+|+.++.++.-. ...
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly-~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLY-GASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHh-cCcCCCccceeEEEeeccCc
Confidence 455888999999999999966532 244666766543 33445667777777776 5569999999988754 458
Q ss_pred EEEEEeccCCCcHHHHHhh-----c---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecc
Q psy12709 86 MVLVLEMVPDGELQRLVDI-----Q---DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI 157 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~-----~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~ 157 (253)
.++++.+..-++|..++.. . ..++..++..++.|++.|+++||++|++|.||.++|.++++.-.+||+|=.+
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaL 442 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSAL 442 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchh
Confidence 8999999999999999872 1 2377889999999999999999999999999999999999999999999999
Q ss_pred ccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCc
Q psy12709 158 SRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDL 233 (253)
Q Consensus 158 ~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 233 (253)
++......- -........||+||.+....++.++|+||+|+++|||+| |+.|+...++.++.--++++.. ..++
T Consensus 443 SRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR-laQP- 520 (563)
T KOG1024|consen 443 SRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR-LAQP- 520 (563)
T ss_pred ccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce-ecCC-
Confidence 986543211 112334569999999999999999999999999999999 9999999999998877766543 2232
Q ss_pred cCCCCHHHHHHHHHhcccCC
Q psy12709 234 FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP 253 (253)
.++|+++..++.-||..+|
T Consensus 521 -~NCPDeLf~vMacCWallp 539 (563)
T KOG1024|consen 521 -FNCPDELFTVMACCWALLP 539 (563)
T ss_pred -CCCcHHHHHHHHHHHhcCc
Confidence 4899999999999999887
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=191.90 Aligned_cols=193 Identities=31% Similarity=0.500 Sum_probs=166.1
Q ss_pred cceeeEEEeecCCCCceEEEEEEecc---CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKI---TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
..|. .+++||.|+|++||++.+.. ..+.|++|.+...... ..+..|+..+.....+.||+.+.+.+..++.
T Consensus 36 ~~~~--~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 36 NAYK--VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhh--hhccccccchhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 4455 89999999999999999987 7788999999876553 3788999999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-CCceEEEeecccccccc-
Q psy12709 86 MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK-DNNIKLCDFGISRVVND- 163 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~-~~~~~l~df~~~~~~~~- 163 (253)
..+|+||++.....++... ++..++..+++.++.|+.++|.+||+||||+|.|++.+. .+.-.|+|||++.....
T Consensus 110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 9999999999999998764 678999999999999999999999999999999999987 47899999999872100
Q ss_pred -------c-------------------------------------ccccccccCccccCcccc-CCCCCCccccHHHHHH
Q psy12709 164 -------V-------------------------------------VEVKEIIGTPDYVAPEVL-SYEPISLATDMWSVGV 198 (253)
Q Consensus 164 -------~-------------------------------------~~~~~~~~~~~~~~PE~~-~~~~~~~~~Di~slG~ 198 (253)
. .......|+++|.|||++ .....+.+.||||.|+
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 000113578899999997 4456788999999999
Q ss_pred HHHHHHhCCCCC
Q psy12709 199 LAYVLLSSHSPF 210 (253)
Q Consensus 199 ~l~~l~~g~~p~ 210 (253)
++..++++..||
T Consensus 267 I~Lslls~~~PF 278 (418)
T KOG1167|consen 267 ILLSLLSRRYPF 278 (418)
T ss_pred eeehhhcccccc
Confidence 999999999997
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=178.56 Aligned_cols=233 Identities=21% Similarity=0.272 Sum_probs=151.4
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcC---------CCCceeeeeE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQK---------SERIVGLHEI 79 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~---------~~~i~~~~~~ 79 (253)
..+....+.||.|+++.||.+.|.+++.++++|++..... .....+++.+|......... +-.++-.++.
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 3344566799999999999999999999999999876653 23346666666655542222 2234444444
Q ss_pred EEe---------C---C-----eEEEEEeccCCCcHHHHHhh---cCC----CCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy12709 80 YET---------P---H-----EMVLVLEMVPDGELQRLVDI---QDG----IPEQDTRSYMKQILEALAFLHDHNITHL 135 (253)
Q Consensus 80 ~~~---------~---~-----~~~lv~e~~~g~~L~~~~~~---~~~----~~~~~~~~~~~~l~~~l~~lh~~~~~h~ 135 (253)
... . . ..+++|+-+ .++|.+++.. ... ........+..|+++.+++||..|++|+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg 169 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG 169 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence 321 1 1 236778877 5588777642 221 2233334555899999999999999999
Q ss_pred CCCCCCEEEcCCCceEEEeecccccccccccccccccCccccCccccCCC--------CCCccccHHHHHHHHHHHHhCC
Q psy12709 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYE--------PISLATDMWSVGVLAYVLLSSH 207 (253)
Q Consensus 136 di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--------~~~~~~Di~slG~~l~~l~~g~ 207 (253)
||+|+|++++.+|.+.|+||+.....+..... ...+..|.|||..... .++.+.|.|+||+++|.|++|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999999999999999877665443222 3445789999976432 4678999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 208 SPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 208 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.||........... ....+..+|+.+++||.++|++||
T Consensus 248 lPf~~~~~~~~~~~--------~f~~C~~~Pe~v~~LI~~lL~~~~ 285 (288)
T PF14531_consen 248 LPFGLSSPEADPEW--------DFSRCRDMPEPVQFLIRGLLQRNP 285 (288)
T ss_dssp -STCCCGGGSTSGG--------GGTTSS---HHHHHHHHHHT-SSG
T ss_pred CCCCCCCccccccc--------cchhcCCcCHHHHHHHHHHccCCc
Confidence 99986544322110 222334889999999999999997
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-24 Score=172.60 Aligned_cols=238 Identities=31% Similarity=0.489 Sum_probs=192.0
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchH-HHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMD-QMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
|.+.+.||.|+|+.||.+.+. ..+++|.+........ ....+.+|+..+.....+++++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 448999999999999999988 7889999987765443 567888888878744444489999999987778899999
Q ss_pred ccCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-ceEEEeecccccccccc--
Q psy12709 92 MVPDGELQRLVDIQD---GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN-NIKLCDFGISRVVNDVV-- 165 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~-~~~l~df~~~~~~~~~~-- 165 (253)
++.++++.+++.... .++......++.+++.++.++|+.+++|+|++|+||+++..+ .++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998777664 799999999999999999999999999999999999999988 79999999987544322
Q ss_pred -----cccccccCccccCccccCC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHhhccccc-ccCC
Q psy12709 166 -----EVKEIIGTPDYVAPEVLSY---EPISLATDMWSVGVLAYVLLSSHSPFAGDNK----QETFLNISQCNFS-FHED 232 (253)
Q Consensus 166 -----~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~i~~~~~~-~~~~ 232 (253)
......++..|.+||.+.+ .......|+|++|++++++++|..||..... ......+...... ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 2355678899999999987 5778899999999999999999999877663 4555555554433 2222
Q ss_pred ccCCC----CHHHHHHHHHhcccCC
Q psy12709 233 LFGHI----SSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 ~~~~~----~~~l~~li~~~l~~dP 253 (253)
..... ...+.+++..|+..+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDP 263 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCc
Confidence 21222 2578899999988765
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=207.64 Aligned_cols=177 Identities=18% Similarity=0.217 Sum_probs=126.2
Q ss_pred CCceeeeeEE-------EeCCeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q psy12709 71 ERIVGLHEIY-------ETPHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNI 142 (253)
Q Consensus 71 ~~i~~~~~~~-------~~~~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni 142 (253)
+||..+++.+ ...+.++.++|++ +.+|.+++.. ...+++.+++.++.|++.||.|||++||+|+||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 4666666665 2234688889987 6699999975 34599999999999999999999999999999999999
Q ss_pred EEcCCCceE-------------------EEeecccccccccc-----------------cccccccCccccCccccCCCC
Q psy12709 143 LLTKDNNIK-------------------LCDFGISRVVNDVV-----------------EVKEIIGTPDYVAPEVLSYEP 186 (253)
Q Consensus 143 ~~~~~~~~~-------------------l~df~~~~~~~~~~-----------------~~~~~~~~~~~~~PE~~~~~~ 186 (253)
+++..|.++ ++|||.++...... ......+++.|+|||++.+..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 997655544 55555543211000 000124677899999999999
Q ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 187 ISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 187 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
++.++||||+||++|||++|..|+..... ....+.....+ +. . ....+...+++.+||++||
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~-~~-~-~~~~~~~~~~~~~~L~~~P 253 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLP-PQ-I-LLNWPKEASFCLWLLHPEP 253 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcC-hh-h-hhcCHHHHHHHHHhCCCCh
Confidence 99999999999999999999888754321 22222221111 11 1 1235567899999999998
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=166.95 Aligned_cols=146 Identities=23% Similarity=0.303 Sum_probs=113.6
Q ss_pred CcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccccccCc
Q psy12709 96 GELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTP 174 (253)
Q Consensus 96 ~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 174 (253)
|+|.+++.. ..++++..++.++.|++.|+.|||+++ +|.||+++.++.+++ ||.+....... ..+++
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence 588898876 456999999999999999999999998 999999999999999 99887654322 25789
Q ss_pred cccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhcccccccC---CccCCCCH--HHHHHHHHh
Q psy12709 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ-ETFLNISQCNFSFHE---DLFGHISS--QAKDFIQSC 248 (253)
Q Consensus 175 ~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~i~~~~~~~~~---~~~~~~~~--~l~~li~~~ 248 (253)
.|+|||++.+..++.++||||+|+++|+|++|+.||...... .....+......... .....+++ ++.++|.+|
T Consensus 69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c 148 (176)
T smart00750 69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVC 148 (176)
T ss_pred cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHH
Confidence 999999999999999999999999999999999999764332 223232221111100 11123344 699999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|+.||
T Consensus 149 l~~~p 153 (176)
T smart00750 149 ASRLP 153 (176)
T ss_pred Hhccc
Confidence 99998
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-25 Score=179.50 Aligned_cols=164 Identities=20% Similarity=0.174 Sum_probs=125.3
Q ss_pred eecceeeEEEeecCCCCceEEEEEEecc-CCceEEEEEeccccc---chHHHHHHHHHHHHHHHhcCCCCcee-eeeEEE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKI-TKVEYAAKFIRKRRR---SMDQMQDILHEAAVLYLAQKSERIVG-LHEIYE 81 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~-~~~~~~ 81 (253)
..++|+ +.+.||+|+||+||+|.+.. ++..+|+|....... .......+.+|+..+. .+.|++++. +++.
T Consensus 16 ~~~~Y~--~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~-~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 16 LSARFV--ETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALK-TVRGIGVVPQLLAT-- 90 (365)
T ss_pred ccCCce--EccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHH-hccCCCCCcEEEEc--
Confidence 456677 99999999999999999886 677789998753311 2233556889999998 667888774 4432
Q ss_pred eCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCCEEEcCCCceEEEeeccccc
Q psy12709 82 TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL-KPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 82 ~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di-~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
+..+++|||++|++|... . . .. ...++.+++.++.+||++|++|+|| +|.||+++.++.++|+|||++..
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~-~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-R-P--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-C-c--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 457999999999999632 1 1 11 1467889999999999999999999 89999999999999999999986
Q ss_pred cccccc---------ccccccCccccCccccCC
Q psy12709 161 VNDVVE---------VKEIIGTPDYVAPEVLSY 184 (253)
Q Consensus 161 ~~~~~~---------~~~~~~~~~~~~PE~~~~ 184 (253)
...... .....+++.|.+||.+..
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 543211 123345677899998744
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=165.52 Aligned_cols=174 Identities=14% Similarity=0.212 Sum_probs=131.5
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHH-HH------HHHHHHHHHHhcCCCCceeeee
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQM-QD------ILHEAAVLYLAQKSERIVGLHE 78 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~-~~------~~~e~~~~~~~~~~~~i~~~~~ 78 (253)
+..++|+ .++.+|.|+||.||++.+ ++..+++|++.......+.. .. +.+|+..+. .+.|++|..+.+
T Consensus 28 ~l~~~y~--~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~-rL~~~GI~~~~d 102 (232)
T PRK10359 28 FLSYNIK--TIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTD-RVRSEGLASLND 102 (232)
T ss_pred HhhCceE--EEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHH-HHHHCCCCcceE
Confidence 4567777 999999999999999766 46689999997655333322 22 467777777 559999999988
Q ss_pred EEEeC--------CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCce
Q psy12709 79 IYETP--------HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNI 150 (253)
Q Consensus 79 ~~~~~--------~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~ 150 (253)
++... ...+++|||++|.+|.++.. +++ ....+++.++..+|+.|++|+|++|.||+++++| +
T Consensus 103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred eeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-E
Confidence 86643 35889999999999987742 333 2456899999999999999999999999999988 9
Q ss_pred EEEeecccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHH
Q psy12709 151 KLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLL 204 (253)
Q Consensus 151 ~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~ 204 (253)
+++|||............. ......+..++|+|+||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~a~d~-----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAKDR-----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhHHH-----------HHHHhHhcccccccceeEeehHHH
Confidence 9999998765432221111 222334567899999999886553
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-26 Score=198.22 Aligned_cols=233 Identities=21% Similarity=0.228 Sum_probs=176.4
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc--cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR--RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
.++..+.||++.|-+|.+|++.+.- |++|++-+.. .+.....+..+|++ ..+.++||.+++..+.+.+...|+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~--vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL--VVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce--EEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHHhhHHHHHH
Confidence 4568999999999999999987433 8899887655 33444555566666 3378999999999998888889999
Q ss_pred EeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc--ccc-c
Q psy12709 90 LEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN--DVV-E 166 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~--~~~-~ 166 (253)
.+|.. -+|.|++..++.+...+.++++.|++.|+..+|+.|+.|||||.+||+++.-+++.|.||..-+... +.+ .
T Consensus 100 Rqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 100 RQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 99994 4999999999999999999999999999999999999999999999999999999999998766432 111 1
Q ss_pred c-----cccccCccccCccccCCC----------C-CCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccc
Q psy12709 167 V-----KEIIGTPDYVAPEVLSYE----------P-ISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSF 229 (253)
Q Consensus 167 ~-----~~~~~~~~~~~PE~~~~~----------~-~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~ 229 (253)
. .......+|.|||.+... + .+++.||||+||+++|+++ |.+||.- ..+...+.+.-..
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~~ 254 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNADD 254 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCccC
Confidence 0 111234599999988542 2 5789999999999999999 8888841 1111122221111
Q ss_pred cCCcc-CCCCHHHHHHHHHhcccCC
Q psy12709 230 HEDLF-GHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 ~~~~~-~~~~~~l~~li~~~l~~dP 253 (253)
++... .--+..++.+|..|++.||
T Consensus 255 ~e~~Le~Ied~~~Rnlil~Mi~rdP 279 (1431)
T KOG1240|consen 255 PEQLLEKIEDVSLRNLILSMIQRDP 279 (1431)
T ss_pred HHHHHHhCcCccHHHHHHHHHccCc
Confidence 11111 1224569999999999998
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-25 Score=192.84 Aligned_cols=237 Identities=23% Similarity=0.351 Sum_probs=183.6
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecc----cccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRK----RRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVL 90 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~----~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 90 (253)
....+|.|++|.++.+......+.+..|.+.. ..........+..|..+-. .+.|+|++.......+.....-.|
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~-~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGS-SLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecc-cccCCchhhhHHHHhhcccchhhh
Confidence 45689999999999998887777666666542 1121111122334444443 778999988888887777666669
Q ss_pred eccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-----c
Q psy12709 91 EMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-----V 165 (253)
Q Consensus 91 e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-----~ 165 (253)
|||++ +|..++.....++..++-.+..|++.+++|+|+.|+.|+|++++|+++..+|.+|++|||.+..+.-. .
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~ 479 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH 479 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence 99999 99999887768999999999999999999999999999999999999999999999999999865432 2
Q ss_pred cccccccCccccCccccCCCCCCc-cccHHHHHHHHHHHHhCCCCCCCCChHHHH--HH---hhcccccccCCccCCCCH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISL-ATDMWSVGVLAYVLLSSHSPFAGDNKQETF--LN---ISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~~---i~~~~~~~~~~~~~~~~~ 239 (253)
......+...|+|||++.+..|++ ..||||.|++++.|.+|+.||.-....+.. .. ........+..+...++.
T Consensus 480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~ 559 (601)
T KOG0590|consen 480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPR 559 (601)
T ss_pred hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchh
Confidence 334567889999999999998876 599999999999999999999765554332 11 111122223345567899
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
.-+.+|.+||++||
T Consensus 560 ~~~~~~~~~l~~~P 573 (601)
T KOG0590|consen 560 ETRIIIYRMLQLDP 573 (601)
T ss_pred hHHHHHHHHccCCh
Confidence 99999999999998
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-24 Score=160.20 Aligned_cols=141 Identities=22% Similarity=0.178 Sum_probs=108.0
Q ss_pred EeecCCCCceEEEEEEeccCCceEEEEEecccccchHH------------------------HHHHHHHHHHHHHhcCCC
Q psy12709 16 FCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ------------------------MQDILHEAAVLYLAQKSE 71 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~------------------------~~~~~~e~~~~~~~~~~~ 71 (253)
.+.||+|++|+||.|.+. +|++||+|+++........ ......|+..+. ...++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLK-RLVTA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHH-HHHHC
Confidence 468999999999999987 8999999999765321111 122344777777 44556
Q ss_pred CceeeeeEEEeCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCCEEEcCCCce
Q psy12709 72 RIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFL-HDHNITHLDLKPQNILLTKDNNI 150 (253)
Q Consensus 72 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~l-h~~~~~h~di~~~ni~~~~~~~~ 150 (253)
++..+..+... ..++||||++|+++........+++...+..++.|++.++.++ |+.|++|+||+|.||+++ ++.+
T Consensus 80 ~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 80 GIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence 65443333222 2389999999887765544456789999999999999999999 799999999999999998 5889
Q ss_pred EEEeecccccc
Q psy12709 151 KLCDFGISRVV 161 (253)
Q Consensus 151 ~l~df~~~~~~ 161 (253)
+|+|||++...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 99999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-25 Score=184.37 Aligned_cols=222 Identities=27% Similarity=0.432 Sum_probs=187.7
Q ss_pred cCCCCceEEEEEEec---cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 19 PSRGKFASVRKCTHK---ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 19 lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
+|.|++|.|+++... ..+.-|++|+..+.............|-..+.....++.++++...+..+...+++.++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 789999999988633 34567899988765532222224555666666567799999999999999999999999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccccccCcc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPD 175 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (253)
+.+...+.....+++.....+..+++-+++.+|+.+++|+|+|++||+++.+|++++.|||.++..-..... +++..
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~e 158 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTYE 158 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccchh
Confidence 999888887888999999999999999999999999999999999999999999999999999865443332 78999
Q ss_pred ccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 176 YVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 176 ~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
|+|||+++ ....+.|.||+|++++++++|..||.. +....|.......|. .++..+++++.+++..||
T Consensus 159 ymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 159 YRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFKRNP 226 (612)
T ss_pred hhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHhhCH
Confidence 99999998 556789999999999999999999987 666777777777766 779999999999998886
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.8e-23 Score=153.69 Aligned_cols=143 Identities=20% Similarity=0.138 Sum_probs=109.5
Q ss_pred EeecCCCCceEEEEEEeccCCceEEEEEecccccchH------------------------HHHHHHHHHHHHHHhcCCC
Q psy12709 16 FCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMD------------------------QMQDILHEAAVLYLAQKSE 71 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~------------------------~~~~~~~e~~~~~~~~~~~ 71 (253)
.+.||+|++|+||+|.+. +|..||+|++........ ......+|...+. ...++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLK-RLYEA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHH-HHHhC
Confidence 578999999999999987 899999999886532110 0122346677776 45667
Q ss_pred CceeeeeEEEeCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCce
Q psy12709 72 RIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQNILLTKDNNI 150 (253)
Q Consensus 72 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~di~~~ni~~~~~~~~ 150 (253)
++..+..+.... .++||||++|+++.........++......++.+++.++.++|+ .|++|+||+|.||+++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 765444443332 48999999887554332234567889999999999999999999 9999999999999999 8999
Q ss_pred EEEeecccccccc
Q psy12709 151 KLCDFGISRVVND 163 (253)
Q Consensus 151 ~l~df~~~~~~~~ 163 (253)
+|+|||++.....
T Consensus 157 ~liDFG~a~~~~~ 169 (190)
T cd05145 157 YIIDVSQAVELDH 169 (190)
T ss_pred EEEEcccceecCC
Confidence 9999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=180.17 Aligned_cols=200 Identities=24% Similarity=0.249 Sum_probs=162.8
Q ss_pred CcceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch-HHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy12709 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM-DQMQDILHEAAVLYLAQKSERIVGLHEIYE 81 (253)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 81 (253)
++.+.-++-.|.|.+.+|.|+||+||+|.+.. |+.||+|+-......+ -...+++..++ ..--+.|.++...+.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk----~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK----PQMLPSIMHISSAHV 764 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc----hhhhcchHHHHHHHc
Confidence 34556667778899999999999999999886 9999999876554211 11122222222 222355666666667
Q ss_pred eCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-------CceEEEe
Q psy12709 82 TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD-------NNIKLCD 154 (253)
Q Consensus 82 ~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~-------~~~~l~d 154 (253)
..+.-++|++|.+-|+|.++++....+++..+..+..|++..++.||..+|+||||||+|+++... -.++|+|
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred cCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 778889999999999999999988889999999999999999999999999999999999999653 3489999
Q ss_pred eccccccc---ccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCC
Q psy12709 155 FGISRVVN---DVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSH 207 (253)
Q Consensus 155 f~~~~~~~---~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~ 207 (253)
||.+..+. +.......+.+..+-++|+..|.+|+++.|.|.++.+++-|+.|+
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 99998553 444556667888999999999999999999999999999999985
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-23 Score=155.75 Aligned_cols=231 Identities=19% Similarity=0.308 Sum_probs=185.3
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEecc
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMV 93 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 93 (253)
.++.+|.....|..|+|..+ |..++.|++.-........+++.+|.-.++ ...||||+.+++.+..+..+.+++.|+
T Consensus 193 nl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lr-ifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALR-IFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCccee-eecCCchhhhhhhccCCCCceEeeeec
Confidence 36678889999999999997 555677888776666666778888888887 999999999999999999999999999
Q ss_pred CCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEcCCCceEEEeecccccccccccccc
Q psy12709 94 PDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHN--ITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE 169 (253)
Q Consensus 94 ~g~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~--~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (253)
+-++|..++..... .+..++.+++.+++++++|||+.. +.---++...++++++-+.+|.--..-..+. -..
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq----e~g 345 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----EVG 345 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee----ccc
Confidence 99999999876543 688899999999999999999975 4445688999999998776654211111111 123
Q ss_pred cccCccccCccccCCCCCC---ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHH
Q psy12709 170 IIGTPDYVAPEVLSYEPIS---LATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~~~~---~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~ 246 (253)
....|.|++||.+...+-+ .++|+||+++++||+.|.++||...++.+---+|.-.+..+ ...+.+|..+..|++
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv--~ippgis~hm~klm~ 423 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV--HIPPGISRHMNKLMN 423 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc--cCCCCccHHHHHHHH
Confidence 4568899999999776543 47999999999999999999999988887766665444333 233589999999999
Q ss_pred HhcccCC
Q psy12709 247 SCLVTDP 253 (253)
Q Consensus 247 ~~l~~dP 253 (253)
-|+..||
T Consensus 424 icmnedp 430 (448)
T KOG0195|consen 424 ICMNEDP 430 (448)
T ss_pred HHhcCCC
Confidence 9999998
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.6e-21 Score=142.75 Aligned_cols=186 Identities=15% Similarity=0.098 Sum_probs=136.8
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchH--HHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMD--QMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
....|++|+||+|+.+.. .+.+++.+.+........ ....+.+|+.++.++..+++++.++++ +..+++|+|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 457899999999997765 677788777665443111 123578899999977778889999886 356999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCCEEEcCCCceEEEeecccccccccccc----
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL-KPQNILLTKDNNIKLCDFGISRVVNDVVEV---- 167 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di-~~~ni~~~~~~~~~l~df~~~~~~~~~~~~---- 167 (253)
+.|.+|...... ....+..+++.++.++|+.|++|+|| +|.||+++.+|.++|+|||++.........
T Consensus 80 I~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L 152 (218)
T PRK12274 80 LAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLL 152 (218)
T ss_pred ecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHH
Confidence 999998654321 11346789999999999999999999 799999999999999999999854432210
Q ss_pred ----------cccccCccccCccccCCC-CCC-ccccHHHHHHHHHHHHhCCCCCCCC
Q psy12709 168 ----------KEIIGTPDYVAPEVLSYE-PIS-LATDMWSVGVLAYVLLSSHSPFAGD 213 (253)
Q Consensus 168 ----------~~~~~~~~~~~PE~~~~~-~~~-~~~Di~slG~~l~~l~~g~~p~~~~ 213 (253)
.-....+.++.|+...-. ..+ .+.+.++.|.-+|.++|+..|.-++
T Consensus 153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 011235566666543222 222 4678889999999999999886543
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.8e-22 Score=172.73 Aligned_cols=202 Identities=30% Similarity=0.514 Sum_probs=159.0
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
.++. .++.|..|++|-||.+.++.+..++++| +.+.... .+. ++. ...++.++
T Consensus 83 ~df~--~IklisngAygavylvrh~~trqrfa~k-iNkq~li-------lRn--ilt-~a~npfvv-------------- 135 (1205)
T KOG0606|consen 83 SDFN--TIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-------LRN--ILT-FAGNPFVV-------------- 135 (1205)
T ss_pred cccc--eeEeeccCCCCceeeeeccccccchhhc-ccccchh-------hhc--ccc-ccCCccee--------------
Confidence 4455 9999999999999999999999999984 3332211 111 111 22333322
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc-----
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND----- 163 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~----- 163 (253)
++-..++..-++++... +.+++|+|+.|++|+|++|+|.+|+.-|++|+.|||+++...-
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 34444444434444333 7789999999999999999999999999999999999874311
Q ss_pred -----------cccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCC
Q psy12709 164 -----------VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHED 232 (253)
Q Consensus 164 -----------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 232 (253)
.......+++|.|.|||++.-+.|....|.|++|+++|+++-|..||.+++.++.+.++......+++.
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 112234578999999999998999999999999999999999999999999999999998888888887
Q ss_pred ccCCCCHHHHHHHHHhcccCC
Q psy12709 233 LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 ~~~~~~~~l~~li~~~l~~dP 253 (253)
-..++++++++|.++|+.||
T Consensus 281 -dea~p~Ea~dli~~LL~qnp 300 (1205)
T KOG0606|consen 281 -DEALPPEAQDLIEQLLRQNP 300 (1205)
T ss_pred -CcCCCHHHHHHHHHHHHhCh
Confidence 57899999999999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-21 Score=149.04 Aligned_cols=151 Identities=22% Similarity=0.130 Sum_probs=115.1
Q ss_pred eeecceeeEEEeecCCCCceEEEEEE-eccCCceEEEEEecccccch--------------------H--HHHHHHHHHH
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCT-HKITKVEYAAKFIRKRRRSM--------------------D--QMQDILHEAA 62 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~-~~~~~~~v~iK~~~~~~~~~--------------------~--~~~~~~~e~~ 62 (253)
+...|+-|.+.+.||+|++|.||+|. +..+|..||+|+++...... . ....+.+|+.
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 45566455599999999999999998 66789999999987543210 0 1123567888
Q ss_pred HHHHhcC-CCCceeeeeEEEeCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCC
Q psy12709 63 VLYLAQK-SERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHN-ITHLDLKPQ 140 (253)
Q Consensus 63 ~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-~~h~di~~~ 140 (253)
.+.+... ...++++++. . ..++|||+++|.++..............+..++.+++.++.+||+.| ++|+|++|+
T Consensus 103 ~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~ 178 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEY 178 (237)
T ss_pred HHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChh
Confidence 8875543 1223444432 2 35899999999888766544455677778899999999999999999 999999999
Q ss_pred CEEEcCCCceEEEeecccccc
Q psy12709 141 NILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 141 ni~~~~~~~~~l~df~~~~~~ 161 (253)
||+++ ++.++++|||.+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 889999999987643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-19 Score=137.19 Aligned_cols=135 Identities=20% Similarity=0.198 Sum_probs=105.4
Q ss_pred EeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhc----CCCCceeeeeEEEeCC---e-EE
Q psy12709 16 FCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ----KSERIVGLHEIYETPH---E-MV 87 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~----~~~~i~~~~~~~~~~~---~-~~ 87 (253)
.+.||+|+++.||. +..++.. +||+...... .....+.+|+..+..+. +|+||++++++++.+. . +.
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 46899999999995 6667666 6888876432 23457899999988553 5899999999999874 3 34
Q ss_pred EEEec--cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHH-HHHHHCCceecCCCCCCEEEcCC----CceEEEeeccc
Q psy12709 88 LVLEM--VPDGELQRLVDIQDGIPEQDTRSYMKQILEAL-AFLHDHNITHLDLKPQNILLTKD----NNIKLCDFGIS 158 (253)
Q Consensus 88 lv~e~--~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l-~~lh~~~~~h~di~~~ni~~~~~----~~~~l~df~~~ 158 (253)
+|+|| +.+++|.+++... .+++. ..++.+++.++ +|||+++|+|+||+|+||+++.+ +.++|+|++-+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 4578999999753 46555 35677888777 89999999999999999999853 37999995433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.4e-19 Score=135.69 Aligned_cols=136 Identities=19% Similarity=0.285 Sum_probs=110.7
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEecccccch------HHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEE
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM------DQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVL 90 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 90 (253)
+.||+|++|.||+|.. .+..+++|+........ .......+|+..+. ...++++..+..++...+..+++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMS-RARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHH-HHHHCCCCCCeEEEEeCCCCEEEE
Confidence 6799999999999987 56778999765432211 11245677887777 556778877777777777889999
Q ss_pred eccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 91 EMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 91 e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
||++|.+|.+++..... ....++.+++.++.++|+.+++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998865332 7888999999999999999999999999999999 78999999998865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.9e-18 Score=131.41 Aligned_cols=132 Identities=18% Similarity=0.249 Sum_probs=103.3
Q ss_pred ecCCCCceEEEEEEeccCCceEEEEEecccccc------hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 18 MPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS------MDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 18 ~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
.||+|++|.||+|.. ++..+++|........ ......+.+|+..+. ...++++..+..+....+..+++||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLS-RARKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHH-HHHHCCCCCCEEEEEECCCCEEEEE
Confidence 489999999999984 5678999986543211 112356678888887 4455555544445555667889999
Q ss_pred ccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 92 MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
+++|++|.+++..... .++.+++.++.++|+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999988754321 7889999999999999999999999999999 89999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=138.91 Aligned_cols=181 Identities=25% Similarity=0.417 Sum_probs=132.9
Q ss_pred cCCCCceeeeeEEE---------------------------eCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHH
Q psy12709 68 QKSERIVGLHEIYE---------------------------TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQI 120 (253)
Q Consensus 68 ~~~~~i~~~~~~~~---------------------------~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l 120 (253)
.+||||+.++..|. .+..+|+||...+ .+|+.++-.+. .+.....-++.|+
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-~s~r~~~~~laQl 350 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-RSYRTGRVILAQL 350 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-CchHHHHHHHHHH
Confidence 46999999998872 2347899999884 49999887554 4566677788999
Q ss_pred HHHHHHHHHCCceecCCCCCCEEEcCCC----ceEEEeecccccccc-------cccccccccCccccCccccCCCCC--
Q psy12709 121 LEALAFLHDHNITHLDLKPQNILLTKDN----NIKLCDFGISRVVND-------VVEVKEIIGTPDYVAPEVLSYEPI-- 187 (253)
Q Consensus 121 ~~~l~~lh~~~~~h~di~~~ni~~~~~~----~~~l~df~~~~~~~~-------~~~~~~~~~~~~~~~PE~~~~~~~-- 187 (253)
++++.+||+.|++|+|+|.+||++.-+. .+.+.|||++-.... .......-|+-.-+|||+....+-
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 9999999999999999999999996542 478999998854322 011112346778999999855431
Q ss_pred ----CccccHHHHHHHHHHHHhCCCCCCCCChHHHH-HHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 188 ----SLATDMWSVGVLAYVLLSSHSPFAGDNKQETF-LNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 188 ----~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
-.++|.|+.|.+.||++....||....+...- .+..+...+ .+...+++.+++++...|+.||
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP---alp~~vpp~~rqlV~~lL~r~p 498 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP---ALPSRVPPVARQLVFDLLKRDP 498 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC---CCcccCChHHHHHHHHHhcCCc
Confidence 23799999999999999999999773332110 111122222 2335889999999999999998
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-18 Score=131.73 Aligned_cols=139 Identities=24% Similarity=0.207 Sum_probs=105.0
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchH--------------------HHHHHHHHHHHHHHhcCCC-
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMD--------------------QMQDILHEAAVLYLAQKSE- 71 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~--------------------~~~~~~~e~~~~~~~~~~~- 71 (253)
|.+.+.||+|++|.||++... ++..|++|+++....... .......|...+... .+.
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHcC
Confidence 448899999999999999875 799999998765431111 112345666666644 444
Q ss_pred -CceeeeeEEEeCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCce
Q psy12709 72 -RIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNI 150 (253)
Q Consensus 72 -~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~ 150 (253)
.++..++ .+..+++|||++|++|...... .....++.+++.++.++|+.|++|+||+|.||+++.++.+
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 3444443 2356899999999998765431 3456788999999999999999999999999999999999
Q ss_pred EEEeecccccccc
Q psy12709 151 KLCDFGISRVVND 163 (253)
Q Consensus 151 ~l~df~~~~~~~~ 163 (253)
+|+|||.+.....
T Consensus 165 ~liDfg~~~~~~~ 177 (198)
T cd05144 165 YIIDWPQMVSTDH 177 (198)
T ss_pred EEEECCccccCCC
Confidence 9999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.9e-17 Score=143.66 Aligned_cols=135 Identities=21% Similarity=0.257 Sum_probs=106.5
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEe-ccccc-----chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFI-RKRRR-----SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~-~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
..+.||+|+||+||++...... +++|+. .+... .......+.+|+..+. ..++++++.+..+...++..++
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLS-EARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHH-hhcccCCCeeEEEEEeCCCCEE
Confidence 5689999999999999875333 333332 22111 1122356778888888 6688888887777777778899
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
+|||++|++|.+++. ....++.+++.++.+||+.|++|+|++|.||++ .++.++++|||++...
T Consensus 414 v~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 414 VMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999999998875 356788999999999999999999999999999 6789999999998653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.2e-17 Score=124.34 Aligned_cols=139 Identities=21% Similarity=0.186 Sum_probs=97.1
Q ss_pred EeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHH----------------------HHHHHHHHHHhcCC-CC
Q psy12709 16 FCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQD----------------------ILHEAAVLYLAQKS-ER 72 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~----------------------~~~e~~~~~~~~~~-~~ 72 (253)
.+.||+|++|+||+|.+. ++..|++|++............ ...|...+.....+ -.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 468999999999999987 8899999998764332221111 12344444433222 12
Q ss_pred ceeeeeEEEeCCeEEEEEeccCCCcHHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCce
Q psy12709 73 IVGLHEIYETPHEMVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQNILLTKDNNI 150 (253)
Q Consensus 73 i~~~~~~~~~~~~~~lv~e~~~g~~L~~-~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~di~~~ni~~~~~~~~ 150 (253)
+.+++.. ...+++|||++|+.+.. .+.... . ...+..++.+++.++.++|. .+++|+|++|+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4444443 23589999999854321 111111 1 16678899999999999999 9999999999999999 8999
Q ss_pred EEEeeccccccc
Q psy12709 151 KLCDFGISRVVN 162 (253)
Q Consensus 151 ~l~df~~~~~~~ 162 (253)
+++|||.+....
T Consensus 154 ~liDfg~a~~~~ 165 (187)
T cd05119 154 YIIDVPQAVEID 165 (187)
T ss_pred EEEECccccccc
Confidence 999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.6e-17 Score=136.44 Aligned_cols=187 Identities=20% Similarity=0.324 Sum_probs=146.9
Q ss_pred hcCCCCceeeeeEEEeCCeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc-eecCCCCCCEEE
Q psy12709 67 AQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNI-THLDLKPQNILL 144 (253)
Q Consensus 67 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~-~h~di~~~ni~~ 144 (253)
...|.|+.++++....+...+.|.++|..|+|.+.+.. .-.++.--...+++++++++.|+|...+ .|+.++..|.++
T Consensus 3 ~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClv 82 (484)
T KOG1023|consen 3 QLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLV 82 (484)
T ss_pred ccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccccee
Confidence 56899999999999999999999999999999999886 3457888888899999999999998865 999999999999
Q ss_pred cCCCceEEEeecccccccc---cccccccccCccccCccccCCCC-------CCccccHHHHHHHHHHHHhCCCCCCCC-
Q psy12709 145 TKDNNIKLCDFGISRVVND---VVEVKEIIGTPDYVAPEVLSYEP-------ISLATDMWSVGVLAYVLLSSHSPFAGD- 213 (253)
Q Consensus 145 ~~~~~~~l~df~~~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~-------~~~~~Di~slG~~l~~l~~g~~p~~~~- 213 (253)
+....+|+.|||+...... ...........-|.|||.+.+.. .+.+.|+||+|++++++++.+-||...
T Consensus 83 d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~ 162 (484)
T KOG1023|consen 83 DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRN 162 (484)
T ss_pred eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccccc
Confidence 9999999999999876532 11112223456899999987641 466799999999999999999999662
Q ss_pred ---ChHHHHHHhhcccccccCC-c--cCCCCHHHHHHHHHhcccCC
Q psy12709 214 ---NKQETFLNISQCNFSFHED-L--FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 214 ---~~~~~~~~i~~~~~~~~~~-~--~~~~~~~l~~li~~~l~~dP 253 (253)
+..+....+......+..+ . .....+++..++++||..+|
T Consensus 163 ~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P 208 (484)
T KOG1023|consen 163 LVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIP 208 (484)
T ss_pred ccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccCh
Confidence 2234555555522222221 1 12566789999999999887
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.8e-19 Score=154.18 Aligned_cols=242 Identities=25% Similarity=0.377 Sum_probs=191.2
Q ss_pred eeEEEeecCCCCceEEEEEEeccCC-ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITK-VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVL 90 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 90 (253)
+|.+.+.||+|+++.|-.+....+. ..++.|.+............+..|........+|.|++..++.....+..++..
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4458999999999999999886443 456777666555455556666777777776666999999999999999999999
Q ss_pred eccCCCcHHHHH-hhcC-CCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCCEEEcCCC-ceEEEeecccccccc---
Q psy12709 91 EMVPDGELQRLV-DIQD-GIPEQDTRSYMKQILEALAFLH-DHNITHLDLKPQNILLTKDN-NIKLCDFGISRVVND--- 163 (253)
Q Consensus 91 e~~~g~~L~~~~-~~~~-~~~~~~~~~~~~~l~~~l~~lh-~~~~~h~di~~~ni~~~~~~-~~~l~df~~~~~~~~--- 163 (253)
++..|+++.+.+ .... ..+......+..|+..++.|+| ..++.|+|++|+|.+++.++ ..++.|||++.....
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g 180 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNG 180 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCC
Confidence 999999998888 4443 6788888999999999999999 99999999999999999999 999999999986543
Q ss_pred -ccccccccc-CccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH-HHhhcccccccCCccCCCCH
Q psy12709 164 -VVEVKEIIG-TPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETF-LNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 164 -~~~~~~~~~-~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~ 239 (253)
.......++ ++.|.|||...+. ...+..|+||+|+++..+++|..|+......... .........+.......++.
T Consensus 181 ~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (601)
T KOG0590|consen 181 AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISD 260 (601)
T ss_pred cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCCh
Confidence 223344567 8999999998874 4467899999999999999999999765444322 22222222333444568889
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
...+++.+++..+|
T Consensus 261 ~~~~~l~k~l~~~~ 274 (601)
T KOG0590|consen 261 QAHDLLHKILKENP 274 (601)
T ss_pred hhhhcccccccCCc
Confidence 99999999887554
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.2e-16 Score=112.47 Aligned_cols=133 Identities=23% Similarity=0.245 Sum_probs=109.8
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEeCCeEEEEEecc
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKS-ERIVGLHEIYETPHEMVLVLEMV 93 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~-~~i~~~~~~~~~~~~~~lv~e~~ 93 (253)
+++.||.|.++.||++.... ..+++|....... ...+.+|+..+.....+ ..+++++.....++..++++||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 56889999999999999864 7799999876543 34677788777755554 68889998888888999999999
Q ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 94 PDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDH---NITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 94 ~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
+|..+..+ +......++.+++.++..+|.. +++|+|++|.||++++.+.++++||+.+..
T Consensus 76 ~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 88777644 4556677889999999999985 699999999999999989999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-15 Score=118.70 Aligned_cols=136 Identities=18% Similarity=0.195 Sum_probs=101.5
Q ss_pred eecC-CCCceEEEEEEeccCCceEEEEEeccccc-----------chHHHHHHHHHHHHHHHhcCCCC--ceeeeeEEEe
Q psy12709 17 CMPS-RGKFASVRKCTHKITKVEYAAKFIRKRRR-----------SMDQMQDILHEAAVLYLAQKSER--IVGLHEIYET 82 (253)
Q Consensus 17 ~~lg-~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-----------~~~~~~~~~~e~~~~~~~~~~~~--i~~~~~~~~~ 82 (253)
..|| .|+.|+||.+... +..+++|.+..... .........+|+..+. .+.+++ ++.++++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~-~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLA-QLYEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHH-HHHhCCCCCceeEeeeee
Confidence 3576 8888888888775 67789998754221 1123356778888887 556656 4667666443
Q ss_pred CC----eEEEEEeccCC-CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecc
Q psy12709 83 PH----EMVLVLEMVPD-GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI 157 (253)
Q Consensus 83 ~~----~~~lv~e~~~g-~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~ 157 (253)
.. ..++|+|+++| .+|.+++.. .+++... +.+++.++.+||+.|++|+|++|.||+++.++.++|+|||.
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 32 23599999997 689888764 3455543 56899999999999999999999999999999999999998
Q ss_pred ccc
Q psy12709 158 SRV 160 (253)
Q Consensus 158 ~~~ 160 (253)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 864
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.6e-17 Score=136.56 Aligned_cols=160 Identities=21% Similarity=0.328 Sum_probs=124.2
Q ss_pred eEEEEEeccCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQD---GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
++++.|++|...+|.+++..+. ..+......+..|+..+++| ++.+|+|++|.||+...+..++|.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 5889999999999999997543 35677888999999999999 99999999999999999999999999998866
Q ss_pred cccc-------cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCc
Q psy12709 162 NDVV-------EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDL 233 (253)
Q Consensus 162 ~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 233 (253)
.... ......++..|++||.+.+..|+.+.|||+||+++++++. =..++.. ...+..+..+.+++..
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~~-- 481 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPEF-- 481 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChHH--
Confidence 5443 4455678999999999999999999999999999999988 3333322 1222334444443221
Q ss_pred cCCCCHHHHHHHHHhcccCC
Q psy12709 234 FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP 253 (253)
..++ ++-.+|+.++|.+.|
T Consensus 482 ~~d~-p~e~~ll~~lls~~p 500 (516)
T KOG1033|consen 482 LQDY-PEEYTLLQQLLSPSP 500 (516)
T ss_pred hhcC-cHHHHHHHHhcCCCc
Confidence 1133 334578888888876
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.8e-16 Score=129.49 Aligned_cols=239 Identities=23% Similarity=0.213 Sum_probs=188.3
Q ss_pred ceeeEEEeecCC--CCceEEEEEEe--ccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 10 GYQTLIFCMPSR--GKFASVRKCTH--KITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 10 ~~~~~~~~~lg~--g~~~~v~~~~~--~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
.+.+.+.+.+|. |.+|.+|.+.. ..++..+++|.-+...........-.+|+....+...|++.++.+..++..+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 344558889999 99999999998 88999999998766655555555667788888888889999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhcC-CCCHHHHHHHHHHHHH----HHHHHHHCCceecCCCCCCEEEcCC-CceEEEeecccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQD-GIPEQDTRSYMKQILE----ALAFLHDHNITHLDLKPQNILLTKD-NNIKLCDFGISR 159 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~l~~----~l~~lh~~~~~h~di~~~ni~~~~~-~~~~l~df~~~~ 159 (253)
.++-+|.+ +.+|..+..... .++...++....+... |+..+|+.+++|-|++|.||++..+ ...+++||+...
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 99999998 567877766544 4888899999999999 9999999999999999999999999 889999999998
Q ss_pred ccccccc------ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCc
Q psy12709 160 VVNDVVE------VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDL 233 (253)
Q Consensus 160 ~~~~~~~------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 233 (253)
.+.+... .....+...|++||..++ -++..+|++++|.++.+..++..+...... ..+..+.... .+.+.
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-~~W~~~r~~~--ip~e~ 347 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN-SSWSQLRQGY--IPLEF 347 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC-CCcccccccc--Cchhh
Confidence 7754331 223357789999998864 457889999999999998888766544311 1122222222 34455
Q ss_pred cCCCCHHHHHHHHHhcccCC
Q psy12709 234 FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP 253 (253)
....+.++.-.+.+|++.+|
T Consensus 348 ~~~~s~~l~~~~~~~~d~~~ 367 (524)
T KOG0601|consen 348 CEGGSSSLRSVTSQMLDEDP 367 (524)
T ss_pred hcCcchhhhhHHHHhcCcch
Confidence 55677888889999998876
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.9e-14 Score=106.53 Aligned_cols=142 Identities=19% Similarity=0.159 Sum_probs=101.5
Q ss_pred EeecCCCCceEEEEEEecc------CCceEEEEEecccc----------------------cch--HHHHHHHHHHHHHH
Q psy12709 16 FCMPSRGKFASVRKCTHKI------TKVEYAAKFIRKRR----------------------RSM--DQMQDILHEAAVLY 65 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~------~~~~v~iK~~~~~~----------------------~~~--~~~~~~~~e~~~~~ 65 (253)
...||.|.-+.||.|.... .+..+|+|+++... .++ .......+|+..+.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998653 35789999874321 001 11223447888887
Q ss_pred HhcCC-CCceeeeeEEEeCCeEEEEEeccCCCcHHH-HHhhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCCE
Q psy12709 66 LAQKS-ERIVGLHEIYETPHEMVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFL-HDHNITHLDLKPQNI 142 (253)
Q Consensus 66 ~~~~~-~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~-~~~~~~~~~~~~~~~~~~~l~~~l~~l-h~~~~~h~di~~~ni 142 (253)
++... -.++.++++ ..-++||||+.+..+.. .+. ...++...+..+..+++.++..+ |+.|++|+|+++.||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 55443 346677765 35689999997654422 222 23456667778889999999988 899999999999999
Q ss_pred EEcCCCceEEEeecccccccc
Q psy12709 143 LLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 143 ~~~~~~~~~l~df~~~~~~~~ 163 (253)
++. ++.+.++||+.+.....
T Consensus 157 L~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred EEE-CCcEEEEECCCceeCCC
Confidence 997 57899999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.56 E-value=6e-14 Score=118.36 Aligned_cols=144 Identities=21% Similarity=0.237 Sum_probs=97.5
Q ss_pred EeecCCCCceEEEEEEeccCCceEEEEEecccccch-H----H---------------------------H------HHH
Q psy12709 16 FCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM-D----Q---------------------------M------QDI 57 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~----~---------------------------~------~~~ 57 (253)
.++||+|++|+||+|... +|+.||||+.+...... . . . -++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 358999999999999876 78999999975432100 0 0 0 012
Q ss_pred HHHHHHHHHh---c-CCCCceeeeeEEEeCCeEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHH-HHHHHHHCC
Q psy12709 58 LHEAAVLYLA---Q-KSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILE-ALAFLHDHN 131 (253)
Q Consensus 58 ~~e~~~~~~~---~-~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~-~l~~lh~~~ 131 (253)
.+|+..+.+. . +++++.-+.-+.......+++|||++|.+|.++.... ...+ ...++..++. .+..+|..|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 2233322221 1 2344433333334445679999999999998876532 2232 3345555555 467889999
Q ss_pred ceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 132 ITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 132 ~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
++|+|++|.||+++.+|.++++|||++...+.
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.4e-14 Score=122.34 Aligned_cols=145 Identities=19% Similarity=0.183 Sum_probs=91.5
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEecccccch--------------------------------HHHHHH------H
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM--------------------------------DQMQDI------L 58 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~--------------------------------~~~~~~------~ 58 (253)
++||+|++|+||+|..+.+|+.||||+.+...... +..+.+ .
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 79999999999999998779999999987542100 011122 2
Q ss_pred HHHHHHHH---hcCCCCceeeeeEE-EeCCeEEEEEeccCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy12709 59 HEAAVLYL---AQKSERIVGLHEIY-ETPHEMVLVLEMVPDGELQRLVD-IQDGIPEQDTRSYMKQILEALAFLHDHNIT 133 (253)
Q Consensus 59 ~e~~~~~~---~~~~~~i~~~~~~~-~~~~~~~lv~e~~~g~~L~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~ 133 (253)
+|+....+ ...+...+.+-.++ +.....+++|||++|+.+.++.. ...+.+...+.....+ .-+..+...|++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~--~~~~Qif~~Gff 282 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVE--VFFTQVFRDGFF 282 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHH--HHHHHHHhCCee
Confidence 22222221 22233333333333 33456789999999999977432 1222332222211111 113344569999
Q ss_pred ecCCCCCCEEEcCCC----ceEEEeecccccccc
Q psy12709 134 HLDLKPQNILLTKDN----NIKLCDFGISRVVND 163 (253)
Q Consensus 134 h~di~~~ni~~~~~~----~~~l~df~~~~~~~~ 163 (253)
|+|++|.||+++.+| .++++|||++...+.
T Consensus 283 HaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 283 HADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred eCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 999999999999988 999999999987654
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.1e-13 Score=117.47 Aligned_cols=183 Identities=17% Similarity=0.186 Sum_probs=136.0
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|.+ +...-++.+..-.|..+.++.+|.+.+...... .....+.+-+..+. ..+||+|+++++.++.+.+.|+|+|.
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lK-tlRHP~Il~yL~t~e~~~~~ylvTEr 90 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLK-TLRHPNILSYLDTTEEEGTLYLVTER 90 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhh-hccCchhhhhhhhhcccCceEEEeec
Confidence 435 444445554444677888999999998876555 22334444455555 88999999999999999999999998
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCCEEEcCCCceEEEeeccccccccccc-cccc
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLH-DHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE-VKEI 170 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~~ 170 (253)
+. .|..++.+.+ ...+..-+.||+.||.+|| ..+++|+++....|+|+..|..+|++|.++........ ....
T Consensus 91 V~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~ 165 (690)
T KOG1243|consen 91 VR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSL 165 (690)
T ss_pred cc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccc
Confidence 74 4666665433 7778888999999999997 56899999999999999999999999998865443221 1112
Q ss_pred ccCccccCccccCCCCCCccccHHHHHHHHHHHHhC
Q psy12709 171 IGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSS 206 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g 206 (253)
.....|..|+.+....+ ..|.|.||+++++++.|
T Consensus 166 ~~~~s~~~P~~~~~s~~--s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 166 YLIESFDDPEEIDPSEW--SIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhcccChhhcCcccc--chhhhhHHHHHHHHhCc
Confidence 22345666665543332 47999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.4e-13 Score=101.89 Aligned_cols=128 Identities=21% Similarity=0.209 Sum_probs=94.4
Q ss_pred EeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 16 FCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
++.++.|.++.||++... +..|++|........ ......|+..+....+...+++++.... ...++||||++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL---LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc---ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence 578999999999999865 778999997654321 1245667777775544444556665543 345799999999
Q ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 96 GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNI-----THLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-----~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
.++... . . .....+.+++.++..||+.++ +|+|++|.||+++ ++.++++||+.+.
T Consensus 76 ~~l~~~----~-~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 76 SELLTE----D-F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred Cccccc----c-c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 887643 1 1 113356789999999999985 9999999999999 6789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.3e-13 Score=115.52 Aligned_cols=195 Identities=23% Similarity=0.196 Sum_probs=155.9
Q ss_pred EEEeecCCCCceEEEEEEec-cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 14 LIFCMPSRGKFASVRKCTHK-ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
..+..||.|.|+.|+.+..+ .++..|++|-+.+.......-..-..|......+..|.+++..+..|.+.+..++=-||
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF 347 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence 38999999999999998866 78889999988776655555556666777777788899999999999999988999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-CceEEEeecccccccccccccccc
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD-NNIKLCDFGISRVVNDVVEVKEII 171 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~-~~~~l~df~~~~~~~~~~~~~~~~ 171 (253)
++++++...+.....+++...+++..|++.++.++|+..++|.|++|.||++.++ +..++.||+++..+.-... ...
T Consensus 348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~--~~~ 425 (524)
T KOG0601|consen 348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG--VFH 425 (524)
T ss_pred hcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceecc--ccc
Confidence 9999988777666678999999999999999999999999999999999999986 7788999998864221111 111
Q ss_pred cCcccc--CccccCCCCCCccccHHHHHHHHHHHHhCCCCC
Q psy12709 172 GTPDYV--APEVLSYEPISLATDMWSVGVLAYVLLSSHSPF 210 (253)
Q Consensus 172 ~~~~~~--~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 210 (253)
...++. ++.......+-.+.|++++|..+.+..+|.+.-
T Consensus 426 ~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls 466 (524)
T KOG0601|consen 426 HIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS 466 (524)
T ss_pred ccccccccchhhccccccccccccccccccccccccCcccC
Confidence 222333 444445556778999999999999998876543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.1e-12 Score=91.79 Aligned_cols=134 Identities=19% Similarity=0.231 Sum_probs=100.3
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEec-ccc--cchHH---HHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEE
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIR-KRR--RSMDQ---MQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVL 90 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~-~~~--~~~~~---~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 90 (253)
..+.+|+-+.++.+... |..+++|.=. +.- ...++ ..+..+|+..+. .....+|.-+.-+..+.+...++|
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~-~a~~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILA-KAREAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHH-HHHHcCCCCCeEEEEcCCCCEEEE
Confidence 46789999999999663 4446666432 211 12222 356677888887 445558877777777888899999
Q ss_pred eccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 91 EMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 91 e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
||++|..|.+.+.... ..+++.+=..+.-||..|++|+|++++||++..++ +.++|||++...
T Consensus 79 e~I~G~~lkd~l~~~~-------~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 79 EYIEGELLKDALEEAR-------PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EEeCChhHHHHHHhcc-------hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999998887551 44556666777779999999999999999999655 999999998743
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.8e-14 Score=110.25 Aligned_cols=180 Identities=18% Similarity=0.267 Sum_probs=128.3
Q ss_pred EEEEEEeccCCceEEEEEecccc-----cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC-----CeEEEEEeccCC
Q psy12709 26 SVRKCTHKITKVEYAAKFIRKRR-----RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP-----HEMVLVLEMVPD 95 (253)
Q Consensus 26 ~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g 95 (253)
.||.+.+.+.|.+|+-..+.... ......+.++ ..+. +..|.|+++...+|.+. .+...+.||+..
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vF---dnll-qlvHsnlvkfH~yw~d~K~~e~~rviFiteymss 156 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVF---DNLL-QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSS 156 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHH---HHHH-HHHHHHHHHHHHhhcccccccccceEEEEecccc
Confidence 45666666666666654443221 1111122222 2333 55688899999998654 368899999999
Q ss_pred CcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEcCCCceEEEeecccccccc-----c
Q psy12709 96 GELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHN--ITHLDLKPQNILLTKDNNIKLCDFGISRVVND-----V 164 (253)
Q Consensus 96 ~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~-----~ 164 (253)
+++..++++ +..+......+|+-|++.|+.|||+.. ++|++++.+.|++..+|-+++..-.-...... .
T Consensus 157 gs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~ 236 (458)
T KOG1266|consen 157 GSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTRE 236 (458)
T ss_pred hhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhH
Confidence 999998875 234788899999999999999999986 99999999999999999999864332221111 1
Q ss_pred ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCC
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSP 209 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 209 (253)
.......+.+.|.+||.-.....+-++|||++|++..+|..|+.-
T Consensus 237 ~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 237 AEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred hhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheec
Confidence 122233456889999876555667789999999999999988765
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1e-11 Score=100.62 Aligned_cols=228 Identities=13% Similarity=0.115 Sum_probs=154.8
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEE--------eCCeE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE--------TPHEM 86 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--------~~~~~ 86 (253)
....||+|+.+-+|..-.- ..-+.|+++++..... ......+...-++|-+-. --.|. .+..+
T Consensus 15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~-----aqk~a~la~~p~~p~~~~-rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQ-----AQKVAELAATPDAPLLNY-RVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchh---hchhheeecCCCchHH-----HHHHHHhccCCCCcchhh-hhcccHHHhhCCCcccee
Confidence 4568999999999987543 2235688887654322 122333443444544322 11121 12247
Q ss_pred EEEEeccCCCcH-HHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 87 VLVLEMVPDGEL-QRLVD------IQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 87 ~lv~e~~~g~~L-~~~~~------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
.++|+.+.|..- ..+.+ .-+..++.-+.+.++.++.+.+.||..|..-+|++++|+++.+++.|.|.|-....
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 788998887633 22221 12347889999999999999999999999999999999999999999999876555
Q ss_pred cccccccccccccCccccCccccC-----CCCCCccccHHHHHHHHHHHHhC-CCCCCCCCh----HHHHH-Hhhc----
Q psy12709 160 VVNDVVEVKEIIGTPDYVAPEVLS-----YEPISLATDMWSVGVLAYVLLSS-HSPFAGDNK----QETFL-NISQ---- 224 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~----~~~~~-~i~~---- 224 (253)
...+.....+..+...|+|||... +..-+...|.|.||+++++++.| ++||.+... ...++ .|..
T Consensus 166 i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 166 INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 545566667788999999999875 33457789999999999999995 899966211 01111 1211
Q ss_pred -------cccccc-CCccCCCCHHHHHHHHHhccc
Q psy12709 225 -------CNFSFH-EDLFGHISSQAKDFIQSCLVT 251 (253)
Q Consensus 225 -------~~~~~~-~~~~~~~~~~l~~li~~~l~~ 251 (253)
+..+.| .....-++++++.|..+|+..
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~ 280 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTE 280 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcc
Confidence 122222 122245789999999999863
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.41 E-value=7.9e-14 Score=123.28 Aligned_cols=237 Identities=25% Similarity=0.351 Sum_probs=180.0
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchH-HHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEecc
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMD-QMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMV 93 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 93 (253)
+.+.+.+|+++.++.+.-..++.....|+......... ..+....+-.... .-.+|.++.....+......++++++.
T Consensus 808 i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i-~p~~P~v~~~~~s~~~rsP~~L~~~~~ 886 (1205)
T KOG0606|consen 808 ITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILI-TPRSPAVVRSFPSFPCRSPLPLVGHYL 886 (1205)
T ss_pred ecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccc-cCCCCceecccCCCCCCCCcchhhHHh
Confidence 77789999999999998777775555554332211000 0111111111111 234455666666667778899999999
Q ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc------c----
Q psy12709 94 PDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN------D---- 163 (253)
Q Consensus 94 ~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~------~---- 163 (253)
+|++|...+...++.+.+-.+.++..+..+.++||...+.|+|++|.|.+...+|..++.+|+...... .
T Consensus 887 ~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~ 966 (1205)
T KOG0606|consen 887 NGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGP 966 (1205)
T ss_pred ccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCcccc
Confidence 999999998877778888888899999999999999999999999999999999999999987332110 0
Q ss_pred ----------------------cccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy12709 164 ----------------------VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLN 221 (253)
Q Consensus 164 ----------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 221 (253)
........+++.|.+||...+......+|.|++|+++++.++|.+||.....+..+++
T Consensus 967 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~n 1046 (1205)
T KOG0606|consen 967 SSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFEN 1046 (1205)
T ss_pred cccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhc
Confidence 0111223567899999999999989999999999999999999999999999999999
Q ss_pred hhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 222 ISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 222 i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+.....+++... ...+.+.++++...|..+|
T Consensus 1047 i~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~ 1077 (1205)
T KOG0606|consen 1047 ILNRDIPWPEGP-EEGSYEAQDLINRLLTEEP 1077 (1205)
T ss_pred cccCCCCCCCCc-cccChhhhhhhhhhhccCc
Confidence 998888777542 4678899999998887765
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.39 E-value=2e-11 Score=88.46 Aligned_cols=143 Identities=23% Similarity=0.243 Sum_probs=107.1
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccc------cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR------RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
.+..+-+|+-+.|+.+... |+.++||.-.... ...-...+..+|+..+.+...- +|.-+.-++.+...-.+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~-GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRAL-GIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHh-CCCCceEEEEecCCCeE
Confidence 5678899999999999875 7777777432211 1223356778888888854443 77767777777777889
Q ss_pred EEeccCC-CcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc---eEEEeeccccc
Q psy12709 89 VLEMVPD-GELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN---IKLCDFGISRV 160 (253)
Q Consensus 89 v~e~~~g-~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~---~~l~df~~~~~ 160 (253)
.|||++| .++.+++... ...+.+....+++++=..+.-||.++++|||++++||++.++|. +.++|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9999988 4667766543 33444445788889999999999999999999999999987653 58999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.9e-11 Score=92.64 Aligned_cols=141 Identities=16% Similarity=0.164 Sum_probs=102.7
Q ss_pred EeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEeCC---eEEEEEe
Q psy12709 16 FCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKS-ERIVGLHEIYETPH---EMVLVLE 91 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~-~~i~~~~~~~~~~~---~~~lv~e 91 (253)
.+.|+.|..+.+|++... +|..+++|........ .....+..|...+.....+ -.+.+++.+..... ..+++||
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 367899999999999875 3678999998764331 1234677788887744442 23566777766543 6789999
Q ss_pred ccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q psy12709 92 MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD------------------------------------------ 129 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~------------------------------------------ 129 (253)
+++|.++.+.+.. ..++......++.++++.+..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999988765431 346666666777777777777763
Q ss_pred --------------CCceecCCCCCCEEEcC--CCceEEEeecccc
Q psy12709 130 --------------HNITHLDLKPQNILLTK--DNNIKLCDFGISR 159 (253)
Q Consensus 130 --------------~~~~h~di~~~ni~~~~--~~~~~l~df~~~~ 159 (253)
..++|+|+++.||+++. ++.+.++||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23689999999999998 5678999998775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=8.7e-11 Score=90.43 Aligned_cols=138 Identities=22% Similarity=0.187 Sum_probs=102.5
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecc------------------cccc--hHHHHHHHHHHHHHHHhcCC-CCc
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRK------------------RRRS--MDQMQDILHEAAVLYLAQKS-ERI 73 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~------------------~~~~--~~~~~~~~~e~~~~~~~~~~-~~i 73 (253)
+..+||-|.-+.||.|.+. .|.++++|+=+. ...+ .-......+|..+++++... -.+
T Consensus 95 iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 6789999999999999987 788899996211 1122 22245667888888855554 357
Q ss_pred eeeeeEEEeCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEE
Q psy12709 74 VGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLC 153 (253)
Q Consensus 74 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~ 153 (253)
++++++-. -.+|||+++|..|...- ++.+....++..++..+.-+-..|++|+|+++-||+++++|.+.++
T Consensus 174 P~P~~~nR----HaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vI 244 (304)
T COG0478 174 PKPIAWNR----HAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVI 244 (304)
T ss_pred CCcccccc----ceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEE
Confidence 77776644 58999999997775442 2344555566667777666668999999999999999999999999
Q ss_pred eeccccccc
Q psy12709 154 DFGISRVVN 162 (253)
Q Consensus 154 df~~~~~~~ 162 (253)
||..+....
T Consensus 245 DwPQ~v~~~ 253 (304)
T COG0478 245 DWPQAVPIS 253 (304)
T ss_pred eCcccccCC
Confidence 998776543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.1e-10 Score=86.94 Aligned_cols=129 Identities=23% Similarity=0.281 Sum_probs=83.3
Q ss_pred EEEEEEeccCCceEEEEEecccc------------------------cchHHHHHHHHHHHHHHHhcCCC-CceeeeeEE
Q psy12709 26 SVRKCTHKITKVEYAAKFIRKRR------------------------RSMDQMQDILHEAAVLYLAQKSE-RIVGLHEIY 80 (253)
Q Consensus 26 ~v~~~~~~~~~~~v~iK~~~~~~------------------------~~~~~~~~~~~e~~~~~~~~~~~-~i~~~~~~~ 80 (253)
.||.|... ++..+|+|+..... ..........+|...|.++...- ++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 37888764 67789999864321 11222467788888998444442 467777554
Q ss_pred EeCCeEEEEEeccC--CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHH-HHHHCCceecCCCCCCEEEcCCCceEEEeecc
Q psy12709 81 ETPHEMVLVLEMVP--DGELQRLVDIQDGIPEQDTRSYMKQILEALA-FLHDHNITHLDLKPQNILLTKDNNIKLCDFGI 157 (253)
Q Consensus 81 ~~~~~~~lv~e~~~--g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~-~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~ 157 (253)
.-++||||++ |..+..+.... ++......++.+++..+. -+|+.|++|||+++.||+++.+ .+.++||+.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3479999998 66665554322 224456667778887544 4689999999999999999987 999999998
Q ss_pred ccccc
Q psy12709 158 SRVVN 162 (253)
Q Consensus 158 ~~~~~ 162 (253)
+....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 86544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=9.2e-10 Score=86.88 Aligned_cols=130 Identities=13% Similarity=0.072 Sum_probs=90.2
Q ss_pred EEEEEeccCCceEEEEEecccccchHH---------HHHHHHHHHHHHHhcCCCCc--eeeeeEEEe-----CCeEEEEE
Q psy12709 27 VRKCTHKITKVEYAAKFIRKRRRSMDQ---------MQDILHEAAVLYLAQKSERI--VGLHEIYET-----PHEMVLVL 90 (253)
Q Consensus 27 v~~~~~~~~~~~v~iK~~~~~~~~~~~---------~~~~~~e~~~~~~~~~~~~i--~~~~~~~~~-----~~~~~lv~ 90 (253)
|..+.. .|+.|.+|........... .....+|...+.++. ..+| +.+..+.+. ...-++|+
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 445543 4678999966332211000 113667777776432 2233 344445443 22578999
Q ss_pred eccCCC-cHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-------CCceEEEeecccc
Q psy12709 91 EMVPDG-ELQRLVDI--QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK-------DNNIKLCDFGISR 159 (253)
Q Consensus 91 e~~~g~-~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~-------~~~~~l~df~~~~ 159 (253)
|++++. +|.+++.. ..+.+......++.++...+..||..|++|+|+++.||+++. +..+.++||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999886 89888754 344567788899999999999999999999999999999985 4679999999875
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.4e-09 Score=89.13 Aligned_cols=166 Identities=22% Similarity=0.279 Sum_probs=122.4
Q ss_pred CceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe----CCeEEEEEeccCCC-c
Q psy12709 23 KFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET----PHEMVLVLEMVPDG-E 97 (253)
Q Consensus 23 ~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~g~-~ 97 (253)
--.+.|++..+.+|..|++|.++.....-. .+...-..++ +...|.|||++.++|.. +..+++|++|.++. +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--nk~t~lve~w-kkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST--NKDTSLVEAW-KKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc--ccchHHHHHH-HHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 447899999999999999999944331111 1122223334 37789999999999873 34799999998765 6
Q ss_pred HHHHH-h--------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc
Q psy12709 98 LQRLV-D--------------IQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN 162 (253)
Q Consensus 98 L~~~~-~--------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~ 162 (253)
|.++- . .+...++..+|.++.|+..|+.++|+.|++..-+.+.+|+++-+.+++|...|......
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 65543 1 12236789999999999999999999999999999999999988888888777765543
Q ss_pred ccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCC
Q psy12709 163 DVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSH 207 (253)
Q Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~ 207 (253)
... .+| +. -..+.|.--||.++..|.+|.
T Consensus 445 ~d~-----------~~~--le---~~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 445 EDP-----------TEP--LE---SQQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred CCC-----------Ccc--hh---HHhhhhHHHHHHHHHHHhhcc
Confidence 322 011 11 123579999999999999984
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.1e-09 Score=80.44 Aligned_cols=105 Identities=24% Similarity=0.300 Sum_probs=81.7
Q ss_pred HHHHHHHHHHHHhcCCCC--ceeeeeEEEeCC----eEEEEEeccCCC-cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Q psy12709 55 QDILHEAAVLYLAQKSER--IVGLHEIYETPH----EMVLVLEMVPDG-ELQRLVDIQDGIPEQDTRSYMKQILEALAFL 127 (253)
Q Consensus 55 ~~~~~e~~~~~~~~~~~~--i~~~~~~~~~~~----~~~lv~e~~~g~-~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 127 (253)
....+|...+..+. ..+ +++++.+.+... ..++|+|.+++. +|.+++......+......++.++...+.-|
T Consensus 56 ~ra~~E~~~~~~L~-~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLR-EAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHH-HcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 45666666655332 223 455666665532 468999999885 7999887644467778889999999999999
Q ss_pred HHCCceecCCCCCCEEEcCCC---ceEEEeeccccc
Q psy12709 128 HDHNITHLDLKPQNILLTKDN---NIKLCDFGISRV 160 (253)
Q Consensus 128 h~~~~~h~di~~~ni~~~~~~---~~~l~df~~~~~ 160 (253)
|..|+.|+|+++.||+++.++ .+.++||+.+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999987 899999987754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=6.9e-09 Score=79.26 Aligned_cols=148 Identities=20% Similarity=0.160 Sum_probs=101.4
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc----------------------hHHHHHHHHHHHHHHH
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS----------------------MDQMQDILHEAAVLYL 66 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~----------------------~~~~~~~~~e~~~~~~ 66 (253)
.++=..+..+|++|.-++||+|.. .++..+|+|++...-.. .........|...|.+
T Consensus 46 rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R 124 (268)
T COG1718 46 RGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKR 124 (268)
T ss_pred CCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 344445778999999999999986 37888999987542211 1112344556656653
Q ss_pred hcC-CCCceeeeeEEEeCCeEEEEEeccCCCcHHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEE
Q psy12709 67 AQK-SERIVGLHEIYETPHEMVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQNIL 143 (253)
Q Consensus 67 ~~~-~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~-~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~di~~~ni~ 143 (253)
.-. .=.+++++.+... .++|||+.....-. .+. ..+++..+...+..+++..+.-|-. .+++|+|++.-||+
T Consensus 125 ~~eAGVrvP~Pi~~~~n----VLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL 199 (268)
T COG1718 125 AYEAGVRVPEPIAFRNN----VLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNIL 199 (268)
T ss_pred HHHcCCCCCCceeecCC----eEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheE
Confidence 222 2335666766654 79999995542211 111 2224444677788888888887777 89999999999999
Q ss_pred EcCCCceEEEeecccccccc
Q psy12709 144 LTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 144 ~~~~~~~~l~df~~~~~~~~ 163 (253)
+. ++.+.++|++.+.....
T Consensus 200 ~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 200 VH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred EE-CCeEEEEECccccccCC
Confidence 99 89999999998876543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.6e-08 Score=75.32 Aligned_cols=141 Identities=21% Similarity=0.230 Sum_probs=89.2
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHH-H------HHHHHHHHHHHh--cCCCCceee
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQM-Q------DILHEAAVLYLA--QKSERIVGL 76 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~-~------~~~~e~~~~~~~--~~~~~i~~~ 76 (253)
+..+.|+ +++.+.......|-+..- ++..+++|.........+.. . ...+.+....+. ........+
T Consensus 28 i~~~~~~--~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 28 ILDNNYK--IIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HHhCCce--EEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 4456666 888888877666666654 57889999887644322211 1 122222222211 112222222
Q ss_pred eeEE-----EeCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceE
Q psy12709 77 HEIY-----ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIK 151 (253)
Q Consensus 77 ~~~~-----~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~ 151 (253)
+... ......+++|||++|..|.+... +++ .+...+..++..+|+.|+.|+|.+|.|++++++ .++
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~ 174 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIR 174 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEE
Confidence 2222 22245779999999988876543 332 244567788999999999999999999999955 599
Q ss_pred EEeecccc
Q psy12709 152 LCDFGISR 159 (253)
Q Consensus 152 l~df~~~~ 159 (253)
++|++...
T Consensus 175 iID~~~k~ 182 (229)
T PF06176_consen 175 IIDTQGKR 182 (229)
T ss_pred EEECcccc
Confidence 99997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.5e-08 Score=75.07 Aligned_cols=139 Identities=14% Similarity=0.087 Sum_probs=96.5
Q ss_pred CCCCceEEEEEEeccCCceEEEEEecc-cccc---hHHHHHHHHHHHHHHHhcCCC-CceeeeeEEEe--C--CeEEEEE
Q psy12709 20 SRGKFASVRKCTHKITKVEYAAKFIRK-RRRS---MDQMQDILHEAAVLYLAQKSE-RIVGLHEIYET--P--HEMVLVL 90 (253)
Q Consensus 20 g~g~~~~v~~~~~~~~~~~v~iK~~~~-~~~~---~~~~~~~~~e~~~~~~~~~~~-~i~~~~~~~~~--~--~~~~lv~ 90 (253)
|+||.+.|+..... |..+-+|.-.. ...+ +.....+.+|...+..+.... .++++...... + -.-++|+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 34899999998765 33688886541 1111 113456777887777443321 14444422211 1 1477999
Q ss_pred eccCC-CcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc--eEEEeeccccc
Q psy12709 91 EMVPD-GELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN--IKLCDFGISRV 160 (253)
Q Consensus 91 e~~~g-~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~--~~l~df~~~~~ 160 (253)
|-++| .+|.+++... .+.+......++.++..++.-||+.|+.|+|+.+.||+++.+|. +.++||..++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97754 4888887653 34577888899999999999999999999999999999987777 99999987763
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.3e-10 Score=97.00 Aligned_cols=136 Identities=21% Similarity=0.314 Sum_probs=96.7
Q ss_pred HHHHHHHHHHHHC-CceecCCCCCCEEEcCCCceEEEeecccccccccccc----------cccccCccccCccccCCCC
Q psy12709 118 KQILEALAFLHDH-NITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV----------KEIIGTPDYVAPEVLSYEP 186 (253)
Q Consensus 118 ~~l~~~l~~lh~~-~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~~~PE~~~~~~ 186 (253)
.+...|+.++|+. +++|++|.|++|+++.++..||+.|+.+....+.... ........|.+||.+.+..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 3444899999976 8999999999999999999999999988755432111 1123456999999999888
Q ss_pred CCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 187 ISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 187 ~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.+.++|++|+|+++|-+.. |+..+........+..-....-.......+.++.++++-+++++..|+
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~ 253 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDS 253 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCc
Confidence 8999999999999999985 555554433322222111111111122235889999999999987663
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.7e-08 Score=84.28 Aligned_cols=144 Identities=22% Similarity=0.255 Sum_probs=96.3
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEecccc---------------------------cch-----HHHHHHHH-----
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRR---------------------------RSM-----DQMQDILH----- 59 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~---------------------------~~~-----~~~~~~~~----- 59 (253)
++|+.++-|+||+|... +|+.||||+.+..- ... +-.+.+..
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 68999999999999987 59999999753211 000 00112222
Q ss_pred -HHHHHHH----hcCCCCceeeeeEEEeCCeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q psy12709 60 -EAAVLYL----AQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNIT 133 (253)
Q Consensus 60 -e~~~~~~----~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~ 133 (253)
|.....+ ..+.+.+.-+.=+++....-.++|||++|..+.+.... ..+++...+.....+++ +..+-..|+.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 2211111 22355555555556666788999999999999887432 35566555444333333 2334448999
Q ss_pred ecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 134 HLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 134 h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
|+|.+|.||++..+|.+.+.|||.....++
T Consensus 288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 288 HADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999987653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.1e-07 Score=71.95 Aligned_cols=134 Identities=14% Similarity=0.114 Sum_probs=83.9
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCC-ceeeeeEEEeCCeEEEEEeccCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER-IVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~-i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
.+|++|..+.||+. .+..+++|..+.... ...+.+|...+..+....- +.+++.+.+.++...++|++++|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFD----KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCC----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 57899999999984 255688999875332 2356778888875544433 57888888888888999999999
Q ss_pred Cc-HHHHHh-------------------hc----CCCCHHHHH-HHHHH----------HHHH-HHHHH----HCCceec
Q psy12709 96 GE-LQRLVD-------------------IQ----DGIPEQDTR-SYMKQ----------ILEA-LAFLH----DHNITHL 135 (253)
Q Consensus 96 ~~-L~~~~~-------------------~~----~~~~~~~~~-~~~~~----------l~~~-l~~lh----~~~~~h~ 135 (253)
.+ +..... -+ ...+..... .+..+ +... ..+|. ...++|+
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 63 211110 01 011111111 11000 0111 11221 1247899
Q ss_pred CCCCCCEEEcCCCceEEEeecccc
Q psy12709 136 DLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 136 di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
|+.|.||+++.++ +.++||+.+.
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcC
Confidence 9999999999888 9999998774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.5e-07 Score=67.13 Aligned_cols=136 Identities=19% Similarity=0.182 Sum_probs=98.8
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.+.|..+..+.|++|.+|.||+|... |..+++|+-..+.. ...+..|+..+..+.....-.+++.+... +
T Consensus 19 ~~~~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg~~----~ 88 (201)
T COG2112 19 EGKYELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYGED----F 88 (201)
T ss_pred ccchhhhhhhhhhcccccEEEEeecc--CceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEechh----h
Confidence 34455557789999999999999876 66889998665443 34777888888866566556777777665 3
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC-CCCEEEcCCCceEEEeeccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK-PQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~-~~ni~~~~~~~~~l~df~~~~~ 160 (253)
+.|||++|-.|.++.... +..++.. ++....-|...||-|+.++ |...++.+++.+.|+||..+..
T Consensus 89 i~me~i~G~~L~~~~~~~---~rk~l~~----vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 89 IRMEYIDGRPLGKLEIGG---DRKHLLR----VLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcCcchhhhhhcc---cHHHHHH----HHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 449999998888775421 4445544 4444555778899999986 5566666667999999998863
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.2e-06 Score=67.18 Aligned_cols=78 Identities=15% Similarity=0.052 Sum_probs=55.2
Q ss_pred eecCCCCc-eEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCC
Q psy12709 17 CMPSRGKF-ASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 17 ~~lg~g~~-~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 95 (253)
..|..|.. +.||++... +..+++|..+... ...+.+|+..+..+..+--+++++.+...++..++||++++|
T Consensus 4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 34555555 899999754 3678889876542 235566777777555554567888888777778999999999
Q ss_pred CcHHHH
Q psy12709 96 GELQRL 101 (253)
Q Consensus 96 ~~L~~~ 101 (253)
.++...
T Consensus 77 ~~l~~~ 82 (244)
T cd05150 77 VPAAAL 82 (244)
T ss_pred ccHhHh
Confidence 877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.9e-06 Score=65.80 Aligned_cols=79 Identities=23% Similarity=0.187 Sum_probs=54.6
Q ss_pred EeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCC-CceeeeeEEE---eCCeEEEEEe
Q psy12709 16 FCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSE-RIVGLHEIYE---TPHEMVLVLE 91 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~-~i~~~~~~~~---~~~~~~lv~e 91 (253)
++.++.|..+.||.+.... ..+++|..... .....+.+|...++.+..+. .+++++.... .....+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 5789999999999999874 58999997654 33446667776666444332 3566666432 3336799999
Q ss_pred ccCCCcHHH
Q psy12709 92 MVPDGELQR 100 (253)
Q Consensus 92 ~~~g~~L~~ 100 (253)
+++|..+..
T Consensus 76 ~i~g~~~~~ 84 (239)
T PF01636_consen 76 YIPGRPLDD 84 (239)
T ss_dssp EESSEEHHH
T ss_pred Eeccccccc
Confidence 999998877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.2e-06 Score=72.49 Aligned_cols=143 Identities=20% Similarity=0.209 Sum_probs=90.3
Q ss_pred EeecCCCCceEEEEEEeccCCceEEEEEecccccc-----------------------------hHHHHHHHHHHHHH--
Q psy12709 16 FCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS-----------------------------MDQMQDILHEAAVL-- 64 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-----------------------------~~~~~~~~~e~~~~-- 64 (253)
-+.|+..+.|+|++|..+. |..||+|+=+..-.. .+-.+.+..|++..
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 3689999999999999884 999999973321100 00012222222211
Q ss_pred -------HHhcCCCC------ceeeeeEEEeCCeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy12709 65 -------YLAQKSER------IVGLHEIYETPHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDH 130 (253)
Q Consensus 65 -------~~~~~~~~------i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~ 130 (253)
++...+-+ |++++ +.......++|||++|..+.++-.. ..+++...+...+.+...- .+=..
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~--qIf~~ 320 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLE--QIFKT 320 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHH--HHHhc
Confidence 11223333 23332 2333468999999999977664322 3447777655544444432 23346
Q ss_pred CceecCCCCCCEEEcC----CCceEEEeecccccccc
Q psy12709 131 NITHLDLKPQNILLTK----DNNIKLCDFGISRVVND 163 (253)
Q Consensus 131 ~~~h~di~~~ni~~~~----~~~~~l~df~~~~~~~~ 163 (253)
|.+|+|=+|.||++.+ ++.+.+.|||+......
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8999999999999995 56799999999976543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.9e-05 Score=70.55 Aligned_cols=83 Identities=7% Similarity=-0.015 Sum_probs=57.5
Q ss_pred EEeecCCCCceEEEEEEeccCC--ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCc--eeeeeEEEeC---CeEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITK--VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERI--VGLHEIYETP---HEMV 87 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~--~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i--~~~~~~~~~~---~~~~ 87 (253)
-++.++.|.+..+|+......+ ..+++|+.+..... .....+.+|...+..+..+.++ ++++.++.+. +..+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 4678899999999998765432 46888887643321 1234677898888855545554 6777766554 4688
Q ss_pred EEEeccCCCcH
Q psy12709 88 LVLEMVPDGEL 98 (253)
Q Consensus 88 lv~e~~~g~~L 98 (253)
+|||+++|..+
T Consensus 121 lVME~v~G~~~ 131 (822)
T PLN02876 121 YIMEYLEGRIF 131 (822)
T ss_pred EEEEecCCccc
Confidence 99999998753
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.22 E-value=4.7e-05 Score=59.32 Aligned_cols=76 Identities=17% Similarity=0.176 Sum_probs=50.2
Q ss_pred EeecCCCCceEEEEEEecc-CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 16 FCMPSRGKFASVRKCTHKI-TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
++.|..|-...+|++.... ++..|++|+...... ......+|...+.......-.++++..... .+++||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeC
Confidence 4678888899999997553 357899998764321 122445677777755455445666554432 37999999
Q ss_pred CCcH
Q psy12709 95 DGEL 98 (253)
Q Consensus 95 g~~L 98 (253)
|.++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 9776
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.19 E-value=6.7e-05 Score=56.28 Aligned_cols=99 Identities=26% Similarity=0.231 Sum_probs=77.0
Q ss_pred HHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCCcHHHH---HhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCc
Q psy12709 59 HEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRL---VDIQDGIPEQDTRSYMKQILEALAFLHD---HNI 132 (253)
Q Consensus 59 ~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~---~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~ 132 (253)
.|...++.....++++++++++-. +++.|+...+++... +..-...++....+++.+++..+++++. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 366666656666799999999843 678899876655321 1112236789999999999999999997 458
Q ss_pred eecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 133 THLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 133 ~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
...|++++|+-++++|.++++|.+.....
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 88999999999999999999999877644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.17 E-value=3e-05 Score=60.46 Aligned_cols=75 Identities=7% Similarity=-0.129 Sum_probs=46.4
Q ss_pred EeecCCCCce-EEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCC--CceeeeeEEEeCC---eEEEE
Q psy12709 16 FCMPSRGKFA-SVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSE--RIVGLHEIYETPH---EMVLV 89 (253)
Q Consensus 16 ~~~lg~g~~~-~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~--~i~~~~~~~~~~~---~~~lv 89 (253)
++.++.|+.. .||... ..+++|+.+... ....+.+|...+..+..+- .+.+++......+ ..+++
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 3567877776 599862 357888765422 1336778888777444331 2445555443322 35889
Q ss_pred EeccCCCcHH
Q psy12709 90 LEMVPDGELQ 99 (253)
Q Consensus 90 ~e~~~g~~L~ 99 (253)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999997763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.16 E-value=0.00015 Score=54.77 Aligned_cols=130 Identities=22% Similarity=0.299 Sum_probs=89.8
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEecccc--------------cchHHHHHHHHHHHHHHHhc-----CCCCceeee
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRR--------------RSMDQMQDILHEAAVLYLAQ-----KSERIVGLH 77 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~--------------~~~~~~~~~~~e~~~~~~~~-----~~~~i~~~~ 77 (253)
..||+|+.-.||.--+ ....+||+..... .......+..+|+.....+. .+.+|.+++
T Consensus 7 ~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 5789999999987643 3445788887655 11223456666776655333 367799999
Q ss_pred eEEEeCCeEEEEEeccC------CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC---
Q psy12709 78 EIYETPHEMVLVLEMVP------DGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN--- 148 (253)
Q Consensus 78 ~~~~~~~~~~lv~e~~~------g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~--- 148 (253)
++.+.+....+|+|.+. ..+|.+++. .+.++. .+... +-.-..+|-+.+|+.+|++|.||++..++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK-EGGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH-cCCccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 99999998899988663 227888885 444665 44433 33445577889999999999999998643
Q ss_pred -ceEEEe
Q psy12709 149 -NIKLCD 154 (253)
Q Consensus 149 -~~~l~d 154 (253)
.+.++|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 355655
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=98.12 E-value=6.5e-05 Score=61.17 Aligned_cols=145 Identities=20% Similarity=0.150 Sum_probs=98.2
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccc----------------------cchHH--HHHHHHHHHHHHHhcC
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR----------------------RSMDQ--MQDILHEAAVLYLAQK 69 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~----------------------~~~~~--~~~~~~e~~~~~~~~~ 69 (253)
.+-.+|+.|.-+.||.|.. .+|..+|||+++... .++.. .-..+.|+..+. ...
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLk-Rl~ 224 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLK-RLN 224 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHH-HHH
Confidence 4567999999999999874 488889999874321 11111 234455666665 334
Q ss_pred CCCceeeeeEEEeCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCC
Q psy12709 70 SERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQNILLTKDN 148 (253)
Q Consensus 70 ~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~di~~~ni~~~~~~ 148 (253)
..+|+-+--+... ..+|||+|+.+..--.-.-+...++...+..+-.+++.-+.-|-+ .+++|.|++--|+++. +|
T Consensus 225 ~aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG 301 (520)
T KOG2270|consen 225 NAGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DG 301 (520)
T ss_pred hcCCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CC
Confidence 4444322222222 357999999654443322234557788888888888888876654 5899999999999988 68
Q ss_pred ceEEEeecccccccc
Q psy12709 149 NIKLCDFGISRVVND 163 (253)
Q Consensus 149 ~~~l~df~~~~~~~~ 163 (253)
.+.++|.+.+.....
T Consensus 302 ~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 302 KLYIIDVSQSVEHDH 316 (520)
T ss_pred EEEEEEccccccCCC
Confidence 999999998876543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.11 E-value=0.00023 Score=53.50 Aligned_cols=127 Identities=24% Similarity=0.250 Sum_probs=86.2
Q ss_pred eeEEEeecCCCCc-eEEEEEEeccCCceEEEEEecc---ccc----------ch------HHHHHHHHHHHHHHHhc--C
Q psy12709 12 QTLIFCMPSRGKF-ASVRKCTHKITKVEYAAKFIRK---RRR----------SM------DQMQDILHEAAVLYLAQ--K 69 (253)
Q Consensus 12 ~~~~~~~lg~g~~-~~v~~~~~~~~~~~v~iK~~~~---~~~----------~~------~~~~~~~~e~~~~~~~~--~ 69 (253)
.++.++.||.|+. |.||++... |+.||+|++.. ... .. .....+..|.++..++. .
T Consensus 38 ~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 38 DIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred cEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 3459999999999 999999875 77999999322 110 00 22345677777666443 3
Q ss_pred CCCc--eeeeeEEEeC------------------CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH
Q psy12709 70 SERI--VGLHEIYETP------------------HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD 129 (253)
Q Consensus 70 ~~~i--~~~~~~~~~~------------------~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~ 129 (253)
++++ ++++++..-. ....+|.||.+... .++...+ .++++-+..+|+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~~----~~~~~dl~~~~k 182 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRDI----PQMLRDLKILHK 182 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhHH----HHHHHHHHHHHH
Confidence 4445 8888887322 13467777775533 2334443 456667777999
Q ss_pred CCceecCCCCCCEEEcCCCceEEEeeccc
Q psy12709 130 HNITHLDLKPQNILLTKDNNIKLCDFGIS 158 (253)
Q Consensus 130 ~~~~h~di~~~ni~~~~~~~~~l~df~~~ 158 (253)
.||+-+|+++.|.. .=+|+||+.+
T Consensus 183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999986 3478888753
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00012 Score=59.23 Aligned_cols=139 Identities=18% Similarity=0.146 Sum_probs=80.4
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCC-CceeeeeE------EEeCCeEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSE-RIVGLHEI------YETPHEMV 87 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~-~i~~~~~~------~~~~~~~~ 87 (253)
-.+.+..|....+|+.... +..+++|+... .. ...+..|+..+..+..+. .+.+++.. ...++..+
T Consensus 18 ~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 18 SFEGISAGIENTNYFVTTD--SGRYVLTLFEK--VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred heecccCccccceEEEEeC--CCcEEEEEcCC--CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 3668888888999998653 45789998864 11 124455555555333221 24444332 23345678
Q ss_pred EEEeccCCCcHHH--------HHh------h-cCCCCH--------HHHH------------HHHHHHHHHHHHHHH---
Q psy12709 88 LVLEMVPDGELQR--------LVD------I-QDGIPE--------QDTR------------SYMKQILEALAFLHD--- 129 (253)
Q Consensus 88 lv~e~~~g~~L~~--------~~~------~-~~~~~~--------~~~~------------~~~~~l~~~l~~lh~--- 129 (253)
++++|++|..+.. +.+ . ...+.. .... .....+..++..+.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999876522 100 0 000000 0000 001112223334332
Q ss_pred ----CCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 130 ----HNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 130 ----~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
.+++|+|++|.|++++.++.+.++||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4699999999999999887788999987753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=98.00 E-value=7.1e-06 Score=65.53 Aligned_cols=137 Identities=16% Similarity=0.142 Sum_probs=91.7
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccc------------------cchHH--HHHHHHHHHHHHHhcCCCC-c
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR------------------RSMDQ--MQDILHEAAVLYLAQKSER-I 73 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~------------------~~~~~--~~~~~~e~~~~~~~~~~~~-i 73 (253)
....||-|.-+-+|.+.+. .|.+.++|+=.... .+|.. .-...+|...+..+-.+.. +
T Consensus 96 vGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV 174 (465)
T KOG2268|consen 96 VGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV 174 (465)
T ss_pred hccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence 6678999999999999876 67777888532111 11211 1233455666664444433 5
Q ss_pred eeeeeEEEeCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEE
Q psy12709 74 VGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLC 153 (253)
Q Consensus 74 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~ 153 (253)
++.+++. +.++|||++.|..|...-.. .+.. .+...++.-+--|-..|++|+|++--||+++.++.++++
T Consensus 175 PkpiD~~----RH~Vvmelv~g~Pl~~v~~v---~d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vI 244 (465)
T KOG2268|consen 175 PKPIDHN----RHCVVMELVDGYPLRQVRHV---EDPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVI 244 (465)
T ss_pred CCccccc----ceeeHHHhhcccceeeeeec---CChH---HHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEe
Confidence 5555554 45899999999887655321 1222 233344455556778999999999999999999999999
Q ss_pred eeccccccc
Q psy12709 154 DFGISRVVN 162 (253)
Q Consensus 154 df~~~~~~~ 162 (253)
||..+...+
T Consensus 245 DFPQmvS~s 253 (465)
T KOG2268|consen 245 DFPQMVSTS 253 (465)
T ss_pred echHhhccC
Confidence 998776544
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00015 Score=58.75 Aligned_cols=77 Identities=16% Similarity=0.064 Sum_probs=50.4
Q ss_pred EeecCCCCceEEEEEEecc------CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 16 FCMPSRGKFASVRKCTHKI------TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
++.+..|-...+|++.... .++.|++|+....... .....+|...+..+....-..+++..+.. ..|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---LIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---eechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 4667778888999997653 2578999997654321 23556677666655444444566666543 358
Q ss_pred EeccCCCcHH
Q psy12709 90 LEMVPDGELQ 99 (253)
Q Consensus 90 ~e~~~g~~L~ 99 (253)
++|++|.++.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.7e-06 Score=74.42 Aligned_cols=183 Identities=20% Similarity=0.258 Sum_probs=128.9
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCC-ceeeeeEEEeCCeEEEEEecc
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER-IVGLHEIYETPHEMVLVLEMV 93 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~-i~~~~~~~~~~~~~~lv~e~~ 93 (253)
.+...++++++++++.........+ .+++..+ ....-++..+. ..+||| .+..++-++.++..++.++++
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLd-K~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLD-KVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHH-HccCCCCcccccccCCcccccchhhhhh
Confidence 5556788999999998766444333 5555443 12233455555 778888 777777777788999999999
Q ss_pred CCC-cHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccccc
Q psy12709 94 PDG-ELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEII 171 (253)
Q Consensus 94 ~g~-~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (253)
.++ +-...... .-.+..-+.....+.-++.++++|+..-+|+| ||+.. ++..+..+|+...............
T Consensus 317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~~~~t~~ 391 (829)
T KOG0576|consen 317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTMKPRTAI 391 (829)
T ss_pred cCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCcccccccCC
Confidence 776 22211111 11234445556667777889999987767777 55554 4789999999887776655556677
Q ss_pred cCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCC
Q psy12709 172 GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFA 211 (253)
Q Consensus 172 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 211 (253)
+++.++|||+.....+....|.|++|.-..++.-|-+|-.
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 8999999999999999999999999987777777776653
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00011 Score=58.01 Aligned_cols=134 Identities=15% Similarity=0.115 Sum_probs=77.8
Q ss_pred ecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCCc
Q psy12709 18 MPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGE 97 (253)
Q Consensus 18 ~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 97 (253)
.+..|-...+|+.. .+++.+++|.......... ....+|...+.....+.-.++++.... -++|++|++|..
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~--~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALG--VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccccccc--CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 46678888999887 3567899998664322210 134567777765544433445554433 268999999876
Q ss_pred HHH-----------HHh---h-c------CCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCceecCCC
Q psy12709 98 LQR-----------LVD---I-Q------DGIPE-QDTRSYMKQI---------LEALAFLHD--------HNITHLDLK 138 (253)
Q Consensus 98 L~~-----------~~~---~-~------~~~~~-~~~~~~~~~l---------~~~l~~lh~--------~~~~h~di~ 138 (253)
+.. +.+ + + .+++. ..+..+..++ ...+..+.. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 532 111 0 1 01121 1222222111 111222222 248999999
Q ss_pred CCCEEEcCCCceEEEeeccccc
Q psy12709 139 PQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 139 ~~ni~~~~~~~~~l~df~~~~~ 160 (253)
+.||+++.++ +.++||+.+..
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCc
Confidence 9999999877 78999988764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.0019 Score=54.12 Aligned_cols=80 Identities=18% Similarity=0.053 Sum_probs=53.1
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEeccccc----c-hHHHHHHHHHHHHHHHhcC--CCCceeeeeEEEeCCeEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR----S-MDQMQDILHEAAVLYLAQK--SERIVGLHEIYETPHEMV 87 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~-~~~~~~~~~e~~~~~~~~~--~~~i~~~~~~~~~~~~~~ 87 (253)
-.+.||.|....||++.+...++.++||....... . .....+...|...+..... ...+++++.+.+ +..+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCE
Confidence 35789999999999999874445899998542211 1 1223455566666664433 245777777744 5678
Q ss_pred EEEeccCCC
Q psy12709 88 LVLEMVPDG 96 (253)
Q Consensus 88 lv~e~~~g~ 96 (253)
+|||++++.
T Consensus 108 lVME~L~~~ 116 (401)
T PRK09550 108 TVMEDLSDH 116 (401)
T ss_pred EEEecCCCc
Confidence 999999764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00082 Score=54.64 Aligned_cols=139 Identities=14% Similarity=0.115 Sum_probs=77.0
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCC-CceeeeeE------EEeCCeEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSE-RIVGLHEI------YETPHEMV 87 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~-~i~~~~~~------~~~~~~~~ 87 (253)
.++.++.|....+|++... +..+++|+...... .+ .+..+...+..+..+. .+++++.. ...++..+
T Consensus 26 ~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~-~~---~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTD--VGRYILTLYEKRVK-AE---ELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred eccccCCccccceEEEEeC--CCcEEEEEecCCCC-HH---HHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 4667888888899998753 34688898765322 22 2333444333221111 13444332 12245678
Q ss_pred EEEeccCCCcHH----H----H---Hh---h-cCCC--------CHHH----HH-----------HHHHHHHHHHHHHH-
Q psy12709 88 LVLEMVPDGELQ----R----L---VD---I-QDGI--------PEQD----TR-----------SYMKQILEALAFLH- 128 (253)
Q Consensus 88 lv~e~~~g~~L~----~----~---~~---~-~~~~--------~~~~----~~-----------~~~~~l~~~l~~lh- 128 (253)
++++|++|..+. . + +. . ...+ .... .. .....+...++++.
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999886431 0 0 00 0 0111 0000 00 00111223344443
Q ss_pred ------HCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 129 ------DHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 129 ------~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
..+++|+|+++.|++++.++.+.++||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2689999999999999998877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.0019 Score=52.73 Aligned_cols=31 Identities=26% Similarity=0.333 Sum_probs=26.4
Q ss_pred CCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 130 HNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 130 ~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
.+++|+|+++.||+++.+....++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4799999999999999665568999998753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0011 Score=53.65 Aligned_cols=145 Identities=12% Similarity=0.143 Sum_probs=86.8
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCC-CceeeeeEEEeCC--eEEEEE
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSE-RIVGLHEIYETPH--EMVLVL 90 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~-~i~~~~~~~~~~~--~~~lv~ 90 (253)
.+++.+..|-...+|...+. +.+++++ .+..........+..+|...+......+ -+...+..+..+. ..+.+|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 36666766666667766654 8889999 4433344455677788888887665542 1334444444444 669999
Q ss_pred eccCCCcHHHHHhhc--------------------------------CCCCHHHHHHHHHHH--------------HHHH
Q psy12709 91 EMVPDGELQRLVDIQ--------------------------------DGIPEQDTRSYMKQI--------------LEAL 124 (253)
Q Consensus 91 e~~~g~~L~~~~~~~--------------------------------~~~~~~~~~~~~~~l--------------~~~l 124 (253)
+|+.|.....-.... ......++.++..+. ....
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 999884221111000 000111222222222 1223
Q ss_pred HHHHHC--------CceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 125 AFLHDH--------NITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 125 ~~lh~~--------~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
.+++.+ .++|+|+++.|+++++++.+-++||+.+..-
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 344432 4789999999999999999999999988754
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00042 Score=63.98 Aligned_cols=155 Identities=21% Similarity=0.239 Sum_probs=114.4
Q ss_pred HHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe----EEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH
Q psy12709 54 MQDILHEAAVLYLAQKSERIVGLHEIYETPHE----MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD 129 (253)
Q Consensus 54 ~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~----~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~ 129 (253)
....+-|+..+. ...|+|+..++.+...... ..+..+++.+.++...+..-...+...++.+..++..++.++|+
T Consensus 226 i~~~E~e~~~l~-k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 226 IQTTEIELESLS-KIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHH-hhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 344555666666 7789999999988766532 22456788888888888877889999999999999999999999
Q ss_pred CCceecCCCCC---CEEEcCCCceEEE--eecccccccccccccccccCccccCccccCCCCCCc--cccHHHHHHHHHH
Q psy12709 130 HNITHLDLKPQ---NILLTKDNNIKLC--DFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISL--ATDMWSVGVLAYV 202 (253)
Q Consensus 130 ~~~~h~di~~~---ni~~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~--~~Di~slG~~l~~ 202 (253)
...-|.-+... ..-++..+.+.+. ||+.+.................+.++|.......+. ..|+|.+|..+..
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 86665555554 3344445666666 888887766655555555667778888876665544 4799999999999
Q ss_pred HHhCCCC
Q psy12709 203 LLSSHSP 209 (253)
Q Consensus 203 l~~g~~p 209 (253)
+..|..+
T Consensus 385 ~~~~~~i 391 (1351)
T KOG1035|consen 385 LSQGEDI 391 (1351)
T ss_pred hhhcCcc
Confidence 8887544
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.002 Score=53.28 Aligned_cols=139 Identities=12% Similarity=0.096 Sum_probs=84.3
Q ss_pred EEeecCCCCceEEEEEEecc----CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKI----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVL 90 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 90 (253)
-++.+..|-...+|++.... .++.|++|+..... .......+|...+..+....--.++++.+..+ .|.
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---CeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 45677778889999987432 34689999887542 12234467787777565555556777777543 578
Q ss_pred eccCCCcHHHH-------H-------h---h-c--C---CCCHHHHHHHHHHH-----------------HHHHHHH---
Q psy12709 91 EMVPDGELQRL-------V-------D---I-Q--D---GIPEQDTRSYMKQI-----------------LEALAFL--- 127 (253)
Q Consensus 91 e~~~g~~L~~~-------~-------~---~-~--~---~~~~~~~~~~~~~l-----------------~~~l~~l--- 127 (253)
+|++|.++... + . . . . +.....+..+..++ ...+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99988776321 0 0 0 0 0 11122222332111 1111111
Q ss_pred -H----HCCceecCCCCCCEEEcC-CCceEEEeeccccc
Q psy12709 128 -H----DHNITHLDLKPQNILLTK-DNNIKLCDFGISRV 160 (253)
Q Consensus 128 -h----~~~~~h~di~~~ni~~~~-~~~~~l~df~~~~~ 160 (253)
. ...++|+|+++.||++++ ++.+.++||..+..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 225899999999999986 46899999998864
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.002 Score=52.98 Aligned_cols=140 Identities=13% Similarity=0.133 Sum_probs=82.2
Q ss_pred EEeecCCCCceEEEEEEeccC---CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 15 IFCMPSRGKFASVRKCTHKIT---KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
-++.+..|=...+|++..... +..|++|+...... ...+..+|...+..+..+.--++++.++..+ +|.+
T Consensus 18 ~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~ 90 (330)
T PLN02421 18 SVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQS 90 (330)
T ss_pred EEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEeCCc----Eeeh
Confidence 456677788889999875432 34799998865322 2335566777777555554446777666432 5889
Q ss_pred ccCCCcHHH--H-----H----h---h-c-CC------CC-HHHHHHHHHHH----------------------HHHHHH
Q psy12709 92 MVPDGELQR--L-----V----D---I-Q-DG------IP-EQDTRSYMKQI----------------------LEALAF 126 (253)
Q Consensus 92 ~~~g~~L~~--~-----~----~---~-~-~~------~~-~~~~~~~~~~l----------------------~~~l~~ 126 (253)
|++|.++.. + + . + + .+ .+ ...+..+..++ ...+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 998876521 0 1 0 0 0 01 11 12222222221 111111
Q ss_pred HH----HCC----ceecCCCCCCEEEcC-CCceEEEeecccccc
Q psy12709 127 LH----DHN----ITHLDLKPQNILLTK-DNNIKLCDFGISRVV 161 (253)
Q Consensus 127 lh----~~~----~~h~di~~~ni~~~~-~~~~~l~df~~~~~~ 161 (253)
+. ..+ ..|.|+.+.||++++ ++.++++||..+...
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 11 112 689999999999975 478999999988643
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0035 Score=50.74 Aligned_cols=106 Identities=17% Similarity=0.085 Sum_probs=72.0
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCC--CCceeeeeEEEe---CCeEEE
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKS--ERIVGLHEIYET---PHEMVL 88 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~--~~i~~~~~~~~~---~~~~~l 88 (253)
.-.+.||.|..+.||..... ++ .+++|..+. ... ...+..|...+..+... -.++++++++.. .+..++
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~-~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS-QG-NPMPLMARS-FST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred heeeecCCccceeEEEEEcC-CC-CEEEEEecc-ccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 35678999999999999654 23 477777543 111 23677788888755554 357888877654 356899
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDH 130 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 130 (253)
|||+++|.++.+. ..+......+..+++.++.-||+.
T Consensus 91 VmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 91 LLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred EEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 9999999877652 123444555666777777778864
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0013 Score=53.84 Aligned_cols=120 Identities=17% Similarity=0.244 Sum_probs=78.2
Q ss_pred hcCCCCceeeeeEE-EeCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEE
Q psy12709 67 AQKSERIVGLHEIY-ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDH-NITHLDLKPQNILL 144 (253)
Q Consensus 67 ~~~~~~i~~~~~~~-~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~di~~~ni~~ 144 (253)
....++..+.+-+- .+....|++|++- |+.+. .+ .....+++..++.+++..++-+..+ ..-|++++..||++
T Consensus 281 ~~g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is-~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI 355 (488)
T COG5072 281 ECGSVFLETLKVVSLDETLYLYLHFKDH-GTPIS-II---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI 355 (488)
T ss_pred hccchhhhcceEEecCCceEEEEEEecC-Cceee-ee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee
Confidence 44555555555554 3334667777753 54443 22 2245778888888888888877765 58899999999999
Q ss_pred cCCCceEEEeecccccccccccccccccCccccCccccCCCCCCccccHHHHH
Q psy12709 145 TKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197 (253)
Q Consensus 145 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG 197 (253)
+ +|+|.|+||-+++...... .....+.--|..+.|.. +.+.+||-+-
T Consensus 356 d-~GnvtLIDfklsRl~~~q~----~isy~rldhp~lF~G~d-d~QFeIYrlM 402 (488)
T COG5072 356 D-EGNVTLIDFKLSRLSYSQG----IISYNRLDHPDLFNGVD-DYQFEIYRLM 402 (488)
T ss_pred e-cCceEEEEeeeeecccCCc----eeeccccCchhhhcCcc-ceeeeHHHHH
Confidence 9 9999999999998433221 12233444555565443 6677777743
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0099 Score=49.02 Aligned_cols=83 Identities=11% Similarity=-0.027 Sum_probs=48.4
Q ss_pred ecCCCCceEEEEEEeccCCceEEEEEeccccc-----chHHHHHHHHHHHHHHHhcC-CC-CceeeeeEEEeCCeEEEEE
Q psy12709 18 MPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-----SMDQMQDILHEAAVLYLAQK-SE-RIVGLHEIYETPHEMVLVL 90 (253)
Q Consensus 18 ~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~~~e~~~~~~~~~-~~-~i~~~~~~~~~~~~~~lv~ 90 (253)
.||.|...-||++.+...++.++||.....-. ......+..-|...+..... .| .+++++.+-+ +...++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~--e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDT--EMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEcc--ccceehH
Confidence 57999999999999764446799997542211 12223344455555554333 23 4555554433 4567889
Q ss_pred eccCCC-cHHHHH
Q psy12709 91 EMVPDG-ELQRLV 102 (253)
Q Consensus 91 e~~~g~-~L~~~~ 102 (253)
|+++.. .++..+
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 988543 343433
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.019 Score=46.00 Aligned_cols=30 Identities=33% Similarity=0.544 Sum_probs=24.8
Q ss_pred CceecCCCCCCEEEcCCCc-eEEEeeccccc
Q psy12709 131 NITHLDLKPQNILLTKDNN-IKLCDFGISRV 160 (253)
Q Consensus 131 ~~~h~di~~~ni~~~~~~~-~~l~df~~~~~ 160 (253)
.++|+|+++.||++++++. .-++||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999987753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0023 Score=49.03 Aligned_cols=118 Identities=22% Similarity=0.274 Sum_probs=62.0
Q ss_pred CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCCcHHH-------HHh-----
Q psy12709 36 KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQR-------LVD----- 103 (253)
Q Consensus 36 ~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~-------~~~----- 103 (253)
++.|++|+...... .......|...++.......-+++++.+..+ .+.+|++|.+|.. .+.
T Consensus 2 ~~~~~~Ri~g~~t~---~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~ 74 (211)
T PF01633_consen 2 PEKYLVRIPGEGTE---NFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKL 74 (211)
T ss_dssp TSEEEEEEEESCGC---SHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcc---cccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHH
Confidence 46789998876522 2357777888887666666667777777553 5668887776522 110
Q ss_pred -------hc-CCCC----HHHHHHH----------------------HHHHHHHHHHHH----H----CCceecCCCCCC
Q psy12709 104 -------IQ-DGIP----EQDTRSY----------------------MKQILEALAFLH----D----HNITHLDLKPQN 141 (253)
Q Consensus 104 -------~~-~~~~----~~~~~~~----------------------~~~l~~~l~~lh----~----~~~~h~di~~~n 141 (253)
.. .... ...+..+ +..+...+..+. + .-+.|+|+.+.|
T Consensus 75 l~~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~N 154 (211)
T PF01633_consen 75 LAKLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGN 154 (211)
T ss_dssp HHHHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGG
T ss_pred HHHHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCcccc
Confidence 00 0000 1112122 011122222222 1 247899999999
Q ss_pred EEE-cCCCceEEEeeccccc
Q psy12709 142 ILL-TKDNNIKLCDFGISRV 160 (253)
Q Consensus 142 i~~-~~~~~~~l~df~~~~~ 160 (253)
|++ ..++.++++||..+..
T Consensus 155 il~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 155 ILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEETSSSSCEEE--GTT-EE
T ss_pred EEeccCCCeEEEecHHHHhh
Confidence 999 7889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.026 Score=47.47 Aligned_cols=77 Identities=9% Similarity=0.014 Sum_probs=51.5
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEeccccc---c--hHHHHHHHHHHHHHHHhcC--CCCceeeeeEEEeCCeEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR---S--MDQMQDILHEAAVLYLAQK--SERIVGLHEIYETPHEMV 87 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~--~~~~~~~~~e~~~~~~~~~--~~~i~~~~~~~~~~~~~~ 87 (253)
-.+.+|.|....||+..+. +..++||.-..... . .-...+...|...+....+ ...+++++.+.+ +.-+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 5678999999999999874 45689998762221 0 0123455555666654433 246777887777 4567
Q ss_pred EEEeccCC
Q psy12709 88 LVLEMVPD 95 (253)
Q Consensus 88 lv~e~~~g 95 (253)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 78999977
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.022 Score=45.77 Aligned_cols=79 Identities=18% Similarity=0.122 Sum_probs=48.1
Q ss_pred eeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHh--cCCCCceeeeeEEEeCCeEEE
Q psy12709 11 YQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLA--QKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~--~~~~~i~~~~~~~~~~~~~~l 88 (253)
.+.+-.+.++.|....+|... .++..+.+|+-..... ..+..|...++.+ ...-.+++++.+....+..++
T Consensus 17 ~~i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~-----~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fL 89 (288)
T PF03881_consen 17 FKITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGR-----DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFL 89 (288)
T ss_dssp ----EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGC-----CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEE
T ss_pred CceeeeEecCCCChhheEEEE--CCCccEEEEecChhhH-----HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceE
Confidence 344567789999999999987 5678899998773222 2556677766644 345558899999988888899
Q ss_pred EEeccCCC
Q psy12709 89 VLEMVPDG 96 (253)
Q Consensus 89 v~e~~~g~ 96 (253)
++||++.+
T Consensus 90 lle~l~~~ 97 (288)
T PF03881_consen 90 LLEFLEMG 97 (288)
T ss_dssp EEE-----
T ss_pred EEEeecCC
Confidence 99999766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.029 Score=46.94 Aligned_cols=78 Identities=14% Similarity=0.031 Sum_probs=48.5
Q ss_pred EeecCCCCceEEEEEEeccCCceEEEEEecccc----cchHHHHHHHHHHHHHHHhcC--CCCceeeeeEEEeCCeEEEE
Q psy12709 16 FCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR----RSMDQMQDILHEAAVLYLAQK--SERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~~~e~~~~~~~~~--~~~i~~~~~~~~~~~~~~lv 89 (253)
.+.||-|.-.-||++.+...++.++||.....- .-.....+..-|...++.... ...+++++.+-+ +...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~--e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS--VMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc--HHhhHH
Confidence 678999999999999985445679998653211 112223455555555554333 234666665544 356788
Q ss_pred EeccCC
Q psy12709 90 LEMVPD 95 (253)
Q Consensus 90 ~e~~~g 95 (253)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888854
|
|
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.012 Score=49.09 Aligned_cols=63 Identities=27% Similarity=0.326 Sum_probs=44.9
Q ss_pred eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCC
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQNILLTKDN 148 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~di~~~ni~~~~~~ 148 (253)
...++-+|..|-++..++...+ -+++..+.++.-...|+-.+-- -+.+|.|++|.||++..+.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred cceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence 4567778999999988887543 4555666666666666544333 4799999999999997543
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.06 Score=45.19 Aligned_cols=78 Identities=12% Similarity=-0.072 Sum_probs=50.9
Q ss_pred EEeecCCCCceEEEEEEeccC-Cc-----eEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKIT-KV-----EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~-~~-----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
.++.+..|-...+|++..... +. .|.++.... ..+...+..+|..++..+..+..-.++++.+.. ++
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~ 126 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FT 126 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC---CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence 456777788899999975432 12 244444321 112233556778888866666667788888865 59
Q ss_pred EEeccCCCcHH
Q psy12709 89 VLEMVPDGELQ 99 (253)
Q Consensus 89 v~e~~~g~~L~ 99 (253)
+.||++|.++.
T Consensus 127 l~efIeGr~l~ 137 (383)
T PTZ00384 127 IQEWVEGNTMG 137 (383)
T ss_pred EEEEeccccCC
Confidence 99999988763
|
|
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.00039 Score=66.18 Aligned_cols=144 Identities=14% Similarity=0.046 Sum_probs=103.6
Q ss_pred cCCCCceeeeeEEEe--CCeEEEEEeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecC
Q psy12709 68 QKSERIVGLHEIYET--PHEMVLVLEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHN-----ITHLD 136 (253)
Q Consensus 68 ~~~~~i~~~~~~~~~--~~~~~lv~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~-----~~h~d 136 (253)
..|.++.....-.+. ...-+..++++.+|.+.+.+-+ .++.+..-+.....+.+....-+|+.. .+|.+
T Consensus 1286 ~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~ 1365 (2724)
T KOG1826|consen 1286 AKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKS 1365 (2724)
T ss_pred hhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhh
Confidence 356665544443332 2357788999999999888754 234555555555555466666655431 67899
Q ss_pred CCCCCEEEcCCCceEEEeeccccccccc-ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCC
Q psy12709 137 LKPQNILLTKDNNIKLCDFGISRVVNDV-VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFA 211 (253)
Q Consensus 137 i~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 211 (253)
+++.|.++.-+..+++.++|+.+..... .......+++.|+.|++.+.-.++.++|+|..|+-+|....|..+|.
T Consensus 1366 Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1366 LKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred hhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 9999999999999999999999833332 23334456778899998888888888999999999999888888873
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.11 Score=44.40 Aligned_cols=77 Identities=12% Similarity=-0.008 Sum_probs=48.8
Q ss_pred EEeecCCCCceEEEEEEeccC--------CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 15 IFCMPSRGKFASVRKCTHKIT--------KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~--------~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
-++.|..|=.-.+|++..... ++.|++|+....... ......|...+..+....--.++++.+..
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~---lIdR~~E~~v~~~ls~~gi~P~l~~~f~g---- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDE---LYNPISEFEVYKTMSKYRIAPQLLNTFSG---- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccc---eeCHHHHHHHHHHHHHCCCCCceEEEeCC----
Confidence 456777888889999875421 467999988653321 22455666666645444333566666542
Q ss_pred EEEEeccCCCcH
Q psy12709 87 VLVLEMVPDGEL 98 (253)
Q Consensus 87 ~lv~e~~~g~~L 98 (253)
+.|.+|++|.+|
T Consensus 182 g~I~efi~g~~l 193 (442)
T PTZ00296 182 GRIEEWLYGDPL 193 (442)
T ss_pred CEEEEeeCCccC
Confidence 467899988744
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.13 Score=42.16 Aligned_cols=135 Identities=20% Similarity=0.184 Sum_probs=75.1
Q ss_pred ecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCC-ceee--------eeEEEeCCeEEE
Q psy12709 18 MPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER-IVGL--------HEIYETPHEMVL 88 (253)
Q Consensus 18 ~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~-i~~~--------~~~~~~~~~~~l 88 (253)
.|.+ .-..+|+.... +++ +++|+.... .+.. .+..|...++-+..+.- +... +.....+...+.
T Consensus 33 ~l~s-~eN~~f~~~~~-~g~-~iLki~~~~-~~~~---~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~ 105 (331)
T COG2334 33 GLNS-EENSNFRVQTE-DGR-YILKIYRPG-WTRA---EIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA 105 (331)
T ss_pred cccc-ccCceEEEEec-CCC-eEEEEecCC-CCHH---HHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence 4445 66788999876 333 499999876 3333 44455555543333322 1111 111111237889
Q ss_pred EEeccCCCcHHH-HH------------------hh----cC-CC---CHH----H---------HHHHHHHHHHHHHHHH
Q psy12709 89 VLEMVPDGELQR-LV------------------DI----QD-GI---PEQ----D---------TRSYMKQILEALAFLH 128 (253)
Q Consensus 89 v~e~~~g~~L~~-~~------------------~~----~~-~~---~~~----~---------~~~~~~~l~~~l~~lh 128 (253)
+++|++|..+.. .- +. ++ .+ ... . -.....++...+..+.
T Consensus 106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~ 185 (331)
T COG2334 106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL 185 (331)
T ss_pred EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence 999999988772 11 00 00 01 010 0 0001122333333333
Q ss_pred H--------CC--ceecCCCCCCEEEcCCCc-eEEEeecccc
Q psy12709 129 D--------HN--ITHLDLKPQNILLTKDNN-IKLCDFGISR 159 (253)
Q Consensus 129 ~--------~~--~~h~di~~~ni~~~~~~~-~~l~df~~~~ 159 (253)
+ .+ ++|+|+.+.||+++.+.. +-++||+-+.
T Consensus 186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 2 23 999999999999999885 8899999775
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.35 Score=39.72 Aligned_cols=28 Identities=32% Similarity=0.337 Sum_probs=24.0
Q ss_pred CCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 130 HNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 130 ~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
.+++|+|+.+.||+++ + .+.++||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4689999999999995 4 57899999775
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.61 Score=44.48 Aligned_cols=31 Identities=35% Similarity=0.499 Sum_probs=26.1
Q ss_pred CCceecCCCCCCEEEcCCC--ceE-EEeeccccc
Q psy12709 130 HNITHLDLKPQNILLTKDN--NIK-LCDFGISRV 160 (253)
Q Consensus 130 ~~~~h~di~~~ni~~~~~~--~~~-l~df~~~~~ 160 (253)
.+++|+|+++.||+++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 454 999997754
|
|
| >KOG2269|consensus | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.031 Score=45.36 Aligned_cols=140 Identities=20% Similarity=0.156 Sum_probs=88.8
Q ss_pred EEeecCCCCceEEEEEEec-------c---CCceEEEEEeccccc----------------------chHHH--HHHHHH
Q psy12709 15 IFCMPSRGKFASVRKCTHK-------I---TKVEYAAKFIRKRRR----------------------SMDQM--QDILHE 60 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~-------~---~~~~v~iK~~~~~~~----------------------~~~~~--~~~~~e 60 (253)
|-..|+.|.-+.|+-|... . ....+|||+++.+.. +...+ -..++|
T Consensus 256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE 335 (531)
T KOG2269|consen 256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE 335 (531)
T ss_pred hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence 5678999999999999542 1 234578887643211 01110 112223
Q ss_pred HHHHHH----hcCCCCceeeeeEEEeCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceec
Q psy12709 61 AAVLYL----AQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLH-DHNITHL 135 (253)
Q Consensus 61 ~~~~~~----~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~~~h~ 135 (253)
...+.+ -+.+|-+|.+. ...+||.|+...-+..---+...++..+....-.|+..++..|. +.-++|.
T Consensus 336 mhNL~RMq~~GlpcP~vV~lk-------khvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHA 408 (531)
T KOG2269|consen 336 MHNLSRMQKHGLPCPQVVKLK-------KHVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHA 408 (531)
T ss_pred HHHHHHHHhcCCCCCceeeee-------cceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheeec
Confidence 322222 23455555443 34688998854433322222445888888888889988887664 5679999
Q ss_pred CCCCCCEEEcCCCceEEEeeccccccc
Q psy12709 136 DLKPQNILLTKDNNIKLCDFGISRVVN 162 (253)
Q Consensus 136 di~~~ni~~~~~~~~~l~df~~~~~~~ 162 (253)
|++-.|++...+ .+.++|...+....
T Consensus 409 DlSEyN~Lw~~g-Kvw~IDVsQsvep~ 434 (531)
T KOG2269|consen 409 DLSEYNLLWTPG-KVWVIDVSQSVEPS 434 (531)
T ss_pred chhhhhheecCC-ceEEEechhccCCC
Confidence 999999999975 99999987775443
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.085 Score=45.54 Aligned_cols=146 Identities=18% Similarity=0.281 Sum_probs=82.7
Q ss_pred HHHHHHHHHHHhcCCCCceeeeeEEEeC-CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy12709 56 DILHEAAVLYLAQKSERIVGLHEIYETP-HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITH 134 (253)
Q Consensus 56 ~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h 134 (253)
++.-....++ ...|++.-.++++-... .+..+|+|++ +.++++.+..+. .-..... +|
T Consensus 28 ~ilgr~~~lk-tl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~------------------~~ 86 (725)
T KOG1093|consen 28 QILGRFQYLK-SLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL------------------AH 86 (725)
T ss_pred HHhhhhHHHH-hhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc------------------cc
Confidence 4555566666 77899998888887754 3688999998 779999887544 2111110 11
Q ss_pred cCCCCCCEEEcCCCceEEEeecccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Q psy12709 135 LDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDN 214 (253)
Q Consensus 135 ~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 214 (253)
+ +.+.|+ +...| ..... + | .+..+++|||++|.++.++..|...+....
T Consensus 87 ~-~~~~~~-------~~~td----~~~t~------------~--~-----~~~~pKsdVwsl~~i~~el~L~~~l~~~~~ 135 (725)
T KOG1093|consen 87 G-VLHLNI-------IYITD----HFLTK------------Y--P-----SPIGPKSDVWSLGFIILELYLGISLEAELT 135 (725)
T ss_pred c-cceehh-------hhccc----ccccc------------C--C-----CCCCcchhhhhHHHHHHHHHHhhHHHHHHH
Confidence 1 111112 22222 00000 0 1 112259999999999999999988776655
Q ss_pred hHHHHHHhhcccccccC--------CccCCCCHHHHHHHHHhcccCC
Q psy12709 215 KQETFLNISQCNFSFHE--------DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 215 ~~~~~~~i~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+...-+.+-...... .....++..+.++...|+-..|
T Consensus 136 ~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~ 182 (725)
T KOG1093|consen 136 ESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEP 182 (725)
T ss_pred HHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCcccc
Confidence 55554443332221111 1123455666666677765443
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.091 Score=42.68 Aligned_cols=29 Identities=31% Similarity=0.485 Sum_probs=25.5
Q ss_pred CCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 130 HNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 130 ~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
.+++|+|+++.||+++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57899999999999997 678999998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.17 E-value=0.11 Score=41.50 Aligned_cols=31 Identities=32% Similarity=0.448 Sum_probs=28.0
Q ss_pred CceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 131 NITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 131 ~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
-++|+|+.+.|++.++.+.+.|+||..+...
T Consensus 154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~ 184 (269)
T COG0510 154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAGLN 184 (269)
T ss_pred eeecCCCCccceEEcCCCcEEEEecccCCCc
Confidence 4889999999999999999999999988643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 253 | ||||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-67 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-56 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-56 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-56 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-56 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-56 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-56 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-56 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-56 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-56 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-56 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-56 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-56 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-55 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-55 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-55 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-55 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-55 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-55 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-55 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-55 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-55 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-55 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-55 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-42 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-42 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-42 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-42 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-37 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-36 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-35 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-34 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-34 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-34 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-34 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-34 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-34 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-34 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-34 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-33 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-33 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-33 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-33 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-33 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-31 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-31 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-31 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-31 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-31 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-31 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-31 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-30 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-30 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-30 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-30 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-29 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-29 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-29 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-29 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-29 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-29 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-29 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-28 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-28 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-28 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-28 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-28 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-28 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-28 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-28 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-27 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-27 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-27 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-27 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-27 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-27 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-27 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-27 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-27 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-27 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-27 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-27 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-27 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-26 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-26 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-26 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-26 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-26 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-26 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-26 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-26 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-25 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-25 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-25 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-25 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-25 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-25 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-25 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-25 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-25 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-25 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-25 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-25 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-25 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-25 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-25 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-25 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-25 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-25 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-25 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-25 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-25 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-25 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-25 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-25 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-25 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-25 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-25 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-25 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-25 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-25 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-25 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-25 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-24 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-24 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-24 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-24 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-24 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-24 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-24 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-24 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-24 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-24 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-24 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-24 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-24 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-24 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-24 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-23 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-23 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-23 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-23 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-23 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-23 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-23 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-23 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-23 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-23 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-23 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-23 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-23 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-23 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-23 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-23 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-23 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-23 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-23 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-23 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-22 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-22 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-22 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-22 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-22 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-22 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-22 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-22 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-22 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-22 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-22 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-22 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-22 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-22 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-22 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-22 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-22 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-22 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-22 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-22 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-22 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-22 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-22 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-22 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-22 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-22 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-22 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-22 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-22 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-22 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-22 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-22 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-22 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-22 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-22 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-22 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-22 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-22 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-22 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-22 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-22 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-22 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-22 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-22 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-22 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-22 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-22 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-22 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-22 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-22 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-22 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-22 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-22 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-21 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-21 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-21 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-21 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-21 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-21 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-21 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-21 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-21 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-21 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-21 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-21 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-21 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-21 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-21 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-21 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-21 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-21 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-21 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-21 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-21 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-21 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-21 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-21 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-21 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-21 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-21 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-21 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-21 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-21 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-21 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-21 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-21 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-21 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-21 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-21 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-21 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-21 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-21 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-21 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-21 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-21 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-21 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-21 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-21 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-21 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-21 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-21 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-21 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-21 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-21 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-21 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-21 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-21 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-20 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-20 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-20 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-20 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-20 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-20 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-20 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-20 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-20 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-20 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-19 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-19 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-19 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-19 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-19 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-19 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-19 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-19 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-19 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-19 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-19 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-19 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-19 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-18 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-18 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-18 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-18 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-18 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-18 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-18 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-18 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-18 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-18 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-18 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-18 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-18 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-18 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-18 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-18 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-18 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-18 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-18 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-18 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-18 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-18 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-18 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-18 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-18 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-18 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-18 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-18 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-18 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-18 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-18 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-18 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-18 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-18 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-18 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-18 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-18 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-18 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-18 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-17 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-17 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-17 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-17 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-17 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-17 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-17 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-16 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-16 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-16 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-15 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-14 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-14 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-14 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-14 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-14 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-14 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-14 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-13 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-13 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-13 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-13 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-13 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-13 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-13 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-13 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-13 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-12 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-12 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-12 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-12 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-12 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-12 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-12 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-12 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-11 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-11 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-11 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-11 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-11 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 9e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-11 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-11 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 9e-11 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-10 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-09 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-09 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-08 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-08 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-08 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-08 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-08 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-08 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-08 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-08 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-08 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-08 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-07 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-07 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-07 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-07 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-06 |
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 324 bits (832), Expect = e-112
Identities = 120/238 (50%), Positives = 164/238 (68%), Gaps = 5/238 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RGKFA VR+C K T EYAAKF++KRRR D +ILHE AVL LA+ R++ LHE+Y
Sbjct: 39 RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98
Query: 81 ETPHEMVLVLEMVPDGEL-QRLVDIQDGI-PEQDTRSYMKQILEALAFLHDHNITHLDLK 138
E E++L+LE GE+ + + E D +KQILE + +LH +NI HLDLK
Sbjct: 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLK 158
Query: 139 PQNILL---TKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
PQNILL +IK+ DFG+SR + E++EI+GTP+Y+APE+L+Y+PI+ ATDMW+
Sbjct: 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWN 218
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+G++AY+LL+ SPF G++ QET+LNISQ N + E+ F +S A DFIQS LV +P
Sbjct: 219 IGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNP 276
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 306 bits (785), Expect = e-105
Identities = 109/242 (45%), Positives = 151/242 (62%), Gaps = 11/242 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR----RSMDQMQDILHEAAVLYLAQKSERIVGL 76
G+FA VRKC K T EYAAKFI+KRR R ++I E +L + I+ L
Sbjct: 15 SGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITL 73
Query: 77 HEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
H+I+E ++VL+LE+V GEL L + ++ + E + ++KQIL+ + +LH I H
Sbjct: 74 HDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHF 132
Query: 136 DLKPQNILLT----KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLAT 191
DLKP+NI+L + IKL DFGI+ + E K I GTP++VAPE+++YEP+ L
Sbjct: 133 DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEA 192
Query: 192 DMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251
DMWS+GV+ Y+LLS SPF G+ KQET NIS N+ F E+ F + S AKDFI+ LV
Sbjct: 193 DMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVK 252
Query: 252 DP 253
DP
Sbjct: 253 DP 254
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 306 bits (786), Expect = e-104
Identities = 93/236 (39%), Positives = 141/236 (59%), Gaps = 6/236 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G+F V KC T ++ AAK I+ R M +++ +E +V+ ++ L++ +
Sbjct: 99 GGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLD-HANLIQLYDAF 155
Query: 81 ETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
E+ +++VLV+E V GEL R++D + E DT +MKQI E + +H I HLDLKP
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKP 215
Query: 140 QNILLT--KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
+NIL IK+ DFG++R ++K GTP+++APEV++Y+ +S TDMWSVG
Sbjct: 216 ENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVG 275
Query: 198 VLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
V+AY+LLS SPF GDN ET NI C + ++ F IS +AK+FI L+ +
Sbjct: 276 VIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-103
Identities = 80/236 (33%), Positives = 133/236 (56%), Gaps = 7/236 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RG+F V +C +K Y AKF++ + + E ++L +A+ I+ LHE +
Sbjct: 15 RGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNIAR-HRNILHLHESF 70
Query: 81 ETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
E+ E+V++ E + ++ +R+ + E++ SY+ Q+ EAL FLH HNI H D++P
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRP 130
Query: 140 QNILLT--KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
+NI+ + + IK+ +FG +R + + + P+Y APEV ++ +S ATDMWS+G
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLG 190
Query: 198 VLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
L YVLLS +PF + Q+ NI ++F E+ F IS +A DF+ LV +
Sbjct: 191 TLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKER 246
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = e-103
Identities = 87/236 (36%), Positives = 138/236 (58%), Gaps = 6/236 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G F V +C K T + AKFI + +E +++ +++ LH+ +
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFINTPYPL--DKYTVKNEISIMNQLH-HPKLINLHDAF 117
Query: 81 ETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
E +EMVL+LE + GEL R+ + E + +YM+Q E L +H+H+I HLD+KP
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKP 177
Query: 140 QNILLT--KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
+NI+ K +++K+ DFG++ +N VK T ++ APE++ EP+ TDMW++G
Sbjct: 178 ENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIG 237
Query: 198 VLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
VL YVLLS SPFAG++ ET N+ +C++ F ED F +S +AKDFI++ L +P
Sbjct: 238 VLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEP 293
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = e-103
Identities = 106/242 (43%), Positives = 154/242 (63%), Gaps = 11/242 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR----RSMDQMQDILHEAAVLYLAQKSERIVGL 76
G+FA V+KC K T +EYAAKFI+KR+ R ++I E ++L ++ L
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITL 80
Query: 77 HEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
H++YE ++VL+LE+V GEL L ++ + E++ S++KQIL+ + +LH I H
Sbjct: 81 HDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 136 DLKPQNILLT----KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLAT 191
DLKP+NI+L +IKL DFG++ + D VE K I GTP++VAPE+++YEP+ L
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEA 199
Query: 192 DMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251
DMWS+GV+ Y+LLS SPF GD KQET NI+ ++ F E+ F H S AKDFI+ LV
Sbjct: 200 DMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVK 259
Query: 252 DP 253
+
Sbjct: 260 ET 261
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = e-103
Identities = 106/242 (43%), Positives = 153/242 (63%), Gaps = 11/242 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR----RSMDQMQDILHEAAVLYLAQKSERIVGL 76
G+FA V+KC K T +EYAAKFI+KR+ R ++I E ++L I+ L
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITL 80
Query: 77 HEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
H++YE ++VL+LE+V GEL L ++ + E++ S++KQIL+ + +LH I H
Sbjct: 81 HDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 136 DLKPQNILLT----KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLAT 191
DLKP+NI+L +IKL DFG++ + D VE K I GTP++VAPE+++YEP+ L
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEA 199
Query: 192 DMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251
DMWS+GV+ Y+LLS SPF GD KQET NI+ ++ F E+ F S AKDFI+ LV
Sbjct: 200 DMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVK 259
Query: 252 DP 253
+
Sbjct: 260 ET 261
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 299 bits (769), Expect = e-102
Identities = 105/242 (43%), Positives = 154/242 (63%), Gaps = 11/242 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR----RSMDQMQDILHEAAVLYLAQKSERIVGL 76
G+FA V+KC K T ++YAAKFI+KRR R +DI E ++L Q ++ L
Sbjct: 21 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITL 79
Query: 77 HEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
HE+YE +++L+LE+V GEL L + ++ + E++ ++KQIL + +LH I H
Sbjct: 80 HEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 136 DLKPQNILLT----KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLAT 191
DLKP+NI+L IK+ DFG++ ++ E K I GTP++VAPE+++YEP+ L
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 192 DMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251
DMWS+GV+ Y+LLS SPF GD KQET N+S N+ F ++ F + S+ AKDFI+ LV
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 252 DP 253
DP
Sbjct: 259 DP 260
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = e-101
Identities = 85/236 (36%), Positives = 135/236 (57%), Gaps = 6/236 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G F V + T + T +AAKF+ + + E + + + +V LH+ +
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLR-HPTLVNLHDAF 223
Query: 81 ETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
E +EMV++ E + GEL +++ D + + E + YM+Q+ + L +H++N HLDLKP
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP 283
Query: 140 QNILLT--KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
+NI+ T + N +KL DFG++ ++ VK GT ++ APEV +P+ TDMWSVG
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG 343
Query: 198 VLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
VL+Y+LLS SPF G+N ET N+ C+++ + F IS KDFI+ L+ DP
Sbjct: 344 VLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADP 399
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 4e-84
Identities = 80/238 (33%), Positives = 130/238 (54%), Gaps = 8/238 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL-YLAQKSERIVGLHEI 79
+G F+ VR+C HK T +E+AAK I ++ S Q + EA + L + IV LH+
Sbjct: 16 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN--IVRLHDS 73
Query: 80 YETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
+ LV ++V GEL + +V ++ E D ++QILE++A+ H + I H +LK
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLK 132
Query: 139 PQNILL-TKDNN--IKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
P+N+LL +K +KL DFG++ VND GTP Y++PEVL +P S D+W+
Sbjct: 133 PENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 192
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
GV+ Y+LL + PF +++ + I + + + ++ +AK I S L +P
Sbjct: 193 CGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNP 250
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 3e-83
Identities = 80/238 (33%), Positives = 130/238 (54%), Gaps = 8/238 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL-YLAQKSERIVGLHEI 79
+G F+ VR+C HK T +E+AAK I ++ S Q + EA + L + IV LH+
Sbjct: 39 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN--IVRLHDS 96
Query: 80 YETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
+ LV ++V GEL + +V ++ E D ++QILE++A+ H + I H +LK
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLK 155
Query: 139 PQNILL-TKDNN--IKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
P+N+LL +K +KL DFG++ VND GTP Y++PEVL +P S D+W+
Sbjct: 156 PENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 215
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
GV+ Y+LL + PF +++ + I + + + ++ +AK I S L +P
Sbjct: 216 CGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNP 273
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 9e-81
Identities = 78/244 (31%), Positives = 128/244 (52%), Gaps = 13/244 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR---RSMDQMQDILHEAAVLYLAQKSERIVGLH 77
+G F+ VR+C ++ T ++A K + + +D+ EA++ ++ K IV L
Sbjct: 34 KGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELL 92
Query: 78 EIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIP---EQDTRSYMKQILEALAFLHDHNIT 133
E Y + + +V E + +L +V D E YM+QILEAL + HD+NI
Sbjct: 93 ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNII 152
Query: 134 HLDLKPQNILL-TKDNN--IKLCDFGISRVVNDVVEV-KEIIGTPDYVAPEVLSYEPISL 189
H D+KP +LL +K+N+ +KL FG++ + + V +GTP ++APEV+ EP
Sbjct: 153 HRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGK 212
Query: 190 ATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249
D+W GV+ ++LLS PF G + F I + + + + HIS AKD ++ L
Sbjct: 213 PVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRML 271
Query: 250 VTDP 253
+ DP
Sbjct: 272 MLDP 275
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 2e-80
Identities = 83/247 (33%), Positives = 119/247 (48%), Gaps = 15/247 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQD-------ILHEAAVLYLAQKSERI 73
RG + VR+C HK T EYA K I ++ L E +L I
Sbjct: 27 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86
Query: 74 VGLHEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNI 132
+ L + YET LV +++ GEL L + + + E++TR M+ +LE + LH NI
Sbjct: 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNI 145
Query: 133 THLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVL------SYEP 186
H DLKP+NILL D NIKL DFG S ++ +++E+ GTP Y+APE++ ++
Sbjct: 146 VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPG 205
Query: 187 ISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246
DMWS GV+ Y LL+ PF + I N+ F + S KD +
Sbjct: 206 YGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVS 265
Query: 247 SCLVTDP 253
LV P
Sbjct: 266 RFLVVQP 272
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 4e-80
Identities = 81/238 (34%), Positives = 133/238 (55%), Gaps = 11/238 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL-YLAQKSERIVGLHEI 79
G F+ V ++T +A K I+K + + +E AVL + ++ IV L +I
Sbjct: 19 SGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHEN--IVTLEDI 74
Query: 80 YETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
YE+ LV+++V GEL R+++ + E+D ++Q+L A+ +LH++ I H DLK
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLK 133
Query: 139 PQNILLT---KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
P+N+L +++ I + DFG+S++ + + + GTP YVAPEVL+ +P S A D WS
Sbjct: 134 PENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACGTPGYVAPEVLAQKPYSKAVDCWS 192
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+GV+ Y+LL + PF + + + F I + + F + IS AKDFI L DP
Sbjct: 193 IGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDP 250
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 8e-79
Identities = 74/241 (30%), Positives = 115/241 (47%), Gaps = 13/241 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLY-LAQKSERIVGLHEI 79
G F V + + +E K I K R S M+ I E VL L + I+ + E+
Sbjct: 32 SGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPN--IIKIFEV 88
Query: 80 YETPHEMVLVLEMVPDGEL-QRLVDIQDGI---PEQDTRSYMKQILEALAFLHDHNITHL 135
+E H M +V+E GEL +R+V Q E MKQ++ ALA+ H ++ H
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK 148
Query: 136 DLKPQNILLT---KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATD 192
DLKP+NIL + IK+ DFG++ + GT Y+APEV + ++ D
Sbjct: 149 DLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD-VTFKCD 207
Query: 193 MWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTD 252
+WS GV+ Y LL+ PF G + +E + ++ + ++ QA D ++ L D
Sbjct: 208 IWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPLTPQAVDLLKQMLTKD 266
Query: 253 P 253
P
Sbjct: 267 P 267
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 4e-78
Identities = 79/240 (32%), Positives = 123/240 (51%), Gaps = 15/240 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLY-LAQKSERIVGLHEI 79
RG + V+ K T++ AAK I K ++ + E ++ L + I+ L+E
Sbjct: 19 RGSWGEVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKSLDHPN--IIRLYET 74
Query: 80 YETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
+E ++ LV+E+ GEL +R+V + E D MK +L A+A+ H N+ H DLK
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLK 133
Query: 139 PQNILLT---KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVL--SYEPISLATDM 193
P+N L D+ +KL DFG++ ++ +GTP YV+P+VL Y P D
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGP---ECDE 190
Query: 194 WSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
WS GV+ YVLL + PF+ E L I + F+F E + ++S QA+ I+ L P
Sbjct: 191 WSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSP 250
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 238 bits (608), Expect = 1e-77
Identities = 78/246 (31%), Positives = 124/246 (50%), Gaps = 14/246 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSM------DQMQDILHEAAVLYLAQKSERIV 74
RG + VR+C H+ T E+A K + + + + E +L I+
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163
Query: 75 GLHEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
L + YE+ M LV +++ GEL L + + + E++TRS M+ +LEA++FLH +NI
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIV 222
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVL------SYEPI 187
H DLKP+NILL + I+L DFG S + +++E+ GTP Y+APE+L ++
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY 282
Query: 188 SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247
D+W+ GV+ + LL+ PF + I + + F + SS KD I
Sbjct: 283 GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISR 342
Query: 248 CLVTDP 253
L DP
Sbjct: 343 LLQVDP 348
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 1e-77
Identities = 70/285 (24%), Positives = 113/285 (39%), Gaps = 53/285 (18%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR---RSMDQMQDILHEAAVLYLAQKSERIVGLH 77
+G + VR T+ A K + K + + ++ I E ++ I L+
Sbjct: 36 QGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLY 94
Query: 78 EIYETPHEMVLVLEMVPDGEL-QRLVD--------------------------------- 103
E+YE + LV+E+ G L +L
Sbjct: 95 EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSI 154
Query: 104 ------IQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN--IKLCDF 155
+ E+ + M+QI AL +LH+ I H D+KP+N L + + + IKL DF
Sbjct: 155 HGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDF 214
Query: 156 GISRVVN-----DVVEVKEIIGTPDYVAPEVLSY--EPISLATDMWSVGVLAYVLLSSHS 208
G+S+ + + GTP +VAPEVL+ E D WS GVL ++LL
Sbjct: 215 GLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274
Query: 209 PFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
PF G N +T + F + +S A+D + + L +
Sbjct: 275 PFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNV 319
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 2e-77
Identities = 86/240 (35%), Positives = 122/240 (50%), Gaps = 13/240 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLY-LAQKSERIVGLHEI 79
+G F V KC +IT+ EYA K I K IL E +L L + I+ L EI
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN--IMKLFEI 89
Query: 80 YETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
E +V E+ GEL ++ + E D +KQ+ + ++H HNI H DLK
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148
Query: 139 PQNILLT---KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVL--SYEPISLATDM 193
P+NILL KD +IK+ DFG+S ++K+ IGT Y+APEVL +Y+ D+
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE---KCDV 205
Query: 194 WSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
WS GV+ Y+LLS PF G N+ + + ++F + IS AKD I+ L P
Sbjct: 206 WSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHP 265
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 3e-77
Identities = 91/239 (38%), Positives = 133/239 (55%), Gaps = 13/239 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL-YLAQKSERIVGLHEI 79
RG + V +C K T+ YA K ++K + + E VL L+ + I+ L EI
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLKKTVD----KKIVRTEIGVLLRLSHPN--IIKLKEI 116
Query: 80 YETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
+ETP E+ LVLE+V GEL R+V+ + E+D +KQILEA+A+LH++ I H DLK
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLK 175
Query: 139 PQNILLT---KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
P+N+L D +K+ DFG+S++V V +K + GTP Y APE+L DMWS
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWS 235
Query: 196 VGVLAYVLLSSHSPFAGD-NKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
VG++ Y+LL PF + Q F I C + F + +S AKD ++ +V DP
Sbjct: 236 VGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDP 294
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 2e-76
Identities = 73/239 (30%), Positives = 120/239 (50%), Gaps = 9/239 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL-YLAQKSERIVGLHEI 79
+G F+ VR+C + EYAA I ++ S Q + EA + L + IV LH+
Sbjct: 21 KGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN--IVRLHDS 78
Query: 80 YETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
L+ ++V GEL + +V ++ E D ++QILEA+ H + H +LK
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLK 137
Query: 139 PQNILL-TKDNN--IKLCDFGISRVVNDVVEV-KEIIGTPDYVAPEVLSYEPISLATDMW 194
P+N+LL +K +KL DFG++ V + GTP Y++PEVL +P D+W
Sbjct: 138 PENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLW 197
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ GV+ Y+LL + PF +++ + I + F + ++ +AKD I L +P
Sbjct: 198 ACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINP 256
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 1e-75
Identities = 72/242 (29%), Positives = 120/242 (49%), Gaps = 16/242 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G ++ ++C HK T +E+A K I K +R D E +L + I+ L ++Y
Sbjct: 32 VGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVY 85
Query: 81 ETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
+ + +V E++ GEL +++ Q E++ + + I + + +LH + H DLKP
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKP 144
Query: 140 QNILL-TKDNN---IKLCDFGISRVVNDVVEV-KEIIGTPDYVAPEVLSYEPISLATDMW 194
NIL + N I++CDFG ++ + + T ++VAPEVL + A D+W
Sbjct: 145 SNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIW 204
Query: 195 SVGVLAYVLLSSHSPFAG---DNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251
S+GVL Y +L+ ++PFA D +E I FS + +S AKD + L
Sbjct: 205 SLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHV 264
Query: 252 DP 253
DP
Sbjct: 265 DP 266
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 2e-75
Identities = 86/240 (35%), Positives = 122/240 (50%), Gaps = 13/240 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL-YLAQKSERIVGLHEI 79
+G F V KC +IT+ EYA K I K IL E +L L + I+ L EI
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN--IMKLFEI 89
Query: 80 YETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
E +V E+ GEL ++ + E D +KQ+ + ++H HNI H DLK
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148
Query: 139 PQNILLT---KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVL--SYEPISLATDM 193
P+NILL KD +IK+ DFG+S ++K+ IGT Y+APEVL +Y+ D+
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE---KCDV 205
Query: 194 WSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
WS GV+ Y+LLS PF G N+ + + ++F + IS AKD I+ L P
Sbjct: 206 WSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHP 265
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 2e-75
Identities = 85/238 (35%), Positives = 126/238 (52%), Gaps = 9/238 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL-YLAQKSERIVGLHEI 79
G + V C K+T VE A K IRK S +L E AVL L + I+ L++
Sbjct: 47 SGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPN--IMKLYDF 104
Query: 80 YETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
+E LV+E GEL ++ + E D +KQ+L + +LH HNI H DLK
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLK 163
Query: 139 PQNILLT---KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
P+N+LL KD IK+ DFG+S V + ++KE +GT Y+APEVL + D+WS
Sbjct: 164 PENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWS 222
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+GV+ ++LL+ + PF G QE + + ++F + ++S AKD I+ L D
Sbjct: 223 IGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDS 280
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 7e-75
Identities = 77/245 (31%), Positives = 123/245 (50%), Gaps = 18/245 (7%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G F+ RKC HK + +A K I KR + + E L L + IV LHE++
Sbjct: 21 EGSFSICRKCVHKKSNQAFAVKIISKRMEA-----NTQKEITALKLCEGHPNIVKLHEVF 75
Query: 81 ETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
LV+E++ GEL +R+ + E + M++++ A++ +HD + H DLKP
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKP 134
Query: 140 QNILLT---KDNNIKLCDFGISRVVNDVVEV-KEIIGTPDYVAPEVLSYEPISLATDMWS 195
+N+L T + IK+ DFG +R+ + K T Y APE+L+ + D+WS
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWS 194
Query: 196 VGVLAYVLLSSHSPFAGDNKQ-------ETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248
+GV+ Y +LS PF ++ E I + +FSF + + ++S +AKD IQ
Sbjct: 195 LGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGL 254
Query: 249 LVTDP 253
L DP
Sbjct: 255 LTVDP 259
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 1e-74
Identities = 80/239 (33%), Positives = 122/239 (51%), Gaps = 10/239 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVL-YLAQKSERIVGLHE 78
+G F V C KIT E A K I KR+ + + +L E +L L + I+ L+E
Sbjct: 36 KGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN--IMKLYE 93
Query: 79 IYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+E LV E+ GEL ++ + E D ++Q+L + ++H + I H DL
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDL 152
Query: 138 KPQNILLT---KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMW 194
KP+N+LL KD NI++ DFG+S ++K+ IGT Y+APEVL D+W
Sbjct: 153 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVW 211
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
S GV+ Y+LLS PF G N+ + + + ++F + +S AKD I+ L P
Sbjct: 212 STGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVP 270
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 1e-73
Identities = 72/247 (29%), Positives = 126/247 (51%), Gaps = 17/247 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR------RSMDQMQDILHEAAVLYLAQKSERIV 74
G V+ + T + A K I KR+ R D ++ E +L I+
Sbjct: 20 SGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCII 78
Query: 75 GLHEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
+ ++ +VLE++ GEL ++V + E + Y Q+L A+ +LH++ I
Sbjct: 79 KIKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGII 136
Query: 134 HLDLKPQNILLT---KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLS---YEPI 187
H DLKP+N+LL+ +D IK+ DFG S+++ + ++ + GTP Y+APEVL
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY 196
Query: 188 SLATDMWSVGVLAYVLLSSHSPFAGDNKQET-FLNISQCNFSFHEDLFGHISSQAKDFIQ 246
+ A D WS+GV+ ++ LS + PF+ Q + I+ ++F +++ +S +A D ++
Sbjct: 197 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVK 256
Query: 247 SCLVTDP 253
LV DP
Sbjct: 257 KLLVVDP 263
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 9e-73
Identities = 71/247 (28%), Positives = 126/247 (51%), Gaps = 17/247 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR------RSMDQMQDILHEAAVLYLAQKSERIV 74
G V+ + T + A + I KR+ R D ++ E +L I+
Sbjct: 145 SGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCII 203
Query: 75 GLHEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
+ ++ +VLE++ GEL ++V + E + Y Q+L A+ +LH++ I
Sbjct: 204 KIKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGII 261
Query: 134 HLDLKPQNILLT---KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLS---YEPI 187
H DLKP+N+LL+ +D IK+ DFG S+++ + ++ + GTP Y+APEVL
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY 321
Query: 188 SLATDMWSVGVLAYVLLSSHSPFAGDNKQET-FLNISQCNFSFHEDLFGHISSQAKDFIQ 246
+ A D WS+GV+ ++ LS + PF+ Q + I+ ++F +++ +S +A D ++
Sbjct: 322 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVK 381
Query: 247 SCLVTDP 253
LV DP
Sbjct: 382 KLLVVDP 388
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 1e-71
Identities = 79/251 (31%), Positives = 126/251 (50%), Gaps = 24/251 (9%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-----------RSMDQMQDILHEAAVL-YLAQ 68
G + V C K E A K I+K + ++I +E ++L L
Sbjct: 46 SGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105
Query: 69 KSERIVGLHEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFL 127
+ I+ L +++E LV E GEL +++++ + E D + MKQIL + +L
Sbjct: 106 PN--IIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYL 162
Query: 128 HDHNITHLDLKPQNILLT---KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVL-- 182
H HNI H D+KP+NILL NIK+ DFG+S + ++++ +GT Y+APEVL
Sbjct: 163 HKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK 222
Query: 183 SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAK 242
Y D+WS GV+ Y+LL + PF G N Q+ + + + F + + +IS +AK
Sbjct: 223 KYNE---KCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAK 279
Query: 243 DFIQSCLVTDP 253
+ I+ L D
Sbjct: 280 ELIKLMLTYDY 290
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 3e-71
Identities = 76/246 (30%), Positives = 111/246 (45%), Gaps = 21/246 (8%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G V +C H+ T + A K + E + A IV + ++Y
Sbjct: 39 LGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVY 91
Query: 81 ETPHEMV----LVLEMVPDGEL-QRLVDIQDGI-PEQDTRSYMKQILEALAFLHDHNITH 134
E H +++E + GEL R+ + D E++ M+ I A+ FLH HNI H
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAH 151
Query: 135 LDLKPQNILLT---KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLAT 191
D+KP+N+L T KD +KL DFG ++ ++ TP YVAPEVL E +
Sbjct: 152 RDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSC 210
Query: 192 DMWSVGVLAYVLLSSHSPFAGDNKQET----FLNISQCNFSFHEDLFGHISSQAKDFIQS 247
DMWS+GV+ Y+LL PF + Q I + F + +S AK I+
Sbjct: 211 DMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRL 270
Query: 248 CLVTDP 253
L TDP
Sbjct: 271 LLKTDP 276
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 6e-71
Identities = 71/246 (28%), Positives = 115/246 (46%), Gaps = 20/246 (8%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G V + +K T+ ++A K ++ E + + A + IV + ++Y
Sbjct: 72 LGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVY 124
Query: 81 ETPHEMV----LVLEMVPDGEL-QRLVDIQDGI-PEQDTRSYMKQILEALAFLHDHNITH 134
E + +V+E + GEL R+ D D E++ MK I EA+ +LH NI H
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 184
Query: 135 LDLKPQNILLT---KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLAT 191
D+KP+N+L T + +KL DFG ++ + TP YVAPEVL E +
Sbjct: 185 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 244
Query: 192 DMWSVGVLAYVLLSSHSPFAGDNKQET----FLNISQCNFSFHEDLFGHISSQAKDFIQS 247
DMWS+GV+ Y+LL + PF ++ I + F + +S + K I++
Sbjct: 245 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 304
Query: 248 CLVTDP 253
L T+P
Sbjct: 305 LLKTEP 310
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 2e-69
Identities = 74/265 (27%), Positives = 113/265 (42%), Gaps = 35/265 (13%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G A V+ C + IT EYA K I K+ + E +LY Q ++ L E +
Sbjct: 23 EGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 81 ETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
E LV E + G + + + E + ++ + AL FLH+ I H DLKP
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKP 139
Query: 140 QNILL-TKDNN--IKLCDFGISRVVNDVVEVKEI--------IGTPDYVAPEVLSYEPIS 188
+NIL + +K+CDF + + + I G+ +Y+APEV+
Sbjct: 140 ENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEE 199
Query: 189 L-----ATDMWSVGVLAYVLLSSHSPFAGDNKQET---------------FLNISQCNFS 228
D+WS+GV+ Y+LLS + PF G + F +I + +
Sbjct: 200 ASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYE 259
Query: 229 FHEDLFGHISSQAKDFIQSCLVTDP 253
F + + HIS AKD I LV D
Sbjct: 260 FPDKDWAHISCAAKDLISKLLVRDA 284
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 5e-67
Identities = 65/249 (26%), Positives = 108/249 (43%), Gaps = 21/249 (8%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL-YLAQKSERIVGLHEI 79
G + V + ++ K YA K++ + +E A L L Q S++I+ L++
Sbjct: 38 SGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
T + +V+E + +L + + I + +SY K +LEA+ +H H I H DLKP
Sbjct: 97 EITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 155
Query: 140 QNILLTKDNNIKLCDFGISRVVND---VVEVKEIIGTPDYVAPEVLSYEP---------- 186
N L+ D +KL DFGI+ + V +GT +Y+ PE +
Sbjct: 156 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 214
Query: 187 -ISLATDMWSVGVLAYVLLSSHSPFAGDNKQ-ETFLNISQCNFSFHEDLFGHISSQAKDF 244
IS +D+WS+G + Y + +PF Q I N + +D
Sbjct: 215 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI--EFPDIPEKDLQDV 272
Query: 245 IQSCLVTDP 253
++ CL DP
Sbjct: 273 LKCCLKRDP 281
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-66
Identities = 65/249 (26%), Positives = 108/249 (43%), Gaps = 21/249 (8%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL-YLAQKSERIVGLHEI 79
G + V + ++ K YA K++ + +E A L L Q S++I+ L++
Sbjct: 19 SGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 77
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
T + +V+E + +L + + I + +SY K +LEA+ +H H I H DLKP
Sbjct: 78 EITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 136
Query: 140 QNILLTKDNNIKLCDFGISRVVND---VVEVKEIIGTPDYVAPEVLSYEP---------- 186
N L+ D +KL DFGI+ + V +GT +Y+ PE +
Sbjct: 137 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 195
Query: 187 -ISLATDMWSVGVLAYVLLSSHSPFAGDNKQ-ETFLNISQCNFSFHEDLFGHISSQAKDF 244
IS +D+WS+G + Y + +PF Q I N + +D
Sbjct: 196 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI--EFPDIPEKDLQDV 253
Query: 245 IQSCLVTDP 253
++ CL DP
Sbjct: 254 LKCCLKRDP 262
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-64
Identities = 58/263 (22%), Positives = 108/263 (41%), Gaps = 36/263 (13%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
+G F V K + + YA K IR +++ IL E +L + +V + +
Sbjct: 16 QGAFGQVVKARNALDSRYYAIKKIRHTE---EKLSTILSEVMLLASL-NHQYVVRYYAAW 71
Query: 81 -------------ETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAF 126
+ + + +E +G L + + +QILEAL++
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 127 LHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI---------------I 171
+H I H DLKP NI + + N+K+ DFG+++ V+ +++ ++ I
Sbjct: 132 IHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 172 GTPDYVAPEVLSYEPI-SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH 230
GT YVA EVL + DM+S+G++ + ++ + G + + + F
Sbjct: 192 GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIEFP 249
Query: 231 EDLFGHISSQAKDFIQSCLVTDP 253
D + K I+ + DP
Sbjct: 250 PDFDDNKMKVEKKIIRLLIDHDP 272
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 1e-64
Identities = 64/249 (25%), Positives = 107/249 (42%), Gaps = 21/249 (8%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLY-LAQKSERIVGLHEI 79
G + V + ++ K YA K++ + +E A L L Q S++I+ L++
Sbjct: 66 SGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 124
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
T + +V+E + +L + + I + +SY K +LEA+ +H H I H DLKP
Sbjct: 125 EITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 183
Query: 140 QNILLTKDNNIKLCDFGISRVVND---VVEVKEIIGTPDYVAPEVLSYEP---------- 186
N L+ D +KL DFGI+ + V +G +Y+ PE +
Sbjct: 184 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242
Query: 187 -ISLATDMWSVGVLAYVLLSSHSPFAG-DNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244
IS +D+WS+G + Y + +PF N+ I N +D
Sbjct: 243 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP--DIPEKDLQDV 300
Query: 245 IQSCLVTDP 253
++ CL DP
Sbjct: 301 LKCCLKRDP 309
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-64
Identities = 58/235 (24%), Positives = 87/235 (37%), Gaps = 10/235 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G + V K K YA K R L E + V L + +
Sbjct: 67 HGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126
Query: 81 ETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
E + L E+ L Q +PE Y++ L ALA LH + HLD+KP
Sbjct: 127 EEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKP 185
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVL 199
NI L KL DFG+ + + G P Y+APE+L A D++S+G+
Sbjct: 186 ANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLT 244
Query: 200 AYVLLSS-HSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ + P G+ Q+ + +SS+ + + L DP
Sbjct: 245 ILEVACNMELPHGGEGWQQLRQGY------LPPEFTAGLSSELRSVLVMMLEPDP 293
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-64
Identities = 75/238 (31%), Positives = 120/238 (50%), Gaps = 13/238 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSER---IVGL 76
+G FA + + TK +A K + K Q + + E ++ +S +VG
Sbjct: 51 KGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI----HRSLAHQHVVGF 106
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
H +E + +VLE+ L L + + E + R Y++QI+ +LH + + H D
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 166
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEII-GTPDYVAPEVLSYEPISLATDMWS 195
LK N+ L +D +K+ DFG++ V E K+++ GTP+Y+APEVLS + S D+WS
Sbjct: 167 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWS 226
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+G + Y LL PF +ET+L I + +S + HI+ A IQ L TDP
Sbjct: 227 IGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 280
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-64
Identities = 75/238 (31%), Positives = 120/238 (50%), Gaps = 13/238 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSER---IVGL 76
+G FA + + TK +A K + K Q + + E ++ +S +VG
Sbjct: 25 KGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI----HRSLAHQHVVGF 80
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
H +E + +VLE+ L L + + E + R Y++QI+ +LH + + H D
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 140
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEII-GTPDYVAPEVLSYEPISLATDMWS 195
LK N+ L +D +K+ DFG++ V E K+++ GTP+Y+APEVLS + S D+WS
Sbjct: 141 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWS 200
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+G + Y LL PF +ET+L I + +S + HI+ A IQ L TDP
Sbjct: 201 IGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 254
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 7e-64
Identities = 70/237 (29%), Positives = 110/237 (46%), Gaps = 9/237 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGLHEI 79
G F +Y K I R S + ++ E AVL A K IV E
Sbjct: 34 EGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVL--ANMKHPNIVQYRES 91
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+E + +V++ G+L + ++ Q G E + QI AL +HD I H D+
Sbjct: 92 FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDI 151
Query: 138 KPQNILLTKDNNIKLCDFGISRVVNDVVEV-KEIIGTPDYVAPEVLSYEPISLATDMWSV 196
K QNI LTKD ++L DFGI+RV+N VE+ + IGTP Y++PE+ +P + +D+W++
Sbjct: 152 KSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWAL 211
Query: 197 GVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
G + Y L + F + + L I +F + H S + + +P
Sbjct: 212 GCVLYELCTLKHAFEAGSMKNLVLKIISGSF---PPVSLHYSYDLRSLVSQLFKRNP 265
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 9e-64
Identities = 71/239 (29%), Positives = 118/239 (49%), Gaps = 14/239 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSER---IVGL 76
+G FA V + T +E A K I K+ +Q + +E + + I+ L
Sbjct: 21 KGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI----HCQLKHPSILEL 76
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHL 135
+ +E + + LVLEM +GE+ R + + E + R +M QI+ + +LH H I H
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHR 136
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEII-GTPDYVAPEVLSYEPISLATDMW 194
DL N+LLT++ NIK+ DFG++ + E + GTP+Y++PE+ + L +D+W
Sbjct: 137 DLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVW 196
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
S+G + Y LL PF D + T + ++ +S +AKD I L +P
Sbjct: 197 SLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS----FLSIEAKDLIHQLLRRNP 251
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-63
Identities = 65/234 (27%), Positives = 108/234 (46%), Gaps = 7/234 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+GKF +V K +K A K + K + + E + + I+ L+
Sbjct: 19 KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGY 77
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
+ + L+LE P G + R + EQ T +Y+ ++ AL++ H + H D+KP
Sbjct: 78 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 137
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVL 199
+N+LL +K+ DFG S ++ GT DY+ PE++ D+WS+GVL
Sbjct: 138 ENLLLGSAGELKIADFGWSVHAPSSRR-TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 196
Query: 200 AYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
Y L PF + QET+ IS+ F+F + ++ A+D I L +P
Sbjct: 197 CYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNP 246
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-61
Identities = 59/275 (21%), Positives = 103/275 (37%), Gaps = 44/275 (16%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
+G A+V + HK T +A K + + + E VL + IV L I
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKL-NHKNIVKLFAIE 76
Query: 81 E--TPHEMVLVLEMVPDGEL-QRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHL 135
E T VL++E P G L L + G+PE + ++ ++ + L ++ I H
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHR 136
Query: 136 DLKPQNILLT----KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPI---- 187
++KP NI+ + KL DFG +R + D + + GT +Y+ P++ +
Sbjct: 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDH 196
Query: 188 ----SLATDMWSVGVLAYVLLSSHSPF----AGDNKQETFLNI----------------- 222
D+WS+GV Y + PF +E I
Sbjct: 197 QKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAEN 256
Query: 223 SQCNFSFHEDLFGHISSQAKD----FIQSCLVTDP 253
++S + +S + + + L D
Sbjct: 257 GPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ 291
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 5e-61
Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 7/234 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+GKF +V K K A K + K + + E + + I+ ++
Sbjct: 24 KGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNY 82
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
+ + L+LE P GEL + + EQ + ++M+++ +AL + H+ + H D+KP
Sbjct: 83 FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKP 142
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVL 199
+N+L+ +K+ DFG S V + + + GT DY+ PE++ + D+W GVL
Sbjct: 143 ENLLMGYKGELKIADFGWS-VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVL 201
Query: 200 AYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
Y L PF + ET I + F +S +KD I L P
Sbjct: 202 CYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSKDLISKLLRYHP 251
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 3e-59
Identities = 64/246 (26%), Positives = 105/246 (42%), Gaps = 41/246 (16%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G V + +K T+ ++A K ++ E + + A + IV + ++Y
Sbjct: 28 LGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVY 80
Query: 81 ETPHEMV----LVLEMVPDGEL-QRLVDIQDGI-PEQDTRSYMKQILEALAFLHDHNITH 134
E + +V+E + GEL R+ D D E++ MK I EA+ +LH NI H
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 140
Query: 135 LDLKPQNILLT---KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLAT 191
D+KP+N+L T + +KL DFG A E E +
Sbjct: 141 RDVKPENLLYTSKRPNAILKLTDFGF--------------------AKETTG-EKYDKSC 179
Query: 192 DMWSVGVLAYVLLSSHSPFAGDNKQET----FLNISQCNFSFHEDLFGHISSQAKDFIQS 247
DMWS+GV+ Y+LL + PF ++ I + F + +S + K I++
Sbjct: 180 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 239
Query: 248 CLVTDP 253
L T+P
Sbjct: 240 LLKTEP 245
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-58
Identities = 47/252 (18%), Positives = 92/252 (36%), Gaps = 35/252 (13%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGLHEI 79
G F V K H+I Y K ++ + E L A+ IV +
Sbjct: 21 SGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKAL--AKLDHVNIVHYNGC 72
Query: 80 YETPHEMV----------------LVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQIL 121
++ + +E G L++ ++ + G + + +QI
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 122 EALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEV 181
+ + ++H + + DLKP NI L +K+ DFG+ + + + GT Y++PE
Sbjct: 133 KGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQ 192
Query: 182 LSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQA 241
+S + D++++G++ LL + F ++ S +
Sbjct: 193 ISSQDYGKEVDLYALGLILAELLHVCDTA--FETSKFFTDLRDGIIS------DIFDKKE 244
Query: 242 KDFIQSCLVTDP 253
K +Q L P
Sbjct: 245 KTLLQKLLSKKP 256
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 5e-58
Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 18/246 (7%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGLHE- 78
G + +K K K + + + Q ++ E +L + K IV ++
Sbjct: 16 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL--RELKHPNIVRYYDR 73
Query: 79 -IYETPHEMVLVLEMVPDGELQRLVD--IQDG--IPEQDTRSYMKQILEALAFLHD---- 129
I T + +V+E G+L ++ ++ + E+ M Q+ AL H
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 130 -HNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV-KEIIGTPDYVAPEVLSYEPI 187
H + H DLKP N+ L N+KL DFG++R++N K +GTP Y++PE ++
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSY 193
Query: 188 SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247
+ +D+WS+G L Y L + PF +++E I + F + S + + I
Sbjct: 194 NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYRYSDELNEIITR 250
Query: 248 CLVTDP 253
L
Sbjct: 251 MLNLKD 256
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 5e-58
Identities = 63/242 (26%), Positives = 110/242 (45%), Gaps = 13/242 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIR-KRRRSMDQMQDILHEAAVLYLAQ-KSERIVGLHE 78
RG+F+ V + + V A K ++ D + E +L Q ++ +
Sbjct: 42 RGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLL--KQLNHPNVIKYYA 99
Query: 79 IYETPHEMVLVLEMVPDGELQRLV----DIQDGIPEQDTRSYMKQILEALAFLHDHNITH 134
+ +E+ +VLE+ G+L R++ + IPE+ Y Q+ AL +H + H
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMH 159
Query: 135 LDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV-KEIIGTPDYVAPEVLSYEPISLATDM 193
D+KP N+ +T +KL D G+ R + ++GTP Y++PE + + +D+
Sbjct: 160 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDI 219
Query: 194 WSVGVLAYVLLSSHSPFAGD--NKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251
WS+G L Y + + SPF GD N I QC++ H S + + + C+
Sbjct: 220 WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP--PLPSDHYSEELRQLVNMCINP 277
Query: 252 DP 253
DP
Sbjct: 278 DP 279
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-57
Identities = 59/275 (21%), Positives = 103/275 (37%), Gaps = 44/275 (16%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
+G A+V + HK T +A K + + + E VL + IV L I
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKL-NHKNIVKLFAIE 76
Query: 81 E--TPHEMVLVLEMVPDGEL-QRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHL 135
E T VL++E P G L L + G+PE + ++ ++ + L ++ I H
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHR 136
Query: 136 DLKPQNILLT----KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPI---- 187
++KP NI+ + KL DFG +R + D + + GT +Y+ P++ +
Sbjct: 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDH 196
Query: 188 ----SLATDMWSVGVLAYVLLSSHSPF----AGDNKQETFLNI----------------- 222
D+WS+GV Y + PF +E I
Sbjct: 197 QKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAEN 256
Query: 223 SQCNFSFHEDLFGHISSQAKD----FIQSCLVTDP 253
++S + +S + + + L D
Sbjct: 257 GPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ 291
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 5e-56
Identities = 51/247 (20%), Positives = 96/247 (38%), Gaps = 22/247 (8%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G ++ + A K I + E +L + + ++
Sbjct: 34 HGAEGTIV-YRGMFDNRDVAVKRILP-----ECFSFADREVQLLRESDEHPNVIRYFCTE 87
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGI-PEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
+ + +E+ LQ V+ +D + + ++Q LA LH NI H DLKP
Sbjct: 88 KDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKP 146
Query: 140 QNILLTKDNN-----IKLCDFGISRVVND----VVEVKEIIGTPDYVAPEVLS---YEPI 187
NIL++ N + DFG+ + + + GT ++APE+LS E
Sbjct: 147 HNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP 206
Query: 188 SLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246
+ D++S G + Y ++S PF +++ + + C+ H A++ I+
Sbjct: 207 TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP-EKHEDVIARELIE 265
Query: 247 SCLVTDP 253
+ DP
Sbjct: 266 KMIAMDP 272
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-55
Identities = 72/238 (30%), Positives = 116/238 (48%), Gaps = 14/238 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER---IVGLH 77
+G FA V+ H +T E A K I K + + +Q + E ++ K IV L
Sbjct: 25 KGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIM----KILNHPNIVKLF 80
Query: 78 EIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
E+ ET + L++E GE+ LV + E++ RS +QI+ A+ + H I H D
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRD 139
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEP-ISLATDMWS 195
LK +N+LL D NIK+ DFG S ++ G P Y APE+ + D+WS
Sbjct: 140 LKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWS 199
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+GV+ Y L+S PF G N +E + + + ++S+ ++ ++ LV +P
Sbjct: 200 LGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKRFLVLNP 253
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-54
Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 21/243 (8%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR----RSMDQMQDILHEAAVLYLAQKSER---I 73
+G F +V +++ A K I + R + E A+L+ +
Sbjct: 41 KGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV 100
Query: 74 VGLHEIYETPHEMVLVLE-MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNI 132
+ L + +ET +LVLE +P +L + + + E +R + Q++ A+ H +
Sbjct: 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGV 160
Query: 133 THLDLKPQNILL-TKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEP-ISLA 190
H D+K +NIL+ + KL DFG +++D + GT Y PE +S +L
Sbjct: 161 VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALP 219
Query: 191 TDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLV 250
+WS+G+L Y ++ PF D + I + F H+S I+ CL
Sbjct: 220 ATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFPA----HVSPDCCALIRRCLA 269
Query: 251 TDP 253
P
Sbjct: 270 PKP 272
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 6e-54
Identities = 62/241 (25%), Positives = 103/241 (42%), Gaps = 19/241 (7%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR----RSMDQMQDILHEAAVLYLAQKSER-IVG 75
G F SV + A K + K R + + E +L ++
Sbjct: 53 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112
Query: 76 LHEIYETPHEMVLVLEMV-PDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITH 134
L + +E P VL+LE P +L + + + E+ RS+ Q+LEA+ H+ + H
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLH 172
Query: 135 LDLKPQNILL-TKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEP-ISLATD 192
D+K +NIL+ +KL DFG ++ D V + GT Y PE + Y +
Sbjct: 173 RDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAA 231
Query: 193 MWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTD 252
+WS+G+L Y ++ PF D + I + F + +SS+ + I+ CL
Sbjct: 232 VWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSSECQHLIRWCLALR 281
Query: 253 P 253
P
Sbjct: 282 P 282
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 9e-54
Identities = 60/256 (23%), Positives = 86/256 (33%), Gaps = 27/256 (10%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
G F+ V YA K I ++ EA + L I+ L
Sbjct: 38 GEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLF-NHPNILRLVAY 94
Query: 80 Y----ETPHEMVLVLEMVPDGEL----QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHN 131
HE L+L G L +RL D + + E + I L +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154
Query: 132 ITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV----------EVKEIIGTPDYVAPEV 181
H DLKP NILL + L D G V + T Y APE+
Sbjct: 155 YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL 214
Query: 182 L---SYEPISLATDMWSVGVLAYVLLSSHSPFAGDN-KQETFLNISQCNFSFHEDLFGHI 237
S+ I TD+WS+G + Y ++ P+ K ++ Q S +
Sbjct: 215 FSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSP--RH 272
Query: 238 SSQAKDFIQSCLVTDP 253
SS + S + DP
Sbjct: 273 SSALWQLLNSMMTVDP 288
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-53
Identities = 73/239 (30%), Positives = 117/239 (48%), Gaps = 15/239 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSER---IVGL 76
G F V+ H++T + A K + +++ RS+D + I E L K R I+ L
Sbjct: 21 VGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL----KLFRHPHIIKL 76
Query: 77 HEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
+++ TP + +V+E V GEL + + E + R +QIL A+ + H H + H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHR 135
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEP-ISLATDMW 194
DLKP+N+LL N K+ DFG+S +++D ++ G+P+Y APEV+S D+W
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIW 195
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
S GV+ Y LL PF ++ F I F E +++ + L DP
Sbjct: 196 SCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE----YLNRSVATLLMHMLQVDP 250
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-53
Identities = 56/262 (21%), Positives = 99/262 (37%), Gaps = 37/262 (14%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGLHEI 79
RG F V + +K+ YA K IR R + ++ E L A+ + IV
Sbjct: 15 RGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-LAREKVMREVKAL--AKLEHPGIVRYFNA 71
Query: 80 YETPHEMV------------LVLEMVPDGELQRLVDIQDG---IPEQDTRSYMKQILEAL 124
+ + + +++ L+ ++ + QI EA+
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 125 AFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI-------------I 171
FLH + H DLKP NI T D+ +K+ DFG+ ++ E + + +
Sbjct: 132 EFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQV 191
Query: 172 GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE 231
GT Y++PE + S D++S+G++ + LL + + T ++ F
Sbjct: 192 GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--YPFSTQMERVRTLTDVRNLKFP--- 246
Query: 232 DLFGHISSQAKDFIQSCLVTDP 253
LF +Q L P
Sbjct: 247 PLFTQKYPCEYVMVQDMLSPSP 268
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 3e-53
Identities = 61/269 (22%), Positives = 104/269 (38%), Gaps = 45/269 (16%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G +V A K + D L E +L + ++ +
Sbjct: 25 YGSSGTVVFQ-GSFQGRPVAVKRMLI-----DFCDIALMEIKLLTESDDHPNVIRYYCSE 78
Query: 81 ETPHEMVLVLEMVPDGELQRLV-------DIQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
T + + LE+ + LQ LV + E + S ++QI +A LH I
Sbjct: 79 TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKII 137
Query: 134 HLDLKPQNILLT-------------KDNNIKLCDFGISRVVND-----VVEVKEIIGTPD 175
H DLKPQNIL++ ++ I + DFG+ + ++ + GT
Sbjct: 138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSG 197
Query: 176 YVAPEVLS-------YEPISLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQCNF 227
+ APE+L ++ + D++S+G + Y +LS PF +E+ NI + F
Sbjct: 198 WRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--NIIRGIF 255
Query: 228 SFHE---DLFGHISSQAKDFIQSCLVTDP 253
S E + ++A D I + DP
Sbjct: 256 SLDEMKCLHDRSLIAEATDLISQMIDHDP 284
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 179 bits (454), Expect = 2e-52
Identities = 55/234 (23%), Positives = 103/234 (44%), Gaps = 14/234 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G F V + H+ T + A K R+ S + E ++ +V E+
Sbjct: 24 TGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKL-NHPNVVSAREVP 81
Query: 81 ETPHEM------VLVLEMVPDGEL-QRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHN 131
+ ++ +L +E G+L + L + G+ E R+ + I AL +LH++
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 132 ITHLDLKPQNILLTKDNN---IKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPIS 188
I H DLKP+NI+L K+ D G ++ ++ E +GT Y+APE+L + +
Sbjct: 142 IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYT 201
Query: 189 LATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAK 242
+ D WS G LA+ ++ PF + + + + + H ++ ++ K
Sbjct: 202 VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVK 255
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-52
Identities = 63/274 (22%), Positives = 110/274 (40%), Gaps = 44/274 (16%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ----KSER---- 72
+GKF + C YA K K + + + ++ K+E
Sbjct: 41 QGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 73 ------IVGLHEIYETPHEMVLVLEMVPDGEL-------QRLVDIQDG-IPEQDTRSYMK 118
+ I E+ ++ E + + + L IP Q + +K
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 119 QILEALAFLHDH-NITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV 177
+L + +++H+ NI H D+KP NIL+ K+ +KL DFG S + D ++K GT +++
Sbjct: 159 SVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD-KKIKGSRGTYEFM 217
Query: 178 APEVLSYEPI--SLATDMWSVGVLAYVLLSSHSPFAGD-NKQETFLNISQCNFSFHEDLF 234
PE S E D+WS+G+ YV+ + PF+ + E F NI N + D
Sbjct: 218 PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRN 277
Query: 235 G---------------HISSQAKDFIQSCLVTDP 253
+S++ DF++ L +P
Sbjct: 278 HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNP 311
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 4e-52
Identities = 67/237 (28%), Positives = 116/237 (48%), Gaps = 9/237 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
G F++V T EYA K + KR +++ + E V+ V L+
Sbjct: 40 EGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFT 98
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++ ++ L +GEL + + E TR Y +I+ AL +LH I H DLKP
Sbjct: 99 FQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKP 158
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKE---IIGTPDYVAPEVLSYEPISLATDMWSV 196
+NILL +D +I++ DFG ++V++ + +GT YV+PE+L+ + ++D+W++
Sbjct: 159 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 218
Query: 197 GVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
G + Y L++ PF N+ F I + + F E +A+D ++ LV D
Sbjct: 219 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPKARDLVEKLLVLDA 271
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-51
Identities = 60/262 (22%), Positives = 96/262 (36%), Gaps = 36/262 (13%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLH-- 77
+ G FA V + + EYA K + ++ + I+ E + IV
Sbjct: 37 AEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 78 -----EIYETPHEMVLVLEMVPDGELQRLVD---IQDGIPEQDTRSYMKQILEALAFLHD 129
E +T L+L + G+L + + + Q A+ +H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 130 HN--ITHLDLKPQNILLTKDNNIKLCDFGISRVVND-------------VVEVKEIIGTP 174
I H DLK +N+LL+ IKLCDFG + ++ V E TP
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 175 DYVAPEVL---SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE 231
Y PE++ S PI D+W++G + Y+L PF K L I +S
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK----LRIVNGKYSIPP 270
Query: 232 DLFGHISSQAKDFIQSCLVTDP 253
+ I++ L +P
Sbjct: 271 HD--TQYTVFHSLIRAMLQVNP 290
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 4e-51
Identities = 72/239 (30%), Positives = 120/239 (50%), Gaps = 15/239 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSER---IVGL 76
G F V+ H++T + A K + +++ RS+D + I E L K R I+ L
Sbjct: 26 VGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL----KLFRHPHIIKL 81
Query: 77 HEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
+++ TP ++ +V+E V GEL + + E+++R +QIL + + H H + H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHR 140
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEP-ISLATDMW 194
DLKP+N+LL N K+ DFG+S +++D ++ G+P+Y APEV+S D+W
Sbjct: 141 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIW 200
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
S GV+ Y LL PF D+ F I F + +++ ++ L DP
Sbjct: 201 SSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ----YLNPSVISLLKHMLQVDP 255
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 7e-51
Identities = 40/272 (14%), Positives = 66/272 (24%), Gaps = 41/272 (15%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKR-----------RRSMDQMQDILHEAAV------ 63
G + V ++A K + +L E+
Sbjct: 72 VGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRR 131
Query: 64 -------LYLAQKSERIVGLHEIYETPHEMVLVLEM-VPDGELQRLVDIQDGIPEQD--- 112
Q L + +L M +L+ L D +
Sbjct: 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDE 191
Query: 113 ----TRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK 168
Q++ A L + H P N+ + D + L D V
Sbjct: 192 GILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GP 249
Query: 169 EIIGTPDYVAPEVL--SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNK--QETFLNISQ 224
Y E L S + A + W +G+ Y + PF + ++ S
Sbjct: 250 ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSL 309
Query: 225 CNFSFHEDLFG---HISSQAKDFIQSCLVTDP 253
FG + K I L D
Sbjct: 310 RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDR 341
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-50
Identities = 59/244 (24%), Positives = 111/244 (45%), Gaps = 21/244 (8%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER---IVGLH 77
G + V+ +++T+ A K + +R +D ++I E + K +V +
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICIN----KMLNHENVVKFY 71
Query: 78 EIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
+ L LE GEL R+ G+PE D + + Q++ + +LH ITH D
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEII---GTPDYVAPEVLS---YEPISLA 190
+KP+N+LL + +N+K+ DFG++ V + + GT YVAPE+L + +
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH--AEP 188
Query: 191 TDMWSVGVLAYVLLSSHSPF-AGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249
D+WS G++ +L+ P+ + + + + + + + I S + L
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WKKIDSAPLALLHKIL 246
Query: 250 VTDP 253
V +P
Sbjct: 247 VENP 250
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-50
Identities = 74/239 (30%), Positives = 127/239 (53%), Gaps = 16/239 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSER---IVGL 76
G F V+ TH T+ + A KFI ++ + D + E + L K R I+ L
Sbjct: 19 EGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL----KLLRHPHIIKL 74
Query: 77 HEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
+++ TP ++V+V+E GEL +V+ + + E + R + +QI+ A+ + H H I H
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHR 132
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEP-ISLATDMW 194
DLKP+N+LL + N+K+ DFG+S ++ D +K G+P+Y APEV++ + D+W
Sbjct: 133 DLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVW 192
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
S G++ YV+L PF + F ++ C + + +S A+ I+ +V DP
Sbjct: 193 SCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPD----FLSPGAQSLIRRMIVADP 247
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-50
Identities = 63/266 (23%), Positives = 109/266 (40%), Gaps = 40/266 (15%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR------------------------RSMDQMQD 56
+G + V+ ++ YA K + K++ + ++
Sbjct: 23 KGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82
Query: 57 ILHEAAVLYLAQKSER---IVGLHEIYETPHEMVL--VLEMVPDGELQRLVDIQDGIPEQ 111
+ E A+L K +V L E+ + P+E L V E+V G + + + E
Sbjct: 83 VYQEIAIL----KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSED 137
Query: 112 DTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV-KEI 170
R Y + +++ + +LH I H D+KP N+L+ +D +IK+ DFG+S +
Sbjct: 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT 197
Query: 171 IGTPDYVAPEVLSYEPIS---LATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNF 227
+GTP ++APE LS A D+W++GV Y + PF + I
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQAL 257
Query: 228 SFHEDLFGHISSQAKDFIQSCLVTDP 253
F + I+ KD I L +P
Sbjct: 258 EFPD--QPDIAEDLKDLITRMLDKNP 281
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-50
Identities = 42/257 (16%), Positives = 90/257 (35%), Gaps = 33/257 (12%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G+F SV KC ++ YA K +K Q+ L E + + +V +
Sbjct: 21 SGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW 80
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDG----IPEQDTRSYMKQILEALAFLHDHNITHLD 136
M++ E G L + E + + + Q+ L ++H ++ H+D
Sbjct: 81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMD 140
Query: 137 LKPQNILLTKDNNI-------------------KLCDFGISRVVNDVVEVKEIIGTPDYV 177
+KP NI +++ + K+ D G ++ + G ++
Sbjct: 141 IKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS---PQVEEGDSRFL 197
Query: 178 APEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGH 236
A EVL D++++ + + ++ + I Q +
Sbjct: 198 ANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQGRLP---RIPQV 251
Query: 237 ISSQAKDFIQSCLVTDP 253
+S + + ++ + DP
Sbjct: 252 LSQEFTELLKVMIHPDP 268
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-50
Identities = 55/248 (22%), Positives = 106/248 (42%), Gaps = 25/248 (10%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR--RSMDQMQDILHEAAVLYLAQKSER---IVG 75
G + V++ T A K ++K++ R + ++ E +L + R ++
Sbjct: 15 EGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL----RRLRHKNVIQ 70
Query: 76 LHEIY--ETPHEMVLVLEMVPDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNI 132
L ++ E +M +V+E G + L + + P Y Q+++ L +LH I
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGI 130
Query: 133 THLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE---VKEIIGTPDYVAPEVLS----YE 185
H D+KP N+LLT +K+ G++ ++ + G+P + PE+ + +
Sbjct: 131 VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFS 190
Query: 186 PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245
D+WS GV Y + + PF GDN + F NI + +++ D +
Sbjct: 191 G--FKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG----DCGPPLSDLL 244
Query: 246 QSCLVTDP 253
+ L +P
Sbjct: 245 KGMLEYEP 252
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 167 bits (423), Expect = 6e-50
Identities = 33/277 (11%), Positives = 74/277 (26%), Gaps = 55/277 (19%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLY----------LAQKS 70
+ + + T + T + R + E + A+
Sbjct: 83 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142
Query: 71 ERIVGLHEIYETPH----------------EMVLVLEMVPDGELQRLVD-------IQDG 107
R + ++ + P L LQ +
Sbjct: 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 202
Query: 108 IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV 167
+ Q++ LA LH + + H L+P +I+L + + L F
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---AR 259
Query: 168 KEIIGTPDYVAPEVLSYE-----------PISLATDMWSVGVLAYVLLSSHSPFAGDNKQ 216
+ + PE+ + ++ + D W++G++ Y + + P D
Sbjct: 260 VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAAL 319
Query: 217 ETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
I + +I + ++ L
Sbjct: 320 GGSEWIFRSCK--------NIPQPVRALLEGFLRYPK 348
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 7e-50
Identities = 76/242 (31%), Positives = 118/242 (48%), Gaps = 14/242 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
RG F V+ HK T+ YA K + K E ++ A S +V L
Sbjct: 79 RGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYA 137
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++ + +V+E +P G+L L+ D +PE+ R Y +++ AL +H H D+KP
Sbjct: 138 FQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 196
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKE--IIGTPDYVAPEVLSYEPISL----ATDM 193
N+LL K ++KL DFG +N V+ +GTPDY++PEVL + D
Sbjct: 197 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 256
Query: 194 WSVGVLAYVLLSSHSPFAGDNKQETFLNI--SQCNFSFHEDLFGHISSQAKDFIQSCLVT 251
WSVGV Y +L +PF D+ T+ I + + +F +D IS +AK+ I + +T
Sbjct: 257 WSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND--ISKEAKNLICA-FLT 313
Query: 252 DP 253
D
Sbjct: 314 DR 315
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 7e-50
Identities = 64/234 (27%), Positives = 111/234 (47%), Gaps = 8/234 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
G F V HK + YA K + K++ + Q++ L+E +L A +V L
Sbjct: 51 TGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL-QAVNFPFLVKLEFS 109
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++ + +V+E V GE+ + E R Y QI+ +LH ++ + DLKP
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVL 199
+N+L+ + I++ DFG ++ V + GTP+ +APE++ + + A D W++GVL
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVL 227
Query: 200 AYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
Y + + + PF D + + I F H SS KD +++ L D
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDL 277
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-49
Identities = 72/246 (29%), Positives = 110/246 (44%), Gaps = 25/246 (10%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER---IVGLH 77
G F R K+TK A K+I + + +Q E +S R IV
Sbjct: 30 SGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINH----RSLRHPNIVRFK 82
Query: 78 EIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
E+ TP + +++E GEL +R+ + E + R + +Q+L +++ H I H D
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRD 141
Query: 137 LKPQNILL--TKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLS---YEPISLAT 191
LK +N LL + +K+CDFG S+ + K +GTP Y+APEVL Y+
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD--GKIA 199
Query: 192 DMWSVGVLAYVLLSSHSPFAGDNKQETF----LNISQCNFSFHEDLFGHISSQAKDFIQS 247
D+WS GV YV+L PF + + I +S +D+ IS + I
Sbjct: 200 DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDI--RISPECCHLISR 257
Query: 248 CLVTDP 253
V DP
Sbjct: 258 IFVADP 263
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-49
Identities = 37/273 (13%), Positives = 78/273 (28%), Gaps = 48/273 (17%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVL---------YLAQKS 70
+ + + T + T + R + ++ + E L A+
Sbjct: 88 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147
Query: 71 ERIVGLHEIYETPH----------------EMVLVLEMVPDGELQRLVD-------IQDG 107
R + ++ + P L LQ +
Sbjct: 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 207
Query: 108 IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND--VV 165
+ Q++ LA LH + + H L+P +I+L + + L F V
Sbjct: 208 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVS 267
Query: 166 EVKEIIGTPDYVAPEVLSYEP-----ISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFL 220
+ P+ A +L + ++ A D W++G+ Y + + P D
Sbjct: 268 PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE 327
Query: 221 NISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
I + +I + ++ L
Sbjct: 328 WIFRSCK--------NIPQPVRALLEGFLRYPK 352
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 4e-49
Identities = 73/244 (29%), Positives = 110/244 (45%), Gaps = 24/244 (9%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V K T YA K ++K D ++ + E +L LA+ + L
Sbjct: 33 KGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCC 92
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++TP + V+E V G+L + E R Y +I+ AL FLHD I + DLK
Sbjct: 93 FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKL 152
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEII----------GTPDYVAPEVLSYEPISL 189
N+LL + + KL DFG+ KE I GTPDY+APE+L
Sbjct: 153 DNVLLDHEGHCKLADFGMC---------KEGICNGVTTATFCGTPDYIAPEILQEMLYGP 203
Query: 190 ATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249
A D W++GVL Y +L H+PF +N+ + F I + + A ++S +
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGILKSFM 259
Query: 250 VTDP 253
+P
Sbjct: 260 TKNP 263
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-49
Identities = 59/244 (24%), Positives = 111/244 (45%), Gaps = 21/244 (8%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER---IVGLH 77
G + V+ +++T+ A K + +R +D ++I E + K +V +
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICIN----KMLNHENVVKFY 71
Query: 78 EIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
+ L LE GEL R+ G+PE D + + Q++ + +LH ITH D
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEII---GTPDYVAPEVLS---YEPISLA 190
+KP+N+LL + +N+K+ DFG++ V + + GT YVAPE+L + +
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH--AEP 188
Query: 191 TDMWSVGVLAYVLLSSHSPF-AGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249
D+WS G++ +L+ P+ + + + + + + + I S + L
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WKKIDSAPLALLHKIL 246
Query: 250 VTDP 253
V +P
Sbjct: 247 VENP 250
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 8e-49
Identities = 71/248 (28%), Positives = 114/248 (45%), Gaps = 32/248 (12%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V K T YA K ++K D ++ + E VL L K + LH
Sbjct: 30 KGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 89
Query: 80 YETPHEMVLVLEMVPDGEL----QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
++T + V+E V G+L Q+ E Y +I L FL I +
Sbjct: 90 FQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 145
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEII----------GTPDYVAPEVLSYE 185
DLK N++L + +IK+ DFG+ KE I GTPDY+APE+++Y+
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMC---------KENIWDGVTTKTFCGTPDYIAPEIIAYQ 196
Query: 186 PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245
P + D W+ GVL Y +L+ +PF G+++ E F +I + N ++ + +S +A
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAIC 252
Query: 246 QSCLVTDP 253
+ + P
Sbjct: 253 KGLMTKHP 260
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 9e-49
Identities = 59/244 (24%), Positives = 95/244 (38%), Gaps = 25/244 (10%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQD------ILHEAAVLYLAQKSER-- 72
G F V K E KFI+K + D + + E A+L
Sbjct: 34 SGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL----SRVEHA 89
Query: 73 -IVGLHEIYETPHEMVLVLEM-VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDH 130
I+ + +I+E LV+E +L +D + E +Q++ A+ +L
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK 149
Query: 131 NITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEP-ISL 189
+I H D+K +NI++ +D IKL DFG + + GT +Y APEVL P
Sbjct: 150 DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGP 209
Query: 190 ATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249
+MWS+GV Y L+ +PF + + +S + + L
Sbjct: 210 ELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPY----LVSKELMSLVSGLL 259
Query: 250 VTDP 253
P
Sbjct: 260 QPVP 263
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-48
Identities = 72/244 (29%), Positives = 111/244 (45%), Gaps = 24/244 (9%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V K T +A K ++K D ++ + E VL LA + + +
Sbjct: 27 KGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT 86
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++T + V+E + G+L + Y +I+ L FLH I + DLK
Sbjct: 87 FQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKL 146
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEII----------GTPDYVAPEVLSYEPISL 189
NILL KD +IK+ DFG+ KE + GTPDY+APE+L + +
Sbjct: 147 DNILLDKDGHIKIADFGMC---------KENMLGDAKTNTFCGTPDYIAPEILLGQKYNH 197
Query: 190 ATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249
+ D WS GVL Y +L SPF G +++E F +I N + + +AKD +
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLLVKLF 253
Query: 250 VTDP 253
V +P
Sbjct: 254 VREP 257
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-48
Identities = 71/246 (28%), Positives = 109/246 (44%), Gaps = 16/246 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
RG F+ V K T YA K + K ++ E VL I LH
Sbjct: 71 RGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFA 129
Query: 80 YETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
++ + + LV+E G+L L + IP + R Y+ +I+ A+ +H H D+K
Sbjct: 130 FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIK 189
Query: 139 PQNILLTKDNNIKLCDFGISR--VVNDVVEVKEIIGTPDYVAPEVL-------SYEPISL 189
P NILL + +I+L DFG + V +GTPDY++PE+L
Sbjct: 190 PDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGP 249
Query: 190 ATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNI--SQCNFSFHEDLFGHISSQAKDFIQS 247
D W++GV AY + +PF D+ ET+ I + + S + +A+DFIQ
Sbjct: 250 ECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD-EGVPEEARDFIQR 308
Query: 248 CLVTDP 253
L+ P
Sbjct: 309 -LLCPP 313
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-48
Identities = 78/249 (31%), Positives = 113/249 (45%), Gaps = 34/249 (13%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V HK +V YA K ++K+ + + I+ E VL K +VGLH
Sbjct: 48 KGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS 107
Query: 80 YETPHEMVLVLEMVPDGEL----QRLVDIQDGI-PEQDTRSYMKQILEALAFLHDHNITH 134
++T ++ VL+ + GEL QR + E R Y +I AL +LH NI +
Sbjct: 108 FQTADKLYFVLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVY 162
Query: 135 LDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEII----------GTPDYVAPEVLSY 184
DLKP+NILL +I L DFG+ KE I GTP+Y+APEVL
Sbjct: 163 RDLKPENILLDSQGHIVLTDFGLC---------KENIEHNSTTSTFCGTPEYLAPEVLHK 213
Query: 185 EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244
+P D W +G + Y +L PF N E + NI +I++ A+
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----NITNSARHL 269
Query: 245 IQSCLVTDP 253
++ L D
Sbjct: 270 LEGLLQKDR 278
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-48
Identities = 71/238 (29%), Positives = 109/238 (45%), Gaps = 8/238 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V C + T YA K + K+R + L+E +L S +V L
Sbjct: 194 KGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYA 252
Query: 80 YETPHEMVLVLEMVPDGEL----QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
YET + LVL ++ G+L + Q G PE Y +I L LH I +
Sbjct: 253 YETKDALCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRERIVYR 310
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWS 195
DLKP+NILL +I++ D G++ V + +K +GT Y+APEV+ E + + D W+
Sbjct: 311 DLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWA 370
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+G L Y +++ SPF K+ + + E+ S QA+ L DP
Sbjct: 371 LGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDP 428
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-48
Identities = 66/234 (28%), Positives = 114/234 (48%), Gaps = 8/234 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
G F V + YA K ++K + Q++ E +L + I+ +
Sbjct: 16 TGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGT 74
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++ ++ ++++ + GEL L+ P + Y ++ AL +LH +I + DLKP
Sbjct: 75 FQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKP 134
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVL 199
+NILL K+ +IK+ DFG ++ V DV + GTPDY+APEV+S +P + + D WS G+L
Sbjct: 135 ENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGIL 192
Query: 200 AYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
Y +L+ ++PF N +T+ I F + KD + + D
Sbjct: 193 IYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLSRLITRDL 242
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 7e-48
Identities = 68/247 (27%), Positives = 117/247 (47%), Gaps = 34/247 (13%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
GK V+K + + YA K ++K + E +L IV LH ++
Sbjct: 38 GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQ 96
Query: 82 TPHEMVLVLEMVPDGEL----QRLVDIQDGI-PEQDTRSYMKQILEALAFLHDHNITHLD 136
T ++ L+L+ + G+L + + + E+D + Y+ ++ AL LH I + D
Sbjct: 97 TEGKLYLILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLGIIYRD 151
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEII----------GTPDYVAPEVLSYEP 186
LKP+NILL ++ +IKL DFG+S KE I GT +Y+APEV++
Sbjct: 152 LKPENILLDEEGHIKLTDFGLS---------KESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 187 ISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246
+ + D WS GVL + +L+ PF G +++ET I + + +S +A+ ++
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLR 258
Query: 247 SCLVTDP 253
+P
Sbjct: 259 MLFKRNP 265
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 7e-48
Identities = 68/246 (27%), Positives = 114/246 (46%), Gaps = 17/246 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILH---EAAVLYLAQKSERIVGLH 77
RG F V K +A K + K M + + E VL S+ I LH
Sbjct: 84 RGAFGEVAVVKLKNADKVFAMKILNKW--EMLKRAETACFREERDVLVNG-DSKWITTLH 140
Query: 78 EIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
++ + + LV++ G+L L +D +PE+ R Y+ +++ A+ +H + H D
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRD 200
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE--IIGTPDYVAPEVLSYEPISL----- 189
+KP NIL+ + +I+L DFG + + V+ +GTPDY++PE+L
Sbjct: 201 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGP 260
Query: 190 ATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNI--SQCNFSFHEDLFGHISSQAKDFIQS 247
D WS+GV Y +L +PF ++ ET+ I + F F + +S AKD I+
Sbjct: 261 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV-TDVSENAKDLIRR 319
Query: 248 CLVTDP 253
+ +
Sbjct: 320 LICSRE 325
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 9e-48
Identities = 75/249 (30%), Positives = 117/249 (46%), Gaps = 36/249 (14%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRR--RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
GK VRK T T +A K ++K R+ E +L K IV L
Sbjct: 31 GKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYA 89
Query: 80 YETPHEMVLVLEMVPDGEL----QRLVDIQDGI-PEQDTRSYMKQILEALAFLHDHNITH 134
++T ++ L+LE + GEL +R +GI E Y+ +I AL LH I +
Sbjct: 90 FQTGGKLYLILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQKGIIY 144
Query: 135 LDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEII----------GTPDYVAPEVLSY 184
DLKP+NI+L ++KL DFG+ KE I GT +Y+APE+L
Sbjct: 145 RDLKPENIMLNHQGHVKLTDFGLC---------KESIHDGTVTHTFCGTIEYMAPEILMR 195
Query: 185 EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244
+ A D WS+G L Y +L+ PF G+N+++T I +C + +++ +A+D
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQEARDL 251
Query: 245 IQSCLVTDP 253
++ L +
Sbjct: 252 LKKLLKRNA 260
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-47
Identities = 70/244 (28%), Positives = 113/244 (46%), Gaps = 24/244 (9%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V K T YA K ++K D ++ + E VL L K + LH
Sbjct: 351 KGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 410
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++T + V+E V G+L + E Y +I L FL I + DLK
Sbjct: 411 FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKL 470
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEII----------GTPDYVAPEVLSYEPISL 189
N++L + +IK+ DFG+ KE I GTPDY+APE+++Y+P
Sbjct: 471 DNVMLDSEGHIKIADFGMC---------KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 521
Query: 190 ATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249
+ D W+ GVL Y +L+ +PF G+++ E F +I + N ++ + +S +A + +
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLM 577
Query: 250 VTDP 253
P
Sbjct: 578 TKHP 581
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 4e-47
Identities = 68/243 (27%), Positives = 114/243 (46%), Gaps = 15/243 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
RG F V C K T YA K + K+R + Q + E +L S IV L
Sbjct: 195 RGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYA 253
Query: 80 YETPHEMVLVLEMVPDGEL----QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
+ET ++ LV+ ++ G++ + + G E Y QI+ L LH NI +
Sbjct: 254 FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYR 313
Query: 136 DLKPQNILLTKDNNIKLCDFGIS-RVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMW 194
DLKP+N+LL D N+++ D G++ + + K GTP ++APE+L E + D +
Sbjct: 314 DLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYF 373
Query: 195 SVGVLAYVLLSSHSPFAGDN----KQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLV 250
++GV Y ++++ PF +E + + ++ + S +KDF ++ L
Sbjct: 374 ALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD----KFSPASKDFCEALLQ 429
Query: 251 TDP 253
DP
Sbjct: 430 KDP 432
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-47
Identities = 70/248 (28%), Positives = 109/248 (43%), Gaps = 33/248 (13%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V K T YA K +RK + D++ + E+ VL + + L
Sbjct: 15 KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYA 73
Query: 80 YETPHEMVLVLEMVPDGEL----QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
++T + V+E GEL R + E+ R Y +I+ AL +LH ++ +
Sbjct: 74 FQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEII----------GTPDYVAPEVLSYE 185
D+K +N++L KD +IK+ DFG+ KE I GTP+Y+APEVL
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLC---------KEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 186 PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245
A D W +GV+ Y ++ PF + + F I F +S +AK +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLL 236
Query: 246 QSCLVTDP 253
L DP
Sbjct: 237 AGLLKKDP 244
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 8e-47
Identities = 57/244 (23%), Positives = 115/244 (47%), Gaps = 20/244 (8%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V TK YA K++ K++ ++++++ E ++ + +V L
Sbjct: 25 KGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYS 83
Query: 80 YETPHEMVLVLEMVPDGEL----QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
++ +M +V++++ G+L Q+ V E+ + ++ +++ AL +L + I H
Sbjct: 84 FQDEEDMFMVVDLLLGGDLRYHLQQNVHF----KEETVKLFICELVMALDYLQNQRIIHR 139
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPI---SLATD 192
D+KP NILL + ++ + DF I+ ++ ++ + GT Y+APE+ S S A D
Sbjct: 140 DMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVD 199
Query: 193 MWSVGVLAYVLLSSHSPF---AGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249
WS+GV AY LL P+ + + +E ++ S + ++ L
Sbjct: 200 WWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS----AWSQEMVSLLKKLL 255
Query: 250 VTDP 253
+P
Sbjct: 256 EPNP 259
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-46
Identities = 72/253 (28%), Positives = 114/253 (45%), Gaps = 33/253 (13%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
RG +A V K T YA K ++K + + + E V A +VGLH
Sbjct: 19 RGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 78
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++T + V+E V G+L + Q +PE+ R Y +I AL +LH+ I + DLK
Sbjct: 79 FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKL 138
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEII----------GTPDYVAPEVLSYEPISL 189
N+LL + +IKL D+G+ KE + GTP+Y+APE+L E
Sbjct: 139 DNVLLDSEGHIKLTDYGMC---------KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 189
Query: 190 ATDMWSVGVLAYVLLSSHSPFA---------GDNKQETFLNISQCNFSFHEDLFGHISSQ 240
+ D W++GVL + +++ SPF + + F I + +S +
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVK 245
Query: 241 AKDFIQSCLVTDP 253
A ++S L DP
Sbjct: 246 AASVLKSFLNKDP 258
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-45
Identities = 71/253 (28%), Positives = 114/253 (45%), Gaps = 33/253 (13%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
RG +A V K T YA + ++K + + + E V A +VGLH
Sbjct: 62 RGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++T + V+E V G+L + Q +PE+ R Y +I AL +LH+ I + DLK
Sbjct: 122 FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKL 181
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEII----------GTPDYVAPEVLSYEPISL 189
N+LL + +IKL D+G+ KE + GTP+Y+APE+L E
Sbjct: 182 DNVLLDSEGHIKLTDYGMC---------KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 232
Query: 190 ATDMWSVGVLAYVLLSSHSPFA---------GDNKQETFLNISQCNFSFHEDLFGHISSQ 240
+ D W++GVL + +++ SPF + + F I + +S +
Sbjct: 233 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVK 288
Query: 241 AKDFIQSCLVTDP 253
A ++S L DP
Sbjct: 289 AASVLKSFLNKDP 301
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-44
Identities = 61/240 (25%), Positives = 104/240 (43%), Gaps = 12/240 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSER--IVGLH 77
RG F V C T YA K + K+R + L+E +L L + IV +
Sbjct: 199 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+ TP ++ +L+++ G+L + E D R Y +I+ L +H+ + + DL
Sbjct: 259 YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDL 318
Query: 138 KPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSV 196
KP NILL + ++++ D G++ + + +GT Y+APEVL + D +S+
Sbjct: 319 KPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSL 377
Query: 197 GVLAYVLLSSHSPFAGDN---KQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
G + + LL HSPF K E + S + + ++ L D
Sbjct: 378 GCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----SFSPELRSLLEGLLQRDV 433
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-44
Identities = 69/236 (29%), Positives = 111/236 (47%), Gaps = 8/236 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V K T YA K ++K + D++ L E VL + + + L
Sbjct: 158 KGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYS 216
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLH-DHNITHLDLK 138
++T + V+E GEL + + E R Y +I+ AL +LH + N+ + DLK
Sbjct: 217 FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLK 276
Query: 139 PQNILLTKDNNIKLCDFGISRV-VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
+N++L KD +IK+ DFG+ + + D +K GTP+Y+APEVL A D W +G
Sbjct: 277 LENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 336
Query: 198 VLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
V+ Y ++ PF + ++ F I F + +AK + L DP
Sbjct: 337 VVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSLLSGLLKKDP 388
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 9e-44
Identities = 74/255 (29%), Positives = 120/255 (47%), Gaps = 40/255 (15%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRR--RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
GK VRK + T YA K ++K + + E VL ++S +V LH
Sbjct: 68 GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 127
Query: 80 YETPHEMVLVLEMVPDGEL----QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
++T ++ L+L+ + GEL + ++ E + + Y+ +I+ AL LH I +
Sbjct: 128 FQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLGIIYR 183
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEII-----------GTPDYVAPEVLSY 184
D+K +NILL + ++ L DFG+S KE + GT +Y+AP+++
Sbjct: 184 DIKLENILLDSNGHVVLTDFGLS---------KEFVADETERAYDFCGTIEYMAPDIVRG 234
Query: 185 EPI--SLATDMWSVGVLAYVLLSSHSPFAGD----NKQETFLNISQCNFSFHEDLFGHIS 238
A D WS+GVL Y LL+ SPF D ++ E I + + + +S
Sbjct: 235 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ----EMS 290
Query: 239 SQAKDFIQSCLVTDP 253
+ AKD IQ L+ DP
Sbjct: 291 ALAKDLIQRLLMKDP 305
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-42
Identities = 59/240 (24%), Positives = 100/240 (41%), Gaps = 16/240 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RG F V + K T + A K +R ++++ S RIV L+
Sbjct: 68 RGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL-VACAGL-------SSPRIVPLYGAV 119
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
+ + +E++ G L +L+ +PE Y+ Q LE L +LH I H D+K
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKAD 179
Query: 141 NILLTKD-NNIKLCDFGISRVVND------VVEVKEIIGTPDYVAPEVLSYEPISLATDM 193
N+LL+ D + LCDFG + + ++ I GT ++APEV+ +P D+
Sbjct: 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDI 239
Query: 194 WSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
WS + +L+ P+ + L I+ ++ + IQ L +P
Sbjct: 240 WSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-EPPPIREIPPSCAPLTAQAIQEGLRKEP 298
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 147 bits (371), Expect = 2e-42
Identities = 44/257 (17%), Positives = 79/257 (30%), Gaps = 35/257 (13%)
Query: 21 RGKFASVRKCTHK-----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVG 75
G FA V + T K ++ K + + + L +
Sbjct: 75 EGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERL-KPSMQHMFMK 131
Query: 76 LHEIYETPHEMVLVLEMVPDGELQRLVD-----IQDGIPEQDTRSYMKQILEALAFLHDH 130
+ + + VLV E+ G L ++ + +P+ S+ ++L + +HD
Sbjct: 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC 191
Query: 131 NITHLDLKPQNILLT-----------KDNNIKLCDFGISRVVN---DVVEVKEIIGTPDY 176
I H D+KP N +L + L D G S + T +
Sbjct: 192 EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGF 251
Query: 177 VAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGH 236
E+LS +P + D + V Y +L + E H D++
Sbjct: 252 QCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL-FRRLPHLDMW-- 308
Query: 237 ISSQAKDFIQSCLVTDP 253
+F L
Sbjct: 309 -----NEFFHVMLNIPD 320
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-41
Identities = 58/304 (19%), Positives = 105/304 (34%), Gaps = 76/304 (25%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIR---------KRRRSMDQMQDILHEAAVLYLA---- 67
RG F V + +K+ YA K IR K R + + + H V Y
Sbjct: 16 RGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLE 75
Query: 68 ------------------------------------------QKSERIVGLHEIYETPHE 85
++ VG +
Sbjct: 76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVY 135
Query: 86 MVLVLEMVPDGELQRLVDIQDGIPEQDT---RSYMKQILEALAFLHDHNITHLDLKPQNI 142
+ + +++ L+ ++ + + +++ QI EA+ FLH + H DLKP NI
Sbjct: 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNI 195
Query: 143 LLTKDNNIKLCDFGISRVVNDVVEVKEI-------------IGTPDYVAPEVLSYEPISL 189
T D+ +K+ DFG+ ++ E + + +GT Y++PE + S
Sbjct: 196 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSH 255
Query: 190 ATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249
D++S+G++ + LL +S + ++ F LF Q +Q L
Sbjct: 256 KVDIFSLGLILFELL--YSFSTQMERVRIITDVRNLKFP---LLFTQKYPQEHMMVQDML 310
Query: 250 VTDP 253
P
Sbjct: 311 SPSP 314
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-40
Identities = 71/242 (29%), Positives = 108/242 (44%), Gaps = 15/242 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL-YLAQKSERIVGLHEI 79
+G + V +V A K I +R Q + E A+ +L K + IV
Sbjct: 32 KGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHL--KHKNIVQYLGS 87
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDG---IPEQDTRSYMKQILEALAFLHDHNITHLD 136
+ + + +E VP G L L+ + G EQ Y KQILE L +LHD+ I H D
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRD 147
Query: 137 LKPQNILL-TKDNNIKLCDFGISRVVNDVVEVKE-IIGTPDYVAPEVLSYEPI--SLATD 192
+K N+L+ T +K+ DFG S+ + + E GT Y+APE++ P A D
Sbjct: 148 IKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAAD 207
Query: 193 MWSVGVLAYVLLSSHSPFAG-DNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251
+WS+G + + PF Q + F H ++ +S++AK FI C
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEPQAAMFKVG--MFKVHPEIPESMSAEAKAFILKCFEP 265
Query: 252 DP 253
DP
Sbjct: 266 DP 267
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-39
Identities = 60/241 (24%), Positives = 113/241 (46%), Gaps = 13/241 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RG F +V K T VE A ++ R+ + + Q EA +L + IV ++ +
Sbjct: 36 RGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEML-KGLQHPNIVRFYDSW 94
Query: 81 ETPHE----MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHN--ITH 134
E+ + +VLV E++ G L+ + + + RS+ +QIL+ L FLH I H
Sbjct: 95 ESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIH 154
Query: 135 LDLKPQNILLTKDN-NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDM 193
DLK NI +T ++K+ D G++ + K +IGTP+++APE+ E + D+
Sbjct: 155 RDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYE-EKYDESVDV 212
Query: 194 WSVGVLAYVLLSSHSPFAG-DNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTD 252
++ G+ + +S P++ N + + ++ + K+ I+ C+ +
Sbjct: 213 YAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQN 270
Query: 253 P 253
Sbjct: 271 K 271
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-37
Identities = 62/244 (25%), Positives = 103/244 (42%), Gaps = 17/244 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G V K + T A K +R R + ++ + IL + V+ + IV +
Sbjct: 35 SGTCGQVWKMRFRKTGHVIAVKQMR-RSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF 93
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKP 139
T ++ + +E++ + +Q IPE+ I++AL +L + H + H D+KP
Sbjct: 94 ITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKP 153
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLAT-----DMW 194
NILL + IKLCDFGIS + D G Y+APE + + D+W
Sbjct: 154 SNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVW 213
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHED---LFGHI--SSQAKDFIQSCL 249
S+G+ L + P+ + E+ L GH+ S + F++ CL
Sbjct: 214 SLGISLVELATGQFPYKNCK-----TDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCL 268
Query: 250 VTDP 253
D
Sbjct: 269 TKDH 272
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-36
Identities = 58/243 (23%), Positives = 99/243 (40%), Gaps = 14/243 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RG + V K H + A K IR + + + +L + + V +
Sbjct: 17 RGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL 75
Query: 81 ETPHEMVLVLEMVP---DGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLD 136
++ + +E++ D ++++D IPE I++AL LH ++ H D
Sbjct: 76 FREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRD 135
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPI----SLATD 192
+KP N+L+ +K+CDFGIS + D V G Y+APE ++ E S+ +D
Sbjct: 136 VKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSD 195
Query: 193 MWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNF--SFHEDLFGHISSQAKDFIQSCLV 250
+WS+G+ L P+ L D F S++ DF CL
Sbjct: 196 IWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF---SAEFVDFTSQCLK 252
Query: 251 TDP 253
+
Sbjct: 253 KNS 255
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-36
Identities = 66/274 (24%), Positives = 109/274 (39%), Gaps = 44/274 (16%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G V K +HK + + A K I I+ E VL+ S IVG + +
Sbjct: 43 AGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAF 100
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKP 139
+ E+ + +E + G L +++ IPEQ +++ L +L + H I H D+KP
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 160
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVL 199
NIL+ IKLCDFG+S + D + +GT Y++PE L S+ +D+WS+G+
Sbjct: 161 SNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLS 219
Query: 200 AYVLLSSHSPFAGDNKQETFLNISQCNFSFHE---------------------------D 232
+ P + +E L +
Sbjct: 220 LVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFE 279
Query: 233 LFGHI-------------SSQAKDFIQSCLVTDP 253
L +I S + +DF+ CL+ +P
Sbjct: 280 LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 313
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-36
Identities = 61/246 (24%), Positives = 99/246 (40%), Gaps = 16/246 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RG + SV K HK + A K IR + + +L + V+ + IV +
Sbjct: 32 RGAYGSVNKMVHKPSGQIMAVKRIR-STVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL 90
Query: 81 ETPHEMVLVLE-MVPDGELQRLVDI-----QDGIPEQDTRSYMKQILEALAFLHD-HNIT 133
+ + +E M + D IPE+ ++AL L + I
Sbjct: 91 FREGDCWICMELM--STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKII 148
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPI----SL 189
H D+KP NILL + NIKLCDFGIS + D + G Y+APE + +
Sbjct: 149 HRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDV 208
Query: 190 ATDMWSVGVLAYVLLSSHSPFAG-DNKQETFLNISQCN-FSFHEDLFGHISSQAKDFIQS 247
+D+WS+G+ Y L + P+ ++ + + + + S +F+
Sbjct: 209 RSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNL 268
Query: 248 CLVTDP 253
CL D
Sbjct: 269 CLTKDE 274
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-36
Identities = 65/270 (24%), Positives = 120/270 (44%), Gaps = 49/270 (18%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQD-----ILHEAAVLYLAQKSERIVGL 76
G + +V K ++ T A K +R +D + L E +L K + IV L
Sbjct: 13 GTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLL-KELKHKNIVRL 66
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVD-IQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
H++ + ++ LV E D +L++ D + + +S++ Q+L+ L F H N+ H
Sbjct: 67 HDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHR 125
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEV--KEIIGTPDYVAPEVL----SYEPISL 189
DLKPQN+L+ ++ +KL +FG++R V E++ T Y P+VL Y S
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLY---ST 181
Query: 190 ATDMWSVGVLAYVLLSSHSP-FAGDNKQETFLNISQ-------------------CNFSF 229
+ DMWS G + L ++ P F G++ + I + +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 230 H------EDLFGHISSQAKDFIQSCLVTDP 253
+ ++ +++ +D +Q+ L +P
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNP 271
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-35
Identities = 72/279 (25%), Positives = 110/279 (39%), Gaps = 66/279 (23%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAA---VLYLAQ-KSERIVGLH 77
G + V KC ++ T A K + ++ + A + L Q K +V L
Sbjct: 14 GSYGVVFKCRNRDTGQIVAIKKFL-----ESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVD-IQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
E++ + LV E D + +D Q G+PE +S Q L+A+ F H HN H D
Sbjct: 69 EVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRD 127
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTP-----DYV------APEVL--- 182
+KP+NIL+TK + IKLCDFG +R ++ P D V +PE+L
Sbjct: 128 VKPENILITKHSVIKLCDFGFAR----------LLTGPSDYYDDEVATRWYRSPELLVGD 177
Query: 183 -SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQC---------------- 225
Y D+W++G + LLS + G + + I +
Sbjct: 178 TQY---GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234
Query: 226 ---NFSFH--------EDLFGHISSQAKDFIQSCLVTDP 253
E F +IS A ++ CL DP
Sbjct: 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDP 273
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-35
Identities = 68/280 (24%), Positives = 104/280 (37%), Gaps = 68/280 (24%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQD-----ILHEAAVLYLAQKSERIVGL 76
G + V KC +K T A K + E +L + E +V L
Sbjct: 36 GSYGMVMKCRNKDTGRIVAIKKFL-----ESDDDKMVKKIAMREIKLL-KQLRHENLVNL 89
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVD-IQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
E+ + LV E V D + ++ +G+ Q + Y+ QI+ + F H HNI H
Sbjct: 90 LEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHR 148
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTP-----DYV------APEVL-- 182
D+KP+NIL+++ +KLCDFG +R + P D V APE+L
Sbjct: 149 DIKPENILVSQSGVVKLCDFGFAR----------TLAAPGEVYDDEVATRWYRAPELLVG 198
Query: 183 --SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQC--------------- 225
Y A D+W++G L + F GD+ + +I C
Sbjct: 199 DVKY---GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255
Query: 226 ----NFSFH--------EDLFGHISSQAKDFIQSCLVTDP 253
E + +S D + CL DP
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDP 295
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 41/144 (28%), Positives = 68/144 (47%), Gaps = 7/144 (4%)
Query: 74 VGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
H +V+E V L+R +P + +Y+ +IL AL++LH +
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRS--KGQKLPVAEAIAYLLEILPALSYLHSIGLV 204
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDM 193
+ DLKP+NI+LT++ +KL D G +N + GTP + APE++ P ++ATD+
Sbjct: 205 YNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYL---YGTPGFQAPEIVRTGP-TVATDI 259
Query: 194 WSVGVLAYVLLSSHSPFAGDNKQE 217
++VG L G
Sbjct: 260 YTVGRTLAALTLDLPTRNGRYVDG 283
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-34
Identities = 65/269 (24%), Positives = 112/269 (41%), Gaps = 48/269 (17%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDI----LHEAAVLYLAQKSERIVGLH 77
G +A+V K K+T A K IR ++ + + E ++L K IV LH
Sbjct: 13 GTYATVYKGKSKLTDNLVALKEIR-----LEHEEGAPCTAIREVSLL-KDLKHANIVTLH 66
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVD-IQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
+I T + LV E + D +L++ +D + I + + ++ Q+L LA+ H + H D
Sbjct: 67 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRD 125
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEV--KEIIGTPDYVAPEVL----SYEPISLA 190
LKPQN+L+ + +KL DFG++R + + E++ T Y P++L Y S
Sbjct: 126 LKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDY---STQ 181
Query: 191 TDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQC-------------------NFSFH- 230
DMW VG + Y + + F G +E I + +++
Sbjct: 182 IDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPK 241
Query: 231 ------EDLFGHISSQAKDFIQSCLVTDP 253
+ S D + L +
Sbjct: 242 YRAEALLSHAPRLDSDGADLLTKLLQFEG 270
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 38/214 (17%)
Query: 73 IVGLHEIYETPHEMVLVLEMVPDGELQRLVD-IQDGIPEQDTRSYMKQILEALAFLHDHN 131
IV L ++ + + LV E + + +L++++D + G+ + + Y+ Q+L +A H H
Sbjct: 81 IVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 132 ITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV--KEIIGTPDYVAPEVL----SYE 185
I H DLKPQN+L+ D +KL DFG++R V E++ T Y AP+VL Y
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKY- 197
Query: 186 PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQC-------------------N 226
S + D+WS+G + +++ F G + I
Sbjct: 198 --STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 227 FSFH-------EDLFGHISSQAKDFIQSCLVTDP 253
+F + + D + + L DP
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDP 289
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-33
Identities = 38/144 (26%), Positives = 73/144 (50%), Gaps = 2/144 (1%)
Query: 73 IVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNI 132
+V +H+ E ++ + + ++ +L ++ Q + + ++QI AL H
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155
Query: 133 THLDLKPQNILLTKDNNIKLCDFGISRVVND--VVEVKEIIGTPDYVAPEVLSYEPISLA 190
TH D+KP+NIL++ D+ L DFGI+ D + ++ +GT Y+APE S +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215
Query: 191 TDMWSVGVLAYVLLSSHSPFAGDN 214
D++++ + Y L+ P+ GD
Sbjct: 216 ADIYALTCVLYECLTGSPPYQGDQ 239
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-33
Identities = 59/274 (21%), Positives = 110/274 (40%), Gaps = 53/274 (19%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQD-----ILHEAAVLYLAQKSERIVGL 76
G + V K +T A K IR ++ ++ + E ++L + I+ L
Sbjct: 45 GTYGEVYKAIDTVTNETVAIKRIR-----LEHEEEGVPGTAIREVSLL-KELQHRNIIEL 98
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
+ H + L+ E + +L++ +D + + +S++ Q++ + F H H D
Sbjct: 99 KSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRD 157
Query: 137 LKPQNILLT-----KDNNIKLCDFGISRVVNDVVEV--KEIIGTPDYVAPEVL----SYE 185
LKPQN+LL+ + +K+ DFG++R + EII T Y PE+L Y
Sbjct: 158 LKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRHY- 215
Query: 186 PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQC-------------------- 225
S + D+WS+ + +L F GD++ + I +
Sbjct: 216 --STSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQ 273
Query: 226 NF------SFHEDLFGHISSQAKDFIQSCLVTDP 253
+F + L + + D + + L DP
Sbjct: 274 SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDP 307
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-33
Identities = 62/235 (26%), Positives = 112/235 (47%), Gaps = 9/235 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGLHEI 79
+G F V K T+ A K I + D+++DI E VL +Q S + +
Sbjct: 32 KGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVL--SQCDSPYVTKYYGS 88
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
Y ++ +++E + G L++ + E + +++IL+ L +LH H D+K
Sbjct: 89 YLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKA 147
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKE-IIGTPDYVAPEVLSYEPISLATDMWSVGV 198
N+LL++ +KL DFG++ + D + +GTP ++APEV+ D+WS+G+
Sbjct: 148 ANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 207
Query: 199 LAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
A L P + + + I + N L G+ S K+F+++CL +P
Sbjct: 208 TAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVEACLNKEP 259
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-33
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 37/213 (17%)
Query: 73 IVGLHEIYETPHEMVLVLEMVPDGELQRLVD-IQDGIPEQDTRSYMKQILEALAFLHDHN 131
IV L+++ T +VLV E + D +L++L+D + G+ +S++ Q+L +A+ HD
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 132 ITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV--KEIIGTPDYVAPEVL----SYE 185
+ H DLKPQN+L+ ++ +K+ DFG++R V EI+ T Y AP+VL Y
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKY- 178
Query: 186 PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQ------------------CNF 227
S D+WSVG + +++ F G ++ + + I + +
Sbjct: 179 --STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 228 SFH-------EDLFGHISSQAKDFIQSCLVTDP 253
+F E + D + L DP
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-32
Identities = 41/144 (28%), Positives = 75/144 (52%), Gaps = 2/144 (1%)
Query: 73 IVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNI 132
IV + ++ E LV+E + L ++ + ++ QIL+ + HD I
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 133 THLDLKPQNILLTKDNNIKLCDFGISRVVND--VVEVKEIIGTPDYVAPEVLSYEPISLA 190
H D+KPQNIL+ + +K+ DFGI++ +++ + + ++GT Y +PE E
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 191 TDMWSVGVLAYVLLSSHSPFAGDN 214
TD++S+G++ Y +L PF G+
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFNGET 216
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-32
Identities = 55/257 (21%), Positives = 105/257 (40%), Gaps = 29/257 (11%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G A V+ K + A K I + M ++L E + IV + +
Sbjct: 25 SGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSF 82
Query: 81 ETPHEMVLVLEMVPDGELQRLV--------DIQDGIPEQDTRSYMKQILEALAFLHDHNI 132
E+ LV++++ G + ++ + E + ++++LE L +LH +
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ 142
Query: 133 THLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE------IIGTPDYVAPEVLS--- 183
H D+K NILL +D ++++ DFG+S + ++ +GTP ++APEV+
Sbjct: 143 IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR 202
Query: 184 -YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQC------NFSFHEDLFGH 236
Y+ D+WS G+ A L + +P+ + + Q +++
Sbjct: 203 GYDF---KADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKK 259
Query: 237 ISSQAKDFIQSCLVTDP 253
+ I CL DP
Sbjct: 260 YGKSFRKMISLCLQKDP 276
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-32
Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 27/219 (12%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDI----LHEAAVLYLAQKSERIVGLH 77
G +A+V K +K T V A K ++ +D + + E +++ K E IV L+
Sbjct: 16 GTYATVYKGLNKTTGVYVALKEVK-----LDSEEGTPSTAIREISLM-KELKHENIVRLY 69
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVD------IQDGIPEQDTRSYMKQILEALAFLHDHN 131
++ T +++ LV E + D +L++ +D G+ + + Q+L+ LAF H++
Sbjct: 70 DVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128
Query: 132 ITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV--KEIIGTPDYVAPEVL----SYE 185
I H DLKPQN+L+ K +KL DFG++R V E++ T Y AP+VL +Y
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMGSRTY- 186
Query: 186 PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQ 224
S + D+WS G + +++ F G N +E I
Sbjct: 187 --STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFD 223
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-32
Identities = 67/281 (23%), Positives = 106/281 (37%), Gaps = 64/281 (22%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQD--------ILHEAAVLYLAQKS--E 71
G + +V K + A K +R + + E A+L +
Sbjct: 20 GAYGTVYKARDPHSGHFVALKSVR-----VPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 72 RIVGLHEIYETPHE-----MVLVLEMVPDGELQRLVDI--QDGIPEQDTRSYMKQILEAL 124
+V L ++ T + LV E V D +L+ +D G+P + + M+Q L L
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133
Query: 125 AFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV-------NDVVEVKEIIGTPDYV 177
FLH + I H DLKP+NIL+T +KL DFG++R+ VV T Y
Sbjct: 134 DFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV-------TLWYR 186
Query: 178 APEVLSYEPISLATDMWSVG-VLAYVLLSSHSP-FAGDNKQETFLNISQC---------- 225
APEVL + DMWSVG + A + P F G+++ + I
Sbjct: 187 APEVLLQSTYATPVDMWSVGCIFAE--MFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244
Query: 226 ------NFSFH-------EDLFGHISSQAKDFIQSCLVTDP 253
+F + + + + L +P
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNP 285
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-31
Identities = 64/220 (29%), Positives = 90/220 (40%), Gaps = 49/220 (22%)
Query: 73 IVGLHEIYETPHE-----MVLVLEMVPDGELQRLVDI--QDGIPEQDTRSYMKQILEALA 125
+V L ++ + LV E V D +L +D + G+P + + M Q+L L
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 126 FLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV-------NDVVEVKEIIGTPDYVA 178
FLH H + H DLKPQNIL+T IKL DFG++R+ + VV T Y A
Sbjct: 135 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-------TLWYRA 187
Query: 179 PEVLSYEPISLATDMWSVG-VLAYVLLSSHSP-FAGDNKQETFLNISQC----------- 225
PEVL + D+WSVG + A + P F G + + I
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAE--MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245
Query: 226 -----NFSFH-------EDLFGHISSQAKDFIQSCLVTDP 253
+FH E I KD + CL +P
Sbjct: 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNP 285
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-31
Identities = 40/131 (30%), Positives = 72/131 (54%), Gaps = 4/131 (3%)
Query: 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD 147
+V+E V L+ +V + + + + +AL F H + I H D+KP NI+++
Sbjct: 93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT 152
Query: 148 NNIKLCDFGISRVVND----VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVL 203
N +K+ DFGI+R + D V + +IGT Y++PE + + +D++S+G + Y +
Sbjct: 153 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212
Query: 204 LSSHSPFAGDN 214
L+ PF GD+
Sbjct: 213 LTGEPPFTGDS 223
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-31
Identities = 64/248 (25%), Positives = 108/248 (43%), Gaps = 21/248 (8%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G + V K H T A K + D+ ++I E +L I + +
Sbjct: 34 NGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 81 ------ETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNI 132
++ LV+E G + L+ G + E+ ++IL L+ LH H +
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKV 150
Query: 133 THLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE-IIGTPDYVAPEVLSYEPISLAT 191
H D+K QN+LLT++ +KL DFG+S ++ V + IGTP ++APEV++ + AT
Sbjct: 151 IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDAT 210
Query: 192 -----DMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNF-SFHEDLFGHISSQAKDFI 245
D+WS+G+ A + P + I + + S + + FI
Sbjct: 211 YDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW---SKKFQSFI 267
Query: 246 QSCLVTDP 253
+SCLV +
Sbjct: 268 ESCLVKNH 275
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-31
Identities = 68/244 (27%), Positives = 114/244 (46%), Gaps = 19/244 (7%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGLHEI 79
G F V K +K T AAK I + S ++++D + E +L A IV L
Sbjct: 29 DGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEIL--ATCDHPYIVKLLGA 84
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
Y ++ +++E P G + ++ D + E + +Q+LEAL FLH I H DLK
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 144
Query: 139 PQNILLTKDNNIKLCDFGISRVVNDVVEVKE-IIGTPDYVAPEVLSYEPISLAT-----D 192
N+L+T + +I+L DFG+S ++ ++ IGTP ++APEV+ E + D
Sbjct: 145 AGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKAD 204
Query: 193 MWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCN---FSFHEDLFGHISSQAKDFIQSCL 249
+WS+G+ + P N L I++ + S + +DF++ L
Sbjct: 205 IWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW----SVEFRDFLKIAL 260
Query: 250 VTDP 253
+P
Sbjct: 261 DKNP 264
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-30
Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 46/272 (16%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
RGK++ V + + + K ++ + + I E +L + I+ L +I
Sbjct: 45 GRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADI 99
Query: 80 YETPHEM--VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+ P LV E V + + ++L + + D R YM +IL+AL + H I H D+
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDV 156
Query: 138 KPQNILLTKDN-NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVL-SYEPISLATDMWS 195
KP N+++ ++ ++L D+G++ + E + + + PE+L Y+ + DMWS
Sbjct: 157 KPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWS 216
Query: 196 VGVLAYVLLSSHSP-FAGDN---------------KQETFLNISQCNFS----------- 228
+G + ++ P F G + +++
Sbjct: 217 LGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHS 276
Query: 229 -------FHEDLFGHISSQAKDFIQSCLVTDP 253
H + +S +A DF+ L D
Sbjct: 277 RKRWERFVHSENQHLVSPEALDFLDKLLRYDH 308
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-30
Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 16/239 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGLHEI 79
G + SV K HK T A K + +Q+I+ E +++ Q S +V +
Sbjct: 39 EGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIM--QQCDSPHVVKYYGS 92
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
Y ++ +V+E G + ++ +++ + E + + ++ L+ L +LH H D+K
Sbjct: 93 YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIK 152
Query: 139 PQNILLTKDNNIKLCDFGISRVVNDVVEVKE-IIGTPDYVAPEVLSYEPISLATDMWSVG 197
NILL + + KL DFG++ + D + + +IGTP ++APEV+ + D+WS+G
Sbjct: 153 AGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLG 212
Query: 198 VLAYVLLSSHSPFAGDNKQETFLNISQCN---FSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ A + P+A + I F E S DF++ CLV P
Sbjct: 213 ITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW----SDNFTDFVKQCLVKSP 267
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-30
Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 52/220 (23%)
Query: 73 IVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHN 131
I+GL + + + LV + + + +L+ ++ + ++YM L+ L +LH H
Sbjct: 74 IIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 132 ITHLDLKPQNILLTKDNNIKLCDFGISRVVND--------VVEVKEIIGTPDYVAPEVL- 182
I H DLKP N+LL ++ +KL DFG+++ VV T Y APE+L
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-------TRWYRAPELLF 185
Query: 183 ---SYEPISLATDMWSVG-VLAYVLLSSHSP-FAGDNKQETFLNISQ------------- 224
Y + DMW+VG +LA L P GD+ + I +
Sbjct: 186 GARMY---GVGVDMWAVGCILAE--LLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240
Query: 225 ------CNFSFH-----EDLFGHISSQAKDFIQSCLVTDP 253
F +F D IQ + +P
Sbjct: 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNP 280
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-29
Identities = 61/237 (25%), Positives = 112/237 (47%), Gaps = 12/237 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
+G +V T E A + + + + + I++E V+ K+ IV + Y
Sbjct: 30 QGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMREN-KNPNIVNYLDSY 86
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
E+ +V+E + G L +V + + E + ++ L+AL FLH + + H D+K
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145
Query: 141 NILLTKDNNIKLCDFGIS-RVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVL 199
NILL D ++KL DFG ++ + + ++GTP ++APEV++ + D+WS+G++
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 205
Query: 200 AYVLLSSHSPFAGDNKQETFLNISQCN---FSFHEDLFGHISSQAKDFIQSCLVTDP 253
A ++ P+ +N I+ E L S+ +DF+ CL D
Sbjct: 206 AIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL----SAIFRDFLNRCLEMDV 258
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-29
Identities = 59/237 (24%), Positives = 113/237 (47%), Gaps = 12/237 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G V K + + A K + R + + + +E ++ + +V +++ Y
Sbjct: 55 EGSTGIVCLAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMR-DYQHFNVVEMYKSY 111
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
E+ +++E + G L +V Q + E+ + + +L+ALA+LH + H D+K
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSD 170
Query: 141 NILLTKDNNIKLCDFGIS-RVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVL 199
+ILLT D +KL DFG ++ DV + K ++GTP ++APEV+S + D+WS+G++
Sbjct: 171 SILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIM 230
Query: 200 AYVLLSSHSPFAGDNKQETFLNISQCN---FSFHEDLFGHISSQAKDFIQSCLVTDP 253
++ P+ D+ + + + S +DF++ LV DP
Sbjct: 231 VIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKV----SPVLRDFLERMLVRDP 283
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 55/259 (21%), Positives = 100/259 (38%), Gaps = 35/259 (13%)
Query: 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL- 64
+ + Y + G F++V + A K +R + + +D E +L
Sbjct: 16 YKDARYI--LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQ 70
Query: 65 YLAQK---------SERIVGL-----HEIYETPHEMVLVLEMVPD--GELQRLVDIQDGI 108
+ + I+ L H+ H +V+V E++ + L + + + GI
Sbjct: 71 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVH-VVMVFEVLGENLLALIKKYEHR-GI 128
Query: 109 PEQDTRSYMKQILEALAFLHDH-NITHLDLKPQNILL------TKDNNIKLCDFGISRVV 161
P + KQ+L L ++H I H D+KP+N+L+ IK+ D G +
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 162 NDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLN 221
++ I T +Y +PEVL P D+WS L + L++ F D +
Sbjct: 189 DE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 222 ISQCNFSFHEDLFGHISSQ 240
+ +L G + S
Sbjct: 247 DDH--IAQIIELLGELPSY 263
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-28
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL-YLAQK----SERIVG 75
+G F V K A K +R +R Q + E +L +L ++ + ++
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE---EIRILEHLRKQDKDNTMNVIH 163
Query: 76 LHEIYETPHEMVLVLEMVPDG--ELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
+ E + + + + E++ EL + Q G R + IL+ L LH + I
Sbjct: 164 MLENFTFRNHICMTFELLSMNLYELIKKNKFQ-GFSLPLVRKFAHSILQCLDALHKNRII 222
Query: 134 HLDLKPQNILLT--KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLAT 191
H DLKP+NILL + IK+ DFG S + V I + Y APEV+ +
Sbjct: 223 HCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPI 280
Query: 192 DMWSVGVLAYVLLSSHSPFAGDNKQE 217
DMWS+G + LL+ + G+++ +
Sbjct: 281 DMWSLGCILAELLTGYPLLPGEDEGD 306
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-28
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER---IVGLH 77
G F +V + + V A K + ++ +++ + L E A++ K R IV
Sbjct: 47 AGSFGTVHRAEWHGSDV--AVKILMEQDFHAERVNEFLREVAIM----KRLRHPNIVLFM 100
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMK---QILEALAFLHDHN--I 132
P + +V E + G L RL+ + D R + + + + +LH+ N I
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 133 THLDLKPQNILLTKDNNIKLCDFGISRVV-NDVVEVKEIIGTPDYVAPEVLSYEPISLAT 191
H +LK N+L+ K +K+CDFG+SR+ + + K GTP+++APEVL EP + +
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 192 DMWSVGVLAYVLLSSHSPFAG 212
D++S GV+ + L + P+
Sbjct: 221 DVYSFGVILWELATLQQPWGN 241
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 63/239 (26%), Positives = 104/239 (43%), Gaps = 14/239 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIR-KRRRSMDQMQDILHEAAVLYLAQ-KSERIVGLHE 78
G F +V A K + ++S ++ QDI+ E V +L + + +
Sbjct: 64 HGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE--VRFLQKLRHPNTIQYRG 121
Query: 79 IYETPHEMVLVLEMVPDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDL 137
Y H LV+E G L+++ + E + + L+ LA+LH HN+ H D+
Sbjct: 122 CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDV 180
Query: 138 KPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPIS---LATDMW 194
K NILL++ +KL DFG + ++ +GTP ++APEV+ D+W
Sbjct: 181 KAGNILLSEPGLVKLGDFGSASIMA---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVW 237
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
S+G+ L P N +I+Q + GH S ++F+ SCL P
Sbjct: 238 SLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS--GHWSEYFRNFVDSCLQKIP 294
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 19/222 (8%)
Query: 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYL 66
Y+ I + +G F V K ++ + A K I+ ++ ++Q E +L L
Sbjct: 52 WMDRYE--IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQ---AQIEVRLLEL 106
Query: 67 AQKSE-----RIVGLHEIYETPHEMVLVLEMVPDG--ELQRLVDIQDGIPEQDTRSYMKQ 119
K + IV L + + + LV EM+ +L R + + G+ TR + +Q
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFR-GVSLNLTRKFAQQ 165
Query: 120 ILEALAFLHDH--NITHLDLKPQNILLT--KDNNIKLCDFGISRVVNDVVEVKEIIGTPD 175
+ AL FL +I H DLKP+NILL K + IK+ DFG S + + + I +
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQYIQSRF 223
Query: 176 YVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQE 217
Y +PEVL P LA DMWS+G + + + F+G N+ +
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-26
Identities = 42/211 (19%), Positives = 84/211 (39%), Gaps = 25/211 (11%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER---IVGLH 77
+G F K TH+ T K + + + + L E V+ + ++
Sbjct: 20 KGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVM----RCLEHPNVLKFI 73
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYM-KQILEALAFLHDHNITHLD 136
+ + + E + G L+ ++ D R K I +A+LH NI H D
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRD 133
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE---------------IIGTPDYVAPEV 181
L N L+ ++ N+ + DFG++R++ D E ++G P ++APE+
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 182 LSYEPISLATDMWSVGVLAYVLLSSHSPFAG 212
++ D++S G++ ++ +
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 18/199 (9%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RG F V K + V A K I S + + + E L IV L+
Sbjct: 18 RGAFGVVCKAKWRAKDV--AIKQIE----SESERKAFIVELRQLSRV-NHPNIVKLYGAC 70
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTR---SYMKQILEALAFLHDHN---ITH 134
P + LV+E G L ++ + +P S+ Q + +A+LH + H
Sbjct: 71 LNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 135 LDLKPQNILLTKDNN-IKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDM 193
DLKP N+LL +K+CDFG + + + G+ ++APEV S D+
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTACDIQT--HMTNNKGSAAWMAPEVFEGSNYSEKCDV 186
Query: 194 WSVGVLAYVLLSSHSPFAG 212
+S G++ + +++ PF
Sbjct: 187 FSWGIILWEVITRRKPFDE 205
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-26
Identities = 42/202 (20%), Positives = 79/202 (39%), Gaps = 13/202 (6%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81
+V +K T + I S + + + E V L IV +
Sbjct: 38 EDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFI 96
Query: 82 TPHEMVLVLEMVPDGELQRLVD--IQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
+E+ +V + G + L+ DG+ E ++ +L+AL ++H H +K
Sbjct: 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKA 156
Query: 140 QNILLTKDNNIKLCDFGIS--------RVVNDVVEVKEIIGTPDYVAPEVL--SYEPISL 189
+IL++ D + L + R K + +++PEVL + +
Sbjct: 157 SHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA 216
Query: 190 ATDMWSVGVLAYVLLSSHSPFA 211
+D++SVG+ A L + H PF
Sbjct: 217 KSDIYSVGITACELANGHVPFK 238
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 37/228 (16%)
Query: 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQD-----ILHEAAVLYLAQKSERIVGL 76
G F V K H+ T + A K + M+ ++ L E +L K E +V L
Sbjct: 28 GTFGEVFKARHRKTGQKVALKKVL-----MENEKEGFPITALREIKIL-QLLKHENVVNL 81
Query: 77 HEI--------YETPHEMVLVLEMVPDGELQRLVD-IQDGIPEQDTRSYMKQILEALAFL 127
EI + LV + + +L L+ + + + M+ +L L ++
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 140
Query: 128 HDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPD-----YVAPEVL 182
H + I H D+K N+L+T+D +KL DFG++R + + T Y PE+L
Sbjct: 141 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 200
Query: 183 ----SYEPISLATDMWSVG-VLAYVLLSSHSP-FAGDNKQETFLNISQ 224
Y P D+W G ++A + + SP G+ +Q ISQ
Sbjct: 201 LGERDYGP---PIDLWGAGCIMAE--MWTRSPIMQGNTEQHQLALISQ 243
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-26
Identities = 46/234 (19%), Positives = 94/234 (40%), Gaps = 33/234 (14%)
Query: 40 AAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER---IVGLHEIYETPHEMVLVLEMVPDG 96
A K + + Q+Q +E VL + R I+ P + +V +
Sbjct: 50 AVKMLNVTAPTPQQLQAFKNEVGVL----RKTRHVNILLFMGYSTAPQ-LAIVTQWCEGS 104
Query: 97 ELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDF 155
L + + + +Q + +LH +I H DLK NI L +DN +K+ DF
Sbjct: 105 SLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDF 164
Query: 156 GISRVVNDVVEVKEI---IGTPDYVAPEVLSYE---PISLATDMWSVGVLAYVLLSSHSP 209
G++ + + G+ ++APEV+ + P S +D+++ G++ Y L++ P
Sbjct: 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
Query: 210 FAG-DNKQETF---------LNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
++ +N+ + ++S+ + + + K + CL
Sbjct: 225 YSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM--------KRLMAECLKKKR 270
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 66/278 (23%), Positives = 105/278 (37%), Gaps = 61/278 (21%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIR--KRR--RSMDQMQDILHEAAVLYLAQKSERIVGL 76
G F V + + A K + KR R + M+ + H IV L
Sbjct: 64 NGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHC-----------NIVRL 112
Query: 77 HEIYETPHEMV------LVLEMVPDGELQRLVD----IQDGIPEQDTRSYMKQILEALAF 126
+ + E LVL+ VP+ + R+ + +P + YM Q+ +LA+
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 127 LHDHNITHLDLKPQNILLTKDNNI-KLCDFGISRVVNDVVEVKEIIGTPDYVAPEVL--- 182
+H I H D+KPQN+LL D + KLCDFG ++ + I + Y APE++
Sbjct: 172 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 231
Query: 183 -SYEPISLATDMWSVG-VLAYVLLSSHSPFAGDN---------------KQETFLNIS-- 223
Y + + D+WS G VLA LL F GD+ +E ++
Sbjct: 232 TDY---TSSIDVWSAGCVLAE-LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287
Query: 224 --QCNF------SFHEDLFGHISSQAKDFIQSCLVTDP 253
+ F + + +A L P
Sbjct: 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 325
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 7e-25
Identities = 36/204 (17%), Positives = 73/204 (35%), Gaps = 22/204 (10%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER---IVGLH 77
+ K + + K ++ R S + +D E L + ++ +
Sbjct: 20 ENHSGELWKGRWQGNDI--VVKVLKVRDWSTRKSRDFNEECPRL----RIFSHPNVLPVL 73
Query: 78 EIYETP--HEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHN-- 131
++P L+ +P G L ++ + + + + +AFLH
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 132 ITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLAT 191
I L +++++ +D ++ + + P +VAPE L +P
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNR 189
Query: 192 ---DMWSVGVLAYVLLSSHSPFAG 212
DMWS VL + L++ PFA
Sbjct: 190 RSADMWSFAVLLWELVTREVPFAD 213
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 2e-24
Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 36/221 (16%)
Query: 20 SRGKFASVRKCTHK--ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLH 77
RG + V K K +YA K I SM ++I L K ++ L
Sbjct: 30 GRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREI-----ALLRELKHPNVISLQ 84
Query: 78 EIYETPHEM--VLVLEMVPDGELQRLVD---------IQDGIPEQDTRSYMKQILEALAF 126
+++ + + L+ + + +L ++ +P +S + QIL+ + +
Sbjct: 85 KVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 127 LHDHNITHLDLKPQNILLTKDNN----IKLCDFGISRVVNDVVEV-----KEIIGTPDYV 177
LH + + H DLKP NIL+ + +K+ D G +R+ N ++ ++ T Y
Sbjct: 144 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYR 202
Query: 178 APEVL----SYEPISLATDMWSVGVLAYVLLSSHSPFAGDN 214
APE+L Y + A D+W++G + LL+S F
Sbjct: 203 APELLLGARHY---TKAIDIWAIGCIFAELLTSEPIFHCRQ 240
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-24
Identities = 47/207 (22%), Positives = 82/207 (39%), Gaps = 20/207 (9%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRK-----RRRSMDQMQDILHEAAVLYLAQKSERIVG 75
+G F V K K A K + +++ Q+ E ++ IV
Sbjct: 29 KGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVK 87
Query: 76 LHEIYETPHEMVLVLEMVPDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHN--I 132
L+ + P +V+E VP G+L + + I M I + ++ + N I
Sbjct: 88 LYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI 145
Query: 133 THLDLKPQNILLTKDN-----NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYE-- 185
H DL+ NI L + K+ DFG+S+ V ++G ++APE + E
Sbjct: 146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEE 203
Query: 186 PISLATDMWSVGVLAYVLLSSHSPFAG 212
+ D +S ++ Y +L+ PF
Sbjct: 204 SYTEKADTYSFAMILYTILTGEGPFDE 230
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-24
Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 24/208 (11%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIR--KRRRSMDQMQDILHEAAVLYLAQKSER---IVG 75
G F V + +V A K R ++++ EA + + I+
Sbjct: 17 IGGFGKVYRAFWIGDEV--AVKAARHDPDEDISQTIENVRQEAKLF----AMLKHPNIIA 70
Query: 76 LHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHN---I 132
L + + LV+E G L R++ + IP ++ QI + +LHD I
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 133 THLDLKPQNILLTK--------DNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSY 184
H DLK NIL+ + + +K+ DFG++R + G ++APEV+
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-TKMSAAGAYAWMAPEVIRA 188
Query: 185 EPISLATDMWSVGVLAYVLLSSHSPFAG 212
S +D+WS GVL + LL+ PF G
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 6e-24
Identities = 65/278 (23%), Positives = 108/278 (38%), Gaps = 62/278 (22%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIR--KRR--RSMDQMQDILHEAAVLYLAQKSERIVGL 76
G F V + + E A K + KR R + M+ + H +V L
Sbjct: 50 NGSFGVVFQAKLVESD-EVAIKKVLQDKRFKNRELQIMRIVKHP-----------NVVDL 97
Query: 77 HEIYETPHEMV------LVLEMVPDGELQRLVD----IQDGIPEQDTRSYMKQILEALAF 126
+ + + LVLE VP+ + R ++ +P + YM Q+L +LA+
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 127 LHDHNITHLDLKPQNILLTKDNN-IKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVL--- 182
+H I H D+KPQN+LL + +KL DFG ++++ I + Y APE++
Sbjct: 157 IHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGA 216
Query: 183 -SYEPISLATDMWSVG-VLAYVLLSSHSPFAGDN---------------KQETFLNIS-- 223
+Y + D+WS G V+A L+ F G++ +E ++
Sbjct: 217 TNY---TTNIDIWSTGCVMAE-LMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN 272
Query: 224 --QCNF------SFHEDLFGHISSQAKDFIQSCLVTDP 253
+ F F + A D I L P
Sbjct: 273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTP 310
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-23
Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 33/224 (14%)
Query: 21 RGKFASVRKCT-HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL-YLAQK----SERIV 74
G F V +C H K + A K IR + + + E VL + +K V
Sbjct: 29 EGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL---EINVLKKIKEKDKENKFLCV 85
Query: 75 GLHEIYETPHEMVLVLEMVPDG--ELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNI 132
+ + + M + E++ E + + Q P R Q+ AL FLH++ +
Sbjct: 86 LMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQ-PYPLPHVRHMAYQLCHALRFLHENQL 144
Query: 133 THLDLKPQNILLT-------------------KDNNIKLCDFGISRVVNDVVEVKEIIGT 173
TH DLKP+NIL K+ +I++ DFG + ++ I+ T
Sbjct: 145 THTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVAT 202
Query: 174 PDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQE 217
Y PEV+ + D+WS+G + + + F +E
Sbjct: 203 RHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-23
Identities = 52/251 (20%), Positives = 103/251 (41%), Gaps = 12/251 (4%)
Query: 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAA 62
+ F V YQ L G V I + A K + + ++ + E
Sbjct: 19 STFTVLKRYQNLKPI--GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV 76
Query: 63 VLYLAQKSERIVGLHEI------YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSY 116
++ + I+GL + E ++ +V+E++ D L ++ IQ + +
Sbjct: 77 LMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQV--IQMELDHERMSYL 132
Query: 117 MKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDY 176
+ Q+L + LH I H DLKP NI++ D +K+ DFG++R + + T Y
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 192
Query: 177 VAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGH 236
APEV+ D+WSVG + ++ F G + + + + + + +
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252
Query: 237 ISSQAKDFIQS 247
+ + ++++
Sbjct: 253 LQPTVRTYVEN 263
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-23
Identities = 47/253 (18%), Positives = 96/253 (37%), Gaps = 31/253 (12%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER---IVGLH 77
+G+F V +V A + I R + DQ++ E + R +V
Sbjct: 43 KGRFGQVYHGRWH-GEV--AIRLIDIERDNEDQLKAFKREVMAY----RQTRHENVVLFM 95
Query: 78 EIYETPHEMVLVLEMVPDGELQRLV-DIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
+P + ++ + L +V D + + TR ++I++ + +LH I H D
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKD 155
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI------IGTPDYVAPEVLS------- 183
LK +N+ + + + DFG+ + + + G ++APE++
Sbjct: 156 LKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 184 --YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDL-FGHISSQ 240
P S +D++++G + Y L + PF + I Q +L + +
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI---IWQMGTGMKPNLSQIGMGKE 271
Query: 241 AKDFIQSCLVTDP 253
D + C +
Sbjct: 272 ISDILLFCWAFEQ 284
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-23
Identities = 62/228 (27%), Positives = 90/228 (39%), Gaps = 37/228 (16%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL-YLAQK---SERIVGL 76
G F V C H K YA K +R ++ + EA +L + + IV
Sbjct: 45 DGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI---EADILKKIQNDDINNNNIVKY 101
Query: 77 HEIYETPHEMVLVLEMVPDG--ELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITH 134
H + M L+ E + E+ + G +D + Y +IL+AL +L ++TH
Sbjct: 102 HGKFMYYDHMCLIFEPLGPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRKMSLTH 160
Query: 135 LDLKPQNILLT-------------------------KDNNIKLCDFGISRVVNDVVEVKE 169
DLKP+NILL K IKL DFG + +D
Sbjct: 161 TDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGS 218
Query: 170 IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQE 217
II T Y APEV+ +++DMWS G + L + F E
Sbjct: 219 IINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHME 266
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 1e-22
Identities = 51/251 (20%), Positives = 102/251 (40%), Gaps = 12/251 (4%)
Query: 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAA 62
+ F V YQ L G V + A K + + ++ + E
Sbjct: 56 STFTVLKRYQNLKPI--GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 113
Query: 63 VLYLAQKSERIVGLHEI------YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSY 116
++ + I+ L + E ++ LV+E++ D L ++ IQ + +
Sbjct: 114 LMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQV--IQMELDHERMSYL 169
Query: 117 MKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDY 176
+ Q+L + LH I H DLKP NI++ D +K+ DFG++R + + T Y
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 229
Query: 177 VAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGH 236
APEV+ D+WSVG + ++ F G + + + + + + +
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 237 ISSQAKDFIQS 247
+ ++++++
Sbjct: 290 LQPTVRNYVEN 300
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-22
Identities = 19/147 (12%), Positives = 40/147 (27%), Gaps = 28/147 (19%)
Query: 72 RIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHN 131
+ + ++ T ++V E + G LQ + D M+ + A H
Sbjct: 92 GVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 132 ITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLAT 191
+ P + ++ D ++ L +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATMP--------------------------DANPQD 183
Query: 192 DMWSVGVLAYVLLSSHSPFAGDNKQET 218
D+ +G Y LL + P +
Sbjct: 184 DIRGIGASLYALLVNRWPLPEAGVRSG 210
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-22
Identities = 52/224 (23%), Positives = 88/224 (39%), Gaps = 33/224 (14%)
Query: 21 RGKFASVRKCT-HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL-YLAQK----SERIV 74
G F V +C HK A K ++ R + + E VL +L + R V
Sbjct: 24 EGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---EIQVLEHLNTTDPNSTFRCV 80
Query: 75 GLHEIYETPHEMVLVLEMVPDG--ELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNI 132
+ E +E + +V E++ + + R QI +++ FLH + +
Sbjct: 81 QMLEWFEHHGHICIVFELLGLSTYDFIKENGFL-PFRLDHIRKMAYQICKSVNFLHSNKL 139
Query: 133 THLDLKPQNILLT-------------------KDNNIKLCDFGISRVVNDVVEVKEIIGT 173
TH DLKP+NIL + +IK+ DFG + ++ ++ T
Sbjct: 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVST 197
Query: 174 PDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQE 217
Y APEV+ S D+WS+G + + F + +E
Sbjct: 198 RHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 7e-22
Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 38/212 (17%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVL-YLAQKSERIVGLHEI 79
G + V + K+ K A K I + + + IL E A+L L + +V + +I
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL--NHDHVVKVLDI 120
Query: 80 YETP-----HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITH 134
E+ +VLE+ D + ++L + E ++ + +L + ++H I H
Sbjct: 121 VIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILH 179
Query: 135 LDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTP-------------------- 174
DLKP N L+ +D ++K+CDFG++R V+ +
Sbjct: 180 RDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQ 239
Query: 175 --DYV------APEV-LSYEPISLATDMWSVG 197
+V APE+ L E + A D+WS+G
Sbjct: 240 LTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 9e-22
Identities = 67/253 (26%), Positives = 120/253 (47%), Gaps = 15/253 (5%)
Query: 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAA 62
+ V YQ L G + SV T + A K + + +S+ + E
Sbjct: 23 TIWEVPERYQNLSPV--GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 80
Query: 63 VLYLAQKSERIVGLHEI------YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSY 116
+L K E ++GL ++ E +++ LV ++ +L +V Q + + +
Sbjct: 81 LLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFL 137
Query: 117 MKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDY 176
+ QIL L ++H +I H DLKP N+ + +D +K+ DFG++R D E+ + T Y
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD--EMTGYVATRWY 195
Query: 177 VAPEV-LSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFG 235
APE+ L++ + D+WSVG + LL+ + F G + + I + + +L
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255
Query: 236 HISSQ-AKDFIQS 247
ISS+ A+++IQS
Sbjct: 256 KISSESARNYIQS 268
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-21
Identities = 57/253 (22%), Positives = 114/253 (45%), Gaps = 16/253 (6%)
Query: 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAA 62
+ + Y + G + SV K + + A K + + +S + E
Sbjct: 18 TAWELPKTYVSPTHV--GSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL 75
Query: 63 VLYLAQKSERIVGLHEIYETPH------EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSY 116
+L + E ++GL +++ + LV+ + +LQ++ + E+ +
Sbjct: 76 LLKHM-QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKI--MGLKFSEEKIQYL 131
Query: 117 MKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDY 176
+ Q+L+ L ++H + H DLKP N+ + +D +K+ DFG++R + E+ + T Y
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA--EMTGYVVTRWY 189
Query: 177 VAPEV-LSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFG 235
APEV LS+ + D+WSVG + +L+ + F G + + I + +
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249
Query: 236 HISSQ-AKDFIQS 247
++ + AK +IQS
Sbjct: 250 KLNDKAAKSYIQS 262
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-21
Identities = 55/254 (21%), Positives = 114/254 (44%), Gaps = 15/254 (5%)
Query: 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAA 62
+ V Y+ L G + +V T + A K + + +S + E
Sbjct: 19 TAWEVRAVYRDLQPV--GSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR 76
Query: 63 VLYLAQKSERIVGLHEI------YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSY 116
+L + E ++GL ++ + + LV+ + +L +L+ + + E +
Sbjct: 77 LLKHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK-LGEDRIQFL 133
Query: 117 MKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDY 176
+ Q+L+ L ++H I H DLKP N+ + +D +K+ DFG++R + E+ + T Y
Sbjct: 134 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWY 191
Query: 177 VAPEV-LSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFG 235
APEV L++ + D+WSVG + +++ + F G + + I + + +
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251
Query: 236 HISSQ-AKDFIQSC 248
+ S AK++++
Sbjct: 252 RLQSDEAKNYMKGL 265
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-21
Identities = 56/230 (24%), Positives = 92/230 (40%), Gaps = 56/230 (24%)
Query: 73 IVGLHEIYETPHE-------MVLVLEMVPDGELQRLVD----IQDGIPEQDTRSYMKQIL 121
IV L + T E + +V+E VPD L R Q P + ++ Q++
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 122 EALAFLHD--HNITHLDLKPQNILLTKDNN-IKLCDFGISRVVNDVVEVKEIIGTPDYVA 178
++ LH N+ H D+KP N+L+ + + +KLCDFG ++ ++ I + Y A
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA 199
Query: 179 PEVL----SYEPISLATDMWSVG-VLAYVLLSSHSP-FAGDN------------------ 214
PE++ Y + A D+WSVG + A ++L P F GDN
Sbjct: 200 PELIFGNQHY---TTAVDIWSVGCIFAEMMLG--EPIFRGDNSAGQLHEIVRVLGCPSRE 254
Query: 215 ---------KQETFLNISQCNFS--FHEDLFGHISSQAKDFIQSCLVTDP 253
N +S F + + +A D + + L P
Sbjct: 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSD-HSLKDAKEAYDLLSALLQYLP 303
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-20
Identities = 69/260 (26%), Positives = 119/260 (45%), Gaps = 25/260 (9%)
Query: 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAA 62
F V Y L + G + V + KV A K I Q L E
Sbjct: 21 QVFDVGPRYTNLSYI--GEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC-QRTLREIK 77
Query: 63 VLYLAQKSERIVGLHEIYETP-----HEMVLVLE-MVPDGELQRLVDIQDGIPEQDTRSY 116
+L + E I+G+++I P ++ +V + M D L +L+ Q + +
Sbjct: 78 ILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLKTQH-LSNDHICYF 133
Query: 117 MKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDY 176
+ QIL L ++H N+ H DLKP N+LL ++K+CDFG++RV + + + +Y
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL--TEY 191
Query: 177 V------APEV-LSYEPISLATDMWSVG-VLAYVLLSSHSPFAGDNKQETFLNISQCNFS 228
V APE+ L+ + + + D+WSVG +LA +LS+ F G + + +I S
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE-MLSNRPIFPGKHYLDQLNHILGILGS 250
Query: 229 FHEDLFGHISSQ-AKDFIQS 247
++ I + A++++ S
Sbjct: 251 PSQEDLNCIINLKARNYLLS 270
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-20
Identities = 41/124 (33%), Positives = 67/124 (54%), Gaps = 8/124 (6%)
Query: 88 LVLEMVPDGELQRLVD----IQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNIL 143
+++E VPD L +++ IP Y+ Q+ A+ F+H I H D+KPQN+L
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL 173
Query: 144 L-TKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEV-LSYEPISLATDMWSVG-VLA 200
+ +KDN +KLCDFG ++ + I + Y APE+ L + + D+WS+G V
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 201 YVLL 204
++L
Sbjct: 234 ELIL 237
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-20
Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 9/187 (4%)
Query: 71 ERIVGLHEIYETPH-----EMVLVLEMVPDGELQRLVDIQDGIPEQD-TRSYMKQILEAL 124
I+GL +I+ ++ LV E++ +L +++ Q + + +M IL L
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 125 AFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEV-LS 183
LH+ + H DL P NILL +N+I +CDF ++R + Y APE+ +
Sbjct: 148 HVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQ 207
Query: 184 YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ-AK 242
++ + DMWS G + + + + F G I + + + SS A+
Sbjct: 208 FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSAR 267
Query: 243 DFIQSCL 249
D++++ L
Sbjct: 268 DYLRNSL 274
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-20
Identities = 41/186 (22%), Positives = 89/186 (47%), Gaps = 12/186 (6%)
Query: 70 SERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD 129
++ + + +V E + + +L +++ + E+ R +M Q+L L ++H
Sbjct: 81 GSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGP-LLEEHARLFMYQLLRGLKYIHS 138
Query: 130 HNITHLDLKPQNILLTKDN-NIKLCDFGISRVVNDVVEVKEIIGTPDYV------APEV- 181
N+ H DLKP N+ + ++ +K+ DFG++R+++ K + + + +P +
Sbjct: 139 ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL--SEGLVTKWYRSPRLL 196
Query: 182 LSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQA 241
LS + A DMW+ G + +L+ + FAG ++ E I + HE+ + S
Sbjct: 197 LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVI 256
Query: 242 KDFIQS 247
+I++
Sbjct: 257 PVYIRN 262
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 9e-20
Identities = 46/212 (21%), Positives = 93/212 (43%), Gaps = 15/212 (7%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKS---ERIVGLH 77
G++ V + K + A K +++ +M+ ++ L EAAV+ K +V L
Sbjct: 230 GGQYGEVYEGVWKKYSLTVAVKTLKED--TMEV-EEFLKEAAVM----KEIKHPNLVQLL 282
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHL 135
+ ++ E + G L + + + QI A+ +L N H
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 342
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDY--VAPEVLSYEPISLATDM 193
+L +N L+ +++ +K+ DFG+SR++ APE L+Y S+ +D+
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 194 WSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
W+ GVL + + + SP+ G + + + + +
Sbjct: 403 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 54/214 (25%), Positives = 84/214 (39%), Gaps = 17/214 (7%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKS---ERIVGLH 77
RG F V + A K + D L EA +L K IV L
Sbjct: 124 RGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARIL----KQYSHPNIVRLI 178
Query: 78 EIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
+ + +V+E+V G+ L + + + + +L H D
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRD 238
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV-----APEVLSYEPISLAT 191
L +N L+T+ N +K+ DFG+SR D V G V APE L+Y S +
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEAD--GVYAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 192 DMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQ 224
D+WS G+L + S SP+ + Q+T + +
Sbjct: 297 DVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-19
Identities = 40/202 (19%), Positives = 73/202 (36%), Gaps = 32/202 (15%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGL--- 76
+G++ V + + + V A K R + E + + E I+G
Sbjct: 18 KGRYGEVWRGSWQGENV--AVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 77 -HEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD------ 129
+ ++ L+ G L + + + + I LA LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 130 --HNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI-----IGTPDYVAPEVL 182
I H DLK +NIL+ K+ + D G++ + + ++ +GT Y+APEVL
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 183 SYEPI------SLATDMWSVGV 198
D+W+ G+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGL 211
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-19
Identities = 43/202 (21%), Positives = 80/202 (39%), Gaps = 32/202 (15%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGL--- 76
+G+F V + + +V A K R + + EA + + E I+G
Sbjct: 52 KGRFGEVWRGKWRGEEV--AVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 77 -HEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDH----- 130
++ T ++ LV + G L ++ + + + LA LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 131 ---NITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI-----IGTPDYVAPEVL 182
I H DLK +NIL+ K+ + D G++ + + +I +GT Y+APEVL
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
Query: 183 ------SYEPISLATDMWSVGV 198
+ D++++G+
Sbjct: 224 DDSINMKHFESFKRADIYAMGL 245
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-19
Identities = 49/204 (24%), Positives = 87/204 (42%), Gaps = 32/204 (15%)
Query: 22 GKFASVRKCTHKI----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGL 76
G F SV C + T A K ++ + + ++D E +L + + IV
Sbjct: 21 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEIL--KSLQHDNIVKY 76
Query: 77 HEIYETPHE--MVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
+ + + L++E +P G L+ L ++ I Y QI + + +L
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI 136
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV------------APEV 181
H DL +NIL+ +N +K+ DFG+++V+ + APE
Sbjct: 137 HRDLATRNILVENENRVKIGDFGLTKVLPQ--------DKEFFKVKEPGESPIFWYAPES 188
Query: 182 LSYEPISLATDMWSVGVLAYVLLS 205
L+ S+A+D+WS GV+ Y L +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 6e-19
Identities = 50/214 (23%), Positives = 98/214 (45%), Gaps = 14/214 (6%)
Query: 21 RGKFASVRKCT----HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVG 75
G F +V K + K+ A K + + S ++IL EA V+ A + +
Sbjct: 25 SGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVM--ASVDNPHVCR 81
Query: 76 LHEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITH 134
L I T L+ +++P G L + + +D I Q ++ QI + + +L D + H
Sbjct: 82 LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 135 LDLKPQNILLTKDNNIKLCDFGISRVV--NDVVEVKEIIGTP-DYVAPEVLSYEPISLAT 191
DL +N+L+ ++K+ DFG+++++ + E P ++A E + + + +
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 192 DMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
D+WS GV + L++ P+ G E + +
Sbjct: 201 DVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 8e-19
Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 13/210 (6%)
Query: 21 RGKFASVRKCTHK-ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V T T+V A K ++ +M + L EA V+ + E++V L+ +
Sbjct: 277 QGCFGEVWMGTWNGTTRV--AIKTLKPG--TMSP-EAFLQEAQVM-KKLRHEKLVQLYAV 330
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+ + +V E + G L + + G + QI +A++ N H DL
Sbjct: 331 V-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 389
Query: 138 KPQNILLTKDNNIKLCDFGISRVVNDVV-EVKEIIGTP-DYVAPEVLSYEPISLATDMWS 195
+ NIL+ ++ K+ DFG++R++ D ++ P + APE Y ++ +D+WS
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449
Query: 196 VGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
G+L L + P+ G +E + +
Sbjct: 450 FGILLTELTTKGRVPYPGMVNREVLDQVER 479
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-18
Identities = 66/280 (23%), Positives = 112/280 (40%), Gaps = 53/280 (18%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G + V THK T A K I + + L E +L K E I+ + I
Sbjct: 21 EGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA-LRTLREIKILKHF-KHENIITIFNIQ 78
Query: 81 ETPH-----EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
E+ ++ E++ +L R++ Q + + + ++ Q L A+ LH N+ H
Sbjct: 79 RPDSFENFNEVYIIQELM-QTDLHRVISTQM-LSDDHIQYFIYQTLRAVKVLHGSNVIHR 136
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTP-----DYV------APEV-LS 183
DLKP N+L+ + ++K+CDFG++R++++ ++V APEV L+
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196
Query: 184 YEPISLATDMWSVG-VLAYVLLSSHSPFAGDN---------------KQETFLN------ 221
S A D+WS G +LA L F G + + L
Sbjct: 197 SAKYSRAMDVWSCGCILAE-LFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPR 255
Query: 222 ----ISQCNF----SFHEDLFGHISSQAKDFIQSCLVTDP 253
I + +F ++ + D +Q LV DP
Sbjct: 256 AREYIKSLPMYPAAPLEK-MFPRVNPKGIDLLQRMLVFDP 294
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-18
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 32/204 (15%)
Query: 22 GKFASVRKCTHKI----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGL 76
G F SV C + T A K ++ + + ++D E +L + + IV
Sbjct: 52 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEIL--KSLQHDNIVKY 107
Query: 77 HEIYETPHE--MVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
+ + + L++E +P G L+ L ++ I Y QI + + +L
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI 167
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV------------APEV 181
H DL +NIL+ +N +K+ DFG+++V+ E Y APE
Sbjct: 168 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEY--------YKVKEPGESPIFWYAPES 219
Query: 182 LSYEPISLATDMWSVGVLAYVLLS 205
L+ S+A+D+WS GV+ Y L +
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT 243
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-18
Identities = 45/223 (20%), Positives = 82/223 (36%), Gaps = 41/223 (18%)
Query: 21 RGKFASVRKCTHKITKVEYAAK-FIRKRRRSMDQMQDIL------HEAAVLYLAQKSERI 73
RG+F V K V A K F + ++S ++ HE + ++ +E+
Sbjct: 34 RGRFGCVWKAQLLNEYV--AVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIG--AEK- 88
Query: 74 VGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEA---LAFLHDH 130
++ L+ G L ++ + LA+LH+
Sbjct: 89 ----RGTSVDVDLWLITAFHEKGSLSDF--LKANVV--SWNELCHIAETMARGLAYLHED 140
Query: 131 ----------NITHLDLKPQNILLTKDNNIKLCDFGISRVV---NDVVEVKEIIGTPDYV 177
I+H D+K +N+LL + + DFG++ + +GT Y+
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM 200
Query: 178 APEVLSYEPI-----SLATDMWSVGVLAYVLLSSHSPFAGDNK 215
APEVL L DM+++G++ + L S + G
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-18
Identities = 41/236 (17%), Positives = 84/236 (35%), Gaps = 33/236 (13%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGL--- 76
+G++ V + KV A K + E + + E I+G
Sbjct: 47 KGRYGEVWMGKWRGEKV--AVKVFFTTEEASWF-----RETEIYQTVLMRHENILGFIAA 99
Query: 77 -HEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHN---- 131
+ + ++ L+ + +G L + + + + L LH
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLK-STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 132 ----ITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI-----IGTPDYVAPEVL 182
I H DLK +NIL+ K+ + D G++ +I +GT Y+ PEVL
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 183 ------SYEPISLATDMWSVGVLAYVLLSSHSPFAG-DNKQETFLNISQCNFSFHE 231
++ + DM+S G++ + + + Q + ++ + S+ +
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-18
Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 13/210 (6%)
Query: 21 RGKFASVRKCTHK-ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V T T+V A K ++ +M + L EA V+ + E++V L+ +
Sbjct: 194 QGCFGEVWMGTWNGTTRV--AIKTLKPG--TMSP-EAFLQEAQVM-KKLRHEKLVQLYAV 247
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+ + +V E + G L + + G + QI +A++ N H DL
Sbjct: 248 V-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 306
Query: 138 KPQNILLTKDNNIKLCDFGISRVVNDVV-EVKEIIGTP-DYVAPEVLSYEPISLATDMWS 195
+ NIL+ ++ K+ DFG++R++ D ++ P + APE Y ++ +D+WS
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 196 VGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
G+L L + P+ G +E + +
Sbjct: 367 FGILLTELTTKGRVPYPGMVNREVLDQVER 396
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 4e-18
Identities = 48/202 (23%), Positives = 84/202 (41%), Gaps = 27/202 (13%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
+G + V K + T A K I ++ Q E +L E IV L +
Sbjct: 19 KGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVL 78
Query: 81 ETPH--EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
+ ++ LV + + + +L ++ + + + Q+++ + +LH + H D+K
Sbjct: 79 RADNDRDVYLVFDYM-ETDLHAVIRANI-LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMK 136
Query: 139 PQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTP----------------DYV----- 177
P NILL + ++K+ DFG+SR ++ V I DYV
Sbjct: 137 PSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWY 196
Query: 178 -APEV-LSYEPISLATDMWSVG 197
APE+ L + DMWS+G
Sbjct: 197 RAPEILLGSTKYTKGIDMWSLG 218
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-18
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 29/221 (13%)
Query: 21 RGKFASVRK--CTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGLH 77
G F +V+K K A K ++ ++L EA V+ Q + IV +
Sbjct: 27 SGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM--QQLDNPYIVRMI 84
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
I E M LV+EM G L + + + +++ + Q+ + +L + N H DL
Sbjct: 85 GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 143
Query: 138 KPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV-------------APEVLSY 184
+N+LL + K+ DFG+S+ + +Y APE ++Y
Sbjct: 144 AARNVLLVTQHYAKISDFGLSKALRA---------DENYYKAQTHGKWPVKWYAPECINY 194
Query: 185 EPISLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQ 224
S +D+WS GVL + S P+ G E + +
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 8e-18
Identities = 45/210 (21%), Positives = 80/210 (38%), Gaps = 39/210 (18%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGL--- 76
RG++ +V K + V A K Q+ ++E + + + + I
Sbjct: 23 RGRYGAVYKGSLDERPV--AVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 77 --HEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD----- 129
+ E +LV+E P+G L + + + + LA+LH
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLS-LHTSDWVSSCRLAHSVTRGLAYLHTELPRG 134
Query: 130 ----HNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE---------IIGTPDY 176
I+H DL +N+L+ D + DFG+S + V+ +GT Y
Sbjct: 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRY 194
Query: 177 VAPEVL-------SYEPISLATDMWSVGVL 199
+APEVL E DM+++G++
Sbjct: 195 MAPEVLEGAVNLRDXESALKQVDMYALGLI 224
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 9e-18
Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 19/199 (9%)
Query: 21 RGKFASVRKCTHKI----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVG 75
G F V C + T + A K + K + + D+ E +L E IV
Sbjct: 31 EGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEIL--RNLYHENIVK 87
Query: 76 LHEI--YETPHEMVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHDHNI 132
I + + + L++E +P G L+ L ++ I + Y QI + + +L
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQY 147
Query: 133 THLDLKPQNILLTKDNNIKLCDFGISRVV---NDVVEVKEIIGTPDYV---APEVLSYEP 186
H DL +N+L+ ++ +K+ DFG+++ + + VK+ +P V APE L
Sbjct: 148 VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP--VFWYAPECLMQSK 205
Query: 187 ISLATDMWSVGVLAYVLLS 205
+A+D+WS GV + LL+
Sbjct: 206 FYIASDVWSFGVTLHELLT 224
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-17
Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 21/225 (9%)
Query: 22 GKFASVRKCTHKI----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGL 76
G F SV C + T A K ++ DQ +D E +L S+ IV
Sbjct: 34 GNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQIL--KALHSDFIVKY 89
Query: 77 HEIYETPHE--MVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
+ P + LV+E +P G L+ L + + Y QI + + +L
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCV 149
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISRVV---NDVVEVKEIIGTPDYV---APEVLSYEPI 187
H DL +NIL+ + ++K+ DFG+++++ D V+E +P + APE LS
Sbjct: 150 HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP--IFWYAPESLSDNIF 207
Query: 188 SLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHE 231
S +D+WS GV+ Y L + + + + + +
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 1e-17
Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 30/158 (18%)
Query: 69 KSERIVGLHEIYETPH-----EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEA 123
KS+ I+ L+++ E+ +VLE+ D +L++L + E+ ++ + +L
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 124 LAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTP--------- 174
F+H+ I H DLKP N LL +D ++K+CDFG++R +N + +
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 175 --------DYV------APEV-LSYEPISLATDMWSVG 197
+V APE+ L E + + D+WS G
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-17
Identities = 45/215 (20%), Positives = 91/215 (42%), Gaps = 18/215 (8%)
Query: 22 GKFASVRKCT----HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKS---ERIV 74
G F +V K + K+ K I + Q + + S IV
Sbjct: 24 GVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-FQAVTDHMLAI----GSLDHAHIV 78
Query: 75 GLHEIYETPHEMVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
L + + LV + +P G L + + + Q ++ QI + + +L +H +
Sbjct: 79 RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 137
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISRVV--NDVVEVKEIIGTP-DYVAPEVLSYEPISLA 190
H +L +N+LL + +++ DFG++ ++ +D + TP ++A E + + +
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQ 197
Query: 191 TDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
+D+WS GV + L++ P+AG E + +
Sbjct: 198 SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-17
Identities = 49/214 (22%), Positives = 98/214 (45%), Gaps = 14/214 (6%)
Query: 21 RGKFASVRKCT----HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVG 75
G F +V K + K+ A K + + S ++IL EA V+ A + +
Sbjct: 25 SGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVM--ASVDNPHVCR 81
Query: 76 LHEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITH 134
L I + L+ +++P G L + + +D I Q ++ QI + + +L D + H
Sbjct: 82 LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 135 LDLKPQNILLTKDNNIKLCDFGISRVV--NDVVEVKEIIGTP-DYVAPEVLSYEPISLAT 191
DL +N+L+ ++K+ DFG+++++ + E P ++A E + + + +
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200
Query: 192 DMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
D+WS GV + L++ P+ G E + +
Sbjct: 201 DVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 80.0 bits (197), Expect = 2e-17
Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 29/221 (13%)
Query: 21 RGKFASVRKCTHKITKVEY--AAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGLH 77
G F SVR+ +++ K + A K + K+ ++++ EA ++ Q + IV L
Sbjct: 346 CGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIM--HQLDNPYIVRLI 402
Query: 78 EIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
+ + M LV+EM G L + LV ++ IP + + Q+ + +L + N H +
Sbjct: 403 GVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV------------APEVLSY 184
L +N+LL + K+ DFG+S+ + Y APE +++
Sbjct: 462 LAARNVLLVNRHYAKISDFGLSKALGA--------DDSYYTARSAGKWPLKWYAPECINF 513
Query: 185 EPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
S +D+WS GV + LS P+ E I Q
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-17
Identities = 55/230 (23%), Positives = 85/230 (36%), Gaps = 38/230 (16%)
Query: 21 RGKFASVRK-----CTHKITKVEYAAKFIRKRRRS-MDQMQDILHEAAVLYLAQKS---E 71
G F VR+ + K V A K ++ S + M D + E + S
Sbjct: 28 DGSFGVVRRGEWDAPSGKTVSV--AVKCLKPDVLSQPEAMDDFIREVNAM----HSLDHR 81
Query: 72 RIVGLHEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDH 130
++ L+ + TP +V E+ P G L RL Q Y Q+ E + +L
Sbjct: 82 NLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 131 NITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV------------A 178
H DL +N+LL + +K+ DFG+ R + YV A
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ--------NDDHYVMQEHRKVPFAWCA 192
Query: 179 PEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNF 227
PE L S A+D W GV + + + P+ G N + I +
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 242
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-17
Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 31/219 (14%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G+F V T+ + A K ++ SM + L EA V+ + +++V LH +
Sbjct: 198 AGQFGEVWMATYN-KHTKVAVKTMKPG--SMSV-EAFLAEANVM-KTLQHDKLVKLHAVV 252
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
T + ++ E + G L + +G P + QI E +AF+ N H DL+
Sbjct: 253 -TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 311
Query: 139 PQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV------------APEVLSYEP 186
NIL++ K+ DFG++RV+ D +Y APE +++
Sbjct: 312 AANILVSASLVCKIADFGLARVIED----------NEYTAREGAKFPIKWTAPEAINFGS 361
Query: 187 ISLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQ 224
++ +D+WS G+L +++ P+ G + E + +
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-17
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 33/223 (14%)
Query: 21 RGKFASVRK----CTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVG 75
G F SVR+ K V A K +++ D ++++ EA ++ Q + IV
Sbjct: 20 CGNFGSVRQGVYRMRKKQIDV--AIKVLKQGTEKADT-EEMMREAQIM--HQLDNPYIVR 74
Query: 76 LHEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITH 134
L + + M LV+EM G L + LV ++ IP + + Q+ + +L + N H
Sbjct: 75 LIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 133
Query: 135 LDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV------------APEVL 182
DL +N+LL + K+ DFG+S+ + Y APE +
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGA--------DDSYYTARSAGKWPLKWYAPECI 185
Query: 183 SYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
++ S +D+WS GV + LS P+ E I Q
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-17
Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKS---ERIVGLH 77
G++ V + K + A K +++ +M+ ++ L EAAV+ K +V L
Sbjct: 23 GGQYGEVYEGVWKKYSLTVAVKTLKED--TMEV-EEFLKEAAVM----KEIKHPNLVQLL 75
Query: 78 EI--YETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNIT 133
+ E P ++ E + G L + + + QI A+ +L N
Sbjct: 76 GVCTREPP--FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 133
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIG------TPDYVAPEVLSYEPI 187
H DL +N L+ +++ +K+ DFG+SR++ T APE L+Y
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKF 189
Query: 188 SLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQ 224
S+ +D+W+ GVL + + + SP+ G + + + + +
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 8e-17
Identities = 53/203 (26%), Positives = 79/203 (38%), Gaps = 31/203 (15%)
Query: 22 GKFASVRKC----THKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLH 77
G F V T+ T A K + K E +L E I+
Sbjct: 42 GHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILR-TLYHEHIIKYK 99
Query: 78 EIYETPHE--MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
E + LV+E VP G L+ + + I + +QI E +A+LH + H
Sbjct: 100 GCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHR 158
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDY-------------VAPEVL 182
DL +N+LL D +K+ DFG+++ V + +Y APE L
Sbjct: 159 DLAARNVLLDNDRLVKIGDFGLAKAVPE---------GHEYYRVREDGDSPVFWYAPECL 209
Query: 183 SYEPISLATDMWSVGVLAYVLLS 205
A+D+WS GV Y LL+
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLT 232
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 2e-16
Identities = 34/161 (21%), Positives = 57/161 (35%), Gaps = 52/161 (32%)
Query: 107 GIPEQDTRSYMKQILEALAFLHDH-NITHLDLKPQNILLT-------------------- 145
G+P + ++Q+L+ L +LH I H D+KP+NILL+
Sbjct: 142 GLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSG 201
Query: 146 -----------------------------KDNNIKLCDFGISRVVNDVVEVKEIIGTPDY 176
+ +K+ D G + V+ E I T Y
Sbjct: 202 APPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQY 259
Query: 177 VAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQE 217
+ EVL + D+WS +A+ L + F + +E
Sbjct: 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEE 300
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-16
Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 37/222 (16%)
Query: 21 RGKFASVRKCTHK-ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKS---ERIVGL 76
G+F V KV A K IR+ +M + +D + EA V+ ++V L
Sbjct: 18 SGQFGLVHLGYWLNKDKV--AIKTIREG--AMSE-EDFIEEAEVM----MKLSHPKLVQL 68
Query: 77 HEIYETPHEMVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
+ + + LV E + G L L + + + E +A+L + + H
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 128
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV------------APEVLS 183
DL +N L+ ++ IK+ DFG++R V D Y +PEV S
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLD----------DQYTSSTGTKFPVKWASPEVFS 178
Query: 184 YEPISLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQ 224
+ S +D+WS GVL + + S P+ + E +IS
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 220
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 3e-16
Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 8/180 (4%)
Query: 50 SMDQMQDILHEAAVLYLAQ-KSERIVGLHEIYETPHEMVLVLEMVPDGELQR-LVDIQDG 107
S + L EA + Q IV L + + ++E+ GEL+ L +
Sbjct: 431 SDSVREKFLQEALTM--RQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRKFS 487
Query: 108 IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV 167
+ Y Q+ ALA+L H D+ +N+L++ ++ +KL DFG+SR + D
Sbjct: 488 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 547
Query: 168 KEIIG-TP-DYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
K G P ++APE +++ + A+D+W GV + +L PF G + I
Sbjct: 548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-16
Identities = 47/189 (24%), Positives = 83/189 (43%), Gaps = 23/189 (12%)
Query: 50 SMDQMQDILHEAAVLYLAQ-KSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGI 108
+ Q D L EA ++ Q I+ L + M+++ E + +G L + + +DG
Sbjct: 86 TEKQRVDFLGEAGIM--GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE 143
Query: 109 PEQDTRSYM-KQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV 167
M + I + +L + N H DL +NIL+ + K+ DFG+SRV+ D E
Sbjct: 144 FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE- 202
Query: 168 KEIIGTPDYV-----------APEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNK 215
Y APE +SY + A+D+WS G++ + +++ P+ +
Sbjct: 203 ------ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256
Query: 216 QETFLNISQ 224
E I+
Sbjct: 257 HEVMKAIND 265
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 4e-16
Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 35/221 (15%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKS---ERIVGLH 77
G+F V+ K + + A K I++ SM + + EA + ++V +
Sbjct: 18 SGQFGVVKLGKWK-GQYDVAVKMIKEG--SMSE-DEFFQEAQTM----MKLSHPKLVKFY 69
Query: 78 EIYETPHEMVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
+ + + +V E + +G L L G+ + E +AFL H H D
Sbjct: 70 GVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRD 129
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV------------APEVLSY 184
L +N L+ +D +K+ DFG++R V D YV APEV Y
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLD----------DQYVSSVGTKFPVKWSAPEVFHY 179
Query: 185 EPISLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQ 224
S +D+W+ G+L + + S P+ E L +SQ
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 7e-16
Identities = 49/217 (22%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKS---ERIVGLH 77
+G+F V ++ KV A K I+ + Q L EA+V+ +V L
Sbjct: 203 KGEFGDVMLGDYRGNKV--AVKCIK--NDATAQ--AFLAEASVM----TQLRHSNLVQLL 252
Query: 78 EI--YETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNIT 133
+ E + V E + G L + + + + + EA+ +L +N
Sbjct: 253 GVIVEEKGGLYI-VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 311
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE-----VKEIIGTPDYVAPEVLSYEPIS 188
H DL +N+L+++DN K+ DFG+++ + + VK + APE L + S
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-------WTAPEALREKKFS 364
Query: 189 LATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQ 224
+D+WS G+L + + S P+ ++ + +
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 9e-16
Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G+F V+ + + + A K I++ SM + + + EA V+ + E++V L+ +
Sbjct: 34 TGQFGVVKYGKWR-GQYDVAIKMIKEG--SMSE-DEFIEEAKVM-MNLSHEKLVQLYGVC 88
Query: 81 ETPHEMVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
+ ++ E + +G L L +++ Q K + EA+ +L H DL
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAA 148
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV------------APEVLSYEPI 187
+N L+ +K+ DFG+SR V D +Y PEVL Y
Sbjct: 149 RNCLVNDQGVVKVSDFGLSRYVLD----------DEYTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 188 SLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQ 224
S +D+W+ GVL + + S P+ ET +I+Q
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-15
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 36/224 (16%)
Query: 21 RGKFASVRK---CTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKS---ERIV 74
G F V + HK K+ A K K+ ++D + + EA ++ K+ IV
Sbjct: 22 EGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIM----KNLDHPHIV 76
Query: 75 GLHEIYETPHEMVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
L I +++E+ P GEL L ++ + Y QI +A+A+L N
Sbjct: 77 KLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCV 135
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV------------APEV 181
H D+ +NIL+ +KL DFG+SR + D DY +PE
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIED----------EDYYKASVTRLPIKWMSPES 185
Query: 182 LSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
+++ + A+D+W V + +LS PF ++ + +
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 229
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-15
Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 31/223 (13%)
Query: 21 RGKFASVRKCTHKIT---KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGL 76
G V ++ V A K + K + Q +D L EA+++ Q I+ L
Sbjct: 59 SGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASIM--GQFDHPNIIRL 115
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYM-KQILEALAFLHDHNITHL 135
+ ++V E + +G L + DG M + + + +L D H
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHR 175
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV-------------APEVL 182
DL +N+L+ + K+ DFG+SRV+ D PD APE +
Sbjct: 176 DLAARNVLVDSNLVCKVSDFGLSRVLED---------DPDAAYTTTGGKIPIRWTAPEAI 226
Query: 183 SYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
++ S A+D+WS GV+ + +L+ P+ ++ ++ +
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-15
Identities = 50/220 (22%), Positives = 93/220 (42%), Gaps = 27/220 (12%)
Query: 22 GKFASVRKCTHKIT---KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGLH 77
G+F V K+ ++ A K + K + Q +D L EA+++ Q I+ L
Sbjct: 56 GEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIM--GQFDHPNIIRLE 112
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYM-KQILEALAFLHDHNITHLD 136
+ +++V E + +G L + D M + I + +L D H D
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 172
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV-----------APEVLSYE 185
L +NIL+ + K+ DFG+ RV+ D E Y +PE ++Y
Sbjct: 173 LAARNILINSNLVCKVSDFGLGRVLEDDPE-------AAYTTRGGKIPIRWTSPEAIAYR 225
Query: 186 PISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
+ A+D+WS G++ + ++S P+ + Q+ + +
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-15
Identities = 48/221 (21%), Positives = 86/221 (38%), Gaps = 22/221 (9%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIR---K--RRRSMDQMQDILHEAAVLYLAQ-KSERIV 74
+G F + K + K + + + A+++ ++ + +V
Sbjct: 18 QGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM--SKLSHKHLV 75
Query: 75 GLHEIYETPHEMVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
+ + E +LV E V G L L ++ I KQ+ A+ FL ++ +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLI 135
Query: 134 HLDLKPQNILLTKDNN--------IKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYE 185
H ++ +NILL ++ + IKL D GIS V ++E I +V PE +
Sbjct: 136 HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI---PWVPPECIENP 192
Query: 186 PI-SLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQ 224
+LATD WS G + + S P + + Q
Sbjct: 193 KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-15
Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 36/224 (16%)
Query: 21 RGKFASVRK-----CTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIV 74
G+F V + + V A K K S + L EA + Q IV
Sbjct: 25 EGQFGDVHQGIYMSPENPALAV--AIKTC-KNCTSDSVREKFLQEALTM--RQFDHPHIV 79
Query: 75 GLHEIYETPHEMVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
L + T + + +++E+ GEL+ L + + Y Q+ ALA+L
Sbjct: 80 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV 138
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV------------APEV 181
H D+ +N+L++ ++ +KL DFG+SR + D Y APE
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMED----------STYYKASKGKLPIKWMAPES 188
Query: 182 LSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
+++ + A+D+W GV + +L PF G + I
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 232
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 3e-15
Identities = 54/223 (24%), Positives = 98/223 (43%), Gaps = 39/223 (17%)
Query: 21 RGKFASVRKCTHK-ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKS---ERIVGL 76
G+F V + TKV A K +++ SM L EA ++ K +R+V L
Sbjct: 23 AGQFGEVWMGYYNGHTKV--AVKSLKQG--SMSP-DAFLAEANLM----KQLQHQRLVRL 73
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITH 134
+ + T + ++ E + +G L + G + QI E +AF+ + N H
Sbjct: 74 YAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 135 LDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV------------APEVL 182
DL+ NIL++ + K+ DFG++R++ D +Y APE +
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIED----------NEYTAREGAKFPIKWTAPEAI 182
Query: 183 SYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
+Y ++ +D+WS G+L +++ P+ G E N+ +
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 6e-15
Identities = 50/218 (22%), Positives = 92/218 (42%), Gaps = 33/218 (15%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQM-QDILHEAAVLYLAQKS---ERIVGL 76
+G+F V ++ KV A K I+ D Q L EA+V+ +V L
Sbjct: 31 KGEFGDVMLGDYRGNKV--AVKCIKN-----DATAQAFLAEASVM----TQLRHSNLVQL 79
Query: 77 HEI--YETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNI 132
+ E + V E + G L + + + + + EA+ +L +N
Sbjct: 80 LGVIVEEKGGLYI-VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 138
Query: 133 THLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE-----VKEIIGTPDYVAPEVLSYEPI 187
H DL +N+L+++DN K+ DFG+++ + + VK + APE L +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-------WTAPEALREKKF 191
Query: 188 SLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQ 224
S +D+WS G+L + + S P+ ++ + +
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 229
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 7e-14
Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 13/142 (9%)
Query: 84 HEMVLVLEMVPDGEL-QRLVDIQDGIP-EQDTRSYMKQILEA---LAFLHDHNITHLDLK 138
++ LV +P+G L RL + P R K A + FLH+++ H D+K
Sbjct: 103 DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR--CKIAQGAANGINFLHENHHIHRDIK 160
Query: 139 PQNILLTKDNNIKLCDFGISRV--VNDVVEVKE-IIGTPDYVAPEVLSYEPISLATDMWS 195
NILL + K+ DFG++R + I+GT Y+APE L E I+ +D++S
Sbjct: 161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYS 219
Query: 196 VGVLAYVLLSSHSPFAGDNKQE 217
GV+ +++ D +E
Sbjct: 220 FGVVLLEIITGLPAV--DEHRE 239
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-13
Identities = 48/229 (20%), Positives = 94/229 (41%), Gaps = 47/229 (20%)
Query: 21 RGKFASVRKCT---HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKS---ERIV 74
+G+F SVR+ + V+ A K ++ + +++ L EAA + K +
Sbjct: 33 KGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM----KEFDHPHVA 88
Query: 75 GL------HEIYETPHEMVLVLEMVPDGELQ------RLVDIQDGIPEQDTRSYMKQILE 122
L +++L + G+L R+ + +P Q +M I
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 123 ALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDY------ 176
+ +L N H DL +N +L +D + + DFG+SR + DY
Sbjct: 149 GMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG----------DYYRQGCA 198
Query: 177 -------VAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAG-DNKQ 216
+A E L+ ++ +D+W+ GV + +++ +P+AG +N +
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-13
Identities = 52/238 (21%), Positives = 90/238 (37%), Gaps = 51/238 (21%)
Query: 21 RGKFASVRKCT-----HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKS---ER 72
G+F SV + KV A K ++ S ++++ L EAA + K
Sbjct: 44 EGEFGSVMEGNLKQEDGTSLKV--AVKTMKLDNSSQREIEEFLSEAACM----KDFSHPN 97
Query: 73 IVGL------HEIYETPHEMVLVLEMVPDGELQ------RLVDIQDGIPEQDTRSYMKQI 120
++ L P MV +L + G+L RL IP Q +M I
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMV-ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 121 LEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDY---- 176
+ +L + N H DL +N +L D + + DFG+S+ + DY
Sbjct: 157 ALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG----------DYYRQG 206
Query: 177 ---------VAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
+A E L+ + +D+W+ GV + + + +P+ G E + +
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-12
Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 13/148 (8%)
Query: 74 VGLHEIYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQD--TRSYMKQIL---EALAFL 127
+ L TP E +LV + +G + L + + P D R + L LA+L
Sbjct: 90 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR--QRIALGSARGLAYL 147
Query: 128 HDH---NITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE--VKEIIGTPDYVAPEVL 182
HDH I H D+K NILL ++ + DFG++++++ + GT ++APE L
Sbjct: 148 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 207
Query: 183 SYEPISLATDMWSVGVLAYVLLSSHSPF 210
S S TD++ GV+ L++ F
Sbjct: 208 STGKSSEKTDVFGYGVMLLELITGQRAF 235
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-12
Identities = 45/221 (20%), Positives = 86/221 (38%), Gaps = 25/221 (11%)
Query: 21 RGKFASVRKCTHKI-----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKS---ER 72
+G F V + + A K + R M Q++ L E ++ +
Sbjct: 31 KGHFGVVYHGEYIDQAQNRIQC--AIKSL-SRITEMQQVEAFLREGLLM----RGLNHPN 83
Query: 73 IVGLHEI--YETPHEMVLVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHD 129
++ L I V +L + G+L + + Q +D S+ Q+ + +L +
Sbjct: 84 VLALIGIMLPPEGLPHV-LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142
Query: 130 HNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV-----APEVLSY 184
H DL +N +L + +K+ DFG++R + D + A E L
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 185 EPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
+ +D+WS GVL + LL+ P+ + + ++Q
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 3e-12
Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 4/121 (3%)
Query: 105 QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV--N 162
+D + + Y Q+ + + FL H DL +NILL++ N +K+CDFG++R + +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 163 DVVEVKEIIGTP-DYVAPEVLSYEPISLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFL 220
K P ++APE + ++ +D+WS GVL + + S SP+ G E F
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306
Query: 221 N 221
Sbjct: 307 R 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-11
Identities = 39/137 (28%), Positives = 67/137 (48%), Gaps = 17/137 (12%)
Query: 85 EMVLVLEMVPDGELQR-LVDIQDGIPEQD--TRSYMKQILEA---LAFLHDHNITHLDLK 138
EM+L+ + + +G L+R L R ++ + A L +LH I H D+K
Sbjct: 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR--LEICIGAARGLHYLHTRAIIHRDVK 166
Query: 139 PQNILLTKDNNIKLCDFGISRVVNDVVE------VKEIIGTPDYVAPEVLSYEPISLATD 192
NILL ++ K+ DFGIS+ ++ + VK GT Y+ PE ++ +D
Sbjct: 167 SINILLDENFVPKITDFGISKKGTELDQTHLSTVVK---GTLGYIDPEYFIKGRLTEKSD 223
Query: 193 MWSVGVLAYVLLSSHSP 209
++S GV+ + +L + S
Sbjct: 224 VYSFGVVLFEVLCARSA 240
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-11
Identities = 36/178 (20%), Positives = 71/178 (39%), Gaps = 35/178 (19%)
Query: 50 SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQ---------- 99
D+ + ++ E ++ + E IV L ++++ E G+L
Sbjct: 89 HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVL 148
Query: 100 ----RLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDF 155
+D + Q+ + +AFL N H D+ +N+LLT + K+ DF
Sbjct: 149 ETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDF 208
Query: 156 GISRVVNDVVEVKEIIGTPDYV------------APEVLSYEPISLATDMWSVGVLAY 201
G++R +I+ +Y+ APE + ++ +D+WS G+L +
Sbjct: 209 GLAR---------DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 257
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-11
Identities = 39/185 (21%), Positives = 68/185 (36%), Gaps = 41/185 (22%)
Query: 46 KRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQ------ 99
K + + + ++ E VL IV L +++ E G+L
Sbjct: 62 KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 100 ------------RLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD 147
+ D + + +D S+ Q+ + +AFL N H DL +NILLT
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181
Query: 148 NNIKLCDFGISRVVNDVVEVKEIIGTPDY-------------VAPEVLSYEPISLATDMW 194
K+CDFG++R + + +APE + + +D+W
Sbjct: 182 RITKICDFGLARDIKND----------SNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 195 SVGVL 199
S G+
Sbjct: 232 SYGIF 236
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-11
Identities = 38/174 (21%), Positives = 71/174 (40%), Gaps = 28/174 (16%)
Query: 50 SMDQMQDILHEAAVLYLAQKSERIVGLH---EIYETPHEMVLVLEMVPDGELQ------- 99
+ + + ++ E +L +V L P +++++E G L
Sbjct: 70 THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP--LMVIVEFCKFGNLSTYLRSKR 127
Query: 100 ---------RLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNI 150
+D + + Y Q+ + + FL H DL +NILL++ N +
Sbjct: 128 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 187
Query: 151 KLCDFGISRVV--NDVVEVKEIIGTPDYV---APEVLSYEPISLATDMWSVGVL 199
K+CDFG++R + + K P + APE + ++ +D+WS GVL
Sbjct: 188 KICDFGLARDIYKDPDYVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVL 239
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-11
Identities = 37/179 (20%), Positives = 74/179 (41%), Gaps = 39/179 (21%)
Query: 50 SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQ---------- 99
+ + D++ E ++ + K + I+ L + +++E G L+
Sbjct: 80 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 100 ------RLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLC 153
++ + +D S Q+ + +L H DL +N+L+T++N +K+
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 154 DFGISRVVNDVVEVKEIIGTPDY-------------VAPEVLSYEPISLATDMWSVGVL 199
DFG++R +N++ DY +APE L + +D+WS GVL
Sbjct: 200 DFGLARDINNI----------DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 248
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-11
Identities = 37/179 (20%), Positives = 74/179 (41%), Gaps = 39/179 (21%)
Query: 50 SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQ---------- 99
+ + D++ E ++ + K + I+ L + +++E G L+
Sbjct: 126 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 185
Query: 100 ------RLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLC 153
++ + +D S Q+ + +L H DL +N+L+T++N +K+
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 245
Query: 154 DFGISRVVNDVVEVKEIIGTPDY-------------VAPEVLSYEPISLATDMWSVGVL 199
DFG++R +N++ DY +APE L + +D+WS GVL
Sbjct: 246 DFGLARDINNI----------DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 294
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-11
Identities = 37/179 (20%), Positives = 74/179 (41%), Gaps = 39/179 (21%)
Query: 50 SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQ---------- 99
+ + D++ E ++ + K + I+ L + +++E G L+
Sbjct: 114 TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 173
Query: 100 ------RLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLC 153
+ ++ + +D S Q+ + +L H DL +N+L+T+DN +K+
Sbjct: 174 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 233
Query: 154 DFGISRVVNDVVEVKEIIGTPDY-------------VAPEVLSYEPISLATDMWSVGVL 199
DFG++R ++ + DY +APE L + +D+WS GVL
Sbjct: 234 DFGLARDIHHI----------DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 282
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-10
Identities = 32/154 (20%), Positives = 64/154 (41%), Gaps = 27/154 (17%)
Query: 88 LVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK 146
+VL + G+L+ + + +D + Q+ + + FL H DL +N +L +
Sbjct: 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE 227
Query: 147 DNNIKLCDFGISRVVNDVVEVKEIIGTPDYV---------------APEVLSYEPISLAT 191
+K+ DFG++R + D ++ A E L + + +
Sbjct: 228 KFTVKVADFGLARDMYDK----------EFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 277
Query: 192 DMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
D+WS GVL + L++ P+ N + + + Q
Sbjct: 278 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-10
Identities = 44/199 (22%), Positives = 75/199 (37%), Gaps = 24/199 (12%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
G F + T E A K + + + E+ + + Q I +
Sbjct: 18 GSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 80 YETPHEMVLVLEMV-PDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDL 137
V+V+E++ P L+ L + + Q++ + ++H N H D+
Sbjct: 74 GAEGDYNVMVMELLGPS--LEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDV 131
Query: 138 KPQNILL---TKDNNIKLCDFGISRVVND--------VVEVKEIIGTPDYVAPEV-LSYE 185
KP N L+ K N + + DFG+++ D E K + GT Y + L E
Sbjct: 132 KPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE 191
Query: 186 PISLATDMWSVGVLAYVLL 204
S D+ S L YVL+
Sbjct: 192 Q-SRRDDLES---LGYVLM 206
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 59.3 bits (143), Expect = 2e-10
Identities = 45/199 (22%), Positives = 80/199 (40%), Gaps = 24/199 (12%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
G F + T+ T E A K + + +L+E+ + + Q I +
Sbjct: 16 GSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWF 71
Query: 80 YETPHEMVLVLEMV-PDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDL 137
VLV++++ P L+ L + + + Q++ + F+H + H D+
Sbjct: 72 GVEGDYNVLVMDLLGPS--LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
Query: 138 KPQNILL---TKDNNIKLCDFGISRVVNDVV--------EVKEIIGTPDYVAPEV-LSYE 185
KP N L+ + N + + DFG+++ D E K + GT Y + L E
Sbjct: 130 KPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE 189
Query: 186 PISLATDMWSVGVLAYVLL 204
S D+ S L YVL+
Sbjct: 190 Q-SRRDDLES---LGYVLM 204
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-10
Identities = 31/120 (25%), Positives = 55/120 (45%), Gaps = 10/120 (8%)
Query: 88 LVLEMVPDGELQR-LVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK 146
+VL + G+L+ + + +D + Q+ + + +L H DL +N +L +
Sbjct: 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDE 163
Query: 147 DNNIKLCDFGISRVVND----VVEVKEIIGTPDYV---APEVLSYEPISLATDMWSVGVL 199
+K+ DFG++R + D V K P V A E L + + +D+WS GVL
Sbjct: 164 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLP--VKWMALESLQTQKFTTKSDVWSFGVL 221
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-10
Identities = 42/169 (24%), Positives = 63/169 (37%), Gaps = 22/169 (13%)
Query: 50 SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQ---------- 99
S D +D E VL I+ L E + L +E P G L
Sbjct: 65 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 124
Query: 100 ------RLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLC 153
+ Q + + + +L H DL +NIL+ ++ K+
Sbjct: 125 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184
Query: 154 DFGISRVVNDVVEVKEIIGTPDYV---APEVLSYEPISLATDMWSVGVL 199
DFG+SR +V K + P V A E L+Y + +D+WS GVL
Sbjct: 185 DFGLSR-GQEVYVKKTMGRLP--VRWMAIESLNYSVYTTNSDVWSYGVL 230
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 29/129 (22%), Positives = 48/129 (37%), Gaps = 21/129 (16%)
Query: 83 PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNI 142
+ + + D S+ QI + + +L + + H DL +NI
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI 181
Query: 143 LLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYV------------APEVLSYEPISLA 190
L+ + +K+ DFG+SR V + YV A E L +
Sbjct: 182 LVAEGRKMKISDFGLSRDVYE---------EDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 191 TDMWSVGVL 199
+D+WS GVL
Sbjct: 233 SDVWSFGVL 241
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-10
Identities = 38/210 (18%), Positives = 74/210 (35%), Gaps = 44/210 (20%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
G F +R + T A K + R+ + E + I ++
Sbjct: 18 GCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 80 YETPHEMVLVLEMV-PDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+VLE++ P L+ L D+ D + Q++ + ++H N+ + D+
Sbjct: 74 GPCGKYNAMVLELLGPS--LEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDV 131
Query: 138 KPQNILL-----TKDNNIKLCDFGISRVVNDVV--------EVKEIIGTPDYVAPEVLSY 184
KP+N L+ I + DF +++ D E K + GT Y+
Sbjct: 132 KPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM------- 184
Query: 185 EPISLAT----------DMWSVGVLAYVLL 204
S+ T D+ + L ++ +
Sbjct: 185 ---SINTHLGKEQSRRDDLEA---LGHMFM 208
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-10
Identities = 36/225 (16%), Positives = 68/225 (30%), Gaps = 59/225 (26%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIV----- 74
G F + + A ++ + + E K + I
Sbjct: 46 GSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPL---FSELKFYQRVAKKDCIKKWIER 102
Query: 75 --------------GLHEIYETPHEMVLVLEMV-PDGELQRLVDIQDGIPEQDTRSYMKQ 119
GL E + +V+E + D LQ++ + +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYR-FMVMERLGID--LQKISGQNGTFKKSTVLQLGIR 159
Query: 120 ILEALAFLHDHNITHLDLKPQNILL--TKDNNIKLCDFGISRVVNDVVEVKEI------- 170
+L+ L ++H++ H D+K N+LL + + L D+G+S K+
Sbjct: 160 MLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKG 219
Query: 171 -IGTPDYVAPEVLSYEPISLAT----------DMWSVGVLAYVLL 204
GT ++ SL D+ L Y +L
Sbjct: 220 HNGTIEF----------TSLDAHKGVALSRRSDVEI---LGYCML 251
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-09
Identities = 44/201 (21%), Positives = 82/201 (40%), Gaps = 26/201 (12%)
Query: 20 SRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
G F + + T+ + + A KF +R + + E L I ++
Sbjct: 19 GEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 80 YETPHEMVLVLEMV-PDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+ VLV++++ P L+ L+D+ + KQ+L + +H+ ++ + D+
Sbjct: 75 GQEGLHNVLVIDLLGPS--LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDI 132
Query: 138 KPQNILL-----TKDNNIKLCDFGISRVVNDVV--------EVKEIIGTPDYVAPEV-LS 183
KP N L+ N I + DFG+ + D V E K + GT Y++ L
Sbjct: 133 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 192
Query: 184 YEPISLATDMWSVGVLAYVLL 204
E S D+ + L +V +
Sbjct: 193 REQ-SRRDDLEA---LGHVFM 209
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-09
Identities = 35/177 (19%), Positives = 75/177 (42%), Gaps = 34/177 (19%)
Query: 46 KRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQ------ 99
SM + + L+EA+V+ +V L + ++++E++ G+L+
Sbjct: 64 NEAASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 122
Query: 100 RLVDIQDGIPEQDTR----SYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDF 155
R + + + +I + +A+L+ + H DL +N ++ +D +K+ DF
Sbjct: 123 RPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 182
Query: 156 GISRVVNDVVEVKEIIGTPDY-------------VAPEVLSYEPISLATDMWSVGVL 199
G++R + + DY ++PE L + +D+WS GV+
Sbjct: 183 GMTRDIYET----------DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 229
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-09
Identities = 35/212 (16%), Positives = 68/212 (32%), Gaps = 45/212 (21%)
Query: 25 ASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIV---------- 74
A + + K + E A K E+I
Sbjct: 54 ADMNSSESVGSDAPCVVKVEPSDNGPL------FTELKFYQRAAKPEQIQKWIRTRKLKY 107
Query: 75 ---------GLHEIYETPHEMVLVLEMV-PDGELQRLVDIQDG-IPEQDTRSYMKQILEA 123
GLH+ + ++++ D LQ++ + + +IL+
Sbjct: 108 LGVPKYWGSGLHDKNGKSYR-FMIMDRFGSD--LQKIYEANAKRFSRKTVLQLSLRILDI 164
Query: 124 LAFLHDHNITHLDLKPQNILL--TKDNNIKLCDFGISRVVNDVVEVKEI--------IGT 173
L ++H+H H D+K N+LL + + L D+G++ K GT
Sbjct: 165 LEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGT 224
Query: 174 PDYVAPEV-LSYEPISLATDMWSVGVLAYVLL 204
++ + + P S D+ L Y ++
Sbjct: 225 IEFTSIDAHNGVAP-SRRGDLEI---LGYCMI 252
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 4e-09
Identities = 42/207 (20%), Positives = 80/207 (38%), Gaps = 45/207 (21%)
Query: 50 SMDQMQDILHEAAVLYLAQKSERIVGLHEI--YETPHEMVLVLEMVPDGELQR------- 100
++ +D EA +L Q E IV + + P +++V E + G+L +
Sbjct: 57 TLAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGDP--LIMVFEYMKHGDLNKFLRAHGP 113
Query: 101 --LVDIQDGIPEQDTRSYMK-------QILEALAFLHDHNITHLDLKPQNILLTKDNNIK 151
++ + + + QI + +L + H DL +N L+ + +K
Sbjct: 114 DAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK 173
Query: 152 LCDFGISRVVNDVVEVKEIIGTPDY-------------VAPEVLSYEPISLATDMWSVGV 198
+ DFG+SR V DY + PE + Y + +D+WS GV
Sbjct: 174 IGDFGMSRDVYST----------DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 223
Query: 199 LAYVLLS-SHSPFAGDNKQETFLNISQ 224
+ + + + P+ + E I+Q
Sbjct: 224 ILWEIFTYGKQPWFQLSNTEVIECITQ 250
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-09
Identities = 26/97 (26%), Positives = 45/97 (46%), Gaps = 21/97 (21%)
Query: 115 SYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTP 174
+ Q+ + + FL + H DL +N+L+T +K+CDFG++R +
Sbjct: 176 CFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS---------DS 226
Query: 175 DYV------------APEVLSYEPISLATDMWSVGVL 199
+YV APE L ++ +D+WS G+L
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 263
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-09
Identities = 29/151 (19%), Positives = 58/151 (38%), Gaps = 24/151 (15%)
Query: 83 PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNI 142
PH + + + + + +Q+ +A+L + H DL +N
Sbjct: 146 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 205
Query: 143 LLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDY-------------VAPEVLSYEPISL 189
L+ ++ +K+ DFG+SR + DY + PE + Y +
Sbjct: 206 LVGENMVVKIADFGLSRNIYSA----------DYYKADGNDAIPIRWMPPESIFYNRYTT 255
Query: 190 ATDMWSVGVLAYVLLS-SHSPFAGDNKQETF 219
+D+W+ GV+ + + S P+ G +E
Sbjct: 256 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI 286
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-09
Identities = 42/205 (20%), Positives = 77/205 (37%), Gaps = 42/205 (20%)
Query: 50 SMDQMQDILHEAAVLYLAQ-KSERIVGLHEIYETPHEMVLVLEMVPDGEL---------- 98
S QD EA +L + + IV + +++V E + G+L
Sbjct: 83 SESARQDFQREAELL--TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPD 140
Query: 99 -QRLVDIQDGIPEQDTR----SYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLC 153
+ L +D P + Q+ + +L + H DL +N L+ + +K+
Sbjct: 141 AKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIG 200
Query: 154 DFGISRVVNDVVEVKEIIGTPDY-------------VAPEVLSYEPISLATDMWSVGVLA 200
DFG+SR + DY + PE + Y + +D+WS GV+
Sbjct: 201 DFGMSRDIYST----------DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 250
Query: 201 YVLLS-SHSPFAGDNKQETFLNISQ 224
+ + + P+ + E I+Q
Sbjct: 251 WEIFTYGKQPWYQLSNTEAIDCITQ 275
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-08
Identities = 32/120 (26%), Positives = 53/120 (44%), Gaps = 24/120 (20%)
Query: 119 QILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDY-- 176
QI + +L H++ H DL +N+L+ N+K+ D G+ R V DY
Sbjct: 136 QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA----------DYYK 185
Query: 177 -----------VAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224
+APE + Y S+ +D+WS GV+ + + S P+ G + Q+ I
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 245
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-08
Identities = 40/206 (19%), Positives = 72/206 (34%), Gaps = 41/206 (19%)
Query: 46 KRRRSMDQMQDILHEAAVLYLAQKS---ERIVGLHEIYETPHEMVLVLEMVPDGELQ--- 99
S D L EA ++ + IV + +++E++ G+L+
Sbjct: 69 PEVCSEQDELDFLMEALII----SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL 124
Query: 100 ---RLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK---DNNIKL 152
R Q + D + I +L +++ H D+ +N LLT K+
Sbjct: 125 RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184
Query: 153 CDFGISRVVNDVVEVKEIIGTPDY-------------VAPEVLSYEPISLATDMWSVGVL 199
DFG++R + Y + PE + TD WS GVL
Sbjct: 185 GDFGMARDIYRA----------SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 234
Query: 200 AYVLLS-SHSPFAGDNKQETFLNISQ 224
+ + S + P+ + QE ++
Sbjct: 235 LWEIFSLGYMPYPSKSNQEVLEFVTS 260
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-08
Identities = 41/197 (20%), Positives = 70/197 (35%), Gaps = 41/197 (20%)
Query: 50 SMDQMQDILHEAAVLYLAQKS---ERIVGLHEIYETPHEMVLVLEMVPDGELQ------R 100
S D L EA ++ + IV + ++LE++ G+L+ R
Sbjct: 114 SEQDELDFLMEALII----SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 169
Query: 101 LVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK---DNNIKLCDFG 156
Q + D + I +L +++ H D+ +N LLT K+ DFG
Sbjct: 170 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229
Query: 157 ISRVVNDVVEVKEIIGTPDY-------------VAPEVLSYEPISLATDMWSVGVLAYVL 203
++R + Y + PE + TD WS GVL + +
Sbjct: 230 MARDIYRA----------GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279
Query: 204 LS-SHSPFAGDNKQETF 219
S + P+ + QE
Sbjct: 280 FSLGYMPYPSKSNQEVL 296
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 50.3 bits (119), Expect = 2e-07
Identities = 23/138 (16%), Positives = 42/138 (30%), Gaps = 14/138 (10%)
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLK 138
+ ++ +VLE G + + +S + Q+ +LA H DL
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLAT-AKSILHQLTASLAVAEASLRFEHRDLH 189
Query: 139 PQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
N+LL K + KL + I + + +L+ V
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSST--------IPSCGLQVSII----DYTLSRLERDGIV 237
Query: 199 LAYVLLSSHSPFAGDNKQ 216
+ + F GD
Sbjct: 238 VFCDVSMDEDLFTGDGDY 255
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-07
Identities = 21/107 (19%), Positives = 39/107 (36%), Gaps = 33/107 (30%)
Query: 118 KQILEALAFLHDHNITHLDLKPQNILL--TKDNNIKLCDFGIS---RVVNDVVEVKE--- 169
++L+AL FLH++ H ++ +NI + + + L +G + V E
Sbjct: 166 CRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSR 225
Query: 170 --IIGTPDYVAPEVLSYEPISLAT----------DMWSVGVLAYVLL 204
G ++ IS+ D+ S L Y +L
Sbjct: 226 SPHEGDLEF----------ISMDLHKGCGPSRRSDLQS---LGYCML 259
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-05
Identities = 14/85 (16%), Positives = 37/85 (43%), Gaps = 11/85 (12%)
Query: 82 TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQN 141
+++ + + +++ D +I E + LH +++ H DL N
Sbjct: 410 DLDNKRIMMSYINGKLAKDVIE--------DNLDIAYKIGEIVGKLHKNDVIHNDLTTSN 461
Query: 142 ILLTKDNNIKLCDFGISRVVNDVVE 166
+ D ++ + DFG+ + ++++ E
Sbjct: 462 FIF--DKDLYIIDFGLGK-ISNLDE 483
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 39.7 bits (92), Expect = 4e-04
Identities = 37/175 (21%), Positives = 63/175 (36%), Gaps = 26/175 (14%)
Query: 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKIT--KVEYAAKFIRKRRRSMDQMQDILHEAAV 63
GY T + + S GK A+V V A K R D+M + L+
Sbjct: 42 LSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDER 101
Query: 64 LYLAQKSERIVG----------LHEIYE----TPH-----EMVLVLEMVPDGEL--QRLV 102
+ + S + L E P + VL++E + + EL LV
Sbjct: 102 FDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLV 161
Query: 103 DIQDGIPEQDTRSYMKQILEALAFLH-DHNITHLDLKPQNILLTKDNNIKLCDFG 156
++ + E D ++E + L+ + + H DL NI+ + + D G
Sbjct: 162 ELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMY--IDKVYFIDMG 214
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 253 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.51 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.25 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.1 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.88 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.88 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.73 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.59 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.41 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.38 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.31 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.28 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.22 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.17 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.1 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.95 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.86 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.69 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.62 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.59 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.58 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.53 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.47 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.45 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.17 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.1 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.85 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.04 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.92 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.87 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 92.17 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 81.76 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-60 Score=380.73 Aligned_cols=238 Identities=28% Similarity=0.499 Sum_probs=217.1
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
++|+ +++.||+|+||+||+|.++.+++.||+|++.+... .......+.+|+.++. .++||||+++++++++++.+|
T Consensus 32 ~dy~--i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 32 EDFK--FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS-RLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp GGEE--EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEE
T ss_pred cccE--EEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEEeCCEEE
Confidence 4466 99999999999999999999999999999986542 2334568899999998 779999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc---
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV--- 164 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~--- 164 (253)
+||||++||+|.+++...+.+++..++.++.|++.|+.|||++||+||||||+||+++.+|.+||+|||+++.....
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
......+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+.+.+|......++. .+|+++++|
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dl 264 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFFPKARDL 264 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TCCHHHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----ccCHHHHHH
Confidence 2344568999999999999999999999999999999999999999999999999999988877665 789999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||++||
T Consensus 265 i~~lL~~dp 273 (311)
T 4aw0_A 265 VEKLLVLDA 273 (311)
T ss_dssp HHHHSCSSG
T ss_pred HHHHccCCH
Confidence 999999998
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-59 Score=381.69 Aligned_cols=239 Identities=28% Similarity=0.438 Sum_probs=210.5
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +++.||+|+||+||+|.+..+|+.||+|++.+........+.+.+|+.++. .++||||+++++++.+++.+|+
T Consensus 24 e~Y~--~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~-~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 24 EKYV--RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLA-NMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCEE--EEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEE
T ss_pred cceE--EeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHH-HCCCCCCCcEEEEEEECCEEEE
Confidence 3555 999999999999999999999999999999887766677788999999998 7799999999999999999999
Q ss_pred EEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-
Q psy12709 89 VLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV- 165 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~- 165 (253)
||||++|++|.+++..+ ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++......
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 99999999999999654 347999999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
.....+|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.++..+..++.. ..+|+++++||
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~---~~~s~~~~~li 257 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVS---LHYSYDLRSLV 257 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC---TTSCHHHHHHH
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCC---ccCCHHHHHHH
Confidence 234567999999999999999999999999999999999999999999999999998887664332 47899999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
.+||++||
T Consensus 258 ~~~L~~dP 265 (350)
T 4b9d_A 258 SQLFKRNP 265 (350)
T ss_dssp HHHTCSSG
T ss_pred HHHccCCh
Confidence 99999998
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-59 Score=368.01 Aligned_cols=237 Identities=32% Similarity=0.553 Sum_probs=199.0
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
++|+ +++.||+|+||+||+|.+..+++.||+|++.+... .......+.+|+..++ .++||||+++++++..++.++
T Consensus 13 g~Y~--i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~~~~~~~~~~~~~ 89 (275)
T 3hyh_A 13 GNYQ--IVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLR-LLRHPHIIKLYDVIKSKDEII 89 (275)
T ss_dssp -CCE--EEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEE
T ss_pred eCeE--EEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHH-HCCCCCCCeEEEEEEECCEEE
Confidence 5677 99999999999999999999999999999986543 2333567889999998 779999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV 167 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 167 (253)
+||||+ +++|.+++..+..+++.+++.++.|++.|++|||++|++||||||+||+++.++.+||+|||+++........
T Consensus 90 ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~ 168 (275)
T 3hyh_A 90 MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 168 (275)
T ss_dssp EEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCcc
Confidence 999999 6799999888888999999999999999999999999999999999999999999999999999877665555
Q ss_pred cccccCccccCccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLSYEPI-SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~ 246 (253)
....|++.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+..+.+..+..+....+. .+|+++++||.
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~ 244 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIK 244 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TSCHHHHHHHH
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHH
Confidence 66789999999999998876 57999999999999999999999999999999988887776654 78999999999
Q ss_pred HhcccCC
Q psy12709 247 SCLVTDP 253 (253)
Q Consensus 247 ~~l~~dP 253 (253)
+||++||
T Consensus 245 ~~L~~dP 251 (275)
T 3hyh_A 245 RMLIVNP 251 (275)
T ss_dssp HHSCSSG
T ss_pred HHccCCh
Confidence 9999998
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-59 Score=374.40 Aligned_cols=239 Identities=27% Similarity=0.461 Sum_probs=207.4
Q ss_pred ecceeeEEEeecCCCCceEEEEEEec---cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHK---ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
.+.|+ +++.||+|+||+||+|.+. .+++.||+|++.+..........+.+|+.++. .++||||+++++++.+++
T Consensus 23 p~~Y~--i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 23 PSQFE--LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV-EVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp GGGEE--EEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCC-CCCCTTEECEEEEEEETT
T ss_pred ccccE--EEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHH-HCCCCCCCeEEEEEEECC
Confidence 34555 9999999999999999874 46788999999876533333446778888887 779999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc-
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND- 163 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~- 163 (253)
.+|+||||++|++|.+++.....+++..++.++.|++.|+.|||++|++||||||+||+++.+|.+||+|||+++....
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 9999999999999999999888899999999999999999999999999999999999999999999999999986433
Q ss_pred cccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
.......+|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+.+.++......++. .+|+++++
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~ 255 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQS 255 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHH
T ss_pred CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----cCCHHHHH
Confidence 33345568999999999999999999999999999999999999999999999999999887776654 78999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
||.+||++||
T Consensus 256 li~~~L~~dP 265 (304)
T 3ubd_A 256 LLRMLFKRNP 265 (304)
T ss_dssp HHHHHTCSSG
T ss_pred HHHHHcccCH
Confidence 9999999998
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-58 Score=371.18 Aligned_cols=236 Identities=25% Similarity=0.399 Sum_probs=210.5
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++++.||+|+||+||+|.++.+|+.||+|++....... .+.+.+|+.++. .++||||+++++++..++.+|+||||
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~-~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMR-DYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHH-hCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 449999999999999999999999999999997654332 346788999998 77999999999999999999999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-ccccccc
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEVKEII 171 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~ 171 (253)
++||+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++...... ......+
T Consensus 153 ~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~ 231 (346)
T 4fih_A 153 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 231 (346)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccc
Confidence 999999999875 56999999999999999999999999999999999999999999999999999876443 3445678
Q ss_pred cCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhccc
Q psy12709 172 GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251 (253)
Q Consensus 172 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (253)
|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+.+..+..... +.......+|+++++||.+||++
T Consensus 232 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~dli~~~L~~ 310 (346)
T 4fih_A 232 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKGFLDRLLVR 310 (346)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHHHHHHHHSCS
T ss_pred cCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHHHHHHHHcCC
Confidence 99999999999999999999999999999999999999999999888888776543 22333457899999999999999
Q ss_pred CC
Q psy12709 252 DP 253 (253)
Q Consensus 252 dP 253 (253)
||
T Consensus 311 dP 312 (346)
T 4fih_A 311 DP 312 (346)
T ss_dssp ST
T ss_pred Ch
Confidence 98
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=372.42 Aligned_cols=236 Identities=25% Similarity=0.399 Sum_probs=210.4
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++++.||+|+||+||+|.++.+|+.||+|++....... .+.+.+|+.+++ .++||||+++++++..++.+|+||||
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~-~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMR-DYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHH-hCCCCCCCceEEEEEECCEEEEEEeC
Confidence 449999999999999999999999999999997654332 346789999998 77999999999999999999999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-ccccccc
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEVKEII 171 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~ 171 (253)
|+||+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+||+++.+|.+||+|||++...... ......+
T Consensus 230 ~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~ 308 (423)
T 4fie_A 230 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 308 (423)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCE
T ss_pred CCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccc
Confidence 999999999874 45999999999999999999999999999999999999999999999999999876443 3445678
Q ss_pred cCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhccc
Q psy12709 172 GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251 (253)
Q Consensus 172 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (253)
|++.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..+..... +.......+|+++++||.+||++
T Consensus 309 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~dli~~~L~~ 387 (423)
T 4fie_A 309 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKGFLDRLLVR 387 (423)
T ss_dssp ECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHHHHHHHHHHSCS
T ss_pred cCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHHHHHHHHHHcCC
Confidence 99999999999999999999999999999999999999999999888888776543 22333457899999999999999
Q ss_pred CC
Q psy12709 252 DP 253 (253)
Q Consensus 252 dP 253 (253)
||
T Consensus 388 dP 389 (423)
T 4fie_A 388 DP 389 (423)
T ss_dssp ST
T ss_pred Ch
Confidence 98
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-57 Score=366.33 Aligned_cols=232 Identities=26% Similarity=0.343 Sum_probs=204.5
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|++.++||+|+||+||+|.++.+|+.||+|+++..... .+|+.++. .++||||+++++++.+++.+|+||||
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~-~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACA-GLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTT-TCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHH-hCCCCCCCcEEEEEEECCEEEEEEec
Confidence 55999999999999999999999999999999865432 35888887 78999999999999999999999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-ceEEEeecccccccccc------
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN-NIKLCDFGISRVVNDVV------ 165 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~-~~~l~df~~~~~~~~~~------ 165 (253)
++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.+| .+||+|||+++......
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 99999999999888899999999999999999999999999999999999999987 69999999998654321
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
.....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+...++.....+. ....+.+|++++++|
T Consensus 212 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~s~~~~~li 290 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI-REIPPSCAPLTAQAI 290 (336)
T ss_dssp --CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGG-GGSCTTSCHHHHHHH
T ss_pred cCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCc-hhcCccCCHHHHHHH
Confidence 1123479999999999999999999999999999999999999999988888888877765433 234568999999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
.+||++||
T Consensus 291 ~~~L~~dP 298 (336)
T 4g3f_A 291 QEGLRKEP 298 (336)
T ss_dssp HHHTCSSG
T ss_pred HHHccCCH
Confidence 99999998
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-56 Score=354.12 Aligned_cols=235 Identities=25% Similarity=0.379 Sum_probs=203.7
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe----CCeEEEE
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET----PHEMVLV 89 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv 89 (253)
.+.+.||+|+||+||+|.+..++..||+|++..........+.+.+|+.++. .++||||+++++++.. ++.+++|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~-~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK-GLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 3778999999999999999999999999999887766677788999999998 7899999999999875 3468999
Q ss_pred EeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEcC-CCceEEEeeccccccccccc
Q psy12709 90 LEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHN--ITHLDLKPQNILLTK-DNNIKLCDFGISRVVNDVVE 166 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~di~~~ni~~~~-~~~~~l~df~~~~~~~~~~~ 166 (253)
|||++|++|.+++.....+++..++.++.|++.|+.|||++| |+||||||+||+++. +|.+||+|||+++.... ..
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-~~ 186 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SF 186 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-TS
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-Cc
Confidence 999999999999998888999999999999999999999999 999999999999985 79999999999975443 33
Q ss_pred ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 167 VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNK-QETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
....+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+. ...+..+.....+ .......++++++||
T Consensus 187 ~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~li 263 (290)
T 3fpq_A 187 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIPEVKEII 263 (290)
T ss_dssp BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCCHHHHHHH
T ss_pred cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC--CCCCccCCHHHHHHH
Confidence 445689999999999875 699999999999999999999999977554 4445555544332 223357899999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
.+||++||
T Consensus 264 ~~~L~~dP 271 (290)
T 3fpq_A 264 EGCIRQNK 271 (290)
T ss_dssp HHHSCSSG
T ss_pred HHHccCCh
Confidence 99999998
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=353.71 Aligned_cols=239 Identities=20% Similarity=0.334 Sum_probs=205.9
Q ss_pred cceeeEEEeecCCCCceEEEEEEec-----cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHK-----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
.+..|.+.+.||+|+||+||+|.+. .++..||||+++.. .....+.+.+|+..+. .++||||+++++++.++
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~-~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLT-NLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHT-TCCCTTBCCEEEEECSS
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHH-hCCCCCCccEEEEEeeC
Confidence 3445559999999999999999865 35788999999754 3445678999999998 77999999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCce
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQ-------------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNI 150 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~-------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~ 150 (253)
+.+++||||+++|+|.+++... ..+++..+..++.|++.|+.|||+++++||||||+||+++.++.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 9999999999999999999753 358999999999999999999999999999999999999999999
Q ss_pred EEEeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhccc
Q psy12709 151 KLCDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCN 226 (253)
Q Consensus 151 ~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~ 226 (253)
||+|||+++...... ......+++.|+|||++.+..++.++||||+|+++|||+| |+.||.+.+..+....+..+.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999998654332 2223468899999999999999999999999999999998 999999999999988888766
Q ss_pred ccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 227 FSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 227 ~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..... ..+|+++.+||.+||+.||
T Consensus 248 ~~~~p---~~~~~~~~~li~~cl~~dP 271 (299)
T 4asz_A 248 VLQRP---RTCPQEVYELMLGCWQREP 271 (299)
T ss_dssp CCCCC---TTCCHHHHHHHHHHTCSSG
T ss_pred CCCCC---ccchHHHHHHHHHHcCCCh
Confidence 43322 4789999999999999998
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-54 Score=345.59 Aligned_cols=238 Identities=21% Similarity=0.378 Sum_probs=198.0
Q ss_pred eeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEE
Q psy12709 11 YQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVL 90 (253)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 90 (253)
-++++.+.||+|+||+||+|..+ ..||||+++.........+.+.+|+..+. .++||||+++++++.. +.+++||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~-~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLR-KTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEC-CeEEEEE
Confidence 34559999999999999999865 36999999877766777889999999998 7899999999998764 5689999
Q ss_pred eccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc---ccc
Q psy12709 91 EMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND---VVE 166 (253)
Q Consensus 91 e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~---~~~ 166 (253)
||++||+|.+++... ..+++..+..++.|++.|++|||+++|+||||||+||+++.++.+||+|||+++.... ...
T Consensus 111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 999999999998654 5699999999999999999999999999999999999999999999999999986543 223
Q ss_pred ccccccCccccCccccCC---CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc--CCccCCCCHHH
Q psy12709 167 VKEIIGTPDYVAPEVLSY---EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH--EDLFGHISSQA 241 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~~l 241 (253)
.....|++.|+|||++.+ .+++.++||||+||++|||+||+.||.+.+.......+.......+ ......+|+++
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l 270 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAM 270 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHH
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHH
Confidence 345679999999999854 3589999999999999999999999988766655544433332222 33456789999
Q ss_pred HHHHHHhcccCC
Q psy12709 242 KDFIQSCLVTDP 253 (253)
Q Consensus 242 ~~li~~~l~~dP 253 (253)
.+||.+||+.||
T Consensus 271 ~~li~~cl~~dP 282 (307)
T 3omv_A 271 KRLVADCVKKVK 282 (307)
T ss_dssp HHHHHHHTCSSS
T ss_pred HHHHHHHcCCCH
Confidence 999999999998
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-54 Score=347.95 Aligned_cols=238 Identities=19% Similarity=0.305 Sum_probs=200.1
Q ss_pred ceeeEEEeecCCCCceEEEEEEec-----cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHK-----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
+..+.+.++||+|+||+||+|... .++..||||+++.. .....+.+.+|+..+. .++||||+++++++.+++
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~-~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLT-MLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHT-TCCCTTBCCEEEEECSSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEEECC
Confidence 344559999999999999999864 46788999999753 3455678999999998 779999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQ---------------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN 149 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~ 149 (253)
.+++||||+++|+|.+++... .++++.++..++.|++.|+.|||+++++||||||+||+++.++.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc
Confidence 999999999999999998653 35899999999999999999999999999999999999999999
Q ss_pred eEEEeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcc
Q psy12709 150 IKLCDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQC 225 (253)
Q Consensus 150 ~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~ 225 (253)
+||+|||+++...... ......+++.|+|||++.+..++.++||||+|+++|||+| |+.||.+.+..+....+..+
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g 276 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999998654322 2234568999999999999999999999999999999999 99999999998888888776
Q ss_pred cccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 226 NFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 226 ~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..... ...+|+++.+|+.+||+.||
T Consensus 277 ~~~~~---p~~~~~~~~~li~~cl~~dP 301 (329)
T 4aoj_A 277 RELER---PRACPPEVYAIMRGCWQREP 301 (329)
T ss_dssp CCCCC---CTTCCHHHHHHHHHHCCSST
T ss_pred CCCCC---cccccHHHHHHHHHHcCcCh
Confidence 43322 24789999999999999998
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-54 Score=346.33 Aligned_cols=237 Identities=19% Similarity=0.316 Sum_probs=204.5
Q ss_pred eeEEEeecCCCCceEEEEEEec-----cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHK-----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
++++.+.||+|+||+||+|... .++..||||.++.... ....+.+.+|+..+. .++||||+++++++..++.+
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~-~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRA-RLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHH-HCCCTTBCCEEEEECSSSSC
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHH-hCCCCCCCCcceEEEECCEE
Confidence 4449999999999999999853 4678899999975432 334567889999998 77999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCce
Q psy12709 87 VLVLEMVPDGELQRLVDIQ----------------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNI 150 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~ 150 (253)
++||||+++|+|.+++..+ ..+++..+..++.|++.|++|||+++++||||+|+||+++.++.+
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCE
Confidence 9999999999999998542 358999999999999999999999999999999999999999999
Q ss_pred EEEeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhccc
Q psy12709 151 KLCDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCN 226 (253)
Q Consensus 151 ~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~ 226 (253)
||+|||+++...... ......+++.|+|||++.+..++.++||||+|+++|||+| |..||.+.+..+....+..+.
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~ 264 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ 264 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTC
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999998654322 2334578899999999999999999999999999999998 899999999999988887765
Q ss_pred ccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 227 FSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 227 ~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+.. ..+|+++.+|+.+||+.||
T Consensus 265 ~~~~p---~~~~~~~~~li~~C~~~dP 288 (308)
T 4gt4_A 265 VLPCP---DDCPAWVYALMIECWNEFP 288 (308)
T ss_dssp CCCCC---TTCCHHHHHHHHHHTCSSG
T ss_pred CCCCc---ccchHHHHHHHHHHcCCCh
Confidence 54332 4789999999999999998
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=354.31 Aligned_cols=243 Identities=23% Similarity=0.384 Sum_probs=210.3
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe----
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET---- 82 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~---- 82 (253)
++++|+ +++.||+|+||+||+|.++.+|+.||||++++........+.+.+|+.+++ .++||||+++++++..
T Consensus 52 i~~~Y~--~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~ 128 (398)
T 4b99_A 52 VGDEYE--IIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILK-HFKHDNIIAIKDILRPTVPY 128 (398)
T ss_dssp CCSSEE--EEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHH-HCCCTTBCCEEEECCCSSCT
T ss_pred CCCCeE--EEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHH-hcCCCCcceEeeeeeccccc
Confidence 445666 999999999999999999999999999999887766666788899999998 7799999999999764
Q ss_pred --CCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 83 --PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 83 --~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
.+.+|+||||++ ++|.+++..+.++++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++.
T Consensus 129 ~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 129 GEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred ccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 357999999996 57999998888899999999999999999999999999999999999999999999999999986
Q ss_pred cccc-----ccccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCC--
Q psy12709 161 VNDV-----VEVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHED-- 232 (253)
Q Consensus 161 ~~~~-----~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~-- 232 (253)
.... ......+|++.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+.+..|......++..
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 5322 223456899999999998765 56899999999999999999999999999998888876654443321
Q ss_pred -------------------------ccCCCCHHHHHHHHHhcccCC
Q psy12709 233 -------------------------LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 -------------------------~~~~~~~~l~~li~~~l~~dP 253 (253)
..+.+|+++.+||.+||+.||
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP 333 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEP 333 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSST
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCCh
Confidence 234679999999999999998
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=362.24 Aligned_cols=240 Identities=36% Similarity=0.662 Sum_probs=219.8
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +++.||+|+||+||+|.++.+|+.||+|++.... ......+.+|+.++. .++||||+++++++..++.+++
T Consensus 157 ~~Y~--i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 157 DHYD--IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMS-VLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GTEE--EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHH-HTCCTTBCCEEEEEECSSEEEE
T ss_pred cccE--EEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHH-hCCCCCCCeEEEEEEECCEEEE
Confidence 4555 9999999999999999999999999999987644 333567889999998 7799999999999999999999
Q ss_pred EEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC--CceEEEeecccccccccc
Q psy12709 89 VLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD--NNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~--~~~~l~df~~~~~~~~~~ 165 (253)
+|||++||+|.+++.. ...+++.+++.++.|++.||.|||++|++||||+|+||+++.+ +.+||+|||++.......
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 9999999999998864 4579999999999999999999999999999999999999864 899999999999877666
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
.....+|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+.+..|......++......+|+++++||
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli 391 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 391 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHH
T ss_pred ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 66667899999999999999999999999999999999999999999999999999999888888877789999999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
.+||+.||
T Consensus 392 ~~~L~~dp 399 (573)
T 3uto_A 392 RKLLLADP 399 (573)
T ss_dssp HTTSCSSG
T ss_pred HHHccCCh
Confidence 99999998
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=359.91 Aligned_cols=240 Identities=25% Similarity=0.421 Sum_probs=202.0
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch-HHHHHHHHHHHHH--HHhcCCCCceeeeeEEEeC
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM-DQMQDILHEAAVL--YLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~--~~~~~~~~i~~~~~~~~~~ 83 (253)
..++|+ +++.||+|+||+||+|.++.+|+.||+|++.+..... .......+|...+ ....+||||++++++|.++
T Consensus 187 slddf~--i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 187 TMNDFS--VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CGGGEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred chHHeE--EEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 345676 9999999999999999999999999999997654211 1122333333322 2256899999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
+.+|+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.....
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999987654
Q ss_pred cccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHhhcccccccCCccCCCCH
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDN---KQETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
. .....+|++.|+|||++.. ..++.++|+|||||++|+|++|+.||.+.+ ..+....+.......+. .+|+
T Consensus 345 ~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~----~~S~ 419 (689)
T 3v5w_A 345 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----SFSP 419 (689)
T ss_dssp C-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCT----TSCH
T ss_pred C-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCc----cCCH
Confidence 3 3345689999999999964 579999999999999999999999997643 33445555555555444 7899
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
++++||.+||++||
T Consensus 420 ~a~dLI~~lL~~dP 433 (689)
T 3v5w_A 420 ELRSLLEGLLQRDV 433 (689)
T ss_dssp HHHHHHHHHTCSCG
T ss_pred HHHHHHHHHccCCH
Confidence 99999999999998
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=335.37 Aligned_cols=233 Identities=24% Similarity=0.365 Sum_probs=184.7
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC--------
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH-------- 84 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-------- 84 (253)
|++++.||+|+||+||+|.++.+++.||+|++..... ....+.+.+|+..+. .++||||+++++++...+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~E~~il~-~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALA-KLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS-HHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEEEC--------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC-HHHHHHHHHHHHHHH-hCCCCCCCeEEEEEEecCcccccccc
Confidence 4499999999999999999999999999999976543 344567889999998 779999999999997654
Q ss_pred ----eEEEEEeccCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecc
Q psy12709 85 ----EMVLVLEMVPDGELQRLVDIQDG---IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI 157 (253)
Q Consensus 85 ----~~~lv~e~~~g~~L~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~ 157 (253)
.+|++|||++|++|.+++..+.. .+...++.++.|++.|++|||++||+||||||+||+++.+|.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 37999999999999999986554 45567889999999999999999999999999999999999999999999
Q ss_pred ccccccccc-------------ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhh
Q psy12709 158 SRVVNDVVE-------------VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ-ETFLNIS 223 (253)
Q Consensus 158 ~~~~~~~~~-------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~i~ 223 (253)
++....... ....+||+.|+|||++.+..++.++||||+||++|+|++ ||.+.... .....+.
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~ 241 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVR 241 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHh
Confidence 986643221 123469999999999999999999999999999999996 78653322 2333344
Q ss_pred cccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 224 QCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 224 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....++ ..+..++.+.+||.+||++||
T Consensus 242 ~~~~p~---~~~~~~~~~~~li~~~L~~dP 268 (299)
T 4g31_A 242 NLKFPP---LFTQKYPCEYVMVQDMLSPSP 268 (299)
T ss_dssp TTCCCH---HHHHHCHHHHHHHHHHTCSSG
T ss_pred cCCCCC---CCcccCHHHHHHHHHHcCCCh
Confidence 333322 223567889999999999998
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=341.12 Aligned_cols=240 Identities=20% Similarity=0.314 Sum_probs=200.1
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccC-----CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC-
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKIT-----KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP- 83 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~- 83 (253)
+-+|++.+.||+|+||+||+|.+... ++.||+|.+..... ....+.+.+|+..+..+.+||||+++++++...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 33455999999999999999997654 35799999876443 344678999999999777789999999998664
Q ss_pred CeEEEEEeccCCCcHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQ----------------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD 147 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~ 147 (253)
+.+++|||||++|+|.+++... ..+++..+..++.|++.|++|||+++++||||||+||+++.+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 221 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence 5799999999999999998652 348899999999999999999999999999999999999999
Q ss_pred CceEEEeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChH-HHHHHh
Q psy12709 148 NNIKLCDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQ-ETFLNI 222 (253)
Q Consensus 148 ~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~-~~~~~i 222 (253)
+.+||+|||+++...... ......+++.|+|||++.+..++.++||||+||++|||+| |+.||.+.+.. .....+
T Consensus 222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i 301 (353)
T 4ase_A 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 301 (353)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999998654322 2234567899999999999999999999999999999998 99999886644 444445
Q ss_pred hcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 223 SQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+..... ...+|+++.++|.+||+.||
T Consensus 302 ~~g~~~~~---p~~~~~~~~~li~~c~~~dP 329 (353)
T 4ase_A 302 KEGTRMRA---PDYTTPEMYQTMLDCWHGEP 329 (353)
T ss_dssp HHTCCCCC---CTTCCHHHHHHHHHHTCSSG
T ss_pred HcCCCCCC---CccCCHHHHHHHHHHcCcCh
Confidence 44433222 23789999999999999998
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=336.17 Aligned_cols=207 Identities=27% Similarity=0.430 Sum_probs=174.0
Q ss_pred eecceeeEEEeecCCCCceEEEEEEec---cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHK---ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
+.++|+ +.+.||+|+||+||+|.++ .+++.||+|.+..... ..++.+|+..+....+||||+++++++..+
T Consensus 19 l~~~Y~--i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 19 LSNVFK--IEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGTCE--EEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred ccCcEE--EEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 346677 9999999999999999876 3578899999876433 346788999998777899999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-CceEEEeeccccccc
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD-NNIKLCDFGISRVVN 162 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~-~~~~l~df~~~~~~~ 162 (253)
+.+++||||++|++|.+++. .+++.+++.++.|++.|++|||++||+||||||+||+++.+ +.+||+|||+++...
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 99999999999999999884 48999999999999999999999999999999999999877 899999999997543
Q ss_pred ccc-----------------------------cccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCC
Q psy12709 163 DVV-----------------------------EVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAG 212 (253)
Q Consensus 163 ~~~-----------------------------~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~ 212 (253)
... .....+||+.|+|||++.+. .++.++||||+||++|+|++|+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 211 12234689999999998765 589999999999999999999999854
Q ss_pred -CChHHHHHHh
Q psy12709 213 -DNKQETFLNI 222 (253)
Q Consensus 213 -~~~~~~~~~i 222 (253)
.+..+.+..|
T Consensus 250 ~~~~~~~l~~I 260 (361)
T 4f9c_A 250 ASDDLTALAQI 260 (361)
T ss_dssp CSSHHHHHHHH
T ss_pred CCCHHHHHHHH
Confidence 4444444333
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=326.28 Aligned_cols=241 Identities=29% Similarity=0.498 Sum_probs=220.1
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
...++|+ +++.||+|+||+||+|.+..+++.||+|++............+.+|+..+. ..+||||+++++++..++.
T Consensus 12 ~~~~~y~--~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 12 PHIGNYR--LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK-ILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp CEETTEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSE
T ss_pred CccCCEE--EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEECCE
Confidence 3456777 999999999999999999999999999999887766677788999999998 7789999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~ 165 (253)
+++||||++|++|.+++..++.+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999998766555
Q ss_pred cccccccCccccCccccCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPIS-LATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
......+++.|+|||++.+..+. .++||||+|+++|+|++|+.||.+.+..+....+..+....+. .+|+++.+|
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l 244 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENL 244 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHH
Confidence 55667899999999999887765 7999999999999999999999999999988888887766554 689999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||+.||
T Consensus 245 i~~~L~~dP 253 (328)
T 3fe3_A 245 LKRFLVLNP 253 (328)
T ss_dssp HHHHCCSST
T ss_pred HHHHCCCCh
Confidence 999999998
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-50 Score=328.51 Aligned_cols=242 Identities=29% Similarity=0.490 Sum_probs=211.0
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
+..++|+ +++.||+|+||+||+|.++.+++.||+|++.+.. ..........+|...+....+|+||+++++++..++
T Consensus 20 ~~~~~y~--~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 20 LGIDNFE--FIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp ---CCEE--EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CchhheE--EEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 3445666 9999999999999999999999999999998653 223345677888989886778999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-c
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-D 163 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~ 163 (253)
.+++||||++|++|..++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.+|.++|+|||++.... .
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 999999999999999999888889999999999999999999999999999999999999999999999999997532 2
Q ss_pred cccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
........+++.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..+.+..+......++. .+++++++
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ 253 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATG 253 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHH
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHH
Confidence 33344567899999999998888999999999999999999999999999999999999888776655 68999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|++||++||
T Consensus 254 li~~lL~~dP 263 (353)
T 3txo_A 254 ILKSFMTKNP 263 (353)
T ss_dssp HHHHHTCSSG
T ss_pred HHHHHhhhCH
Confidence 9999999998
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=326.68 Aligned_cols=244 Identities=44% Similarity=0.789 Sum_probs=220.4
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch----HHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM----DQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
+.++|+ +.+.||+|+||+||+|.+..++..||+|++.+..... .....+.+|+..+. ..+||||+++++++..
T Consensus 10 ~~~~y~--~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 10 VEDFYD--IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR-QVLHPNIITLHDVYEN 86 (361)
T ss_dssp GGGTEE--EEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHT-TCCCTTBCCEEEEEEC
T ss_pred hhhceE--EeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHH-hCCCcCCCcEEEEEEe
Confidence 456677 9999999999999999999999999999998754321 12457889999998 7789999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC----ceEEEeeccc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN----NIKLCDFGIS 158 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~----~~~l~df~~~ 158 (253)
++.+++||||++|++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++ .++|+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999999999998888899999999999999999999999999999999999998877 7999999999
Q ss_pred ccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCC
Q psy12709 159 RVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHIS 238 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 238 (253)
.............+++.|+|||++.+..++.++|+||+|+++|+|++|..||.+.+..+.+..+......++......+|
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 246 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence 87665555556678999999999999899999999999999999999999999999999999998888777766667899
Q ss_pred HHHHHHHHHhcccCC
Q psy12709 239 SQAKDFIQSCLVTDP 253 (253)
Q Consensus 239 ~~l~~li~~~l~~dP 253 (253)
+++++||.+||++||
T Consensus 247 ~~~~~li~~~L~~dP 261 (361)
T 2yab_A 247 ELAKDFIRKLLVKET 261 (361)
T ss_dssp HHHHHHHHHHSCSST
T ss_pred HHHHHHHHHHCCCCh
Confidence 999999999999998
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=325.71 Aligned_cols=243 Identities=32% Similarity=0.577 Sum_probs=221.1
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +.+.||+|+||+||+|.+..++..||+|++............+.+|+..+. .++||||+++++++..++..+
T Consensus 28 ~~~y~--~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 28 SDNYD--VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR-KLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHEE--EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEE
T ss_pred ccCeE--EeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEEeCCEEE
Confidence 44566 999999999999999999999999999999877666666788999999998 679999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC---ceEEEeeccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN---NIKLCDFGISRVVNDV 164 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~---~~~l~df~~~~~~~~~ 164 (253)
+|||+++|++|.+.+.....+++..+..++.|++.|+.|||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999999999999988788899999999999999999999999999999999999998654 5999999999876655
Q ss_pred ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
.......+++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.+..+.+..+..+...++......+|+++++|
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 264 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHH
T ss_pred cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 55555678999999999999899999999999999999999999999999989998888888777776667899999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||+.||
T Consensus 265 i~~~L~~dP 273 (362)
T 2bdw_A 265 IDSMLTVNP 273 (362)
T ss_dssp HHHHSCSSG
T ss_pred HHHHcCCCh
Confidence 999999998
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=321.39 Aligned_cols=239 Identities=28% Similarity=0.476 Sum_probs=213.1
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
.++|+ +++.||+|+||+||+|.++.+++.||+|++.+... .......+.+|+..+. ..+||||+++++++...+.+
T Consensus 4 ~~~y~--~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~l~~~~~~~~~~ 80 (337)
T 1o6l_A 4 MNDFD--YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-NTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp GGGEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-SCCCTTBCCEEEEEECSSEE
T ss_pred hHHeE--EEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHH-hCCCCcCcceEEEEEeCCEE
Confidence 35666 99999999999999999999999999999976532 2234567888888887 77999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-ccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVV 165 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~~ 165 (253)
++||||++|++|...+.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.+|.++|+|||++.... ...
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999997532 333
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+....+..+......++. .+|++++++|
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li 236 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLL 236 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Confidence 445567899999999999999999999999999999999999999999888888888777665554 7899999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
.+||+.||
T Consensus 237 ~~lL~~dP 244 (337)
T 1o6l_A 237 AGLLKKDP 244 (337)
T ss_dssp HHHTCSST
T ss_pred HHHhhcCH
Confidence 99999998
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=321.21 Aligned_cols=241 Identities=29% Similarity=0.452 Sum_probs=213.7
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
..++|+ +.+.||+|+||+||+|.++.+++.||+|++.+... ..........|...+....+||||+++++++..++.
T Consensus 15 ~~~~y~--~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 15 KIEDFI--LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp -CTTEE--EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred ChHHeE--EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345666 99999999999999999999999999999986531 123345677888888877799999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-cc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DV 164 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~ 164 (253)
+++||||++|++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.+|.++|+|||++.... ..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 99999999999999999887889999999999999999999999999999999999999999999999999997542 22
Q ss_pred ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
.......+++.|+|||++.+..++.++|+||+|+++|+|++|+.||.+.+..+.+..+.......+. .+|++++++
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l 248 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDL 248 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc----ccCHHHHHH
Confidence 3345567899999999999999999999999999999999999999999999999888877665544 689999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||+.||
T Consensus 249 i~~lL~~dp 257 (345)
T 1xjd_A 249 LVKLFVREP 257 (345)
T ss_dssp HHHHSCSSG
T ss_pred HHHHhcCCH
Confidence 999999998
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=329.58 Aligned_cols=243 Identities=31% Similarity=0.544 Sum_probs=219.6
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +.+.||+|+||+||+|.+..++..||+|++............+.+|+..+. .++||||+++++++..++..+
T Consensus 10 ~~~Y~--i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 10 TEEYQ--LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR-LLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHEE--EEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHH-HCCBTTBCCEEEEEECSSEEE
T ss_pred cCCeE--EEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHH-hCCCcCCCeEEEEEEECCEEE
Confidence 45666 999999999999999999999999999999877666666778899999998 779999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc---CCCceEEEeeccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLT---KDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~---~~~~~~l~df~~~~~~~~~ 164 (253)
+|||+++|++|.+.+..+..+++..+..++.|++.|+.|||++|++|+||+|+||+++ .++.++|+|||++......
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999999999999998888899999999999999999999999999999999999998 4578999999999765543
Q ss_pred -ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 165 -VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 165 -~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
.......+++.|+|||++.+..++.++||||+|+++|+|++|..||.+.+..+.+..+..+...++.+....+|+++++
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 246 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 2234567899999999999989999999999999999999999999999999999999998888887777789999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
||.+||+.||
T Consensus 247 li~~~L~~dP 256 (444)
T 3soa_A 247 LINKMLTINP 256 (444)
T ss_dssp HHHHHSCSST
T ss_pred HHHHHcCCCh
Confidence 9999999998
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=324.34 Aligned_cols=240 Identities=29% Similarity=0.474 Sum_probs=208.2
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc-hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS-MDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
.++|+ +++.||+|+||+||+|.++.+++.||+|++.+.... ......+.+|...+....+||||+++++++..++.+
T Consensus 51 ~~~y~--~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 51 LQDFD--LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp GGGEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred hhHcE--EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 34566 999999999999999999999999999999876432 233456778888888777999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc-ccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV-VNDVV 165 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~-~~~~~ 165 (253)
++||||++|++|..++.....+++..++.++.|++.|+.|||++|++||||+|+||+++.+|.++|+|||+++. .....
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 208 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999975 33334
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHhhcccccccCCccCC
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGD---------NKQETFLNISQCNFSFHEDLFGH 236 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---------~~~~~~~~i~~~~~~~~~~~~~~ 236 (253)
......+++.|+|||++.+..++.++|+||||+++|+|++|+.||... .....+..+.......+. .
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~----~ 284 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----S 284 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT----T
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC----c
Confidence 455668999999999999999999999999999999999999999642 233455566666555544 7
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
+|+++++||++||+.||
T Consensus 285 ~s~~~~~li~~lL~~dP 301 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDP 301 (396)
T ss_dssp SCHHHHHHHHHHTCSCT
T ss_pred CCHHHHHHHHHHhcCCH
Confidence 89999999999999998
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=322.48 Aligned_cols=241 Identities=29% Similarity=0.504 Sum_probs=214.3
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
..++|+ +++.||+|+||+||+|.++.+++.||+|++.+... .......+..|...+....+|++|+++++.+...+.
T Consensus 18 ~~~~y~--~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 18 KLTDFN--FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp -CTTEE--EEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred chHHcE--EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 345666 99999999999999999999999999999986532 223356777888888766689999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-cc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DV 164 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~ 164 (253)
+++||||++|++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.+|.++|+|||++.... ..
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 99999999999999999887889999999999999999999999999999999999999999999999999997532 23
Q ss_pred ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
.......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..+.+..+......++. .+|++++++
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l 251 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAI 251 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHH
Confidence 3445567899999999999999999999999999999999999999999999999998887766654 789999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||+.||
T Consensus 252 i~~lL~~dP 260 (353)
T 2i0e_A 252 CKGLMTKHP 260 (353)
T ss_dssp HHHHTCSCT
T ss_pred HHHHhhcCH
Confidence 999999998
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=316.98 Aligned_cols=241 Identities=29% Similarity=0.463 Sum_probs=209.7
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
..++|+ +++.||+|+||+||+|.++.+++.||+|++.+... .......+.+|...+....+||||+++++++..++.
T Consensus 7 ~~~~y~--~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 7 GLQDFD--LLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CGGGEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred chhheE--EEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 345666 99999999999999999999999999999987653 344566788899999867799999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-cc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DV 164 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~ 164 (253)
+++||||++|++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.+|.++|+|||++.... ..
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999999999999887889999999999999999999999999999999999999999999999999997532 23
Q ss_pred ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC---------CChHHHHHHhhcccccccCCccC
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAG---------DNKQETFLNISQCNFSFHEDLFG 235 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~---------~~~~~~~~~i~~~~~~~~~~~~~ 235 (253)
.......+++.|+|||++.+..++.++|+||+|+++|+|++|+.||.. ......+..+.......+.
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~---- 240 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR---- 240 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT----
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC----
Confidence 344556789999999999999999999999999999999999999965 2334455566665554443
Q ss_pred CCCHHHHHHHHHhcccCC
Q psy12709 236 HISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 236 ~~~~~l~~li~~~l~~dP 253 (253)
.+|++++++|.+||+.||
T Consensus 241 ~~s~~~~~li~~lL~~dP 258 (345)
T 3a8x_A 241 SLSVKAASVLKSFLNKDP 258 (345)
T ss_dssp TSCHHHHHHHHHHTCSST
T ss_pred CCCHHHHHHHHHHhcCCH
Confidence 789999999999999998
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=317.64 Aligned_cols=240 Identities=33% Similarity=0.597 Sum_probs=216.8
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +.+.||+|+||+||+|.+..++..|++|.+.... .....+.+|+..+. ..+||||+++++++...+.++
T Consensus 4 ~~~y~--~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 4 YEKYM--IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILN-IARHRNILHLHESFESMEELV 77 (321)
T ss_dssp TTTEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHH-HSCCTTBCCEEEEEEETTEEE
T ss_pred hhceE--eeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHH-hCCCCCCCeEeEEEecCCEEE
Confidence 46677 9999999999999999999999999999987543 33456788999988 779999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC--CCceEEEeeccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK--DNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~--~~~~~l~df~~~~~~~~~ 164 (253)
+||||++|++|.+++... ..+++..++.++.|++.|+.|||++|++|+||+|+||+++. ++.++|+|||.+......
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999999998765 46999999999999999999999999999999999999997 789999999999877655
Q ss_pred ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
.......+++.|+|||++.+..++.++||||+|+++|+|++|..||.+.+..+....+......++....+.+|+++.++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHH
Confidence 55555678999999999998888999999999999999999999999999999999998888877776677899999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||+.||
T Consensus 238 i~~~L~~dp 246 (321)
T 1tki_A 238 VDRLLVKER 246 (321)
T ss_dssp HHTTSCSSG
T ss_pred HHHHcCCCh
Confidence 999999998
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=316.39 Aligned_cols=244 Identities=43% Similarity=0.778 Sum_probs=218.2
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch----HHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM----DQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
+.++|+ +.+.||+|+||+||+|.+..++..||+|++....... .....+.+|+..+. .++||||+++++++..
T Consensus 9 ~~~~y~--~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 9 VDDYYD--TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK-EIQHPNVITLHEVYEN 85 (326)
T ss_dssp HHHHEE--EEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHH-HCCCTTBCCEEEEEEC
T ss_pred cccceE--eceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHH-hCCCCCCCcEEEEEEe
Confidence 445677 9999999999999999999999999999997654321 12467889999998 7789999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC----ceEEEeeccc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN----NIKLCDFGIS 158 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~----~~~l~df~~~ 158 (253)
++.+++||||++|++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++ .++|+|||++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999999998888899999999999999999999999999999999999999887 7999999999
Q ss_pred ccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCC
Q psy12709 159 RVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHIS 238 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 238 (253)
.............+++.|+|||++.+..++.++||||+|+++|+|++|..||.+.+..+....+.......+......+|
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 87655444555678999999999998899999999999999999999999999998888888888777777666667899
Q ss_pred HHHHHHHHHhcccCC
Q psy12709 239 SQAKDFIQSCLVTDP 253 (253)
Q Consensus 239 ~~l~~li~~~l~~dP 253 (253)
+++++||.+||+.||
T Consensus 246 ~~~~~li~~~L~~dP 260 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDP 260 (326)
T ss_dssp HHHHHHHHHHSCSSG
T ss_pred HHHHHHHHHHccCCh
Confidence 999999999999998
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=314.41 Aligned_cols=237 Identities=29% Similarity=0.518 Sum_probs=212.0
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
.++|+ +++.||+|+||+||+|.+..+++.||+|++.+... .......+.+|...+. ..+||||+++++++...+.+
T Consensus 5 ~~~y~--~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 5 LQDFQ--ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS-IVTHPFIIRMWGTFQDAQQI 81 (318)
T ss_dssp GGGEE--EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-SCCBTTBCCEEEEEECSSEE
T ss_pred hHHcE--EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHh-hCCCCCCceEeEEEEeCCEE
Confidence 35666 99999999999999999999999999999976532 1233456778888887 77999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE 166 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 166 (253)
++||||++|++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.+|.++|+|||++......
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 999999999999999988888999999999999999999999999999999999999999999999999999865442
Q ss_pred ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHH
Q psy12709 167 VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~ 246 (253)
.....+++.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..+.+..+.......+. .++++++++|.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~ 235 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLS 235 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHH
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHH
Confidence 23457899999999999999999999999999999999999999999998888888887665554 78999999999
Q ss_pred HhcccCC
Q psy12709 247 SCLVTDP 253 (253)
Q Consensus 247 ~~l~~dP 253 (253)
+||+.||
T Consensus 236 ~lL~~dp 242 (318)
T 1fot_A 236 RLITRDL 242 (318)
T ss_dssp HHTCSCT
T ss_pred HHhccCH
Confidence 9999998
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=316.69 Aligned_cols=234 Identities=18% Similarity=0.222 Sum_probs=177.8
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC----eEEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH----EMVL 88 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----~~~l 88 (253)
|.+.+.||+|+||+||+|.+ +|..||||++..... .....+.|+..+. .++||||+++++++..++ .+++
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~---~~~~~e~Ei~~~~-~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTV-MLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHTST-TCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch---hhHHHHHHHHHHh-cCCCCCCCcEEEEEEecCCCceEEEE
Confidence 44999999999999999987 588999999875432 1122334444444 678999999999998654 5899
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDH--------NITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--------~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
||||+++++|.+++... ++++..+.+++.|++.|+.|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 79 V~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 99999999999999754 589999999999999999999987 999999999999999999999999999986
Q ss_pred cccccc-----ccccccCccccCccccCCC------CCCccccHHHHHHHHHHHHhCCCCCCCC---------------C
Q psy12709 161 VNDVVE-----VKEIIGTPDYVAPEVLSYE------PISLATDMWSVGVLAYVLLSSHSPFAGD---------------N 214 (253)
Q Consensus 161 ~~~~~~-----~~~~~~~~~~~~PE~~~~~------~~~~~~Di~slG~~l~~l~~g~~p~~~~---------------~ 214 (253)
...... .....+++.|+|||++.+. .++.++||||+||++|||++|..||... .
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 543221 2235789999999998764 3567999999999999999997665321 1
Q ss_pred hHHHHHHhhcccccccCC--c-cCCCCHHHHHHHHHhcccCC
Q psy12709 215 KQETFLNISQCNFSFHED--L-FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 215 ~~~~~~~i~~~~~~~~~~--~-~~~~~~~l~~li~~~l~~dP 253 (253)
.......+......+..+ . ....++.+.+|+.+||+.||
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP 279 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 279 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSG
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCH
Confidence 223333333333222111 1 11234578999999999998
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=306.79 Aligned_cols=244 Identities=32% Similarity=0.576 Sum_probs=223.3
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
+.++|+ +.+.||+|+||+||+|.+..++..|++|++............+.+|+..+. ..+|+||+++++++..++..
T Consensus 4 ~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 4 FSDNYD--VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR-KLQHPNIVRLHDSIQEESFH 80 (284)
T ss_dssp TTTTEE--EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhh--hhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHH-HcCCCCcCeEEEEEEcCCEE
Confidence 467788 999999999999999999999999999999887766777788899999998 66899999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc---eEEEeecccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN---IKLCDFGISRVVND 163 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~---~~l~df~~~~~~~~ 163 (253)
+++||++++++|.+.+..+..+++..+..++.|++.++.+||++|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999999998888888999999999999999999999999999999999999987655 99999999987766
Q ss_pred cccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
........+++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.+.......+.......+......+++++.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence 55555667899999999999999999999999999999999999999999999999888888887777767789999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 241 li~~~l~~dp 250 (284)
T 3kk8_A 241 LIDSMLTVNP 250 (284)
T ss_dssp HHHHHSCSST
T ss_pred HHHHHcccCh
Confidence 9999999998
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=310.76 Aligned_cols=244 Identities=23% Similarity=0.390 Sum_probs=207.9
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
+.++|+ +++.||+|+||+||+|.+..++..||+|.+.... ........+.+|+..+. ..+||||+++++++..++.
T Consensus 9 ~~~~y~--i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 9 INERYK--IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS-QLSHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp EETTEE--EEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHT-TCCBTTBCCEEEEEECSSE
T ss_pred hhccEE--EEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHh-cCCCCCCceEEEeeeeCCe
Confidence 467788 9999999999999999999999999999986654 33455678888998887 7799999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~ 165 (253)
+++||||++|++|.+++....++++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999998654332
Q ss_pred --cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccc-ccCCccCCCCHHHH
Q psy12709 166 --EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFS-FHEDLFGHISSQAK 242 (253)
Q Consensus 166 --~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~l~ 242 (253)
......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||.+.+.............+ .+......+|+.+.
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence 223346899999999999999999999999999999999999999988877665554443332 22344568999999
Q ss_pred HHHHHhcccCC
Q psy12709 243 DFIQSCLVTDP 253 (253)
Q Consensus 243 ~li~~~l~~dP 253 (253)
++|.+||++||
T Consensus 246 ~li~~~l~~dp 256 (294)
T 4eqm_A 246 NVILRATEKDK 256 (294)
T ss_dssp HHHHHHSCSSG
T ss_pred HHHHHHhcCCH
Confidence 99999999998
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=321.85 Aligned_cols=242 Identities=30% Similarity=0.491 Sum_probs=206.0
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
...++|+ +++.||+|+||+||+|.++.++..||+|++.+... .......+.+|...+.+..+|+||+++++.+..++
T Consensus 35 ~~~~~y~--~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 35 AKPSDFH--FLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp CCGGGEE--EEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CChhheE--EEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 3445666 99999999999999999999999999999987653 22334556666666545789999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-c
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-D 163 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~ 163 (253)
.+++||||++|++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.+|.++|+|||++.... .
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 999999999999999999888889999999999999999999999999999999999999999999999999997532 3
Q ss_pred cccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
........+++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+.+..+.......+. .+++++++
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~ 268 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----NITNSARH 268 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS----SSCHHHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC----CCCHHHHH
Confidence 33445567899999999999999999999999999999999999999999999999888877655443 78999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 269 li~~lL~~dp 278 (373)
T 2r5t_A 269 LLEGLLQKDR 278 (373)
T ss_dssp HHHHHTCSSG
T ss_pred HHHHHcccCH
Confidence 9999999997
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=317.49 Aligned_cols=238 Identities=27% Similarity=0.448 Sum_probs=213.6
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
..++|+ +++.||+|+||+||+|.+..+++.||+|++.+... .......+.+|+..+. ..+||||+++++++..++.
T Consensus 39 ~~~~y~--~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 39 QLDQFD--RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ-AVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CGGGEE--EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSE
T ss_pred CHHHCE--EEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEEcCCE
Confidence 345666 99999999999999999999999999999976542 2234567888888887 7799999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~ 165 (253)
+++||||++|++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.+|.++|+|||++......
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999999999988788999999999999999999999999999999999999999999999999999866443
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
.....+++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+.+..+..+....+. .+|+++.++|
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li 269 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLL 269 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHHHHHH
T ss_pred -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Confidence 23457899999999999999999999999999999999999999999999999888887766554 7899999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
.+||+.||
T Consensus 270 ~~lL~~dp 277 (350)
T 1rdq_E 270 RNLLQVDL 277 (350)
T ss_dssp HHHSCSCT
T ss_pred HHHhhcCH
Confidence 99999998
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=317.99 Aligned_cols=242 Identities=23% Similarity=0.447 Sum_probs=210.1
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
-+..++|+ +++.||+|+||+||+|.+..+++.||+|++.+.. ........+.+|+..+. ..+||||+++++++...
T Consensus 11 ~v~~~~y~--i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 11 DVNFDHFE--ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ-GLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp CCCGGGEE--EEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-TCCCTTBCCEEEEEECS
T ss_pred CCChHHeE--EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEEeC
Confidence 34456677 9999999999999999999999999999997654 22334567888999998 77999999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
+.+++||||+.|++|..++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.+|.++|+|||++.....
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999999999998888899999999999999999999999999999999999999999999999999987766
Q ss_pred cccccccccCccccCccccCC---CCCCccccHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHhhcccccccCCccCCC
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSY---EPISLATDMWSVGVLAYVLLSSHSPFAGD---NKQETFLNISQCNFSFHEDLFGHI 237 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~~~~i~~~~~~~~~~~~~~~ 237 (253)
........+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||... ...+....+.......+. .+
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~----~~ 243 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS----AW 243 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT----TS
T ss_pred CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC----cC
Confidence 555566789999999999864 45888999999999999999999999753 344455555555544443 78
Q ss_pred CHHHHHHHHHhcccCC
Q psy12709 238 SSQAKDFIQSCLVTDP 253 (253)
Q Consensus 238 ~~~l~~li~~~l~~dP 253 (253)
|+++.+||.+||+.||
T Consensus 244 s~~~~~li~~lL~~dP 259 (384)
T 4fr4_A 244 SQEMVSLLKKLLEPNP 259 (384)
T ss_dssp CHHHHHHHHHHSCSSG
T ss_pred CHHHHHHHHHHhcCCH
Confidence 9999999999999998
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=312.77 Aligned_cols=247 Identities=22% Similarity=0.335 Sum_probs=208.4
Q ss_pred cceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 4 KFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
.-.+.++|+ +.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+..+. ..+|+||+++++++..
T Consensus 7 ~~~~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~ 83 (311)
T 3ork_A 7 PSHLSDRYE--LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA-ALNHPAIVAVYDTGEA 83 (311)
T ss_dssp CSEETTTEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCC-CCCCTTBCCEEEEEEE
T ss_pred cceecCcEE--EEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHH-cCCCCCcceEEEeeec
Confidence 345677888 99999999999999999999999999999987543 3344567788888887 7799999999999876
Q ss_pred CC----eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccc
Q psy12709 83 PH----EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGIS 158 (253)
Q Consensus 83 ~~----~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~ 158 (253)
.+ ..++||||++|++|.+++.....+++..++.++.|++.++.|||++|++|+||+|+||+++.++.++|+|||.+
T Consensus 84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 84 ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 54 35999999999999999988888999999999999999999999999999999999999999999999999999
Q ss_pred cccccc----ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCcc
Q psy12709 159 RVVNDV----VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLF 234 (253)
Q Consensus 159 ~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 234 (253)
...... .......+++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.+..+....+......++....
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence 765432 1222345799999999999889999999999999999999999999998888877777666666655555
Q ss_pred CCCCHHHHHHHHHhcccCC
Q psy12709 235 GHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP 253 (253)
..+|+++.++|.+||+.||
T Consensus 244 ~~~~~~l~~li~~~l~~dP 262 (311)
T 3ork_A 244 EGLSADLDAVVLKALAKNP 262 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSG
T ss_pred CCCCHHHHHHHHHHHhcCH
Confidence 6899999999999999998
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=310.14 Aligned_cols=244 Identities=44% Similarity=0.799 Sum_probs=218.3
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch----HHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM----DQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
+.++|+ +.+.||+|+||.||+|.+..++..||+|++....... .....+.+|+..+. ...|+||+++++++..
T Consensus 10 ~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 10 VEDFYD--IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR-QVLHHNVITLHDVYEN 86 (321)
T ss_dssp HHHHEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHH-HCCCTTBCCEEEEEEC
T ss_pred hhccEE--EeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHH-hCCCCCcceEEEEEec
Confidence 356677 9999999999999999999999999999997654322 12467888999988 7789999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC----ceEEEeeccc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN----NIKLCDFGIS 158 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~----~~~l~df~~~ 158 (253)
++.+++|||++++++|.+++.....+++..++.++.|++.|+.+||++|++|+||+|+||+++.++ .++|+|||.+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999999999999998888899999999999999999999999999999999999999888 7999999999
Q ss_pred ccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCC
Q psy12709 159 RVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHIS 238 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 238 (253)
.............+++.|+|||++.+..++.++|+||+|+++|+|++|..||.+.+..+....+.......+......+|
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence 87665544455678999999999998999999999999999999999999999999888888888877766666667899
Q ss_pred HHHHHHHHHhcccCC
Q psy12709 239 SQAKDFIQSCLVTDP 253 (253)
Q Consensus 239 ~~l~~li~~~l~~dP 253 (253)
+.+.++|.+||+.||
T Consensus 247 ~~~~~li~~~l~~dp 261 (321)
T 2a2a_A 247 ELAKDFIRKLLVKET 261 (321)
T ss_dssp HHHHHHHHTTSCSST
T ss_pred HHHHHHHHHHcCCCh
Confidence 999999999999998
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=315.84 Aligned_cols=240 Identities=31% Similarity=0.538 Sum_probs=207.6
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc-hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS-MDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
...++|+ +.+.||+|+||+||+|.+..++..||+|++.+.... ......+.+|+..+. ..+||||+++++++..++
T Consensus 6 ~~i~~Y~--i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~ 82 (336)
T 3h4j_B 6 RHIGPYI--IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLK-LLRHPHIIKLYDVITTPT 82 (336)
T ss_dssp SEETTEE--EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHT-TCCCTTBCCEEEEEECSS
T ss_pred cccCCEE--EEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHH-hCCCCCCCeEEEEEEeCC
Confidence 3456787 999999999999999999999999999998764321 122357788999887 789999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
.+++||||+ +++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999999999 6788888877788999999999999999999999999999999999999999999999999999877665
Q ss_pred ccccccccCccccCccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPI-SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
.......+++.|+|||++.+..+ +.++||||+|+++|+|++|+.||...........+..+....+ ..+|+++++
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~ 237 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP----DFLSPGAQS 237 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC----TTSCHHHHH
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc----ccCCHHHHH
Confidence 55566789999999999988776 6899999999999999999999988766655555544444333 368999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
||.+||+.||
T Consensus 238 li~~~L~~dP 247 (336)
T 3h4j_B 238 LIRRMIVADP 247 (336)
T ss_dssp HHHTTSCSSG
T ss_pred HHHHHcCCCh
Confidence 9999999998
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=315.56 Aligned_cols=240 Identities=36% Similarity=0.664 Sum_probs=214.8
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +.+.||+|+||+||+|.+..++..||+|++..... .....+.+|+..+. .++|+||+++++++..++.+++
T Consensus 51 ~~y~--i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 51 DYYD--ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMN-QLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GTEE--EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHT-TCCSTTBCCEEEEEECSSEEEE
T ss_pred cceE--EEEEEecCCCEEEEEEEECCCCCEEEEEEecccch--hhHHHHHHHHHHHH-hCCCcCCCeEEEEEEeCCEEEE
Confidence 5566 99999999999999999999999999999876432 33457888999987 7799999999999999999999
Q ss_pred EEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC--CCceEEEeecccccccccc
Q psy12709 89 VLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK--DNNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~--~~~~~l~df~~~~~~~~~~ 165 (253)
||||++|++|.+++... ..+++..++.++.|++.|+.|||++|++|+||+|+||+++. ++.++|+|||++.......
T Consensus 126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999999988754 36999999999999999999999999999999999999985 4779999999998766544
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.......+......+|+++++||
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 285 (387)
T 1kob_A 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 285 (387)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence 44556789999999999998999999999999999999999999999998888888888887777777778999999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
.+||+.||
T Consensus 286 ~~~L~~dP 293 (387)
T 1kob_A 286 KNLLQKEP 293 (387)
T ss_dssp HTTSCSSG
T ss_pred HHHcCCCh
Confidence 99999998
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=311.13 Aligned_cols=245 Identities=50% Similarity=0.847 Sum_probs=216.0
Q ss_pred eecceeeEEE-eecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 7 VNGGYQTLIF-CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 7 ~~~~~~~~~~-~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
++++|. +. +.||+|+||+||+|.+..+++.||+|++............+.+|+..+.....|+||+++++++..++.
T Consensus 26 ~~~~y~--~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 26 FNNFYI--LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHEE--EEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhEEe--eccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 345566 76 899999999999999999999999999987765555567889999999977788999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC---CCceEEEeeccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK---DNNIKLCDFGISRV 160 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~---~~~~~l~df~~~~~ 160 (253)
+++||||+++++|.+++... ..+++..++.++.|++.++.+||++|++|+||+|+||+++. ++.++|+|||.+..
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 99999999999999988543 56999999999999999999999999999999999999998 78999999999987
Q ss_pred ccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHH
Q psy12709 161 VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
...........+++.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..+....+......++......+++.
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 263 (327)
T 3lm5_A 184 IGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263 (327)
T ss_dssp C---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred cCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHH
Confidence 76555555567899999999999999999999999999999999999999999999888888888887777777889999
Q ss_pred HHHHHHHhcccCC
Q psy12709 241 AKDFIQSCLVTDP 253 (253)
Q Consensus 241 l~~li~~~l~~dP 253 (253)
+.++|.+||+.||
T Consensus 264 ~~~li~~~L~~dP 276 (327)
T 3lm5_A 264 ATDFIQSLLVKNP 276 (327)
T ss_dssp HHHHHHHHSCSSG
T ss_pred HHHHHHHHcCCCh
Confidence 9999999999998
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=326.14 Aligned_cols=243 Identities=36% Similarity=0.605 Sum_probs=215.8
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
+.++|+ +++.||+|+||+||+|.+..++..||+|++.+..........+.+|+..+. .++||||+++++++..++.+
T Consensus 20 ~~~~y~--~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 20 FAERYN--IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK-KLDHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHHHEE--EEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEE
T ss_pred hhcceE--EeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHH-hCCCCCcCeEEEEEEcCCEE
Confidence 445677 999999999999999999999999999999765543444568889999998 67999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC---CCceEEEeecccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK---DNNIKLCDFGISRVVND 163 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~---~~~~~l~df~~~~~~~~ 163 (253)
++|||++.|++|.+.+.....+++..++.++.|++.|+.|||++|++|+||+|+||+++. ++.++|+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999999999998887888999999999999999999999999999999999999954 56799999999987665
Q ss_pred cccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
........+++.|+|||++.+ .++.++||||+|+++|+|++|..||.+.+..+....+..+...++.+....+|+++++
T Consensus 177 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 255 (486)
T 3mwu_A 177 NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (486)
T ss_dssp C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence 555556678999999999876 5899999999999999999999999999999999999888877776666789999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
||.+||+.||
T Consensus 256 li~~~L~~dp 265 (486)
T 3mwu_A 256 LIRKMLTFHP 265 (486)
T ss_dssp HHHHHTCSST
T ss_pred HHHHHcCCCh
Confidence 9999999998
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=304.40 Aligned_cols=239 Identities=26% Similarity=0.423 Sum_probs=206.4
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +++.||+|+||+||+|.+..+++.||+|++....... ...+.+|+..+. ..+||||+++++++..++.++
T Consensus 19 ~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~ 93 (297)
T 3fxz_A 19 KKKYT--RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMR-ENKNPNIVNYLDSYLVGDELW 93 (297)
T ss_dssp GGTBC--CCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEE
T ss_pred hhcee--eeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHh-cCCCCCCCeEeEEEEECCEEE
Confidence 34566 9999999999999999999999999999987654433 356788888887 789999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-cc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VE 166 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~ 166 (253)
+||||++|++|.+++... .+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp EEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 999999999999998755 5899999999999999999999999999999999999999999999999998765433 23
Q ss_pred ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHH
Q psy12709 167 VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~ 246 (253)
.....+++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.+.......+....... ......+|+.++++|.
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 251 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLSAIFRDFLN 251 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-CSCGGGSCHHHHHHHH
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-CCCccccCHHHHHHHH
Confidence 344578999999999999999999999999999999999999999888776666554433222 2223478999999999
Q ss_pred HhcccCC
Q psy12709 247 SCLVTDP 253 (253)
Q Consensus 247 ~~l~~dP 253 (253)
+||+.||
T Consensus 252 ~~l~~dp 258 (297)
T 3fxz_A 252 RCLEMDV 258 (297)
T ss_dssp HHSCSST
T ss_pred HHccCCh
Confidence 9999998
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=301.26 Aligned_cols=241 Identities=32% Similarity=0.497 Sum_probs=217.2
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
+.++|+ +.+.||+|+||+||+|.+..++..+++|++....... ...+.+|+..+. ..+|+||+++++++..++..
T Consensus 7 ~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~ 81 (277)
T 3f3z_A 7 INQYYT--LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMK-SLDHPNIIRLYETFEDNTDI 81 (277)
T ss_dssp HHHHEE--EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEE
T ss_pred hhhhEE--eeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHH-hCCCCCEeeEEEEEecCCeE
Confidence 456677 9999999999999999999999999999998654432 457888999988 67999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---cCCCceEEEeecccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILL---TKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~---~~~~~~~l~df~~~~~~~~ 163 (253)
++||||+++++|.+++.....+++..++.++.|++.++.+||++|++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999999999998888889999999999999999999999999999999999999 7789999999999987665
Q ss_pred cccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
........+++.|+|||++.+. ++.++|+||+|+++|+|++|+.||...+..+....+.......+......+++++.+
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T 3f3z_A 162 GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240 (277)
T ss_dssp TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence 5555566789999999998755 889999999999999999999999999999999888888887777666689999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 241 li~~~l~~dp 250 (277)
T 3f3z_A 241 LIRRLLTKSP 250 (277)
T ss_dssp HHHHHTCSST
T ss_pred HHHHHccCCh
Confidence 9999999998
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=321.97 Aligned_cols=242 Identities=30% Similarity=0.464 Sum_probs=206.6
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
.++|+ +++.||+|+||+||+|.++.+++.||+|++.+... .......+.+|...+. ..+||||+++++++..++.+
T Consensus 68 ~~~y~--~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 68 AEDYE--VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp GGGEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHH-HCCCTTBCCEEEEEECSSEE
T ss_pred ccccE--EEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHH-hCCCCCCCeEEEEEEECCEE
Confidence 34565 99999999999999999999999999999976321 1111234667888887 78999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV- 165 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~- 165 (253)
++||||++|++|.+++.. ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.+|.++|+|||++.......
T Consensus 145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 999999999999999875 468999999999999999999999999999999999999999999999999998654432
Q ss_pred -cccccccCccccCccccCCCC----CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHH
Q psy12709 166 -EVKEIIGTPDYVAPEVLSYEP----ISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 166 -~~~~~~~~~~~~~PE~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
......+++.|+|||++.+.. ++.++|+||||+++|+|++|+.||.+.+..+.+.++.........+....+|++
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 303 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 303 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHH
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHH
Confidence 233567999999999987665 788999999999999999999999999999999888776433333333578999
Q ss_pred HHHHHHHhcccCC
Q psy12709 241 AKDFIQSCLVTDP 253 (253)
Q Consensus 241 l~~li~~~l~~dP 253 (253)
+++||.+||+.+|
T Consensus 304 ~~~li~~lL~~~~ 316 (410)
T 3v8s_A 304 AKNLICAFLTDRE 316 (410)
T ss_dssp HHHHHHHHSSCGG
T ss_pred HHHHHHHHccChh
Confidence 9999999998654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=313.70 Aligned_cols=246 Identities=31% Similarity=0.528 Sum_probs=208.5
Q ss_pred cceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc---chHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy12709 4 KFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR---SMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80 (253)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 80 (253)
...+.++|+ +.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+..+. .++||||+++++++
T Consensus 19 ~~~~~~~y~--~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~ 95 (351)
T 3c0i_A 19 DVLFEDVYE--LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH-MLKHPHIVELLETY 95 (351)
T ss_dssp -CCHHHHEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHH-HCCCTTBCCEEEEE
T ss_pred CCccccceE--EeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHH-hCCCCCCCcEEEEE
Confidence 345567777 99999999999999999999999999999875431 1113467889999998 77999999999999
Q ss_pred EeCCeEEEEEeccCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc---eEEE
Q psy12709 81 ETPHEMVLVLEMVPDGELQRLVDIQ----DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN---IKLC 153 (253)
Q Consensus 81 ~~~~~~~lv~e~~~g~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~---~~l~ 153 (253)
..++.+++||||++|++|.+.+... ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++. ++|+
T Consensus 96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEe
Confidence 9999999999999999998776542 34899999999999999999999999999999999999987655 9999
Q ss_pred eeccccccccccc-ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCC
Q psy12709 154 DFGISRVVNDVVE-VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHED 232 (253)
Q Consensus 154 df~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 232 (253)
|||++........ .....+++.|+|||++.+..++.++||||+|+++|+|++|..||.+. ..+.+..+.......+..
T Consensus 176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~ 254 (351)
T 3c0i_A 176 GFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPR 254 (351)
T ss_dssp CCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHH
T ss_pred cCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcc
Confidence 9999986654322 33457899999999999889999999999999999999999999874 455666666666655554
Q ss_pred ccCCCCHHHHHHHHHhcccCC
Q psy12709 233 LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 ~~~~~~~~l~~li~~~l~~dP 253 (253)
....+|+++++||.+||+.||
T Consensus 255 ~~~~~s~~~~~li~~~L~~dP 275 (351)
T 3c0i_A 255 QWSHISESAKDLVRRMLMLDP 275 (351)
T ss_dssp HHTTSCHHHHHHHHHHTCSST
T ss_pred ccccCCHHHHHHHHHHCCCCh
Confidence 556889999999999999998
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=307.87 Aligned_cols=241 Identities=27% Similarity=0.437 Sum_probs=201.9
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEec---cCCceEEEEEeccccc--chHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHK---ITKVEYAAKFIRKRRR--SMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 80 (253)
+..++|+ +.+.||+|+||+||+|.+. .+++.||+|++.+... .......+.+|+..+. ..+|+||+++++++
T Consensus 14 ~~~~~y~--~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 14 IRPECFE--LLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE-EVKHPFIVDLIYAF 90 (327)
T ss_dssp CCGGGEE--EEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHH-HCCCTTBCCEEEEE
T ss_pred CCHHHeE--EEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHH-hCCCCCccceeEEE
Confidence 3456666 9999999999999999985 6889999999986542 2233456778888888 77899999999999
Q ss_pred EeCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 81 ~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
..++.+++||||++|++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999999998888899999999999999999999999999999999999999999999999999875
Q ss_pred ccc-cccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCH
Q psy12709 161 VND-VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 161 ~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
... ........+++.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..+....+.......+. .+++
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~ 246 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQ 246 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT----TSCH
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCH
Confidence 432 22334457899999999999889999999999999999999999999999888888888777665544 7899
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
+++++|.+||+.||
T Consensus 247 ~~~~li~~~L~~dp 260 (327)
T 3a62_A 247 EARDLLKKLLKRNA 260 (327)
T ss_dssp HHHHHHHHHSCSCG
T ss_pred HHHHHHHHHHhcCH
Confidence 99999999999998
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=325.57 Aligned_cols=241 Identities=35% Similarity=0.552 Sum_probs=212.4
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +++.||+|+||+||+|.+..++..||+|++.+..........+.+|+..+. .++||||+++++++..++.+++
T Consensus 37 ~~y~--~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 37 EMYQ--RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLK-LLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHEE--EEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeE--EeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHH-hCCCCCCCeEEEEEEeCCEEEE
Confidence 3566 999999999999999999999999999999876544444567889999998 7899999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC---CceEEEeecccccccccc
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD---NNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~---~~~~l~df~~~~~~~~~~ 165 (253)
||||++|++|.+.+.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 99999999999988888889999999999999999999999999999999999999764 459999999998776655
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
......+++.|+|||++. ..++.++||||+|+++|+|++|..||.+.+..+....+..+...++.+....+|+++++||
T Consensus 194 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 272 (494)
T 3lij_A 194 KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLI 272 (494)
T ss_dssp CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHH
T ss_pred cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHH
Confidence 556677999999999986 4689999999999999999999999999999999999998888877777778999999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
.+||+.||
T Consensus 273 ~~~L~~dp 280 (494)
T 3lij_A 273 KQMLQFDS 280 (494)
T ss_dssp HHHTCSST
T ss_pred HHHCCCCh
Confidence 99999998
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=312.52 Aligned_cols=244 Identities=38% Similarity=0.636 Sum_probs=212.3
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
+.+.|++...+.||+|+||+||+|.+..++..||+|++..... .....+.+|+..+. .++|+||+++++++..++.+
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~ 161 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMN-QLDHANLIQLYDAFESKNDI 161 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHH-hCCCCCCCeEEEEEEECCEE
Confidence 4566887778899999999999999999999999999976432 34567889999988 77999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE--cCCCceEEEeecccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILL--TKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~--~~~~~~~l~df~~~~~~~~ 163 (253)
++||||+++++|.+++... ..+++..++.++.|++.|+.|||++|++|+||+|+||++ +.++.++|+|||++.....
T Consensus 162 ~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp EEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 9999999999998877653 469999999999999999999999999999999999999 4567899999999987665
Q ss_pred cccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
........+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+.+..+.......+......+++++++
T Consensus 242 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 321 (373)
T 2x4f_A 242 REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKE 321 (373)
T ss_dssp TCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHH
T ss_pred ccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHH
Confidence 55555567899999999999888999999999999999999999999999999888888888877777667789999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
||.+||+.||
T Consensus 322 li~~~L~~dp 331 (373)
T 2x4f_A 322 FISKLLIKEK 331 (373)
T ss_dssp HHHTTSCSSG
T ss_pred HHHHHcCCCh
Confidence 9999999998
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=321.92 Aligned_cols=241 Identities=29% Similarity=0.495 Sum_probs=215.2
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
+..++|+ +.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+..+. ..+||||+++++++..++
T Consensus 13 ~~~~~Y~--l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~-~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 13 VKIGHYI--LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK-LFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CEETTEE--EEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHT-TCCCTTBCCEEEEEECSS
T ss_pred ceecCEE--EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEEECC
Confidence 4567777 99999999999999999999999999999976532 2233567888999987 789999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
.+++||||++|++|.+++..+..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999999876655
Q ss_pred ccccccccCccccCccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPI-SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
.......+++.|+|||++.+..+ +.++||||+|+++|+|++|+.||...+....+..+..+....+. .+++++.+
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~ 245 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ----YLNPSVIS 245 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCT----TCCHHHHH
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCc----cCCHHHHH
Confidence 55556678999999999988765 68999999999999999999999998888888888877655443 68999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
||.+||+.||
T Consensus 246 Li~~~L~~dP 255 (476)
T 2y94_A 246 LLKHMLQVDP 255 (476)
T ss_dssp HHHHHTCSST
T ss_pred HHHHHcCCCc
Confidence 9999999998
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=312.41 Aligned_cols=241 Identities=30% Similarity=0.541 Sum_probs=209.7
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
.-+.++|+ +.+.||+|+||+||+|.++.++..||+|++.+.... ..+|+..+.+..+||||+++++++..++
T Consensus 18 ~~~~~~y~--~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~ 89 (342)
T 2qr7_A 18 IQFTDGYE--VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGK 89 (342)
T ss_dssp -CHHHHEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred cCccccEE--EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence 34566777 999999999999999999999999999999765432 2357777877779999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC----CceEEEeeccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD----NNIKLCDFGISRV 160 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~----~~~~l~df~~~~~ 160 (253)
.+++||||++|++|.+.+.....+++..+..++.|++.|+.|||++|++|+||+|+||++..+ +.++|+|||++..
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999999999999888889999999999999999999999999999999999998543 3599999999986
Q ss_pred cccc-ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC---CChHHHHHHhhcccccccCCccCC
Q psy12709 161 VNDV-VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAG---DNKQETFLNISQCNFSFHEDLFGH 236 (253)
Q Consensus 161 ~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~---~~~~~~~~~i~~~~~~~~~~~~~~ 236 (253)
.... .......+++.|+|||++.+..++.++|+||||+++|+|++|..||.+ .+..+....+..+....+......
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 249 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence 5432 233455789999999999888889999999999999999999999976 456677778888877777666678
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
+|+++++||.+||+.||
T Consensus 250 ~s~~~~~li~~~L~~dP 266 (342)
T 2qr7_A 250 VSDTAKDLVSKMLHVDP 266 (342)
T ss_dssp SCHHHHHHHHHHTCSST
T ss_pred CCHHHHHHHHHHCCCCh
Confidence 99999999999999998
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=304.03 Aligned_cols=245 Identities=24% Similarity=0.419 Sum_probs=201.5
Q ss_pred cceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 4 KFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
..+.....+|++.+.||+|+||+||+|.+ .+..||+|++............+.+|+..+. ..+|+||+++++++..+
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMK-RLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHH-HCCCTTBCCEEEEECST
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEEC
Confidence 33344444555999999999999999977 5888999999887766777788999999998 67899999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEcCCCceEEEeeccc
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQDG---IPEQDTRSYMKQILEALAFLHDHN--ITHLDLKPQNILLTKDNNIKLCDFGIS 158 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~--~~h~di~~~ni~~~~~~~~~l~df~~~ 158 (253)
+.+++||||+++++|.+++..... +++..++.++.|++.|+.|||++| ++|+||+|+||+++.++.++|+|||++
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999999999986543 899999999999999999999999 999999999999999999999999998
Q ss_pred cccccc-ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCC
Q psy12709 159 RVVNDV-VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHI 237 (253)
Q Consensus 159 ~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 237 (253)
...... .......+++.|+|||++.+..++.++||||+|+++|+|++|+.||...+..+....+....... .....+
T Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~ 264 (309)
T 3p86_A 187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL--EIPRNL 264 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC--CCCTTS
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCccC
Confidence 754332 22334568999999999999999999999999999999999999999988887777664433322 223478
Q ss_pred CHHHHHHHHHhcccCC
Q psy12709 238 SSQAKDFIQSCLVTDP 253 (253)
Q Consensus 238 ~~~l~~li~~~l~~dP 253 (253)
++++.++|.+||+.||
T Consensus 265 ~~~l~~li~~~l~~dP 280 (309)
T 3p86_A 265 NPQVAAIIEGCWTNEP 280 (309)
T ss_dssp CHHHHHHHHHHTCSSG
T ss_pred CHHHHHHHHHHccCCh
Confidence 9999999999999998
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=334.35 Aligned_cols=240 Identities=29% Similarity=0.508 Sum_probs=215.5
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
.++|+ +++.||+|+||+||+|.++.+++.||+|++.+.. ........+..|...+....+|++|+.+++++...+.+
T Consensus 340 ~~~f~--~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 340 LTDFN--FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp CTTEE--EEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccceE--EEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34555 9999999999999999999999999999998653 12233567778888888677899999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc-ccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVV 165 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~~ 165 (253)
++||||++|++|.+++.....+++..++.++.|++.||.|||++||+|+||+|+||+++.+|.++|+|||++.... ...
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 497 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence 9999999999999999887889999999999999999999999999999999999999999999999999998532 333
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..+.+..|......++. .+|+++++||
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li 573 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAIC 573 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCHHHHHHH
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHH
Confidence 445567999999999999999999999999999999999999999999999999999988777665 7899999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
++||++||
T Consensus 574 ~~lL~~dP 581 (674)
T 3pfq_A 574 KGLMTKHP 581 (674)
T ss_dssp HHHSCSSS
T ss_pred HHHccCCH
Confidence 99999998
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=309.70 Aligned_cols=239 Identities=36% Similarity=0.618 Sum_probs=194.7
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +.+.||+|+||+||+|.+..+++.||+|++.... ....+.+|+..+. .++|+||+++++++..++.++
T Consensus 52 ~~~y~--~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 52 SDFFE--VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLL-RLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp GGTEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHH-HCCCTTBCCEEEEEECSSEEE
T ss_pred cCcEE--EeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHH-hCCCCCCcceeeeEecCCeEE
Confidence 45566 9999999999999999999999999999997643 2346678888888 778999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC---CCceEEEeeccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK---DNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~---~~~~~l~df~~~~~~~~~ 164 (253)
+||||+++++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++. ++.++|+|||++......
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999999999999988888999999999999999999999999999999999999976 889999999999876554
Q ss_pred ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-HHHHhhcccccccCCccCCCCHHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQE-TFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
.......+++.|+|||++.+..++.++||||+|+++|+|++|+.||....... .+..+.......+......+++++.+
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 284 (349)
T 2w4o_A 205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284 (349)
T ss_dssp --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHH
Confidence 44445678999999999999899999999999999999999999997755544 66667777666666666789999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
||.+||+.||
T Consensus 285 li~~~L~~dP 294 (349)
T 2w4o_A 285 LVRKLIVLDP 294 (349)
T ss_dssp HHHTTSCSSG
T ss_pred HHHHHccCCh
Confidence 9999999998
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=300.72 Aligned_cols=244 Identities=45% Similarity=0.791 Sum_probs=212.7
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch----HHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM----DQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
+.++|+ +.+.||+|+||+||+|.+..+++.|++|++....... .....+.+|+..+. ..+|+||+++++++..
T Consensus 3 ~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~ 79 (283)
T 3bhy_A 3 VEDHYE--MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR-EIRHPNIITLHDIFEN 79 (283)
T ss_dssp HHHHEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHH-HCCCTTBCCEEEEEEC
T ss_pred hhhhhh--hHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHH-hCCCCCeeehhheecC
Confidence 456677 9999999999999999999999999999987654221 12567888999988 6789999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC----ceEEEeeccc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN----NIKLCDFGIS 158 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~----~~~l~df~~~ 158 (253)
++..+++||++++++|.+++.....+++..+..++.|++.++.+||++|++|+||+|+||+++.++ .++|+|||.+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 999999999999999999998878899999999999999999999999999999999999999877 7999999999
Q ss_pred ccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCC
Q psy12709 159 RVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHIS 238 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 238 (253)
.............+++.|+|||++.+..++.++|+||+|+++|+|++|..||.+.+..+....+.......+......++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T 3bhy_A 160 HKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239 (283)
T ss_dssp EECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred eeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCC
Confidence 87655444455568899999999998899999999999999999999999999988888888887777666666667899
Q ss_pred HHHHHHHHHhcccCC
Q psy12709 239 SQAKDFIQSCLVTDP 253 (253)
Q Consensus 239 ~~l~~li~~~l~~dP 253 (253)
+.+.++|.+||+.||
T Consensus 240 ~~~~~li~~~l~~dp 254 (283)
T 3bhy_A 240 ELAKDFIRRLLVKDP 254 (283)
T ss_dssp HHHHHHHHTTSCSSG
T ss_pred HHHHHHHHHHccCCH
Confidence 999999999999998
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=321.99 Aligned_cols=238 Identities=29% Similarity=0.481 Sum_probs=202.1
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
++|+ +++.||+|+||+||+|.+..++..||+|++.... ........+.+|+..+. ..+|+||+++++++..++.++
T Consensus 148 ~~y~--~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 148 NEFE--YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ-NSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp GGEE--EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCC-CCSCTTSCCEEEEEEETTEEE
T ss_pred HHcE--EeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHH-hCCCCeEeeEEEEEeeCCEEE
Confidence 4555 9999999999999999999999999999998653 23334456677888777 778999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCceEEEeeccccccc-ccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVV 165 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~-~~~ 165 (253)
+||||++|++|.+.+.....+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++.... ...
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence 999999999999999888889999999999999999999998 999999999999999999999999999997533 233
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
......+++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.+.......+.......+. .+++++.+||
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li 380 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSLL 380 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHH
Confidence 344567899999999999999999999999999999999999999999998888888777666554 6899999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
.+||+.||
T Consensus 381 ~~~L~~dP 388 (446)
T 4ejn_A 381 SGLLKKDP 388 (446)
T ss_dssp HHHTCSST
T ss_pred HHHcccCH
Confidence 99999998
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=323.08 Aligned_cols=243 Identities=33% Similarity=0.538 Sum_probs=213.7
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch-----------HHHHHHHHHHHHHHHhcCCCCcee
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM-----------DQMQDILHEAAVLYLAQKSERIVG 75 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-----------~~~~~~~~e~~~~~~~~~~~~i~~ 75 (253)
+.++|+ +++.||+|+||+||+|.+..++..||+|++.+..... .....+.+|+..+. .++||||++
T Consensus 34 i~~~Y~--~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~ 110 (504)
T 3q5i_A 34 IGESYF--KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK-SLDHPNIIK 110 (504)
T ss_dssp GGGTEE--EEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHH-TCCCTTBCC
T ss_pred cccceE--EEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHH-hCCCCCCCe
Confidence 345666 9999999999999999999999999999997654221 23467888999998 779999999
Q ss_pred eeeEEEeCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC---ceEE
Q psy12709 76 LHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN---NIKL 152 (253)
Q Consensus 76 ~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~---~~~l 152 (253)
+++++..++.+++||||++|++|.+.+.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++ .++|
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 9999999999999999999999999988888899999999999999999999999999999999999999876 6999
Q ss_pred EeecccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCC
Q psy12709 153 CDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHED 232 (253)
Q Consensus 153 ~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 232 (253)
+|||++.............+++.|+|||++. ..++.++||||+|+++|+|++|..||.+.+..+....+..+...++..
T Consensus 191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp CCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred EECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 9999998776655555667899999999987 468999999999999999999999999999999999998888777666
Q ss_pred ccCCCCHHHHHHHHHhcccCC
Q psy12709 233 LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 ~~~~~~~~l~~li~~~l~~dP 253 (253)
....+|+++++||.+||++||
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp 290 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDY 290 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSST
T ss_pred ccCCCCHHHHHHHHHHcCCCh
Confidence 667899999999999999998
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=324.54 Aligned_cols=244 Identities=33% Similarity=0.538 Sum_probs=218.7
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc-hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS-MDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
.+.++|+ +.+.||+|+||+||+|.+..++..||+|++.+.... ......+.+|+..+. .++||||+++++++...+
T Consensus 23 ~~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 23 IFSDRYK--GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK-QLDHPNIMKLYEFFEDKG 99 (484)
T ss_dssp CHHHHEE--EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHT-TCCCTTBCCEEEEEECSS
T ss_pred cccCceE--EeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHH-hCCCCCCCcEEEEEEeCC
Confidence 3456677 999999999999999999999999999999765422 334567889999998 779999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---cCCCceEEEeecccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILL---TKDNNIKLCDFGISRVV 161 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~---~~~~~~~l~df~~~~~~ 161 (253)
.+++|||++.|++|.+.+.....+++..++.++.|++.|+.|||++|++|+||+|+||++ +.++.++|+|||++...
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 999999999999999999888889999999999999999999999999999999999999 46789999999999876
Q ss_pred cccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHH
Q psy12709 162 NDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQA 241 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 241 (253)
..........+++.|+|||++.+ .++.++||||+|+++|+|++|..||.+.+..+....+..+...++.+....+|+++
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 180 EASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp CCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred ccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 65555555678999999999876 68999999999999999999999999999999999999888877766667899999
Q ss_pred HHHHHHhcccCC
Q psy12709 242 KDFIQSCLVTDP 253 (253)
Q Consensus 242 ~~li~~~l~~dP 253 (253)
++||.+||++||
T Consensus 259 ~~li~~~L~~dp 270 (484)
T 3nyv_A 259 KDLIRKMLTYVP 270 (484)
T ss_dssp HHHHHHHTCSSG
T ss_pred HHHHHHHCCCCh
Confidence 999999999998
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=299.68 Aligned_cols=242 Identities=25% Similarity=0.387 Sum_probs=202.5
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +++.||+|+||+||+|.+..+++.||+|++............+.+|+..+. ..+|+||+++++++..++.+++
T Consensus 2 ~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~l 78 (292)
T 3o0g_A 2 QKYE--KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK-ELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEE--EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEEEE
T ss_pred CCce--eeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHh-cCCCCCEeeEEeEEEeCCEEEE
Confidence 3555 999999999999999999999999999999877666666678889999998 7789999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-ccc
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEV 167 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~ 167 (253)
||||++++.+..+...+..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 79 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 9999987555555555677999999999999999999999999999999999999999999999999999865432 233
Q ss_pred cccccCccccCccccCCCC-CCccccHHHHHHHHHHHHhCCCC-CCCCChHHHHHHhhcccccccC--------------
Q psy12709 168 KEIIGTPDYVAPEVLSYEP-ISLATDMWSVGVLAYVLLSSHSP-FAGDNKQETFLNISQCNFSFHE-------------- 231 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p-~~~~~~~~~~~~i~~~~~~~~~-------------- 231 (253)
....+++.|+|||++.+.. ++.++||||+|+++|+|++|..| |.+.+..+....+......+..
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 4456789999999987665 79999999999999999987776 6666666666655442222111
Q ss_pred -----------CccCCCCHHHHHHHHHhcccCC
Q psy12709 232 -----------DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 232 -----------~~~~~~~~~l~~li~~~l~~dP 253 (253)
...+.+++++++||.+||+.||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 271 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNP 271 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSG
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccCh
Confidence 1224688999999999999998
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=319.57 Aligned_cols=242 Identities=28% Similarity=0.471 Sum_probs=204.9
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
.++|+ +++.||+|+||+||+|.++.+++.||+|++.+... .......+.+|...+. ..+|+||+++++++..++.+
T Consensus 73 ~~~y~--~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~-~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 73 REDFE--ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV-NGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp GGGEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHH-HSCTTTBCCEEEEEECSSEE
T ss_pred hhheE--EEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHH-hCCCCCEEEEEEEEeeCCEE
Confidence 34555 99999999999999999999999999999976331 1112234677888887 67999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~ 165 (253)
++||||++|++|.+++.. ...+++..++.++.|++.|+.|||++|++||||+|+||+++.++.+||+|||++.......
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 999999999999999986 4679999999999999999999999999999999999999999999999999997654322
Q ss_pred --cccccccCccccCccccC-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccc--ccccCCccCC
Q psy12709 166 --EVKEIIGTPDYVAPEVLS-----YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCN--FSFHEDLFGH 236 (253)
Q Consensus 166 --~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~ 236 (253)
......+++.|+|||++. ...++.++|+||+|+++|+|++|+.||.+.+..+.+..+.... ...+. ....
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~ 308 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT-QVTD 308 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS-SCCC
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc-cccc
Confidence 223457899999999986 4568899999999999999999999999999998888886543 22222 2246
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
+|+++++||++||..+|
T Consensus 309 ~s~~~~dLi~~lL~~~~ 325 (437)
T 4aw2_A 309 VSENAKDLIRRLICSRE 325 (437)
T ss_dssp SCHHHHHHHHTTSSCGG
T ss_pred CCHHHHHHHHHHhcccc
Confidence 89999999999997654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=312.62 Aligned_cols=237 Identities=29% Similarity=0.467 Sum_probs=196.5
Q ss_pred ecceeeEEE-eecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe----
Q psy12709 8 NGGYQTLIF-CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET---- 82 (253)
Q Consensus 8 ~~~~~~~~~-~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~---- 82 (253)
.++|. +. +.||+|+||+||+|.+..+++.||+|++... ....+|+..+.+..+|+||+++++++..
T Consensus 60 ~~~y~--~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 60 IDDYK--VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGTEE--EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccce--eccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 45565 65 7899999999999999999999999998632 2456788888778899999999999876
Q ss_pred CCeEEEEEeccCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC---CCceEEEeecc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK---DNNIKLCDFGI 157 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~---~~~~~l~df~~ 157 (253)
++.+++||||++|++|.+++.... .+++..++.++.|++.|+.|||++|++|+||+|+||+++. ++.++|+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 567999999999999999997643 5999999999999999999999999999999999999998 78899999999
Q ss_pred cccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH----HHHHHhhcccccccCCc
Q psy12709 158 SRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ----ETFLNISQCNFSFHEDL 233 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~i~~~~~~~~~~~ 233 (253)
+.............+++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.... .....+..+....+...
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 290 (400)
T 1nxk_A 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290 (400)
T ss_dssp CEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred ccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence 98765544455667899999999999999999999999999999999999999775433 24455666666666555
Q ss_pred cCCCCHHHHHHHHHhcccCC
Q psy12709 234 FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP 253 (253)
...+|+++++||.+||+.||
T Consensus 291 ~~~~s~~~~~li~~~L~~dP 310 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEP 310 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSG
T ss_pred cccCCHHHHHHHHHHCCCCh
Confidence 56899999999999999998
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=308.08 Aligned_cols=238 Identities=29% Similarity=0.478 Sum_probs=191.6
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +++.||+|+||+||+|.+..+++.||+|++....... ..+.+|+..+. .++|+||+++++++..++.++
T Consensus 19 ~~~y~--~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 19 SDRYD--FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHR-SLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp TTTEE--EEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEE
T ss_pred CCcEE--EEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHH-hCCCCCCCcEEEEEeeCCEEE
Confidence 45566 9999999999999999999999999999997654333 35678888887 778999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc--eEEEeecccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN--IKLCDFGISRVVNDVV 165 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~--~~l~df~~~~~~~~~~ 165 (253)
+||||++|++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999999999999988788999999999999999999999999999999999999988765 9999999987544444
Q ss_pred cccccccCccccCccccCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHhhcccccccCCccCCCCHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLA-TDMWSVGVLAYVLLSSHSPFAGDNK----QETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
......+++.|+|||++.+..++.+ +||||+|+++|+|++|+.||.+... ......+.......+.. ..+|++
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~ 250 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD--IRISPE 250 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT--SCCCHH
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc--CCCCHH
Confidence 4455678999999999988777655 8999999999999999999987544 33344444444444332 368999
Q ss_pred HHHHHHHhcccCC
Q psy12709 241 AKDFIQSCLVTDP 253 (253)
Q Consensus 241 l~~li~~~l~~dP 253 (253)
+.+||.+||+.||
T Consensus 251 ~~~li~~~L~~dP 263 (361)
T 3uc3_A 251 CCHLISRIFVADP 263 (361)
T ss_dssp HHHHHHHHSCSCT
T ss_pred HHHHHHHHccCCh
Confidence 9999999999998
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=306.04 Aligned_cols=238 Identities=33% Similarity=0.563 Sum_probs=188.9
Q ss_pred cceeeEEE---eecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 9 GGYQTLIF---CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 9 ~~~~~~~~---~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
++|+ +. +.||+|+||+||+|.+..+++.||+|++.+. ......+|+..+.....|+||+++++++..++.
T Consensus 8 ~~y~--~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~ 80 (325)
T 3kn6_A 8 QHYD--LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH 80 (325)
T ss_dssp HHEE--ECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hccc--cccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence 4566 54 7899999999999999999999999998653 234667889999866679999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC---ceEEEeeccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN---NIKLCDFGISRVVN 162 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~---~~~l~df~~~~~~~ 162 (253)
.++||||++|++|.+++.....+++..++.++.|++.++.|||++|++|+||+|+||+++.++ .++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999999999999999888899999999999999999999999999999999999998766 79999999997554
Q ss_pred cc-ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHhhcccccccCCcc
Q psy12709 163 DV-VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDN-------KQETFLNISQCNFSFHEDLF 234 (253)
Q Consensus 163 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~i~~~~~~~~~~~~ 234 (253)
.. .......+++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.. ..+....+..+...++....
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (325)
T 3kn6_A 161 PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAW 240 (325)
T ss_dssp C----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHH
T ss_pred CCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccc
Confidence 32 23344567899999999999999999999999999999999999997643 34666777777776666555
Q ss_pred CCCCHHHHHHHHHhcccCC
Q psy12709 235 GHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP 253 (253)
..+|+++++||.+||+.||
T Consensus 241 ~~~s~~~~~li~~~L~~dP 259 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDP 259 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCT
T ss_pred cCCCHHHHHHHHHHCCCCh
Confidence 6799999999999999998
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=301.01 Aligned_cols=244 Identities=25% Similarity=0.380 Sum_probs=201.6
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc---hHHHHHHHHHHHHHHHh--cCCCCceeeeeEEE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS---MDQMQDILHEAAVLYLA--QKSERIVGLHEIYE 81 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~~e~~~~~~~--~~~~~i~~~~~~~~ 81 (253)
..++|+ +++.||+|+||+||+|.+..+++.||+|++...... ........+|+..+... .+|+||+++++++.
T Consensus 7 ~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 7 ATSRYE--PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp ---CCE--EEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccceE--EEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 456777 999999999999999999999999999998754321 11123455566655533 36999999999998
Q ss_pred eCC-----eEEEEEeccCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEe
Q psy12709 82 TPH-----EMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCD 154 (253)
Q Consensus 82 ~~~-----~~~lv~e~~~g~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~d 154 (253)
... .+++++|++. ++|.+++..... +++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence 765 5899999996 499998876544 99999999999999999999999999999999999999999999999
Q ss_pred ecccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC---
Q psy12709 155 FGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE--- 231 (253)
Q Consensus 155 f~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--- 231 (253)
||.+.............+++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.+..+....+......++.
T Consensus 164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (308)
T 3g33_A 164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243 (308)
T ss_dssp CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred CccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 99998766555555667899999999998889999999999999999999999999998888887776543222221
Q ss_pred --------------------CccCCCCHHHHHHHHHhcccCC
Q psy12709 232 --------------------DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 232 --------------------~~~~~~~~~l~~li~~~l~~dP 253 (253)
...+.+++++.+||.+||+.||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 285 (308)
T 3g33_A 244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNP 285 (308)
T ss_dssp CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSST
T ss_pred cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCC
Confidence 1224689999999999999998
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=315.64 Aligned_cols=242 Identities=29% Similarity=0.454 Sum_probs=204.2
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
.++|+ +++.||+|+||+||+|.++.+++.||+|++.+... .......+.+|...+. ..+|++|+++++++..++.+
T Consensus 60 ~~~f~--~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~-~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 60 RDDFE--ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV-NGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp GGGEE--EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHH-HSCTTTBCCEEEEEECSSEE
T ss_pred hhhEE--EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHH-hcCCCCeeeEEEEEeeCCEE
Confidence 45566 99999999999999999999999999999976432 1223345677888887 77999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~ 165 (253)
++||||++|++|.+++... ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.+|.++|+|||++.......
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 9999999999999999764 479999999999999999999999999999999999999999999999999998654432
Q ss_pred c--ccccccCccccCccccC-------CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC-CccC
Q psy12709 166 E--VKEIIGTPDYVAPEVLS-------YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE-DLFG 235 (253)
Q Consensus 166 ~--~~~~~~~~~~~~PE~~~-------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-~~~~ 235 (253)
. .....+++.|+|||++. ...++.++|+||+|+++|+|++|+.||.+.+..+.+.++......... ....
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 296 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE 296 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence 2 23457899999999986 356889999999999999999999999999998888887764322211 1224
Q ss_pred CCCHHHHHHHHHhcccCC
Q psy12709 236 HISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 236 ~~~~~l~~li~~~l~~dP 253 (253)
.+|+++++||++||+ ||
T Consensus 297 ~~s~~~~dli~~lL~-~p 313 (412)
T 2vd5_A 297 GVPEEARDFIQRLLC-PP 313 (412)
T ss_dssp CCCHHHHHHHHTTSS-CG
T ss_pred CCCHHHHHHHHHHcC-Ch
Confidence 789999999999998 76
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=309.37 Aligned_cols=249 Identities=20% Similarity=0.269 Sum_probs=204.6
Q ss_pred cceeecceeeEEEeecCCC--CceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy12709 4 KFFVNGGYQTLIFCMPSRG--KFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81 (253)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g--~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 81 (253)
+-+...+-+|++++.||+| +||+||+|.+..++..||+|++............+.+|+..+. .++|+||+++++++.
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~ 96 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK-LFNHPNIVPYRATFI 96 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEE
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHH-hCCCCCCCcEeEEEE
Confidence 3444444455599999999 9999999999999999999999887766677788888999988 778999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 82 TPHEMVLVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 82 ~~~~~~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
.++.+++||||+++++|.+++... ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 999999999999999999998765 669999999999999999999999999999999999999999999999999876
Q ss_pred ccccc--------ccccccccCccccCccccCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccc-
Q psy12709 160 VVNDV--------VEVKEIIGTPDYVAPEVLSY--EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFS- 228 (253)
Q Consensus 160 ~~~~~--------~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~- 228 (253)
..... .......+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+.+.......+......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 43211 11122367888999999987 57899999999999999999999999887666555444332211
Q ss_pred -----------------------------------------ccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 229 -----------------------------------------FHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 229 -----------------------------------------~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+.......+++++.+||.+||+.||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 322 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNP 322 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCT
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCc
Confidence 0112334689999999999999998
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=301.73 Aligned_cols=241 Identities=25% Similarity=0.391 Sum_probs=196.7
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +++.||+|+||+||+|.+. +++.||+|++............+.+|+..+. ..+|+||+++++++..++.++
T Consensus 20 ~~~y~--~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 20 MEKYQ--KLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLK-ELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp SCEEE--EEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHH-HCCCTTBCCEEEEECCSSCEE
T ss_pred HhhhH--hhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHH-HcCCCCEeeeeeEEccCCEEE
Confidence 35666 9999999999999999986 5899999999876555555677889999998 679999999999999999999
Q ss_pred EEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-c
Q psy12709 88 LVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-V 165 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~ 165 (253)
+||||+++ +|.+.+.. ...+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp EEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred EEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 99999976 67666654 455999999999999999999999999999999999999999999999999999865432 2
Q ss_pred cccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC-------------
Q psy12709 166 EVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE------------- 231 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~------------- 231 (253)
......+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+.+..+....+......+..
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 3334567899999999876 56899999999999999999999999987777666655432211111
Q ss_pred -------------CccCCCCHHHHHHHHHhcccCC
Q psy12709 232 -------------DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 232 -------------~~~~~~~~~l~~li~~~l~~dP 253 (253)
...+.+++++.+||.+||+.||
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 289 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDP 289 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCT
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCCh
Confidence 1224578999999999999998
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=311.46 Aligned_cols=243 Identities=23% Similarity=0.339 Sum_probs=195.5
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC--
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH-- 84 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-- 84 (253)
+.++|+ +++.||+|+||+||+|.+..+++.||+|++..............+|+..+.....|+||+++++++..++
T Consensus 7 ~~~~y~--~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 7 VLRKYE--LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHTTEE--EEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred ccCceE--EEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 345677 9999999999999999999999999999998776666777888999999996767999999999998654
Q ss_pred eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc-
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND- 163 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~- 163 (253)
.+++||||++ ++|..++.. ..+++..+..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 7999999997 589888875 4689999999999999999999999999999999999999999999999999975432
Q ss_pred ---------------------cccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy12709 164 ---------------------VVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLN 221 (253)
Q Consensus 164 ---------------------~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 221 (253)
........+++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 111223468899999999876 6789999999999999999999999999888877776
Q ss_pred hhcccccccCC-------------------------------------------ccCCCCHHHHHHHHHhcccCC
Q psy12709 222 ISQCNFSFHED-------------------------------------------LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 222 i~~~~~~~~~~-------------------------------------------~~~~~~~~l~~li~~~l~~dP 253 (253)
+......+... ....+++++.+||.+||+.||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 65322221110 012679999999999999998
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=298.38 Aligned_cols=244 Identities=25% Similarity=0.460 Sum_probs=202.4
Q ss_pred cceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch------------------------HHHHHHHH
Q psy12709 4 KFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM------------------------DQMQDILH 59 (253)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~------------------------~~~~~~~~ 59 (253)
.....++|+ +.+.||+|+||+||+|.+..++..||+|++....... .....+.+
T Consensus 8 ~~~~~~~y~--~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (298)
T 2zv2_A 8 DCVQLNQYT--LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQ 85 (298)
T ss_dssp --CEETTEE--EEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHH
T ss_pred CceeecceE--EEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHH
Confidence 344567777 9999999999999999999999999999987653211 12356788
Q ss_pred HHHHHHHhcCCCCceeeeeEEEe--CCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy12709 60 EAAVLYLAQKSERIVGLHEIYET--PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137 (253)
Q Consensus 60 e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di 137 (253)
|+..+. .++|+||+++++++.. ++.+++||||+++++|.++.. ...+++..++.++.|++.|+.|||++|++|+||
T Consensus 86 E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl 163 (298)
T 2zv2_A 86 EIAILK-KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDI 163 (298)
T ss_dssp HHHHHH-TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHHH-hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 999998 7799999999999987 568999999999999988754 456999999999999999999999999999999
Q ss_pred CCCCEEEcCCCceEEEeeccccccccc-ccccccccCccccCccccCCCC---CCccccHHHHHHHHHHHHhCCCCCCCC
Q psy12709 138 KPQNILLTKDNNIKLCDFGISRVVNDV-VEVKEIIGTPDYVAPEVLSYEP---ISLATDMWSVGVLAYVLLSSHSPFAGD 213 (253)
Q Consensus 138 ~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~ 213 (253)
+|+||+++.++.++|+|||++...... .......+++.|+|||++.+.. .+.++||||+|+++|+|++|+.||...
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999999865433 2234457899999999997765 367899999999999999999999988
Q ss_pred ChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 214 NKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 214 ~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
........+.......+. ...+++++.++|.+||+.||
T Consensus 244 ~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp 281 (298)
T 2zv2_A 244 RIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNP 281 (298)
T ss_dssp SHHHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCT
T ss_pred cHHHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcCh
Confidence 877777777665554443 34789999999999999998
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=297.17 Aligned_cols=244 Identities=34% Similarity=0.534 Sum_probs=215.3
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-------chHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-------SMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 80 (253)
.++|+ +.+.||+|++|.||+|.+..+++.||+|++..... .......+.+|+..+.+..+|+||+++++++
T Consensus 16 ~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 16 YENYE--PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp TTTEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhccc--eeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 45666 99999999999999999999999999999976431 1233467788999998777899999999999
Q ss_pred EeCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 81 ~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
..++..++|||++++++|.+++..+..+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999999998888899999999999999999999999999999999999999999999999999987
Q ss_pred ccccccccccccCccccCccccC------CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCcc
Q psy12709 161 VNDVVEVKEIIGTPDYVAPEVLS------YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLF 234 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 234 (253)
...........+++.|+|||++. ...++.++|+||||+++|+|++|..||...+.......+.......+.+..
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccc
Confidence 66554555567899999999974 456788999999999999999999999998888888888877776666555
Q ss_pred CCCCHHHHHHHHHhcccCC
Q psy12709 235 GHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP 253 (253)
..+++++.++|.+||+.||
T Consensus 254 ~~~~~~l~~li~~~l~~dp 272 (298)
T 1phk_A 254 DDYSDTVKDLVSRFLVVQP 272 (298)
T ss_dssp GGSCHHHHHHHHHHCCSSG
T ss_pred cccCHHHHHHHHHHccCCc
Confidence 6889999999999999998
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=305.16 Aligned_cols=243 Identities=32% Similarity=0.530 Sum_probs=213.6
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc------hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS------MDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
++|+ +.+.||+|++|+||+|.+..+|+.||+|++...... ......+.+|+..+....+|+||+++++++..
T Consensus 94 ~~y~--~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 94 QKYD--PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhcc--cceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 4566 999999999999999999999999999998764421 12245677899999866699999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN 162 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~ 162 (253)
.+..++||||++|++|.+++.....+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 99999999999999999999887889999999999999999999999999999999999999999999999999998766
Q ss_pred ccccccccccCccccCccccCC------CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCC
Q psy12709 163 DVVEVKEIIGTPDYVAPEVLSY------EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGH 236 (253)
Q Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 236 (253)
.........+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+.......+..+...++.+....
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 331 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD 331 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSS
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence 5555556678999999999853 3578899999999999999999999999888888888877776665555568
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
+++++.++|.+||+.||
T Consensus 332 ~~~~~~~li~~~L~~dP 348 (365)
T 2y7j_A 332 RSSTVKDLISRLLQVDP 348 (365)
T ss_dssp SCHHHHHHHHHHSCSST
T ss_pred CCHHHHHHHHHHcCCCh
Confidence 89999999999999998
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=318.59 Aligned_cols=243 Identities=22% Similarity=0.337 Sum_probs=199.4
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC-
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP- 83 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~- 83 (253)
+.+.++|+ +++.||+|+||+||+|.+..+++.||+|++............+.+|+..+. ..+|+||+++++++...
T Consensus 58 ~~~~~~y~--~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~ 134 (464)
T 3ttj_A 58 FTVLKRYQ--NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQK 134 (464)
T ss_dssp EEEETTEE--EEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHH-HCCCTTBCCCSEEECSCC
T ss_pred eeecCCeE--EEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHH-hCCCCCCCcEEEEEccCC
Confidence 34567777 999999999999999999999999999999877666677788899999998 77999999999999654
Q ss_pred -----CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccc
Q psy12709 84 -----HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGIS 158 (253)
Q Consensus 84 -----~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~ 158 (253)
..+++||||++++ +.+.+. ..+++..++.++.|++.|++|||++|++||||+|+||+++.++.++|+|||++
T Consensus 135 ~~~~~~~~~lv~E~~~~~-l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 135 TLEEFQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp STTTCCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred ccccCCeEEEEEeCCCCC-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 3679999999764 555553 34899999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCcc----
Q psy12709 159 RVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLF---- 234 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~---- 234 (253)
.............+++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+.+..+......+.....
T Consensus 212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 212 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp -----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred eecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 8766554555567899999999999999999999999999999999999999998888777776553322211100
Q ss_pred ----------------------C------------CCCHHHHHHHHHhcccCC
Q psy12709 235 ----------------------G------------HISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 235 ----------------------~------------~~~~~l~~li~~~l~~dP 253 (253)
+ ..++++++||.+||+.||
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP 344 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 344 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSST
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCCh
Confidence 0 015679999999999998
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=304.72 Aligned_cols=244 Identities=18% Similarity=0.238 Sum_probs=204.0
Q ss_pred CCcceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy12709 2 CNKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81 (253)
Q Consensus 2 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 81 (253)
-+.++++++|+ +.+.||+|+||+||+|.+..+++.||+|++...... ..+.+|+..+..+.+|+||+++++++.
T Consensus 2 ~~~~~~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~ 75 (330)
T 2izr_A 2 MGVLMVGPNFR--VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGP 75 (330)
T ss_dssp --CCEETTTEE--EEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEE
T ss_pred CceEEEcCCeE--EEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEe
Confidence 35677888898 999999999999999999999999999998765432 257789999986669999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc-----eEEEee
Q psy12709 82 TPHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN-----IKLCDF 155 (253)
Q Consensus 82 ~~~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~-----~~l~df 155 (253)
.++..++|||++ +++|.+++.. ...+++..++.++.|++.|+.|||++|++|+||+|+||+++.++. ++|+||
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 76 CGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDF 154 (330)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred cCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence 999999999999 8999999876 467999999999999999999999999999999999999999887 999999
Q ss_pred ccccccccccc--------ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHhhc
Q psy12709 156 GISRVVNDVVE--------VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDN---KQETFLNISQ 224 (253)
Q Consensus 156 ~~~~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~i~~ 224 (253)
|++........ .....+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+ ..+.+..+..
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 99986543221 234578999999999999999999999999999999999999998743 3444555544
Q ss_pred ccccccCC-ccCCCCHHHHHHHHHhcccCC
Q psy12709 225 CNFSFHED-LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 225 ~~~~~~~~-~~~~~~~~l~~li~~~l~~dP 253 (253)
.....+.. .....| ++.++|.+||+.||
T Consensus 235 ~~~~~~~~~~~~~~p-~~~~li~~~l~~~p 263 (330)
T 2izr_A 235 TKRATPIEVLCENFP-EMATYLRYVRRLDF 263 (330)
T ss_dssp HHHHSCHHHHTTTCH-HHHHHHHHHHHCCT
T ss_pred hhccCCHHHHhccCh-HHHHHHHHHHhCCC
Confidence 43333322 222345 99999999999998
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=323.49 Aligned_cols=240 Identities=29% Similarity=0.469 Sum_probs=206.6
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
..++|+ +.+.||+|+||+||+|.+..+++.||+|++.+... .......+.+|+..+. ..+|+||+++++++..++.
T Consensus 182 ~~~~f~--~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 182 TKNTFR--QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE-KVNSRFVVSLAYAYETKDA 258 (576)
T ss_dssp CGGGEE--EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSE
T ss_pred cccceE--EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHH-HcCCCCEeeEEEEEeeCCE
Confidence 345566 99999999999999999999999999999976432 1223456788999988 7799999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
+++||||++|++|.+++.... .+++..++.++.|++.|+.|||++|++|+||+|+||+++.+|.++|+|||++.....
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999999887643 499999999999999999999999999999999999999999999999999987655
Q ss_pred cccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHhhcccccccCCccCCCCH
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDN----KQETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
........+++.|+|||++.+..++.++|+||+|+++|+|++|+.||.+.. .......+.......+ ..+|+
T Consensus 339 ~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~s~ 414 (576)
T 2acx_A 339 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSP 414 (576)
T ss_dssp TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTSCH
T ss_pred CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccCCH
Confidence 544455689999999999998889999999999999999999999998753 3444555554444333 47899
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
++++||.+||+.||
T Consensus 415 ~~~dLI~~lL~~dP 428 (576)
T 2acx_A 415 QARSLCSQLLCKDP 428 (576)
T ss_dssp HHHHHHHHHTCSSG
T ss_pred HHHHHHHHhccCCH
Confidence 99999999999998
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=298.35 Aligned_cols=241 Identities=34% Similarity=0.567 Sum_probs=212.0
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
+.++|+ +.+.||+|+||+||+|.+..+++.|++|++...... ....+.+|+..+. ..+|+||+++++++..++.+
T Consensus 7 ~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~ 81 (304)
T 2jam_A 7 IRKTFI--FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLK-KIKHENIVTLEDIYESTTHY 81 (304)
T ss_dssp HHHHEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHH-HCCCTTBCCEEEEEECSSEE
T ss_pred hhccce--eeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHH-hCCCCCeeehhhhcccCCEE
Confidence 456677 999999999999999999999999999999864322 2346778999888 67999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---cCCCceEEEeecccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILL---TKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~---~~~~~~~l~df~~~~~~~~ 163 (253)
+++||++++++|.+++.....+++..++.++.|++.++.+||++|++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999999999998877889999999999999999999999999999999999999 6788999999999875443
Q ss_pred cccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
. ......+++.|+|||++.+..++.++|+||+|+++|+|++|+.||...+.......+.......+......+|+++.+
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (304)
T 2jam_A 162 G-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD 240 (304)
T ss_dssp B-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred C-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence 2 223346789999999999989999999999999999999999999999888888888887777666666789999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 241 li~~~l~~dp 250 (304)
T 2jam_A 241 FICHLLEKDP 250 (304)
T ss_dssp HHHHHHCSST
T ss_pred HHHHHcCCCh
Confidence 9999999998
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=294.35 Aligned_cols=237 Identities=31% Similarity=0.499 Sum_probs=210.1
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVL 90 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 90 (253)
+|++.+.||+|+||+||+|.+..+++.|++|++.... ........+.+|+..+. ...|+||+++++++..++..+++|
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR-SLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHH-hCCCCCEeeeeeeeccCCEEEEEE
Confidence 4449999999999999999999999999999987654 33445667888998888 779999999999999999999999
Q ss_pred eccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc-cccccc
Q psy12709 91 EMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVEVKE 169 (253)
Q Consensus 91 e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~-~~~~~~ 169 (253)
|++++++|.+++.....+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+..... ......
T Consensus 95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 174 (294)
T ss_dssp ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccccc
Confidence 9999999999998878899999999999999999999999999999999999999999999999999976542 222334
Q ss_pred cccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 170 IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
..+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||......+.+..+.......+. .+++++.++|.+||
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l 250 (294)
T 2rku_A 175 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKML 250 (294)
T ss_dssp CCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHHHHHHHHT
T ss_pred ccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc----ccCHHHHHHHHHHc
Confidence 56789999999999888999999999999999999999999998888888777776655443 78999999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
+.||
T Consensus 251 ~~~p 254 (294)
T 2rku_A 251 QTDP 254 (294)
T ss_dssp CSSG
T ss_pred ccCh
Confidence 9997
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=299.16 Aligned_cols=242 Identities=29% Similarity=0.416 Sum_probs=202.6
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +++.||+|+||+||+|.+..++..||+|++............+.+|+..+. ..+|+||+++++++..++..++
T Consensus 3 ~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 3 EKYE--KIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLK-QLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp CCEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEE
T ss_pred ccce--EeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHH-hCCCCCccchhheeecCCeEEE
Confidence 5666 999999999999999999999999999999877666666677888999998 7789999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-ccc
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEV 167 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~ 167 (253)
||||+++++|.+++.....+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence 9999999999999887888999999999999999999999999999999999999999999999999999865532 223
Q ss_pred cccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc-----------------
Q psy12709 168 KEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF----------------- 229 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----------------- 229 (253)
....+++.|+|||++.+ ..++.++|+||+|+++|+|++|..||.+.+..+....+.......
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 34567899999999865 567999999999999999999999999988777665544321110
Q ss_pred ----c------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 ----H------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 ----~------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+ ....+.+|+++.+||.+||+.||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 273 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDP 273 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSST
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCCh
Confidence 0 01124789999999999999998
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=295.52 Aligned_cols=243 Identities=26% Similarity=0.449 Sum_probs=211.8
Q ss_pred CcceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc-hHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy12709 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS-MDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81 (253)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 81 (253)
...+..++|+ +.+.||+|+||.||+|.+..++..|++|++...... ......+.+|+..+. ..+|+||+++++++.
T Consensus 8 ~~~~~~~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 8 KRKFTIDDFD--IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS-HLRHPNILRMYNYFH 84 (284)
T ss_dssp --CCCGGGEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-TCCCTTBCCEEEEEE
T ss_pred ccchhhhhce--eeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHh-cCCCCCEeeEEEEEE
Confidence 3445667788 999999999999999999999999999998764321 122457788888888 778999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 82 TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 82 ~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
.++..+++||++++++|.+++.....+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 99999999999999999999988788999999999999999999999999999999999999999999999999998755
Q ss_pred cccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHH
Q psy12709 162 NDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQA 241 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 241 (253)
... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....+.......+ ..+++++
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 239 (284)
T 2vgo_A 165 PSL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGS 239 (284)
T ss_dssp SSS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHH
T ss_pred ccc-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHH
Confidence 432 22345688999999999988899999999999999999999999999888888877777655444 3789999
Q ss_pred HHHHHHhcccCC
Q psy12709 242 KDFIQSCLVTDP 253 (253)
Q Consensus 242 ~~li~~~l~~dP 253 (253)
+++|.+||+.||
T Consensus 240 ~~li~~~l~~~p 251 (284)
T 2vgo_A 240 KDLISKLLRYHP 251 (284)
T ss_dssp HHHHHHHSCSSG
T ss_pred HHHHHHHhhcCH
Confidence 999999999998
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=303.07 Aligned_cols=242 Identities=32% Similarity=0.543 Sum_probs=202.3
Q ss_pred ecceeeEEE-eecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 8 NGGYQTLIF-CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 8 ~~~~~~~~~-~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
.++|+ +. +.||+|+||+||+|.+..+++.||+|++..... .....+.+|+..+.+..+|+||+++++++..++.+
T Consensus 11 ~~~y~--i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 11 EDVYQ--LQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp TTSCE--ECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ceeEE--ecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 45566 85 789999999999999999999999999976543 23457889999998778999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc---eEEEeecccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN---IKLCDFGISRVVND 163 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~---~~l~df~~~~~~~~ 163 (253)
++|||+++|++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999999999988888999999999999999999999999999999999999998776 99999999875432
Q ss_pred c--------ccccccccCccccCccccCC-----CCCCccccHHHHHHHHHHHHhCCCCCCCCCh---------------
Q psy12709 164 V--------VEVKEIIGTPDYVAPEVLSY-----EPISLATDMWSVGVLAYVLLSSHSPFAGDNK--------------- 215 (253)
Q Consensus 164 ~--------~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------------- 215 (253)
. .......+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+...
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 1 11223458899999999865 4578899999999999999999999977542
Q ss_pred HHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 216 QETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 216 ~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
......+.......+......+++++++||.+||+.||
T Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 284 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDA 284 (316)
T ss_dssp HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSST
T ss_pred HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCCh
Confidence 34556666666666655556789999999999999998
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=318.03 Aligned_cols=240 Identities=29% Similarity=0.466 Sum_probs=207.1
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc-hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS-MDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
..++|+ +.+.||+|+||+||+|.++.+++.||+|++.+.... ......+.+|+..+. ..+|+||+++++++...+.
T Consensus 183 ~~~~f~--~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 183 GEDWFL--DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA-KVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp CGGGEE--EEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSE
T ss_pred ChhheE--EEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHH-hcCCCCEeeEEEEEeeCCE
Confidence 345666 999999999999999999999999999999765421 233467788999888 6799999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQ----DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
+++||||++|++|..++... ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.+|.++|+|||++...
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999999988653 36999999999999999999999999999999999999999999999999999866
Q ss_pred cccc-cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHhhcccccccCCccCC
Q psy12709 162 NDVV-EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGD----NKQETFLNISQCNFSFHEDLFGH 236 (253)
Q Consensus 162 ~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~----~~~~~~~~i~~~~~~~~~~~~~~ 236 (253)
.... ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.+. ...+....+.......+ ..
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~~ 415 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DK 415 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----TT
T ss_pred cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----cc
Confidence 5432 233457899999999999999999999999999999999999999875 33556666666555444 37
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
+|++++++|.+||++||
T Consensus 416 ~s~~~~~li~~lL~~dP 432 (543)
T 3c4z_A 416 FSPASKDFCEALLQKDP 432 (543)
T ss_dssp SCHHHHHHHHHHSCSSG
T ss_pred cCHHHHHHHHHhccCCH
Confidence 89999999999999998
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=304.24 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=203.6
Q ss_pred CCCcceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy12709 1 MCNKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80 (253)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 80 (253)
|+.....+++|+ +.+.||+|+||+||+|.+..+++.||+|++...... .....+.+|+..+. ..+|+||+++++++
T Consensus 1 m~~~~~~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~-~l~h~~iv~~~~~~ 76 (319)
T 4euu_A 1 MGSQSTSNHLWL--LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLK-KLNHKNIVKLFAIE 76 (319)
T ss_dssp -CEEECSSEEEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHH-HCCCTTBCCEEEEE
T ss_pred CCcccCCCCCEE--EEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHH-hcCCCCcceEEEEe
Confidence 566677788888 999999999999999999999999999999764422 22456778999988 67899999999999
Q ss_pred EeCC--eEEEEEeccCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE----cCCCceE
Q psy12709 81 ETPH--EMVLVLEMVPDGELQRLVDIQD---GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILL----TKDNNIK 151 (253)
Q Consensus 81 ~~~~--~~~lv~e~~~g~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~----~~~~~~~ 151 (253)
...+ ..++||||+++++|.+++.... .+++..++.++.|++.|+.|||++|++|+||+|+||++ +.++.++
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 156 (319)
T 4euu_A 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYK 156 (319)
T ss_dssp ECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEE
T ss_pred ecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEE
Confidence 8765 7899999999999999997643 38999999999999999999999999999999999999 7778899
Q ss_pred EEeecccccccccccccccccCccccCccccC--------CCCCCccccHHHHHHHHHHHHhCCCCCCCCC----hHHHH
Q psy12709 152 LCDFGISRVVNDVVEVKEIIGTPDYVAPEVLS--------YEPISLATDMWSVGVLAYVLLSSHSPFAGDN----KQETF 219 (253)
Q Consensus 152 l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~ 219 (253)
|+|||.+.............+++.|+|||++. +..++.++||||+|+++|+|++|+.||.... ..+..
T Consensus 157 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 157 LTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred EccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 99999998776655555667899999999985 4678899999999999999999999996432 23344
Q ss_pred HHhhccccc---------------------ccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 220 LNISQCNFS---------------------FHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 220 ~~i~~~~~~---------------------~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+...... ........+++.+.++|.+||+.||
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 291 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ 291 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCT
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCCh
Confidence 444333221 1111223456679999999999998
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=304.64 Aligned_cols=239 Identities=20% Similarity=0.336 Sum_probs=204.2
Q ss_pred cceeeEEEeecCCCCceEEEEEEec-------cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHK-------ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 81 (253)
++|+ +.+.||+|+||+||+|.+. .++..||+|++.... .......+.+|+..+....+||||+++++++.
T Consensus 81 ~~~~--~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 81 DKLT--LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGEE--EEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHCE--eeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 4555 9999999999999999875 245679999997653 34556789999999996669999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc
Q psy12709 82 TPHEMVLVLEMVPDGELQRLVDIQD----------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLT 145 (253)
Q Consensus 82 ~~~~~~lv~e~~~g~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~ 145 (253)
.++.+++||||+++++|.+++.... .++...++.++.|++.|+.|||++|++|+||+|+||+++
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence 9999999999999999999987643 378999999999999999999999999999999999999
Q ss_pred CCCceEEEeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy12709 146 KDNNIKLCDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLN 221 (253)
Q Consensus 146 ~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~ 221 (253)
.++.++|+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~ 317 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999998654322 2223345678999999998999999999999999999999 9999999888887777
Q ss_pred hhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 222 ISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 222 i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+..+.... ....+++++.++|.+||+.||
T Consensus 318 ~~~~~~~~---~~~~~~~~l~~li~~~l~~dP 346 (370)
T 2psq_A 318 LKEGHRMD---KPANCTNELYMMMRDCWHAVP 346 (370)
T ss_dssp HHTTCCCC---CCTTSCHHHHHHHHHHTCSSG
T ss_pred HhcCCCCC---CCCCCCHHHHHHHHHHcCCCh
Confidence 66654322 224789999999999999998
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=293.34 Aligned_cols=242 Identities=30% Similarity=0.487 Sum_probs=203.5
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
.+..++|+ +.+.||+|+||.||+|.+..+++.|++|++..... .......+.+|+..+. ..+|+||+++++++..+
T Consensus 7 ~~~~~~y~--i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 7 RVKIGHYV--LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRHPHIIKLYQVISTP 83 (276)
T ss_dssp CCEETTEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-TCCCTTBCCEEEEEECS
T ss_pred cceeccEE--EEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHh-cCCCCCEeEEEEEEecC
Confidence 34567788 99999999999999999999999999999876432 2233567888998888 77899999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
+..+++||++++++|.+++.....+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999999999998888899999999999999999999999999999999999999999999999999987655
Q ss_pred cccccccccCccccCccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHH
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSYEPI-SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAK 242 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~ 242 (253)
........+++.|+|||.+.+..+ +.++|+||+|+++|+|++|+.||...........+.......+. .+++++.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~ 239 (276)
T 2h6d_A 164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE----YLNRSVA 239 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHH
T ss_pred CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCch----hcCHHHH
Confidence 444445568899999999987765 68999999999999999999999998888888777766554443 6799999
Q ss_pred HHHHHhcccCC
Q psy12709 243 DFIQSCLVTDP 253 (253)
Q Consensus 243 ~li~~~l~~dP 253 (253)
++|.+||+.||
T Consensus 240 ~li~~~l~~~p 250 (276)
T 2h6d_A 240 TLLMHMLQVDP 250 (276)
T ss_dssp HHHHHHTCSSG
T ss_pred HHHHHHccCCh
Confidence 99999999998
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=298.74 Aligned_cols=238 Identities=31% Similarity=0.495 Sum_probs=210.9
Q ss_pred eeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 11 YQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
.+|++.+.||+|+||+||+|.+..+++.|++|++.... ........+.+|+..+. ..+|+||+++++++..++..+++
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR-SLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEecCCeEEEE
Confidence 34559999999999999999999999999999997654 33455677888998888 77999999999999999999999
Q ss_pred EeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc-ccccc
Q psy12709 90 LEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVEVK 168 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~-~~~~~ 168 (253)
|||+++++|.+++.....+++..++.++.|++.++.|||++|++|+||+|+||+++.++.++|+|||.+..... .....
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 199 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccccc
Confidence 99999999999998878899999999999999999999999999999999999999999999999999986542 22333
Q ss_pred ccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 169 EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
...+++.|+|||++.+..++.++||||||+++|+|++|+.||......+.+..+.......+. .+++++.++|.+|
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~ 275 (335)
T 2owb_A 200 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKM 275 (335)
T ss_dssp CCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHHHHHHHHH
T ss_pred ccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc----cCCHHHHHHHHHH
Confidence 456889999999998888999999999999999999999999998888888777776655443 7899999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|+.||
T Consensus 276 l~~dp 280 (335)
T 2owb_A 276 LQTDP 280 (335)
T ss_dssp TCSSG
T ss_pred ccCCh
Confidence 99997
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=293.86 Aligned_cols=241 Identities=27% Similarity=0.464 Sum_probs=209.2
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch-HHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM-DQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
-+..++|+ +.+.||+|+||+||+|.+..++..|++|++....... .....+.+|+..+. ..+|+||+++++++..+
T Consensus 5 ~~~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~ 81 (279)
T 3fdn_A 5 QWALEDFE--IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS-HLRHPNILRLYGYFHDA 81 (279)
T ss_dssp CCCGGGEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHT-TCCCTTBCCEEEEEECS
T ss_pred eeecccEE--EeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHH-cCCCCCCcchhheEecC
Confidence 35567777 9999999999999999999999999999987644222 22456777888887 77899999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
+..+++|||+++++|.+.+.....+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999999999998878899999999999999999999999999999999999999999999999998865433
Q ss_pred cccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
.. .....+++.|+|||.+.+..++.++||||+|+++|+|++|..||...+..+....+.......+. .+++++.+
T Consensus 162 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 236 (279)
T 3fdn_A 162 SR-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 236 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHHHH
T ss_pred cc-ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC----cCCHHHHH
Confidence 22 23456789999999999989999999999999999999999999999988888888776665554 68999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 237 li~~~l~~~p 246 (279)
T 3fdn_A 237 LISRLLKHNP 246 (279)
T ss_dssp HHHHHCCSSG
T ss_pred HHHHHhccCh
Confidence 9999999998
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=305.57 Aligned_cols=243 Identities=29% Similarity=0.468 Sum_probs=206.9
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc---cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR---RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
.++|+ +.+.||+|+||+||+|.+..++..||+|++.... ........+.+|+..+. .++||||+++++++..++
T Consensus 25 ~~~y~--~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 25 QKKYH--LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK-KLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHEE--EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHH-HCCCTTBCCEEEEEECSS
T ss_pred hhhee--ecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHH-hCCCCCcceeehhhccCC
Confidence 45566 9999999999999999999999999999997653 13344678889999998 668999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhh----------------------------------------cCCCCHHHHHHHHHHHHHHH
Q psy12709 85 EMVLVLEMVPDGELQRLVDI----------------------------------------QDGIPEQDTRSYMKQILEAL 124 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~----------------------------------------~~~~~~~~~~~~~~~l~~~l 124 (253)
..++||||++|++|.+++.. ...+++..++.++.|++.++
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 99999999999999998852 11136778899999999999
Q ss_pred HHHHHCCceecCCCCCCEEEcCCC--ceEEEeecccccccccc-----cccccccCccccCccccCC--CCCCccccHHH
Q psy12709 125 AFLHDHNITHLDLKPQNILLTKDN--NIKLCDFGISRVVNDVV-----EVKEIIGTPDYVAPEVLSY--EPISLATDMWS 195 (253)
Q Consensus 125 ~~lh~~~~~h~di~~~ni~~~~~~--~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~s 195 (253)
.|||++|++|+||+|+||+++.++ .++|+|||.+....... ......+++.|+|||++.+ ..++.++||||
T Consensus 182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 999999999999999999998776 89999999998653211 2234568899999999865 67889999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 196 lG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
||+++|+|++|+.||.+.+..+....+.......+.+....+++++.++|.+||+.||
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 319 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNV 319 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCT
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCCh
Confidence 9999999999999999999998888888877777766666799999999999999998
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=295.51 Aligned_cols=242 Identities=36% Similarity=0.601 Sum_probs=213.9
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +.+.||+|++|+||+|.+..++..|++|++............+.+|+..+. ..+|+||+++++++..++.++
T Consensus 21 ~~~y~--i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 21 AERYN--IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK-KLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHEE--EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEEE
T ss_pred hhcce--eeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHH-hccCCCccEEEEEEeCCCeEE
Confidence 45677 999999999999999999999999999999876554455678889999998 679999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC---CceEEEeeccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD---NNIKLCDFGISRVVNDV 164 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~---~~~~l~df~~~~~~~~~ 164 (253)
+++|++++++|.+.+.....+++..++.++.|++.++.+||++|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 999999999999988877789999999999999999999999999999999999999764 46999999998866554
Q ss_pred ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
.......+++.|+|||.+.+. ++.++|+||+|+++|+|++|..||.+.+..+....+.......+.+....+|+++.++
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (287)
T 2wei_A 178 TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (287)
T ss_dssp SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence 444445678899999998764 8899999999999999999999999998888888888877666655556899999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||+.||
T Consensus 257 i~~~l~~dp 265 (287)
T 2wei_A 257 IRKMLTFHP 265 (287)
T ss_dssp HHHHTCSSG
T ss_pred HHHHcccCh
Confidence 999999998
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=302.61 Aligned_cols=240 Identities=24% Similarity=0.445 Sum_probs=198.9
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +++.||+|+||+||+|.+..+++.||+|++...... .....+.+|+..+. ..+|+||+++++++..++..+
T Consensus 6 ~~~y~--i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 6 VEDWD--LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINK-MLNHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTCEE--EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHH-HCCCTTBCCEEEEEECSSEEE
T ss_pred hhhce--eeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHH-hCCCCCCCeEEEEEecCCeEE
Confidence 46677 999999999999999999999999999998754332 22356778888887 779999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc---
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV--- 164 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~--- 164 (253)
+||||++|++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999999999987778999999999999999999999999999999999999999999999999999754322
Q ss_pred ccccccccCccccCccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhcccccccCCccCCCCHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPI-SLATDMWSVGVLAYVLLSSHSPFAGDNKQ-ETFLNISQCNFSFHEDLFGHISSQAK 242 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~l~ 242 (253)
.......+++.|+|||++.+..+ +.++||||+|+++|+|++|+.||...... ..+.......... .....+++++.
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 239 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--NPWKKIDSAPL 239 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS--TTGGGSCHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC--CccccCCHHHH
Confidence 22334578999999999977765 77899999999999999999999875554 2222222222221 11247899999
Q ss_pred HHHHHhcccCC
Q psy12709 243 DFIQSCLVTDP 253 (253)
Q Consensus 243 ~li~~~l~~dP 253 (253)
+||.+||+.||
T Consensus 240 ~li~~~L~~dP 250 (323)
T 3tki_A 240 ALLHKILVENP 250 (323)
T ss_dssp HHHHHHSCSST
T ss_pred HHHHHHccCCh
Confidence 99999999998
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=299.11 Aligned_cols=236 Identities=25% Similarity=0.325 Sum_probs=197.1
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +++.||+|+||+||+|.+..+++.||+|++...............|+..+.....|+||+++++++..++.+++
T Consensus 57 ~~y~--~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 57 QSFQ--RLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHEE--EEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhee--eeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 5566 99999999999999999999999999999887666666666777788888778899999999999999999999
Q ss_pred EEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccc
Q psy12709 89 VLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV 167 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 167 (253)
|||++ +++|.+.+.. ...+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCC
Confidence 99999 5688777665 456999999999999999999999999999999999999999999999999999876655555
Q ss_pred cccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~ 247 (253)
....+++.|+|||++.+ .++.++||||+|+++|+|++|..|+.... .+..+..... +......+++++.++|.+
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~l~~li~~ 287 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYL--PPEFTAGLSSELRSVLVM 287 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCC--CHHHHTTSCHHHHHHHHH
T ss_pred cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCC--CcccccCCCHHHHHHHHH
Confidence 55678999999999876 68999999999999999999977665432 2333333322 223345789999999999
Q ss_pred hcccCC
Q psy12709 248 CLVTDP 253 (253)
Q Consensus 248 ~l~~dP 253 (253)
||+.||
T Consensus 288 ~L~~dP 293 (311)
T 3p1a_A 288 MLEPDP 293 (311)
T ss_dssp HSCSST
T ss_pred HcCCCh
Confidence 999998
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=296.34 Aligned_cols=240 Identities=26% Similarity=0.431 Sum_probs=197.4
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +++.||+|+||+||+|.+ .+++.||+|++............+.+|+..+. ..+||||+++++++..++.+++
T Consensus 2 ~~y~--~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~l 77 (288)
T 1ob3_A 2 EKYH--GLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILK-ELKHSNIVKLYDVIHTKKRLVL 77 (288)
T ss_dssp CSEE--EEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGG-GCCCTTBCCEEEEEECSSCEEE
T ss_pred ccch--hhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHH-hcCCCCEeeeeeEEccCCeEEE
Confidence 3566 999999999999999998 57899999999766544434467788999888 7789999999999999999999
Q ss_pred EEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-cc
Q psy12709 89 VLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VE 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~ 166 (253)
|||++++ +|.+++... ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (288)
T ss_dssp EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence 9999976 888887753 66999999999999999999999999999999999999999999999999999765432 22
Q ss_pred ccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc---------------
Q psy12709 167 VKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH--------------- 230 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--------------- 230 (253)
.....+++.|+|||++.+. .++.++||||+|+++|+|++|+.||.+.+..+....+......+.
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 3344678999999998664 589999999999999999999999999887777666543211110
Q ss_pred ----------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 ----------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 ----------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
......+++++.+||.+||+.||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 269 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSST
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCc
Confidence 11224689999999999999998
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=303.53 Aligned_cols=242 Identities=22% Similarity=0.377 Sum_probs=201.1
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
+-+.++|+ +++.||+|+||+||+|.+..+++.||+|++............+.+|+..+. ..+|+||+++++++..++
T Consensus 21 ~~~~~~y~--~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 21 WEVRAVYR--DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK-HMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp ECCBSSEE--EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHH-HCCBTTBCCCSEEECSCS
T ss_pred eeecceEE--EeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHH-hCCCcCCCCceeeEecCC
Confidence 34566677 999999999999999999999999999999776666666778899999998 778999999999998763
Q ss_pred ------eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccc
Q psy12709 85 ------EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGIS 158 (253)
Q Consensus 85 ------~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~ 158 (253)
.+++|||++ +++|.+++.. ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 8899999875 56999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc-------
Q psy12709 159 RVVNDVVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH------- 230 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~------- 230 (253)
...... .....+++.|+|||++.+ ..++.++|+||+||++|+|++|+.||.+.+..+.+..+......++
T Consensus 176 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 176 RQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp EECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 865432 234567899999999876 6789999999999999999999999999888777766544322221
Q ss_pred --------------------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 --------------------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 --------------------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+..++++.+||.+||+.||
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP 296 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 296 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSST
T ss_pred hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCCh
Confidence 12335679999999999999998
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=292.72 Aligned_cols=241 Identities=29% Similarity=0.485 Sum_probs=200.9
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
+.++|+ +.+.||+|+||+||+|.+..++..+++|++...... .....+.+|+..+. ..+|+||+++++++...+..
T Consensus 20 i~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 20 IDDLFI--FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLK-SLDHPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp HHHHEE--EEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEE
T ss_pred hhhhee--ecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHH-hCCCchHHhHHHheecCCeE
Confidence 346677 999999999999999999999999999999875432 23467888999998 77999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc---CCCceEEEeecccc
Q psy12709 87 VLVLEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLT---KDNNIKLCDFGISR 159 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~---~~~~~~l~df~~~~ 159 (253)
++|||++++++|.+.+.. ...+++..++.++.|++.|+.+||++|++|+||+|+||+++ .++.++|+|||.+.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999999888753 36799999999999999999999999999999999999994 45789999999998
Q ss_pred cccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCH
Q psy12709 160 VVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
............+++.|+|||++. ..++.++||||+|+++|+|++|+.||.+.+..+....+.......... ...+++
T Consensus 176 ~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 253 (285)
T 3is5_A 176 LFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPLTP 253 (285)
T ss_dssp C----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCH
T ss_pred ecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCcCCH
Confidence 765554455567899999999986 467899999999999999999999999988887777665554443322 245899
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
++.++|.+||+.||
T Consensus 254 ~~~~li~~~L~~dP 267 (285)
T 3is5_A 254 QAVDLLKQMLTKDP 267 (285)
T ss_dssp HHHHHHHHHTCSCT
T ss_pred HHHHHHHHHccCCh
Confidence 99999999999998
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=295.80 Aligned_cols=242 Identities=21% Similarity=0.306 Sum_probs=198.3
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
.++|+ +.+.||+|+||+||+|.+..+++.|++|++..... .......+.+|+..+. ..+|+||+++++++..++..
T Consensus 33 ~~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 33 FGPYR--LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAG-RLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp -CCEE--EEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEE
T ss_pred eccEE--EEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHh-hcCCCCeeEEEEEEeeCCeE
Confidence 45677 99999999999999999999999999999987543 3344577888988887 77999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV- 165 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~- 165 (253)
++++|+++|++|.+++.....+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987654322
Q ss_pred -cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 166 -EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 166 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...........+. .....+....+.+|+++.++
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l 268 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-QAIPRPSTVRPGIPVAFDAV 268 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH-SCCCCGGGTSTTCCTHHHHH
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc-cCCCCccccCCCCCHHHHHH
Confidence 2234467899999999998899999999999999999999999998876654444333 33334444556899999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||+.||
T Consensus 269 i~~~l~~dP 277 (309)
T 2h34_A 269 IARGMAKNP 277 (309)
T ss_dssp HHHHTCSSG
T ss_pred HHHhccCCH
Confidence 999999998
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=298.13 Aligned_cols=245 Identities=18% Similarity=0.287 Sum_probs=201.5
Q ss_pred CcceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
..++-.++|+ +.+.||+|+||+||+|.+..++..|++|.+... .......+.+|+..+. ..+|+||+++++++..
T Consensus 4 ~~~~~~~~~~--~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~ 78 (310)
T 3s95_A 4 HRIFRPSDLI--HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMR-CLEHPNVLKFIGVLYK 78 (310)
T ss_dssp CEEECGGGEE--EEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEE
T ss_pred ceeeChhHee--ccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHH-hCCCcCcccEEEEEec
Confidence 4556677888 999999999999999999999999999988653 3455678889999988 7789999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
++..++||||+++++|.+++.. ...+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 79 DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLM 158 (310)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceec
Confidence 9999999999999999999987 466999999999999999999999999999999999999999999999999999865
Q ss_pred cccccc---------------cccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccc
Q psy12709 162 NDVVEV---------------KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCN 226 (253)
Q Consensus 162 ~~~~~~---------------~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~ 226 (253)
...... ....+++.|+|||++.+..++.++||||+|+++|+|++|..|+...............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~- 237 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR- 237 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH-
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh-
Confidence 432211 1346889999999999999999999999999999999999998653221110000000
Q ss_pred ccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 227 FSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 227 ~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..........+|+++.++|.+||+.||
T Consensus 238 ~~~~~~~~~~~~~~l~~li~~~l~~dP 264 (310)
T 3s95_A 238 GFLDRYCPPNCPPSFFPITVRCCDLDP 264 (310)
T ss_dssp HHHHHTCCTTCCTTHHHHHHHHTCSSG
T ss_pred ccccccCCCCCCHHHHHHHHHHccCCh
Confidence 000011224789999999999999998
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=298.75 Aligned_cols=248 Identities=27% Similarity=0.433 Sum_probs=204.8
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
+++..--+|++++.||+|+||+||+|.+..+++.||+|++............+.+|+..+. ..+|+||+++++++..++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~ 97 (331)
T 4aaa_A 19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLK-QLRHENLVNLLEVCKKKK 97 (331)
T ss_dssp CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEEETT
T ss_pred hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHh-hCCCCCEeeEEEEeecCC
Confidence 3444444455999999999999999999999999999999877666666677888999988 778999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
..++||||+++++|.++......+++..+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999999999999998877778999999999999999999999999999999999999999999999999999765432
Q ss_pred -ccccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc-------------
Q psy12709 165 -VEVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF------------- 229 (253)
Q Consensus 165 -~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~------------- 229 (253)
.......+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||.+.+..+....+.......
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 223345688999999998775 68899999999999999999999999988776665543321111
Q ss_pred --------------cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 --------------HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 --------------~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.....+.+|+++.+||.+||+.||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 295 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDP 295 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCc
Confidence 011224689999999999999998
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=289.94 Aligned_cols=240 Identities=24% Similarity=0.345 Sum_probs=205.2
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
|..+.-+|++.+.||+|+||+||+|.+. ++..||+|++....... ..+.+|+..+. ..+|+||+++++++..++.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMM-KLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHH-TCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH---HHHHHHHHHHH-hCCCCCEeeEEEEEecCCc
Confidence 3333344459999999999999999987 57779999998765443 46788999998 7789999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
.+++|||+++++|.+++... ..+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999999998654 45899999999999999999999999999999999999999999999999999865432
Q ss_pred c--cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHH
Q psy12709 165 V--EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQA 241 (253)
Q Consensus 165 ~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 241 (253)
. ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |+.||...+..+....+......... ..+++++
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 236 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHV 236 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTSCHHH
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCC---CcCCHHH
Confidence 2 2223345678999999988899999999999999999999 99999999988888877765433322 3679999
Q ss_pred HHHHHHhcccCC
Q psy12709 242 KDFIQSCLVTDP 253 (253)
Q Consensus 242 ~~li~~~l~~dP 253 (253)
.++|.+||+.||
T Consensus 237 ~~li~~~l~~~p 248 (269)
T 4hcu_A 237 YQIMNHCWRERP 248 (269)
T ss_dssp HHHHHHHTCSSG
T ss_pred HHHHHHHccCCc
Confidence 999999999998
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=301.22 Aligned_cols=243 Identities=23% Similarity=0.357 Sum_probs=195.6
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
..++|+ +++.||+|+||+||+|.+..+++.||+|++............+.+|+..+. ..+|+||+++++++..++.+
T Consensus 32 ~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 32 SIDRYR--RITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLK-ELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp CGGGEE--EEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGG-GCCCTTBCCEEEEEEETTEE
T ss_pred chhhEE--EEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHH-HcCCCCcceEEEEEecCCEE
Confidence 345666 999999999999999999999999999999876655555667778999888 67999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc-----CCCceEEEeecccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLT-----KDNNIKLCDFGISRVV 161 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~-----~~~~~~l~df~~~~~~ 161 (253)
++||||++| +|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++ .++.++|+|||.+...
T Consensus 109 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 999999975 9999998888899999999999999999999999999999999999995 4455999999999765
Q ss_pred ccc-ccccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCc------
Q psy12709 162 NDV-VEVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDL------ 233 (253)
Q Consensus 162 ~~~-~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~------ 233 (253)
... .......+++.|+|||++.+. .++.++||||+|+++|+|++|+.||.+.+..+....+......++...
T Consensus 188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 432 223344678999999998774 479999999999999999999999999888877776654322222111
Q ss_pred --------------------cCCCCHHHHHHHHHhcccCC
Q psy12709 234 --------------------FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 --------------------~~~~~~~l~~li~~~l~~dP 253 (253)
...+++++.+||.+||+.||
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 307 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDP 307 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSG
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCCh
Confidence 01278999999999999998
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=298.67 Aligned_cols=240 Identities=19% Similarity=0.279 Sum_probs=204.0
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCc---eEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKV---EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
..++|+ +.+.||+|+||+||+|.+..++. .||+|++.... .......+.+|+..+. .++|+||+++++++..+
T Consensus 47 ~~~~y~--i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 47 EASRIH--IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMG-QFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp CGGGEE--EEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHT-TCCCTTBCCEEEEECGG
T ss_pred ChhHeE--EeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEEeC
Confidence 345666 99999999999999999986554 49999997643 3445677889999998 67899999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN 162 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~ 162 (253)
+..++||||++|++|.+++... ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999999998654 579999999999999999999999999999999999999999999999999998654
Q ss_pred ccc----cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCC
Q psy12709 163 DVV----EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHI 237 (253)
Q Consensus 163 ~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 237 (253)
... ......+++.|+|||++.+..++.++||||+|+++|+|++ |..||.+....+....+......+. ...+
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 279 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA---PMGC 279 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---CTTC
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC---CCCc
Confidence 321 1122234668999999988889999999999999999999 9999999998888887776543332 2478
Q ss_pred CHHHHHHHHHhcccCC
Q psy12709 238 SSQAKDFIQSCLVTDP 253 (253)
Q Consensus 238 ~~~l~~li~~~l~~dP 253 (253)
++++.++|.+||+.||
T Consensus 280 ~~~l~~li~~~l~~dp 295 (325)
T 3kul_A 280 PHALHQLMLDCWHKDR 295 (325)
T ss_dssp CHHHHHHHHHHTCSSG
T ss_pred CHHHHHHHHHHccCCh
Confidence 9999999999999998
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=301.35 Aligned_cols=241 Identities=26% Similarity=0.362 Sum_probs=200.7
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe------
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET------ 82 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~------ 82 (253)
++|+ +++.||+|+||+||+|.+..+++.||+|++............+.+|+..+. ..+|+||+++++++..
T Consensus 17 ~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 17 SKYE--KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ-LLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGEE--EEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHH-HCCCTTBCCEEEEEEEC-----
T ss_pred ccee--EEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHH-hccCCCcccHhheeeccccccc
Confidence 5566 999999999999999999999999999999776654444557778999998 7789999999999987
Q ss_pred --CCeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 83 --PHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 83 --~~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
++.+++||||+++ +|...+.. ...+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4468999999976 66555543 4679999999999999999999999999999999999999999999999999997
Q ss_pred cccc-----cccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCc
Q psy12709 160 VVND-----VVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDL 233 (253)
Q Consensus 160 ~~~~-----~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 233 (253)
.... ........+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+.+.......+......++...
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 6542 122234467899999999876 4579999999999999999999999999888888777766444444332
Q ss_pred cCC----------------------------CCHHHHHHHHHhcccCC
Q psy12709 234 FGH----------------------------ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 ~~~----------------------------~~~~l~~li~~~l~~dP 253 (253)
.+. .++++.+||.+||+.||
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 300 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 300 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSG
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCCh
Confidence 222 27889999999999998
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=298.22 Aligned_cols=241 Identities=27% Similarity=0.404 Sum_probs=188.3
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +++.||+|+||+||+|.+..++..||+|.+..... ......+.+|+..+. .++||||+++++++..++.++
T Consensus 4 ~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~ 79 (317)
T 2pmi_A 4 SSQFK--QLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMK-ELKHENIVRLYDVIHTENKLT 79 (317)
T ss_dssp -----------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHT-TCCBTTBCCEEEEECCTTEEE
T ss_pred cccee--EeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHH-hcCCCCcceEEEEEEECCeEE
Confidence 34566 99999999999999999999999999999876542 222356778999888 779999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQ------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
+||||+++ +|.+++... ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus 80 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 80 LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp EEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 99999975 888887643 35899999999999999999999999999999999999999999999999999865
Q ss_pred ccc-ccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC--------
Q psy12709 162 NDV-VEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE-------- 231 (253)
Q Consensus 162 ~~~-~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-------- 231 (253)
... .......+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+.+..+....+......++.
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 432 22334567899999999876 46899999999999999999999999998887777666442211110
Q ss_pred ----------------------CccCCCCHHHHHHHHHhcccCC
Q psy12709 232 ----------------------DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 232 ----------------------~~~~~~~~~l~~li~~~l~~dP 253 (253)
.....+++++.+||.+||+.||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 282 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNP 282 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSG
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCc
Confidence 1113578999999999999998
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=302.63 Aligned_cols=242 Identities=22% Similarity=0.333 Sum_probs=194.5
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC-
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH- 84 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~- 84 (253)
.+.++|+ +++.||+|+||+||+|.+..+++.||+|++............+.+|+..+. ..+|+||+++++++...+
T Consensus 22 ~~~~~y~--~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~ 98 (371)
T 2xrw_A 22 TVLKRYQ--NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKS 98 (371)
T ss_dssp EEETTEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHH-HCCCTTBCCEEEEECSCCS
T ss_pred chhhhee--EeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHH-hcCCCCccceEEeeccccc
Confidence 4556777 999999999999999999999999999999876666666778889999988 779999999999997665
Q ss_pred -----eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 85 -----EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 85 -----~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
.+++|||++++ +|.+.+. ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 99 ~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 99 LEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp TTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred cccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 78999999975 7777765 348999999999999999999999999999999999999999999999999998
Q ss_pred cccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCcc-----
Q psy12709 160 VVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLF----- 234 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~----- 234 (253)
............+++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.+..+.+..+......+.....
T Consensus 176 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred ccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 765544444567899999999999989999999999999999999999999998888777766553322211000
Q ss_pred --------------------------C-------CCCHHHHHHHHHhcccCC
Q psy12709 235 --------------------------G-------HISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 235 --------------------------~-------~~~~~l~~li~~~l~~dP 253 (253)
+ ..++++++||.+||+.||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP 307 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 307 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSG
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCCh
Confidence 0 115679999999999998
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=294.21 Aligned_cols=244 Identities=20% Similarity=0.268 Sum_probs=203.9
Q ss_pred CcceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
....+.++|+ +.+.||+|+||+||+|.+..+++.||+|++...... ..+.+|+..+.....|++++.+++++..
T Consensus 4 ~~~~~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 4 QNNVVGVHYK--VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp --CEETTTEE--EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred cCcccccceE--EEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 3455677788 999999999999999999999999999998754332 2567788888877799999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc-----eEEEeec
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN-----IKLCDFG 156 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~-----~~l~df~ 156 (253)
+...+++||++ +++|.+++... ..+++..++.++.|++.|+.+||++|++|+||+|+||+++.++. ++|+|||
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred CceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 99999999999 99999999864 45999999999999999999999999999999999999987776 9999999
Q ss_pred ccccccccc--------cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHhhcc
Q psy12709 157 ISRVVNDVV--------EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGD---NKQETFLNISQC 225 (253)
Q Consensus 157 ~~~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~~~~i~~~ 225 (253)
.+....... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+. .....+..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 998654332 123456889999999999999999999999999999999999999874 334444444333
Q ss_pred ccc-ccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 226 NFS-FHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 226 ~~~-~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
... +.......+|+++.++|.+||+.||
T Consensus 237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp 265 (298)
T 1csn_A 237 KQSTPLRELCAGFPEEFYKYMHYARNLAF 265 (298)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCT
T ss_pred ccCccHHHHHhhCcHHHHHHHHHHhcCCc
Confidence 222 2233445789999999999999998
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=293.64 Aligned_cols=236 Identities=24% Similarity=0.419 Sum_probs=204.5
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
|...+.||+|+||+||+|.+..+|+.||+|++...... ....+.+|+..+. ..+|+||+++++++..++..++||||
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMR-DYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHH-hCCCCCcceEEEEEEECCEEEEEEec
Confidence 44888999999999999999999999999998765432 2456778998887 77999999999999999999999999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-ccccccc
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEVKEII 171 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~~ 171 (253)
++|++|.+++.. ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++...... .......
T Consensus 124 ~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 202 (321)
T 2c30_A 124 LQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 202 (321)
T ss_dssp CCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred CCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccccc
Confidence 999999999874 56999999999999999999999999999999999999999999999999998765432 2234457
Q ss_pred cCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhccc
Q psy12709 172 GTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251 (253)
Q Consensus 172 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (253)
+++.|+|||++.+..++.++||||+|+++|+|++|+.||...+.......+....... ......++++++++|.+||+.
T Consensus 203 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~ 281 (321)
T 2c30_A 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-LKNSHKVSPVLRDFLERMLVR 281 (321)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-CTTGGGSCHHHHHHHHHHSCS
T ss_pred CCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-cCccccCCHHHHHHHHHHccC
Confidence 8999999999998899999999999999999999999999888877777666543322 222346899999999999999
Q ss_pred CC
Q psy12709 252 DP 253 (253)
Q Consensus 252 dP 253 (253)
||
T Consensus 282 dp 283 (321)
T 2c30_A 282 DP 283 (321)
T ss_dssp ST
T ss_pred Ch
Confidence 98
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=291.80 Aligned_cols=238 Identities=30% Similarity=0.530 Sum_probs=180.7
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc-hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS-MDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
++|+ +.+.||+|+||+||+|.+..++..|++|++...... ......+.+|+..+. ..+|+||+++++++..++..+
T Consensus 11 ~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 11 EDFK--VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC-QLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp GGEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHT-TBCCTTBCCEEEEEECSSEEE
T ss_pred ccce--eeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHH-hCCCCCeEeEEEEEccCCeEE
Confidence 4555 999999999999999999999999999999754321 122467788888887 779999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-c
Q psy12709 88 LVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-V 165 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~ 165 (253)
++||++++++|.+++... ..+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999999999998765 56999999999999999999999999999999999999999999999999999765432 2
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...........+....... ...+++++.++|
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li 243 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM----PSFLSIEAKDLI 243 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCC----CTTSCHHHHHHH
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCC----ccccCHHHHHHH
Confidence 2233567899999999998889999999999999999999999998877666655554433332 236899999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
.+||+.||
T Consensus 244 ~~~l~~dp 251 (278)
T 3cok_A 244 HQLLRRNP 251 (278)
T ss_dssp HHHSCSSG
T ss_pred HHHcccCH
Confidence 99999998
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=300.46 Aligned_cols=240 Identities=20% Similarity=0.335 Sum_probs=206.0
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccC-------CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKIT-------KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-------~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 80 (253)
.++|+ +.+.||+|+||+||+|.+... +..||+|++.... .......+.+|+..+....+|+||+++++++
T Consensus 68 ~~~y~--i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 68 RDRLV--LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp GGGEE--EEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheE--eeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 34555 999999999999999997533 3579999997653 3455678899999999777999999999999
Q ss_pred EeCCeEEEEEeccCCCcHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE
Q psy12709 81 ETPHEMVLVLEMVPDGELQRLVDIQD----------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILL 144 (253)
Q Consensus 81 ~~~~~~~lv~e~~~g~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~ 144 (253)
..++..++||||+++++|.+++.... .+++..++.++.|++.|+.|||++|++|+||+|+||++
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 99999999999999999999997643 48999999999999999999999999999999999999
Q ss_pred cCCCceEEEeeccccccccc---ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q psy12709 145 TKDNNIKLCDFGISRVVNDV---VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFL 220 (253)
Q Consensus 145 ~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~ 220 (253)
+.++.++|+|||++...... .......+++.|+|||++.+..++.++||||+|+++|+|++ |..||.+....+...
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~ 304 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999865432 22233455778999999999999999999999999999999 999999988888887
Q ss_pred HhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 221 NISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 221 ~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.+........ ...+++++.++|.+||+.||
T Consensus 305 ~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP 334 (382)
T 3tt0_A 305 LLKEGHRMDK---PSNCTNELYMMMRDCWHAVP 334 (382)
T ss_dssp HHHTTCCCCC---CSSCCHHHHHHHHHHTCSSG
T ss_pred HHHcCCCCCC---CccCCHHHHHHHHHHcCCCh
Confidence 7766543332 24789999999999999998
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=307.19 Aligned_cols=201 Identities=28% Similarity=0.443 Sum_probs=175.0
Q ss_pred cceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 4 KFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
.+.+.++|+ +.+.||+|+||+||+|.+..+++.||+|++............+.+|+..+. .++|+||+++++++...
T Consensus 21 ~~~i~~~y~--~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~ 97 (432)
T 3n9x_A 21 NVHVPDNYI--IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILN-RLKSDYIIRLYDLIIPD 97 (432)
T ss_dssp GCCCCTTEE--EEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHH-HCCCTTBCCEEEECCCS
T ss_pred cceecCCEE--EEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHH-HcCCCCcceEEEEEecC
Confidence 456778888 999999999999999999999999999999877666667788999999998 67899999999999876
Q ss_pred -----CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccc
Q psy12709 84 -----HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGIS 158 (253)
Q Consensus 84 -----~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~ 158 (253)
+.+++|||+++ ++|.+++.....+++..++.++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 98 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 98 DLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 57999999985 599999988888999999999999999999999999999999999999999999999999999
Q ss_pred ccccccc-----------------------cccccccCccccCcccc-CCCCCCccccHHHHHHHHHHHHhCCC
Q psy12709 159 RVVNDVV-----------------------EVKEIIGTPDYVAPEVL-SYEPISLATDMWSVGVLAYVLLSSHS 208 (253)
Q Consensus 159 ~~~~~~~-----------------------~~~~~~~~~~~~~PE~~-~~~~~~~~~Di~slG~~l~~l~~g~~ 208 (253)
....... ......+++.|+|||++ .+..++.++||||+||++|+|++|..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 8654321 12445778999999985 56679999999999999999998433
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=297.51 Aligned_cols=242 Identities=21% Similarity=0.339 Sum_probs=190.0
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCc---eEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKV---EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
+..++|+ +.+.||+|+||+||+|.+..++. .||+|++..........+.+.+|+..+. ..+|+||+++++++..
T Consensus 20 i~~~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 20 IPEQQFT--LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK-EFDHPHVAKLVGVSLR 96 (323)
T ss_dssp CC---CE--EEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHT-TCCCTTBCCCCEEEEC
T ss_pred cChhHeE--EeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHH-HCCCCceehhhceeec
Confidence 4455666 99999999999999999887664 8999999876655566788999999998 6699999999999988
Q ss_pred CCeE------EEEEeccCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCce
Q psy12709 83 PHEM------VLVLEMVPDGELQRLVDIQD------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNI 150 (253)
Q Consensus 83 ~~~~------~lv~e~~~g~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~ 150 (253)
.+.. ++++||+++++|.+++.... .+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 7655 99999999999999886432 58999999999999999999999999999999999999999999
Q ss_pred EEEeeccccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhccc
Q psy12709 151 KLCDFGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCN 226 (253)
Q Consensus 151 ~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~ 226 (253)
+|+|||.+........ .....+++.|+|||.+.+..++.++||||+|+++|+|++ |..||.+.+..+....+....
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 9999999976543221 122345678999999998999999999999999999999 999999988888887776654
Q ss_pred ccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 227 FSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 227 ~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.... ...+++++.++|.+||+.||
T Consensus 257 ~~~~---~~~~~~~l~~li~~~l~~dp 280 (323)
T 3qup_A 257 RLKQ---PPECMEEVYDLMYQCWSADP 280 (323)
T ss_dssp CCCC---CTTCCHHHHHHHHHTTCSSG
T ss_pred CCCC---CCccCHHHHHHHHHHccCCh
Confidence 3322 24789999999999999998
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=298.28 Aligned_cols=239 Identities=20% Similarity=0.322 Sum_probs=205.4
Q ss_pred ecceeeEEEeecCCCCceEEEEEEec-----cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHK-----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
.++|+ +.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+..+. ..+|+||+++++++..
T Consensus 46 ~~~~~--~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 46 RNNIE--YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMA-EFDNPNIVKLLGVCAV 121 (343)
T ss_dssp GGGCE--EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHH-TCCCTTBCCEEEEECS
T ss_pred HHHCe--eeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHH-hCCCCCEEEEEEEEcc
Confidence 45666 9999999999999999987 345889999998653 3445678889999998 6699999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQ------------------------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~ 138 (253)
++..++||||+++++|.+++... ..+++..++.++.|++.++.|||++|++|+||+
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 99999999999999999998763 568999999999999999999999999999999
Q ss_pred CCCEEEcCCCceEEEeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCC
Q psy12709 139 PQNILLTKDNNIKLCDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDN 214 (253)
Q Consensus 139 ~~ni~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~ 214 (253)
|+||+++.++.++|+|||.+....... ......+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+..
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 999999999999999999997654322 2223456788999999988889999999999999999999 999999988
Q ss_pred hHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 215 KQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 215 ~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+....+........ ...+++++.++|.+||+.||
T Consensus 282 ~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p 317 (343)
T 1luf_A 282 HEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLP 317 (343)
T ss_dssp HHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSG
T ss_pred hHHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCc
Confidence 8888877776654332 24789999999999999998
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=301.40 Aligned_cols=233 Identities=26% Similarity=0.385 Sum_probs=198.9
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch------HHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM------DQMQDILHEAAVLYLAQKSERIVGLHEIYE 81 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 81 (253)
.++|+ +.+.||+|+||+||+|.+..+++.||+|++....... .....+.+|+..+. ..+|+||+++++++.
T Consensus 23 ~~~y~--~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 23 SQKYS--TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS-RVEHANIIKVLDIFE 99 (335)
T ss_dssp HHHEE--EEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHT-TCCCTTBCCEEEEEE
T ss_pred ccceE--EEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHH-hCCCCCEeeEEEEEe
Confidence 34566 9999999999999999999999999999998654211 12345667888888 669999999999999
Q ss_pred eCCeEEEEEeccCCC-cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 82 TPHEMVLVLEMVPDG-ELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 82 ~~~~~~lv~e~~~g~-~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
.++.+++|||++.++ +|.+++.....+++..++.++.|++.++.|||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999999999998666 9999998888899999999999999999999999999999999999999999999999999987
Q ss_pred ccccccccccccCccccCccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCH
Q psy12709 161 VNDVVEVKEIIGTPDYVAPEVLSYEPI-SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
...........+++.|+|||++.+..+ +.++||||+|+++|+|++|..||..... ........ ...+|+
T Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~----~~~~~~ 249 (335)
T 3dls_A 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHP----PYLVSK 249 (335)
T ss_dssp CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCC----SSCCCH
T ss_pred CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCC----CcccCH
Confidence 765555556678999999999988776 7899999999999999999999975322 11222222 236899
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
++.++|.+||++||
T Consensus 250 ~l~~li~~~L~~dP 263 (335)
T 3dls_A 250 ELMSLVSGLLQPVP 263 (335)
T ss_dssp HHHHHHHHHTCSSG
T ss_pred HHHHHHHHHccCCh
Confidence 99999999999998
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=286.90 Aligned_cols=238 Identities=23% Similarity=0.356 Sum_probs=204.4
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
+..++|+ +.+.||+|+||+||+|.+. ++..||+|++....... ..+.+|+..+. ..+|+||+++++++..++.
T Consensus 5 l~~~~y~--~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 5 LKREEIT--LLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE---DEFFQEAQTMM-KLSHPKLVKFYGVCSKEYP 77 (268)
T ss_dssp CCGGGEE--EEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH---HHHHHHHHHHH-HCCCTTBCCEEEEECSSSS
T ss_pred echhhee--eeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH---HHHHHHHHHHH-hCCCCCEeeEEEEEccCCc
Confidence 3456666 9999999999999999776 56779999998765443 46788999988 6789999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
.++|||++++++|.+++... ..+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999999998765 35999999999999999999999999999999999999999999999999999765433
Q ss_pred cc--ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHH
Q psy12709 165 VE--VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQA 241 (253)
Q Consensus 165 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 241 (253)
.. .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||......+....+......... ..+|+++
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l 234 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASDTI 234 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSCHHH
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcChHHH
Confidence 22 223345668999999988889999999999999999999 99999998888888777665544333 3679999
Q ss_pred HHHHHHhcccCC
Q psy12709 242 KDFIQSCLVTDP 253 (253)
Q Consensus 242 ~~li~~~l~~dP 253 (253)
.++|.+||+.||
T Consensus 235 ~~li~~~l~~~p 246 (268)
T 3sxs_A 235 YQIMYSCWHELP 246 (268)
T ss_dssp HHHHHHTTCSSG
T ss_pred HHHHHHHcCCCh
Confidence 999999999998
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=286.48 Aligned_cols=242 Identities=25% Similarity=0.372 Sum_probs=204.5
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe----
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET---- 82 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~---- 82 (253)
..++..|.+.+.||+|+||+||+|.+..++..|++|.+............+.+|+..+. ..+|+||+++++++..
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK-GLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEEESSS
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHH-hCCCCCeeeeeeeeccccCC
Confidence 34454566999999999999999999999999999999887766777788899999998 7799999999999875
Q ss_pred CCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEc-CCCceEEEeecccc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHN--ITHLDLKPQNILLT-KDNNIKLCDFGISR 159 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~di~~~ni~~~-~~~~~~l~df~~~~ 159 (253)
+..+++||||+++++|.+++.....++...++.++.|++.++.|||++| ++|+||+|+||+++ .++.++|+|||.+.
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 3569999999999999999988788999999999999999999999999 99999999999998 78999999999987
Q ss_pred cccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhcccccccCCccCCCC
Q psy12709 160 VVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ-ETFLNISQCNFSFHEDLFGHIS 238 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~ 238 (253)
..... ......+++.|+|||++.+ .++.++|+||+|+++|+|++|+.||...... .....+..... +.......+
T Consensus 181 ~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 256 (290)
T 1t4h_A 181 LKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAI 256 (290)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCC
T ss_pred ccccc-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC--ccccCCCCC
Confidence 54432 2334568899999998874 5899999999999999999999999885444 44444433322 223334678
Q ss_pred HHHHHHHHHhcccCC
Q psy12709 239 SQAKDFIQSCLVTDP 253 (253)
Q Consensus 239 ~~l~~li~~~l~~dP 253 (253)
+++.++|.+||+.||
T Consensus 257 ~~l~~li~~~l~~dp 271 (290)
T 1t4h_A 257 PEVKEIIEGCIRQNK 271 (290)
T ss_dssp HHHHHHHHHHSCSSG
T ss_pred HHHHHHHHHHccCCh
Confidence 999999999999998
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=295.13 Aligned_cols=234 Identities=26% Similarity=0.385 Sum_probs=200.9
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
|++++.||+|+||+||+|.+..++..||+|++.... ........+.+|+..+. ..+|+||+++++++..++..++|||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ-KLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEECCeEEEEEe
Confidence 449999999999999999999999999999997654 33344577889999998 6799999999999999999999999
Q ss_pred ccCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccccccc
Q psy12709 92 MVPDGELQRLVD-IQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEI 170 (253)
Q Consensus 92 ~~~g~~L~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (253)
|+.| +|.+++. ....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 135 ~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~~ 210 (348)
T 1u5q_A 135 YCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSF 210 (348)
T ss_dssp CCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCC
T ss_pred cCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---Ccc
Confidence 9975 6766664 4567999999999999999999999999999999999999999999999999999765432 335
Q ss_pred ccCccccCccccC---CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHH
Q psy12709 171 IGTPDYVAPEVLS---YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247 (253)
Q Consensus 171 ~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~ 247 (253)
.+++.|+|||++. ...++.++||||+|+++|+|++|+.||.+.+.......+.....+... ...+++.+.++|.+
T Consensus 211 ~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~ 288 (348)
T 1u5q_A 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEYFRNFVDS 288 (348)
T ss_dssp CSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCC--CTTSCHHHHHHHHH
T ss_pred cCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHH
Confidence 6899999999984 567889999999999999999999999988877776666655433322 24789999999999
Q ss_pred hcccCC
Q psy12709 248 CLVTDP 253 (253)
Q Consensus 248 ~l~~dP 253 (253)
||+.||
T Consensus 289 ~l~~dP 294 (348)
T 1u5q_A 289 CLQKIP 294 (348)
T ss_dssp HTCSSG
T ss_pred HcccCh
Confidence 999998
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=304.76 Aligned_cols=240 Identities=22% Similarity=0.302 Sum_probs=204.3
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
+.-+|++.+.||+|+||+||+|.+..++..||+|.+.... .......+.+|+..+. ..+||||+++++++..++.+++
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILK-QYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHT-TCCCTTBCCEEEEECSSSSCEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHH-hCCCCCEEEEEEEEecCCCcEE
Confidence 3345559999999999999999999999999999987542 3344567788999888 7799999999999999999999
Q ss_pred EEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccc
Q psy12709 89 VLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV 167 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 167 (253)
||||+++++|.+++... ..++...+..++.|++.|++|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999998764 35899999999999999999999999999999999999999999999999998754332111
Q ss_pred ---cccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 168 ---KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 168 ---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
....+++.|+|||++.+..++.++||||+|+++|+|++ |..||.+.+..+....+..+...+.. ..+|+++.+
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~ 346 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCP---ELCPDAVFR 346 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCC---TTCCHHHHH
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCCHHHHH
Confidence 11224568999999988889999999999999999998 99999998888777776655433222 368999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 347 li~~cl~~dP 356 (377)
T 3cbl_A 347 LMEQCWAYEP 356 (377)
T ss_dssp HHHHHTCSSG
T ss_pred HHHHHcCCCc
Confidence 9999999998
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=293.82 Aligned_cols=245 Identities=26% Similarity=0.407 Sum_probs=197.6
Q ss_pred cceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEe
Q psy12709 4 KFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKS-ERIVGLHEIYET 82 (253)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~-~~i~~~~~~~~~ 82 (253)
+.+...+.+|++++.||+|+||+||+|.+. ++..||+|++............+.+|+..+..+..| +||+++++++..
T Consensus 2 e~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 80 (343)
T 3dbq_A 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 80 (343)
T ss_dssp CCEESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred ceeeeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence 344445555669999999999999999885 688999999987766666678889999999855543 999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN 162 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~ 162 (253)
++.+++|||+ .+++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++ ++.++|+|||++....
T Consensus 81 ~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 81 DQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp SSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred CCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 9999999995 5789999999888899999999999999999999999999999999999997 6889999999998654
Q ss_pred ccc---cccccccCccccCccccCC-----------CCCCccccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhcccc
Q psy12709 163 DVV---EVKEIIGTPDYVAPEVLSY-----------EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ-ETFLNISQCNF 227 (253)
Q Consensus 163 ~~~---~~~~~~~~~~~~~PE~~~~-----------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~i~~~~~ 227 (253)
... ......+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||...... .....+.....
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence 322 1234568999999999854 56788999999999999999999999875443 33333333222
Q ss_pred cccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 228 SFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 228 ~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.. ......++++.++|.+||+.||
T Consensus 239 ~~--~~~~~~~~~l~~li~~~L~~dp 262 (343)
T 3dbq_A 239 EI--EFPDIPEKDLQDVLKCCLKRDP 262 (343)
T ss_dssp CC--CCCCCSCHHHHHHHHHHTCSST
T ss_pred cc--CCcccCCHHHHHHHHHHcCCCh
Confidence 22 2223668899999999999998
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=300.13 Aligned_cols=239 Identities=19% Similarity=0.275 Sum_probs=201.6
Q ss_pred ecceeeEEEeecCCCCceEEEEEE-----eccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCT-----HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~-----~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
.++|+ +.+.||+|+||+||+|. +..++..||+|+++... .......+.+|+..+. .++|+||+++++++..
T Consensus 70 ~~~~~--~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 70 RKNIT--LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIIS-KFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp GGGEE--EEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHH-HCCCTTBCCEEEEECS
T ss_pred HhHeE--EeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHH-hCCCCCCCeEEEEEec
Confidence 34555 99999999999999999 44567889999997543 3344557888998888 6699999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC---ceEE
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQ-------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN---NIKL 152 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~---~~~l 152 (253)
++..++||||++|++|.+++... ..++...++.++.|++.|+.|||++|++|+||+|+||+++.++ .++|
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999999998764 2489999999999999999999999999999999999999655 4999
Q ss_pred Eeeccccccccc---ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhccccc
Q psy12709 153 CDFGISRVVNDV---VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFS 228 (253)
Q Consensus 153 ~df~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~ 228 (253)
+|||++...... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+......
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999999754321 22233456889999999988899999999999999999998 99999999998888887776543
Q ss_pred ccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 229 FHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
... ..+++++.++|.+||+.||
T Consensus 306 ~~~---~~~~~~l~~li~~~l~~dP 327 (367)
T 3l9p_A 306 DPP---KNCPGPVYRIMTQCWQHQP 327 (367)
T ss_dssp CCC---TTCCHHHHHHHHHHTCSSG
T ss_pred CCC---ccCCHHHHHHHHHHcCCCH
Confidence 332 4789999999999999998
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=306.63 Aligned_cols=242 Identities=29% Similarity=0.502 Sum_probs=195.6
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc------hHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS------MDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 81 (253)
.++|+ +.+.||+|+||+||+|.+..+++.||+|++.+.... ......+.+|+..+. .++||||+++++++.
T Consensus 134 ~~~y~--~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 134 RDEYI--MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK-KLNHPCIIKIKNFFD 210 (419)
T ss_dssp HTTEE--EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHH-HCCCTTBCCCCEEEE
T ss_pred hccEE--EEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHH-hCCCCCEeeEEEEEe
Confidence 34566 999999999999999999999999999999765321 222335778999998 679999999999986
Q ss_pred eCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC---ceEEEeeccc
Q psy12709 82 TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN---NIKLCDFGIS 158 (253)
Q Consensus 82 ~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~---~~~l~df~~~ 158 (253)
. +..++||||+++++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++ .++|+|||++
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred c-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 5 46899999999999999988888899999999999999999999999999999999999997654 4999999999
Q ss_pred ccccccccccccccCccccCccccCC---CCCCccccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhcccccccCCcc
Q psy12709 159 RVVNDVVEVKEIIGTPDYVAPEVLSY---EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ-ETFLNISQCNFSFHEDLF 234 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~ 234 (253)
.............+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||...... .....+............
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 87766555556678999999999853 56788999999999999999999999775443 444555666555555555
Q ss_pred CCCCHHHHHHHHHhcccCC
Q psy12709 235 GHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP 253 (253)
..+++++.+||.+||+.||
T Consensus 370 ~~~~~~~~~li~~~L~~dP 388 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDP 388 (419)
T ss_dssp TTSCHHHHHHHHHHSCSST
T ss_pred cccCHHHHHHHHHHccCCh
Confidence 6899999999999999998
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=290.96 Aligned_cols=239 Identities=24% Similarity=0.353 Sum_probs=205.3
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe--CCeE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET--PHEM 86 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~ 86 (253)
++|+ +.+.||+|+||+||+|.+..+++.|++|.+............+.+|+..+. ..+|+||+++++++.. +..+
T Consensus 6 ~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 6 EDYE--VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR-ELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGEE--EEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEEEGGGTEE
T ss_pred hhee--eehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHH-hcCCCCCCeEEEEEecCCCceE
Confidence 4566 999999999999999999999999999999877666667788999999998 6689999999998754 5689
Q ss_pred EEEEeccCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCCEEEcCCCceEEEeecc
Q psy12709 87 VLVLEMVPDGELQRLVDIQ----DGIPEQDTRSYMKQILEALAFLHDHN-----ITHLDLKPQNILLTKDNNIKLCDFGI 157 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~-----~~h~di~~~ni~~~~~~~~~l~df~~ 157 (253)
+++|||+++++|.+++... ..+++..++.++.|++.++.+||+.| ++|+||+|+||+++.++.++|+|||.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999999988653 34899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccc-cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCC
Q psy12709 158 SRVVNDVV-EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGH 236 (253)
Q Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 236 (253)
+....... ......+++.|+|||++.+..++.++|+||+|+++|+|++|+.||...+..+....+..+.... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~ 239 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYR 239 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---CCTT
T ss_pred heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc---CCcc
Confidence 87654322 2233467899999999988889999999999999999999999999988888777777665432 2247
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
+++++.++|.+||+.||
T Consensus 240 ~~~~l~~li~~~l~~~p 256 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKD 256 (279)
T ss_dssp SCHHHHHHHHHHTCSSG
T ss_pred cCHHHHHHHHHHcCCCc
Confidence 89999999999999998
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=308.64 Aligned_cols=205 Identities=27% Similarity=0.444 Sum_probs=165.3
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP-- 83 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-- 83 (253)
-+.++|+ +++.||+|+||+||+|.+..+++.||+|++............+.+|+..+. .++|+||+++++++...
T Consensus 50 ~~~~~y~--~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 50 QIPDRYE--IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILN-RLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp CSCTTEE--ECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHH-HCCCTTBCCEEEECCCSCT
T ss_pred ccCCCeE--EeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHH-hCCCCCCCceEEEEecCCc
Confidence 3456777 999999999999999999999999999999876666667788999999998 66999999999999433
Q ss_pred ---CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 84 ---HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 84 ---~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
..+++|||++ +++|.+++.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 127 EKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp TTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred ccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 5799999998 568999998888899999999999999999999999999999999999999999999999999986
Q ss_pred ccccc----------------------------cccccccCccccCcccc-CCCCCCccccHHHHHHHHHHHHh------
Q psy12709 161 VNDVV----------------------------EVKEIIGTPDYVAPEVL-SYEPISLATDMWSVGVLAYVLLS------ 205 (253)
Q Consensus 161 ~~~~~----------------------------~~~~~~~~~~~~~PE~~-~~~~~~~~~Di~slG~~l~~l~~------ 205 (253)
..... ......+++.|+|||++ .+..++.++||||+||++|+|++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 53211 12334678999999986 56679999999999999999998
Q ss_pred -----CCCCCCCCC
Q psy12709 206 -----SHSPFAGDN 214 (253)
Q Consensus 206 -----g~~p~~~~~ 214 (253)
|+++|.+.+
T Consensus 286 ~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 286 AYHADRGPLFPGSS 299 (458)
T ss_dssp SSGGGCCCSCC---
T ss_pred cccccccccCCCCc
Confidence 777776644
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=301.13 Aligned_cols=242 Identities=25% Similarity=0.409 Sum_probs=189.0
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC-
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP- 83 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~- 83 (253)
+-+.++|+ +++.||+|+||+||+|.+..++..||+|++............+.+|+..+. .++|+||+++++++...
T Consensus 25 ~~~~~~y~--~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 25 WEVPERYQ--NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK-HMKHENVIGLLDVFTPAR 101 (367)
T ss_dssp EEEETTEE--EEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHH-HCCCTTBCCCSEEECSCS
T ss_pred cCCCCceE--EeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEecCC
Confidence 44567777 999999999999999999999999999999876666666778889999998 77899999999998754
Q ss_pred -----CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccc
Q psy12709 84 -----HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGIS 158 (253)
Q Consensus 84 -----~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~ 158 (253)
..+++++|++ +++|.+++.. ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 102 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 102 SLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp SGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred ccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 5689999998 7899988874 56999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc-------
Q psy12709 159 RVVNDVVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH------- 230 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~------- 230 (253)
...... .....+++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+.+..+......+.
T Consensus 180 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 180 RHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred cccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 765432 234568899999999876 6789999999999999999999999999887777666544222111
Q ss_pred --------------------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 --------------------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 --------------------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+..++++.+||.+||+.||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP 300 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 300 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSG
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCc
Confidence 11234678999999999999998
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=298.03 Aligned_cols=213 Identities=30% Similarity=0.448 Sum_probs=184.7
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhc----CCCCceeeeeEE
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ----KSERIVGLHEIY 80 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~----~~~~i~~~~~~~ 80 (253)
..+.++|+ +++.||+|+||+||+|.+..+++.||+|++... .........|+..+.... .|+||+++++++
T Consensus 31 ~~~~~~y~--~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 31 MLLNNAFL--VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp CEETTTEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred eEecCEEE--EEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 35567788 999999999999999999999999999999743 233456677888887554 499999999999
Q ss_pred EeCCeEEEEEeccCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC------------
Q psy12709 81 ETPHEMVLVLEMVPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK------------ 146 (253)
Q Consensus 81 ~~~~~~~lv~e~~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~------------ 146 (253)
...+..++|||++ +++|.+++.... .++...++.++.|++.|+.|||++|++|+||+|+||+++.
T Consensus 106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 106 MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred eECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhc
Confidence 9999999999999 889999987654 5999999999999999999999999999999999999975
Q ss_pred -------------CCceEEEeecccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Q psy12709 147 -------------DNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGD 213 (253)
Q Consensus 147 -------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 213 (253)
++.++|+|||++...... .....+++.|+|||++.+..++.++||||+|+++|+|++|+.||...
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 788999999999764432 23456899999999999999999999999999999999999999988
Q ss_pred ChHHHHHHhhcc
Q psy12709 214 NKQETFLNISQC 225 (253)
Q Consensus 214 ~~~~~~~~i~~~ 225 (253)
+..+....+...
T Consensus 263 ~~~~~~~~~~~~ 274 (360)
T 3llt_A 263 EHMEHLAMMESI 274 (360)
T ss_dssp SHHHHHHHHHHH
T ss_pred cHHHHHHHHHHh
Confidence 887777665543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=287.05 Aligned_cols=236 Identities=23% Similarity=0.348 Sum_probs=201.2
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +++.||+|+||+||+|.+. ++..||+|++....... ..+.+|+..+. ..+|+||+++++++..++..+
T Consensus 23 ~~~y~--~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 23 PKDLT--FLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMM-NLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp GGGEE--EEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHH-TCCCTTBCCEEEEECSSSSEE
T ss_pred HHHHH--hHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH---HHHHHHHHHHh-cCCCCCEeeEEEEEecCCCeE
Confidence 34555 9999999999999999876 67789999998765443 36778999888 778999999999999999999
Q ss_pred EEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-
Q psy12709 88 LVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV- 165 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~- 165 (253)
+||||+++++|.+++.. ...+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999999999999876 4669999999999999999999999999999999999999999999999999998654332
Q ss_pred -cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 166 -EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 166 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
......+++.|+|||++.+..++.++|+||+|+++|+|++ |+.||...+..+....+......... ..+++++.+
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~ 252 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASEKVYT 252 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTCCHHHHH
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcCCHHHHH
Confidence 2223345678999999988889999999999999999998 99999998888888887766443333 367999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 253 li~~~l~~~p 262 (283)
T 3gen_A 253 IMYSCWHEKA 262 (283)
T ss_dssp HHHHTTCSSG
T ss_pred HHHHHccCCh
Confidence 9999999998
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=300.23 Aligned_cols=241 Identities=21% Similarity=0.361 Sum_probs=199.0
Q ss_pred ecceeeEEEeecCCCCceEEEEEE-----eccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCT-----HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~-----~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
.++|+ +.+.||+|+||.||+|. +..+++.||+|++.... .......+.+|+..+....+|+||+++++++..
T Consensus 21 ~~~y~--~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 21 RDRLK--LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp GGGEE--EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccee--eceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 34555 99999999999999999 45567899999997643 344467889999999977799999999999987
Q ss_pred CC-eEEEEEeccCCCcHHHHHhhcCC------------------------------------------------------
Q psy12709 83 PH-EMVLVLEMVPDGELQRLVDIQDG------------------------------------------------------ 107 (253)
Q Consensus 83 ~~-~~~lv~e~~~g~~L~~~~~~~~~------------------------------------------------------ 107 (253)
.+ .++++|||+++++|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 65 59999999999999999876432
Q ss_pred ------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc---cccccccc
Q psy12709 108 ------------IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV---VEVKEIIG 172 (253)
Q Consensus 108 ------------~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~ 172 (253)
+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...... .......+
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 899999999999999999999999999999999999999999999999999755332 12233456
Q ss_pred CccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhccc
Q psy12709 173 TPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251 (253)
Q Consensus 173 ~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (253)
++.|+|||++.+..++.++||||+|+++|+|++ |..||.+....+............. ....+++++.++|.+||+.
T Consensus 258 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~ 335 (359)
T 3vhe_A 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHG 335 (359)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC--CCTTCCHHHHHHHHHHTCS
T ss_pred CceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHccC
Confidence 789999999988899999999999999999998 9999988665444433333222221 2247899999999999999
Q ss_pred CC
Q psy12709 252 DP 253 (253)
Q Consensus 252 dP 253 (253)
||
T Consensus 336 dP 337 (359)
T 3vhe_A 336 EP 337 (359)
T ss_dssp SG
T ss_pred Ch
Confidence 98
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=302.45 Aligned_cols=239 Identities=29% Similarity=0.433 Sum_probs=197.0
Q ss_pred cceeeEEEeecCCCCceEEEEEEec---cCCceEEEEEeccccc--chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHK---ITKVEYAAKFIRKRRR--SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
++|+ +.+.||+|+||+||+|.+. .+++.||+|++..... .......+.+|+..+.....|+||+++++++..+
T Consensus 54 ~~y~--~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 54 ENFE--LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp GGEE--EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cceE--EEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 4555 9999999999999999984 5789999999876431 1122335667888888666899999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
+.+++||||+++++|.+++.....+++..++.++.|++.++.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 99999999999999999998888899999999999999999999999999999999999999999999999999975532
Q ss_pred c--ccccccccCccccCccccCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHhhcccccccCCccC
Q psy12709 164 V--VEVKEIIGTPDYVAPEVLSYE--PISLATDMWSVGVLAYVLLSSHSPFAGDNK----QETFLNISQCNFSFHEDLFG 235 (253)
Q Consensus 164 ~--~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~i~~~~~~~~~~~~~ 235 (253)
. .......+++.|+|||++.+. .++.++||||||+++|+|++|+.||..... ......+....... ..
T Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~ 287 (355)
T 1vzo_A 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY----PQ 287 (355)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC----CT
T ss_pred CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC----Cc
Confidence 2 223345689999999999753 468899999999999999999999975432 33333343333333 34
Q ss_pred CCCHHHHHHHHHhcccCC
Q psy12709 236 HISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 236 ~~~~~l~~li~~~l~~dP 253 (253)
.+++.+.+||.+||+.||
T Consensus 288 ~~~~~~~~li~~~L~~dP 305 (355)
T 1vzo_A 288 EMSALAKDLIQRLLMKDP 305 (355)
T ss_dssp TSCHHHHHHHHHHTCSSG
T ss_pred ccCHHHHHHHHHHhhhCH
Confidence 789999999999999998
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=297.54 Aligned_cols=240 Identities=27% Similarity=0.414 Sum_probs=197.6
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQK-SERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~-~~~i~~~~~~~~~~~~~~ 87 (253)
.+..|++.+.||+|+||+||+|.+.. +..||+|++............+.+|+..+..+.. |+||+++++++..++.++
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 34445699999999999999999875 8899999998776666677889999999986654 799999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc--
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-- 165 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-- 165 (253)
+||| +.+++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++ ++.++|+|||++.......
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9999 56889999998888899999999999999999999999999999999999995 6899999999998654322
Q ss_pred -cccccccCccccCccccCC-----------CCCCccccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhcccccccCC
Q psy12709 166 -EVKEIIGTPDYVAPEVLSY-----------EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ-ETFLNISQCNFSFHED 232 (253)
Q Consensus 166 -~~~~~~~~~~~~~PE~~~~-----------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~i~~~~~~~~~~ 232 (253)
......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...... ..+..+........
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~-- 288 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-- 288 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC--
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC--
Confidence 2234568999999999865 36888999999999999999999999875433 44444444333222
Q ss_pred ccCCCCHHHHHHHHHhcccCC
Q psy12709 233 LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 ~~~~~~~~l~~li~~~l~~dP 253 (253)
.....++++.+||.+||+.||
T Consensus 289 ~~~~~~~~~~~li~~~L~~dP 309 (390)
T 2zmd_A 289 FPDIPEKDLQDVLKCCLKRDP 309 (390)
T ss_dssp CCCCSCHHHHHHHHHHTCSST
T ss_pred CCccchHHHHHHHHHHcccCh
Confidence 223558899999999999998
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=287.15 Aligned_cols=237 Identities=18% Similarity=0.285 Sum_probs=200.1
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
.+.++|+ +.+.||+|+||+||+|.+..+++.|++|.+............+.+|+..+....+||||+++++++..++.
T Consensus 8 ~~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~ 85 (289)
T 1x8b_A 8 RYTTEFH--ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH 85 (289)
T ss_dssp HHHHHEE--EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred cccchhh--hhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence 3456677 99999999999999999999999999999987766566677888999999866699999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC--------------
Q psy12709 86 MVLVLEMVPDGELQRLVDIQ----DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD-------------- 147 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~-------------- 147 (253)
.++||||++|++|.+++... ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999998764 669999999999999999999999999999999999999854
Q ss_pred -----CceEEEeecccccccccccccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy12709 148 -----NNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLN 221 (253)
Q Consensus 148 -----~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 221 (253)
..++|+|||.+....... ...+++.|+|||++.+. .++.++||||+|+++|+|++|..|+..... ...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~ 239 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHE 239 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHH
T ss_pred ccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHH
Confidence 479999999987664432 23588999999998766 566899999999999999999987754433 333
Q ss_pred hhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 222 ISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 222 i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+.....+ .....+++++.++|.+||+.||
T Consensus 240 ~~~~~~~---~~~~~~~~~~~~li~~~l~~dp 268 (289)
T 1x8b_A 240 IRQGRLP---RIPQVLSQEFTELLKVMIHPDP 268 (289)
T ss_dssp HHTTCCC---CCSSCCCHHHHHHHHHHTCSSG
T ss_pred HHcCCCC---CCCcccCHHHHHHHHHHhCCCc
Confidence 4443332 2224789999999999999998
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=296.36 Aligned_cols=242 Identities=29% Similarity=0.502 Sum_probs=199.9
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc------chHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR------SMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 81 (253)
.++|+ +.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+..+. .++|+||+++++++.
T Consensus 9 ~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 9 RDEYI--MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK-KLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHH-HCCCTTBCCEEEEEE
T ss_pred hhcee--EeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHH-hCCCCCCceEeeEEc
Confidence 45666 99999999999999999999999999999876432 1223345778999888 679999999999998
Q ss_pred eCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc---eEEEeeccc
Q psy12709 82 TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN---IKLCDFGIS 158 (253)
Q Consensus 82 ~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~---~~l~df~~~ 158 (253)
.++ .++||||+++++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++. ++|+|||.+
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 765 8999999999999999887888999999999999999999999999999999999999987665 999999999
Q ss_pred ccccccccccccccCccccCccccC---CCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhcccccccCCcc
Q psy12709 159 RVVNDVVEVKEIIGTPDYVAPEVLS---YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ-ETFLNISQCNFSFHEDLF 234 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~ 234 (253)
.............+++.|+|||++. ...++.++||||+|+++|+|++|..||...... .....+............
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 8765544444556899999999963 467889999999999999999999999775443 334445555554444444
Q ss_pred CCCCHHHHHHHHHhcccCC
Q psy12709 235 GHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP 253 (253)
..+++++.++|.+||+.||
T Consensus 245 ~~~~~~~~~li~~~l~~dP 263 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDP 263 (322)
T ss_dssp TTSCHHHHHHHHHHSCSST
T ss_pred hhcCHHHHHHHHHHcccCH
Confidence 6789999999999999998
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=292.96 Aligned_cols=238 Identities=21% Similarity=0.316 Sum_probs=203.3
Q ss_pred eeeEEEeecCCCCceEEEEEEec-----cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 11 YQTLIFCMPSRGKFASVRKCTHK-----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
.+|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+..+. ..+||||+++++++..++.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLK-QVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHT-TCCCTTBCCEEEEECSSSS
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHh-hCCCCceeeEEEEEecCCc
Confidence 34449999999999999999974 455889999997543 3455678889999998 6699999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q psy12709 86 MVLVLEMVPDGELQRLVDIQDG------------------------IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQN 141 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~~~------------------------~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~n 141 (253)
.+++|||+++++|.+++..... +++..++.++.|++.|+.|||++|++|+||+|+|
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 180 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchhe
Confidence 9999999999999999976433 8899999999999999999999999999999999
Q ss_pred EEEcCCCceEEEeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHH
Q psy12709 142 ILLTKDNNIKLCDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQE 217 (253)
Q Consensus 142 i~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~ 217 (253)
|+++.++.++|+|||.+....... ......+++.|+|||.+.+..++.++||||+|+++|+|++ |..||.+.....
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 260 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999997654322 1223345678999999988889999999999999999999 999999988887
Q ss_pred HHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 218 TFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 218 ~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+....... ....+++++.++|.+||+.||
T Consensus 261 ~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp 293 (314)
T 2ivs_A 261 LFNLLKTGHRME---RPDNCSEEMYRLMLQCWKQEP 293 (314)
T ss_dssp HHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHhhcCCcCC---CCccCCHHHHHHHHHHccCCh
Confidence 777766654322 224789999999999999998
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=289.60 Aligned_cols=238 Identities=22% Similarity=0.322 Sum_probs=200.1
Q ss_pred eeeEEEe-ecCCCCceEEEEEEe--ccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 11 YQTLIFC-MPSRGKFASVRKCTH--KITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 11 ~~~~~~~-~lg~g~~~~v~~~~~--~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.+|++.+ .||+|+||+||+|.+ ..++..|++|++............+.+|+..+. ..+|+||+++++++ ..+..+
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ-QLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHH-TCCCTTBCCEEEEE-ESSSEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHH-hCCCCCEEEEEEEE-CCCCcE
Confidence 3444888 999999999999954 566788999999876655566778899999998 67999999999999 556789
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc-
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE- 166 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~- 166 (253)
+|||++++++|.+++.....+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999976543222
Q ss_pred ---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHH
Q psy12709 167 ---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAK 242 (253)
Q Consensus 167 ---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~ 242 (253)
.....+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+....... ....+++++.
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~ 250 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCPREMY 250 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHH
T ss_pred ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHH
Confidence 112234578999999988888999999999999999999 999999988888777776654332 2347899999
Q ss_pred HHHHHhcccCC
Q psy12709 243 DFIQSCLVTDP 253 (253)
Q Consensus 243 ~li~~~l~~dP 253 (253)
++|.+||+.||
T Consensus 251 ~li~~~l~~dp 261 (291)
T 1xbb_A 251 DLMNLCWTYDV 261 (291)
T ss_dssp HHHHHHTCSST
T ss_pred HHHHHHcCCCh
Confidence 99999999998
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=293.10 Aligned_cols=244 Identities=20% Similarity=0.323 Sum_probs=204.9
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEec-------cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeee
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHK-------ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHE 78 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~ 78 (253)
|....-+|++.+.||+|+||+||+|.+. .++..||+|++.... .......+.+|+..+....+|+||+++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 3333344559999999999999999975 356789999997653 34556788899999996669999999999
Q ss_pred EEEeCCeEEEEEeccCCCcHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q psy12709 79 IYETPHEMVLVLEMVPDGELQRLVDIQD----------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNI 142 (253)
Q Consensus 79 ~~~~~~~~~lv~e~~~g~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni 142 (253)
++..++.+++||||+++++|.+++.... .++...++.++.|++.|+.|||++|++|+||+|+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 9999999999999999999999997643 388999999999999999999999999999999999
Q ss_pred EEcCCCceEEEeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHH
Q psy12709 143 LLTKDNNIKLCDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQET 218 (253)
Q Consensus 143 ~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~ 218 (253)
+++.++.++|+|||.+....... ......+++.|+|||++.+..++.++||||+|+++|+|++ |..||.+....+.
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 268 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence 99999999999999998654322 1223345678999999988889999999999999999999 9999999888887
Q ss_pred HHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 219 FLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 219 ~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
...+....... ....+++++.++|.+||+.||
T Consensus 269 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp 300 (334)
T 2pvf_A 269 FKLLKEGHRMD---KPANCTNELYMMMRDCWHAVP 300 (334)
T ss_dssp HHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHhcCCCCC---CCccCCHHHHHHHHHHccCCh
Confidence 77766654322 224789999999999999998
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=288.10 Aligned_cols=241 Identities=22% Similarity=0.329 Sum_probs=184.0
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
..++|+ +.+.||+|+||+||+|.+..+++.||+|++........ ......+.....+..+|+||+++++++..++..
T Consensus 5 ~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 5 KADDLE--PIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE-QKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CGGGEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHH-HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cHHhhh--hHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHH-HHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 345666 99999999999999999999999999999987644333 334444555545588999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 87 VLVLEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDH-NITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
++|||+++| +|.+++.. ...+++..++.++.|++.++.|||++ |++|+||+|+||+++.++.++|+|||.+...
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999975 77666543 56799999999999999999999998 9999999999999999999999999999876
Q ss_pred cccccccccccCccccCcccc----CCCCCCccccHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhcccccccCCccCC
Q psy12709 162 NDVVEVKEIIGTPDYVAPEVL----SYEPISLATDMWSVGVLAYVLLSSHSPFAG-DNKQETFLNISQCNFSFHEDLFGH 236 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~PE~~----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~~~~~ 236 (253)
..........+++.|+|||++ .+..++.++|+||+|+++|+|++|+.||.. ................. .....
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 238 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ--LPADK 238 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC--CCTTT
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC--ccccc
Confidence 555444455788999999996 455788999999999999999999999986 33333333333322222 12247
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
+|+++.++|.+||+.||
T Consensus 239 ~~~~~~~li~~~l~~~p 255 (290)
T 3fme_A 239 FSAEFVDFTSQCLKKNS 255 (290)
T ss_dssp SCHHHHHHHHHHTCSSG
T ss_pred CCHHHHHHHHHHhhcCh
Confidence 89999999999999998
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=286.87 Aligned_cols=236 Identities=26% Similarity=0.437 Sum_probs=205.6
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
.|++++.||+|+||+||+|.+..++..|++|++...... .....+.+|+..+. ..+|+||+++++++..++.+++|||
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLS-QCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHH-hCCCCCEeEEEEEEecCCeEEEEEE
Confidence 344999999999999999999999999999999765432 34567888999888 6799999999999999999999999
Q ss_pred ccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-ccccc
Q psy12709 92 MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-EVKEI 170 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-~~~~~ 170 (253)
|+++++|.+++.. ..+++..+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 179 (303)
T 3a7i_A 101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 179 (303)
T ss_dssp CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCC
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCcc
Confidence 9999999999874 569999999999999999999999999999999999999999999999999997654332 23345
Q ss_pred ccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcc
Q psy12709 171 IGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLV 250 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (253)
.+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...........+...... .....+++++.++|.+||+
T Consensus 180 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~ 256 (303)
T 3a7i_A 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPLKEFVEACLN 256 (303)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---CCCSSCCHHHHHHHHHHCC
T ss_pred CCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC---CCccccCHHHHHHHHHHcC
Confidence 6789999999999888999999999999999999999999988877777666554432 2335789999999999999
Q ss_pred cCC
Q psy12709 251 TDP 253 (253)
Q Consensus 251 ~dP 253 (253)
.||
T Consensus 257 ~dp 259 (303)
T 3a7i_A 257 KEP 259 (303)
T ss_dssp SSG
T ss_pred CCh
Confidence 998
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=295.36 Aligned_cols=240 Identities=23% Similarity=0.318 Sum_probs=201.3
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceE--EEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEY--AAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v--~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
.++|+ +.+.||+|+||+||+|.+..++..+ ++|.+.... .......+.+|+..+.+..+||||+++++++..++.
T Consensus 24 ~~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 24 WNDIK--FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp GGGCE--EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred HHHcc--ceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 35666 9999999999999999999888765 889887532 233456788899999855599999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQD----------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN 149 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~ 149 (253)
.++|||++++++|.+++.... .+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence 999999999999999997653 6899999999999999999999999999999999999999999
Q ss_pred eEEEeecccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhccccc
Q psy12709 150 IKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFS 228 (253)
Q Consensus 150 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~ 228 (253)
++|+|||++.............+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+......
T Consensus 181 ~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~ 260 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 260 (327)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC
T ss_pred EEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCC
Confidence 99999999875443333334456789999999988888999999999999999998 99999998888887777665322
Q ss_pred ccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 229 FHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
. ....+++++.++|.+||+.||
T Consensus 261 ~---~~~~~~~~l~~li~~~l~~dp 282 (327)
T 1fvr_A 261 E---KPLNCDDEVYDLMRQCWREKP 282 (327)
T ss_dssp C---CCTTBCHHHHHHHHHHTCSSG
T ss_pred C---CCCCCCHHHHHHHHHHccCCh
Confidence 2 224789999999999999998
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=286.91 Aligned_cols=238 Identities=21% Similarity=0.341 Sum_probs=191.8
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccC---CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKIT---KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
.++|+ +.+.||+|+||+||+|.+..+ +..|++|...... .....+.+.+|+..+. ..+||||+++++++. ++
T Consensus 14 ~~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 14 RERIE--LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMR-QFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp GGGEE--EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEC-SS
T ss_pred hHHeE--EEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHH-hCCCCccceEEEEEc-cC
Confidence 44555 999999999999999998754 4569999987543 3445667888999888 779999999999985 46
Q ss_pred eEEEEEeccCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQD-GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
..++||||+++++|.+++.... .+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 7899999999999999987654 699999999999999999999999999999999999999999999999999986543
Q ss_pred ccc--ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHH
Q psy12709 164 VVE--VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQ 240 (253)
Q Consensus 164 ~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (253)
... .....+++.|+|||++.+..++.++|+||+|+++|+|++ |..||.+....+....+....... ....+|++
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~ 245 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNCPPT 245 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTCCHH
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC---CCCCCCHH
Confidence 322 222345678999999988899999999999999999997 999999988888877776654332 23478999
Q ss_pred HHHHHHHhcccCC
Q psy12709 241 AKDFIQSCLVTDP 253 (253)
Q Consensus 241 l~~li~~~l~~dP 253 (253)
+.++|.+||+.||
T Consensus 246 l~~li~~~l~~~p 258 (281)
T 1mp8_A 246 LYSLMTKCWAYDP 258 (281)
T ss_dssp HHHHHHHHTCSSG
T ss_pred HHHHHHHHccCCh
Confidence 9999999999998
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=295.28 Aligned_cols=239 Identities=21% Similarity=0.334 Sum_probs=197.3
Q ss_pred eeEEEeecCCCCceEEEEEEec-----cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHK-----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
+|++.+.||+|+||+||+|.+. .++..||+|++.... .......+.+|+..+..+.+||||+++++++..++..
T Consensus 46 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 3449999999999999999973 356689999997543 2334568889999999666999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEE
Q psy12709 87 VLVLEMVPDGELQRLVDIQD-----------------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNIL 143 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~-----------------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~ 143 (253)
++||||+++++|.+++.... .+++..++.++.|++.|+.|||++|++|+||+|+||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 204 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 204 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence 99999999999999997643 2789999999999999999999999999999999999
Q ss_pred EcCCCceEEEeeccccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy12709 144 LTKDNNIKLCDFGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETF 219 (253)
Q Consensus 144 ~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~ 219 (253)
++.++.++|+|||.+........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.......
T Consensus 205 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 284 (344)
T 1rjb_A 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 284 (344)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred EcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHH
Confidence 99999999999999976543221 223345778999999988899999999999999999998 99999887665555
Q ss_pred HHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 220 LNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 220 ~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+.......+. ...+++++.++|.+||+.||
T Consensus 285 ~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp 316 (344)
T 1rjb_A 285 YKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDS 316 (344)
T ss_dssp HHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCc
Confidence 544443333322 24789999999999999998
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=296.90 Aligned_cols=240 Identities=27% Similarity=0.377 Sum_probs=192.7
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +++.||+|+||+||+|.+..+++.||+|++...... .....+.+|+..+. ..+|+||+++++++..++..++
T Consensus 2 ~~y~--~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~l 77 (324)
T 3mtl_A 2 ETYI--KLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLK-DLKHANIVTLHDIIHTEKSLTL 77 (324)
T ss_dssp CSEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHS-CCCCTTBCCEEEEEECSSCEEE
T ss_pred CceE--EEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHH-hcCCCCCCeeeeEEeeCCEEEE
Confidence 3566 999999999999999999999999999998754321 11123446788887 7789999999999999999999
Q ss_pred EEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-cc
Q psy12709 89 VLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VE 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~ 166 (253)
||||++| +|.+++... ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 78 VFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp EEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred Eeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 9999975 787777654 45999999999999999999999999999999999999999999999999998755432 22
Q ss_pred ccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCC-------------
Q psy12709 167 VKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHED------------- 232 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~------------- 232 (253)
.....+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+.+..+....+......++..
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 334467899999999876 568999999999999999999999999988888777665533322211
Q ss_pred -------------ccCCCCHHHHHHHHHhcccCC
Q psy12709 233 -------------LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 -------------~~~~~~~~l~~li~~~l~~dP 253 (253)
..+.+++++.+||.+||+.||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 270 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEG 270 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSG
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCc
Confidence 123578999999999999998
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=288.05 Aligned_cols=238 Identities=20% Similarity=0.322 Sum_probs=205.1
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
..++|+ +.+.||+|+||+||+|.+..++..|++|.+..... ....+.+|+..+. ..+|+||+++++++..++..
T Consensus 11 ~~~~~~--~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 11 ERTDIT--MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMK-EIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CGGGEE--EEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST---HHHHHHHHHHHHH-HCCCTTBCCEEEEECSSSSE
T ss_pred ccccee--EEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH---HHHHHHHHHHHHH-hCCCCCEeeEEEEEccCCCE
Confidence 344555 99999999999999999999999999999976433 3457888999988 77899999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
++|||+++|++|.+++... ..+++..++.++.+++.++.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 9999999999999999763 44899999999999999999999999999999999999999999999999999865433
Q ss_pred c--cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHH
Q psy12709 165 V--EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQA 241 (253)
Q Consensus 165 ~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 241 (253)
. ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||...+.......+....... ....+|+++
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l 241 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME---RPEGCPEKV 241 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC---CCTTCCHHH
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCC---CCCCCCHHH
Confidence 2 2223345678999999988899999999999999999999 999999988877777665543322 224789999
Q ss_pred HHHHHHhcccCC
Q psy12709 242 KDFIQSCLVTDP 253 (253)
Q Consensus 242 ~~li~~~l~~dP 253 (253)
.++|.+||+.||
T Consensus 242 ~~li~~~l~~dp 253 (288)
T 3kfa_A 242 YELMRACWQWNP 253 (288)
T ss_dssp HHHHHHHTCSSG
T ss_pred HHHHHHHhCCCh
Confidence 999999999998
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=290.35 Aligned_cols=241 Identities=23% Similarity=0.375 Sum_probs=201.8
Q ss_pred ecceeeEEEeecCCCCceEEEEEEe-----ccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTH-----KITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
.++|+ +.+.||+|+||+||+|.+ ..++..|++|.+..... ......+.+|+..+....+|+||+++++++..
T Consensus 22 ~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 22 RNRLS--FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp GGGEE--EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhhhh--HHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh-HHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34555 999999999999999985 45678899999976533 34467888999999966699999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQD------------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILL 144 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~~------------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~ 144 (253)
++..++|||++++++|.+++.... .+++..++.++.|++.|+.+||++|++|+||+|+||++
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 999999999999999999987643 48999999999999999999999999999999999999
Q ss_pred cCCCceEEEeeccccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q psy12709 145 TKDNNIKLCDFGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFL 220 (253)
Q Consensus 145 ~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~ 220 (253)
+.++.++|+|||.+........ .....+++.|+|||.+.+..++.++||||+|+++|+|++ |..||.+........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 9999999999999986544322 223345678999999988899999999999999999999 999998876555444
Q ss_pred HhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 221 NISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 221 ~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
........... ...+++++.++|.+||+.||
T Consensus 259 ~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp 289 (313)
T 1t46_A 259 KMIKEGFRMLS--PEHAPAEMYDIMKTCWDADP 289 (313)
T ss_dssp HHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSG
T ss_pred HHhccCCCCCC--cccCCHHHHHHHHHHcCCCc
Confidence 44333322222 24789999999999999998
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=291.60 Aligned_cols=243 Identities=28% Similarity=0.417 Sum_probs=200.1
Q ss_pred ecceeeEEEeecCCCCceEEEEEEec-cCCceEEEEEecccccchHHHHHHHHHHHHHHHh--cCCCCceeeeeEEE---
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHK-ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLA--QKSERIVGLHEIYE--- 81 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~--~~~~~i~~~~~~~~--- 81 (253)
.++|+ +.+.||+|+||+||+|.+. .+++.||+|++............+.+|+..+... ..|+||+++++++.
T Consensus 10 ~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 10 DQQYE--CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGTEE--EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred hhcee--eeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 35555 9999999999999999995 6788999999976543332223455666666533 38999999999987
Q ss_pred --eCCeEEEEEeccCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecc
Q psy12709 82 --TPHEMVLVLEMVPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI 157 (253)
Q Consensus 82 --~~~~~~lv~e~~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~ 157 (253)
.+...++++|+++ ++|.+++.... .+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 4568999999997 59999887643 489999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccc---------
Q psy12709 158 SRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFS--------- 228 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~--------- 228 (253)
+.............+++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.+..+....+......
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 167 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred cccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 98765544445567889999999999889999999999999999999999999998887777665432111
Q ss_pred --------------ccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 229 --------------FHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 229 --------------~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
........+++++++||.+||+.||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 285 (326)
T 1blx_A 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNP 285 (326)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSST
T ss_pred cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCc
Confidence 1112335789999999999999998
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=285.43 Aligned_cols=239 Identities=22% Similarity=0.327 Sum_probs=196.2
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHH-----HHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ-----MQDILHEAAVLYLAQKSERIVGLHEIY 80 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~-----~~~~~~e~~~~~~~~~~~~i~~~~~~~ 80 (253)
+..++|+ +.+.||+|+||+||+|.+..+++.||+|++......... .+.+.+|+..+. ..+|+||+++++++
T Consensus 16 ~~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 16 LADNEIE--YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS-NLNHPNIVKLYGLM 92 (287)
T ss_dssp CCSTTEE--EEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHT-TCCCTTBCCEEEEE
T ss_pred hhhccce--ehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHH-hCCCCCchhhheee
Confidence 4456666 999999999999999999999999999998765432221 167888999998 66899999999999
Q ss_pred EeCCeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEcCCCc-----eEE
Q psy12709 81 ETPHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHN--ITHLDLKPQNILLTKDNN-----IKL 152 (253)
Q Consensus 81 ~~~~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~di~~~ni~~~~~~~-----~~l 152 (253)
.... +++|||+++++|.+.+.. ...+++..++.++.|++.++.|||++| ++|+||+|+||+++.++. ++|
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 7665 689999999999887754 456999999999999999999999999 999999999999998876 999
Q ss_pred EeecccccccccccccccccCccccCccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--HHHhhccccc
Q psy12709 153 CDFGISRVVNDVVEVKEIIGTPDYVAPEVLS--YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQET--FLNISQCNFS 228 (253)
Q Consensus 153 ~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~i~~~~~~ 228 (253)
+|||.+..... ......+++.|+|||++. ...++.++||||+|+++|+|++|+.||........ ...+......
T Consensus 171 ~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 4f0f_A 171 ADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248 (287)
T ss_dssp CCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred CCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence 99999875433 233456889999999984 44568899999999999999999999987654443 3333333322
Q ss_pred ccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 229 FHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
......+|+++.++|.+||+.||
T Consensus 249 --~~~~~~~~~~l~~li~~~l~~dp 271 (287)
T 4f0f_A 249 --PTIPEDCPPRLRNVIELCWSGDP 271 (287)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSG
T ss_pred --CCCCcccCHHHHHHHHHHhcCCh
Confidence 23345889999999999999998
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=283.56 Aligned_cols=240 Identities=24% Similarity=0.445 Sum_probs=201.1
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +.+.||+|+||+||+|.+..++..|++|++...... .....+.+|+..+. ..+|+||+++++++..++..+
T Consensus 6 ~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 6 VEDWD--LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINK-MLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHEE--EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHH-TCCCTTBCCEEEEEEETTEEE
T ss_pred ecceE--EEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHH-hcCCCCceeeeeEEEcCCEEE
Confidence 35666 999999999999999999999999999998765432 33567888888887 779999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc---
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV--- 164 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~--- 164 (253)
+++|++++++|.+++.....+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999999999999987778999999999999999999999999999999999999999999999999998754322
Q ss_pred ccccccccCccccCccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhcccccccCCccCCCCHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPI-SLATDMWSVGVLAYVLLSSHSPFAGDNKQ-ETFLNISQCNFSFHEDLFGHISSQAK 242 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~l~ 242 (253)
.......+++.|+|||.+.+..+ +.++|+||+|+++|+|++|+.||...... ..+..+....... .....+++++.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 239 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--NPWKKIDSAPL 239 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS--TTGGGSCHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc--CchhhcCHHHH
Confidence 12334567899999999987665 77899999999999999999999875543 2333333322211 12246899999
Q ss_pred HHHHHhcccCC
Q psy12709 243 DFIQSCLVTDP 253 (253)
Q Consensus 243 ~li~~~l~~dP 253 (253)
++|.+||+.||
T Consensus 240 ~li~~~l~~~p 250 (276)
T 2yex_A 240 ALLHKILVENP 250 (276)
T ss_dssp HHHHHHSCSST
T ss_pred HHHHHHCCCCc
Confidence 99999999998
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=288.60 Aligned_cols=239 Identities=25% Similarity=0.403 Sum_probs=196.8
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe-----
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET----- 82 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----- 82 (253)
.++|+ +.+.||+|+||+||+|.+..+++.|++|++...... ...+.+|+..+....+|+||+++++++..
T Consensus 23 ~~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 23 AGIFE--LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp TTTEE--EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCcEE--EEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 45666 999999999999999999999999999998765433 34778899999877799999999999987
Q ss_pred -CCeEEEEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 83 -PHEMVLVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 83 -~~~~~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
.+.+++||||+++++|.+++... ..+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 46899999999999999998764 468999999999999999999999999999999999999999999999999987
Q ss_pred ccccc-ccccccccCccccCccccC-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCc
Q psy12709 160 VVNDV-VEVKEIIGTPDYVAPEVLS-----YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDL 233 (253)
Q Consensus 160 ~~~~~-~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 233 (253)
..... .......+++.|+|||++. +..++.++||||||+++|+|++|..||...........+........ .
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~ 255 (326)
T 2x7f_A 178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL--K 255 (326)
T ss_dssp -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--S
T ss_pred ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccC--C
Confidence 65432 2223446789999999986 45688999999999999999999999988887776666555433222 2
Q ss_pred cCCCCHHHHHHHHHhcccCC
Q psy12709 234 FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP 253 (253)
...+|+.+.++|.+||+.||
T Consensus 256 ~~~~~~~l~~li~~~l~~dp 275 (326)
T 2x7f_A 256 SKKWSKKFQSFIESCLVKNH 275 (326)
T ss_dssp CSCSCHHHHHHHHHHCCSSG
T ss_pred ccccCHHHHHHHHHHhccCh
Confidence 35789999999999999998
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=298.21 Aligned_cols=236 Identities=25% Similarity=0.379 Sum_probs=194.2
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe-----
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET----- 82 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----- 82 (253)
.++|+ +.+.||+|+||+||+|.+..+++.||+|++....... .+|+..++ .++|+||+++++++..
T Consensus 6 ~~~y~--~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~------~~E~~il~-~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 6 SKKYS--LGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK------NRELDIMK-VLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp CTTEE--EEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSC------CHHHHHHT-TCCCTTBCCEEEEEEEC----
T ss_pred cceEE--EEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchH------HHHHHHHH-HcCCCCccchhheeeecCccc
Confidence 45666 9999999999999999999999999999987654322 25788887 7799999999999844
Q ss_pred ---------------------------------CCeEEEEEeccCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHH
Q psy12709 83 ---------------------------------PHEMVLVLEMVPDGELQRLVD----IQDGIPEQDTRSYMKQILEALA 125 (253)
Q Consensus 83 ---------------------------------~~~~~lv~e~~~g~~L~~~~~----~~~~~~~~~~~~~~~~l~~~l~ 125 (253)
+..+++||||+++ +|.+.+. ....+++..++.++.|++.|+.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3358999999975 6665554 3567999999999999999999
Q ss_pred HHHHCCceecCCCCCCEEEc-CCCceEEEeecccccccccccccccccCccccCccccCCC-CCCccccHHHHHHHHHHH
Q psy12709 126 FLHDHNITHLDLKPQNILLT-KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVL 203 (253)
Q Consensus 126 ~lh~~~~~h~di~~~ni~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l 203 (253)
|||++|++|+||+|+||+++ .++.++|+|||.+.............+++.|+|||++.+. .++.++||||+|+++|+|
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 99999999999999999998 5889999999999876555455556788999999998765 489999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhccccccc-------------------------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 204 LSSHSPFAGDNKQETFLNISQCNFSFH-------------------------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 204 ~~g~~p~~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
++|+.||.+.+..+.+..+......+. ......+|+++.+||.+||+.||
T Consensus 236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 999999999888877776654222211 01223589999999999999998
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=288.54 Aligned_cols=242 Identities=20% Similarity=0.295 Sum_probs=195.9
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEecc---CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKI---TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
+..++|+ +.+.||+|+||+||+|.+.. ++..||+|.+............+.+|+..+. ..+|+||+++++++..
T Consensus 31 ~~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 31 IDRNLLI--LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK-DFSHPNVIRLLGVCIE 107 (313)
T ss_dssp CCGGGEE--EEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHH-TCCCTTBCCCCEEEEC
T ss_pred cCHHHee--eccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHh-cCCCCCeeeeeEEEee
Confidence 3445566 99999999999999998775 4458999999877766777788999999998 7789999999999987
Q ss_pred CC-----eEEEEEeccCCCcHHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceE
Q psy12709 83 PH-----EMVLVLEMVPDGELQRLVD------IQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIK 151 (253)
Q Consensus 83 ~~-----~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~ 151 (253)
.+ ..++++|++++++|.+++. ....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence 65 3599999999999999884 235699999999999999999999999999999999999999999999
Q ss_pred EEeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccc
Q psy12709 152 LCDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNF 227 (253)
Q Consensus 152 l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~ 227 (253)
|+|||.+....... ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||...........+.....
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence 99999997654321 1223345778999999998999999999999999999999 9999999888877777666543
Q ss_pred cccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 228 SFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 228 ~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.. ....+++++.++|.+||+.||
T Consensus 268 ~~---~~~~~~~~l~~li~~~l~~dp 290 (313)
T 3brb_A 268 LK---QPEDCLDELYEIMYSCWRTDP 290 (313)
T ss_dssp CC---CBTTCCHHHHHHHHHTTCSSG
T ss_pred CC---CCccccHHHHHHHHHHcCCCh
Confidence 22 224789999999999999998
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=295.33 Aligned_cols=240 Identities=27% Similarity=0.418 Sum_probs=202.1
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
..++|+ +.+.||+|+||+||+|.+..++..||+|++.... .......+.+|+..+. .++|+||+++++++..++.+
T Consensus 31 ~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 31 KDDDFE--KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLH-ECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CGGGEE--EEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGG-GCCCTTBCCEEEEEEETTEE
T ss_pred ccccce--eeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHH-HCCCCCEEEEeEEEEECCEE
Confidence 455666 9999999999999999999999999999997653 3445677888998888 67999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCceEEEeecccccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDH-NITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~ 165 (253)
++||||++|++|.+++.....+++..+..++.+++.++.|||+. |++|+||+|+||+++.++.++|+|||.+......
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999999999998888899999999999999999999996 9999999999999999999999999998755332
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHh-----------------------
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNI----------------------- 222 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i----------------------- 222 (253)
......+++.|+|||++.+..++.++||||+|+++|+|++|+.||...+..+....+
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 223456889999999999999999999999999999999999999876655432221
Q ss_pred -------------------hcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 223 -------------------SQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 223 -------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.... .+......+|+++.+||.+||+.||
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP 313 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNP 313 (360)
T ss_dssp --------CCCHHHHHHHHHHSC--CCCCCTTTSCHHHHHHHHHHHCSST
T ss_pred ccccCCCCcccchhhhhHHhccC--CCCCCcccccHHHHHHHHHHhhcCh
Confidence 1111 1111123579999999999999998
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=281.72 Aligned_cols=236 Identities=24% Similarity=0.344 Sum_probs=203.4
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +.+.||+|+||+||+|.+. ++..|++|.+....... ..+.+|+..+. ..+|+||+++++++..++..+
T Consensus 7 ~~~y~--~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 7 PSELT--FVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMM-KLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp GGGEE--EEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH---HHHHHHHHHHH-TCCCTTBCCEEEEECSSSSCE
T ss_pred hhhee--eeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH---HHHHHHHHHHH-hCCCCCEeeEEEEEccCCCeE
Confidence 34555 9999999999999999987 67789999998765443 46788999888 678999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-
Q psy12709 88 LVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV- 165 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~- 165 (253)
++||++++++|.+++... ..+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999999999998765 558999999999999999999999999999999999999999999999999987654321
Q ss_pred -cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 166 -EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 166 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
......+++.|+|||++.+..++.++|+||+|+++|+|++ |+.||...+..+....+......... ..+++++.+
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~l~~ 236 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHVYQ 236 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTSCHHHHH
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCC---ccCcHHHHH
Confidence 2223445678999999988889999999999999999999 99999998888888777665433222 367999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 237 li~~~l~~~p 246 (267)
T 3t9t_A 237 IMNHCWRERP 246 (267)
T ss_dssp HHHHHTCSSG
T ss_pred HHHHHccCCh
Confidence 9999999998
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=298.28 Aligned_cols=241 Identities=20% Similarity=0.323 Sum_probs=195.0
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEec---cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHK---ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
+..++|+ +.+.||+|+||+||+|.+. .++..||+|.+.... .....+.+.+|+..+. ..+|+||+++++++..
T Consensus 42 ~~~~~~~--~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 42 LDATNIS--IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMG-QFDHPNIIRLEGVVTK 117 (373)
T ss_dssp CCGGGCC--CCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHT-TCCCTTBCCEEEEECS
T ss_pred cCHhhce--eeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEee
Confidence 3445666 9999999999999999987 466789999997643 3445678889999998 7799999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQD-GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
++..++||||+++++|.+++.... .+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999999999997653 6999999999999999999999999999999999999999999999999999865
Q ss_pred ccccc----ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCC
Q psy12709 162 NDVVE----VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGH 236 (253)
Q Consensus 162 ~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 236 (253)
..... .....+++.|+|||++.+..++.++||||+|+++|++++ |+.||...+..+....+......+. ...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~---~~~ 274 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP---PMD 274 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC---CTT
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---Ccc
Confidence 43221 112234568999999998899999999999999999998 9999999888888777766533322 237
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
+++++.++|.+||+.||
T Consensus 275 ~~~~l~~li~~cl~~dp 291 (373)
T 2qol_A 275 CPAALYQLMLDCWQKDR 291 (373)
T ss_dssp CBHHHHHHHHHHTCSSG
T ss_pred ccHHHHHHHHHHhCcCh
Confidence 89999999999999998
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=283.32 Aligned_cols=236 Identities=25% Similarity=0.414 Sum_probs=190.7
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc--hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS--MDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
++|+ +.+.||+|+||+||+|.+. +..||+|++...... ....+.+.+|+..+. ..+|+||+++++++..++..
T Consensus 7 ~~~~--~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 7 AELT--LEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFA-MLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp TSEE--EEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHH-HCCCTTBCCEEEEECCC--C
T ss_pred hhee--eeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHH-hcCCCCEeeEEEEEecCCce
Confidence 4555 9999999999999999975 788999998765432 233467788888887 77899999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCCEEEcC--------CCceEEEee
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHN---ITHLDLKPQNILLTK--------DNNIKLCDF 155 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~di~~~ni~~~~--------~~~~~l~df 155 (253)
+++|||+++++|.+++. ...+++..++.++.|++.++.+||++| ++|+||+|+||+++. ++.++|+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999986 556999999999999999999999999 889999999999986 678999999
Q ss_pred cccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccC
Q psy12709 156 GISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFG 235 (253)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 235 (253)
|.+........ ....+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||.+.+.......+.......+ ...
T Consensus 161 g~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 237 (271)
T 3dtc_A 161 GLAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP--IPS 237 (271)
T ss_dssp CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC--CCT
T ss_pred Ccccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC--CCc
Confidence 99976544322 245688999999999888899999999999999999999999999888777766665554433 235
Q ss_pred CCCHHHHHHHHHhcccCC
Q psy12709 236 HISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 236 ~~~~~l~~li~~~l~~dP 253 (253)
.+++++.++|.+||+.||
T Consensus 238 ~~~~~~~~li~~~l~~~p 255 (271)
T 3dtc_A 238 TCPEPFAKLMEDCWNPDP 255 (271)
T ss_dssp TCCHHHHHHHHHHTCSSG
T ss_pred ccCHHHHHHHHHHhcCCc
Confidence 789999999999999998
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=304.27 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=202.1
Q ss_pred CCCcceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy12709 1 MCNKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80 (253)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 80 (253)
|+.....+++|+ +.+.||+|+||+||+|.+..+++.||+|++..... ......+.+|+..+. ..+|+||+++++++
T Consensus 1 m~~~~~~~~~y~--i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~ 76 (396)
T 4eut_A 1 MGSQSTSNHLWL--LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLK-KLNHKNIVKLFAIE 76 (396)
T ss_dssp -CEEECSSEEEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHH-HCCCTTBCCEEEEE
T ss_pred CCCCCCCCCceE--EEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHH-hcCCCCCCeEEEee
Confidence 445556677777 99999999999999999999999999999976442 222456778999988 67899999999999
Q ss_pred EeCC--eEEEEEeccCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE----cCCCceE
Q psy12709 81 ETPH--EMVLVLEMVPDGELQRLVDIQD---GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILL----TKDNNIK 151 (253)
Q Consensus 81 ~~~~--~~~lv~e~~~g~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~----~~~~~~~ 151 (253)
...+ ..++||||++|++|.+++.... .+++..++.++.|++.|+.|||++|++|+||+|+||++ +.++.++
T Consensus 77 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 156 (396)
T 4eut_A 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYK 156 (396)
T ss_dssp ECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEE
T ss_pred ccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEE
Confidence 8765 7899999999999999987643 38999999999999999999999999999999999999 6777899
Q ss_pred EEeecccccccccccccccccCccccCccccCC--------CCCCccccHHHHHHHHHHHHhCCCCCCC----CChHHHH
Q psy12709 152 LCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSY--------EPISLATDMWSVGVLAYVLLSSHSPFAG----DNKQETF 219 (253)
Q Consensus 152 l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~----~~~~~~~ 219 (253)
|+|||.+.............+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||.. ....+..
T Consensus 157 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 157 LTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp ECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred EecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 999999987766555556678999999999864 4567899999999999999999999964 3333444
Q ss_pred HHhhcccccc---------------------cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 220 LNISQCNFSF---------------------HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 220 ~~i~~~~~~~---------------------~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+..+.... .......+++.+.++|.+||+.||
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP 291 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ 291 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCT
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccCh
Confidence 4444433211 111122356679999999999998
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=293.87 Aligned_cols=243 Identities=28% Similarity=0.470 Sum_probs=202.4
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC-
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP- 83 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~- 83 (253)
+-++++|+ +++.||+|+||+||+|.+..++..||+|++.... .......+.+|+..+. ..+|+||+++++++...
T Consensus 23 ~~~~~~y~--~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~ 98 (364)
T 3qyz_A 23 FDVGPRYT--NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILL-RFRHENIIGINDIIRAPT 98 (364)
T ss_dssp CCCTTTEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHH-HCCCTTBCCCCEEECCSS
T ss_pred ccccccEE--EEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHH-hcCCCCCccceeEEecCC
Confidence 33456777 9999999999999999999999999999997533 3344577889999998 77899999999999765
Q ss_pred ----CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 84 ----HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 84 ----~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
...++++|++++ +|.+++.. ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 99 ~~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 99 IEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp TTTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 368999999965 89888874 459999999999999999999999999999999999999999999999999998
Q ss_pred ccccccc----ccccccCccccCccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc----
Q psy12709 160 VVNDVVE----VKEIIGTPDYVAPEVLS-YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH---- 230 (253)
Q Consensus 160 ~~~~~~~----~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---- 230 (253)
....... .....+++.|+|||++. +..++.++||||+|+++|+|++|+.||.+.+..+....+......++
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 6543322 23347899999999864 45589999999999999999999999999887777766643222211
Q ss_pred -----------------------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 -----------------------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 -----------------------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+.+++++.+||.+||+.||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 302 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP 302 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSST
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCCh
Confidence 11235689999999999999998
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=287.75 Aligned_cols=241 Identities=21% Similarity=0.333 Sum_probs=193.7
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEE----eccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCT----HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 80 (253)
.+..++|+ +++.||+|+||+||+|. +..++..||+|++... .....+.+.+|+..+. ..+|+||+++++++
T Consensus 6 ~~~~~~~~--~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~ 80 (295)
T 3ugc_A 6 QFEERHLK--FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILK-SLQHDNIVKYKGVC 80 (295)
T ss_dssp CCCGGGEE--EEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHH-TCCCTTBCCEEEEE
T ss_pred cCCHHHhh--hhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHH-hCCCCCEeeEEEEE
Confidence 35566777 99999999999999998 5678899999998754 3444568889999998 77899999999998
Q ss_pred EeC--CeEEEEEeccCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecc
Q psy12709 81 ETP--HEMVLVLEMVPDGELQRLVDIQD-GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI 157 (253)
Q Consensus 81 ~~~--~~~~lv~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~ 157 (253)
... ..+++||||+++++|.+++.... .+++..++.++.|++.++.|||++|++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 654 46899999999999999997654 499999999999999999999999999999999999999999999999999
Q ss_pred ccccccccc----ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH----------------H
Q psy12709 158 SRVVNDVVE----VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ----------------E 217 (253)
Q Consensus 158 ~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------------~ 217 (253)
+........ .....++..|+|||.+.+..++.++||||+|+++|+|++|..|+...... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 986543221 12234566799999999899999999999999999999999998653221 1
Q ss_pred HHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 218 TFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 218 ~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+..... ......+|+++.++|.+||+.||
T Consensus 241 ~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp 273 (295)
T 3ugc_A 241 LIELLKNNGR---LPRPDGCPDEIYMIMTECWNNNV 273 (295)
T ss_dssp HHHHHHTTCC---CCCCTTCCHHHHHHHHHHSCSSG
T ss_pred HHHHHhccCc---CCCCcCcCHHHHHHHHHHcCCCh
Confidence 1112222211 12234789999999999999998
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=285.04 Aligned_cols=241 Identities=26% Similarity=0.481 Sum_probs=191.3
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
.++|+ +.+.||+|+||.||+|.+..++..||+|++.... ........+.+|+..+. ..+|+||+++++++..++..
T Consensus 31 ~~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 31 LANFR--IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLK-QLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp GGGEE--EEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEEETTEE
T ss_pred ccceE--EEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEcCCcE
Confidence 34566 9999999999999999999999999999998643 34455677888999988 77999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN 162 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~ 162 (253)
+++||++++++|.+++.. ...+++..++.++.+++.++.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999998864 4568999999999999999999999999999999999999999999999999987654
Q ss_pred cc-ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHhhcccccccCCccCCCCH
Q psy12709 163 DV-VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDN--KQETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 163 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
.. .......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.+.. .......+........ ....+++
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 265 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL--PSDHYSE 265 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCC--CTTTSCH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCC--cccccCH
Confidence 32 22234467889999999998899999999999999999999999997643 3344444444433322 2247899
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
++.++|.+||+.||
T Consensus 266 ~l~~li~~~l~~dp 279 (310)
T 2wqm_A 266 ELRQLVNMCINPDP 279 (310)
T ss_dssp HHHHHHHHHTCSSG
T ss_pred HHHHHHHHHcCCCh
Confidence 99999999999998
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=283.26 Aligned_cols=237 Identities=18% Similarity=0.297 Sum_probs=204.0
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP-- 83 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-- 83 (253)
+..++|+ +.+.||+|+||+||+|.+. +..||+|++............+.+|+..+. ..+|+||+++++++..+
T Consensus 7 i~~~~y~--~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 7 IDFKQLN--FLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLR-IFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCGGGCE--EEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGC-CCSCTTEECEEEEECTTTS
T ss_pred CCHHHhH--HHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHH-hcCCCchhheEEEEccCCC
Confidence 3446666 9999999999999999985 888999999887766677778899999887 67999999999999887
Q ss_pred CeEEEEEeccCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHN--ITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
+..+++|||+++++|.+++.... .+++..++.++.|++.|+.|||++| ++|+||+|+||+++.++.++++||++..
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 78999999999999999998754 4899999999999999999999999 9999999999999999999999998875
Q ss_pred cccccccccccccCccccCccccCCCCCCc---cccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCC
Q psy12709 160 VVNDVVEVKEIIGTPDYVAPEVLSYEPISL---ATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGH 236 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~---~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 236 (253)
.... ....+++.|+|||.+.+...+. ++||||+|+++|+|++|+.||...+..+....+......+. ....
T Consensus 162 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~ 235 (271)
T 3kmu_A 162 SFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT--IPPG 235 (271)
T ss_dssp TTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC--CCTT
T ss_pred eecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC--CCCC
Confidence 4322 2345789999999997765444 79999999999999999999999888877776665444332 2347
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
+++++.++|.+||+.||
T Consensus 236 ~~~~~~~li~~~l~~~p 252 (271)
T 3kmu_A 236 ISPHVSKLMKICMNEDP 252 (271)
T ss_dssp CCHHHHHHHHHHTCSSG
T ss_pred CCHHHHHHHHHHcCCCh
Confidence 89999999999999998
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=283.04 Aligned_cols=238 Identities=21% Similarity=0.350 Sum_probs=200.4
Q ss_pred ecceeeEEEe-ecCCCCceEEEEEEec--cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 8 NGGYQTLIFC-MPSRGKFASVRKCTHK--ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 8 ~~~~~~~~~~-~lg~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
.++|. +.+ .||+|+||+||+|.+. .++..|++|++.... .......+.+|+..+. ..+|+||+++++++ ..+
T Consensus 8 ~~~~~--i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 8 RDNLL--IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMH-QLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp GGGEE--EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHH-HCCCTTBCCEEEEE-ESS
T ss_pred HHHhh--hhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHH-hCCCCCEeEEEEEe-cCC
Confidence 34444 777 9999999999999864 467789999998653 3455678889999998 66999999999999 456
Q ss_pred eEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
..++|||++++++|.+++... ..+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 799999999999999988653 5699999999999999999999999999999999999999999999999999986543
Q ss_pred ccc----ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCC
Q psy12709 164 VVE----VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHIS 238 (253)
Q Consensus 164 ~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 238 (253)
... .....+++.|+|||++.+..++.++|+||+|+++|+|++ |+.||......+....+....... ....+|
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~ 239 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPPECP 239 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC---CCTTCC
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCC---CCCCcC
Confidence 221 122345688999999988889999999999999999998 999999988888777776654322 224789
Q ss_pred HHHHHHHHHhcccCC
Q psy12709 239 SQAKDFIQSCLVTDP 253 (253)
Q Consensus 239 ~~l~~li~~~l~~dP 253 (253)
+++.++|.+||+.||
T Consensus 240 ~~l~~li~~~l~~~p 254 (287)
T 1u59_A 240 PELYALMSDCWIYKW 254 (287)
T ss_dssp HHHHHHHHHTTCSSG
T ss_pred HHHHHHHHHHcCCCh
Confidence 999999999999997
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=282.34 Aligned_cols=247 Identities=22% Similarity=0.325 Sum_probs=201.2
Q ss_pred CCCcceeecceeeEEEeecCCCCceEEEEEEeccC---CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeee
Q psy12709 1 MCNKFFVNGGYQTLIFCMPSRGKFASVRKCTHKIT---KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLH 77 (253)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~ 77 (253)
|++..+....-+|++.+.||+|+||+||+|.+... +..|++|.+.... .......+.+|+..+. ..+||||++++
T Consensus 2 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~i~~~~ 79 (281)
T 3cc6_A 2 MGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMK-NLDHPHIVKLI 79 (281)
T ss_dssp --CCCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHH-HHCCTTBCCEE
T ss_pred CCCccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHH-hCCCCCcceEE
Confidence 44554555555555999999999999999987643 3469999988653 3445678889999998 56899999999
Q ss_pred eEEEeCCeEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeec
Q psy12709 78 EIYETPHEMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFG 156 (253)
Q Consensus 78 ~~~~~~~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~ 156 (253)
+++..+ ..+++||++++++|.+++... ..++...+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||
T Consensus 80 ~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 80 GIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp EEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred EEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccC
Confidence 998754 568999999999999998764 459999999999999999999999999999999999999999999999999
Q ss_pred ccccccccc--cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCc
Q psy12709 157 ISRVVNDVV--EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDL 233 (253)
Q Consensus 157 ~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 233 (253)
.+....... ......+++.|+|||++.+..++.++|+||+|+++|+|++ |+.||......+....+......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 236 (281)
T 3cc6_A 159 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP-- 236 (281)
T ss_dssp GGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC--
T ss_pred CCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC--
Confidence 987654322 1223345678999999988899999999999999999998 99999887777777666655433322
Q ss_pred cCCCCHHHHHHHHHhcccCC
Q psy12709 234 FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP 253 (253)
..+++.+.++|.+||+.||
T Consensus 237 -~~~~~~l~~li~~~l~~~p 255 (281)
T 3cc6_A 237 -DLCPPVLYTLMTRCWDYDP 255 (281)
T ss_dssp -TTCCHHHHHHHHHHTCSSG
T ss_pred -CCCCHHHHHHHHHHccCCc
Confidence 3689999999999999998
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=283.59 Aligned_cols=238 Identities=25% Similarity=0.399 Sum_probs=198.5
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
..+|++.+.||+|+||.||+|.+..++..|++|.+..... ...+.+|+..+. .++|+||+++++++..++.++++
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQ-QCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHH-TCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHH-hCCCCCCccEEEEEEeCCEEEEE
Confidence 3345599999999999999999999999999999976432 346778898888 77999999999999999999999
Q ss_pred EeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-ccc
Q psy12709 90 LEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEV 167 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~ 167 (253)
|||+++++|.+++.. ...+++..++.++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 182 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR 182 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCB
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcccc
Confidence 999999999999863 567999999999999999999999999999999999999999999999999999765433 223
Q ss_pred cccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~ 247 (253)
....+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...........+...... .......+++++.++|.+
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~ 261 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELWSDNFTDFVKQ 261 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGSCHHHHHHHHH
T ss_pred CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccCCHHHHHHHHH
Confidence 3456789999999999888999999999999999999999999887776665554443321 122234679999999999
Q ss_pred hcccCC
Q psy12709 248 CLVTDP 253 (253)
Q Consensus 248 ~l~~dP 253 (253)
||+.||
T Consensus 262 ~l~~dp 267 (314)
T 3com_A 262 CLVKSP 267 (314)
T ss_dssp HTCSCT
T ss_pred HccCCh
Confidence 999998
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=290.89 Aligned_cols=242 Identities=21% Similarity=0.295 Sum_probs=195.5
Q ss_pred cceeecceeeEEEeecCCCCceEEEEEEeccCCce----EEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeE
Q psy12709 4 KFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVE----YAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79 (253)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~----v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~ 79 (253)
+++..++|+ +.+.||+|+||+||+|.+..++.. |++|.+.... .......+.+|+..+. ..+|+||++++++
T Consensus 10 ~~l~~~~y~--~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~ 85 (327)
T 3poz_A 10 RILKETEFK--KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMA-SVDNPHVCRLLGI 85 (327)
T ss_dssp EECCGGGEE--EEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHH-HCCBTTBCCEEEE
T ss_pred hhcCHHHcc--cceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHH-hCCCCCEeEEEEE
Confidence 345556676 999999999999999998877665 4777765432 2233567888999998 7799999999999
Q ss_pred EEeCCeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccc
Q psy12709 80 YETPHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGIS 158 (253)
Q Consensus 80 ~~~~~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~ 158 (253)
+..+. .+++++++.+++|.+++.. ...+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 86 ~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 86 CLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred EecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcce
Confidence 98765 7788999999999998876 456999999999999999999999999999999999999999999999999999
Q ss_pred cccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCcc
Q psy12709 159 RVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLF 234 (253)
Q Consensus 159 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 234 (253)
........ .....+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||.+....+....+........ .
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~ 241 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---P 241 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---C
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC---C
Confidence 86543222 222345678999999999999999999999999999999 9999998888777766665543322 2
Q ss_pred CCCCHHHHHHHHHhcccCC
Q psy12709 235 GHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP 253 (253)
..++.++.+++.+||+.||
T Consensus 242 ~~~~~~~~~li~~~l~~~p 260 (327)
T 3poz_A 242 PICTIDVYMIMVKCWMIDA 260 (327)
T ss_dssp TTBCHHHHHHHHHHTCSCG
T ss_pred ccCCHHHHHHHHHHcCCCh
Confidence 4789999999999999998
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=288.54 Aligned_cols=239 Identities=22% Similarity=0.318 Sum_probs=197.2
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCC----ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITK----VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
..+|+ +.+.||+|+||+||+|.+..++ ..|++|.+.... .......+.+|+..+. ..+|+||+++++++...
T Consensus 43 ~~~~~--~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 43 PSCVT--RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMG-QFSHHNIIRLEGVISKY 118 (333)
T ss_dssp TTTEE--EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHH-TCCCTTBCCEEEEECSS
T ss_pred hHHhh--cccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEecC
Confidence 44555 9999999999999999987543 359999987643 3344567888999988 77999999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN 162 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~ 162 (253)
+..++|||++++++|.+++... ..+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999999998764 569999999999999999999999999999999999999999999999999998654
Q ss_pred cccc----ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCC
Q psy12709 163 DVVE----VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHI 237 (253)
Q Consensus 163 ~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 237 (253)
.... .....+++.|+|||++.+..++.++||||+|+++|+|++ |+.||......+....+..+...+. ...+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~ 275 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT---PMDC 275 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTC
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC---cccC
Confidence 3221 112234678999999998899999999999999999999 9999998888888777766533222 2478
Q ss_pred CHHHHHHHHHhcccCC
Q psy12709 238 SSQAKDFIQSCLVTDP 253 (253)
Q Consensus 238 ~~~l~~li~~~l~~dP 253 (253)
++++.++|.+||+.||
T Consensus 276 ~~~l~~li~~~l~~~p 291 (333)
T 1mqb_A 276 PSAIYQLMMQCWQQER 291 (333)
T ss_dssp BHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHcCCCh
Confidence 9999999999999998
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=295.82 Aligned_cols=241 Identities=13% Similarity=0.176 Sum_probs=184.4
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccC-----CceEEEEEecccccchHHHHH---------HHHHHHHHHHhcCCCCce
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKIT-----KVEYAAKFIRKRRRSMDQMQD---------ILHEAAVLYLAQKSERIV 74 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~---------~~~e~~~~~~~~~~~~i~ 74 (253)
++|+ +.+.||+|+||+||+|.+..+ ++.||+|++............ ...|+..+. ..+|+||+
T Consensus 35 ~~y~--~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~-~l~h~~iv 111 (364)
T 3op5_A 35 AAWK--VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTR-KLKYLGVP 111 (364)
T ss_dssp CEEE--EEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHT-TCSCCCSC
T ss_pred CeEE--EEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHh-hccCCCCC
Confidence 3555 999999999999999998764 578999998765421111111 111222222 55699999
Q ss_pred eeeeEEEeC----CeEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc--CC
Q psy12709 75 GLHEIYETP----HEMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLT--KD 147 (253)
Q Consensus 75 ~~~~~~~~~----~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~--~~ 147 (253)
++++++... ...++||||+ |++|.+++... ..+++..++.++.|++.|+.|||++|++|+||+|+||+++ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998765 4689999999 99999999765 5799999999999999999999999999999999999999 88
Q ss_pred CceEEEeeccccccccccc--------ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy12709 148 NNIKLCDFGISRVVNDVVE--------VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETF 219 (253)
Q Consensus 148 ~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 219 (253)
+.++|+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.......
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 9999999999976543221 12334899999999999999999999999999999999999999863332222
Q ss_pred HHhhccccccc-CC------ccCCCCHHHHHHHHHhcccCC
Q psy12709 220 LNISQCNFSFH-ED------LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 220 ~~i~~~~~~~~-~~------~~~~~~~~l~~li~~~l~~dP 253 (253)
........... .. ....+|+++.+++.+||+.||
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 311 (364)
T 3op5_A 271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDY 311 (364)
T ss_dssp HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCT
T ss_pred HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCC
Confidence 21111110000 00 014789999999999999998
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=285.38 Aligned_cols=241 Identities=21% Similarity=0.370 Sum_probs=191.1
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
+..++|+ +.+.||+|+||+||+|.+. ..|++|++............+.+|+..+. ..+|+||++++++. ..+.
T Consensus 21 i~~~~y~--~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 21 IPDGQIT--VGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLR-KTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp CCTTSCE--EEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEE-CSSS
T ss_pred cCcccee--eeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHH-hCCCCcEEEEEeec-cCCc
Confidence 3456677 9999999999999999865 35999999887777777788999999988 78999999999965 4567
Q ss_pred EEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc-
Q psy12709 86 MVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND- 163 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~- 163 (253)
.++||||+++++|.+++.. ...+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 8999999999999998854 45699999999999999999999999999999999999999999999999999875432
Q ss_pred --cccccccccCccccCccccC---CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH-Hhhccccccc-CCccCC
Q psy12709 164 --VVEVKEIIGTPDYVAPEVLS---YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFL-NISQCNFSFH-EDLFGH 236 (253)
Q Consensus 164 --~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~i~~~~~~~~-~~~~~~ 236 (253)
........+++.|+|||.+. +..++.++||||+|+++|+|++|+.||.+....+... .+......+. ......
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence 22223456789999999986 5667889999999999999999999998865554443 3434333322 334457
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
+|+++.++|.+||+.||
T Consensus 254 ~~~~l~~li~~~l~~~p 270 (289)
T 3og7_A 254 CPKRMKRLMAECLKKKR 270 (289)
T ss_dssp SCHHHHHHHHHHTCSSG
T ss_pred CCHHHHHHHHHHccCCh
Confidence 89999999999999997
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=294.00 Aligned_cols=240 Identities=24% Similarity=0.369 Sum_probs=200.5
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
-+.++|+ +.+.||+|+||+||+|.+..+++.||+|++............+.+|+..+. ..+|+||+++++++...+.
T Consensus 39 ~l~~~y~--~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 39 ELPKTYV--SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK-HMQHENVIGLLDVFTPASS 115 (371)
T ss_dssp EEETTEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHH-HCCCTTBCCCSEEECSCSS
T ss_pred cccccEE--EEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHH-hcCCCCchhhhhheeccCC
Confidence 3566777 999999999999999999999999999999877666666788889999998 7789999999999988765
Q ss_pred E------EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 86 M------VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 86 ~------~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
. +++||++. ++|.+.+. ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 116 ~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp STTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred cccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 4 99999996 58887764 348999999999999999999999999999999999999999999999999997
Q ss_pred cccccccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc--------
Q psy12709 160 VVNDVVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH-------- 230 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-------- 230 (253)
..... .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+......++
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 193 HADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred ccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 65432 234567899999999877 6789999999999999999999999999887777766544222111
Q ss_pred -------------------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 -------------------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 -------------------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+.+++++.+||.+||+.||
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 312 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV 312 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCT
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCCh
Confidence 11224679999999999999998
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=293.30 Aligned_cols=242 Identities=27% Similarity=0.402 Sum_probs=196.2
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch---HHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM---DQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
.++|+ +.+.||+|+||+||+|.+..++..||+|++....... .....+.+|+..+. ..+|+||+++++++..++
T Consensus 9 ~~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 9 AKRYE--KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ-ELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp ----C--EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHH-HCCCTTBCCEEEEECCTT
T ss_pred hcccE--EEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHh-hCCCCCCCeEEEEEeeCC
Confidence 35566 9999999999999999999999999999997643222 11246778999888 678999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
..++||||+++ +|.+.+... ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99999999976 788877654 4589999999999999999999999999999999999999999999999999986543
Q ss_pred c-ccccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCC---------
Q psy12709 164 V-VEVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHED--------- 232 (253)
Q Consensus 164 ~-~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~--------- 232 (253)
. .......+++.|+|||++.+. .++.++||||+|+++|+|++|..||.+.+..+.+..+......+...
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 2 233345678999999998654 57899999999999999999999999988887777665432222111
Q ss_pred ---------------ccCCCCHHHHHHHHHhcccCC
Q psy12709 233 ---------------LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 ---------------~~~~~~~~l~~li~~~l~~dP 253 (253)
....+++++++||.+||+.||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 280 (346)
T 1ua2_A 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNP 280 (346)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSST
T ss_pred ccccccccCCCChHHhhccCCHHHHHHHHHHhccCh
Confidence 124678999999999999998
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=288.29 Aligned_cols=239 Identities=18% Similarity=0.314 Sum_probs=203.8
Q ss_pred ecceeeEEEeecCCCCceEEEEEEec-----cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHK-----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
.++|+ +.+.||+|+||+||+|.+. .++..|++|.+.... .......+.+|+..+. ..+|+||+++++++..
T Consensus 24 ~~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 24 REKIT--MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMK-EFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp GGGEE--EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGG-GCCCTTBCCEEEEECS
T ss_pred hhhee--eeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHH-hcCCCCEeeeEEEEcc
Confidence 34555 9999999999999999877 357889999997543 3344567888999888 7799999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEE
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQ----------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKL 152 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l 152 (253)
++..++|||++++++|.+++... ..++...++.++.|++.|+.+||++|++|+||+|+||+++.++.++|
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence 99999999999999999988652 35789999999999999999999999999999999999999999999
Q ss_pred Eeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhccccc
Q psy12709 153 CDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFS 228 (253)
Q Consensus 153 ~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~ 228 (253)
+|||.+....... ......+++.|+|||++.+..++.++||||+|+++|+|++ |..||.+.+..+....+......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 259 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcC
Confidence 9999997654322 1223345788999999988889999999999999999999 89999998888888777665543
Q ss_pred ccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 229 FHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.. ...+++++.++|.+||+.||
T Consensus 260 ~~---~~~~~~~l~~li~~~l~~dp 281 (322)
T 1p4o_A 260 DK---PDNCPDMLFELMRMCWQYNP 281 (322)
T ss_dssp CC---CTTCCHHHHHHHHHHTCSSG
T ss_pred CC---CCCCCHHHHHHHHHHcCCCc
Confidence 32 24789999999999999998
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=299.91 Aligned_cols=230 Identities=20% Similarity=0.323 Sum_probs=196.8
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC-eEEEEE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH-EMVLVL 90 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~ 90 (253)
+|++.+.||+|+||+||+|.+. +..||+|+++... ..+.+.+|+..+. ..+|+||+++++++...+ .+++||
T Consensus 194 ~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 194 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMT-QLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHH-TCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred HeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHH-hccCCCEEEEEEEEEcCCCceEEEE
Confidence 4449999999999999999875 7799999998653 2357888999998 779999999999987665 799999
Q ss_pred eccCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccccc
Q psy12709 91 EMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK 168 (253)
Q Consensus 91 e~~~g~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 168 (253)
||+++++|.+++..... ++...++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~ 344 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--D 344 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--c
Confidence 99999999999986543 7999999999999999999999999999999999999999999999999997543322 2
Q ss_pred ccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHH
Q psy12709 169 EIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~ 247 (253)
...+++.|+|||++.+..++.++||||+|+++|+|++ |+.||...+..+....+..+.... ....+|+++.++|.+
T Consensus 345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~ 421 (450)
T 1k9a_A 345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---APDGCPPAVYDVMKN 421 (450)
T ss_dssp --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC---CCTTCCHHHHHHHHH
T ss_pred CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCcCCHHHHHHHHH
Confidence 2356789999999999999999999999999999998 999999988887777776654322 224789999999999
Q ss_pred hcccCC
Q psy12709 248 CLVTDP 253 (253)
Q Consensus 248 ~l~~dP 253 (253)
||+.||
T Consensus 422 cl~~dp 427 (450)
T 1k9a_A 422 CWHLDA 427 (450)
T ss_dssp HTCSSG
T ss_pred HcCCCh
Confidence 999998
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=293.69 Aligned_cols=243 Identities=19% Similarity=0.277 Sum_probs=199.4
Q ss_pred CcceeecceeeEEEeecCCCCceEEEEEEeccCCce----EEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeee
Q psy12709 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVE----YAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHE 78 (253)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~----v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~ 78 (253)
.+++..++|+ +++.||+|+||+||+|.+..++.. |++|.+..... ......+.+|+..+. ..+|+||+++++
T Consensus 7 ~~~~~~~~y~--~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~-~l~h~~iv~~~~ 82 (325)
T 3kex_A 7 ARIFKETELR--KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIG-SLDHAHIVRLLG 82 (325)
T ss_dssp CCBCCTTTEE--EEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHH-TCCCTTBCCEEE
T ss_pred HhhcCHhHce--eeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHh-cCCCCCcCeEEE
Confidence 3556677777 999999999999999999877765 67776654321 122335567777777 779999999999
Q ss_pred EEEeCCeEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecc
Q psy12709 79 IYETPHEMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI 157 (253)
Q Consensus 79 ~~~~~~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~ 157 (253)
++. ++..++|+||+.+++|.+++... ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 161 (325)
T 3kex_A 83 LCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGV 161 (325)
T ss_dssp EEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred EEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCc
Confidence 886 45789999999999999988764 5689999999999999999999999999999999999999999999999999
Q ss_pred cccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCc
Q psy12709 158 SRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDL 233 (253)
Q Consensus 158 ~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 233 (253)
+....... ......+++.|+|||++.+..++.++||||+|+++|+|++ |..||.+....+....+.........
T Consensus 162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 239 (325)
T 3kex_A 162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP-- 239 (325)
T ss_dssp GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC--
T ss_pred ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC--
Confidence 98654322 2233456779999999998899999999999999999999 99999998887777777665433322
Q ss_pred cCCCCHHHHHHHHHhcccCC
Q psy12709 234 FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP 253 (253)
..+++++.++|.+||+.||
T Consensus 240 -~~~~~~~~~li~~~l~~dp 258 (325)
T 3kex_A 240 -QICTIDVYMVMVKCWMIDE 258 (325)
T ss_dssp -TTBCTTTTHHHHHHTCSCT
T ss_pred -CcCcHHHHHHHHHHcCCCh
Confidence 3678899999999999998
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=283.19 Aligned_cols=241 Identities=20% Similarity=0.263 Sum_probs=196.8
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
.+.++|+ +.+.||+|+||+||+|.+..+++.||+|++...... ..+.+|+..+.....++++..+..+...++.
T Consensus 6 ~~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 6 RVGNRYR--LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp EETTTEE--EEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred eeccEEE--EEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence 4567777 999999999999999999999999999998765432 2577888888855555556666666677789
Q ss_pred EEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---cCCCceEEEeecccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILL---TKDNNIKLCDFGISRVV 161 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~---~~~~~~~l~df~~~~~~ 161 (253)
.+++||++ +++|.+++.. ...+++..++.++.|++.|+.|||++|++|+||+|+||++ +.++.++|+|||.+...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99999999 8899999874 4569999999999999999999999999999999999999 47899999999999865
Q ss_pred ccccc--------ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHhhccccccc
Q psy12709 162 NDVVE--------VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDN---KQETFLNISQCNFSFH 230 (253)
Q Consensus 162 ~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~i~~~~~~~~ 230 (253)
..... .....+++.|+|||.+.+..++.++||||+|+++|+|++|+.||.... ..+.+..+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 44322 234568899999999999999999999999999999999999997633 2334444433333222
Q ss_pred -CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 -EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 -~~~~~~~~~~l~~li~~~l~~dP 253 (253)
......+|+++.++|.+||+.||
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp 262 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRF 262 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCT
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCc
Confidence 22335789999999999999998
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=293.16 Aligned_cols=242 Identities=28% Similarity=0.446 Sum_probs=205.5
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchH---------------HHHHHHHHHHHHHHhcCC
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMD---------------QMQDILHEAAVLYLAQKS 70 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~---------------~~~~~~~e~~~~~~~~~~ 70 (253)
+..++|+ +.+.||+|+||.||+|.+ +++.||+|.+........ ....+.+|+..+. ..+|
T Consensus 28 ~~~~~y~--~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h 102 (348)
T 2pml_X 28 KYINDYR--IIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT-DIKN 102 (348)
T ss_dssp EEETTEE--EEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT-TCCC
T ss_pred cccCceE--EEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH-hCCC
Confidence 4456777 999999999999999998 899999999976543211 1167888999998 6789
Q ss_pred CCceeeeeEEEeCCeEEEEEeccCCCcHHHH------Hhh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCC
Q psy12709 71 ERIVGLHEIYETPHEMVLVLEMVPDGELQRL------VDI--QDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQN 141 (253)
Q Consensus 71 ~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~------~~~--~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~di~~~n 141 (253)
+||+++++++..++..++||||+++++|.++ +.. ...+++..++.++.|++.|+.+||+ .|++|+||+|+|
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999999999999999999999999999998 665 5679999999999999999999999 999999999999
Q ss_pred EEEcCCCceEEEeecccccccccccccccccCccccCccccCCC-CCCc-cccHHHHHHHHHHHHhCCCCCCCCCh-HHH
Q psy12709 142 ILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYE-PISL-ATDMWSVGVLAYVLLSSHSPFAGDNK-QET 218 (253)
Q Consensus 142 i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~-~~~ 218 (253)
|+++.++.++|+|||.+...... ......+++.|+|||++.+. .++. ++|+||+|+++|+|++|+.||..... .+.
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 99999999999999999865443 33445688999999999877 5665 99999999999999999999988776 677
Q ss_pred HHHhhcccccccCCc---------------cCCCCHHHHHHHHHhcccCC
Q psy12709 219 FLNISQCNFSFHEDL---------------FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 219 ~~~i~~~~~~~~~~~---------------~~~~~~~l~~li~~~l~~dP 253 (253)
...+.......+... ...+++++.++|.+||+.||
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 311 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNP 311 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSG
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCCh
Confidence 777766655554211 14789999999999999998
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=304.59 Aligned_cols=238 Identities=20% Similarity=0.314 Sum_probs=204.8
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
...+|++.+.||+|+||+||+|.++.++..||+|.+...... ...+.+|+..+. .++|+||+++++++..++.+++
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMK-EIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHH-HCCCTTBCCEEEEECSSSSCEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHH-hcCCCCEeeEEEEEecCCcEEE
Confidence 334455999999999999999999988999999999865433 457888999998 6799999999999999999999
Q ss_pred EEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-
Q psy12709 89 VLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV- 165 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~- 165 (253)
||||+++++|.+++... ..++...++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999999999763 458999999999999999999999999999999999999999999999999998654322
Q ss_pred -cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 166 -EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 166 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
......+++.|+|||++.+..++.++||||+|+++|+|++ |..||.+.+..+....+....... ....+++++.+
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~ 450 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME---RPEGCPEKVYE 450 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC---CCTTCCHHHHH
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHH
Confidence 1223345678999999988889999999999999999999 999999988887777665543322 22478999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 451 li~~cl~~dP 460 (495)
T 1opk_A 451 LMRACWQWNP 460 (495)
T ss_dssp HHHHHTCSSG
T ss_pred HHHHHcCcCh
Confidence 9999999998
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=289.75 Aligned_cols=236 Identities=24% Similarity=0.362 Sum_probs=191.2
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC----
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH---- 84 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~---- 84 (253)
++|+ +++.||+|+||+||+|.+..+++.||+|++..... ......+.+|+..+. .++||||+++++++...+
T Consensus 6 ~~y~--~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 6 TDFE--PIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALA-KLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHEE--EEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST-TTHHHHHHHHHHHHT-SCCCTTBCCEEEEEEECCSCHH
T ss_pred hcCc--eeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc-hhHHHHHHHHHHHHH-hCCCCCEeeEEEEEEEeccchh
Confidence 5666 99999999999999999999999999999976543 334567889999998 679999999999986543
Q ss_pred -----------------------------------------------------eEEEEEeccCCCcHHHHHhhcCC---C
Q psy12709 85 -----------------------------------------------------EMVLVLEMVPDGELQRLVDIQDG---I 108 (253)
Q Consensus 85 -----------------------------------------------------~~~lv~e~~~g~~L~~~~~~~~~---~ 108 (253)
..+++|||++|++|.+++..... .
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 38999999999999999986543 5
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-------------cccccccCcc
Q psy12709 109 PEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-------------EVKEIIGTPD 175 (253)
Q Consensus 109 ~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-------------~~~~~~~~~~ 175 (253)
+...++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+....... ......+++.
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 666789999999999999999999999999999999999999999999998665431 2233468899
Q ss_pred ccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 176 YVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 176 ~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
|+|||++.+..++.++||||+|+++|+|++|..|+.. .......+.....+. .....++++.++|.+||+.||
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p 314 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPL---LFTQKYPQEHMMVQDMLSPSP 314 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCH---HHHHHCHHHHHHHHHHHCSSG
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCc---ccccCChhHHHHHHHHccCCC
Confidence 9999999999999999999999999999998776532 122222233322221 223568889999999999998
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=289.65 Aligned_cols=239 Identities=20% Similarity=0.325 Sum_probs=199.9
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCc-----eEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKV-----EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
+|++.+.||+|+||+||+|.+..++. .|++|.+..... ......+.+|+..+..+.+||||+++++++..++.+
T Consensus 47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 125 (333)
T 2i1m_A 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH-ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125 (333)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC-hHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence 34499999999999999999876554 799999876543 345678889999999666999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEE
Q psy12709 87 VLVLEMVPDGELQRLVDIQ--------------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKL 152 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l 152 (253)
++||||+++++|.+++... ..++...++.++.|++.|+.|||++|++|+||+|+||+++.++.++|
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 205 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKI 205 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEB
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEE
Confidence 9999999999999988642 35799999999999999999999999999999999999999999999
Q ss_pred Eeeccccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhccccc
Q psy12709 153 CDFGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFS 228 (253)
Q Consensus 153 ~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~ 228 (253)
+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.........+......
T Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 285 (333)
T 2i1m_A 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ 285 (333)
T ss_dssp CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCC
T ss_pred CccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCC
Confidence 99999975533221 223345678999999988889999999999999999998 99999887665555544443333
Q ss_pred ccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 229 FHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
... ....++++.++|.+||+.||
T Consensus 286 ~~~--~~~~~~~l~~li~~~l~~~p 308 (333)
T 2i1m_A 286 MAQ--PAFAPKNIYSIMQACWALEP 308 (333)
T ss_dssp CCC--CTTCCHHHHHHHHHHTCSSG
T ss_pred CCC--CCCCCHHHHHHHHHHhccCh
Confidence 322 24679999999999999998
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=284.50 Aligned_cols=243 Identities=28% Similarity=0.433 Sum_probs=200.2
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
+...++|+ +++.||+|+||+||+|.+..++..|++|++..... .....+.+|+..+. ..+|+||+++++++..++
T Consensus 15 ~~~~~~y~--i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~ 89 (302)
T 2j7t_A 15 LDPNEVWE--IVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILA-TCDHPYIVKLLGAYYHDG 89 (302)
T ss_dssp SCGGGTEE--EEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHH-HCCCTTBCCEEEEEECC-
T ss_pred cCCcccee--ecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHh-cCCCCCEeeeeeeeeeCC
Confidence 34455666 99999999999999999999999999999876433 23467888999888 679999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
..++|||++++++|.+++.. ...+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 90 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999999998765 46699999999999999999999999999999999999999999999999998754322
Q ss_pred -cccccccccCccccCcccc-----CCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCC
Q psy12709 164 -VVEVKEIIGTPDYVAPEVL-----SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHI 237 (253)
Q Consensus 164 -~~~~~~~~~~~~~~~PE~~-----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 237 (253)
........+++.|+|||.+ .+..++.++|+||+|+++|+|++|+.||...+.......+....... ......+
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 248 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT-LLTPSKW 248 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSSGGGS
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-cCCcccc
Confidence 1222344678999999998 46678899999999999999999999999888877776665544322 1223467
Q ss_pred CHHHHHHHHHhcccCC
Q psy12709 238 SSQAKDFIQSCLVTDP 253 (253)
Q Consensus 238 ~~~l~~li~~~l~~dP 253 (253)
|.++.++|.+||+.||
T Consensus 249 ~~~l~~li~~~l~~dp 264 (302)
T 2j7t_A 249 SVEFRDFLKIALDKNP 264 (302)
T ss_dssp CHHHHHHHHHHSCSCT
T ss_pred CHHHHHHHHHHcccCh
Confidence 9999999999999998
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=287.57 Aligned_cols=241 Identities=21% Similarity=0.354 Sum_probs=199.3
Q ss_pred eecceeeEEEeecCCCCceEEEEEEe-----ccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTH-----KITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 81 (253)
..++|+ +.+.||+|+||+||+|.+ ..+++.||+|++.... .......+.+|+..+....+|+||+++++++.
T Consensus 25 ~~~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 25 PRDRLK--LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CGGGEE--EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred chhhee--eeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 345666 999999999999999985 3567889999997653 34456788899999997778999999999988
Q ss_pred eCC-eEEEEEeccCCCcHHHHHhhcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE
Q psy12709 82 TPH-EMVLVLEMVPDGELQRLVDIQDG----------------IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILL 144 (253)
Q Consensus 82 ~~~-~~~lv~e~~~g~~L~~~~~~~~~----------------~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~ 144 (253)
..+ .++++|||+++++|.+++..... +++..++.++.|++.|+.+||++|++|+||+|+||++
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 765 59999999999999999986543 8899999999999999999999999999999999999
Q ss_pred cCCCceEEEeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHH-
Q psy12709 145 TKDNNIKLCDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETF- 219 (253)
Q Consensus 145 ~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~- 219 (253)
+.++.++|+|||.+....... ......+++.|+|||++.+..++.++||||+|+++|+|++ |..||.+.......
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 999999999999997653321 1223456788999999988899999999999999999998 99999876644333
Q ss_pred HHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 220 LNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 220 ~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+...... .....+++++.++|.+||+.||
T Consensus 262 ~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp 292 (316)
T 2xir_A 262 RRLKEGTRM---RAPDYTTPEMYQTMLDCWHGEP 292 (316)
T ss_dssp HHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHhccCccC---CCCCCCCHHHHHHHHHHcCCCh
Confidence 333333222 1224689999999999999998
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=285.01 Aligned_cols=239 Identities=23% Similarity=0.454 Sum_probs=200.3
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc--chHHHHHHHHHHHHHHHhcCCCCceeeeeEEE--e
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR--SMDQMQDILHEAAVLYLAQKSERIVGLHEIYE--T 82 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~ 82 (253)
+.++|+ +.+.||+|+||.||+|.+..++..|++|++..... .......+.+|+..+. ..+|+||+++++++. .
T Consensus 3 l~~~y~--i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~ 79 (305)
T 2wtk_C 3 LIGKYL--MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR-RLRHKNVIQLVDVLYNEE 79 (305)
T ss_dssp --CCBC--CCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHT-TCCCTTBCCEEEEEECC-
T ss_pred ccccee--EeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHH-hcCCCCeeEEEEEEEcCC
Confidence 346777 99999999999999999999999999999986542 1234567888999888 778999999999984 4
Q ss_pred CCeEEEEEeccCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDI--QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
++..++||||++++ |.+++.. ...+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus 80 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 80 KQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp --CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 55899999999876 6666654 35689999999999999999999999999999999999999999999999999976
Q ss_pred ccc---cccccccccCccccCccccCCCCC--CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccC
Q psy12709 161 VND---VVEVKEIIGTPDYVAPEVLSYEPI--SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFG 235 (253)
Q Consensus 161 ~~~---~~~~~~~~~~~~~~~PE~~~~~~~--~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 235 (253)
... ........+++.|+|||++.+... +.++||||+|+++|+|++|+.||.+.+..+....+.......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~---- 234 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG---- 234 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCS----
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCC----
Confidence 542 222234567899999999876543 67999999999999999999999998888888888776654443
Q ss_pred CCCHHHHHHHHHhcccCC
Q psy12709 236 HISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 236 ~~~~~l~~li~~~l~~dP 253 (253)
.+++++.++|.+||+.||
T Consensus 235 ~~~~~l~~li~~~l~~dp 252 (305)
T 2wtk_C 235 DCGPPLSDLLKGMLEYEP 252 (305)
T ss_dssp SSCHHHHHHHHHHTCSST
T ss_pred ccCHHHHHHHHHHccCCh
Confidence 789999999999999998
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=284.98 Aligned_cols=237 Identities=24% Similarity=0.432 Sum_probs=194.9
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe--CC
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET--PH 84 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~ 84 (253)
..++|+ +.+.||+|+||+||+|.+..+++.||+|++.... ...+.+|+..+..+..|+||+++++++.. ..
T Consensus 34 ~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 34 NQDDYQ--LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSR 106 (330)
T ss_dssp EGGGEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CCCceE--EEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence 345666 9999999999999999999999999999987432 34678899999977779999999999998 56
Q ss_pred eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-ceEEEeecccccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN-NIKLCDFGISRVVND 163 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~-~~~l~df~~~~~~~~ 163 (253)
..+++||++++++|.+++.. +++..++.++.|++.|+.|||++|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 107 ~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp CEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 89999999999999998753 88999999999999999999999999999999999999777 899999999987665
Q ss_pred cccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhcc-------------ccc
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAG-DNKQETFLNISQC-------------NFS 228 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~i~~~-------------~~~ 228 (253)
........+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||.. ....+....+... ...
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 555556678899999999876 6789999999999999999999999944 3333333222111 100
Q ss_pred c--------------------cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 229 F--------------------HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 229 ~--------------------~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
. .......+++++.+||.+||+.||
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 308 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 308 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSG
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCc
Confidence 0 011112379999999999999998
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=284.42 Aligned_cols=234 Identities=22% Similarity=0.308 Sum_probs=194.5
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCC-------ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITK-------VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-------~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~ 79 (253)
..++|+ +.+.||+|+||+||+|.+..++ ..|++|.+..... .....+.+|+..+. ..+|+||++++++
T Consensus 6 ~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~-~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 6 RNEDLI--FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR--NYSESFFEAASMMS-KLSHKHLVLNYGV 80 (289)
T ss_dssp CGGGEE--EEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG--GGHHHHHHHHHHHH-TSCCTTBCCEEEE
T ss_pred chhHee--eeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH--HHHHHHHHHHHHHH-hCCCCCEeEEEEE
Confidence 456666 9999999999999999998776 4699999876443 33467888999888 7789999999999
Q ss_pred EEeCCeEEEEEeccCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc--------e
Q psy12709 80 YETPHEMVLVLEMVPDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN--------I 150 (253)
Q Consensus 80 ~~~~~~~~lv~e~~~g~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~--------~ 150 (253)
+..++..++||||++|++|.+++..... +++..++.++.|++.|+.|||++|++|+||+|+||+++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999999987544 999999999999999999999999999999999999999887 9
Q ss_pred EEEeecccccccccccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhhccccc
Q psy12709 151 KLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQCNFS 228 (253)
Q Consensus 151 ~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~i~~~~~~ 228 (253)
+|+|||.+....... ...+++.|+|||++.+ ..++.++||||+|+++|+|++| ..||............ .....
T Consensus 161 kl~Dfg~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-~~~~~ 236 (289)
T 4fvq_A 161 KLSDPGISITVLPKD---ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-EDRHQ 236 (289)
T ss_dssp EECCCCSCTTTSCHH---HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTTCC
T ss_pred eeccCcccccccCcc---ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-hccCC
Confidence 999999987554322 2346788999999977 6789999999999999999995 5566655554444333 33332
Q ss_pred ccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 229 FHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.+ ...++++.++|.+||+.||
T Consensus 237 ~~----~~~~~~l~~li~~~l~~dp 257 (289)
T 4fvq_A 237 LP----APKAAELANLINNCMDYEP 257 (289)
T ss_dssp CC----CCSSCTTHHHHHHHSCSSG
T ss_pred CC----CCCCHHHHHHHHHHcCCCh
Confidence 22 3568899999999999998
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=302.48 Aligned_cols=231 Identities=15% Similarity=0.212 Sum_probs=184.8
Q ss_pred eeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHH--hcCCCCceeee-------eEE
Q psy12709 11 YQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYL--AQKSERIVGLH-------EIY 80 (253)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~--~~~~~~i~~~~-------~~~ 80 (253)
.+|++.+.||+|+||+||+|.+..+++.||+|++.... ........+.+|+..+.. ..+||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 34559999999999999999999999999999998653 333455678888855443 34899999988 666
Q ss_pred EeCC-----------------eEEEEEeccCCCcHHHHHhhcCCCCH-------HHHHHHHHHHHHHHHHHHHCCceecC
Q psy12709 81 ETPH-----------------EMVLVLEMVPDGELQRLVDIQDGIPE-------QDTRSYMKQILEALAFLHDHNITHLD 136 (253)
Q Consensus 81 ~~~~-----------------~~~lv~e~~~g~~L~~~~~~~~~~~~-------~~~~~~~~~l~~~l~~lh~~~~~h~d 136 (253)
..++ ..+++|||+ +++|.+++.....+++ ..++.++.|++.|+.|||++|++|+|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 6553 288999999 6799999986544554 78888999999999999999999999
Q ss_pred CCCCCEEEcCCCceEEEeecccccccccccccccccCccccCccccCCC-----------CCCccccHHHHHHHHHHHHh
Q psy12709 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYE-----------PISLATDMWSVGVLAYVLLS 205 (253)
Q Consensus 137 i~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----------~~~~~~Di~slG~~l~~l~~ 205 (253)
|+|+||+++.++.++|+|||++..... ......+ +.|+|||++.+. .++.++||||||+++|+|++
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ellt 308 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHH
Confidence 999999999999999999999986443 2234456 999999999877 78999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 206 SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 206 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
|+.||...+.......+.. ....+|+++.++|.+||+.||
T Consensus 309 g~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dp 348 (377)
T 3byv_A 309 ADLPITKDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPK 348 (377)
T ss_dssp SSCCC------CCSGGGGS--------SCCCCCHHHHHHHHHHTCSSG
T ss_pred CCCCCcccccccchhhhhh--------hccCCCHHHHHHHHHHcCCCc
Confidence 9999987655443333322 124789999999999999998
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=299.09 Aligned_cols=236 Identities=21% Similarity=0.374 Sum_probs=201.3
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
..-+|++.+.||+|+||+||+|.++ .+..||+|.+...... .+.+.+|+..+. .++|+||+++++++. .+.+++
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~-~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS---VEAFLAEANVMK-TLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHT-TCCCTTBCCEEEEEC-SSSCEE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCcc---HHHHHHHHHHHh-hCCCCCEeeEEEEEe-CCccEE
Confidence 3444559999999999999999986 4678999999865433 457889999998 779999999999986 567899
Q ss_pred EEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-
Q psy12709 89 VLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV- 165 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~- 165 (253)
||||+++++|.+++... ..++...+..++.|++.|+.|||++|++|+||+|+||+++.++.+||+|||++.......
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999999998753 358999999999999999999999999999999999999999999999999998654322
Q ss_pred -cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 166 -EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 166 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||.+.+..+....+..+...+.. ..+|+++.+
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~---~~~~~~l~~ 416 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP---ENCPEELYN 416 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCC---TTSCHHHHH
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCCHHHHH
Confidence 1223345678999999988899999999999999999999 99999999888888877665433322 478999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 417 li~~cl~~dp 426 (454)
T 1qcf_A 417 IMMRCWKNRP 426 (454)
T ss_dssp HHHHHTCSSG
T ss_pred HHHHHccCCh
Confidence 9999999998
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=282.71 Aligned_cols=239 Identities=25% Similarity=0.367 Sum_probs=180.1
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
+|++++.||+|+||+||+|.+..+++.||+|++........ ..+...|...+....+|+||+++++++..++.+++|||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE-NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHH-HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchH-HHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 44599999999999999999999999999999986654333 33444555555558899999999999999999999999
Q ss_pred ccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCceEEEeecccccccccccccc
Q psy12709 92 MVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDH-NITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE 169 (253)
Q Consensus 92 ~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (253)
++ ++.+..+... ...+++..++.++.+++.++.|||++ |++|+||+|+||+++.++.++|+|||.+...........
T Consensus 105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (318)
T 2dyl_A 105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDR 183 (318)
T ss_dssp CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccc
Confidence 99 6667666554 56799999999999999999999996 999999999999999999999999999976655444445
Q ss_pred cccCccccCccccC-----CCCCCccccHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 170 IIGTPDYVAPEVLS-----YEPISLATDMWSVGVLAYVLLSSHSPFAG-DNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 170 ~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
..+++.|+|||++. ...++.++||||+|+++|+|++|+.||.. ....+....+....... ......+++++.+
T Consensus 184 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 262 (318)
T 2dyl_A 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL-LPGHMGFSGDFQS 262 (318)
T ss_dssp ---CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC-CCSSSCCCHHHHH
T ss_pred cCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC-CCccCCCCHHHHH
Confidence 57889999999984 45678899999999999999999999987 34445555554443322 1222468999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 263 li~~~l~~dp 272 (318)
T 2dyl_A 263 FVKDCLTKDH 272 (318)
T ss_dssp HHHHHTCSCT
T ss_pred HHHHHccCCh
Confidence 9999999998
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=279.64 Aligned_cols=244 Identities=20% Similarity=0.283 Sum_probs=202.0
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCCc---eEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITKV---EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 81 (253)
++-....+|.+.+.||+|+||+||+|.+..++. .+++|.+.... .....+.+.+|+..+. ..+|+||+++++++.
T Consensus 15 ~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~ 92 (298)
T 3pls_A 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMR-GLNHPNVLALIGIML 92 (298)
T ss_dssp BCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHH-TCCCTTBCCCCEEEC
T ss_pred EccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHH-hCCCCCeeeEEEEEe
Confidence 444556677788999999999999999765544 79999987533 3445678889999988 679999999999998
Q ss_pred eCCeE-EEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 82 TPHEM-VLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 82 ~~~~~-~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
.++.. ++++|++.+++|.+++.. ...+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 93 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 93 PPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp CSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred cCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence 77654 999999999999999876 4568999999999999999999999999999999999999999999999999997
Q ss_pred cccccc-----cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCc
Q psy12709 160 VVNDVV-----EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDL 233 (253)
Q Consensus 160 ~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 233 (253)
...... ......+++.|+|||.+.+..++.++||||+|+++|+|++ |.+||...+..+....+........
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~--- 249 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ--- 249 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC---
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC---
Confidence 553321 2223456789999999999999999999999999999999 5566777777666666655543322
Q ss_pred cCCCCHHHHHHHHHhcccCC
Q psy12709 234 FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP 253 (253)
...+++++.++|.+||+.||
T Consensus 250 ~~~~~~~l~~li~~~l~~~p 269 (298)
T 3pls_A 250 PEYCPDSLYQVMQQCWEADP 269 (298)
T ss_dssp CTTCCHHHHHHHHHHTCSSG
T ss_pred CccchHHHHHHHHHHccCCh
Confidence 24789999999999999998
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=286.50 Aligned_cols=241 Identities=18% Similarity=0.269 Sum_probs=198.5
Q ss_pred eeecceeeEEEeecCCCCceEEEEEE-----eccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCT-----HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~-----~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 80 (253)
+..++|+ +.+.||+|+||+||+|. +..++..||+|.+.... .......+.+|+..+. ..+|+||+++++++
T Consensus 27 ~~~~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~ 102 (327)
T 2yfx_A 27 VPRKNIT--LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIIS-KFNHQNIVRCIGVS 102 (327)
T ss_dssp CCGGGCE--EEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHH-HCCCTTBCCEEEEE
T ss_pred CChhheE--EEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHh-hCCCCCCCeEEEEE
Confidence 3456666 99999999999999999 55678899999997543 3344567888999888 66999999999999
Q ss_pred EeCCeEEEEEeccCCCcHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC---Cce
Q psy12709 81 ETPHEMVLVLEMVPDGELQRLVDIQD-------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD---NNI 150 (253)
Q Consensus 81 ~~~~~~~lv~e~~~g~~L~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~---~~~ 150 (253)
..++..++||||+++++|.+++.... .++...++.++.|++.|+.+||++|++|+||+|+||+++.+ ..+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999999997653 48999999999999999999999999999999999999954 469
Q ss_pred EEEeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhccc
Q psy12709 151 KLCDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCN 226 (253)
Q Consensus 151 ~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~ 226 (253)
+|+|||.+....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+....
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 999999987543221 2223456789999999988889999999999999999998 999999988888777776654
Q ss_pred ccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 227 FSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 227 ~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..... ..+++.+.++|.+||+.||
T Consensus 263 ~~~~~---~~~~~~l~~li~~~l~~dp 286 (327)
T 2yfx_A 263 RMDPP---KNCPGPVYRIMTQCWQHQP 286 (327)
T ss_dssp CCCCC---TTCCHHHHHHHHHHTCSSG
T ss_pred CCCCC---CCCCHHHHHHHHHHhcCCh
Confidence 43322 4789999999999999998
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=292.38 Aligned_cols=241 Identities=14% Similarity=0.115 Sum_probs=185.3
Q ss_pred cceeeEEEeecCCCCceEEEEEEecc---CCceEEEEEecccccchHH---------HHHHHHHHHHHHHhcCCCCceee
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKI---TKVEYAAKFIRKRRRSMDQ---------MQDILHEAAVLYLAQKSERIVGL 76 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~v~iK~~~~~~~~~~~---------~~~~~~e~~~~~~~~~~~~i~~~ 76 (253)
++|+ +.+.||+|+||+||+|.+.. ++..+++|+.......... ...+.+|+..+. ..+|+||+++
T Consensus 37 ~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~-~l~h~ni~~~ 113 (345)
T 2v62_A 37 NQWV--LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK-QLDYLGIPLF 113 (345)
T ss_dssp CEEE--EEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHH-TCSCCCCCCE
T ss_pred ceEE--EEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhc-cccccCccee
Confidence 4555 99999999999999999987 7788999998765432111 122445555565 7799999999
Q ss_pred eeEEEe----CCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC--ce
Q psy12709 77 HEIYET----PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN--NI 150 (253)
Q Consensus 77 ~~~~~~----~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~--~~ 150 (253)
++++.. +...++|||++ |++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999988 67899999999 999999998777899999999999999999999999999999999999999887 99
Q ss_pred EEEeecccccccccc--------cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC--ChHHHHH
Q psy12709 151 KLCDFGISRVVNDVV--------EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGD--NKQETFL 220 (253)
Q Consensus 151 ~l~df~~~~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~ 220 (253)
+|+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||... .......
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 999999997653321 113446889999999999889999999999999999999999999652 2222222
Q ss_pred HhhcccccccC---Ccc--CCCCHHHHHHHHHhcccCC
Q psy12709 221 NISQCNFSFHE---DLF--GHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 221 ~i~~~~~~~~~---~~~--~~~~~~l~~li~~~l~~dP 253 (253)
.........+. ... ..+|+++.++|.+||+.||
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 310 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAY 310 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCT
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCc
Confidence 11111111111 111 1789999999999999998
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=296.76 Aligned_cols=207 Identities=25% Similarity=0.401 Sum_probs=178.0
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhc-----CCCCceeeeeEEEeCCeE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-----KSERIVGLHEIYETPHEM 86 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~-----~~~~i~~~~~~~~~~~~~ 86 (253)
+|++++.||+|+||+||+|.+..++..||+|++.... .....+.+|+..+.... .|+||+++++.+...+.+
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc---chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 3449999999999999999999999999999997543 33446667777766442 677999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc--eEEEeeccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN--IKLCDFGISRVVN 162 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~--~~l~df~~~~~~~ 162 (253)
+++||++. ++|.+++.... .+++..++.++.|++.|+.|||++|++|+||+|+||+++.++. ++|+|||++....
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 99999995 58888887643 4899999999999999999999999999999999999999987 9999999997544
Q ss_pred ccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhc
Q psy12709 163 DVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQ 224 (253)
Q Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~ 224 (253)
.. .....+++.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+.+..+..
T Consensus 254 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~ 313 (429)
T 3kvw_A 254 QR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE 313 (429)
T ss_dssp CC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred Cc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 32 2345688999999999999999999999999999999999999999888777765543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=289.63 Aligned_cols=240 Identities=31% Similarity=0.508 Sum_probs=174.0
Q ss_pred cceeecceeeEEEe-ecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 4 KFFVNGGYQTLIFC-MPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 4 ~~~~~~~~~~~~~~-~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
+..+.++|+ +.+ .||+|+||+||+|.+..+++.||+|++.... ...+|+..+.....|+||+++++++..
T Consensus 23 ~~~~~~~y~--i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 23 KYAVTDDYQ--LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp CSCGGGTEE--EEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CccccceeE--ecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 456778888 855 6999999999999999999999999986532 233455555568899999999999976
Q ss_pred ----CCeEEEEEeccCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC---CceEEE
Q psy12709 83 ----PHEMVLVLEMVPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD---NNIKLC 153 (253)
Q Consensus 83 ----~~~~~lv~e~~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~---~~~~l~ 153 (253)
+..+++||||++|++|.+++.... .+++..++.++.|++.|+.|||++|++|+||+|+||+++.+ +.++|+
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence 456899999999999999997653 59999999999999999999999999999999999999864 559999
Q ss_pred eecccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH----HHHhhcccccc
Q psy12709 154 DFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQET----FLNISQCNFSF 229 (253)
Q Consensus 154 df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~i~~~~~~~ 229 (253)
|||.+...... ......+++.|+|||++.+..++.++||||+|+++|+|++|+.||........ ...+.......
T Consensus 174 Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T 3fhr_A 174 DFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252 (336)
T ss_dssp CCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred ccccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence 99999765432 23345678999999999888889999999999999999999999977655433 22333344444
Q ss_pred cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+......+++++++||.+||+.||
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP 276 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDP 276 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSG
T ss_pred CchhhccCCHHHHHHHHHHCCCCh
Confidence 444446889999999999999998
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=288.59 Aligned_cols=241 Identities=21% Similarity=0.297 Sum_probs=195.7
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCCceE----EEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEY----AAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v----~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 80 (253)
++..++|+ +++.||+|+||+||+|.+..++..+ ++|.+.... .......+.+|+..+. ..+|+||+++++++
T Consensus 11 ~l~~~~y~--~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~ 86 (327)
T 3lzb_A 11 ILKETEFK--KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMA-SVDNPHVCRLLGIC 86 (327)
T ss_dssp ECCTTTEE--EEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHT-TCCBTTBCCCCEEE
T ss_pred ccCHhHce--EEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHH-hCCCCCeeEEEEEE
Confidence 44566777 9999999999999999998877655 666654332 2233567888999988 77999999999999
Q ss_pred EeCCeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 81 ETPHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 81 ~~~~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
..+. .+++++++.+++|.+++.. ...+++..++.++.|++.++.|||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 87 ~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 87 LTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp ESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred ecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 8765 7888999999999998876 4569999999999999999999999999999999999999999999999999998
Q ss_pred ccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccC
Q psy12709 160 VVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFG 235 (253)
Q Consensus 160 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 235 (253)
....... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+......+. ..
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 242 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PP 242 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CT
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---Cc
Confidence 6543222 222345678999999999999999999999999999999 9999999888877776665543332 24
Q ss_pred CCCHHHHHHHHHhcccCC
Q psy12709 236 HISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 236 ~~~~~l~~li~~~l~~dP 253 (253)
.+++++.++|.+||+.||
T Consensus 243 ~~~~~l~~li~~~l~~dp 260 (327)
T 3lzb_A 243 ICTIDVYMIMRKCWMIDA 260 (327)
T ss_dssp TBCHHHHHHHHHHTCSSG
T ss_pred cCCHHHHHHHHHHcCCCh
Confidence 789999999999999998
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=282.31 Aligned_cols=242 Identities=20% Similarity=0.263 Sum_probs=191.8
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
+.+.++|+ +.+.||+|+||+||+|.+..+++.||+|++...... ..+.+|+..+.....++++..+..++..++
T Consensus 5 ~~~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (296)
T 4hgt_A 5 LRVGNRYR--LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 78 (296)
T ss_dssp ------CE--EEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred cccCCceE--EeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence 34567777 999999999999999999999999999987654332 246678888885555566666666667888
Q ss_pred eEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---cCCCceEEEeeccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILL---TKDNNIKLCDFGISRV 160 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~---~~~~~~~l~df~~~~~ 160 (253)
..+++||++ +++|.+++.. ...+++..++.++.|++.|+.|||++|++|+||+|+||++ +.++.++|+|||.+..
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999999999 8899999874 4569999999999999999999999999999999999999 7889999999999986
Q ss_pred ccccc--------cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---HHHHHhhcccccc
Q psy12709 161 VNDVV--------EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ---ETFLNISQCNFSF 229 (253)
Q Consensus 161 ~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~i~~~~~~~ 229 (253)
..... ......+++.|+|||.+.+..++.++||||+|+++|+|++|+.||.+.+.. .....+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 54332 123456889999999999999999999999999999999999999764332 3333333332222
Q ss_pred c-CCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 H-EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 ~-~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+ ......+|+++.++|.+||+.||
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p 262 (296)
T 4hgt_A 238 PIEVLCKGYPSEFATYLNFCRSLRF 262 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCT
T ss_pred hhhhhhccCCHHHHHHHHHHHhcCC
Confidence 2 22335789999999999999998
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=279.64 Aligned_cols=233 Identities=21% Similarity=0.363 Sum_probs=198.1
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
+|++.+.||+|+||+||+|.+. ++..|++|.+...... ...+.+|+..+. ..+|+||+++++++.. +..+++||
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~-~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMK-QLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHH-HCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred hhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHH-hCCCcCcceEEEEEcC-CCcEEEEe
Confidence 4449999999999999999976 5678999999765443 347788999988 6799999999999874 46899999
Q ss_pred ccCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc--c
Q psy12709 92 MVPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE--V 167 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~--~ 167 (253)
++++++|.+++.... .+++..+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 999999999987543 689999999999999999999999999999999999999999999999999986643322 2
Q ss_pred cccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~ 246 (253)
....+++.|+|||.+.+..++.++||||+|+++|+|++ |..||.+.+..+....+........ ...+++++.++|.
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~ 244 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---PDNCPEELYQLMR 244 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHH
T ss_pred cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCC---cccccHHHHHHHH
Confidence 23345678999999988888999999999999999999 9999999888887777766533222 2478999999999
Q ss_pred HhcccCC
Q psy12709 247 SCLVTDP 253 (253)
Q Consensus 247 ~~l~~dP 253 (253)
+||+.||
T Consensus 245 ~~l~~~p 251 (279)
T 1qpc_A 245 LCWKERP 251 (279)
T ss_dssp HHTCSSG
T ss_pred HHhccCh
Confidence 9999998
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=283.61 Aligned_cols=241 Identities=20% Similarity=0.310 Sum_probs=193.1
Q ss_pred eeecceeeEEEeecCCCCceEEEEEE----eccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCT----HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 81 (253)
+....|+ +.+.||+|+||.||+|. +..+++.||+|++..... ......+.+|+..+. ..+|+||+++++++.
T Consensus 18 ~~~~~~~--~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 18 FEKRFLK--RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILR-NLYHENIVKYKGICT 93 (302)
T ss_dssp CCGGGEE--EEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHH-TCCCTTBCCEEEEEE
T ss_pred hhhhhhh--hhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHH-hCCCCCeeeeeeEEe
Confidence 3445566 99999999999999998 567889999999986542 233467888999998 778999999999998
Q ss_pred eC--CeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccc
Q psy12709 82 TP--HEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGIS 158 (253)
Q Consensus 82 ~~--~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~ 158 (253)
.. ..++++|||+++++|.+++.. ...+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 77 678999999999999999854 456999999999999999999999999999999999999999999999999999
Q ss_pred ccccccc----cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------------hH-HHH
Q psy12709 159 RVVNDVV----EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDN--------------KQ-ETF 219 (253)
Q Consensus 159 ~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------------~~-~~~ 219 (253)
....... ......++..|+|||++.+..++.++|+||+|+++|+|++|..|+.... .. ...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 8664432 2223456778999999988888999999999999999999998863321 11 112
Q ss_pred HHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 220 LNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 220 ~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+..... ......+|+++.++|.+||+.||
T Consensus 254 ~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp 284 (302)
T 4e5w_A 254 NTLKEGKR---LPCPPNCPDEVYQLMRKCWEFQP 284 (302)
T ss_dssp HHHHTTCC---CCCCTTCCHHHHHHHHHTTCSSG
T ss_pred HHHhccCC---CCCCCCCCHHHHHHHHHHcCCCC
Confidence 22222221 22335789999999999999998
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=285.64 Aligned_cols=245 Identities=23% Similarity=0.265 Sum_probs=194.8
Q ss_pred CcceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
++++..++-+|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+..+. ..+|+||+++++++..
T Consensus 21 g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~ 97 (317)
T 2buj_A 21 GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHR-LFNHPNILRLVAYCLR 97 (317)
T ss_dssp EEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHH-TCCCTTBCCCCEEEEE
T ss_pred ccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHh-hcCCCCeeeEEEEEEe
Confidence 456666666677999999999999999999999999999998653 3345667888999888 7799999999999873
Q ss_pred ----CCeEEEEEeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEe
Q psy12709 83 ----PHEMVLVLEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCD 154 (253)
Q Consensus 83 ----~~~~~lv~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~d 154 (253)
....++++||+++++|.+++.. ...+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|
T Consensus 98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~d 177 (317)
T 2buj_A 98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMD 177 (317)
T ss_dssp EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECC
T ss_pred ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEe
Confidence 3478999999999999998875 46699999999999999999999999999999999999999999999999
Q ss_pred eccccccccccc----------ccccccCccccCccccCCCC---CCccccHHHHHHHHHHHHhCCCCCCCCC--hHHHH
Q psy12709 155 FGISRVVNDVVE----------VKEIIGTPDYVAPEVLSYEP---ISLATDMWSVGVLAYVLLSSHSPFAGDN--KQETF 219 (253)
Q Consensus 155 f~~~~~~~~~~~----------~~~~~~~~~~~~PE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~ 219 (253)
||.+........ .....+++.|+|||++.+.. ++.++||||||+++|+|++|+.||.... .....
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 257 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence 998875432111 11234688999999987554 6889999999999999999999995411 11111
Q ss_pred HHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 220 LNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 220 ~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+.. ....+ ....+++++.++|.+||+.||
T Consensus 258 ~~~~~-~~~~~--~~~~~~~~l~~li~~~l~~dp 288 (317)
T 2buj_A 258 LAVQN-QLSIP--QSPRHSSALWQLLNSMMTVDP 288 (317)
T ss_dssp HHHHC-C--CC--CCTTSCHHHHHHHHHHTCSSG
T ss_pred HHhhc-cCCCC--ccccCCHHHHHHHHHHhhcCh
Confidence 22222 22222 224789999999999999998
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=280.99 Aligned_cols=244 Identities=18% Similarity=0.286 Sum_probs=200.6
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCC---ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEE-
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITK---VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY- 80 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~- 80 (253)
.+.....+|++.+.||+|+||+||+|.+..++ ..+++|.+... ........+.+|+..+. ..+|+||+++++++
T Consensus 19 ~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~ 96 (298)
T 3f66_A 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMK-DFSHPNVLSLLGICL 96 (298)
T ss_dssp BCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHH-TCCCTTBCCCCEEEC
T ss_pred ecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHH-hCCCCCEeeeeeEEE
Confidence 45556777889999999999999999976433 35889988753 33455678889999888 77899999999985
Q ss_pred EeCCeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 81 ETPHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 81 ~~~~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
..++..+++||++++++|.+++.. ...++...++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 97 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 97 RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred cCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccc
Confidence 455688999999999999999975 3458999999999999999999999999999999999999999999999999997
Q ss_pred cccccc-----cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCc
Q psy12709 160 VVNDVV-----EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDL 233 (253)
Q Consensus 160 ~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 233 (253)
...... ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |.+||......+....+.........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 254 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP-- 254 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC--
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC--
Confidence 654322 1223345678999999998899999999999999999999 67788887777776666665544333
Q ss_pred cCCCCHHHHHHHHHhcccCC
Q psy12709 234 FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP 253 (253)
..+++++.++|.+||+.||
T Consensus 255 -~~~~~~l~~li~~~l~~~p 273 (298)
T 3f66_A 255 -EYCPDPLYEVMLKCWHPKA 273 (298)
T ss_dssp -TTCCHHHHHHHHHHTCSSG
T ss_pred -ccCCHHHHHHHHHHcCCCh
Confidence 3689999999999999998
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=295.74 Aligned_cols=242 Identities=14% Similarity=0.104 Sum_probs=179.4
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhc-CCCCceeee-------eE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQ-KSERIVGLH-------EI 79 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~-~~~~i~~~~-------~~ 79 (253)
..++|++.+.||+|+||+||+|.+..++..||+|++..... .......+.+|+..+..+. +||||++++ ++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 34557799999999999999999999999999999988654 3344566677755444333 799988755 44
Q ss_pred EEeC-----------------CeEEEEEeccCCCcHHHHHhhc-CCCCHHHH------HHHHHHHHHHHHHHHHCCceec
Q psy12709 80 YETP-----------------HEMVLVLEMVPDGELQRLVDIQ-DGIPEQDT------RSYMKQILEALAFLHDHNITHL 135 (253)
Q Consensus 80 ~~~~-----------------~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~------~~~~~~l~~~l~~lh~~~~~h~ 135 (253)
+..+ ..+++||||++ ++|.+++... ..++.... ..++.|++.|++|||++|++|+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr 218 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence 4433 34899999998 7999998763 33444444 6777999999999999999999
Q ss_pred CCCCCCEEEcCCCceEEEeecccccccccccccccccCccccCccccCC--CCCCccccHHHHHHHHHHHHhCCCCCCCC
Q psy12709 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSY--EPISLATDMWSVGVLAYVLLSSHSPFAGD 213 (253)
Q Consensus 136 di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 213 (253)
||+|+||+++.++.++|+|||++........ ...+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||...
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGP--ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEEE--GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCcc--CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999999986654321 3345699999999987 67899999999999999999999999876
Q ss_pred ChHHH--HHH---hhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 214 NKQET--FLN---ISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 214 ~~~~~--~~~---i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..... +.. ..........+....+|+++.+||.+||+.||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 341 (371)
T 3q60_A 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDR 341 (371)
T ss_dssp CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSST
T ss_pred CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCCh
Confidence 43211 110 11111222223335889999999999999998
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=288.48 Aligned_cols=239 Identities=24% Similarity=0.374 Sum_probs=198.5
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe-
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE- 85 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~- 85 (253)
+.++|+ +.+.||+|+||+||+|.+..+++.||+|++............+.+|+..+. ..+|+||+++++++...+.
T Consensus 22 l~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~ 98 (353)
T 3coi_A 22 LPKTYV--SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK-HMQHENVIGLLDVFTPASSL 98 (353)
T ss_dssp EETTEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHH-HCCCTTBCCCSEEECSCSSG
T ss_pred cCceEE--EeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHH-hcCCCCcccHhheEeccccc
Confidence 456777 999999999999999999999999999999876666666778889999998 7789999999999987654
Q ss_pred -----EEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 86 -----MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 86 -----~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
++++||++. ++|.+++. ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus 99 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 99 RNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp GGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred ccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 599999996 58887764 3489999999999999999999999999999999999999999999999999976
Q ss_pred ccccccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc----------
Q psy12709 161 VNDVVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF---------- 229 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~---------- 229 (253)
.... .....+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+.+..+.+..+......+
T Consensus 176 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 176 ADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred CCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 5432 234467899999999876 678999999999999999999999999887766665543321111
Q ss_pred -----------------cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 -----------------HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 -----------------~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.....+.+++++.++|.+||+.||
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 294 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV 294 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCc
Confidence 112335789999999999999998
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=292.14 Aligned_cols=241 Identities=24% Similarity=0.357 Sum_probs=189.9
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc---------chHHHHHHHHHHHHHHHhcCCCCceeeee
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR---------SMDQMQDILHEAAVLYLAQKSERIVGLHE 78 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~ 78 (253)
.++|+ +.+.||+|+||.||+|.+.. +..||+|.+..... .......+.+|+..+. ..+|+||+++++
T Consensus 21 ~~~y~--~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~ 96 (362)
T 3pg1_A 21 QSPYT--VQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN-HFHHPNILGLRD 96 (362)
T ss_dssp TCSCE--EEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHH-HCCCTTBCCCSE
T ss_pred ccceE--EeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHH-hCCCcCccceee
Confidence 46677 99999999999999999864 89999999876432 2233478889999998 678999999999
Q ss_pred EEEe-----CCeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEE
Q psy12709 79 IYET-----PHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKL 152 (253)
Q Consensus 79 ~~~~-----~~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l 152 (253)
++.. ...+++|||+++| +|.+.+.. ...+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred eEEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 9854 3378999999975 67666654 446999999999999999999999999999999999999999999999
Q ss_pred EeecccccccccccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc-
Q psy12709 153 CDFGISRVVNDVVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH- 230 (253)
Q Consensus 153 ~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~- 230 (253)
+|||.+.............+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+.+..+....+......+.
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 255 (362)
T 3pg1_A 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255 (362)
T ss_dssp CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 99999986555444455678899999999876 6789999999999999999999999999887777666543221111
Q ss_pred ---------------------------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 ---------------------------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 ---------------------------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+.+++.+.+||.+||+.||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 305 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP 305 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSG
T ss_pred HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCCh
Confidence 11234678999999999999998
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=292.88 Aligned_cols=236 Identities=24% Similarity=0.336 Sum_probs=189.8
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC---
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH--- 84 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--- 84 (253)
..+|+ +.+.||+|+||+||+|.+..++. +++|++....... .+|+..+. ..+|+||+++++++...+
T Consensus 39 ~~~Y~--~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~------~~E~~il~-~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 39 EIAYT--NCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFK------NRELQIMR-IVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp EEEEE--EEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSC------CHHHHHHH-TCCCTTBCCEEEEEEEESSSS
T ss_pred cceEE--EeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchH------HHHHHHHH-hCCCCCcceEEEEEEecCCCC
Confidence 34455 99999999999999999886666 7777775543221 25788887 779999999999996543
Q ss_pred ---eEEEEEeccCCCcHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc-CCCceEEEeecc
Q psy12709 85 ---EMVLVLEMVPDGELQRLV---DIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLT-KDNNIKLCDFGI 157 (253)
Q Consensus 85 ---~~~lv~e~~~g~~L~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~-~~~~~~l~df~~ 157 (253)
.+++||||++++.+.... .....+++..++.++.|++.|+.|||++|++|+||+|+||+++ .++.++|+|||.
T Consensus 109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 388999999876444333 2356799999999999999999999999999999999999999 789999999999
Q ss_pred cccccccccccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc------
Q psy12709 158 SRVVNDVVEVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH------ 230 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~------ 230 (253)
+.............+++.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+.+..+.....++.
T Consensus 189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 189 AKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred cccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 9876554444556789999999998664 589999999999999999999999999888777766544221111
Q ss_pred -------------------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 -------------------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 -------------------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+.+++++.+||.+||+.||
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTP 310 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCCh
Confidence 11223589999999999999998
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=282.86 Aligned_cols=243 Identities=25% Similarity=0.367 Sum_probs=194.7
Q ss_pred cceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEE--
Q psy12709 4 KFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE-- 81 (253)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-- 81 (253)
.+.+.++|+ +++.||+|+||+||+|.+..+++.||+|.+... .......+.+|+..+. ..+|+||+++++++.
T Consensus 6 ~~~~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 6 GFDLGSRYM--DLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIR-RLDHDNIVKVFEILGPS 80 (320)
T ss_dssp CEEETTTEE--EEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHH-TCCCTTBCCEEEEECTT
T ss_pred cCccCCcee--EEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHH-hcCCCCeeEEEEecccc
Confidence 345677888 999999999999999999999999999998754 3445678889999998 779999999999873
Q ss_pred ------------eCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc-CCC
Q psy12709 82 ------------TPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLT-KDN 148 (253)
Q Consensus 82 ------------~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~-~~~ 148 (253)
.....+++||+++ ++|.+++. ..++++..++.++.|++.|+.+||++|++|+||+|+||+++ .++
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTT
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC
Confidence 3468999999997 59999886 45689999999999999999999999999999999999997 467
Q ss_pred ceEEEeeccccccccc----ccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q psy12709 149 NIKLCDFGISRVVNDV----VEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNIS 223 (253)
Q Consensus 149 ~~~l~df~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~ 223 (253)
.++|+|||.+...... .......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+.+..+....+.
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999865422 12233456889999998755 678999999999999999999999999888777666554
Q ss_pred cccccc--------------------------cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 224 QCNFSF--------------------------HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 224 ~~~~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
...... .....+.+|+++.++|.+||+.||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 294 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSG
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCc
Confidence 432211 111234689999999999999998
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=286.29 Aligned_cols=243 Identities=22% Similarity=0.326 Sum_probs=199.4
Q ss_pred CcceeecceeeEEEeecCCCCceEEEEEE----eccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeee
Q psy12709 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCT----HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHE 78 (253)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~ 78 (253)
+.++-.++|+ +.+.||+|+||+||+|. +..++..|++|++.... ....+.+.+|+..+. ..+|+||+++++
T Consensus 17 ~~~~~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~-~l~h~~i~~~~~ 91 (327)
T 3lxl_A 17 PTIFEERHLK--YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILK-ALHSDFIVKYRG 91 (327)
T ss_dssp CCBCCGGGEE--EEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHH-TCCCTTBCCEEE
T ss_pred hhhhchhhhh--hhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHH-hcCCCceeEEEE
Confidence 3456667777 99999999999999998 56788999999997643 344567889999998 679999999999
Q ss_pred EEE--eCCeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEee
Q psy12709 79 IYE--TPHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDF 155 (253)
Q Consensus 79 ~~~--~~~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df 155 (253)
++. ....+++||||+++++|.+++.. ...+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+||
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Df 171 (327)
T 3lxl_A 92 VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 171 (327)
T ss_dssp EEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCG
T ss_pred EEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccc
Confidence 886 44579999999999999999876 456999999999999999999999999999999999999999999999999
Q ss_pred cccccccccc----cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---------------
Q psy12709 156 GISRVVNDVV----EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ--------------- 216 (253)
Q Consensus 156 ~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------------- 216 (253)
|.+....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHH
Confidence 9998654322 122334677899999998888899999999999999999999998653332
Q ss_pred HHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 217 ETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 217 ~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.....+..... ......+++++.++|.+||+.||
T Consensus 252 ~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP 285 (327)
T 3lxl_A 252 RLLELLEEGQR---LPAPPACPAEVHELMKLCWAPSP 285 (327)
T ss_dssp HHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHHhhcccC---CCCCCcccHHHHHHHHHHcCCCh
Confidence 11222222221 12235789999999999999998
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=280.66 Aligned_cols=232 Identities=20% Similarity=0.327 Sum_probs=190.9
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC-CeE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP-HEM 86 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~ 86 (253)
.++|+ +.+.||+|+||+||+|.+. +..|++|.+.... ..+.+.+|+..+. ..+|+||+++++++... +..
T Consensus 20 ~~~y~--~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 20 MKELK--LLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMT-QLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp GGGEE--EEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHT-TCCCTTBCCEEEEECCC--CC
T ss_pred hhhce--EEeEEecCCCceEEEEEEc--CCEEEEEEecchh----HHHHHHHHHHHHH-hCCCCCEeeEEEEEEcCCCce
Confidence 34555 9999999999999999874 8899999987543 3457788998888 77899999999997554 479
Q ss_pred EEEEeccCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
+++||++++++|.+++..... +++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 999999999999999876543 899999999999999999999999999999999999999999999999998755432
Q ss_pred ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
. ....+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||......+....+...... .....+++++.+
T Consensus 171 ~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~ 245 (278)
T 1byg_A 171 Q--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPPAVYE 245 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC---CCCTTCCHHHHH
T ss_pred c--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---CCcccCCHHHHH
Confidence 2 22356788999999988889999999999999999998 99999988887777766554322 223478999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 246 li~~~l~~~p 255 (278)
T 1byg_A 246 VMKNCWHLDA 255 (278)
T ss_dssp HHHHHTCSSG
T ss_pred HHHHHhcCCh
Confidence 9999999998
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=293.89 Aligned_cols=234 Identities=24% Similarity=0.326 Sum_probs=189.7
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC------Ce
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP------HE 85 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~------~~ 85 (253)
+|++.+.||+|+||+||+|.+..+++.||+|++...... ..+|+..+. .++|+||+++++++... ..
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~E~~il~-~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMR-KLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHH-TCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh------HHHHHHHHH-HcCCCCccceeeEEeccCCCCccee
Confidence 455999999999999999999999999999998754322 235888887 77999999999998542 24
Q ss_pred EEEEEeccCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-CceEEEeeccccc
Q psy12709 86 MVLVLEMVPDGELQRLVD----IQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD-NNIKLCDFGISRV 160 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~-~~~~l~df~~~~~ 160 (253)
+++||||+++ ++.+.+. ....+++..++.++.|++.||.|||++|++|+||+|+||+++.+ +.+||+|||++..
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 7799999976 5555443 35679999999999999999999999999999999999999965 5689999999986
Q ss_pred ccccccccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc----------
Q psy12709 161 VNDVVEVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF---------- 229 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~---------- 229 (253)
...........+++.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+.+..+......+
T Consensus 207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~ 286 (420)
T 1j1b_A 207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286 (420)
T ss_dssp CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 6544444455789999999998664 78999999999999999999999999988777666554321111
Q ss_pred -------cC--------CccCCCCHHHHHHHHHhcccCC
Q psy12709 230 -------HE--------DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 -------~~--------~~~~~~~~~l~~li~~~l~~dP 253 (253)
+. ...+.+++++.+||.+||+.||
T Consensus 287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP 325 (420)
T 1j1b_A 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 325 (420)
T ss_dssp CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSG
T ss_pred hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCCh
Confidence 00 0124678999999999999998
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=284.17 Aligned_cols=241 Identities=23% Similarity=0.360 Sum_probs=179.5
Q ss_pred cceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEE--
Q psy12709 4 KFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE-- 81 (253)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-- 81 (253)
+.+..++.+|++.+.||+|+||+||+|.+..+++.||+|.+... .......+.+|+..+.+..+|+||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 44455566677999999999999999999999999999998654 33445678899999997777999999999994
Q ss_pred ------eCCeEEEEEeccCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEcCCCce
Q psy12709 82 ------TPHEMVLVLEMVPDGELQRLVDI---QDGIPEQDTRSYMKQILEALAFLHDHN--ITHLDLKPQNILLTKDNNI 150 (253)
Q Consensus 82 ------~~~~~~lv~e~~~g~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~di~~~ni~~~~~~~~ 150 (253)
....+++++|+++ ++|.+++.. ...+++..++.++.|++.++.|||+.| ++|+||+|+||+++.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 3346899999996 588887754 456999999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccccccc-------------cccccCccccCcccc---CCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Q psy12709 151 KLCDFGISRVVNDVVEV-------------KEIIGTPDYVAPEVL---SYEPISLATDMWSVGVLAYVLLSSHSPFAGDN 214 (253)
Q Consensus 151 ~l~df~~~~~~~~~~~~-------------~~~~~~~~~~~PE~~---~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 214 (253)
+|+|||.+......... ....+++.|+|||++ .+..++.++||||||+++|+|++|+.||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 99999999865432211 133578899999998 56678899999999999999999999997655
Q ss_pred hHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 215 KQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 215 ~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....... ....+ .....++.+.++|.+||+.||
T Consensus 258 ~~~~~~~----~~~~~--~~~~~~~~~~~li~~~l~~~p 290 (337)
T 3ll6_A 258 KLRIVNG----KYSIP--PHDTQYTVFHSLIRAMLQVNP 290 (337)
T ss_dssp ------------CCCC--TTCCSSGGGHHHHHHHSCSSG
T ss_pred HHHhhcC----cccCC--cccccchHHHHHHHHHccCCh
Confidence 5433222 12111 224678889999999999998
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=284.48 Aligned_cols=242 Identities=23% Similarity=0.402 Sum_probs=182.0
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +.+.||+|+||+||+|.+..++..||+|.+..... ......+.+|+..+. ..+|+||+++++++..++..+
T Consensus 14 ~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 14 RDDYE--LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMS-QCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp CCCCE--EEEECC---CCCEEEEEC----CEEEEECCC-----------------CCC-CCCCTTBCCEEEEEESSSCEE
T ss_pred hhhhh--hhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHh-hcCCCCEeeEEEEEeecCCcE
Confidence 34555 99999999999999999998999999999876432 233456778888877 678999999999999999999
Q ss_pred EEEeccCCCcHHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 88 LVLEMVPDGELQRLVDI--------QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
+||||++|++|.+++.. ...+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999998863 3558999999999999999999999999999999999999999999999999987
Q ss_pred ccccc------ccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc--
Q psy12709 160 VVNDV------VEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH-- 230 (253)
Q Consensus 160 ~~~~~------~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-- 230 (253)
..... .......+++.|+|||++.+ ..++.++|+||+|+++|+|++|+.||....................
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence 55322 11223467889999999865 5688999999999999999999999988776665554433322211
Q ss_pred ----CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 ----EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 ----~~~~~~~~~~l~~li~~~l~~dP 253 (253)
......+++++.++|.+||+.||
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~dp 276 (303)
T 2vwi_A 250 GVQDKEMLKKYGKSFRKMISLCLQKDP 276 (303)
T ss_dssp -----CCCCCCCHHHHHHHHHHCCSSG
T ss_pred ccccchhhhhhhHHHHHHHHHHccCCh
Confidence 12335789999999999999998
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=286.78 Aligned_cols=241 Identities=20% Similarity=0.240 Sum_probs=187.2
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC-
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH- 84 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~- 84 (253)
+..+.-+|++.+.||+|+||+||+|.+. ++.||+|++..... .......|+..+. ..+||||+++++++..+.
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK---QSWQNEYEVYSLP-GMKHENILQFIGAEKRGTS 92 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH---HHHHHHHHHHTST-TCCCTTBCCEEEEEEEECS
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch---HHHHHHHHHHHHh-cCCCCCchhhcceeccCCC
Confidence 3334444559999999999999999875 78999999975432 2345556777776 678999999999998754
Q ss_pred ---eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CceecCCCCCCEEEcCCCceE
Q psy12709 85 ---EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDH----------NITHLDLKPQNILLTKDNNIK 151 (253)
Q Consensus 85 ---~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----------~~~h~di~~~ni~~~~~~~~~ 151 (253)
.+++||||+++++|.+++..+ .+++..++.++.|++.|+.|||+. |++|+||+|+||+++.++.++
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred CCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 479999999999999999754 499999999999999999999999 999999999999999999999
Q ss_pred EEeeccccccccccc---ccccccCccccCccccCCC-----CCCccccHHHHHHHHHHHHhCCCCCCCCCh--------
Q psy12709 152 LCDFGISRVVNDVVE---VKEIIGTPDYVAPEVLSYE-----PISLATDMWSVGVLAYVLLSSHSPFAGDNK-------- 215 (253)
Q Consensus 152 l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------- 215 (253)
|+|||.+........ .....+++.|+|||++.+. .++.++||||+|+++|+|++|+.||.+...
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999976543222 2335689999999998763 456688999999999999999999976422
Q ss_pred --------HHHHHHhhcccccccCCc---cCCCCHHHHHHHHHhcccCC
Q psy12709 216 --------QETFLNISQCNFSFHEDL---FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 216 --------~~~~~~i~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP 253 (253)
......+......+.... ....++++.++|.+||+.||
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 300 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSG
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCCh
Confidence 122222222222111110 01224569999999999998
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=279.41 Aligned_cols=229 Identities=19% Similarity=0.344 Sum_probs=194.1
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe-----
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET----- 82 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----- 82 (253)
.++|+ +.+.||+|+||.||+|.+..+++.|++|.+..... .+.+|+..+. ..+|+||+++++++..
T Consensus 10 ~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 10 GMDFK--EIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE------KAEREVKALA-KLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHEE--EEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG------GGHHHHHHHH-HCCCTTBCCEEEEEEEEEEC-
T ss_pred ccccc--eeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH------HHHHHHHHHH-hCCCCCEEEEeeeEeccccCc
Confidence 45566 99999999999999999999999999999976432 4557888887 6799999999998864
Q ss_pred -----------CCeEEEEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc
Q psy12709 83 -----------PHEMVLVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN 149 (253)
Q Consensus 83 -----------~~~~~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~ 149 (253)
...++++|||+++++|.+++... ..+++..++.++.|++.++.+||++|++|+||+|+||+++.++.
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC
Confidence 44689999999999999999654 56999999999999999999999999999999999999999999
Q ss_pred eEEEeecccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc
Q psy12709 150 IKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF 229 (253)
Q Consensus 150 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~ 229 (253)
++|+|||.+.............+++.|+|||.+.+..++.++|+||+|+++|+|++|..|+... ......+....
T Consensus 161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~~--- 235 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDGI--- 235 (284)
T ss_dssp EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTTC---
T ss_pred EEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhccc---
Confidence 9999999998765544444557899999999999889999999999999999999999887432 22333333322
Q ss_pred cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+++++.++|.+||+.||
T Consensus 236 ---~~~~~~~~~~~li~~~l~~dp 256 (284)
T 2a19_B 236 ---ISDIFDKKEKTLLQKLLSKKP 256 (284)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSG
T ss_pred ---ccccCCHHHHHHHHHHccCCh
Confidence 123689999999999999998
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=305.91 Aligned_cols=232 Identities=22% Similarity=0.350 Sum_probs=199.2
Q ss_pred eecCCCCceEEEEEEec--cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 17 CMPSRGKFASVRKCTHK--ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
+.||+|+||+||+|.+. .++..||+|+++...........+.+|+..+. .++|+||+++++++.. +.+++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ-QLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHH-HCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 48999999999999654 56688999999876665566778999999998 6789999999999975 46889999999
Q ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc----cccc
Q psy12709 95 DGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE----VKEI 170 (253)
Q Consensus 95 g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~ 170 (253)
+++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 532 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 532 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCC
Confidence 999999998888899999999999999999999999999999999999999999999999999986543221 1223
Q ss_pred ccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 171 IGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
.+++.|+|||++.+..++.++||||+|+++|+|++ |+.||.+.+..+....+..+...... ..+|+++.++|.+||
T Consensus 533 ~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p---~~~~~~l~~li~~cl 609 (635)
T 4fl3_A 533 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP---AGCPREMYDLMNLCW 609 (635)
T ss_dssp --CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHT
T ss_pred CCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHc
Confidence 45678999999998899999999999999999998 99999999998888887776543322 478999999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
+.||
T Consensus 610 ~~dP 613 (635)
T 4fl3_A 610 TYDV 613 (635)
T ss_dssp CSST
T ss_pred CCCH
Confidence 9998
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=295.44 Aligned_cols=235 Identities=21% Similarity=0.308 Sum_probs=196.0
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
.-+|++.+.||+|+||+||+|.+.. +..||+|++...... ...+.+|+..+. .++|+||+++++++.. +..++|
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~-~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMK-KLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHH-HCCCTTBCCEEEEECS-SSCEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHH-hCCCCCEeeEEEEEcC-CceEEE
Confidence 3345599999999999999999874 466999999865433 347888999998 7799999999999876 678999
Q ss_pred EeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc--
Q psy12709 90 LEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-- 165 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-- 165 (253)
|||+++++|.+++... ..++...+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999999998743 458999999999999999999999999999999999999999999999999998654321
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||.+....+....+..+...+. ...+|+++.++
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~l 413 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPESLHDL 413 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTSCHHHHHH
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHH
Confidence 1223345678999999988899999999999999999999 9999999988888887766543322 24789999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||+.||
T Consensus 414 i~~cl~~dP 422 (452)
T 1fmk_A 414 MCQCWRKEP 422 (452)
T ss_dssp HHHHTCSSG
T ss_pred HHHHccCCh
Confidence 999999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=285.64 Aligned_cols=241 Identities=26% Similarity=0.403 Sum_probs=176.3
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +.+.||+|+||.||+|.+..+++.||+|++..... ......+..|+..+.+..+|+||+++++++..++..++
T Consensus 22 ~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 22 EDLK--DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp CSEE--C-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhh--ehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 4555 99999999999999999999999999999976543 33445666777766668899999999999999999999
Q ss_pred EEeccCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCCceEEEeeccccccc
Q psy12709 89 VLEMVPDGELQRLVDI-----QDGIPEQDTRSYMKQILEALAFLHDH-NITHLDLKPQNILLTKDNNIKLCDFGISRVVN 162 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~ 162 (253)
|||++++ +|.+++.. ...+++..+..++.+++.++.+||++ |++|+||+|+||+++.++.++|+|||.+....
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9999976 78777653 56789999999999999999999999 99999999999999999999999999998765
Q ss_pred ccccccccccCccccCcccc----CCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhcccc-cccCCccCC
Q psy12709 163 DVVEVKEIIGTPDYVAPEVL----SYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ-ETFLNISQCNF-SFHEDLFGH 236 (253)
Q Consensus 163 ~~~~~~~~~~~~~~~~PE~~----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~i~~~~~-~~~~~~~~~ 236 (253)
.........+++.|+|||++ .+..++.++||||+|+++|+|++|+.||...... +....+..+.. ..+......
T Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3aln_A 178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEERE 257 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCC
T ss_pred cccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCccccc
Confidence 54444445688999999998 4566889999999999999999999999864432 22222222221 222223346
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
+++++.++|.+||+.||
T Consensus 258 ~~~~l~~li~~~l~~dp 274 (327)
T 3aln_A 258 FSPSFINFVNLCLTKDE 274 (327)
T ss_dssp CCHHHHHHHHHHTCSSG
T ss_pred CCHHHHHHHHHHhhCCh
Confidence 89999999999999998
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=285.48 Aligned_cols=241 Identities=28% Similarity=0.455 Sum_probs=197.2
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC---
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP--- 83 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--- 83 (253)
+.++|+ +.+.||+|+||+||+|.+..+++.||+|++.... .......+.+|+..+. ..+|+||+++++++..+
T Consensus 9 i~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 9 ISSDFQ--LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILK-HFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp SCTTEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHH-HCCCTTBCCEEEECCCSCST
T ss_pred cccceE--EeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHH-hCcCCCcCCeeeeecccccC
Confidence 456666 9999999999999999999999999999996533 3444567788999998 67899999999988764
Q ss_pred --CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 84 --HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 84 --~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
...++++|++. ++|.+++.. ..+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus 85 ~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 85 NFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp TCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 67999999996 589888875 56999999999999999999999999999999999999999999999999999865
Q ss_pred ccccc-----------ccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc
Q psy12709 162 NDVVE-----------VKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF 229 (253)
Q Consensus 162 ~~~~~-----------~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~ 229 (253)
..... .....+++.|+|||++.+ ..++.++|+||+|+++|+|++|+.||.+.+..+....+......+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 43211 122357889999998754 678999999999999999999999999887766555443211111
Q ss_pred c----------------------------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 H----------------------------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 ~----------------------------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
. ....+.+++++.++|.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 294 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSG
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCc
Confidence 1 11234789999999999999998
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=279.43 Aligned_cols=242 Identities=20% Similarity=0.333 Sum_probs=193.2
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEecc-CCc--eEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKI-TKV--EYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYE 81 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~--~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 81 (253)
+..++|+ +.+.||+|+||+||+|.+.. ++. .|++|++..... .......+.+|+..+. ..+|+||+++++++.
T Consensus 15 ~~~~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 15 IGEKDLR--LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH-SLDHRNLIRLYGVVL 91 (291)
T ss_dssp CCGGGEE--EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHH-HCCCTTBCCEEEEEC
T ss_pred cchhHee--eeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHH-hCCCCCcccEEEEEc
Confidence 3344555 99999999999999998653 333 589999876542 3345678889999998 668999999999998
Q ss_pred eCCeEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 82 TPHEMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 82 ~~~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
.++ .++++|++++++|.+++... ..+++..+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus 92 ~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 92 TPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp SSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred cCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 765 88999999999999988764 5689999999999999999999999999999999999999999999999999876
Q ss_pred cccccc----ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccC
Q psy12709 161 VNDVVE----VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFG 235 (253)
Q Consensus 161 ~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 235 (253)
...... .....+++.|+|||++.+..++.++|+||+|+++|+|++ |+.||...+..+....+.......+. ..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 248 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PE 248 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CT
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--Cc
Confidence 543221 122345678999999988888999999999999999999 99999998888888777665544433 34
Q ss_pred CCCHHHHHHHHHhcccCC
Q psy12709 236 HISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 236 ~~~~~l~~li~~~l~~dP 253 (253)
.+|+++.++|.+||+.||
T Consensus 249 ~~~~~l~~li~~~l~~~p 266 (291)
T 1u46_A 249 DCPQDIYNVMVQCWAHKP 266 (291)
T ss_dssp TCCHHHHHHHHHHTCSSG
T ss_pred CcCHHHHHHHHHHccCCc
Confidence 789999999999999998
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=283.59 Aligned_cols=241 Identities=22% Similarity=0.287 Sum_probs=194.1
Q ss_pred ceeecce-eeEEEeecCCCCceEEEEEE----eccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeE
Q psy12709 5 FFVNGGY-QTLIFCMPSRGKFASVRKCT----HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79 (253)
Q Consensus 5 ~~~~~~~-~~~~~~~lg~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~ 79 (253)
..+.++| + +++.||+|+||+||++. +..++..||+|++.... .......+.+|+..+. ..+|+||++++++
T Consensus 26 ~~~~~r~~~--~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~ 101 (318)
T 3lxp_A 26 TVFHKRYLK--KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILR-TLYHEHIIKYKGC 101 (318)
T ss_dssp CBCCGGGEE--EEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHH-HCCCTTBCCEEEE
T ss_pred ceecHHHHh--hhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHH-hCCCcchhhEEEE
Confidence 3444555 6 99999999999997764 44578899999998653 3445677889999998 6789999999999
Q ss_pred EEeC--CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecc
Q psy12709 80 YETP--HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI 157 (253)
Q Consensus 80 ~~~~--~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~ 157 (253)
+... ..+++||||+++++|.+++... .+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.
T Consensus 102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 102 CEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp EEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred EecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccc
Confidence 9874 5899999999999999999754 499999999999999999999999999999999999999999999999999
Q ss_pred cccccccc----cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---------------HH
Q psy12709 158 SRVVNDVV----EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ---------------ET 218 (253)
Q Consensus 158 ~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------------~~ 218 (253)
+....... ......+++.|+|||++.+..++.++||||+|+++|+|++|..||...... ..
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 260 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence 98664432 122345677899999998888899999999999999999999999653221 11
Q ss_pred HHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 219 FLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 219 ~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
...+..... ......+++++.++|.+||+.||
T Consensus 261 ~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP 292 (318)
T 3lxp_A 261 TELLERGER---LPRPDKCPAEVYHLMKNCWETEA 292 (318)
T ss_dssp HHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHhcccC---CCCCccccHHHHHHHHHHcCCCc
Confidence 112222211 12234789999999999999998
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=289.37 Aligned_cols=239 Identities=26% Similarity=0.348 Sum_probs=182.3
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe---
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE--- 85 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~--- 85 (253)
++|+ +.+.||+|+||+||+|.+..++..||+|++........ ...+++..+. ..+|+||+++++++...+.
T Consensus 23 ~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~l~-~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 23 DRFQ--VERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN---RELQIMQDLA-VLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp TTEE--EC----------CEEEEETTTCCEEEEEEEECCTTCCC---HHHHHHHHHH-HHCCTTBCCEEEEEEEECSSCT
T ss_pred cceE--EEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccH---HHHHHHHHHH-hcCCCCcccHHHhhhccccccc
Confidence 5666 99999999999999999999999999998865443222 3445555555 5689999999999976433
Q ss_pred ----EEEEEeccCCCcHHH---HHhhcCCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCCEEEcC-CCceEEEee
Q psy12709 86 ----MVLVLEMVPDGELQR---LVDIQDGIPEQDTRSYMKQILEALAFLH--DHNITHLDLKPQNILLTK-DNNIKLCDF 155 (253)
Q Consensus 86 ----~~lv~e~~~g~~L~~---~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~~~h~di~~~ni~~~~-~~~~~l~df 155 (253)
++++|||++++.+.. .......+++..++.++.|++.++.||| ++|++|+||+|+||+++. ++.++|+||
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 889999998753332 2234567899999999999999999999 999999999999999997 899999999
Q ss_pred cccccccccccccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC---
Q psy12709 156 GISRVVNDVVEVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE--- 231 (253)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--- 231 (253)
|++.............+++.|+|||++.+. .++.++||||+|+++|+|++|+.||.+.+....+..+......++.
T Consensus 177 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 177 GSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp TTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 999877655555556789999999998654 4899999999999999999999999998888777766543222110
Q ss_pred -------------------------CccCCCCHHHHHHHHHhcccCC
Q psy12709 232 -------------------------DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 232 -------------------------~~~~~~~~~l~~li~~~l~~dP 253 (253)
......++++.+||.+||+.||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 303 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLP 303 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSG
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCc
Confidence 1112367899999999999998
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=289.70 Aligned_cols=232 Identities=18% Similarity=0.217 Sum_probs=183.5
Q ss_pred cceeeEEEeecCCCCceEEEEE-----EeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhc--CCCCceeeeeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKC-----THKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ--KSERIVGLHEIYE 81 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~--~~~~i~~~~~~~~ 81 (253)
++-+|++.+.||+|+||+||+| .+..+++.||+|++.... ...+..|+..+..+. .|++|+.+++.+.
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3445559999999999999999 466788999999997542 224555665555322 3899999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC----------
Q psy12709 82 TPHEMVLVLEMVPDGELQRLVDI-----QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK---------- 146 (253)
Q Consensus 82 ~~~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~---------- 146 (253)
.++..++||||++|++|.+++.. ...+++..++.++.|++.|++|||++|++|+||+|+||+++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999999973 456999999999999999999999999999999999999998
Q ss_pred -CCceEEEeeccccccc---ccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q psy12709 147 -DNNIKLCDFGISRVVN---DVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNI 222 (253)
Q Consensus 147 -~~~~~l~df~~~~~~~---~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i 222 (253)
++.++|+|||++.... .........+++.|+|||++.+..++.++||||+|+++|+|++|+.||......... +
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~ 295 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--P 295 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--E
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--e
Confidence 8999999999996543 233344567899999999999999999999999999999999999998543221100 0
Q ss_pred hcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 223 SQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.. .. .. ...++.+.+++..||+.+|
T Consensus 296 ~~---~~-~~--~~~~~~~~~~~~~~l~~~p 320 (365)
T 3e7e_A 296 EG---LF-RR--LPHLDMWNEFFHVMLNIPD 320 (365)
T ss_dssp CS---CC-TT--CSSHHHHHHHHHHHHCCCC
T ss_pred ch---hc-cc--cCcHHHHHHHHHHHcCCCC
Confidence 00 00 00 1346678888888888876
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=288.23 Aligned_cols=234 Identities=14% Similarity=0.185 Sum_probs=187.4
Q ss_pred cceeeEEEeecCCCCceEEEEEEecc--------CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCcee-----
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKI--------TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVG----- 75 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~--------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~----- 75 (253)
++|+ +.+.||+|+||+||+|.+.. ++..||+|.+... ..+.+|+..+. ..+|+||++
T Consensus 42 ~~y~--~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~-~l~h~niv~~~~~~ 111 (352)
T 2jii_A 42 RQWK--LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQ-RAAKPLQVNKWKKL 111 (352)
T ss_dssp CEEE--EEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHH-HHCCHHHHHHHHHH
T ss_pred CeEE--EEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHH-Hhcccchhhhhhhh
Confidence 4555 99999999999999999987 4889999998754 25667888887 557888776
Q ss_pred ----------eeeEEEe-CCeEEEEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q psy12709 76 ----------LHEIYET-PHEMVLVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNI 142 (253)
Q Consensus 76 ----------~~~~~~~-~~~~~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni 142 (253)
+++++.. ++..++||||+ +++|.+++... ..+++..++.++.|++.|+.|||++|++|+||+|+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 6777766 67899999999 99999999875 6799999999999999999999999999999999999
Q ss_pred EEcCCC--ceEEEeeccccccccccc--------ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Q psy12709 143 LLTKDN--NIKLCDFGISRVVNDVVE--------VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAG 212 (253)
Q Consensus 143 ~~~~~~--~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 212 (253)
+++.++ .++|+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 899999999976543221 1234688999999999998999999999999999999999999987
Q ss_pred CC--hHHHHHHhh---cccccccC--CccCCCCHHHHHHHHHhcccCC
Q psy12709 213 DN--KQETFLNIS---QCNFSFHE--DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 213 ~~--~~~~~~~i~---~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP 253 (253)
.. ......... ........ .....+++++.++|.+||+.||
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 318 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTY 318 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCT
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCCh
Confidence 53 322222221 11111111 1113579999999999999998
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=275.69 Aligned_cols=240 Identities=27% Similarity=0.425 Sum_probs=194.1
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcC-CCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQK-SERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~-~~~i~~~~~~~~~~~~~~ 87 (253)
.+.+|++++.||+|+||.||+|.+. ++..||+|++............+.+|+..+..... |+||+++++++..++..+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 3444559999999999999999986 58889999998766666677888999999986654 799999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc-
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE- 166 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~- 166 (253)
++|| +.+++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++ ++.++|+|||.+........
T Consensus 105 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-------
T ss_pred EEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcccc
Confidence 9999 55889999998888899999999999999999999999999999999999996 58999999999986543221
Q ss_pred --ccccccCccccCccccCC-----------CCCCccccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhcccccccCC
Q psy12709 167 --VKEIIGTPDYVAPEVLSY-----------EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ-ETFLNISQCNFSFHED 232 (253)
Q Consensus 167 --~~~~~~~~~~~~PE~~~~-----------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~i~~~~~~~~~~ 232 (253)
.....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...... .....+....... .
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~ 260 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI--E 260 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC--C
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc--C
Confidence 223467899999999865 46788999999999999999999999875433 3333333332222 2
Q ss_pred ccCCCCHHHHHHHHHhcccCC
Q psy12709 233 LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 ~~~~~~~~l~~li~~~l~~dP 253 (253)
.....++++.++|.+||+.||
T Consensus 261 ~~~~~~~~l~~li~~~l~~dp 281 (313)
T 3cek_A 261 FPDIPEKDLQDVLKCCLKRDP 281 (313)
T ss_dssp CCCCSCHHHHHHHHHHTCSST
T ss_pred CcccchHHHHHHHHHHccCCc
Confidence 223568999999999999998
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=286.15 Aligned_cols=210 Identities=30% Similarity=0.467 Sum_probs=179.2
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCC-----ceeeeeEEEe
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER-----IVGLHEIYET 82 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~-----i~~~~~~~~~ 82 (253)
.++|+ +.+.||+|+||+||+|.+..+++.||+|++.... ........|+..+.....|++ |+++++++..
T Consensus 53 ~~~y~--~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 53 MDRYE--IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TTTEE--EEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred eeeEE--EEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH---HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 35566 9999999999999999999999999999997532 334566677777775555664 9999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCCEEEcC--CCceEEEeec
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLH--DHNITHLDLKPQNILLTK--DNNIKLCDFG 156 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh--~~~~~h~di~~~ni~~~~--~~~~~l~df~ 156 (253)
++..++|||++++ +|.+++... ..+++..++.++.|++.|+.||| +.|++|+||+|+||+++. ++.++|+|||
T Consensus 128 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 128 RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 9999999999965 998888764 45899999999999999999999 579999999999999954 6789999999
Q ss_pred ccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcc
Q psy12709 157 ISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQC 225 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~ 225 (253)
++...... .....+++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.+..+....+...
T Consensus 207 ~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 273 (382)
T 2vx3_A 207 SSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273 (382)
T ss_dssp TCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred Cceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99866432 23456889999999999999999999999999999999999999998888777666543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=284.03 Aligned_cols=240 Identities=24% Similarity=0.350 Sum_probs=195.0
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEe-ccCCceEEEEEecccccchHHHHHHHHHHHHHHHhc-----CCCCceeeeeE
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTH-KITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-----KSERIVGLHEI 79 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~-----~~~~i~~~~~~ 79 (253)
.+.++|+ +.+.||+|+||+||+|.+ ..++..||+|++.... .....+.+|+..+.... .++++++++++
T Consensus 11 ~~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 11 VLSARYE--IVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD---RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp EETTTEE--EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred CccCceE--EEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC---chhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 4556777 999999999999999998 5678999999997532 33456677777776332 23469999999
Q ss_pred EEeCCeEEEEEeccCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-----------
Q psy12709 80 YETPHEMVLVLEMVPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK----------- 146 (253)
Q Consensus 80 ~~~~~~~~lv~e~~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~----------- 146 (253)
+..++.+++|||++ +++|.+++.... ++++..++.++.|++.|+.|||++|++|+||+|+||+++.
T Consensus 86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 86 FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 99999999999999 889999887654 6899999999999999999999999999999999999987
Q ss_pred --------CCceEEEeecccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy12709 147 --------DNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQET 218 (253)
Q Consensus 147 --------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 218 (253)
++.++|+|||.+...... .....+++.|+|||++.+..++.++||||+|+++|+|++|..||...+..+.
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 667999999998764432 2345688999999999999999999999999999999999999998877766
Q ss_pred HHHhhcccccccCC----------------------------------------ccCCCCHHHHHHHHHhcccCC
Q psy12709 219 FLNISQCNFSFHED----------------------------------------LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 219 ~~~i~~~~~~~~~~----------------------------------------~~~~~~~~l~~li~~~l~~dP 253 (253)
...+.....+.+.. .....++++.+||.+||+.||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 55443322221110 011235779999999999998
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=287.98 Aligned_cols=241 Identities=18% Similarity=0.294 Sum_probs=191.9
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCC---ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEE-eC
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITK---VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYE-TP 83 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~ 83 (253)
....+|++.+.||+|+||+||+|.+..++ ..|++|.+.... .......+.+|+..+. ..+||||+++++++. .+
T Consensus 86 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~ 163 (373)
T 3c1x_A 86 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMK-DFSHPNVLSLLGICLRSE 163 (373)
T ss_dssp STTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTST-TCCCTTBCCCCEEECCCS
T ss_pred hhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHH-hCCCCCcceEEEEEEcCC
Confidence 34556779999999999999999976433 458999887533 3445678889999888 679999999999865 45
Q ss_pred CeEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN 162 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~ 162 (253)
+..++||||+++++|.+++... ..++...++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 6889999999999999999764 458999999999999999999999999999999999999999999999999997553
Q ss_pred ccc-----cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCC
Q psy12709 163 DVV-----EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGH 236 (253)
Q Consensus 163 ~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 236 (253)
... ......+++.|+|||++.+..++.++||||+|+++|+|++ |.+||...+..+....+..+...... ..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p---~~ 320 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---EY 320 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCC---TT
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCC---CC
Confidence 321 1122345678999999998999999999999999999999 78899887777666666655433322 37
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
+++++.++|.+||+.||
T Consensus 321 ~~~~l~~li~~cl~~dp 337 (373)
T 3c1x_A 321 CPDPLYEVMLKCWHPKA 337 (373)
T ss_dssp CCHHHHHHHHHHTCSSG
T ss_pred CCHHHHHHHHHHcCCCh
Confidence 89999999999999998
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=294.67 Aligned_cols=241 Identities=20% Similarity=0.287 Sum_probs=200.4
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
.+.++|+ +.+.||+|+||.||+|.+..++..||+|++....... .+.+|+..+..+..++++..+..++..++.
T Consensus 4 ~i~~~y~--i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~ 77 (483)
T 3sv0_A 4 RVGNKFR--LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVEGDY 77 (483)
T ss_dssp EETTTEE--CCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred CcCCcEE--EEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence 5667888 9999999999999999999999999999877544322 467788888866677888888888888889
Q ss_pred EEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---cCCCceEEEeecccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILL---TKDNNIKLCDFGISRVV 161 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~---~~~~~~~l~df~~~~~~ 161 (253)
.++||||+ +++|.+++.. ...+++..++.++.||+.+|.|||++|++|+||+|+||++ +.++.++|+|||++...
T Consensus 78 ~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99999999 8899999875 4579999999999999999999999999999999999999 68899999999999865
Q ss_pred ccccc--------ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHhhccccc-c
Q psy12709 162 NDVVE--------VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNK---QETFLNISQCNFS-F 229 (253)
Q Consensus 162 ~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~i~~~~~~-~ 229 (253)
..... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||.+... ...+..+...... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 44321 1245688999999999999999999999999999999999999987443 3333333332221 2
Q ss_pred cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.......+++++.++|.+||+.||
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP 260 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRF 260 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCT
T ss_pred HHHHhcCCcHHHHHHHHHHhcCCh
Confidence 223335789999999999999998
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=278.19 Aligned_cols=238 Identities=25% Similarity=0.434 Sum_probs=194.8
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe----
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET---- 82 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~---- 82 (253)
+.++|+ +.+.||+|+||+||+|.+..+++.|++|.+... ......+.+|+..+. ..+|+||+++++++..
T Consensus 4 ~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~ 77 (303)
T 1zy4_A 4 YASDFE--EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLA-SLNHQYVVRYYAAWLERRNF 77 (303)
T ss_dssp HHHHEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEECCCC
T ss_pred ccccch--hhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHH-hcCchHHHHHHHHHHhhcch
Confidence 456677 999999999999999999999999999999653 344567888999888 7799999999998864
Q ss_pred ---------CCeEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEE
Q psy12709 83 ---------PHEMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKL 152 (253)
Q Consensus 83 ---------~~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l 152 (253)
.+..+++||++++++|.+++... ..+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp CC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred hhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence 45789999999999999999754 35788999999999999999999999999999999999999999999
Q ss_pred Eeeccccccccc---------------ccccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCC-CCh
Q psy12709 153 CDFGISRVVNDV---------------VEVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAG-DNK 215 (253)
Q Consensus 153 ~df~~~~~~~~~---------------~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~ 215 (253)
+|||.+...... .......+++.|+|||++.+. .++.++|+||+|+++|+|++ ||.. ...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~ 234 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence 999998765321 122334578899999998765 68999999999999999998 5543 333
Q ss_pred HHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 216 QETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 216 ~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
......+.......+.......++.++++|.+||+.||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 272 (303)
T 1zy4_A 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDP 272 (303)
T ss_dssp HHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSG
T ss_pred HHHHHhccccccccCccccccchHHHHHHHHHHHhcCc
Confidence 44555666666666666667888999999999999998
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=291.26 Aligned_cols=201 Identities=25% Similarity=0.405 Sum_probs=170.0
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhc-------CCCCceeeeeE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-------KSERIVGLHEI 79 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~-------~~~~i~~~~~~ 79 (253)
+.++|+ +.+.||+|+||+||+|.+..+++.||+|++... ......+.+|+..+.... .|+||+++++.
T Consensus 35 ~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 35 FNGRYH--VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp ETTTEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred cCCeEE--EEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 456777 999999999999999999999999999999753 333457778888887554 27889999999
Q ss_pred EE----eCCeEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEcCCC-----
Q psy12709 80 YE----TPHEMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDH-NITHLDLKPQNILLTKDN----- 148 (253)
Q Consensus 80 ~~----~~~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~di~~~ni~~~~~~----- 148 (253)
+. .+..+++|||++.++.+..+.... ..+++..++.++.|++.||.|||++ |++|+||+|+||+++.++
T Consensus 110 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred eeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence 98 456899999999554444444433 5699999999999999999999998 999999999999999775
Q ss_pred --------------------------------------------ceEEEeecccccccccccccccccCccccCccccCC
Q psy12709 149 --------------------------------------------NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSY 184 (253)
Q Consensus 149 --------------------------------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~ 184 (253)
.++|+|||.+...... .....+++.|+|||++.+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHT
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcC
Confidence 7999999999765432 334568999999999999
Q ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCCCC
Q psy12709 185 EPISLATDMWSVGVLAYVLLSSHSPFAGDN 214 (253)
Q Consensus 185 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 214 (253)
..++.++||||||+++|+|++|+.||...+
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 899999999999999999999999997654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=287.22 Aligned_cols=240 Identities=20% Similarity=0.289 Sum_probs=193.8
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +.+.||+|+||+||+|.+. ++..||+|.+..... .....+.+|+..+. ..+|+||+++++++..++..+
T Consensus 38 ~~~y~--~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 38 TNNFD--HKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS--QGIEEFETEIETLS-FCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCS--CCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS--SHHHHHHHHHHGGG-SCCCTTBCCEEEECCCTTCCE
T ss_pred HhccC--ccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh--HHHHHHHHHHHHHH-hCCCCCEeeEEEEEcCCCeEE
Confidence 45677 9999999999999999965 688999998876543 33567888999887 778999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQD----GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
+||||+++++|.+++.... .+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999999886542 489999999999999999999999999999999999999999999999999875432
Q ss_pred c---ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH-------Hhhccc------c
Q psy12709 164 V---VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFL-------NISQCN------F 227 (253)
Q Consensus 164 ~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-------~i~~~~------~ 227 (253)
. .......+++.|+|||++.+..++.++||||+|+++|+|++|+.||......+... ...... .
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence 2 12233457899999999988889999999999999999999999997644322110 001110 0
Q ss_pred cccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 228 SFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 228 ~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.......+..+..+.+++.+||+.||
T Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP 297 (321)
T 2qkw_B 272 NLADKIRPESLRKFGDTAVKCLALSS 297 (321)
T ss_dssp SCTTCSCHHHHHHHHHHHHHHTCSSG
T ss_pred hhccccCHHHHHHHHHHHHHHcCCCc
Confidence 11111223456779999999999998
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=301.55 Aligned_cols=235 Identities=22% Similarity=0.365 Sum_probs=196.5
Q ss_pred eEEEe-ecCCCCceEEEEEEecc--CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 13 TLIFC-MPSRGKFASVRKCTHKI--TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 13 ~~~~~-~lg~g~~~~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
+.+.+ .||+|+||+||+|.+.. ++..||+|+++.... ......+.+|+..+. .++|+||+++++++.. +.+++|
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~-~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMH-QLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHT-TCCCTTBCCEEEEEES-SSEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHH-hCCCCCEeeEEEEecc-CCeEEE
Confidence 33666 89999999999998763 456799999986532 334568889999998 7799999999999976 569999
Q ss_pred EeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc--
Q psy12709 90 LEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE-- 166 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~-- 166 (253)
|||+++++|.+++... ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 9999999999988654 4599999999999999999999999999999999999999999999999999986543221
Q ss_pred --ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 167 --VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 167 --~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
.....+++.|+|||++.+..++.++||||+|+++|+|++ |+.||.+.+..+....+..+..... ...+++++.+
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~ 570 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPECPPELYA 570 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCC---CTTCCHHHHH
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCHHHHH
Confidence 112234578999999998899999999999999999998 9999999888888888777654322 2478999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 571 li~~cl~~dP 580 (613)
T 2ozo_A 571 LMSDCWIYKW 580 (613)
T ss_dssp HHHHTTCSST
T ss_pred HHHHHcCCCh
Confidence 9999999998
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=282.86 Aligned_cols=234 Identities=27% Similarity=0.443 Sum_probs=195.4
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch----HHHHHHHHHHHHHHHhc-CCCCceeeeeEEE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM----DQMQDILHEAAVLYLAQ-KSERIVGLHEIYE 81 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~ 81 (253)
+.++|+ +.+.||+|+||+||+|.+..++..||+|++....... .....+.+|+..+.+.. .|+||+++++++.
T Consensus 41 ~~~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 41 LESQYQ--VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp CTTTEE--EEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred ccCceE--EEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 456676 9999999999999999999999999999997654221 12235566888887555 4799999999999
Q ss_pred eCCeEEEEEeccCC-CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc-CCCceEEEeecccc
Q psy12709 82 TPHEMVLVLEMVPD-GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLT-KDNNIKLCDFGISR 159 (253)
Q Consensus 82 ~~~~~~lv~e~~~g-~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~-~~~~~~l~df~~~~ 159 (253)
.++..++++|++.+ ++|.+++.....+++..++.++.|++.|+.|||++|++|+||+|+||+++ +++.++|+|||.+.
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99999999999976 89999998888899999999999999999999999999999999999999 68999999999998
Q ss_pred cccccccccccccCccccCccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCC
Q psy12709 160 VVNDVVEVKEIIGTPDYVAPEVLSYEPI-SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHIS 238 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 238 (253)
..... ......+++.|+|||++.+..+ +.++||||||+++|+|++|+.||..... +....... ...++
T Consensus 199 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~~----~~~~~ 267 (320)
T 3a99_A 199 LLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFF----RQRVS 267 (320)
T ss_dssp ECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCCCCC----SSCCC
T ss_pred ccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcccccc----cccCC
Confidence 66543 2234568899999999877665 6789999999999999999999975321 22222222 24789
Q ss_pred HHHHHHHHHhcccCC
Q psy12709 239 SQAKDFIQSCLVTDP 253 (253)
Q Consensus 239 ~~l~~li~~~l~~dP 253 (253)
+++.++|.+||+.||
T Consensus 268 ~~~~~li~~~l~~dp 282 (320)
T 3a99_A 268 SECQHLIRWCLALRP 282 (320)
T ss_dssp HHHHHHHHHHTCSSG
T ss_pred HHHHHHHHHHccCCh
Confidence 999999999999998
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=297.58 Aligned_cols=236 Identities=21% Similarity=0.304 Sum_probs=200.6
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
..-+|++.+.||+|+||+||+|.+.. +..||+|++...... .+.+.+|+..+. .++|+||+++++++.. +.+++
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~-~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMK-KLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHH-HCCCTTBCCEEEEECS-SSCEE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHH-hCCCCCEeeEEEEEee-ccceE
Confidence 33345599999999999999999874 466999999865433 347888999998 7799999999999876 67899
Q ss_pred EEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-
Q psy12709 89 VLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV- 165 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~- 165 (253)
||||+.+++|.+++... ..++...++.++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999999998743 458999999999999999999999999999999999999999999999999998654321
Q ss_pred -cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 166 -EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 166 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
......++..|+|||++.+..++.++||||||+++|+|++ |+.||.+....+....+..+..... ...+++++.+
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~ 495 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPESLHD 495 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHH
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHH
Confidence 1223345678999999988899999999999999999999 9999999988888887766543322 2478999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
||.+||+.||
T Consensus 496 li~~cl~~dP 505 (535)
T 2h8h_A 496 LMCQCWRKEP 505 (535)
T ss_dssp HHHHHTCSSG
T ss_pred HHHHHcCCCh
Confidence 9999999997
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=277.78 Aligned_cols=238 Identities=19% Similarity=0.309 Sum_probs=184.6
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHh-cCCCCceeeeeEEEe--
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLA-QKSERIVGLHEIYET-- 82 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~-- 82 (253)
.+.++|+ +.+.||+|+||+||+|.+ ++..||+|++.... .....+|...+... .+|+||+++++++..
T Consensus 5 ~~~~~y~--~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 5 TVARDIT--LLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCGGGCE--EEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred cccCcEE--EEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 4567888 999999999999999987 58899999987532 23444555555533 799999999998654
Q ss_pred --CCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCCEEEcCCCceEE
Q psy12709 83 --PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLH--------DHNITHLDLKPQNILLTKDNNIKL 152 (253)
Q Consensus 83 --~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--------~~~~~h~di~~~ni~~~~~~~~~l 152 (253)
...+++||||+++++|.++++ ...+++..++.++.|++.|+.||| +.|++|+||+|+||+++.++.++|
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 346899999999999999996 456999999999999999999999 999999999999999999999999
Q ss_pred Eeeccccccccccc-----ccccccCccccCccccCCC------CCCccccHHHHHHHHHHHHhC----------CCCCC
Q psy12709 153 CDFGISRVVNDVVE-----VKEIIGTPDYVAPEVLSYE------PISLATDMWSVGVLAYVLLSS----------HSPFA 211 (253)
Q Consensus 153 ~df~~~~~~~~~~~-----~~~~~~~~~~~~PE~~~~~------~~~~~~Di~slG~~l~~l~~g----------~~p~~ 211 (253)
+|||++........ .....+++.|+|||++.+. .++.++||||+|+++|+|++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 99999975543221 1233688999999999776 345789999999999999999 88885
Q ss_pred CCC----hHHHHHHhhc-cccc--ccCC-ccCCCCHHHHHHHHHhcccCC
Q psy12709 212 GDN----KQETFLNISQ-CNFS--FHED-LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 212 ~~~----~~~~~~~i~~-~~~~--~~~~-~~~~~~~~l~~li~~~l~~dP 253 (253)
... .......... .... .+.. .....++++.++|.+||+.||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 284 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNP 284 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSG
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcCh
Confidence 522 1222222221 1111 1111 112356789999999999998
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=276.16 Aligned_cols=232 Identities=28% Similarity=0.451 Sum_probs=189.2
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCC
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDG 96 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 96 (253)
..||+|+||+||+|.+..++..|++|.+..... .....+.+|+..+. ..+|+||+++++++..++..+++||+++++
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 104 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHK-HLKHKNIVQYLGSFSENGFIKIFMEQVPGG 104 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHH-TCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCch--HHHHHHHHHHHHHH-hCCCCCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence 389999999999999999999999999876532 33457888888888 779999999999999999999999999999
Q ss_pred cHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-CCceEEEeeccccccccc-ccccccc
Q psy12709 97 ELQRLVDIQ---DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK-DNNIKLCDFGISRVVNDV-VEVKEII 171 (253)
Q Consensus 97 ~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~-~~~~~l~df~~~~~~~~~-~~~~~~~ 171 (253)
+|.+++... ..+++..+..++.|++.|+.+||++|++|+||+|+||+++. ++.++|+|||.+...... .......
T Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 184 (295)
T 2clq_A 105 SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT 184 (295)
T ss_dssp EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCC
T ss_pred CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccC
Confidence 999998764 24678999999999999999999999999999999999998 899999999999765432 2233456
Q ss_pred cCccccCccccCCCC--CCccccHHHHHHHHHHHHhCCCCCCCCChHHH-HHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 172 GTPDYVAPEVLSYEP--ISLATDMWSVGVLAYVLLSSHSPFAGDNKQET-FLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 172 ~~~~~~~PE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
+++.|+|||++.+.. ++.++|+||+|+++|+|++|+.||........ ....... .........+++++.++|.+|
T Consensus 185 ~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~ 262 (295)
T 2clq_A 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF--KVHPEIPESMSAEAKAFILKC 262 (295)
T ss_dssp CCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH--CCCCCCCTTSCHHHHHHHHHT
T ss_pred CCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc--cccccccccCCHHHHHHHHHH
Confidence 789999999986643 78899999999999999999999976433322 2111111 112223357899999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|+.||
T Consensus 263 l~~dp 267 (295)
T 2clq_A 263 FEPDP 267 (295)
T ss_dssp TCSST
T ss_pred ccCCh
Confidence 99998
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=275.43 Aligned_cols=219 Identities=15% Similarity=0.144 Sum_probs=182.9
Q ss_pred cceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc-hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 4 KFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS-MDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
...+.++|+ +.+.||+|+||+||+|.+..+++.||+|++...... ......+.+|+..+. ..+|+||+++++++..
T Consensus 26 ~~~~~~~y~--i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 26 ARIANGRYR--LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLS-RIDKPGVARVLDVVHT 102 (286)
T ss_dssp CEETTTTEE--EEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEEE
T ss_pred CEEecCcEE--EEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHh-cCCCCCcceeeEEEEE
Confidence 335667788 999999999999999999999999999999876543 455678888998887 7899999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN 162 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~ 162 (253)
++..++||||++|++|.+++... ....++..++.|++.++.|||++|++|+||+|+||+++.+|.++|++++
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred CCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------
Confidence 99999999999999999998643 4667789999999999999999999999999999999999999997443
Q ss_pred ccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH---HhhcccccccCCccCCCCH
Q psy12709 163 DVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFL---NISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~ 239 (253)
|++ .++.++||||||+++|+|++|+.||.+.+...... .........+......+|+
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCH
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCH
Confidence 222 36889999999999999999999998866543221 1122333333344568999
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
++.++|.+||+.||
T Consensus 235 ~l~~li~~~l~~dP 248 (286)
T 3uqc_A 235 QISAVAARSVQGDG 248 (286)
T ss_dssp HHHHHHHHHHCTTS
T ss_pred HHHHHHHHHcccCC
Confidence 99999999999998
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=273.55 Aligned_cols=230 Identities=22% Similarity=0.364 Sum_probs=184.3
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +.+.||+|+||+||+|.+. ++.|++|.+... .....+.+|+..+. ..+|+||+++++++.. ..+
T Consensus 7 ~~~~~--~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 7 YKEIE--VEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLS-RVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp GGGEE--EEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHH-HCCCTTBCCEEEBCTT--TTE
T ss_pred HhHee--eeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHh-cCCCCCcCeEEEEEcC--CcE
Confidence 34555 9999999999999999875 788999998643 23457888999988 6799999999998874 489
Q ss_pred EEEeccCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCCCCEEEcCCCc-eEEEeeccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQD---GIPEQDTRSYMKQILEALAFLHD---HNITHLDLKPQNILLTKDNN-IKLCDFGISRV 160 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~di~~~ni~~~~~~~-~~l~df~~~~~ 160 (253)
+||||++|++|.+++.... .++...++.++.|++.++.|||+ +|++|+||+|+||+++.++. ++|+|||.+..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999997654 37899999999999999999999 89999999999999998887 79999999875
Q ss_pred ccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--HHHHHhhcccccccCCccCCCC
Q psy12709 161 VNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ--ETFLNISQCNFSFHEDLFGHIS 238 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~ 238 (253)
.... .....+++.|+|||++.+..++.++||||+|+++|+|++|+.||...... .....+..... ......+|
T Consensus 156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 230 (307)
T 2eva_A 156 IQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR---PPLIKNLP 230 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC---CCCBTTCC
T ss_pred cccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC---CCcccccC
Confidence 5432 22345889999999999989999999999999999999999999764332 22223333222 22335789
Q ss_pred HHHHHHHHHhcccCC
Q psy12709 239 SQAKDFIQSCLVTDP 253 (253)
Q Consensus 239 ~~l~~li~~~l~~dP 253 (253)
+.+.++|.+||+.||
T Consensus 231 ~~l~~li~~~l~~dp 245 (307)
T 2eva_A 231 KPIESLMTRCWSKDP 245 (307)
T ss_dssp HHHHHHHHHHTCSSG
T ss_pred HHHHHHHHHHhcCCh
Confidence 999999999999998
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=278.11 Aligned_cols=239 Identities=21% Similarity=0.337 Sum_probs=193.4
Q ss_pred eecceeeEEEeecCCCCceEEEEEE----eccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCT----HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
..++|+ +++.||+|+||+||+|. +..++..||+|++... .....+.+.+|+..+. ..+|+||+++++++..
T Consensus 39 ~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 39 EERHLK--FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILK-SLQHDNIVKYKGVCYS 113 (326)
T ss_dssp CGGGEE--EEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHH-TCCCTTBCCEEEEECC
T ss_pred CHHHce--eeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHH-hCCCCCeeeEEEEEEe
Confidence 345566 99999999999999998 4568899999998764 3345678889999998 6799999999999876
Q ss_pred CC--eEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 83 PH--EMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 83 ~~--~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
.+ .+++|||++++++|.+++... ..+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 54 789999999999999999875 459999999999999999999999999999999999999999999999999998
Q ss_pred ccccccc----ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH----------------HHH
Q psy12709 160 VVNDVVE----VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ----------------ETF 219 (253)
Q Consensus 160 ~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------------~~~ 219 (253)
....... .....++..|+|||.+.+..++.++||||||+++|+|++|..|+...... ...
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 6643322 12234566799999998888899999999999999999999998642111 111
Q ss_pred HHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 220 LNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 220 ~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+..... . .....+++++.++|.+||+.||
T Consensus 274 ~~~~~~~~-~--~~~~~~~~~l~~li~~cl~~dP 304 (326)
T 2w1i_A 274 ELLKNNGR-L--PRPDGCPDEIYMIMTECWNNNV 304 (326)
T ss_dssp HHHHTTCC-C--CCCTTCCHHHHHHHHHHSCSSG
T ss_pred HHhhcCCC-C--CCCCcccHHHHHHHHHHcCCCh
Confidence 11222111 1 2234789999999999999998
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=281.46 Aligned_cols=211 Identities=24% Similarity=0.398 Sum_probs=174.1
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCC-ceEEEEEecccccchHHHHHHHHHHHHHHHhcC-----CCCceeeeeE
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITK-VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQK-----SERIVGLHEI 79 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~-----~~~i~~~~~~ 79 (253)
++.++|+ +.+.||+|+||+||+|.+..++ ..||+|++.... .....+.+|+..+..+.. +.+++.++++
T Consensus 16 ~~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 16 WLQERYE--IVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---KYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp EETTTEE--EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred eecccEE--EEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc---cchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 4567777 9999999999999999998776 689999997532 334566677777764322 2238999999
Q ss_pred EEeCCeEEEEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE-------------
Q psy12709 80 YETPHEMVLVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILL------------- 144 (253)
Q Consensus 80 ~~~~~~~~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~------------- 144 (253)
+...+..++|||++. +++.+.+... ..+++..++.++.|++.|+.|||++|++|+||+|+||++
T Consensus 91 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 91 FNFHGHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEETTEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eeeCCeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 999999999999994 5555555443 469999999999999999999999999999999999999
Q ss_pred ------cCCCceEEEeecccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy12709 145 ------TKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQET 218 (253)
Q Consensus 145 ------~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 218 (253)
+.++.++|+|||.+...... .....+++.|+|||++.+..++.++||||||+++|+|++|..||...+..+.
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56789999999999764432 2345688999999999999999999999999999999999999998877766
Q ss_pred HHHhhc
Q psy12709 219 FLNISQ 224 (253)
Q Consensus 219 ~~~i~~ 224 (253)
...+..
T Consensus 248 ~~~~~~ 253 (355)
T 2eu9_A 248 LVMMEK 253 (355)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 655443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=282.01 Aligned_cols=237 Identities=19% Similarity=0.289 Sum_probs=194.6
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +.+.||+|+||+||+|.+.. .+++|++............+.+|+..+. ..+|+||+++++++..++.++
T Consensus 32 ~~~~~--~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 32 FEQLE--IGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYR-QTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp CSCEE--CCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGT-TCCCTTBCCCCEEEECSSCEE
T ss_pred HHHeE--EeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHh-cCCCCCEeEEEEEEecCCceE
Confidence 34555 99999999999999998763 5999998865544433445667888887 779999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc---
Q psy12709 88 LVLEMVPDGELQRLVDIQD-GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND--- 163 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~--- 163 (253)
+++|+++|++|.+++.... .+++..++.++.|++.|+.+||++|++|+||+|+||+++ ++.++|+|||++.....
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 9999999999999997654 689999999999999999999999999999999999998 78999999998765421
Q ss_pred ---cccccccccCccccCccccCC---------CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC
Q psy12709 164 ---VVEVKEIIGTPDYVAPEVLSY---------EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE 231 (253)
Q Consensus 164 ---~~~~~~~~~~~~~~~PE~~~~---------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 231 (253)
........+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||...........+.........
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 264 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS 264 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCC
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCC
Confidence 122233457889999999864 34788999999999999999999999998888877777665443322
Q ss_pred CccCCCCHHHHHHHHHhcccCC
Q psy12709 232 DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 232 ~~~~~~~~~l~~li~~~l~~dP 253 (253)
...+++++.++|.+||+.||
T Consensus 265 --~~~~~~~l~~li~~~l~~~p 284 (319)
T 2y4i_B 265 --QIGMGKEISDILLFCWAFEQ 284 (319)
T ss_dssp --CSSCCTTHHHHHHHHHCSST
T ss_pred --cCCCCHHHHHHHHHHhcCCh
Confidence 23689999999999999998
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=278.96 Aligned_cols=234 Identities=26% Similarity=0.456 Sum_probs=187.3
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch----HHHHHHHHHHHHHHHhc---CCCCceeeeeE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM----DQMQDILHEAAVLYLAQ---KSERIVGLHEI 79 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~e~~~~~~~~---~~~~i~~~~~~ 79 (253)
+.++|+ +.+.||+|+||.||+|.+..++..||+|++....... .....+.+|+..+.+.. +|+||++++++
T Consensus 29 ~~~~y~--~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 29 FEAEYR--LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ----CE--EEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhceE--EeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 456677 9999999999999999999999999999997654321 12334556777777444 89999999999
Q ss_pred EEeCCeEEEEEec-cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc-CCCceEEEeecc
Q psy12709 80 YETPHEMVLVLEM-VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLT-KDNNIKLCDFGI 157 (253)
Q Consensus 80 ~~~~~~~~lv~e~-~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~-~~~~~~l~df~~ 157 (253)
+...+..++++|+ +.+++|.+++.....+++..++.++.|++.++.+||++|++|+||+|+||+++ .++.++|+|||.
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999999 78999999998888899999999999999999999999999999999999999 789999999999
Q ss_pred cccccccccccccccCccccCccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCC
Q psy12709 158 SRVVNDVVEVKEIIGTPDYVAPEVLSYEPI-SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGH 236 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 236 (253)
+...... ......+++.|+|||++.+..+ +.++||||+|+++|+|++|+.||.... .+....... ...
T Consensus 187 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~----~~~ 255 (312)
T 2iwi_A 187 GALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHF----PAH 255 (312)
T ss_dssp CEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCC----CTT
T ss_pred hhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCC----ccc
Confidence 8866543 2334568899999999876665 458999999999999999999997532 122222222 247
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
+++++.++|.+||+.||
T Consensus 256 ~~~~~~~li~~~l~~~p 272 (312)
T 2iwi_A 256 VSPDCCALIRRCLAPKP 272 (312)
T ss_dssp SCHHHHHHHHHHTCSST
T ss_pred CCHHHHHHHHHHccCCh
Confidence 89999999999999998
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=286.30 Aligned_cols=200 Identities=26% Similarity=0.450 Sum_probs=155.1
Q ss_pred ecceeeEE-EeecCCCCceEEEEEEec--cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe--
Q psy12709 8 NGGYQTLI-FCMPSRGKFASVRKCTHK--ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET-- 82 (253)
Q Consensus 8 ~~~~~~~~-~~~lg~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-- 82 (253)
.+.|+ + .++||+|+||+||+|.++ .++..||+|++...... ..+.+|+..+. .++|+||+++++++..
T Consensus 19 ~~~y~--~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~-~l~hpniv~~~~~~~~~~ 91 (405)
T 3rgf_A 19 EDLFE--YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLR-ELKHPNVISLQKVFLSHA 91 (405)
T ss_dssp HHHEE--CSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHH-HCCCTTBCCCCEEEEETT
T ss_pred hhhhh--hcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHH-hcCCCCeeeEeeEEecCC
Confidence 44555 5 458999999999999966 56889999999765433 25678999988 7789999999999954
Q ss_pred CCeEEEEEeccCCCcHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE----cCCCc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQ---------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILL----TKDNN 149 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~----~~~~~ 149 (253)
+..+++||||+.+ +|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||++ +.++.
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 92 DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred CCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 6689999999965 777666421 248999999999999999999999999999999999999 67789
Q ss_pred eEEEeeccccccccc----ccccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q psy12709 150 IKLCDFGISRVVNDV----VEVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNK 215 (253)
Q Consensus 150 ~~l~df~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 215 (253)
++|+|||++...... .......+++.|+|||++.+. .++.++||||+||++|+|++|+.||.+...
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 999999999865432 222345678999999998774 589999999999999999999999976544
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=284.04 Aligned_cols=204 Identities=25% Similarity=0.401 Sum_probs=170.3
Q ss_pred CcceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhc----------CCCC
Q psy12709 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ----------KSER 72 (253)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~----------~~~~ 72 (253)
+..+..++|+ +.+.||+|+||+||+|.+..++..||+|++.... .....+.+|+..+.... .|+|
T Consensus 13 ~~~~~~~~y~--~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 13 GEPYKDARYI--LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp TCEETTTTEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCcccCCeEE--EEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc---cchhhhhHHHHHHHHhhcccccchhccccch
Confidence 3444556777 9999999999999999999999999999997533 23456677887777543 2789
Q ss_pred ceeeeeEEEeCC----eEEEEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEc
Q psy12709 73 IVGLHEIYETPH----EMVLVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDH-NITHLDLKPQNILLT 145 (253)
Q Consensus 73 i~~~~~~~~~~~----~~~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~di~~~ni~~~ 145 (253)
|+++++++...+ .++++||++ +++|.+++... ..+++..++.++.|++.|+.|||++ |++|+||+|+||+++
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~ 166 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEe
Confidence 999999998654 799999999 88999988763 4599999999999999999999998 999999999999995
Q ss_pred C------CCceEEEeecccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Q psy12709 146 K------DNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDN 214 (253)
Q Consensus 146 ~------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 214 (253)
. .+.++|+|||.+...... .....+++.|+|||++.+..++.++||||+|+++|+|++|+.||...+
T Consensus 167 ~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 167 IVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 4 347999999999765442 234468899999999999899999999999999999999999998654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=295.35 Aligned_cols=236 Identities=21% Similarity=0.341 Sum_probs=197.6
Q ss_pred eeEEEeecCCCCceEEEEEEeccC---CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKIT---KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
+|++.+.||+|+||+||+|.+..+ +..|++|...... .....+.+.+|+..+. ..+||||+++++++. ++..++
T Consensus 391 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMR-QFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEC-SSSCEE
T ss_pred cEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEe-cCceEE
Confidence 344999999999999999998643 4569999887543 3344567888999888 779999999999985 457899
Q ss_pred EEeccCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc-
Q psy12709 89 VLEMVPDGELQRLVDIQD-GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE- 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~- 166 (253)
||||+++++|.+++..+. .+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 547 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 547 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcce
Confidence 999999999999987653 689999999999999999999999999999999999999999999999999986644322
Q ss_pred -ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 167 -VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 167 -~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
.....+++.|+|||++.+..++.++||||+|+++|+|++ |..||.+....+....+....... ..+.+|+++.++
T Consensus 548 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~l 624 (656)
T 2j0j_A 548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNCPPTLYSL 624 (656)
T ss_dssp ------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---CCTTCCHHHHHH
T ss_pred eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---CCccccHHHHHH
Confidence 122345678999999988899999999999999999997 999999988888887776654332 234789999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||+.||
T Consensus 625 i~~~l~~dP 633 (656)
T 2j0j_A 625 MTKCWAYDP 633 (656)
T ss_dssp HHHHTCSSG
T ss_pred HHHHcCCCh
Confidence 999999998
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=278.97 Aligned_cols=241 Identities=21% Similarity=0.281 Sum_probs=189.1
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +.+.||+|+||+||+|.+. ++..||+|++....... ....+.+|+..+. ...|+||+++++++..++..+
T Consensus 29 ~~~y~--~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 29 SDNFS--NKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG-GELQFQTEVEMIS-MAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp TTSSC--STTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGG-TCCCTTBCCCCEEECCSSCCE
T ss_pred hhccc--cceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch-HHHHHHHHHHHHH-hccCCCccceEEEEecCCceE
Confidence 45677 9999999999999999854 68899999997654321 1235778888887 778999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQD----GIPEQDTRSYMKQILEALAFLHDH---NITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
+||||+++++|.+++.... .+++..+..++.|++.|+.|||++ |++|+||+|+||+++.++.++|+|||.+..
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 9999999999999987543 489999999999999999999999 999999999999999999999999999986
Q ss_pred cccc--ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC-----CChHHHHHHhhc---cc----
Q psy12709 161 VNDV--VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAG-----DNKQETFLNISQ---CN---- 226 (253)
Q Consensus 161 ~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-----~~~~~~~~~i~~---~~---- 226 (253)
.... .......+++.|+|||++.+..++.++||||+|+++|+|++|+.||.. .........+.. ..
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (326)
T 3uim_A 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA 263 (326)
T ss_dssp CCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred cCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence 5432 223344589999999999888899999999999999999999999952 111111111110 00
Q ss_pred ---ccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 227 ---FSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 227 ---~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
...........++++.+++.+||+.||
T Consensus 264 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 293 (326)
T 3uim_A 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSP 293 (326)
T ss_dssp SSCTTCTTSCCHHHHHHHHHHHHHHTCSCG
T ss_pred hcChhhccccCHHHHHHHHHHHHHHhCcCC
Confidence 000011112334779999999999998
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=273.68 Aligned_cols=236 Identities=18% Similarity=0.278 Sum_probs=181.6
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHH-hcCCCCceeeeeEEEeC---
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYL-AQKSERIVGLHEIYETP--- 83 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~-~~~~~~i~~~~~~~~~~--- 83 (253)
.++|+ +.+.||+|+||+||+|.+. +..||+|++..... ....+|...+.. ..+|+||+++++++...
T Consensus 36 ~~~y~--~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 36 AKQIQ--MVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE-----ASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHCE--EEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccceE--EEeEeecCCCeEEEEEEEC--CceEEEEEEecccc-----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 45666 9999999999999999875 88999999864322 233334444432 35899999999999887
Q ss_pred -CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCCEEEcCCCceEEEe
Q psy12709 84 -HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDH--------NITHLDLKPQNILLTKDNNIKLCD 154 (253)
Q Consensus 84 -~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--------~~~h~di~~~ni~~~~~~~~~l~d 154 (253)
..+++||||+++++|.+++... .+++..++.++.|++.|+.|||++ |++|+||+|+||+++.++.++|+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 7899999999999999999754 589999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccc-----ccccccCccccCccccCCCCCCcc------ccHHHHHHHHHHHHhC----------CCCCCCC
Q psy12709 155 FGISRVVNDVVE-----VKEIIGTPDYVAPEVLSYEPISLA------TDMWSVGVLAYVLLSS----------HSPFAGD 213 (253)
Q Consensus 155 f~~~~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~------~Di~slG~~l~~l~~g----------~~p~~~~ 213 (253)
||.+........ .....+++.|+|||++.+...... +||||+|+++|+|++| +.||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 999975543221 123468899999999987766554 9999999999999999 7777543
Q ss_pred Ch-----HHHHHHhhcccc--cccCC-ccCCCCHHHHHHHHHhcccCC
Q psy12709 214 NK-----QETFLNISQCNF--SFHED-LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 214 ~~-----~~~~~~i~~~~~--~~~~~-~~~~~~~~l~~li~~~l~~dP 253 (253)
.. ......+..... ..+.. ....+++++.++|.+||+.||
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 313 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNP 313 (337)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSG
T ss_pred cCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhCh
Confidence 21 122222211111 11111 112467789999999999998
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=271.93 Aligned_cols=235 Identities=21% Similarity=0.291 Sum_probs=188.8
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccc--cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEec
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR--RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
..+.||+|+||+||+|.+ ++..|++|++.... ........+.+|+..+. ..+|+||+++++++..++..+++||+
T Consensus 35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~ 111 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMA-KCQHENLVELLGFSSDGDDLCLVYVY 111 (307)
T ss_dssp TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHH-HCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHH-hcCCCCeEEEEEEEecCCceEEEEEe
Confidence 558899999999999986 57889999987643 23344667889999988 77999999999999999999999999
Q ss_pred cCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc---c
Q psy12709 93 VPDGELQRLVDI---QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV---E 166 (253)
Q Consensus 93 ~~g~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~---~ 166 (253)
+++++|.+++.. ..++++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 191 (307)
T 2nru_A 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191 (307)
T ss_dssp CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEE
T ss_pred cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccccc
Confidence 999999998864 3468999999999999999999999999999999999999999999999999987654321 2
Q ss_pred ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH----hhcccccc-------cCCccC
Q psy12709 167 VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLN----ISQCNFSF-------HEDLFG 235 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----i~~~~~~~-------~~~~~~ 235 (253)
.....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||........... +....... ......
T Consensus 192 ~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (307)
T 2nru_A 192 TSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADS 270 (307)
T ss_dssp CSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCH
T ss_pred ccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccch
Confidence 233467899999999875 478899999999999999999999977544322211 11111100 011112
Q ss_pred CCCHHHHHHHHHhcccCC
Q psy12709 236 HISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 236 ~~~~~l~~li~~~l~~dP 253 (253)
..++.+.+++.+||+.||
T Consensus 271 ~~~~~l~~li~~cl~~~p 288 (307)
T 2nru_A 271 TSVEAMYSVASQCLHEKK 288 (307)
T ss_dssp HHHHHHHHHHHHHTCSST
T ss_pred HHHHHHHHHHHHHcCCCc
Confidence 346779999999999998
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=273.86 Aligned_cols=236 Identities=19% Similarity=0.257 Sum_probs=188.0
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHh-cCCCCceeeeeEEEeCC--
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLA-QKSERIVGLHEIYETPH-- 84 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~~~-- 84 (253)
.++|+ +.+.||+|+||+||+|.+ +++.||+|++.... ...+.+|...+... .+|+||+++++++..++
T Consensus 41 ~~~y~--~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 41 ARTIV--LQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHCE--EEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred cccEE--EEeeecCCCCcEEEEEEE--cCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 45666 999999999999999988 48899999986432 24566777777643 79999999999998876
Q ss_pred --eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCCEEEcCCCceEEEe
Q psy12709 85 --EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLH--------DHNITHLDLKPQNILLTKDNNIKLCD 154 (253)
Q Consensus 85 --~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--------~~~~~h~di~~~ni~~~~~~~~~l~d 154 (253)
.+++||||+++++|.+++.. ..+++..++.++.|++.++.+|| +.|++|+||+|+||+++.++.++|+|
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred cceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 89999999999999999975 45899999999999999999999 89999999999999999999999999
Q ss_pred ecccccccccc-----cccccccCccccCccccCCCC------CCccccHHHHHHHHHHHHhC----------CCCCCCC
Q psy12709 155 FGISRVVNDVV-----EVKEIIGTPDYVAPEVLSYEP------ISLATDMWSVGVLAYVLLSS----------HSPFAGD 213 (253)
Q Consensus 155 f~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~------~~~~~Di~slG~~l~~l~~g----------~~p~~~~ 213 (253)
||.+....... ......+++.|+|||++.+.. ++.++||||+|+++|+|++| +.||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 99997654432 223446889999999987652 33689999999999999999 7898664
Q ss_pred C-----hHHHHHHhhcccccccCC---ccCCCCHHHHHHHHHhcccCC
Q psy12709 214 N-----KQETFLNISQCNFSFHED---LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 214 ~-----~~~~~~~i~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP 253 (253)
. .......+......+... .....++.+.++|.+||+.||
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 318 (342)
T 1b6c_B 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 318 (342)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSG
T ss_pred CcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccCh
Confidence 2 233333333322222111 012345679999999999998
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=295.56 Aligned_cols=241 Identities=24% Similarity=0.384 Sum_probs=198.2
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe------
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET------ 82 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~------ 82 (253)
++|+ +.+.||+|+||+||+|.+..++..||+|++.... .......+.+|+..+. ..+||||+++++++..
T Consensus 14 grY~--i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~-~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 14 GPWE--MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMK-KLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ---C--CCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHH-HCCBTTBCCEEECCTTTCCCCT
T ss_pred CCeE--EEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHH-hCCCCCCCceeeeecccccccC
Confidence 6777 9999999999999999999999999999987643 3455677889999998 6799999999999765
Q ss_pred CCeEEEEEeccCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc---eEEEeec
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQD---GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN---IKLCDFG 156 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~---~~l~df~ 156 (253)
++..++||||++|++|.+++.... .+++..++.++.+++.|+.|||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 678899999999999999997643 5899999999999999999999999999999999999998765 9999999
Q ss_pred ccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH--------------h
Q psy12709 157 ISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLN--------------I 222 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--------------i 222 (253)
.+.............+++.|+|||.+.+..++.++||||+|+++|+|++|..||.+......+.. .
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence 99877655555556789999999999999999999999999999999999999976433221100 0
Q ss_pred hcc------cccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 223 SQC------NFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 223 ~~~------~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+ ..+.+......+++.+.++|.+||+.||
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP 286 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQ 286 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSC
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccCCH
Confidence 001 1111222334577899999999999998
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=266.01 Aligned_cols=217 Identities=28% Similarity=0.467 Sum_probs=176.9
Q ss_pred eecceeeEEE-eecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe---
Q psy12709 7 VNGGYQTLIF-CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET--- 82 (253)
Q Consensus 7 ~~~~~~~~~~-~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--- 82 (253)
+.++|. +. +.||+|+||.||+|.+..+++.||+|++... ....+|+..+.+...|+||+++++++..
T Consensus 15 ~~~~y~--~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 15 IIDDYK--VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp GGGTEE--EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccchh--hcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 445666 66 7899999999999999999999999998642 2556788888778899999999999987
Q ss_pred -CCeEEEEEeccCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC---CCceEEEeec
Q psy12709 83 -PHEMVLVLEMVPDGELQRLVDIQD--GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK---DNNIKLCDFG 156 (253)
Q Consensus 83 -~~~~~lv~e~~~g~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~---~~~~~l~df~ 156 (253)
+..+++||||++|++|.+++.... .+++..++.++.|++.|+.|||++|++|+||+|+||+++. ++.++|+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 678999999999999999998754 5999999999999999999999999999999999999998 7889999999
Q ss_pred ccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH----hhcccccccCC
Q psy12709 157 ISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLN----ISQCNFSFHED 232 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----i~~~~~~~~~~ 232 (253)
++.... +..++.++||||+|+++|+|++|+.||.+......... +.......+..
T Consensus 166 ~a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (299)
T 3m2w_A 166 FAKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224 (299)
T ss_dssp TCEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHH
T ss_pred cccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCch
Confidence 885432 13467789999999999999999999977655443322 22222222222
Q ss_pred ccCCCCHHHHHHHHHhcccCC
Q psy12709 233 LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 ~~~~~~~~l~~li~~~l~~dP 253 (253)
....+|+++.++|.+||+.||
T Consensus 225 ~~~~~~~~~~~li~~~l~~dP 245 (299)
T 3m2w_A 225 EWSEVSEEVKMLIRNLLKTEP 245 (299)
T ss_dssp HHTTSCHHHHHHHHHHTCSST
T ss_pred hcccCCHHHHHHHHHHcccCh
Confidence 235789999999999999998
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=276.81 Aligned_cols=194 Identities=23% Similarity=0.376 Sum_probs=156.0
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHH-HhcCCCCceeeeeEEEe---
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLY-LAQKSERIVGLHEIYET--- 82 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~-~~~~~~~i~~~~~~~~~--- 82 (253)
..++|+ +.+.||+|+||+||+|.+ ++..||+|++..... .....|..... ...+|+||+++++.+..
T Consensus 11 ~~~~y~--~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 11 DLDNLK--LLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp CTTSEE--EEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred ChHHhh--eeeecccCCCeEEEEEEE--CCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence 345666 999999999999999976 688999999875432 12222333222 25799999999975542
Q ss_pred --CCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCCEEEcCCCceE
Q psy12709 83 --PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDH---------NITHLDLKPQNILLTKDNNIK 151 (253)
Q Consensus 83 --~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---------~~~h~di~~~ni~~~~~~~~~ 151 (253)
...+++||||+++++|.+++.... .+...+..++.|++.|+.|||+. |++|+||+|+||+++.++.++
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred CCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 236789999999999999997554 58999999999999999999999 999999999999999999999
Q ss_pred EEeeccccccccc---------ccccccccCccccCccccCC-------CCCCccccHHHHHHHHHHHHhCCCCC
Q psy12709 152 LCDFGISRVVNDV---------VEVKEIIGTPDYVAPEVLSY-------EPISLATDMWSVGVLAYVLLSSHSPF 210 (253)
Q Consensus 152 l~df~~~~~~~~~---------~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~ 210 (253)
|+|||++...... .......+++.|+|||++.+ ..++.++||||+|+++|+|++|..||
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 9999999765432 11223468899999999976 34567899999999999999997665
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=277.97 Aligned_cols=235 Identities=26% Similarity=0.315 Sum_probs=179.3
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.+.|. +.+.||+|+||+||.+ ...+++.||+|.+.... .....+|+..+....+||||+++++++..++.++
T Consensus 14 ~~~~~--~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 85 (434)
T 2rio_A 14 KNLVV--SEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY 85 (434)
T ss_dssp SSCEE--EEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred hheee--ccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence 34444 7889999999999875 44579999999986532 2356789999987779999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCC-------CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-------------
Q psy12709 88 LVLEMVPDGELQRLVDIQDGI-------PEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD------------- 147 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~-------~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~------------- 147 (253)
+|||+++ ++|.+++...... ++..++.++.|++.|+.|||++|++|+||+|+||+++.+
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence 9999996 5999999765432 233457899999999999999999999999999999764
Q ss_pred CceEEEeeccccccccccc-----ccccccCccccCccccCC-------CCCCccccHHHHHHHHHHHHh-CCCCCCCCC
Q psy12709 148 NNIKLCDFGISRVVNDVVE-----VKEIIGTPDYVAPEVLSY-------EPISLATDMWSVGVLAYVLLS-SHSPFAGDN 214 (253)
Q Consensus 148 ~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~ 214 (253)
+.++|+|||++........ .....+++.|+|||++.+ ..++.++||||+||++|+|++ |..||....
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 4799999999986654321 223568999999999865 568899999999999999999 999997655
Q ss_pred hHHHHHHhhcccccccCC---ccCCCCHHHHHHHHHhcccCC
Q psy12709 215 KQETFLNISQCNFSFHED---LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 215 ~~~~~~~i~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP 253 (253)
.... .+.......+.. ....+++++.++|.+||+.||
T Consensus 245 ~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 284 (434)
T 2rio_A 245 SRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDP 284 (434)
T ss_dssp THHH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSG
T ss_pred hhHH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCCh
Confidence 4432 233332222211 112346889999999999998
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=277.96 Aligned_cols=243 Identities=21% Similarity=0.301 Sum_probs=184.5
Q ss_pred CcceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
.+.+..++.+|.+.+.||+|+||+|+. ....+++.||||.+...... ...+|+..+....+||||+++++++..
T Consensus 16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~ 89 (432)
T 3p23_A 16 TSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKD 89 (432)
T ss_dssp --CEEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEE
T ss_pred CCcEEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEec
Confidence 345677787888999999999999764 34457899999998754332 245788888866699999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-----CceEEEeec
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQD-GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD-----NNIKLCDFG 156 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~-----~~~~l~df~ 156 (253)
++..++|||++. ++|.+++.... ......++.++.|++.|+.|||++|++|+||+|+||+++.+ ..++|+|||
T Consensus 90 ~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG 168 (432)
T 3p23_A 90 RQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFG 168 (432)
T ss_dssp TTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred CCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence 999999999996 49998887643 45666778999999999999999999999999999999542 357899999
Q ss_pred cccccccc----ccccccccCccccCccccC---CCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhccccc
Q psy12709 157 ISRVVNDV----VEVKEIIGTPDYVAPEVLS---YEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFS 228 (253)
Q Consensus 157 ~~~~~~~~----~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~ 228 (253)
++...... .......+++.|+|||++. ...++.++||||+||++|+|++ |..||...........+......
T Consensus 169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~ 248 (432)
T 3p23_A 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLD 248 (432)
T ss_dssp EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCT
T ss_pred ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcc
Confidence 99865432 1223456899999999997 4567889999999999999999 99999765554443333222222
Q ss_pred ccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 229 FHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
... .....+..+++||.+||+.||
T Consensus 249 ~~~-~~~~~~~~~~~li~~~L~~dP 272 (432)
T 3p23_A 249 CLH-PEKHEDVIARELIEKMIAMDP 272 (432)
T ss_dssp TSC-TTCHHHHHHHHHHHHHSCSSG
T ss_pred ccC-ccccccHHHHHHHHHHHhCCH
Confidence 111 112345668999999999998
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=291.69 Aligned_cols=227 Identities=23% Similarity=0.343 Sum_probs=184.8
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEecc-CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKI-TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
.+.++|+ +.+.||+|+||+||+|.+.. +++.|++|++.... .......+.+|+..+. ..+|+||+++++++...+
T Consensus 77 ~~~~~y~--i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 77 IVAGQYE--VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLA-EVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp EETTTEE--EEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGG-GCCCTTBCCEEEEEEEEC
T ss_pred EeCCceE--EEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHH-hcCCCCcCeEeeeEeecC
Confidence 3457777 99999999999999999986 78999999987533 3344567788888887 778999999999998766
Q ss_pred e-----EEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 85 E-----MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 85 ~-----~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
. .++||||++|++|.+++.. .+++..++.++.|++.++.|||++|++|+||+|+||+++.+ .++|+|||++.
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 5 7999999999999988754 69999999999999999999999999999999999999975 99999999998
Q ss_pred cccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCH
Q psy12709 160 VVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
..... ....+++.|+|||++.+.. +.++||||+|+++|+|++|..||.+..... . +........++
T Consensus 230 ~~~~~---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------~-~~~~~~~~~~~ 295 (681)
T 2pzi_A 230 RINSF---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------L-PEDDPVLKTYD 295 (681)
T ss_dssp ETTCC---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------C-CTTCHHHHHCH
T ss_pred hcccC---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------c-cccccccccCH
Confidence 65443 3456899999999987654 889999999999999999999986522110 0 01111123468
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
.+.++|.+||++||
T Consensus 296 ~l~~li~~~l~~dP 309 (681)
T 2pzi_A 296 SYGRLLRRAIDPDP 309 (681)
T ss_dssp HHHHHHHHHTCSSG
T ss_pred HHHHHHhhhccCCh
Confidence 89999999999998
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=270.97 Aligned_cols=235 Identities=16% Similarity=0.172 Sum_probs=181.0
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc------chHHHHHHHHHHHHHHHhc--------CCCCc
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR------SMDQMQDILHEAAVLYLAQ--------KSERI 73 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~~~e~~~~~~~~--------~~~~i 73 (253)
.++|+ +.+.||+|+||+||+|.+ ++..||+|++..... .......+.+|+..++.+. .|+||
T Consensus 19 ~~~y~--~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 19 TEKLQ--RCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp HHHHH--TCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccch--heeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 46677 999999999999999998 679999999987542 2223467888888887655 47777
Q ss_pred eeeeeEEE-----------------e-------------CCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHH
Q psy12709 74 VGLHEIYE-----------------T-------------PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEA 123 (253)
Q Consensus 74 ~~~~~~~~-----------------~-------------~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~ 123 (253)
+++.+++. . ++.+++||||++++++.+.+. ...+++..++.++.|++.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-TTCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-hcCCCHHHHHHHHHHHHHH
Confidence 76666542 2 678999999999986655554 3568999999999999999
Q ss_pred HHHHH-HCCceecCCCCCCEEEcCCC--------------------ceEEEeecccccccccccccccccCccccCcccc
Q psy12709 124 LAFLH-DHNITHLDLKPQNILLTKDN--------------------NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVL 182 (253)
Q Consensus 124 l~~lh-~~~~~h~di~~~ni~~~~~~--------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~ 182 (253)
+.||| ++|++||||||+||+++.++ .+||+|||+++..... ...+++.|+|||++
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGG
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhh
Confidence 99999 99999999999999999987 8999999999866442 34689999999999
Q ss_pred CCCCCCccccHHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHhh---cccccccCCccCCCCHHHHHHHHHhcccC
Q psy12709 183 SYEPISLATDMWSVGVL-AYVLLSSHSPFAGDNK-QETFLNIS---QCNFSFHEDLFGHISSQAKDFIQSCLVTD 252 (253)
Q Consensus 183 ~~~~~~~~~Di~slG~~-l~~l~~g~~p~~~~~~-~~~~~~i~---~~~~~~~~~~~~~~~~~l~~li~~~l~~d 252 (253)
.+.. +.++||||++++ .+++++|..||.+... ......+. .............+|+++++||.+||+.|
T Consensus 250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 323 (336)
T 2vuw_A 250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS 323 (336)
T ss_dssp CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred cCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence 8776 889999998777 6778889999854211 11111222 11112222223467899999999999976
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=274.16 Aligned_cols=230 Identities=14% Similarity=0.169 Sum_probs=175.0
Q ss_pred eeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCC-CCc---------ee----
Q psy12709 11 YQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKS-ERI---------VG---- 75 (253)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~-~~i---------~~---- 75 (253)
.++...+.||+|+||+||+|.+..+++.||||++.... ......+.+.+|+..+. .+.| ++. +.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~-~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR-LLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGG-GSTTCCSHHHHHHHTCBCCCCEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHH-hhccCCCHHHHHHhcccccchhh
Confidence 44668999999999999999999999999999988433 22233567778888777 4444 221 11
Q ss_pred --------eeeEEEe-----CCeEEEEEeccCCCcHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy12709 76 --------LHEIYET-----PHEMVLVLEMVPDGELQRLVDI-------QDGIPEQDTRSYMKQILEALAFLHDHNITHL 135 (253)
Q Consensus 76 --------~~~~~~~-----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~ 135 (253)
+...+.. ...++++|+.+ +++|.++++. ...+++..++.++.|++.|+.|||++|++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1111111 12467888866 6799888841 2337788899999999999999999999999
Q ss_pred CCCCCCEEEcCCCceEEEeecccccccccccccccccCccccCcccc----------CCCCCCccccHHHHHHHHHHHHh
Q psy12709 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVL----------SYEPISLATDMWSVGVLAYVLLS 205 (253)
Q Consensus 136 di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~----------~~~~~~~~~Di~slG~~l~~l~~ 205 (253)
||||+||+++.++.+||+|||++...... .....+ +.|+|||++ .+..++.++||||+|+++|+|++
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 99999999999999999999998765543 334456 999999998 55568889999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 206 SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 206 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
|+.||...+..+....+.. ....+|+++.+||.+||+.||
T Consensus 313 g~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dP 352 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPK 352 (413)
T ss_dssp SSCCCCTTGGGSCSGGGGS--------SCCCCCHHHHHHHHHHTCSSG
T ss_pred CCCCCCCcchhhhHHHHHh--------hcccCCHHHHHHHHHHccCCh
Confidence 9999987665443333211 123789999999999999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=243.57 Aligned_cols=189 Identities=17% Similarity=0.168 Sum_probs=138.1
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccc--------cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR--------RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
.......|+.|.+..+.....|..|++|++.+.. ......+.+.+|+..+++...|+||+++++++++++.+
T Consensus 238 w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~ 317 (569)
T 4azs_A 238 WQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG 317 (569)
T ss_dssp EECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred hhhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence 3356778888888888887889999999997642 22344567999999999888999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-c
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-V 165 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~ 165 (253)
|+||||++|++|.+++...++++.. +++.|++.||.|+|++||+||||||+||+++.+|.+||+|||+++..... .
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 9999999999999999988888765 47899999999999999999999999999999999999999999865432 3
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCC
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSH 207 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~ 207 (253)
.....++++.|+|||++.+. +..++|+|++|++++.+.++.
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp CSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred cccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 34456789999999999764 566899999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=209.35 Aligned_cols=183 Identities=15% Similarity=0.154 Sum_probs=141.7
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccc------hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS------MDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
..+.||+|+||+||+|. ..+..+++|........ ....+.+.+|+..+. ..+|+||+.+..+...++..++
T Consensus 340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~-~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLA-LVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHH-HGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHH-hcCCCCcCceEEEEEeCCccEE
Confidence 35689999999999994 35778888876543221 112455789999998 6699999966666667778899
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccccc--
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE-- 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~-- 166 (253)
||||++|++|.+++.. +..++.|++.++.|||++|++|+||||+||+++. .++|+|||+++.......
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999999874 5689999999999999999999999999999998 999999999987654322
Q ss_pred ------ccccccCccccCccccCC--CCCCccccHHHHHHHHHHHHhCCCCC
Q psy12709 167 ------VKEIIGTPDYVAPEVLSY--EPISLATDMWSVGVLAYVLLSSHSPF 210 (253)
Q Consensus 167 ------~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~ 210 (253)
.....+++.|+|||++.. ..|+...|+|+..+-..+-..++-+|
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 134578999999999976 56777889999888777777766665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=177.29 Aligned_cols=134 Identities=24% Similarity=0.297 Sum_probs=107.7
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch----------------HHHHHHHHHHHHHHHhcCCCCceee
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM----------------DQMQDILHEAAVLYLAQKSERIVGL 76 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----------------~~~~~~~~e~~~~~~~~~~~~i~~~ 76 (253)
|.+.+.||+|+||.||+|.+ .++..||+|+++...... .....+.+|+..+.... | +++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~---~-~~v 166 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ---G-LAV 166 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT---T-SSS
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc---C-CCc
Confidence 33779999999999999999 789999999997543211 23567889999998555 3 555
Q ss_pred eeEEEeCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeec
Q psy12709 77 HEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFG 156 (253)
Q Consensus 77 ~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~ 156 (253)
.+++.. +..++||||++|++|.+ +.. .....++.|++.++.+||+.|++|+||+|+||+++ ++.++|+|||
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 555544 45699999999999988 421 23557999999999999999999999999999999 9999999999
Q ss_pred cccc
Q psy12709 157 ISRV 160 (253)
Q Consensus 157 ~~~~ 160 (253)
.+..
T Consensus 238 ~a~~ 241 (282)
T 1zar_A 238 QSVE 241 (282)
T ss_dssp TCEE
T ss_pred CCeE
Confidence 9864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=153.57 Aligned_cols=144 Identities=21% Similarity=0.210 Sum_probs=108.1
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCce--EEEEEecccccch----------------------HHHHHHHHHHHH
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVE--YAAKFIRKRRRSM----------------------DQMQDILHEAAV 63 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~--v~iK~~~~~~~~~----------------------~~~~~~~~e~~~ 63 (253)
..++-|++.+.||+|+||+||+|.+..+|.. ||+|+++...... .....+.+|+..
T Consensus 44 ~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 123 (258)
T 1zth_A 44 AKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRN 123 (258)
T ss_dssp HTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHH
T ss_pred hCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHH
Confidence 3455566999999999999999999778988 9999876532111 112367788888
Q ss_pred HHHhcCCCC--ceeeeeEEEeCCeEEEEEeccCC-C----cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceec
Q psy12709 64 LYLAQKSER--IVGLHEIYETPHEMVLVLEMVPD-G----ELQRLVDIQDGIPEQDTRSYMKQILEALAFLH-DHNITHL 135 (253)
Q Consensus 64 ~~~~~~~~~--i~~~~~~~~~~~~~~lv~e~~~g-~----~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~~~h~ 135 (253)
+. .+.|++ ++.++.. +..++||||+.+ + +|.+.... .++..+..++.|++.++.+|| +.|++|+
T Consensus 124 l~-~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHr 195 (258)
T 1zth_A 124 LE-RAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHA 195 (258)
T ss_dssp HH-HHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred HH-HHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 87 444444 3344432 356899999942 2 67665432 235567889999999999999 9999999
Q ss_pred CCCCCCEEEcCCCceEEEeecccccc
Q psy12709 136 DLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 136 di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
||+|.||+++. .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.7e-18 Score=141.70 Aligned_cols=138 Identities=15% Similarity=0.120 Sum_probs=98.9
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc------------------hHH--HHHHHHHHHHHHHhcCCCC
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS------------------MDQ--MQDILHEAAVLYLAQKSER 72 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~------------------~~~--~~~~~~e~~~~~~~~~~~~ 72 (253)
|.+.+.||+|++|.||+|.+. +|+.||||+++..... +.. ......|...+.++ .+.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YEEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HHTT
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-HhcC
Confidence 559999999999999999985 6899999987543211 000 01123455555533 2233
Q ss_pred c--eeeeeEEEeCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC--
Q psy12709 73 I--VGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN-- 148 (253)
Q Consensus 73 i--~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~-- 148 (253)
+ ..+++.. ..++||||++|.+|..+.. ......++.|++.++.+||+.|++|+||||.||+++++|
T Consensus 175 v~vp~p~~~~----~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPEPIAQS----RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCCEEEEE----TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCeeeecc----CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 2 2333221 2379999999988876543 123467889999999999999999999999999999877
Q ss_pred --------ceEEEeeccccccc
Q psy12709 149 --------NIKLCDFGISRVVN 162 (253)
Q Consensus 149 --------~~~l~df~~~~~~~ 162 (253)
.+.|+||+.+....
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEETT
T ss_pred ccccccccceEEEEeCCcccCC
Confidence 38999999887544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=2e-13 Score=107.10 Aligned_cols=140 Identities=15% Similarity=0.116 Sum_probs=109.9
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +...++.|+.+.||++... +..+++|..+...... ...+.+|+..+..+..+..+++++++....+..++
T Consensus 14 ~~~~--~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 14 EKYR--CVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp TTSE--EEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred ccce--eEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 4566 8889999999999999754 6789999987532111 23577888888866567778899999998889999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD--------------------------------------- 129 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--------------------------------------- 129 (253)
|||+++|.++.+... +......++.++..++..||+
T Consensus 88 v~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999999987632 122334677889999999998
Q ss_pred --------------------CCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 130 --------------------HNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 130 --------------------~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
..++|+|+++.||+++.++.+.++||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 348899999999999876566799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.33 E-value=1.8e-11 Score=95.58 Aligned_cols=131 Identities=17% Similarity=0.108 Sum_probs=94.2
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCC-ceeeeeEEEeCCeEEEEEecc
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER-IVGLHEIYETPHEMVLVLEMV 93 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~-i~~~~~~~~~~~~~~lv~e~~ 93 (253)
+....+.|..+.||++.. .+|..+++|...... ...+.+|...++.+..+.- +++++.+...++..+++||++
T Consensus 24 ~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 24 WAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp EEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred eEecccCCCCceEEEEec-CCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 433444666799999964 467789999976531 1356677877775555532 667888888888899999999
Q ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------------------
Q psy12709 94 PDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHN------------------------------------------ 131 (253)
Q Consensus 94 ~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~------------------------------------------ 131 (253)
+|.++. .. ..+. ..++.++...+..||+..
T Consensus 98 ~G~~l~--~~---~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
T 1nd4_A 98 PGQDLL--SS---HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 169 (264)
T ss_dssp SSEETT--TS---CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred CCcccC--cC---cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence 998884 21 1122 245566677777777643
Q ss_pred ----------------ceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 132 ----------------ITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 132 ----------------~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
++|+|++|.||+++.++.+.++||+.+.
T Consensus 170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 8999999999999877667799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.25 E-value=7.7e-11 Score=96.57 Aligned_cols=141 Identities=14% Similarity=0.193 Sum_probs=104.7
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEec--ccccchHHHHHHHHHHHHHHHhcCC-CCceeeeeEEEeC---CeEEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIR--KRRRSMDQMQDILHEAAVLYLAQKS-ERIVGLHEIYETP---HEMVL 88 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~--~~~~~~~~~~~~~~e~~~~~~~~~~-~~i~~~~~~~~~~---~~~~l 88 (253)
-++.++.|.++.||++... +..+++|+.+ .... ......+.+|...+..+... ..+++++.+.... +..++
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 5678999999999999864 4678999876 3221 12234677888888755542 3478888888766 45899
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD--------------------------------------- 129 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--------------------------------------- 129 (253)
|||+++|..+.+.. ...++......++.++...+..||+
T Consensus 119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99999998875421 2346788888999999999999997
Q ss_pred -------------------CCceecCCCCCCEEEcCCCc--eEEEeeccccc
Q psy12709 130 -------------------HNITHLDLKPQNILLTKDNN--IKLCDFGISRV 160 (253)
Q Consensus 130 -------------------~~~~h~di~~~ni~~~~~~~--~~l~df~~~~~ 160 (253)
..++|+|+++.||+++.++. +.++||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999998754 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.10 E-value=1.5e-10 Score=92.61 Aligned_cols=184 Identities=14% Similarity=0.184 Sum_probs=120.0
Q ss_pred EeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCC--ceeeeeEEEeCC---eEEEEE
Q psy12709 16 FCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER--IVGLHEIYETPH---EMVLVL 90 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~--i~~~~~~~~~~~---~~~lv~ 90 (253)
++.++.|....||.+. ..+++|+.... .....+.+|...+..+..+.. +.+++.....++ ..|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 4568899999999874 56899986543 345678889888875545444 345554443333 458899
Q ss_pred eccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q psy12709 91 EMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD----------------------------------------- 129 (253)
Q Consensus 91 e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~----------------------------------------- 129 (253)
++++|.++.+... ..++..+...++.++...+..||+
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999998865332 236777777888888888888885
Q ss_pred -----------------CCceecCCCCCCEEEcC--CCceEEEeecccccccccccccccccCccccCccccCC-----C
Q psy12709 130 -----------------HNITHLDLKPQNILLTK--DNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSY-----E 185 (253)
Q Consensus 130 -----------------~~~~h~di~~~ni~~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~ 185 (253)
..++|+|+++.||+++. .+.+.++||+.+.................-.+|+.... .
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 13699999999999998 45688999998764322111000000000012221100 0
Q ss_pred C---------CCccccHHHHHHHHHHHHhCCCCC
Q psy12709 186 P---------ISLATDMWSVGVLAYVLLSSHSPF 210 (253)
Q Consensus 186 ~---------~~~~~Di~slG~~l~~l~~g~~p~ 210 (253)
. .....+.|+++.++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 111268999999999999998776
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.88 E-value=1.2e-07 Score=74.35 Aligned_cols=132 Identities=17% Similarity=0.179 Sum_probs=94.3
Q ss_pred cCCCCc-eEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCCc
Q psy12709 19 PSRGKF-ASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGE 97 (253)
Q Consensus 19 lg~g~~-~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 97 (253)
+..|.. +.||+.....++..+++|..+.. ....+.+|...+..+...=-+.+++.+...++..++||++++|.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 334444 47899888877888999986542 344677788888756554447888999999999999999999998
Q ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------------
Q psy12709 98 LQRLVDIQDGIPEQDTRSYMKQILEALAFLHDH----------------------------------------------- 130 (253)
Q Consensus 98 L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----------------------------------------------- 130 (253)
+.+..... ......+..++...+..||+.
T Consensus 107 ~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 107 AFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred ccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 87765422 122233444555555555520
Q ss_pred -----------CceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 131 -----------NITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 131 -----------~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
.++|+|+++.||+++.++.+-|+||+.+.
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 26899999999999987777899998774
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=4.1e-07 Score=72.71 Aligned_cols=134 Identities=16% Similarity=0.123 Sum_probs=90.5
Q ss_pred EeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCC--CceeeeeEEE-eCCeEEEEEec
Q psy12709 16 FCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSE--RIVGLHEIYE-TPHEMVLVLEM 92 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~--~i~~~~~~~~-~~~~~~lv~e~ 92 (253)
++.++.|....||.. +..+++|+... ......+.+|...+..+..+- .+.+++.+.. ..+..+++|++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 456788888999998 46789998532 233567888999888655542 2566666664 34567899999
Q ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q psy12709 93 VPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD------------------------------------------- 129 (253)
Q Consensus 93 ~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~------------------------------------------- 129 (253)
++|.++.+..- ..++......++.++...+..||+
T Consensus 95 i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 95 VQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred cCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 99988865311 113344444444444444444443
Q ss_pred -----------------CCceecCCCCCCEEEcC---CCc-eEEEeeccccc
Q psy12709 130 -----------------HNITHLDLKPQNILLTK---DNN-IKLCDFGISRV 160 (253)
Q Consensus 130 -----------------~~~~h~di~~~ni~~~~---~~~-~~l~df~~~~~ 160 (253)
..++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 23589999999999998 455 48999997764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=3.3e-06 Score=69.90 Aligned_cols=80 Identities=11% Similarity=-0.038 Sum_probs=49.0
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEeccccc----c-hHHHHHHHHHHHHHHHhcCC-C-CceeeeeEEEeCCeEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR----S-MDQMQDILHEAAVLYLAQKS-E-RIVGLHEIYETPHEMV 87 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~-~~~~~~~~~e~~~~~~~~~~-~-~i~~~~~~~~~~~~~~ 87 (253)
-.+.+|.|..+.||++....++..+++|....... . .........|...+...... + .+++++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 46789999999999998766678899998653211 0 01123455677777654442 3 34455544 344568
Q ss_pred EEEeccCCC
Q psy12709 88 LVLEMVPDG 96 (253)
Q Consensus 88 lv~e~~~g~ 96 (253)
+|||+++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=1.7e-06 Score=70.49 Aligned_cols=85 Identities=12% Similarity=0.015 Sum_probs=54.7
Q ss_pred EEeec-CCCCceEEEEEEec--c----CCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCC--CCceeeeeEEEeC-
Q psy12709 15 IFCMP-SRGKFASVRKCTHK--I----TKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKS--ERIVGLHEIYETP- 83 (253)
Q Consensus 15 ~~~~l-g~g~~~~v~~~~~~--~----~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~--~~i~~~~~~~~~~- 83 (253)
..+.| +.|....+|++... . ++..+++|..+.... .......+.+|...+..+..+ -.+.+++.+...+
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 56788 89999999998753 1 256799998765320 000012455666666644443 2467777776655
Q ss_pred --CeEEEEEeccCCCcHH
Q psy12709 84 --HEMVLVLEMVPDGELQ 99 (253)
Q Consensus 84 --~~~~lv~e~~~g~~L~ 99 (253)
+..+++||+++|.++.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 3578999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.31 E-value=2.9e-05 Score=62.65 Aligned_cols=31 Identities=26% Similarity=0.362 Sum_probs=27.8
Q ss_pred CCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 130 HNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 130 ~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
..++|+|+++.||+++.++.+.++||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888999999998753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.22 E-value=2.1e-05 Score=65.61 Aligned_cols=77 Identities=6% Similarity=-0.056 Sum_probs=47.9
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccc----cc---hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR----RS---MDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
-++.+|.|..+.||++.. ++..+++|...... .. ......++.|+..+........+++++.+. .+..+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 467899999999999964 46789999432110 00 001223444554444333334567777665 46789
Q ss_pred EEEecc-CC
Q psy12709 88 LVLEMV-PD 95 (253)
Q Consensus 88 lv~e~~-~g 95 (253)
+|||++ +|
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 77
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.17 E-value=3.9e-05 Score=61.24 Aligned_cols=77 Identities=14% Similarity=0.015 Sum_probs=59.0
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCC--CCceeeeeEEEeCCeEEEEEec
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKS--ERIVGLHEIYETPHEMVLVLEM 92 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~--~~i~~~~~~~~~~~~~~lv~e~ 92 (253)
-.+.++.|....+|+... ++..+++|..... ....+..|...+..+... ..+++++.+...++..+++||+
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 567899999999999975 4678999987643 134567777777655443 5578888888888899999999
Q ss_pred cCCCcH
Q psy12709 93 VPDGEL 98 (253)
Q Consensus 93 ~~g~~L 98 (253)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.10 E-value=4.6e-05 Score=56.88 Aligned_cols=123 Identities=17% Similarity=0.148 Sum_probs=82.2
Q ss_pred CCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCceEEEeeccccccccccccccccc
Q psy12709 95 DGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIG 172 (253)
Q Consensus 95 g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 172 (253)
..+|.++++. ..+++++++|.++.|++.++.-+-. +.-...-+.|..|++..+|.|.+.+- .+. ..
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~~-~s~-----------~~ 99 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAPA-ADD-----------AG 99 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECCC-----------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceecccc-ccc-----------cc
Confidence 4488888876 5789999999999999999876622 22234445678999999999987641 110 12
Q ss_pred CccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhccc
Q psy12709 173 TPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251 (253)
Q Consensus 173 ~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (253)
...+.|||... ...+.+.=|||||+++|..+--.. ++.....+|++|.+||..|..-
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL---------------------~e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL---------------------KENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC---------------------CTTEEECCCHHHHHHHHHHTTC
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC---------------------CcccchhhCHHHHHHHHHHHhc
Confidence 23566888763 344567889999999997766222 2233358899999999998753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.95 E-value=2.9e-05 Score=61.66 Aligned_cols=72 Identities=14% Similarity=0.030 Sum_probs=44.4
Q ss_pred EeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEecc-C
Q psy12709 16 FCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMV-P 94 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 94 (253)
++.|+.|....+|++ ..+++|+....... .....+|...+.....+.-..+++... ++.-+++++|+ +
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence 678889999999999 56899988753211 112345666665444333334555443 33457899999 7
Q ss_pred CCcH
Q psy12709 95 DGEL 98 (253)
Q Consensus 95 g~~L 98 (253)
|.++
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 7655
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=0.00011 Score=60.22 Aligned_cols=138 Identities=17% Similarity=0.183 Sum_probs=82.9
Q ss_pred EeecCCCCceEEEEEEecc-------CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 16 FCMPSRGKFASVRKCTHKI-------TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++.+..|-...+|++.... ++..|++|+..... .....+.+|...++.+..+.-..+++..+.. .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 4577888889999998642 35789999974421 1234566788888766666555677766654 29
Q ss_pred EEeccCCCcHHHH-----------H---h---h-cCC----CC--HHHHHHHHHHHHH-------------------HHH
Q psy12709 89 VLEMVPDGELQRL-----------V---D---I-QDG----IP--EQDTRSYMKQILE-------------------ALA 125 (253)
Q Consensus 89 v~e~~~g~~L~~~-----------~---~---~-~~~----~~--~~~~~~~~~~l~~-------------------~l~ 125 (253)
|+||++|.++... . . . ..+ .. ...+.++..++-. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999998765311 0 0 0 001 11 2344445443321 122
Q ss_pred H----HHH----CCceecCCCCCCEEEcCC----CceEEEeeccccc
Q psy12709 126 F----LHD----HNITHLDLKPQNILLTKD----NNIKLCDFGISRV 160 (253)
Q Consensus 126 ~----lh~----~~~~h~di~~~ni~~~~~----~~~~l~df~~~~~ 160 (253)
. |.. ..++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 222 248999999999999886 7899999998863
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00025 Score=56.64 Aligned_cols=140 Identities=13% Similarity=0.079 Sum_probs=74.6
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCC-CceeeeeE------EEeCCeEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSE-RIVGLHEI------YETPHEMV 87 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~-~i~~~~~~------~~~~~~~~ 87 (253)
-++.|+.|....+|++... + ..+++|........ ..+..|...+..+..+. .+.+++.. ...++..+
T Consensus 26 ~~~~i~~G~~n~~~~v~~~-~-g~~vlk~~~~~~~~----~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT-K-DPLILTLYEKRVEK----NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEEECC---EEEEEEEES-S-CCEEEEEECC---C----CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred EeeccCCCcccceEEEEeC-C-ccEEEEEeCCCCCH----HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 4667888999999999764 3 36899998763111 13334444443222221 13333321 22346789
Q ss_pred EEEeccCCCcHHH----H----------Hh-hcCC--------CCHHHHHHHH---------------HHHHHHHHHHHH
Q psy12709 88 LVLEMVPDGELQR----L----------VD-IQDG--------IPEQDTRSYM---------------KQILEALAFLHD 129 (253)
Q Consensus 88 lv~e~~~g~~L~~----~----------~~-~~~~--------~~~~~~~~~~---------------~~l~~~l~~lh~ 129 (253)
++++|++|..+.. . +. .... .........+ ..+...+..+.+
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 9999999865311 0 00 0000 0111000000 012233444442
Q ss_pred -------CCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 130 -------HNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 130 -------~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
.+++|+|+++.||+++.++.+.++||+.+..
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3689999999999999876668999987753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00034 Score=58.48 Aligned_cols=76 Identities=12% Similarity=0.081 Sum_probs=50.4
Q ss_pred EEeecCCCCceEEEEEEecc-------CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKI-------TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
-++.|+.|....+|++.... .+..+++|+.... .. ...+.+|...+..+..+.-.+++++.+.. .
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 45688899999999998653 2578999998542 11 12334677777655555444667766543 2
Q ss_pred EEEeccCCCcH
Q psy12709 88 LVLEMVPDGEL 98 (253)
Q Consensus 88 lv~e~~~g~~L 98 (253)
+|++|++|.++
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999987544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.59 E-value=0.0012 Score=52.81 Aligned_cols=137 Identities=16% Similarity=0.140 Sum_probs=75.2
Q ss_pred eecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCC-CceeeeeE-----EEeCCeEEEEE
Q psy12709 17 CMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSE-RIVGLHEI-----YETPHEMVLVL 90 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~-~i~~~~~~-----~~~~~~~~lv~ 90 (253)
..++ |....||++... +|+.+++|.......... .+..|...+..+..+. .+++++.. ...++..++++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~---~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTAD---QILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHH---HHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHH---HHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 3556 788899988653 466799999864322222 4444555544333221 13444432 22345678899
Q ss_pred eccCCCcHH-----HH---H---------hhc------CCCCHHHH----------------------HHHHHHHHHHHH
Q psy12709 91 EMVPDGELQ-----RL---V---------DIQ------DGIPEQDT----------------------RSYMKQILEALA 125 (253)
Q Consensus 91 e~~~g~~L~-----~~---~---------~~~------~~~~~~~~----------------------~~~~~~l~~~l~ 125 (253)
++++|..+. .. . ... ...+.... ...+.+++..+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 999886432 10 0 000 01121111 111112222222
Q ss_pred HH----HHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 126 FL----HDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 126 ~l----h~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
-+ ....++|+|+++.||+++ + .+.++||+.+..
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 21 234588999999999999 4 899999987653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.0026 Score=49.91 Aligned_cols=80 Identities=10% Similarity=-0.030 Sum_probs=54.1
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCC--ceeeeeEEEeCCeEEEE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER--IVGLHEIYETPHEMVLV 89 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~--i~~~~~~~~~~~~~~lv 89 (253)
+..-++.+|.|..+.||++... +|+.|++|+.+...... ...+..|...++.+..... +++++... .-+++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 4446788999999999999865 78899999876543222 1246678888775544433 44555442 23788
Q ss_pred EeccCCCcH
Q psy12709 90 LEMVPDGEL 98 (253)
Q Consensus 90 ~e~~~g~~L 98 (253)
||++++...
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999877643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00031 Score=56.48 Aligned_cols=32 Identities=22% Similarity=0.358 Sum_probs=27.2
Q ss_pred CCceecCCCCCCEEEcCC----CceEEEeecccccc
Q psy12709 130 HNITHLDLKPQNILLTKD----NNIKLCDFGISRVV 161 (253)
Q Consensus 130 ~~~~h~di~~~ni~~~~~----~~~~l~df~~~~~~ 161 (253)
..++|+|+++.||+++.+ +.+.++||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999875 67999999987643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00078 Score=54.98 Aligned_cols=77 Identities=12% Similarity=-0.009 Sum_probs=44.6
Q ss_pred EEeecCCCCceEEEEEEecc--------CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 15 IFCMPSRGKFASVRKCTHKI--------TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~--------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
-++.++.|....+|++.... .+..+++|+....... ......|...+..+..+.-+++++.... -
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~ 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE---LYNTISEFEVYKTMSKYKIAPQLLNTFN----G 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG---TSCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc---eecHHHHHHHHHHHHhcCCCCceEEecC----C
Confidence 35678889899999998653 1367999987653211 1123456666654444433456665442 2
Q ss_pred EEEEeccCCCcH
Q psy12709 87 VLVLEMVPDGEL 98 (253)
Q Consensus 87 ~lv~e~~~g~~L 98 (253)
+++++|++|.++
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999988644
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.0011 Score=55.81 Aligned_cols=77 Identities=9% Similarity=0.086 Sum_probs=50.1
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
-++.|+.|-...+|++.....+..+++|+....... ..+..+|...+..+..+.-.++++..+. + ..|++|++
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 456888999999999987644578999987543211 1123567777775655544567777763 2 25999998
Q ss_pred CCcH
Q psy12709 95 DGEL 98 (253)
Q Consensus 95 g~~L 98 (253)
|.++
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 8655
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0097 Score=47.93 Aligned_cols=31 Identities=19% Similarity=0.387 Sum_probs=27.4
Q ss_pred CCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 130 HNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 130 ~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4689999999999999888899999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0051 Score=51.15 Aligned_cols=77 Identities=9% Similarity=-0.060 Sum_probs=50.9
Q ss_pred EEeecCCCCceEEEEEEeccC-------CceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKIT-------KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~-------~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
-++.+..|-...+|++..... +..|++|+..... +...+..+|...+..+....-..++++.+. -+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 456788888999999987521 5789999976432 112234567777765555544566665432 27
Q ss_pred EEEeccCCCcH
Q psy12709 88 LVLEMVPDGEL 98 (253)
Q Consensus 88 lv~e~~~g~~L 98 (253)
.|++|++|.+|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.04 E-value=0.04 Score=45.45 Aligned_cols=29 Identities=34% Similarity=0.458 Sum_probs=24.8
Q ss_pred ceecCCCCCCEEEc------CCCceEEEeeccccc
Q psy12709 132 ITHLDLKPQNILLT------KDNNIKLCDFGISRV 160 (253)
Q Consensus 132 ~~h~di~~~ni~~~------~~~~~~l~df~~~~~ 160 (253)
++|+|+.+.||++. .++.+.++||.++..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 67999999999994 456799999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.92 E-value=0.39 Score=35.68 Aligned_cols=116 Identities=16% Similarity=0.229 Sum_probs=80.2
Q ss_pred hcCCCCceeeeeEEEeCCeEEEEEeccC-CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc
Q psy12709 67 AQKSERIVGLHEIYETPHEMVLVLEMVP-DGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLT 145 (253)
Q Consensus 67 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~ 145 (253)
...+|++++. .+-+.++.+.+.++.-+ +.++..+. ..+....++++.+++....+ ...-+|--++|+|++++
T Consensus 41 ~~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik----~~~~~eKlr~l~ni~~l~~~--~~~r~tf~L~P~NL~f~ 113 (215)
T 4ann_A 41 EQHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK----SFTKNEKLRYLLNIKNLEEV--NRTRYTFVLAPDELFFT 113 (215)
T ss_dssp GSCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG----GSCHHHHHHHHHHGGGGGGG--GGSSEECCCSGGGEEEC
T ss_pred hccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH----hcCHHHHHHHHHHHHHHHHH--hcCceEEEEecceEEEc
Confidence 5568888877 67777777777777554 33444432 27888999999999887743 34567788999999999
Q ss_pred CCCceEEEeecccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCC
Q psy12709 146 KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPF 210 (253)
Q Consensus 146 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 210 (253)
.++.+++.=-|... -++|. ..+...-.-..=+++..+++++..|
T Consensus 114 ~~~~p~i~~RGik~----------------~l~P~-----~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 114 RDGLPIAKTRGLQN----------------VVDPL-----PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp TTSCEEESCCEETT----------------TBSCC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred CCCCEEEEEccCcc----------------CCCCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 99999987544321 12332 2344444556668888899998887
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.87 E-value=1.3 Score=33.06 Aligned_cols=116 Identities=10% Similarity=0.135 Sum_probs=78.8
Q ss_pred hcCCCCceeeeeEEEeCCeEEEEEeccCCC-cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc
Q psy12709 67 AQKSERIVGLHEIYETPHEMVLVLEMVPDG-ELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLT 145 (253)
Q Consensus 67 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~-~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~ 145 (253)
...+|++ ...+-..++.+.+.++--++. ++..+ + .++..+.++++.+++..... |...-.|--++|+|++++
T Consensus 46 ~~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-~---~~~~~eKlrll~nl~~L~~~-~~~~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 46 KEVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-R---KTTLLSRIRAAIHLVSKVKH-HSARRLIFIVCPENLMFN 118 (219)
T ss_dssp GGSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-H---TSCHHHHHHHHHHHHHHHSS-CCSSSEECCCCGGGEEEC
T ss_pred hccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-H---hcCHHHHHHHHHHHHHHHHH-hhhCceeEEEeCceEEEe
Confidence 5567888 566667778888887765333 44433 2 27889999998888886651 225577888999999999
Q ss_pred CCCceEEEeecccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCC
Q psy12709 146 KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPF 210 (253)
Q Consensus 146 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 210 (253)
.++.+++.=.|.. ..+||. ..+...=.-+.=+++..++.++..|
T Consensus 119 ~~~~p~i~hRGi~----------------~~lpP~-----e~~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 119 RALEPFFLHVGVK----------------ESLPPD-----EWDDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp TTCCEEESCCEET----------------TTBSSC-----SCCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred CCCcEEEEEcCCc----------------ccCCCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 9999999755543 223442 2333334445667888888887776
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=92.17 E-value=2.4 Score=37.45 Aligned_cols=104 Identities=14% Similarity=0.187 Sum_probs=64.9
Q ss_pred hHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCCcHHHHHhhcCC-----------------CCHHHH
Q psy12709 51 MDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDG-----------------IPEQDT 113 (253)
Q Consensus 51 ~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~-----------------~~~~~~ 113 (253)
+.-..++.+-++.+.+....+--+..|.+...+....+| |+++..++.+++...+. +.....
T Consensus 453 D~rv~Ql~~lmn~il~~~~~~L~i~~Y~Vipls~~~GLI-E~V~s~tl~~i~~~~~~l~~~f~~~~p~~~~~~~~~~~ar 531 (696)
T 2x6h_A 453 DQLILQMITLMDKLLRRENLDLKLTPYKVLATSSKHGFL-QYVDSCTVAEVLAREGNIHNFFRKHHPCDNGPYGISAEVM 531 (696)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCCCEEESSTTCEEE-ECCCCEEHHHHHHHSSSHHHHHHHHSBCTTSSSSBCHHHH
T ss_pred hHHHHHHHHHHHHHHHhCCCCcEEeccEEEeccCCCCee-eeCCCccHHHHHHhcChHHHHHHHHCCCccchhhhHHHHH
Confidence 333455555555555444433346677777777666666 66677777776653321 112334
Q ss_pred HHHHHHHH--HHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 114 RSYMKQIL--EALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 114 ~~~~~~l~--~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
..+++.++ ..+.|+=. -+|-+++||+++.+|.+.=+|||...
T Consensus 532 ~nF~~SlA~~Svv~YILG----lGDRH~~NILid~tG~v~HIDFG~~f 575 (696)
T 2x6h_A 532 DTYIKSCAGYCVITYLLG----VGDRHLDNLLLTTNGKLFHIDFGYIL 575 (696)
T ss_dssp HHHHHHHHHHHHHHHHHT----CCCCCTTTEEECTTSCEEECCCCSCT
T ss_pred HHHHHHHHHHHHHHHHcc----CCCCCCcceEEeCCCCEEEEeehhhh
Confidence 55555554 23444432 26889999999999999999999875
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=81.76 E-value=25 Score=30.51 Aligned_cols=125 Identities=14% Similarity=0.142 Sum_probs=73.8
Q ss_pred EEEeccCCce--EEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccCCCcHHHHHhhcC
Q psy12709 29 KCTHKITKVE--YAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVPDGELQRLVDIQD 106 (253)
Q Consensus 29 ~~~~~~~~~~--v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~ 106 (253)
......+|.. +.+|.- .+.+.+.-..++.+-++.+.+....+--+..|.+...+....+| |++++.++.+.+...+
T Consensus 356 l~~~gsDG~~y~~i~K~g-DDLRQD~~~~Ql~~l~n~il~~~~ldL~i~~Y~Vipls~~~GlI-E~V~~~tl~~il~~~~ 433 (614)
T 3ls8_A 356 LFFKTEDGGKYPVIFKHG-DDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFM-QFIQSVPVAEVLDTEG 433 (614)
T ss_dssp EEEEETTSCEEEEEEEES-SCCHHHHHHHHHHHHHHHHHHHTTCCCCCCCCCEEESSSSEEEE-ECCCCEEHHHHHHHTS
T ss_pred EEEEccCCCEEEEEEecC-CcchHHHHHHHHHHHHHHHHHhcCCCceeeccEEEEecCCCceE-EEeCCccHHHHHHccC
Confidence 3333345554 455542 22233344455555555555443333346778888877776665 6777766666554221
Q ss_pred C-----------------CCHHHHHHHHHHHH--HHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 107 G-----------------IPEQDTRSYMKQIL--EALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 107 ~-----------------~~~~~~~~~~~~l~--~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
. ........+++.++ ..+.|+=.- +|=+++||+++.+|.+.=+|||...
T Consensus 434 ~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YILGi----gDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 434 SIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGV----GDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp SHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHHTC----CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred hHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhheeeec----cCCCCcceeEcCCCCEeeeehHHhh
Confidence 1 12334455555554 234455333 5889999999999999999999874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 253 | ||||
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-64 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-64 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-62 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-62 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-61 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-58 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-57 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-57 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-54 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-54 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-54 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-52 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-52 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-51 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-50 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-49 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-48 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-45 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-45 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-44 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-44 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-42 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-42 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-41 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-40 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-39 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-39 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-38 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-35 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-15 |
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 202 bits (516), Expect = 1e-64
Identities = 85/236 (36%), Positives = 132/236 (55%), Gaps = 6/236 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G F V + T + T +AAKF+ S + + E + + + +V LH+ +
Sbjct: 36 TGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVL-RHPTLVNLHDAF 92
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
E +EMV++ E + GEL V + + E + YM+Q+ + L +H++N HLDLKP
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP 152
Query: 140 QNILLTKDNN--IKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
+NI+ T + +KL DFG++ ++ VK GT ++ APEV +P+ TDMWSVG
Sbjct: 153 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG 212
Query: 198 VLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
VL+Y+LLS SPF G+N ET N+ C+++ + F IS KDFI+ L+ DP
Sbjct: 213 VLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADP 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 5e-64
Identities = 65/233 (27%), Positives = 108/233 (46%), Gaps = 5/233 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
+GKF +V K +K A K + K + ++ L + + I+ L+ +
Sbjct: 16 KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 75
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
+ L+LE P G + R + EQ T +Y+ ++ AL++ H + H D+KP+
Sbjct: 76 HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 135
Query: 141 NILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLA 200
N+LL +K+ DFG S + GT DY+ PE++ D+WS+GVL
Sbjct: 136 NLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLC 194
Query: 201 YVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
Y L PF + QET+ IS+ F+F + ++ A+D I L +P
Sbjct: 195 YEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNP 243
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 194 bits (495), Expect = 2e-62
Identities = 82/246 (33%), Positives = 117/246 (47%), Gaps = 13/246 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKR-------RRSMDQMQDILHEAAVLYLAQKSERI 73
RG + VR+C HK T EYA K I + + L E +L I
Sbjct: 13 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72
Query: 74 VGLHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNIT 133
+ L + YET LV +++ GEL + + + E++TR M+ +LE + LH NI
Sbjct: 73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIV 132
Query: 134 HLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLS------YEPI 187
H DLKP+NILL D NIKL DFG S ++ +++E+ GTP Y+APE++ +
Sbjct: 133 HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY 192
Query: 188 SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247
DMWS GV+ Y LL+ PF + I N+ F + S KD +
Sbjct: 193 GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSR 252
Query: 248 CLVTDP 253
LV P
Sbjct: 253 FLVVQP 258
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 197 bits (501), Expect = 3e-62
Identities = 87/236 (36%), Positives = 138/236 (58%), Gaps = 6/236 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G F V +C K T + AKFI + +E +++ +++ LH+ +
Sbjct: 39 SGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQL-HHPKLINLHDAF 95
Query: 81 ETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
E +EMVL+LE + GEL R+ + E + +YM+Q E L +H+H+I HLD+KP
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKP 155
Query: 140 QNILL--TKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
+NI+ K +++K+ DFG++ +N VK T ++ APE++ EP+ TDMW++G
Sbjct: 156 ENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIG 215
Query: 198 VLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
VL YVLLS SPFAG++ ET N+ +C++ F ED F +S +AKDFI++ L +P
Sbjct: 216 VLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEP 271
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 5e-61
Identities = 67/237 (28%), Positives = 116/237 (48%), Gaps = 9/237 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
G F++V T EYA K + KR +++ + E V+ V L+
Sbjct: 18 EGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFT 76
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++ ++ L +GEL + + E TR Y +I+ AL +LH I H DLKP
Sbjct: 77 FQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKP 136
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSV 196
+NILL +D +I++ DFG ++V++ + +GT YV+PE+L+ + ++D+W++
Sbjct: 137 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 196
Query: 197 GVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
G + Y L++ PF N+ F I + + F E +A+D ++ LV D
Sbjct: 197 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPKARDLVEKLLVLDA 249
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 5e-60
Identities = 80/236 (33%), Positives = 132/236 (55%), Gaps = 7/236 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RG+F V +C +K Y AKF++ + + E ++L +A + I+ LHE +
Sbjct: 15 RGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIA-RHRNILHLHESF 70
Query: 81 ETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
E+ E+V++ E + ++ +R+ + E++ SY+ Q+ EAL FLH HNI H D++P
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRP 130
Query: 140 QNILLTKDNN--IKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
+NI+ + IK+ +FG +R + + + P+Y APEV ++ +S ATDMWS+G
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLG 190
Query: 198 VLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
L YVLLS +PF + Q+ NI ++F E+ F IS +A DF+ LV +
Sbjct: 191 TLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKER 246
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 4e-59
Identities = 71/240 (29%), Positives = 113/240 (47%), Gaps = 11/240 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G F V K +K T V AAK I + S ++++D + E +L IV L + +
Sbjct: 22 DGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASC-DHPNIVKLLDAF 78
Query: 81 ETPHEMVLVLEMVPDGELQRLV-DIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
+ + +++E G + ++ +++ + E + KQ L+AL +LHD+ I H DLK
Sbjct: 79 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKA 138
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEV-KEIIGTPDYVAPEVLSYE-----PISLATDM 193
NIL T D +IKL DFG+S ++ IGTP ++APEV+ E P D+
Sbjct: 139 GNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADV 198
Query: 194 WSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
WS+G+ + P N L I++ SS KDF++ CL +
Sbjct: 199 WSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ-PSRWSSNFKDFLKKCLEKNV 257
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (471), Expect = 2e-58
Identities = 61/237 (25%), Positives = 98/237 (41%), Gaps = 10/237 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKR-RRSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
G F +V A K + ++S ++ QDI+ E L + +
Sbjct: 25 HGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGC 83
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
Y H LV+E L + + E + + L+ LA+LH HN+ H D+K
Sbjct: 84 YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 143
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVL---SYEPISLATDMWSV 196
NILL++ +KL DFG + ++ +GTP ++APEV+ D+WS+
Sbjct: 144 GNILLSEPGLVKLGDFGSASIMA---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200
Query: 197 GVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
G+ L P N +I+Q + GH S ++F+ SCL P
Sbjct: 201 GITCIELAERKPPLFNMNAMSALYHIAQNESPALQS--GHWSEYFRNFVDSCLQKIP 255
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 3e-58
Identities = 105/241 (43%), Positives = 154/241 (63%), Gaps = 9/241 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR----RSMDQMQDILHEAAVLYLAQKSERIVGL 76
G+FA V+KC K T ++YAAKFI+KRR R +DI E ++L Q ++ L
Sbjct: 20 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITL 78
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
HE+YE +++L+LE+V GEL + ++ + E++ ++KQIL + +LH I H D
Sbjct: 79 HEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFD 138
Query: 137 LKPQNILLTKDN----NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATD 192
LKP+NI+L N IK+ DFG++ ++ E K I GTP++VAPE+++YEP+ L D
Sbjct: 139 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEAD 198
Query: 193 MWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTD 252
MWS+GV+ Y+LLS SPF GD KQET N+S N+ F ++ F + S+ AKDFI+ LV D
Sbjct: 199 MWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 258
Query: 253 P 253
P
Sbjct: 259 P 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-57
Identities = 60/234 (25%), Positives = 113/234 (48%), Gaps = 6/234 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
+G +V T E A + + ++ + + I++E V+ K+ IV + Y
Sbjct: 30 QGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMREN-KNPNIVNYLDSY 86
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
E+ +V+E + G L +V + + E + ++ L+AL FLH + + H D+K
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145
Query: 141 NILLTKDNNIKLCDFGISRVVN-DVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVL 199
NILL D ++KL DFG + + + ++GTP ++APEV++ + D+WS+G++
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 205
Query: 200 AYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
A ++ P+ +N I+ N + +S+ +DF+ CL D
Sbjct: 206 AIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAIFRDFLNRCLDMDV 258
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (461), Expect = 7e-57
Identities = 84/236 (35%), Positives = 129/236 (54%), Gaps = 5/236 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G F+ V K T+ A K I K+ + + +E AVL+ K IV L +IY
Sbjct: 19 TGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKI-KHPNIVALDDIY 76
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
E+ + L++++V GEL + + E+D + Q+L+A+ +LHD I H DLKP+
Sbjct: 77 ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPE 136
Query: 141 NILLT---KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
N+L +D+ I + DFG+S++ + + GTP YVAPEVL+ +P S A D WS+G
Sbjct: 137 NLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIG 196
Query: 198 VLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
V+AY+LL + PF +N + F I + + F + IS AKDFI+ + DP
Sbjct: 197 VIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDP 252
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-56
Identities = 71/235 (30%), Positives = 112/235 (47%), Gaps = 6/235 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMD-QMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V K T +A K ++K MD ++ + E VL LA + + +
Sbjct: 12 KGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT 71
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++T + V+E + G+L + Y +I+ L FLH I + DLK
Sbjct: 72 FQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKL 131
Query: 140 QNILLTKDNNIKLCDFGISR-VVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
NILL KD +IK+ DFG+ + + + GTPDY+APE+L + + + D WS GV
Sbjct: 132 DNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGV 191
Query: 199 LAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
L Y +L SPF G +++E F +I N + + +AKD + V +P
Sbjct: 192 LLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLLVKLFVREP 242
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 5e-56
Identities = 59/237 (24%), Positives = 114/237 (48%), Gaps = 7/237 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G + V+ +++T+ A K + +R ++D ++I E + + E +V +
Sbjct: 15 EGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLN-HENVVKFYGHR 72
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
+ L LE GEL ++ G+PE D + + Q++ + +LH ITH D+KP+
Sbjct: 73 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 132
Query: 141 NILLTKDNNIKLCDFGISRVV---NDVVEVKEIIGTPDYVAPEVLSYEPI-SLATDMWSV 196
N+LL + +N+K+ DFG++ V N + ++ GT YVAPE+L + D+WS
Sbjct: 133 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 192
Query: 197 GVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
G++ +L+ P+ + + + ++ + + I S + LV +P
Sbjct: 193 GIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPWKKIDSAPLALLHKILVENP 248
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-55
Identities = 60/240 (25%), Positives = 107/240 (44%), Gaps = 11/240 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RG F +V K T VE A ++ R+ + + Q EA +L Q IV ++ +
Sbjct: 19 RGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSW 77
Query: 81 ETP----HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHN--ITH 134
E+ +VLV E++ G L+ + + + RS+ +QIL+ L FLH I H
Sbjct: 78 ESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIH 137
Query: 135 LDLKPQNILLT-KDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDM 193
DLK NI +T ++K+ D G++ + K +IGTP+++APE+ E + D+
Sbjct: 138 RDLKCDNIFITGPTGSVKIGDLGLATLKRASF-AKAVIGTPEFMAPEMYE-EKYDESVDV 195
Query: 194 WSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
++ G+ + +S P++ + K+ I+ C+ +
Sbjct: 196 YAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV-KPASFDKVAIPEVKEIIEGCIRQNK 254
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 1e-54
Identities = 60/245 (24%), Positives = 104/245 (42%), Gaps = 16/245 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G + +K K K + + + Q ++ E +L K IV ++
Sbjct: 14 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRI 72
Query: 81 --ETPHEMVLVLEMVPDGELQRLVD----IQDGIPEQDTRSYMKQILEALAFLHD----- 129
T + +V+E G+L ++ + + E+ M Q+ AL H
Sbjct: 73 IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGG 132
Query: 130 HNITHLDLKPQNILLTKDNNIKLCDFGISRVVN-DVVEVKEIIGTPDYVAPEVLSYEPIS 188
H + H DLKP N+ L N+KL DFG++R++N D K +GTP Y++PE ++ +
Sbjct: 133 HTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYN 192
Query: 189 LATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248
+D+WS+G L Y L + PF +++E I + F + S + + I
Sbjct: 193 EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---RRIPYRYSDELNEIITRM 249
Query: 249 LVTDP 253
L
Sbjct: 250 LNLKD 254
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 176 bits (447), Expect = 1e-54
Identities = 65/234 (27%), Positives = 113/234 (48%), Gaps = 8/234 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
G F V + YA K ++K + Q++ E +L + I+ +
Sbjct: 14 TGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGT 72
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++ ++ ++++ + GEL L+ P + Y ++ AL +LH +I + DLKP
Sbjct: 73 FQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKP 132
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVL 199
+NILL K+ +IK+ DFG ++ V D + GTPDY+APEV+S +P + + D WS G+L
Sbjct: 133 ENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGIL 190
Query: 200 AYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
Y +L+ ++PF N +T+ I F + KD + + D
Sbjct: 191 IYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLSRLITRDL 240
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 7e-54
Identities = 66/274 (24%), Positives = 110/274 (40%), Gaps = 44/274 (16%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G V K +HK + + A K I + + I+ E VL+ S IVG + +
Sbjct: 16 AGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR-NQIIRELQVLHEC-NSPYIVGFYGAF 73
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKP 139
+ E+ + +E + G L +++ IPEQ +++ L +L + H I H D+KP
Sbjct: 74 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 133
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVL 199
NIL+ IKLCDFG+S + D + +GT Y++PE L S+ +D+WS+G+
Sbjct: 134 SNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLS 192
Query: 200 AYVLLSSHSPFAGDNKQETFLNISQ----------------------------------- 224
+ P + +E L
Sbjct: 193 LVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFE 252
Query: 225 -----CNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
N + G S + +DF+ CL+ +P
Sbjct: 253 LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 286
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-52
Identities = 50/242 (20%), Positives = 103/242 (42%), Gaps = 14/242 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G F +V K + A K + + Q+Q +E VL + I+ Y
Sbjct: 18 SGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMG-Y 72
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
T ++ +V + L + I + +Q + + +LH +I H DLK
Sbjct: 73 STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKS 132
Query: 140 QNILLTKDNNIKLCDFGISRVVNDV---VEVKEIIGTPDYVAPEVLSYE---PISLATDM 193
NI L +D +K+ DFG++ V + + +++ G+ ++APEV+ + P S +D+
Sbjct: 133 NNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDV 192
Query: 194 WSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE--DLFGHISSQAKDFIQSCLVT 251
++ G++ Y L++ P++ N ++ + + + + + + K + CL
Sbjct: 193 YAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKK 252
Query: 252 DP 253
Sbjct: 253 KR 254
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-52
Identities = 68/246 (27%), Positives = 114/246 (46%), Gaps = 20/246 (8%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G V + +K T+ ++A K ++ + E + + A + IV + ++Y
Sbjct: 22 LGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRASQCPHIVRIVDVY 74
Query: 81 ETPHE----MVLVLEMVPDGELQRLVD--IQDGIPEQDTRSYMKQILEALAFLHDHNITH 134
E + +++V+E + GEL + E++ MK I EA+ +LH NI H
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 134
Query: 135 LDLKPQNILLTKDNN---IKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLAT 191
D+KP+N+L T +KL DFG ++ + TP YVAPEVL E +
Sbjct: 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 194
Query: 192 DMWSVGVLAYVLLSSHSPFAGDNKQET----FLNISQCNFSFHEDLFGHISSQAKDFIQS 247
DMWS+GV+ Y+LL + PF ++ I + F + +S + K I++
Sbjct: 195 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 254
Query: 248 CLVTDP 253
L T+P
Sbjct: 255 LLKTEP 260
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-51
Identities = 68/235 (28%), Positives = 112/235 (47%), Gaps = 7/235 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
+G F V K T YA K +RK + D++ + E+ VL + + L
Sbjct: 15 KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYA 73
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++T + V+E GEL + + E+ R Y +I+ AL +LH ++ + D+K
Sbjct: 74 FQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133
Query: 140 QNILLTKDNNIKLCDFGISR-VVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198
+N++L KD +IK+ DFG+ + ++D +K GTP+Y+APEVL A D W +GV
Sbjct: 134 ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 193
Query: 199 LAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ Y ++ PF + + F I F +S +AK + L DP
Sbjct: 194 VMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 244
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 167 bits (423), Expect = 1e-50
Identities = 63/237 (26%), Positives = 109/237 (45%), Gaps = 6/237 (2%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQD-ILHEAAVLYLAQK--SERIVGLH 77
RG F V C T YA K + K+R M Q + L+E +L L IV +
Sbjct: 14 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 73
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+ TP ++ +L+++ G+L + E D R Y +I+ L +H+ + + DL
Sbjct: 74 YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDL 133
Query: 138 KPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSV 196
KP NILL + ++++ D G++ + + +GT Y+APEVL + D +S+
Sbjct: 134 KPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSL 192
Query: 197 GVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
G + + LL HSPF ++ I + + +L S + + ++ L D
Sbjct: 193 GCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV 248
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (416), Expect = 2e-50
Identities = 54/242 (22%), Positives = 98/242 (40%), Gaps = 10/242 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
G + V + A K +R R EA IV +++
Sbjct: 17 FGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDT 75
Query: 80 YETPHE----MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
E +V+E V L+ +V + + + + +AL F H + I H
Sbjct: 76 GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHR 135
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVV----NDVVEVKEIIGTPDYVAPEVLSYEPISLAT 191
D+KP NI+++ N +K+ DFGI+R + N V + +IGT Y++PE + + +
Sbjct: 136 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS 195
Query: 192 DMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251
D++S+G + Y +L+ PF GD+ + + +S+ + L
Sbjct: 196 DVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAK 255
Query: 252 DP 253
+P
Sbjct: 256 NP 257
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 9e-49
Identities = 64/262 (24%), Positives = 102/262 (38%), Gaps = 30/262 (11%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ---MQDILHEAAVLYLAQKSERIVGLH 77
G+FA+V K K T A K I+ RS + + L E +L I+GL
Sbjct: 8 EGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLL 66
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+ + + LV + + + D + ++YM L+ L +LH H I H DL
Sbjct: 67 DAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDL 126
Query: 138 KPQNILLTKDNNIKLCDFGISRVVNDVVEV-KEIIGTPDYVAPEVL-SYEPISLATDMWS 195
KP N+LL ++ +KL DFG+++ + T Y APE+L + DMW+
Sbjct: 127 KPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWA 186
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHED----------------------- 232
VG + LL GD+ + I + + E+
Sbjct: 187 VGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLH 246
Query: 233 -LFGHISSQAKDFIQSCLVTDP 253
+F D IQ + +P
Sbjct: 247 HIFSAAGDDLLDLIQGLFLFNP 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-48
Identities = 63/241 (26%), Positives = 106/241 (43%), Gaps = 19/241 (7%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRS----MDQMQDILHEAAVLY-LAQKSERIVG 75
G F SV + A K + K R S + + E +L ++ ++
Sbjct: 14 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73
Query: 76 LHEIYETPHEMVLVLEMV-PDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITH 134
L + +E P VL+LE P +L + + + E+ RS+ Q+LEA+ H+ + H
Sbjct: 74 LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLH 133
Query: 135 LDLKPQNILLTKDN-NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEP-ISLATD 192
D+K +NIL+ + +KL DFG ++ D V + GT Y PE + Y +
Sbjct: 134 RDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAA 192
Query: 193 MWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTD 252
+WS+G+L Y ++ PF D I + F + +SS+ + I+ CL
Sbjct: 193 VWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ----RVSSECQHLIRWCLALR 242
Query: 253 P 253
P
Sbjct: 243 P 243
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (399), Expect = 4e-47
Identities = 63/234 (26%), Positives = 110/234 (47%), Gaps = 8/234 (3%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
G F V HK + YA K + K++ + Q++ L+E +L +V L
Sbjct: 51 TGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFS 109
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
++ + +V+E V GE+ + E R Y QI+ +LH ++ + DLKP
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVL 199
+N+L+ + I++ DFG ++ V + GTP+ +APE++ + + A D W++GVL
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVL 227
Query: 200 AYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
Y + + + PF D + + I F H SS KD +++ L D
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDL 277
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 4e-47
Identities = 55/240 (22%), Positives = 98/240 (40%), Gaps = 12/240 (5%)
Query: 21 RGKFASVRKCTHKITKV--EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHE 78
G F +V+K +++ KV A K ++ ++L EA V+ + IV +
Sbjct: 17 SGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIG 75
Query: 79 IYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
I E M LV+EM G L + + + +++ + Q+ + +L + N H DL
Sbjct: 76 ICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 134
Query: 139 PQNILLTKDNNIKLCDFGISRVVNDVVEVKE----IIGTPDYVAPEVLSYEPISLATDMW 194
+N+LL + K+ DFG+S+ + + + APE ++Y S +D+W
Sbjct: 135 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 194
Query: 195 SVGVLAYVLLSS-HSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
S GVL + S P+ G E + + + D + C D
Sbjct: 195 SFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---GERMGCPAGCPREMYDLMNLCWTYDV 251
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 151 bits (382), Expect = 2e-45
Identities = 61/260 (23%), Positives = 108/260 (41%), Gaps = 29/260 (11%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G + V K + +A K IR + + E ++L K IV L+++
Sbjct: 12 EGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVI 69
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
T +VLV E + + L + G+ +S++ Q+L +A+ HD + H DLKPQ
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQ 129
Query: 141 NILLTKDNNIKLCDFGISRVV-NDVVEVKEIIGTPDYVAPEVL-SYEPISLATDMWSVGV 198
N+L+ ++ +K+ DFG++R V + I T Y AP+VL + S D+WSVG
Sbjct: 130 NLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC 189
Query: 199 LAYVLLSSHSPFAGDNKQETFLNISQCNFSFH-------------------------EDL 233
+ +++ F G ++ + + I + + + E
Sbjct: 190 IFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESF 249
Query: 234 FGHISSQAKDFIQSCLVTDP 253
+ D + L DP
Sbjct: 250 LKGLDESGIDLLSKMLKLDP 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-45
Identities = 54/251 (21%), Positives = 92/251 (36%), Gaps = 21/251 (8%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEI 79
G F V K K + A R + S D +D E VL I+ L
Sbjct: 20 EGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA 79
Query: 80 YETPHEMVLVLEMVPDGELQRLV----------------DIQDGIPEQDTRSYMKQILEA 123
E + L +E P G L + + Q + +
Sbjct: 80 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 139
Query: 124 LAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLS 183
+ +L H DL +NIL+ ++ K+ DFG+SR V+ ++A E L+
Sbjct: 140 MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN 199
Query: 184 YEPISLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAK 242
Y + +D+WS GVL + ++S +P+ G E + + Q + + + +
Sbjct: 200 YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---GYRLEKPLNCDDEVY 256
Query: 243 DFIQSCLVTDP 253
D ++ C P
Sbjct: 257 DLMRQCWREKP 267
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-45
Identities = 62/275 (22%), Positives = 100/275 (36%), Gaps = 43/275 (15%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
+G F V K H+ T + A K + L E +L L K E +V L EI
Sbjct: 20 QGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEIC 78
Query: 81 ETPHE--------MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNI 132
T + LV + L ++ + + M+ +L L ++H + I
Sbjct: 79 RTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKI 138
Query: 133 THLDLKPQNILLTKDNNIKLCDFGISRVVNDV-----VEVKEIIGTPDYVAPEVLSYE-P 186
H D+K N+L+T+D +KL DFG++R + + T Y PE+L E
Sbjct: 139 LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERD 198
Query: 187 ISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHI--------- 237
D+W G + + + G+ +Q ISQ S +++ ++
Sbjct: 199 YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKL 258
Query: 238 -------------------SSQAKDFIQSCLVTDP 253
A D I LV DP
Sbjct: 259 ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 293
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 8e-45
Identities = 67/265 (25%), Positives = 102/265 (38%), Gaps = 32/265 (12%)
Query: 21 RGKFASVRKCTHKITKVEYAA-KFIRKRRRSMDQMQDILHEAAVLYLAQKSER--IVGLH 77
G + V K + A K +R + + E AVL + E +V L
Sbjct: 17 EGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 76
Query: 78 EIYETPHE-----MVLVLEMVPDGELQRLVDIQD-GIPEQDTRSYMKQILEALAFLHDHN 131
++ + LV E V L + + G+P + + M Q+L L FLH H
Sbjct: 77 DVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR 136
Query: 132 ITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLAT 191
+ H DLKPQNIL+T IKL DFG++R+ + + + ++ T Y APEVL +
Sbjct: 137 VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPV 196
Query: 192 DMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHED------------------- 232
D+WSVG + + F G + + I E+
Sbjct: 197 DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQ 256
Query: 233 ----LFGHISSQAKDFIQSCLVTDP 253
I KD + CL +P
Sbjct: 257 PIEKFVTDIDELGKDLLLKCLTFNP 281
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-44
Identities = 51/237 (21%), Positives = 98/237 (41%), Gaps = 16/237 (6%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHE-I 79
+G+F V ++ KV A K I+ Q L EA+V+ + +V L I
Sbjct: 17 KGEFGDVMLGDYRGNKV--AVKCIKNDA----TAQAFLAEASVMTQLR-HSNLVQLLGVI 69
Query: 80 YETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDL 137
E + +V E + G L + + + + + EA+ +L +N H DL
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 129
Query: 138 KPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
+N+L+++DN K+ DFG+++ + + APE L + S +D+WS G
Sbjct: 130 AARNVLVSEDNVAKVSDFGLTKEASS--TQDTGKLPVKWTAPEALREKKFSTKSDVWSFG 187
Query: 198 VLAYVLLSS-HSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+L + + S P+ ++ + + + D + +++C D
Sbjct: 188 ILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPPAVYEVMKNCWHLDA 241
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 3e-44
Identities = 71/242 (29%), Positives = 118/242 (48%), Gaps = 9/242 (3%)
Query: 21 RGKFASV---RKCTHKITKVEYAAKFIRKRR--RSMDQMQDILHEAAVLYLAQKSERIVG 75
G + V RK + T YA K ++K + + E VL ++S +V
Sbjct: 34 TGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVT 93
Query: 76 LHEIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
LH ++T ++ L+L+ + GEL + ++ E + + Y+ +I+ AL LH I +
Sbjct: 94 LHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYR 153
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVV--EVKEIIGTPDYVAPEVL--SYEPISLAT 191
D+K +NILL + ++ L DFG+S+ + GT +Y+AP+++ A
Sbjct: 154 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV 213
Query: 192 DMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251
D WS+GVL Y LL+ SPF D ++ + IS+ +S+ AKD IQ L+
Sbjct: 214 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMK 273
Query: 252 DP 253
DP
Sbjct: 274 DP 275
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 3e-44
Identities = 53/241 (21%), Positives = 103/241 (42%), Gaps = 14/241 (5%)
Query: 21 RGKFASVRKCTHKITK--VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHE 78
G F SVR+ +++ K ++ A K +++ ++++ EA +++ + IV L
Sbjct: 19 CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLD-NPYIVRLIG 76
Query: 79 IYETPHEMVLVLEMVPDGEL-QRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+ + ++LV+EM G L + LV ++ IP + + Q+ + +L + N H DL
Sbjct: 77 VCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 135
Query: 138 KPQNILLTKDNNIKLCDFGISRVVND----VVEVKEIIGTPDYVAPEVLSYEPISLATDM 193
+N+LL + K+ DFG+S+ + + APE +++ S +D+
Sbjct: 136 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 195
Query: 194 WSVGVLAYVLLSS-HSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTD 252
WS GV + LS P+ E I Q + + + C +
Sbjct: 196 WSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPECPPELYALMSDCWIYK 252
Query: 253 P 253
Sbjct: 253 W 253
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 4e-44
Identities = 55/237 (23%), Positives = 95/237 (40%), Gaps = 12/237 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G+F V+ + + + A K I++ S D+ + EA V+ E++V L+ +
Sbjct: 14 TGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDE---FIEEAKVMMNLS-HEKLVQLYGVC 68
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
+ ++ E + +G L + Q K + EA+ +L H DL
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAA 128
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVKE--IIGTPDYVAPEVLSYEPISLATDMWSVG 197
+N L+ +K+ DFG+SR V D + PEVL Y S +D+W+ G
Sbjct: 129 RNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG 188
Query: 198 VLAYVLLSS-HSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
VL + + S P+ ET +I+Q + S + + SC
Sbjct: 189 VLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH---LASEKVYTIMYSCWHEKA 242
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-44
Identities = 52/265 (19%), Positives = 103/265 (38%), Gaps = 35/265 (13%)
Query: 21 RGKFASVRKCTHKITK-----VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVG 75
G F V T ++ A K ++++ S + + ++ E ++ E IV
Sbjct: 47 SGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMTQLGSHENIVN 105
Query: 76 LHEIYETPHEMVLVLEMVPDGELQRLV-----------------------DIQDGIPEQD 112
L + L+ E G+L + + + + +D
Sbjct: 106 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 165
Query: 113 TRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN---DVVEVKE 169
+ Q+ + + FL + H DL +N+L+T +K+CDFG++R + + V
Sbjct: 166 LLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGN 225
Query: 170 IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQCNFS 228
++APE L ++ +D+WS G+L + + S +P+ G F + Q F
Sbjct: 226 ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK 285
Query: 229 FHEDLFGHISSQAKDFIQSCLVTDP 253
+ + + + +QSC D
Sbjct: 286 MDQPF--YATEEIYIIMQSCWAFDS 308
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-43
Identities = 66/261 (25%), Positives = 110/261 (42%), Gaps = 29/261 (11%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G + V K +K+T A K IR + + E ++L IV L ++
Sbjct: 12 EGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK-ELNHPNIVKLLDVI 70
Query: 81 ETPHEMVLVLEMVPDGELQRL-VDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
T +++ LV E + + + GIP +SY+ Q+L+ LAF H H + H DLKP
Sbjct: 71 HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 130
Query: 140 QNILLTKDNNIKLCDFGISRVVNDVVEVK-EIIGTPDYVAPEVL-SYEPISLATDMWSVG 197
QN+L+ + IKL DFG++R V + T Y APE+L + S A D+WS+G
Sbjct: 131 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 190
Query: 198 VLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE-------------------------D 232
+ +++ + F GD++ + I + + E
Sbjct: 191 CIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSK 250
Query: 233 LFGHISSQAKDFIQSCLVTDP 253
+ + + + L DP
Sbjct: 251 VVPPLDEDGRSLLSQMLHYDP 271
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 146 bits (368), Expect = 3e-43
Identities = 41/250 (16%), Positives = 83/250 (33%), Gaps = 21/250 (8%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G F + + T+ + + A KF +R + E L I ++
Sbjct: 15 EGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
+ VLV++++ L + KQ+L + +H+ ++ + D+KP
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPD 130
Query: 141 NILLTK-----DNNIKLCDFGISRVVND--------VVEVKEIIGTPDYVAPEVLSYEPI 187
N L+ + N I + DFG+ + D E K + GT Y++
Sbjct: 131 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ 190
Query: 188 SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNF----SFHEDLFGHISSQAKD 243
S D+ ++G + L P+ G + + +L +
Sbjct: 191 SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYK 250
Query: 244 FIQSCLVTDP 253
++
Sbjct: 251 YMHYARNLAF 260
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (368), Expect = 5e-43
Identities = 51/243 (20%), Positives = 93/243 (38%), Gaps = 14/243 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIR--KRRRSMDQMQDILHEAAVLYLAQKSERIVGLHE 78
G+F V K+ I+ K + Q +D L EA+++ ++ L
Sbjct: 36 AGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNVIHLEG 94
Query: 79 IYETPHEMVLVLEMVPDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+ ++++ E + +G L + DG ++ I + +L D N H DL
Sbjct: 95 VVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDL 154
Query: 138 KPQNILLTKDNNIKLCDFGISRVVND------VVEVKEIIGTPDYVAPEVLSYEPISLAT 191
+NIL+ + K+ DFG+SR + D + APE + Y + A+
Sbjct: 155 AARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSAS 214
Query: 192 DMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLV 250
D+WS G++ + ++S P+ Q+ I Q + S + C
Sbjct: 215 DVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLPPPMDCPSALHQLMLDCWQ 271
Query: 251 TDP 253
D
Sbjct: 272 KDR 274
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 6e-43
Identities = 56/269 (20%), Positives = 97/269 (36%), Gaps = 43/269 (15%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G F V + + A K + + +R ++ I+ + IV L +
Sbjct: 30 NGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-------DHCNIVRLRYFF 82
Query: 81 ETPHE------MVLVLEMVPDGELQRLVDI---QDGIPEQDTRSYMKQILEALAFLHDHN 131
+ E + LVL+ VP+ + + +P + YM Q+ +LA++H
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 132 ITHLDLKPQNILLTKDNNI-KLCDFGISRVVNDVVEVKEIIGTPDYVAP-EVLSYEPISL 189
I H D+KPQN+LL D + KLCDFG ++ + I + Y AP + +
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 202
Query: 190 ATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQC------------------------ 225
+ D+WS G + LL F GD+ + + I +
Sbjct: 203 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 262
Query: 226 -NFSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ + +A L P
Sbjct: 263 KAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-42
Identities = 60/261 (22%), Positives = 110/261 (42%), Gaps = 29/261 (11%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G + +V K ++ T A K +R L E +L K + IV LH++
Sbjct: 12 EGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVL 70
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
+ ++ LV E + + + +S++ Q+L+ L F H N+ H DLKPQ
Sbjct: 71 HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQ 130
Query: 141 NILLTKDNNIKLCDFGISRVVNDVVEV-KEIIGTPDYVAPEVLSYEPI-SLATDMWSVGV 198
N+L+ ++ +KL +FG++R V + T Y P+VL + S + DMWS G
Sbjct: 131 NLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGC 190
Query: 199 LAYVLLSSHSP-FAGDNKQETFLNISQCNFSFHED------------------------- 232
+ L ++ P F G++ + I + + E+
Sbjct: 191 IFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVN 250
Query: 233 LFGHISSQAKDFIQSCLVTDP 253
+ +++ +D +Q+ L +P
Sbjct: 251 VVPKLNATGRDLLQNLLKCNP 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-42
Identities = 54/238 (22%), Positives = 104/238 (43%), Gaps = 14/238 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G+F V + + A K +++ S D L EA ++ Q +R+V L+ +
Sbjct: 23 AGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQ-HQRLVRLYAVV 77
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIP--EQDTRSYMKQILEALAFLHDHNITHLDLK 138
T + ++ E + +G L + GI QI E +AF+ + N H DL+
Sbjct: 78 -TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 139 PQNILLTKDNNIKLCDFGISRVV--NDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSV 196
NIL++ + K+ DFG++R++ N+ + + APE ++Y ++ +D+WS
Sbjct: 137 AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 196
Query: 197 GVLAYVLLSS-HSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
G+L +++ P+ G E N+ + D + + ++ C P
Sbjct: 197 GILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD---NCPEELYQLMRLCWKERP 251
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-42
Identities = 46/240 (19%), Positives = 92/240 (38%), Gaps = 11/240 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRR---SMDQMQDILHEAAVLYLAQKSERIVGLH 77
G F +V K + K R S ++IL EA V+ + + L
Sbjct: 19 SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLL 77
Query: 78 EIYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDL 137
I T ++ M L + + +D I Q ++ QI + + +L D + H DL
Sbjct: 78 GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDL 137
Query: 138 KPQNILLTKDNNIKLCDFGISRVVND---VVEVKEIIGTPDYVAPEVLSYEPISLATDMW 194
+N+L+ ++K+ DFG+++++ + ++A E + + + +D+W
Sbjct: 138 AARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVW 197
Query: 195 SVGVLAYVLLSS-HSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
S GV + L++ P+ G E + + + + C + D
Sbjct: 198 SYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQPPICTIDVYMIMVKCWMIDA 254
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 3e-42
Identities = 64/269 (23%), Positives = 111/269 (41%), Gaps = 39/269 (14%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G + V + KV A K I Q L E +L + E I+G+++I
Sbjct: 18 EGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFR-HENIIGINDII 75
Query: 81 ETP----HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
P + V ++ + +L +L+ + ++ QIL L ++H N+ H D
Sbjct: 76 RAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANVLHRD 134
Query: 137 LKPQNILLTKDNNIKLCDFGISRVV----NDVVEVKEIIGTPDYVAPEVLSYE-PISLAT 191
LKP N+LL ++K+CDFG++RV + + E + T Y APE++ + +
Sbjct: 135 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 194
Query: 192 DMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHED------------------- 232
D+WSVG + +LS+ F G + + +I S ++
Sbjct: 195 DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPH 254
Query: 233 --------LFGHISSQAKDFIQSCLVTDP 253
LF + S+A D + L +P
Sbjct: 255 KNKVPWNRLFPNADSKALDLLDKMLTFNP 283
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (361), Expect = 4e-42
Identities = 42/248 (16%), Positives = 78/248 (31%), Gaps = 19/248 (7%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G F + T E A K + + + E+ + + Q I +
Sbjct: 17 SGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQ 140
V+V+E++ + Q++ + ++H N H D+KP
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPD 132
Query: 141 NILLT---KDNNIKLCDFGISRVVND--------VVEVKEIIGTPDYVAPEVLSYEPISL 189
N L+ K N + + DFG+++ D E K + GT Y + S
Sbjct: 133 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSR 192
Query: 190 ATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF----HEDLFGHISSQAKDFI 245
D+ S+G + P+ G + + E L S+ ++
Sbjct: 193 RDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYL 252
Query: 246 QSCLVTDP 253
C
Sbjct: 253 NFCRSLRF 260
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 5e-42
Identities = 52/238 (21%), Positives = 95/238 (39%), Gaps = 14/238 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
+G F V T T A K ++ S + L EA V+ + E++V L+ +
Sbjct: 27 QGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPE---AFLQEAQVMKKL-RHEKLVQLYAVV 81
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIP--EQDTRSYMKQILEALAFLHDHNITHLDLK 138
+ + +V E + G L + + G QI +A++ N H DL+
Sbjct: 82 -SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 140
Query: 139 PQNILLTKDNNIKLCDFGISRVVND--VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSV 196
NIL+ ++ K+ DFG++R++ D + + APE Y ++ +D+WS
Sbjct: 141 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 200
Query: 197 GVLAYVLLSS-HSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
G+L L + P+ G +E + + + D + C +P
Sbjct: 201 GILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECPESLHDLMCQCWRKEP 255
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-42
Identities = 53/243 (21%), Positives = 88/243 (36%), Gaps = 14/243 (5%)
Query: 21 RGKFASVRKCTHKITK---VEYAAKFIRKRRRSMDQ-MQDILHEAAVLYLAQKSERIVGL 76
G F VR+ V A K ++ S + M D + E ++ ++ L
Sbjct: 18 DGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRL 76
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHL 135
+ + TP M +V E+ P G L + G Y Q+ E + +L H
Sbjct: 77 YGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHR 135
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVND----VVEVKEIIGTPDYVAPEVLSYEPISLAT 191
DL +N+LL + +K+ DFG+ R + V + + APE L S A+
Sbjct: 136 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS 195
Query: 192 DMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLV 250
D W GV + + + P+ G N + I + + + C
Sbjct: 196 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP--EDCPQDIYNVMVQCWA 253
Query: 251 TDP 253
P
Sbjct: 254 HKP 256
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 1e-41
Identities = 58/237 (24%), Positives = 98/237 (41%), Gaps = 12/237 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G+F V K + A K IR+ S +D + EA V+ ++V L+ +
Sbjct: 15 SGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKL-SHPKLVQLYGVC 69
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDGI-PEQDTRSYMKQILEALAFLHDHNITHLDLKP 139
+ LV E + G L + Q G+ + + E +A+L + + H DL
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAA 129
Query: 140 QNILLTKDNNIKLCDFGISRVVND--VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVG 197
+N L+ ++ IK+ DFG++R V D + +PEV S+ S +D+WS G
Sbjct: 130 RNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFG 189
Query: 198 VLAYVLLSS-HSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
VL + + S P+ + E +IS + L S+ + C P
Sbjct: 190 VLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRL---ASTHVYQIMNHCWKERP 243
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (354), Expect = 4e-41
Identities = 44/237 (18%), Positives = 96/237 (40%), Gaps = 10/237 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G++ V + K + A K +++ ++++ L EAAV+ + +V L +
Sbjct: 27 GGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIK-HPNLVQLLGVC 82
Query: 81 ETPHEMVLVLEMVPDGELQRLVDIQDG--IPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
++ E + G L + + + QI A+ +L N H DL
Sbjct: 83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 142
Query: 139 PQNILLTKDNNIKLCDFGISRVVNDVVEVKE--IIGTPDYVAPEVLSYEPISLATDMWSV 196
+N L+ +++ +K+ DFG+SR++ + APE L+Y S+ +D+W+
Sbjct: 143 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 202
Query: 197 GVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
GVL + + + + + ++ + + +++C +P
Sbjct: 203 GVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE--GCPEKVYELMRACWQWNP 257
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 140 bits (353), Expect = 1e-40
Identities = 55/271 (20%), Positives = 112/271 (41%), Gaps = 46/271 (16%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
RGK++ V + + + K ++ ++ + I E +L + I+ L +I
Sbjct: 45 RGKYSEVFEAINITNNEKVVVKILKPVKK-----KKIKREIKILENLRGGPNIITLADIV 99
Query: 81 ETP--HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLK 138
+ P LV E V + + ++L + + D R YM +IL+AL + H I H D+K
Sbjct: 100 KDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVK 156
Query: 139 PQNILLTKDNN-IKLCDFGISRVVNDVVEVKEIIGTPDYVAPEV-LSYEPISLATDMWSV 196
P N+++ ++ ++L D+G++ + E + + + PE+ + Y+ + DMWS+
Sbjct: 157 PHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSL 216
Query: 197 GVLAYVLLSSHSPF-AGDNKQETFLNISQCNFS--------------------------- 228
G + ++ PF G + + + I++ +
Sbjct: 217 GCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSR 276
Query: 229 ------FHEDLFGHISSQAKDFIQSCLVTDP 253
H + +S +A DF+ L D
Sbjct: 277 KRWERFVHSENQHLVSPEALDFLDKLLRYDH 307
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 6e-40
Identities = 53/265 (20%), Positives = 105/265 (39%), Gaps = 35/265 (13%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G + +V T + A K + + +S + E +L + E ++GL +++
Sbjct: 28 SGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVF 86
Query: 81 ETPHE----MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
L M G + + + E + + Q+L+ L ++H I H D
Sbjct: 87 TPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRD 146
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEV-LSYEPISLATDMWS 195
LKP N+ + +D +K+ DFG++R + E+ + T Y APEV L++ + D+WS
Sbjct: 147 LKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWS 204
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHED----------------------- 232
VG + +++ + F G + + I + + +
Sbjct: 205 VGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK 264
Query: 233 ----LFGHISSQAKDFIQSCLVTDP 253
+ + S A + ++ LV D
Sbjct: 265 DFASILTNASPLAVNLLEKMLVLDA 289
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-39
Identities = 51/239 (21%), Positives = 98/239 (41%), Gaps = 11/239 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ--MQDILHEAAVLYLAQKSERIVGLHE 78
G+F V + + + A I+ + + L EA + IV L
Sbjct: 17 EGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIG 75
Query: 79 IYETPHEMVLVLEMVPDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHLDL 137
+ T + + +++E+ GEL+ + ++ + Y Q+ ALA+L H D+
Sbjct: 76 VI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDI 134
Query: 138 KPQNILLTKDNNIKLCDFGISRVVNDVVEVK--EIIGTPDYVAPEVLSYEPISLATDMWS 195
+N+L++ ++ +KL DFG+SR + D K + ++APE +++ + A+D+W
Sbjct: 135 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 194
Query: 196 VGVLAYVLLSS-HSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253
GV + +L PF G + I + + + C DP
Sbjct: 195 FGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPNCPPTLYSLMTKCWAYDP 250
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-39
Identities = 56/260 (21%), Positives = 99/260 (38%), Gaps = 30/260 (11%)
Query: 21 RGKFASVRKCT-----HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVG 75
G F V + T + A K ++ + + + ++ E VL IV
Sbjct: 33 AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVN 91
Query: 76 LHEIYETPHEMVLVLEMVPDGELQRLV------------------DIQDGIPEQDTRSYM 117
L +++ E G+L + D + + +D S+
Sbjct: 92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 151
Query: 118 KQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND---VVEVKEIIGTP 174
Q+ + +AFL N H DL +NILLT K+CDFG++R + + V
Sbjct: 152 YQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 211
Query: 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSP-FAGDNKQETFLNISQCNFSFHEDL 233
++APE + + +D+WS G+ + L S S + G F + + F
Sbjct: 212 KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP- 270
Query: 234 FGHISSQAKDFIQSCLVTDP 253
H ++ D +++C DP
Sbjct: 271 -EHAPAEMYDIMKTCWDADP 289
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-39
Identities = 58/265 (21%), Positives = 107/265 (40%), Gaps = 35/265 (13%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G + SV T + A K + + +S+ + E +L K E ++GL +++
Sbjct: 28 SGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVF 86
Query: 81 ETPHEMV----LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLD 136
+ + L G + + + + + QIL L ++H +I H D
Sbjct: 87 TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 146
Query: 137 LKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEV-LSYEPISLATDMWS 195
LKP N+ + +D +K+ DFG++R +D E+ + T Y APE+ L++ + D+WS
Sbjct: 147 LKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWS 204
Query: 196 VGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDL---------------------- 233
VG + LL+ + F G + + I + + +L
Sbjct: 205 VGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKM 264
Query: 234 -----FGHISSQAKDFIQSCLVTDP 253
F + A D ++ LV D
Sbjct: 265 NFANVFIGANPLAVDLLEKMLVLDS 289
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (342), Expect = 3e-39
Identities = 48/266 (18%), Positives = 94/266 (35%), Gaps = 38/266 (14%)
Query: 21 RGKFASVRKCTHKI-----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVG 75
G F V + A K +++ S D D EAA++ + IV
Sbjct: 23 EGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFD-NPNIVK 80
Query: 76 LHEIYETPHEMVLVLEMVPDGELQRLVDIQDG------------------------IPEQ 111
L + M L+ E + G+L + +
Sbjct: 81 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 140
Query: 112 DTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE-- 169
+ +Q+ +A+L + H DL +N L+ ++ +K+ DFG+SR + K
Sbjct: 141 EQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADG 200
Query: 170 -IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNF 227
++ PE + Y + +D+W+ GV+ + + S P+ G +E + N
Sbjct: 201 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI 260
Query: 228 SFHEDLFGHISSQAKDFIQSCLVTDP 253
+ + + + ++ C P
Sbjct: 261 LACPE---NCPLELYNLMRLCWSKLP 283
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-38
Identities = 49/260 (18%), Positives = 106/260 (40%), Gaps = 31/260 (11%)
Query: 21 RGKFASVRKCTHKITK-------VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERI 73
G F V + A K ++ + + D++ E ++ + K + I
Sbjct: 23 EGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNI 81
Query: 74 VGLHEIYETPHEMVLVLEMVPDGELQRLV----------------DIQDGIPEQDTRSYM 117
+ L + +++E G L+ + + ++ + +D S
Sbjct: 82 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 141
Query: 118 KQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE---IIGTP 174
Q+ + +L H DL +N+L+T+DN +K+ DFG++R ++ + K+
Sbjct: 142 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 201
Query: 175 DYVAPEVLSYEPISLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQCNFSFHEDL 233
++APE L + +D+WS GVL + + + SP+ G +E F + + + D
Sbjct: 202 KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH---RMDK 258
Query: 234 FGHISSQAKDFIQSCLVTDP 253
+ +++ ++ C P
Sbjct: 259 PSNCTNELYMMMRDCWHAVP 278
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 2e-38
Identities = 52/242 (21%), Positives = 96/242 (39%), Gaps = 13/242 (5%)
Query: 21 RGKFASVRKCTHKIT----KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGL 76
G+F V K K + +V A K ++ Q D L EA ++ I+ L
Sbjct: 17 AGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQF-SHHNIIRL 74
Query: 77 HEIYETPHEMVLVLEMVPDGELQRLVDIQDG-IPEQDTRSYMKQILEALAFLHDHNITHL 135
+ M+++ E + +G L + + +DG ++ I + +L + N H
Sbjct: 75 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHR 134
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVNDVVE----VKEIIGTPDYVAPEVLSYEPISLAT 191
DL +NIL+ + K+ DFG+SRV+ D E + APE +SY + A+
Sbjct: 135 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS 194
Query: 192 DMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCLVT 251
D+WS G++ + +++ + + F + S + C
Sbjct: 195 DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM--DCPSAIYQLMMQCWQQ 252
Query: 252 DP 253
+
Sbjct: 253 ER 254
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 3e-38
Identities = 45/233 (19%), Positives = 94/233 (40%), Gaps = 10/233 (4%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
G V + A K + + ++ + E ++ + I+ L ++
Sbjct: 27 SGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVF 85
Query: 81 ------ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITH 134
E ++ LV+E++ Q IQ + + + Q+L + LH I H
Sbjct: 86 TPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 142
Query: 135 LDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMW 194
DLKP NI++ D +K+ DFG++R + + T Y APEV+ D+W
Sbjct: 143 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 202
Query: 195 SVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247
SVG + ++ F G + + + + + + + + ++++++
Sbjct: 203 SVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-36
Identities = 47/244 (19%), Positives = 93/244 (38%), Gaps = 16/244 (6%)
Query: 21 RGKFASVRKCTH---KITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLH 77
RG F V T K+ A K + R + ++ L E ++ ++ L
Sbjct: 37 RGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFS-HPNVLSLL 94
Query: 78 EI-YETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTR-SYMKQILEALAFLHDHNITHL 135
I + ++VL + G+L+ + + P + Q+ + + FL H
Sbjct: 95 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 154
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVND-----VVEVKEIIGTPDYVAPEVLSYEPISLA 190
DL +N +L + +K+ DFG++R + D V ++A E L + +
Sbjct: 155 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK 214
Query: 191 TDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249
+D+WS GVL + L++ P+ N + + + Q + + + + C
Sbjct: 215 SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE---YCPDPLYEVMLKCW 271
Query: 250 VTDP 253
Sbjct: 272 HPKA 275
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-35
Identities = 52/259 (20%), Positives = 101/259 (38%), Gaps = 29/259 (11%)
Query: 21 RGKFASVRKCT-----HKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVG 75
RG F V + T A K +++ + + + ++ E +L +V
Sbjct: 23 RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVN 81
Query: 76 LHE-IYETPHEMVLVLEMVPDGELQRLVD----------------IQDGIPEQDTRSYMK 118
L + +++++E G L + +D + + Y
Sbjct: 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 141
Query: 119 QILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN---DVVEVKEIIGTPD 175
Q+ + + FL H DL +NILL++ N +K+CDFG++R + D V +
Sbjct: 142 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 201
Query: 176 YVAPEVLSYEPISLATDMWSVGVLAYVLLSSH-SPFAGDNKQETFLNISQCNFSFHEDLF 234
++APE + ++ +D+WS GVL + + S SP+ G E F +
Sbjct: 202 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--RAP 259
Query: 235 GHISSQAKDFIQSCLVTDP 253
+ + + + C +P
Sbjct: 260 DYTTPEMYQTMLDCWHGEP 278
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 7e-35
Identities = 43/252 (17%), Positives = 105/252 (41%), Gaps = 24/252 (9%)
Query: 21 RGKFASVRKCTHK-----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVG 75
+G F V + K + A K + + SM + + L+EA+V+ +V
Sbjct: 30 QGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFN-CHHVVR 87
Query: 76 LHEIYETPHEMVLVLEMVPDGELQRLVDIQDG----------IPEQDTRSYMKQILEALA 125
L + ++++E++ G+L+ + +I + +A
Sbjct: 88 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 147
Query: 126 FLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVK---EIIGTPDYVAPEVL 182
+L+ + H DL +N ++ +D +K+ DFG++R + + + + + +++PE L
Sbjct: 148 YLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 207
Query: 183 SYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQA 241
+ +D+WS GV+ + + + + P+ G + ++ + + D +
Sbjct: 208 KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL---LDKPDNCPDML 264
Query: 242 KDFIQSCLVTDP 253
+ ++ C +P
Sbjct: 265 FELMRMCWQYNP 276
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 3e-32
Identities = 45/275 (16%), Positives = 89/275 (32%), Gaps = 50/275 (18%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ-KSERIVGLHEI 79
+G+F V + E A K R + + EA + + E I+G
Sbjct: 13 KGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 80 YETPH----EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDH----- 130
+ ++ LV + G L ++ + + + LA LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 131 ---NITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV-----KEIIGTPDYVAPEVL 182
I H DLK +NIL+ K+ + D G++ + + +GT Y+APEVL
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 183 S------YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGH 236
+ D++++G++ + + S + + E++
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 237 ISSQ------------------AKDFIQSCLVTDP 253
+ Q ++ C +
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 279
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (271), Expect = 2e-28
Identities = 51/296 (17%), Positives = 94/296 (31%), Gaps = 65/296 (21%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQ-------MQDILHEAAVLYLAQKSERI 73
G F++V + A K +R + + +Q + + + I
Sbjct: 23 WGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82
Query: 74 VGLHEIYETPHEMVLVLEMVPDGELQRLVDI-----QDGIPEQDTRSYMKQILEALAFLH 128
+ L + + + + MV + + L+ + GIP + KQ+L L ++H
Sbjct: 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH 142
Query: 129 -DHNITHLDLKPQNILLTKDN------NIKLCDFGISRVVNDVVEVKEIIGTPDYVAPEV 181
I H D+KP+N+L+ + IK+ D G + ++ I T +Y +PEV
Sbjct: 143 RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEV 200
Query: 182 LSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCN--------------- 226
L P D+WS L + L++ F D +
Sbjct: 201 LLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLR 260
Query: 227 -----------------------------FSFHEDLFGHISSQAKDFIQSCLVTDP 253
+ + + DF+ L DP
Sbjct: 261 NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 70.2 bits (171), Expect = 2e-15
Identities = 25/147 (17%), Positives = 49/147 (33%), Gaps = 8/147 (5%)
Query: 21 RGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIY 80
GK ++V C + E KF + S ++++ + +
Sbjct: 10 EGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRAL 68
Query: 81 ETPH-----EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHL 135
+ ++ EL + ++ + ILE +A + I H
Sbjct: 69 QKLQGLAVPKVYAWEGNAVLMELID-AKELYRVRVENPDEVLDMILEEVAKFYHRGIVHG 127
Query: 136 DLKPQNILLTKDNNIKLCDFGISRVVN 162
DL N+L++ + I + DF S V
Sbjct: 128 DLSQYNVLVS-EEGIWIIDFPQSVEVG 153
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 253 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.75 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.49 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.2 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.7 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.0 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.98 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-57 Score=357.33 Aligned_cols=240 Identities=28% Similarity=0.466 Sum_probs=215.7
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
|..++|+ +.+.||+|+||+||+|.++.++..||+|++.+... .......+.+|+..+. .++||||+++++++.+++
T Consensus 3 ~~l~dy~--i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~ 79 (263)
T d2j4za1 3 WALEDFE--IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS-HLRHPNILRLYGYFHDAT 79 (263)
T ss_dssp CCGGGEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-TCCCTTBCCEEEEEECSS
T ss_pred cchhHeE--EEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHH-hcCCCCCCeEEEEEEECC
Confidence 3446677 99999999999999999999999999999976542 2233457788999988 789999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
.+++||||++|++|.+++.....+++..++.++.|++.|++|||++|++||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999999866543
Q ss_pred ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
. .....|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+.+.++.......+. .+|+++++|
T Consensus 160 ~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l 234 (263)
T d2j4za1 160 R-RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDL 234 (263)
T ss_dssp C-CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHHHH
T ss_pred c-ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHHHH
Confidence 2 34457899999999999999999999999999999999999999999999999988887766554 689999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||++||
T Consensus 235 i~~~L~~dp 243 (263)
T d2j4za1 235 ISRLLKHNP 243 (263)
T ss_dssp HHHHTCSSG
T ss_pred HHHHccCCH
Confidence 999999998
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-57 Score=362.75 Aligned_cols=243 Identities=35% Similarity=0.552 Sum_probs=202.9
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
+.+.|+ +.+.||+|+||+||+|.++.+++.||+|++.+..... ....+.+|+.++. .++||||+++++++.+++.+
T Consensus 7 i~d~Y~--~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~ 82 (307)
T d1a06a_ 7 IRDIYD--FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLH-KIKHPNIVALDDIYESGGHL 82 (307)
T ss_dssp GGGTEE--EEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHH-TCCCTTBCCEEEEEECSSEE
T ss_pred CccceE--EEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHH-hCCCCCCCcEEEEEEECCEE
Confidence 355677 9999999999999999999999999999998655332 2356778999998 77999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc---CCCceEEEeecccccccc
Q psy12709 87 VLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLT---KDNNIKLCDFGISRVVND 163 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~---~~~~~~l~df~~~~~~~~ 163 (253)
++||||++|++|.+++...+.+++.++..++.|++.|++|||++|++||||+|+||++. .++.+||+|||++.....
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999999999998888899999999999999999999999999999999999995 478999999999987765
Q ss_pred cccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 164 VVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
........|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+....+......++.+....+|+++++
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 242 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHH
Confidence 55556678999999999999999999999999999999999999999999999999999988888877777889999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
||.+||++||
T Consensus 243 li~~~L~~dP 252 (307)
T d1a06a_ 243 FIRHLMEKDP 252 (307)
T ss_dssp HHHHHSCSSG
T ss_pred HHHHHccCCH
Confidence 9999999998
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-57 Score=359.67 Aligned_cols=238 Identities=28% Similarity=0.498 Sum_probs=212.6
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
++|+ +++.||+|+||+||+|.+..+++.||+|++.+.. ........+.+|+.++. .++||||+++++++.+++.++
T Consensus 8 ~dy~--i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 8 EDFK--FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS-RLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp GGEE--EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-HCCSTTBCCEEEEEECSSEEE
T ss_pred CCCE--EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHH-HcCCCCeeEEEEEEEECCEEE
Confidence 4566 9999999999999999999999999999997654 22334567889999998 779999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc---
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV--- 164 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~--- 164 (253)
+||||++|++|.+++...+.+++..++.++.|++.|+.|||++|++||||+|+||+++.++.++|+|||+++.....
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999999999999988888999999999999999999999999999999999999999999999999999866432
Q ss_pred ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
.......|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+.+.++......++. .+|+++++|
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l 240 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPKARDL 240 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT----TCCHHHHHH
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc----cCCHHHHHH
Confidence 2233457899999999999999999999999999999999999999999999999999887776654 789999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||++||
T Consensus 241 i~~~L~~dP 249 (288)
T d1uu3a_ 241 VEKLLVLDA 249 (288)
T ss_dssp HHTTSCSSG
T ss_pred HHHHccCCH
Confidence 999999998
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-56 Score=360.31 Aligned_cols=238 Identities=28% Similarity=0.475 Sum_probs=216.4
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
++|+ +++.||+|+||+||+|.++.+++.||+|++.+... .......+.+|+.++. ..+||||+++++++.+++.++
T Consensus 5 ~dy~--~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 5 NDFD--YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-NTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp GGEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-SCCCTTBCCEEEEEECSSEEE
T ss_pred HhcE--EEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHH-hCCCCCEEEEEeeeccccccc
Confidence 4566 99999999999999999999999999999986542 2334567889999998 778999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc-ccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVE 166 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~-~~~ 166 (253)
+||||++|++|.+++.....+++..++.++.|++.|++|||++|++||||+|+||+++.+|.+||+|||+++.... ...
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence 9999999999999999888899999999999999999999999999999999999999999999999999986543 334
Q ss_pred ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHH
Q psy12709 167 VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~ 246 (253)
....+|++.|+|||++.+..++.++|+||+||++|+|++|+.||.+.+..+.+..+......+|. .+|+++++||.
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dli~ 237 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLA 237 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHH
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHHHHHHH
Confidence 45568999999999999999999999999999999999999999999999999998888776665 78999999999
Q ss_pred HhcccCC
Q psy12709 247 SCLVTDP 253 (253)
Q Consensus 247 ~~l~~dP 253 (253)
+||++||
T Consensus 238 ~~L~~dP 244 (337)
T d1o6la_ 238 GLLKKDP 244 (337)
T ss_dssp HHTCSST
T ss_pred hhccCCc
Confidence 9999998
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-56 Score=355.79 Aligned_cols=244 Identities=43% Similarity=0.778 Sum_probs=221.8
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch----HHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM----DQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
+.++|+ +.+.||+|+||+||+|.++.+|+.||+|++.+..... ...+.+.+|+..++ .++||||+++++++.+
T Consensus 8 i~d~Y~--~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 8 VDDYYD--TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK-EIQHPNVITLHEVYEN 84 (293)
T ss_dssp GGGTEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHH-HCCCTTBCCEEEEEEC
T ss_pred cccCEE--EeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHH-hCCCCCCCcEEEEEEE
Confidence 456777 9999999999999999999999999999997654222 23568889999998 7799999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC----ceEEEeeccc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN----NIKLCDFGIS 158 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~----~~~l~df~~~ 158 (253)
++.+++||||++|++|.+++..+..+++..++.++.|++.|++|||++|++||||+|+||+++.++ .+|++|||++
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999999999999998888899999999999999999999999999999999999999876 4999999999
Q ss_pred ccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCC
Q psy12709 159 RVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHIS 238 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 238 (253)
.............+++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+.+..+......++....+.+|
T Consensus 165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence 87766555666788999999999999999999999999999999999999999999999999998888877777777899
Q ss_pred HHHHHHHHHhcccCC
Q psy12709 239 SQAKDFIQSCLVTDP 253 (253)
Q Consensus 239 ~~l~~li~~~l~~dP 253 (253)
+++++||++||++||
T Consensus 245 ~~~~~li~~~L~~dP 259 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDP 259 (293)
T ss_dssp HHHHHHHHTTSCSSG
T ss_pred HHHHHHHHHHccCCh
Confidence 999999999999998
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-56 Score=351.41 Aligned_cols=238 Identities=26% Similarity=0.423 Sum_probs=208.8
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +++.||+|+||+||+|.+..+|..||+|++....... .+.+.+|+..++ .++||||+++++++..++.+++
T Consensus 20 ~~Y~--~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~i 94 (293)
T d1yhwa1 20 KKYT--RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMR-ENKNPNIVNYLDSYLVGDELWV 94 (293)
T ss_dssp TTBC--SCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEE
T ss_pred cccE--EEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHH-hCCCCCEeeEeEEEEECCEEEE
Confidence 3566 9999999999999999999999999999998654332 457889999988 7899999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc-cccc
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVEV 167 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~-~~~~ 167 (253)
||||++|++|.+++.. .++++..++.++.|++.|+.|||++|++||||||+||+++.+|.+||+|||++..... ....
T Consensus 95 vmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp EEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence 9999999999998865 4699999999999999999999999999999999999999999999999999987643 2344
Q ss_pred cccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~ 247 (253)
....+++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+....+....... ......+|+++++||.+
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-CSSGGGSCHHHHHHHHH
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC-CCCcccCCHHHHHHHHH
Confidence 55679999999999999999999999999999999999999999888877776665543322 22335789999999999
Q ss_pred hcccCC
Q psy12709 248 CLVTDP 253 (253)
Q Consensus 248 ~l~~dP 253 (253)
||++||
T Consensus 253 ~L~~dP 258 (293)
T d1yhwa1 253 CLDMDV 258 (293)
T ss_dssp HTCSST
T ss_pred HccCCh
Confidence 999998
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-56 Score=351.58 Aligned_cols=240 Identities=24% Similarity=0.430 Sum_probs=201.0
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +++.||+|+||+||+|.++.+++.||+|++..... .+..+.+.+|+..++ .++||||+++++++..++.+++
T Consensus 5 ~dy~--~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~-~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 5 EDWD--LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINK-MLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TEEE--EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHH-TCCCTTBCCEEEEEEETTEEEE
T ss_pred cceE--EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHH-hCCCCCEeeEeeeeccCceeEE
Confidence 4566 99999999999999999999999999999976543 223457889999988 7899999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc---c
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV---V 165 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~---~ 165 (253)
||||++|++|.+++..+..+++.+++.++.|++.|++|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 9999999999999987888999999999999999999999999999999999999999999999999999865432 2
Q ss_pred cccccccCccccCccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPI-SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
......|++.|+|||++.+..+ +.++||||+||++|+|++|+.||.................... .....+|+++++|
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~l 239 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-NPWKKIDSAPLAL 239 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS-TTGGGSCHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CccccCCHHHHHH
Confidence 2345678999999999988776 5789999999999999999999977554433332222222221 2234789999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||+.||
T Consensus 240 i~~~L~~dP 248 (271)
T d1nvra_ 240 LHKILVENP 248 (271)
T ss_dssp HHHHSCSST
T ss_pred HHHHcCCCh
Confidence 999999998
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-55 Score=359.63 Aligned_cols=241 Identities=37% Similarity=0.663 Sum_probs=219.1
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.++|+ +++.||+|+||+||+|.+..+|+.||+|++.+... .....+.+|+..+. .++||||+++++++..++.++
T Consensus 28 ~d~Y~--i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~Ei~il~-~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 28 YDYYD--ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMN-QLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GGTEE--EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHT-TCCSTTBCCEEEEEECSSEEE
T ss_pred ccceE--EEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch--hHHHHHHHHHHHHH-hCCCCCCCcEEEEEEECCEEE
Confidence 35566 99999999999999999999999999999876542 33457788999888 779999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEc--CCCceEEEeeccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLT--KDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~--~~~~~~l~df~~~~~~~~~ 164 (253)
+||||++|++|.+.+... .++++.+++.++.|++.|+.|||++|++||||||+||+++ .++.+||+|||++......
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999999998877654 4699999999999999999999999999999999999998 5689999999999887766
Q ss_pred ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
.......+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......++......+|+++++|
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 55666788999999999999999999999999999999999999999999999999999988888887778999999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||++||
T Consensus 263 i~~~L~~dp 271 (352)
T d1koba_ 263 IKNLLQKEP 271 (352)
T ss_dssp HHTTSCSSG
T ss_pred HHHHccCCh
Confidence 999999998
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-56 Score=349.81 Aligned_cols=239 Identities=24% Similarity=0.348 Sum_probs=201.9
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe--CCeE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET--PHEM 86 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~ 86 (253)
+.|+ +++.||+|+||+||+|.++.+|+.||+|.+..........+.+.+|+..+. .++||||+++++++.+ ++.+
T Consensus 4 edy~--~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 4 EDYE--VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR-ELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGEE--EEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTT-SCCCTTBCCEEEEEEC----CE
T ss_pred hhCE--EeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHH-HCCCCCEeeEEEEEEeCCCCEE
Confidence 3566 999999999999999999999999999999887766777788999999987 7899999999999864 4578
Q ss_pred EEEEeccCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCCEEEcCCCceEEEeecc
Q psy12709 87 VLVLEMVPDGELQRLVDI----QDGIPEQDTRSYMKQILEALAFLHDHN-----ITHLDLKPQNILLTKDNNIKLCDFGI 157 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~-----~~h~di~~~ni~~~~~~~~~l~df~~ 157 (253)
++||||++|++|.+++.. +..+++..++.++.|++.|+.|||++| ++||||||+||+++.++.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999999999998854 457999999999999999999999976 99999999999999999999999999
Q ss_pred ccccccc-ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCC
Q psy12709 158 SRVVNDV-VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGH 236 (253)
Q Consensus 158 ~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 236 (253)
+...... .......+++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+....+..+..... ...
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~---~~~ 237 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---PYR 237 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---CTT
T ss_pred eeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC---Ccc
Confidence 9876543 233456789999999999999999999999999999999999999999999888888877665432 247
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
+|+++++||.+||+.||
T Consensus 238 ~s~~l~~li~~~L~~dp 254 (269)
T d2java1 238 YSDELNEIITRMLNLKD 254 (269)
T ss_dssp SCHHHHHHHHHHTCSSG
T ss_pred cCHHHHHHHHHHcCCCh
Confidence 89999999999999998
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-55 Score=359.07 Aligned_cols=240 Identities=36% Similarity=0.666 Sum_probs=218.5
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +++.||+|+||+||+|.+..+|..||+|++..... ...+.+.+|+..+. .++||||+++++++..++.+++
T Consensus 26 ~~Y~--i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 26 DHYD--IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMS-VLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GTEE--EEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH--HHHHHHHHHHHHHH-HTCCTTBCCEEEEEEETTEEEE
T ss_pred cCeE--EEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch--hhHHHHHHHHHHHH-hCCCCCCCcEEEEEEECCEEEE
Confidence 4566 99999999999999999999999999999976543 34567889999998 6789999999999999999999
Q ss_pred EEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC--CCceEEEeecccccccccc
Q psy12709 89 VLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK--DNNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~--~~~~~l~df~~~~~~~~~~ 165 (253)
||||++|++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++. ++.+||+|||++.......
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999999999998853 457999999999999999999999999999999999999964 5789999999998877666
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
......+++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+.+.++......++......+|+++++||
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 260 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHH
T ss_pred ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 66667899999999999999999999999999999999999999999999999999999888887777778999999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
.+||++||
T Consensus 261 ~~~L~~dP 268 (350)
T d1koaa2 261 RKLLLADP 268 (350)
T ss_dssp HHHCCSSG
T ss_pred HHHccCCh
Confidence 99999998
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.2e-55 Score=345.45 Aligned_cols=244 Identities=34% Similarity=0.538 Sum_probs=219.1
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccc-------hHHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS-------MDQMQDILHEAAVLYLAQKSERIVGLHEIY 80 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 80 (253)
.++|+ +.+.||+|+||+||+|.+..+++.||+|++++.... ......+.+|+..+.++..||||+++++++
T Consensus 2 ~~~y~--~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 79 (277)
T d1phka_ 2 YENYE--PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 79 (277)
T ss_dssp TTTEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred cccCE--EceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec
Confidence 45676 999999999999999999999999999999765422 122356888999999777799999999999
Q ss_pred EeCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 81 ETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 81 ~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
.+++.+++||||++|++|.+++..+.++++..++.++.|++.|++|||++|++|+||+|+||+++.++.+||+|||++..
T Consensus 80 ~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 80 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 99999999999999999999998888999999999999999999999999999999999999999999999999999987
Q ss_pred ccccccccccccCccccCccccCC------CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCcc
Q psy12709 161 VNDVVEVKEIIGTPDYVAPEVLSY------EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLF 234 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 234 (253)
...........+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+..+....+......++....
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 766555556778999999999843 34678999999999999999999999999999999888888777777667
Q ss_pred CCCCHHHHHHHHHhcccCC
Q psy12709 235 GHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP 253 (253)
..+|+++++||.+||++||
T Consensus 240 ~~~s~~~~~li~~~L~~~p 258 (277)
T d1phka_ 240 DDYSDTVKDLVSRFLVVQP 258 (277)
T ss_dssp GGSCHHHHHHHHHHCCSSG
T ss_pred ccCCHHHHHHHHHHccCCh
Confidence 7899999999999999998
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-55 Score=352.60 Aligned_cols=236 Identities=29% Similarity=0.525 Sum_probs=214.4
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
++|+ +++.||+|+||+||+|.++.+|+.||+|++++... .....+.+.+|+.++. .++||||+++++++..++.++
T Consensus 4 ~dy~--i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~ 80 (316)
T d1fota_ 4 QDFQ--ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS-IVTHPFIIRMWGTFQDAQQIF 80 (316)
T ss_dssp GGEE--EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-SCCBTTBCCEEEEEECSSEEE
T ss_pred hHeE--EEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHH-hccCcChhheeeeEeeCCeee
Confidence 4566 99999999999999999999999999999976542 2234567888999988 889999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV 167 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 167 (253)
+||||++|++|..++.....+++..++.++.|++.|+.|||++|++||||||+||+++.+|.+||+|||++.......
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-- 158 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 158 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccc--
Confidence 999999999999999988889999999999999999999999999999999999999999999999999998765432
Q ss_pred cccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~ 247 (253)
....|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+...++..+....+. .+|++++++|.+
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~ 234 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLSR 234 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHH
T ss_pred ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHH
Confidence 3467999999999999999999999999999999999999999999999999998887766554 789999999999
Q ss_pred hcccCC
Q psy12709 248 CLVTDP 253 (253)
Q Consensus 248 ~l~~dP 253 (253)
||++||
T Consensus 235 ~L~~dp 240 (316)
T d1fota_ 235 LITRDL 240 (316)
T ss_dssp HTCSCT
T ss_pred HhhhCH
Confidence 999998
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-55 Score=352.52 Aligned_cols=239 Identities=30% Similarity=0.456 Sum_probs=214.8
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
++|+ +++.||+|+||+||+|.+..+++.||+|++++.. ......+.+..|...+.+..+||||+++++++.+++.+|
T Consensus 2 ddy~--i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y 79 (320)
T d1xjda_ 2 EDFI--LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 79 (320)
T ss_dssp TTEE--EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred CCeE--EeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence 3466 9999999999999999999999999999998654 223345677788888877899999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc-ccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND-VVE 166 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~-~~~ 166 (253)
+||||++||+|.+++.....+++.+++.++.|++.|+.|||++|++||||+|+||++++++.++|+|||.++.... ...
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 159 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccc
Confidence 9999999999999999888899999999999999999999999999999999999999999999999999986543 333
Q ss_pred ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHH
Q psy12709 167 VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQ 246 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~ 246 (253)
.....|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+.+..+....+..+. .+|+++++||.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dli~ 235 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLLV 235 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHH
T ss_pred ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHHHHHH
Confidence 34467899999999999999999999999999999999999999999999999988887765554 78999999999
Q ss_pred HhcccCC
Q psy12709 247 SCLVTDP 253 (253)
Q Consensus 247 ~~l~~dP 253 (253)
+||++||
T Consensus 236 ~~L~~dP 242 (320)
T d1xjda_ 236 KLFVREP 242 (320)
T ss_dssp HHSCSSG
T ss_pred HhcccCC
Confidence 9999998
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-55 Score=347.45 Aligned_cols=239 Identities=29% Similarity=0.446 Sum_probs=208.1
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
+.|+ +++.||+|+||+||+|.+..++..||+|++..... ...+.+.+|+..++ .++||||+++++++..++.+++
T Consensus 12 d~Y~--i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 12 DFWE--IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILA-SCDHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GTEE--EEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHH-HCCCTTBCCEEEEEEETTEEEE
T ss_pred cCeE--EeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHH-hCCCCCCCeEEEEEeeCCeEEE
Confidence 3466 99999999999999999999999999999876432 33457888999998 7799999999999999999999
Q ss_pred EEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-cc
Q psy12709 89 VLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VE 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~ 166 (253)
||||++|++|.+++.. ..++++..++.++.|++.|+.|||++|++||||||+||+++.++.+||+|||++...... ..
T Consensus 87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence 9999999999998765 456999999999999999999999999999999999999999999999999999765432 23
Q ss_pred ccccccCccccCccccC-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHH
Q psy12709 167 VKEIIGTPDYVAPEVLS-----YEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQA 241 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 241 (253)
.....+++.|+|||++. +..++.++||||+||++|+|++|+.||.+.+..+.+.++.....+.. .....+|+++
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~~~ 245 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRWSSNF 245 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-SSGGGSCHHH
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-CccccCCHHH
Confidence 34567899999999984 44678999999999999999999999999988888888877654332 2234789999
Q ss_pred HHHHHHhcccCC
Q psy12709 242 KDFIQSCLVTDP 253 (253)
Q Consensus 242 ~~li~~~l~~dP 253 (253)
++||.+||++||
T Consensus 246 ~~li~~~L~~dp 257 (288)
T d2jfla1 246 KDFLKKCLEKNV 257 (288)
T ss_dssp HHHHHHHSCSST
T ss_pred HHHHHHHccCCh
Confidence 999999999998
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-54 Score=347.37 Aligned_cols=235 Identities=26% Similarity=0.370 Sum_probs=208.1
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
|+.++.||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+..+. .++||||+++++++..++.+++|||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ-KLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHH-HCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4499999999999999999999999999999987653 3445677899999998 7799999999999999999999999
Q ss_pred ccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccccc
Q psy12709 92 MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKEII 171 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (253)
|+.|+++..++..+.++++..++.++.|++.|+.|||++|++||||+|+||+++.++.+||+|||++...... ....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~~~~ 172 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFV 172 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCCC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC---Cccc
Confidence 9999999887777888999999999999999999999999999999999999999999999999999865432 3457
Q ss_pred cCccccCccccCC---CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 172 GTPDYVAPEVLSY---EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 172 ~~~~~~~PE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
|++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+.....+... ...+|+++++||.+|
T Consensus 173 GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~li~~~ 250 (309)
T d1u5ra_ 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEYFRNFVDSC 250 (309)
T ss_dssp SCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--CTTSCHHHHHHHHHH
T ss_pred cCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCCCHHHHHHHHHH
Confidence 8999999999854 35788999999999999999999999998888888777766554433 247899999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|++||
T Consensus 251 L~~dP 255 (309)
T d1u5ra_ 251 LQKIP 255 (309)
T ss_dssp TCSSG
T ss_pred CcCCh
Confidence 99998
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.9e-55 Score=354.19 Aligned_cols=236 Identities=27% Similarity=0.458 Sum_probs=214.6
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccc-cchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRR-RSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
++|+ +++.||+|+||+||+|.++.+|+.||+|++.+.. ........+.+|+.++. .++||||+++++++.....++
T Consensus 41 d~y~--i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 41 DQFD--RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ-AVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp GGEE--EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEE
T ss_pred cCeE--EEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHH-HcCCCcEeecccccccccccc
Confidence 5566 9999999999999999999999999999997654 22344567889999987 789999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEV 167 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 167 (253)
+|+|++.|++|...+.....+++..++.++.|++.||.|||++|++||||||+||+++.+|.+||+|||+++..... .
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~ 195 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--T 195 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--B
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--c
Confidence 99999999999999988888999999999999999999999999999999999999999999999999999876543 2
Q ss_pred cccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHH
Q psy12709 168 KEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQS 247 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~ 247 (253)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.++.......+. .+|+++.+||++
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~ 271 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRN 271 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHHHHHHHH
T ss_pred ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHHHHHHHH
Confidence 3457899999999999999999999999999999999999999999999999988887766654 789999999999
Q ss_pred hcccCC
Q psy12709 248 CLVTDP 253 (253)
Q Consensus 248 ~l~~dP 253 (253)
||++||
T Consensus 272 ~L~~dP 277 (350)
T d1rdqe_ 272 LLQVDL 277 (350)
T ss_dssp HSCSCT
T ss_pred HhhhCH
Confidence 999998
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-55 Score=351.34 Aligned_cols=239 Identities=33% Similarity=0.606 Sum_probs=217.3
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +++.||+|+||+||+|.++.+++.||+|++++... ....+.+|+.++. .++||||+++++++.+++.+|+
T Consensus 5 ~rY~--i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---~~~~~~~Ei~il~-~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 5 EKYM--IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILN-IARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHH-HSCCTTBCCEEEEEEETTEEEE
T ss_pred cceE--EEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc---cHHHHHHHHHHHH-hCCCCCCCeEEEEEEECCEEEE
Confidence 5666 99999999999999999999999999999986543 2346778999887 7899999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC--CceEEEeecccccccccc
Q psy12709 89 VLEMVPDGELQRLVDIQD-GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD--NNIKLCDFGISRVVNDVV 165 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~--~~~~l~df~~~~~~~~~~ 165 (253)
||||++|++|.+++...+ .+++.+++.++.|++.|+.|||++|++||||+|+||+++.+ +.++|+|||++.......
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 999999999999997654 69999999999999999999999999999999999999864 479999999998776555
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
......+++.|+|||...+..++.++||||+||++|+|++|+.||.+.+..+.+.++......++....+.+|+++++||
T Consensus 159 ~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T d1tkia_ 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHH
Confidence 55566789999999999999999999999999999999999999999999999999999888888777788999999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
.+||++||
T Consensus 239 ~~~L~~dp 246 (321)
T d1tkia_ 239 DRLLVKER 246 (321)
T ss_dssp HTTSCSSG
T ss_pred HHHccCCh
Confidence 99999998
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-54 Score=338.12 Aligned_cols=235 Identities=25% Similarity=0.380 Sum_probs=202.6
Q ss_pred EEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe----CCeEEEE
Q psy12709 14 LIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET----PHEMVLV 89 (253)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv 89 (253)
.+.+.||+|+||+||+|.+..++..||+|++..........+.+.+|+..+. .++||||+++++++.. +..+++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK-GLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHH-hCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 4778999999999999999999999999999877666666788999999998 7889999999999875 3468999
Q ss_pred EeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEc-CCCceEEEeeccccccccccc
Q psy12709 90 LEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHN--ITHLDLKPQNILLT-KDNNIKLCDFGISRVVNDVVE 166 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~di~~~ni~~~-~~~~~~l~df~~~~~~~~~~~ 166 (253)
|||++|++|.+++.....+++..++.++.|++.|++|||+++ ++||||||+||+++ +++.+||+|||++...... .
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-~ 169 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-F 169 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-S
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-c
Confidence 999999999999988888999999999999999999999999 99999999999996 4789999999999764432 3
Q ss_pred ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhhcccccccCCccCCCCHHHHHHH
Q psy12709 167 VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNK-QETFLNISQCNFSFHEDLFGHISSQAKDFI 245 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~l~~li 245 (253)
.....|++.|+|||++.+ .++.++||||+||++|+|++|+.||..... ...+..+..+..+ .......++++++||
T Consensus 170 ~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~li 246 (270)
T d1t4ha_ 170 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIPEVKEII 246 (270)
T ss_dssp BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCCHHHHHHH
T ss_pred cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC--cccCccCCHHHHHHH
Confidence 345679999999999875 589999999999999999999999977544 4445555544332 233357899999999
Q ss_pred HHhcccCC
Q psy12709 246 QSCLVTDP 253 (253)
Q Consensus 246 ~~~l~~dP 253 (253)
.+||++||
T Consensus 247 ~~~l~~dp 254 (270)
T d1t4ha_ 247 EGCIRQNK 254 (270)
T ss_dssp HHHSCSSG
T ss_pred HHHccCCH
Confidence 99999998
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.1e-54 Score=342.53 Aligned_cols=244 Identities=22% Similarity=0.342 Sum_probs=211.5
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC-
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH- 84 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~- 84 (253)
+.++|+ +.+.||+|+||+||+|.+..+++.||+|++++... .......+.+|+..+. ..+||||+++++++...+
T Consensus 5 l~drY~--i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~-~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 5 LSDRYE--LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA-ALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp ETTTEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEEEECS
T ss_pred ccceeE--EeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHH-hcCCCCCCcccceeeeccC
Confidence 456777 99999999999999999999999999999987653 3455677899999997 889999999999998654
Q ss_pred ---eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 85 ---EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 85 ---~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
.+|+||||++|++|.+++...+++++.+++.++.|++.|++|||++|++||||||+||+++.++..+++|||.+...
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence 48999999999999999988888999999999999999999999999999999999999999999999999988754
Q ss_pred ccc----ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCC
Q psy12709 162 NDV----VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHI 237 (253)
Q Consensus 162 ~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 237 (253)
... .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.+..+...++......++......+
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 322 2333457899999999999999999999999999999999999999999988888888877777777777789
Q ss_pred CHHHHHHHHHhcccCC
Q psy12709 238 SSQAKDFIQSCLVTDP 253 (253)
Q Consensus 238 ~~~l~~li~~~l~~dP 253 (253)
|+++.++|.+||++||
T Consensus 242 s~~l~~li~~~L~~dp 257 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNP 257 (277)
T ss_dssp CHHHHHHHHHHTCSSG
T ss_pred CHHHHHHHHHHccCCH
Confidence 9999999999999998
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-54 Score=347.55 Aligned_cols=204 Identities=27% Similarity=0.450 Sum_probs=182.5
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
+++|+ +++.||+|+||+||+|.+..++..||+|+++.... ......+.+|+..++ .++||||+++++++..++.++
T Consensus 5 ~d~y~--~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 5 DDDFE--KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLH-ECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp GGGEE--EEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGG-GCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCE--EEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHH-hCCCCCCCcEEEEEEECCEEE
Confidence 56777 99999999999999999999999999999976543 334567889999998 789999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCCceEEEeeccccccccccc
Q psy12709 88 LVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVE 166 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 166 (253)
+||||++|++|.+++.+...+++..++.++.|++.|+.|||+ +|++||||||+||+++.+|.+||+|||++...... .
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~ 159 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M 159 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-T
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-c
Confidence 999999999999999888889999999999999999999997 49999999999999999999999999999865443 2
Q ss_pred ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH
Q psy12709 167 VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQ 216 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 216 (253)
.....|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 33568999999999999999999999999999999999999999775543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.4e-53 Score=344.94 Aligned_cols=240 Identities=25% Similarity=0.428 Sum_probs=198.3
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchH-HHHHHHHH---HHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMD-QMQDILHE---AAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~-~~~~~~~e---~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
++|+ +++.||+|+||+||+|.+..+|+.||+|++.+...... ....+.+| +..+. ..+||||+++++++..++
T Consensus 4 ddy~--i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~-~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 4 NDFS--VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS-TGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp TTEE--EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHS-SSCCTTBCCEEEEEECSS
T ss_pred HhCe--eeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHh-cCCCCcEEEEEEEEEECC
Confidence 4566 99999999999999999999999999999875432111 12233333 33333 568999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
.+++||||++|++|.+++..+..+++..++.++.|++.|+.|||++|++||||||+||+++.+|.+||+|||++......
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
......|++.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+........ ......+......+|+++++
T Consensus 161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~~ 238 (364)
T d1omwa3 161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELPDSFSPELRS 238 (364)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH-HHSSSCCCCCCSSSCHHHHH
T ss_pred -cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhcccCCCCCCCCCCHHHHH
Confidence 3345679999999999864 56899999999999999999999999876544333222 22222223333478999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
||.+||++||
T Consensus 239 li~~~L~~dP 248 (364)
T d1omwa3 239 LLEGLLQRDV 248 (364)
T ss_dssp HHHHHTCSST
T ss_pred HHHHHcccCH
Confidence 9999999998
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=344.83 Aligned_cols=238 Identities=29% Similarity=0.476 Sum_probs=203.1
Q ss_pred eecceeeEEEe-ecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe---
Q psy12709 7 VNGGYQTLIFC-MPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET--- 82 (253)
Q Consensus 7 ~~~~~~~~~~~-~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--- 82 (253)
+.++|+ +++ .||+|+||+||+|.+..+++.||+|++... ....+|+..+.+..+||||++++++++.
T Consensus 9 i~~~y~--i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 9 IIDDYK--VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp GGGTEE--EEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccCEE--EeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 456777 775 699999999999999999999999998642 2566788887778899999999999975
Q ss_pred -CCeEEEEEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC---CCceEEEeec
Q psy12709 83 -PHEMVLVLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK---DNNIKLCDFG 156 (253)
Q Consensus 83 -~~~~~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~---~~~~~l~df~ 156 (253)
+..+++|||||+||+|.+++..+ ..+++.+++.++.|++.|++|||++|++||||+|+||+++. ++.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 45799999999999999999764 36999999999999999999999999999999999999986 4679999999
Q ss_pred ccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH----HHhhcccccccCC
Q psy12709 157 ISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETF----LNISQCNFSFHED 232 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~i~~~~~~~~~~ 232 (253)
++.............+++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..... ..+......++..
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 160 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp TCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred eeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 998776666666678999999999999999999999999999999999999999876654433 3344455555555
Q ss_pred ccCCCCHHHHHHHHHhcccCC
Q psy12709 233 LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 ~~~~~~~~l~~li~~~l~~dP 253 (253)
....+|+++++||.+||++||
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP 260 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEP 260 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSST
T ss_pred ccccCCHHHHHHHHHHccCCh
Confidence 556789999999999999998
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-52 Score=333.67 Aligned_cols=238 Identities=19% Similarity=0.308 Sum_probs=202.3
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
+.-+|++.+.||+|+||+||+|.++.++..||+|+++..... .+.+.+|+..+. .++||||+++++++..++.+++
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMK-EIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHH-HCCCTTBCCEEEEECSSSSCEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHH-hCCCCCEecCCccEeeCCeeEE
Confidence 334555999999999999999999999999999999765443 347889999998 7799999999999999999999
Q ss_pred EEeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-
Q psy12709 89 VLEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV- 165 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~- 165 (253)
+|||+++|+|.+++... ..+++..++.++.|++.|++|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999999988653 568999999999999999999999999999999999999999999999999998764432
Q ss_pred -cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCC-CCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 166 -EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSP-FAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 166 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p-~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
......+++.|+|||++.+..++.++||||+|+++|+|++|..| +.+.+....+..+..+... +....+|+++.+
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~ 247 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPEGCPEKVYE 247 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHH
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC---CCCccchHHHHH
Confidence 22334578899999999999999999999999999999996555 5566666666555444322 222478999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
||.+||+.||
T Consensus 248 li~~cl~~dP 257 (287)
T d1opja_ 248 LMRACWQWNP 257 (287)
T ss_dssp HHHHHTCSSG
T ss_pred HHHHHcCCCH
Confidence 9999999998
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=331.11 Aligned_cols=232 Identities=22% Similarity=0.344 Sum_probs=197.6
Q ss_pred eecCCCCceEEEEEEec--cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 17 CMPSRGKFASVRKCTHK--ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 17 ~~lg~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
++||+|+||+||+|.++ .+++.||+|+++...........+.+|+..+. .++||||+++++++.. +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ-QLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHH-TCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHH-hCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 47999999999999865 34578999999876655566678999999998 7799999999999865 46789999999
Q ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc----ccccc
Q psy12709 95 DGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV----EVKEI 170 (253)
Q Consensus 95 g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~----~~~~~ 170 (253)
+++|.+++.....+++..+..++.|++.|++|||+++++||||+|+||+++.++.++++|||+++...... .....
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 99999999988889999999999999999999999999999999999999999999999999998654321 12234
Q ss_pred ccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHhc
Q psy12709 171 IGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSCL 249 (253)
Q Consensus 171 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (253)
.+++.|+|||++.+..++.++||||+|+++|+|++ |+.||.+.+..+....+..+..... ...+|+++.+||.+||
T Consensus 171 ~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~~~~li~~cl 247 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PAGCPREMYDLMNLCW 247 (277)
T ss_dssp CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHT
T ss_pred CCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC---CcccCHHHHHHHHHHc
Confidence 67889999999998899999999999999999998 9999999988888887776544332 2478999999999999
Q ss_pred ccCC
Q psy12709 250 VTDP 253 (253)
Q Consensus 250 ~~dP 253 (253)
+.||
T Consensus 248 ~~dp 251 (277)
T d1xbba_ 248 TYDV 251 (277)
T ss_dssp CSST
T ss_pred CCCH
Confidence 9998
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-52 Score=333.49 Aligned_cols=239 Identities=21% Similarity=0.311 Sum_probs=195.4
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCc---eEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKV---EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
.+.|+ +.+.||+|+||+||+|.++.+++ .||+|.+..... ....+.+.+|+..+. .++||||+++++++..++
T Consensus 25 ~~~~~--~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~-~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 25 ISCVK--IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMG-QFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp GGGEE--EEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC-HHHHHHHHHHHHHHT-TCCCTTBCCEEEEECSSS
T ss_pred hhhcE--EeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC-HHHHHHHHHHHHHHH-hCCCCCCccEEEEEeeCC
Confidence 45555 99999999999999999886664 588888765433 344667899999998 779999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
.+++||||+++++|.+++... +.+++.++..++.|++.|+.|||+++++||||+|+||+++.++.+||+|||+++....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999999999988764 4699999999999999999999999999999999999999999999999999986543
Q ss_pred ccc------ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCC
Q psy12709 164 VVE------VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGH 236 (253)
Q Consensus 164 ~~~------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 236 (253)
... .....+++.|+|||.+.+..++.++||||+||++|||+| |+.||.+.+..+....+..+...+.. ..
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~---~~ 257 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP---MD 257 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TT
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---cc
Confidence 221 112346789999999999999999999999999999998 89999999998888887765443322 47
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
+|+++.+||.+||+.||
T Consensus 258 ~~~~l~~li~~cl~~~P 274 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDR 274 (299)
T ss_dssp CCHHHHHHHHHHTCSST
T ss_pred chHHHHHHHHHHcCCCH
Confidence 89999999999999998
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-53 Score=332.26 Aligned_cols=239 Identities=21% Similarity=0.358 Sum_probs=196.7
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.+.|+ +.+.||+|+||+||+|..+ ..||+|+++.........+.+.+|+..+. .++||||++++++... +.++
T Consensus 7 ~~~~~--~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~-~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 7 DGQIT--VGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLR-KTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp TTCCC--CCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHT-TCCCTTBCCEEEEECS-SSCE
T ss_pred cccEE--EEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHH-hCCCCCEeeeeEEEec-cEEE
Confidence 35566 9999999999999999754 46999999877666667788999999998 7799999999998654 5689
Q ss_pred EEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc--
Q psy12709 88 LVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-- 164 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-- 164 (253)
+||||++|++|.+++... ..+++..+..++.|++.|++|||+++++||||||+||+++.++.+||+|||++......
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999999988654 56999999999999999999999999999999999999999999999999999765432
Q ss_pred -ccccccccCccccCccccCCC---CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHh-hcccccc-cCCccCCCC
Q psy12709 165 -VEVKEIIGTPDYVAPEVLSYE---PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNI-SQCNFSF-HEDLFGHIS 238 (253)
Q Consensus 165 -~~~~~~~~~~~~~~PE~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i-~~~~~~~-~~~~~~~~~ 238 (253)
.......+++.|+|||++.+. .++.++||||+|+++|+|++|+.||.+.+.......+ ..+...+ .......+|
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 239 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccch
Confidence 223445789999999998643 4788999999999999999999999987666554443 3332222 233456789
Q ss_pred HHHHHHHHHhcccCC
Q psy12709 239 SQAKDFIQSCLVTDP 253 (253)
Q Consensus 239 ~~l~~li~~~l~~dP 253 (253)
+++.+||.+||+.||
T Consensus 240 ~~l~~li~~cl~~dp 254 (276)
T d1uwha_ 240 KAMKRLMAECLKKKR 254 (276)
T ss_dssp HHHHHHHHHHTCSSG
T ss_pred HHHHHHHHHHcCCCH
Confidence 999999999999998
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=327.21 Aligned_cols=236 Identities=24% Similarity=0.349 Sum_probs=195.8
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.+.|+ +++.||+|+||+||+|.+. ++..||||++....... +++.+|+..+. .++||||+++++++..++.++
T Consensus 4 p~~~~--~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~---~~~~~E~~~l~-~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 4 PSELT--FVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMM-KLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp CSCEE--EEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH---HHHHHHHHHHH-HCCCTTBCCEEEEECSSSSCE
T ss_pred hHHcE--EEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcH---HHHHHHHHHHH-hcCCCCcccccceeccCCceE
Confidence 34555 9999999999999999976 56789999998655443 47889999998 779999999999999999999
Q ss_pred EEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc-
Q psy12709 88 LVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV- 165 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~- 165 (253)
+||||+++++|.+++... ..+++..++.++.|++.|++|||+++++||||+|+||+++.++.+||+|||+++......
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999999999987654 568999999999999999999999999999999999999999999999999998654332
Q ss_pred -cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 166 -EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 166 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
......+++.|+|||++.+..++.++||||+|+++|||++ |.+||...+..+....+..+...... ...|+++.+
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p---~~~~~~l~~ 233 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHVYQ 233 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCC---TTSCHHHHH
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCc---cccCHHHHH
Confidence 2233567899999999999999999999999999999999 67888888888888887775443332 367999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
+|.+||+.||
T Consensus 234 li~~cl~~~p 243 (263)
T d1sm2a_ 234 IMNHCWKERP 243 (263)
T ss_dssp HHHHHTCSSG
T ss_pred HHHHHccCCH
Confidence 9999999998
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=336.31 Aligned_cols=239 Identities=21% Similarity=0.329 Sum_probs=199.9
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCc-----eEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKV-----EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
+|++.+.||+|+||+||+|.+...++ .||+|.+..... ......+.+|+..+.+..+||||+++++++...+.+
T Consensus 38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 45599999999999999999875543 689998875432 233457888999998777999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEE
Q psy12709 87 VLVLEMVPDGELQRLVDIQ-----------------------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNIL 143 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~-----------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~ 143 (253)
++||||+++++|.+++..+ ..+++..++.++.|++.|++|||+++++||||||+||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 196 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence 9999999999999998654 24789999999999999999999999999999999999
Q ss_pred EcCCCceEEEeeccccccccccc---ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy12709 144 LTKDNNIKLCDFGISRVVNDVVE---VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETF 219 (253)
Q Consensus 144 ~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~ 219 (253)
++.++.+||+|||+++....... .....+++.|+|||++.+..++.++||||+||++|+|++ |+.||.+.+..+.+
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~ 276 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 276 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999986543322 234457899999999999999999999999999999998 89999987776666
Q ss_pred HHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 220 LNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 220 ~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
..+......++. ...+|+++++||.+||+.||
T Consensus 277 ~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP 308 (325)
T d1rjba_ 277 YKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDS 308 (325)
T ss_dssp HHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCCh
Confidence 665555444332 24789999999999999998
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-52 Score=328.20 Aligned_cols=239 Identities=22% Similarity=0.357 Sum_probs=202.5
Q ss_pred cceeeEEEe-ecCCCCceEEEEEEecc--CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 9 GGYQTLIFC-MPSRGKFASVRKCTHKI--TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 9 ~~~~~~~~~-~lg~g~~~~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
.+.++.+.+ +||+|+||+||+|.++. ++..||||+++... .....+.+.+|+..+. .++||||+++++++.. +.
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~-~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMH-QLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEES-SS
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHH-hCCCCCEeeEeeeecc-Ce
Confidence 344555888 49999999999998764 44579999997643 3445678899999998 6799999999999865 46
Q ss_pred EEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV 164 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~ 164 (253)
+++||||+++++|.+++.. +..+++..+..++.|++.|+.|||++|++||||+|+||+++.++.+||+|||+++.....
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 8999999999999998754 467999999999999999999999999999999999999999999999999999866432
Q ss_pred cc----ccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCH
Q psy12709 165 VE----VKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 165 ~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
.. .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||.+.+..+....+..+..... ...+|+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~ 239 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPECPP 239 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC---CTTCCH
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCH
Confidence 22 223457889999999998899999999999999999998 9999999888888888877654332 247899
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
++.+||.+||+.||
T Consensus 240 ~l~~li~~cl~~~p 253 (285)
T d1u59a_ 240 ELYALMSDCWIYKW 253 (285)
T ss_dssp HHHHHHHHTTCSSG
T ss_pred HHHHHHHHHcCCCH
Confidence 99999999999998
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-52 Score=323.75 Aligned_cols=236 Identities=23% Similarity=0.350 Sum_probs=206.6
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
.+.|+ +++.||+|+||+||+|.++ ++..||||++++..... .++.+|+..+. .++||||+++++++..++.++
T Consensus 3 ~~~~~--~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~-~l~HpnIv~~~g~~~~~~~~~ 75 (258)
T d1k2pa_ 3 PKDLT--FLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMM-NLSHEKLVQLYGVCTKQRPIF 75 (258)
T ss_dssp CCCCC--CCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH---HHHHHHHHHHH-TCCCTTBCCEEEEECCSSSEE
T ss_pred hHHCE--EeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH---HHHHHHHHHHH-hcCCCceeeEEEEEeeCCceE
Confidence 35566 9999999999999999985 77889999998765544 47889999998 779999999999999999999
Q ss_pred EEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc--
Q psy12709 88 LVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-- 164 (253)
Q Consensus 88 lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-- 164 (253)
+||||+++++|..++.. ...+++..+++++.|++.|++|||++|++|+||+|+||+++.++.+||+|||++......
T Consensus 76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred EEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999999999888654 456899999999999999999999999999999999999999999999999999765432
Q ss_pred ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHH
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKD 243 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 243 (253)
.......+++.|+|||.+.+..++.++||||+|+++|+|+| |+.||.+.+..+....+..+...+.. ...++++.+
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p---~~~~~~l~~ 232 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASEKVYT 232 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC---TTCCHHHHH
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc---ccccHHHHH
Confidence 22234567889999999999999999999999999999998 89999999999998888776443333 478999999
Q ss_pred HHHHhcccCC
Q psy12709 244 FIQSCLVTDP 253 (253)
Q Consensus 244 li~~~l~~dP 253 (253)
||.+||+.||
T Consensus 233 li~~cl~~dP 242 (258)
T d1k2pa_ 233 IMYSCWHEKA 242 (258)
T ss_dssp HHHHTTCSSG
T ss_pred HHHHHccCCH
Confidence 9999999998
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-52 Score=331.00 Aligned_cols=238 Identities=27% Similarity=0.374 Sum_probs=199.5
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccch---HHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEe
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM---DQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLE 91 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 91 (253)
.++.||+|+||+||+|.++.+|+.||+|++....... .....+.+|+..++ ..+||||+++++++..++.+++|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ-ELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHH-HCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHH-hCCCCCEeEEEeeeccCCceeehhh
Confidence 5789999999999999999999999999997654322 12356889999998 7899999999999999999999999
Q ss_pred ccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-cccccc
Q psy12709 92 MVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEVKEI 170 (253)
Q Consensus 92 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~~~ 170 (253)
|+.|+++..+...+..+++..++.++.|++.|++|||++|++||||||+||+++.++.+||+|||.+...... ......
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~ 160 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 160 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence 9999888888776777999999999999999999999999999999999999999999999999999865443 233445
Q ss_pred ccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC------------------
Q psy12709 171 IGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE------------------ 231 (253)
Q Consensus 171 ~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~------------------ 231 (253)
.+++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+...++.....++..
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ua2a_ 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240 (299)
T ss_dssp CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccC
Confidence 78999999999865 45799999999999999999999999999888887776543222211
Q ss_pred ------CccCCCCHHHHHHHHHhcccCC
Q psy12709 232 ------DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 232 ------~~~~~~~~~l~~li~~~l~~dP 253 (253)
...+.+|+++.+||.+||+.||
T Consensus 241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP 268 (299)
T d1ua2a_ 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNP 268 (299)
T ss_dssp CCCCHHHHCTTCCHHHHHHHHHHHCSST
T ss_pred CCCChHHhcccCCHHHHHHHHHHccCCh
Confidence 1224678999999999999998
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=323.59 Aligned_cols=235 Identities=20% Similarity=0.357 Sum_probs=199.1
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
.-+|++.+.||+|+||+||+|.++ ++..||||++....... +.+.+|+..+. .++||||+++++++.. +.+++|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~---~~~~~E~~~l~-~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP---DAFLAEANLMK-QLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCH---HHHHHHHHHHH-HCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCH---HHHHHHHHHHH-hCCCCCEeEEEeeecc-CCeEEE
Confidence 334559999999999999999976 67789999998655443 46889999998 6699999999998754 567899
Q ss_pred EeccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc--
Q psy12709 90 LEMVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-- 165 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-- 165 (253)
|||+++|+|.+++... ..+++..++.++.|++.|+.|||+++++||||||+||+++.++.+||+|||+++......
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999999999876543 358999999999999999999999999999999999999999999999999998764332
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
......+++.|+|||++.+..++.++||||+|+++|+|+| |.+|+...+..+....+..+...... ..+|+++.+|
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p---~~~~~~l~~l 242 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP---DNCPEELYQL 242 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---TTCCHHHHHH
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCc---ccChHHHHHH
Confidence 2334567889999999988889999999999999999999 56677777887888777765443322 4789999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||+.||
T Consensus 243 i~~cl~~~P 251 (272)
T d1qpca_ 243 MRLCWKERP 251 (272)
T ss_dssp HHHHTCSSG
T ss_pred HHHHcCCCH
Confidence 999999998
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-51 Score=324.62 Aligned_cols=242 Identities=27% Similarity=0.393 Sum_probs=199.3
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +++.||+|+||+||+|.+..+++.||+|+++...........+.+|+.+++ .++||||+++++++..++.+++
T Consensus 2 d~Y~--~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~-~l~Hp~Iv~~~~~~~~~~~~~i 78 (298)
T d1gz8a_ 2 ENFQ--KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK-ELNHPNIVKLLDVIHTENKLYL 78 (298)
T ss_dssp TTEE--EEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCE--eccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHH-hCCCCcEEEeccccccccceeE
Confidence 4566 999999999999999999999999999999776544444568889999998 7899999999999999999999
Q ss_pred EEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-cc
Q psy12709 89 VLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VE 166 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~ 166 (253)
|||++.++.+...... ...+++..++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||.+...... ..
T Consensus 79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 9999976555444333 456999999999999999999999999999999999999999999999999999866433 33
Q ss_pred ccccccCccccCccccCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC--------------
Q psy12709 167 VKEIIGTPDYVAPEVLSYEP-ISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE-------------- 231 (253)
Q Consensus 167 ~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-------------- 231 (253)
.....+++.|+|||.+.... ++.++|+||+|+++|+|++|+.||.+.+..+...++......+.+
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 44457899999999876655 578999999999999999999999998887777665432222111
Q ss_pred -----------CccCCCCHHHHHHHHHhcccCC
Q psy12709 232 -----------DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 232 -----------~~~~~~~~~l~~li~~~l~~dP 253 (253)
...+.+|+++.+||++||++||
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP 271 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 271 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSST
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCCh
Confidence 1224678999999999999998
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-51 Score=325.98 Aligned_cols=244 Identities=27% Similarity=0.409 Sum_probs=202.3
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccC-CceEEEEEecccccchHHHHHHHHHHHHHHHh--cCCCCceeeeeEEEe--
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKIT-KVEYAAKFIRKRRRSMDQMQDILHEAAVLYLA--QKSERIVGLHEIYET-- 82 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~--~~~~~i~~~~~~~~~-- 82 (253)
+++|+ +++.||+|+||+||+|.+..+ ++.||+|+++.............+|+..++.+ .+||||+++++++..
T Consensus 6 ~~~Y~--i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 6 DQQYE--CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGTEE--EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred cCCEE--EEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 46676 999999999999999999765 56799999977654433334556677766643 489999999999853
Q ss_pred ---CCeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccc
Q psy12709 83 ---PHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGIS 158 (253)
Q Consensus 83 ---~~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~ 158 (253)
+..+++++|+++++.+...... ...+++..++.++.|++.|++|||++|++||||||+||+++.++.++|+|||.+
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 3478999999988877654443 456899999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccc----------
Q psy12709 159 RVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFS---------- 228 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~---------- 228 (253)
.............+++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+.+.++......
T Consensus 164 ~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 164 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 8776666666778999999999999999999999999999999999999999998888777766432111
Q ss_pred -------------ccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 229 -------------FHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 229 -------------~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+.......+|+++++||.+||++||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP 281 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNP 281 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSST
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCCh
Confidence 1122345689999999999999998
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-51 Score=322.53 Aligned_cols=233 Identities=27% Similarity=0.447 Sum_probs=195.4
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccch----HHHHHHHHHHHHHHHhc-CCCCceeeeeEEEe
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSM----DQMQDILHEAAVLYLAQ-KSERIVGLHEIYET 82 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~ 82 (253)
.++|+ +.+.||+|+||+||+|.+..++..||+|++.+..... ....++.+|+..+.+.. .||||+++++++..
T Consensus 3 ~~~Y~--i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 3 ESQYQ--VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp TTTEE--EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CCeEE--EeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence 46677 9999999999999999999999999999987643211 11234567888888554 48999999999999
Q ss_pred CCeEEEEEeccCC-CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCC-CceEEEeeccccc
Q psy12709 83 PHEMVLVLEMVPD-GELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKD-NNIKLCDFGISRV 160 (253)
Q Consensus 83 ~~~~~lv~e~~~g-~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~-~~~~l~df~~~~~ 160 (253)
++..++|||++.+ +++.+++..+..+++.+++.++.|++.|+.|||++|++||||||+||+++.+ +.++|+|||++..
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 9999999999976 5788888888889999999999999999999999999999999999999854 7999999999976
Q ss_pred ccccccccccccCccccCccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCH
Q psy12709 161 VNDVVEVKEIIGTPDYVAPEVLSYEPI-SLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
.... ......|++.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+ .+.......+ ..+|+
T Consensus 161 ~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~----~~~s~ 229 (273)
T d1xwsa_ 161 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR----QRVSS 229 (273)
T ss_dssp CCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS----SCCCH
T ss_pred cccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCC----CCCCH
Confidence 5443 2334578999999999977665 567999999999999999999997532 2344444333 37899
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
++++||.+||++||
T Consensus 230 ~~~~li~~~L~~dp 243 (273)
T d1xwsa_ 230 ECQHLIRWCLALRP 243 (273)
T ss_dssp HHHHHHHHHTCSSG
T ss_pred HHHHHHHHHccCCH
Confidence 99999999999998
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=317.56 Aligned_cols=238 Identities=21% Similarity=0.335 Sum_probs=193.1
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCC---ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITK---VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
+-+|++.+.||+|+||+||+|.+..++ ..||+|.++... .......+.+|+..+. .++||||+++++++. ++.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMR-QFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEC-SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEe-cCeE
Confidence 334559999999999999999987543 468888886533 3445677889999998 779999999999986 4678
Q ss_pred EEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-
Q psy12709 87 VLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV- 164 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~- 164 (253)
++||||++++++.+++.. ...+++..++.++.|++.|+.|||+++++||||+|+||+++.++.+||+|||+++.....
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999999999987665 456899999999999999999999999999999999999999999999999999865432
Q ss_pred -ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHH
Q psy12709 165 -VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAK 242 (253)
Q Consensus 165 -~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~ 242 (253)
.......+++.|+|||++.+..++.++||||+|+++|+|++ |.+||.+.+..+....+..+...+ ..+.+|+++.
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~---~~~~~~~~~~ 239 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNCPPTLY 239 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTCCHHHH
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHH
Confidence 22334467889999999999999999999999999999998 899999999998888887765433 2358899999
Q ss_pred HHHHHhcccCC
Q psy12709 243 DFIQSCLVTDP 253 (253)
Q Consensus 243 ~li~~~l~~dP 253 (253)
+||.+||+.||
T Consensus 240 ~li~~cl~~dp 250 (273)
T d1mp8a_ 240 SLMTKCWAYDP 250 (273)
T ss_dssp HHHHHHTCSSG
T ss_pred HHHHHHcCCCH
Confidence 99999999998
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-50 Score=316.39 Aligned_cols=236 Identities=22% Similarity=0.319 Sum_probs=193.1
Q ss_pred eEEEeecCCCCceEEEEEEeccCC----ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITK----VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
|++.+.||+|+||+||+|.++.++ ..||||.+..... ......+.+|+..+. .++||||+++++++..++..++
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~-~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMG-QFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHH-TCCCTTBCCEEEEECSSSSEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC-hHHHHHHHHHHHHHH-hcCCCCEeeeeEEEecCCceEE
Confidence 449999999999999999987554 4699999875443 344567889999998 7799999999999999999999
Q ss_pred EEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc--
Q psy12709 89 VLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-- 165 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-- 165 (253)
+||++.++++.+.+... ..+++..+..++.|++.|+.|||+++++||||||+||+++.++.+||+|||+++......
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 99999999998877654 569999999999999999999999999999999999999999999999999998654321
Q ss_pred --cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhhcccccccCCccCCCCHHHH
Q psy12709 166 --EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAK 242 (253)
Q Consensus 166 --~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~ 242 (253)
......+++.|+|||++.+..++.++||||+|+++|||++| .+|+...+..+.+..+..+...+.. ..+|+++.
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~---~~~~~~l~ 243 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP---MDCPSAIY 243 (283)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTCBHHHH
T ss_pred ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCc---hhhHHHHH
Confidence 22234578899999999999999999999999999999995 5556667777777776665433222 37899999
Q ss_pred HHHHHhcccCC
Q psy12709 243 DFIQSCLVTDP 253 (253)
Q Consensus 243 ~li~~~l~~dP 253 (253)
+||.+||+.||
T Consensus 244 ~li~~cl~~~p 254 (283)
T d1mqba_ 244 QLMMQCWQQER 254 (283)
T ss_dssp HHHHHHTCSST
T ss_pred HHHHHHCcCCH
Confidence 99999999998
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-50 Score=315.98 Aligned_cols=235 Identities=22% Similarity=0.307 Sum_probs=193.5
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
.-+|++.+.||+|+||+||+|.++.+ ..||||+++...... +.+.+|+..+. .++|+||+++++++.+ +.+++|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~---~~~~~E~~~l~-~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMK-KLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCH---HHHHHHHHHHH-HCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCH---HHHHHHHHHHH-hcccCCEeEEEEEEec-CCeEEE
Confidence 34455999999999999999998744 579999998655433 46889999988 7899999999999854 568899
Q ss_pred EeccCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccc--
Q psy12709 90 LEMVPDGELQRLVDI--QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVV-- 165 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~-- 165 (253)
|||+++|+|..++.. ...+++.+++.++.+++.|++|||++|++|+||+|+||+++.++.+||+|||++.......
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 999999999887754 3569999999999999999999999999999999999999999999999999998654322
Q ss_pred cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHH
Q psy12709 166 EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDF 244 (253)
Q Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~l 244 (253)
......+++.|+|||++.+..++.++||||+|+++|+|++| .+|+......+....+......+ ....+|++++++
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~l 246 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---CPPECPESLHDL 246 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTSCHHHHHH
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC---CCcccCHHHHHH
Confidence 22335678999999999999999999999999999999995 56667777777777776654322 235889999999
Q ss_pred HHHhcccCC
Q psy12709 245 IQSCLVTDP 253 (253)
Q Consensus 245 i~~~l~~dP 253 (253)
|.+||+.||
T Consensus 247 i~~cl~~dP 255 (285)
T d1fmka3 247 MCQCWRKEP 255 (285)
T ss_dssp HHHHTCSSG
T ss_pred HHHHcccCH
Confidence 999999998
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.5e-50 Score=319.05 Aligned_cols=241 Identities=25% Similarity=0.395 Sum_probs=201.8
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEE
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVL 88 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 88 (253)
++|+ +++.||+|+||+||+|.++ +++.||+|++............+.+|+.+++ .++||||+++++.+..++..++
T Consensus 2 ~~Y~--~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~~~i 77 (286)
T d1ob3a_ 2 EKYH--GLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILK-ELKHSNIVKLYDVIHTKKRLVL 77 (286)
T ss_dssp CSEE--EEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGG-GCCCTTBCCEEEEEECSSCEEE
T ss_pred CCce--eccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHH-hCCCCcEEeeeeecccCCceeE
Confidence 3565 9999999999999999986 7899999999876555555678889999998 7799999999999999999999
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-ccc
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEV 167 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~ 167 (253)
+++++.++.+..+......+++..++.++.|++.||+|||++|++||||||+||+++.++.+|++|||.+...... ...
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 9999988777777777788999999999999999999999999999999999999999999999999999876443 223
Q ss_pred cccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc----------------
Q psy12709 168 KEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH---------------- 230 (253)
Q Consensus 168 ~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---------------- 230 (253)
....+++.|.|||.+.+. .++.++|+||+|+++|+|++|+.||.+.+..+...++......+.
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 444678999999998654 568999999999999999999999998887777666543211111
Q ss_pred ---------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 ---------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 ---------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
......+|+++++||++||++||
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP 269 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSST
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCCh
Confidence 12335679999999999999998
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=316.34 Aligned_cols=244 Identities=19% Similarity=0.325 Sum_probs=203.4
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCC-------ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeee
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITK-------VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHE 78 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-------~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~ 78 (253)
|..+.-+|++.+.||+|+||+||+|.+...+ ..||+|++++... ......+.+|...+.+..+||||+++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC-hHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence 5444455669999999999999999976544 4699999976543 4446788888888887889999999999
Q ss_pred EEEeCCeEEEEEeccCCCcHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q psy12709 79 IYETPHEMVLVLEMVPDGELQRLVDIQD----------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNI 142 (253)
Q Consensus 79 ~~~~~~~~~lv~e~~~g~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni 142 (253)
++.+++.+++||||+++++|.+++.... .+++..++.++.|++.|++|||+++++||||||+||
T Consensus 87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166 (299)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence 9999999999999999999999996542 489999999999999999999999999999999999
Q ss_pred EEcCCCceEEEeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHH
Q psy12709 143 LLTKDNNIKLCDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQET 218 (253)
Q Consensus 143 ~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~ 218 (253)
+++.++.+||+|||.+....... ......+++.|+|||.+.++.++.++||||+|+++|+|++ |..||.+.+..+.
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 99999999999999998664432 2333567889999999999999999999999999999998 7999999888888
Q ss_pred HHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 219 FLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 219 ~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+..+..+..... ...+|+++.+||.+||+.||
T Consensus 247 ~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~dP 278 (299)
T d1fgka_ 247 FKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVP 278 (299)
T ss_dssp HHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSG
T ss_pred HHHHHcCCCCCC---CccchHHHHHHHHHHccCCH
Confidence 877766543322 24789999999999999998
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-50 Score=315.59 Aligned_cols=241 Identities=21% Similarity=0.323 Sum_probs=193.9
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccC-C--ceEEEEEeccccc-chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKIT-K--VEYAAKFIRKRRR-SMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~--~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
..+.|+ +++.||+|+||+||+|..... + ..||+|++.+... .....+.+.+|+..+. ..+||||+++++++..
T Consensus 6 ~~~d~~--~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~-~l~H~nIv~~~g~~~~ 82 (273)
T d1u46a_ 6 GEKDLR--LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH-SLDHRNLIRLYGVVLT 82 (273)
T ss_dssp CGGGEE--EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHH-HCCCTTBCCEEEEECS
T ss_pred chHHeE--EEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHH-hCCCCCEEEEEEEEee
Confidence 344555 999999999999999986533 2 3689999876543 3344678899999998 6699999999999976
Q ss_pred CCeEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccc
Q psy12709 83 PHEMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVV 161 (253)
Q Consensus 83 ~~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~ 161 (253)
+..++||||++++++.+.+.. ...+++..++.++.|++.|+.|||++|++||||+|+||+++.++.+||+|||++...
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred -cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 467899999999999887655 456999999999999999999999999999999999999999999999999999876
Q ss_pred cccc----cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCC
Q psy12709 162 NDVV----EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGH 236 (253)
Q Consensus 162 ~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 236 (253)
.... ......++..|+|||++.+..++.++||||+|+++|||++ |+.||.+.+..+....+......++. ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~ 239 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PED 239 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTT
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC--ccc
Confidence 4322 1223346779999999999999999999999999999998 89999999999998888776554433 357
Q ss_pred CCHHHHHHHHHhcccCC
Q psy12709 237 ISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 237 ~~~~l~~li~~~l~~dP 253 (253)
+|+++.+||.+||+.||
T Consensus 240 ~~~~l~~li~~cl~~dp 256 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKP 256 (273)
T ss_dssp CCHHHHHHHHHHTCSSG
T ss_pred ccHHHHHHHHHHcCCCh
Confidence 89999999999999998
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=323.10 Aligned_cols=243 Identities=28% Similarity=0.423 Sum_probs=206.3
Q ss_pred cceeeEEEeecCCCCceEEEEEEec---cCCceEEEEEeccccc--chHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHK---ITKVEYAAKFIRKRRR--SMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP 83 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 83 (253)
++|+ +++.||+|+||+||+|.+. .+|+.||+|++.+... .......+.+|+..+.++..||||+++++++...
T Consensus 24 ~~y~--~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 24 ENFE--LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp GGEE--EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred hceE--EEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 5566 9999999999999999874 4689999999876542 2223456788999999777779999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 84 HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 84 ~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
..+++++|++.+++|.+.+.....+++..++.++.|++.|+.|+|++|++|+||+|+||+++.+|.++|+|||++.....
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999976543
Q ss_pred c--ccccccccCccccCccccCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCccCCCCH
Q psy12709 164 V--VEVKEIIGTPDYVAPEVLSYE--PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 164 ~--~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
. .......+++.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.+..+....+..............+|+
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 261 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 261 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCH
Confidence 2 233445788999999998665 467899999999999999999999988776666666655544444444458999
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
++++||.+||++||
T Consensus 262 ~~~~li~~~l~~dP 275 (322)
T d1vzoa_ 262 LAKDLIQRLLMKDP 275 (322)
T ss_dssp HHHHHHHHHTCSSG
T ss_pred HHHHHHHHHcccCH
Confidence 99999999999998
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=318.88 Aligned_cols=240 Identities=22% Similarity=0.314 Sum_probs=201.9
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCce--EEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVE--YAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~--v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
.+.|+ +.+.||+|+||+||+|.++.++.. |+||.+..... ....+.+.+|+..+.++.+||||+++++++..++.
T Consensus 9 ~~~~~--~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 9 WNDIK--FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp GGGCE--EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred HHHcE--EEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 35566 999999999999999999988764 66777654322 23456789999999966689999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQ----------------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN 149 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~ 149 (253)
+++||||+++++|.+++..+ ..+++..+..++.|++.|+.|+|+++++||||+|+||+++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 99999999999999998643 46899999999999999999999999999999999999999999
Q ss_pred eEEEeecccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhhccccc
Q psy12709 150 IKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQCNFS 228 (253)
Q Consensus 150 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~i~~~~~~ 228 (253)
+||+|||++.............++..|+|||.+.+..++.++||||+|+++|+|++| .+||.+.+..+....+..+...
T Consensus 166 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~ 245 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 245 (309)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC
T ss_pred eEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC
Confidence 999999999866554444555688999999999999999999999999999999996 5689999988888888765433
Q ss_pred ccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 229 FHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.. ...+|+++.+||.+||+.||
T Consensus 246 ~~---~~~~~~~~~~li~~cl~~dP 267 (309)
T d1fvra_ 246 EK---PLNCDDEVYDLMRQCWREKP 267 (309)
T ss_dssp CC---CTTBCHHHHHHHHHHTCSSG
T ss_pred CC---CccCCHHHHHHHHHHcCCCh
Confidence 22 24789999999999999998
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-49 Score=316.78 Aligned_cols=243 Identities=26% Similarity=0.348 Sum_probs=200.8
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe-----
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET----- 82 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----- 82 (253)
.++|+ +++.||+|+||+||+|.+..+|+.||||++............+.+|+.+++ ..+|+||+++++++..
T Consensus 9 ~~rY~--i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~-~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 9 VSKYE--KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ-LLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp GGGEE--EEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHH-HCCCTTBCCEEEEEEC-----
T ss_pred cCCEE--EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHH-HhcCCCccceEeeeecccccc
Confidence 36777 999999999999999999999999999999876655555677889999998 6789999999999855
Q ss_pred ---CCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 83 ---PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 83 ---~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
++.++++||++.++.+.........+++..++.++.|++.|+.|||++|++||||+|+||+++.++.++++|||++.
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 34689999999888777776666779999999999999999999999999999999999999999999999999997
Q ss_pred ccccc-----ccccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCCc
Q psy12709 160 VVNDV-----VEVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHEDL 233 (253)
Q Consensus 160 ~~~~~-----~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 233 (253)
..... .......+++.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+......++...
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 65432 122334689999999998655 688999999999999999999999999888888777655444333322
Q ss_pred cC----------------------------CCCHHHHHHHHHhcccCC
Q psy12709 234 FG----------------------------HISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 234 ~~----------------------------~~~~~l~~li~~~l~~dP 253 (253)
.. ..++++.+||.+||++||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP 293 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 293 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSST
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCCh
Confidence 11 137788999999999998
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-49 Score=319.59 Aligned_cols=240 Identities=23% Similarity=0.385 Sum_probs=198.7
Q ss_pred eecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC--
Q psy12709 7 VNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH-- 84 (253)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-- 84 (253)
+.++|+ +++.||+|+||+||+|.++.+|+.||+|++++..........+.+|+..+. .++||||+++++++...+
T Consensus 16 ~~~~Y~--~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~-~l~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 16 VRAVYR--DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK-HMRHENVIGLLDVFTPDETL 92 (346)
T ss_dssp CBSSEE--EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHH-HCCBTTBCCCSEEECSCSST
T ss_pred cCCcEE--EEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHH-hcCCCCeeEEEEEeccCccc
Confidence 466676 999999999999999999999999999999877666677788999999998 779999999999998655
Q ss_pred ----eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 85 ----EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 85 ----~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
.+++||||+ |.+|..+.. +..+++..++.++.|++.||+|||++|++|+||||+||+++.++.++++|||.+..
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence 579999999 668887765 55699999999999999999999999999999999999999999999999999986
Q ss_pred ccccccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhccccccc---------
Q psy12709 161 VNDVVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFH--------- 230 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--------- 230 (253)
.... .....+++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+....+..+......++
T Consensus 171 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 171 ADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp CCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred cCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 6543 334578999999999865 4568999999999999999999999998877766554433222211
Q ss_pred ------------------CCccCCCCHHHHHHHHHhcccCC
Q psy12709 231 ------------------EDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 231 ------------------~~~~~~~~~~l~~li~~~l~~dP 253 (253)
......+|+++.+||.+||+.||
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP 289 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 289 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSST
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCCh
Confidence 12335679999999999999998
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=316.87 Aligned_cols=237 Identities=21% Similarity=0.292 Sum_probs=193.7
Q ss_pred cceeeEEEeecCCCCceEEEEEEeccCCc----eEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 9 GGYQTLIFCMPSRGKFASVRKCTHKITKV----EYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
+.|+ +++.||+|+||+||+|.+..+|+ +||+|.+..... ....+.+.+|+..+. .++||||+++++++..+
T Consensus 9 ~dy~--~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~-~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 9 TEFK--KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMA-SVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp TTEE--EEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHH-HCCCTTBCCEEEEEESS-
T ss_pred HHCE--EeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC-HHHHHHHHHHHHHHH-hCCCCCEeeEEEEEecC-
Confidence 4455 99999999999999999887765 578887764332 233567899999998 67999999999999875
Q ss_pred eEEEEEeccCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccc
Q psy12709 85 EMVLVLEMVPDGELQRLVDI-QDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVND 163 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~ 163 (253)
..+++++++.+++|.+.+.. ...+++..++.++.|++.|+.|||++|++||||+|+||+++.++.+||+|||++.....
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 56677788888888876665 46799999999999999999999999999999999999999999999999999986543
Q ss_pred cc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCH
Q psy12709 164 VV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISS 239 (253)
Q Consensus 164 ~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (253)
.. ......+++.|+|||++.+..++.++||||+|+++|+|+| |+.||.+.+..+....+..+...+.. +.+|+
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p---~~~~~ 240 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP---PICTI 240 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCC---TTBCH
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC---cccCH
Confidence 22 2223457899999999999999999999999999999998 89999998888887777665433222 47899
Q ss_pred HHHHHHHHhcccCC
Q psy12709 240 QAKDFIQSCLVTDP 253 (253)
Q Consensus 240 ~l~~li~~~l~~dP 253 (253)
++.+||.+||+.||
T Consensus 241 ~~~~li~~cl~~dP 254 (317)
T d1xkka_ 241 DVYMIMVKCWMIDA 254 (317)
T ss_dssp HHHHHHHHHTCSSG
T ss_pred HHHHHHHHhCCCCh
Confidence 99999999999998
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.2e-49 Score=313.94 Aligned_cols=237 Identities=20% Similarity=0.319 Sum_probs=203.6
Q ss_pred eeEEEeecCCCCceEEEEEEec-----cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHK-----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
+|++.+.||+|+||+||+|..+ .++..||||++.... ......++.+|+..+. .++|+||+++++++..++..
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~-~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMA-EFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHH-TCCCTTBCCEEEEECSSSSC
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHH-hcCCCCcccceeeeccCCce
Confidence 3459999999999999999975 355789999987543 3445678899999998 78999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q psy12709 87 VLVLEMVPDGELQRLVDIQD------------------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNI 142 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~------------------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni 142 (253)
++++|++++++|.+++.... .++...+..++.|++.|++|||+++++||||+|+||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI 171 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 171 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence 99999999999999886432 378899999999999999999999999999999999
Q ss_pred EEcCCCceEEEeeccccccccc---ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCC-CCCCCCChHHH
Q psy12709 143 LLTKDNNIKLCDFGISRVVNDV---VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSH-SPFAGDNKQET 218 (253)
Q Consensus 143 ~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~-~p~~~~~~~~~ 218 (253)
+++.++.+||+|||++...... .......+++.|+|||.+.+..++.++||||+|+++|+|++|. .||.+.+..+.
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~ 251 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHH
Confidence 9999999999999999765432 2223456788999999999999999999999999999999985 78999999998
Q ss_pred HHHhhcccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 219 FLNISQCNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 219 ~~~i~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
...+..+..+.. ...+|+++.+||.+||+.||
T Consensus 252 ~~~v~~~~~~~~---p~~~~~~~~~li~~cl~~~P 283 (301)
T d1lufa_ 252 IYYVRDGNILAC---PENCPLELYNLMRLCWSKLP 283 (301)
T ss_dssp HHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHHcCCCCCC---CccchHHHHHHHHHHcCCCh
Confidence 888887665432 24789999999999999998
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=314.81 Aligned_cols=238 Identities=21% Similarity=0.347 Sum_probs=187.7
Q ss_pred eeEEEeecCCCCceEEEEEEecc-----CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC-Ce
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKI-----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP-HE 85 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~ 85 (253)
+|++.+.||+|+||+||+|.+.. +++.||+|++..... ....+.+.+|...+.+..+|+||+.+++++..+ +.
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 34499999999999999999764 346799999875443 344567788888888788999999999987665 47
Q ss_pred EEEEEeccCCCcHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQ----------------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNN 149 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~ 149 (253)
++++|||+++++|.+++... ..+++..++.++.|++.|++|||++|++||||||+||+++.++.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~ 172 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 172 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc
Confidence 89999999999999998643 24889999999999999999999999999999999999999999
Q ss_pred eEEEeecccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhC-CCCCCCCChHHHHHH-hhc
Q psy12709 150 IKLCDFGISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLN-ISQ 224 (253)
Q Consensus 150 ~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~-i~~ 224 (253)
+||+|||+++...... ......+++.|+|||++.+..++.++||||+||++|+|++| ..||.+....+.+.. +..
T Consensus 173 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~ 252 (299)
T d1ywna1 173 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 252 (299)
T ss_dssp EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHH
T ss_pred EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 9999999997554322 22345688999999999999999999999999999999986 578887665544443 333
Q ss_pred ccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 225 CNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 225 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+.. ++ ....+|++++++|.+||+.||
T Consensus 253 ~~~-~~--~~~~~~~~l~~li~~cl~~dP 278 (299)
T d1ywna1 253 GTR-MR--APDYTTPEMYQTMLDCWHGEP 278 (299)
T ss_dssp TCC-CC--CCTTCCHHHHHHHHHHTCSSG
T ss_pred CCC-CC--CCccCCHHHHHHHHHHcCCCh
Confidence 322 22 224789999999999999998
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=309.08 Aligned_cols=229 Identities=20% Similarity=0.313 Sum_probs=190.7
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe-CCeEEEEEe
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET-PHEMVLVLE 91 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e 91 (253)
|++.+.||+|+||.||+|..+ +..||+|+++.... .+.+.+|+..+. .++||||+++++++.+ .+.+++|||
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~----~~~~~~E~~~l~-~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT----AQAFLAEASVMT-QLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHT-TCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred eEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHH----HHHHHHHHHHHH-hCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 449999999999999999985 77899999976432 357889999998 7799999999998854 457899999
Q ss_pred ccCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecccccccccccccc
Q psy12709 92 MVPDGELQRLVDIQ--DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDVVEVKE 169 (253)
Q Consensus 92 ~~~g~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (253)
|+++++|.+++..+ ..+++..++.++.|++.|+.|||+++++|+||+|+||+++.++.++++|||.++...... ..
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--~~ 159 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DT 159 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCC--cc
Confidence 99999999998654 358999999999999999999999999999999999999999999999999998654432 23
Q ss_pred cccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcccccccCCccCCCCHHHHHHHHHh
Q psy12709 170 IIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQCNFSFHEDLFGHISSQAKDFIQSC 248 (253)
Q Consensus 170 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (253)
..+++.|+|||++.+..++.++||||+|+++|+|++ |++||...+..+....+..+..+. ....+++++++||.+|
T Consensus 160 ~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~~~~li~~c 236 (262)
T d1byga_ 160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---APDGCPPAVYEVMKNC 236 (262)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC---CCTTCCHHHHHHHHHH
T ss_pred ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCccCCHHHHHHHHHH
Confidence 456889999999988899999999999999999998 799999988888888876654332 2347899999999999
Q ss_pred cccCC
Q psy12709 249 LVTDP 253 (253)
Q Consensus 249 l~~dP 253 (253)
|+.||
T Consensus 237 l~~dP 241 (262)
T d1byga_ 237 WHLDA 241 (262)
T ss_dssp TCSSG
T ss_pred cccCH
Confidence 99998
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=316.19 Aligned_cols=245 Identities=28% Similarity=0.446 Sum_probs=197.4
Q ss_pred CcceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 3 NKFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
+.+-++.+|+ +++.||+|+||+||+|.+..++..||||++.+.. .......+.+|+.+++ .++|+||+++++++..
T Consensus 2 ~~~~i~~rY~--~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~-~l~hp~iv~~~~~~~~ 77 (345)
T d1pmea_ 2 QVFDVGPRYT--NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILL-RFRHENIIGINDIIRA 77 (345)
T ss_dssp CCCCCCTTEE--EEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHH-HCCCTTBCCCCEEECC
T ss_pred CccCcCCCeE--EEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHH-HcCCCCCCcEEEEEee
Confidence 4455667777 9999999999999999999999999999997644 3444668889999998 7799999999999976
Q ss_pred CC-----eEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecc
Q psy12709 83 PH-----EMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI 157 (253)
Q Consensus 83 ~~-----~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~ 157 (253)
.. .+++++ ++.|++|.+++.. ..+++..++.++.|++.|++|||++|++||||||+||+++.++.+||+|||+
T Consensus 78 ~~~~~~~~~~l~~-~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 78 PTIEQMKDVYLVT-HLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp SSTTTCCCEEEEE-ECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ccccccceEEEEE-eecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCc
Confidence 53 345554 5668999999874 4699999999999999999999999999999999999999999999999999
Q ss_pred cccccccc----cccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc---
Q psy12709 158 SRVVNDVV----EVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF--- 229 (253)
Q Consensus 158 ~~~~~~~~----~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--- 229 (253)
+....... ......+++.|+|||++.. ..++.++||||+|+++|+|++|+.||.+.+..+...........+
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235 (345)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence 97654322 2344568899999999844 467889999999999999999999999887765554432211111
Q ss_pred ------------------------cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 ------------------------HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 ------------------------~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.....+.+|+++++||.+||+.||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 283 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP 283 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSST
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCCh
Confidence 112345788999999999999998
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-48 Score=311.13 Aligned_cols=242 Identities=19% Similarity=0.212 Sum_probs=192.9
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH 84 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 84 (253)
+-++++|+ +.+.||+|+||+||+|.+..+++.||+|++...... ..+..|+..+.....|++|+.+..++..++
T Consensus 3 ~~vg~rY~--l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 3 LRVGNRYR--LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp CEETTTEE--EEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred CeECCEEE--EeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 45678888 999999999999999999999999999998764432 246778888885656666778888888889
Q ss_pred eEEEEEeccCCCcHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC---CCceEEEeeccccc
Q psy12709 85 EMVLVLEMVPDGELQRLV-DIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK---DNNIKLCDFGISRV 160 (253)
Q Consensus 85 ~~~lv~e~~~g~~L~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~---~~~~~l~df~~~~~ 160 (253)
..++|||++.+ ++...+ .....+++..+..++.|++.|++|||++|++||||||+||+++. +..++++|||++..
T Consensus 77 ~~~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 77 YNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEEEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 99999999955 555544 44567999999999999999999999999999999999999864 45799999999986
Q ss_pred ccccc--------cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHh---hccc-cc
Q psy12709 161 VNDVV--------EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNI---SQCN-FS 228 (253)
Q Consensus 161 ~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i---~~~~-~~ 228 (253)
..... ......+++.|+|||++.+..++.++||||+|+++|+|++|+.||...........+ .... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 64321 223457899999999999999999999999999999999999999876554433322 1211 12
Q ss_pred ccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 229 FHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
+.+.....+|+++.++|.+||+.||
T Consensus 236 ~~~~~~~~~p~~~~~li~~cl~~~p 260 (299)
T d1ckia_ 236 PIEVLCKGYPSEFATYLNFCRSLRF 260 (299)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHSCT
T ss_pred ChhHhccCCCHHHHHHHHHHccCCh
Confidence 2233445899999999999999998
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.5e-48 Score=308.71 Aligned_cols=241 Identities=19% Similarity=0.260 Sum_probs=199.7
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCe
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHE 85 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 85 (253)
+++++|+ +.+.||+|+||+||+|.+..+++.||+|++...... ..+.+|+..+..+.++++++.+++++..+..
T Consensus 2 vig~~Y~--i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 75 (293)
T d1csna_ 2 VVGVHYK--VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 75 (293)
T ss_dssp EETTTEE--EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred CCCCceE--EEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCc
Confidence 4577888 999999999999999999999999999998654332 2456778888867778999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcC-----CCceEEEeecccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTK-----DNNIKLCDFGISR 159 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~-----~~~~~l~df~~~~ 159 (253)
.++|||++ +++|.+++... ..++...+..++.|++.++++||++|++||||||+||+++. ++.++|+|||+++
T Consensus 76 ~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 76 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred cEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99999998 67998888664 46999999999999999999999999999999999999974 5789999999998
Q ss_pred ccccc--------ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHhhccc-c
Q psy12709 160 VVNDV--------VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNK---QETFLNISQCN-F 227 (253)
Q Consensus 160 ~~~~~--------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~i~~~~-~ 227 (253)
..... .......|++.|+|||++.+..+++++||||||+++|+|++|+.||.+... ......+.... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 65432 122345689999999999999999999999999999999999999976433 33333333322 2
Q ss_pred cccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 228 SFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 228 ~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.++......+|+++.+++..|++.+|
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~ 260 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAF 260 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCT
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCc
Confidence 23344556889999999999999876
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-48 Score=313.56 Aligned_cols=235 Identities=24% Similarity=0.308 Sum_probs=193.7
Q ss_pred eeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC------Ce
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP------HE 85 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~------~~ 85 (253)
+|..++.||+|+||+||+|.+..+++.||||++.+..... .+|+.+++ .++|+||+++++++... ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~------~~Ei~il~-~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NRELQIMR-KLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSC------CHHHHHHH-HCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHH------HHHHHHHH-hcCCCCCCcEEEEEEecCccCCceE
Confidence 4559999999999999999999999999999997654322 36888887 67999999999998542 35
Q ss_pred EEEEEeccCCCcHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-ceEEEeecccccc
Q psy12709 86 MVLVLEMVPDGELQRLV---DIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN-NIKLCDFGISRVV 161 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~-~~~l~df~~~~~~ 161 (253)
+++||||++++.+..+. .....+++..++.++.|++.|++|||++||+||||||+||+++.++ .+||+|||++...
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 89999999876544433 3456799999999999999999999999999999999999999775 8999999999877
Q ss_pred cccccccccccCccccCccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccc-----------
Q psy12709 162 NDVVEVKEIIGTPDYVAPEVLSY-EPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSF----------- 229 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----------- 229 (253)
..........+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||...+..+.+..+.....++
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 65555556678999999998765 568999999999999999999999999988877776654321111
Q ss_pred --------------cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 --------------HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 --------------~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.....+..|+++.+||.+||+.||
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP 291 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSG
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCCh
Confidence 011224679999999999999998
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-48 Score=308.74 Aligned_cols=239 Identities=23% Similarity=0.374 Sum_probs=201.9
Q ss_pred eeEEEeecCCCCceEEEEEEec-----cCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHK-----ITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
+|++.+.||+|+||.||+|... .+++.||+|.++.... ......+.+|+..+.++.+||||+++++++..++.+
T Consensus 24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC-HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 4449999999999999999863 4567899999986543 445668889999999777899999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC
Q psy12709 87 VLVLEMVPDGELQRLVDIQD------------------GIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN 148 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~~------------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~ 148 (253)
+++|||+++++|.+++.... .+++..+..++.|++.|++|||+++++||||+|+||+++.++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~ 182 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR 182 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC
Confidence 99999999999999986532 489999999999999999999999999999999999999999
Q ss_pred ceEEEeeccccccccc---ccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhc
Q psy12709 149 NIKLCDFGISRVVNDV---VEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLS-SHSPFAGDNKQETFLNISQ 224 (253)
Q Consensus 149 ~~~l~df~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~ 224 (253)
.++++|||.++..... .......+++.|+|||.+.+..++.++||||+|+++|+|++ |.+||...+..+.+..+..
T Consensus 183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~ 262 (311)
T d1t46a_ 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262 (311)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH
T ss_pred cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 9999999999865432 22233567899999999999999999999999999999998 7777877776666555544
Q ss_pred ccccccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 225 CNFSFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 225 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
....+.. ....|+++.+||.+||+.||
T Consensus 263 ~~~~~~~--~~~~~~~l~~Li~~cl~~dP 289 (311)
T d1t46a_ 263 EGFRMLS--PEHAPAEMYDIMKTCWDADP 289 (311)
T ss_dssp HTCCCCC--CTTSCHHHHHHHHHHTCSSG
T ss_pred cCCCCCC--cccccHHHHHHHHHHcCCCh
Confidence 4333332 24689999999999999998
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=303.78 Aligned_cols=241 Identities=24% Similarity=0.373 Sum_probs=205.8
Q ss_pred ceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEE
Q psy12709 10 GYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLV 89 (253)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 89 (253)
+|+ +++.||+|+||+||+|.+..+++.||+|+++...........+.+|+..++ ..+|+||+++++++...+..+++
T Consensus 3 ry~--~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~-~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 3 KYE--KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK-ELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp SEE--EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCE--eeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHH-hcCcCCEEeeccccccccceeEE
Confidence 556 999999999999999999999999999999877666667788999999998 78999999999999999999999
Q ss_pred EeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccccc-cccc
Q psy12709 90 LEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVNDV-VEVK 168 (253)
Q Consensus 90 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~~~-~~~~ 168 (253)
++++.++++..++.....+++..++.++.|++.|++|||++|++|+||||+||+++.++.++++|||.+...... ....
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence 999999999998888888999999999999999999999999999999999999999999999999999866543 2333
Q ss_pred ccccCccccCccccCCCC-CCccccHHHHHHHHHHHHhCCCCC-CCCChHHHHHHhhcccccc-----------------
Q psy12709 169 EIIGTPDYVAPEVLSYEP-ISLATDMWSVGVLAYVLLSSHSPF-AGDNKQETFLNISQCNFSF----------------- 229 (253)
Q Consensus 169 ~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~-~~~~~~~~~~~i~~~~~~~----------------- 229 (253)
...+++.|.|||.+.+.. ++.++||||+||++|+|++|+.|| .+.+..+....+......+
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence 445678999999987665 689999999999999999999885 5555555555543322211
Q ss_pred --------cCCccCCCCHHHHHHHHHhcccCC
Q psy12709 230 --------HEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 230 --------~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.......+++++.+||.+||+.||
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP 271 (292)
T d1unla_ 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNP 271 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSG
T ss_pred ccccccchhhhccccCCHHHHHHHHHHccCCh
Confidence 122335678999999999999998
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=313.78 Aligned_cols=244 Identities=23% Similarity=0.310 Sum_probs=193.1
Q ss_pred cceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe-
Q psy12709 4 KFFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET- 82 (253)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~- 82 (253)
.|.+.++|+ +++.||+|+||+||+|.+..+|..||+|++.+..........+.+|+..++ .++||||+++++++..
T Consensus 12 ~f~i~~~Y~--i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~~~~~f~~~ 88 (355)
T d2b1pa1 12 TFTVLKRYQ--NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQ 88 (355)
T ss_dssp EEEEETTEE--EEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHH-HCCCTTBCCCSEEECSC
T ss_pred ceeecCCeE--EEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHH-hcCCCCeeEEEEEEecc
Confidence 344557777 999999999999999999999999999999887766666778999999998 6799999999999964
Q ss_pred -----CCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeecc
Q psy12709 83 -----PHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGI 157 (253)
Q Consensus 83 -----~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~ 157 (253)
...+|+||||+.++.+..+ ...+++..++.++.|++.|+.|||++|++|+||||+||+++.++.++++|||.
T Consensus 89 ~~~~~~~~~~iv~Ey~~~~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 89 KTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp CSTTTCCEEEEEEECCSEEHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred cccccCceeEEEEeccchHHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhh
Confidence 3689999999977655544 34589999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccCC-----
Q psy12709 158 SRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHED----- 232 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~----- 232 (253)
+.............+++.|+|||++.+..++.++||||+||++++|++|+.||.+.+.......+......+..+
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred hhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 887766656666678999999999999999999999999999999999999999887776665543322211100
Q ss_pred ---------------------------------ccCCCCHHHHHHHHHhcccCC
Q psy12709 233 ---------------------------------LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 ---------------------------------~~~~~~~~l~~li~~~l~~dP 253 (253)
.....|+++.+||++||++||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP 299 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSST
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCCh
Confidence 001246789999999999998
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-48 Score=313.81 Aligned_cols=240 Identities=25% Similarity=0.396 Sum_probs=199.8
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC----
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP---- 83 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~---- 83 (253)
.++|+ +++.||+|+||+||+|.+..+|+.||+|++.+..........+.+|+.+++ .++|+||+++++++...
T Consensus 17 ~~rY~--i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~-~l~h~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 17 PERYQ--NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK-HMKHENVIGLLDVFTPARSLE 93 (348)
T ss_dssp ETTEE--EEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHH-HCCCTTBCCCSEEECSCSSTT
T ss_pred CCCeE--EEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHH-hcCCCCeeeEEEEEeeccccc
Confidence 56777 999999999999999999999999999999987777777788999999998 77999999999998643
Q ss_pred -CeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccccc
Q psy12709 84 -HEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRVVN 162 (253)
Q Consensus 84 -~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~~~ 162 (253)
...+++++++.|++|.+++. ...+++..++.++.|++.||+|||++|++||||||+||+++.+|.++++|||.+....
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred cCceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence 23455566677999999986 4569999999999999999999999999999999999999999999999999987654
Q ss_pred ccccccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcccccccC----------
Q psy12709 163 DVVEVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQETFLNISQCNFSFHE---------- 231 (253)
Q Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------- 231 (253)
. ......+++.|+|||...+. .++.++||||+|+++|+|++|+.||.+.+.......+......+..
T Consensus 173 ~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 173 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp G--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred c--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 3 23345688999999987665 4688999999999999999999999998887777766544332221
Q ss_pred -----------------CccCCCCHHHHHHHHHhcccCC
Q psy12709 232 -----------------DLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 232 -----------------~~~~~~~~~l~~li~~~l~~dP 253 (253)
.....+|+++++||.+||+.||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP 289 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 289 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSG
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCCh
Confidence 1224689999999999999998
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=305.82 Aligned_cols=237 Identities=18% Similarity=0.317 Sum_probs=204.2
Q ss_pred eeEEEeecCCCCceEEEEEEecc-----CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeE
Q psy12709 12 QTLIFCMPSRGKFASVRKCTHKI-----TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEM 86 (253)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 86 (253)
+|++.+.||+|+||+||+|.+.. ++..||||+++... .......+.+|+..+. .+.||||+++++++..++..
T Consensus 21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~-~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMK-EFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGG-GCCCTTBCCEEEEECSSSSC
T ss_pred HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHH-HcCCCCEeeeeeEEecCCce
Confidence 34499999999999999999863 35789999997543 3455667889999998 77899999999999999999
Q ss_pred EEEEeccCCCcHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeec
Q psy12709 87 VLVLEMVPDGELQRLVDIQ----------DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFG 156 (253)
Q Consensus 87 ~lv~e~~~g~~L~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~ 156 (253)
++||||+++|+|.+++... ..++...+..++.+++.|+.|||+++++||||+|+||+++.++.+||+|||
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFG 178 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 178 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecc
Confidence 9999999999999987532 236889999999999999999999999999999999999999999999999
Q ss_pred ccccccccc---cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhhcccccccCC
Q psy12709 157 ISRVVNDVV---EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSS-HSPFAGDNKQETFLNISQCNFSFHED 232 (253)
Q Consensus 157 ~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~i~~~~~~~~~~ 232 (253)
++....... ......+++.|+|||.+.+..++.++||||+|+++|+|++| +.||.+.+..+.+..+..+......
T Consensus 179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p- 257 (308)
T d1p4oa_ 179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP- 257 (308)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCC-
T ss_pred cceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCc-
Confidence 998654322 22334578999999999999999999999999999999997 6899999999999888776654333
Q ss_pred ccCCCCHHHHHHHHHhcccCC
Q psy12709 233 LFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 233 ~~~~~~~~l~~li~~~l~~dP 253 (253)
..+|+++.++|.+||+.||
T Consensus 258 --~~~~~~l~~li~~cl~~~P 276 (308)
T d1p4oa_ 258 --DNCPDMLFELMRMCWQYNP 276 (308)
T ss_dssp --TTCCHHHHHHHHHHTCSSG
T ss_pred --ccchHHHHHHHHHHcCCCh
Confidence 4789999999999999998
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=301.58 Aligned_cols=243 Identities=18% Similarity=0.267 Sum_probs=195.6
Q ss_pred eeecceeeEEEeecCCCCceEEEEEEeccCC---ceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q psy12709 6 FVNGGYQTLIFCMPSRGKFASVRKCTHKITK---VEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYET 82 (253)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 82 (253)
+..+..++++.+.||+|+||+||+|.+..++ ..||||.+++. ......+++.+|+..+. .++||||+++++++..
T Consensus 22 ~~~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~-~l~HpnIv~~~g~~~~ 99 (311)
T d1r0pa_ 22 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMK-DFSHPNVLSLLGICLR 99 (311)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHH-TCCCTTBCCCCEEEEE
T ss_pred eChHHceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHH-hCCCCCEeEEeEEEEe
Confidence 3345555556789999999999999987543 35899998753 34555678999999998 7799999999999765
Q ss_pred -CCeEEEEEeccCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 83 -PHEMVLVLEMVPDGELQRLVDIQ-DGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 83 -~~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
+...++||||+++++|.+++... ...+...++.++.|++.|+.|+|+.+++||||+|+||+++.++.+||+|||++..
T Consensus 100 ~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 100 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 179 (311)
T ss_dssp TTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred cCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhh
Confidence 45899999999999999988754 4578889999999999999999999999999999999999999999999999986
Q ss_pred ccccc-----cccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhcccccccCCcc
Q psy12709 161 VNDVV-----EVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAG-DNKQETFLNISQCNFSFHEDLF 234 (253)
Q Consensus 161 ~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~~~ 234 (253)
..... ......+++.|+|||.+.+..++.++||||+|+++|||++|..||.. .+..+....+..+......
T Consensus 180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p--- 256 (311)
T d1r0pa_ 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--- 256 (311)
T ss_dssp TTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCC---
T ss_pred ccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCc---
Confidence 54322 12224578899999999989999999999999999999997766654 4454555566655443322
Q ss_pred CCCCHHHHHHHHHhcccCC
Q psy12709 235 GHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP 253 (253)
..+++++.+||.+||+.||
T Consensus 257 ~~~~~~l~~li~~cl~~dP 275 (311)
T d1r0pa_ 257 EYCPDPLYEVMLKCWHPKA 275 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSG
T ss_pred ccCcHHHHHHHHHHcCCCH
Confidence 4789999999999999998
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-46 Score=304.96 Aligned_cols=236 Identities=24% Similarity=0.425 Sum_probs=193.1
Q ss_pred ecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeC--Ce
Q psy12709 8 NGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETP--HE 85 (253)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~ 85 (253)
.++|+ +++.||+|+||+||+|.+..+++.||+|+++... ...+.+|+..+..+..|+||+++++++... ..
T Consensus 34 ~d~y~--i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 34 QDDYQ--LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp GGGEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CcCeE--EEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 45566 9999999999999999999999999999987532 346788999998777899999999999854 47
Q ss_pred EEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCC-ceEEEeeccccccccc
Q psy12709 86 MVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDN-NIKLCDFGISRVVNDV 164 (253)
Q Consensus 86 ~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~-~~~l~df~~~~~~~~~ 164 (253)
+++||||+++++|.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||.+......
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999999997763 4599999999999999999999999999999999999999765 5999999999877665
Q ss_pred ccccccccCccccCccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhccc-------------c--
Q psy12709 165 VEVKEIIGTPDYVAPEVLSYE-PISLATDMWSVGVLAYVLLSSHSPFAGDNKQ-ETFLNISQCN-------------F-- 227 (253)
Q Consensus 165 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~i~~~~-------------~-- 227 (253)
.......+++.|+|||.+.+. .++.++|+||+||+++++++|+.||...... +....+.... .
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 555666789999999997665 4789999999999999999999999764432 2222221100 0
Q ss_pred ------------------cccCCccCCCCHHHHHHHHHhcccCC
Q psy12709 228 ------------------SFHEDLFGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 228 ------------------~~~~~~~~~~~~~l~~li~~~l~~dP 253 (253)
.........+|+++.+||++||+.||
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP 307 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 307 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSG
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCCh
Confidence 01111223578999999999999998
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=288.66 Aligned_cols=234 Identities=18% Similarity=0.219 Sum_probs=176.6
Q ss_pred eEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCC----eEEE
Q psy12709 13 TLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPH----EMVL 88 (253)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----~~~l 88 (253)
|.+.+.||+|+||+||+|.. +|..||||++..... .....+.|+..+. ..+||||+++++++..++ .+++
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~---~~~~~e~ei~~~~-~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTV-MLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHTST-TCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch---hHHHHHHHHHHHh-hCCCCcCcceEEEEEeCCCcceEEEE
Confidence 44999999999999999986 588999999865322 1122233444443 568999999999997654 6899
Q ss_pred EEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 89 VLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHD--------HNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 89 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--------~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
||||+++++|.+++... ++++...+.++.+++.++.|+|+ +|++|+||+|+||+++.++.+||+|||++..
T Consensus 79 v~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 99999999999999754 58999999999999999999996 5999999999999999999999999999986
Q ss_pred ccccc-----cccccccCccccCccccCCCC------CCccccHHHHHHHHHHHHhCCCCCCCC---------------C
Q psy12709 161 VNDVV-----EVKEIIGTPDYVAPEVLSYEP------ISLATDMWSVGVLAYVLLSSHSPFAGD---------------N 214 (253)
Q Consensus 161 ~~~~~-----~~~~~~~~~~~~~PE~~~~~~------~~~~~Di~slG~~l~~l~~g~~p~~~~---------------~ 214 (253)
..... ......+++.|+|||++.+.. ++.++||||+|+++|+|++|..||... .
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 54322 223457899999999986643 567899999999999999998876321 1
Q ss_pred hHHHHHHhhccccccc--CCc-cCCCCHHHHHHHHHhcccCC
Q psy12709 215 KQETFLNISQCNFSFH--EDL-FGHISSQAKDFIQSCLVTDP 253 (253)
Q Consensus 215 ~~~~~~~i~~~~~~~~--~~~-~~~~~~~l~~li~~~l~~dP 253 (253)
.......+......+. ... ....+..+.+|+.+||+.||
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp 279 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 279 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSG
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCH
Confidence 1222222222222211 111 11234569999999999998
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.7e-40 Score=268.08 Aligned_cols=202 Identities=25% Similarity=0.403 Sum_probs=159.5
Q ss_pred ceeecceeeEEEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhc----------CCCCce
Q psy12709 5 FFVNGGYQTLIFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQ----------KSERIV 74 (253)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~----------~~~~i~ 74 (253)
.+-+++|+ +++.||+|+||+||+|.+..+|..||||++.+... ......+|+..++... .|+||+
T Consensus 9 ~~~~~rY~--i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~---~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv 83 (362)
T d1q8ya_ 9 PYKDARYI--LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 83 (362)
T ss_dssp EETTTTEE--EEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CccCCcEE--EEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc---chHHHHHHHHHHHHhcchhhhhhhhcCcCceE
Confidence 34455677 99999999999999999999999999999986532 2345666777665432 468999
Q ss_pred eeeeEEEeC--CeEEEEEeccCCCc-HHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEcCCC
Q psy12709 75 GLHEIYETP--HEMVLVLEMVPDGE-LQRLVD--IQDGIPEQDTRSYMKQILEALAFLHD-HNITHLDLKPQNILLTKDN 148 (253)
Q Consensus 75 ~~~~~~~~~--~~~~lv~e~~~g~~-L~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~di~~~ni~~~~~~ 148 (253)
++++++... ...++++.++.... ...... ....+++..++.++.|++.|+.|||+ .|++||||||+||+++.++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~ 163 (362)
T d1q8ya_ 84 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 163 (362)
T ss_dssp CCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred EEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccC
Confidence 999998653 45556655554433 222222 24568999999999999999999998 8999999999999998765
Q ss_pred c------eEEEeecccccccccccccccccCccccCccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Q psy12709 149 N------IKLCDFGISRVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGVLAYVLLSSHSPFAGD 213 (253)
Q Consensus 149 ~------~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 213 (253)
. ++++|||.+..... ......+++.|+|||++.+..++.++|+||+|+++++|++|+.||...
T Consensus 164 ~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 164 SPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp TTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 4 99999999876543 234457899999999999999999999999999999999999999754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=2e-25 Score=165.86 Aligned_cols=168 Identities=19% Similarity=0.163 Sum_probs=116.4
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccc----------------hHHHHHHHHHHHHHHHhcCCCCceeeee
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRS----------------MDQMQDILHEAAVLYLAQKSERIVGLHE 78 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~----------------~~~~~~~~~e~~~~~~~~~~~~i~~~~~ 78 (253)
+.+.||+|+||+||+|.+. +|+.||+|+++..... .........|...+. ...+.+++..++
T Consensus 4 vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~v~~~~~ 81 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ-KLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHH-HTTTSSSCCEEE
T ss_pred hCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHH-HccCCCcceEEE
Confidence 7899999999999999885 7889999987532111 111233445666666 667888888776
Q ss_pred EEEeCCeEEEEEeccCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEcCCCceEEEeeccc
Q psy12709 79 IYETPHEMVLVLEMVPDGELQRLVDIQDGIPEQDTRSYMKQILEALAFLHDHNITHLDLKPQNILLTKDNNIKLCDFGIS 158 (253)
Q Consensus 79 ~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~di~~~ni~~~~~~~~~l~df~~~ 158 (253)
... .+++||++++..+.. ++...+..++.|++.++.+||++|++|+||||+||+++++ .++|+|||.+
T Consensus 82 ~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a 149 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQS 149 (191)
T ss_dssp EET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTC
T ss_pred ecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCc
Confidence 532 379999998865543 3445567899999999999999999999999999999965 4889999998
Q ss_pred ccccccccccccccCccccCccccCCCCCCccccHHHHHH
Q psy12709 159 RVVNDVVEVKEIIGTPDYVAPEVLSYEPISLATDMWSVGV 198 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~ 198 (253)
.....+........+... -.+.+ ...+..++|+||+.-
T Consensus 150 ~~~~~~~~~~~l~rd~~~-~~~~f-~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 150 VEVGEEGWREILERDVRN-IITYF-SRTYRTEKDINSAID 187 (191)
T ss_dssp EETTSTTHHHHHHHHHHH-HHHHH-HHHHCCCCCHHHHHH
T ss_pred ccCCCCCcHHHHHHHHHH-HHHHH-cCCCCCcccHHHHHH
Confidence 765433221100000000 00111 245778899999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.75 E-value=1.1e-07 Score=72.14 Aligned_cols=136 Identities=13% Similarity=0.072 Sum_probs=89.1
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEEEEEeccC
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
..+..+.++.+.||+... ++..+++|......... ...+.+|...+..+..+--+.+++.+...++..++||++++
T Consensus 18 ~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~ 93 (263)
T d1j7la_ 18 CVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp EEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred EEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecc
Confidence 666666666689998863 46667888876543222 22456677777645444446788888888899999999999
Q ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q psy12709 95 DGELQRLVDIQDGIPEQDTRSYMKQILEALAFLH---------------------------------------------- 128 (253)
Q Consensus 95 g~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---------------------------------------------- 128 (253)
|.++.+..... ... ..++.++...+..||
T Consensus 94 G~~~~~~~~~~--~~~---~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T d1j7la_ 94 GVLCSEEYEDE--QSP---EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp SEEHHHHTTTC--SCH---HHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHH
T ss_pred ccccccccccc--ccH---HHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHH
Confidence 98886543211 111 112222333333333
Q ss_pred -------H------CCceecCCCCCCEEEcCCCceEEEeecccc
Q psy12709 129 -------D------HNITHLDLKPQNILLTKDNNIKLCDFGISR 159 (253)
Q Consensus 129 -------~------~~~~h~di~~~ni~~~~~~~~~l~df~~~~ 159 (253)
+ ..++|+|+.+.||++++++.+.++||+.+.
T Consensus 169 ~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 127899999999999977667799998774
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.49 E-value=5.9e-07 Score=72.33 Aligned_cols=82 Identities=10% Similarity=-0.040 Sum_probs=50.5
Q ss_pred EEeecCCCCceEEEEEEeccCCceEEEEEeccccc-----chHHHHHHHHHHHHHHHhcCC--CCceeeeeEEEeCCeEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKITKVEYAAKFIRKRRR-----SMDQMQDILHEAAVLYLAQKS--ERIVGLHEIYETPHEMV 87 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~~~e~~~~~~~~~~--~~i~~~~~~~~~~~~~~ 87 (253)
..+.+|.|....||++.+..+++.+++|....... ......+...|...+.....+ ..+++++.+ +++..+
T Consensus 30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~ 107 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 107 (392)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred eEEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence 35679999999999999887888999997543211 111223455677766655544 335555544 445668
Q ss_pred EEEeccCCCcH
Q psy12709 88 LVLEMVPDGEL 98 (253)
Q Consensus 88 lv~e~~~g~~L 98 (253)
++||++++..+
T Consensus 108 lvmE~L~~~~~ 118 (392)
T d2pula1 108 TVMEDLSHLKI 118 (392)
T ss_dssp EEECCCTTSEE
T ss_pred EEEeccCCccc
Confidence 89999977543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.20 E-value=1.1e-05 Score=60.49 Aligned_cols=77 Identities=17% Similarity=0.110 Sum_probs=51.5
Q ss_pred eecCCCCc-eEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCC-CceeeeeEEEeCCeEEEEEeccC
Q psy12709 17 CMPSRGKF-ASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSE-RIVGLHEIYETPHEMVLVLEMVP 94 (253)
Q Consensus 17 ~~lg~g~~-~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~-~i~~~~~~~~~~~~~~lv~e~~~ 94 (253)
+.+..|.. +.||+.... ++..+++|..+..... .+..|...++.+..+. .+.+++....+++..+++|++++
T Consensus 16 ~~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~~-----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGALN-----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp EECSCTTSSCEEEEEECT-TSCCEEEEEECSCTTS-----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EEcCCcccCCeEEEEEeC-CCCEEEEEeCCccCHh-----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 35555554 688998754 5667899987654322 3455555555333332 26778888888889999999999
Q ss_pred CCcHH
Q psy12709 95 DGELQ 99 (253)
Q Consensus 95 g~~L~ 99 (253)
|.++.
T Consensus 90 G~~~~ 94 (255)
T d1nd4a_ 90 GQDLL 94 (255)
T ss_dssp SEETT
T ss_pred ccccc
Confidence 87763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.70 E-value=0.00014 Score=58.18 Aligned_cols=76 Identities=12% Similarity=0.074 Sum_probs=55.3
Q ss_pred EEeecCCCCceEEEEEEecc-------CCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCCceeeeeEEEeCCeEE
Q psy12709 15 IFCMPSRGKFASVRKCTHKI-------TKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSERIVGLHEIYETPHEMV 87 (253)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 87 (253)
-++.|+.|-.-.+|++.... .++.|++++...... .....+|...++.+..+.-.++++.++.. .
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~----~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET----ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch----hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 45788999999999998653 346788888774332 23566788888866666556788887764 5
Q ss_pred EEEeccCCCcH
Q psy12709 88 LVLEMVPDGEL 98 (253)
Q Consensus 88 lv~e~~~g~~L 98 (253)
.|++|++|.++
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 88999988655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.00 E-value=0.0049 Score=47.10 Aligned_cols=31 Identities=26% Similarity=0.319 Sum_probs=27.5
Q ss_pred CCceecCCCCCCEEEcCCCceEEEeeccccc
Q psy12709 130 HNITHLDLKPQNILLTKDNNIKLCDFGISRV 160 (253)
Q Consensus 130 ~~~~h~di~~~ni~~~~~~~~~l~df~~~~~ 160 (253)
.|++|+|+.++|++++.+...-++||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999887778999998863
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.98 E-value=0.0083 Score=46.08 Aligned_cols=73 Identities=16% Similarity=0.185 Sum_probs=43.8
Q ss_pred CCceEEEEEEeccCCceEEEEEecccccchHHHHHHHHHHHHHHHhcCCCC-ceeee-----eEEEeCCeEEEEEeccCC
Q psy12709 22 GKFASVRKCTHKITKVEYAAKFIRKRRRSMDQMQDILHEAAVLYLAQKSER-IVGLH-----EIYETPHEMVLVLEMVPD 95 (253)
Q Consensus 22 g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~-i~~~~-----~~~~~~~~~~lv~e~~~g 95 (253)
+..-.||++... +|..|++|+.+....+.+ .+..|...+..+..+.- ++.+. ..+..++..+.++++++|
T Consensus 33 s~EN~vy~v~~~-dg~~~VlK~~rp~~~s~~---~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQDE-DRRRFVVKFYRPERWTAD---QILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECCT-TCCCEEEEEECTTTSCHH---HHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cccceeEEEEcC-CCCEEEEEEeCCCCCCHH---HHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 334689999764 788899999876544443 45556655543332211 11111 223456678899999987
Q ss_pred CcH
Q psy12709 96 GEL 98 (253)
Q Consensus 96 ~~L 98 (253)
..+
T Consensus 109 ~~~ 111 (325)
T d1zyla1 109 RQF 111 (325)
T ss_dssp EEC
T ss_pred cCC
Confidence 543
|